PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Arteaga, A; Pyron, RA; Penafiel, N; Romero-Barreto, P; Culebras, J; Bustamante, L; Yanez-Munoz, MH; Guayasamin, JM				Arteaga, Alejandro; Alexander Pyron, R.; Penafiel, Nicolas; Romero-Barreto, Paulina; Culebras, Jaime; Bustamante, Lucas; Yanez-Munoz, Mario H.; Guayasamin, Juan M.			Comparative Phylogeography Reveals Cryptic Diversity and Repeated Patterns of Cladogenesis for Amphibians and Reptiles in Northwestern Ecuador	PLOS ONE			English	Article							VIPERIDAE BOTHROPS-ASPER; PITVIPERS SERPENTES; MOLECULAR PHYLOGENY; HABITAT SELECTION; CLIMATIC ZONATION; SPECIES RICHNESS; MOUNTAIN PASSES; RAIN-FOREST; SPECIATION; DIVERSIFICATION	Comparative phylogeography allow us to understand how shared historical circumstances have shaped the formation of lineages, by examining a broad spectrum of co-distributed populations of different taxa. However, these types of studies are scarce in the Neotropics, a region that is characterized by high diversity, complex geology, and poorly understood biogeography. Here, we investigate the diversification patterns of five lineages of amphibians and reptiles, co-distributed across the Choco and Andes ecoregions in northwestern Ecuador. Mitochondrial DNA and occurrence records were used to determine the degree of geographic genetic divergence within species. Our results highlight congruent patterns of parapatric speciation and common geographical barriers for distantly related taxa. These comparisons indicate similar biological and demographic characteristics for the included clades, and reveal the existence of two new species of Pristimantis previously subsumed under P. walkeri, which we describe herein. Our data supports the hypothesis that widely distributed Chocoan taxa may generally experience their greatest opportunities for isolation and parapatric speciation across thermal elevational gradients. Finally, our study provides critical information to predict which unstudied lineages may harbor cryptic diversity, and how geology and climate are likely to have shaped their evolutionary history.	[Arteaga, Alejandro; Romero-Barreto, Paulina; Bustamante, Lucas] Trop Herping, Quito, Ecuador; [Arteaga, Alejandro; Penafiel, Nicolas; Culebras, Jaime; Bustamante, Lucas; Guayasamin, Juan M.] Univ Tecnol Indoamer, Ctr Invest Biodiversidad & Cambio Climat BioCamb, Ingn Biodiversidad & Recursos Genet, Fac Ciencias Medio Ambiente, Quito, Ecuador; [Alexander Pyron, R.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Romero-Barreto, Paulina] Fdn EcoCiencia, Programa Conservac Especies & Ecosistemas Amenaza, Quito, Ecuador; [Yanez-Munoz, Mario H.] Museo Ecuatoriano Ciencias Nat, Div Herpetol, Quito, Ecuador	George Washington University	Arteaga, A (corresponding author), Trop Herping, Quito, Ecuador.; Arteaga, A (corresponding author), Univ Tecnol Indoamer, Ctr Invest Biodiversidad & Cambio Climat BioCamb, Ingn Biodiversidad & Recursos Genet, Fac Ciencias Medio Ambiente, Quito, Ecuador.	alejandro@tropicalherping.com	Arteaga, Alejandro/AAL-3432-2020; Pyron, Robert/F-1681-2014	Arteaga, Alejandro/0000-0002-0014-3728; Culebras, Jaime/0000-0003-2211-6605; Guayasamin, Juan/0000-0003-0098-978X; Pyron, Robert/0000-0003-2524-1794	EcoCiencia; Universidad Tecnologica Indoamerica; George Washington University; US NSF [DBI-0905765, DEB-1441719, DEB-114179, DEB-1046408, DEB-1045960, DEB-1045991]; Tropical Herping; U.S. National Science Foundation; Programa de Becas de Investigacion para la Conservacion de la Biodiversidad; Direct For Biological Sciences [1045960] Funding Source: National Science Foundation	EcoCiencia; Universidad Tecnologica Indoamerica; George Washington University; US NSF(National Science Foundation (NSF)); Tropical Herping; U.S. National Science Foundation(National Science Foundation (NSF)); Programa de Becas de Investigacion para la Conservacion de la Biodiversidad; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Fieldwork was funded by: (1) EcoCiencia through a grant given to AA; (2) Universidad Tecnologica Indoamerica (www.uti.edu.ec), through a grant given to JMG; (3) The George Washington University (www.gwu.edu), through a grant given to RAP; and (4) US NSF (www.nsf.gov) grants to RAP (DBI-0905765 & DEB-1441719) and to JMG (DEB-114179, DBI-0905765; Dimensions of Biodiversity grant, DEB-1046408, DEB-1045960 and DEB-1045991). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Tropical Herping provided support in the form of salaries for authors AA, LB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This article was greatly improved by comments of two anonymous reviewers. For granting access to their protected forests, we are grateful to Fundacion Jocotoco, Reserva Itapoa and Reserva de Biodiversidad Mashpi. Special thanks to Paolo Escobar, Daniel Mideros, Angela Leon, Rita Hidalgo, Diana Troya, Carlos Morochz, Silvia Cevallos, Paulina Romero, Chelsea Carson, Javier Aznar, Jose Vieira, Daniel Romero and Rossana Romo for their assistance and companionship in the field. For granting access to specimens under his care, we are grateful to Jorge Valencia. Fieldwork was made possible with the support of the Programa de Becas de Investigacion para la Conservacion de la Biodiversidad. Laboratoy work was carried out at Universidad Tecnologica Indoamerica in Quito. Sequencing was made possible with support of the George Washington University, and the U.S. National Science Foundation.	Almendariz A, 2007, LISTA ACTUALIZADA AN; Amaral A., 1923, Proceedings of the New England Zoological Club, V8, P85; [Anonymous], 2009, TERRESTRIAL BREEDING; [Anonymous], 2011, ECOLOGICAL NICHES GE; [Anonymous], 1999, SNAKE SPECIES WORLD; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Arteaga A, 2013, AMPHIBIANS REPTILES; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Brumfield RT, 2007, EVOLUTION, V61, P346, DOI 10.1111/j.1558-5646.2007.00039.x; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Burbrink FT, 2005, EVOLUTION, V54, P2107; Butantan-British IBothrops/I Systematics Project, 2002, P111; Campbell H.W., 1982, U S FISH AND WILDLIFE SERVICE WILDLIFE RESEARCH REPORT, V13, P193; Campbell J. A., 2004, VENOMOUS REPTILES W; Campbell J.A., 1992, OCCAS PAP MUS TEXAS, V153, P1; Carrasco PA, 2012, ZOOL SCR, V41, P109, DOI 10.1111/j.1463-6409.2011.00511.x; Coyne J.A., 2004, SPECIATION; Cadena CD, 2012, P ROY SOC B-BIOL SCI, V279, P194, DOI 10.1098/rspb.2011.0720; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darst CR, 2004, MOL PHYLOGENET EVOL, V31, P462, DOI 10.1016/j.ympev.2003.09.003; Daza JM, 2010, ECOGRAPHY, V33, P343, DOI 10.1111/j.1600-0587.2010.06281.x; De Fraga R, 2013, COPEIA, P684, DOI 10.1643/CE-11-098; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Drummond AJ, 2010, GENEIOUS V5 5 BIOMAT; DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elmer KR, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-59; Feldman CR, 2006, MOL ECOL, V15, P2201, DOI 10.1111/j.1365-294X.2006.02930.x; Fenker J, 2014, DIVERS DISTRIB, V20, P1108, DOI 10.1111/ddi.12217; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Freire-Lascano A., 1991, PUBLICACIONES TRABAJ, V2, P1; GARCIAR JC, 2012, PLOS ONE, V0007; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guayasamin Juan M., 2015, Neotropical Biodiversity, V1, P2, DOI 10.1080/23766808.2015.1074407; Guayasamin JM, 2015, ZOOL J LINN SOC-LOND, V173, P913, DOI 10.1111/zoj.12222; Hall JPW, 2005, P ROY SOC B-BIOL SCI, V272, P2457, DOI 10.1098/rspb.2005.3254; Hedges SB, 2008, ZOOTAXA, P1; Heinicke MP, 2007, P NATL ACAD SCI USA, V104, P10092, DOI 10.1073/pnas.0611051104; Hendry CR, 2014, J EVOLUTION BIOL, V27, P760, DOI 10.1111/jeb.12349; Hermelin-Vivien ML, 1989, VERTEBRATES COMPLEX; Heyer W.R., 1994, MEASURING MONITORING; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Hutter CR, 2013, ECOL LETT, V16, P1135, DOI 10.1111/ele.12148; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kessler Michael, 2008, P35; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kohler G, 2012, HERPETOL MONOGR, V26, P173, DOI 10.1655/HERPMONOGRAPHS-D-10-00011.1; Kozak KH, 2007, P ROY SOC B-BIOL SCI, V274, P2995, DOI 10.1098/rspb.2007.1106; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2007, BIOL LETTERS, V3, P646, DOI 10.1098/rsbl.2007.0368; Lehr E, 2008, HERPETOLOGICA, V64, P354, DOI 10.1655/07-089.1; Lopez AD, 1998, ESTUIDO DIVERSIDAD H; Lynch J.D., 1980, Breviora, P1; Lynch J.D., 1976, Occasional Papers Mus Nat Hist Univ Kans, VNo. 55, P1; LYNCH J D, 1980, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Lynch JD, 1997, U KANSAS NATURAL HIS, V23, P1, DOI DOI 10.5962/BHL.TITLE.7951; Lynch John D., 2005, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V29, P581; Lynch John D., 1994, Occasional Papers of the Museum of Natural History University of Kansas, V170, P1; Lynch RL, 2014, AMPHIB REPTILE CONSE, V8; MAE, 2012, LIN BAS DEF EC CONT; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, P3, DOI DOI 10.1007/978-3-642-20992-5_1; Miyata K., 1976, ANNOTATED CHECKLIST; Morales MA, 2004, DINAMICA POBLACIONAL; Morales-Mite MA, 2013, HERPETOFAUNA AREAS P; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Ortega-Andrade H. Mauricio, 2010, Check List, V6, P119; Ortega-Andrade HM, 2004, APROXIMACION CONOCIM; Padial JM, 2014, ZOOTAXA, V3825, P1, DOI 10.11646/zootaxa.3825.1.1; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; Pellegrino KCM, 2011, BIOL J LINN SOC, V74, P315; Peracca M.G., 1904, BOLLETTINO MUSEI ZOO, V19, P1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Price T, 2008, SPECIATION BIRDS; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Pyron RA, 2010, J BIOGEOGR, V37, P2005, DOI 10.1111/j.1365-2699.2010.02336.x; Pyron RA, 2013, P R SOC B; Rambaut A., 2003, TRACER VERSION 1 4 1; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ree RH, 2009, J BIOGEOGR, V36, P1211, DOI 10.1111/j.1365-2699.2008.02068.x; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Reyes A., 2008, INVENTARIO HERPETOFA; Ribas CC, 2007, P ROY SOC B-BIOL SCI, V274, P2399, DOI 10.1098/rspb.2007.0613; Rivera-Prieto DA, 2014, ZOOTAXA, V3900, P223, DOI 10.11646/zootaxa.3900.2.3; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Pinto-Sanchez NR, 2012, MOL PHYLOGENET EVOL, V62, P954, DOI 10.1016/j.ympev.2011.11.022; Rolland J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001775; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Savit Aaron Z., 2006, Iguana, V13, P94; SCHATTI B, 1993, REV SUISSE ZOOL, V100, P235, DOI 10.5962/bhl.part.79860; Sedano RE, 2010, J BIOGEOGR, V37, P325, DOI 10.1111/j.1365-2699.2009.02200.x; Sierra R, 1999, PROPUESTA PRELIMINAR; Smith BT, 2014, NATURE, V515, P406, DOI 10.1038/nature13687; Smith SA, 2007, EVOLUTION, V61, P1188, DOI 10.1111/j.1558-5646.2007.00085.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stephens PR, 2003, AM NAT, V161, P112, DOI 10.1086/345091; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Torres-Carvajal O, 2014, J BIOGEOGR, V41, P1883, DOI 10.1111/jbi.12375; Torres-Carvajal O, 2014, ZOOKEYS, P105, DOI 10.3897/zookeys.410.7401; Torres-Carvajal O, 2013, MOL PHYLOGENET EVOL, V68, P212, DOI 10.1016/j.ympev.2013.03.013; Valencia JH, 2011, GUIA ANFIBIOS REPTIL; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Wake D.B., 1976, NAT HIST MUS LOS ANG, V25, P1; Wasko DK, 2012, ZOOLOGY, V115, P179, DOI 10.1016/j.zool.2011.10.001; Wasko DK, 2010, HERPETOLOGICA, V66, P148, DOI 10.1655/08-064R2.1; Weir JT, 2011, MOL ECOL, V20, P4550, DOI 10.1111/j.1365-294X.2011.05294.x; Wiens JJ, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234625; Wiens JJ, 1999, EVOLUTION, V53, P1884, DOI 10.1111/j.1558-5646.1999.tb04570.x; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Yanez-Munoz M., 2005, EVALUACION CARACTERI; Yanez-Munoz M, 2004, CARACTERIZACION COMP; Yanez-Munoz MH, 2009, GUIA CAMPO PEQUENOS; Yanez-Munoz MH, 2013, B TECNICO, V11, P125; Zink RM, 2002, INTEGR COMP BIOL, V42, P953, DOI 10.1093/icb/42.5.953	122	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0151746	10.1371/journal.pone.0151746	http://dx.doi.org/10.1371/journal.pone.0151746			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120100	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200006
J	Lum, S; Bountziouka, V; Quanjer, P; Sonnappa, S; Wade, A; Beardsmore, C; Chhabra, SK; Chudasama, RK; Cook, DG; Harding, S; Kuehni, CE; Prasad, KVV; Whincup, PH; Lee, S; Stocks, J				Lum, Sooky; Bountziouka, Vassiliki; Quanjer, Philip; Sonnappa, Samatha; Wade, Angela; Beardsmore, Caroline; Chhabra, Sunil K.; Chudasama, Rajesh K.; Cook, Derek G.; Harding, Seeromanie; Kuehni, Claudia E.; Prasad, K. V. V.; Whincup, Peter H.; Lee, Simon; Stocks, Janet			Challenges in Collating Spirometry Reference Data for South-Asian Children: An Observational Study	PLOS ONE			English	Article							ADULT LUNG-FUNCTION; BODY-MASS INDEX; REFERENCE VALUES; REFERENCE EQUATIONS; ETHNIC-DIFFERENCES; PULMONARY-FUNCTION; FUNCTION TESTS; SOCIOECONOMIC-FACTORS; INDIAN CHILDREN; CHILDHOOD	Availability of sophisticated statistical modelling for developing robust reference equations has improved interpretation of lung function results. In 2012, the Global Lung function Initiative( GLI) published the first global all-age, multi-ethnic reference equations for spirometry but these lacked equations for those originating from the Indian subcontinent (South-Asians). The aims of this study were to assess the extent to which existing GLI-ethnic adjustments might fit South-Asian paediatric spirometry data, assess any similarities and discrepancies between South-Asian datasets and explore the feasibility of deriving a suitable South-Asian GLI-adjustment. Methods Spirometry datasets from South-Asian children were collated from four centres in India and five within the UK. Records with transcription errors, missing values for height or spirometry, and implausible values were excluded(n = 110). Results Following exclusions, cross-sectional data were available from 8,124 children (56.3% male; 5-17 years). When compared with GLI-predicted values from White Europeans, forced expired volume in 1s (FEV1) and forced vital capacity (FVC) in South-Asian children were on average 15% lower, ranging from 4-19% between centres. By contrast, proportional reductions in FEV1 and FVC within all but two datasets meant that the FEV1/FVC ratio remained independent of ethnicity. The 'GLI-Other' equation fitted data from North India reasonably well while 'GLI-Black' equations provided a better approximation for South-Asian data than the 'GLI-White' equation. However, marked discrepancies in the mean lung function z-scores between centres especially when examined according to socio-economic conditions precluded derivation of a single South-Asian GLI-adjustment. Conclusion Until improved and more robust prediction equations can be derived, we recommend the use of 'GLI-Black' equations for interpreting most South-Asian data, although 'GLI-Other' may be more appropriate for North Indian data. Prospective data collection using standardised protocols to explore potential sources of variation due to socio-economic circumstances, secular changes in growth/predictors of lung function and ethnicities within the South-Asian classification are urgently required.	[Lum, Sooky; Bountziouka, Vassiliki; Sonnappa, Samatha; Lee, Simon; Stocks, Janet] Inst Child Hlth, UCL, Resp Crit Care & Anaesthesia Sect, Portex Unit, London, England; [Quanjer, Philip] Erasmus Univ, Erasmus Med Ctr, Dept Pulm Dis, Rotterdam, Netherlands; [Quanjer, Philip] Erasmus Univ, Erasmus Med Ctr, Dept Paediat Pulm Dis, Rotterdam, Netherlands; [Sonnappa, Samatha] Rainbow Childrens Hosp, Dept Paediat Pulmonol, Bangalore, Karnataka, India; [Wade, Angela] Inst Child Hlth, Clin Epidemiol Nutr & Biostat Sect, UCL, London, England; [Beardsmore, Caroline] Univ Leicester, Inst Lung Hlth, NIHR Leicester Resp Biomed Res Unit, Leicester, Leics, England; [Beardsmore, Caroline] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Chhabra, Sunil K.] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Pulm Med, Delhi 110007, India; [Chudasama, Rajesh K.] PDU Med Coll, Dept Community Med, Rajkot, Gujarat, India; [Cook, Derek G.; Whincup, Peter H.] Univ London, Populat Hlth Res Inst, London, England; [Harding, Seeromanie] Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England; [Kuehni, Claudia E.] Univ Bern, Inst Social & Preventat Med, CH-3012 Bern, Switzerland; [Prasad, K. V. V.] Vemana Yoga Res Inst, Dept Physiol, Hyderabad, Andhra Pradesh, India	University of London; University College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; University of Leicester; University of Leicester; University of Delhi; University of London; University of London; King's College London; University of Bern	Lum, S (corresponding author), Inst Child Hlth, UCL, Resp Crit Care & Anaesthesia Sect, Portex Unit, London, England.	s.lum@ucl.ac.uk	Bountziouka, Vasiliki/I-6297-2018; Bountziouka, Vasiliki/S-6886-2019	Bountziouka, Vasiliki/0000-0003-2522-1582; Bountziouka, Vasiliki/0000-0003-2522-1582; Harding, Seeromanie/0000-0003-1964-6656; Kuehni, Claudia E./0000-0001-8957-2002; CHUDASAMA, RAJESH/0000-0003-1033-2060; Whincup, Peter/0000-0002-5589-4107; Cook, Derek/0000-0002-9723-5759	Wellcome Trust [WT094129MA, 068362/Z/02/Z]; Asthma UK [10/013, 07/048]; Indian Council of Medical Research; Swiss National Science Foundation [32003B-122341, 32003B_144068, PZ00P3_147987/1, PDFMP3_123162]; Medical Research Council [MC_U130015185/MC_UU_12017/1]; National Institute for Health Research (NIHR), through the Comprehensive Clinical Research Network; NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; MRC [MC_U130015185, MC_UU_12017/1, MR/N015959/1, MC_EX_G0701943] Funding Source: UKRI; Medical Research Council [MC_U130015185, MR/N015959/1, MC_EX_G0701943, MC_UU_12017/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Asthma UK; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR), through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust [WT094129MA (SLum); 068362/Z/02/Z(PHW)], Asthma UK [10/013(JS); 07/048(CEK)], Indian Council of Medical Research(SS), The Swiss National Science Foundation (CEK) [32003B-122341; 32003B_144068, PZ00P3_147987/1, PDFMP3_123162] and the Medical Research Council (SH) [MC_U130015185/MC_UU_12017/1]. The SLIC study team acknowledges the support of the National Institute for Health Research (NIHR), through the Comprehensive Clinical Research Network and the NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 1999, CHEST, V115, P869, DOI 10.1378/chest.115.3.869; Aggarwal AN, 2007, RESPIROLOGY, V12, P763, DOI 10.1111/j.1440-1843.2007.01123.x; Ali M, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-86; Barone-Adesi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142565; Budhiraja S, 2010, IRAN J PEDIATR, V20, P82; Burney PGJ, 2012, INT J EPIDEMIOL, V41, P782, DOI 10.1093/ije/dys011; Chhabra S K, 2014, Indian J Chest Dis Allied Sci, V56, P221; Chhabra S K, 2012, Indian J Chest Dis Allied Sci, V54, P59; Chhabra Sunil K, 2009, Indian J Chest Dis Allied Sci, V51, P7; Doctor TH, 2010, LUNG INDIA, V27, P145, DOI 10.4103/0970-2113.68317; Duong M, 2013, LANCET RESP MED, V1, P599, DOI 10.1016/S2213-2600(13)70164-4; Harik-Khan RI, 2001, AM J RESP CRIT CARE, V164, P1647, DOI 10.1164/ajrccm.164.9.2106075; Jackson B, 2004, INT J EPIDEMIOL, V33, P271, DOI 10.1093/ije/dyh003; Kelley EC, 1951, WORKSHOP WAY OF LEAR; Khadilkar VV, 2009, INDIAN PEDIATR, V46, P477; Khongsdier R, 2001, ANN HUM BIOL, V28, P374, DOI 10.1080/03014460010004610; Kirkby J, 2008, PEDIATR PULM, V43, P1233, DOI 10.1002/ppul.20950; Kirkby J, 2014, EUR RESPIR J, V44; Kuehni CE, 2015, EUR RESPIR J, V45, P1163, DOI 10.1183/09031936.00152114; Lawlor DA, 2004, THORAX, V59, P199, DOI 10.1136/thorax.2003.008482; Lum S, 2015, EUR RESPIR J, V46, P1662, DOI 10.1183/13993003.00415-2015; Lum S, 2015, EUR RESPIR J, V45, P1576, DOI 10.1183/09031936.00223814; Majumder PP, 1998, EVOL ANTHROPOL, V6, P100, DOI 10.1002/(SICI)1520-6505(1998)6:3<100::AID-EVAN4>3.0.CO;2-I; Memon Muhammad Asif, 2007, J Pak Med Assoc, V57, P193; Menezes AMB, 2015, EUR RESPIR J, V45, P1582, DOI 10.1183/09031936.00112114; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Prasad Rajendra, 2006, Indian J Chest Dis Allied Sci, V48, P103; Quanjer PH, 2011, EUR RESPIR J, V37, P658, DOI 10.1183/09031936.00110010; Quanjer PH, 2010, EUR RESPIR J, V36, P1391, DOI 10.1183/09031936.00164109; Quanjer PH, 2015, CHEST, V147, P792, DOI 10.1378/chest.14-1365; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Raju P. Sitarama, 2004, Indian Journal of Pediatrics, V71, P893; Raju P Sitarama, 2003, Indian Pediatr, V40, P705; Raju PS, 2005, PEDIATR PULM, V39, P528, DOI 10.1002/ppul.20206; SINGH SP, 1987, ANN HUM BIOL, V14, P169, DOI 10.1080/03014468700006892; Sonnappa S, 2015, AM J RESP CRIT CARE, V191, P79, DOI 10.1164/rccm.201406-1049OC; Stanojevic S, 2010, EUR RESPIR J, V36, P12, DOI 10.1183/09031936.00143209; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Stanojevic S, 2007, PEDIATR PULM, V42, P962, DOI 10.1002/ppul.20691; Stein CE, 1997, THORAX, V52, P895, DOI 10.1136/thx.52.10.895; Strippoli MPF, 2013, PEDIATRICS, V131, pE1842, DOI 10.1542/peds.2012-3003; Subbarao P, 2004, PEDIATR PULM, V37, P515, DOI 10.1002/ppul.20015; Swanney MP, 2004, CHEST, V126, P1861, DOI 10.1378/chest.126.6.1861; Vijayan V K, 2000, Indian J Chest Dis Allied Sci, V42, P147; Whincup PH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000263; Whitrow MJ, 2008, AM J RESP CRIT CARE, V177, P1262, DOI 10.1164/rccm.200706-867OC; Whittaker AL, 2005, ARCH DIS CHILD-FETAL, V90, pF423, DOI 10.1136/adc.2004.062497	48	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154336	10.1371/journal.pone.0154336	http://dx.doi.org/10.1371/journal.pone.0154336			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119342	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000374976200061
J	Wang, XL; Zhou, YL; Sun, W; Li, L				Wang, Xiao-Lin; Zhou, Yuan-Li; Sun, Wei; Li, Li			Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-kappa B Pathway	PLOS ONE			English	Article							NF-KAPPA-B; POTENTIAL THERAPEUTIC TARGET; COA REDUCTASE INHIBITORS; ACUTE CORONARY SYNDROMES; HUMAN VASCULAR CELLS; PLAQUE RUPTURE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR-DISEASE; MOLECULAR-MECHANISMS; CD40-CD40 LIGAND	CD40L and statins exhibit pro-inflammatory and anti-inflammatory effects, respectively. They are both pleiotropic and can regulate extracellular matrix (ECM) degeneration in an atherosclerotic plaque. Statins can decrease both the CD40 expression and the resulting inflammation. However, the effects of CD40L and stains on atherosclerotic plaque ECM production and the underlying mechanisms are not well established. Moreover, prolyl-4-hydroxylase alpha 1 (P4H alpha 1) is involved in collagen synthesis but its correlations with CD40L and statins are unknown. In the present study, CD40L suppressed P4H alpha 1 expression in human aortic smooth muscle cells (HASMCs) in a dose-and time-dependent manner, with insignificant changes in MMP2 expression and negative enzymatic activity of MMP9. CD40L increased TRAF6 expression, JNK phosphorylation, NF-kappa B nuclear translocation as well as DNA binding. Furthermore, silencing TRAF6, JNK or NF-kappa B genes abolished CD40L-induced suppression of P4H alpha 1. Lower NF-kappa B nuclear import rates were observed when JNK or TRAF6 silenced HASMCs were stimulated with CD40L compared to HASMCs with active JNK or TRAF6. Together, these results indicate that CD40L suppresses P4H alpha 1 expression in HASMCs by activating the TRAF6-JNK-NF-kappa B pathway. We also found that rosuvastatin inhibits CD40L-induced activation of the TRAF6-JNK-NF-kappa B pathway, thereby significantly rescuing the CD40L stimulated P4H alpha 1 inhibition. The results from this study will help find potential targets for stabilizing vulnerable atherosclerotic plaques.	[Wang, Xiao-Lin; Li, Li] Shandong Univ, Dept Cardiol, Jinan Cent Hosp, Jinan 250013, Shandong, Peoples R China; [Zhou, Yuan-Li] Shandong Univ, Dept Hlth, Jinan Cent Hosp, Jinan 250013, Shandong, Peoples R China; [Sun, Wei] Shandong Acad Med Sci, Dept Cardiol, Jinan 250062, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Li, L (corresponding author), Shandong Univ, Dept Cardiol, Jinan Cent Hosp, Jinan 250013, Shandong, Peoples R China.	lili74@medmail.com.cn	Stefanadis, Christodoulos/ABH-2232-2020; wang, xiao/HGB-7081-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; wang, xiao/0000-0002-4088-3341	National Natural Science Funds for Young Scholar [81200211]; Key R & D program in Shandong Province [2015GGA01027]; Shandong Young Scientists Award Fund [2012BSA01018]; Scientific and Technology Development program of Jinan [20120144]	National Natural Science Funds for Young Scholar; Key R & D program in Shandong Province; Shandong Young Scientists Award Fund; Scientific and Technology Development program of Jinan	This study was supported by the National Natural Science Funds for Young Scholar (No. 81200211), the Key R & D program in Shandong Province (No. 2015GGA01027), grants from the Shandong Young Scientists Award Fund (No. 2012BSA01018) and grants from Scientific and Technology Development program of Jinan (No. 20120144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bishop GA, 2002, J LEUKOCYTE BIOL, V72, P19; Chen JW, 2004, J CARDIOVASC PHARM, V44, P446, DOI 10.1097/01.fjc.0000140205.74180.3c; Chen L, 2006, J BIOL CHEM, V281, P10849, DOI 10.1074/jbc.M511237200; Dabek J, 2010, PHARMACOL REP, V62, P778; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; Donners MMPC, 2008, BLOOD, V111, P4596, DOI 10.1182/blood-2007-05-088906; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Guo HY, 2009, ARCH MED RES, V40, P345, DOI 10.1016/j.arcmed.2009.07.006; Heo SH, 2011, J CLIN NEUROL, V7, P69, DOI 10.3988/jcn.2011.7.2.69; Kampoli AM, 2012, CURR TOP MED CHEM, V12, P1192, DOI 10.2174/1568026611208011192; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022819; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Luan ZX, 2003, ARTERIOSCL THROM VAS, V23, P769, DOI 10.1161/01.ATV.0000068646.76823.AE; Lutgens E, 2002, TRENDS CARDIOVAS MED, V12, P27, DOI 10.1016/S1050-1738(01)00142-6; Lutgens E, 2007, TRENDS CARDIOVAS MED, V17, P118, DOI 10.1016/j.tcm.2007.02.004; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Mach F, 1997, CIRCULATION, V96, P396; Madonna R, 2012, VASC PHARMACOL, V57, P41, DOI 10.1016/j.vph.2012.02.005; Massaro M, 2010, CARDIOVASC RES, V86, P311, DOI 10.1093/cvr/cvp375; Mulhaupt F, 2003, CARDIOVASC RES, V59, P755, DOI 10.1016/S0008-6363(03)00515-7; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Padro T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038935; Pamukcu B, 2011, THROMB RES, V128, P117, DOI 10.1016/j.thromres.2011.03.025; Pateras I, 2014, EXPERT OPIN THER TAR, V18, P1089, DOI 10.1517/14728222.2014.938051; Pignatelli P, 2012, BIOCHEM PHARMACOL, V84, P1635, DOI 10.1016/j.bcp.2012.09.011; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Schonbeck U, 1997, CIRC RES, V81, P448, DOI 10.1161/01.RES.81.3.448; Schonbeck U, 2002, CIRCULATION, V106, P2888, DOI 10.1161/01.CIR.0000043029.52803.7B; Schonbeck U, 2001, CIRC RES, V89, P1092, DOI 10.1161/hh2401.101272; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Werner N, 2002, BASIC RES CARDIOL, V97, P105, DOI 10.1007/s003950200000; Wu M, 2006, MOL CELL BIOCHEM, V282, P141, DOI 10.1007/s11010-006-1741-8; Ye S, 2006, CARDIOVASC RES, V69, P636, DOI 10.1016/j.cardiores.2005.07.015; Zhang C, 2007, ARTERIOSCL THROM VAS, V27, P1760, DOI 10.1161/ATVBAHA.107.144881; Zhang K, 2013, J MOL CELL CARDIOL, V65, P43, DOI 10.1016/j.yjmcc.2013.09.010	46	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153919	10.1371/journal.pone.0153919	http://dx.doi.org/10.1371/journal.pone.0153919			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120457	Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200039
J	Zhang, LL; Zhou, JK; Han, JX; Hu, B; Hou, NN; Shi, Y; Huang, XX; Lou, X				Zhang, Linlin; Zhou, Jiankui; Han, Jinxiong; Hu, Bian; Hou, Ningning; Shi, Yun; Huang, Xingxu; Lou, Xin			Generation of an Oocyte-Specific Cas9 Transgenic Mouse for Genome Editing	PLOS ONE			English	Article							MODIFIED MICE; DNA; CRISPR-CAS9; SYSTEM; NUCLEASES	The CRISPR/Cas9 system has been developed as an easy-handle and multiplexable approach for engineering eukaryotic genomes by zygote microinjection of Cas9 and sgRNA, while preparing Cas9 for microinjection is laborious and introducing inconsistency into the experiment. Here, we describe a modified strategy for gene targeting through using oocyte-specific Cas9 transgenic mouse. With this mouse line, we successfully achieve precise gene targeting by injection of sgRNAs only into one-cell-stage embryos. Through comprehensive analysis, we also show allele complexity and off-target mutagenesis induced by this strategy is obviously lower than Cas9 mRNA/sgRNA injection. Thus, injection of sgRNAs into oocyte-specific Cas9 transgenic mouse embryo provides a convenient, efficient and reliable approach for mouse genome editing.	[Zhang, Linlin; Zhou, Jiankui; Han, Jinxiong; Hu, Bian; Hou, Ningning; Shi, Yun; Huang, Xingxu; Lou, Xin] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Huang, Xingxu] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Nanjing University; ShanghaiTech University	Huang, XX; Lou, X (corresponding author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China.; Huang, XX (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.	xingxuhuang@nju.edu.cn; xin.lou@nju.edu.cn	Shi, Yun S/T-8845-2018; Shi, Yun/B-5623-2009	Shi, Yun/0000-0002-8842-9818; Lou, Xin/0000-0002-6715-0375; huang, xingxu/0000-0001-8934-1247	National Natural Science Foundation of China [NSFC 31471354, NSFC 31471400]; Nanjing University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing University(Nanjing University)	This work was supported by grants from National Natural Science Foundation of China (NSFC 31471354 to X.L. and NSFC 31471400 to X.H.) and starting fund from Nanjing University to X.L.	Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; LIRA SA, 1990, P NATL ACAD SCI USA, V87, P7215, DOI 10.1073/pnas.87.18.7215; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017	22	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154364	10.1371/journal.pone.0154364	http://dx.doi.org/10.1371/journal.pone.0154364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119535	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200063
J	Bueno-Vargas, P; Manzano, M; Diaz-Castro, J; Lopez-Aliaga, I; Rueda, R; Lopez-Pedrosa, JM				Bueno-Vargas, Pilar; Manzano, Manuel; Diaz-Castro, Javier; Lopez-Aliaga, Inmaculada; Rueda, Ricardo; Maria Lopez-Pedrosa, Jose			Maternal Dietary Supplementation with Oligofructose-Enriched Inulin in Gestating/Lactating Rats Preserves Maternal Bone and Improves Bone Microarchitecture in Their Offspring	PLOS ONE			English	Article							CALCIUM SUPPLEMENTATION; SODIUM-BUTYRATE; VITAMIN-D; YOUNG ADOLESCENTS; MINERAL DENSITY; BIRTH-WEIGHT; SHORT-CHAIN; PREGNANCY; LACTATION; ABSORPTION	Nutrition during pregnancy and lactation could exert a key role not only on maternal bone, but also could influence the skeletal development of the offspring. This study was performed in rats to assess the relationship between maternal dietary intake of prebiotic oligofructose-enriched inulin and its role in bone turnover during gestation and lactation, as well as its effect on offspring peak bone mass/architecture during early adulthood. Rat dams were fed either with standard rodent diet (CC group), calcium-fortified diet (Ca group), or prebiotic oligofructose-enriched inulin supplemented diet (Pre group), during the second half of gestation and lactation. Bone mineral density (BMD) and content (BMC), as well as microstructure of dams and offspring at different stages were analysed. Dams in the Pre group had significantly higher trabecular thickness (Tb.Th), trabecular bone volume fraction (BV/TV) and smaller specific bone surface (BS/BV) of the tibia in comparison with CC dams. The Pre group offspring during early adulthood had an increase of the lumbar vertebra BMD when compared with offspring of CC and Ca groups. The Pre group offspring also showed significant increase versus CC in cancellous and cortical structural parameters of the lumbar vertebra 4 such as Tb.Th, cortical BMD and decreased BS/BV. The results indicate that oligofructose-enriched inulin supplementation can be considered as a plausible nutritional option for protecting against maternal bone loss during gestation and lactation preventing bone fragility and for optimizing peak bone mass and architecture of the offspring in order to increase bone strength.	[Bueno-Vargas, Pilar; Manzano, Manuel; Rueda, Ricardo; Maria Lopez-Pedrosa, Jose] Abbott Nutr R&D, Granada, Spain; [Bueno-Vargas, Pilar; Diaz-Castro, Javier; Lopez-Aliaga, Inmaculada] Univ Granada, Fac Pharm, Dept Physiol, E-18071 Granada, Spain; [Bueno-Vargas, Pilar; Diaz-Castro, Javier; Lopez-Aliaga, Inmaculada] Univ Granada, Inst Nutr & Food Technol Jose Mataix, Granada, Spain	University of Granada; University of Granada	Bueno-Vargas, P (corresponding author), Abbott Nutr R&D, Granada, Spain.; Bueno-Vargas, P (corresponding author), Univ Granada, Fac Pharm, Dept Physiol, E-18071 Granada, Spain.; Bueno-Vargas, P (corresponding author), Univ Granada, Inst Nutr & Food Technol Jose Mataix, Granada, Spain.	pilar.bueno@abbott.com	Díaz-Castro, Javier/AAX-6697-2021; Diaz-Castro, Javier/H-2985-2015	Díaz-Castro, Javier/0000-0003-3659-1757; Diaz-Castro, Javier/0000-0003-3659-1757; Bueno-Vargas, Pilar/0000-0002-3733-2047; Lopez-Aliaga, Inmaculada/0000-0001-7627-8760; Manzano, Manuel/0000-0003-2856-6295	Abbott Nutrition RD; Abbott Nutrition	Abbott Nutrition RD; Abbott Nutrition(Abbott Laboratories)	This study was funded by Abbott Nutrition R&D, and co-authors PBV, MM, JMLP and RR receive salary from Abbott Nutrition. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abrams SA, 2005, AM J CLIN NUTR, V82, P471; BARTELS H, 1972, Medizinische Welt, V23, P961; Bosscher D, 2006, INT DAIRY J, V16, P1092, DOI 10.1016/j.idairyj.2005.10.028; Cashman KD, 2006, NUTR REV, V64, P189, DOI 10.1111/j.1753-4887.2006.tb00201.x; Chen TH, 2007, BIOCHEM BIOPH RES CO, V355, P913, DOI 10.1016/j.bbrc.2007.02.057; Cole ZA, 2009, J BONE MINER RES, V24, P663, DOI 10.1359/JBMR.081212; Cooper C, 2009, ADV EXP MED BIOL, V646, P31, DOI 10.1007/978-1-4020-9173-5_3; CORBELLINI CN, 1991, CALCIFIED TISSUE INT, V48, P37, DOI 10.1007/BF02555794; Curtis EM, 2014, CURR OSTEOPOROS REP, V12, P194, DOI 10.1007/s11914-014-0210-7; Davey MR, 2012, JEMDSA, V17, P149, DOI 10.1080/22201009.2012.10872295; Demmer E, 2014, FASEB J S, V28; Devlin MJ, 2013, J ENDOCRINOL, V217, P69, DOI 10.1530/JOE-12-0403; Franck A, 2006, NUTR BULL, V31, P341, DOI 10.1111/j.1467-3010.2006.00584.x; Ganpule A, 2006, J CLIN ENDOCR METAB, V91, P2994, DOI 10.1210/jc.2005-2431; Gibbons MJ, 2004, ASIA PAC J CLIN NUTR, V13, P341; Grieger JA, 2015, NUTRIENTS, V7, P153, DOI 10.3390/nu7010153; Griffin IJ, 2002, BRIT J NUTR, V87, pS187, DOI [10.1079/BJN2001503, 10.1079/BJN/2002536]; Griffin IJ, 2003, NUTR RES, V23, P901, DOI 10.1016/S0271-5317(03)00085-X; GRUBER HE, 1994, BONE, V15, P167, DOI 10.1016/8756-3282(94)90704-8; Hacker AN, 2012, NUTR REV, V70, P397, DOI 10.1111/j.1753-4887.2012.00491.x; Hess MW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138881; Holloway L, 2007, BRIT J NUTR, V97, P365, DOI 10.1017/S000711450733674X; Holroyd C, 2012, OSTEOPOROSIS INT, V23, P401, DOI 10.1007/s00198-011-1671-5; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P138, DOI 10.1111/j.1365-3016.2012.01274.x; IWAMI K, 1993, INT J BIOCHEM, V25, P1631, DOI 10.1016/0020-711X(93)90522-G; Jarjou LMA, 2013, AM J CLIN NUTR, V98, P723, DOI 10.3945/ajcn.113.061630; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; Jones G, 2000, CALCIFIED TISSUE INT, V67, P304, DOI 10.1007/s002230001148; Karlsson C, 2001, OSTEOPOROSIS INT, V12, P828, DOI 10.1007/s001980170033; Katono T, 2008, ARCH ORAL BIOL, V53, P903, DOI 10.1016/j.archoralbio.2008.02.016; Koo WWK, 1999, OBSTET GYNECOL, V94, P577, DOI 10.1016/S0029-7844(99)00371-3; Kovacs CS, 2008, AM J CLIN NUTR, V88, p520S, DOI 10.1093/ajcn/88.2.520S; Kovacs CS, 2011, ENDOCRIN METAB CLIN, V40, P795, DOI 10.1016/j.ecl.2011.08.002; Kovacs CS, 2006, ENDOCRIN METAB CLIN, V35, P21, DOI 10.1016/j.ecl.2005.09.004; Kruger MC, 2003, EXP BIOL MED, V228, P683, DOI 10.1177/153537020322800606; Lapillonne A, 2004, AM J CLIN NUTR, V80, P1595, DOI 10.1093/ajcn/80.6.1595; Liu Z, 2011, ARCH GYNECOL OBSTET, V283, P205, DOI 10.1007/s00404-009-1345-0; Lopez JM, 1996, OSTEOPOROSIS INT, V6, P153, DOI 10.1007/BF01623940; MATKOVIC V, 1992, AM J CLIN NUTR, V55, P992, DOI 10.1093/ajcn/55.5.992; Maurer AD, 2011, BRIT J NUTR, V105, P329, DOI 10.1017/S0007114510003533; Nauta AJ, 2013, AM J CLIN NUTR, V98, p586S, DOI 10.3945/ajcn.112.039644; NIH Consensus Development Panel on Osteoporosis Prevention D Therapy, 2001, JAMA, V285; Nzeusseu A, 2006, BONE, V38, P394, DOI 10.1016/j.bone.2005.09.006; Ohta A, 2002, J NUTR, V132, P2048; Prentice A, 2003, J NUTR, V133, p1693S, DOI 10.1093/jn/133.5.1693S; Prentice A, 2000, AM J CLIN NUTR, V71, p1312S, DOI 10.1093/ajcn/71.5.1312s; Prentice A, 2000, ANNU REV NUTR, V20, P249, DOI 10.1146/annurev.nutr.20.1.249; Prentice A, 2006, P NUTR SOC, V65, P348, DOI 10.1079/PNS2006519; Ramakrishnan U, 1999, NUTR RES, V19, P103, DOI 10.1016/S0271-5317(98)00178-X; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reeves PG, 1997, J NUTR, V127, pS838; Rendina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060569; Roberfroid MB, 2007, J NUTR, V137, p2493S, DOI 10.1093/jn/137.11.2493S; Roberfroid MB, 2002, J NUTR, V132, P3599, DOI 10.1093/jn/132.12.3599; Scholz-Ahrens KE, 2007, J NUTR, V137, p2513S, DOI 10.1093/jn/137.11.2513S; Scholz-Ahrens KE, 2002, BRIT J NUTR, V88, P365, DOI 10.1079/BJN2002661; SHACKELFORD ME, 1994, FOOD CHEM TOXICOL, V32, P255, DOI 10.1016/0278-6915(94)90198-8; Suntornsaratoon P, 2014, AM J PHYSIOL-ENDOC M, V306, pE177, DOI 10.1152/ajpendo.00556.2013; Thomas DW, 2010, PEDIATRICS, V126, P1217, DOI 10.1542/peds.2010-2548; Thomas M, 2006, AM J OBSTET GYNECOL, V194, P937, DOI 10.1016/j.ajog.2005.05.032; TIETZ NW, 1983, J CLIN CHEM CLIN BIO, V21, P731; Tobias JH, 2005, OSTEOPOROSIS INT, V16, P1731, DOI 10.1007/s00198-005-1912-6; van den Heuvel EGHM, 1999, AM J CLIN NUTR, V69, P544; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; World Health Organization, 2004, SUMM M REP; Yang LC, 2013, BRIT J NUTR, V109, P1779, DOI 10.1017/S0007114512003777; Yin J, 2010, EUR J CLIN NUTR, V64, P131, DOI 10.1038/ejcn.2009.117; Zeni SN, 1999, BONE, V25, P681, DOI 10.1016/S8756-3282(99)00228-8	69	10	13	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154120	10.1371/journal.pone.0154120	http://dx.doi.org/10.1371/journal.pone.0154120			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115490	Green Published, gold			2022-12-27	WOS:000374973600044
J	Liu, YL; Tabata, D; Imai, R				Liu, Yuelin; Tabata, Daisuke; Imai, Ryozo			A Cold-Inducible DEAD-Box RNA Helicase from Arabidopsis thaliana Regulates Plant Growth and Development under Low Temperature	PLOS ONE			English	Article							SHOCK DOMAIN PROTEIN-3; RESPONSIVE GENE-REGULATION; 50S RIBOSOMAL-SUBUNITS; ESCHERICHIA-COLI; ABSCISIC-ACID; BIOGENESIS; MUTATIONS; FAMILY; TRANSLATION; RESISTANCE	DEAD-box RNA helicases comprise a large family and are involved in a range of RNA processing events. Here, we identified one of the Arabidopsis thaliana DEAD-box RNA helicases, AtRH7, as an interactor of Arabidopsis COLD SHOCK DOMAIN PROTEIN 3 (AtCSP3), which is an RNA chaperone involved in cold adaptation. Promoter: GUS transgenic plants revealed that AtRH7 is expressed ubiquitously and that its levels of the expression are higher in rapidly growing tissues. Knockout mutant lines displayed several morphological alterations such as disturbed vein pattern, pointed first true leaves, and short roots, which resemble ribosome-related mutants of Arabidopsis. In addition, aberrant floral development was also observed in rh7 mutants. When the mutants were germinated at low temperature (12 degrees C), both radicle and first leaf emergence were severely delayed; after exposure of seedlings to a long period of cold, the mutants developed aberrant, fewer, and smaller leaves. RNA blots and circular RT-PCR revealed that 35S and 18S rRNA precursors accumulated to higher levels in the mutants than in WT under both normal and cold conditions, suggesting the mutants are partially impaired in pre-rRNA processing. Taken together, the results suggest that AtRH7 affects rRNA biogenesis and plays an important role in plant growth under cold.	[Liu, Yuelin; Imai, Ryozo] Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan; [Liu, Yuelin; Tabata, Daisuke; Imai, Ryozo] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan	National Agriculture & Food Research Organization - Japan; Hokkaido University	Imai, R (corresponding author), Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan.; Imai, R (corresponding author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan.	rzi@affrc.go.jp						Abbasi N, 2010, PLANT J, V64, P960, DOI 10.1111/j.1365-313X.2010.04393.x; Abdelhaleem M, 2003, GENOMICS, V81, P618, DOI 10.1016/S0888-7543(03)00049-1; Asakura Y, 2012, PLANT PHYSIOL, V159, P961, DOI 10.1104/pp.112.197525; Awano N, 2007, J BACTERIOL, V189, P5808, DOI 10.1128/JB.00655-07; Boudet N, 2001, GENOME RES, V11, P2101, DOI 10.1101/gr.200801; Calo E, 2015, NATURE, V518, P249, DOI 10.1038/nature13923; Charollais J, 2004, NUCLEIC ACIDS RES, V32, P2751, DOI 10.1093/nar/gkh603; Charollais J, 2003, MOL MICROBIOL, V48, P1253, DOI 10.1046/j.1365-2958.2003.03513.x; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; CHERNOFF YO, 1994, EMBO J, V13, P906, DOI 10.1002/j.1460-2075.1994.tb06334.x; Chi W, 2012, PLANT PHYSIOL, V158, P693, DOI 10.1104/pp.111.186775; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Guan QM, 2013, PLANT CELL, V25, P342, DOI 10.1105/tpc.112.108340; GUTHRIE C, 1969, P NATL ACAD SCI USA, V63, P384, DOI 10.1073/pnas.63.2.384; Hang RL, 2014, P NATL ACAD SCI USA, V111, P16190, DOI 10.1073/pnas.1412697111; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; HONORE N, 1994, ANTIMICROB AGENTS CH, V38, P238, DOI 10.1128/AAC.38.2.238; Hsu YF, 2014, PLANT J, V77, P119, DOI 10.1111/tpj.12371; Huang C-K, 2016, PLANT CELL PHYSL, V57, P175; Huang CK, 2010, PLANT CELL PHYSIOL, V51, P694, DOI 10.1093/pcp/pcq045; Huang TS, 2010, PLANT PHYSIOL, V152, P255, DOI 10.1104/pp.109.147983; Hunger K, 2006, J BACTERIOL, V188, P240, DOI 10.1128/JB.188.1.240-248.2006; Jain C, 2008, RNA, V14, P381, DOI 10.1261/rna.800308; Juntawong P, 2013, PLANT J, V74, P1016, DOI 10.1111/tpj.12187; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kant P, 2007, PLANT PHYSIOL, V145, P814, DOI 10.1104/pp.107.099895; Karlson D, 2002, J BIOL CHEM, V277, P35248, DOI 10.1074/jbc.M205774200; Kehrenberg C, 2007, ANTIMICROB AGENTS CH, V51, P2244, DOI 10.1128/AAC.00229-07; Khan A, 2014, PLANT J, V79, DOI 10.1111/tpj.12533; Kim JS, 2008, PLANT CELL PHYSIOL, V49, P1563, DOI 10.1093/pcp/pcn125; Kim MH, 2013, FEBS OPEN BIO, V3, P438, DOI 10.1016/j.fob.2013.10.003; Kim MH, 2013, CELL STRESS CHAPERON, V18, P517, DOI 10.1007/s12192-012-0398-3; Kim MH, 2009, J BIOL CHEM, V284, P23454, DOI 10.1074/jbc.M109.025791; Kim SY, 2013, PLANT CELL, V25, P2970, DOI 10.1105/tpc.113.114264; Kohler D, 2010, PLANT MOL BIOL, V72, P459, DOI 10.1007/s11103-009-9584-9; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Lange H, 2011, PLANT J, V68, P51, DOI 10.1111/j.1365-313X.2011.04675.x; Lee KH, 2013, PLANT J, V73, P720, DOI 10.1111/tpj.12055; Linder P, 2013, BBA-GENE REGUL MECH, V1829, P750, DOI 10.1016/j.bbagrm.2013.03.007; Liu M, 2010, J INTEGR PLANT BIOL, V52, P817, DOI 10.1111/j.1744-7909.2010.00972.x; Matthes A, 2007, PLANT PHYSIOL, V145, P1637, DOI 10.1104/pp.107.108076; Mingam A, 2004, PLANT BIOTECHNOL J, V2, P401, DOI 10.1111/j.1467-7652.2004.00084.x; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MORITZ M, 1991, MOL CELL BIOL, V11, P5681, DOI 10.1128/MCB.11.11.5681; Nakaminami K, 2006, P NATL ACAD SCI USA, V103, P10122, DOI 10.1073/pnas.0603168103; Nashchekin D, 2006, J BIOL CHEM, V281, P14263, DOI 10.1074/jbc.M600262200; Nayak NR, 2013, PLANT CELL, V25, P2573, DOI 10.1105/tpc.113.113456; Nishimura K, 2010, PLANT J, V63, P766, DOI 10.1111/j.1365-313X.2010.04276.x; Nishimura T, 2005, PLANT CELL, V17, P2940, DOI 10.1105/tpc.105.036533; Petricka JJ, 2007, PLANT PHYSIOL, V144, P173, DOI 10.1104/pp.106.093575; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rodriguez-Galan O, 2013, BBA-GENE REGUL MECH, V1829, P775, DOI 10.1016/j.bbagrm.2013.01.007; Rosado A, 2012, P NATL ACAD SCI USA, V109, P19537, DOI 10.1073/pnas.1214774109; Rosado A, 2010, PLANT CELL, V22, P143, DOI 10.1105/tpc.109.068320; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Sasaki K, 2007, BIOCHEM BIOPH RES CO, V364, P633, DOI 10.1016/j.bbrc.2007.10.059; Sasaki K, 2013, NEW PHYTOL, V198, P95, DOI 10.1111/nph.12118; Scheer Ulrich, 1993, Trends in Cell Biology, V3, P236, DOI 10.1016/0962-8924(93)90123-I; Schmidt S, 2013, PLANT PHYSIOL, V163, P1623, DOI 10.1104/pp.113.223925; Shimizu H, 2005, PLANT CELL PHYSIOL, V46, P1623, DOI 10.1093/pcp/pci178; Shinohara N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00159; TAI PC, 1969, J BACTERIOL, V97, P1298, DOI 10.1128/JB.97.3.1298-1304.1969; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WALDRON C, 1974, MOL GEN GENET, V134, P115, DOI 10.1007/BF00268414; Weis BL, 2014, PLANT J, V80, P1043, DOI 10.1111/tpj.12703; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	75	34	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154040	10.1371/journal.pone.0154040	http://dx.doi.org/10.1371/journal.pone.0154040			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116354	gold, Green Submitted, Green Published			2022-12-27	WOS:000374973600039
J	Sun, QL; Zeng, ZG; Chen, S; Sun, L				Sun, Qing-lei; Zeng, Zhi-gang; Chen, Shuai; Sun, Li			First Comparative Analysis of the Community Structures and Carbon Metabolic Pathways of the Bacteria Associated with Alvinocaris longirostris in a Hydrothermal Vent of Okinawa Trough	PLOS ONE			English	Article							SULFUR-OXIDIZING CHEMOLITHOAUTOTROPH; SHRIMP RIMICARIS-EXOCULATA; MICROBIAL COMMUNITY; RIFTIA-PACHYPTILA; SP-NOV.; DIVERSITY; SEQUENCES; SYMBIOSIS; RIDGE; DETOXIFICATION	Alvinocaris longirostris is a species of shrimp existing in the hydrothermal fields of Okinawa Trough. To date the structure and function of the microbial community associated with A. longirostris are essentially unknown. In this study, by employment of the techniques of high through-put sequencing and clone library construction and analysis, we compared for the first time the community structures and metabolic profiles of microbes associated with the gill and gut of A. longirostris in a hydrothermal field of Okinawa Trough. Fourteen phyla were detected in the gill and gut communities, of which 11 phyla were shared by both tissues. Proteobacteria made up a substantial proportion in both tissues, while Firmicutes was abundant only in gut. Although gill and gut communities were similar in bacterial diversities, the bacterial community structures in these two tissues were significantly different. Further, we discovered for the first time the existence in the gill and gut communities of A. longirostris the genes (cbbM and aclB) encoding the key enzymes of Calvin-Benson-Bassham (CBB) cycle and the reductive tricarboxylic acid (rTCA) cycle, and that both cbbM and aclB were significantly more abundant in gill than in gut. Taken together, these results provide the first evidence that at least two carbon fixation pathways are present in both the gill and the gut communities of A. longirostris, and that the communities in different tissues likely differ in autotrophic productivity.	[Sun, Qing-lei; Sun, Li] Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China; [Zeng, Zhi-gang; Chen, Shuai] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Geol & Environm, Qingdao, Peoples R China; [Sun, Qing-lei; Sun, Li] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Sun, Qing-lei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, L (corresponding author), Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China.; Sun, L (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.	lsun@qdio.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDA11030401]; National Basic Research Program of China [2013CB429700]; Taishan Scholar Program of Shandong Province	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Taishan Scholar Program of Shandong Province	This work was supported by the grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA11030401), the National Basic Research Program of China (2013CB429700), and the Taishan Scholar Program of Shandong Province. We thank the research vessel KEXUE of the Chinese Academy of Sciences for collecting samples and WPOS sample center for providing samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson RE, 2013, FEMS MICROBIOL ECOL, V83, P324, DOI 10.1111/j.1574-6941.2012.01478.x; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Campbell BJ, 2004, APPL ENVIRON MICROB, V70, P6282, DOI 10.1128/AEM.70.10.6282-6289.2004; Campbell BJ, 2003, APPL ENVIRON MICROB, V69, P5070, DOI 10.1128/AEM.69.9.5070-5078.2003; Cao HL, 2014, MBIO, V5, DOI 10.1128/mBio.00980-13; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cary SC, 1997, APPL ENVIRON MICROB, V63, P1124, DOI 10.1128/AEM.63.3.1124-1130.1997; CAVANAUGH CM, 1992, APPL ENVIRON MICROB, V58, P3799, DOI 10.1128/AEM.58.12.3799-3803.1992; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; CAVANAUGH CM, 1987, NATURE, V325, P346, DOI 10.1038/325346a0; CHAO A, 1984, SCAND J STAT, V11, P265; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Durand L, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv101; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; EDWARDS DB, 1991, APPL ENVIRON MICROB, V57, P1082, DOI 10.1128/AEM.57.4.1082-1088.1991; Glaubitz S, 2013, APPL ENVIRON MICROB, V79, P2767, DOI 10.1128/AEM.03777-12; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Grote J, 2012, P NATL ACAD SCI USA, V109, P506, DOI 10.1073/pnas.1111262109; He TL, 2016, MAR BIOTECHNOL, V18, P232, DOI 10.1007/s10126-015-9683-3; Hugler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016018; Inagaki F, 2004, INT J SYST EVOL MICR, V54, P1477, DOI 10.1099/ijs.0.03042-0; Jan C, 2014, ENVIRON MICROBIOL, V16, P2723, DOI 10.1111/1462-2920.12406; Klose Julia, 2015, Proc Natl Acad Sci U S A, V112, P11300, DOI 10.1073/pnas.1501160112; Long H, 2014, FISH SHELLFISH IMMUN, V37, P66, DOI 10.1016/j.fsi.2014.01.013; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McLoughlin K, 2016, CELL HOST MICROBE, V19, P550, DOI 10.1016/j.chom.2016.02.021; MOYER CL, 1995, APPL ENVIRON MICROB, V61, P1555, DOI 10.1128/AEM.61.4.1555-1562.1995; Nakagawa S, 2005, FEMS MICROBIOL ECOL, V54, P141, DOI 10.1016/j.femsec.2005.03.007; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; POWELL MA, 1986, BIOL BULL, V171, P274, DOI 10.2307/1541923; Ravenschlag K, 1999, APPL ENVIRON MICROB, V65, P3982; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Takai K, 2004, APPL ENVIRON MICROB, V70, P2404, DOI 10.1128/AEM.70.4.2404-2413.2004; Takai K, 2001, APPL ENVIRON MICROB, V67, P3618, DOI 10.1128/AEM.67.8.3618-3629.2001; Takai K, 2006, INT J SYST EVOL MICR, V56, P1725, DOI 10.1099/ijs.0.64255-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072958; Thiel V, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00423; Tokuda G, 2008, MAR ECOL-EVOL PERSP, V29, P106, DOI 10.1111/j.1439-0485.2007.00211.x; Tokuda G, 2006, BIOL LETTERS, V2, P257, DOI 10.1098/rsbl.2005.0420; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watsuji TO, 2014, ISME J, V8, P1020, DOI 10.1038/ismej.2013.226; Watsuji TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046282; Zbinden M, 2008, J EXP MAR BIOL ECOL, V359, P131, DOI 10.1016/j.jembe.2008.03.009; Zhang J, 2015, MICROBIOL RES, V177, P43, DOI 10.1016/j.micres.2015.05.006; Zhang JX, 2015, APPL MICROBIOL BIOT, V99, P3291, DOI 10.1007/s00253-014-6262-x	53	9	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154359	10.1371/journal.pone.0154359	http://dx.doi.org/10.1371/journal.pone.0154359			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111851	gold, Green Published, Green Submitted			2022-12-27	WOS:000374970600059
J	Tyurin-Kuzmin, PA; Zhdanovskaya, ND; Sukhova, AA; Sagaradze, GD; Albert, EA; Ageeva, LV; Sharonov, GV; Vorotnikov, AV; Tkachuk, VA				Tyurin-Kuzmin, Pyotr A.; Zhdanovskaya, Nadezhda D.; Sukhova, Anna A.; Sagaradze, George D.; Albert, Eugene A.; Ageeva, Ludmila V.; Sharonov, George V.; Vorotnikov, Alexander V.; Tkachuk, Vsevolod A.			Nox4 and Duox1/2 Mediate Redox Activation of Mesenchymal Cell Migration by PDGF	PLOS ONE			English	Article							AKT/PROTEIN KINASE-B; GROWTH-FACTOR; NADPH OXIDASES; MECHANISMS; CHEMOTAXIS; GRADIENT; AKT/PKB; AKT2; PHOSPHORYLATION; PATHWAY	Platelet derived growth factor (PDGF) orchestrates wound healing and tissue regeneration by regulating recruitment of the precursor mesenchymal stromal cells (MSC) and fibroblasts. PDGF stimulates generation of hydrogen peroxide that is required for cell migration, but the sources and intracellular targets of H2O2 remain obscure. Here we demonstrate sustained live responses of H2O2 to PDGF and identify PKB/Akt, but not Erk1/2, as the target for redox regulation in cultured 3T3 fibroblasts and MSC. Apocynin, cell-permeable catalase and LY294002 inhibited PDGF-induced migration and mitotic activity of these cells indicating involvement of PI3-kinase pathway and H2O2. Real-time PCR revealed Nox4 and Duox1/2 as the potential sources of H2O2. Silencing of Duox1/2 in fibroblasts or Nox4 in MSC reduced PDGF-stimulated intracellular H2O2, PKB/Akt phosphorylation and migration, but had no such effect on Erk1/2. In contrast to PDGF, EGF failed to increase cytoplasmic H2O2, phosphorylation of PKB/Akt and migration of fibroblasts and MSC, confirming the critical impact of redox signaling. We conclude that PDGF-induced migration of mesenchymal cells requires Nox4 and Duox1/2 enzymes, which mediate redox-sensitive activation of PI3-kinase pathway and PKB/Akt.	[Tyurin-Kuzmin, Pyotr A.; Zhdanovskaya, Nadezhda D.; Sukhova, Anna A.; Sagaradze, George D.; Albert, Eugene A.; Ageeva, Ludmila V.; Sharonov, George V.; Vorotnikov, Alexander V.; Tkachuk, Vsevolod A.] Moscow MV Lomonosov State Univ, Fac Fundamental Med, Dept Biochem & Mol Med, Moscow, Russia; [Vorotnikov, Alexander V.; Tkachuk, Vsevolod A.] Russian Cardiol Res Ctr, Inst Expt Cardiol, Moscow, Russia; [Sharonov, George V.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Dept Biol Struct, Lab Opt Microscopy & Spect Biomol, Moscow, Russia; [Zhdanovskaya, Nadezhda D.] Univ Roma La Sapienza, Dept Mol Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Albert, Eugene A.] Tech Univ Dresden, Dresden Cluster Excellence, DFG Ctr Regenerat Therapies, Dresden, Germany	Lomonosov Moscow State University; National Medical Research Center of Cardiology; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Sapienza University Rome; German Research Foundation (DFG); Technische Universitat Dresden	Vorotnikov, AV (corresponding author), Moscow MV Lomonosov State Univ, Fac Fundamental Med, Dept Biochem & Mol Med, Moscow, Russia.; Vorotnikov, AV (corresponding author), Russian Cardiol Res Ctr, Inst Expt Cardiol, Moscow, Russia.	a.vorotnikov@cardio.ru	Vorotnikov, Alexander/AAN-3080-2020; Sagaradze, Georgy/AAN-4809-2020; Ageeva, Liudmila/B-2173-2014; Sharonov, George V/B-1323-2014; Zhdanovskaya, Nadezda/AAQ-7504-2021; Tkachuk, Vsevolod/AAE-1136-2022; Tyurin-Kuzmin, Pyotr A./A-8193-2014; Tkachuk, Vsevolod A/J-9357-2012; albert, eugene/AAD-9436-2019	Vorotnikov, Alexander/0000-0002-1460-971X; Sharonov, George V/0000-0001-8610-5054; Zhdanovskaya, Nadezda/0000-0003-1973-1121; Tyurin-Kuzmin, Pyotr A./0000-0002-1901-1637; Tkachuk, Vsevolod/0000-0002-7492-747X; Sagaradze, Georgy/0000-0003-2551-5118	Russian Science Foundation [14-24-00086, 14-35-00026]; Russian Foundation for Basic Research [14-04-01746a]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	Russian Science Foundation (http://pH(sic)p(sic)/en/) grants 14-24-00086 (fibroblast migration and proliferation) and 14-35-00026 (microscopy and redox imaging) to VAT, Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng) grant 14-04-01746a to AVV (redox signaling and PKB/Akt phosphorylation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Agarwal NK, 2013, ONCOGENE, V32, P2521, DOI 10.1038/onc.2012.287; AnandApte B, 1997, STEM CELLS, V15, P259, DOI 10.1002/stem.150259; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Corcoran A, 2013, FEBS J, V280, P1944, DOI 10.1111/febs.12224; den Hertog J, 2005, ARCH BIOCHEM BIOPHYS, V434, P11, DOI 10.1016/j.abb.2004.05.024; DEUEL TF, 1991, ANNU REV MED, V42, P567, DOI 10.1146/annurev.me.42.020191.003031; Esposito F, 2003, J BIOL CHEM, V278, P20828, DOI 10.1074/jbc.M211841200; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Haugh JM, 2006, BIOPHYS J, V90, P2297, DOI 10.1529/biophysj.105.077610; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang JS, 2013, FREE RADICAL BIO MED, V65, P1246, DOI 10.1016/j.freeradbiomed.2013.09.011; Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Kong QJ, 2011, EXP CELL RES, V317, P1491, DOI 10.1016/j.yexcr.2011.04.003; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Meng D, 2008, CARDIOVASC RES, V80, P299, DOI 10.1093/cvr/cvn173; Mishina NM, 2011, ANTIOXID REDOX SIGN, V14, P1, DOI 10.1089/ars.2010.3539; Mora-Pale M, 2009, BIOORGAN MED CHEM, V17, P5146, DOI 10.1016/j.bmc.2009.05.061; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Ronnstrand L, 2001, INT J CANCER, V91, P757, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1136>3.0.CO;2-J; San Martin A, 2010, ANTIOXID REDOX SIGN, V12, P625, DOI 10.1089/ars.2009.2852; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schroder K, 2007, ARTERIOSCL THROM VAS, V27, P1736, DOI 10.1161/ATVBAHA.107.142117; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Small JV, 1996, BIOSCIENCE REP, V16, P351, DOI 10.1007/BF01207261; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; VIAU A T, 1986, Journal of Free Radicals in Biology and Medicine, V2, P283, DOI 10.1016/S0748-5514(86)80011-3; Vorotnikov AV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1528, DOI 10.1134/S0006297911130104; Vorotnikov AV, 2014, GENES DIS, V1, P162, DOI 10.1016/j.gendis.2014.09.006; Wani R, 2011, CELL CYCLE, V10, P3263, DOI 10.4161/cc.10.19.17738; Weiger MC, 2009, J CELL SCI, V122, P313, DOI 10.1242/jcs.037564; Woolley JF, 2013, ANTIOXID REDOX SIGN, V19, P1815, DOI 10.1089/ars.2012.5028; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yoeli-Lerner M, 2009, MOL CANCER RES, V7, P425, DOI 10.1158/1541-7786.MCR-08-0342; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	56	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154157	10.1371/journal.pone.0154157	http://dx.doi.org/10.1371/journal.pone.0154157			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110716	gold, Green Submitted, Green Published			2022-12-27	WOS:000374970600039
J	Gomes, TD; Magnet, A; Izquierdo, F; Vaccaro, L; Redondo, F; Bueno, S; Sanchez, ML; Angulo, S; Fenoy, S; Hurtado, C; del Aguila, C				Gomes, Thiago dos Santos; Magnet, Angela; Izquierdo, Fernando; Vaccaro, Lucianna; Redondo, Fernando; Bueno, Sara; Luisa Sanchez, Maria; Angulo, Santiago; Fenoy, Soledad; Hurtado, Carolina; del Aguila, Carmen			Acanthamoeba spp. in Contact Lenses from Healthy Individuals from Madrid, Spain	PLOS ONE			English	Article							WATER CONTAMINATION; AMEBIC KERATITIS; CANARY-ISLANDS; TAP WATER; DIAGNOSIS; IDENTIFICATION; PATHOGENESIS; SPECIMENS; BACTERIAL; TENERIFE	Purpose Acanthamoeba keratitis (AK) is a painful and potentially blinding corneal infection caused by Acanthamoeba spp. In Madrid, environmental studies have demonstrated a high presence of these free-living amoebae in tap water. Since most of AK cases occur in contact lenses (CL) wearers with inadequate hygiene habits, the presence of Acanthamoeba in discarded CL has been studied and compared with other common etiological agents of keratitis, such as Pseudomonas aeruginosa and Staphylococcus aureus. Methods One hundred and seventy-seven healthy individuals from Madrid contributed their discarded CL and answered a questionnaire on hygiene habits. DNA was extracted from the CL solution and analyzed by real-time PCR for Acanthamoeba, Pseudomonas aeruginosa and Staphylococcus aureus. These CL and their solutions were also cultured on non-nutrient agar to isolate Acanthamoeba. Results Among the 177 samples, Acanthamoeba DNA was detected in 87 (49.2%), P. aeruginosa DNA in 14 (7.9%) and S. aureus DNA in 19 (10.7%). Cultivable amoebae, however, were observed in only one sample (0.6%). This isolate was genotyped as T4. The habits reported by this CL owner included some recognized risk factors for AK, but in this study only the practice of "not cleaning the CL case" presented some statistical significant association with Acanthamoeba DNA presence. Detection of the investigated bacterial DNA did not demonstrate statistical significant association with the studied practices, but the presence of P. aeruginosa revealed a possible inhibition of Acanthamoeba in these samples. Conclusions The PCR results suggest a high presence of Acanthamoeba spp. in healthy CL wearers from Madrid, but we can assume that CL solutions are properly disinfecting the CL since only 1.1% of the positive PCR samples correspond to viable amoebae and, after four years, only one participant reported stronger ocular problems. Nevertheless, more studies are necessary to corroborate this hypothesis.	[Gomes, Thiago dos Santos; Magnet, Angela; Izquierdo, Fernando; Vaccaro, Lucianna; Redondo, Fernando; Bueno, Sara; Luisa Sanchez, Maria; Angulo, Santiago; Fenoy, Soledad; Hurtado, Carolina; del Aguila, Carmen] Univ San Pablo CEU, Fac Farm, Urbanizac Monteprincipe, Madrid, Spain; [Gomes, Thiago dos Santos] Minist Educ Brazil, CAPES Fdn, BR-70040020 Brasilia, DF, Brazil	San Pablo CEU University; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	del Aguila, C (corresponding author), Univ San Pablo CEU, Fac Farm, Urbanizac Monteprincipe, Madrid, Spain.	cagupue@ceu.es	Redondo, Fernando/T-9254-2018; Sánchez, María Luisa/AAB-5302-2019; del Aguila, Carmen/A-6063-2016; Díaz-Parreño, Santiago Angulo/L-3035-2014; Magnet, Angela/G-5325-2013; Fenoy, Soledad/A-9633-2016; Bueno, Sara/AAB-5304-2019; Hurtado-Marcos, Carolina/AAH-3586-2020; Arias, Fernando Izquierdo/AAE-3073-2019	Redondo, Fernando/0000-0002-9679-1120; Sánchez, María Luisa/0000-0002-2542-0381; del Aguila, Carmen/0000-0003-0063-7899; Magnet, Angela/0000-0002-8642-4343; Fenoy, Soledad/0000-0002-5218-6308; Bueno, Sara/0000-0001-5329-8312; Hurtado-Marcos, Carolina/0000-0003-0364-7742; Arias, Fernando Izquierdo/0000-0003-0367-007X; Vaccaro Munoz, Lucianna/0000-0002-2644-4393; Gomes, Thiago/0000-0001-6781-6969	Instituto de Salud Carlos III (FISS) [PI12/02725]; FEDER; Fundacion Universitaria San Pablo CEU [USPCEU-PC07/2013]; Research Program EADS CASA-Brasil I; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil [BEX 9132/13-9]; FPU of Ministerio de Educacion, Cultura y Deporte, Spain [AP2009-0415]	Instituto de Salud Carlos III (FISS)(Instituto de Salud Carlos III); FEDER(European Commission); Fundacion Universitaria San Pablo CEU; Research Program EADS CASA-Brasil I; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FPU of Ministerio de Educacion, Cultura y Deporte, Spain	This project was supported by grant PI12/02725 from Instituto de Salud Carlos III (FISS) (http://www.isciii.es/) and FEDER and by grant USPCEU-PC07/2013 of the Fundacion Universitaria San Pablo CEU (http://www.ceu.es/). TSG was supported by Research Program EADS CASA-Brasil I and by grant BEX 9132/13-9 of the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/Brazil (http://www.capes.gov.br/). AM was supported by FPU grant AP2009-0415 of Ministerio de Educacion, Cultura y Deporte, Spain (http://www.mecd.gob.es/portada-mecd/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalich-Montiel F, 2012, J CATARACT REFR SURG, V38, P1853, DOI 10.1016/j.jcrs.2012.08.022; Arnalich-Montiel F, 2014, J CLIN MICROBIOL, V52, P1213, DOI 10.1128/JCM.00031-14; Boggild AK, 2009, J CLIN MICROBIOL, V47, P1314, DOI 10.1128/JCM.00173-09; Boost M, 2008, OPTOMETRY VISION SCI, V85, P526, DOI 10.1097/OPX.0b013e31817dba7c; Booton GC, 2005, J CLIN MICROBIOL, V43, P1689, DOI 10.1128/JCM.43.4.1689-1693.2005; Booton GC, 2002, J CLIN MICROBIOL, V40, P1621, DOI 10.1128/JCM.40.5.1621-1625.2002; Cohen EJ, 1996, CORNEA, V15, P566, DOI 10.1097/00003226-199611000-00005; Cruz M., 2004, ENF EMERG, V6, P98; de Miguel I, 1999, Enferm Infecc Microbiol Clin, V17, P445; Fuerst PA, 2015, J EUKARYOT MICROBIOL, V62, P69, DOI 10.1111/jeu.12186; Gadsby NJ, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.004; Gast RJ, 1996, J EUKARYOT MICROBIOL, V43, P498, DOI 10.1111/j.1550-7408.1996.tb04510.x; Graffi S, 2013, BRIT J OPHTHALMOL, V97, P1382, DOI 10.1136/bjophthalmol-2013-303386; GRAY TB, 1995, BRIT J OPHTHALMOL, V79, P601, DOI 10.1136/bjo.79.6.601; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heredero-Bermejo I, 2015, PARASITOLOGY, V142, P363, DOI 10.1017/S0031182014001140; Jeong Hae Jin, 2005, Korean Journal of Parasitology, V43, P47, DOI 10.3347/kjp.2005.43.2.47; JOHN DT, 1995, PARASITOL RES, V81, P193; Johnston SP, 2009, J CLIN MICROBIOL, V47, P2040, DOI 10.1128/JCM.00575-09; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kilvington S, 2004, INVEST OPHTH VIS SCI, V45, P165, DOI 10.1167/iovs.03-0559; LARKIN DFP, 1990, BRIT J OPHTHALMOL, V74, P133, DOI 10.1136/bjo.74.3.133; Lee S M, 1997, Korean J Ophthalmol, V11, P39; Lopez L, 2000, Enferm Infecc Microbiol Clin, V18, P229; Lorenzo-Morales J, 2005, PARASITOL RES, V95, P273, DOI 10.1007/s00436-005-1301-2; Lorenzo-Morales J, 2007, PARASITOL RES, V102, P167, DOI 10.1007/s00436-007-0754-x; Lorenzo-Morales J, 2015, PARASITE, V22, DOI 10.1051/parasite/2015010; Lorenzo-Morales J, 2013, TRENDS PARASITOL, V29, P181, DOI 10.1016/j.pt.2013.01.006; Lorenzo-Morales J, 2011, CONTACT LENS ANTERIO, V34, P83, DOI 10.1016/j.clae.2010.10.007; Madrigal Sesma MJ, 1982, REV IBERICA PARASITO, VExtra, P124; Magnet A, 2015, SCI TOTAL ENVIRON, V505, P889, DOI 10.1016/j.scitotenv.2014.10.064; Magnet A, 2014, PARASITOL RES, V113, P2845, DOI 10.1007/s00436-014-3945-2; Magnet A, 2013, WATER RES, V47, P6966, DOI 10.1016/j.watres.2013.09.065; Magnet A, 2012, PARASITOL RES, V111, P383, DOI 10.1007/s00436-012-2849-2; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Martin-Navarro CM, 2008, J MED MICROBIOL, V57, P1399, DOI 10.1099/jmm.0.2008/003459-0; Mathers WD, 1998, BRIT J OPHTHALMOL, V82, P1143, DOI 10.1136/bjo.82.10.1143; Moreno-Montanes J, 2011, CASE REP OPHTHALM, V2, P354, DOI 10.1159/000334785; Moriyama AS, 2008, ARQ BRAS OFTALMOL, V71, P32, DOI 10.1590/S0004-27492008000700007; Niyyati M, 2014, IRAN J PARASITOL, V9, P14; Panjwani N, 2010, OCUL SURF, V8, P70, DOI 10.1016/S1542-0124(12)70071-X; Pens CJ, 2008, PARASITOL RES, V103, P1241, DOI 10.1007/s00436-008-1120-3; Perez-Pomata T, 2006, ENFERM INFEC MICR CL, V24, P280, DOI 10.1016/S0213-005X(06)73775-2; Qvarnstrom Y, 2006, J CLIN MICROBIOL, V44, P3589, DOI 10.1128/JCM.00875-06; Risler A, 2013, PARASITOL RES, V112, P3807, DOI 10.1007/s00436-013-3572-3; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Thakur DV, 2014, INDIAN J MED RES, V140, P307; Wang XH, 1997, CURR MICROBIOL, V34, P212, DOI 10.1007/s002849900170; Wu YT, 2011, INVEST OPHTH VIS SCI, V52, P5287, DOI 10.1167/iovs.10-6785; Wu YT, 2010, INVEST OPHTH VIS SCI, V51, P6329, DOI 10.1167/iovs.10-5796; Yu Hak-Sun, 2001, Korean Journal of Parasitology, V39, P161, DOI 10.3347/kjp.2001.39.2.161	51	18	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154246	10.1371/journal.pone.0154246	http://dx.doi.org/10.1371/journal.pone.0154246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105183	gold, Green Submitted, Green Published			2022-12-27	WOS:000374565100062
J	Kiesslich, T; Weineck, SB; Koelblinger, D				Kiesslich, Tobias; Weineck, Silke B.; Koelblinger, Dorothea			Reasons for Journal Impact Factor Changes: Influence of Changing Source Items	PLOS ONE			English	Article							CITATION; BIAS	Both the concept and the application of the impact factor (IF) have been subject to widespread critique, including concerns over its potential manipulation. This study provides a systematic analysis of significant journal Impact Factor changes, based on the relative contribution of either one or both variables of the IF equation (i.e. citations / articles as the numerator /denominator of the quotient). A cohort of JCR-listed journals which faced the most dramatic absolute IF changes between 2013 and 2014 (Delta IF >= 3.0, n = 49) was analyzed for the causes resulting in IF changes that theses journals have experienced in the last five years. Along with the variation by number of articles and citations, this analysis includes the relative change of both variables compared to each other and offers a classification of 'valid` and 'invalid` scenarios of IF variation in terms of the intended goal of the IF to measure journal quality. The sample cohort features a considerable incidence of IF increases (18%) which are qualified as 'invalid` according to this classification because the IF increase is merely based on a favorably changing number of articles (denominator). The results of this analysis point out the potentially delusive effect of IF increases gained through effective shrinkage of publication output. Therefore, careful consideration of the details of the IF equation and possible implementation of control mechanisms versus the volatile factor of number of articles may help to improve the expressiveness of this metric.	[Kiesslich, Tobias] Paracelsus Med Univ, Lab Tumour Biol & Expt Therapies TREAT, Inst Physiol & Pathophysiol, Strubergasse 21, A-5020 Salzburg, Austria; [Kiesslich, Tobias] Paracelsus Med Univ, Salzburger Landeskliniken, Dept Internal Med 1, Mullner Hauptstr 48, A-5020 Salzburg, Austria; [Weineck, Silke B.; Koelblinger, Dorothea] Paracelsus Med Univ, Res Off, Strubergasse 21, A-5020 Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Kiesslich, T (corresponding author), Paracelsus Med Univ, Lab Tumour Biol & Expt Therapies TREAT, Inst Physiol & Pathophysiol, Strubergasse 21, A-5020 Salzburg, Austria.; Kiesslich, T (corresponding author), Paracelsus Med Univ, Salzburger Landeskliniken, Dept Internal Med 1, Mullner Hauptstr 48, A-5020 Salzburg, Austria.	tobias.kiesslich@pmu.ac.at		Kiesslich, Tobias/0000-0001-5403-9478				Althouse BM, 2009, J AM SOC INF SCI TEC, V60, P27, DOI 10.1002/asi.20936; [Anonymous], 2011, NAT MATER, V10, P645, DOI 10.1038/nmat3114; [Anonymous], 2003, NAT NEUROSCI, V6, P783, DOI 10.1038/nn0803-783; [Anonymous], 2006, PLOS MED, V3, P707, DOI 10.1371/journal.pmed.0030291; Clarke T, 2003, NATURE, V423, P373, DOI 10.1038/423373a; Falagas ME, 2008, ARCH IMMUNOL THER EX, V56, P223, DOI 10.1007/s00005-008-0024-5; Franck G, 2012, CELL CYCLE, V11, P4115, DOI 10.4161/cc.22151; Garfield E, 1999, CAN MED ASSOC J, V161, P979; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Garfield E, 1996, BRIT MED J, V313, P411, DOI 10.1136/bmj.313.7054.411; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Joseph KS, 1999, CAN MED ASSOC J, V161, P977; Krell FT, 2014, EUROPEAN SCI EDITING, V40, P36; Kurmis AP, 2003, J BONE JOINT SURG AM, V85A, P2449, DOI 10.2106/00004623-200312000-00028; Mathur Vijay Prakash, 2009, Indian J Dent Res, V20, P81; McVeigh ME, 2009, JAMA-J AM MED ASSOC, V302, P1107, DOI 10.1001/jama.2009.1301; Mutz R, 2012, J INFORMETR, V6, P169, DOI 10.1016/j.joi.2011.12.006; Neff BD, 2010, BIOSCIENCE, V60, P455, DOI 10.1525/bio.2010.60.6.9; Ogden TL, 2008, ANN OCCUP HYG, V52, P73, DOI 10.1093/annhyg/men002; Opthof T, 2002, CARDIOVASC RES, V55, P215, DOI 10.1016/S0008-6363(02)00500-X; Schutte HK, 2007, FOLIA PHONIATR LOGO, V59, P281, DOI 10.1159/000108334; Scully C, 2005, BRIT DENT J, V198, P391, DOI 10.1038/sj.bdj.4812185; Seglen PO, 1997, BRIT MED J, V314, P498; TAYLOR M, 2008, ETHICS SCI ENV POLIT, V8, P17, DOI DOI 10.3354/ESEP00086; Vanclay JK, 2012, SCIENTOMETRICS, V92, P211, DOI 10.1007/s11192-011-0561-0; Weale Andy R, 2004, BMC Med Res Methodol, V4, P14, DOI 10.1186/1471-2288-4-14; Weineck SB, 2015, CHIRURG, V86, P355, DOI 10.1007/s00104-014-2766-2; Wilhite AW, 2012, SCIENCE, V335, P542, DOI 10.1126/science.1212540	29	37	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154199	10.1371/journal.pone.0154199	http://dx.doi.org/10.1371/journal.pone.0154199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27105434	gold, Green Published			2022-12-27	WOS:000374565100055
J	Ro, YS; Shin, SD; Song, KJ; Kim, JY; Lee, EJ; Lee, YJ; Ahn, KO; Hong, KJ				Ro, Young Sun; Shin, Sang Do; Song, Kyoung Jun; Kim, Joo Yeong; Lee, Eui Jung; Lee, Yu Jin; Ahn, Ki Ok; Hong, Ki Jeong		Cardiac Arrest Pursuit Trial	Risk of Diabetes Mellitus on Incidence of Out-of-Hospital Cardiac Arrests: A Case-Control Study	PLOS ONE			English	Article							DEATH; ASSOCIATION; OUTCOMES; EPIDEMIOLOGY; MORTALITY; SURVIVAL; LEVEL; MEN	Background This study aimed to determine the risk of diabetes mellitus (DM) on incidence of out-of-hospital cardiac arrest (OHCA) and to investigate whether difference in effects of DM between therapeutic methods was observed. Methods This study was a case-control study using the Cardiac Arrest Pursuit Trial with Unique Registration and Epidemiologic Surveillance (CAPTURES) project database and 2013 Korean Community Health Survey (CHS). Cases were defined as EMS-treated adult (18 year old and older) OHCA patients with presumed cardiac etiology collected at 27 emergency departments from January to December 2014. OHCA patients whose arrest occurred at nursing homes or clinics and cases with unknown information on DM were excluded. Four controls were matched to one case with strata including age, gender, and county from the Korean CHS database. Multivariable conditional logistic regression analysis was conducted to estimate the risk of DM and treatment modality on incidence of OHCA. Results Total 1,386 OHCA patients and 5,544 community-based controls were analyzed. A total of 370 (26.7%) among cases and 860 (15.5%) among controls were diagnosed with DM. DM was associated with increasing risk of OHCA (AOR: 1.92 (1.65-2.24)). By DM treatment modality comparing with non-DM group, AOR (95% CI) was the highest in non-pharmacotherapy only group (4.65 (2.00-10.84)), followed by no treatment group (4.17 (2.91-5.96)), insulin group (2.69 (1.82-3.96)), and oral hypoglycemic agent group (1.55 (1.31-1.85)). Conclusion DM increased the risk of OHCA, which was the highest in the non-pharmacotherapy group and decreased in magnitude with pharmacotherapy.	[Ro, Young Sun; Shin, Sang Do; Song, Kyoung Jun; Kim, Joo Yeong; Lee, Eui Jung; Lee, Yu Jin; Ahn, Ki Ok; Hong, Ki Jeong] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Emergency Med Serv, Seoul 110744, South Korea; [Shin, Sang Do; Song, Kyoung Jun; Lee, Eui Jung; Lee, Yu Jin] Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul, South Korea; [Kim, Joo Yeong] Korea Univ, Ansan Hosp, Dept Emergency Med, Ansan, South Korea; [Hong, Ki Jeong] Seoul Natl Univ, Dept Emergency Med, Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Seoul National University Hospital	Shin, SD (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Lab Emergency Med Serv, Seoul 110744, South Korea.; Shin, SD (corresponding author), Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul, South Korea.	shinsangdo@medimail.co.kr	안, 기옥/L-5596-2019; Lee, Jae Hyuk/W-5616-2018	안, 기옥/0000-0002-8446-3269; Lee, Jae Hyuk/0000-0003-2429-4085; Hong, Ki Jeong/0000-0003-3334-817X	Korea Centers for Disease Control and Prevention [2013E3300500/2014E3300100]	Korea Centers for Disease Control and Prevention	This study was supported and funded by the Korea Centers for Disease Control and Prevention (2013-2014) (Grant No. 2013E3300500/2014E3300100).	Andersson C, 2012, DIABETOLOGIA, V55, P2348, DOI 10.1007/s00125-012-2584-3; Bergner DW, 2010, CARDIOL J, V17, P117; Cheng YLJ, 2013, DIABETES CARE, V36, P2690, DOI 10.2337/dc12-2074; Cuddy TE, 2006, CAN J CARDIOL, V22, P205; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Jouven X, 2005, EUR HEART J, V26, P2142, DOI 10.1093/eurheartj/ehi376; Kim MJ, 2015, RESUSCITATION, V97, P115, DOI 10.1016/j.resuscitation.2015.08.019; Kucharska-Newton AM, 2010, ACTA DIABETOL, V47, pS161, DOI 10.1007/s00592-009-0157-9; McEwen LN, 2011, DIABETES CARE, V34, P1529, DOI 10.2337/dc10-2312; McNally B, 2011, MMWR SURVEILL SUMM, V60, P1; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Oh DH, 2013, J KOREAN MED SCI, V28, P128, DOI 10.3346/jkms.2013.28.1.128; Ro YS, 2015, RESUSCITATION, V90, P35, DOI 10.1016/j.resuscitation.2015.02.006; Ro YS, 2013, RESUSCITATION, V84, P547, DOI 10.1016/j.resuscitation.2012.12.020; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Singh JP, 2000, AM J CARDIOL, V86, P309, DOI 10.1016/S0002-9149(00)00920-6; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	22	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154245	10.1371/journal.pone.0154245	http://dx.doi.org/10.1371/journal.pone.0154245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105059	Green Submitted, gold, Green Published			2022-12-27	WOS:000374565100061
J	Sun, YY; Sun, L				Sun, Yuan-yuan; Sun, Li			A Teleost Bactericidal Permeability-Increasing Protein Kills Gram-Negative Bacteria, Modulates Innate Immune Response, and Enhances Resistance against Bacterial and Viral Infection	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; CYNOGLOSSUS-SEMILAEVIS; EXPRESSION ANALYSIS; TONGUE SOLE; MOLECULAR-CLONING; ESCHERICHIA-COLI; TERMINAL DOMAIN; HOST INFECTION; BPI/LBP CDNA; BPI	Bactericidal/permeability-increasing protein (BPI) is an important factor of innate immunity that in mammals is known to take part in the clearance of invading Gram-negative bacteria. In teleost, the function of BPI is unknown. In the present work, we studied the function of tongue sole (Cynoglossus semilaevis) BPI, CsBPI. We found that CsBPI was produced extra-cellularly by peripheral blood leukocytes (PBL). Recombinant CsBPI (rCsBPI) was able to bind to a number of Gram-negative bacteria but not Gram-positive bacteria. Binding to bacteria led to bacterial death through membrane permeabilization and structural destruction, and the bound bacteria were more readily taken up by PBL. In vivo, rCsBPI augmented the expression of a wide arrange of genes involved in antibacterial and antiviral immunity. Furthermore, rCsBPI enhanced the resistance of tongue sole against bacterial as well as viral infection. These results indicate for the first time that a teleost BPI possesses immunoregulatory effect and plays a significant role in antibacterial and antiviral defense.	[Sun, Yuan-yuan; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Sun, Yuan-yuan; Sun, Li] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Sun, Yuan-yuan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.; Sun, L (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.	lsun@qdio.ac.cn			National Natural Science Foundation of China [31330081]; National Basic Research Program of China [2012CB114406]; Taishan Scholar Program of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Taishan Scholar Program of Shandong Province	This work was supported by the grants from the National Natural Science Foundation of China (31330081), the National Basic Research Program of China (2012CB114406), and the Taishan Scholar Program of Shandong Province.	Beamer LJ, 1998, PROTEIN SCI, V7, P906; Beamer LJ, 2003, BIOCHEM SOC T, V31, P791, DOI 10.1042/BST0310791; Capodici C, 1996, J IMMUNOL, V156, P4789; Elsbach P, 1998, J LEUKOCYTE BIOL, V64, P14, DOI 10.1002/jlb.64.1.14; ELSBACH P, 1993, IMMUNOBIOLOGY, V187, P417, DOI 10.1016/S0171-2985(11)80354-2; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hu YH, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-23; Inagawa H, 2002, J IMMUNOL, V168, P5638, DOI 10.4049/jimmunol.168.11.5638; Iovine N, 2002, J BIOL CHEM, V277, P7970, DOI 10.1074/jbc.M109622200; Iovine NM, 1997, P NATL ACAD SCI USA, V94, P10973, DOI 10.1073/pnas.94.20.10973; KHEMLANI LS, 1994, J LEUKOCYTE BIOL, V56, P784, DOI 10.1002/jlb.56.6.784; Kim JW, 2012, FISH SHELLFISH IMMUN, V33, P75, DOI 10.1016/j.fsi.2012.04.003; Kono T, 2003, MOL IMMUNOL, V40, P269, DOI 10.1016/S0161-5890(03)00103-2; Lamping N, 1996, J IMMUNOL, V157, P4648; Levy O, 2000, INFECT IMMUN, V68, P5120, DOI 10.1128/IAI.68.9.5120-5125.2000; Levy O, 2003, BIOCHEM SOC T, V31, P795, DOI 10.1042/BST0310795; Li MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096222; Li YX, 2012, DEV COMP IMMUNOL, V37, P55, DOI 10.1016/j.dci.2011.12.007; Li YX, 2011, FISH SHELLFISH IMMUN, V31, P446, DOI 10.1016/j.fsi.2011.06.017; LITTLE RG, 1994, J BIOL CHEM, V269, P1865; Long H, 2014, FISH SHELLFISH IMMUN, V37, P66, DOI 10.1016/j.fsi.2014.01.013; Magor BG, 2001, DEV COMP IMMUNOL, V25, P651, DOI 10.1016/S0145-305X(01)00029-5; MANNION BA, 1990, J CLIN INVEST, V85, P853, DOI 10.1172/JCI114512; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Nam BH, 2010, VET IMMUNOL IMMUNOP, V133, P256, DOI 10.1016/j.vetimm.2009.07.010; OOI CE, 1987, J BIOL CHEM, V262, P14891; Srivastava A, 2007, INFECT IMMUN, V75, P342, DOI 10.1128/IAI.01089-06; Stenvik J, 2004, DEV COMP IMMUNOL, V28, P307, DOI 10.1016/j.dci.2003.09.002; Sun YY, 2016, DEV COMP IMMUNOL, V55, P194, DOI 10.1016/j.dci.2015.10.003; Suzuki K, 2009, FISHERIES SCI, V75, P673, DOI 10.1007/s12562-009-0072-6; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Wang JJ, 2015, J PROTEOMICS, V124, P1, DOI 10.1016/j.jprot.2015.04.011; Wang T, 2016, DEV COMP IMMUNOL, V55, P12, DOI 10.1016/j.dci.2015.10.002; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044884; WEINRAUCH Y, 1994, CLIN RES, V42, pA152; WEISS J, 1975, J CLIN INVEST, V55, P33, DOI 10.1172/JCI107915; WEISS J, 1978, J BIOL CHEM, V253, P2664; Xu P, 2005, DEV COMP IMMUNOL, V29, P865, DOI 10.1016/j.dci.2005.03.004; Zarember K, 1997, BLOOD, V89, P672, DOI 10.1182/blood.V89.2.672; Zhang BC, 2015, DEV COMP IMMUNOL, V53, P96, DOI 10.1016/j.dci.2015.07.004; Zhang J, 2015, FISH SHELLFISH IMMUN, V45, P486, DOI 10.1016/j.fsi.2015.05.006; Zhang J, 2015, FISH SHELLFISH IMMUN, V44, P272, DOI 10.1016/j.fsi.2015.02.033; Zhang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106543; Zhou ZJ, 2015, VET MICROBIOL, V177, P332, DOI 10.1016/j.vetmic.2015.03.030; Zhou ZJ, 2015, DEV COMP IMMUNOL, V50, P69, DOI 10.1016/j.dci.2015.01.007	47	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154045	10.1371/journal.pone.0154045	http://dx.doi.org/10.1371/journal.pone.0154045			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105425	Green Submitted, Green Published, gold			2022-12-27	WOS:000374565100037
J	Mula, RVR; Machiah, D; Holland, L; Wang, XY; Parihar, H; Sharma, AC; Selvaraj, P; Shashidharamurthy, R				Mula, Ramanjaneya V. R.; Machiah, Deepa; Holland, Lauren; Wang, Xinyu; Parihar, Harish; Sharma, Avadhesh C.; Selvaraj, Periasamy; Shashidharamurthy, Rangaiah			Immune Complex-Induced, Nitric Oxide-Mediated Vascular Endothelial Cell Death by Phagocytes Is Prevented with Decoy Fc gamma Receptors	PLOS ONE			English	Article							NEUTROPHIL RECRUITMENT; EXPRESSION; APOPTOSIS; SYNTHASE; TISSUE; ARTHRITIS; ADHESION; ACTIVATION; DEPOSITION; MOLECULES	Autoimmune vasculitis is an endothelial inflammatory disease that results from the deposition of immune-complexes (ICs) in blood vessels. The interaction between Fcgamma receptors (Fc gamma Rs) expressed on inflammatory cells with ICs is known to cause blood vessel damage. Hence, blocking the interaction of ICs and inflammatory cells is essential to prevent the IC-mediated blood vessel damage. Thus we tested if uncoupling the interaction of Fc gamma Rs and ICs prevents endothelium damage. Herein, we demonstrate that dimeric Fc gamma R-Igs prevented nitric oxide (NO) mediated apoptosis of human umbilical vein endothelial cells (HUVECs) in an in vitro vasculitis model. Dimeric Fc gamma R-Igs significantly inhibited the IC-induced upregulation of inducible nitric oxide synthase (iNOS) and nitric oxide (NO) release by murine monocytic cell line. However, Fc gamma R-Igs did not affect the exogenously added NO-induced upregulation of pro-apoptotic genes such as Bax (15 fold), Bak (35 fold), cytochrome-C (11 fold) and caspase-3 (30 fold) in HUVECs. In conclusion, these data suggest that IC-induced NO could be one of the major inflammatory mediator promoting blood vessel inflammation and endothelial cell death during IC-mediated vasculitis which can be effectively blocked by dimeric decoy Fc gamma Rs.	[Mula, Ramanjaneya V. R.; Holland, Lauren; Wang, Xinyu; Sharma, Avadhesh C.; Shashidharamurthy, Rangaiah] Philadelphia Coll Osteopath Med, Sch Pharm, Dept Pharmaceut Sci, Suwanee, GA USA; [Parihar, Harish] Philadelphia Coll Osteopath Med, Dept Pharm Practice, Sch Pharm, Suwanee, GA USA; [Machiah, Deepa] Yerkes Natl Primate Res Ctr, Dept Mol Pathol Lab, Atlanta, GA USA; [Selvaraj, Periasamy] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Shashidharamurthy, R (corresponding author), Philadelphia Coll Osteopath Med, Sch Pharm, Dept Pharmaceut Sci, Suwanee, GA USA.	rangaiahsh@pcom.edu	WANG, XINYU/J-8507-2019	WANG, XINYU/0000-0003-2085-8824	American Heart Association Award [11SDG5710004]; Philadelphia College of Osteopathic Medicine	American Heart Association Award(American Heart Association); Philadelphia College of Osteopathic Medicine	This work was supported by American Heart Association Award (11SDG5710004) and Chief Scientific Officer (CSO) funding from Philadelphia College of Osteopathic Medicine to RS and XW.	Avdagic N, 2013, BOSNIAN J BASIC MED, V13, P5; Banda NK, 2007, J IMMUNOL, V179, P4101, DOI 10.4049/jimmunol.179.6.4101; Beltran B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602; BREEDVELD FC, 1988, CLIN IMMUNOL IMMUNOP, V48, P202, DOI 10.1016/0090-1229(88)90084-0; Brune B, 2003, CELL DEATH DIFFER, V10, P864, DOI 10.1038/sj.cdd.4401261; Calza L, 1997, P NATL ACAD SCI USA, V94, P3368, DOI 10.1073/pnas.94.7.3368; Clahsen T, 2008, J LEUKOCYTE BIOL, V84, P1521, DOI 10.1189/jlb.0308178; CLARK RAF, 1986, J CELL SCI, V82, P263; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Daeron M, 2014, CURR TOP MICROBIOL, V382, P131, DOI 10.1007/978-3-319-07911-0_7; Dhillon SS, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.17; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Gauley J, 2010, J LEUKOCYTE BIOL, V87, P1115, DOI 10.1189/jlb.0709465; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Hooper DC, 1997, P NATL ACAD SCI USA, V94, P2528, DOI 10.1073/pnas.94.6.2528; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; Jea JC, 1998, J LEUKOCYTE BIOL, V64, P451, DOI 10.1002/jlb.64.4.451; Lauterbach M, 2008, J LEUKOCYTE BIOL, V83, P1423, DOI 10.1189/jlb.0607421; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; MCCARTNEYFRANCIS N, 1993, J EXP MED, V178, P749, DOI 10.1084/jem.178.2.749; MOZAFFARIAN N, 1995, J LEUKOCYTE BIOL, V57, P657, DOI 10.1002/jlb.57.4.657; MULLIGAN MS, 1992, BRIT J PHARMACOL, V107, P1159, DOI 10.1111/j.1476-5381.1992.tb13423.x; MULLIGAN MS, 1991, P NATL ACAD SCI USA, V88, P6338, DOI 10.1073/pnas.88.14.6338; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; Niarakis A, 2014, CURR TOP MICROBIOL, V382, P69, DOI 10.1007/978-3-319-07911-0_4; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Ohtani H, 2012, NITRIC OXIDE-BIOL CH, V26, P95, DOI 10.1016/j.niox.2011.12.007; Pei H, 2013, J TRADIT CHIN MED, V33, P486, DOI 10.1016/S0254-6272(13)60153-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; Shashidharamurthy R, 2012, GENE THER, V19, P877, DOI 10.1038/gt.2011.175; Shashidharamurthy R, 2008, BLOOD, V111, P894, DOI 10.1182/blood-2007-04-085944; Shashidharamurthy R, 2009, J IMMUNOL, V183, P8216, DOI 10.4049/jimmunol.0902550; Shen YH, 1998, FEBS LETT, V433, P125, DOI 10.1016/S0014-5793(98)00844-8; Silvescu CI, 2014, P NATL ACAD SCI USA, V111, P10696, DOI 10.1073/pnas.1320833111; Sioutas A, 2008, FERTIL STERIL, V89, P948, DOI 10.1016/j.fertnstert.2007.04.018; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; SMILEY JD, 1989, AM J MED SCI, V298, P267, DOI 10.1097/00000441-198910000-00012; Stokol T, 2004, J EXP MED, V200, P835, DOI 10.1084/jem.20040501; Suzuki Y, 2003, J IMMUNOL, V170, P3243, DOI 10.4049/jimmunol.170.6.3243; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Taylor EL, 2003, CELL DEATH DIFFER, V10, P418, DOI 10.1038/sj.cdd.4401152; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Vitecek J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/318087; Wang BY, 1999, CIRCULATION, V99, P1236, DOI 10.1161/01.CIR.99.9.1236; WEINBERG JB, 1994, J EXP MED, V179, P651, DOI 10.1084/jem.179.2.651; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Williams MR, 2008, ENDOTHELIUM-J ENDOTH, V15, P73, DOI 10.1080/10623320802092443	56	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153620	10.1371/journal.pone.0153620	http://dx.doi.org/10.1371/journal.pone.0153620			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101012	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500045
J	Wang, HL; Lai, HH; Chuang, TH; Shih, YW; Huang, SC; Lee, MJ; Chen, SU				Wang, Huai-Ling; Lai, Hsing-Hua; Chuang, Tzu-Hsuan; Shih, Yu-Wei; Huang, Shih-Chieh; Lee, Meng-Ju; Chen, Shee-Uan			A Patient Friendly Corifollitropin Alfa Protocol without Routine Pituitary Suppression in Normal Responders	PLOS ONE			English	Article							CONTROLLED OVARIAN STIMULATION; LUTEINIZING-HORMONE SURGES; GNRH ANTAGONIST; RECOMBINANT FSH; CETRORELIX; GANIRELIX; HYPERSTIMULATION; COMBINATION; FEEDBACK; FAILURE	The release of corifollitropin alfa simplifies daily injections of short-acting recombinant follicular stimulating hormone (rFSH), and its widely-used protocol involves short-acting gonadotropins supplements and a fixed GnRH antagonist regimen, largely based on follicle size. In this study, the feasibility of corifollitropin alfa without routine pituitary suppression was evaluated. A total of 288 patients were stimulated by corifollitropin alfa on cycle day 3 following with routine serum hormone monitoring and follicle scanning every other day after 5 days of initial stimulation, and a GnRH antagonist (0.25 mg) was only used prophylactically when the luteinizing hormone (LH) was >= 6 IU/L (over half of the definitive LH surge). The incidence of premature LH surge (>= 10 IU/L) was 2.4% (7/288) before the timely injection of a single GnRH antagonist, and the elevated LH level was dropped down from 11.9 IU/L to 2.2 IU/L after the suppression. Two hundred fifty-one patients did not need any antagonist (87.2% [251/288]) throughout the whole stimulation. No adverse effects were observed regarding oocyte competency (fertilization rate: 78%; blastocyst formation rate: 64%). The live birth rate per OPU cycle after the first cryotransfer was 56.3%(161/286), and the cumulative live birth rate per OPU cycle after cyrotransfers was 69.6% (199/286). Of patients who did and did not receive GnRH antagonist during stimulation, no significant difference existed in the cumulative live birth rates (78.4% vs. 68.3%, p = 0.25). The results demonstrated that the routine GnRH antagonist administration is not required in the corifollitropin-alfa cycles using a flexible and hormone-depended antagonist regimen, while the clinical outcome is not compromised. This finding reveals that the use of a GnRH antagonist only occasionally may be needed.	[Wang, Huai-Ling; Lai, Hsing-Hua; Chuang, Tzu-Hsuan; Shih, Yu-Wei; Huang, Shih-Chieh; Lee, Meng-Ju] Stork Ladies Clin, Stork Fertil Ctr, Hsinchu, Taiwan; [Chen, Shee-Uan] Natl Taiwan Univ Hosp & Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital	Chen, SU (corresponding author), Natl Taiwan Univ Hosp & Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan.	sheeuan@ntu.edu.tw	, 李孟儒/AAO-6724-2021	CHEN, SHEE-UAN/0000-0001-7592-3238; Chuang, Tzu-Hsuan/0000-0003-4263-9374; Lee, Meng Ju/0000-0003-3102-709X				Albano C, 2000, HUM REPROD, V15, P526, DOI 10.1093/humrep/15.3.526; Bhattacharya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082249; Borm G, 2000, HUM REPROD, V15, P1490; de Greef R, 2010, CLIN PHARMACOL THER, V88, P79, DOI 10.1038/clpt.2010.54; Del Gadillo JCB, 2002, EUR J OBSTET GYN R B, V102, P179, DOI 10.1016/S0301-2115(01)00580-2; Devroey P, 2004, J CLIN ENDOCR METAB, V89, P2062, DOI 10.1210/jc.2003-031766; Devroey P, 2009, HUM REPROD, V24, P3063, DOI 10.1093/humrep/dep291; DIEDRICH K, 1994, HUM REPROD, V9, P788, DOI 10.1093/oxfordjournals.humrep.a138597; Fauser BCJM, 2010, REPROD BIOMED ONLINE, V21, P593, DOI 10.1016/j.rbmo.2010.06.032; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Fowler PA, 2003, REPRODUCTION, V126, P689, DOI 10.1530/reprod/126.6.689; FRYDMAN R, 1992, HUM REPROD, V7, P930, DOI 10.1093/oxfordjournals.humrep.a137773; Griesinger G, 2006, FERTIL STERIL, V85, P791, DOI 10.1016/j.fertnstert.2005.08.048; Griesinger G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149615; Lainas T, 2005, HUM REPROD, V20, P2426, DOI 10.1093/humrep/dei106; Messinis IE, 2005, HUM REPROD, V20, P3192, DOI 10.1093/humrep/dei210; Messinis IE, 2006, HUM REPROD UPDATE, V12, P557, DOI 10.1093/humupd/dml020; Messinis IE, 2014, REPROD BIOMED ONLINE, V28, P714, DOI 10.1016/j.rbmo.2014.02.003; Messinis IE, 2010, FERTIL STERIL, V94, P1554, DOI 10.1016/j.fertnstert.2009.12.055; Olivennes F, 2002, HUM REPROD UPDATE, V8, P279, DOI 10.1093/humupd/8.3.279; Olivennes F, 2003, Reprod Biomed Online, V6, P432; Pouwer AW, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009577.pub2; Reichman DE, 2014, FERTIL STERIL, V102, P99, DOI 10.1016/j.fertnstert.2014.04.010; Seyhan A, 2011, INT J WOMENS HEALTH, V3, P243, DOI 10.2147/IJWH.S15002; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; Tarlatzis BC, 2006, HUM REPROD UPDATE, V12, P333, DOI 10.1093/humupd/dml001; Wilcox J, 2005, FERTIL STERIL, V84, P108, DOI 10.1016/j.fertnstert.2005.03.016; WILDT L, 1986, HUM REPROD, V1, P15, DOI 10.1093/oxfordjournals.humrep.a136334; Xiao JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106854	29	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154123	10.1371/journal.pone.0154123	http://dx.doi.org/10.1371/journal.pone.0154123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100388	Green Published, gold			2022-12-27	WOS:000374898500149
J	Yazbek, DC; de Carvalho, AB; Barros, CS; Pestana, JOM; Canziani, MEF				Yazbek, Daniel Constantino; de Carvalho, Aluizio Barbosa; Barros, Cinara Sa; Pestana, Jose Osmar Medina; Canziani, Maria Eugenia F.			Effect of Statins on the Progression of Coronary Calcification in Kidney Transplant Recipients	PLOS ONE			English	Article							LIPID-LOWERING THERAPY; ARTERY CALCIFICATION; CARDIOVASCULAR EVENTS; CARDIAC OUTCOMES; LDL CHOLESTEROL; RISK-FACTORS; ATORVASTATIN; FLUVASTATIN; ATHEROSCLEROSIS; INFLAMMATION	Background Coronary calcification (CAC) is highly prevalent in kidney transplant recipients (KTRs) and has been associated with cardiovascular morbidity and mortality. Some studies have shown a reduction in CAC progression with statin therapy in the general and chronic kidney disease (CKD) populations. Objectives and Methods The aim of the present study was to evaluate the effect of statins on CAC progression in incident kidney transplant recipients. Patients were randomly assigned to the statin (n = 61, 10 mg daily) and control group (n = 59). CAC and biochemical analyses were performed at baseline and 12 months. Results At baseline, CAC was observed in 30% and 21% of patients in the statin and control groups, respectively (p = 0.39). The calcium score at baseline and its absolute and relative changes over 12 months of follow up were similar among the groups. In the statin group, total cholesterol (p < 0.001), low density lipoprotein cholesterol (p < 0.001) and triglycerides (p = 0.005) decreased, and the estimated glomerular function rate increased (p < 0.001) significantly. CRP levels remained stable (p = 0.52) in the statin group but increased in the control group (p = 0.01). In the multivariate model, there was no difference in CAC progression between the groups (group effect p = 0.034; time-effect p = 0.23; interaction p = 0.74). Similar results were obtained when only patients with >= 10AU calcium score (calcified) were analyzed (group effect p = 0.051; time-effect p = 0.58; interaction p = 0.99). Conclusion Although statins reduce the levels of cholesterol, triglycerides, inflammation and improve graft function, the dose adopted in the current study did not delay CAC progression within 12 months of follow up.	[Yazbek, Daniel Constantino; de Carvalho, Aluizio Barbosa; Barros, Cinara Sa; Pestana, Jose Osmar Medina; Canziani, Maria Eugenia F.] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Canziani, MEF (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, SP, Brazil.	dialisefor@uol.com.br	Canziani, Maria E F/AGI-3240-2022		Fundacao de ampara a pesquisa do estado de Sao Paulo (FAPESP)	Fundacao de ampara a pesquisa do estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Fundacao de ampara a pesquisa do estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini S, 2009, CLIN J AM SOC NEPHRO, V4, P1246, DOI 10.2215/CJN.00930209; Achenbach S, 2002, CIRCULATION, V106, P1077, DOI 10.1161/01.CIR.0000027567.49283.FF; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Baragetti A, 2013, J INTERN MED, V274, P252, DOI 10.1111/joim.12081; Bayes B, 2005, TRANSPL P, V37, P3808, DOI 10.1016/j.transproceed.2005.08.064; Budoff MJ, 2000, AM J CARDIOL, V86, P8, DOI 10.1016/S0002-9149(00)00820-1; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; D'Ascenzo F, 2013, ATHEROSCLEROSIS, V226, P178, DOI 10.1016/j.atherosclerosis.2012.10.065; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Fellstrom B, 2005, AM J TRANSPLANT, V5, P1986, DOI 10.1111/j.1600-6143.2005.00983.x; Fellstrom B, 2004, KIDNEY INT, V66, P1549, DOI 10.1111/j.1523-1755.2004.00919.x; Hariparshad SP, 2009, TRANSPL P, V41, P4178, DOI 10.1016/j.transproceed.2009.08.075; Holdaas H, 2005, AM J TRANSPLANT, V5, P2929, DOI 10.1111/j.1600-6143.2005.01105.x; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Holdaas H, 2011, J AM SOC NEPHROL, V22, P1335, DOI 10.1681/ASN.2010090987; Kanbay M, 2006, TRANSPL P, V38, P502, DOI 10.1016/j.transproceed.2005.12.052; KASISKE BL, 1988, AM J MED, V84, P985, DOI 10.1016/0002-9343(88)90302-6; Kasiske BL, 1996, J AM SOC NEPHROL, V7, P158; Konstadinidou I, 2003, TRANSPLANT P, V35, P1364, DOI 10.1016/S0041-1345(03)00376-2; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT S, V3, P1, DOI [DOI 10.1038/KISUP.2012.73, 10.1038/kisup.2012.73]; Marechal C, 2012, AM J KIDNEY DIS, V59, P258, DOI 10.1053/j.ajkd.2011.07.019; Martin-Ramirez J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099890; Masterson R, 2005, TRANSPLANTATION, V80, P332, DOI 10.1097/01.tp.0000168941.19689.cf; Moe SM, 2004, NEPHROL DIAL TRANSPL, V19, P2387, DOI 10.1093/ndt/gfh303; Morales JM, 2008, KIDNEY INT, V74, pS94, DOI 10.1038/ki.2008.547; Mulders TA, 2012, JACC-CARDIOVASC IMAG, V5, P252, DOI 10.1016/j.jcmg.2011.11.014; Nakamura Y, 2012, TRANSPL P, V44, P124, DOI 10.1016/j.transproceed.2011.11.051; Navarro-Munoz M, 2007, TRANSPL P, V39, P2259, DOI 10.1016/j.transproceed.2007.06.007; Neipp M, 2006, TRANSPLANTATION, V81, P1640, DOI 10.1097/01.tp.0000226070.74443.fb; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Oschatz E, 2006, AM J KIDNEY DIS, V48, P307, DOI 10.1053/j.ajkd.2006.04.066; Ozaki K, 2006, J ATHEROSCLER THROMB, V13, P216, DOI 10.5551/jat.13.216; Palmer S, 2015, NEPHROLOGY, V20, P304, DOI 10.1111/nep.12436; Perez V, 2009, TRANSPL P, V41, P2111, DOI 10.1016/j.transproceed.2009.06.170; Perez V, 2011, PHARMACOLOGY, V87, P161, DOI 10.1159/000324311; Roe P, 2010, ATHEROSCLEROSIS, V212, P589, DOI 10.1016/j.atherosclerosis.2010.05.016; Schankel K, 2007, AM J TRANSPLANT, V7, P2158, DOI 10.1111/j.1600-6143.2007.01903.x; Seyahi N, 2012, NEPHROL DIAL TRANSPL, V27, P2101, DOI 10.1093/ndt/gfr558; Shu KH, 2012, TRANSPL P, V44, P687, DOI 10.1016/j.transproceed.2011.11.031; Singh U, 2008, AM J CARDIOL, V102, P321, DOI 10.1016/j.amjcard.2008.03.057; Spinelli GA, 2011, TRANSPL P, V43, P3730, DOI 10.1016/j.transproceed.2011.08.074; Tawakol A, 2013, J AM COLL CARDIOL, V62, P909, DOI 10.1016/j.jacc.2013.04.066; Tenenbaum A, 2011, INT J CARDIOL, V150, P130, DOI 10.1016/j.ijcard.2010.03.001; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Wiesbauer F, 2008, J AM SOC NEPHROL, V19, P2211, DOI 10.1681/ASN.2008010101; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	52	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0151797	10.1371/journal.pone.0151797	http://dx.doi.org/10.1371/journal.pone.0151797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100788	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500007
J	Zanotto, A; Dashnamoorthy, R; Loranc, E; de Souza, LHT; Moreira, JCF; Suresh, U; Chen, YD; Bishop, AJR				Zanotto-Filho, Alfeu; Dashnamoorthy, Ravi; Loranc, Eva; de Souza, Luis H. T.; Moreira, Jose C. F.; Suresh, Uthra; Chen, Yidong; Bishop, Alexander J. R.			Combined Gene Expression and RNAi Screening to Identify Alkylation Damage Survival Pathways from Fly to Human	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CANCER-CELLS; DNA-DAMAGE; RESISTANCE; CISPLATIN; CYCLOPHOSPHAMIDE; INVOLVEMENT; GLUTATHIONE; NRF2	Alkylating agents are a key component of cancer chemotherapy. Several cellular mechanisms are known to be important for its survival, particularly DNA repair and xenobiotic detoxification, yet genomic screens indicate that additional cellular components may be involved. Elucidating these components has value in either identifying key processes that can be modulated to improve chemotherapeutic efficacy or may be altered in some cancers to confer chemoresistance. We therefore set out to reevaluate our prior Drosophila RNAi screening data by comparison to gene expression arrays in order to determine if we could identify any novel processes in alkylation damage survival. We noted a consistent conservation of alkylation survival pathways across platforms and species when the analysis was conducted on a pathway/process level rather than at an individual gene level. Better results were obtained when combining gene lists from two datasets (RNAi screen plus microarray) prior to analysis. In addition to previously identified DNA damage responses (p53 signaling and Nucleotide Excision Repair), DNA-mRNA-protein metabolism (transcription/translation) and proteasome machinery, we also noted a highly conserved cross-species requirement for NRF2, glutathione (GSH)-mediated drug detoxification and Endoplasmic Reticulum stress (ER stress)/Unfolded Protein Responses (UPR) in cells exposed to alkylation. The requirement for GSH, NRF2 and UPR in alkylation survival was validated by metabolomics, protein studies and functional cell assays. From this we conclude that RNAi/gene expression fusion is a valid strategy to rapidly identify key processes that may be extendable to other contexts beyond damage survival.	[Zanotto-Filho, Alfeu; Dashnamoorthy, Ravi; Loranc, Eva; Suresh, Uthra; Chen, Yidong; Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Children s Canc Res Inst, San Antonio, TX 78229 USA; [Dashnamoorthy, Ravi] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA; [Dashnamoorthy, Ravi] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Zanotto-Filho, Alfeu; de Souza, Luis H. T.; Moreira, Jose C. F.] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil; [Suresh, Uthra; Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Tufts Medical Center; Tufts University; University of Texas System; University of Texas Health San Antonio; Universidade Federal do Rio Grande do Sul; University of Texas System; University of Texas Health San Antonio	Bishop, AJR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Children s Canc Res Inst, San Antonio, TX 78229 USA.; Bishop, AJR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	bishopa@uthscsa.edu	ZANOTTO-FILHO, ALFEU/A-8172-2016; moreira, jose claudio/AAO-6400-2021	ZANOTTO-FILHO, ALFEU/0000-0002-4188-3095; Bishop, Alexander/0000-0002-5742-4387; Dashnamoorthy, Ravi/0000-0002-6108-2076	National Institutes of Health (NIH) [K22ES012264, 1R15ES019128, 1R01CA152063]; Voelcker Fund Young Investigator Award; GCCRI Ambassador's Circle Research Support Award; San Antonio Area Foundation grant; CPRIT [RP150445]; DOD-CDMRP Breast Cancer Research Program Postdoctoral Fellowship [W81XWH-14-1-0026]; MCTI/CNPq Universal [485758/13-0]; NIH P30 Cancer Center Support Grant [CA054174]; NATIONAL CANCER INSTITUTE [R01CA152063, P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019128, K22ES012264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067761] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Voelcker Fund Young Investigator Award; GCCRI Ambassador's Circle Research Support Award; San Antonio Area Foundation grant; CPRIT; DOD-CDMRP Breast Cancer Research Program Postdoctoral Fellowship; MCTI/CNPq Universal; NIH P30 Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was by the National Institutes of Health (NIH) (K22ES012264, 1R15ES019128 and 1R01CA152063), Voelcker Fund Young Investigator Award, GCCRI Ambassador's Circle Research Support Award, San Antonio Area Foundation grant and CPRIT (RP150445) to AJRB; DOD-CDMRP Breast Cancer Research Program Postdoctoral Fellowship (W81XWH-14-1-0026) to AZF, and MCTI/CNPq Universal (485758/13-0) to AZF and JCFM; and a NIH P30 Cancer Center Support Grant (CA054174) to CTRC.; We are grateful to CTRC Office of Scientific Writing for manuscript comments and UTHSCSA/CTRC Metabolomics core. Funding was by the NIH (K22ES012264, 1R15ES019128 and 1R01CA152063), Voelcker Fund Young Investigator Award, GCCRI Ambassador's Circle Research Support Award, San Antonio Area Foundation grant and CPRIT (RP150445) to AJRB; DOD-CDMRP Breast Cancer Research Program Postdoctoral Fellowship (W81XWH-14-1-0026) to AZF, and MCTI/CNPq Universal (485758/13-0) to AZF and JCFM; and a NIH P30 Cancer Center Support Grant (CA054174) to CTRC.	Abdelrahman AM, 2010, J APPL TOXICOL, V30, P15, DOI 10.1002/jat.1465; Anders S, 2014, HTSEQ PYTHON FRAMEWO, DOI [10.1101/ 002824, DOI 10.1101/002824, 10.1101/002824]; Anderson CP, 1997, EUR J CANCER, V33, P2016, DOI 10.1016/S0959-8049(97)00203-7; Bakal C, 2011, BRIEF FUNCT GENOMICS, V10, P197, DOI 10.1093/bfgp/elr015; Carra S, 2010, J BIOL CHEM, V285, P37811, DOI 10.1074/jbc.M110.127498; Castro MAA, 2009, BIOINFORMATICS, V25, P1468, DOI 10.1093/bioinformatics/btp246; Chen Helen H. W., 2010, Metal-Based Drugs, P430939, DOI 10.1155/2010/430939; Chen N, 2008, BRIT J PHARMACOL, V153, P1364, DOI 10.1038/bjp.2008.15; FRIEDMAN HS, 1992, CANCER RES, V52, P5373; Fry RC, 2005, ANNU REV MICROBIOL, V59, P357, DOI 10.1146/annurev.micro.59.031805.133658; Fujimori S, 2004, INT J ONCOL, V25, P413; Goto S, 1999, FREE RADICAL RES, V31, P549, DOI 10.1080/10715769900301121; Hao LH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003235; Hooper SD, 2005, BIOINFORMATICS, V21, P4432, DOI 10.1093/bioinformatics/bti696; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lee HR, 2008, MOL CELL BIOCHEM, V318, P23, DOI 10.1007/s11010-008-9853-y; Lee MW, 2007, YEAST, V24, P145, DOI 10.1002/yea.1446; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035122; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; MOORE MJ, 1991, CLIN PHARMACOKINET, V20, P194, DOI 10.2165/00003088-199120030-00002; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sugimoto C, 1996, ANTICANCER RES, V16, P675; Walhout AJM, 2002, CURR BIOL, V12, P1952, DOI 10.1016/S0960-9822(02)01279-4; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441	33	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153970	10.1371/journal.pone.0153970	http://dx.doi.org/10.1371/journal.pone.0153970			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100653	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500114
J	Jiang, GJ; Zhang, T; An, T; Zhao, DD; Yang, XY; Zhang, DW; Zhang, Y; Mu, QQ; Yu, N; Ma, XS; Gao, SH				Jiang, Guang-Jian; Zhang, Teng; An, Tian; Zhao, Dan-Dan; Yang, Xiu-Yan; Zhang, Dong-Wei; Zhang, Yi; Mu, Qian-Qian; Yu, Na; Ma, Xue-Shan; Gao, Si-Hua			Differential Expression of Long Noncoding RNAs between Sperm Samples from Diabetic and Non-Diabetic Mice	PLOS ONE			English	Article							EPIGENETIC REGULATION; SPERMATOZOAL RNAS; DNA METHYLATION; SPERMATOGENESIS; GENE; INHERITANCE; CANCER	To investigate the potential core reproduction-related genes associated with the development of diabetes, the expression profiles of long noncoding RNA (lncRNA) and messenger RNA (mRNA) in the sperm of diabetic mice were studied. We used microarray analysis to detect the expression of lncRNAs and coding transcripts in six diabetic and six normal sperm samples, and differentially expressed lncRNAs and mRNAs were identified through Volcano Plot filtering. The function of differentially expressed mRNA was determined by pathway and gene ontology (GO) analysis, and the function of lncRNAs was studied by subgroup analysis and their physical or functional relationships with corresponding mRNAs. A total of 7721 lncRNAs and 6097 mRNAs were found to be differentially expressed between the diabetic and normal sperm groups. The diabetic sperm exhibited aberrant expression profiles for lncRNAs and mRNAs, and GO and pathway analyses showed that the functions of differentially expressed mRNAs were closely related with many processes involved in the development of diabetes. Furthermore, potential core genes that might play important roles in the pathogenesis of diabetes-related low fertility were revealed by lncRNA- and mRNA-interaction studies, as well as coding-noncoding gene co-expression analysis based on the microarray expression profiles.	[Jiang, Guang-Jian; An, Tian; Zhao, Dan-Dan; Yang, Xiu-Yan; Zhang, Dong-Wei; Zhang, Yi; Mu, Qian-Qian; Yu, Na; Gao, Si-Hua] Beijing Univ Chinese Med, Diabet Res Ctr, Beijing, Peoples R China; [Zhang, Teng; Ma, Xue-Shan] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China	Beijing University of Chinese Medicine; Chinese Academy of Sciences; Institute of Zoology, CAS	Gao, SH (corresponding author), Beijing Univ Chinese Med, Diabet Res Ctr, Beijing, Peoples R China.	sihuagaopaper@sina.com	An, Tian/AAS-3747-2021; Zhang, Dongwei/AAS-8384-2020	Zhang, Dongwei/0000-0002-7793-1482	National Natural Science Foundation of China [NSFC81274041, NSFC81273995]; MOE [2011DFA30920]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOE(Ministry of Higher Education & Scientific Research (MHESR))	Funded by National Natural Science Foundation of China (NSFC81274041, NSFC81273995); the International Cooperation Projects of MOE (2011DFA30920). G,J,Z,A,M,Z,Y,Z,Z,M,M.	Akhade VS, 2015, NUCL ACIDS RES; Annalisa DR, 2013, NATURE, V503, P371, DOI [10.1038/nature12598, DOI 10.1038/NATURE12598]; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Ding GL, 2015, ASIAN J ANDROL, V17, P948, DOI 10.4103/1008-682X.150844; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fukuda N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003858; Garcia-Jimenez C, 2014, J MOL ENDOCRINOL, V52, pR51, DOI 10.1530/JME-13-0152; Garzon R, 2014, P NATL ACAD SCI USA, V111, P18679, DOI 10.1073/pnas.1422050112; Ghanbari E, 2015, INT J FERTIL STERIL, V9, P113; Jodar M, 2013, HUM REPROD UPDATE, V19, P604, DOI 10.1093/humupd/dmt031; Kerr GE, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.112.105809; Kurian L, 2015, CIRCULATION, V131, P1278, DOI 10.1161/CIRCULATIONAHA.114.013303; Lambrot R, 2012, J ANDROL, V33, P1058, DOI 10.2164/jandrol.111.013870; Li YL, 2015, ONCOTARGET, V6, P27641, DOI 10.18632/oncotarget.4737; Luk ACS, 2014, REPRODUCTION, V147, pR131, DOI 10.1530/REP-13-0594; Ma LN, 2013, RNA BIOL, V10, P925, DOI 10.4161/rna.24604; Merry CR, 2015, HUM MOL GENET, V24, P6240, DOI 10.1093/hmg/ddv343; Nolasco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042536; Ostermeier GC, 2005, J ANDROL, V26, P70; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Pinney SE, 2012, CURR DIABETES REP, V12, P67, DOI 10.1007/s11892-011-0248-1; Sendler E, 2013, NUCLEIC ACIDS RES, V41, P4104, DOI 10.1093/nar/gkt132; Song XD, 2014, J CELL MOL MED, V18, P991, DOI 10.1111/jcmm.12243; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wei YC, 2015, HUM REPROD UPDATE, V21, P194, DOI 10.1093/humupd/dmu061; Yang L, 2014, TRENDS BIOCHEM SCI, V39, P35, DOI 10.1016/j.tibs.2013.10.002; Zamudio NM, 2008, REPRODUCTION, V136, P131, DOI 10.1530/REP-07-0576	30	22	24	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154028	10.1371/journal.pone.0154028	http://dx.doi.org/10.1371/journal.pone.0154028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119337	Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200041
J	Schrimshaw, EW; Antebi-Gruszka, N; Downing, MJ				Schrimshaw, Eric W.; Antebi-Gruszka, Nadav; Downing, Martin J., Jr.			Viewing of Internet-Based Sexually Explicit Media as a Risk Factor for Condomless Anal Sex among Men Who Have Sex with Men in Four US Cities	PLOS ONE			English	Article							HIV-NEGATIVE MEN; ONLINE MEDIA; PORNOGRAPHY; PREVENTION; TRANSMISSION; BEHAVIORS; SEEKING; STATES; MSM	The last decade has seen a dramatic increase in the availability of sexually explicit media (SEM) on the Internet. Men who have sex with men (MSM) report near universal use of SEM. However, this widespread use of SEM among MSM may contribute to more condomless anal sex. To examine the association of viewing SEM on the Internet and the number of condomless anal sex encounters among MSM, in 2012, an online survey was conducted of 265 MSM from New York, Philadelphia, Baltimore, or Washington D.C. who reported viewing SEM online in the past 3 months. Analyses were performed using negative binomial regression. Nearly all men reported viewing SEM featuring anal sex with (91%) or without (92%) condoms in the past 3 months. Neither viewing more hours of SEM per week or compulsively viewing SEM were associated with more condomless anal sex encounters. Rather, viewing a greater proportion of SEM containing condomless anal sex was associated with engaging in more condomless anal encounters (IRR = 1.25), while viewing a greater proportion of SEM containing anal sex where condoms were used was associated with fewer condomless anal sex encounters (IRR = 0.62). MSM reported that viewing SEM caused changes in their sexual fantasies, desires, and behaviors. These findings provide important insights for health policy and the design of interventions addressing SEM and condomless sex among MSM. The findings suggest that condom use by SEM performers may benefit not only actor health, but also have health implications for SEM viewers.	[Schrimshaw, Eric W.; Antebi-Gruszka, Nadav] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY USA; [Downing, Martin J., Jr.] Publ Hlth Solut Inc, Res & Evaluat, New York, NY USA	Columbia University	Schrimshaw, EW (corresponding author), Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY USA.	es458@cumc.columbia.edu		Schrimshaw, Eric/0000-0003-2755-1796	National Research and Development Institutes; U.S. National Institute on Drug Abuse [T32-DA007233]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007233] Funding Source: NIH RePORTER	National Research and Development Institutes; U.S. National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	EWS and NAG received no external funding for the data collection, analysis, or writing of this work. Data collection efforts for MJD were supported by a postdoctoral fellowship from the National Research and Development Institutes with funding from the U.S. National Institute on Drug Abuse (T32-DA007233). The funder provided support in the form of salary for MJD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of the article is that of the authors and does not necessarily represent the views of the funders - the National Institute of Drug Abuse or the National Institutes of Health.	[Anonymous], SAF SEX; Bandura A., 1969, SOCIAL FDN THOUGHT A; Bishop CJ, 2015, PSYCHOL SEX, V6, P5, DOI 10.1080/19419899.2014.983739; Chiasson MA, 2007, JAIDS-J ACQ IMM DEF, V44, P235, DOI 10.1097/QAI.0b013e31802e298c; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; Dines G., 2010, PORNLAND PORN HIJACK; Downing MJ, 2014, ARCH SEX BEHAV, V43, P811, DOI 10.1007/s10508-013-0121-1; Downing MJ, 2014, ADDICT BEHAV, V39, P1126, DOI 10.1016/j.addbeh.2014.03.007; Eaton LA, 2012, SEX HEALTH, V9, P166, DOI 10.1071/SH10092; Escoffier J., 2009, BIGGER LIFE HIST GAY; Grov C, 2012, AIDS BEHAV, V16, P807, DOI 10.1007/s10461-011-9999-6; Grov C, 2010, AIDS BEHAV, V14, P1387, DOI 10.1007/s10461-009-9661-8; Hald GM, 2013, J SEX MED, V10, P757, DOI 10.1111/j.1743-6109.2012.02988.x; Hernandez-Romieu AC, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.3342; Hirshfield S, 2015, AM J PUBLIC HEALTH, V105, P1849, DOI 10.2105/AJPH.2014.302346; KALICHMAN SC, 1995, J PERS ASSESS, V65, P586, DOI 10.1207/s15327752jpa6503_16; Kendall CN, 2004, J HOMOSEXUAL, V47, P83, DOI 10.1300/J082v47n03_06; Madden M, 2011, 65 ONLINE ADULTS USE; Nelson KM, 2016, J SEX RES, V53, P588, DOI 10.1080/00224499.2015.1066744; Nelson KM, 2014, ARCH SEX BEHAV, V43, P833, DOI 10.1007/s10508-013-0238-2; Nelson KM, 2014, AIDS CARE, V26, P931, DOI 10.1080/09540121.2013.871219; Rosser BRS, 2013, AIDS BEHAV, V17, P1488, DOI 10.1007/s10461-013-0454-8; Rosser BRS, 2012, AIDS BEHAV, V16, P1373, DOI 10.1007/s10461-012-0135-z; Stein D, 2012, ARCH SEX BEHAV, V41, P411, DOI 10.1007/s10508-011-9789-2; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Sullivan PS, 2013, JAIDS-J ACQ IMM DEF, V63, pS102, DOI 10.1097/QAI.0b013e3182949e85; Vial AC, 2014, AIDS EDUC PREV, V26, P56, DOI 10.1521/aeap.2014.26.1.56; Wilken JA, 2016, MMWR-MORBID MORTAL W, V65, P110, DOI 10.15585/mmwr.mm6505a3; Wright PJ, 2013, J SEX RES, V50, P60, DOI 10.1080/00224499.2011.628132	29	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154439	10.1371/journal.pone.0154439	http://dx.doi.org/10.1371/journal.pone.0154439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119990	gold, Green Submitted, Green Published			2022-12-27	WOS:000374976200075
J	Bao, GQ; Qu, FL; He, L; Zhao, HD; Wang, N; Ji, G; He, XL				Bao, Guoqiang; Qu, Falin; He, Li; Zhao, Huadong; Wang, Nan; Ji, Gang; He, Xianli			Prognostic Significance of Tag SNP rs1045411 in HMGB1 of the Aggressive Gastric Cancer in a Chinese Population	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; CELL LUNG-CANCER; GENETIC POLYMORPHISMS; CHROMATIN PROTEIN; TUMOR-CELLS; EXPRESSION; ASSOCIATION; OVEREXPRESSION; CHEMOTHERAPY; SUPPRESSION	Compelling evidences have suggested that high mobility group box-1 (HMGB1) gene plays a crucial role in cancer development and progression. This study aimed to evaluate the effects of single nucleotide polymorphisms (SNPs) in HMGB1 gene on the survival of gastric cancer (GC) patients. Three tag SNPs from HMGB1 gene were selected and genotyped using Sequenom iPEX genotyping system in a cohort of 1030 GC patients (704 in training set, 326 in validation set). Multivariate Cox proportional hazard model and Kaplan-Meier Curve were used for prognosis analysis. AG/AA genotypes of SNP rs1045411 in HMGB1 gene were significantly associated with better overall survival (OS) in a set of 704 GC patients when compared with GG genotypes (HR = 0.77, 95% CI: 0.60-0.97, P = 0.032). This prognostic effect was verified in an independent validation set and pooled analysis (HR = 0.80, 95% CI: 0.62-0.99, P = 0.046; HR = 0.78, 95% CI: 0.55-0.98, P = 0.043, respectively). In stratified analysis, the protective effect of rs1045411 AG/AA genotypes was more prominent in patients with adverse strata, compared with patients with favorable strata. Furthermore, strong joint predictive effects on OS of GC patients were noted between rs1045411 genotypes and Lauren classification, differentiation, stage or adjuvant chemotherapy. Additionally, functional assay indicated a significant effect of rs1045411 on HMGB1 expression. Our results suggest that rs1045411 in HMGB1 is significantly associated with clinical outcomes of Chinese GC patients after surgery, especially in those with aggressive status, which warrants further validation in other ethnic populations.	[Bao, Guoqiang; Qu, Falin; Zhao, Huadong; Wang, Nan; He, Xianli] Fourth Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian 710032, Peoples R China; [He, Li] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; [Ji, Gang] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China	Air Force Military Medical University; Emory University; Air Force Military Medical University	Bao, GQ; He, XL (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian 710032, Peoples R China.	guoqiang@fmmu.edu.cn; wanghe@fmmu.edu.cn	JI, Gang/AAG-9877-2020	JI, Gang/0000-0002-2415-6275	National Natural Science Foundation of China [81272201, 81572916, 81200330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China ( No. 81272201 and No. 81572916 to GB; No. 81200330 to NW).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker KF, 2000, SURG ONCOL, V9, P5, DOI 10.1016/S0960-7404(00)00016-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Catalano V, 2005, CRIT REV ONCOL HEMAT, V54, P209, DOI 10.1016/j.critrevonc.2005.01.002; Choi YR, 2003, CANCER RES, V63, P2188; Chung HW, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-38; Demoulin S, 2015, INT J CANCER, V137, P345, DOI 10.1002/ijc.29389; Dong XD, 2007, J IMMUNOTHER, V30, P596, DOI 10.1097/CJI.0b013e31804efc76; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Evans A, 2004, J SURG ONCOL, V88, P86, DOI 10.1002/jso.20136; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferro A, 2014, EUR J CANCER, V50, P1330, DOI 10.1016/j.ejca.2014.01.029; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1957, DOI 10.1111/j.1745-7254.2007.00669.x; Kornblit B, 2007, TISSUE ANTIGENS, V70, P151, DOI 10.1111/j.1399-0039.2007.00854.x; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Lee HJ, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0034318; Li QL, 2014, ONCOTARGET, V5, P6387, DOI 10.18632/oncotarget.2201; Liu FR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-135; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; McLean MIH, 2014, NAT REV GASTRO HEPAT, V11, P664, DOI 10.1038/nrgastro.2014.143; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Naumnik W, 2009, FOLIA HISTOCHEM CYTO, V47, P703, DOI 10.2478/v10042-009-0025-z; Pu X, 2013, CANCER RES, V73, P1867, DOI 10.1158/0008-5472.CAN-12-0873; Shen XK, 2009, ONCOL REP, V22, P535, DOI 10.3892/or_00000468; Supic G, 2015, ORAL DIS, V21, P536, DOI 10.1111/odi.12318; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Ueda M, 2014, ANTICANCER RES, V34, P5357; Ulrich CM, 2003, NAT REV CANCER, V3, P912, DOI 10.1038/nrc1233; Volp K, 2006, GUT, V55, P234, DOI 10.1136/gut.2004.062729; Wang ML, 2011, INT J CANCER, V129, P1207, DOI 10.1002/ijc.25740; Wang Y, 2014, CLIN EXP PHARMACOL P, V41, P408, DOI 10.1111/1440-1681.12232; Wild CA, 2012, ORAL ONCOL, V48, P409, DOI 10.1016/j.oraloncology.2011.12.009; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Xiang YY, 1997, INT J CANCER, V74, P1; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Zhang J., 2014, INT J DISTRIB SENS N, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0110734	39	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154378	10.1371/journal.pone.0154378	http://dx.doi.org/10.1371/journal.pone.0154378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116470	Green Published, gold, Green Submitted			2022-12-27	WOS:000374973600064
J	Cui, JY; Good, NM; Hu, B; Yang, J; Wang, QW; Sadilek, M; Yang, S				Cui, Jinyu; Good, Nathan M.; Hu, Bo; Yang, Jing; Wang, Qianwen; Sadilek, Martin; Yang, Song			Metabolomics Revealed an Association of Metabolite Changes and Defective Growth in Methylobacterium extorquens AM1 Overexpressing ecm during Growth on Methanol	PLOS ONE			English	Article							ETHYLMALONYL-COA PATHWAY; TRANSCRIPTIONAL REGULATOR; MASS-SPECTROMETRY; GENE; IDENTIFICATION; DEHYDROGENASE; ACID; METHYLOTROPHY; MEVALONATE; OXIDATION	Methylobacterium extorquens AM1 is a facultative methylotroph capable of growth on both single-carbon and multi-carbon compounds. The ethylmalonyl-CoA (EMC) pathway is one of the central assimilatory pathways in M. extorquens during growth on C1 and C2 substrates. Previous studies had shown that ethylmalonyl-CoA mutase functioned as a control point during the transition from growth on succinate to growth on ethylamine. In this study we overexpressed ecm, phaA, mcmAB and found that upregulating ecm by expressing it from the strong constitutive mxaF promoter caused a 27% decrease in growth rate on methanol compared to the strain with an empty vector. Targeted metabolomics demonstrated that most of the central intermediates in the ecm over-expressing strain did not change significantly compared to the control strain; However, poly-beta-hydroxybutyrate (PHB) was 4.5-fold lower and 3-hydroxybutyryl-CoA was 1.6-fold higher. Moreover, glyoxylate, a toxic and highly regulated essential intermediate, was determined to be 2.6-fold higher when ecm was overexpressed. These results demonstrated that overexpressing ecm can manipulate carbon flux through the EMC pathway and divert it from the carbon and energy storage product PHB, leading to an accumulation of glyoxylate. Furthermore, untargeted metabolomics discovered two unusual metabolites, alanine (Ala)-meso-diaminopimelic acid (mDAP) and Ala-mDAP-Ala, each over 45-fold higher in the ecm over-expressing strain. These two peptides were also found to be highly produced in a dose-dependent manner when glyoxylate was added to the control strain. Overall, this work has explained a direct association of ecm overexpression with glyoxylate accumulation up to a toxic level, which inhibits cell growth on methanol. This research provides useful insight for manipulating the EMC pathway for efficiently producing high-value chemicals in M. extorquens.	[Cui, Jinyu; Yang, Jing; Yang, Song] Qingdao Agr Univ, Sch Life Sci, Shandong Prov Key Lab Appl Mycol, Qingdao, Shandong, Peoples R China; [Cui, Jinyu; Yang, Jing; Yang, Song] Qingdao Int Ctr Microbes Utilizing Biogas, Qingdao, Shandong, Peoples R China; [Good, Nathan M.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Hu, Bo] Kemin Ind, KI Res & Dev, Des Moines, IA USA; [Wang, Qianwen] Qingdao Agr Univ, Cent Lab, Qingdao, Shandong, Peoples R China; [Sadilek, Martin] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Yang, Song] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China	Qingdao Agricultural University; University of Washington; University of Washington Seattle; Qingdao Agricultural University; University of Washington; University of Washington Seattle; Tianjin University	Yang, S (corresponding author), Qingdao Agr Univ, Sch Life Sci, Shandong Prov Key Lab Appl Mycol, Qingdao, Shandong, Peoples R China.; Yang, S (corresponding author), Qingdao Int Ctr Microbes Utilizing Biogas, Qingdao, Shandong, Peoples R China.; Yang, S (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China.	yangsong1209@163.com	Cui, Jinyu/AAV-9450-2020		Petrochemical Joint Fund of National Natural Science Foundation of China [U1462109]; Shandong Province Natural Science Foundation [ZR2013CM024]; Key Laboratory for Industrial Biocatalysis (Tsinghua University) Ministry of Education [2015102]; USA DOE [DE-SC0006871]	Petrochemical Joint Fund of National Natural Science Foundation of China; Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Key Laboratory for Industrial Biocatalysis (Tsinghua University) Ministry of Education; USA DOE(United States Department of Energy (DOE))	This work was supported by a grant from the Petrochemical Joint Fund of National Natural Science Foundation of China (Grant No. U1462109, www.nsfc.gov.cn), a grant from Shandong Province Natural Science Foundation (Grant No. ZR2013CM024), a grant from Key Laboratory for Industrial Biocatalysis (Tsinghua University) Ministry of Education (No. 2015102) to SY, and a grant from USA DOE (Grant No. DE-SC0006871, www.energy.gov/) to MEL. The funder (Grant No. DE-SC0006871) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM A, 1984, MED RES REV, V4, P111, DOI 10.1002/med.2610040202; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Alber BE, 2011, APPL MICROBIOL BIOT, V89, P17, DOI 10.1007/s00253-010-2873-z; Amoroso A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002571; Anthony C., 1982, BIOCH METHYLOTROPHS; Avery EL, 1998, ARCH ENVIRON CON TOX, V35, P229, DOI 10.1007/s002449900371; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bertau M., 2014, METHANOL BASIC CHEM; Bourque D, 1995, APPL MICROBIOL BIOT, V44, P367; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova L, 2007, J BACTERIOL, V189, P9076, DOI 10.1128/JB.01229-07; Choi YJ, 2006, APPL ENVIRON MICROB, V72, P7723, DOI 10.1128/AEM.02002-06; Chou HH, 2012, CELL REP, V1, P133, DOI 10.1016/j.celrep.2011.12.003; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Ewald JC, 2013, MOL BIOSYST, V9, P440, DOI 10.1039/c2mb25423a; Gerlich M, 2013, J MASS SPECTROM, V48, P291, DOI 10.1002/jms.3123; Good NM, 2015, J BACTERIOL, V197, P727, DOI 10.1128/JB.02478-14; GOODELL EW, 1985, J BACTERIOL, V162, P391, DOI 10.1128/JB.162.1.391-397.1985; Guo XF, 2006, ARCH MICROBIOL, V186, P139, DOI 10.1007/s00203-006-0131-7; Holman J. D., 2014, BIOINFORMATICS, V46, DOI DOI 10.1002/0471250953.BI1324S46; Hu B, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0156-0; Hu B, 2012, J BACTERIOL, V194, P2802, DOI 10.1128/JB.00061-12; Kalyuzhnaya MG, 2003, J BACTERIOL, V185, P1229, DOI 10.1128/JB.185.4.1229-1235.2003; Kataoka N, 2015, J BIOTECHNOL, V204, P25, DOI 10.1016/j.jbiotec.2015.03.027; Kiefer P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007831; Korotkova N, 2002, J BACTERIOL, V184, P1750, DOI 10.1128/JB.184.6.1750-1758.2002; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; NUNN DN, 1986, J BACTERIOL, V166, P581, DOI 10.1128/jb.166.2.581-590.1986; Ochsner AM, 2015, APPL MICROBIOL BIOT, V99, P517, DOI 10.1007/s00253-014-6240-3; Okubo Y, 2007, OMICS, V11, P325, DOI 10.1089/omi.2007.0027; Okubo Y, 2010, J BACTERIOL, V192, P1813, DOI 10.1128/JB.01166-09; Orita I, 2014, APPL MICROBIOL BIOT, V98, P3715, DOI 10.1007/s00253-013-5490-9; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Peyraud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048271; Peyraud R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-189; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Schiesel S, 2010, ANAL BIOANAL CHEM, V396, P1655, DOI 10.1007/s00216-009-3432-2; Schneider K, 2012, J BIOL CHEM, V287, P757, DOI 10.1074/jbc.M111.305219; Schrader J, 2009, TRENDS BIOTECHNOL, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; Silva F, 2012, BIOTECHNOL ADV, V30, P691, DOI 10.1016/j.biotechadv.2011.12.005; Skovran E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014091; Smejkalova H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013001; Sonntag F, 2015, METAB ENG, V32, P82, DOI 10.1016/j.ymben.2015.09.004; Sonntag F, 2015, APPL MICROBIOL BIOT, V99, P3407, DOI 10.1007/s00253-015-6418-3; Sonntag F, 2014, APPL MICROBIOL BIOT, V98, P4533, DOI 10.1007/s00253-013-5456-y; Tabata K, 2004, BIOTECHNOL LETT, V26, P1487, DOI 10.1023/B:BILE.0000044449.08268.7d; Van Dien SJ, 2003, BIOTECHNOL BIOENG, V84, P45, DOI 10.1002/bit.10745; von Borzyskowski LS, 2015, ACS SYNTH BIOL, V4, P430, DOI 10.1021/sb500221v; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yang S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00070; Yang S, 2009, J CHROMATOGR A, V1216, P3280, DOI 10.1016/j.chroma.2009.02.030; Zhu WL, 2016, APPL MICROBIOL BIOT, V100, P2171, DOI 10.1007/s00253-015-7078-z	56	14	16	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154043	10.1371/journal.pone.0154043	http://dx.doi.org/10.1371/journal.pone.0154043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116459	gold, Green Published, Green Submitted			2022-12-27	WOS:000374973600040
J	Bayle, N; Patel, AS; Crisan, D; Guo, LJ; Hutin, E; Weisz, DJ; Moore, ST; Gracies, JM				Bayle, Nicolas; Patel, Amar S.; Crisan, Diana; Guo, Lanjun J.; Hutin, Emilie; Weisz, Donald J.; Moore, Steven T.; Gracies, Jean-Michel			Contribution of Step Length to Increase Walking and Turning Speed as a Marker of Parkinson's Disease Progression	PLOS ONE			English	Article							GAIT; DISORDERS; PEOPLE; FORCE; BRADYKINESIA; RELIABILITY; ACCURACY; TASK; BODY	When increasing ambulation speed in Parkinson's disease, step cadence increases more than stride length, indicating movement scaling difficulties that affect step generation in particular. We investigated whether step length variation when increasing ambulation speed was related to disease progression. Patients with Parkinson's disease (N = 39) and controls (N = 152) performed two timed ambulation tasks: at a 'free' (self-selected) pace and then at 'maximal' speed. The total number of steps (including during turns) and time to complete the task were clinically measured. The relative contribution of step length and cadence to increased ambulation speed was determined using two methods: the ratios of change in step length or in cadence to the change in ambulation speed, and the step length index. While the relative contribution of step length and cadence to increased ambulation speed was independent of age in both control and patient groups, in Parkinson's disease there was a negative correlation between time from diagnosis and the ratio of change in step length to change in ambulation speed (R = 0.54; p = 0.0004) and the step length index (R = 0.56, p = 0.0002). In parallel, there was a positive correlation between time since diagnosis and the ratio of change in cadence to change in ambulation speed (R = 0.57; p = 0.0002). The relative contribution of step length and cadence to increased ambulation speed is age invariant but a marker of Parkinson's disease advancement, and can be easily determined in the clinical setting.	[Bayle, Nicolas; Hutin, Emilie; Gracies, Jean-Michel] Univ Paris Est Creteil, Hop Univ Henri Mondor, AP HP, Lab Anal & Restaurat Mouvement,EA BIOTN 7377, Creteil, France; [Patel, Amar S.; Moore, Steven T.; Gracies, Jean-Michel] Mt Sinai Sch Med, Dept Neurol, Robert & John M Bendheim Parkinson & Movement Dis, New York, NY USA; [Crisan, Diana; Guo, Lanjun J.; Weisz, Donald J.] Mt Sinai Sch Med, Neurosurg Dept, New York, NY USA; [Moore, Steven T.] Mt Sinai Sch Med, Dept Neurol, Human Aerosp Lab, New York, NY USA	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bayle, N (corresponding author), Univ Paris Est Creteil, Hop Univ Henri Mondor, AP HP, Lab Anal & Restaurat Mouvement,EA BIOTN 7377, Creteil, France.	nicolas.bayle@aphp.fr	Moore, Steven T/W-2204-2019	Moore, Steven/0000-0003-3995-4912; nicolas, bayle/0000-0002-3726-2712				ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; BLIN O, 1991, J NEUROL SCI, V103, P51, DOI 10.1016/0022-510X(91)90283-D; Canning CG, 2006, ARCH PHYS MED REHAB, V87, P371, DOI 10.1016/j.apmr.2005.11.021; Corcos DM, 1996, ANN NEUROL, V39, P79, DOI 10.1002/ana.410390112; Cunnington R, 2001, MOVEMENT DISORD, V16, P849, DOI 10.1002/mds.1181; Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C; Duncan RP, 2011, DISABIL REHABIL, V33, P1440, DOI 10.3109/09638288.2010.533245; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Guimaraes R M, 1980, Int Rehabil Med, V2, P177; HAGEMAN PA, 1986, PHYS THER, V66, P1382, DOI 10.1093/ptj/66.9.1382; HALLETT M, 1980, BRAIN, V103, P301, DOI 10.1093/brain/103.2.301; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161, DOI 10.1249/00005768-198820020-00010; Hirasaki E, 1999, EXP BRAIN RES, V127, P117, DOI 10.1007/s002210050781; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Lang AE, 2006, MOVEMENT DISORD, V21, pS171, DOI 10.1002/mds.20955; Moore ST, 2007, GAIT POSTURE, V26, P200, DOI 10.1016/j.gaitpost.2006.09.011; Moore ST, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-82; Morris M, 1998, MOVEMENT DISORD, V13, P61, DOI 10.1002/mds.870130115; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; MORRIS ME, 1994, J NEUROL NEUROSUR PS, V57, P1532, DOI 10.1136/jnnp.57.12.1532; Morris S, 2001, PHYS THER, V81, P810, DOI 10.1093/ptj/81.2.810; O'Sullivan JD, 1998, MOVEMENT DISORD, V13, P900, DOI 10.1002/mds.870130607; Parkinson J, 1817, ESSAY SHAKING PALSY; Peterson DS, 2015, J NEUROL NEUROSUR PS, V86, P786, DOI 10.1136/jnnp-2014-308840; PHILLIPS JG, 1994, J NEUROL, V241, P439, DOI 10.1007/BF00900963; Post B, 2005, MOVEMENT DISORD, V20, P1577, DOI 10.1002/mds.20640; Rand MK, 2000, NEUROPSYCHOLOGIA, V38, P203, DOI 10.1016/S0028-3932(99)00059-7; Snijders AH, 2007, LANCET NEUROL, V6, P63, DOI 10.1016/S1474-4422(06)70678-0; STELMACH GE, 1989, EXP BRAIN RES, V76, P165; STELMACH GE, 1988, NEUROPSYCHOLOGIA, V26, P93, DOI 10.1016/0028-3932(88)90033-4; Stocchi F, 2013, MOVEMENT DISORD, V28, P3, DOI 10.1002/mds.25337; TEASDALE N, 1990, J NEUROL NEUROSUR PS, V53, P862, DOI 10.1136/jnnp.53.10.862; Teo WP, 2013, EXP BRAIN RES, V227, P323, DOI 10.1007/s00221-013-3491-7; van Loo MA, 2003, DISABIL REHABIL, V25, P1195, DOI 10.1080/09638280310001599989; Zijlstra W, 1998, GAIT POSTURE, V7, P53, DOI 10.1016/S0966-6362(97)00037-4	37	18	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152469	10.1371/journal.pone.0152469	http://dx.doi.org/10.1371/journal.pone.0152469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111531	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600002
J	Malin, SK; Rynders, CA; Weltman, JY; Barrett, EJ; Weltman, A				Malin, Steven K.; Rynders, Corey A.; Weltman, Judy Y.; Barrett, Eugene J.; Weltman, Arthur			Exercise Intensity Modulates Glucose-Stimulated Insulin Secretion when Adjusted for Adipose, Liver and Skeletal Muscle Insulin Resistance	PLOS ONE			English	Article							BETA-CELL FUNCTION; CARBOHYDRATE-METABOLISM; SENSITIVITY; FAT; TOLERANCE; INDEX; RISK; OVERWEIGHT; INCREASES; RECOVERY	Little is known about the effects of exercise intensity on compensatory changes in glucose-stimulated insulin secretion (GSIS) when adjusted for adipose, liver and skeletal muscle insulin resistance (IR). Fifteen participants (8F, Age: 49.9 +/- 3.6yr; BMI: 31.0 +/- 1.5kg/m(2); VO(2)peak: 23.2 +/- 1.2mg/kg/min) with prediabetes (ADA criteria, 75g OGTT and/or HbA(1c)) underwent a time-course matched Control, and isocaloric (200kcal) exercise at moderate (MIE; at lactate threshold (LT)), and high-intensity (HIE; 75% of difference between LT and VO(2)peak). A 75g OGTT was conducted 1 hour post-exercise/Control, and plasma glucose, insulin, C-peptide and free fatty acids were determined for calculations of skeletal muscle (1/Oral Minimal Model; SMIR), hepatic (HOMA(IR)), and adipose (ADIPOSE(IR)) IR. Insulin secretion rates were determined by deconvolution modeling for GSIS, and disposition index (DI; GSIS/IR; DISMIR, DIHOMAIR, DIADIPOSEIR) calculations. Compared to Control, exercise lowered SMIR independent of intensity (P< 0.05), with HIE raising HOMA(IR) and ADIPOSE(IR) compared with Control (P< 0.05). GSIS was not reduced following exercise, but DIHOMAIR and DIADIPOSEIR were lowered more following HIE compared with Control (P< 0.05). However, DISMIR increased in an intensity based manner relative to Control (P< 0.05), which corresponded with lower post-prandial blood glucose levels. Taken together, pancreatic insulin secretion adjusts in an exercise intensity dependent manner to match the level of insulin resistance in skeletal muscle, liver and adipose tissue. Further work is warranted to understand the mechanism by which exercise influences the cross-talk between tissues that regulate blood glucose in people with prediabetes.	[Malin, Steven K.; Weltman, Arthur] Univ Virginia, Dept Kinesiol, Charlottesville, VA USA; [Malin, Steven K.; Barrett, Eugene J.; Weltman, Arthur] Univ Virginia, Div Endocrinol & Metab, Charlottesville, VA USA; [Malin, Steven K.; Weltman, Judy Y.; Weltman, Arthur] Univ Virginia, Exercise Physiol Core Lab, Charlottesville, VA USA; [Rynders, Corey A.] Univ Colorado Anschutz Med Campus, Div Geriatr Med, Aurora, CO USA	University of Virginia; University of Virginia; University of Virginia; University of Colorado System; University of Colorado Anschutz Medical Campus	Malin, SK (corresponding author), Univ Virginia, Dept Kinesiol, Charlottesville, VA USA.; Malin, SK (corresponding author), Univ Virginia, Div Endocrinol & Metab, Charlottesville, VA USA.; Malin, SK (corresponding author), Univ Virginia, Exercise Physiol Core Lab, Charlottesville, VA USA.	skm6n@virginia.edu		Weltman, Arthur/0000-0002-0125-3769; Malin, Steven/0000-0002-7360-6711; Rynders, Corey/0000-0001-5767-6261	Curry School of Education Foundation; Virginia Commonwealth Health Research Board;  [NIH-RR00847]	Curry School of Education Foundation; Virginia Commonwealth Health Research Board; 	This research was supported by the Curry School of Education Foundation (SKM) and Virginia Commonwealth Health Research Board and NIH-RR00847 (AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; [Anonymous], 2015, DIABETES CARE, V38, pS4, DOI 10.2337/dc15-S003; BAHR R, 1991, ACTA PHYSIOL SCAND, V143, P105, DOI 10.1111/j.1748-1716.1991.tb09205.x; Bilet L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09709; Bloem CJ, 2008, J CLIN ENDOCR METAB, V93, P387, DOI 10.1210/jc.2007-1734; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Cobelli C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1, DOI 10.1152/ajpendo.00421.2006; Dalla Man C, 2005, AM J PHYSIOL-ENDOC M, V289, pE954, DOI 10.1152/ajpendo.00076.2005; Davis CL, 2012, JAMA-J AM MED ASSOC, V308, P1103, DOI 10.1001/2012.jama.10762; DeFronzo RA, 2011, J CLIN ENDOCR METAB, V96, P2354, DOI 10.1210/jc.2011-0246; Dela F, 2004, AM J PHYSIOL-ENDOC M, V287, pE1024, DOI 10.1152/ajpendo.00056.2004; Egger A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070865; Faerch K, 2010, J PHYSIOL-LONDON, V588, P759, DOI 10.1113/jphysiol.2009.184028; Flier SN, 2001, P NATL ACAD SCI USA, V98, P7475, DOI 10.1073/pnas.131192998; GARETTO LP, 1984, AM J PHYSIOL, V246, pE471, DOI 10.1152/ajpendo.1984.246.6.E471; Hamer M, 2012, CIRC-CARDIOVASC QUAL, V5, P494, DOI 10.1161/CIRCOUTCOMES.112.965434; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; HODGETTS V, 1991, J APPL PHYSIOL, V71, P445, DOI 10.1152/jappl.1991.71.2.445; Honka H, 2014, J CLIN ENDOCR METAB, V99, pE981, DOI 10.1210/jc.2013-4369; Hunt DG, 2002, J APPL PHYSIOL, V93, P1638, DOI 10.1152/japplphysiol.00445.2002; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kanat M, 2011, ACTA DIABETOL, V48, P209, DOI 10.1007/s00592-011-0285-x; Kimber NE, 2003, J PHYSIOL-LONDON, V548, P919, DOI 10.1113/jphysiol.2002.031179; KING DS, 1990, AM J PHYSIOL, V259, pE155, DOI 10.1152/ajpendo.1990.259.2.E155; Knudsen SH, 2015, DIABETES OBES METAB, V17, P207, DOI 10.1111/dom.12413; Knudsen SH, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12114; Lorenzo C, 2013, J CLIN ENDOCR METAB, V98, P1622, DOI 10.1210/jc.2012-3185; MAEHLUM S, 1978, AM J PHYSIOL, V235, pE255, DOI 10.1152/ajpendo.1978.235.3.E255; Magkos F, 2008, CLIN SCI, V114, P59, DOI 10.1042/CS20070134; Malin SK, 2014, DIABETES CARE, V37, P2940, DOI 10.2337/dc13-3011; Malin SK, 2013, AM J PHYSIOL-ENDOC M, V305, pE1248, DOI 10.1152/ajpendo.00260.2013; Malin SK, 2012, DIABETES CARE, V35, P131, DOI 10.2337/dc11-0925; Marion-Latard F, 2003, HORM METAB RES, V35, P97, DOI 10.1055/s-2003-39051; Marliss EB, 2002, DIABETES, V51, pS271, DOI 10.2337/diabetes.51.2007.S271; Mauvais-Jarvis F, 2000, DIABETES, V49, P2126, DOI 10.2337/diabetes.49.12.2126; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; Muzumdar R, 2004, DIABETES, V53, P441, DOI 10.2337/diabetes.53.2.441; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; RICHTER EA, 1984, AM J PHYSIOL, V246, pE476, DOI 10.1152/ajpendo.1984.246.6.E476; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Rose AJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE766, DOI 10.1152/ajpendo.2001.281.4.E766; Rynders CA, 2014, J CLIN ENDOCR METAB, V99, P220, DOI 10.1210/jc.2013-2687; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Slentz CA, 2009, DIABETES CARE, V32, P1807, DOI 10.2337/dc09-0032; Solomon TPJ, 2014, AM J PHYSIOL-ENDOC M, V307, pE822, DOI 10.1152/ajpendo.00269.2014; Solomon TPJ, 2010, DIABETES CARE, V33, P1561, DOI 10.2337/dc09-2021; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Stephens BR, 2007, APPL PHYSIOL NUTR ME, V32, P1139, DOI 10.1139/H07-126; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Utzschneider KM, 2004, DIABETES, V53, P2867, DOI 10.2337/diabetes.53.11.2867; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Weltman A, 2006, J APPL PHYSL, V100, P1623	58	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154063	10.1371/journal.pone.0154063	http://dx.doi.org/10.1371/journal.pone.0154063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111219	gold, Green Submitted, Green Published			2022-12-27	WOS:000374970600031
J	McKenzie, M; Duchen, MR				McKenzie, Matthew; Duchen, Michael R.			Impaired Cellular Bioenergetics Causes Mitochondrial Calcium Handling Defects in MT-ND5 Mutant Cybrids	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; DNA MUTATIONS; CELLS; DEATH; ENCEPHALOMYOPATHY; HOMEOSTASIS; APOPTOSIS; NEURONS; MTDNA; GENE	Mutations in mitochondrial DNA (mtDNA) can cause mitochondrial disease, a group of metabolic disorders that affect both children and adults. Interestingly, individual mtDNA mutations can cause very different clinical symptoms, however the factors that determine these phenotypes remain obscure. Defects in mitochondrial oxidative phosphorylation can disrupt cell signaling pathways, which may shape these disease phenotypes. In particular, mitochondria participate closely in cellular calcium signaling, with profound impact on cell function. Here, we examined the effects of a homoplasmic m.13565C>T mutation in MT-ND5 on cellular calcium handling using transmitochondrial cybrids (ND5 mutant cybrids). We found that the oxidation of NADH and mitochondrial membrane potential (Delta psi(m)) were significantly reduced in ND5 mutant cybrids. These metabolic defects were associated with a significant decrease in calcium uptake by ND5 mutant mitochondria in response to a calcium transient. Inhibition of glycolysis with 2-deoxy-D-glucose did not affect cytosolic calcium levels in control cybrids, but caused an increase in cytosolic calcium in ND5 mutant cybrids. This suggests that glycolytically-generated ATP is required not only to maintain Delta psi(m) in ND5 mutant mitochondria but is also critical for regulating cellular calcium homeostasis. We conclude that the m.13565C>T mutation in MT-ND5 causes defects in both mitochondrial oxidative metabolism and mitochondrial calcium sequestration. This disruption of mitochondrial calcium handling, which leads to defects in cellular calcium homeostasis, may be an important contributor to mitochondrial disease pathogenesis.	[McKenzie, Matthew] Hudson Inst Med Res, Ctr Genet Dis, Melbourne, Vic 3168, Australia; [McKenzie, Matthew] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia; [Duchen, Michael R.] UCL, Dept Physiol, Gower St, London WC1E 6BT, England	Hudson Institute of Medical Research; Monash University; University of London; University College London	McKenzie, M (corresponding author), Hudson Inst Med Res, Ctr Genet Dis, Melbourne, Vic 3168, Australia.; McKenzie, M (corresponding author), Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia.	matthew.mckenzie@hudson.org.au	McKenzie, Matthew/H-4926-2019; duchen, michael/A-2116-2009	McKenzie, Matthew/0000-0001-7508-1800; duchen, michael/0000-0003-2548-4294	Wellcome Trust; Medical Research Council; Australian Research Council [FT120100459]; William Buckland Foundation; Monash University; Victorian Government	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Research Council(Australian Research Council); William Buckland Foundation; Monash University(Monash University); Victorian Government	This work was supported by the Wellcome Trust (GB) (wellcome.ac.uk/funding/) to MRD, Medical Research Council (GB) (mrc.ac.uk/funding/) to MRD, Australian Research Council Future Fellowship Scheme (FT120100459) (arc.gov.au/future-fellowships) to MMCK, William Buckland Foundation (eqt.com.au/charities-and-not-for-profits/grants/the-william-buckland-foundation) to MMCK, Monash University (monash.edu) to MMCK and Victorian Government Infrastructure Program (premier.vic.gov.au/funding-to-support-victorias-medical-research-institutes/) to MMCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Bhosale G, 2015, ANN NY ACAD SCI, V1350, P107, DOI 10.1111/nyas.12885; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; DILISA F, 1995, J PHYSIOL-LONDON, V486, P1; Duchen MR, 2012, PFLUG ARCH EUR J PHY, V464, P111, DOI 10.1007/s00424-012-1112-0; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; Jacobson J, 2004, MOL CELL BIOCHEM, V256, P209, DOI 10.1023/B:MCBI.0000009869.29827.df; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kamer KJ, 2015, NAT REV MOL CELL BIO, V16, P545, DOI 10.1038/nrm4039; Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537; Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059; Manfredi G, 2003, J BIOL CHEM, V278, P5639, DOI 10.1074/jbc.M203080200; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200; Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93; MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729; Nicholls DG, 2003, CELL CALCIUM, V34, P407, DOI 10.1016/S0143-4160(03)00144-1; Rajakulendran S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145500; Rommelaere G, 2012, INT J BIOCHEM CELL B, V44, P139, DOI 10.1016/j.biocel.2011.10.009; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Szczepanowska J, 2004, FEBS LETT, V578, P316, DOI 10.1016/j.febslet.2004.11.022; Trevelyan AJ, 2010, BRAIN, V133, P787, DOI 10.1093/brain/awq023	28	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154371	10.1371/journal.pone.0154371	http://dx.doi.org/10.1371/journal.pone.0154371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110715	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600061
J	McManus, M; Mick, E; Hudson, R; Mofenson, LM; Sullivan, JL; Somasundaran, M; Luzuriaga, K				McManus, Margaret; Mick, Eric; Hudson, Richard; Mofenson, Lynne M.; Sullivan, John L.; Somasundaran, Mohan; Luzuriaga, Katherine		PACTG 356 Investigators	Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1-INFECTED CHILDREN; LATENT RESERVOIR; IMMUNE-RESPONSES; INFECTION; DYNAMICS; ESTABLISHMENT; PERSISTENCE; ABSENCE; TRIAL	The primary aim of this study was to measure HIV-1 persistence following combination anti-retroviral therapy (cART) in infants and children. Peripheral blood mononuclear cell (PBMC) HIV-1 DNA was quantified prior to and after 1 year of cART in 30 children, stratified by time of initiation (early, age <3 months, ET; late, age >3 months-2 years, LT). Pre-therapy PBMC HIV-1 DNA levels correlated with pre-therapy plasma HIV-1 levels (r = 0.59, p<0.001), remaining statistically significant (p = 0.002) after adjustment for prior perinatal antiretroviral exposure and age at cART initiation. PBMC HIV-1 DNA declined significantly after 1 year of cART (Overall: -0.91 +/- 0.08 log(10) copies per million PBMC, p<0.001; ET: -1.04 +/- 0.11 log(10) DNA copies per million PBMC, p<0.001; LT: -0.74 +/- 0.13 log(10) DNA copies per million PBMC, p<0.001) but rates of decline did not differ significantly between ET and LT. HIV-1 replication exposure over the first 12 months of cART, estimated as area-under-the-curve (AUC) of circulating plasma HIV-1 RNA levels, was significantly associated with PBMC HIV-1 DNA at one year (r = 0.51, p = 0.004). In 21 children with sustained virologic suppression after 1 year of cART, PBMC HIV-1 DNA levels continued to decline between years 1 and 4 (slope -0.21 log(10) DNA copies per million PBMC per year); decline slopes did not differ significantly between ET and LT. PBMC HIV-1 DNA levels at 1 year and 4 years of cART correlated with age at cART initiation (1 year: p = 0.04; 4 years: p = 0.03) and age at virologic control (1 and 4 years, p = 0.02). Altogether, these data indicate that reducing exposure to HIV-1 replication and younger age at cART initiation are associated with lower HIV1 DNA levels at and after one year of age, supporting the concept that HIV-1 diagnosis and cART initiation in infants should occur as early as possible.	[McManus, Margaret; Hudson, Richard; Sullivan, John L.; Somasundaran, Mohan; Luzuriaga, Katherine] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Mick, Eric] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Mofenson, Lynne M.] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Luzuriaga, K (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA.	katherine.luzuriaga@umassmed.edu	Mofenson, Lynne/P-9631-2019	Mofenson, Lynne/0000-0002-2818-9808	National Institutes of Health [AI32907, K24-HD01489]; University of Massachusetts Center for AIDS Research [AI428845]; University of Massachusetts Center for Clinical and Translational Science [UL1-TR001453]; International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001489] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068616, U01AI032907, UM1AI068632, UM1AI106716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Center for AIDS Research; University of Massachusetts Center for Clinical and Translational Science; International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI32907, K24-HD01489, the University of Massachusetts Center for AIDS Research (AI428845), and the University of Massachusetts Center for Clinical and Translational Science (UL1-TR001453) to Katherine Luzuriaga. Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2014, AIDS, V28, P1015, DOI 10.1097/QAD.0000000000000178; Greenough TC, 1999, J INFECT DIS, V180, P1790, DOI 10.1086/315128; Hill AL, 2014, P NATL ACAD SCI USA, V111, P13475, DOI 10.1073/pnas.1406663111; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Laanani M, 2015, CLIN INFECT DIS, V60, P1715, DOI 10.1093/cid/civ171; Luzuriaga K, 2000, J VIROL, V74, P6984, DOI 10.1128/JVI.74.15.6984-6991.2000; Luzuriaga K, 2004, NEW ENGL J MED, V350, P2471, DOI 10.1056/NEJMoa032706; Luzuriaga K, 1997, NEW ENGL J MED, V336, P1343, DOI 10.1056/NEJM199705083361902; Luzuriaga K, 2016, ANNU REV MED, V67, P201, DOI 10.1146/annurev-med-091114-111159; Martinez-Bonet M, 2015, CLIN INFECT DIS, V61, P1169, DOI 10.1093/cid/civ456; Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, 2016, GUID US ANT AG PED H; Payne H, 2015, LANCET INFECT DIS, V15, P803, DOI 10.1016/S1473-3099(15)00087-0; Persaud D, 2000, J CLIN INVEST, V105, P995, DOI 10.1172/JCI9006; Persaud D, 2014, JAMA PEDIATR, V168, P1138, DOI 10.1001/jamapediatrics.2014.1560; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Persaud D, 2012, AIDS, V26, P1483, DOI 10.1097/QAD.0b013e3283553638; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Uprety P, 2015, CLIN INFECT DIS, V61, P1862, DOI 10.1093/cid/civ688; van Zyl GU, 2015, J INFECT DIS, V212, P39, DOI 10.1093/infdis/jiu827; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organization, 2015, GUID START ANT THER; Zanchetta M, 2008, ANTIVIR THER, V13, P47	23	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154391	10.1371/journal.pone.0154391	http://dx.doi.org/10.1371/journal.pone.0154391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104621	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100075
J	Miura, R; Kasakura, K; Nakano, N; Hara, M; Maeda, K; Okumura, K; Ogawa, H; Yashiro, T; Nishiyama, C				Miura, Ryosuke; Kasakura, Kazumi; Nakano, Nobuhiro; Hara, Mutsuko; Maeda, Keiko; Okumura, Ko; Ogawa, Hideoki; Yashiro, Takuya; Nishiyama, Chiharu			Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							TRANSACTIVATOR PROMOTER-III; GENE-EXPRESSION; B-CELL; T-CELL; REQUIREMENT; ACTIVATION; GAMMA	The cofactor CIITA is a master regulator of MHC class II expression and several transcription factors regulating the cell type-specific expression of CIITA have been identified. Although the MHC class II expression in plasmacytoid dendritic cells (pDCs) is also mediated by CIITA, the transcription factors involved in the CIITA expression in pDCs are largely unknown. In the present study, we analyzed the role of a hematopoietic lineage-specific transcription factor, PU.1, in CIITA transcription in pDCs. The introduction of PU.1 siRNA into mouse pDCs and a human pDC cell line, CAL-1, reduced the mRNA levels of MHC class II and CIITA. When the binding of PU.1 to the 3rd promoter of CIITA (pIII) in CAL-1 and mouse pDCs was analyzed by a chromatin immunoprecipitation assay, a significant amount of PU.1 binding to the pIII was detected, which was definitely decreased in PU.1 siRNA-transfected cells. Reporter assays showed that PU.1 knockdown reduced the pIII promoter activity and that three Ets-motifs in the human pIII promoter were candidates of cis-enhancing elements. By electrophoretic mobility shift assays, it was confirmed that two Ets-motifs, GGAA (-181/-178) and AGAA (-114/-111), among three candidates, were directly bound with PU.1. When mouse pDCs and CAL-1 cells were stimulated by GM-CSF, mRNA levels of PU.1, pIII-driven CIITA, total CIITA, MHC class II, and the amount of PU.1 binding to pIII were significantly increased. The GM-CSF-mediated up-regulation of these mRNAs was canceled in PU.1 siRNA-introduced cells. Taking these results together, we conclude that PU.1 transactivates the pIII through direct binding to Ets-motifs in the promoter in pDCs.	[Miura, Ryosuke; Kasakura, Kazumi; Yashiro, Takuya; Nishiyama, Chiharu] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Lab Mol Biol & Immunol,Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan; [Nakano, Nobuhiro; Hara, Mutsuko; Maeda, Keiko; Okumura, Ko; Ogawa, Hideoki] Juntendo Univ, Atopy Allergy Res Ctr, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan	Tokyo University of Science; Juntendo University	Nishiyama, C (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Lab Mol Biol & Immunol,Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	chinishi@rs.tus.ac.jp	yashiro, takuya/Y-1543-2019; Nishiyama, Chiharu/GPW-9372-2022	Miura, Ryosuke/0000-0003-1249-7803	Ministry of Education, Culture, Sports, Science and Technology of Japan [LS111]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Atopy (Allergy) Research Center, Juntendo University School of Medicine); Tokyo Biochemical Research Foundation; Tokyo University of Science; Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists) [3241, 10792]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Translational Research Center, Tokyo University of Science)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Atopy (Allergy) Research Center, Juntendo University School of Medicine); Tokyo Biochemical Research Foundation; Tokyo University of Science; Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists); MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Translational Research Center, Tokyo University of Science)	This work was supported by the Funding Program for Next Generation World-Leading Researchers from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to CN, #LS111), the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Atopy (Allergy) Research Center, Juntendo University School of Medicine; Translational Research Center, Tokyo University of Science), and the Tokyo Biochemical Research Foundation. KK is supported by Postdoctoral Fellowships of Tokyo University of Science (from 2014 to 2015) and by Research Fellowships of the Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists #3241; from 2016). TY has been supported by Research Fellowships of the Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists #10792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Baba Y, 2012, J BIOL CHEM, V287, P32689, DOI 10.1074/jbc.M112.374876; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Fukai T, 2009, BIOCHEM BIOPH RES CO, V388, P102, DOI 10.1016/j.bbrc.2009.07.126; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Holling TM, 2002, J IMMUNOL, V168, P763, DOI 10.4049/jimmunol.168.2.763; Ito T, 2005, J IMMUNOL, V174, P376, DOI 10.4049/jimmunol.174.1.376; Ito T, 2009, INT IMMUNOL, V21, P803, DOI 10.1093/intimm/dxp048; Kanada S, 2011, BLOOD, V117, P2211, DOI 10.1182/blood-2010-06-291898; Kitamura N, 2012, J ALLERGY CLIN IMMUN, V129, P814, DOI 10.1016/j.jaci.2011.10.019; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; Lohsen S, 2014, GENES IMMUN, V15, P543, DOI 10.1038/gene.2014.49; Maeda K, 2006, BLOOD, V108, P262, DOI 10.1182/blood-2005-07-2878; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nakano N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.138966; Pai RK, 2002, J IMMUNOL, V169, P1326, DOI 10.4049/jimmunol.169.3.1326; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Smith MA, 2011, J BIOL CHEM, V286, P7893, DOI 10.1074/jbc.M110.165431; van der Stoep N, 2004, BLOOD, V104, P2849, DOI 10.1182/blood-2004-03-0790; Yashiro T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137699; Yoon H, 2010, J IMMUNOL, V184, P5018, DOI 10.4049/jimmunol.1000079	28	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154094	10.1371/journal.pone.0154094	http://dx.doi.org/10.1371/journal.pone.0154094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105023	Green Submitted, Green Published, gold			2022-12-27	WOS:000374565100043
J	Rahimi, S; Mashhadi, HR; Banadaky, MD; Mesgaran, MB				Rahimi, Salman; Mashhadi, Hamid Rahimian; Banadaky, Mehdi Dehghan; Mesgaran, Mohsen Beheshtian			Variation in Weed Seed Fate Fed to Different Holstein Cattle Groups	PLOS ONE			English	Article							FORAGE PARTICLE-SIZE; CHEWING ACTIVITY; DIET QUALITY; RUMINAL PH; RECOVERY; PASSAGE; GERMINATION; MANAGEMENT; DIGESTION; SURVIVAL	Weed seeds may maintain their viability when passing through the digestive tract of cattle and can be therefore dispersed by animal movement or the application of manure. Whether different cattle types of the same species can cause differential weed seed fate is largely unknown to us particularly under non-grazed systems similar to Holstein-Friesian dairy farming. We investigated the effect on the seed survival of four weed species in the digestive tracts of four groups of Holstein cattle: lactating cows, feedlot male calves, dry cows and growing heifers. The weed species used were Cuscuta campestris, Polygonum aviculare, Rumex crispus and Sorghum halepense. Cattle excretion was sampled for recovery and viability of seeds at four 24 hourly intervals after seed intake. The highest seed recovery occurred two days after seed intake in all cattle groups. Averaged over weed species, dry and lactating cows had the lowest and highest seed recovery of 36.4% and 74.4% respectively. No significant differences were observed in seed recovery of the four weed species when their seeds were fed to dry cows. Based on a power model fitted to seed viability data, the estimated time to 50% viability loss after seed intake, over all cattle groups ranged from 65 h (R. crispus) to 76 h (P. aviculare). Recovered seeds from the dung of feedlot male calves showed the highest mortality among cattle groups. Significant correlation was found between seed viability and ruminal pH (r = 0.86; P<0.05). This study shows that management programs aiming to minimize weed infestation caused by livestock should account for the variation amongst cattle groups in seed persistence. Our findings can be used as a guideline for evaluating the potential risk of the spread of weeds via the application of cattle manure.	[Rahimi, Salman; Mashhadi, Hamid Rahimian] Univ Tehran, Dept Agron & Plant Breeding, Coll Agr Sci & Engn, Karaj, Iran; [Banadaky, Mehdi Dehghan] Univ Tehran, Dept Anim Sci, Coll Agr Sci & Engn, Karaj, Iran; [Mesgaran, Mohsen Beheshtian] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia; [Rahimi, Salman] Ferdowsi Univ Mashhad, Fac Agr, Dept Agron, Mashhad, Khorasan Razavi, Iran	University of Tehran; University of Tehran; University of Melbourne; Ferdowsi University Mashhad	Mesgaran, MB (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia.	mohsenm@unimelb.edu.au		Mesgaran, Mohsen/0000-0002-0841-6188	University of Tehran's Vice-President of Research	University of Tehran's Vice-President of Research	This work was supported by a graduate student grant from the University of Tehran's Vice-President of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD RLB, 1990, WEED RES, V30, P81, DOI 10.1111/j.1365-3180.1990.tb01690.x; Barberi P, 2002, WEED RES, V42, P177, DOI 10.1046/j.1365-3180.2002.00277.x; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Baskin Jerry M., 2000, Plant Species Biology, V15, P139, DOI 10.1046/j.1442-1984.2000.00034.x; BASKIN JM, 1985, WEED SCI, V33, P340, DOI 10.1017/S0043174500082382; BLACKSHAW RE, 1991, WEED SCI, V39, P104, DOI 10.1017/S0043174500057957; Bodmer RE, 2006, LARGE HERBIVORE ECOL; Calsamiglia S, 2008, J ANIM SCI, V86, P702, DOI 10.2527/jas.2007-0146; COLUCCI PE, 1982, J DAIRY SCI, V65, P1445, DOI 10.3168/jds.S0022-0302(82)82367-9; Cook AR, 2007, WEED TECHNOL, V21, P389, DOI 10.1614/WT-06-043.1; Cudney D. W., 1992, California Agriculture, V46, P31; Doucette KM, 2001, J RANGE MANAGE, V54, P575, DOI 10.2307/4003587; Fenner M., 2005, ECOLOGY SEEDS; Frost RA, 2013, RANGELAND ECOL MANAG, V66, P51, DOI 10.2111/REM-D-11-00218.1; GARDENER CJ, 1993, J APPL ECOL, V30, P63, DOI 10.2307/2404271; GARDENER CJ, 1993, J APPL ECOL, V30, P75, DOI 10.2307/2404272; Gokbulak F., 2006, Online Journal of Biological Sciences, V6, P23; Haidar MA, 2010, WEED RES, V50, P467, DOI 10.1111/j.1365-3180.2010.00797.x; HARMON GEORGE W., 1934, JOUR AMER SOC AGRON, V26, P762; Hogan JP, 2011, ANIM PROD SCI, V51, P391, DOI 10.1071/AN10141; International Seed Testing Association, 2003, INT RUL SEED TEST, V2003rd; Iranian Council of Animal Care, 1995, GUIDE CARE USE EXPT; JONES RM, 1987, AUST J EXP AGR, V27, P253, DOI 10.1071/EA9870253; Kennedy P M, 1988, Nutr Res Rev, V1, P189, DOI 10.1079/NRR19880014; Krause KM, 2002, J DAIRY SCI, V85, P1947, DOI 10.3168/jds.S0022-0302(02)74271-9; Kruk BC, 1998, WEED SCI, V46, P83, DOI 10.1017/S0043174500090214; Kukovics S., 2013, Milk and dairy products in human nutrition: production, composition and health, P80; Larney FJ, 2007, BIORESOURCE TECHNOL, V98, P3221, DOI 10.1016/j.biortech.2006.07.005; National Research Council, 2001, NUTR REQ DAIR CATTL, V7th; NETO MS, 1987, AUST J EXP AGR, V27, P239, DOI 10.1071/EA9870239; Nishida T, 1998, JARQ-JPN AGR RES Q, V32, P55; PLEASANT JM, 1994, WEED TECHNOL, V8, P304; Salimi H., 2000, Rostaniha, V1, P33; Scofield DG, 2012, AM NAT, V180, P719, DOI 10.1086/668202; Shepherd MA, 2002, SOIL USE MANAGE, V18, P284, DOI 10.1079/SUM2002134; Tjelele J, 2014, RANGELAND ECOL MANAG, V67, P423, DOI 10.2111/REM-D-13-00115.1; Tuomisto HL, 2012, J ENVIRON MANAGE, V112, P309, DOI 10.1016/j.jenvman.2012.08.018; Van Soest P. J, 1994, NUTR ECOLOGY RUMINAN, DOI DOI 10.7591/9781501732355; WELCH JG, 1982, J ANIM SCI, V54, P885, DOI 10.2527/jas1982.544885x; Whitacre MK, 2006, WEST N AM NATURALIST, V66, P121, DOI 10.3398/1527-0904(2006)66[121:RAGONS]2.0.CO;2; Will H, 2008, J ECOL, V96, P1011, DOI 10.1111/j.1365-2745.2007.01341.x; Yang WZ, 2006, J DAIRY SCI, V89, P217, DOI 10.3168/jds.S0022-0302(06)72086-0; Yang WZ, 2001, J DAIRY SCI, V84, P2203, DOI 10.3168/jds.S0022-0302(01)74667-X; Zand E, 2009, WEED RES J, V1, P83; Zebeli Q, 2007, J DAIRY SCI, V90, P1929, DOI 10.3168/jds.2006-354	45	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154057	10.1371/journal.pone.0154057	http://dx.doi.org/10.1371/journal.pone.0154057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104783	gold, Green Published			2022-12-27	WOS:000374565100041
J	Voukkalis, N; Koutroumani, M; Zarkadas, C; Nikolakaki, E; Vlassi, M; Giannakouros, T				Voukkalis, Nikolaos; Koutroumani, Maria; Zarkadas, Christoforos; Nikolakaki, Eleni; Vlassi, Metaxia; Giannakouros, Thomas			SRPK1 and Akt Protein Kinases Phosphorylate the RS Domain of Lamin B Receptor with Distinct Specificity: A Combined Biochemical and In Silico Approach	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; SUBSTRATE SPECIFICITIES; CRYSTAL-STRUCTURE; SPLICING FACTORS; FORCE-FIELD; SR PROTEIN; NUCLEAR; MOTIF; RICH; ASSOCIATION	Activated Akt has been previously implicated in acting on RS domain-containing proteins. However, it has been questioned whether its action is direct or it is mediated by co-existing SR kinase activity. To address this issue we studied in detail the phosphorylation of Lamin B Receptor (LBR) by Akt. Using synthetic peptides and a set of recombinant proteins expressing mutants of the LBR RS domain we now demonstrate that while all serines of the RS domain represent more or less equal phosphoacceptor sites for SRPK1, Ser80 and Ser82 are mainly targeted by Akt. 3D-modeling combined with molecular dynamics (MD) simulations show that amongst short, overlapping LBR RS-containing peptides complying with the minimum Akt recognition consensus sequence, only those bearing phosphosites either at Ser80 or Ser82 are able to fit into the active site of Akt, at least as effectively as its known substrate, GSK3-beta. Combined our results provide evidence that Akt kinases directly phosphorylate an RS domain-containing protein and that both the residues N-terminal the phosphosite and at position + 1 are essential for Akt specificity, with the latter substrate position being compatible with the arginine residue of RS-repeats.	[Voukkalis, Nikolaos; Koutroumani, Maria; Nikolakaki, Eleni; Giannakouros, Thomas] Aristotle Univ Thessaloniki, Dept Chem, Biochem Lab, GR-54006 Thessaloniki, Greece; [Zarkadas, Christoforos; Vlassi, Metaxia] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece	Aristotle University of Thessaloniki; National Centre of Scientific Research "Demokritos"	Giannakouros, T (corresponding author), Aristotle Univ Thessaloniki, Dept Chem, Biochem Lab, GR-54006 Thessaloniki, Greece.; Vlassi, M (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece.	meta@bio.demokritos.gr; giannako@chem.auth.gr	Vlassi, Metaxia/B-8692-2013; GIANNAKOUROS, THOMAS/R-3204-2019	Vlassi, Metaxia/0000-0003-0931-2660	THALES Programme [379440]; European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)	THALES Programme(Thales Group); European Union (European Social Fund - ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)	MV and TG were funded by the THALES Programme (http://excellence.minedu.gov.gr/thales; grant number 379440), co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Aubol BE, 2013, BIOCHEMISTRY-US, V52, P7595, DOI 10.1021/bi4010864; Aubol BE, 2013, J MOL BIOL, V425, P2894, DOI 10.1016/j.jmb.2013.05.013; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Giannakouros T, 2011, FEBS J, V278, P570, DOI 10.1111/j.1742-4658.2010.07987.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Hamelberg D, 2007, P NATL ACAD SCI USA, V104, P14947, DOI 10.1073/pnas.0703151104; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ilouz R, 2006, J BIOL CHEM, V281, P30621, DOI 10.1074/jbc.M604633200; Jang SW, 2009, J BIOL CHEM, V284, P24512, DOI 10.1074/jbc.M109.026237; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Li CQ, 2014, J PHYS CHEM B, V118, P1273, DOI 10.1021/jp411111g; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lukasiewicz R, 2007, J MOL BIOL, V367, P249, DOI 10.1016/j.jmb.2006.12.031; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mylonis I, 2004, J BIOL CHEM, V279, P11626, DOI 10.1074/jbc.M311949200; Nam SY, 2010, J BIOL CHEM, V285, P31157, DOI 10.1074/jbc.M110.122044; Ngo JCK, 2008, MOL CELL, V29, P563, DOI 10.1016/j.molcel.2007.12.017; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Nikolakaki E, 1996, J BIOL CHEM, V271, P8365, DOI 10.1074/jbc.271.14.8365; Nikolakaki E, 2008, BBA-GEN SUBJECTS, V1780, P214, DOI 10.1016/j.bbagen.2007.10.014; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Papoutsopoulou S, 1999, BIOCHEM BIOPH RES CO, V255, P602, DOI 10.1006/bbrc.1999.0249; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Sellis D, 2012, BBA-GEN SUBJECTS, V1820, P44, DOI 10.1016/j.bbagen.2011.10.010; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	46	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154198	10.1371/journal.pone.0154198	http://dx.doi.org/10.1371/journal.pone.0154198			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105349	Green Published, gold			2022-12-27	WOS:000374565100054
J	Bordoloi, NK; Bhagowati, P; Chaudhuri, MK; Mukherjee, AK				Bordoloi, Naba K.; Bhagowati, Pabitra; Chaudhuri, Mihir K.; Mukherjee, Ashis K.			Proteomics and Metabolomics Analyses to Elucidate the Desulfurization Pathway of Chelatococcus sp.	PLOS ONE			English	Article							ORGANIC SULFUR-COMPOUNDS; RHODOCOCCUS-ERYTHROPOLIS KA2-5-1; MICROBIAL DESULFURIZATION; DEEP-DESULFURIZATION; DIESEL OIL; DIBENZOTHIOPHENE DESULFURIZATION; BACILLUS-SUBTILIS; CRUDE-OIL; BIODESULFURIZATION; OVEREXPRESSION	Desulfurization of dibenzothiophene (DBT) and alkylated DBT derivatives present in transport fuel through specific cleavage of carbon-sulfur (C-S) bonds by a newly isolated bacterium Chelatococcus sp. is reported for the first time. Gas chromatography-mass spectrometry (GC-MS) analysis of the products of DBT degradation by Chelatococcus sp. showed the transient formation of 2-hydroxybiphenyl (2-HBP) which was subsequently converted to 2-methoxybiphenyl (2-MBP) by methylation at the hydroxyl group of 2-HBP. The relative ratio of 2-HBP and 2-MBP formed after 96 h of bacterial growth was determined at 4: 1 suggesting partial conversion of 2-HBP or rapid degradation of 2-MBP. Nevertheless, the enzyme involved in this conversion process remains to be identified. This production of 2-MBP rather than 2-HBP from DBT desulfurization has a significant metabolic advantage for enhancing the growth and sulfur utilization from DBT by Chelatococcus sp. and it also reduces the environmental pollution by 2-HBP. Furthermore, desulfurization of DBT derivatives such as 4-M-DBT and 4, 6-DM-DBT by Chelatococcus sp. resulted in formation of 2-hydroxy-3-methyl-biphenyl and 2-hydroxy -3, 3'-dimethyl-biphenyl, respectively as end product. The GC and X-ray fluorescence studies revealed that Chelatococcus sp. after 24 h of treatment at 37 degrees C reduced the total sulfur content of diesel fuel by 12% by per gram resting cells, without compromising the quality of fuel. The LC-MS/MS analysis of tryptic digested intracellular proteins of Chelatococcus sp. when grown in DBT demonstrated the biosynthesis of 4S pathway desulfurizing enzymes viz. monoxygenases (DszC, DszA), desulfinase (DszB), and an NADH-dependent flavin reductase (DszD). Besides, several other intracellular proteins of Chelatococcus sp. having diverse biological functions were also identified by LC-MS/MS analysis. Many of these enzymes are directly involved with desulfurization process whereas the other enzymes/proteins support growth of bacteria at an expense of DBT. These combined results suggest that Chelatococcus sp. prefers sulfur-specific extended 4S pathway for deep-desulphurization which may have an advantage for its intended future application as a promising biodesulfurizing agent.	[Bordoloi, Naba K.; Bhagowati, Pabitra; Chaudhuri, Mihir K.; Mukherjee, Ashis K.] Tezpur Univ, Dept Mol Biol & Biotechnol, ONGC Ctr Petr Biotechnol, Tezpur 784028, Assam, India	Tezpur University	Chaudhuri, MK; Mukherjee, AK (corresponding author), Tezpur Univ, Dept Mol Biol & Biotechnol, ONGC Ctr Petr Biotechnol, Tezpur 784028, Assam, India.	mkc@tezu.ernet.in; akm@tezu.ernet.in		Mukherjee, Ashis/0000-0001-9869-858X	ONGC-CPBT; DBT, New Delhi	ONGC-CPBT; DBT, New Delhi(Department of Biotechnology (DBT) India)	This research work received partial support from the ONGC-CPBT project entitled-"Proteomics study of aromatic hydrocarbons degradation enzymes of some bacterial strains prospecting strategies for environmental bioremediation" and DBT, New Delhi sponsored the research project entitled "Strengthening of biotechnology teaching, training and research in universities and colleges in the Northeast India" granted to AKM. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Rahman RNZR, 2007, J IND MICROBIOL BIOT, V34, P509, DOI 10.1007/s10295-007-0222-8; Abin-Fuentes A, 2014, BIOTECHNOL BIOENG, V111, P876, DOI 10.1002/bit.25148; Abin-Fuentes A, 2013, APPL ENVIRON MICROB, V79, P7807, DOI 10.1128/AEM.02696-13; Aggarwal S, 2012, MOL BIOSYST, V8, P2724, DOI 10.1039/c2mb25127b; ALONSO JM, 1982, BIOCHIM BIOPHYS ACTA, V719, P165, DOI 10.1016/0304-4165(82)90322-1; Ausubel FM, 1995, SHORT PROTOCOLS MOL, P212; Bordoloi NK, 2014, FUEL PROCESS TECHNOL, V119, P236, DOI 10.1016/j.fuproc.2013.10.014; Bressler DC, 2001, APPL ENVIRON MICROB, V67, P5084, DOI 10.1128/AEM.67.11.5084-5093.2001; Caro A, 2007, BIOCHEM ENG J, V35, P191, DOI 10.1016/j.bej.2007.01.013; de Araujo HWC, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-33; Chen H, 2009, BIORESOURCE TECHNOL, V100, P2085, DOI 10.1016/j.biortech.2008.10.010; Chen H, 2008, BIORESOURCE TECHNOL, V99, P6928, DOI 10.1016/j.biortech.2008.01.033; CRAWFORD DL, 1990, CURR MICROBIOL, V21, P229, DOI 10.1007/BF02092161; Daniel W.W., 2000, BIOSTATISTICS FDN AN, V7th ed., P166; Das K, 2007, BIORESOURCE TECHNOL, V98, P1339, DOI 10.1016/j.biortech.2006.05.032; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; Grossman MJ, 1999, APPL ENVIRON MICROB, V65, P181; Hirasawa K, 2001, BIOSCI BIOTECH BIOCH, V65, P239, DOI 10.1271/bbb.65.239; Kilbane JJ, 2007, APPL MICROBIOL BIOT, V75, P843, DOI 10.1007/s00253-007-0895-y; Kilbane JJ, 2006, CURR OPIN BIOTECH, V17, P305, DOI 10.1016/j.copbio.2006.04.005; Kirimura K, 2002, APPL ENVIRON MICROB, V68, P3867, DOI 10.1128/AEM.68.8.3867-3872.2002; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Li FL, 2003, FEMS MICROBIOL LETT, V223, P301, DOI 10.1016/S0378-1097(03)00397-5; Li FL, 2007, J BIOTECHNOL, V127, P222, DOI 10.1016/j.jbiotec.2006.07.002; Li M, 2010, J PROTEOME RES, V9, P4295, DOI 10.1021/pr100527g; Li W, 2005, FEMS MICROBIOL LETT, V247, P45, DOI 10.1016/j.femsle.2005.04.025; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma T, 2010, MICROBIOL MONOGR, V16, P207, DOI 10.1007/978-3-642-12937-7_8; Matsubara T, 2001, APPL ENVIRON MICROB, V67, P1179, DOI 10.1128/AEM.67.3.1179-1184; Mohamed MES, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00112; Mohebali G, 2008, MICROBIOL-SGM, V154, P2169, DOI 10.1099/mic.0.2008/017608-0; Monticello DJ, 2000, CURR OPIN BIOTECH, V11, P540, DOI 10.1016/S0958-1669(00)00154-3; Mukherjee AK, 2005, FEMS MICROBIOL ECOL, V54, P479, DOI 10.1016/j.femsec.2005.06.003; Mukherjee AK, 2014, THROMB RES, V134, P1150, DOI 10.1016/j.thromres.2014.09.009; Nakayama N, 2002, BBA-PROTEINS PROTEOM, V1598, P122, DOI 10.1016/S0167-4838(02)00365-5; Nejad NF, 2015, PETROL SCI, V12, P330, DOI 10.1007/s12182-015-0020-2; Ohshiro T, 1996, J FERMENT BIOENG, V81, P121, DOI 10.1016/0922-338X(96)87588-X; Ohshiro T, 1999, BIOSCI BIOTECH BIOCH, V63, P1, DOI 10.1271/bbb.63.1; OHSHIRO T, 1994, FEMS MICROBIOL LETT, V118, P341, DOI 10.1016/0378-1097(94)90526-6; Okada H, 2002, J BIOSCI BIOENG, V93, P491, DOI 10.1016/S1389-1723(02)80097-4; Oldfield C, 1998, ANTON LEEUW INT J G, V74, P119, DOI 10.1023/A:1001724516342; Onaka T, 2000, J CHROMATOGR A, V903, P193, DOI 10.1016/S0021-9673(00)00892-X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shavandi M, 2009, BIORESOURCE TECHNOL, V100, P475, DOI 10.1016/j.biortech.2008.06.011; Soleimani M, 2007, BIOTECHNOL ADV, V25, P570, DOI 10.1016/j.biotechadv.2007.07.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thakur R, 2015, TOXICON, V100, P1, DOI 10.1016/j.toxicon.2015.03.019; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Vandera E, 2015, J PROTEOMICS, V113, P73, DOI 10.1016/j.jprot.2014.08.018; Vermeij P, 1999, J BACTERIOL, V181, P5833, DOI 10.1128/JB.181.18.5833-5837.1999; Watkins LM, 2003, ARCH BIOCHEM BIOPHYS, V415, P14, DOI 10.1016/S0003-9861(03)00230-3; Yu B, 2006, APPL ENVIRON MICROB, V72, P54, DOI 10.1128/AEM.72.1.54-58.2006; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1; Zhang HB, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/315901	56	17	21	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153547	10.1371/journal.pone.0153547	http://dx.doi.org/10.1371/journal.pone.0153547			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100386	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500041
J	De Luca, G; Bosello, SL; Gabrielli, FA; Berardi, G; Parisi, F; Rucco, M; Canestrari, G; Loperfido, F; Galiuto, L; Crea, F; Ferraccioli, G				De Luca, Giacomo; Bosello, Silvia Laura; Gabrielli, Francesca Augusta; Berardi, Giorgia; Parisi, Federico; Rucco, Manuela; Canestrari, Giovanni; Loperfido, Francesco; Galiuto, Leonarda; Crea, Filippo; Ferraccioli, Gianfranco			Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; CARDIOVASCULAR MAGNETIC-RESONANCE; PULMONARY ARTERIAL-HYPERTENSION; MYOCARDIAL FIBROSIS; HEART INVOLVEMENT; ARRHYTHMIAS; SCLERODERMA; RISK; ASSOCIATION; DYSFUNCTION	Background Arrhythmias are frequent in Systemic Sclerosis (SSc) and portend a bad prognosis, accounting alone for 6% of total deaths. Many of these patients die suddenly, thus prevention and intensified risk-stratification represent unmet medical needs. The major goal of this study was the definition of ECG indexes of poor prognosis. Methods We performed a prospective cohort study to define the role of 24h-ECG-Holter as an additional risk-stratification technique in the identification of SSc-patients at high risk of life-threatening arrhythmias and sudden cardiac death (SCD). One-hundred SSc-patients with symptoms and/or signs suggestive of cardiac involvement underwent 24h-ECG-Holter. The primary end-point was a composite of SCD or need for implantable cardioverter defibrillator (ICD). Results Fifty-six patients (56%) had 24h-ECG-Holter abnormalities and 24(24%) presented frequent ventricular ectopic beats (VEBs). The number of VEBs correlated with high-sensitive cardiac troponin T (hs-cTnT) levels and inversely correlated with left-ventricular ejection fraction (LV-EF) on echocardiography. During a mean follow-up of 23.1 +/- 16.0 months, 5 patients died suddenly and two required ICD-implantation. The 7 patients who met the composite end-point had a higher number of VEBs, higher levels of hs-cTnT and NT-proBNP and lower LV-EF (p = 0.001 for all correlations). All these 7 patients had frequent VEBs, while LV-EF was not reduced in all and its range was wide. At ROC curve, VEBs> 1190/24h showed 100% of sensitivity and 83% of specificity to predict the primary end-point (AUROC = 0.92, p< 0.0001). Patients with VEBS> 1190/24h had lower LV-EF and higher hs-cTnT levels and, at multivariate analysis, the presence of increased hs-cTnT and of right bundle branch block on ECG emerged as independent predictors of VEBs> 1190/24h. None of demographic or disease-related characteristics emerged as predictors of poor outcome. Conclusions VEBS> 1190/24h identify patients at high risk of life-threatening arrhythmic complications. Thus, 24h-ECG-Holter should be considered a useful additional risk-stratification test to select SSc-patients at high-risk of SCD, in whom an ICD-implantation could represent a potential life-saving intervention.	[De Luca, Giacomo; Bosello, Silvia Laura; Berardi, Giorgia; Parisi, Federico; Rucco, Manuela; Canestrari, Giovanni; Ferraccioli, Gianfranco] Univ Cattolica Sacro Cuore, Inst Rheumatol & Affine Sci, Dept Rheumatol, I-00168 Rome, Italy; [Gabrielli, Francesca Augusta; Loperfido, Francesco; Galiuto, Leonarda] Complesso Integrato Columbus, Div Heart Failure & Cardiac Rehabil, Rome, Italy; [Loperfido, Francesco; Galiuto, Leonarda; Crea, Filippo] Univ Cattolica Sacro Cuore, Inst Cardiol, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Ferraccioli, G (corresponding author), Univ Cattolica Sacro Cuore, Inst Rheumatol & Affine Sci, Dept Rheumatol, I-00168 Rome, Italy.	gf.ferraccioli@rm.unicatt.it	De+Luca, Giacomo/AAB-2933-2019; Bosello, Silvia L/L-1622-2018	Bosello, Silvia L/0000-0002-4837-447X; Ferraccioli, Gianfranco/0000-0002-6884-4301; De Luca, Giacomo/0000-0002-5306-7714	ASRALES foundation; GILS	ASRALES foundation; GILS	The authors acknowledge the ASRALES foundation and GILS for supporting the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; [Anonymous], 1974, Circulation, V49, P390; Assassi S, 2009, ARTHRIT CARE RES, V61, P1403, DOI 10.1002/art.24734; Ataklte F, 2013, AM J CARDIOL, V112, P1263, DOI 10.1016/j.amjcard.2013.05.065; Barron HV, 1996, J AM COLL CARDIOL, V27, P1053, DOI 10.1016/0735-1097(95)00615-X; Bernardo P, 2011, J RHEUMATOL, V38, P1617, DOI 10.3899/jrheum.100480; Bosello S, 2015, NEW ENGL J MED, V373, P1977, DOI 10.1056/NEJMc1511645; Brisinda D, 2012, CIRC J, V76, P1345, DOI 10.1253/circj.CJ-11-1374; BULKLEY BH, 1976, CIRCULATION, V53, P483, DOI 10.1161/01.CIR.53.3.483; CLEMSON BS, 1992, CHEST, V101, P872, DOI 10.1378/chest.101.3.872; Coghlan JG, 2014, ANN RHEUM DIS, V73, P1340, DOI 10.1136/annrheumdis-2013-203301; Cozzolino D, 2002, RHEUMATOLOGY, V41, P586, DOI 10.1093/rheumatology/41.5.586; DESOYZA N, 1979, CIRCULATION, V60, P814, DOI 10.1161/01.CIR.60.4.814; Draeger HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078808; Ferri C, 2005, LUPUS, V14, P702, DOI 10.1191/0961203305lu2204oa; FOLLANSBEE WP, 1993, AM HEART J, V125, P194, DOI 10.1016/0002-8703(93)90075-K; FOLLANSBEE WP, 1990, J RHEUMATOL, V17, P656; Hachulla AL, 2009, ANN RHEUM DIS, V68, P1878, DOI 10.1136/ard.2008.095836; HATLE L, 1981, BRIT HEART J, V45, P157; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; KOSTIS JB, 1988, AM J MED, V84, P1007, DOI 10.1016/0002-9343(88)90305-1; Kuhl U, 1996, HEART, V75, P295, DOI 10.1136/hrt.75.3.295; LEROY EC, 1988, J RHEUMATOL, V15, P202; LOWN B, 1967, J AMER MED ASSOC, V199, P188, DOI 10.1001/jama.199.3.188; Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P46, DOI 10.1016/j.acvd.2009.06.009; Mueller KAL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126707; MYERBURG RJ, 1993, ANN INTERN MED, V119, P1187, DOI 10.7326/0003-4819-119-12-199312150-00006; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; Passman R, 2007, CIRCULATION, V116, P561, DOI 10.1161/CIRCULATIONAHA.106.655704; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pieroni M, 2014, SEMIN ARTHRITIS RHEU, V43, P526, DOI 10.1016/j.semarthrit.2013.07.006; Rajdev A, 2012, PROG CARDIOVASC DIS, V55, P180, DOI 10.1016/j.pcad.2012.06.002; Rosato E, 2015, INT J CARDIOL, V182, P20, DOI 10.1016/j.ijcard.2014.12.069; Schumm J, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-14; Smedema JP, 2005, J AM COLL CARDIOL, V45, P1683, DOI 10.1016/j.jacc.2005.01.047; Stack J, 2010, SCAND J RHEUMATOL, V39, P349, DOI 10.3109/03009740903493741; Thakkar V, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3876; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; Tzelepis GE, 2007, ARTHRITIS RHEUM-US, V56, P3827, DOI 10.1002/art.22971; Vacca A, 2013, RHEUMATOLOGY OXFORD; Zipes DP, 2006, EUR HEART J, V27, P2099, DOI 10.1093/eurheartj/ehl199	42	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153012	10.1371/journal.pone.0153012	http://dx.doi.org/10.1371/journal.pone.0153012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101136	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500022
J	Hu, XS; He, WW; Wen, SM; Feng, XQ; Fu, X; Liu, YS; Pu, K				Hu, Xingsheng; He, Wenwu; Wen, Shimin; Feng, Xuqin; Fu, Xi; Liu, Yusong; Pu, Ke			Is IMRT Superior or Inferior to 3DCRT in Radiotherapy for NSCLC? A Meta-Analysis	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; CELL LUNG-CANCER; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; TREATMENT-RELATED PNEUMONITIS; RADIATION-THERAPY; CONCURRENT CHEMOTHERAPY; ORGAN MOTION; 3D; DELIVERY; VOLUME	Introduction There are no adequate data to determine whether intensity-modulated radiotherapy (IMRT) is superior to three-dimensional conformal radiotherapy (3DCRT) in the treatment of nonsmall cell lung cancer (NSCLC). This meta-analysis was conducted to compare the clinical outcomes of IMRT and 3DCRT in the treatment of NSCLC. Methods No exclusions were made based on types of study design. We performed a literature search in PubMed, EMBASE and the Cochrane library databases from their inceptions to April 30, 2015. The overall survival (OS) and relative risk (RR) of radiation pneumonitis and radiation oesophagitis were evaluated. Two authors independently assessed the methodological quality and extracted data. Publication bias was evaluated by funnel plot using Egger's test results. Results From the literature search, 10 retrospective studies were collected, and of those, 5 (12,896 patients) were selected for OS analysis, 4 (981 patients) were selected for radiation pneumonitis analysis, and 4 (1339 patients) were selected for radiation oesophagitis analysis. Cox multivariate proportional hazards models revealed that 3DCRT and IMRT had similar OS (HR = 0.96, P = 0.477) but that IMRT reduced the incidence of grade 2 radiation pneumonitis (RR = 0.74, P = 0.009) and increased the incidence of grade 3 radiation oesophagitis (RR = 2.47, P = 0.000). Conclusions OS of IMRT for NSCLC is not inferior to that of 3DCRT, but IMRT significantly reduces the risk of radiation pneumonitis and increases the risk of radiation oesophagitis compared to 3DCRT.	[Hu, Xingsheng; Wen, Shimin; Feng, Xuqin; Fu, Xi] Nanchong Cent Hosp, North Sichuan Med Coll, Affiliated Hosp 2, Dept Oncol, Nanchong, Sichuan Provinc, Peoples R China; [He, Wenwu] Nanchong Cent Hosp, Dept Cardiothorac Surg, Nanchong, Sichuan Provinc, Peoples R China; [Liu, Yusong] Peoples Hosp Shifang, Dept Clin Lab, Shifang, Sichuan Provinc, Peoples R China; [Pu, Ke] DaZhou Coll Chinese Med, Dazhou, Sichuan Provinc, Peoples R China	North Sichuan Medical University; North Sichuan Medical University	Pu, K (corresponding author), DaZhou Coll Chinese Med, Dazhou, Sichuan Provinc, Peoples R China.	137666745@qq.com						Bauman G, 2012, Clin Oncol (R Coll Radiol), V24, P461, DOI 10.1016/j.clon.2012.05.002; Bortfeld T, 2002, PHYS MED BIOL, V47, P2203, DOI 10.1088/0031-9155/47/13/302; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Chen AB, 2014, J THORAC ONCOL, V9, P1788, DOI 10.1097/JTO.0000000000000331; Chino F, 2014, ONCOLOGIST, V19, P414, DOI 10.1634/theoncologist.2013-0374; Chui CS, 2003, MED PHYS, V30, P1736, DOI 10.1118/1.1578771; Court LE, 2008, MED PHYS, V35, P1926, DOI 10.1118/1.2896083; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gomez D, 2011, RADIOTHERAPY ONCO S1, V99; Harris JP, 2014, INT J RADIAT ONCOL, V88, P872, DOI 10.1016/j.ijrobp.2013.12.010; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Hsia TC, 2014, ANTICANCER RES, V34, P5175; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang SB, 2003, PHYS MED BIOL, V48, P1773, DOI 10.1088/0031-9155/48/12/307; Liao ZXX, 2010, INT J RADIAT ONCOL, V76, P775, DOI 10.1016/j.ijrobp.2009.02.032; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lievens Y, 2011, INT J RADIAT ONCOL, V80, p[1, 306]; Liu HH, 2004, INT J RADIAT ONCOL, V58, P1268, DOI 10.1016/j.ijrobp.2003.09.085; Guerra JLL, 2012, INT J RADIAT ONCOL, V83, pE537, DOI 10.1016/j.ijrobp.2012.01.019; Marta GN, 2014, RADIOTHER ONCOL, V110, P9, DOI 10.1016/j.radonc.2013.11.010; McCloskey PM, 2012, INT J RADIAT ONCOL, V84, pS597, DOI 10.1016/j.ijrobp.2012.07.1594; Murshed H, 2004, INT J RADIAT ONCOL, V58, P1258, DOI 10.1016/j.ijrobp.2003.09.086; Noh JM, 2015, CANC RES TREAT, V12; Nutting CM, 2002, BRIT J RADIOL, V75, P151, DOI 10.1259/bjr.75.890.750151; Paliwal BR, 2004, MED PHYS, V31, P1, DOI 10.1118/1.1630968; Rehman S, 2014, INT J RADIAT ONCOL, V90, pS161, DOI 10.1016/j.ijrobp.2014.05.654; Schwarz M, 2005, INT J RADIAT ONCOL, V62, P561, DOI 10.1016/j.ijrobp.2005.02.011; Schwarz M, 2006, INT J RADIAT ONCOL, V65, P1260, DOI 10.1016/j.ijrobp.2006.03.035; Sejpal S, 2011, CANCER-AM CANCER SOC, V117, P3004, DOI 10.1002/cncr.25848; Shirvani SM, 2013, LUNG CANCER, V82, P252, DOI 10.1016/j.lungcan.2013.08.015; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Wagner Henry, 2003, Cancer Control, V10, P277; Wang SL, 2006, INT J RADIAT ONCOL, V66, P1399, DOI 10.1016/j.ijrobp.2006.07.1337; Yom SS, 2007, INT J RADIAT ONCOL, V68, P94, DOI 10.1016/j.ijrobp.2006.12.031; Zafar SY, 2013, ONCOLOGIST, V18, P381, DOI 10.1634/theoncologist.2012-0279	35	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0151988	10.1371/journal.pone.0151988	http://dx.doi.org/10.1371/journal.pone.0151988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100968	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500009
J	Bento-Torres, NVO; Rodrigues, AR; Cortes, MIT; Bonci, DMD; Ventura, DF; Silveira, LCD				Oliver Bento-Torres, Natali Valim; Rodrigues, Anderson Raiol; Tentes Cortes, Maria Izabel; de Oliveira Bonci, Daniela Maria; Ventura, Dora Fix; de Lima Silveira, Luiz Carlos			Psychophysical Evaluation of Congenital Colour Vision Deficiency: Discrimination between Protans and Deutans Using Mollon-Reffin's Ellipses and the Farnsworth-Munsell 100-Hue Test	PLOS ONE			English	Article							DESATURATED PANEL D-15; PARKINSONS-DISEASE; IMPAIRMENT; DEFECTS	We have used the Farnsworth-Munsell 100-hue (FM 100) test and Mollon-Reffin (MR) test to evaluate the colour vision of 93 subjects, 30.4 +/- 9.7 years old, who had red-green congenital colour vision deficiencies. All subjects lived in Belem (State of Para, Brazil) and were selected by the State of Para Traffic Department. Selection criteria comprised the absence of visual dysfunctions other than Daltonism and no history of systemic diseases that could impair the visual system performance. Results from colour vision deficient were compared with those from 127 normal trichromats, 29.3 +/- 10.3 years old. For the MR test, measurements were taken around five points of the CIE 1976 colour space, along 20 directions irradiating from each point, in order to determine with high-resolution the corresponding colour discrimination ellipses (MacAdam ellipses). Three parameters were used to compare results obtained from different subjects: diameter of circle with same ellipse area, ratio between ellipse's long and short axes, and ellipse long axis angle. For the FM 100 test, the parameters were: logarithm of the total number of mistakes and positions of mistakes in the FM diagram. Data were also simultaneously analysed in two or three dimensions as well as by using multidimensional cluster analysis. For the MR test, Mollon-Reffin Ellipse #3 (u' = 0.225, v' = 0.415) discriminated more efficiently than the other four ellipses between protans and deutans once it provided larger angular difference in the colour space between protan and deutan confusion lines. The MR test was more sensitive than the FM 100 test. It separated individuals by dysfunctional groups with greater precision, provided a more sophisticated quantitative analysis, and its use is appropriate for a more refined evaluation of different phenotypes of red-green colour vision deficiencies.	[Oliver Bento-Torres, Natali Valim; Rodrigues, Anderson Raiol; de Lima Silveira, Luiz Carlos] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Oliver Bento-Torres, Natali Valim] Fed Univ Para, Inst Ciencias Saude, BR-66059 Belem, Para, Brazil; [Rodrigues, Anderson Raiol; de Lima Silveira, Luiz Carlos] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil; [Tentes Cortes, Maria Izabel] Univ Fed Amapa, Programa Posgrad Ciencias Saude, Macapa, Amapa, Brazil; [de Oliveira Bonci, Daniela Maria; Ventura, Dora Fix] Univ Sao Paulo, Dept Psicol Expt, Inst Psicol, Sao Paulo, Brazil; [de Lima Silveira, Luiz Carlos] Univ Ceuma, Sao Luis, Maranhao, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Fundacao Universidade Federal do Amapa; Universidade de Sao Paulo; Universidade Ceuma	Silveira, LCD (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.; Silveira, LCD (corresponding author), Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil.; Silveira, LCD (corresponding author), Univ Ceuma, Sao Luis, Maranhao, Brazil.	luiz@ufpa.br	Rodrigues, Anderson Raiol/AAE-4365-2021; Ventura, Dora F/B-9071-2012; Bento-Torres, Natáli Valim Oliver/AAU-7248-2020; Silveira, Luiz Carlos/H-9647-2014	Rodrigues, Anderson Raiol/0000-0002-3115-7903; Ventura, Dora F/0000-0002-7616-4031; Bento-Torres, Natáli Valim Oliver/0000-0003-0978-211X; Silveira, Luiz Carlos/0000-0001-9414-1573	Financiadora de Estudos e Projetos: FINEP IBN-Net [1723]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico: CNPq-PRONEX [1079, 2268]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior: CAPES-PROCAD [0019/01-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: FAPESP [02/12733-8]; FINEP IBN-Net [1723]; CNPq-PRONEX [1079, 2268]; CNPq [471815/2004-7]; CAPES-PROCAD [0019/01-1]; FAPESP [02/12733-8]; CAPES; CNPq	Financiadora de Estudos e Projetos: FINEP IBN-Net(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico: CNPq-PRONEX(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior: CAPES-PROCAD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FINEP IBN-Net(Financiadora de Inovacao e Pesquisa (Finep)); CNPq-PRONEX(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-PROCAD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding provided by Financiadora de Estudos e Projetos (http://www.finep.gov.br): FINEP IBN-Net #1723. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br): CNPq-PRONEX #1079 and #2268, CNPq #471815/2004-7. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br): CAPES-PROCAD #0019/01-1. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br): FAPESP #02/12733-8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the following grants: FINEP IBN-Net #1723 (LCLS); CNPq-PRONEX #1079 and #2268 (LCLS); CNPq #471815/2004-7 (LCLS); CAPES-PROCAD #0019/01-1 (DFV); FAPESP #02/12733-8 (DFV). NVOBT, ARR, and DMOB received CAPES or CNPq fellowships for graduate students. DFV and LCLS are CNPq research fellows.	AYRES M., 2003, BIOESTAT3 0 APLICACO; Bailey JE, 2004, VISUAL NEUROSCI, V21, P431, DOI 10.1017/S0952523804213463; Bieber ML, 1998, VISION RES, V38, P3293, DOI 10.1016/S0042-6989(98)00067-4; BIRCH J, 1989, OPHTHAL PHYSL OPT, V9, P156, DOI 10.1111/j.1475-1313.1989.tb00836.x; Birch J., 2001, DIAGNOSIS DEFECTIVE; Brasil A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140169; Chibret J. B. P. L., 1887, REV GENERALE OPHTALM, P49; COLE B L, 1963, Br J Physiol Opt, V20, P113; Cole BL, 2006, CLIN EXP OPTOM, V89, P73, DOI 10.1111/j.1444-0938.2006.00015.x; Costa MF, 2007, AM J HUM GENET, V80, P1064, DOI 10.1086/518127; Dain Stephen J, 2004, Clin Exp Optom, V87, P276; Moura ALD, 2008, VISUAL NEUROSCI, V25, P463, DOI 10.1017/S0952523808080437; DEEB SS, 1992, AM J HUM GENET, V51, P687; Farnsworth D, 1943, J OPT SOC AM, V33, P568, DOI 10.1364/JOSA.33.000568; Farnsworth D, 1947, FARNSWORTH DICHOTOMO; Farnsworth D., 1957, FARNSWORTH MUNSELL 1; Feitosa-Santana C, 2010, OPHTHAL PHYSL OPT, V30, P717, DOI 10.1111/j.1475-1313.2010.00776.x; Ghose S, 2014, INT OPHTHALMOL, V34, P747, DOI 10.1007/s10792-013-9865-9; HARDY LH, 1954, J OPT SOC AM, V44, P509, DOI 10.1364/JOSA.44.000509; Ishihara S., 1997, SERIES PLATES DESIGN; Ishihara S., 1917, TESTS COLOR BLINDNES; Lagerlof O, 1991, COLOR VISION DEFICIE, P241; LAKOWSKI R, 1969, BRIT J IND MED, V26, P265; LAKOWSKI R, 1969, BRIT J IND MED, V26, P173; LANTHONY P, 1978, DOC OPHTHALMOL, V46, P185; LANTHONY P, 1994, J FR OPHTALMOL, V17, P15; Latshaw VV., 1957, AM MATH MON, V64, P685, DOI [10.2307/2309989, DOI 10.2307/2309989]; LINKSZ A, 1966, AM J OPHTHALMOL, V62, P27, DOI 10.1016/0002-9394(66)91673-4; MacAdam DL, 1942, J OPT SOC AM, V32, P247, DOI 10.1364/JOSA.32.000247; MOLLON JD, 1989, J PHYSL, V414, P5; Paramei GV, 2014, J OPT SOC AM A, V31, pA375, DOI 10.1364/JOSAA.31.00A375; Paramei GV, 2012, J OPT SOC AM A, V29, pA290, DOI 10.1364/JOSAA.29.00A290; RAND G, 1956, ARCH OPHTHALMOL-CHIC, V56, P736, DOI 10.1001/archopht.1956.00930040744013; REGAN BC, 1994, VISION RES, V34, P1279, DOI 10.1016/0042-6989(94)90203-8; Regan BC, 1998, VISION RES, V38, P3427, DOI 10.1016/S0042-6989(97)00402-1; Regan BC, 1993, COLOUR VISION DEFICI, P445; Regan JD., 2000, CAMBRIDGE COLOUR TES; Rodrigues AR, 2007, BRAZ J MED BIOL RES, V40, P415, DOI 10.1590/S0100-879X2007000300018; SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657; Shevell SK, 1998, VISION RES, V38, P3371, DOI 10.1016/S0042-6989(97)00434-3; Silva MF, 2005, BRAIN, V128, P2260, DOI 10.1093/brain/awh581; Silveira LCL, 2003, NORMAL DEFECTIVE COL, P407; Souza GS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01291; Stilling J, 1877, PRUFUNG FARBENSINNES, DOI 10.3931/e-rara-77368/PublicDomainMark; Ventura D. F., 2003, NORMAL DEFECTIVE COL, P395, DOI [10.1093/acprof:oso/9780198525301.003.0042, DOI 10.1093/ACPROF:OSO/9780198525301.003.0042]; VENTURA DF, 2003, NORMAL DEFECTIVE COL, P331	46	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152214	10.1371/journal.pone.0152214	http://dx.doi.org/10.1371/journal.pone.0152214			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101124	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500010
J	Shen, XJ; Yi, L; Jiang, XP; He, TT; Hu, XH; Yang, JC				Shen, Xianjun; Yi, Li; Jiang, Xingpeng; He, Tingting; Hu, Xiaohua; Yang, Jincai			Mining Temporal Protein Complex Based on the Dynamic PIN Weighted with Connected Affinity and Gene Co-Expression	PLOS ONE			English	Article							FUNCTIONAL MODULES; TIME-COURSE; PPI NETWORKS; CONSTRUCTION; ORGANIZATION; DATABASE; CYCLE	The identification of temporal protein complexes would make great contribution to our knowledge of the dynamic organization characteristics in protein interaction networks (PINs). Recent studies have focused on integrating gene expression data into static PIN to construct dynamic PIN which reveals the dynamic evolutionary procedure of protein interactions, but they fail in practice for recognizing the active time points of proteins with low or high expression levels. We construct a Time-Evolving PIN (TEPIN) with a novel method called Deviation Degree, which is designed to identify the active time points of proteins based on the deviation degree of their own expression values. Owing to the differences between protein interactions, moreover, we weight TEPIN with connected affinity and gene co-expression to quantify the degree of these interactions. To validate the efficiencies of our methods, ClusterONE, CAMSE and MCL algorithms are applied on the TEPIN, DPIN (a dynamic PIN constructed with state-of-the-art three-sigma method) and SPIN (the original static PIN) to detect temporal protein complexes. Each algorithm on our TEPIN outperforms that on other networks in terms of match degree, sensitivity, specificity, F-measure and function enrichment etc. In conclusion, our Deviation Degree method successfully eliminates the disadvantages which exist in the previous state-of-the-art dynamic PIN construction methods. Moreover, the biological nature of protein interactions can be well described in our weighted network. Weighted TEPIN is a useful approach for detecting temporal protein complexes and revealing the dynamic protein assembly process for cellular organization.	[Shen, Xianjun; Yi, Li; Jiang, Xingpeng; He, Tingting; Hu, Xiaohua; Yang, Jincai] Cent China Normal Univ, Sch Comp, Wuhan, Peoples R China; [Hu, Xiaohua] Drexel Univ, Coll Comp & Informat, Philadelphia, PA 19104 USA	Central China Normal University; Drexel University	Yang, JC (corresponding author), Cent China Normal Univ, Sch Comp, Wuhan, Peoples R China.	jcyang@mail.ccnu.edu.cn			National Natural Science Foundation of China [61532008]; International Cooperation Project of Hubei Province [2014BHE0017]; Self-determined Research Funds of CCNU from the Colleges' Basic Research and Operation of MOE [CCNU14A02008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project of Hubei Province; Self-determined Research Funds of CCNU from the Colleges' Basic Research and Operation of MOE	National Natural Science Foundation of China, No. 61532008, XH; International Cooperation Project of Hubei Province, No. 2014BHE0017, TH; Self-determined Research Funds of CCNU from the Colleges' Basic Research and Operation of MOE, No. CCNU14A02008, XS.; This research is supported by the National Natural Science Foundation of China (No. 61532008), the International Cooperation Project of Hubei Province (No. 2014BHE0017), and the Self-determined Research Funds of CCNU from the Colleges' Basic Research and Operation of MOE (No. CCNU14A02008).	Chen BL, 2014, BRIEF BIOINFORM, V15, P177, DOI 10.1093/bib/bbt039; Chen BL, 2013, IEEE T NANOBIOSCI, V12, P165, DOI 10.1109/TNB.2013.2264097; Chen BL, 2013, PROTEOMICS, V13, P269, DOI 10.1002/pmic.201200336; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Dongen SM, 2000, THESIS U UTRECHT NET; He TT, 2014, IEEE INT C BIOINF BI; Kim Y, 2014, BRIEF BIOINFORM, V15, P212, DOI 10.1093/bib/bbt028; Li M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-109; Li P, 2013, IEEE INT C BIOINFORM; Li X, 2007, IEEE COMP SOC BIOINF; Lin CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09386; Liu W, 2014, PROG BIOCHEM BIOPHYS, V41, P115, DOI 10.3724/SP.J.1206.2013.00055; Luo F, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S4; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Srihari S, 2015, FEBS LETT, V589, P2590, DOI 10.1016/j.febslet.2015.04.026; Srihari S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S16; Tang X, 2012, IEEE 6 INT C SYST BI; Tang XW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-339; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wang JX, 2014, PROTEOMICS, V14, P338, DOI 10.1002/pmic.201300257; Wang JX, 2013, PROTEOMICS, V13, P301, DOI 10.1002/pmic.201200277; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yong CH, 2015, J BIOINF COMPUT BIOL, V13, DOI 10.1142/S0219720015710018; Zhang XF, 2014, BMC BIOINFORMATICS, V15, DOI [10.1186/1471-2105-15-186, 10.1186/1471-2105-15-335]	28	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153967	10.1371/journal.pone.0153967	http://dx.doi.org/10.1371/journal.pone.0153967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100396	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500113
J	Elfers, K; Marr, I; Wilkens, MR; Breves, G; Langeheine, M; Brehm, R; Muscher-Banse, AS				Elfers, Kristin; Marr, Isabell; Wilkens, Mirja R.; Breves, Gerhard; Langeheine, Marion; Brehm, Ralph; Muscher-Banse, Alexandra S.			Expression of Tight Junction Proteins and Cadherin 17 in the Small Intestine of Young Goats Offered a Reduced N and/or Ca Diet	PLOS ONE			English	Article							CATION-SELECTIVE CHANNELS; CALCIUM-ABSORPTION; EPITHELIAL-CELLS; PHOSPHATE-TRANSPORT; ZONULA OCCLUDENS; GENE-EXPRESSION; RAT INTESTINE; ZO-1; BARRIER; PERMEABILITY	Diets fed to ruminants should contain nitrogen (N) as low as possible to reduce feed costs and environmental pollution. Though possessing effective N-recycling mechanisms to maintain the N supply for rumen microbial protein synthesis and hence protein supply for the host, an N reduction caused substantial changes in calcium (Ca) and phosphate homeostasis in young goats including decreased intestinal transepithelial Ca absorption as reported for monogastric species. In contrast to the transcellular component of transepithelial Ca transport, the paracellular route has not been investigated in young goats. Therefore, the aim of the present study was to characterise the effects of dietary N and/or Ca reduction on paracellular transport mechanisms in young goats. Electrophysiological properties of intestinal epithelia were investigated by Ussing chamber experiments. The expression of tight junction (TJ) and adherens junction (AJ) proteins in intestinal epithelia were examined on mRNA level by qPCR and on protein level by western blot analysis. Dietary N reduction led to a segment specific increase in tissue conductances in the proximal jejunum which might be linked to concomitantly decreased expression of cadherin 17 mRNA. Expression of occludin (OCLN) and zonula occludens protein 1 was increased in mid jejunal epithelia of N reduced fed goats on mRNA and partly on protein level. Reduced dietary Ca supply resulted in a segment specific increase in claudin 2 and claudin 12 expression and decreased the expression of OCLN which might have been mediated at least in part by calcitriol. These data show that dietary N as well as Ca reduction affected expression of TJ and AJ proteins in a segment specific manner in young goats and may thus be involved in modulation of paracellular Ca permeability.	[Elfers, Kristin; Marr, Isabell; Wilkens, Mirja R.; Breves, Gerhard; Muscher-Banse, Alexandra S.] Univ Vet Med Hannover, Dept Physiol, Bischofsholer Damm 15-102, D-30173 Hannover, Germany; [Langeheine, Marion; Brehm, Ralph] Univ Vet Med Hannover, Inst Anat, Bischofsholer Damm 15-122, D-30173 Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Muscher-Banse, AS (corresponding author), Univ Vet Med Hannover, Dept Physiol, Bischofsholer Damm 15-102, D-30173 Hannover, Germany.	alexandra.muscher@tiho-hannover.de	Muscher-Banse, Alexandra S/V-9687-2018; Breves, Gerhard/ABI-1315-2020	Muscher-Banse, Alexandra S/0000-0002-4149-7987; Wilkens, Mirja/0000-0003-1734-5024; Marr, Isabell/0000-0001-6272-0482	German Research Foundation (DFG) [Mu3585/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was funded by the German Research Foundation (DFG, www.dfg.de/), grant number: Mu3585/1-1.	Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Angst BD, 2001, J CELL SCI, V114, P629; Auchere D, 1998, AM J PHYSIOL-GASTR L, V275, pG951, DOI 10.1152/ajpgi.1998.275.5.G951; Benn BS, 2008, ENDOCRINOLOGY, V149, P3196, DOI 10.1210/en.2007-1655; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Chirayath MV, 1998, AM J PHYSIOL-GASTR L, V274, pG389, DOI 10.1152/ajpgi.1998.274.2.G389; Christakos S, 2010, J STEROID BIOCHEM, V121, P183, DOI 10.1016/j.jsbmb.2010.03.005; Dubois-Ferriere V, 2011, ENDOCRINOLOGY, V152, P1839, DOI 10.1210/en.2010-1079; Elfers K, 2015, J STEROID BIOCH MOL; Elfers K, 2015, BRIT J NUTR, V114, P1949, DOI 10.1017/S000711451500375X; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fujita H, 2008, MOL BIOL CELL, V19, P1912, DOI 10.1091/mbc.E07-09-0973; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Gaffney-Stomberg E, 2010, ENDOCRINOLOGY, V151, P1071, DOI 10.1210/en.2009-0744; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hwang I, 2013, INT J MOL SCI, V14, P22997, DOI 10.3390/ijms141122997; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; KAMINSKY NI, 1970, J CLIN INVEST, V49, P2387, DOI 10.1172/JCI106458; Kerstetter JE, 1998, AM J CLIN NUTR, V68, P859, DOI 10.1093/ajcn/68.4.859; Ko JA, 2009, CELL BIOCHEM FUNCT, V27, P388, DOI 10.1002/cbf.1587; Kreft B, 1997, J CELL BIOL, V136, P1109, DOI 10.1083/jcb.136.5.1109; Kutuzova GD, 2004, ARCH BIOCHEM BIOPHYS, V432, P152, DOI 10.1016/j.abb.2004.09.004; Markov AG, 2010, J COMP PHYSIOL B, V180, P591, DOI 10.1007/s00360-009-0440-7; MORENO JH, 1975, J GEN PHYSIOL, V66, P97, DOI 10.1085/jgp.66.1.97; Muscher A, 2010, J STEROID BIOCHEM, V121, P304, DOI 10.1016/j.jsbmb.2010.03.084; Muscher AS, 2012, BRIT J NUTR, V108, P628, DOI 10.1017/S0007114511005976; ORWOLL E, 1992, AM J CLIN NUTR, V56, P314, DOI 10.1093/ajcn/56.2.314; Pacheco II, 2008, AM J PHYSIOL-GASTR L, V295, pG748, DOI 10.1152/ajpgi.00560.2007; RUIFROK PG, 1983, BIOCHEM PHARMACOL, V32, P637, DOI 10.1016/0006-2952(83)90487-2; SIMMONS NL, 1976, BIOCHIM BIOPHYS ACTA, V448, P426, DOI 10.1016/0005-2736(76)90298-4; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Todini L, 2007, ANIMAL, V1, P997, DOI 10.1017/S1751731107000262; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2004, PHYSIOLOGY, V19, P331, DOI 10.1152/physiol.00027.2004; Wilkens MR, 2012, COMP BIOCHEM PHYS A, V163, P396, DOI 10.1016/j.cbpa.2012.06.011; Wilkens MR, 2011, COMP BIOCHEM PHYS B, V158, P199, DOI 10.1016/j.cbpb.2010.11.008; Wilkens MR, 2009, VET J, V182, P294, DOI 10.1016/j.tvjl.2008.06.020; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004; Zhang BK, 2009, BRIT J NUTR, V102, P687, DOI 10.1017/S0007114509289033	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154311	10.1371/journal.pone.0154311	http://dx.doi.org/10.1371/journal.pone.0154311			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120348	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200058
J	Matsusaka, K; Ishikawa, S; Nakayama, A; Ushiku, T; Nishimoto, A; Urabe, M; Kaneko, N; Kunita, A; Kaneda, A; Aburatani, H; Fujishiro, M; Seto, Y; Fukayama, M				Matsusaka, Keisuke; Ishikawa, Shumpei; Nakayama, Atsuhito; Ushiku, Tetsuo; Nishimoto, Aiko; Urabe, Masayuki; Kaneko, Nobuyuki; Kunita, Akiko; Kaneda, Atsushi; Aburatani, Hiroyuki; Fujishiro, Mitsuhiro; Seto, Yasuyuki; Fukayama, Masashi			Tumor Content Chart-Assisted HER2/CEP17 Digital PCR Analysis of Gastric Cancer Biopsy Specimens	PLOS ONE			English	Article							BREAST-CANCER; CLINICAL ONCOLOGY/COLLEGE; ADJUVANT CHEMOTHERAPY; FORMALIN FIXATION; AMERICAN SOCIETY; C-ERBB-2 PROTEIN; EXPRESSION; RECEPTOR; AMPLIFICATION; OVEREXPRESSION	Evaluating HER2 gene amplification is an essential component of therapeutic decision-making for advanced or metastatic gastric cancer. A simple method that is applicable to small, formalin-fixed, paraffin-embedded biopsy specimens is desirable as an adjunct to or as a substitute for currently used HER2 immunohistochemistry and in situ hybridization protocols. In this study, we developed a microfluidics-based digital PCR method for determining HER2 and chromosome 17 centromere (CEP17) copy numbers and estimating tumor content ratio (TCR). The HER2/CEP17 ratio is determined by three variables-TCR and absolute copy numbers of HER2 and CEP17-by examining tumor cells; only the ratio of the latter two can be obtained by digital PCR using the whole specimen without purifying tumor cells. TCR was determined by semi-automatic image analysis. We developed a Tumor Content chart, which is a plane of rectangular coordinates consisting of HER2/CEP17 digital PCR data and TCR that delineates amplified, non-amplified, and equivocal areas. By applying this method, 44 clinical gastric cancer biopsy samples were classified as amplified (n = 13), non-amplified (n = 25), or equivocal (n = 6). By comparison, 11 samples were positive, 11 were negative, and 22 were equivocally immunohistochemistry. Thus, our novel method reduced the number of equivocal samples from 22 to 6, thereby obviating the need for confirmation by fluorescence or dual-probe in situ hybridization to <30% of cases. Tumor content chart-assisted digital PCR analysis is also applicable to multiple sites in surgically resected tissues. These results indicate that this analysis is a useful alternative to HER2 immunohistochemistry in gastric cancers that can serve as a basis for the automated evaluation of HER2 status.	[Matsusaka, Keisuke; Kaneko, Nobuyuki; Fukayama, Masashi] Tokyo Univ Hosp, Div Diagnost Pathol, Tokyo 113, Japan; [Matsusaka, Keisuke; Urabe, Masayuki; Kaneda, Atsushi] Chiba Univ, Grad Sch Med, Dept Mol Oncol, Chiba, Japan; [Ishikawa, Shumpei; Nakayama, Atsuhito; Ushiku, Tetsuo; Nishimoto, Aiko; Urabe, Masayuki; Kunita, Akiko; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Ishikawa, Shumpei] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Pathol, Tokyo, Japan; [Urabe, Masayuki; Seto, Yasuyuki] Tokyo Univ Hosp, Dept Gastrointestinal Surg, Tokyo 113, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Fujishiro, Mitsuhiro] Tokyo Univ Hosp, Dept Endoscopy & Endoscop Surg, Tokyo 113, Japan	University of Tokyo; Chiba University; University of Tokyo; Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; University of Tokyo	Fukayama, M (corresponding author), Tokyo Univ Hosp, Div Diagnost Pathol, Tokyo 113, Japan.; Fukayama, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan.	mfukayama-tky@unin.ac.jp	Urabe, Masayuki/AAO-1582-2021; 藤城, 光弘/AAN-3131-2020	Nakayama, Atsuhito/0000-0002-9832-9415; Urabe, Masayuki/0000-0002-5558-4184	Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for medical research and development; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [26253021] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for medical research and development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was conducted as a part of the BioBank Japan Project (http://www.src.riken.jp/english/project/person/) that was supported by Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/english/), Japan Agency for medical research and development (http://www.amed.go.jp/en/), and Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber DA, 2002, APPL IMMUNOHISTO M M, V10, P183, DOI 10.1097/00022744-200206000-00015; Bang YJ, 2010, LANCET, V376, P1302; COOMBS LM, 1991, BRIT J CANCER, V63, P601, DOI 10.1038/bjc.1991.139; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; FALCK VG, 1989, J PATHOL, V159, P107, DOI 10.1002/path.1711590204; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Hanley KZ, 2009, CANCER CYTOPATHOL, V117, P279, DOI 10.1002/cncy.20034; Ibarra JA, 2010, AM J CLIN PATHOL, V134, P594, DOI 10.1309/AJCPAIJPSN4A9MJI; Jacquemier J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-351; Khoury T, 2009, MODERN PATHOL, V22, P1457, DOI 10.1038/modpathol.2009.117; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Koeppen HKW, 2001, HISTOPATHOLOGY, V38, P96, DOI 10.1046/j.1365-2559.2001.01084.x; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; MCCULLOCH PG, 1995, CANCER, V75, P920, DOI 10.1002/1097-0142(19950215)75:4<920::AID-CNCR2820750405>3.0.CO;2-E; Middleton LP, 2009, ARCH PATHOL LAB MED, V133, P775, DOI 10.1043/1543-2165-133.5.775; MOTOJIMA K, 1994, SURGERY, V115, P349; Nakajima M, 1999, CANCER, V85, P1894; Ota S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039954; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; TATEISHI M, 1992, J SURG ONCOL, V49, P209, DOI 10.1002/jso.2930490402; Tong LC, 2011, AM J SURG PATHOL, V35, P545, DOI 10.1097/PAS.0b013e31820e6237; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; UCHINO S, 1993, CANCER, V72, P3179, DOI 10.1002/1097-0142(19931201)72:11<3179::AID-CNCR2820721108>3.0.CO;2-#; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Ye P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143207; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622	34	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154430	10.1371/journal.pone.0154430	http://dx.doi.org/10.1371/journal.pone.0154430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119558	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200073
J	Pecha, S; Kennergren, C; Yildirim, Y; Gosau, N; Aydin, A; Willems, S; Treede, H; Reichenspurner, H; Hakmi, S				Pecha, Simon; Kennergren, Charles; Yildirim, Yalin; Gosau, Nils; Aydin, Ali; Willems, Stephan; Treede, Hendrik; Reichenspurner, Hermann; Hakmi, Samer			Coronary Sinus Lead Removal: A Comparison between Active and Passive Fixation Leads	PLOS ONE			English	Article							EXTRACTION; EXPERIENCE; THERAPY; VEIN	Background Implantation of coronary sinus (CS) leads may be a difficult procedure due to different vein anatomies and a possible lead dislodgement. The mode of CS lead fixation has changed and developed in recent years. Objectives We compared the removal procedures of active and passive fixation leads. Methods Between January 2009 and January 2014, 22 patients at our centre underwent CS lead removal, 6 active and 16 passive fixation leads were attempted using simple traction or lead locking devices with or without laser extraction sheaths. Data on procedural variables and success rates were collected and retrospectively analyzed. Results The mean patient age was 67.2 +/- 9.8 years, and 90.9% were male. The indication for lead removal was infection in all cases. All active fixation leads were Medtronic (R) Attain StarFix (TM) Model 4195 (Medtronic Inc., Minneapolis, MN, USA). The mean time from implantation for the active and passive fixation leads was 9.9 +/- 11.7 months (range 1.0-30.1) and 48.7 +/- 33.6 months (range 5.7-106.4), respectively (p = 0.012). Only 3 of 6 StarFix leads were successfully removed (50%) compared to 16 of 16 (100%) of the passive fixation CS leads (p = 0.013). No death or complications occurred during the 30-day follow-up. Conclusion According to our experience, removal of the Starfix active fixation CS leads had a higher procedural failure rate compared to passive.	[Pecha, Simon; Yildirim, Yalin; Treede, Hendrik; Reichenspurner, Hermann; Hakmi, Samer] Univ Heart Ctr Hamburg, Dept Cardiovasc Surg, Hamburg, Germany; [Kennergren, Charles] Sahlgrens Univ Hosp, Dept Cardiothorac Surg, Gothenburg, Sweden; [Gosau, Nils; Willems, Stephan] Univ Heart Ctr Hamburg, Dept Cardiol, Electrophysiol, Hamburg, Germany; [Aydin, Ali] St Adolf Stift Hosp Reinbek, Dept Cardiol, Reinbek, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Sahlgrenska University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Pecha, S (corresponding author), Univ Heart Ctr Hamburg, Dept Cardiovasc Surg, Hamburg, Germany.	s.pecha@uke.de	Treede, Hendrik/I-3630-2017; Kennergren, Charles/AAQ-4871-2020	Gosau, Nils/0000-0002-7888-9204				Baranowski B, 2011, PACE, V34, pE64, DOI 10.1111/j.1540-8159.2010.02911.x; Bontempi L, 2015, EUROPACE; Boriani G, 2012, HEART, V98, P1828, DOI 10.1136/heartjnl-2012-301845; Cronin EM, 2013, J INTERV CARD ELECTR, V36, P81, DOI 10.1007/s10840-012-9704-3; Deharo JC, 2012, EUROPACE, V14, P124, DOI 10.1093/europace/eur338; Di Cori A, 2012, PACE, V35, P215, DOI 10.1111/j.1540-8159.2011.03273.x; Gould PA, 2006, JAMA-J AM MED ASSOC, V295, P1907, DOI 10.1001/jama.295.16.1907; Hamid S, 2009, EUROPACE, V11, P213, DOI 10.1093/europace/eun374; Hansky B, 2002, J INTERV CARD ELECTR, V6, P71, DOI 10.1023/A:1014140716802; Kypta A, 2014, EUROPACE; Luedorff G, 2010, EUROPACE, V12, P825, DOI 10.1093/europace/euq078; Maytin M, 2012, PACE, V35, P641, DOI 10.1111/j.1540-8159.2012.03353.x; Mond HG, 2008, PACE, V31, P1202, DOI 10.1111/j.1540-8159.2008.01164.x; Nagele H, 2007, EUROPACE, V9, P437, DOI 10.1093/europace/eum061; Tacker WA, 1998, PACE, V21, P296, DOI 10.1111/j.1540-8159.1998.tb01108.x; Wilkoff BL, 2009, HEART RHYTHM, V6, P1085, DOI 10.1016/j.hrthm.2009.05.020; Williams SE, 2011, PACE, V34, P1209, DOI 10.1111/j.1540-8159.2011.03149.x	17	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153651	10.1371/journal.pone.0153651	http://dx.doi.org/10.1371/journal.pone.0153651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119368	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200032
J	Queen, AE; Moerdyk-Schauwecker, M; McKee, LM; Leamy, LJ; Huet, YM				Queen, Ashleigh Everhardt; Moerdyk-Schauwecker, Megan; McKee, Leslie M.; Leamy, Larry J.; Huet, Yvette M.			Differential Expression of Inflammatory Cytokines and Stress Genes in Male and Female Mice in Response to a Lipopolysaccharide Challenge	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; MESSENGER-RNA; MORTALITY; GENDER; MACROPHAGES; INFECTION; LUNG	Background Sex plays a key role in an individual's immune response against pathogenic challenges such that females fare better when infected with certain pathogens. It is thought that sex hormones impact gene expression in immune cells and lead to sexually dimorphic responses to pathogens. We predicted that, in the presence of E. coli gram-negative lipopolysaccharide (LPS), there would be a sexually dimorphic response in proinflammatory cytokine production and acute phase stress gene expression and that these responses might vary among different mouse strains and times in a pattern opposite to that of body temperature associated with LPS-induced shock. Materials and Methods Interleukin-6 (IL-6), macrophage inflammatory protein-I beta (MIP-1 beta), tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) as well as beta-fibrinogen (Fgb) and metallothionein-1 (Mt-1) mRNA expression were measured at four time points (0, 2, 4 and 7 hours) after injection of E. coli LPS in mice from three inbred strains. Results Statistical analysis using analyses of variance (ANOVAs) showed that the levels of the all six traits changed over time, generally peaking at 2 hours after LPS injection. Mt-1, Fgb, and IL-6 showed differences among strains, although these were time-specific. Sexual dimorphism was seen for Fgb and IL6, and was most pronounced at the latest time period (7 hours) where male levels exceeded those for females. Trends for all six cytokine/gene expression traits were negatively correlated with those for body temperatures. Discussion The higher levels of expression of Fgb and IL6 in males compared with females are consistent with the greater vulnerability of males to infection and subsequent inflammation. Temperature appears to be a useful proxy for mortality in endotoxic shock, but sexual dimorphism in cytokine and stress gene expression levels may persist after an LPS challenge even if temperatures in the two sexes are similar and have begun to stabilize.	[Queen, Ashleigh Everhardt] Dept Kinesiol, Williamsburg, VA USA; [Moerdyk-Schauwecker, Megan] Univ Oregon, Dept Biol, Eugene, OR 97403 USA; [McKee, Leslie M.; Huet, Yvette M.] Univ N Carolina, Dept Kinesiol, Charlotte, NC 28223 USA; [Leamy, Larry J.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA	University of Oregon; University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Huet, YM (corresponding author), Univ N Carolina, Dept Kinesiol, Charlotte, NC 28223 USA.	ymhuet@uncc.edu	Huet, Yvette/J-4901-2013	Huet, Yvette/0000-0002-8783-8679				BAUSS F, 1987, INFECT IMMUN, V55, P1622, DOI 10.1128/IAI.55.7.1622-1625.1987; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Arroyo IC, 2011, CURR TOP MED CHEM, V11, P1661; De Maio A, 1998, SHOCK, V10, P319; DE SK, 1990, J BIOL CHEM, V265, P15267; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Garcia-Gomez E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/928290; Ghoshal K, 2001, MOL CELL BIOL, V21, P8301, DOI 10.1128/MCB.21.24.8301-8317.2001; Imahara SD, 2005, SURGERY, V138, P275, DOI 10.1016/j.surg.2005.03.020; Kanekiyo M, 2002, BIOCHEM J, V361, P363, DOI 10.1042/0264-6021:3610363; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Lin JY, 1996, INT IMMUNOL, V8, P499, DOI 10.1093/intimm/8.4.499; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; McClelland EE, 2011, ARCH IMMUNOL THER EX, V59, P203, DOI 10.1007/s00005-011-0124-3; MCGOWAN JE, 1975, J INFECT DIS, V132, P316, DOI 10.1093/infdis/132.3.316; Merkel SM, 2001, INFECT IMMUN, V69, P6119, DOI 10.1128/IAI.69.10.6119-6122.2001; Miller L, 1998, J IMMUNOL, V160, P5098; Moxley G, 2002, ARTHRITIS RHEUM, V46, P250, DOI 10.1002/1529-0131(200201)46:1<250::AID-ART10064>3.0.CO;2-T; Naor R, 2009, BRAIN BEHAV IMMUN, V23, P611, DOI 10.1016/j.bbi.2008.10.001; Oliver JD, 2013, MICROB ECOL, V65, P793, DOI 10.1007/s00248-012-0140-9; Pillet S, 2005, TOXICOLOGY, V209, P289, DOI 10.1016/j.tox.2004.12.007; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Sokal RR, 1995, BIOMETRY; Steuerwald N, 2000, MOL HUM REPROD, V6, P448, DOI 10.1093/molehr/6.5.448; ULICH TR, 1989, AM J PATHOL, V134, P11; Vlach KD, 2000, COMPARATIVE MED, V50, P160; Wichmann MW, 2000, INTENS CARE MED, V26, P167, DOI 10.1007/s001340050041; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368	30	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152289	10.1371/journal.pone.0152289	http://dx.doi.org/10.1371/journal.pone.0152289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120355	Green Submitted, gold, Green Published			2022-12-27	WOS:000374976200008
J	Teng, H; Chen, L; Huang, Q; Wang, JL; Lin, QY; Liu, MX; Lee, WY; Song, HB				Teng, Hui; Chen, Lei; Huang, Qun; Wang, Jinli; Lin, Qiyang; Liu, Mingxin; Lee, Won Young; Song, Hongbo			Ultrasonic-Assisted Extraction of Raspberry Seed Oil and Evaluation of Its Physicochemical Properties, Fatty Acid Compositions and Antioxidant Activities	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; GAMMA-LINOLENIC ACID; VITAMIN-E; ANTHOCYANINS; OPTIMIZATION; PHENOLICS; BERRIES; SOXHLET; WINE	Ultrasonic-assisted extraction was employed for highly efficient separation of aroma oil from raspberry seeds. A central composite design with two variables and five levels was employed and effects of process variables of sonication time and extraction temperature on oil recovery and quality were investigated. Optimal conditions predicted by response surface methodology were sonication time of 37 min and extraction temperature of 54 degrees C. Specifically, ultrasonic-assisted extraction (UAE) was able to provide a higher content of beneficial unsaturated fatty acids, whereas conventional Soxhlet extraction (SE) resulted in a higher amount of saturated fatty acids. Moreover, raspberry seed oil contained abundant amounts of edible linoleic acid and linolenic acid, which suggest raspberry seeds could be valuable edible sources of natural.-linolenic acid products. In comparison with SE, UAE exerted higher free radical scavenging capacities. In addition, UAE significantly blocked H2O2-induced intracellular reactive oxygen species (ROS) generation.	[Teng, Hui; Chen, Lei; Huang, Qun; Wang, Jinli; Lin, Qiyang; Liu, Mingxin; Song, Hongbo] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Peoples R China; [Lee, Won Young] Kyungpook Natl Univ, Food & Bioind Res Inst, Taegu 702701, South Korea; [Lee, Won Young] Kyungpook Natl Univ, Sch Food Sci & Biotechnol, 1370 Sankyunk Dong, Taegu 702701, South Korea	Fujian Agriculture & Forestry University; Kyungpook National University; Kyungpook National University	Chen, L; Song, HB (corresponding author), Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Peoples R China.; Lee, WY (corresponding author), Kyungpook Natl Univ, Food & Bioind Res Inst, Taegu 702701, South Korea.; Lee, WY (corresponding author), Kyungpook Natl Univ, Sch Food Sci & Biotechnol, 1370 Sankyunk Dong, Taegu 702701, South Korea.	chenlei841114@hotmail.com; wonyoung@knu.ac.kr; sghgbode@163.com	Chen, Lei/Y-3308-2019; Lee, Wonyoung/AAL-2780-2021	Lee, Wonyoung/0000-0001-5850-9692; /0000-0003-1930-586X	Construction Project of Top University at Fujian Agriculture and Forestry University of China [612014042]	Construction Project of Top University at Fujian Agriculture and Forestry University of China	This research was supported by the Construction Project of Top University at Fujian Agriculture and Forestry University of China (Grant No. 612014042).	[Anonymous], 1983, J SYST EVOL; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bushman BS, 2004, J AGR FOOD CHEM, V52, P7982, DOI 10.1021/jf049149a; Carnat A, 1978, ANTIOXYDANT ACTIVITY, P119; Celli GB, 2015, ULTRASON SONOCHEM, V27, P449, DOI 10.1016/j.ultsonch.2015.06.014; d'Alessandro LG, 2012, SEP PURIF TECHNOL, V93, P42, DOI 10.1016/j.seppur.2012.03.024; Daubeny H.A., 1996, FRUIT BREEDING, V2; de Castro MDL, 1998, ANAL CHIM ACTA, V369, P1; Hall H, 2009, PLANT BREEDING REV, V32, P353; Intl A, 1995, OFFICIAL METHODS ANA; Jeong JH, 2010, FOOD CHEM, V123, P338, DOI 10.1016/j.foodchem.2010.04.040; Johansson A, 1997, Z LEBENSM UNTERS F A, V204, P300, DOI 10.1007/s002170050081; Kapoor R, 2006, CURR PHARM BIOTECHNO, V7, P531, DOI 10.2174/138920106779116874; Kaufmann B, 2002, PHYTOCHEM ANALYSIS, V13, P105, DOI 10.1002/pca.631; Ku CS, 2008, BIORESOURCE TECHNOL, V99, P2852, DOI 10.1016/j.biortech.2007.06.005; Nohynek LJ, 2006, NUTR CANCER, V54, P18, DOI 10.1207/s15327914nc5401_4; Oh HH, 2007, J AM OIL CHEM SOC, V84, P549, DOI 10.1007/s11746-007-1065-1; Oomah BD, 2000, FOOD CHEM, V69, P187, DOI 10.1016/S0308-8146(99)00260-5; Orak HH, 2007, SCI HORTIC-AMSTERDAM, V111, P235, DOI 10.1016/j.scienta.2006.10.019; Parry J, 2005, J AGR FOOD CHEM, V53, P566, DOI 10.1021/jf048615t; Parry J, 2004, J FOOD SCI, V69, pC189; Peres VF, 2006, J CHROMATOGR A, V1105, P115, DOI 10.1016/j.chroma.2005.07.113; Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Stanisavljevic IT, 2007, ULTRASON SONOCHEM, V14, P646, DOI 10.1016/j.ultsonch.2006.10.003; TATE G, 1989, J RHEUMATOL, V16, P729; Teng H, 2014, FOOD ANAL METHOD, P1; Vinatoru M, 2001, ULTRASON SONOCHEM, V8, P303, DOI 10.1016/S1350-4177(01)00071-2; Zigoneanu IG, 2008, BIORESOURCE TECHNOL, V99, P4910, DOI 10.1016/j.biortech.2007.09.067	29	28	31	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153457	10.1371/journal.pone.0153457	http://dx.doi.org/10.1371/journal.pone.0153457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120053	Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200026
J	Audirac-Chalifour, A; Torres-Poveda, K; Bahena-Roman, M; Tellez-Sosa, J; Martinez-Barnetche, J; Cortina-Ceballos, B; Lopez-Estrada, G; Delgado-Romero, K; Burguete-Garcia, AI; Cantu, D; Garcia-Carranca, A; Madrid-Marina, V				Audirac-Chalifour, Astride; Torres-Poveda, Kirvis; Bahena-Roman, Margarita; Tellez-Sosa, Juan; Martinez-Barnetche, Jesus; Cortina-Ceballos, Bernardo; Lopez-Estrada, Guillermina; Delgado-Romero, Karina; Burguete-Garcia, Ana I.; Cantu, David; Garcia-Carranca, Alejandro; Madrid-Marina, Vicente			Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; HUMAN-PAPILLOMAVIRUS INFECTION; FUSOBACTERIUM-NUCLEATUM; BACTERIAL VAGINOSIS; E-CADHERIN; IFN-GAMMA; VAGINAL MICROBIOME; POOLED ANALYSIS; BETA-CATENIN; IL-10 GENE	Cervical cancer (CC) is caused by high-risk human papillomavirus persistence due to the immunosuppressive tumor microenvironment mediated by cytokines. Vaginal microbiota determines the presence of certain cytokines locally. We assessed the association between cervical microbiota diversity and the histopathological diagnosis of each stage of CC, and we evaluated mRNA cervical expression levels of IL-4, IL-6, IL-10, TGF-beta 1, TNF-alpha and IFN-gamma across the histopathological diagnosis and specific bacterial clusters. We determined the cervical microbiota by high throughput sequencing of 16S rDNA amplicons and classified it in community state types (CST). Mean difference analyses between alpha-diversity and histopathological diagnosis were carried out, as well as a beta-diversity analysis within the histological diagnosis. Cervical cytokine mRNA expression was analyzed across the CSTs and the histopathological diagnoses. We found a significant difference in microbiota's diversity in NCLHPV negative women vs those with squamous intraepithelial lesions (SIL) and CC(p = 0.006, p = 0.036). When beta-diversity was evaluated, the CC samples showed the highest variation within groups (p<0.0006) and the largest distance compared to NCL-HPV negative ones (p<0.00001). The predominant bacteria in women with normal cytology were L. crispatus and L. iners, whereas for SIL, it was Sneathia spp. and for CC, Fusobacterium spp. We found higher median cervical levels of IL-4 and TGF-beta 1 mRNA in the CST dominated by Fusobacterium spp. These results suggest that the cervical microbiotamay be implicated in cervical cancer pathology. Further cohort studies are needed to validate these findings.	[Audirac-Chalifour, Astride; Torres-Poveda, Kirvis; Bahena-Roman, Margarita; Tellez-Sosa, Juan; Martinez-Barnetche, Jesus; Cortina-Ceballos, Bernardo; Burguete-Garcia, Ana I.; Madrid-Marina, Vicente] Natl Publ Hlth Inst, Chron Infect Dis & Canc Div, Ctr Res Infect Dis, Cuernavaca, Morelos, Mexico; [Lopez-Estrada, Guillermina] Private Hlth Ctr Gynecol, Cuernavaca, Morelos, Mexico; [Delgado-Romero, Karina] Hlth Serv State Morelos, Ctr Womens Hlth, Ctr Atenc Salud Mujer CAPASAM, Cuernavaca, Morelos, Mexico; [Cantu, David] Inst Nacl Cancerol INCan, Div Clin Res, SS, Mexico City, DF, Mexico; [Garcia-Carranca, Alejandro] Inst Nacl Cancerol INCan, Basic Res Div, SS, Mexico City, DF, Mexico; [Torres-Poveda, Kirvis] Consejo Nacl Ciencia & Tecnol Mexico CONACyT, Mexico City, DF, Mexico; [Garcia-Carranca, Alejandro] Univ Nacl Autonoma Mexico, Unit Biomed Res Canc, Inst Nacl Cancerol INCan, SS, Mexico City 04510, DF, Mexico; [Garcia-Carranca, Alejandro] Univ Nacl Autonoma Mexico, Biomed Res Inst, Mexico City 04510, DF, Mexico	Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Madrid-Marina, V (corresponding author), Natl Publ Hlth Inst, Chron Infect Dis & Canc Div, Ctr Res Infect Dis, Cuernavaca, Morelos, Mexico.	vmarina@insp.mx	; Cantu-de Leon, David/P-7930-2017	Cortina-Ceballos, Bernardo/0000-0003-0227-8885; TORRES-POVEDA, KIRVIS/0000-0001-9608-9617; Martinez-Barnetche, Jesus/0000-0002-5228-3554; Cantu-de Leon, David/0000-0002-0229-7931				Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Alcocer-Gonzalez JM, 2006, VIRAL IMMUNOL, V19, P481, DOI 10.1089/vim.2006.19.481; Almonte M, 2008, VACCINE, V26, pL16, DOI 10.1016/j.vaccine.2008.06.008; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Caixeta RCA, 2015, DIAGN CYTOPATHOL, V43, P780, DOI 10.1002/dc.23301; Auvinen E, 2013, NEOPLASMA, V60, P56, DOI 10.4149/neo_2013_008; Behbakht Kian, 2002, Infect Dis Obstet Gynecol, V10, P181, DOI 10.1155/S1064744902000200; Bermudez-Morales VH, 2011, MOL MED REP, V4, P369, DOI 10.3892/mmr.2011.429; Bermudez-Morales VH, 2008, CANCER INVEST, V26, P1037, DOI 10.1080/07357900802112693; BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/infdis/170.5.1077; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Branca M, 2006, EUR J GYNAECOL ONCOL, V27, P215; Burns MB, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0177-8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chase D, 2015, GYNECOL ONCOL, V138, P190, DOI 10.1016/j.ygyno.2015.04.036; Chen ZF, 2012, EUR J GYNAECOL ONCOL, V33, P502; Clarke MA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-33; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dols JAM, 2012, DIAGN CYTOPATHOL, V40, P472, DOI 10.1002/dc.21786; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El-Sherif AM, 2001, J PATHOL, V195, P179, DOI 10.1002/path.929; Feng QH, 2012, GYNECOL ONCOL, V127, P412, DOI 10.1016/j.ygyno.2012.07.098; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gao WJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-271; Giannini SL, 1998, CLIN EXP IMMUNOL, V113, P183; Gillet E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-10; Girke T, 2013, R LANG ENV STAT COMP; Gosmann C, 2014, J INVEST DERMATOL, V134, P2562, DOI 10.1038/jid.2014.201; GUIJON F, 1992, INT J GYNECOL OBSTET, V37, P185, DOI 10.1016/0020-7292(92)90379-W; Guo YI, 2012, INT J STD AIDS, V23, P581, DOI 10.1258/ijsa.2012.011342; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Harwich MD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S4; Hu T, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0254-8; Huang YE, 2015, MICROB ECOL, V69, P407, DOI 10.1007/s00248-014-0487-1; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; INEGI, 2012, EST MORT CUB DIN CON; Insinga RP, 2011, CANCER EPIDEM BIOMAR, V20, P287, DOI 10.1158/1055-9965.EPI-10-0791; ITO Y, 1980, CANCER RES, V40, P4329; Kim TK, 2009, J CLIN MICROBIOL, V47, P1181, DOI 10.1128/JCM.00854-08; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Lee D-H, 2015, ANN CLIN BIOCH INT J; Lee JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063514; Lehtinen M, 2011, SEX TRANSM INFECT, V87, P372, DOI 10.1136/sti.2010.044354; Linhares I. M., 2011, AM J OBSTET GYNECOL, V120, P1, DOI [10.1016/j.ajog.2010.07.010, DOI 10.1016/J.AJOG.2010.07.010, DOI 10.1016/J.AJ0G.2010.07.010]; Louie KS, 2011, CANCER EPIDEM BIOMAR, V20, P1379, DOI 10.1158/1055-9965.EPI-11-0284; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marangon AV, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/146079; Prata TTM, 2015, IMMUNOLOGY, V146, P113, DOI 10.1111/imm.12487; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nawrot R, 2010, EUR J GYNAECOL ONCOL, V31, P425; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Oh H Y, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.02.026; Ohnmacht C, 2015, SCIENCE; Peralta-Zaragoza O, 2006, VIRAL IMMUNOL, V19, P468, DOI 10.1089/vim.2006.19.468; Punt S, 2015, CANCER IMMUNOL IMMUN, V64, P745, DOI 10.1007/s00262-015-1678-4; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rodriguez-Sastre MA, 2005, GYNECOL ONCOL, V97, P330, DOI 10.1016/j.ygyno.2004.12.062; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Shah NB, 2010, J INFECTION, V60, P491, DOI 10.1016/j.jinf.2010.02.008; Sheu BC, 2001, J IMMUNOL, V167, P2972, DOI 10.4049/jimmunol.167.5.2972; Shew ML, 2013, J INFECT DIS, V208, P1416, DOI 10.1093/infdis/jit346; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Shondel SM, 2007, INT J GYNECOL CANCER, V17, P1278, DOI 10.1111/j.1525-1438.2007.00705.x; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Smith BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040425; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865; Torres-Poveda K, 2015, BMC CANC UNPUB; Torres-Poveda K, 2014, WORLD J CLIN ONCOL, V5, P753, DOI 10.5306/wjco.v5.i4.753; Torres-Poveda K, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-32; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P2148, DOI 10.1158/1055-9965.EPI-06-0556; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Velsko IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129795; Vriend HJ, 2015, CANCER MED; Yang W, 2013, IMMUNOLOGY, V139, P513, DOI 10.1111/imm.12101; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524, DOI 10.1111/j.1349-7006.1991.tb01882.x; Zhang X, 2014, BJOG-INT J OBSTET GY, V121, P664, DOI 10.1111/1471-0528.12638	86	153	177	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153274	10.1371/journal.pone.0153274	http://dx.doi.org/10.1371/journal.pone.0153274			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115350	Green Submitted, gold, Green Published			2022-12-27	WOS:000374973600019
J	Gallien, L; Thuiller, W; Fort, N; Boleda, M; Alberto, FJ; Rioux, D; Laine, J; Lavergne, S				Gallien, Laure; Thuiller, Wilfried; Fort, Noemie; Boleda, Marti; Alberto, Florian J.; Rioux, Delphine; Laine, Juliette; Lavergne, Sebastien			Is There Any Evidence for Rapid, Genetically-Based, Climatic Niche Expansion in the Invasive Common Ragweed?	PLOS ONE			English	Article							DRY-MATTER CONTENT; AMBROSIA-ARTEMISIIFOLIA; GENE FLOW; EVOLUTION; ADAPTATION; MODELS; DIFFERENTIATION; POPULATIONS; HISTORY; NEUTRALITY	Climatic niche shifts have been documented in a number of invasive species by comparing the native and adventive climatic ranges in which they occur. However, these shifts likely represent changes in the realized climatic niches of invasive species, and may not necessarily be driven by genetic changes in climatic affinities. Until now the role of rapid niche evolution in the spread of invasive species remains a challenging issue with conflicting results. Here, we document a likely genetically-based climatic niche expansion of an annual plant invader, the common ragweed (Ambrosia artemisiifolia L.), a highly allergenic invasive species causing substantial public health issues. To do so, we looked for recent evolutionary change at the upward migration front of its adventive range in the French Alps. Based on species climatic niche models estimated at both global and regional scales we stratified our sampling design to adequately capture the species niche, and localized populations suspected of niche expansion. Using a combination of species niche modeling, landscape genetics models and common garden measurements, we then related the species genetic structure and its phenotypic architecture across the climatic niche. Our results strongly suggest that the common ragweed is rapidly adapting to local climatic conditions at its invasion front and that it currently expands its niche toward colder and formerly unsuitable climates in the French Alps (i.e. in sites where niche models would not predict its occurrence). Such results, showing that species climatic niches can evolve on very short time scales, have important implications for predictive models of biological invasions that do not account for evolutionary processes.	[Gallien, Laure; Thuiller, Wilfried; Boleda, Marti; Alberto, Florian J.; Rioux, Delphine; Laine, Juliette; Lavergne, Sebastien] Univ Grenoble Alpes, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Gallien, Laure; Thuiller, Wilfried; Boleda, Marti; Alberto, Florian J.; Rioux, Delphine; Laine, Juliette; Lavergne, Sebastien] CNRS, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Fort, Noemie] Conservatoire Bot Natl Alpin, F-05000 Domaine De Charance, Gap, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Gallien, L (corresponding author), Univ Grenoble Alpes, Lab Ecol Alpine LECA, F-38000 Grenoble, France.; Gallien, L (corresponding author), CNRS, Lab Ecol Alpine LECA, F-38000 Grenoble, France.	laure.gallien@gmail.com	Thuiller, Wilfried/G-3283-2010; Gallien, Laure/G-8384-2014	Thuiller, Wilfried/0000-0002-5388-5274; Gallien, Laure/0000-0003-4882-1580	French Agence Nationale de la Recherche [ANR-09-PEXT-011]; European Research Council under the European Community [281422]	French Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council under the European Community(European Research Council (ERC))	LG, SL and MB received support from the French Agence Nationale de la Recherche with the project EVORANGE (ANR-09-PEXT-011). The research leading to these results received funding from the European Research Council under the European Community's Seven Framework Programme FP7/2007-2013 grant agreement no. 281422 (TEEMBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CH, 2010, ECOGRAPHY, V33, P1028, DOI 10.1111/j.1600-0587.2010.06421.x; Alexander JM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1446; Alexander JM, 2010, OIKOS, V119, P1377, DOI 10.1111/j.1600-0706.2009.17977.x; Barton NH, 2004, EVOLUTION, V58, P2111; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Calsbeek B, 2009, EVOLUTION, V63, P2627, DOI 10.1111/j.1558-5646.2009.00735.x; Chauvel B, 2006, J BIOGEOGR, V33, P665, DOI 10.1111/j.1365-2699.2005.01401.x; Cheverud JM, 1996, J EVOLUTION BIOL, V9, P5, DOI 10.1046/j.1420-9101.1996.9010005.x; Chun YJ, 2011, MOL ECOL, V20, P1378, DOI 10.1111/j.1365-294X.2011.05013.x; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; de Villemereuil P, 2014, MOL ECOL, V23, P2006, DOI 10.1111/mec.12705; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Friedman J, 2008, ANN BOT-LONDON, V101, P1303, DOI 10.1093/aob/mcn039; Fumanal B, 2007, ANN BOT-LONDON, V100, P305, DOI 10.1093/aob/mcm108; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Gallien L, 2010, DIVERS DISTRIB, V16, P331, DOI 10.1111/j.1472-4642.2010.00652.x; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI 10.2307/2410956; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Gladieux P, 2011, BIOL INVASIONS, V13, P933, DOI 10.1007/s10530-010-9880-y; Goncalves E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111468; Goudet J, 2006, GENETICS, V172, P1337, DOI 10.1534/genetics.105.050583; Goudet J, 2007, GENETICS, V176, P1371, DOI 10.1534/genetics.106.067173; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill MP, 2013, GLOBAL ECOL BIOGEOGR, V22, P942, DOI 10.1111/geb.12059; Hodgins KA, 2011, J EVOLUTION BIOL, V24, P2731, DOI 10.1111/j.1420-9101.2011.02404.x; Hodgins KA, 2013, MOL ECOL, V22, P2496, DOI 10.1111/mec.12179; Hodgson JG, 2011, ANN BOT-LONDON, V108, P1337, DOI 10.1093/aob/mcr225; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Holt RD, 2005, OIKOS, V108, P3, DOI 10.1111/j.0030-1299.2005.13145.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kirkpatrick M, 2009, GENETICA, V136, P271, DOI 10.1007/s10709-008-9302-6; Lankau RA, 2009, P NATL ACAD SCI USA, V106, P15362, DOI 10.1073/pnas.0905446106; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Li XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029350, 10.1371/journal.pone.0051199]; Luo WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071749; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martin G, 2008, GENETICS, V180, P2135, DOI 10.1534/genetics.107.080820; Merila J, 2001, GENETICA, V112, P199, DOI 10.1023/A:1013391806317; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Pritchard JK, 2000, GENETICS, V155, P945; Reich PB, 2014, P NATL ACAD SCI USA, V111, P13721, DOI 10.1073/pnas.1216053111; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323	55	13	14	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0152867	10.1371/journal.pone.0152867	http://dx.doi.org/10.1371/journal.pone.0152867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116455	gold, Green Published			2022-12-27	WOS:000374973600016
J	Hug, F; Hodges, PW; Carroll, TJ; De Martino, E; Magnard, J; Tucker, K				Hug, Francois; Hodges, Paul W.; Carroll, Timothy J.; De Martino, Enrico; Magnard, Justine; Tucker, Kylie			Motor Adaptations to Pain during a Bilateral Plantarflexion Task: Does the Cost of Using the Non-Painful Limb Matter?	PLOS ONE			English	Article							COORDINATION	During a force-matched bilateral task, when pain is induced in one limb, a shift of load to the non-painful leg is classically observed. This study aimed to test the hypothesis that this adaptation to pain depends on the mechanical efficiency of the non-painful leg. We studied a bilateral plantarflexion task that allowed flexibility in the relative force produced with each leg, but constrained the sum of forces from both legs to match a target. We manipulated the mechanical efficiency of the non-painful leg by imposing scaling factors: 1, 0.75, or 0.25 to decrease mechanical efficiency (Decreased efficiency experiment: 18 participants); and 1, 1.33 or 4 to increase mechanical efficiency (Increased efficiency experiment: 17 participants). Participants performed multiple sets of three submaximal bilateral isometric plantar-flexions with each scaling factor during two conditions (Baseline and Pain). Pain was induced by injection of hypertonic saline into the soleus. Force was equally distributed between legs during the Baseline contractions (laterality index was close to 1; Decreased efficiency experiment: 1.16+/-0.33; Increased efficiency experiment: 1.11+/-0.32), with no significant effect of Scaling factor. The laterality index was affected by Pain such that the painful leg contributed less than the non-painful leg to the total force (Decreased efficiency experiment: 0.90+/-0.41, P< 0.001; Increased efficiency experiment: 0.75+/-0.32, P< 0.001), regardless of the efficiency (scaling factor) of the non-painful leg. When compared to the force produced during Baseline of the corresponding scaling condition, a decrease in force produced by the painful leg was observed for all conditions, except for scaling 0.25. This decrease in force was correlated with a decrease in drive to the soleus muscle. These data highlight that regardless of the overall mechanical cost, the nervous system appears to prefer to alter force sharing between limbs such that force produced by the painful leg is reduced relative to the non-painful leg.	[Hug, Francois; Hodges, Paul W.; De Martino, Enrico; Tucker, Kylie] Univ Queensland, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Hug, Francois; Magnard, Justine] Univ Nantes, Lab EA Movement Interact Performance 4334, Nantes, France; [Carroll, Timothy J.] Univ Queensland, Ctr Sensorimotor Performance, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia; [De Martino, Enrico] Univ Siena, Sports Med Specializat Sch, Med Surg & Neurosci Dept, Via Laterina 8, I-53100 Siena, Italy; [Tucker, Kylie] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; Nantes Universite; University of Queensland; University of Siena; University of Queensland	Hug, F (corresponding author), Univ Queensland, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.; Hug, F (corresponding author), Univ Nantes, Lab EA Movement Interact Performance 4334, Nantes, France.	francois.hug@univ-nantes.fr	Hug, François/AAV-2415-2020; Hodges, Paul W/B-6578-2008; Carroll, Timothy/C-3513-2008; Tucker, Kylie/M-4887-2013	Hug, François/0000-0002-6432-558X; Hodges, Paul W/0000-0002-1206-9107; Carroll, Timothy/0000-0003-0761-1819; Tucker, Kylie/0000-0003-4976-7483; De Martino, Enrico/0000-0003-3211-3723	National Health and Medical research Council (NHMRC) [ID401599, ID1009410]; Australian Research Council (ARC) [FT120100391]; NHMRC [ID631717]	National Health and Medical research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical research Council (NHMRC; https://www.nhmrc.gov.au/) provide research fellowships for PH: ID401599 and KT: ID1009410. The Australian Research Council (ARC; http://www.arc.gov.au/) provides fellowship support for TC ( FT120100391). Project support was provided by an NHMRC Program grant ( PH: ID631717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank PJM, 2013, EUR J PAIN, V17, P145, DOI 10.1002/j.1532-2149.2012.00186.x; Bernstein N, 1967, COORDINATION REGULAT; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRESSWELL AG, 1995, EXP BRAIN RES, V105, P283; de Rugy A, 2012, J NEUROSCI, V32, P7384, DOI 10.1523/JNEUROSCI.5792-11.2012; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hodges PW, 2013, EUR J PAIN; Hu XG, 2011, J APPL PHYSIOL, V111, P1671, DOI 10.1152/japplphysiol.00760.2011; Hu XG, 2011, J NEUROPHYSIOL, V105, P2169, DOI 10.1152/jn.01086.2010; Hu XG, 2011, NEUROSCI LETT, V490, P121, DOI 10.1016/j.neulet.2010.12.040; Hu XG, 2011, EXP BRAIN RES, V208, P533, DOI 10.1007/s00221-010-2502-1; Hug F, 2014, J APPL PHYSL; Hug F, 2014, J NEUROPHYSIOL, V111, P2298, DOI 10.1152/jn.00911.2013; Hug F, 2014, EUR J APPL PHYSIOL, V114, P1057, DOI 10.1007/s00421-014-2840-y; Hug F, 2013, J ELECTROMYOGR KINES, V23, P1413, DOI 10.1016/j.jelekin.2013.08.014; LUND JP, 1991, CAN J PHYSIOL PHARM, V69, P683, DOI 10.1139/y91-102; Mochizuki G, 2006, EXP BRAIN RES, V175, P584, DOI 10.1007/s00221-006-0575-7; Moseley GL, 2006, BEHAV NEUROSCI, V120, P474, DOI 10.1037/0735-7044.120.2.474; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; Oda S, 1997, JPN J PHYSIOL, V47, P487, DOI 10.2170/jjphysiol.47.487; Prilutsky BI, 2002, EXERC SPORT SCI REV, V30, P32, DOI 10.1097/00003677-200201000-00007; Salimpour Y, 2014, J NEUROSCI, V34, P1806, DOI 10.1523/JNEUROSCI.3095-13.2014; Sarabon N, 2013, EXP BRAIN RES, V227, P121, DOI 10.1007/s00221-013-3494-4; Tucker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091899; Tucker K, 2012, PAIN, V153, P636, DOI 10.1016/j.pain.2011.11.024; WALL PD, 1978, BRAIN, V101, P1, DOI 10.1093/brain/101.1.1; Weerakkody NS, 2003, SOMATOSENS MOT RES, V20, P27, DOI 10.1080/0899022031000083816	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154524	10.1371/journal.pone.0154524	http://dx.doi.org/10.1371/journal.pone.0154524			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115991	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000374973600072
J	Yu, ZY; Zhang, J; Yin, DQ				Yu, ZhenYang; Zhang, Jing; Yin, DaQiang			Multigenerational Effects of Heavy Metals on Feeding, Growth, Initial Reproduction and Antioxidants in Caenorhabditis elegans	PLOS ONE			English	Article							OXIDATIVE STRESS; IN-VIVO; TRADE-OFF; TOXICITY; EXPOSURE; NEMATODE; PROGENY; BEHAVIOR; COPPER; SULFAMETHOXAZOLE	Earlier studies showed that toxicities of excessive metals lasted over generations. Yet, these studies mainly employed one-generation exposure, and the effects of multigenerational challenges need further studies. Presently, Caenorhabditis elegans were exposed to cadmium, copper, lead and zinc for four consecutive generations (G1 to G4) at environmental concentrations. The feeding, growth, initial reproduction, superoxide dismutase (SOD) and catalase (CAT) were determined. All data were represented in the percentage of that in control (POC), and POC in the control was normalized to 100%. In G1 and G2, the POC values in feeding, growth and initial reproduction were generally within 10% of the control (100%), indicating non-significant effects. The POC values in SOD and CAT were significantly higher than 100%, showing stimulatory effects. In G3 and G4, the POC values in feeding, growth and initial reproduction were significantly lower than 100%, showing inhibitory effects which were more severe in G4 than in G3. Meanwhile, SOD and CAT continuously showed stimulatory effects, and the stimulatory effects on SOD increased from G1 to G4. The effects with multigenerational challenges were different from those in one-generation exposure. The effects in later generations demonstrated the importance of multigenerational challenges in judging long-term influences of metals.	[Yu, ZhenYang; Yin, DaQiang] Tongji Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Yangtze River Water Environm, Shanghai 200092, Peoples R China; [Zhang, Jing] Jiaxing Univ, Coll Biol Chem Sci & Engn, Jiaxing 314001, Zhejiang, Peoples R China	Tongji University; Jiaxing University	Zhang, J (corresponding author), Jiaxing Univ, Coll Biol Chem Sci & Engn, Jiaxing 314001, Zhejiang, Peoples R China.	zhjshy@163.com			National Natural Science Foundation of China [21307095, 51278353]; Collaborative Innovation Center for Regional Environmental Quality; Swedish Research Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center for Regional Environmental Quality; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the National Natural Science Foundation of China, No. 21307095, ( https://isisn.nsfc.gov.cn/egrantweb/) to ZYY, The National Natural Science Foundation of China, No. 51278353, ( https://isisn.nsfc.gov.cn/egrantweb/) to DQY, The Collaborative Innovation Center for Regional Environmental Quality to DQY and The Swedish Research Council to the project, No. D0691301, ( http://www.vr.se/) to DQY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonaylo VN, 1999, TOXICOLOGY, V135, P77, DOI 10.1016/S0300-483X(99)00051-7; Anderson GL, 2004, ENVIRON TOXICOL CHEM, V23, P1235, DOI 10.1897/03-264; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P3049, DOI 10.1897/02-565; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P2768, DOI 10.1897/02-573; BRENNER S, 1974, GENETICS, V77, P71; DARR D, 1995, FREE RADICAL BIO MED, V18, P195, DOI 10.1016/0891-5849(94)00118-4; Ferreira HS, 2008, TALANTA, V77, P73, DOI 10.1016/j.talanta.2008.05.056; Guo YL, 2009, REPROD TOXICOL, V28, P90, DOI 10.1016/j.reprotox.2009.03.007; Hall ME, 2010, FUNCT ECOL, V24, P365, DOI 10.1111/j.1365-2435.2009.01635.x; Ibiam U., 2015, Middle East Journal of Scientific Research, V23, P186; Kafel A, 2012, ENVIRON POLLUT, V162, P8, DOI 10.1016/j.envpol.2011.09.034; Kim SW, 2013, ENVIRON SCI TECHNOL, V47, P5393, DOI 10.1021/es304511z; Kim SY, 2011, EVOL ECOL, V25, P461, DOI 10.1007/s10682-010-9426-x; Lane RS, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0566-9; Li HY, 2015, AQUAT TOXICOL, V166, P42, DOI 10.1016/j.aquatox.2015.06.015; Liu SY, 2013, CHEMOSPHERE, V93, P2373, DOI 10.1016/j.chemosphere.2013.08.036; Mohan N, 2010, NANO LETT, V10, P3692, DOI 10.1021/nl1021909; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Monteiro L, 2014, EUR J SOIL BIOL, V62, P1, DOI 10.1016/j.ejsobi.2014.02.005; Niu Y, 2015, B ENVIRON CONTAM TOX, V95, P618, DOI 10.1007/s00128-015-1654-x; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Polkki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038832; Qu Y, 2011, NANO LETT, V11, P3174, DOI 10.1021/nl201391e; Singhal J, 2015, INT J SCI RES, V4, P304; Sirivarasai J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/856319; Smith SW, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0161-8; Tamae THK., 2010, APPL ENV SOIL SCI, V2010; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Wang DY, 2008, ENVIRON POLLUT, V151, P585, DOI 10.1016/j.envpol.2007.04.003; Wang D, 2007, ENVIRON TOXICOL PHAR, V24, P223, DOI 10.1016/j.etap.2007.05.009; Wang Y, 2007, ENVIRON TOXICOL CHEM, V26, P2405, DOI 10.1897/06-646R1.1; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Yu ZY, 2012, CHEMOSPHERE, V87, P1361, DOI 10.1016/j.chemosphere.2012.02.029; Yu ZY, 2015, ECOTOX ENVIRON SAFE, V111, P66, DOI 10.1016/j.ecoenv.2014.09.026; Yu ZY, 2013, J HAZARD MATER, V250, P198, DOI 10.1016/j.jhazmat.2013.01.078; Yu ZY, 2013, ECOTOX ENVIRON SAFE, V88, P178, DOI 10.1016/j.ecoenv.2012.11.012; Yu ZY, 2011, J ENVIRON SCI-CHINA, V23, P294, DOI 10.1016/S1001-0742(10)60436-6; Zanni E, 2012, NANO LETT, V12, P2740, DOI 10.1021/nl204388p; Zhou D, 2016, ENVIRON POLLUT, V208, P767, DOI 10.1016/j.envpol.2015.10.057	40	32	35	7	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154529	10.1371/journal.pone.0154529	http://dx.doi.org/10.1371/journal.pone.0154529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116222	gold, Green Published, Green Submitted			2022-12-27	WOS:000374973600074
J	Blokzijl, A; Chen, LE; Gustafsdottir, SM; Vuu, J; Ullenhag, G; Kampe, O; Landegren, U; Kamali-Moghaddam, M; Hedstrand, H				Blokzijl, Andries; Chen, Lei E.; Gustafsdottir, Sigrun M.; Vuu, Jimmy; Ullenhag, Gustav; Kampe, Olle; Landegren, Ulf; Kamali-Moghaddam, Masood; Hedstrand, Hakan			Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; EXPRESSION; PROTEIN; MAINTENANCE; TUMORS; GENE; DIFFERENTIATION; MARKER; S100B; LIFE	Background The diagnosis of malignant melanoma currently relies on clinical inspection of the skin surface and on the histopathological status of the excised tumor. The serum marker S100B is used for prognostic estimates at later stages of the disease, but analyses are marred by false positives and inadequate sensitivity in predicting relapsing disorder. Objectives To investigate SOX10 as a potential biomarker for melanoma and vitiligo. Methods In this study we have applied proximity ligation assay (PLA) to detect the transcription factor SOX10 as a possible serum marker for melanoma. We studied a cohort of 110 melanoma patients. We further investigated a second cohort of 85 patients with vitiligo, which is a disease that also affects melanocytes. Results The specificity of the SOX10 assay in serum was high, with only 1% of healthy blood donors being positive. In contrast, elevated serum SOX10 was found with high frequency among vitiligo and melanoma patients. In patients with metastases, lack of SOX10 detection was associated with treatment benefit. In two responding patients, a change from SOX10 positivity to undetectable levels was seen before the response was evident clinically. Conclusions We show for the first time that SOX10 represents a promising new serum melanoma marker for detection of early stage disease, complementing the established S100B marker. Our findings imply that SOX10 can be used to monitor responses to treatment and to assess if the treatment is of benefit at stages earlier than what is possible radiologically.	[Blokzijl, Andries; Chen, Lei E.; Gustafsdottir, Sigrun M.; Landegren, Ulf; Kamali-Moghaddam, Masood] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Box 815, SE-75108 Uppsala, Sweden; [Ullenhag, Gustav] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, SE-75108 Uppsala, Sweden; [Vuu, Jimmy; Kampe, Olle; Hedstrand, Hakan] Uppsala Univ, Dept Med Sci, SE-75108 Uppsala, Sweden; [Blokzijl, Andries] Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Box 595, SE-75124 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Ludwig Institute for Cancer Research; Uppsala University	Hedstrand, H (corresponding author), Uppsala Univ, Dept Med Sci, SE-75108 Uppsala, Sweden.	hakan.hedstrand@medsci.uu.se	Landegren, Ulf D/A-8197-2019; Chen, Lei/ABC-8660-2020	Chen, Lei/0000-0002-5226-1427; Kampe, Olle/0000-0001-6091-9914	Research Foundation Stiftelsen Onkologiska Klinikens Forskningsfond in Uppsala; Hudfonden; Welanders stiftelse; Hedlunds stiftelse; Selanders stiftelse; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC [294409, 316929]; Ludwig institute for cancer research (LICR), Uppsala Branch, Sweden; Uppsala Berzelii Technology Centre for Neurodiagnostics - Swedish Governmental Agency for Innovation Systems; Swedish Research Council; Uppsala University; LiSUM; Novo Nordisk Fonden [NNF14OC0011003, NNF13OC0005975] Funding Source: researchfish	Research Foundation Stiftelsen Onkologiska Klinikens Forskningsfond in Uppsala; Hudfonden; Welanders stiftelse; Hedlunds stiftelse; Selanders stiftelse; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC(European Research Council (ERC)); Ludwig institute for cancer research (LICR), Uppsala Branch, Sweden; Uppsala Berzelii Technology Centre for Neurodiagnostics - Swedish Governmental Agency for Innovation Systems; Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala University; LiSUM; Novo Nordisk Fonden(Novo Nordisk Foundation)	The Research Foundation Stiftelsen Onkologiska Klinikens Forskningsfond in Uppsala, Hudfonden, Welanders stiftelse, Hedlunds stiftelse, Selanders stiftelse, the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreements No. 294409 (ProteinSeq) and No. 316929 (GastricGlycoExpolorer) and personnel at Department of Oncology, Uppsala and Department of Dermatology at Landstinget in Gavleborg, for kindly supporting this study. AB was partly supported by the Ludwig institute for cancer research (LICR), Uppsala Branch, Sweden and partly supported by the Uppsala Berzelii Technology Centre for Neurodiagnostics, financed by the Swedish Governmental Agency for Innovation Systems, the Swedish Research Council, and Uppsala University during this work. LEC was partly supported by a LiSUM PhD scholarship.	Agnarsdottir M, 2010, MELANOMA RES, V20, P468, DOI 10.1097/CMR.0b013e3283403ccd; Boasberg PD, 2006, J INVEST DERMATOL, V126, P2658, DOI 10.1038/sj.jid.5700545; Bondurand N, 1998, FEBS LETT, V432, P168, DOI 10.1016/S0014-5793(98)00843-6; Cimino-Mathews A, 2013, HUM PATHOL, V44, P959, DOI 10.1016/j.humpath.2012.09.005; Darmanis S, 2010, MOL CELL PROTEOMICS, V9, P327, DOI 10.1074/mcp.M900248-MCP200; Egberts F, 2010, ANTICANCER RES, V30, P1799; FAGNART OC, 1988, CLIN CHEM, V34, P1387; Ferletta M, 2007, MOL CANCER RES, V5, P891, DOI 10.1158/1541-7786.MCR-07-0113; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Grotz TE, 2012, MELANOMA RES, V22, P9, DOI 10.1097/CMR.0b013e32834e1f33; Harris ML, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003644; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Hsiao JJ, 2014, ARCH BIOCHEM BIOPHYS, V563, P28, DOI 10.1016/j.abb.2014.07.019; Ivanov SV, 2013, BRIT J CANCER, V109, P444, DOI 10.1038/bjc.2013.326; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P23033, DOI 10.1074/jbc.273.36.23033; Le Gal FA, 2001, J INVEST DERMATOL, V117, P1464, DOI 10.1046/j.0022-202x.2001.01605.x; Miettinen M, 2015, AM J SURG PATHOL, V39, P826, DOI 10.1097/PAS.0000000000000398; Naveh Hadas Prag, 2013, Pigment Cell Melanoma Res, V26, P796, DOI 10.1111/pcmr.12161; Nonaka D, 2008, AM J SURG PATHOL, V32, P1291, DOI 10.1097/PAS.0b013e3181658c14; Ogg GS, 1998, J EXP MED, V188, P1203, DOI 10.1084/jem.188.6.1203; Ohtomo R, 2013, MODERN PATHOL, V26, P1041, DOI 10.1038/modpathol.2013.54; Palermo B, 2001, J INVEST DERMATOL, V117, P326, DOI 10.1046/j.1523-1747.2001.01408.x; Passeron T, 2005, J AUTOIMMUN, V25, P63, DOI 10.1016/j.jaut.2005.10.001; Quaglino P, 2010, ANN ONCOL, V21, P409, DOI 10.1093/annonc/mdp325; Ronnstrand L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0648-y; Schadendorf D, 2014, ANN ONCOL, V25, P700, DOI 10.1093/annonc/mdt580; Schallreuter KU, 2008, EXP DERMATOL, V17, P139, DOI [10.1111/j.1600-0625.2007.00666_1.x, 10.1111/j.1600-0625.2007.00666.x]; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154214	10.1371/journal.pone.0154214	http://dx.doi.org/10.1371/journal.pone.0154214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110718	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600050
J	Cohen, DO; Duchin, S; Feldman, M; Zarivach, R; Aharoni, A; Levy, D				Cohen, Dan Od; Duchin, Shai; Feldman, Michal; Zarivach, Raz; Aharoni, Amir; Levy, Dan			Engineering of Methylation State Specific 3xMBT Domain Using ELISA Screening	PLOS ONE			English	Article							LYSINE METHYLATION; MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; METHYLTRANSFERASE; PROTEINS; IDENTIFICATION; CHROMATIN; PROTEOME; HISTONES; SUBUNIT	The e-amino group of lysine residues may be mono-, di- or tri-methylated by protein lysine methyltransferases. In the past few years it has been highly considered that methylation of both histone and non-histone proteins has fundamental role in development and progression of various human diseases. Thus, the establishment of tools to study lysine methylation that will distinguish between the different states of methylation is required to elucidate their cellular functions. The 3X malignant brain tumor domain (3XMBT) repeats of the Lethal(3) malignant brain tumor-like protein 1 (L3MBTL1) have been utilized in the past as an affinity reagent for the identification of mono-and di-methylated lysine residues on individual proteins and on a proteomic scale. Here, we have utilized the 3XMBT domain to develop an enzyme-linked immunosorbent assay (ELISA) that allows the high-throughput detection of 3XMBT binding to methylated lysines. We demonstrated that this system allows the detection of methylated peptides, methylated proteins and PKMT activity on both peptides and proteins. We also optimized the assay to detect 3XMBT binding in crude E. coli lysates which facilitated the high throughput screening of 3XMBT mutant libraries. We have utilized protein engineering tools and generated a double site saturation 3XMBT library of residues 361 and 411 that were shown before to be important for binding mono and di-methylated substrates and identified variants that can exclusively recognize only di-methylated peptides. Together, our results demonstrate a powerful new approach that will contribute to deeper understanding of lysine methylation biology and that can be utilized for the engineering of domains for specific binders of other post-translational modifications.	[Cohen, Dan Od; Feldman, Michal; Levy, Dan] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel; [Duchin, Shai; Zarivach, Raz; Aharoni, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Cohen, Dan Od; Duchin, Shai; Feldman, Michal; Zarivach, Raz; Aharoni, Amir; Levy, Dan] Ben Gurion Univ Negev, NIBN, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University	Levy, D (corresponding author), Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel.; Aharoni, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.; Aharoni, A; Levy, D (corresponding author), Ben Gurion Univ Negev, NIBN, IL-84105 Beer Sheva, Israel.	aaharoni@bgu.ac.il; ledan@post.bgu.ac.il	ZARIVACH, RAZ/F-1671-2012; Levy, Dan/A-3226-2013	ZARIVACH, RAZ/0000-0001-6543-0296; Levy, Dan/0000-0003-0719-0305; Aharoni, Amir/0000-0003-2701-6996	NIBN; Israel Science Foundation [285/14]	NIBN; Israel Science Foundation(Israel Science Foundation)	This work was supported by a grant from the NIBN to AA and DL and by a grant from the Israel Science Foundation (285/14) to DL.	Afjehi-Sadat L, 2013, CURR OPIN CHEM BIOL, V17, P12, DOI 10.1016/j.cbpa.2012.12.023; Beltrao P, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304521; Britton LMP, 2011, EXPERT REV PROTEOMIC, V8, P631, DOI [10.1586/epr.11.47, 10.1586/EPR.11.47]; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; Carlson SM, 2014, J MOL BIOL, V426, P3350, DOI 10.1016/j.jmb.2014.04.024; Carlson SM, 2014, NAT PROTOC, V9, P37, DOI 10.1038/nprot.2013.164; Chen A., 2016, BIOCH BIOPHYS ACTA; Del Rizzo PA, 2011, EPIGENETICS-US, V6, P1059, DOI 10.4161/epi.6.9.16069; Duchin S, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0048-y; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Florea M, 2012, CHEM-EUR J, V18, P3521, DOI 10.1002/chem.201103397; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Levy D, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-19; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Liu HD, 2013, MOL CELL, V50, P723, DOI 10.1016/j.molcel.2013.04.025; Lu T, 2015, CANCER RES, V75, P3692, DOI 10.1158/0008-5472.CAN-15-1022; Minguez P, 2015, NUCLEIC ACIDS RES, V43, pD494, DOI 10.1093/nar/gku1081; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; Nady N, 2012, J MOL BIOL, V423, P702, DOI 10.1016/j.jmb.2012.08.022; Noberini R, 2015, EPIGENOMICS; Onder O, 2015, EXPERT REV PROTEOMIC, V12, P499, DOI 10.1586/14789450.2015.1084231; Oudhoff MJ, 2013, DEV CELL, V26, P188, DOI 10.1016/j.devcel.2013.05.025; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Pradhan S, 2009, EPIGENETICS, V4, P383, DOI DOI 10.4161/EPI.4.6.9450; Quinn AM, 2010, MOL BIOSYST, V6, P782, DOI 10.1039/b921912a; Sprung R, 2008, J PROTEOME RES, V7, P1001, DOI [10.1021/pr0705338, 10.1021/pr8005155]; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	35	3	3	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154207	10.1371/journal.pone.0154207	http://dx.doi.org/10.1371/journal.pone.0154207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111853	gold, Green Published			2022-12-27	WOS:000374970600048
J	Vazquez-Guerrero, J; Moras, G; Baeza, J; Rodriguez-Jimenez, S				Vazquez-Guerrero, Jairo; Moras, Gerard; Baeza, Jennifer; Rodriguez-Jimenez, Sergio			Force Outputs during Squats Performed Using a Rotational Inertia Device under Stable versus Unstable Conditions with Different Loads	PLOS ONE			English	Article							ELITE SOCCER PLAYERS; BENCH PRESS; ELECTROMYOGRAPHIC ACTIVITY; ECCENTRIC-OVERLOAD; MUSCLE ACTIVATION; RESISTANCE; INSTABILITY; SURFACES; FLYWHEEL; STRENGTH	The purpose of the study was to compare the force outputs achieved during a squat exercise using a rotational inertia device in stable versus unstable conditions with different loads and in concentric and eccentric phases. Thirteen male athletes (mean +/- SD: age 23.7 +/- 3.0 years, height 1.80 +/- 0.08 m, body mass 77.4 +/- 7.9 kg) were assessed while squatting, performing one set of three repetitions with four different loads under stable and unstable conditions at maximum concentric effort. Overall, there were no significant differences between the stable and unstable conditions at each of the loads for any of the dependent variables. Mean force showed significant differences between some of the loads in stable and unstable conditions (P < 0.010) and peak force output differed between all loads for each condition (P < 0.045). Mean force outputs were greater in the concentric than in the eccentric phase under both conditions and with all loads (P < 0.001). There were no significant differences in peak force between concentric and eccentric phases at any load in either stable or unstable conditions. In conclusion, squatting with a rotational inertia device allowed the generation of similar force outputs under stable and unstable conditions at each of the four loads. The study also provides empirical evidence of the different force outputs achieved by adjusting load conditions on the rotational inertia device when performing squats, especially in the case of peak force. Concentric force outputs were significantly higher than eccentric outputs, except for peak force under both conditions. These findings support the use of the rotational inertia device to train the squatting exercise under unstable conditions for strength and conditioning trainers. The device could also be included in injury prevention programs for muscle lesions and ankle and knee joint injuries.	[Vazquez-Guerrero, Jairo; Moras, Gerard; Rodriguez-Jimenez, Sergio] Inst Nacl Educ Fis Catalunya, Sport Performance, Ctr Barcelona, Barcelona, Spain; [Vazquez-Guerrero, Jairo] FCBarcelona, Barcelona, Spain; [Baeza, Jennifer] Fundacio Univ Bages, Barcelona, Spain		Moras, G (corresponding author), Inst Nacl Educ Fis Catalunya, Sport Performance, Ctr Barcelona, Barcelona, Spain.	jairosport.vg@gmail.com	Vázquez-Guerrero, Jairo/AAD-5487-2019		Institut Nacional d'Educacio Fisica de Catalunya (INEFC) de la Generalitat de Catalunya [PRE/2730/2012]; Institut Nacional d'Educacio Fisica de Catalunya (INEFC); FCBarcelona	Institut Nacional d'Educacio Fisica de Catalunya (INEFC) de la Generalitat de Catalunya; Institut Nacional d'Educacio Fisica de Catalunya (INEFC); FCBarcelona	This work was supported by the Institut Nacional d'Educacio Fisica de Catalunya (INEFC) de la Generalitat de Catalunya (PRE/2730/2012). Jairo Vazquez-Guerrero is the recipient of a predoctoral fellowship from the Institut Nacional d'Educacio Fisica de Catalunya (INEFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FCBarcelona provided support in the form of salary for author JVG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Anderson K, 2005, SPORTS MED, V35, P43, DOI 10.2165/00007256-200535010-00004; Anderson KG, 2004, J STRENGTH COND RES, V18, P637; Askling C, 2003, SCAND J MED SCI SPOR, V13, P244, DOI 10.1034/j.1600-0838.2003.00312.x; Balshaw G, 2012, J ELECTROMYOGR KINES, V22, P308, DOI 10.1016/j.jelekin.2011.11.009; Behm D, 2012, INT J SPORTS PHYS TH, V7, P226; Behm DG, 2006, J STRENGTH COND RES, V20, P716; BERG HE, 1994, AVIAT SPACE ENVIR MD, V65, P752; Berg HE, 1998, ACTA ASTRONAUT, V42, P219, DOI 10.1016/S0094-5765(98)00119-2; Blatnik JA, 2012, J STRENGTH COND RES, V26, P3204, DOI 10.1519/JSC.0b013e3182736641; Channell BT, 2008, J STRENGTH COND RES, V22, P1522, DOI 10.1519/JSC.0b013e318181a3d0; Chiu LZF, 2006, J STRENGTH COND RES, V20, P555; Cowley PM, 2007, INT J SPORTS MED, V28, P829, DOI 10.1055/s-2007-964893; de Hoyo M, 2015, INT J SPORT PHYSIOL, V10, P46, DOI 10.1123/ijspp.2013-0547; Drinkwater EJ, 2005, J STRENGTH COND RES, V19, P382; Drinkwater EJ, 2007, INT J SPORT PHYSIOL, V2, P400, DOI 10.1123/ijspp.2.4.400; Hyong IH, 2013, J PHYS THER SCI, V25, P915, DOI 10.1589/jpts.25.915; Kang JH, 2012, J PHYS THER SCI, V24, P1333, DOI 10.1589/jpts.24.1333; Keogh JWL, 2010, J STRENGTH COND RES, V24, P422, DOI 10.1519/JSC.0b013e3181c7c6b9; Kohler JM, 2010, J STRENGTH COND RES, V24, P313, DOI 10.1519/JSC.0b013e3181c8655a; Koshida S, 2008, J STRENGTH COND RES, V22, P1584, DOI 10.1519/JSC.0b013e31817b03a1; McBride JM, 2006, J STRENGTH COND RES, V20, P915; McBride JM, 2010, INT J SPORT PHYSIOL, V5, P177, DOI 10.1123/ijspp.5.2.177; Norrbrand L, 2008, EUR J APPL PHYSIOL, V102, P271, DOI 10.1007/s00421-007-0583-8; Norrbrand L, 2011, AVIAT SPACE ENVIR MD, V82, P13, DOI 10.3357/ASEM.2867.2011; Norrbrand L, 2010, EUR J APPL PHYSIOL, V110, P997, DOI 10.1007/s00421-010-1575-7; Norwood JT, 2007, J STRENGTH COND RES, V21, P343, DOI 10.1519/R-17435.1; Onambele GL, 2008, J BIOMECH, V41, P3133, DOI 10.1016/j.jbiomech.2008.09.004; Romero-Rodriguez D, 2011, PHYS THER SPORT, V12, P43, DOI 10.1016/j.ptsp.2010.10.003; Saeterbakken AH, 2013, J STRENGTH COND RES, V27, P1101, DOI 10.1519/JSC.0b013e3182606d3d; Saeterbakken AH, 2013, J STRENGTH COND RES, V27, P130, DOI 10.1519/JSC.0b013e3182541d43; Tesch PA, 2004, ACTA PHYSIOL SCAND, V180, P89, DOI 10.1046/j.0001-6772.2003.01225.x; Uribe BP, 2010, J STRENGTH COND RES, V24, P1028, DOI 10.1519/JSC.0b013e3181ca4fb8; Zemkova E, 2014, J APPL BIOMECH, V30, P213, DOI 10.1123/jab.2012-0229; Zemkova E, 2012, J STRENGTH COND RES, V26, P3230, DOI 10.1519/JSC.0b013e31824bc197	34	18	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154346	10.1371/journal.pone.0154346	http://dx.doi.org/10.1371/journal.pone.0154346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111766	gold, Green Submitted, Green Published			2022-12-27	WOS:000374970600058
J	Daskalopoulou, M; George, J; Walters, K; Osborn, DP; Batty, GD; Stogiannis, D; Rapsomaniki, E; Pujades-Rodriguez, M; Denaxas, S; Udumyan, R; Kivimaki, M; Hemingway, H				Daskalopoulou, Marina; George, Julie; Walters, Kate; Osborn, David P.; Batty, G. David; Stogiannis, Dimitris; Rapsomaniki, Eleni; Pujades-Rodriguez, Mar; Denaxas, Spiros; Udumyan, Ruzan; Kivimaki, Mika; Hemingway, Harry			Depression as a Risk Factor for the Initial Presentation of Twelve Cardiac, Cerebrovascular, and Peripheral Arterial Diseases: Data Linkage Study of 1.9 Million Women and Men	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASES; MYOCARDIAL-INFARCTION; SOCIAL SUPPORT; METAANALYSIS; STROKE; HEALTH; PREVALENCE; DISORDERS; SMOKING	Background Depression is associated with coronary heart disease and stroke, but associations with a range of pathologically diverse cardiovascular diseases are not well understood. We examine the risk of 12 cardiovascular diseases according to depression status (history or new onset). Methods Cohort study of 1,937,360 adult men and women, free from cardiovascular disease at baseline, using linked UK electronic health records between 1997 and 2010. The exposures were new-onset depression (a new GP diagnosis of depression and/or prescription for antidepressants during a one-year baseline), and history of GP-diagnosed depression before baseline. The primary endpoint was initial presentation of 12 cardiovascular diseases after baseline. We used disease-specific Cox proportional hazards models with multiple imputation adjusting for cardiovascular risk factors (age, sex, socioeconomic status, smoking, blood pressure, diabetes, cholesterol). Results Over a median [IQR] 6.9 [2.1-10.5] years of follow-up, 18.9% had a history of depression and 94,432 incident cardiovascular events occurred. After adjustment for cardiovascular risk factors, history of depression was associated with: stable angina (Hazard Ratio = 1.38, 95% CI 1.32-1.45), unstable angina (1.70, 1.60-1.82), myocardial infarction (1.21, 1.16-1.27), unheralded coronary death (1.23, 1.14-1.32), heart failure (1.18, 1.13-1.24), cardiac arrest (1.14, 1.03-1.26), transient ischemic attack (1.31, 1.25-1.38), ischemic stroke (1.26, 1.18-1.34), subarachnoid haemorrhage (1.17, 1.01-1.35), intracerebral haemorrhage (1.30, 1.17-1.45), peripheral arterial disease (1.24, 1.18-1.30), and abdominal aortic aneurysm (1.12,1.01-1.24). New onset depression developed in 2.9% of people, among whom 63,761 cardiovascular events occurred. New onset depression was similarly associated with each of the 12 diseases, with no evidence of stronger associations compared to history of depression. The strength of association between depression and these cardiovascular diseases did not differ between women and men. Conclusion Depression was prospectively associated with cardiac, cerebrovascular, and peripheral diseases, with no evidence of disease specificity. Further research is needed in understanding the specific pathophysiology of heart and vascular disease triggered by depression in healthy populations.	[Daskalopoulou, Marina] UCL, Dept Infect & Populat Hlth, London, England; [George, Julie; Stogiannis, Dimitris; Rapsomaniki, Eleni; Pujades-Rodriguez, Mar; Denaxas, Spiros; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, London, England; [Walters, Kate] UCL, Dept Primary Care & Populat Hlth, London, England; [Osborn, David P.] UCL, Div Psychiat, London, England; [Batty, G. David; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Udumyan, Ruzan] Univ Orebro, Sch Med Sci, Clin Epidemiol & Biostat, SE-70182 Orebro, Sweden	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Orebro University	Daskalopoulou, M (corresponding author), UCL, Dept Infect & Populat Hlth, London, England.	m.daskalopoulou@ucl.ac.uk	Batty, GD/Y-4401-2018; Pujades-Rodriguez, Mar/T-1129-2018; Kivimaki, Mika/B-3607-2012; Udumyan, Ruzan/ABG-1943-2021; Hemingway, Harry/C-1219-2009; Osborn PhD FRCPsych, David/B-8165-2009	Batty, GD/0000-0003-1822-5753; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Kivimaki, Mika/0000-0002-4699-5627; Hemingway, Harry/0000-0003-2279-0624; Walters, Kate/0000-0003-2173-2430; Denaxas, Spiros/0000-0001-9612-7791; Osborn PhD FRCPsych, David/0000-0003-2519-1539	National Institute for Health Research [RP-PG-0407-10314]; Wellcome Trust [086091/Z/08/Z, MR/K006584/1]; Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership [G0902393/99558]; Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research; Alzheimer Scotland; University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative [G0700704/ 84698]; BBSRC; EPSRC; ESRC; MRC; UCL Provost's Strategic Development Fund Fellowship; NIHR Doctoral Fellowship [DRF-2009-02-50]; Medical Research Council [K013351]; National Heart, Lung and Blood Institute [HL36310]; National Institute of Aging [AG034454]; NIHR; British Heart Foundation [RG/13/2/30098] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1, ES/L007517/1] Funding Source: researchfish; Medical Research Council [MR/K026992/1, MR/K013351/1, MR/L01629X/1, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [DRF-2009-02-50] Funding Source: researchfish; Stroke Association [TSA2008/05] Funding Source: researchfish; ESRC [ES/L007517/1, ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1, MR/L01629X/1] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; Alzheimer Scotland; University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL Provost's Strategic Development Fund Fellowship; NIHR Doctoral Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIHR(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Stroke Association; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the National Institute for Health Research (HH, RP-PG-0407-10314), Wellcome Trust (HH, 086091/Z/08/Z), and the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (HH, G0902393/99558), and by awards to establish the Farr Institute of Health Informatics Research at UCL Partners (HH, SD), from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (HH, grant MR/K006584/1). This study was carried out on behalf of the CArdiovascular disease research using Linked Bespoke studies and Electronic health Records (CALIBER) programme. GDB is a member of the Alzheimer Scotland Dementia Research Centre funded by Alzheimer Scotland, and the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/ 84698). Funding from the BBSRC, EPSRC, ESRC, and MRC is gratefully acknowledged. SD is supported by a UCL Provost's Strategic Development Fund Fellowship. JG was funded by an NIHR Doctoral Fellowship (DRF-2009-02-50). MK is supported by the Medical Research Council (K013351), the National Heart, Lung and Blood Institute (HL36310), the National Institute of Aging (AG034454), and a professorial fellowship from the Economic and Social Research Council. This article presents independent research funded in part by the NIHR. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Brunner EJ, 2014, EUR J PREV CARDIOL, V21, P340, DOI 10.1177/2047487314520785; Carter CS, 1997, J CLIN PSYCHIAT, V58, P70; COX DR, 1972, J R STAT SOC B, V34, P187; De Rango P, 2014, EUR J VASC ENDOVASC, V47, P243, DOI 10.1016/j.ejvs.2013.12.007; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Dong JY, 2012, STROKE, V43, P32, DOI 10.1161/STROKEAHA.111.630871; Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Funk M., 2008, INT MENT HLTH PRIM C; Germano G, 2012, EUR HEART J, V33, P137; Goff D. C., 2013, CIRCULATION; Health Protection Agency, 2005, HLTH PROT 21 CENT UN; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2013, EUR HEART J-ACUTE CA, V2, P235, DOI 10.1177/2048872613487495; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Idris I, 2006, INT J CLIN PRACT, V60, P48, DOI 10.1111/j.1368-5031.2006.00682.x; Lederle FA, 2003, J VASC SURG, V38, P329, DOI 10.1016/S0741-5214(03)00136-8; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Nabi H, 2010, INT J EPIDEMIOL, V39, P1016, DOI 10.1093/ije/dyq050; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Noble M, 2008, ENGLISH INDICES DEPR; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Rahman I, 2013, EUR J EPIDEMIOL; Rait G, 2009, BRIT J PSYCHIAT, V195, P520, DOI 10.1192/bjp.bp.108.058636; Rapsomaniki E, 2014, LANCET IN PRESS; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Surtees PG, 2008, NEUROLOGY, V70, P788, DOI 10.1212/01.wnl.0000304109.18563.81; The British Psychological Society and The Royal College of Psychiatrists, 2010, DEPR NICE GUID TREAT; Thompson SG, 1997, STAT MED, V16, P2063, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2063::AID-SIM642>3.0.CO;2-8; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Waraich P, 2004, CAN J PSYCHIAT, V49, P124, DOI 10.1177/070674370404900208; Williams SA, 2002, PSYCHOSOM MED, V64, P6, DOI 10.1097/00006842-200201000-00002; Wulsin LR, 2003, PSYCHOSOM MED, V65, P201, DOI 10.1097/01.PSY.0000058371.50240.E3	39	83	84	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153838	10.1371/journal.pone.0153838	http://dx.doi.org/10.1371/journal.pone.0153838			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105076	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100025
J	Lau, A; Barrie, J; Winter, C; Elamy, AH; Tyrrell, G; Long, R				Lau, Angela; Barrie, James; Winter, Christopher; Elamy, Abdel-Halim; Tyrrell, Gregory; Long, Richard			Chest Radiographic Patterns and the Transmission of Tuberculosis: Implications for Automated Systems	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; CONTACT INVESTIGATIONS; CLOSED ENVIRONMENT; SMEAR; EPIDEMIOLOGY; RECOMMENDATIONS; VARIABILITY; INFECTION; AEROSOLS	Background Computer-aided detection to identify and diagnose pulmonary tuberculosis is being explored. While both cavitation on chest radiograph and smear-positivity on microscopy are independent risk factors for the infectiousness of pulmonary tuberculosis it is unknown which radiographic pattern, were it detectable, would provide the greatest public health benefit; i.e. reduced transmission. Herein we provide that evidence. Objectives 1) to determine whether pulmonary tuberculosis in a high income, low incidence country is more likely to present with "typical" adult-type pulmonary tuberculosis radiographic features and 2) to determine whether those with "typical" radiographic features are more likely than those without such features to transmit the organism and/or cause secondary cases. Methods Over a three-year period beginning January 1, 2006 consecutive adults with smear-positive pulmonary tuberculosis in the Province of Alberta, Canada, were identified and their pretreatment radiographs scored by three independent readers as "typical" (having an upper lung zone predominant infiltrate, with or without cavitation but no discernable adenopathy) or "atypical" (all others). Each patient's pre-treatment bacillary burden was carefully documented and, during a 30-month transmission window, each patient's transmission events were recorded. Mycobacteriology, radiology and transmission were compared in those with "typical" versus "atypical" radiographs. Findings A total of 97 smear-positive pulmonary tuberculosis cases were identified, 69 (71.1%) with and 28 (28.9%) without "typical" chest radiographs. "Typical" cases were more likely to have high bacillary burdens and cavitation (Odds Ratios and 95% Confidence Intervals: 2.75 [1.04-7.31] and 9.10 [2.51-32.94], respectively). Typical cases were also responsible for most transmission events-78% of tuberculin skin test conversions (p<0.002) and 95% of secondary cases in reported close contacts (p<0.01); 94% of secondary cases in "unreported" contacts (p<0.02). Conclusion As a group, smear-positive pulmonary tuberculosis patients with typical radiographic features constitute the greatest public health risk. This may have implications for automated detection systems.	[Lau, Angela; Elamy, Abdel-Halim; Long, Richard] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Barrie, James; Winter, Christopher] Univ Alberta, Dept Radiol, Edmonton, AB, Canada; [Long, Richard] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Tyrrell, Gregory] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Tyrrell, Gregory] Alberta Hlth Serv, Prov Lab Publ Hlth, Edmonton, AB, Canada; [Tyrrell, Gregory] Alberta Hlth Serv, Prov Lab Publ Hlth, Calgary, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Alberta Health Services (AHS); Alberta Health Services (AHS); University of Calgary	Long, R (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.; Long, R (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	richard.long@ualberta.ca	Tyrrell, Gregory/ABA-7203-2021					Alberta Health and Wellness, 2007, TUB PREV CONTR GUID; Bailey WC, 2002, JAMA-J AM MED ASSOC, V287, P996, DOI 10.1001/jama.287.8.996; Bark CM, 2011, TUBERCULOSIS, V91, P257, DOI 10.1016/j.tube.2011.01.004; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Breuninger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106381; Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895; Canetti G., 1955, TUBERCLE BACILLUS PU; CATANZARO A, 1982, AM REV RESPIR DIS, V125, P559, DOI 10.1164/arrd.1982.125.5.559; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; Diacon AH, 2014, TUBERCULOSIS, V94, P148, DOI 10.1016/j.tube.2013.12.002; Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC; Ferebee SH, 1969, ADV TUBERC RES, V17, P29; Ferguson Robert George, 1955, STUDIES TUBERCULOSIS; Grandjean L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001843; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P26, DOI 10.1080/00039896.1968.10665011; HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P4, DOI 10.1080/00039896.1968.10665007; Jensen M, 2012, INT J TUBERC LUNG D, V16, P43, DOI 10.5588/ijtld.11.0374; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; KHAN MA, 1977, AM J MED, V62, P31, DOI 10.1016/0002-9343(77)90346-1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LIIPPO KK, 1993, AM REV RESPIR DIS, V148, P235, DOI 10.1164/ajrccm/148.1.235; Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129; LONG R, 1991, CHEST, V99, P123, DOI 10.1378/chest.99.1.123; Long R, 2015, CAN RESPIR J, V22, P317, DOI 10.1155/2015/826035; Long R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098993; Loudon RG, 1969, AM REV RESPIR DIS, V99, P1969; Maduskar P, 2013, INT J TUBERC LUNG D, V17, P1613, DOI 10.5588/ijtld.13.0325; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Medlar EM., 1955, AM REV TUBERC LUNG D; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; Parhar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117036; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; SULTAN L, 1960, AM REV RESPIR DIS, V82, P358; The Canadian Lung Association and the Public Health Agency of Canada, 2007, CAN LUNG ASS PUBL HL; Toman K., 1979, TUBERCULOSIS CASE FI; Van Dyck P, 2003, EUR RADIOL, V13, P1771, DOI 10.1007/s00330-002-1612-y; van Ginneken B, 2009, EUR J RADIOL, V72, P226, DOI 10.1016/j.ejrad.2009.05.061; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Xu T, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-3; [No title captured]	42	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154032	10.1371/journal.pone.0154032	http://dx.doi.org/10.1371/journal.pone.0154032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105337	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100036
J	Mu, R; Cutting, AS; Del Rosario, Y; Villarino, N; Stewart, L; Weston, TA; Patras, KA; Doran, KS				Mu, Rong; Cutting, Andrew S.; Del Rosario, Yvette; Villarino, Nicholas; Stewart, Lara; Weston, Thomas A.; Patras, Kathryn A.; Doran, Kelly S.			Identification of CiaR Regulated Genes That Promote Group B Streptococcal Virulence and Interaction with Brain Endothelial Cells	PLOS ONE			English	Article							INTRACELLULAR SURVIVAL; RESPONSE REGULATOR; BETA-HEMOLYSIN/CYTOLYSIN; BARRIER PENETRATION; SIGNAL-TRANSDUCTION; LIPOTEICHOIC ACID; RAB GTPASES; 2-COMPONENT; RESISTANCE; PROTEIN	Group B Streptococcus (GBS) is a major causative agent of neonatal meningitis due to its ability to efficiently cross the blood-brain barrier (BBB) and enter the central nervous system (CNS). It has been demonstrated that GBS can invade human brain microvascular endothelial cells (hBMEC), a primary component of the BBB; however, the mechanism of intracellular survival and trafficking is unclear. We previously identified a two component regulatory system, CiaR/H, which promotes GBS intracellular survival in hBMEC. Here we show that a GBS strain deficient in the response regulator, CiaR, localized more frequently with Rab5, Rab7 and LAMP1 positive vesicles. Further, lysosomes isolated from hBMEC contained fewer viable bacteria following initial infection with the Delta ciaR mutant compared to the WT strain. To characterize the contribution of CiaR-regulated genes, we constructed isogenic mutant strains lacking the two most down-regulated genes in the CiaR-deficient mutant, SAN_2180 and SAN_0039. These genes contributed to bacterial uptake and intracellular survival. Furthermore, competition experiments in mice showed that WT GBS had a significant survival advantage over the Delta 2180 and Delta 0039 mutants in the bloodstream and brain.	[Mu, Rong; Cutting, Andrew S.; Del Rosario, Yvette; Villarino, Nicholas; Stewart, Lara; Weston, Thomas A.; Patras, Kathryn A.; Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Mu, Rong; Cutting, Andrew S.; Del Rosario, Yvette; Villarino, Nicholas; Stewart, Lara; Weston, Thomas A.; Patras, Kathryn A.; Doran, Kelly S.] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Doran, Kelly S.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego	Doran, KS (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.; Doran, KS (corresponding author), San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA.; Doran, KS (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.	kdoran@mail.sdsu.edu	Villarino, Nicholas/HGC-5191-2022; Patras, Kathryn/AAA-3286-2021	Patras, Kathryn/0000-0003-2631-8810; Mu, Rong/0000-0001-6846-3659	Rees Stealy Research Foundation/SDSU Heart Institute Scholarship; San Diego Chapter ARCS Scholarship; NIH/NINDS [R01-NS051247]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER	Rees Stealy Research Foundation/SDSU Heart Institute Scholarship; San Diego Chapter ARCS Scholarship; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Rees Stealy Research Foundation/SDSU Heart Institute Scholarship to A.S.C., the San Diego Chapter ARCS Scholarship to K.A.P., and NIH/NINDS R01-NS051247 to K.S.D.	Akesson M, 2007, FEMS MICROBIOL LETT, V270, P155, DOI 10.1111/j.1574-6968.2007.00669.x; Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Bera A, 2007, J BACTERIOL, V189, P280, DOI 10.1128/JB.01221-06; Blanchette-Cain K, 2013, MBIO, V4, DOI 10.1128/mBio.00745-13; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Cornacchione P, 1998, IMMUNOLOGY, V93, P86; Cumley NJ, 2012, INFECT IMMUN, V80, P1650, DOI 10.1128/IAI.05443-11; Cutting AS, 2014, J BIOL CHEM, V289, P35711, DOI 10.1074/jbc.M114.588657; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Faralla C, 2014, MBIO, V5, DOI 10.1128/mBio.00870-14; Gargis SR, 2009, APPL ENVIRON MICROB, V75, P6205, DOI 10.1128/AEM.01011-09; Gargis SR, 2009, APPL ENVIRON MICROB, V75, P72, DOI 10.1128/AEM.01647-08; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Klinzing DC, 2013, MICROBIOL-SGM, V159, P1521, DOI 10.1099/mic.0.064444-0; Lai ACY, 2002, FEMS MICROBIOL LETT, V215, P133, DOI 10.1016/S0378-1097(02)00919-9; Lembo A, 2010, MOL MICROBIOL, V77, P431, DOI 10.1111/j.1365-2958.2010.07215.x; Lemire P, 2012, CELL MICROBIOL, V14, P1707, DOI 10.1111/j.1462-5822.2012.01830.x; Lemire P, 2012, MICROBES INFECT, V14, P1064, DOI 10.1016/j.micinf.2012.05.015; Libster R, 2012, PEDIATRICS, V130, pE8, DOI 10.1542/peds.2011-3453; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; Mascher T, 2006, J BACTERIOL, V188, P1959, DOI 10.1128/JB.188.5.1959-1968.2006; Mascher T, 2003, J BACTERIOL, V185, P60, DOI 10.1128/JB.185.1.60-70.2003; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Mu R, 2014, INFECT IMMUN, V82, P2276, DOI 10.1128/IAI.01559-13; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Qi FX, 2004, INFECT IMMUN, V72, P4895, DOI 10.1128/IAI.72.8.4895-4899.2004; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Sagar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060160; Spellerberg B, 2002, INFECT IMMUN, V70, P2434, DOI 10.1128/IAI.70.5.2434-2440.2002; Stein MP, 2012, TRAFFIC, V13, P1565, DOI 10.1111/tra.12000; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Terebiznik MR, 2006, INFECT IMMUN, V74, P6599, DOI 10.1128/IAI.01085-06; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; ValentinWeigand P, 1996, INFECT IMMUN, V64, P2467, DOI 10.1128/IAI.64.7.2467-2473.1996; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Vollmer W, 2002, INFECT IMMUN, V70, P7176, DOI 10.1128/IAI.70.12.7176-7178.2002; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wang LR, 2008, MICROBIOL-SGM, V154, P1900, DOI 10.1099/mic.0.2007/015172-0; WILKINSON HW, 1977, J CLIN MICROBIOL, V6, P183; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	52	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153891	10.1371/journal.pone.0153891	http://dx.doi.org/10.1371/journal.pone.0153891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100296	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500088
J	Ng, KK; Motoda, Y; Watanabe, S; Othman, AS; Kigawa, T; Kodama, Y; Numata, K				Ng, Kiaw Kiaw; Motoda, Yoko; Watanabe, Satoru; Othman, Ahmad Sofiman; Kigawa, Takanori; Kodama, Yutaka; Numata, Keiji			Intracellular Delivery of Proteins via Fusion Peptides in Intact Plants	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; GENE; INTERNALIZATION; TRANSDUCTION; ARABIDOPSIS; MECHANISMS; BP100	In current plant biotechnology, the introduction of exogenous DNA encoding desired traits is the most common approach used to modify plants. However, general plant transformation methods can cause random integration of exogenous DNA into the plant genome. To avoid these events, alternative methods, such as a direct protein delivery system, are needed to modify the plant. Although there have been reports of the delivery of proteins into cultured plant cells, there are currently no methods for the direct delivery of proteins into intact plants, owing to their hierarchical structures. Here, we demonstrate the efficient fusion-peptide-based delivery of proteins into intact Arabidopsis thaliana. Bovine serum albumin (BSA, 66 kDa) was selected as a model protein to optimize conditions for delivery into the cytosol. The general applicability of our method to large protein cargo was also demonstrated by the delivery of alcohol dehydrogenase (ADH, 150 kDa) into the cytosol. The compatibility of the fusion peptide system with the delivery of proteins to specific cellular organelles was also demonstrated using the fluorescent protein Citrine (27 kDa) conjugated to either a nuclear localization signal (NLS) or a peroxisomal targeting signal (PTS). In conclusion, our designed fusion peptide system can deliver proteins with a wide range of molecular weights (27 to 150 kDa) into the cells of intact A. thaliana without interfering with the organelle-targeting peptide conjugated to the protein. We expect that this efficient protein delivery system will be a powerful tool in plant biotechnology.	[Ng, Kiaw Kiaw; Motoda, Yoko; Numata, Keiji] RIKEN Ctr Sustainable Resource Sci, Enzyme Res Team, Biomass Engn Res Div, Wako, Saitama, Japan; [Ng, Kiaw Kiaw; Othman, Ahmad Sofiman] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Motoda, Yoko; Watanabe, Satoru; Kigawa, Takanori] RIKEN Quantitat Biol Ctr QBiC, Lab Biomol Struct & Dynam, Yokohama, Kanagawa, Japan; [Kigawa, Takanori] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan; [Kodama, Yutaka] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi 321, Japan	RIKEN; Universiti Sains Malaysia; RIKEN; Tokyo Institute of Technology; Utsunomiya University	Numata, K (corresponding author), RIKEN Ctr Sustainable Resource Sci, Enzyme Res Team, Biomass Engn Res Div, Wako, Saitama, Japan.	keiji.numata@riken.jp	Othman, Ahmad Sofiman/GVT-4237-2022; Numata, Keiji/H-9751-2012; watanabe, satoru s/E-9501-2012; Kigawa, Takanori/A-7679-2010	Othman, Ahmad Sofiman/0000-0002-4944-4177; Numata, Keiji/0000-0003-2199-7420; watanabe, satoru s/0000-0001-5329-9278; Kigawa, Takanori/0000-0003-0146-9719	Cross-ministerial Strategic Innovation Promotion Program (SIP)	Cross-ministerial Strategic Innovation Promotion Program (SIP)	This study was supported financially by Cross-ministerial Strategic Innovation Promotion Program (SIP).	Adler AF, 2010, NANO TODAY, V5, P553, DOI 10.1016/j.nantod.2010.10.007; Alberts B., 2008, MOL BIOL CELL, VFifth; Altman A, 2012, PLANT BIOTECHNOLOGY AND AGRICULTURE: PROSPECTS FOR THE 21ST CENTURY, P1; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Chang M, 2005, PLANT CELL PHYSIOL, V46, P482, DOI 10.1093/pcp/pci046; Chang M, 2007, NEW PHYTOL, V174, P46, DOI 10.1111/j.1469-8137.2007.01977.x; Chang M, 2014, CURR PHARM BIOTECHNO, V15, P267, DOI 10.2174/1389201015666140617095415; Chen QR, 2000, GENE THER, V7, P1698, DOI 10.1038/sj.gt.3301294; Dietz KJ, 2001, PROG BOT, V62, P215; Eggenberger K, 2011, CHEMBIOCHEM, V12, P132, DOI 10.1002/cbic.201000402; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Jain A, 2015, FEBS J, V282, P732, DOI 10.1111/febs.13178; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Lakshmanan M, 2015, PLANT BIOTECHNOL-NAR, V32, P39, DOI 10.5511/plantbiotechnology.14.1210b; Lakshmanan M, 2013, BIOMACROMOLECULES, V14, P10, DOI 10.1021/bm301275g; Lau W, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001879; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Leonetti JP, 1990, BIOCONJUGATE CHEM, V1, P149, DOI 10.1021/bc00002a010; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lu SW, 2010, J AGR FOOD CHEM, V58, P2288, DOI 10.1021/jf903039j; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; Mizuno T, 2009, J PEPT SCI, V15, P259, DOI 10.1002/psc.1079; Mori O, 1997, COLLOID SURFACE B, V9, P31, DOI 10.1016/S0927-7765(97)00005-2; Muntz K, 2007, J EXP BOT, V58, P2391, DOI 10.1093/jxb/erm089; Munyendo WL, 2012, BIOMOLECULES, V2, P187, DOI 10.3390/biom2020187; Nielsen KM, 1998, FEMS MICROBIOL REV, V22, P79, DOI 10.1111/j.1574-6976.1998.tb00362.x; Numata K, 2015, POLYM J, V47, P537, DOI 10.1038/pj.2015.35; Numata K, 2014, PLANT BIOTECHNOL J, V12, P1027, DOI 10.1111/pbi.12208; Numata K, 2012, BIOMACROMOLECULES, V13, P3450, DOI 10.1021/bm301276k; Numata K, 2012, MACROMOL BIOSCI, V12, P75, DOI 10.1002/mabi.201100274; Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009; Numata K, 2010, BIOMACROMOLECULES, V11, P3189, DOI 10.1021/bm101055m; Ohtani M, 2013, PLANT CELL, V25, P2056, DOI 10.1105/tpc.113.111922; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Sarker SR, 2014, MOL PHARMACEUT, V11, P164, DOI 10.1021/mp400363z; Scheuring D, 2011, PLANT CELL, V23, P3463, DOI 10.1105/tpc.111.086918; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SPIRIN AS, 1988, SCIENCE, V242, P1162, DOI 10.1126/science.3055301; Trabulo S, 2010, PHARMACEUTICALS, V3, P961, DOI 10.3390/ph3040961; Wadhwani P, 2014, BBA-BIOMEMBRANES, V1838, P940, DOI 10.1016/j.bbamem.2013.11.001; Wang YH, 2006, BIOCHEM BIOPH RES CO, V346, P758, DOI 10.1016/j.bbrc.2006.05.205; Xia YJ, 2004, CELL MICROBIOL, V6, P905, DOI 10.1111/j.1462-5822.2004.00438.x; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	49	37	38	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154081	10.1371/journal.pone.0154081	http://dx.doi.org/10.1371/journal.pone.0154081			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100681	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500138
J	Tchicaya, A; Lorentz, N; Demarest, S				Tchicaya, Anastase; Lorentz, Nathalie; Demarest, Stefaan			Socioeconomic Inequalities in Smoking and Smoking Cessation Due to a Smoking Ban: General Population-Based Cross-Sectional Study in Luxembourg	PLOS ONE			English	Article							EDUCATIONAL INEQUALITIES; DISPARITIES; HEALTH; AGE; CONSUMPTION; PREVALENCE; INTENTIONS; ABSTINENCE; INITIATION; MORTALITY	This study aimed to measure changes in socioeconomic inequalities in smoking and smoking cessation due to the 2006 smoking ban in Luxembourg. Data were derived from the PSELL3/EU-SILC (Panel Socio-Economique Liewen Zu Letzebuerg/European Union-Statistic on Income and Living Conditions) survey, which was a representative survey of the general population aged >= 16 years conducted in Luxembourg in 2005, 2007, and 2008. Smoking prevalence and smoking cessation due to the 2006 smoking ban were used as the main smoking outcomes. Two inequality measures were calculated to assess the magnitude and temporal trends of socioeconomic inequalities in smoking: the prevalence ratio and the disparity index. Smoking cessation due to the smoking ban was considered as a positive outcome. Three multiple logistic regression models were used to assess social inequalities in smoking cessation due to the 2006 smoking ban. Education level, income, and employment status served as proxies for socioeconomic status. The prevalence of smoking decreased by 22.5% between 2005 and 2008 (from 23.1% in 2005 to 17.9% in 2008), but socioeconomic inequalities in smoking persisted. Smoking prevalence decreased by 24.2% and 20.2% in men and women, respectively; this difference was not statistically significant. Smoking cessation in daily smokers due to the 2006 smoking ban was associated with education level, employment status, and income, with higher percentages of quitters among those with a lower socioeconomic status. The decrease in smoking prevalence after the 2006 law was also associated with a reduction in socioeconomic inequalities, including differences in education level, income, and employment status. Although the smoking ban contributed to a reduction of such inequalities, they still persist, indicating the need for a more targeted approach of smoke-free policies directed toward lower socioeconomic groups.	[Tchicaya, Anastase; Lorentz, Nathalie] LISER, Dept Living Condit, Hlth Res Team, Esch Sur Alzette, Luxembourg; [Demarest, Stefaan] Sci Inst Publ Hlth WIV ISP, OD Publ Hlth & Surveillance, Brussels, Belgium		Tchicaya, A (corresponding author), LISER, Dept Living Condit, Hlth Res Team, Esch Sur Alzette, Luxembourg.	anastase.tchicaya@liser.lu	TCHICAYA, Anastase/AAI-4994-2020	Demarest, Stefaan/0000-0003-2823-1372	 [FNR/C12/BM/3978355]		This work was supported by Project FNR/C12/BM/3978355: Monitoring and Dynamics of Health Status through the Risk Factors for Cardiovascular Disease in Luxembourg-MDYNRFC (www.fnr.lu).	Anger S, 2011, J HEALTH ECON, V30, P591, DOI 10.1016/j.jhealeco.2011.03.003; Bauld L, 2011, IMPACT SMOKEFREE LEG; Bosdriesz JR, 2015, J EPIDEMIOL COMMUN H, V69, P886, DOI 10.1136/jech-2014-205171; Buonanno P, 2013, HEALTH POLICY, V109, P192, DOI 10.1016/j.healthpol.2012.10.009; Cavelaars AEJM, 2000, BRIT MED J, V320, P1102, DOI 10.1136/bmj.320.7242.1102; Charafeddine R, 2013, EUR J PUBLIC HEALTH, V23, P546, DOI 10.1093/eurpub/cks083; Dinno A, 2009, SOC SCI MED, V68, P1439, DOI 10.1016/j.socscimed.2009.02.003; Djikanovic B, 2011, J PUBLIC HEALTH-UK, V33, P31, DOI 10.1093/pubmed/fdq080; Djikanovic B, 2013, PUBLIC HEALTH, V127, P521, DOI 10.1016/j.puhe.2012.12.029; EUROSTAT, 2013, EUR UN STAT INC LIV; Farrelly MC, 2012, AM J PREV MED, V43, P475, DOI 10.1016/j.amepre.2012.07.023; Federico B, 2009, TOB CONTROL, V18, P393, DOI 10.1136/tc.2008.029280; Federico B, 2007, AM J PUBLIC HEALTH, V97, P838, DOI 10.2105/AJPH.2005.067082; Fondation Cancer, 2012, HAB TAB LUX 2011, P33; Fukuda Y, 2005, ANN EPIDEMIOL, V15, P365, DOI 10.1016/j.annepidem.2004.09.003; Giskes K, 2005, J EPIDEMIOL COMMUN H, V59, P395, DOI 10.1136/jech.2004.025684; Hiscock R, 2011, J PUBLIC HEALTH-UK, V33, P39, DOI 10.1093/pubmed/fdq097; Huisman M, 2005, TOB CONTROL, V14, P106, DOI 10.1136/tc.2004.008573; Irish Tobacco Manufacturers' Advisory Committee (ITMAC), 2014, EUR PRIC COMP 2014; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Kahende JW, 2011, INT J ENV RES PUB HE, V8, P3871, DOI 10.3390/ijerph8103871; Kaleta D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675496; Kaleta D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1020; Klumbiene J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1525-8; Kotz D, 2009, TOB CONTROL, V18, P43, DOI 10.1136/tc.2008.025981; Lawlor DA, 2003, AM J PUBLIC HEALTH, V93, P266, DOI 10.2105/AJPH.93.2.266; Lee CW, 2007, AM J PUBLIC HEALTH, V97, P1503, DOI 10.2105/AJPH.2005.083527; Mackenbach JP, 2007, EC IMPLICATIONS SOCI, P166; Marti J, 2010, INT J ENV RES PUB HE, V7, P2789, DOI 10.3390/ijerph7072789; Nagelhout GE, 2013, HEALTH EDUC RES, V28, P83, DOI 10.1093/her/cys101; Nagelhout GE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-303; Nonnemaker JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102943; Pampel FC, 2009, SOC PROBL, V56, P526, DOI 10.1525/sp.2009.56.3.526; Pearcy JN, 2002, PUBLIC HEALTH REP, V117, P273, DOI 10.1016/S0033-3549(04)50161-9; Perez-Rios M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128305; Pieroni L, 2013, HEALTH POLICY, V111, P116, DOI 10.1016/j.healthpol.2013.04.001; Platt S, 2002, REDUCING INEQUALITIE, P125; Regidor E, 2001, PREV MED, V33, P241, DOI 10.1006/pmed.2001.0872; Reid JL, 2010, NICOTINE TOB RES, V12, pS20, DOI 10.1093/ntr/ntq051; Reid JL, 2010, CAN J PUBLIC HEALTH, V101, P73, DOI 10.1007/BF03405567; Schaap MM, 2008, TOB CONTROL, V17, P248, DOI 10.1136/tc.2007.024265; Semyonov L, 2012, SCI WORLD J, DOI 10.1100/2012/286472; Shaw M, 2007, HDB INEQUALITY SOCIO, P238; Siahpush M, 2006, J EPIDEMIOL COMMUN H, V60, P1077, DOI 10.1136/jech.2005.042572; UNESCO, 1997, INT STAND CLASS ED I, P1; [No title captured]	46	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153966	10.1371/journal.pone.0153966	http://dx.doi.org/10.1371/journal.pone.0153966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100293	gold, Green Submitted, Green Published			2022-12-27	WOS:000374898500112
J	Zhao, ZC; Liu, GB; Li, XY; Huang, J; Xiao, YJ; Du, XY; Yu, M				Zhao, Zhichao; Liu, Guangbin; Li, Xinyun; Huang, Ji; Xiao, Yujing; Du, Xiaoyong; Yu, Mei			Characterization of the Promoter Regions of Two Sheep Keratin-Associated Protein Genes for Hair Cortex-Specific Expression	PLOS ONE			English	Article							HIGH GLYCINE-TYROSINE; TRANSGENIC MICE; KAP GENES; WOOL; FOLLICLE; DOMAIN; ACTIVATION; BINDING; FAMILY; CELLS	The keratin-associated proteins (KAPs) are the structural proteins of hair fibers and are thought to play an important role in determining the physical properties of hair fibers. These proteins are activated in a striking sequential and spatial pattern in the keratinocytes of hair fibers. Thus, it is important to elucidate the mechanism that underlies the specific transcriptional activity of these genes. In this study, sheep KRTAP 3-3 and KRTAP11-1 genes were found to be highly expressed in wool follicles in a tissue-specific manner. Subsequently, the promoter regions of the two genes that contained the 5' flanking/5' untranslated regions and the coding regions were cloned. Using an in vivo transgenic approach, we found that the promoter regions from the two genes exhibited transcriptional activity in hair fibers. A much stronger and more uniformly expressed green fluorescent signal was observed in the KRTAP11-1-ZsGreen1 transgenic mice. In situ hybridization revealed the symmetrical expression of sheep KRTAP11-1 in the entire wool cortex. Consistently, immunohistochemical analysis demonstrated that the pattern of ZsGreen1 expression in the hair cortex of transgenic mice matches that of the endogenous KRTAP11-1 gene, indicating that the cloned promoter region contains elements that are sufficient to govern the wool cortex-specific transcription of KRTAP11-1. Furthermore, regulatory regions in the 50 upstream sequence of the sheep KRTAP11-1 gene that may regulate the observed hair keratinocyte specificity were identified using in vivo reporter assays.	[Zhao, Zhichao; Liu, Guangbin; Li, Xinyun; Huang, Ji; Xiao, Yujing; Yu, Mei] Huazhong Agr Univ, Coll Anim Sci & Technol, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan 430070, Peoples R China; [Du, Xiaoyong] Huazhong Agr Univ, Coll Informat, Wuhan 430070, Peoples R China; [Liu, Guangbin] South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; South China Agricultural University	Yu, M (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Technol, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan 430070, Peoples R China.	yumei@mail.hzau.edu.cn			National High Technology Research and Development Program ("863" Program) of China [2013AA102506]; National Nature Scientific Foundation of China [31402040]; National Program of Transgenic Variety Development of China [2011ZX08009-004]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Program of Transgenic Variety Development of China	This work was supported by grants from the National High Technology Research and Development Program ("863" Program) of China (2013AA102506), the National Nature Scientific Foundation of China (No. 31402040), and the National Program of Transgenic Variety Development of China (2011ZX08009-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson DL, 2004, GENOMICS, V83, P95, DOI 10.1016/S0888-7543(03)00210-6; Auerbach AB, 2004, ACTA BIOCHIM POL, V51, P9; BYRNE C, 1993, MOL CELL BIOL, V13, P3176, DOI 10.1128/MCB.13.6.3176; Cheng LL, 2010, J BIOL CHEM, V285, P5836, DOI 10.1074/jbc.M109.072124; Dunn SM, 1998, J CELL SCI, V111, P3487; FRENKEL MJ, 1989, GENOMICS, V4, P182, DOI 10.1016/0888-7543(89)90298-X; Fujimoto S, 2014, J DERMATOL SCI, V74, P39, DOI 10.1016/j.jdermsci.2013.12.006; FURTH PA, 1991, NUCLEIC ACIDS RES, V19, P6205, DOI 10.1093/nar/19.22.6205; Gilon M, 2008, DIFFERENTIATION, V76, P518, DOI 10.1111/j.1432-0436.2007.00246.x; Gong H, 2011, MOL BIOL REP, V38, P5429, DOI 10.1007/s11033-011-0697-2; Hong LJ, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114181; KEOUGH R, 1995, J CELL SCI, V108, P957; Khan I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-779; Lanzini J, 2015, BIOCHIMIE, V118, P234, DOI 10.1016/j.biochi.2015.09.029; Lee D, 1999, DEV BIOL, V208, P362, DOI 10.1006/dbio.1999.9221; Liu GB, 2015, INT J MOL SCI, V16, P9152, DOI 10.3390/ijms16059152; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma SH, 1997, GENE EXPRESSION, V6, P361; Marh J, 2012, P NATL ACAD SCI USA, V109, P19184, DOI 10.1073/pnas.1216473109; Matsunaga R, 2013, J STRUCT BIOL, V183, P484, DOI 10.1016/j.jsb.2013.06.005; McLaren RJ, 1997, MAMM GENOME, V8, P938, DOI 10.1007/s003359900616; MCNAB AR, 1990, P NATL ACAD SCI USA, V87, P6848, DOI 10.1073/pnas.87.17.6848; Murakami S, 2014, TOXICOL SCI, V138, P47, DOI 10.1093/toxsci/kft273; NELSON WG, 1983, J CELL BIOL, V97, P244, DOI 10.1083/jcb.97.1.244; Plowman JE, 2007, EXP DERMATOL, V16, P707, DOI 10.1111/j.1600-0625.2007.00576.x; Plowman JE, 2009, J AGR FOOD CHEM, V57, P2174, DOI 10.1021/jf803290h; Potter CS, 2011, J INVEST DERMATOL, V131, P828, DOI 10.1038/jid.2010.391; Powell B C, 1997, EXS, V78, P59; POWELL BC, 1991, ANN NY ACAD SCI, V642, P1; Rogers MA, 2005, J INVEST DERMATOL, V124, pVII, DOI 10.1111/j.0022-202X.2005.23728.x; Rogers MA, 2002, J BIOL CHEM, V277, P48993, DOI 10.1074/jbc.M206422200; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; Schlake T, 2000, DEV DYNAM, V217, P368, DOI 10.1002/(SICI)1097-0177(200004)217:4<368::AID-DVDY4>3.0.CO;2-Z; Shimomura Y, 2005, J INVEST DERM SYMP P, V10, P230, DOI 10.1111/j.1087-0024.2005.10112.x; Sinha S, 2000, MOL CELL BIOL, V20, P2543, DOI 10.1128/MCB.20.7.2543-2555.2000; Sugihara TM, 2001, J BIOL CHEM, V276, P33036, DOI 10.1074/jbc.M103000200; Yang Z, 2014, MOL BIOL REP, V41, P6089, DOI 10.1007/s11033-014-3485-y; Yu ZD, 2011, EXP DERMATOL, V20, P582, DOI 10.1111/j.1600-0625.2011.01274.x	38	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153936	10.1371/journal.pone.0153936	http://dx.doi.org/10.1371/journal.pone.0153936			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100288	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500100
J	Torner, N; Martinez, A; Broner, S; Moreno, A; Camps, N; Dominguez, A				Torner, Nuria; Martinez, Ana; Broner, Sonia; Moreno, Antonio; Camps, Neus; Dominguez, Angela		Working Grp Study Acute Viral	Epidemiology of Acute Gastroenteritis Outbreaks Caused by Human Calicivirus (Norovirus and Sapovirus) in Catalonia: A Two Year Prospective Study, 2010-2011	PLOS ONE			English	Article							EXCESS MORTALITY; RISK-FACTORS; DIVERSITY; EMERGENCE; INFECTION; VARIANTS; PROGRESS; PATTERN; ILLNESS; SPAIN	Background The epidemiology of cases of acute gastroenteritis (AGE) of viral etiology is a relevant public health issue. Due to underreporting, the study of outbreaks is an accepted approach to investigate their epidemiology. The objective of this study was to investigate the epidemiological characteristics of AGE outbreaks due to norovirus (NoV) and sapovirus (SV) in Catalonia. Material and Methods Prospective study of AGE outbreaks of possible viral etiology notified during two years in Catalonia. NoV and SV were detected by real time reverse transcription polymerase (RTPCR). Results A total of 101 outbreaks were registered affecting a total of 2756 persons and 12 hospitalizations (hospitalization rate: 0.8x1,000,000 persons-year); 49.5% of outbreaks were foodborne, 45.5% person to person and 5% waterborne. The distribution of outbreaks according to the setting showed a predominance of catering services (39.6%), nursing homes and long term care facilities (26.8%) and schools (11.9%). The median number of cases per outbreak was 17 (range 2-191). The total Incidence rate (IR) was 18.3 per 100,000 personsyears (95% CI: 17.6-19.0). The highest IR was in persons aged >= 65 years (43.6x100,000 (95% CI: 41.0-46.2)) (p<0.001). A total of 1065 samples were analyzed with a positivity rate of 60.8%. 98% of positive samples were NoV (GII 56.3%; GI 4.2%; GII+GI 4.2%; non-typable 33.0%). SV was identified in two person-to-person transmission outbreaks in children. Conclusions These results confirm the relevance of viral AGE outbreaks, both foodborne and person-to-person, especially in institutionalized persons. SV should be taken into account when investigating viral AGE outbreaks.	[Torner, Nuria; Martinez, Ana; Camps, Neus] Publ Hlth Agcy Catalonia, Barcelona, Spain; [Torner, Nuria; Martinez, Ana; Broner, Sonia; Dominguez, Angela] Carlos III Hlth Inst, CIBERESP, CIBER Epidemiol & Salud Publ, Madrid, Spain; [Torner, Nuria; Dominguez, Angela] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain; [Moreno, Antonio] Publ Hlth Agcy Barcelona, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Public Health Agency of Barcelona	Torner, N (corresponding author), Publ Hlth Agcy Catalonia, Barcelona, Spain.; Torner, N (corresponding author), Carlos III Hlth Inst, CIBERESP, CIBER Epidemiol & Salud Publ, Madrid, Spain.; Torner, N (corresponding author), Univ Barcelona, Dept Publ Hlth, Barcelona, Spain.	nuria.torner@gencat.cat	, Nuria/AAG-8951-2019	, Nuria/0000-0003-0143-5295	Catalan Agency for the Management of Grants for University Research (AGAUR) [2014/SGR 43]; Instituto de Salud Carlos III [FIS PS0902516]	Catalan Agency for the Management of Grants for University Research (AGAUR); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Support was provided by the Catalan Agency for the Management of Grants for University Research (AGAUR grant number 2014/SGR 43) (recipients: Angela Dominguez, Nuria Torner) and Instituto de Salud Carlos III (FIS PS0902516) (recipient: Angela Dominguez).	Ahmed Sharia M, 2013, PLoS One, V8, pe75922, DOI 10.1371/journal.pone.0075922; [Anonymous], 2012, REP COMM INF DIS INT; Atmar RL, 2010, FOOD ENVIRON VIROL, V2, P117, DOI 10.1007/s12560-010-9038-1; Bruggink L, 2011, J MICROBIOL IMMUNOL, V44, P241, DOI 10.1016/j.jmii.2010.08.001; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; Dey SK, 2012, EPIDEMIOL INFECT, V140, P74, DOI 10.1017/S0950268811000240; Dominguez A, 2008, J CLIN VIROL, V43, P126, DOI 10.1016/j.jcv.2008.03.016; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Esposito S, 2014, EUR J CLIN MICROBIOL, V33, P285, DOI 10.1007/s10096-013-1967-9; Fernandez J, 2011, AGING CLIN EXP RES, V23, P145, DOI 10.3275/7040; Fioretti JM, 2011, MEM I OSWALDO CRUZ, V106, P942, DOI 10.1590/S0074-02762011000800008; Franck KT, 2015, J INFECT DIS, V211, P563, DOI 10.1093/infdis/jiu479; Godoy P, 2015, EPIDEMIOL INFECT, V143, P725, DOI 10.1017/S0950268814001204; Gonzalez-Galan V, 2011, CLIN MICROBIOL INFEC, V17, P1895, DOI 10.1111/j.1469-0691.2011.03506.x; Green KY, 2006, FIELDS VIROLOGY, P949; Gustavsson L, 2011, J HOSP INFECT, V79, P27, DOI 10.1016/j.jhin.2011.05.018; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Huhti L, 2011, J INFECT DIS, V203, P1442, DOI 10.1093/infdis/jir039; Jones S, 2011, BRIT J BIOMED SCI, V68, P116; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; KAPLAN JE, 1982, AM J PUBLIC HEALTH, V72, P1329, DOI 10.2105/AJPH.72.12.1329; Koopmans M, 2008, CURR OPIN INFECT DIS, V21, P544, DOI 10.1097/QCO.0b013e3283108965; Lee LE, 2012, EMERG INFECT DIS, V18, P873, DOI 10.3201/eid1805.111843; Li JR, 2012, ANNU REV FOOD SCI T, V3, P331, DOI 10.1146/annurev-food-022811-101234; Matthews JE, 2012, EPIDEMIOL INFECT, V140, P1161, DOI 10.1017/S0950268812000234; Medici MC, 2012, J MED VIROL, V84, P643, DOI 10.1002/jmv.23231; Naito M, 2014, J EPIDEMIOL, V24, P435, DOI 10.2188/jea.JE20140182; NAKATA S, 1983, J CLIN MICROBIOL, V17, P198, DOI 10.1128/JCM.17.2.198-201.1983; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Perez-Sautu U, 2012, ENVIRON MICROBIOL, V14, P494, DOI 10.1111/j.1462-2920.2011.02642.x; Phillips G, 2011, EPIDEMIOL INFECT, V139, P1676, DOI 10.1017/S0950268810002839; Repp KK, 2012, J INFECT DIS, V205, P1639, DOI 10.1093/infdis/jis250; Rohayem J, 2009, CLIN MICROBIOL INFEC, V15, P524, DOI 10.1111/j.1469-0691.2009.02846.x; Rondy M, 2011, EPIDEMIOL INFECT, V139, P453, DOI 10.1017/S0950268810000993; Sala MR, 2014, CLIN MICROBIOL INFEC, V20, P793, DOI 10.1111/1469-0691.12522; Sano D, 2011, APPL ENVIRON MICROB, V77, P1111, DOI 10.1128/AEM.01721-10; Scaioli G, 2013, EUR J PUBLIC HLTH S1, V23; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Surveillance for foodborne disease outbreaks-United States, 2008, MMWR MORB MORTAL WKL, V60, P1197; Svraka S, 2010, J CLIN MICROBIOL, V48, P2191, DOI 10.1128/JCM.02427-09; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Ueki Y, 2010, MICROBIOL IMMUNOL, V54, P483, DOI 10.1111/j.1348-0421.2010.00239.x; Verhoef L, 2008, EMERG INFECT DIS, V14, P238, DOI 10.3201/eid1402.061567	44	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152503	10.1371/journal.pone.0152503	http://dx.doi.org/10.1371/journal.pone.0152503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120472	Green Submitted, gold, Green Published			2022-12-27	WOS:000374976200009
J	Fadel, F; Zhao, YG; Cousido-Siah, A; Ruiz, FX; Mitschler, A; Podjarny, A				Fadel, Firas; Zhao, Yuguang; Cousido-Siah, Alexandra; Ruiz, Francesc X.; Mitschler, Andre; Podjarny, Alberto			X-Ray Crystal Structure of the Full Length Human Chitotriosidase (CHIT1) Reveals Features of Its Chitin Binding Domain	PLOS ONE			English	Article							BACILLUS-CIRCULANS WL-12; MORITELLA-MARINA; PROTEINS; RESIDUES; MODULE; FAMILY; IDENTIFICATION; INFLAMMATION; DEGRADATION; SPECIFICITY	Chitinases are enzymes that catalyze the hydrolysis of chitin. Human chitotriosidase (CHIT1) is one of the two active human chitinases, involved in the innate immune response and highly expressed in a variety of diseases. CHIT1 is composed of a catalytic domain linked by a hinge to its chitin binding domain (ChBD). This latter domain belongs to the carbohydrate-binding module family 14 (CBM14 family) and facilitates binding to chitin. So far, the available crystal structures of the human chitinase CHIT1 and the Acidic Mammalian Chitinase (AMCase) comprise only their catalytic domain. Here, we report a crystallization strategy combining cross-seeding and micro-seeding cycles which allowed us to obtain the first crystal structure of the full length CHIT1 (CHIT1-FL) at 1.95 angstrom resolution. The CHIT1 chitin binding domain (ChBD(CHIT1)) structure shows a distorted beta-sandwich 3D fold, typical of CBM14 family members. Accordingly, ChBD(CHIT1) presents six conserved cysteine residues forming three disulfide bridges and several exposed aromatic residues that probably are involved in chitin binding, including the highly conserved Trp465 in a surface-exposed conformation. Furthermore, ChBD(CHIT1) presents a positively charged surface which may be involved in electrostatic interactions. Our data highlight the strong structural conservation of CBM14 family members and uncover the structural similarity between the human ChBD(CHIT1), tachycitin and house mite dust allergens. Overall, our new CHIT1-FL structure, determined with an adapted crystallization approach, is one of the few complete bi-modular chitinase structures available and reveals the structural features of a human CBM14 domain.	[Fadel, Firas; Cousido-Siah, Alexandra; Ruiz, Francesc X.; Mitschler, Andre; Podjarny, Alberto] Univ Strasbourg, Inst Genet & Mol & Cellular Biol IGBMC, Dept Integrat Biol, CNRS,UMR 7104,INSERM,U964, Illkirch Graffenstaden, France; [Zhao, Yuguang] Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genom Med, Oxford, England; [Fadel, Firas] Aix Marseille Univ, Lab Ingn Syst Macromol, UMR7255, CNRS, Case 932, Marseille, France; [Fadel, Firas] Aix Marseille Univ, Architecture & Fonct Macromol Biol, UMR7257, CNRS, Case 932, Marseille, France; [Ruiz, Francesc X.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Rutgers State University New Brunswick	Fadel, F; Podjarny, A (corresponding author), Univ Strasbourg, Inst Genet & Mol & Cellular Biol IGBMC, Dept Integrat Biol, CNRS,UMR 7104,INSERM,U964, Illkirch Graffenstaden, France.; Fadel, F (corresponding author), Aix Marseille Univ, Lab Ingn Syst Macromol, UMR7255, CNRS, Case 932, Marseille, France.; Fadel, F (corresponding author), Aix Marseille Univ, Architecture & Fonct Macromol Biol, UMR7257, CNRS, Case 932, Marseille, France.	firasfadel1@gmail.com; podjarny@igbmc.fr	Ruiz, Francesc Xavier/AAA-1324-2020	Ruiz, Francesc Xavier/0000-0002-0457-0030; Podjarny, Alberto/0000-0002-7685-1077; Cousido-Siah, Alexandra/0000-0002-3051-1560	CNRS; INSERM; Universite de Strasbourg; Biostruct-X (FP7) [283570]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg; Biostruct-X (FP7); French Infrastructure for Integrated Structural Biology (FRISBI)	This work has been supported by the CNRS, the INSERM, the Universite de Strasbourg. The authors wish to acknowledge the following grant funding: Biostruct-X (FP7, contract 283570, http://www.biostruct-x.eu/), and the French Infrastructure for Integrated Structural Biology (FRISBI, ANR-10-INSB-05-01, http://frisbi.eu/).	Abbott DW, 2014, CURR OPIN STRUC BIOL, V28, P32, DOI 10.1016/j.sbi.2014.07.004; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akagi K, 2006, J BIOCHEM, V139, P483, DOI 10.1093/jb/mvj062; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSEN NH, 1993, BIOCHEMISTRY-US, V32, P1407, DOI 10.1021/bi00057a004; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Asensio JL, 2000, CHEM BIOL, V7, P529, DOI 10.1016/S1074-5521(00)00136-8; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bianchetti CM, 2013, J MOL BIOL, V425, P4267, DOI 10.1016/j.jmb.2013.05.030; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brunner F, 1998, PLANT J, V14, P225, DOI 10.1046/j.1365-313X.1998.00116.x; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Di Rosa M, 2014, BONE, V61, P55, DOI 10.1016/j.bone.2014.01.005; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fadel F, 2015, ACTA CRYSTALLOGR D, V71, P1455, DOI 10.1107/S139900471500783X; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gordon-Thomson C, 2009, CELL MOL LIFE SCI, V66, P1116, DOI 10.1007/s00018-009-8765-7; Hashimoto M, 2000, J BACTERIOL, V182, P3045, DOI 10.1128/JB.182.11.3045-3054.2000; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Ikegami T, 2000, J BIOL CHEM, V275, P13654, DOI 10.1074/jbc.275.18.13654; Jee JG, 2002, J BIOL CHEM, V277, P1388, DOI 10.1074/jbc.M109726200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanneganti Manasa, 2012, J Epithel Biol Pharmacol, V5, P1; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kzhyshkowska J, 2007, BIOMARK INSIGHTS, V2, P128; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen T, 2014, FEBS LETT, V588, P746, DOI 10.1016/j.febslet.2013.12.035; Lee CG, 2009, YONSEI MED J, V50, P22, DOI 10.3349/ymj.2009.50.1.22; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Malaguarnera L, 2006, CELL MOL LIFE SCI, V63, P3018, DOI 10.1007/s00018-006-6269-2; Malecki PH, 2014, ACTA CRYSTALLOGR D, V70, P676, DOI 10.1107/S1399004713032264; Malecki PH, 2013, ACTA CRYSTALLOGR D, V69, P821, DOI 10.1107/S0907444913002011; Marshall KC, 1990, ADV MICROB ECOL, P387, DOI DOI 10.1007/978-1-4684-7612-5_10; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller GA, 2015, CLIN EXPT ALLERGY; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Ohno T, 1996, J BACTERIOL, V178, P5065, DOI 10.1128/jb.178.17.5065-5070.1996; Olland AM, 2009, PROTEIN SCI, V18, P569, DOI 10.1002/pro.63; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Renkema GH, 1997, EUR J BIOCHEM, V244, P279, DOI 10.1111/j.1432-1033.1997.00279.x; Stewart PDS, 2011, CRYST GROWTH DES, V11, P3432, DOI 10.1021/cg2001442; Stockinger LW, 2015, BBA-PROTEINS PROTEOM, V1854, P1494, DOI 10.1016/j.bbapap.2015.06.008; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; Suzuki K, 1999, BIOCHEM J, V343, P587, DOI 10.1042/0264-6021:3430587; Tjoelker LW, 2000, J BIOL CHEM, V275, P514, DOI 10.1074/jbc.275.1.514; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; van den Burg HA, 2004, J BIOL CHEM, V279, P16786, DOI 10.1074/jbc.M312594200; Vandevenne M, 2011, PROTEIN SCI, V20, P1451, DOI 10.1002/pro.676; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994	63	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154190	10.1371/journal.pone.0154190	http://dx.doi.org/10.1371/journal.pone.0154190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111557	Green Published, Green Submitted, gold			2022-12-27	WOS:000374970600045
J	Gottschick, C; Szafranski, SP; Kunze, B; Sztajer, H; Masur, C; Abels, C; Wagner-Dobler, I				Gottschick, Cornelia; Szafranski, Szymon P.; Kunze, Brigitte; Sztajer, Helena; Masur, Clarissa; Abels, Christoph; Wagner-Doebler, Irene			Screening of Compounds against Gardnerella vaginalis Biofilms	PLOS ONE			English	Article							BACTERIAL-VAGINOSIS; IN-VITRO; TRACT INFECTIONS; MICROBIOME; PREVALENCE; RECURRENCE; SUGGESTS; THERAPY; WOMEN; MODEL	Bacterial vaginosis (BV) is a common infection in reproductive age woman and is characterized by dysbiosis of the healthy vaginal flora which is dominated by Lactobacilli, followed by growth of bacteria like Gardnerella vaginalis. The ability of G. vaginalis to form biofilms contributes to the high rates of recurrence that are typical for BV and which unfortunately make repeated antibiotic therapy inevitable. Here we developed a biofilm model for G. vaginalis and screened a large spectrum of compounds for their ability to prevent biofilm formation and to resolve an existing G. vaginalis biofilm. The antibiotics metronidazole and tobramycin were highly effective in preventing biofilm formation, but had no effect on an established biofilm. The application of the amphoteric tenside sodium cocoamphoacetate (SCAA) led to disintegration of existing biofilms, reducing biomass by 51% and viability by 61% and it was able to increase the effect of metronidazole by 40% (biomass) and 61% (viability). Our data show that attacking the biofilm and the bacterial cells by the combination of an amphoteric tenside with the antibiotic metronidazole might be a useful strategy against BV.	[Gottschick, Cornelia; Szafranski, Szymon P.; Kunze, Brigitte; Sztajer, Helena; Wagner-Doebler, Irene] Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Masur, Clarissa; Abels, Christoph] Dr August Wolff GmbH & Co KG Arzneimittel, Sudbrackstr 56, D-33611 Bielefeld, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Gottschick, C (corresponding author), Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany.	Cornelia.Gottschick@helmholtz-hzi.de	Abels, Christoph/GYU-0286-2022; Wagner-Döbler, Irene/Y-1685-2019	Wagner-Dobler, Irene/0000-0001-5883-2502; Szafranski, Szymon/0000-0002-0607-6976	Bundesministerium fur Wirtschaft und Energie (BMWi), Germany [KF3134201MD3]	Bundesministerium fur Wirtschaft und Energie (BMWi), Germany	Authors CA and CM are employed by the commercial company Dr. August Wolff GmbH & Co. KG Arzneimittel. The research, however, was not funded by this company, but instead a grant was applied for by IWD and CA at the Bundesministerium fur Wirtschaft und Energie (BMWi), Germany. Grant number: KF3134201MD3. http://www.zim-bmwi.de/. Therefore the funders (BMWi) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors	Abdelwahab NS, 2015, J CHROMATOGR SCI; Algburi A, 2015, PATHOG DIS      0402; Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Ansorg R, 2003, ARZNEIMITTELFORSCH, V53, P368; Bradshaw CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057688; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Braga PC, 2010, ARZNEIMITTELFORSCH, V60, P675, DOI 10.1055/s-0031-1296346; BURGER RM, 1994, ANTIMICROB AGENTS CH, V38, P886, DOI 10.1128/AAC.38.4.886; Castro J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11640; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Coelho T, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.00330, 10.3389/fmicb.2015.01528]; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Goossens A, 2006, CONTACT DERMATITIS, V55, P302, DOI 10.1111/j.1600-0536.2006.00933.x; Gupta P., 2015, ARCH MICROBIOL; Hardy L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136658; Hooven TA, 2012, J ANTIMICROB CHEMOTH, V67, P2870, DOI 10.1093/jac/dks305; Hymes SR, 2013, J INFECT DIS, V207, P1491, DOI 10.1093/infdis/jit047; Kenyon CR, 2014, CURR OPIN OBSTET GYN, V26, P448, DOI 10.1097/GCO.0000000000000112; Kumon H, 2001, INT J ANTIMICROB AG, V17, P311, DOI 10.1016/S0924-8579(00)00360-5; Machado A, 2015, J INFECT DIS; Machado D, 2015, J MICROBIOL METH, V118, P143, DOI 10.1016/j.mimet.2015.09.007; Malanovic N, 2015, BBA-BIOMEMBRANES, V1848, P2437, DOI 10.1016/j.bbamem.2015.07.010; Mankodi S, 2005, AM J DENT, V18; Mastromarino P, 2013, NEW MICROBIOL, V36, P229; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; MCKENZIE HA, 1991, ADV PROTEIN CHEM, V41, P173; McMillan A, 2011, COLLOID SURFACE B, V86, P58, DOI 10.1016/j.colsurfb.2011.03.016; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; Muzny CA, 2015, CLIN INFECT DIS, V61, P601, DOI 10.1093/cid/civ353; Nunn KL, 2015, MBIO, V6, DOI 10.1128/mBio.01084-15; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Palmeira-de-Oliveira R, 2015, ADV DRUG DELIVER REV, V92, P105, DOI 10.1016/j.addr.2015.06.008; Parasion S, 2014, POL J MICROBIOL, V63, P137; Patrone V, 2010, CURR MICROBIOL, V60, P237, DOI 10.1007/s00284-009-9531-7; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; Price KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141192; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reichman O, 2009, SEX TRANSM DIS, V36, P732, DOI 10.1097/OLQ.0b013e3181b08456; Reid G, 2008, MICROBIAL ECOLOGY IN, V20; SHEINESS D, 1992, J CLIN MICROBIOL, V30, P642, DOI 10.1128/JCM.30.3.642-648.1992; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Strandberg KL, 2010, ANTIMICROB AGENTS CH, V54, P597, DOI 10.1128/AAC.01151-09; Stute P, 2015, CLIMACTERIC, V18, P582, DOI 10.3109/13697137.2015.1036854; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Swidsinski A, 2015, ARCH GYNECOL OBSTET, V291, P605, DOI 10.1007/s00404-014-3484-1; Swidsinski A, 2011, FEMS IMMUNOL MED MIC, V61, P41, DOI 10.1111/j.1574-695X.2010.00743.x; Twin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076892; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Wu H, 2015, INT J ORAL SCI, V7, P1, DOI 10.1038/ijos.2014.65	54	26	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154086	10.1371/journal.pone.0154086	http://dx.doi.org/10.1371/journal.pone.0154086			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111438	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600033
J	Kim, J; Ye, A				Kim, Joomyeong; Ye, An			Phylogenetic and Epigenetic Footprinting of the Putative Enhancers of the Peg3 Domain	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; IMPRINTED GENE; METHYLATION; SEQUENCES; REVEALS; PROTEIN; GROWTH; REGION	The Peg3 (Paternally Expressed Gene 3) imprinted domain is predicted to be regulated through a large number of evolutionarily conserved regions (ECRs) that are localized within its middle 200-kb region. In the current study, we characterized these potential cis-regulatory regions using phylogenetic and epigenetic approaches. According to the results, the majority of these ECRs are potential enhancers for the transcription of the Peg3 domain. Also, these potential enhancers can be divided into two groups based on their histone modification and DNA methylation patterns: ubiquitous and tissue-specific enhancers. Phylogenetic and bioinformatic analyses further revealed that several cis-regulatory motifs are frequently associated with the ECRs, such as the E box, PITX2, NF-kappa B and RFX1 motifs. A series of subsequent ChIP experiments demonstrated that the trans factor MYOD indeed binds to the E box of several ECRs, further suggesting that MYOD may play significant roles in the transcriptional control of the Peg3 domain. Overall, the current study identifies, for the first time, a set of cis-regulatory motifs and corresponding trans factors that may be critical for the transcriptional regulation of the Peg3 domain.	[Kim, Joomyeong; Ye, An] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu			National Institutes of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bretz CL, 2015, EPIGENETICS-US, V10, P1111, DOI 10.1080/15592294.2015.1110672; Broad KD, 2011, P NATL ACAD SCI USA, V108, P15237, DOI 10.1073/pnas.1106022108; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chen MY, 2011, CANCER-AM CANCER SOC, V117, P4424, DOI 10.1002/cncr.26073; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Flisikowski K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015116; Fong AP, 2013, CURR OPIN GENET DEV, V23, P568, DOI 10.1016/j.gde.2013.05.002; Frey WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144459; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; GUMUCIO DL, 1993, P NATL ACAD SCI USA, V90, P6018, DOI 10.1073/pnas.90.13.6018; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Ivanova E, 2011, J MOL ENDOCRINOL, V47, pR67, DOI 10.1530/JME-11-0065; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim J, 2000, GENOME RES, V10, P1138, DOI 10.1101/gr.10.8.1138; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv867; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee S, 2015, INT J NANOMED, V10, P3, DOI 10.2147/IJN.S91389; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Pannerec A, 2013, DEVELOPMENT, V140, P2879, DOI 10.1242/dev.089326; Perera BPU, 2016, ANAL BIOCHEM, V494, P82, DOI 10.1016/j.ab.2015.11.006; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Sen R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000257; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Suh H, 2002, DEVELOPMENT, V129, P329; Thiaville MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075417; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Waite MR, 2015, J NEUROSCI RES, V93, P195, DOI 10.1002/jnr.23471; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Ye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108596	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154216	10.1371/journal.pone.0154216	http://dx.doi.org/10.1371/journal.pone.0154216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104590	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100057
J	Shimizu, J; Kubota, T; Takada, E; Takai, K; Fujiwara, N; Arimitsu, N; Ueda, Y; Wakisaka, S; Suzuki, T; Suzuki, N				Shimizu, Jun; Kubota, Takao; Takada, Erika; Takai, Kenji; Fujiwara, Naruyoshi; Arimitsu, Nagisa; Ueda, Yuji; Wakisaka, Sueshige; Suzuki, Tomoko; Suzuki, Noboru			Bifidobacteria Abundance-Featured Gut Microbiota Compositional Change in Patients with Behcet's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHAIN FATTY-ACIDS; T-CELLS; BACTERIA; INTERLEUKIN-17; IL23R-IL12RB2; COLCHICINE; DIVERSITY; GAMMA; IL10	Gutmicrobiota compositional alteration may have an association with immune dysfunction in patients with Behcet's disease (BD). We conducted a fecal metagenomic analysis of BD patients. We analyzed fecal microbiota obtained from 12 patients with BD and 12 normal individuals by sequencing of 16S ribosomal RNA gene. We compared the relative abundance of bacterial taxa. Direct comparison of the relative abundance of bacterial taxa demonstrated that the genera Bifidobacterium and Eggerthella increased significantly and the genera Megamonas and Prevotella decreased significantly in BD patients compared with normal individuals. A linear discriminant analysis of bacterial taxa showed that the phylum Actinobacteria, including Bifidobacterium, and the family Lactobacillaceae exhibited larger positive effect sizes than other bacteria in patients with BD. The phylum Firmicutes and the class Clostridia had large effect sizes in normal individuals. There was no significant difference in annotated species numbers (as numbers of operational taxonomic unit; OTU) and bacterial diversity of each sample (alpha diversity) between BD patients and normal individuals. We next assigned each sample to a position using three axes by principal coordinates analysis of the OTU table. The two groups had a significant distance as beta diversity in the 3-axis space. Fecal sIgA concentrations increased significantly in BD patients but did not correlate with any bacterial taxonomic abundance. These data suggest that the compositional changes of gut microbesmay be one type of dysbiosis (unfavorable microbiota alteration) in patients with BD. The dysbiosis may have an association with the pathophysiology of BD.	[Shimizu, Jun; Takada, Erika; Takai, Kenji; Fujiwara, Naruyoshi; Arimitsu, Nagisa; Ueda, Yuji; Wakisaka, Sueshige; Suzuki, Tomoko; Suzuki, Noboru] St Marianna Univ, Sch Med, Dept Immunol & Med, Kawasaki, Kanagawa, Japan; [Kubota, Takao] Japan Self Def Forces Cent Hosp, Dept Med, Tokyo, Japan	Saint Marianna University	Suzuki, N (corresponding author), St Marianna Univ, Sch Med, Dept Immunol & Med, Kawasaki, Kanagawa, Japan.	n3suzuki@marianna-u.ac.jp			Japan Society for the Promotion of Science [30509964]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research (Grant Number 30509964) of Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhakta BB, 1999, RHEUMATOLOGY, V38, P728, DOI 10.1093/rheumatology/38.8.728; Chi W, 2010, MOL VIS, V16, P880; Consolandi C, 2015, AUTOIMMUN REV, V14, P269, DOI 10.1016/j.autrev.2014.11.009; Cua DJ, 2011, NAT MED, V17, P1055, DOI 10.1038/nm0911-1055; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Franzosa EA, 2015, P NATL ACAD SCI USA, V112, pE2930, DOI 10.1073/pnas.1423854112; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Fung TC, 2014, IMMUNOL REV, V260, P35, DOI 10.1111/imr.12186; Geri G, 2011, J ALLERGY CLIN IMMUN, V128, P655, DOI 10.1016/j.jaci.2011.05.029; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Hamzaoui K, 2011, MED SCI MONITOR, V17, pCR227, DOI 10.12659/MSM.881720; Hamzaoui K, 2011, J NEUROIMMUNOL, V233, P249, DOI 10.1016/j.jneuroim.2011.01.012; Hatemi G, 2004, ANN RHEUM DIS, V63, P1450, DOI 10.1136/ard.2003.017467; Iacobuzio-Donahue CA, 2001, AM J SURG PATHOL, V25, P1067, DOI 10.1097/00000478-200108000-00012; International Study Group for Beh~et's Disease, 1990, LANCET, V335, P1078, DOI DOI 10.1016/0140-; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaneko S, 1997, CLIN EXP IMMUNOL, V108, P204, DOI 10.1046/j.1365-2249.1997.3611265.x; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Ktsoyan ZA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00002; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Marquet P, 2009, FEMS MICROBIOL LETT, V299, P128, DOI 10.1111/j.1574-6968.2009.01750.x; Miura T, 2005, ORAL MICROBIOL IMMUN, V20, P167, DOI 10.1111/j.1399-302X.2005.00207.x; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Morita H, 2007, MICROBES ENVIRON, V22, P214, DOI 10.1264/jsme2.22.214; Na SY, 2013, CLIN EXP RHEUMATOL, V31, pS32; Nanthakumar NN, 2013, GLYCOBIOLOGY, V23, P1131, DOI 10.1093/glycob/cwt050; Nara K, 2008, CLIN EXP IMMUNOL, V152, P245, DOI 10.1111/j.1365-2249.2008.03626.x; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Nielsen OH, 1999, AM J GASTROENTEROL, V94, P2923, DOI 10.1016/S0002-9270(99)00495-5; OHNO S, 1982, ARCH OPHTHALMOL-CHIC, V100, P1455; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Seoudi N, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.27150; Shimizu J, 2012, CLIN EXP IMMUNOL, V168, P68, DOI 10.1111/j.1365-2249.2011.04543.x; Shimizu J, 2016, CLIN RHEUMATOL, V35, P1857, DOI 10.1007/s10067-015-2966-2; Shimizu J, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/105205; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	48	62	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153746	10.1371/journal.pone.0153746	http://dx.doi.org/10.1371/journal.pone.0153746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105322	gold, Green Published, Green Submitted			2022-12-27	WOS:000374565100018
J	Yamagishi, J; Sato, Y; Shinozaki, N; Ye, B; Tsuboi, A; Nagasaki, M; Yamashita, R				Yamagishi, Junya; Sato, Yukuto; Shinozaki, Natsuko; Ye, Bin; Tsuboi, Akito; Nagasaki, Masao; Yamashita, Riu			Comparison of Boiling and Robotics Automation Method in DNA Extraction for Metagenomic Sequencing of Human Oral Microbes	PLOS ONE			English	Article							BACTERIAL; SOILS; BLAST; KITS	The rapid improvement of next-generation sequencing performance now enables us to analyze huge sample sets with more than ten thousand specimens. However, DNA extraction can still be a limiting step in such metagenomic approaches. In this study, we analyzed human oral microbes to compare the performance of three DNA extraction methods: PowerSoil (a method widely used in this field), QIAsymphony (a robotics method), and a simple boiling method. Dental plaque was initially collected from three volunteers in the pilot study and then expanded to 12 volunteers in the follow-up study. Bacterial flora was estimated by sequencing the V4 region of 16S rRNA following species-level profiling. Our results indicate that the efficiency of PowerSoil and QIAsymphony was comparable to the boiling method. Therefore, the boiling method may be a promising alternative because of its simplicity, cost effectiveness, and short handling time. Moreover, this method was reliable for estimating bacterial species and could be used in the future to examine the correlation between oral flora and health status. Despite this, differences in the efficiency of DNA extraction for various bacterial species were observed among the three methods. Based on these findings, there is no "gold standard" for DNA extraction. In future, we suggest that the DNA extraction method should be selected on a case-by-case basis considering the aims and specimens of the study.	[Yamagishi, Junya] Hokkaido Univ, Div Collaborat & Educ, Res Ctr Zoonosis Control, Kita Ku, North 20,West 10, Sapporo, Hokkaido 0010020, Japan; [Yamagishi, Junya] Hokkaido Univ, Global Stn Zoonosis Control, GI CoRE, Kita Ku, North 20,West 10, Sapporo, Hokkaido 0010020, Japan; [Yamagishi, Junya; Sato, Yukuto; Shinozaki, Natsuko; Ye, Bin; Nagasaki, Masao; Yamashita, Riu] Tohoku Univ, Dept Integrat Genom, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan; [Tsuboi, Akito] Tohoku Univ, Dept Community Med Supports, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan	Hokkaido University; Hokkaido University; Tohoku University; Tohoku University	Nagasaki, M; Yamashita, R (corresponding author), Tohoku Univ, Dept Integrat Genom, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan.	nagasaki@megabank.tohoku.ac.jp; ryamasi@megabank.tohoku.ac.jp		Nagasaki, Masao/0000-0002-4292-8785; Sato, Yukuto/0000-0001-5175-6316	MEXT Tohoku Medical Megabank Project; Center of Innovation Program from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science	MEXT Tohoku Medical Megabank Project; Center of Innovation Program from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by MEXT Tohoku Medical Megabank Project and was partially supported by the Center of Innovation Program from the Japan Science and Technology Agency (JST) and Grants-in-Aid from the Japan Society for the Promotion of Science to RY. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ariefdjohan MW, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-23; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carrigg C, 2007, APPL MICROBIOL BIOT, V77, P955, DOI 10.1007/s00253-007-1219-y; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Kholy K, 2015, TRENDS ENDOCRIN MET, V26, P315, DOI 10.1016/j.tem.2015.03.001; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Frostegard A, 1999, APPL ENVIRON MICROB, V65, P5409; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martin-Platero AM, 2010, ANAL BIOCHEM, V397, P253, DOI 10.1016/j.ab.2009.10.041; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Noble JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114959; Peng X, 2013, J MICROBIOL METH, V95, P455, DOI 10.1016/j.mimet.2013.07.015; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sato Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131607; Sato Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-664; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Team RC, 2014, R LANG ENV STAT COMP; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yeoh N, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0314-y; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865	31	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154389	10.1371/journal.pone.0154389	http://dx.doi.org/10.1371/journal.pone.0154389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104353	Green Published, gold			2022-12-27	WOS:000374565100074
J	Hwang, JP; Lim, I; Kong, CB; Jeon, DG; Byun, BH; Kim, BI; Choi, CW; Lim, SM				Hwang, Jae Pil; Lim, Ilhan; Kong, Chang-Bae; Jeon, Dae Geun; Byun, Byung Hyun; Kim, Byung Il; Choi, Chang Woon; Lim, Sang Moo			Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma	PLOS ONE			English	Article							FDG-PET; DIAGNOSTIC-ACCURACY; THERAPY RESPONSE; TUMORS; CANCER; FAMILY; BONE; CHEMOTHERAPY; RECURRENCE; SURVIVAL	Aim The aim of this retrospective study was to determine whether glucose metabolism assessed by using Fluorine-18 (F-18) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) provides prognostic information independent of established prognostic factors in patients with Ewing sarcoma. Methods We retrospectively reviewed the medical records of 34 patients (men, 19; women, 15; mean age, 14.5 +/- 9.7 years) with pathologically proven Ewing sarcoma. They had undergone F-18 FDG PET/CT as part of a pretreatment workup between September 2006 and April 2012. In this analysis, patients were classified by age, sex, initial location, size, and maximum standardized uptake value (SUVmax). The relationship between FDG uptake and survival was analyzed using the Kaplan-Meier method with the log-rank test and Cox's proportional hazards regression model. Results The median survival time for all 34 subjects was 999 days and the median SUV by using PET/CT was 5.8 (range, 2-18.1). Patients with a SUVmax <= 5.8 survived significantly longer than those with a SUVmax > 5.8 (median survival time, 1265 vs. 656 days; p = 0.002). Survival was also found to be significantly related to age (p = 0.024), size (p = 0.03), and initial tumor location (p = 0.036). Multivariate analysis revealed that a higher SUVmax (p = 0.003; confidence interval [CI], 3.63-508.26; hazard ratio [HR], 42.98), older age (p = 0.023; CI, 1.34-54.80; HR, 8.59), and higher stage (p = 0.03; CI, 1.21-43.95; HR, 7.3) were associated with worse overall survival. Conclusions SUVmax measured by pretreatment F-18-FDG PET/CT can predict overall survival in patients with Ewing sarcoma.	[Hwang, Jae Pil] Soonchunhyang Univ, Dept Nucl Med, Bucheon Hosp, Bucheon, South Korea; [Lim, Ilhan; Byun, Byung Hyun; Kim, Byung Il; Choi, Chang Woon; Lim, Sang Moo] Korea Inst Radiol & Med Sci, Dept Nucl Med, Seoul, South Korea; [Lim, Ilhan; Byun, Byung Hyun; Kim, Byung Il; Choi, Chang Woon; Lim, Sang Moo] Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea; [Kong, Chang-Bae; Jeon, Dae Geun] Korea Inst Radiol & Med Sci, Dept Orthoped Surg, Seoul, South Korea	Soonchunhyang University; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences	Lim, I (corresponding author), Korea Inst Radiol & Med Sci, Dept Nucl Med, Seoul, South Korea.; Lim, I (corresponding author), Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea.	ilhan@kcch.re.kr			NRF [2011-0030162]; Korea Institute of Radiological and Medical Sciences (KIRAMS); Ministry of Science, ICT and Future Planning, Republic of Korea [1711031799/50441-2016]	NRF; Korea Institute of Radiological and Medical Sciences (KIRAMS); Ministry of Science, ICT and Future Planning, Republic of Korea	This study was partially supported by a grant of the NRF (Grant No. 2011-0030162) and Korea Institute of Radiological and Medical Sciences (KIRAMS), funded by Ministry of Science, ICT and Future Planning, Republic of Korea (1711031799/50441-2016).	Andersen KF, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001142; Bestic JM, 2009, RADIOGRAPHICS, V29, P1487, DOI 10.1148/rg.295095024; Delbeke D, 2001, RADIOL CLIN N AM, V39, P883, DOI 10.1016/S0033-8389(05)70319-5; Eary JF, 2002, EUR J NUCL MED MOL I, V29, P1149, DOI 10.1007/s00259-002-0859-5; Esiashvili N, 2008, J PEDIAT HEMATOL ONC, V30, P425, DOI 10.1097/MPH.0b013e31816e22f3; Ferrari S, 2007, J PEDIAT HEMATOL ONC, V29, P364, DOI 10.1097/MPH.0b013e3180640d08; Franzius C, 2001, ANN ONCOL, V12, P479, DOI 10.1023/A:1011111322376; Furth C, 2006, PEDIATR BLOOD CANCER, V47, P607, DOI 10.1002/pbc.20662; Gaston LL, 2011, SKELETAL RADIOL, V40, P1007, DOI 10.1007/s00256-011-1096-4; Gupta K, 2011, CLIN NUCL MED, V36, P973, DOI 10.1097/RLU.0b013e31822f684b; Hawkins DE, 2010, PRINCIPLES PRACTICE, P987; Hawkins DS, 2005, J CLIN ONCOL, V23, P8828, DOI 10.1200/JCO.2005.01.7079; Hustinx R, 2002, SEMIN NUCL MED, V32, P35, DOI 10.1053/snuc.2002.29272; Lee J, 2010, CANCER-AM CANCER SOC, V116, P1964, DOI 10.1002/cncr.24937; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; McCarville MB, 2005, AM J ROENTGENOL, V184, P1293, DOI 10.2214/ajr.184.4.01841293; Newman EN, 2013, PEDIATR BLOOD CANCER, V60, P1113, DOI 10.1002/pbc.24406; Raciborska A, 2015, CLIN TRANSL ONCOL; Sharma P, 2013, EUR J NUCL MED MOL I, V40, P1036, DOI 10.1007/s00259-013-2388-9; Treglia G, 2012, SKELETAL RADIOL, V41, P249, DOI 10.1007/s00256-011-1298-9; van Maldegem AM, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-7; Wasilewski-Masker K, 2009, J NATL CANCER I, V101, P1709, DOI 10.1093/jnci/djp417	22	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153281	10.1371/journal.pone.0153281	http://dx.doi.org/10.1371/journal.pone.0153281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100297	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500028
J	Rahbar, S; Pan, W; Jonz, MG				Rahbar, Saman; Pan, Wen; Jonz, Michael G.			Purinergic and Cholinergic Drugs Mediate Hyperventilation in Zebrafish: Evidence from a Novel Chemical Screen	PLOS ONE			English	Article							PERIPHERAL ARTERIAL CHEMORECEPTORS; CAROTID-BODY CHEMORECEPTORS; HYPOXIC VENTILATORY RESPONSE; TROUT ONCORHYNCHUS-MYKISS; NEUROEPITHELIAL CELLS; RAINBOW-TROUT; DANIO-RERIO; OXYGEN CHEMORECEPTORS; GILL; FISH	A rapid test to identify drugs that affect autonomic responses to hypoxia holds therapeutic and ecologic value. The zebrafish (Danio rerio) is a convenient animal model for investigating peripheral O-2 chemoreceptors and respiratory reflexes in vertebrates; however, the neurotransmitters and receptors involved in this process are not adequately defined. The goals of the present study were to demonstrate purinergic and cholinergic control of the hyperventilatory response to hypoxia in zebrafish, and to develop a procedure for screening of neurochemicals that affect respiration. Zebrafish larvae were screened in multi-well plates for sensitivity to the cholinergic receptor agonist, nicotine, and antagonist, atropine; and to the purinergic receptor antagonists, suramin and A-317491. Nicotine increased ventilation frequency (f(V)) maximally at 100 mu M (EC50 = 24.5 mu M). Hypoxia elevated f(V) from 93.8 to 145.3 breaths min(-1). Atropine reduced the hypoxic response only at 100 mu M. Suramin and A-317491 maximally reduced f(V) at 50 mu M (EC50 = 30.4 and 10.8 mu M) and abolished the hyperventilatory response to hypoxia. Purinergic P2X3 receptors were identified in neurons and O-2-chemosensory neuroepithelial cells of the gills using immunohistochemistry and confocal microscopy. These studies suggest a role for purinergic and nicotinic receptors in O-2 sensing in fish and implicate ATP and acetylcholine in excitatory neurotransmission, as in the mammalian carotid body. We demonstrate a rapid approach for screening neuroactive chemicals in zebrafish with implications for respiratory medicine and carotid body disease in humans; as well as for preservation of aquatic ecosystems.	[Rahbar, Saman; Pan, Wen; Jonz, Michael G.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	University of Ottawa	Jonz, MG (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	mjonz@uottawa.ca			Natural Sciences and Engineering Research Council of Canada [342303]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (grant no. 342303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah SJ, 2015, PFLUG ARCH EUR J PHY, V467, P399, DOI 10.1007/s00424-014-1514-2; Brooks BW, 2003, CHEMOSPHERE, V52, P135, DOI 10.1016/S0045-6535(03)00103-6; Buckler KJ, 2007, RESP PHYSIOL NEUROBI, V157, P55, DOI 10.1016/j.resp.2007.02.013; Burleson ML, 2006, BRAIN RES, V1092, P100, DOI 10.1016/j.brainres.2006.03.085; BURLESON ML, 1995, RESP PHYSIOL, V100, P231, DOI 10.1016/0034-5687(95)91595-X; BURLESON ML, 1995, RESP PHYSIOL, V101, P289, DOI 10.1016/0034-5687(95)00029-D; DUNELERB S, 1982, J APPL PHYSIOL, V53, P1342, DOI 10.1152/jappl.1982.53.6.1342; Fu XW, 2001, AM J PHYSIOL-LUNG C, V281, pL931, DOI 10.1152/ajplung.2001.281.4.L931; Gao L, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00398; Gauda EB, 2007, RESP PHYSIOL NEUROBI, V157, P162, DOI 10.1016/j.resp.2007.02.016; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; He L, 2006, J APPL PHYSIOL, V100, P157, DOI 10.1152/japplphysiol.00859.2005; Iturriaga R, 2004, BRAIN RES REV, V47, P46, DOI 10.1016/j.brainresrev.2004.05.007; Jonz MG, 2005, J EXP BIOL, V208, P1537, DOI 10.1242/jeb.01564; Jonz MG, 2004, J PHYSIOL-LONDON, V560, P737, DOI 10.1113/jphysiol.2004.069294; Jonz MG, 2003, J COMP NEUROL, V461, P1, DOI 10.1002/cne.10680; Jonz MG, 2015, COMP BIOCHEM PHYS A, V186, P27, DOI 10.1016/j.cbpa.2014.09.002; Jonz MG, 2014, CRC MAR BIOL SER, P149; Kahlin J, 2014, EXP PHYSIOL, V99, P1089, DOI 10.1113/expphysiol.2014.078873; Kermorgant M, 2014, GEN COMP ENDOCR, V205, P176, DOI 10.1016/j.ygcen.2014.03.012; Kinnamon SC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00264; Kokel D, 2011, METHOD CELL BIOL, V105, P517, DOI 10.1016/B978-0-12-381320-6.00022-9; Kumar P, 2012, COMPR PHYSIOL, V2, P141, DOI 10.1002/cphy.c100069; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; Milsom WK, 2007, RESP PHYSIOL NEUROBI, V157, P4, DOI 10.1016/j.resp.2007.02.007; Milsom WK, 2012, RESP PHYSIOL NEUROBI, V184, P326, DOI 10.1016/j.resp.2012.07.013; Nurse CA, 2014, J PHYSIOL-LONDON, V592, P3419, DOI 10.1113/jphysiol.2013.269829; Nurse CA, 2013, SEMIN CELL DEV BIOL, V24, P22, DOI 10.1016/j.semcdb.2012.09.006; Nurse CA, 2010, EXP PHYSIOL, V95, P657, DOI 10.1113/expphysiol.2009.049312; Peers C, 2010, RESP PHYSIOL NEUROBI, V174, P292, DOI 10.1016/j.resp.2010.08.010; Perry SF, 2009, FISH PHYSIOL, V27, P193, DOI 10.1016/S1546-5098(08)00005-8; Porteus CS, 2014, J PHYSIOL-LONDON, V592, P3075, DOI 10.1113/jphysiol.2014.271098; Porteus CS, 2012, RESP PHYSIOL NEUROBI, V184, P316, DOI 10.1016/j.resp.2012.06.019; Porteus CS, 2015, J EXP BIOL IN PRESS; Regan KS, 2011, J EXP BIOL, V214, P2560, DOI 10.1242/jeb.056333; Rennekamp AJ, 2015, CURR OPIN CHEM BIOL, V24, P58, DOI 10.1016/j.cbpa.2014.10.025; Rombough P, 2002, J EXP BIOL, V205, P1787; Saltys HA, 2006, CELL TISSUE RES, V323, P1, DOI 10.1007/s00441-005-0048-5; Shakarchi K, 2013, J EXP BIOL, V216, P869, DOI 10.1242/jeb.079657; Tamplin OJ, 2012, WIRES DEV BIOL, V1, P459, DOI 10.1002/wdev.37; Turesson J, 2006, COMP BIOCHEM PHYS A, V143, P332, DOI 10.1016/j.cbpa.2005.12.008; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Zachar PC, 2012, ACTA HISTOCHEM, V114, P101, DOI 10.1016/j.acthis.2011.03.006; Zhang DP, 2012, PHYSIOL GENOMICS, V44, P1133, DOI 10.1152/physiolgenomics.00079.2012; Zhang L, 2011, J EXP BIOL, V214, P2678, DOI 10.1242/jeb.055541; Zhang L, 2009, RESP PHYSIOL NEUROBI, V168, P261, DOI 10.1016/j.resp.2009.07.011; Zhang M, 2000, J PHYSIOL-LONDON, V525, P143, DOI 10.1111/j.1469-7793.2000.t01-1-00143.x; Zhang M, 2000, BRAIN RES, V872, P199, DOI 10.1016/S0006-8993(00)02499-9; Zhang M, 2003, J PHYSIOL-LONDON, V551, P825, DOI 10.1113/jphysiol.2003.038489	53	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154261	10.1371/journal.pone.0154261	http://dx.doi.org/10.1371/journal.pone.0154261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100625	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500174
J	Urano-Tashiro, Y; Takahashi, Y; Oguchi, R; Konishi, K				Urano-Tashiro, Yumiko; Takahashi, Yukihiro; Oguchi, Riyo; Konishi, Kiyoshi			Two Arginine Residues of Streptococcus gordonii Sialic Acid-Binding Adhesin Hsa Are Essential for Interaction to Host Cell Receptors	PLOS ONE			English	Article							DL1; IDENTIFICATION; GLYCOPROTEIN; ACTINOMYCES; GSPB	Hsa is a large, serine-rich protein of Streptococcus gordonii DL1 that mediates binding to alpha 2-3-linked sialic acid termini of glycoproteins, including platelet glycoprotein Ib alpha, and erythrocyte membrane protein glycophorin A, and band 3. The binding of Hsa to platelet glycoprotein Ib alpha contributes to the pathogenesis of infective endocarditis. This interaction appears to be mediated by a second non-repetitive region (NR2) of Hsa. However, the molecular details of the interaction between the Hsa NR2 region and these glycoproteins are not well understood. In the present study, we identified the amino acid residues of the Hsa NR2 region that are involved in sialic acid recognition. To identify the sialic acid-binding site of Hsa NR2 region, we prepared various mutants of Hsa NR2 fused with glutathione transferase. Fusion proteins harboring Arg340 to Asn (R340N) or Arg365 to Asn (R365N) substitutions in the NR2 domain exhibited significantly reduced binding to human erythrocytes and platelets. A sugar-binding assay showed that these mutant proteins abolished binding to alpha 2-3-linked sialic acid. Furthermore, we established S. gordonii DL1 derivatives that encoded the corresponding Hsa mutant protein. In whole-cell assays, these mutant strains showed significant reductions in hemagglutination, in platelet aggregation, and in adhesion to human leukocytes. These results indicate that the Arg340 and Arg365 residues of Hsa play an important role in the binding of Hsa to alpha 2-3-linked sialic acid-containing glycoproteins.	[Urano-Tashiro, Yumiko; Takahashi, Yukihiro; Konishi, Kiyoshi] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Microbiol, Chiyoda Ku, Tokyo, Japan; [Oguchi, Riyo] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Pediat Dent, Chiyoda Ku, Tokyo, Japan	Nippon Dental University; Nippon Dental University	Urano-Tashiro, Y (corresponding author), Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Microbiol, Chiyoda Ku, Tokyo, Japan.	yumiurano@tky.ndu.ac.jp	Takahashi, Yukihiro/ABA-4333-2020; TASHIRO, Yumiko/AAV-2054-2020	Tashiro, Yumiko/0000-0002-8328-2634				BADDOUR LM, 1994, INFECT IMMUN, V62, P2143, DOI 10.1128/IAI.62.6.2143-2148.1994; BADDOUR LM, 1989, REV INFECT DIS, V11, P452; Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Deng LQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004540; DURACK DT, 1995, NEW ENGL J MED, V332, P38, DOI 10.1056/NEJM199501053320107; Herzberg MC, 1996, CRIT REV ORAL BIOL M, V7, P222, DOI 10.1177/10454411960070030201; Kerrigan SW, 2007, INFECT IMMUN, V75, P5740, DOI 10.1128/IAI.00909-07; Mitchell J, 2009, INFECT IMMUN, V77, P3485, DOI 10.1128/IAI.01573-08; NICE CfCPa, 2008, PROPH INF END ANT PR; PERRY D, 1983, INFECT IMMUN, V41, P722, DOI 10.1128/IAI.41.2.722-727.1983; Petersen HJ, 2010, INFECT IMMUN, V78, P413, DOI 10.1128/IAI.00664-09; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Ruhl S, 2000, INFECT IMMUN, V68, P6346, DOI 10.1128/IAI.68.11.6346-6354.2000; Ruhl S, 2004, J DENT RES, V83, P505, DOI 10.1177/154405910408300614; Seo HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064204; Takahashi Y, 2004, INFECT IMMUN, V72, P3876, DOI 10.1128/IAI.72.7.3876-3882.2004; Takahashi Y, 2002, INFECT IMMUN, V70, P1209, DOI 10.1128/IAI.70.3.1209-1218.2002; Takahashi Y, 1997, INFECT IMMUN, V65, P5042, DOI 10.1128/IAI.65.12.5042-5051.1997; Takahashi Y, 2002, ORAL MICROBIOL IMMUN, V17, P257, DOI 10.1034/j.1399-302X.2002.170409.x; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Urano-Tashiro Y, 2008, INFECT IMMUN, V76, P4686, DOI 10.1128/IAI.00238-08; Urano-Tashiro Y, 2012, ODONTOLOGY, V100, P144, DOI 10.1007/s10266-011-0044-z; Werdan K, 2014, NAT REV CARDIOL, V11, P35, DOI 10.1038/nrcardio.2013.174; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; Yajima A, 2005, MICROBIOL IMMUNOL, V49, P795, DOI 10.1111/j.1348-0421.2005.tb03659.x; Yajima A, 2008, MICROBIOL IMMUNOL, V52, P69, DOI 10.1111/j.1348-0421.2008.00015.x	28	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154098	10.1371/journal.pone.0154098	http://dx.doi.org/10.1371/journal.pone.0154098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101147	Green Published, gold			2022-12-27	WOS:000374898500142
J	Kim, SE; Kim, HN; Cho, J; Kwon, MJ; Chang, Y; Ryu, S; Shin, H; Kim, HL				Kim, Song E.; Kim, Han-Na; Cho, Juhee; Kwon, Min-Jung; Chang, Yoosoo; Ryu, Seungho; Shin, Hocheol; Kim, Hyung-Lae			Direct and Indirect Effects of Five Factor Personality and Gender on Depressive Symptoms Mediated by Perceived Stress	PLOS ONE			English	Article							ADULT LIFE-SPAN; MAJOR DEPRESSION; NEUROTICISM; ANXIETY; MODELS; DIMENSIONS; STRATEGIES; REACTIVITY; DISORDERS; SEVERITY	This study was designed to investigate associations among five factor personality traits, perceived stress, and depressive symptoms and to examine the roles of personality and perceived stress in the relationship between gender and depressive symptoms. The participants (N = 3,950) were part of a cohort study for health screening and examination at the Kangbuk Samsung Hospital. Personality was measured with the Revised NEO Personality Inventory (NEO-PI-R). Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CES-D). Perceived stress level was evaluated with a self-reported stress questionnaire developed for the Korea National Health and Nutrition Examination Survey. A higher degree of neuroticism and lower degrees of extraversion, agreeableness, and conscientiousness were significantly associated with greater perceived stress and depressive symptoms. Neuroticism and extraversion had significant direct and indirect effects (via stress as a mediator) on depressive symptoms in both genders. Agreeableness and conscientiousness had indirect effects on depression symptoms in both genders. Multiple mediation models were used to examine the mediational roles of each personality factor and perceived stress in the link between gender and depressive symptoms. Four of the personality factors (except openness) were significant mediators, along with stress, on the relationship between gender and depressive symptoms. Our findings suggest that the links between personality factors and depressive symptoms are mediated by perceived stress. As such, personality is an important factor to consider when examining the link between gender and depression.	[Kim, Song E.; Kim, Han-Na; Kim, Hyung-Lae] Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea; [Cho, Juhee; Kwon, Min-Jung; Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Ctr Cohort Studies, Total Healthcare Ctr,Kangbuk Samsung Hosp, Seoul, South Korea; [Cho, Juhee] Sungkyunkwan Univ, SAHIST, Dept Hlth Sci & Technol, Seoul, South Korea; [Cho, Juhee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biostat & Clin Epidemiol Ctr,Res Inst Future Med, Seoul, South Korea; [Cho, Juhee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc & Epidemiol, Baltimore, MD USA; [Kwon, Min-Jung] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Lab Med, Seoul, South Korea; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat Med, Seoul, South Korea; [Shin, Hocheol] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Family Med, Seoul, South Korea; [Shin, Hocheol] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Hlth Screening Ctr, Seoul, South Korea	Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, HN; Kim, HL (corresponding author), Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea.	o147942@ewha.ac.kr; hyung@ewha.ac.kr	Cho, Juhee/ABD-2280-2021	Chang, Yoosoo/0000-0002-6945-9050	National Research Foundation of Korea; Ministry of Education; Ministry of Science, ICT & Future Planning	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education; Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by the National Research Foundation of Korea, funded by the Ministry of Education (http://www.nrf.re.kr/nrf_eng_cms/) and Ministry of Science, ICT & Future Planning (http://english.msip.go.kr/english/main/main.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C-K., 1997, KOREAN J COUNS PSYCH, V9, P443; Barnhofer T, 2010, BEHAV RES THER, V48, P275, DOI 10.1016/j.brat.2009.12.005; Bartley CE, 2011, PERS INDIV DIFFER, V50, P79, DOI 10.1016/j.paid.2010.08.027; Besser A, 2007, PERS INDIV DIFFER, V42, P1333, DOI 10.1016/j.paid.2006.10.011; Bluml V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076646; Bono JE, 2002, J PERS, V70, P311, DOI 10.1111/1467-6494.05007; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Charbonneau AM, 2009, J YOUTH ADOLESCENCE, V38, P1050, DOI 10.1007/s10964-009-9398-8; Cho MJ, 2015, PSYCHIAT INVEST, V12, P164, DOI 10.4306/pi.2015.12.2.164; CORYELL W, 1992, ARCH GEN PSYCHIAT, V49, P117; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Finch JF, 2001, J PERS, V69, P27, DOI 10.1111/1467-6494.00135; GARNEFSKI N, 1990, ACTA PSYCHIAT SCAND, V81, P295, DOI 10.1111/j.1600-0447.1990.tb06500.x; Goodwin RD, 2004, PSYCHIAT RES, V126, P135, DOI 10.1016/j.psychres.2003.12.024; Gordon AM, 2013, PERS RELATIONSHIP, V20, P635, DOI 10.1111/pere.12005; Hamilton JL, 2013, J ABNORM CHILD PSYCH, V41, P1027, DOI 10.1007/s10802-013-9742-z; Hasel KM, 2013, INT J BEHAV MED, V20, P286, DOI 10.1007/s12529-012-9226-5; Hayes AF, 2011, COMMUN SER, P434; Hyde JS, 2008, PSYCHOL REV, V115, P291, DOI 10.1037/0033-295X.115.2.291; Jensen-Campbell LA, 2001, J PERS, V69, P323, DOI 10.1111/1467-6494.00148; Kendler KS, 2010, PSYCHOL MED, V40, P801, DOI 10.1017/S0033291709991140; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; Kercher AJ, 2009, J ABNORM CHILD PSYCH, V37, P903, DOI 10.1007/s10802-009-9325-1; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Klein DN, 2011, ANNU REV CLIN PSYCHO, V7, P269, DOI 10.1146/annurev-clinpsy-032210-104540; Koorevaar AML, 2013, J AFFECT DISORDERS, V151, P178, DOI 10.1016/j.jad.2013.05.075; Leach LS, 2008, SOC PSYCH PSYCH EPID, V43, P983, DOI 10.1007/s00127-008-0388-z; Lee ES., 2010, DEV STRESS QUESTIONN; Lee-Baggley D, 2005, J PERS, V73, P1141, DOI 10.1111/j.1467-6494.2005.00345.x; McCrae RR, 1999, DEV PSYCHOL, V35, P466, DOI 10.1037/0012-1649.35.2.466; Naragon-Gainey K, 2009, J ABNORM PSYCHOL, V118, P299, DOI 10.1037/a0015637; Panayiotou G, 2014, J PSYCHOL, V148, P549, DOI 10.1080/00223980.2013.817375; Parker G, 2010, INT REV PSYCHIATR, V22, P429, DOI 10.3109/09540261.2010.492391; Piedmont RL, 1997, J CROSS CULT PSYCHOL, V28, P131, DOI 10.1177/0022022197282001; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Resseguier N, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-28; Roesch SC, 2009, ANXIETY STRESS COPIN, V22, P263, DOI 10.1080/10615800802158419; Rosellini AJ, 2011, ASSESSMENT, V18, P27, DOI 10.1177/1073191110382848; Schneider TR, 2012, STRESS HEALTH, V28, P102, DOI 10.1002/smi.1409; Uehara T, 1999, PSYCHOTHER PSYCHOSOM, V68, P26, DOI 10.1159/000012307; Uliaszek AA, 2010, ANXIETY STRESS COPIN, V23, P363, DOI 10.1080/10615800903377264; van Buuren S, 2011, J STAT SOFTW, V45, P1; Van de Velde S, 2010, SOC SCI MED, V71, P305, DOI 10.1016/j.socscimed.2010.03.035; Weber K, 2012, AGING MENT HEALTH, V16, P472, DOI 10.1080/13607863.2011.630375; Weisberg YJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00178; Wolfenstein M, 1997, J PERS ASSESS, V69, P614, DOI 10.1207/s15327752jpa6903_14; Yoon KL, 2013, ANXIETY STRESS COPIN, V26, P558, DOI 10.1080/10615806.2012.734810	50	25	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154140	10.1371/journal.pone.0154140	http://dx.doi.org/10.1371/journal.pone.0154140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120051	Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200046
J	Timar, B; Timar, R; Gaita, L; Oancea, C; Levai, C; Lungeanu, D				Timar, Bogdan; Timar, Romulus; Gaita, Laura; Oancea, Cristian; Levai, Codrina; Lungeanu, Diana			The Impact of Diabetic Neuropathy on Balance and on the Risk of Falls in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study	PLOS ONE			English	Article							CARDIAC AUTONOMIC NEUROPATHY; OLDER-ADULTS; PERIPHERAL NEUROPATHY; PEDAL SENSIBILITY; COMPLICATIONS; IMPAIRMENT; MODELS; GAIT	Introduction Diabetic neuropathy (DN) is a prevalent complication of Type 2 Diabetes Mellitus (T2DM) with a major impact on the health of the affected patient. We hypothesized that mediated by the dysfunctionalities associated with DN's three major components: sensitive (lack of motion associated sensory), motor (impairments in movement coordination) and autonomic (the presence of postural hypotension), the presence of DN may impair the balance in the affected patients. Our study's main aim is to evaluate the possible association between the presence and severity of DN and both the balance impairment and the risk of falls in patients with T2DM. Material and Method In this cross-sectional study we enrolled, according to a consecutive-case population-based setting 198 patients with T2DM. The presence and severity of DN was evaluated using the Michigan Neuropathy Screening Instrument, a tool which allows both diagnosing and severity staging of DN. The balance impairment and the risk of falls were evaluated using four validated and standardized tools: Berg Balance Scale (BBS), Timed-up and Go test (TUG), Single Leg Stand test (SLS) and Fall Efficacy Scale (FES-I). Results The presence of DN was associated with significant decreases in the BBS score (40.5 vs. 43.7 points; p<0.001) and SLS time (9.3 vs. 10.3 seconds; p = 0.003) respectively increases in TUG time (8.9 vs. 7.6 seconds; p = 0.002) and FES-I score (38 vs. 33 points; p = 0.034). The MNSI score was reverse and significantly correlated with both BBS score (Spearman's r = -0.479; p<0.001) and SLS time (Spearman's r = -0.169; p = 0.017). In the multivariate regression model, we observed that patient's age, DN severity and depression's symptoms acted as independent, significant predictors for the risk of falls in patients with T2DM. Conclusions The presence of DN in patients with DM is associated with impaired balance and with a consecutively increase in the risk of falls.	[Timar, Bogdan; Lungeanu, Diana] Victor Babes Univ Med & Pharm, Dept Funct Sci, Timisoara, Romania; [Timar, Romulus] Victor Babes Univ Med & Pharm, Dept Internal Med 2, Timisoara, Romania; [Gaita, Laura] Victor Babes Univ Med & Pharm, Dept Cardiol, Timisoara, Romania; [Oancea, Cristian] Victor Babes Univ Med & Pharm, Dept Infect Dis, Timisoara, Romania; [Levai, Codrina] Victor Babes Univ Med & Pharm, Legal Dept, Timisoara, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Timar, R (corresponding author), Victor Babes Univ Med & Pharm, Dept Internal Med 2, Timisoara, Romania.	timar.romulus@umft.ro	Lungeanu, Diana/AAD-3280-2020	Lungeanu, Diana/0000-0002-0274-1377; Timar, Bogdan/0000-0002-0993-6206	"Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania [PLURINEURODIAB. PII-C4-TC-2016-16441-01]	"Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania	This research was supported by an internal grant, funded by "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania (PLURINEURODIAB. PII-C4-TC-2016-16441-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allet L, 2009, DIABETIC MED, V26, P1003, DOI 10.1111/j.1464-5491.2009.02811.x; Beauchet O, 2011, J NUTR HEALTH AGING, V15, P933, DOI 10.1007/s12603-011-0062-0; Berry Sarah D, 2008, Curr Osteoporos Rep, V6, P149, DOI 10.1007/s11914-008-0026-4; Boulton AJM, 1998, MED CLIN N AM, V82, P909, DOI 10.1016/S0025-7125(05)70029-8; Brown SJ, 2015, DIABETES CARE, V38, P1116, DOI 10.2337/dc14-1982; Dimitropoulos G, 2014, WORLD J DIABETES, V5, P17, DOI 10.4239/wjd.v5.i1.17; Ducic I, 2006, ANN PLAS SURG, V56, P145, DOI 10.1097/01.sap.0000194246.18332.23; Ducic I, 2004, ANN PLAS SURG, V52, P535, DOI 10.1097/01.sap.0000122654.65588.f0; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Greenberg SA, 2012, CLIN NURS RES, V21, P113, DOI 10.1177/1054773811433824; Herman WH, 2012, DIABETIC MED, V29, P937, DOI 10.1111/j.1464-5491.2012.03644.x; Hewston P, 2016, CAN J DIABETES, V40, P6, DOI 10.1016/j.jcjd.2015.08.005; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Karmakar Rathindra Nath, 2011, J Indian Med Assoc, V109, P396; Lagani V, 2013, J DIABETES COMPLICAT, V27, P407, DOI 10.1016/j.jdiacomp.2012.11.003; Lee IH, 2014, J PHYS THER SCI, V26, P1519, DOI 10.1589/jpts.26.1519; Manea L, 2015, GEN HOSP PSYCHIAT, V37, P67, DOI 10.1016/j.genhosppsych.2014.09.009; Morrison S, 2014, J DIABETES COMPLICAT, V28, P715, DOI 10.1016/j.jdiacomp.2014.04.007; Mota M, 2016, J DIABETES, V8, P336, DOI 10.1111/1753-0407.12297; Muir SW, 2010, J CLIN EPIDEMIOL, V63, P389, DOI 10.1016/j.jclinepi.2009.06.010; Pop-Busui R, 2012, J CARDIOVASC TRANSL, V5, P463, DOI 10.1007/s12265-012-9367-6; Roman de Mettelinge T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067055; Taguri M, 2014, BIOMETRICS, V70, P724, DOI 10.1111/biom.12165; Tahrani AA, 2014, DIABETOLOGIA, V57, P1249, DOI 10.1007/s00125-014-3211-2; Tesfaye S, 2012, DIABETES-METAB RES, V28, P8, DOI 10.1002/dmrr.2239; Trignano E, 2016, MICROSURG, V36, P37, DOI 10.1002/micr.22378; Vinik AI, 2013, ENDOCRIN METAB CLIN, V42, P747, DOI 10.1016/j.ecl.2013.06.001	28	83	88	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154654	10.1371/journal.pone.0154654	http://dx.doi.org/10.1371/journal.pone.0154654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119372	Green Submitted, gold, Green Published			2022-12-27	WOS:000374976200092
J	Miyawaki, A; Toyokawa, S; Inoue, K; Miyoshi, Y; Kobayashi, Y				Miyawaki, Atsushi; Toyokawa, Satoshi; Inoue, Kazuo; Miyoshi, Yuji; Kobayashi, Yasuki			Self-Reported Periodontitis and Incident Type 2 Diabetes among Male Workers from a 5-Year Follow-Up to MY Health Up Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; IMPAIRED FASTING GLUCOSE; C-REACTIVE PROTEIN; DIAGNOSTIC-CRITERIA; ALCOHOL-CONSUMPTION; NATIONAL-HEALTH; JAPANESE; DISEASE; RISK; MELLITUS	Aims The purpose of this study was to examine whether periodontitis is associated with incident type 2 diabetes in a Japanese male worker cohort. Methods The study participants were Japanese men, aged 36-55 years, without diabetes. Data were extracted from the MY Health Up study, consisting of self-administered questionnaire surveys at baseline and following annual health examinations for an insurance company in Japan. The oral health status of the participants was classified by two self-reported indicators: (1) gingival hemorrhage and (2) tooth loosening. Type 2 diabetes incidence was determined by self-reporting or blood test data. Modified Poisson regression approach was used to estimate the relative risks and the 95% confidence intervals of incident diabetes with periodontitis. Covariates included age, body mass index, family history of diabetes, hypertension, current smoking habits, alcohol use, dyslipidemia, and exercise habits. Results Of the 2895 candidates identified at baseline in 2004, 2469 men were eligible for follow-up analysis, 133 of whom were diagnosed with diabetes during the 5-year follow-up period. Tooth loosening was associated with incident diabetes [adjusted relative risk = 1.73, 95% confidence interval = 1.14-2.64] after adjusting for other confounding factors. Gingival hemorrhage displayed a similar trend but was not significantly associated with incident diabetes [adjusted relative risk = 1.32, 95% confidence interval = 0.95-1.85]. Conclusions Tooth loosening is an independent predictor of incident type 2 diabetes in Japanese men.	[Miyawaki, Atsushi; Toyokawa, Satoshi; Kobayashi, Yasuki] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Inoue, Kazuo] Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan; [Miyoshi, Yuji] Meiji Yasuda Life Insurance Co, Tokyo, Japan	University of Tokyo; Teikyo University	Toyokawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan.	toyokawa@m.u-tokyo.ac.jp	Miyawaki, Atsushi/GWR-2569-2022	Miyawaki, Atsushi/0000-0001-6126-1464	Meiji Yasuda Life Company	Meiji Yasuda Life Company	The Meiji Yasuda Life Company provided financial support in the form of YM salaries, and provided opportunity to use the screening dataset secondarily to contribute to public health concerns. Distribution and retrieval of questionnaires, and data input were handled by the Meiji Yasuda Life Insurance Company. The study does not contribute to company profit.	Aguiree F., 2013, IDF DIABETES ATLAS; Al-Zahrani MS, 2005, J DENT, V33, P703, DOI 10.1016/j.jdent.2005.01.004; Alhazmi A, 2012, J AM COLL NUTR, V31, P243, DOI 10.1080/07315724.2012.10720425; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Arora N, 2014, J CLIN PERIODONTOL, V41, P643, DOI 10.1111/jcpe.12258; Buhlin K, 2002, COMMUNITY DENT ORAL, V30, P431, DOI 10.1034/j.1600-0528.2002.00014.x; Artese HPC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128344; Chalmers J, 1999, J HYPERTENS, V17, P151; Choi YH, 2011, DIABETES CARE, V34, P381, DOI 10.2337/dc10-1354; Demmer RT, 2008, DIABETES CARE, V31, P1373, DOI 10.2337/dc08-0026; Demmer RT, 2010, DIABETES CARE, V33, P1037, DOI 10.2337/dc09-1778; Dietrich T, 2004, J PERIODONTOL, V75, P16, DOI 10.1902/jop.2004.75.1.16; Dotevall A, 2004, DIABETIC MED, V21, P615, DOI 10.1111/j.1464-5491.2004.01189.x; Ide R, 2011, J DENT RES, V90, P41, DOI 10.1177/0022034510381902; Inoue K, 2009, DIABETIC MED, V26, P1175, DOI 10.1111/j.1464-5491.2009.02850.x; Inoue M, 2007, J OCCUP HEALTH, V49, P376, DOI 10.1539/joh.49.376; JIN LJ, 1992, J CLIN PERIODONTOL, V19, P92, DOI 10.1111/j.1600-051X.1992.tb00446.x; Kadowaki Takashi, 2008, Journal of the Japan Diabetes Society, V51, P281; Kaneto C, 2013, DIABETES RES CLIN PR, V102, P138, DOI 10.1016/j.diabres.2013.08.011; Lin YS, 2005, ANN EPIDEMIOL, V15, P590, DOI 10.1016/j.annepidem.2004.10.010; Ministry of Health and Welfare, TOKY REP SURV DENT D; Natti J, 2009, EUR J PUBLIC HEALTH, V19, P150, DOI 10.1093/eurpub/ckp002; Nesto R, 2004, DIABETIC MED, V21, P810, DOI 10.1111/j.1464-5491.2004.01296.x; Noguchi S, 2015, J PUBLIC HEALTH-UK, V37, P605, DOI 10.1093/pubmed/fdu076; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Rabi DM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-124; Ripsin CM, 2009, AM FAM PHYSICIAN, V79, P29; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Teeuw WJ, 2010, DIABETES CARE, V33, P421, DOI 10.2337/dc09-1378; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P155, DOI 10.5551/jat.E537; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Yamamoto T, 2009, J OCCUP HEALTH, V51, P137, DOI 10.1539/joh.L8108; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	37	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153464	10.1371/journal.pone.0153464	http://dx.doi.org/10.1371/journal.pone.0153464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115749	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600022
J	Tong, HI; Kang, W; Davy, PMC; Shi, YL; Sun, S; Allsopp, RC; Lu, YA				Tong, Hsin-I; Kang, Wen; Davy, Philip M. C.; Shi, Yingli; Sun, Si; Allsopp, Richard C.; Lu, Yuanan			Monocyte Trafficking, Engraftment, and Delivery of Nanoparticles and an Exogenous Gene into the Acutely Inflamed Brain Tissue - Evaluations on Monocyte-Based Delivery System for the Central Nervous System	PLOS ONE			English	Article							DEFECTIVE LENTIVIRAL VECTORS; BLOOD MONOCYTES; BONE-MARROW; INFLAMMATORY RESPONSE; ANTIRETROVIRAL DRUG; MACROPHAGE DELIVERY; MURINE MODEL; STEM-CELLS; IN-VIVO; MICROGLIA	The ability of monocytes and monocyte-derived macrophages (MDM) to travel towards chemotactic gradient, traverse tissue barriers, and accumulate precisely at diseased sites makes them attractive candidates as drug carriers and therapeutic gene delivery vehicles targeting the brain, where treatments are often hampered by the blockade of the blood brain barrier (BBB). This study was designed to fully establish an optimized cell-based delivery system using monocytes and MDM, by evaluating their homing efficiency, engraftment potential, as well as carriage and delivery ability to transport nano-scaled particles and exogenous genes into the brain, following the non-invasive intravenous (IV) cell adoptive transfer in an acute neuroinflammation mouse model induced by intracranial injection of Escherichia coli lipopolysaccharides. We demonstrated that freshly isolated monocytes had superior inflamed-brain homing ability over MDM cultured in the presence of macrophage colony stimulating factor. In addition, brain trafficking of IV infused monocytes was positively correlated with the number of adoptive transferred cells, and could be further enhanced by transient disruption of the BBB with IV administration of Mannitol, Bradykinin or Serotonin right before cell infusion. A small portion of transmigrated cells was detected to differentiate into IBA-1 positive cells with microglia morphology in the brain. Finally, with the use of superparamagnetic iron oxide nanoparticles SHP30, the ability of nanoscale agent-carriage monocytes to enter the inflamed brain region was validated. In addition, lentiviral vector DHIV-101 was used to introduce green fluorescent protein (GFP) gene into monocytes, and the exogenous GFP gene was detected in the brain at 48 hours following IV infusion of the transduced monocytes. All together, our study has set up the optimized conditions for the more-in-depth tests and development of monocyte-mediated delivery, and our data supported the notion to use monocytes as a non-invasive cell-based delivery system for the brain.	[Tong, Hsin-I; Kang, Wen; Shi, Yingli; Sun, Si; Lu, Yuanan] Univ Hawaii Manoa, Off Publ Hlth Studies, Honolulu, HI 96822 USA; [Tong, Hsin-I] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Davy, Philip M. C.; Allsopp, Richard C.] Univ Hawaii Manoa, Inst Biogenesis Res, Honolulu, HI 96822 USA; [Kang, Wen] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi, Peoples R China; [Shi, Yingli] Chinese Acad Sci, Inst Oceanol, Qingdao, Shandong, Peoples R China	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Air Force Military Medical University; Chinese Academy of Sciences; Institute of Oceanology, CAS	Lu, YA (corresponding author), Univ Hawaii Manoa, Off Publ Hlth Studies, Honolulu, HI 96822 USA.	yuanan@hawaii.edu		Tong, Hsin-I/0000-0002-1567-5006	National Institute of Mental Health of National Institutes of Health [R01 MH079717]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079717] Funding Source: NIH RePORTER	National Institute of Mental Health of National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the National Institute of Mental Health of National Institutes of Health (R01 MH079717). https://www.nimh.nih.gov/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169, DOI 10.1016/0306-4522(92)90347-5; Andreesen R, 1998, J LEUKOCYTE BIOL, V64, P419, DOI 10.1002/jlb.64.4.419; Bechmann I, 2005, FASEB J, V19, P647, DOI 10.1096/fj.04-2599fje; Brynskikh AM, 2010, NANOMEDICINE-UK, V5, P379, DOI [10.2217/nnm.10.7, 10.2217/NNM.10.7]; Burke B, 2003, EXPERT OPIN BIOL TH, V3, P919, DOI 10.1517/14712598.3.6.919; Burke B., 2002, MACROPHAGE; Colgan J, 2005, J IMMUNOL, V174, P6030, DOI 10.4049/jimmunol.174.10.6030; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Dou HY, 2009, J IMMUNOL, V183, P661, DOI 10.4049/jimmunol.0900274; Fiala M, 1998, MOL MED, V4, P480, DOI 10.1007/BF03401753; Fidler I J, 1994, Adv Pharmacol, V30, P271, DOI 10.1016/S1054-3589(08)60177-5; Francke A, 2011, J HISTOCHEM CYTOCHEM, V59, P813, DOI 10.1369/0022155411416007; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; Kennedy DW, 1998, P NATL ACAD SCI USA, V95, P14944, DOI 10.1073/pnas.95.25.14944; Klimatcheva E, 2001, MOL THER, V3, P928, DOI 10.1006/mthe.2001.0344; Lebson L, 2010, J NEUROSCI, V30, P9651, DOI 10.1523/JNEUROSCI.0329-10.2010; Lech M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/951390; Liu R, 2005, GENE THER, V12, P647, DOI 10.1038/sj.gt.3302445; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; McCarty DM, 2009, GENE THER, V16, P1340, DOI 10.1038/gt.2009.85; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Pardridge William M, 2005, NeuroRx, V2, P3; Persidsky Y, 1999, AM J PATHOL, V155, P1599, DOI 10.1016/S0002-9440(10)65476-4; Pires MD, 2001, ANAL QUANT CYTOL, V23, P427; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Roth JC, 2008, GENE THER, V15, P716, DOI 10.1038/gt.2008.38; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; VANFURTH R, 1973, J EXP MED, V138, P1314, DOI 10.1084/jem.138.6.1314; WINKLER T, 1995, NEUROSCIENCE, V68, P1097, DOI 10.1016/0306-4522(95)00194-N; Wu C, 2007, CELL MOL BIOL, V53, P67, DOI 10.1170/T810; Wu JM, 2006, BRAIN RES, V1098, P79, DOI 10.1016/j.brainres.2006.04.074; Xu HP, 2005, J IMMUNOL, V175, P6915, DOI 10.4049/jimmunol.175.10.6915; Zeng LB, 2006, J GENE MED, V8, P18, DOI 10.1002/jgm.825; Zeng LB, 2006, J VIROL METHODS, V134, P66, DOI 10.1016/j.jviromet.2005.12.006	41	45	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154022	10.1371/journal.pone.0154022	http://dx.doi.org/10.1371/journal.pone.0154022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115998	Green Published, gold			2022-12-27	WOS:000374973600036
J	Fahlenkamp, AV; Stoppe, C; Cremer, J; Biener, IA; Peters, D; Leuchter, R; Eisert, A; Apfel, CC; Rossaint, R; Coburn, M				Fahlenkamp, Astrid V.; Stoppe, Christian; Cremer, Jan; Biener, Ingeborg A.; Peters, Dirk; Leuchter, Ricarda; Eisert, Albrecht; Apfel, Christian C.; Rossaint, Rolf; Coburn, Mark			Nausea and Vomiting following Balanced Xenon Anesthesia Compared to Sevoflurane: A Post-Hoc Explorative Analysis of a Randomized Controlled Trial	PLOS ONE			English	Article							POSTOPERATIVE NAUSEA; PROPOFOL ANESTHESIA; ELECTIVE SURGERY; HYPNOTIC DEPTH; BREAST SURGERY; NITROUS-OXIDE; RISK SCORE; DEXAMETHASONE; ISOFLURANE; PREVENTION	Objective Like other inhalational anesthetics xenon seems to be associated with post-operative nausea and vomiting (PONV). We assessed nausea incidence following balanced xenon anesthesia compared to sevoflurane, and dexamethasone for its prophylaxis in a randomized controlled trial with post-hoc explorative analysis. Methods 220 subjects with elevated PONV risk (Apfel score >= 2) undergoing elective abdominal surgery were randomized to receive xenon or sevoflurane anesthesia and dexamethasone or placebo after written informed consent. 93 subjects in the xenon group and 94 subjects in the sevoflurane group completed the trial. General anesthesia was maintained with 60% xenon or 2.0% sevoflurane. Dexamethasone 4mg or placebo was administered in the first hour. Subjects were analyzed for nausea and vomiting in predefined intervals during a 24h post-anesthesia follow-up. Results Logistic regression, controlled for dexamethasone and anesthesia/dexamethasone interaction, showed a significant risk to develop nausea following xenon anesthesia (OR 2.30, 95% CI 1.02-5.19, p = 0.044). Early-onset nausea incidence was 46% after xenon and 35% after sevoflurane anesthesia (p = 0.138). After xenon, nausea occurred significantly earlier (p = 0.014), was more frequent and rated worse in the beginning. Dexamethasone did not markedly reduce nausea occurrence in both groups. Late-onset nausea showed no considerable difference between the groups. Conclusion In our study setting, xenon anesthesia was associated with an elevated risk to develop nausea in sensitive subjects. Dexamethasone 4mg was not effective preventing nausea in our study. Group size or dosage might have been too small, and change of statistical analysis parameters in the post-hoc evaluation might have further contributed to a limitation of our results. Further trials will be needed to address prophylaxis of xenon-induced nausea.	[Fahlenkamp, Astrid V.; Stoppe, Christian; Cremer, Jan; Biener, Ingeborg A.; Peters, Dirk; Leuchter, Ricarda; Rossaint, Rolf; Coburn, Mark] Univ Hosp Aachen, Dept Anesthesiol, Aachen, Germany; [Eisert, Albrecht] Univ Hosp Aachen, Hosp Pharm, Aachen, Germany; [Apfel, Christian C.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Apfel, Christian C.] SageMedic Inc, Larkspur, CA USA	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University of California System; University of California San Francisco	Coburn, M (corresponding author), Univ Hosp Aachen, Dept Anesthesiol, Aachen, Germany.	mcoburn@ukaachen.de		Stoppe, Christian/0000-0002-2028-2039	Air Liquide Sante International	Air Liquide Sante International	This work was supported by a project grant (financial support, drug supply) from Air Liquide Sante International to MC. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PLR, 1992, BRIT J ANAESTH, V69, pS2, DOI 10.1093/bja/69.supplement_1.2S; Apfel CC, 2012, BRIT J ANAESTH, V109, P742, DOI 10.1093/bja/aes276; Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Apfel CC, 2004, NEW ENGL J MED, V350, P2441, DOI 10.1056/NEJMoa032196; Apfel CC, 2002, ACTA ANAESTH SCAND, V46, P921, DOI 10.1034/j.1399-6576.2002.460801.x; Apfel CC, 2002, BRIT J ANAESTH, V88, P659, DOI 10.1093/bja/88.5.659; Apfel CC, 1998, ACTA ANAESTH SCAND, V42, P495, DOI 10.1111/j.1399-6576.1998.tb05157.x; Baumert JH, 2008, BRIT J ANAESTH, V100, P605, DOI 10.1093/bja/aen050; Coburn M, 2008, BRIT J ANAESTH, V100, P787, DOI 10.1093/bja/aen077; Coburn M, 2007, BRIT J ANAESTH, V98, P756, DOI 10.1093/bja/aem103; Coburn M, 2005, BRIT J ANAESTH, V94, P198, DOI 10.1093/bja/aei023; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; De Jr OG, 2013, ANESTH ANALG, V116, P58, DOI [10.1213/ANE.0b013e31826f0a0a, DOI 10.1213/ANE.0B013E31826F0A0A]; Fahlenkamp AV, 2014, BRIT J ANAESTH, V112, P272, DOI 10.1093/bja/aet330; Fahlenkamp AV, 2010, BRIT J ANAESTH, V105, P334, DOI 10.1093/bja/aeq163; Gan TJ, 2014, ANESTH ANALG, V118, P85, DOI 10.1213/ANE.0000000000000002; Goto T, 1997, BRIT J ANAESTH, V79, P595, DOI 10.1093/bja/79.5.595; Goto T, 1997, ANESTHESIOLOGY, V86, P1273, DOI 10.1097/00000542-199706000-00007; Henzi I, 2000, ANESTH ANALG, V90, P186, DOI 10.1097/00000539-200001000-00038; KAZEMIKJELLBERG F, 2001, BMC ANESTHESIOL, V1, P2, DOI DOI 10.1186/1471-2253-1-2; Koivuranta M, 1997, ANAESTHESIA, V52, P443, DOI 10.1111/j.1365-2044.1997.117-az0113.x; Pham A, 2012, OBSTET GYNECOL, V120, P1451, DOI [http://10.1097/AOG.0b013e31827590f3, 10.1097/AOG.0b013e31827590f3]; Rossaint R, 2003, ANESTHESIOLOGY, V98, P6, DOI 10.1097/00000542-200301000-00005; Schaefer MS, 2015, BRIT J ANAESTH, V115, P61, DOI 10.1093/bja/aev115; Stoppe C, 2012, BRIT J ANAESTH, V108, P80, DOI 10.1093/bja/aer393; Stoppe C, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-12; Suzuki T, 2002, ANESTHESIOLOGY, V96, P699, DOI 10.1097/00000542-200203000-00028; Sweis I, 2013, AESTHET PLAST SURG, V37, P625, DOI 10.1007/s00266-013-0067-7; Visser K, 2001, ANESTHESIOLOGY, V95, P616, DOI 10.1097/00000542-200109000-00012; Voigt M, 2011, J CLIN ANESTH, V23, P461, DOI 10.1016/j.jclinane.2011.01.005; Wang JJ, 2000, ANESTH ANALG, V91, P136, DOI 10.1097/00000539-200007000-00025; Wappler F, 2007, ANESTHESIOLOGY, V106, P463, DOI 10.1097/00000542-200703000-00010; Wattwil M, 2003, ACTA ANAESTH SCAND, V47, P823, DOI 10.1034/j.1399-6576.2003.00172.x; Wu JI, 2009, J CLIN ANESTH, V21, P469, DOI 10.1016/j.jclinane.2008.11.007	34	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153807	10.1371/journal.pone.0153807	http://dx.doi.org/10.1371/journal.pone.0153807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111335	Green Published, Green Submitted, gold			2022-12-27	WOS:000374970600022
J	Heidker, RM; Caiozzi, GC; Ricketts, ML				Heidker, Rebecca M.; Caiozzi, Gianella C.; Ricketts, Marie-Louise			Grape Seed Procyanidins and Cholestyramine Differentially Alter Bile Acid and Cholesterol Homeostatic Gene Expression in Mouse Intestine and Liver	PLOS ONE			English	Article							FARNESOID-X RECEPTOR; LOWERS PLASMA-CHOLESTEROL; LOWER TRIGLYCERIDE LEVELS; MICROSOMAL TRIGLYCERIDE; TRANSFER PROTEIN; CHOLIC-ACID; STEROL 12-ALPHA-HYDROXYLASE; LIPID-ACCUMULATION; NUCLEAR RECEPTOR; FXR	Bile acid (BA) sequestrants, lipid-lowering agents, may be prescribed as a monotherapy or combination therapy to reduce the risk of coronary artery disease. Over 33% of adults in the United States use complementary and alternative medicine strategies, and we recently reported that grape seed procyanidin extract (GSPE) reduces enterohepatic BA recirculation as a means to reduce serum triglyceride (TG) levels. The current study was therefore designed to assess the effects on BA, cholesterol and TG homeostatic gene expression following co-administration with GSPE and the BA sequestrant, cholestyramine (CHY). Eight-week old male C57BL/6 mice were treated for 4 weeks with either a control or 2% CHY-supplemented diet, after which, they were administered vehicle or GSPE for 14 hours. Liver and intestines were harvested and gene expression was analyzed. BA, cholesterol, non-esterified fatty acid and TG levels were also analyzed in serum and feces. Results reveal that GSPE treatment alone, and co-administration with CHY, regulates BA, cholesterol and TG metabolism differently than CHY administration alone. Notably, GSPE decreased intestinal apical sodium-dependent bile acid transporter (Asbt) gene expression, while CHY significantly induced expression. Administration with GSPE or CHY robustly induced hepatic BA biosynthetic gene expression, especially cholesterol 7 alpha-hydroxylase (Cyp7a1), compared to control, while co-administration further enhanced expression. Treatment with CHY induced both intestinal and hepatic cholesterologenic gene expression, while co-administration with GSPE attenuated the CHY-induced increase in the liver but not intestine. CHY also induced hepatic lipogenic gene expression, which was attenuated by co-administration with GSPE. Consequently, a 25% decrease in serum TG levels was observed in the CHY+GSPE group, compared to the CHY group. Collectively, this study presents novel evidence demonstrating that GSPE provides additive and complementary efficacy as a lipid-lowering combination therapy in conjunction with CHY by attenuating hepatic cholesterol synthesis, enhancing BA biosynthesis and decreasing lipogenesis, which warrants further investigation.	[Heidker, Rebecca M.; Caiozzi, Gianella C.; Ricketts, Marie-Louise] Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA; [Caiozzi, Gianella C.] Hosp Urgencia Asistencia Publ, Portugal 125, Santiago, Chile	Nevada System of Higher Education (NSHE); University of Nevada Reno	Ricketts, ML (corresponding author), Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA.	mricketts@cabnr.unr.edu		Ricketts, Marie-Louise/0000-0002-8306-7563	University of Nevada, Reno; USDA National Institute of Food and Agriculture [Hatch-NEV0738, W-3122]; CONICYT Bicentennial Becas-Chile Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103554] Funding Source: NIH RePORTER	University of Nevada, Reno; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); CONICYT Bicentennial Becas-Chile Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the University of Nevada, Reno and USDA National Institute of Food and Agriculture (Hatch-NEV0738 and Multistate project W-3122: Beneficial and Adverse Effects of Natural Chemicals on Human Health and Food Safety) to MLR. GCC was the recipient of a CONICYT Bicentennial Becas-Chile Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNHARDSSON C, 1973, BIOCHEM BIOPH RES CO, V54, P1030, DOI 10.1016/0006-291X(73)90797-3; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; CASSIDY MM, 1980, DIGEST DIS SCI, V25, P504, DOI 10.1007/BF01315212; CASSIDY MM, 1985, DIGEST DIS SCI, V30, P468, DOI 10.1007/BF01318181; CDC, 2015, UNDERLYING CAUSE DEA; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Clarke TC, 2015, NATL HLTH STAT REPOR, P1; CROUSE JR, 1987, AM J MED, V83, P243, DOI 10.1016/0002-9343(87)90692-9; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Del Bas JM, 2008, MOL NUTR FOOD RES, V52, P1172, DOI 10.1002/mnfr.200800054; DIETSCHY JM, 1971, J CLIN INVEST, V50, P872, DOI 10.1172/JCI106559; DIETSCHY JM, 1968, J CLIN INVEST, V47, P166, DOI 10.1172/JCI105725; DIETSCHY JM, 1965, J CLIN INVEST, V44, P1311, DOI 10.1172/JCI105237; DIETSCHY JM, 1971, AM J CLIN NUTR, V24, P70; Downing LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140267; Eggertsen G, 1996, J BIOL CHEM, V271, P32269, DOI 10.1074/jbc.271.50.32269; Feng D, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-40; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hayashi AA, 2011, AM J PHYSIOL-GASTR L, V301, pG326, DOI 10.1152/ajpgi.00425.2010; Heidker RM, 2016, MOL NUTR FOOD RES, V60, P727, DOI 10.1002/mnfr.201500795; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Hou R, 2009, ENDOCRIN METAB CLIN, V38, P79, DOI 10.1016/j.ecl.2008.11.007; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Insull W, 2006, SOUTH MED J, V99, P257, DOI 10.1097/01.smj.0000208120.73327.db; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Jahn D, 2015, CYTOKINE GROWTH F R, V26, P625, DOI 10.1016/j.cytogfr.2015.07.016; Kamisako T, 2007, J GASTROEN HEPATOL, V22, P1832, DOI 10.1111/j.1440-1746.2007.04910.x; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; Li H, 2005, AM J PHYSIOL-GASTR L, V288, pG60, DOI 10.1152/ajpgi.00170.2004; Li H, 2004, METABOLISM, V53, P927, DOI 10.1016/j.metabol.2004.01.017; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; LINDSEY CA, 1965, J LIPID RES, V6, P173; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Del Bas JM, 2009, MOL NUTR FOOD RES, V53, P805, DOI 10.1002/mnfr.200800364; Modica Salvatore, 2011, Curr Protoc Mouse Biol, V1, P289, DOI 10.1002/9780470942390.mo100226; O'Brien PJ, 2005, CLIN CHEM, V51, P351, DOI 10.1373/clinchem.2004.040824; Out C, 2012, CURR OPIN LIPIDOL, V23, P43, DOI 10.1097/MOL.0b013e32834f0ef3; Pandak WM, 2001, GASTROENTEROLOGY, V120, P1801, DOI 10.1053/gast.2001.24833; Praslickova D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050810; Schmitt J, 2015, LIVER INT, V35, P1133, DOI 10.1111/liv.12456; Schwarz M, 1997, J BIOL CHEM, V272, P23995, DOI 10.1074/jbc.272.38.23995; Seok S, 2013, J BIOL CHEM, V288, P23252, DOI 10.1074/jbc.M113.452037; SHEPHERD J, 1989, CARDIOLOGY, V76, P65, DOI 10.1159/000174548; SRERE PA, 1950, J BIOL CHEM, V182, P629; Sugimoto-Kawabata K, 2013, J LIPID RES, V54, P1255, DOI 10.1194/jlr.M032839; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; van der Vliet HN, 2002, BIOCHEM BIOPH RES CO, V295, P1156, DOI 10.1016/S0006-291X(02)00808-2; Vlahcevic ZR, 2000, GASTROENTEROLOGY, V118, P599, DOI 10.1016/S0016-5085(00)70267-8; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; West KL, 2003, ATHEROSCLEROSIS, V171, P201, DOI 10.1016/j.atherosclerosis.2003.08.019; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; WETTERAU JR, 1985, CHEM PHYS LIPIDS, V38, P205, DOI 10.1016/0009-3084(85)90068-4; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P4406, DOI 10.1021/bi00232a006; Yamakoshi J, 2002, FOOD CHEM TOXICOL, V40, P599, DOI 10.1016/S0278-6915(02)00006-6; Yu CD, 2005, J BIOL CHEM, V280, P17707, DOI 10.1074/jbc.M411771200	61	20	20	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154305	10.1371/journal.pone.0154305	http://dx.doi.org/10.1371/journal.pone.0154305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111442	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600055
J	Huang, SG; Guo, WL; Wang, J; Sheng, M; Lan, XH; Fang, L				Huang, Shun-gen; Guo, Wan-liang; Wang, Jian; Sheng, Mao; Lan, Xing-hao; Fang, Lin			Factors Interfering with Delineation on MRCP of Pancreaticobiliary Maljunction in Paediatric Patients	PLOS ONE			English	Article							MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY; COMMON BILE-DUCT; CHOLEDOCHAL CYSTS; BILIARY DILATATION; CHILDREN; DIAGNOSIS; MALFORMATION; JUNCTION; INFANTS	Background The aim of this study was to assess factors for delineating the pancreaticobiliary junction in the presence of pediatric congenital choledochal cysts (CCC) using Magnetic resonance cholangiopancreatography (MRCP). Methods Retrospective review of medical records for 48 patients with CCC was conducted, including demographics, biliary amylase and MRCP findings if available. With univariate and multivariate logistic regression, we measured significant factors affecting pancreaticobiliary maljunction( PBM) diagnoses by MRCP. Results Of the subjects enrolled with CCC. Twenty-eight cases had PBM according to MRCP. Univariate analysis confirmed that age, cyst diameter >30 mm and cysts that descended to the introitus pelvis affected junctional delineation and detection of PBM (P<0.05). Stepwise logistic regression analysis confirmed large cysts in the introitus pelvis predicted pancreaticobiliary junctional delineation in MRCP and these data agreed with the literature. A correlation between cyst diameter and the length of the common channel was found as was cyst diameter and biliary amylase although there were no significant differences between them. Conclusions Age, cyst diameter >30 mm and descending cysts into the introitus pelvis affected junctional delineation of the pancreatic and bile duct in PBM with MRCP. Large cyst descension into the introitus pelvis was an independent factors affecting PBM detection.	[Huang, Shun-gen; Wang, Jian] Soochow Univ, Childrens Hosp, Dept Gen Surg, Suzhou 215003, Peoples R China; [Guo, Wan-liang; Sheng, Mao; Lan, Xing-hao; Fang, Lin] Soochow Univ, Childrens Hosp, Dept Radiol, Suzhou 215003, Peoples R China	Soochow University - China; Soochow University - China	Guo, WL (corresponding author), Soochow Univ, Childrens Hosp, Dept Radiol, Suzhou 215003, Peoples R China.	gwlsuzhou@163.com			Suzhou key clinical disease diagnosis and treatment Projects [LCZX201306]; Suzhou Foundation and Application Grants [SYS201563]; Jiangsu Province Health and Family planning Projects [H201519, H201520]; Jiangsu Province social development program standardized diagnosis and treatment of key disease in clinical [BE2015643]	Suzhou key clinical disease diagnosis and treatment Projects; Suzhou Foundation and Application Grants; Jiangsu Province Health and Family planning Projects; Jiangsu Province social development program standardized diagnosis and treatment of key disease in clinical	This research was supported by Suzhou key clinical disease diagnosis and treatment Projects (#LCZX201306), Suzhou Foundation and Application Grants (No. SYS201563), Jiangsu Province Health and Family planning Projects (H201519, H201520) and Jiangsu Province social development program standardized diagnosis and treatment of key disease in clinical (#BE2015643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CSENDES A, 1979, GASTROENTEROLOGY, V77, P1203; Deng YL, 2011, HEPATOB PANCREAT DIS, V10, P570, DOI 10.1016/S1499-3872(11)60098-2; Diao M, 2014, INT J SURG, V12, P412, DOI 10.1016/j.ijsu.2014.03.007; Fitoz S, 2007, CLIN IMAG, V31, P93, DOI 10.1016/j.clinimag.2006.11.002; Guo WL, 2012, PEDIATR SURG INT, V28, P983, DOI 10.1007/s00383-012-3159-6; Gwal K, 2015, PEDIATR RADIOL, V45, P1153, DOI 10.1007/s00247-015-3296-x; Hung MH, 2011, EUR J PEDIATR, V170, P1179, DOI 10.1007/s00431-011-1429-2; Irie H, 1998, AM J ROENTGENOL, V171, P1381, DOI 10.2214/ajr.171.5.9798883; Kamisawa T, 2007, ABDOM IMAGING, V32, P129, DOI 10.1007/s00261-006-9005-3; Kamisawa T, 2014, J HEPATO-BIL-PAN SCI, V21, P159, DOI 10.1002/jhbp.57; Kamisawa T, 2012, J GASTROENTEROL, V47, P731, DOI 10.1007/s00535-012-0611-2; Kamisawa T, 2009, CLIN GASTROENTEROL H, V7, pS84, DOI 10.1016/j.cgh.2009.08.024; Kim MJ, 2002, AM J ROENTGENOL, V179, P209, DOI 10.2214/ajr.179.1.1790209; Li L, 2003, PEDIATR SURG INT, V19, P180, DOI 10.1007/s00383-002-0914-0; Miyazaki T, 1998, AM J ROENTGENOL, V170, P33, DOI 10.2214/ajr.170.1.9423593; Nagi B, 2003, ABDOM IMAGING, V28, P847, DOI 10.1007/s00261-003-0031-0; Noda Y, 2007, J GASTROENTEROL, V42, P211, DOI 10.1007/s00535-006-1991-y; Saito T, 2011, SURGERY, V149, P569, DOI 10.1016/j.surg.2010.11.004; Siles P, 2014, PEDIATR RADIOL, V44, P1077, DOI 10.1007/s00247-014-2953-9; Sugiyama M, 1998, SURGERY, V123, P391, DOI 10.1067/msy.1998.86581; Suzuki M, 2006, J PEDIATR GASTR NUTR, V42, P539, DOI 10.1097/01.mpg.0000221894.44124.8e; Takuma K, 2012, ADV MED SCI-POLAND, V57, P244, DOI 10.2478/v10039-012-0041-7; Takuma K, 2012, WORLD J GASTROENTERO, V18, P3409, DOI 10.3748/wjg.v18.i26.3409; Tang Y, 2001, COMPUT MED IMAG GRAP, V25, P423, DOI 10.1016/S0895-6111(00)00070-7; Tipnis Neelesh A, 2007, Curr Gastroenterol Rep, V9, P225, DOI 10.1007/s11894-007-0023-2; Tipnis NA, 2008, J PEDIATR GASTR NUTR, V46, P59, DOI 10.1097/01.mpg.0000304455.76928.0e; Yamataka A, 1997, J PEDIATR SURG, V32, P1560, DOI 10.1016/S0022-3468(97)90452-8	27	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154178	10.1371/journal.pone.0154178	http://dx.doi.org/10.1371/journal.pone.0154178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104956	gold, Green Published			2022-12-27	WOS:000374565100051
J	Liu, YD; Bahar, R; Kalia, S; Huang, RY; Phillips, A; Su, MW; Yang, S; Zhang, XJ; Zhou, PY; Zhou, YW				Liu, Yudan; Bahar, Rayeheh; Kalia, Sunil; Huang, Rachel Yuanshen; Phillips, Arlie; Su, Mingwan; Yang, Sen; Zhang, Xuejun; Zhou, Pingyu; Zhou, Youwen			Hyperhidrosis Prevalence and Demographical Characteristics in Dermatology Outpatients in Shanghai and Vancouver	PLOS ONE			English	Article							PALMAR HYPERHIDROSIS; POPULATION	Background There is a wide variation in the reported prevalence of primary hyperhidrosis in the literature. Further, it is unknown if primary hyperhidrosis is a lifelong condition, or if demographical factors influence hyperhidrosis prevalence. Objectives This study aims to examine the prevalence of hyperhidrosis in multiple ethnic groups from two ethnically diverse cities and to determine if the prevalence of primary hyperhidrosis changes according to age, gender, ethnicity, body mass index, and geographical locations. Methods In total, 1010 consecutive subjects attending dermatology outpatient clinics in Shanghai Skin Disease Hospital and 1018 subjects in Skin Care Center of Vancouver General Hospital were invited to fill out a questionnaire on their presenting concerns, demographical information, and sweating symptoms. The subjects were then classified to have primary hyperhidrosis using the criteria of International Hyperhidrosis Society, late-onset hyperhidrosis, or no-hyperhidrosis. The prevalence of primary HH and late-onset HH was calculated for the entire study population and in subgroups stratified according to age of examination, sex, ethnicity, presenting diagnosis, bodymass index, and specific study cities. Multivariate logistic regression analyses were performed to assess the impact of these factors on HH prevalence. Results The prevalence of primary hyperhidrosis is very similar in Shanghai and in Vancouver, at 14.5% and 12.3% respectively. In addition, 4.0% of subjects in Shanghai and 4.4% subjects in Vancouver suffer from late-onset HH. Primary HH has highest prevalence in those younger than 30 years of age, decreasing dramatically in later years. Caucasian subjects are at least 2.5 times more likely to develop axillary hyperhidrosis compared to Chinese subjects. Obesity does not have much influence on primary HH presentation, although it does increase significantly the development of late-onset HH. Finally, there is no major difference of hyperhidrosis between Chinese subjects in Shanghai and Vancouver. Limitations The data were gathered according to patients' self-reports only and the sample size was relatively small in some groups after stratification for gender, ethnicity and age. Conclusion Prevalence of primary HH and late-onset HH is similar in dermatology outpatients independent of geographical locations. However, certain specific HH subtypes can show great variations according to ethnicity, age, body mass index and sex.	[Liu, Yudan; Zhou, Pingyu] Anhui Med Univ, Sch Clin, Shanghai Skin Dis Hosp, Shanghai, Peoples R China; [Bahar, Rayeheh; Kalia, Sunil; Huang, Rachel Yuanshen; Phillips, Arlie; Su, Mingwan; Zhou, Youwen] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Bahar, Rayeheh; Huang, Rachel Yuanshen; Su, Mingwan; Zhou, Youwen] Vancouver Coastal Hlth Res Inst, Mol Med Lab, Vancouver, BC, Canada; [Bahar, Rayeheh; Huang, Rachel Yuanshen; Su, Mingwan; Zhou, Youwen] Vancouver Coastal Hlth Res Inst, Chieng Genom Ctr, Vancouver, BC, Canada; [Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Zhou, Pingyu] Shanghai Skin Dis Hosp, Sexually Transmitted Dis Inst, Shanghai, Peoples R China	Anhui Medical University; University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver Coastal Health Research Institute; Anhui Medical University	Zhou, PY (corresponding author), Anhui Med Univ, Sch Clin, Shanghai Skin Dis Hosp, Shanghai, Peoples R China.; Zhou, YW (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.; Zhou, YW (corresponding author), Vancouver Coastal Hlth Res Inst, Mol Med Lab, Vancouver, BC, Canada.; Zhou, YW (corresponding author), Vancouver Coastal Hlth Res Inst, Chieng Genom Ctr, Vancouver, BC, Canada.; Zhou, PY (corresponding author), Shanghai Skin Dis Hosp, Sexually Transmitted Dis Inst, Shanghai, Peoples R China.	zpyls@yahoo.com; youwen.zhou@ubc.ca	Kalia, Sunil/AAD-8008-2021		Canadian Dermatology Foundation; Canadian Institutes of Health Research [CCI-132563]; National Natural Sciences Foundation of China (NSFC) [81271749, 81361128014]	Canadian Dermatology Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Sciences Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants from Canadian Dermatology Foundation (to YZ), Canadian Institutes of Health Research (CCI-132563 to YZ), and National Natural Sciences Foundation of China (NSFC#81271749 to YZ, and NSFC#81361128014 to SY).	Augustin M, 2013, DERMATOLOGY, V227, P10, DOI 10.1159/000351292; CLOWARD R B, 1957, Hawaii Med J, V16, P381; Fujimoto T, 2013, J DERMATOL, V40, P886, DOI 10.1111/1346-8138.12258; Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537; Gross KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092412; Hoeldtke RD, 2001, DIABETES, V50, P436, DOI 10.2337/diabetes.50.2.436; Hornberger J, 2004, J AM ACAD DERMATOL, V51, P274, DOI 10.1016/j.jaad.2003.12.029; Li X, 2007, CHINESE MED J-PEKING, V120, P2215, DOI 10.1097/00029330-200712020-00011; Manca D, 2000, CLIN NEUROPHYSIOL, V111, P1767, DOI 10.1016/S1388-2457(00)00394-1; SATO K, 1989, J AM ACAD DERMATOL, V20, P713, DOI 10.1016/S0190-9622(89)70081-5; Stashak AB, 2014, CLIN COSMET INVESTI, V7, P285, DOI 10.2147/CCID.S53119; Strutton DR, 2004, J AM ACAD DERMATOL, V51, P241, DOI 10.1016/j.jaad.2003.12.040	12	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153719	10.1371/journal.pone.0153719	http://dx.doi.org/10.1371/journal.pone.0153719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105064	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100016
J	Mol, JPS; Pires, SF; Chapeaurouge, AD; Perales, J; Santos, RL; Andrade, HM; Lage, AP				Mol, Juliana P. S.; Pires, Simone F.; Chapeaurouge, Alexander D.; Perales, Jonas; Santos, Renato L.; Andrade, Helida M.; Lage, Andrey P.			Proteomic Profile of Brucella abortus-Infected Bovine Chorioallantoic Membrane Explants	PLOS ONE			English	Article							INTRACELLULAR REPLICATION; PROTEINS; LIPOPOLYSACCHARIDE; INFLAMMATION; INHIBITION; ACTIVATION; MATURATION; SECRETION; VIRULENCE; REVEALS	Brucella abortus is the etiological agent of bovine brucellosis, a zoonotic disease that causes significant economic losses worldwide. The differential proteomic profile of bovine chorioallantoic membrane (CAM) explants at early stages of infection with B. abortus (0.5, 2, 4, and 8 h) was determined. Analysis of CAM explants at 0.5 and 4 h showed the highest differences between uninfected and infected CAM explants, and therefore were used for the Differential Gel Electrophoresis (DIGE). A total of 103 spots were present in only one experimental group and were selected for identification by mass spectrometry (MALDI/ToF-ToF). Proteins only identified in extracts of CAM explants infected with B. abortus were related to recognition of PAMPs by TLR, production of reactive oxygen species, intracellular trafficking, and inflammation.	[Mol, Juliana P. S.; Lage, Andrey P.] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Belo Horizonte, MG, Brazil; [Pires, Simone F.; Andrade, Helida M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Chapeaurouge, Alexander D.; Perales, Jonas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Toxinol, Rio De Janeiro, Rio De Janeiro, Brazil; [Santos, Renato L.] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Lage, AP (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Belo Horizonte, MG, Brazil.	alage@vet.ufmg.br	de Lima Santos, Renato/A-1134-2008	de Lima Santos, Renato/0000-0002-4830-0470; Mol, Juliana/0000-0002-6946-8213	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - PRONEX); CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - PRONEX)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - PRONEX). JPSM, APL, and RLS have fellowships from CNPq.	Al Dahouk S, 2008, PROTEOMICS, V8, P3862, DOI 10.1002/pmic.200800026; [Anonymous], [No title captured]; Boschiroli ML, 2002, VET MICROBIOL, V90, P341, DOI 10.1016/S0378-1135(02)00219-5; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Campbell-Valois FX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016378; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Capelluto DGS, 2012, MICROBES INFECT, V14, P140, DOI 10.1016/j.micinf.2011.08.018; Celli J, 2005, P NATL ACAD SCI USA, V102, P1673, DOI 10.1073/pnas.0406873102; Celli J, 2004, CURR OPIN MICROBIOL, V7, P93, DOI 10.1016/j.mib.2003.11.001; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; de Almeida LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023135; DelVecchio VG, 2002, VET MICROBIOL, V90, P593, DOI 10.1016/S0378-1135(02)00239-0; Ding Y, 2010, PROTEOMICS, V10, P2620, DOI 10.1002/pmic.200900572; EVANS H E, 1973, Zentralblatt fuer Veterinaermedizin Reihe C, V2, P11; Gee JM, 2005, INFECT IMMUN, V73, P2873, DOI 10.1128/IAI.73.5.2873-2880.2005; Ghebrehiwet B, 2001, IMMUNOL REV, V180, P65, DOI 10.1034/j.1600-065X.2001.1800106.x; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Hauck SM, 2007, J PROTEOME RES, V6, P2121, DOI 10.1021/pr060668y; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Ikeda N, 2011, DIABETOLOGIA, V54, P2183, DOI 10.1007/s00125-011-2197-2; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Larnontagne J, 2009, J PROTEOME RES, V8, P1594, DOI 10.1021/pr800978p; Lauer SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091706; Liu LX, 2002, MOL BIOL CELL, V13, P4266, DOI 10.1091/mbc.E02-03-0136; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Mol JPS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108606; Mota LJ, 2009, CELL MICROBIOL, V11, P1236, DOI 10.1111/j.1462-5822.2009.01329.x; Neta AVC, 2008, INFECT IMMUN, V76, P1897, DOI 10.1128/IAI.01554-07; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Richmond JY, 1993, BIOSAFETY MICROBIOLO, P85; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Salcedo SP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00028; Sampaio I.B.M., 1998, ESTATISTICA APLICADA, P221; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Sloane JA, 2010, NEUROMOL MED, V12, P149, DOI 10.1007/s12017-009-8094-x; Srivastava SK, 2011, CHEM-BIOL INTERACT, V191, P330, DOI 10.1016/j.cbi.2011.02.023; Tumurkhuu G, 2006, MICROBIOL IMMUNOL, V50, P421, DOI 10.1111/j.1348-0421.2006.tb03810.x; Wu QL, 2005, J PHARMACOL EXP THER, V313, P705, DOI 10.1124/jpet.104.080416; Wu YP, 2014, ELECTROPHORESIS, V35, P1130, DOI 10.1002/elps.201300378; Xavier MN, 2009, J COMP PATHOL, V140, P149, DOI 10.1016/j.jcpa.2008.10.004; Yadav UCS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006535	42	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154209	10.1371/journal.pone.0154209	http://dx.doi.org/10.1371/journal.pone.0154209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104343	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100056
J	Raza, A; Malik, HJ; Shafiq, M; Amin, I; Scheffler, JA; Scheffler, BE; Mansoor, S				Raza, Amir; Malik, Hassan Jamil; Shafiq, Muhammad; Amin, Imran; Scheffler, Jodi A.; Scheffler, Brian E.; Mansoor, Shahid			RNA Interference based Approach to Down Regulate Osmoregulators of Whitefly (Bemisia tabaci): Potential Technology for the Control of Whitefly	PLOS ONE			English	Article							MANAGING RESISTANCE; CROP PROTECTION; PLANTS; GENE; EXPRESSION; CHALLENGES; COTTON; PESTS	Over the past decade RNA interference (RNAi) technology has emerged as a successful tool not only for functional genomics, but in planta expression of short interfering RNAs (siR-NAs) that could offer great potential for insect pest management. The diet of insects feeding exclusively on phloem sieves contains water and sugars as main components, and the uptake of the liquid food greatly depends on the osmotic pressure within the insect body. Based on this physiological mechanism, transgenic plants of Nicotiana tabacum were generated expressing double stranded RNA (dsRNA) against both aquaporin (AQP) and a sucrase gene, alpha glucosidase (AGLU). These two genes are involved in osmotic pressure maintenance particularly in sap sucking insects, and the aim was to disrupt osmoregulation within the insect ultimately leading to mortality. Real time quantitative PCR (RT-qPCR) was performed to assess the suppression of gene expression in Bemisia tabaci (B. tabaci) and mortality was recorded during transgenic tobacco feeding bioassays. Feeding of insects on plants expressing dsRNA significantly reduced the transcript level of the target genes in B. tabaci after six days of feeding and more than 70% mortality was observed in B. tabaci fed on transgenic plants compared to the control plants. Our data shows that down-regulation of genes related to osmoregulation may find practical applications for the control of this important pest in cotton and other crops.	[Raza, Amir; Malik, Hassan Jamil; Shafiq, Muhammad; Amin, Imran; Mansoor, Shahid] NIBGE, Mol Virol & Gene Silencing Lab, Agr Biotechnol Div, Jhang Rd,POB 577, Faisalabad, Pakistan; [Raza, Amir; Malik, Hassan Jamil; Shafiq, Muhammad] PIEAS, Islamabad, Pakistan; [Scheffler, Jodi A.] USDA ARS, Crop Genet Res Unit, 141 Expt Stn Rd, Stoneville, MS 38776 USA; [Scheffler, Brian E.] USDA ARS, Genom & Bioinformat Res Unit, 141 Expt Stn Rd, Stoneville, MS 38776 USA	Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Mansoor, S (corresponding author), NIBGE, Mol Virol & Gene Silencing Lab, Agr Biotechnol Div, Jhang Rd,POB 577, Faisalabad, Pakistan.	shahidmansoor7@gmail.com	Malik, Hassan J/A-1753-2019	Scheffler, Brian/0000-0003-1968-8952; Mansoor, Shahid/0000-0001-7418-1826; Shafiq, Muhammad/0000-0002-1308-1538	Higher Education Commission; Pakistan - United States Cotton Productivity Enhancement Program; United States Department of Agriculture Agricultural Research Service [58-6402-0-178F]; ARS [ARS-0425112] Funding Source: Federal RePORTER	Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); Pakistan - United States Cotton Productivity Enhancement Program; United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding provided by Higher Education Commission, AR, MS Pakistan - United States Cotton Productivity Enhancement Program, United States Department of Agriculture Agricultural Research Service Project No. 58-6402-0-178F.	[Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Boykin LM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-228; Burow MD., 1990, PLANT MOL BIOL REP, V8, P124, DOI [10.1007/BF02669766, DOI 10.1007/BF02669766]; Chassy BM, 2010, ISB NEWS REPORT; Christiaens O, 2014, CURR OPIN INSECT SCI, V6, P15, DOI 10.1016/j.cois.2014.09.012; De Barro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025579; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Denholm I, 1998, PHILOS T R SOC B, V353, P1757, DOI 10.1098/rstb.1998.0328; Dhaliwal G. S., 2010, Indian Journal of Ecology, V37, P1; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dutta TK, 2013, FRONTIERS MICROBIOLO, V5; Escobar MA, 2001, P NATL ACAD SCI USA, V98, P13437, DOI 10.1073/pnas.241276898; Gatehouse JA, 2008, PLANT PHYSIOL, V146, P881, DOI 10.1104/pp.107.111096; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Gheysen G, 2007, TRENDS BIOTECHNOL, V25, P89, DOI 10.1016/j.tibtech.2007.01.007; Guerineau F., 1993, Plant molecular biology labfax., P121; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Horowitz AR, 1999, PESTIC SCI, V55, P272, DOI 10.1002/(SICI)1096-9063(199903)55:3&lt;272::AID-PS908&gt;3.0.CO;2-; HOROWITZ AR, 1994, PESTIC SCI, V42, P113, DOI 10.1002/ps.2780420208; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Koch A, 2014, PLANT BIOTECHNOL J, V12, P821, DOI 10.1111/pbi.12226; Kos M, 2009, TRENDS BIOTECHNOL, V27, P621, DOI 10.1016/j.tibtech.2009.08.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Mansoor S, 2006, TRENDS PLANT SCI, V11, P559, DOI 10.1016/j.tplants.2006.09.010; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Mehta A, 1998, FEBS LETT, V430, P17, DOI 10.1016/S0014-5793(98)00525-0; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Nawaz-Ul-Rehman MS, 2009, FEBS LETT, V583, P1825, DOI 10.1016/j.febslet.2009.05.045; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Roberts AF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00958; Rosell RC, 1997, ANN ENTOMOL SOC AM, V90, P575, DOI 10.1093/aesa/90.5.575; Samih M, 2005, COMMUNICATIONS AGR A, V71, P613; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thakur N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087235; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Upadhyay SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083692; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang J, 2015, SCIENCE, V347, P991, DOI 10.1126/science.1261680; Zotti MJ, 2015, NEOTROP ENTOMOL, V44, P197, DOI 10.1007/s13744-015-0291-8	49	44	44	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153883	10.1371/journal.pone.0153883	http://dx.doi.org/10.1371/journal.pone.0153883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105353	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100027
J	Dhana, K; Koolhaas, CM; van Rossum, EFC; Ikram, MA; Hofman, A; Kavousi, M; Franco, OH				Dhana, Klodian; Koolhaas, Chantal M.; van Rossum, Elisabeth F. C.; Ikram, M. Arfan; Hofman, Albert; Kavousi, Maryam; Franco, Oscar H.			Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the Elderly Population	PLOS ONE			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; OLDER US; OVERWEIGHT; ASSOCIATION; PREVALENCE; OUTCOMES; MODEL; AGE	Background Whether being metabolically healthy obese (MHO)-defined by the presence of obesity in the absence of metabolic syndrome-is associated with subsequent cardiovascular disease (CVD) remains unclear and may depend on the participants' age. We examined the association of being MHO with CVD risk in the elderly. Methods and Findings This study included 5,314 individuals (mean age 68 years) from the prospective population-based Rotterdam Study. We categorized our population in groups according to body mass index (BMI) and presence and absence of metabolic syndrome, and estimated the hazard ratio (HR) and 95% confidence interval (95% CI) for every group by using Cox proportional hazard models. Among 1048 (19.7%) obese individuals we identified 260 (24.8%) MHO subjects. Over 14 years of follow-up there were 861 incident CVD cases. In the multivariable adjusted analysis, we did not observe an increased CVD risk in MHO individuals (HR 1.07, 95%CI 0.75-1.53), compared to normal weight individuals without metabolic syndrome. CVD risk was increased by the presence of metabolic syndrome in normal weight (HR 1.35, 95%CI 1.02-1.80), overweight (HR 1.32, 95%CI 1.09-1.60) and obese (HR 1.33, 95%CI 1.07-1.66) individuals, compared to those with normal weight without metabolic syndrome. In a mediation analysis, 71.3% of the association between BMI and CVD was explained by the presence of metabolic syndrome. Conclusions In our elderly population, we found that the presence of obesity without metabolic syndrome did not confer a higher CVD risk. However, metabolic syndrome was strongly associated with CVD risk, and was associated with an increased risk in all BMI categories. Therefore, preventive interventions targeting cardiometabolic risk factors could be considered in elderly, regardless of weight status.	[Dhana, Klodian; Koolhaas, Chantal M.; Ikram, M. Arfan; Hofman, Albert; Kavousi, Maryam; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Rossum, Elisabeth F. C.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Hofman, Albert] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health	Dhana, K (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	k.dhana@erasmusmc.nl	van Rossum, Elisabeth/AAP-9388-2020; Ikram, M. Arfan/AAM-5225-2021; Kavousi, Maryam/F-1174-2018; Franco, Óscar H/ABE-2305-2020	Kavousi, Maryam/0000-0001-5976-6519; Franco, Óscar H/0000-0002-4606-4929; Dhana, Klodian/0000-0002-6397-7009	Erasmus MC and Erasmus University, Rotterdam; the Netherlands; Netherlands Organisation for Scientific Research (NWO); Netherlands Organisation for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Erasmus Mundus Western Balkans (ERAWEB); European Commission; Vereniging Trustfonds Erasmus Universiteit Rotterdam; Nestle Nutrition (Nestec Ltd.); Metagenics Inc. Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; AXA Research Fund; Netherlands Heart Foundation [2012T008]	Erasmus MC and Erasmus University, Rotterdam; the Netherlands(Netherlands Government); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Erasmus Mundus Western Balkans (ERAWEB); European Commission(European CommissionEuropean Commission Joint Research Centre); Vereniging Trustfonds Erasmus Universiteit Rotterdam; Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc. Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc.; AXA Research Fund(AXA Research Fund); Netherlands Heart Foundation(Netherlands Heart Foundation)	The Rotterdam Study is funded by Erasmus MC and Erasmus University, Rotterdam, the Netherlands; the Netherlands Organisation for Scientific Research (NWO); the Netherlands Organisation for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. KD is supported by Erasmus Mundus Western Balkans (ERAWEB), a project funded by the European Commission and received additional funding from Vereniging Trustfonds Erasmus Universiteit Rotterdam. CMK and OHF work in ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd.) and Metagenics Inc. Nestle Nutrition (Nestec Ltd.) and Metagenics Inc. MK is supported by the AXA Research Fund. MAI is supported by the Netherlands Heart Foundation (2012T008). These funding sources had no role in design and conduct of this manuscript; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of this manuscript.	Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bos MJ, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001634; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; CASPERSEN CJ, 1991, AM J EPIDEMIOL, V133, P1078, DOI 10.1093/oxfordjournals.aje.a115821; Chapman I., 2008, OBESITY IN OLD AGE; Chapman IM, 2010, INTERD T GERONT GERI, V37, P20, DOI 10.1159/000319992; Dhana K, 2015, HEART, V101, P377, DOI 10.1136/heartjnl-2014-306704; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; Hinnouho GM, 2015, EUR HEART J, V36, P551, DOI 10.1093/eurheartj/ehu123; Hofman A, 2015, EUR J EPIDEMIOL, V30, P661, DOI 10.1007/s10654-015-0082-x; Janssen I, 2004, ANN EPIDEMIOL, V14, P585, DOI 10.1016/j.annepidem.2004.01.007; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Kip KE, 2004, CIRCULATION, V109, P706, DOI 10.1161/01.CIR.0000115514.44135.A8; Koller MT, 2012, ANN INTERN MED, V157, P389, DOI 10.7326/0003-4819-157-6-201209180-00002; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Leening MJG, 2012, EUR J EPIDEMIOL, V27, P173, DOI 10.1007/s10654-012-9668-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Myint PK, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1214; Ortega FB, 2013, EUR HEART J, V34, P390, DOI 10.1093/eurheartj/ehs174; RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385; ROCHE AF, 1981, AM J CLIN NUTR, V34, P2831, DOI 10.1093/ajcn/34.12.2831; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Song YQ, 2007, AM J CARDIOL, V100, P1654, DOI 10.1016/j.amjcard.2007.06.073; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Thomsen M, 2014, JAMA INTERN MED, V174, P15, DOI 10.1001/jamainternmed.2013.10522; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wildman RP, 2009, CURR OPIN CLIN NUTR, V12, P438, DOI 10.1097/MCO.0b013e32832c6db7	35	35	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154273	10.1371/journal.pone.0154273	http://dx.doi.org/10.1371/journal.pone.0154273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100779	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500175
J	Ghadiry, M; Gholami, M; Lai, CK; Ahmad, H; Chong, WY				Ghadiry, Mahdiar; Gholami, Mehrdad; Lai, C. K.; Ahmad, Harith; Chong, W. Y.			Ultra-Sensitive Humidity Sensor Based on Optical Properties of Graphene Oxide and Nano-Anatase TiO2	PLOS ONE			English	Article							RELATIVE-HUMIDITY; LINEAR-RESPONSE	Generally, in a waveguide-based humidity sensors, increasing the relative humidity (RH) causes the cladding refractive index (RI) to increase due to cladding water absorption. However, if graphene oxide (GO) is used, a reverse phenomenon is seen due to a gap increase in graphene layers. In this paper, this interesting property is applied in order to fabricate differential humidity sensor using the difference between RI of reduced GO (rGO) and nano-anatase TiO2 in a chip. First, a new approach is proposed to prepare high quality nano-anatase TiO2 in solution form making the fabrication process simple and straightforward. Then, the resulted solutions (TiO2 and GO) are effortlessly drop casted and reduced on SU8 two channels waveguide and extensively examined against several humid conditions. Investigating the sensitivity and performance (response time) of the device, reveals a great linearity in a wide range of RH (35% to 98%) and a variation of more than 30 dB in transmitted optical power with a response time of only similar to 0.7 sec. The effect of coating concentration and UV treatment are studied on the performance and repeatability of the sensor and the attributed mechanisms explained. In addition, we report that using the current approach, devices with high sensitivity and very low response time of only 0.3 sec can be fabricated. Also, the proposed device was comprehensively compared with other state of the art proposed sensors in the literature and the results were promising. Since high sensitivity similar to 0.47dB/% RH and high dynamic performances were demonstrated, this sensor is a proper choice for biomedical applications.	[Ghadiry, Mahdiar; Lai, C. K.; Ahmad, Harith; Chong, W. Y.] Univ Malaya, Photon Res Ctr, Kuala Lumpur 50603, Malaysia; [Gholami, Mehrdad] Islamic Azad Univ, Marvdasht Branch, Dept Chem, POB 465, Marvdasht, Iran	Universiti Malaya; Islamic Azad University	Ghadiry, M (corresponding author), Univ Malaya, Photon Res Ctr, Kuala Lumpur 50603, Malaysia.	mahdiar@um.edu.my	Chong, Wu Yi/AAE-3826-2022; Gholami, Mehrdad/GNP-4688-2022; Ahmad, Harith/A-3387-2009; Chong, Wu Yi/I-1174-2014; Lai, Choon Kong/AAZ-1792-2021	Ahmad, Harith/0000-0002-9599-2086; Chong, Wu Yi/0000-0002-2053-7783; Lai, Choon Kong/0000-0002-1807-859X	University of Malaya [GA010-2014, UM.C/625/1/HIR/MOHE/SCI/29]	University of Malaya(Universiti Malaya)	The authors would like to acknowledge the full support from University of Malaya through their funding LRGS (2015), NGOD/um/KPT, GA010-2014, UM.C/625/1/HIR/MOHE/SCI/29.	Alvarez-Herrero A, 2004, IEEE SENS J, V4, P52, DOI 10.1109/JSEN.2003.822214; Aneesh R, 2012, APPL OPTICS, V51, P2164, DOI 10.1364/AO.51.002164; Aneesh R, 2011, APPL OPTICS, V50, P5310, DOI 10.1364/AO.50.005310; Ansari ZA, 1997, THIN SOLID FILMS, V305, P330, DOI 10.1016/S0040-6090(97)00146-6; Basu S, 2012, SENSOR ACTUAT B-CHEM, V173, P1, DOI 10.1016/j.snb.2012.07.092; Borini S, 2013, ACS NANO, V7, P11166, DOI 10.1021/nn404889b; Corres JM, 2008, IEEE SENS J, V8, P281, DOI 10.1109/JSEN.2008.917487; Gaston A, 2003, IEEE SENS J, V3, P806, DOI 10.1109/JSEN.2003.820349; Ghadiry M, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010039; Guo CY, 2015, SENSOR ACTUAT B-CHEM, V206, P407, DOI 10.1016/j.snb.2014.09.058; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Huang NM, 2011, INT J NANOMED, V6, P3443, DOI 10.2147/IJN.S26812; Kuang Q, 2007, J AM CHEM SOC, V129, P6070, DOI 10.1021/ja070788m; Lim WH, 2014, SENSORS-BASEL, V14, P24329, DOI 10.3390/s141224329; Liu DZJ, 2015, INT J CLIN PHARM TH, V53, P172, DOI 10.5414/CP202146; Liu Y, 2007, IEEE PHOTONIC TECH L, V19, P880, DOI 10.1109/LPT.2007.897551; Lu GH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/44/445502; Mathew J., 2013, THESIS DUBLIN I TECH; Lopez-Higuera JM, 2011, J LIGHTWAVE TECHNOL, V29, P587, DOI 10.1109/JLT.2011.2106479; Mogera U, 2014, SCI REP-UK, V4, DOI 10.1038/srep04103; Ren YT, 2001, SENSOR ACTUAT B-CHEM, V75, P76, DOI 10.1016/S0925-4005(01)00538-X; Shibata T, 2003, J PHYS CHEM B, V107, P10696, DOI 10.1021/jp0357830; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; STEWART G, 1993, SENSOR ACTUAT B-CHEM, V11, P521, DOI 10.1016/0925-4005(93)85297-N; Su PG, 2007, SENSOR ACTUAT B-CHEM, V123, P501, DOI 10.1016/j.snb.2006.09.052; Tan KM, 2005, SENSOR ACTUAT B-CHEM, V110, P335, DOI 10.1016/j.snb.2005.02.012; Vakil A, 2011, SCIENCE, V332, P1291, DOI 10.1126/science.1202691; Vijayan A, 2008, SENSOR ACTUAT B-CHEM, V129, P106, DOI 10.1016/j.snb.2007.07.113; Wei N, 2014, ACS APPL MATER INTER, V6, P5877, DOI 10.1021/am500777b; Xie LJ, 2014, ANAL BIOANAL CHEM, V406, P377, DOI 10.1007/s00216-013-7302-6; Xie X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02117; Yao BC, 2014, SENSOR ACTUAT B-CHEM, V194, P142, DOI 10.1016/j.snb.2013.12.085; Yeo TL, 2008, SENSOR ACTUAT A-PHYS, V144, P280, DOI 10.1016/j.sna.2008.01.017; Yeo TL, 2005, SENSOR ACTUAT B-CHEM, V110, P148, DOI 10.1016/j.snb.2005.01.033; Zhang DZ, 2014, SENSOR ACTUAT B-CHEM, V197, P66, DOI 10.1016/j.snb.2014.02.078; Zhang YS, 2005, APPL SURF SCI, V242, P212, DOI 10.1016/j.apsusc.2004.08.013	36	27	29	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153949	10.1371/journal.pone.0153949	http://dx.doi.org/10.1371/journal.pone.0153949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101247	gold, Green Published			2022-12-27	WOS:000374898500107
J	Han, LH; Zhang, ML; Wang, MM; Jia, JC; Zhao, MY; Fan, YM; Li, XR				Han, Longhui; Zhang, Minglian; Wang, Mengmeng; Jia, Jinchen; Zhao, Miying; Fan, Yiming; Li, Xiaorong			High Mobility Group Box-1 Promotes Inflammation-Induced Lymphangiogenesis via Toll-Like Receptor 4-Dependent Signalling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-C; KAPPA-B; HMGB1; MACROPHAGES; PROTEIN; EXPRESSION; CANCER; METASTASIS; CELLS; ACTIVATION	Lymphangiogenesis in inflammation has received considerable attention in recent years. Administration of modulating lymphangiogenesis provides more possibilities of treating inflammation-associated diseases. However, the main mediators and factors governing inflammation-induced lymphangiogenesis (ILA) are yet to be defined. Here, we explored the role of HMGB1-TLR4 signalling pathway in modulating inflammation-induced lymphangiogenesis and its underlying mechanisms using an ILA mouse model and 2 cell lines. Our results show that HMGB1 promoted VEGF-C-induced HDLECs proliferation in a dose-dependent manner and TLR4 mediates HMGB1-induced LECs proliferation and tube formation in vitro. And in vivo, rHMGB1 treatment significantly promoted ILA, and the promoting effects was inhibited notably when HMGB1-TLR4 was blocked. HMGB1-associated ILA is primarily dependent on TLR4 but not on TLR2. In mechanisms, the recruitment and activation of CD11b+ cells are important cellular mechanisms in HMGB1-TLR4 associated ILA, and multiple key pro-lymphangiogenesis molecules mediates HMGB1-TLR4 associated ILA, including VEGF-C/VEGFR3, inflammatory factors IL-1 beta and TNF-alpha, MMP-2 and MMP-9 and NF-kappa B p65. In conclusion, HMGB1-associated ILA is primarily dependent on TLR4, and CD11b+ cells and multiple molecular mechanisms mediate HMGB1-TLR4 associated ILA. Furthermore, the ILA can be effectively modulated by HMGB1-TLR4 signalling. Consequently, administration of modulating ILA through HMGB1-TLR4 pathway may provide us more possibilities of treating inflammation and lymphangiogenesis associated diseases.	[Han, Longhui; Li, Xiaorong] Tianjin Med Univ, Hosp Eye, Sch Optometry & Ophthalmol, Inst Eye, Tianjin, Peoples R China; [Han, Longhui; Zhang, Minglian; Wang, Mengmeng; Jia, Jinchen; Zhao, Miying; Fan, Yiming] Hebei Prov Eye Hosp, Hebei Prov Eye Inst, Hebei Prov Key Lab Ophthalmol, Xingtai, Hebei, Peoples R China	Tianjin Medical University	Han, LH (corresponding author), Tianjin Med Univ, Hosp Eye, Sch Optometry & Ophthalmol, Inst Eye, Tianjin, Peoples R China.; Han, LH (corresponding author), Hebei Prov Eye Hosp, Hebei Prov Eye Inst, Hebei Prov Key Lab Ophthalmol, Xingtai, Hebei, Peoples R China.	han-longhui@163.com		Wang, Mengmeng/0000-0002-4939-611X				Attout T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008234; BACK A, 1995, BLOOD, V85, P1017, DOI 10.1182/blood.V85.4.1017.bloodjournal8541017; Bennuru S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000688; Cai JJ, 2015, ARTERIOSCL THROM VAS, V35, P2579, DOI 10.1161/ATVBAHA.115.305789; Cao RH, 2011, NAT PROTOC, V6, P817, DOI 10.1038/nprot.2011.359; CHEN Y, 2015, NANOSCALE RES LETT, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0140918; Corliss BA, 2016, MICROCIRCULATION, V23, P95, DOI 10.1111/micc.12259; Coso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039558; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Cursiefen C, 2011, J EXP MED, V208, P1083, DOI 10.1084/jem.20092277; Detry B, 2012, BLOOD, V119, P5048, DOI 10.1182/blood-2011-12-400267; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Hall KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031794; Han LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108931; HICKSTEIN DD, 1988, J BIOL CHEM, V263, P13863; HICKSTEIN DD, 1989, J BIOL CHEM, V264, P21812; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P2320, DOI 10.1161/01.ATV.0000145573.36113.8a; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; Kang S, 2009, BLOOD, V113, P2605, DOI 10.1182/blood-2008-07-166934; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Li Y, 2015, J INT MED RES, V43, P494, DOI 10.1177/0300060515581671; Liao S, 2014, ANGIOGENESIS, V17, P325, DOI 10.1007/s10456-014-9416-7; Liu AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035379; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Miyamoto A, 2014, J ANIM SCI, V92, P1834, DOI 10.2527/jas.2013-7332; Nadatani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080130; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Qiu YY, 2012, MED ONCOL, V29, P358, DOI 10.1007/s12032-010-9778-7; Ran Sophia, 2012, Cancers (Basel), V4, P618, DOI 10.3390/cancers4030618; Sasahira T, 2008, CANCER SCI, V99, P1806, DOI 10.1111/j.1349-7006.2008.00894.x; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tan KW, 2013, BLOOD, V122, P3666, DOI 10.1182/blood-2012-11-466532; van Zoelen MAD, 2009, SHOCK, V31, P280, DOI 10.1097/SHK.0b013e318186262d; Van't HEF, 2014, ONCOIMMUNOLOGY, V3, DOI DOI 10.4161/ONCI.29080; Velegraki M, 2012, J CLIN IMMUNOL, V32, P312, DOI 10.1007/s10875-011-9620-9; Vitali R, 2011, AM J GASTROENTEROL, V106, P2029, DOI 10.1038/ajg.2011.231; Volk-Draper L, 2014, CANCER RES, V74, P5421, DOI 10.1158/0008-5472.CAN-14-0067; Wang FL, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-284; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117; Wang J, 2009, BIOCHEM PHARMACOL, V78, P178, DOI 10.1016/j.bcp.2009.03.031; Wu WQ, 2012, ASIAN PAC J CANCER P, V13, P991, DOI 10.7314/APJCP.2012.13.3.991; Yan HX, 2013, J HEPATOL, V59, P762, DOI 10.1016/j.jhep.2013.05.029; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC709, DOI 10.1152/ajpcell.00284.2011; Zampell JC, 2011, AM J PHYSIOL-CELL PH, V300, pC1107, DOI 10.1152/ajpcell.00378.2010; Zhang WQ, 2014, TUMOR BIOL, V35, P2175, DOI 10.1007/s13277-013-1288-8	51	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154187	10.1371/journal.pone.0154187	http://dx.doi.org/10.1371/journal.pone.0154187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100831	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500163
J	Kim, HW; Kwon, SR; Jung, KH; Kim, SK; Baek, HJ; Seo, MR; Bang, SY; Lee, HS; Suh, CH; Jung, JY; Son, CN; Shim, SC; Lee, SH; Lee, SG; Lee, YA; Lee, EY; Kim, TH; Kim, YG				Kim, Hye Won; Kwon, Seong Ryul; Jung, Kyong-Hee; Kim, Seong-Kyu; Baek, Han Joo; Seo, Mi Ryung; Bang, So-Young; Lee, Hye-Soon; Suh, Chang-Hee; Jung, Ju Yang; Son, Chang-Nam; Shim, Seung Cheol; Lee, Sang-Hoon; Lee, Seung-Geun; Lee, Yeon-Ah; Lee, Eun Young; Kim, Tae-Hwan; Kim, Yong-Gil		Korean Soc Spondyloarthrit Res	Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research	PLOS ONE			English	Article							FACTOR ANTAGONISTS; RHEUMATOID-ARTHRITIS; ALPHA INHIBITORS; RISK; THERAPY; INFLIXIMAB; INFECTION; RECOMMENDATIONS; COMPLICATION; REACTIVATION	Backgrounds Patients who develop an active tuberculosis infection during tumor necrosis factor (TNF) inhibitor treatment typically discontinue TNF inhibitor and receive standard anti-tuberculosis treatment. However, there is currently insufficient information on patient outcomes following resumption of TNF inhibitor treatment during ongoing anti-tuberculosis treatment. Our study was designed to investigate the safety of resuming TNF inhibitors in ankylosing spondylitis (AS) patients who developed tuberculosis as a complication of the use of TNF inhibitors. Methods Through the nationwide registry of the Korean Society of Spondyloarthritis Research, 3929 AS patients who were prescribed TNF inhibitors were recruited between June 2003 and June 2014 at fourteen referral hospitals. Clinical information was analyzed about the patients who experienced tuberculosis after exposure to TNF inhibitors. The clinical features of resumers and non-resumers of TNF inhibitors were compared and the outcomes of tuberculosis were surveyed individually. Findings Fifty-six AS patients were treated for tuberculosis associated with TNF inhibitors. Among them, 23 patients resumed TNF inhibitors, and these patients were found to be exposed to TNF inhibitors for a longer period of time and experienced more frequent disease flare-up after discontinuation of TNF inhibitors compared with those who did not resume. Fifteen patients resumed TNF inhibitors during anti-tuberculosis treatment (early resumers) and 8 after completion of anti-tuberculosis treatment (late resumers). Median time to resuming TNF inhibitor from tuberculosis was 3.3 and 9.0 months in the early and late resumers, respectively. Tuberculosis was treated successfully in all resumers and did not relapse in any of them during follow-up (median 33.8 [IQR; 20.8-66.7] months). Conclusions Instances of tuberculosis were treated successfully in our AS patients, even when given concomitantly with TNF inhibitors. We suggest that early resumption of TNF inhibitors in AS patients could be safe under effective coverage of tuberculosis.	[Kim, Hye Won] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med,Div Rheumatol, Seoul, South Korea; [Kwon, Seong Ryul; Jung, Kyong-Hee] Inha Univ, Sch Med, Dept Internal Med, Div Rheumatol, Incheon, South Korea; [Kim, Seong-Kyu] Catholic Univ Daegu, Sch Med, Arthrit & Autoimmun Res Ctr, Div Rheumatol,Dept Internal Med, Daegu, South Korea; [Baek, Han Joo; Seo, Mi Ryung] Gachon Univ, Gil Hosp, Dept Internal Med, Div Rheumatol, Incheon, South Korea; [Bang, So-Young; Lee, Hye-Soon] Hanyang Univ, Guri Hosp, Dept Internal Med, Div Rheumatol, Guri, South Korea; [Suh, Chang-Hee; Jung, Ju Yang] Ajou Univ Hosp, Dept Internal Med, Div Rheumatol, Suwon, South Korea; [Son, Chang-Nam] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Rheumatol, Daegu, South Korea; [Shim, Seung Cheol] Chungnam Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Daejeon, South Korea; [Lee, Sang-Hoon] Kyung Hee Univ Hosp Gangdong, Ctr Arthrit & Rheumatism, Dept Rheumatol, Seoul, South Korea; [Lee, Seung-Geun] Pusan Natl Univ Hosp, Div Rheumatol, Dept Internal Med, Busan, South Korea; [Lee, Yeon-Ah] Kyung Hee Univ, Med Ctr, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Lee, Eun Young] Seoul Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Seoul 110744, South Korea; [Kim, Tae-Hwan] Hanyang Univ Hosp Rheumat Dis, Div Rheumatol, Seoul, South Korea; [Kim, Yong-Gil] Univ Ulsan, Coll Med, Asan Med Ctr, Div Rheumatol,Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Inha University; Catholic University of Daegu; Gachon University; Hanyang University; Ajou University; Ajou University Hospital; Keimyung University; Chungnam National University; Chungnam National University Hospital; Kyung Hee University; Kyung Hee University Hospital; Pusan National University; Pusan National University Hospital; Kyung Hee University; Seoul National University (SNU); Seoul National University Hospital; Hanyang University; Hanyang University Hospital; University of Ulsan; Asan Medical Center	Kim, TH (corresponding author), Hanyang Univ Hosp Rheumat Dis, Div Rheumatol, Seoul, South Korea.; Kim, YG (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Rheumatol,Dept Internal Med, Seoul, South Korea.	thkim@hanyang.ac.kr; bestmd2000@amc.seoul.kr	KWON, SEONG-RYUL/GWN-2603-2022; Song, Young Goo/AGV-5104-2022; Suh, Chang-Hee/H-9723-2019	Song, Young Goo/0000-0002-0733-4156; Suh, Chang-Hee/0000-0001-6156-393X; Park, Min-Chan/0000-0003-1189-7637; Shim, Seung cheol/0000-0002-3199-359X; Lee, Seung-Geun/0000-0002-5205-3978				Abreu C, 2013, J CROHNS COLITIS, V7, P175, DOI [10.1016/j.crohns.2012.04.018, 10.1016/j.crohns.2013.03.004]; [Anonymous], 2005, THORAX, V60, P800, DOI DOI 10.1136/THX.2005.046797; Baraliakos X, 2005, ARTHRITIS RES THER, V7, pR439, DOI 10.1186/ar1693; Baraliakos X, 2012, RHEUMATOLOGY, V51, P1378, DOI 10.1093/rheumatology/kes026; Baronnet L, 2011, JOINT BONE SPINE, V78, P279, DOI 10.1016/j.jbspin.2010.12.004; Brandt J, 2000, ARTHRITIS RHEUM-US, V43, P1346, DOI 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E; Braun J, 2015, EXPERT OPIN EMERG DR, V20, P1, DOI 10.1517/14728214.2015.993378; Cantini F, 2014, J RHEUMATOL, V41, P78, DOI 10.3899/jrheum.140106; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Denis B, 2008, CLIN MICROBIOL INFEC, V14, P183, DOI 10.1111/j.1469-0691.2007.01891.x; Ergun T, 2015, INT J DERMATOL, V54, P594, DOI 10.1111/ijd.12628; Evangelopoulos D, 2015, INT J INFECT DIS, V32, P76, DOI 10.1016/j.ijid.2014.11.028; Gomez-Reino JJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P756, DOI 10.1002/art.22768; Grijalva CG, 2011, JAMA-J AM MED ASSOC, V306, P2331, DOI 10.1001/jama.2011.1692; Joint Committee for the Revision of Korean Guidelines for Tuberculosis KCfDCaP, 2014, JOINT COMMITTEE FOR; Jung SM, 2015, INT J RHEUM DIS, V18, P323, DOI 10.1111/1756-185X.12530; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kim HW, 2014, CLIN RHEUMATOL, V33, P1307, DOI 10.1007/s10067-013-2387-z; Kim YJ, 2014, RHEUMATOLOGY, V53, P1477, DOI 10.1093/rheumatology/keu041; Lee YM, 2014, J INFECTION, V69, P165, DOI 10.1016/j.jinf.2014.02.019; Mariette X, 2003, Ann Rheum Dis, V62, P791, DOI 10.1136/ard.62.8.791; Maxwell LJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005468.pub2; Poddubnyy D, 2013, THER ADV MUSCULOSKEL, V5, P45, DOI 10.1177/1759720X12468658; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Suh YS, 2014, J KOREAN MED SCI, V29, P38, DOI 10.3346/jkms.2014.29.1.38; Tam LS, 2010, CLIN EXP RHEUMATOL, V28, P679; Toussi SS, 2013, CLIN INFECT DIS, V57, P1318, DOI 10.1093/cid/cit489; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wallis RS, 2009, CLIN INFECT DIS, V48, P1429, DOI 10.1086/598504; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153816	10.1371/journal.pone.0153816	http://dx.doi.org/10.1371/journal.pone.0153816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101309	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500071
J	Li, R; Dudemaine, PL; Zhao, X; Lei, CZ; Ibeagha-Awemu, EM				Li, Ran; Dudemaine, Pier-Luc; Zhao, Xin; Lei, Chuzhao; Ibeagha-Awemu, Eveline Mengwi			Comparative Analysis of the miRNome of Bovine Milk Fat, Whey and Cells	PLOS ONE			English	Article							IMMUNE-RELATED MICRORNAS; MAMMARY-GLAND; GENE-EXPRESSION; MESSENGER-RNA; SOMATIC-CELLS; TRANSCRIPTOME; LACTATION; IDENTIFICATION; ADAPTATION; SEQUENCES	Abundant miRNAs have been identified in milk and mammary gland tissues of different species. Typically, RNA in milk can be extracted from different fractions including fat, whey and cells and the mRNA transcriptome of milk could serve as an indicator of the transcriptome of mammary gland tissue. However, it has not been adequately validated if the miRNA transcriptome of any milk fraction could be representative of that of mammary gland tissue. The objectives of this study were to (1) characterize the miRNA expression spectra from three milk fractions-fat, whey and cells; (2) compare miRNome profiles of milk fractions (fat, whey and cells) with mammary gland tissue miRNome, and (3) determine which milk fraction miRNome profile could be a better representative of the miRNome profile of mammary gland tissue. Milk from four healthy Canadian Holstein cows in mid lactation was collected and fractionated. Total RNA extracted from each fraction was used for library preparation followed by small RNA sequencing. In addition, miRNA transcripts of mammary gland tissues from twelve Holstein cows in our previous study were used to compare our data. We identified 210, 200 and 249 known miRNAs from milk fat, whey and cells, respectively, with 188 universally expressed in the three fractions. In addition, 33, 31 and 36 novel miRNAs from milk fat, whey and cells were identified, with 28 common in the three fractions. Among 20 most highly expressed miRNAs in each fraction, 14 were expressed in common and 11 were further shared with mammary gland tissue. The three milk fractions demonstrated a clear separation from each other using a hierarchical cluster analysis with milk fat and whey being most closely related. The miRNome correlation between milk fat and mammary gland tissue (r(mean) = 0.866) was significantly higher than the other two pairs (p < 0.01), whey/mammary gland tissue (r(mean) = 0.755) and milk cell/mammary gland tissue (r(mean) = 0.75), suggesting that milk fat could be an alternative non-invasive source of RNA in assessing miRNA activities in bovine mammary gland. Predicted target genes (1802) of 14 highly expressed miRNAs in milk fractions were enriched in fundamental cellular functions, infection, organ and tissue development. Furthermore, some miRNAs were highly enriched (FDR < 0.05) in milk whey (3), cells (11) and mammary gland tissue (14) suggesting specific regulatory functions in the various fractions. In conclusion, we have obtained a comprehensive miRNA profile of the different milk fractions using high throughput sequencing. Our comparative analysis showed that miRNAs from milk fat accurately portrayed the miRNome of mammary gland tissue. Functional annotation of the top expressed miRNAs in milk confirmed their critical regulatory roles in mammary gland functions and potentially to milk recipients.	[Li, Ran; Zhao, Xin; Lei, Chuzhao] Northwest A&F Univ, Coll Anim Sci & Technol, Xian 712100, Shaanxi, Peoples R China; [Li, Ran; Dudemaine, Pier-Luc; Ibeagha-Awemu, Eveline Mengwi] Agr & Agri Food Canada, Sherbrooke Res & Dev Ctr, Sherbrooke, PQ J1M 0C8, Canada; [Zhao, Xin] McGill Univ, Dept Anim Sci, 21111 Lakeshore Rd, Ste Anne De Bellevue, PQ J1M 0C8, Canada	Northwest A&F University - China; Agriculture & Agri Food Canada; McGill University	Lei, CZ; Ibeagha-Awemu, EM (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Xian 712100, Shaanxi, Peoples R China.; Ibeagha-Awemu, EM (corresponding author), Agr & Agri Food Canada, Sherbrooke Res & Dev Ctr, Sherbrooke, PQ J1M 0C8, Canada.	leichuzhao1118@126.com; eveline.ibeagha-awemu@agr.gc.ca	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332; Ibeagha-Awemu, Eveline/0000-0001-8810-9294	Agriculture and Agri-Food Canada [J-000733]; National Science Foundation of China [31372282]; China Scholarship Council [201206300128]	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by funding from Agriculture and Agri-Food Canada (grant number J-000733) to EIA and from National Science Foundation of China (grant number 31372282) to XZ. Ran Li was supported by a doctoral fellowship from the China Scholarship Council (201206300128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaweed M, 2015, J CELL BIOCHEM, V116, P2397, DOI 10.1002/jcb.25207; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boutinaud M, 2002, J ANIM SCI, V80, P1258; Brenaut P, 2012, J DAIRY SCI, V95, P6130, DOI 10.3168/jds.2012-5604; Bu DP, 2015, J DAIRY SCI, V98, P1696, DOI 10.3168/jds.2014-8217; Canovas A, 2013, J DAIRY SCI, V96, P2637, DOI 10.3168/jds.2012-6213; Canovas A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05297; Chen T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-100; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Cui W, 2011, MOL CELL BIOCHEM, V355, P17, DOI 10.1007/s11010-011-0834-1; Finucane KA, 2008, FUNCT INTEGR GENOMIC, V8, P251, DOI 10.1007/s10142-008-0074-y; Fordham JB, 2015, J LEUKOCYTE BIOL, V67, P609; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Fu XH, 2015, J CLIN INVEST, V125, P2497, DOI 10.1172/JCI75438; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Howard KM, 2015, J AGR FOOD CHEM, V63, P588, DOI 10.1021/jf505526w; HUSTON GE, 1990, J DAIRY SCI, V73, P2061, DOI 10.3168/jds.S0022-0302(90)78885-6; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Izumi H, 2015, J DAIRY SCI, V98, P2920, DOI 10.3168/jds.2014-9076; Izumi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088843; Izumi Hirohisa, 2013, Methods Mol Biol, V1024, P191, DOI 10.1007/978-1-62703-453-1_15; Jin WW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-181; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Krappmann K, 2012, RES VET SCI, V93, P970, DOI 10.1016/j.rvsc.2011.12.021; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Guillou S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091938; Lemay DG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-872; Li R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1965-7; Li R, 2015, INT J MOL SCI, V16, P4997, DOI 10.3390/ijms16034997; Li Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-731; Liu YL, 2015, LIFE SCI, V122, P26, DOI 10.1016/j.lfs.2014.11.023; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; McLean CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127089; Melnik BC, 2014, J TRANSL MED, V12, P153; Melnik BC, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-103; Modepalli V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1012; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Murrieta CM, 2006, J ANIM SCI, V84, P2399, DOI 10.2527/jas.2005-677; Nissen A, 2013, J DAIRY SCI, V96, P7854, DOI 10.3168/jds.2013-7106; Pandey A, 2015, J NEUROCHEM, V133, P640, DOI 10.1111/jnc.13089; Power ML, 2013, APPL TRANSL GENOM, V2, P55, DOI 10.1016/j.atg.2013.06.001; Sun JJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2044-9; Sun Q, 2013, PROTEIN CELL, V4, P197, DOI 10.1007/s13238-013-2119-9; Vigneault Francois, 2012, Curr Protoc Hum Genet, VChapter 11, DOI 10.1002/0471142905.hg1112s73; Wang M, 2012, J DAIRY SCI, V95, P6529, DOI 10.3168/jds.2012-5748; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wicik Z, 2016, J ANIM BREED GENET, V133, P31, DOI 10.1111/jbg.12172; Yamin HB, 2014, MOL NUTR FOOD RES, V58, P1061, DOI 10.1002/mnfr.201300650; Zempleni J, 2015, CAN J PHYSIOL PHARM, V93, P1097, DOI 10.1139/cjpp-2014-0392; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	55	26	26	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154129	10.1371/journal.pone.0154129	http://dx.doi.org/10.1371/journal.pone.0154129			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100870	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500152
J	Rajhi, M; Ghedira, K; Chouikha, A; Djebbi, A; Cheikh, I; Ben Yahia, A; Sadraoui, A; Hammami, W; Azouz, M; Ben Mami, N; Triki, H				Rajhi, Mouna; Ghedira, Kais; Chouikha, Anissa; Djebbi, Ahlem; Cheikh, Imed; Ben Yahia, Ahlem; Sadraoui, Amel; Hammami, Walid; Azouz, Msaddek; Ben Mami, Nabil; Triki, Henda			Phylogenetic Analysis and Epidemic History of Hepatitis C Virus Genotype 2 in Tunisia, North Africa	PLOS ONE			English	Article							GENETIC DIVERSITY; WEST-AFRICA; MOLECULAR EPIDEMIOLOGY; RAPID TRANSMISSION; INFECTION; SUBTYPES; SEQUENCES; PATTERNS; STRAINS; CAMEROON	HCV genotype 2 (HCV-2) has a worldwide distribution with prevalence rates that vary from country to country. High genetic diversity and long-term endemicity were suggested in West African countries. A global dispersal of HCV-2 would have occurred during the 20th century, especially in European countries. In Tunisia, genotype 2 was the second prevalent genotype after genotype 1 and most isolates belong to subtypes 2c and 2k. In this study, phylogenetic analyses based on the NS5B genomic sequences of 113 Tunisian HCV isolates from subtypes 2c and 2k were carried out. A Bayesian coalescent-based framework was used to estimate the origin and the spread of these subtypes circulating in Tunisia. Phylogenetic analyses of HCV-2c sequences suggest the absence of country-specific or time-specific variants. In contrast, the phylogenetic grouping of HCV-2k sequences shows the existence of two major genetic clusters that may represent two distinct circulating variants. Coalescent analysis indicated a most recent common ancestor (tMRCA) of Tunisian HCV-2c around 1886 (1869-1902) before the introduction of HCV-2k in 1901 (1867-1931). Our findings suggest that the introduction of HCV-2c in Tunisia is possibly a result of population movements between Tunisia and European population following the French colonization.	[Rajhi, Mouna; Ghedira, Kais; Chouikha, Anissa; Djebbi, Ahlem; Ben Yahia, Ahlem; Sadraoui, Amel; Hammami, Walid; Triki, Henda] Inst Pasteur, Tunis, Tunisia; [Rajhi, Mouna; Chouikha, Anissa; Djebbi, Ahlem; Ben Yahia, Ahlem; Sadraoui, Amel; Hammami, Walid; Triki, Henda] WHO Reg Reference Lab Poliomyelitis & Measles, Lab Clin Virol, Tunis, Tunisia; [Ghedira, Kais] Lab Bioinformat Math & Stat, Tunis, Tunisia; [Ben Mami, Nabil] La Rabta Hosp, Dept Gastroenterol, Tunis, Tunisia; [Cheikh, Imed] Reg Hosp Bizerte, Dept Gastroenterol, Bizerte, Tunisia; [Azouz, Msaddek] Reg Hosp Nabeul, Dept Gastroenterol, Nabeul, Tunisia; [Ghedira, Kais; Triki, Henda] Univ Tunis El Manar, Tunis 1036, Tunisia; [Rajhi, Mouna] Univ Carthage, Fac Sci, Bizerte, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Hopital La Rabta; Universite de Tunis-El-Manar; Universite de Carthage	Rajhi, M (corresponding author), Inst Pasteur, Tunis, Tunisia.; Rajhi, M (corresponding author), WHO Reg Reference Lab Poliomyelitis & Measles, Lab Clin Virol, Tunis, Tunisia.; Rajhi, M (corresponding author), Univ Carthage, Fac Sci, Bizerte, Tunisia.	rajhimouna@yahoo.fr	CHOUIKHA, Anissa/AAO-9251-2020	CHOUIKHA, Anissa/0000-0001-5616-0204; Ghedira, Kais/0000-0002-3387-6493	Tunisian Ministry for High Education and Scientific Research [LR11-IPT09]	Tunisian Ministry for High Education and Scientific Research	This study was totally supported by the Tunisian Ministry for High Education and Scientific Research (Grant LR11-IPT09).	Al Naamani K, 2013, CAN J GASTROENTEROL, V27, pE8, DOI 10.1155/2013/624986; Ansaldi F, 2005, J MED VIROL, V76, P327, DOI 10.1002/jmv.20376; Ben Othman S, 2004, J VIROL METHODS, V119, P177, DOI 10.1016/j.jviromet.2004.03.002; Brahim I, 2012, ARCH VIROL, V157, P515, DOI 10.1007/s00705-011-1193-7; Campiotto S, 2005, BRAZ J MED BIOL RES, V38, P41, DOI 10.1590/S0100-879X2005000100007; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; Cantaloube JF, 2008, J MED VIROL, V80, P1732, DOI 10.1002/jmv.21285; Cavalcante LN, 2015, WORLD J HEPATOL, V7, P1617, DOI 10.4254/wjh.v7.i12.1617; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cristina Juan, 2005, J Clin Virol, V34 Suppl 2, pS1; Daw MA, 2012, SCI WORLD J, V2012, DOI DOI 10.1100/2012/719494; Djebbi A, 2003, EPIDEMIOL INFECT, V130, P501, DOI 10.1017/S095026880300846X; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ezequiel R, 2012, FUTURE VIROL, V7, P1089; Gelman A, 1998, STAT SCI, V13, P163; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Jeannel D, 1998, J MED VIROL, V55, P92, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;92::AID-JMV2&gt;3.0.CO;2-I; Jordier F, 2013, J MED VIROL, V85, P1754, DOI 10.1002/jmv.23674; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Li CH, 2012, J GEN VIROL, V93, P1173, DOI 10.1099/vir.0.038315-0; Marascio N, 2014, INFECT GENET EVOL, V26, P352, DOI 10.1016/j.meegid.2014.06.006; Markov PV, 2012, J VIROL, V86, P7677, DOI 10.1128/JVI.06910-11; Markov PV, 2009, J GEN VIROL, V90, P2086, DOI 10.1099/vir.0.011569-0; Martial J, 2004, J CLIN MICROBIOL, V42, P784, DOI 10.1128/JCM.42.2.784-791.2004; Mejri S, 2005, J MED VIROL, V76, P185, DOI 10.1002/jmv.20342; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Njouom R, 2007, INFECT GENET EVOL, V7, P361, DOI 10.1016/j.meegid.2006.10.003; Njouom R, 2009, J GEN VIROL, V90, P2452, DOI 10.1099/vir.0.011981-0; OGATA Y, 1989, NUMER MATH, V55, P137, DOI 10.1007/BF01406511; Pouillot R, 2008, INFECT GENET EVOL, V8, P676, DOI 10.1016/j.meegid.2008.06.001; Pujol FH, 2007, J CLIN GASTROENTEROL, V41, P518, DOI 10.1097/01.mcg.0000248010.55149.ce; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Quarleri JF, 2000, J CLIN MICROBIOL, V38, P4560, DOI 10.1128/JCM.38.12.4560-4568.2000; Rajhi M, 2014, VIRUS GENES, V48, P209, DOI 10.1007/s11262-013-1010-3; Re VE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019471; Ruggieri A, 1996, J GEN VIROL, V77, P2073, DOI 10.1099/0022-1317-77-9-2073; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Sulbaran MZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014315; Thomas F, 2007, J MED VIROL, V79, P26, DOI 10.1002/jmv.20765; Wantuck JM, 2014, ALIMENT PHARM THER, V39, P137, DOI 10.1111/apt.12551; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153761	10.1371/journal.pone.0153761	http://dx.doi.org/10.1371/journal.pone.0153761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100294	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500064
J	Sepsiova, R; Necasova, I; Willcox, S; Prochazkova, K; Gorilak, P; Nosek, J; Hofr, C; Griffith, JD; Tomaska, L				Sepsiova, Regina; Necasova, Ivona; Willcox, Smaranda; Prochazkova, Katarina; Gorilak, Peter; Nosek, Jozef; Hofr, Ctirad; Griffith, Jack D.; Tomaska, Lubomir			Evolution of Telomeres in Schizosaccharomyces pombe and Its Possible Relationship to the Diversification of Telomere Binding Proteins	PLOS ONE			English	Article							MYB-DOMAIN PROTEIN; FISSION YEAST; HUMAN RAP1; USTILAGO-MAYDIS; TAY1 PROTEIN; DNA; TAZ1; TRF2; IDENTIFICATION; SEQUENCE	Telomeres of nuclear chromosomes are usually composed of an array of tandemly repeated sequences that are recognized by specific Myb domain containing DNA-binding proteins (telomere-binding proteins, TBPs). Whereas in many eukaryotes the length and sequence of the telomeric repeat is relatively conserved, telomeric sequences in various yeasts are highly variable. Schizosaccharomyces pombe provides an excellent model for investigation of co-evolution of telomeres and TBPs. First, telomeric repeats of S. pombe differ from the canonical mammalian type TTAGGG sequence. Second, S. pombe telomeres exhibit a high degree of intratelomeric heterogeneity. Third, S. pombe contains all types of known TBPs (Rap1p [a version unable to bind DNA], Tay1p/Teb1p, and Taz1p) that are employed by various yeast species to protect their telomeres. With the aim of reconstructing evolutionary paths leading to a separation of roles between Teb1p and Taz1p, we performed a comparative analysis of the DNA-binding properties of both proteins using combined qualitative and quantitative biochemical approaches. Visualization of DNA-protein complexes by electron microscopy revealed qualitative differences of binding of Teb1p and Taz1p to mammalian type and fission yeast telomeres. Fluorescence anisotropy analysis quantified the binding affinity of Teb1p and Taz1p to three different DNA substrates. Additionally, we carried out electrophoretic mobility shift assays using mammalian type telomeres and native substrates (telomeric repeats, histone-box sequences) as well as their mutated versions. We observed relative DNA sequence binding flexibility of Taz1p and higher binding stringency of Teb1p when both proteins were compared directly to each other. These properties may have driven replacement of Teb1p by Taz1p as the TBP in fission yeast.	[Sepsiova, Regina; Prochazkova, Katarina; Gorilak, Peter; Tomaska, Lubomir] Comenius Univ, Dept Genet, Fac Nat Sci, Ilkovicova 6, Bratislava 84215, Slovakia; [Necasova, Ivona; Hofr, Ctirad] Masaryk Univ, Chromatin Mol Complexes, Cent European Inst Technol, CZ-62500 Brno, Czech Republic; [Necasova, Ivona; Hofr, Ctirad] Masaryk Univ, Lab Funct Genom & Prote, Fac Sci, Natl Ctr Biomol Res, CZ-62500 Brno, Czech Republic; [Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Nosek, Jozef] Comenius Univ, Dept Biochem, Fac Nat Sci, Ilkovicova 6, Bratislava 84215, Slovakia	Comenius University Bratislava; Masaryk University Brno; Masaryk University Brno; University of North Carolina; University of North Carolina Chapel Hill; Comenius University Bratislava	Tomaska, L (corresponding author), Comenius Univ, Dept Genet, Fac Nat Sci, Ilkovicova 6, Bratislava 84215, Slovakia.	tomaska@fns.uniba.sk	Nečasová, Ivona/ABB-7674-2020; Prochazkova, Katarina/ABE-1222-2021; Tomaska, Lubomir/I-3071-2014; Nosek, Jozef/A-7581-2008; Gorilák, Peter/O-3519-2017	Prochazkova, Katarina/0000-0003-4147-6577; Tomaska, Lubomir/0000-0003-4886-1910; Nosek, Jozef/0000-0002-1020-5451; Gorilák, Peter/0000-0002-5119-7144; Sepsiova, Regina/0000-0002-8709-7882	Slovak grant agencies APVV [0035-11, 14-0253]; VEGA [1/0311/12, 1/0052/16, 1/0333/15]; National Institutes of Health [2R01ES013773-06A1, GM31819]; Czech Science Foundation [GACR P205/12/0550]; Ministry of Education, Youth and Sports of Czech Republic [LH13054]; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013773, R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	Slovak grant agencies APVV(Slovak Research and Development Agency); VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Slovak grant agencies APVV (http://www.apvv.sk/agentura?lang=en) [0035-11 (LT) and 14-0253 (JN)], VEGA (https://www.minedu.sk/about-the-ministry/) [1/0311/12 and 1/0052/16 (LT) and 1/0333/15 (JN)], National Institutes of Health (http://www.nih.gov) [2R01ES013773-06A1 and GM31819 (JDG)], the Czech Science Foundation (http://gacr.cz/en/)[GACR P205/12/0550 to CH] and the Ministry of Education, Youth and Sports of Czech Republic (http://www.msmt.cz/?lang=2) [LH13054 to CH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arat NO, 2012, J BIOL CHEM, V287, P41583, DOI 10.1074/jbc.M112.415984; Brevet V, 2003, EMBO J, V22, P1697, DOI 10.1093/emboj/cdg155; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P5086, DOI 10.1128/MCB.8.12.5086; Cisse OH, 2013, MBIO, V4, DOI 10.1128/mBio.00055-13; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Deng W, 2015, CELL RES, V25, P881, DOI 10.1038/cr.2015.76; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunisova S, 2009, RNA, V15, P546, DOI 10.1261/rna.1194009; GUZMAN PA, 1994, MICROBIOL-UK, V140, P551, DOI 10.1099/00221287-140-3-551; Henning KA, 1998, P NATL ACAD SCI USA, V95, P5667, DOI 10.1073/pnas.95.10.5667; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hiraoka Y, 1998, TRENDS BIOCHEM SCI, V23, P126, DOI 10.1016/S0968-0004(98)01176-1; Hogues H, 2008, MOL CELL, V29, P552, DOI 10.1016/j.molcel.2008.02.006; Janouskova E, 2015, NUCLEIC ACIDS RES, V43, P2691, DOI 10.1093/nar/gkv097; Jin Y, 2002, GENETICS, V160, P861; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Kinsky S, 2010, CURR GENET, V56, P413, DOI 10.1007/s00294-010-0310-6; Klutstein M, 2015, NAT CELL BIOL, V17, P458, DOI 10.1038/ncb3132; Kramara J, 2010, J BIOL CHEM, V285, P38078, DOI 10.1074/jbc.M110.127605; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lue NF, 2010, TRENDS BIOCHEM SCI, V35, P8, DOI 10.1016/j.tibs.2009.08.006; Lukes J, 2011, IUBMB LIFE, V63, P528, DOI 10.1002/iub.489; Lustig AJ, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00010; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; MCEACHERN MJ, 1994, P NATL ACAD SCI USA, V91, P3453, DOI 10.1073/pnas.91.8.3453; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Pitt CW, 2008, J BIOL CHEM, V283, P2693, DOI 10.1074/jbc.M708784200; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rhodin Edso Jenny, 2011, Genome Integr, V2, P2, DOI 10.1186/2041-9414-2-2; Sanchez-Alonso P, 2008, FUNGAL GENET BIOL, V45, pS54, DOI 10.1016/j.fgb.2008.04.009; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Spink KG, 2000, NUCLEIC ACIDS RES, V28, P527, DOI 10.1093/nar/28.2.527; Stansel RM, 2001, EMBO J, V20, P5532; Steinberg-Neifach O, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00162; Steinberg-Neifach O, 2015, NUCLEIC ACIDS RES, V43, P2164, DOI 10.1093/nar/gkv092; Sugawara N. F., 1988, THESIS HARVARD U; Tomaska L, 2004, J BIOL CHEM, V279, P50764, DOI 10.1074/jbc.M409790200; Valente LP, 2013, EMBO J, V32, P450, DOI 10.1038/emboj.2012.339; Vassetzky NS, 1999, NUCLEIC ACIDS RES, V27, P4687, DOI 10.1093/nar/27.24.4687; Visacka K, 2012, J BIOL CHEM, V287, P32206, DOI 10.1074/jbc.M112.385591; Yu EY, 2010, MOL CELL BIOL, V30, P1254, DOI 10.1128/MCB.00986-09	53	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154225	10.1371/journal.pone.0154225	http://dx.doi.org/10.1371/journal.pone.0154225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101289	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500167
J	Kjaergaard, J; Stensballe, LG; Birk, NM; Nissen, TN; Foss, KT; Thostesen, LM; Pihl, GT; Andersen, A; Kofoed, PE; Pryds, O; Greisen, G				Kjaergaard, Jesper; Stensballe, Lone Graff; Birk, Nina Marie; Nissen, Thomas Norrelykke; Foss, Kim Thestrup; Thostesen, Lisbeth Marianne; Pihl, Gitte Thybo; Andersen, Andreas; Kofoed, Poul-Erik; Pryds, Ole; Greisen, Gorm			Lack of a Negative Effect of BCG-Vaccination on Child Psychomotor Development: Results from the Danish Calmette Study - A Randomised Clinical Trial	PLOS ONE			English	Article							GUINEA-BISSAU; GUERIN VACCINATION; INFANTS; BIRTH; SCAR; TUBERCULOSIS; MORBIDITY; SURVIVAL; NEWBORNS; DISEASE	Objectives To assess the non-specific effect of Bacillus Calmette-Guerin (BCG) vaccination at birth on psychomotor development. Design This is a pre-specified secondary outcome from a randomised, clinical trial. Setting Maternity units and paediatric wards at three university hospitals in Denmark. Participants Children born at gestational age (GA) 32 weeks and above. All women planning to give birth at the three sites were invited during the recruitment period. Out of 4262 randomised children, 144 were premature (GA < 37 weeks). There were 2129 children (71 premature) randomised to BCG and 2133 randomised (73 premature) to the control group. Interventions BCG vaccination 0.05 ml was given intradermally in the upper left arm at the hospital within seven days of birth. Children in the control group did not receive any intervention. Parents were not blinded to allocation. Main outcome measures Psychomotor development measured using Ages and Stages Questionnaire (ASQ) completed by the parents at 12 months. Additionally, parents of premature children (gestational age < 37 weeks) completed an ASQ at 6 and 22 months. Developmental assessment was available for 3453/4262 (81%). Results The mean difference in ASQ score at 12 months adjusted for age and prematurity was -0.7 points (BCG vs. control, 95% confidence interval; -3.7 to 2.4), p = 0.67, corresponding to an effect size of Cohen's d = -0.015 (-0.082 to 0.052). The mean difference in ASQ score for premature children at 22 months was -7.8 points (-20.6 to 5.0, p = 0.23), d = -0.23 (-0.62 to 0.15). Conclusions A negative non-specific effect of BCG vaccination at birth on psychomotor development was excluded in term children.	[Kjaergaard, Jesper; Stensballe, Lone Graff] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Dept Paediat & Adolescent Med, Copenhagen, Denmark; [Kjaergaard, Jesper; Greisen, Gorm] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Neonatal Dept, Copenhagen, Denmark; [Birk, Nina Marie; Nissen, Thomas Norrelykke; Pryds, Ole] Copenhagen Univ Hosp Hvidovre, Dept Paediat 460, Hvidovre, Denmark; [Foss, Kim Thestrup] Copenhagen Univ Hosp Herlev, Dept Neurol, Herlev, Denmark; [Thostesen, Lisbeth Marianne; Pihl, Gitte Thybo; Kofoed, Poul-Erik] Univ Southern Denmark, Dept Paediat, Kolding Hosp, Kolding, Denmark; [Andersen, Andreas] Statens Serum Inst, Res Ctr Vitamins & Vaccines CVIVA, Bandim Hlth Project, Artillerivej 5, DK-2300 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Kolding Hospital; University of Southern Denmark; Statens Serum Institut	Kjaergaard, J (corresponding author), Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Dept Paediat & Adolescent Med, Copenhagen, Denmark.; Kjaergaard, J (corresponding author), Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Neonatal Dept, Copenhagen, Denmark.	Jesper.kjaergaard@regionh.dk	Stensballe, Lone Graff/AAS-4137-2020; Greisen, Gorm/AAA-6463-2022	Stensballe, Lone Graff/0000-0003-1569-153X; Greisen, Gorm/0000-0001-8042-3262; Kjaergaard, Jesper/0000-0003-2181-4743; Nissen, Thomas Norrelykke/0000-0001-8565-9629; Foss, Kim/0000-0002-8442-7436; Pihl, Gitte/0000-0002-2227-5860	Danish National Research Foundation [DNRF108]; Rigshospitalets Forskningsfond; Dagmar Marshall fonden; Else og Mogens Wedell Wedellsborgs fond; Christian Larsen og Dommer Ellen Larsens Fond	Danish National Research Foundation(Danmarks Grundforskningsfond); Rigshospitalets Forskningsfond; Dagmar Marshall fonden; Else og Mogens Wedell Wedellsborgs fond; Christian Larsen og Dommer Ellen Larsens Fond	The Danish National Research Foundation provided a grant (DNRF108) for their Center of Excellency - Center for Vaccines and Vitamins (www.cviva.dk), who allocated part of the grant to the condution of The Danish Calmette Study. JK received addtional funding from Rigshospitalets Forskningsfond, Dagmar Marshall fonden, Else og Mogens Wedell Wedellsborgs fond, and Christian Larsen og Dommer Ellen Larsens Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Bilbo SD, 2012, FRONT NEUROENDOCRIN, V33, P267, DOI 10.1016/j.yfrne.2012.08.006; Chau K, 2015, PEDIATR DRUGS, V17, P17, DOI 10.1007/s40272-014-0105-1; COLDITZ GA, 1995, PEDIATRICS, V96, P29; Czeh M, 2011, DEV NEUROSCI-BASEL, V33, P199, DOI 10.1159/000328989; Grange J M, 1998, Commun Dis Public Health, V1, P84; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Jensen KJ, 2015, J INFECT DIS, V211, P956, DOI 10.1093/infdis/jiu508; Johansen A, 2009, DANSKE BORNS SUNDHED; Keogh MJ, 2012, AM J PHYSIOL-REG I, V303, pR270, DOI 10.1152/ajpregu.00216.2012; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Pereira SM, 2007, REV SAUDE PUBL, V41, DOI 10.1590/S0034-89102007000800009; Petersen SM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-126; Plomgaard AM, 2006, ACTA PAEDIATR, V95, P1488, DOI 10.1080/08035250600684438; Ristori G, 2014, NEUROLOGY, V82, P41, DOI 10.1212/01.wnl.0000438216.93319.ab; Ritz N, 2008, FEMS MICROBIOL REV, V32, P821, DOI 10.1111/j.1574-6976.2008.00118.x; Roth A, 2005, INT J EPIDEMIOL, V34, P540, DOI 10.1093/ije/dyh392; Roth A, 2006, EPIDEMIOLOGY, V17, P562, DOI 10.1097/01.ede.0000231546.14749.ab; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Shastri A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/342931; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Squires J., 1999, ASQ USERS GUIDE AGES; Statens Serum Institut, 2015, PRODUCT INFORM; Steenhuis TJ, 2008, CLIN EXP ALLERGY, V38, P79, DOI 10.1111/j.1365-2222.2007.02859.x; Stensballe LG, 2005, VACCINE, V23, P1251, DOI 10.1016/j.vaccine.2004.09.006; Storgaard L, 2015, CLIN INFECT DIS, V61, P950, DOI 10.1093/cid/civ452; Thostesen LM, 2015, CONTEMP CLIN TRIALS, V42, P213, DOI 10.1016/j.cct.2015.04.006; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; World Health Organization, 2004, Weekly Epidemiological Record, V79, P27	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2016	11	4							e0154541	10.1371/journal.pone.0154541	http://dx.doi.org/10.1371/journal.pone.0154541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK8XE	27123570	Green Published, Green Submitted, gold			2022-12-27	WOS:000375211700102
J	Li, GP; Reisig, D; Miao, J; Gould, F; Huang, FN; Feng, HQ				Li, Guoping; Reisig, Dominic; Miao, Jin; Gould, Fred; Huang, Fangneng; Feng, Hongqiang			Frequency of Cry1F Non-Recessive Resistance Alleles in North Carolina Field Populations of Spodoptera frugiperda (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							FALL ARMYWORM LEPIDOPTERA; HELICOVERPA-ZEA LEPIDOPTERA; HYBRIDS EXPRESSING CRY1F; EUROPEAN CORN-BORER; BT TRANSGENIC CORN; UNITED-STATES; PUERTO-RICO; COTTON; MAIZE; SINGLE	Fall armyworm, Spodoptera frugiperda (J.E. Smith) (Lepidoptera: Noctuidae), is a target species of transgenic corn (Zea mays L.) that expresses single and pyramided Bacillus thuringiensis (Bt) toxin. In 2014, S. frugiperda were collected from a light trap in North Carolina, and a total of 212 F-1/F-2 isofemale lines of S. frugiperda were screened for resistance to Bt and non-Bt corn. All of the 212 isolines were susceptible to corn tissue expressing Cry1A.105 + Cry2Ab, Cry1F + Cry1A.105 + Cry2Ab, and Cry1F + Cry1Ab + Vip3Aa20. Growth rate bioassays were performed to isolate non-recessive Bt resistance alleles. Seven individuals out of the 212 isofemale lines carried major non-recessive alleles conferring resistance to Cry1F. A pooled colony was created from the seven individuals. This colony was 151.21 times more resistant to Cry1F than a known-susceptible population and was also resistant to Cry1A.105, but was not resistant to Cry2Ab and Vip3Aa20. The results demonstrate that field populations of S. frugiperda collected from North Carolina are generally susceptible to Cry1F, but that some individuals carry resistant alleles. The data generated in this study can be used as baseline data for resistance monitoring.	[Li, Guoping; Reisig, Dominic; Miao, Jin] N Carolina State Univ, Dept Entomol, Vernon G James Res & Extens Ctr, 207 Res Stn Rd, Plymouth, NC 27962 USA; [Li, Guoping; Miao, Jin; Feng, Hongqiang] Henan Acad Agr Sci, Henan Key Lab Crop Pest Control, MOAS Reg Key Lab Crop IPM Southern Part Northern, Inst Plant Protect, Zhengzhou 450002, Peoples R China; [Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Huang, Fangneng] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA	University of North Carolina; North Carolina State University; Henan Academy of Agricultural Sciences; University of North Carolina; North Carolina State University; Louisiana State University System; Louisiana State University	Reisig, D (corresponding author), N Carolina State Univ, Dept Entomol, Vernon G James Res & Extens Ctr, 207 Res Stn Rd, Plymouth, NC 27962 USA.	ddreisig@ncsu.edu		Reisig, Dominic/0000-0002-9979-5813; Feng, Hongqiang/0000-0002-1171-248X	Reisig laboratory; Key project for Breeding Genetically modified Organisms [2014ZX08012-004, 2016ZX08012004-007, 2016ZX08012-004]; China scholarship Council [2011841039]; Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences [2016YQ15]	Reisig laboratory; Key project for Breeding Genetically modified Organisms; China scholarship Council(China Scholarship Council); Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences	This research was supported by ad-hoc funding of the Reisig laboratory, and the Key project for Breeding Genetically modified Organisms (No. 2014ZX08012-004, 2016ZX08012004-007), China scholarship Council (No. 2011841039) and Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences (Grant no. 2016YQ15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dow AgroSciences for providing Cry1F protein, Monsanto for providing Cry2Ab2 and Cry1A.105 protein, and Syngenta for providing Vip3Aa20 protein. We would like to acknowledge the help of Emily Goldsworthy and Donna Michel for assistance in the laboratory and the research staff at the Vernon James Center in Plymouth for assisting with greenhouse cultivation of the corn plants. This research was supported by ad-hoc funding of the Reisig laboratory, and the Key project for Breeding Genetically modified Organisms (No. 2014ZX08012-004, 2016ZX08012-004), China scholarship Council (No. 2011841039) and Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences (Grant no. 2016YQ15).	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; ALI A, 1989, ENVIRON ENTOMOL, V18, P881, DOI 10.1093/ee/18.5.881; Andow DA, 1998, J ECON ENTOMOL, V91, P572, DOI 10.1093/jee/91.3.572; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Bourguet D, 2003, THEOR APPL GENET, V106, P1225, DOI 10.1007/s00122-002-1172-1; Brevault T, 2013, P NATL ACAD SCI USA, V110, P5806, DOI 10.1073/pnas.1216719110; BUNTIN GD, 1986, FLA ENTOMOL, V69, P549, DOI 10.2307/3495389; Burd AD, 2003, J ECON ENTOMOL, V96, P137, DOI 10.1603/0022-0493-96.1.137; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; Coates BS, 2015, INSECT BIOCHEM MOLEC, V63, P86, DOI 10.1016/j.ibmb.2015.06.003; Dangal V, 2015, J INVERTEBR PATHOL, V127, P81, DOI 10.1016/j.jip.2015.03.004; Fabrick JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097900; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112958; LeOra Software, 2003, POLO PC US GUID PROB; Li GP, 2004, ENTOMOL EXP APPL, V112, P135, DOI 10.1111/j.0013-8703.2004.00191.x; Li GP, 2007, ECOL ENTOMOL, V32, P366, DOI 10.1111/j.1365-2311.2007.00891.x; MITCHELL ER, 1991, J ENTOMOL SCI, V26, P39, DOI 10.18474/0749-8004-26.1.39; Nagoshi RN, 2012, ECOL EVOL, V2, P1458, DOI 10.1002/ece3.268; Niu Y, 2013, FLA ENTOMOL, V96, P701, DOI 10.1653/024.096.0302; PAIR SD, 1987, SOUTHWEST ENTOMOL, V12, P89; PASHLEY DP, 1988, FLA ENTOMOL, V71, P227, DOI 10.2307/3495425; Reisig DD, 2015, J ECON ENTOMOL, V108, P157, DOI 10.1093/jee/tou009; Hernandez-Rodriguez CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068164; *SAS I, 1998, SAS STAT US GUID REL; Sena JAD, 2009, APPL ENVIRON MICROB, V75, P2236, DOI 10.1128/AEM.02342-08; Siebert MW, 2012, J ECON ENTOMOL, V105, P1825, DOI 10.1603/EC12155; Siebert MW, 2008, FLA ENTOMOL, V91, P555; Siebert MW, 2008, J ENTOMOL SCI, V43, P41, DOI 10.18474/0749-8004-43.1.41; Siegfried Blair D., 2007, American Entomologist, V53, P208; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Storer NP, 2003, J ECON ENTOMOL, V96, P156, DOI 10.1603/0022-0493-96.1.156; Storer NP, 2003, J ECON ENTOMOL, V96, P173, DOI 10.1603/0022-0493-96.1.173; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005646; Tabashnik BE, 2014, J ECON ENTOMOL, V107, P496, DOI 10.1603/EC13458; Tay WT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005534; Velez AM, 2013, B ENTOMOL RES, V103, P700, DOI 10.1017/S0007485313000448; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; Yang F, 2013, FLA ENTOMOL, V96, P714, DOI 10.1653/024.096.0303	45	54	68	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154492	10.1371/journal.pone.0154492	http://dx.doi.org/10.1371/journal.pone.0154492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119741	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200084
J	Reddy, AT; Lakshmi, SP; Muchumarri, RR; Reddy, RC				Reddy, Aravind T.; Lakshmi, Sowmya P.; Muchumarri, Ramamohan R.; Reddy, Raju C.			Nitrated Fatty Acids Reverse Cigarette Smoke-Induced Alveolar Macrophage Activation and Inhibit Protease Activity via Electrophilic S-Alkylation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NITROLINOLEIC ACID; GAMMA; INFLAMMATION; TRANSDUCTION; ISCHEMIA; CYSTEINE	Nitrated fatty acids (NFAs), endogenous products of nonenzymatic reactions of NO-derived reactive nitrogen species with unsaturated fatty acids, exhibit substantial anti-inflammatory activities. They are both reversible electrophiles and peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists, but the physiological implications of their electrophilic activity are poorly understood. We tested their effects on inflammatory and emphysema-related biomarkers in alveolar macrophages (AMs) of smoke-exposed mice. NFA (10-nitro-oleic acid or 12-nitrolinoleic acid) treatment downregulated expression and activity of the inflammatory transcription factor NF-kappa B while upregulating those of PPAR gamma. It also downregulated production of inflammatory cytokines and chemokines and of the protease cathepsin S (Cat S), a key mediator of emphysematous septal destruction. Cat S downregulation was accompanied by decreased AM elastolytic activity, a major mechanism of septal destruction. NFAs downregulated both Cat S expression and activity in AMs of wild-type mice, but only inhibited its activity in AMs of PPAR. knockout mice, pointing to a PPAR gamma-independent mechanism of enzyme inhibition. We hypothesized that this mechanism was electrophilic S-alkylation of target Cat S cysteines, and found that NFAs bind directly to Cat S following treatment of intact AMs and, as suggested by in silico modeling and calculation of relevant parameters, elicit S-alkylation of Cys25 when incubated with purified Cat S. These results demonstrate that NFAs' electrophilic activity, in addition to their role as PPAR. agonists, underlies their protective effects in chronic obstructive pulmonary disease (COPD) and support their therapeutic potential in this disease.	[Reddy, Aravind T.; Lakshmi, Sowmya P.; Muchumarri, Ramamohan R.; Reddy, Raju C.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Reddy, Aravind T.; Lakshmi, Sowmya P.; Muchumarri, Ramamohan R.; Reddy, Raju C.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Reddy, RC (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA.; Reddy, RC (corresponding author), Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA.	reddyrc@upmc.edu	Reddy, Aravind/P-1847-2018; Lakshmi, Sowmya P./P-1851-2018; Reddy, Raju C/GLR-5338-2022	Reddy, Aravind/0000-0001-8628-3467; Lakshmi, Sowmya P./0000-0003-1708-9462; Reddy, Raju C/0000-0001-7079-1520	U.S. Department of Veterans Affairs; National Institutes of Health [HL093196]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093196] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Merit Review award from the U.S. Department of Veterans Affairs and National Institutes of Health grant HL093196 to RCR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NUMB DEATHS LEAD CAU; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bonacci G, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.225029; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Francois M, 2004, J BIOL CHEM, V279, P28411, DOI 10.1074/jbc.M312708200; Geisler AC, 2012, BBA-GEN SUBJECTS, V1820, P777, DOI 10.1016/j.bbagen.2011.06.014; Gosset P, 1999, J ALLERGY CLIN IMMUN, V103, P289, DOI 10.1016/S0091-6749(99)70504-X; Guo CJ, 2011, NITRIC OXIDE-BIOL CH, V25, P366, DOI 10.1016/j.niox.2011.07.003; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Lakshmi SP, 2014, J BIOL CHEM, V289, P6383, DOI 10.1074/jbc.M113.536805; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; Liu HY, 2008, AM J PHYSIOL-RENAL, V295, pF942, DOI 10.1152/ajprenal.90236.2008; Pauly TA, 2003, BIOCHEMISTRY-US, V42, P3203, DOI 10.1021/bi027308i; Reddy AT, 2014, FASEB J, V28, P5299, DOI 10.1096/fj.14-256263; Reddy AT, 2012, J IMMUNOL, V189, P5411, DOI 10.4049/jimmunol.1201487; Reddy AT, 2012, PPAR RES, V2012, DOI 10.1155/2012/617063; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Russell REK, 2002, AM J PHYSIOL-LUNG C, V283, pL867, DOI 10.1152/ajplung.00020.2002; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Tsujita T, 2011, GENES CELLS, V16, P46, DOI 10.1111/j.1365-2443.2010.01466.x; Turkenburg JP, 2002, ACTA CRYSTALLOGR D, V58, P451, DOI 10.1107/S0907444901021825	28	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153336	10.1371/journal.pone.0153336	http://dx.doi.org/10.1371/journal.pone.0153336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119365	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000374976200022
J	Thoret, E; Aramaki, M; Bringoux, L; Ystad, S; Kronland-Martinet, R				Thoret, Etienne; Aramaki, Mitsuko; Bringoux, Lionel; Ystad, Solvi; Kronland-Martinet, Richard			Seeing Circles and Drawing Ellipses: When Sound Biases Reproduction of Visual Motion	PLOS ONE			English	Article							COORDINATION DYNAMICS; PERCEPTION; TRACKING; GAIT	The perception and production of biological movements is characterized by the 1/3 power law, a relation linking the curvature and the velocity of an intended action. In particular, motions are perceived and reproduced distorted when their kinematics deviate from this biological law. Whereas most studies dealing with this perceptual-motor relation focused on visual or kinaesthetic modalities in a unimodal context, in this paper we show that auditory dynamics strikingly biases visuomotor processes. Biologically consistent or inconsistent circular visual motions were used in combination with circular or elliptical auditory motions. Auditory motions were synthesized friction sounds mimicking those produced by the friction of the pen on a paper when someone is drawing. Sounds were presented diotically and the auditory motion velocity was evoked through the friction sound timbre variations without any spatial cues. Remarkably, when subjects were asked to reproduce circular visual motion while listening to sounds that evoked elliptical kinematics without seeing their hand, they drew elliptical shapes. Moreover, distortion induced by inconsistent elliptical kinematics in both visual and auditory modalities added up linearly. These results bring to light the substantial role of auditory dynamics in the visuo-motor coupling in a multisensory context.	[Thoret, Etienne; Aramaki, Mitsuko; Ystad, Solvi; Kronland-Martinet, Richard] Aix Marseille Univ, Lab Mecan & Acoust, CNRS, UPR 7051,Cent Marseille, Marseille, France; [Bringoux, Lionel] Aix Marseille Univ, CNRS, ISM, UMR 7287, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Thoret, E (corresponding author), Aix Marseille Univ, Lab Mecan & Acoust, CNRS, UPR 7051,Cent Marseille, Marseille, France.	etienne.thoret@mcgill.ca	Thoret, Etienne/G-8637-2016; Ystad, Sølvi/AAN-4517-2020	Thoret, Etienne/0000-0002-8214-6278; Ystad, Sølvi/0000-0001-9022-9690	French National Research Agency (ANR) [ANR-10-CORD-0003, ANR-14-CE24-0018]	French National Research Agency (ANR)(French National Research Agency (ANR))	This work was funded by the French National Research Agency (ANR) under the MetaSon: Metaphores Sonores (Sound Metaphors) project (ANR-10-CORD-0003) in the CONTINT 2010 framework and the SoniMove Project (ANR-14-CE24-0018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Aramaki M, 2011, IEEE T AUDIO SPEECH, V19, P301, DOI 10.1109/TASL.2010.2047755; Arrighi R, 2009, J VISION, V9, DOI 10.1167/9.4.25; Athenes S, 2004, HUM MOVEMENT SCI, V23, P621, DOI 10.1016/j.humov.2004.10.004; Brooks A, 2007, NEUROPSYCHOLOGIA, V45, P523, DOI 10.1016/j.neuropsychologia.2005.12.012; Campbell JC, 2014, EXP BRAIN RES, V232, P2775, DOI 10.1007/s00221-014-3958-1; Campos JL, 2012, EXP BRAIN RES, V218, P551, DOI 10.1007/s00221-012-3048-1; Campos JL, 2010, EUR J NEUROSCI, V31, P1889, DOI 10.1111/j.1460-9568.2010.07212.x; Chowning J, 1977, COMPUT MUSIC J, V1, P48, DOI [10.2307/3679609, DOI 10.2307/3679609]; Conan S, 2014, COMPUT MUSIC J, V38, P24, DOI 10.1162/COMJ_a_00266; Craig CM, 2000, NATURE, V405, P295, DOI 10.1038/35012690; Danna J, 2015, HUM MOVEMENT SCI, V43, P216, DOI 10.1016/j.humov.2014.12.002; Danna J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128388; Danna J, 2011, HUM MOVEMENT SCI, V30, P698, DOI 10.1016/j.humov.2010.08.019; Dounskaia N, 2000, EXP BRAIN RES, V135, P127, DOI 10.1007/s002210000495; GAVER WW, 1993, ECOL PSYCHOL, V5, P285, DOI 10.1207/s15326969eco0504_2; HOLLERBACH JM, 1981, BIOL CYBERN, V39, P139, DOI 10.1007/BF00336740; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Kitagawa N, 2002, NATURE, V416, P172, DOI 10.1038/416172a; Kronland-Martinet R, 2008, EURASIP J AUDIO SPEE, DOI 10.1155/2008/849696; La Scaleia B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093020; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; McGarry LM, 2012, EXP BRAIN RES, V218, P527, DOI 10.1007/s00221-012-3046-3; Merer A, 2013, ACM T APPL PERCEPT, V10, DOI 10.1145/2422105.2422106; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Rodger MWM, 2014, IEEE T NEUR SYS REH, V22, P543, DOI 10.1109/TNSRE.2013.2285410; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Soto-Faraco S, 2003, NEUROPSYCHOLOGIA, V41, P1847, DOI 10.1016/S0028-3932(03)00185-4; Thoret E, 2016, NEUROSCI LETT, V612, P225, DOI 10.1016/j.neulet.2015.12.022; Thoret E, 2014, J EXP PSYCHOL HUMAN, V40, P983, DOI 10.1037/a0035441; van den Doel K, 2001, P ACM SIGGRAPH 2001, DOI [10.1145/383259.383322, DOI 10.1145/383259.383322]; Varlet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044082; Viviani P, 1997, J EXP PSYCHOL HUMAN, V23, P1232, DOI 10.1037/0096-1523.23.4.1232; VIVIANI P, 1989, PERCEPT PSYCHOPHYS, V46, P266, DOI 10.3758/BF03208089; VIVIANI P, 1987, J EXP PSYCHOL HUMAN, V13, P62, DOI 10.1037/0096-1523.13.1.62; Young W, 2013, J EXP PSYCHOL HUMAN, V39, P464, DOI 10.1037/a0029402; Young WR, 2014, NEUROPSYCHOLOGIA, V57, P140, DOI 10.1016/j.neuropsychologia.2014.03.009	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154475	10.1371/journal.pone.0154475	http://dx.doi.org/10.1371/journal.pone.0154475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119411	Green Published, gold			2022-12-27	WOS:000374976200082
J	Chambers, EA; Hebert, PDN				Chambers, E. Anne; Hebert, Paul D. N.			Assessing DNA Barcodes for Species Identification in North American Reptiles and Amphibians in Natural History Collections	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; DIVERSITY; HYBRIDIZATION; CONSERVATION; POPULATION; TAXONOMY; FROGS; UNDERESTIMATION; HERPETOFAUNA; SALAMANDER	Background High rates of species discovery and loss have led to the urgent need for more rapid assessment of species diversity in the herpetofauna. DNA barcoding allows for the preliminary identification of species based on sequence divergence. Prior DNA barcoding work on reptiles and amphibians has revealed higher biodiversity counts than previously estimated due to cases of cryptic and undiscovered species. Past studies have provided DNA barcodes for just 14% of the North American herpetofauna, revealing the need for expanded coverage. Methodology/Principal Findings This study extends the DNA barcode reference library for North American herpetofauna, assesses the utility of this approach in aiding species delimitation, and examines the correspondence between current species boundaries and sequence clusters designated by the BIN system. Sequences were obtained from 730 specimens, representing 274 species (43%) from the North American herpetofauna. Mean intraspecific divergences were 1% and 3%, while average congeneric sequence divergences were 16% and 14% in amphibians and reptiles, respectively. BIN assignments corresponded with current species boundaries in 79% of amphibians, 100% of turtles, and 60% of squamates. Deep divergences (> 2%) were noted in 35% of squamate and 16% of amphibian species, and low divergences (< 2%) occurred in 12% of reptiles and 23% of amphibians, patterns reflected in BIN assignments. Sequence recovery declined with specimen age, and variation in recovery success was noted among collections. Within collections, barcodes effectively flagged seven mislabeled tissues, and barcode fragments were recovered from five formalin-fixed specimens. Conclusions/Significance This study demonstrates that DNA barcodes can effectively flag errors in museum collections, while BIN splits and merges reveal taxa belonging to deeply diverged or hybridizing lineages. This study is the first effort to compile a reference library of DNA barcodes for herpetofauna on a continental scale.	[Chambers, E. Anne] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Chambers, E. Anne; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Ctr Biodivers Genom, Guelph, ON N1G 2W1, Canada	University of Texas System; University of Texas Austin; University of Guelph	Chambers, EA (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.; Chambers, EA (corresponding author), Univ Guelph, Biodivers Inst Ontario, Ctr Biodivers Genom, Guelph, ON N1G 2W1, Canada.	eachambers@utexas.edu			Natural Sciences and Engineering Research Council of Canada (NSERC); Government of Canada through Genome Canada; Ontario Genomics Institute	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute	This project was funded, in part, by the Natural Sciences and Engineering Research Council of Canada (NSERC). Sequencing work was funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arif IA, 2011, GENET MOL RES, V10, P3559, DOI 10.4238/2011.October.31.3; Blagoev GA, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-44; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Brandley MC, 2012, ZOOL J LINN SOC-LOND, V165, P163, DOI 10.1111/j.1096-3642.2011.00801.x; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Cole CJ, 2010, AM MUS NOVIT, P1, DOI 10.1206/3698.2; Crawford AJ, 2011, ZOOTAXA, P65; Crawford AJ, 2013, MOL ECOL RESOUR, V13, P1005, DOI 10.1111/1755-0998.12054; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; DAUGHERTY CH, 1990, NATURE, V347, P177, DOI 10.1038/347177a0; Dean MD, 2001, ENTOMOL EXP APPL, V98, P279, DOI 10.1023/A:1018963131302; Dubey B, 2011, FORENSIC SCI INT-GEN, V5, P181, DOI 10.1016/j.fsigen.2010.03.001; Fitzpatrick BM, 2008, MOL ECOL, V17, P4107, DOI 10.1111/j.1365-294X.2008.03885.x; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Gehring PS, 2010, SALAMANDRA, V46, P214; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hawlitschek O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073368; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hykin SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141579; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Jeong TJ, 2013, MOL ECOL RESOUR, V13, P1019, DOI 10.1111/1755-0998.12055; Jockusch EL, 2002, BIOL J LINN SOC, V76, P361, DOI 10.1046/j.1095-8312.2002.d01-6.x; KARLIN AA, 1981, COPEIA, P371; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirchman JJ, 2010, BIOL LETTERS, V6, P112, DOI 10.1098/rsbl.2009.0545; LAMB T, 1992, J EVOLUTION BIOL, V5, P465, DOI 10.1046/j.1420-9101.1992.5030465.x; Leache AD, 2007, MOL ECOL, V16, P1035, DOI 10.1111/j.1365-294X.2006.03194.x; Lemmon EM, 2007, MOL PHYLOGENET EVOL, V44, P1068, DOI 10.1016/j.ympev.2007.04.010; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Murphy RW, 2013, MOL ECOL RESOUR, V13, P161, DOI 10.1111/1755-0998.12050; Murphy RW, 2011, ZOOKEYS, P39, DOI 10.3897/zookeys.113.1353; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Nazarov R, 2012, ZOOTAXA, P1; Pincheira-Donoso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059741; Placyk JS, 2012, CONSERV GENET, V13, P649, DOI 10.1007/s10592-012-0315-4; Puillandre N, 2012, MOL ECOL RESOUR, V12, P396, DOI 10.1111/j.1755-0998.2011.03105.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rissler LJ, 2003, MOL PHYLOGENET EVOL, V27, P197, DOI 10.1016/S1055-7903(02)00405-0; Rosenblum EB, 2008, J HERPETOL, V42, P572, DOI 10.1670/07-196.1; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savage WK, 2010, MOL ECOL, V19, P3301, DOI 10.1111/j.1365-294X.2010.04718.x; SHARBEL TF, 1995, COPEIA, P466; Shepard DB, 2011, MOL PHYLOGENET EVOL, V59, P399, DOI 10.1016/j.ympev.2011.03.007; Skage M, 2007, MAR BIOL RES, V3, P289, DOI 10.1080/17451000701473942; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Spinks PQ, 2012, ZOOL J LINN SOC-LOND, V164, P811, DOI 10.1111/j.1096-3642.2011.00788.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor HL, 2006, J HERPETOL, V40, P294, DOI 10.1670/0022-1511(2006)40[294:PCOAPC]2.0.CO;2; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Vargas SM, 2009, GENET MOL BIOL, V32, P608, DOI 10.1590/S1415-47572009005000050; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences M., 2012, METHODS MOL BIOL, V858, P79, DOI [10.1007/978, DOI 10.1007/978-1-61779-591-6_]; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wilgenbusch J, 2000, SYST BIOL, V49, P592, DOI 10.1080/10635159950127411; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia Y, 2012, MOL ECOL RESOUR, V12, P48, DOI 10.1111/j.1755-0998.2011.03055.x; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	73	53	56	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154363	10.1371/journal.pone.0154363	http://dx.doi.org/10.1371/journal.pone.0154363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116180	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600061
J	Baranowski, A; Klein, A; Ritz, U; Ackermann, A; Anthonissen, J; Kaufmann, KB; Brendel, C; Gotz, H; Rommens, PM; Hofmann, A				Baranowski, Andreas; Klein, Anja; Ritz, Ulrike; Ackermann, Angelika; Anthonissen, Joris; Kaufmann, Kerstin B.; Brendel, Christian; Goetz, Hermann; Rommens, Pol M.; Hofmann, Alexander			Surface Functionalization of Orthopedic Titanium Implants with Bone Sialoprotein	PLOS ONE			English	Article							BIODEGRADABLE COLLOIDAL GELS; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; CELL ATTACHMENT; GENE-EXPRESSION; IN-VITRO; COLLAGEN; HYDROXYAPATITE; PROLIFERATION; MECHANISMS	Orthopedic implant failure due to aseptic loosening and mechanical instability remains a major problem in total joint replacement. Improving osseointegration at the bone-implant interface may reduce micromotion and loosening. Bone sialoprotein (BSP) has been shown to enhance bone formation when coated onto titanium femoral implants and in rat calvarial defect models. However, the most appropriate method of BSP coating, the necessary level of BSP coating, and the effect of BSP coating on cell behavior remain largely unknown. In this study, BSP was covalently coupled to titanium surfaces via an aminosilane linker (APTES), and its properties were compared to BSP applied to titanium via physisorption and untreated titanium. Cell functions were examined using primary human osteoblasts (hOBs) and L929 mouse fibroblasts. Gene expression of specific bone turnover markers at the RNA level was detected at different intervals. Cell adhesion to titanium surfaces treated with BSP via physisorption was not significantly different from that of untreated titanium at any time point, whereas BSP application via covalent coupling caused reduced cell adhesion during the first few hours in culture. Cell migration was increased on titanium disks that were treated with higher concentrations of BSP solution, independent of the coating method. During the early phases of hOB proliferation, a suppressive effect of BSP was observed independent of its concentration, particularly when BSP was applied to the titanium surface via physisorption. Although alkaline phosphatase activity was reduced in the BSP-coated titanium groups after 4 days in culture, increased calcium deposition was observed after 21 days. In particular, the gene expression level of RUNX2 was upregulated by BSP. The increase in calcium deposition and the stimulation of cell differentiation induced by BSP highlight its potential as a surface modifier that could enhance the osseointegration of orthopedic implants. Both physisorption and covalent coupling of BSP are similarly effective, feasible methods, although a higher BSP concentration is recommended.	[Baranowski, Andreas; Klein, Anja; Ritz, Ulrike; Ackermann, Angelika; Anthonissen, Joris; Rommens, Pol M.; Hofmann, Alexander] Johannes Gutenberg Univ Mainz, Dept Orthoped & Traumatol, Univ Med Ctr, D-55122 Mainz, Germany; [Kaufmann, Kerstin B.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Brendel, Christian] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA USA; [Goetz, Hermann] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Platform Biomat Res, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Harvard University; Boston Children's Hospital; Harvard Medical School; Johannes Gutenberg University of Mainz	Hofmann, A (corresponding author), Johannes Gutenberg Univ Mainz, Dept Orthoped & Traumatol, Univ Med Ctr, D-55122 Mainz, Germany.	hofmann.trauma-surgery@gmx.net	Brendel, Christian/HDN-6077-2022; Ritz, Ulrike/N-6871-2016; Hofmann, Alexander/C-3943-2013	Ritz, Ulrike/0000-0001-8936-3227; Kaufmann, Kerstin B./0000-0001-5013-6123; Baranowski, Andreas/0000-0001-7954-5289; Brendel, Christian/0000-0003-4081-4351	Immundiagnostik AG (Bensheim, Germany)	Immundiagnostik AG (Bensheim, Germany)	The research project was funded by Immundiagnostik AG (Bensheim, Germany) (http://www.immundiagnostik.com/en/home.html). The funder was involved in the study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4; Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363; [Anonymous], 2006, J ORTHOPAEDIC RES WI; Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.0.CO;2-J; AUBIN JE, 1992, INT CONGR SER, V1002, P267; Balloni S, 2009, INT J ORAL MAX IMPL, V24, P627; Bellahcene A, 2000, CIRC RES, V86, P885, DOI 10.1161/01.RES.86.8.885; Bernards MT, 2008, J BIOMED MATER RES A, V86A, P779, DOI 10.1002/jbm.a.31650; Boing J., 2003, MODIFIZIERUNG GLAS T; Bopp Stephanie K., 2008, BMC Pharmacology, V8, P8, DOI 10.1186/1471-2210-8-8; Boyan BD, 2001, ANN REV MATER RES, V31, P357, DOI 10.1146/annurev.matsci.31.1.357; Brendel C, 2012, GENE THER, V19, P1018, DOI 10.1038/gt.2011.167; Brunski J B, 1999, Adv Dent Res, V13, P99; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Cao Y, 2005, CANCER RES, V65, P1124, DOI 10.1158/0008-5472.CAN-04-2128; Chan WD, 2010, J BIOMED MATER RES A, V94A, P945, DOI 10.1002/jbm.a.32715; Christensen FB, 2000, EUR SPINE J, V9, P97, DOI 10.1007/s005860050218; Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Drees P, 2007, NAT CLIN PRACT RHEUM, V3, P165, DOI 10.1038/ncprheum0428; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Duyck J, 2006, ARCH ORAL BIOL, V51, P1, DOI 10.1016/j.archoralbio.2005.04.003; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1; Forsprecher J, 2011, CELL ADHES MIGR, V5, P65, DOI 10.4161/cam.5.1.13369; Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Graf HL, 2008, INT J ORAL MAX SURG, V37, P634, DOI 10.1016/j.ijom.2008.01.021; HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49; HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9; Hata K, 2007, J BIOMED MATER RES A, V81A, P446, DOI 10.1002/jbm.a.31086; HAZAN R, 1993, BIOMATERIALS, V14, P570, DOI 10.1016/0142-9612(93)90172-X; Hilbig H, 2007, EUR J MED RES, V12, P6; Hoffmann M, 2014, EUR J TRAUMA EMERG S, V40, P273, DOI 10.1007/s00068-014-0412-9; Hofmann A, 2008, BONE, V42, P894, DOI 10.1016/j.bone.2008.01.013; Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; Kuhn S, 2014, J MATER SCI-MATER M, V25, P2549, DOI 10.1007/s10856-014-5278-1; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kutty MG, 2004, J MATER SCI-MATER M, V15, P145, DOI 10.1023/B:JMSM.0000011815.50383.bd; Liu F, 1997, EXP CELL RES, V232, P97, DOI 10.1006/excr.1997.3501; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maehata Y, 2006, MATRIX BIOL, V25, P47, DOI 10.1016/j.matbio.2005.09.001; MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202; Misawa H, 2006, CELL TRANSPLANT, V15, P903, DOI 10.3727/000000006783981369; Mizuno M, 2000, CALCIFIED TISSUE INT, V66, P388, DOI 10.1007/s002230010078; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nanci A, 1998, J BIOMED MATER RES, V40, P324; Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3; Pan J, 1996, J BIOMED MATER RES, V30, P393; Peng HS, 2014, J MATER CHEM B, V2, P6435, DOI 10.1039/c4tb00344f; Pierres A., 2002, European Cells & Materials, V3, P31; Pierres A, 2000, PHYSICAL CHEMISTRY OF BIOLOGICAL INTERFACES, P459; Pohler OEM, 2000, INJURY, V31, pS7; Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X; Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b; Rammelt S, 2004, CELLS TISSUES ORGANS, V178, P146, DOI 10.1159/000082245; Rammelt S, 2004, J ORTHOPAED RES, V22, P1025, DOI 10.1016/j.orthres.2004.02.011; Rapuano BE, 2004, J ORTHOP RES, V22, P353, DOI 10.1016/S0736-0266(03)00180-3; RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702; Schaeren S, 2010, J BIOMED MATER RES A, V92A, P1461, DOI 10.1002/jbm.a.32459; Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x; Shen H, 2008, MECH MATER, V40, P708, DOI 10.1016/j.mechmat.2008.03.009; Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Song FF, 2015, J BIOMED NANOTECHNOL, V11, P40, DOI 10.1166/jbn.2015.1962; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K; Thiele K, 2015, J BONE JOINT SURG AM, V97A, P715, DOI 10.2106/JBJS.M.01534; Tye CE, 2003, J BIOL CHEM, V278, P7949, DOI 10.1074/jbc.M211915200; Valverde P, 2008, J BONE MINER RES, V23, P1775, DOI 10.1359/JBMR.080605; van der Zande M, 2008, J BIOMED MATER RES A, V86A, P788, DOI 10.1002/jbm.a.31645; Wang JX, 2006, CALCIFIED TISSUE INT, V79, P179, DOI 10.1007/s00223-006-0018-2; Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099; Wang Q, 2013, TISSUE ENG PT A, V19, P2586, DOI [10.1089/ten.TEA.2013.0075, 10.1089/ten.tea.2013.0075]; Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000; Wang Q, 2010, BIOMATERIALS, V31, P4980, DOI 10.1016/j.biomaterials.2010.02.052; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Yang Y, 2010, LANGMUIR, V26, P9848, DOI 10.1021/la100192z; Zhao ZR, 2005, MOL THER, V12, P247, DOI 10.1016/j.ymthe.2005.03.009; ZHOU HY, 1995, CALCIFIED TISSUE INT, V56, P403, DOI 10.1007/BF00301610	85	28	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153978	10.1371/journal.pone.0153978	http://dx.doi.org/10.1371/journal.pone.0153978			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111551	Green Published, Green Submitted, gold			2022-12-27	WOS:000374970600024
J	Ingersoll, T; Cole, S; Madren-Whalley, J; Booker, L; Dorsey, R; Li, A; Salem, H				Ingersoll, Thomas; Cole, Stephanie; Madren-Whalley, Janna; Booker, Lamont; Dorsey, Russell; Li, Albert; Salem, Harry			Generalized Additive Mixed-Models for Pharmacology Using Integrated Discrete Multiple Organ Co-Culture	PLOS ONE			English	Article							CYTOTOXIC METABOLITES; CYCLOPHOSPHAMIDE; PARAAMINOPHENOL; TOXICITY; MOUSE	Integrated Discrete Multiple Organ Co-culture (IDMOC) is emerging as an in-vitro alternative to in-vivo animal models for pharmacology studies. IDMOC allows dose-response relationships to be investigated at the tissue and organoid levels, yet, these relationships often exhibit responses that are far more complex than the binary responses often measured in whole animals. To accommodate departure from binary endpoints, IDMOC requires an expansion of analytic techniques beyond simple linear probit and logistic models familiar in toxicology. IDMOC dose-responses may be measured at continuous scales, exhibit significant non-linearity such as local maxima or minima, and may include non-independent measures. Generalized additive mixed-modeling (GAMM) provides an alternative description of dose-response that relaxes assumptions of independence and linearity. We compared GAMMs to traditional linear models for describing dose-response in IDMOC pharmacology studies.	[Ingersoll, Thomas] Def Threat Reduct Agcy, Joint CBRN Ctr Excellence, Aberdeen Proving Ground, MD USA; [Cole, Stephanie; Madren-Whalley, Janna; Dorsey, Russell; Salem, Harry] US Army Res Dev & Engn Command, Edgewood Chem Biol Ctr, Aberdeen Proving Ground, MD USA; [Booker, Lamont] US FDA, Silver Spring, MD USA; [Li, Albert] In Vitro ADMET Labs, Columbia, MD USA	United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Food & Drug Administration (FDA)	Ingersoll, T (corresponding author), Def Threat Reduct Agcy, Joint CBRN Ctr Excellence, Aberdeen Proving Ground, MD USA.	thomas.e.ingersoll.civ@mail.mil	Li, Albert P./AAN-5971-2020	Li, Albert P./0000-0001-5772-6265	ADMET Laboratories; Defense Threat Reduction Agency; US Army Research, Development, and Engineering Command; National Research Council, Research Associate Program	ADMET Laboratories; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); US Army Research, Development, and Engineering Command; National Research Council, Research Associate Program	The authors received no specific funding for this work, other than support in the form of authors' salaries. One co-author (AL) is employed by a commercial company: ADMET Laboratories. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. ADMET Laboratories provided support in the form of salary for co-author AL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors would like to thank the Defense Threat Reduction Agency, the US Army Research, Development, and Engineering Command, and the National Research Council, Research Associate Program for sponsoring this research.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003; Bliss CI, 1934, P NATL ACAD SCI USA, V79, P38; Bolker B, 2008, ECOLOGICAL MODELS DA; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chambers JM., 1992, STAT MODELS S; Chatterjee S, 2014, TOXICOL APPL PHARM, V274, P124, DOI 10.1016/j.taap.2013.10.032; Cole S.D., 2014, J BIOMOLECULAR SCREE; Cronin MTD, 2003, J MOL STRUC-THEOCHEM, V622, P39, DOI 10.1016/S0166-1280(02)00616-4; Davis JA, 2011, TOXICOL APPL PHARM, V254, P181, DOI 10.1016/j.taap.2010.10.016; DYBING E, 1972, ACTA PHARMACOL TOX, V31, P153, DOI 10.1111/j.1600-0773.1972.tb00708.x; FINNEY DJ, 1952, J PHARMACOL EXP THER, V104, P440; Hirata K, 2008, PHARMACOGENOMICS J, V8, P29, DOI 10.1038/sj.tpj.6500442; Li AP, 2012, CHEM-BIOL INTERACT, V199, P1, DOI 10.1016/j.cbi.2012.05.003; Link WA, 1997, BIOMETRICS, V53, P488, DOI 10.2307/2533952; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; R Core Team, 2013, R VERS 3 0 1 R LANG; Ren SJ, 2003, J CHEM INF COMP SCI, V43, P2106, DOI 10.1021/ci034092y; SHARMA RP, 1981, CAN J COMP MED, V45, P60; STRUCK RF, 1987, CANCER RES, V47, P2723; VERONESI B, 1993, TOXICOL APPL PHARM, V120, P240, DOI 10.1006/taap.1993.1108; Wei MX, 1995, CLIN CANCER RES, V1, P1171; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yan ZM, 2000, DRUG METAB DISPOS, V28, P880; Zuur Alain F., 2009, P1	27	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152985	10.1371/journal.pone.0152985	http://dx.doi.org/10.1371/journal.pone.0152985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110941	gold, Green Submitted, Green Published			2022-12-27	WOS:000374970600008
J	Yan, HJ; Li, JJ; Raymond, HF; Huan, XP; Guan, WH; Hu, HY; Yang, HT; McFarland, W; Wei, CY				Yan, Hongjing; Li, Jianjun; Raymond, H. Fisher; Huan, Xiping; Guan, Wenhui; Hu, Haiyang; Yang, Haitao; McFarland, Willi; Wei, Chongyi			Increased HIV Testing among Men Who Have Sex with Men from 2008 to 2012, Nanjing, China	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; INFECTION; SURVEILLANCE; SETTINGS; COHORT	Background HIV testing is the first point of HIV treatment entry for HIV-infected individuals and an avenue to engage persons at risk in prevention. In China, where the prevalence of HIV among men who have sex with men (MSM) has been rising over the last decade, uptake of HIV testing has been low. Methods We examined changes in HIV testing in the preceding 12 months through two cross-sectional surveys conducted among MSM in Nanjing, Jiangsu province, China in 2008 and 2012. Respondent-driven sampling (RDS) was used to recruit participants. Questionnaire interviews and venous blood were collected to measure HIV testing, risk behaviors, and prevalence of HIV, syphilis, and HSV-2. Results A total of 430 and 589 MSM were surveyed in 2008 and 2012, respectively, with comparable samples in each round with respect to demographic characteristics. HIV testing in the past 12 months increased significantly from 20.1% (95% CI 13.3-26.8) in 2008 to 46.0% (95% CI 39.3-51.4, p < 0.001) in 2012. HIV prevalence was stable, at 6.6% (95% CI 2.5-11.3) in 2008 and 10.1% (95% CI 6.6-13.9, p = 0.240) in 2012, as was syphilis (14.3% in 2008 vs. 9.9% in 2012, p = 0.240). HSV-2 prevalence (18.6% in 2008 vs. 10.2% in 2012, p = 0.040) and self-reported STI in the last year (24.3% in 2008 vs. 14.3% in 2012, p = 0.020) significantly decreased. Changes in reported sexual behaviors were mixed and the profiles of who did and did not test varied between 2008 and 2012. Conclusions HIV testing uptake more than doubled among MSM in Nanjing from 2008 to 2012 -a period of massive promotion and scale up of testing programs for MSM. However, additional efforts are still needed to further increase the proportion of men being not only tested but also undergoing repeat testing if they engage in continued risk taking behavior.	[Yan, Hongjing; Li, Jianjun; Huan, Xiping; Guan, Wenhui; Hu, Haiyang; Yang, Haitao] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Raymond, H. Fisher; McFarland, Willi; Wei, Chongyi] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Raymond, H. Fisher; McFarland, Willi] San Francisco Dept Publ Hlth, San Francisco, CA USA	Jiangsu Provincial Center for Disease Control & Prevention; University of California System; University of California San Francisco; San Francisco Department of Public Health	Wei, CY (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	Chongyi.Wei@ucsf.edu		Raymond, Henry/0000-0001-8621-2749	Outstanding Medical Academic Leader Program of Jiangsu Provincial Center for Diseases Control and Prevention [JKRC2011003]; Jiangsu Department of Health Program [H201330]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	Outstanding Medical Academic Leader Program of Jiangsu Provincial Center for Diseases Control and Prevention; Jiangsu Department of Health Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Outstanding Medical Academic Leader Program of Jiangsu Provincial Center for Diseases Control and Prevention (JKRC2011003) and the Jiangsu Department of Health Program (H201330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, 2012 CHIN AIDS RESP; [Anonymous], 2015, NOT EST HIV AIDS TRE; [Anonymous], 2012, STAT YB NANJ MUN 201; [Chinese Center for Diseases Prevention and Control National Center for HIV/AIDS/ STD Prevention and Control], 2014, NAT PROT COMPR HIV A; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cumming G, 2009, STAT MED, V28, P205, DOI 10.1002/sim.3471; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Hao C, 2011, SEX TRANSM INFECT, V87, P199, DOI 10.1136/sti.2010.042903; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Johnston LG, 2013, AIDS BEHAV, V17, P2202, DOI 10.1007/s10461-012-0394-8; Li DL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001829; Li HM, 2009, SEX TRANSM INFEC, V85, P354; Li H, 2010, INT J EPIDEMIOL, V39, pII65, DOI 10.1093/ije/dyq223; Lin W, 2012, WEST PAC SURVEILL RE, V3, P78, DOI [10.5365/WPSAR.2012.3.3.004, 10.5365/wpsar.2012.3.3.004]; Ma X, 2007, J ACQ IMMUN DEF SYND, V45, P581; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Meng XJ, 2013, SEX HEALTH, V10, P211, DOI 10.1071/SH12093; Tao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102812; Wang QQ, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18849; Wei CY, 2011, SEX TRANSM INFECT, V87, P225, DOI 10.1136/sti.2010.047407; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Yan H, 2010, CHIN J AIDS STD, VTD16, P29; Yan HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103146; Yan HJ, 2012, JAIDS-J ACQ IMM DEF, V59, P177, DOI 10.1097/QAI.0b013e318239c947; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59; Yin YP, 2012, SEX TRANSM DIS, V39, P354, DOI 10.1097/OLQ.0b013e318244aef0; Zhang DP, 2015, INT J STD AIDS, V26, P402, DOI 10.1177/0956462414542986; Zhang L, 2012, SEX HEALTH, V9, P261, DOI 10.1071/SH11104; Zhao YJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000534	31	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154466	10.1371/journal.pone.0154466	http://dx.doi.org/10.1371/journal.pone.0154466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111540	Green Submitted, gold, Green Published			2022-12-27	WOS:000374970600067
J	Mensing, LA; Rinkel, GJE; Vlak, MHM; van der Schaaf, IC; Ruigrok, YM				Mensing, Liselore A.; Rinkel, Gabriel J. E.; Vlak, Monique H. M.; van der Schaaf, Irene C.; Ruigrok, Ynte M.			Difference in Aneurysm Characteristics between Patients with Familial and Sporadic Aneurysmal Subarachnoid Haemorrhage	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; RISK-FACTORS; RUPTURE; HISTORY; GENETICS; SMOKING; COHORT; FLOW; AGE	Object Patients with familial intracranial aneurysms (IA) have a higher risk of rupture than patients with sporadic IA. We compared geometric and morphological risk factors for aneurysmal rupture between patients with familial and sporadic aneurysmal subarachnoid hemorrhage (aSAH) to analyse if these risk factors contribute to the increased rupture rate of familial IA. Methods Geometric and morphological aneurysm characteristics were studied on CT-angiography in a prospectively collected series of patients with familial and sporadic aSAH, admitted between September 2006 and September 2009, and additional patients with familial aSAH retrieved from the prospectively collected database of familial IA patients of our center. Odds ratios (OR) with corresponding 95% confidence intervals (95% CI) were calculated to compare the aneurysm characteristics between patients with familial and sporadic aSAH. Results We studied 67 patients with familial and 184 with sporadic aSAH. OR's for familial compared with sporadic aSAH were for oval shape 1.16(95% CI: 0.65-2.09), oblong shape 0.26 (95% CI: 0.03-2.13), irregular shape 0.83(95% CI: 0.47-1.49), aspect ratio >= 1.6 0.94(95% CI: 0.54-1.66), contact with the perianeurysmal environment (PAE) 1.15(95% CI: 0.56-2.40), deformation by the PAE 1.05(95% CI: 0.47-2.35) and for dominance of the posterior communicating artery (PCoA) in case of PCoA aneurysms 1.97(95% CI: 0.50-7.83). Conclusions The geometric and morphological risk factors for aneurysm rupture do not have a higher prevalence in familial than in sporadic aSAH and thus do not explain the increased risk of IA rupture in patients with familial IA. We recommend further search for other potential risk factors for rupture of familial IA, such as genetic factors.	[Mensing, Liselore A.; Rinkel, Gabriel J. E.; Ruigrok, Ynte M.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [van der Schaaf, Irene C.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Vlak, Monique H. M.] Med Ctr Haaglanden, Dept Neurol, The Hague, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Haaglanden Medical Center	Mensing, LA (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands.	L.A.Mensing-3@umcutrecht.nl			NWO-VENI grant by the Netherlands Organisation for Scientific Research (NWO) [91610016]	NWO-VENI grant by the Netherlands Organisation for Scientific Research (NWO)	YMR was supported by NWO-VENI grant by the Netherlands Organisation for Scientific Research (NWO) (project no. 91610016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenta PS, 2012, NEUROSURGERY, V70, P693, DOI 10.1227/NEU.0b013e3182354d68; Backes D, 2014, STROKE, V45, P1299, DOI 10.1161/STROKEAHA.113.004421; Bor ASE, 2015, STROKE, V46, P42, DOI 10.1161/STROKEAHA.114.005963; Broderick JP, 2009, STROKE, V40, P1952, DOI 10.1161/STROKEAHA.108.542571; Bromberg JEC, 1996, STROKE, V27, P630, DOI 10.1161/01.STR.27.4.630; Bromberg JEC, 1995, ANN NEUROL, V38, P929, DOI 10.1002/ana.410380614; de Rooij NK, 2009, J NEUROL, V256, P45, DOI 10.1007/s00415-009-0028-x; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Huttunen T, 2010, NEUROSURGERY, V66, P631, DOI 10.1227/01.NEU.0000367634.89384.4B; Lee JS, 2008, J KOREAN NEUROSURG S, V44, P136, DOI 10.3340/jkns.2008.44.3.136; Rasing I, 2012, J NEUROL NEUROSUR PS, V83, P541, DOI 10.1136/jnnp-2011-301147; Ruigrok YM, 2005, LANCET NEUROL, V4, P179, DOI 10.1016/S1474-4422(05)01015-X; Ruigrok YM, 2004, NEUROLOGY, V62, P891, DOI 10.1212/01.WNL.0000115104.19787.8E; Schievink WI, 1997, NEUROSURGERY, V40, P651, DOI 10.1097/00006123-199704000-00001; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Woo D, 2009, NEUROLOGY, V72, P69, DOI 10.1212/01.wnl.0000338567.90260.46; You SH, 2010, J NEUROL NEUROSUR PS, V81, P479, DOI 10.1136/jnnp.2008.169573	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154281	10.1371/journal.pone.0154281	http://dx.doi.org/10.1371/journal.pone.0154281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27112915	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100065
J	Trejo-Soto, C; Costa-Miracle, E; Rodriguez-Villarreal, I; Cid, J; Alarcon, T; Hernandez-Machado, A				Trejo-Soto, C.; Costa-Miracle, E.; Rodriguez-Villarreal, I.; Cid, J.; Alarcon, T.; Hernandez-Machado, Aurora			Capillary Filling at the Microscale: Control of Fluid Front Using Geometry	PLOS ONE			English	Article							MICROFLUIDICS; WATER	We propose an experimental and theoretical framework for the study of capillary filling at the micro-scale. Our methodology enables us to control the fluid flow regime so that we can characterise properties of Newtonian fluids such as their viscosity. In particular, we study a viscous, non-inertial, non-Washburn regime in which the position of the fluid front increases linearly with time for the whole duration of the experiment. The operating shear-rate range of our apparatus extends over nearly two orders of magnitude. Further, we analyse the advancement of a fluid front within a microcapillary in a system of two immiscible Newtonian liquids. We observe a non-Washburn regime in which the front can accelerate or decelerate depending on the viscosity contrast between the two liquids. We then propose a theoretical model which enables us to study and explain both non-Washburn regimes. Furthermore, our theoretical model allows us to put forward ways to control the emergence of these regimes by means of geometrical parameters of the experimental set-up. Our methodology allows us to design and calibrate a micro-viscosimetre which works at constant pressure.	[Trejo-Soto, C.; Hernandez-Machado, Aurora] Univ Barcelona, Fac Fis, Dept ECM, Diagonal 645, E-08028 Barcelona, Spain; [Trejo-Soto, C.; Costa-Miracle, E.; Rodriguez-Villarreal, I.; Alarcon, T.; Hernandez-Machado, Aurora] Ctr Recerca Matemat, Edifici C,Campus Bellaterra, Bellaterra 08193, Barcelona, Spain; [Costa-Miracle, E.; Alarcon, T.] Univ Autonoma Barcelona, Dept Matemat, Bellaterra 08193, Barcelona, Spain; [Costa-Miracle, E.; Alarcon, T.; Hernandez-Machado, Aurora] Barcelona Grad Sch Math BGSMath, Barcelona, Spain; [Cid, J.] Hosp Clin Barcelona, Serv Hemoterapia & Hemostasia, Barcelona, Spain; [Alarcon, T.] ICREA, Barcelona, Spain	University of Barcelona; Centre de Recerca Matematica (CRM); Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; ICREA	Hernandez-Machado, A (corresponding author), Univ Barcelona, Fac Fis, Dept ECM, Diagonal 645, E-08028 Barcelona, Spain.; Hernandez-Machado, A (corresponding author), Ctr Recerca Matemat, Edifici C,Campus Bellaterra, Bellaterra 08193, Barcelona, Spain.; Hernandez-Machado, A (corresponding author), Barcelona Grad Sch Math BGSMath, Barcelona, Spain.	a.hernandezmachado@gmail.com	Rodriguez-Villarreal, Angeles Ivon/K-9205-2014; Trejo-Soto, Claudia Andrea/G-8551-2016; Alarcon, Tomas/D-9083-2013; Hernandez-Machado, Aurora/N-3362-2019; Cid, Joan/F-7778-2016; Alarcon, Tomas/AAW-2908-2021; Hernandez-Machado, Aurora/H-7425-2012	Rodriguez-Villarreal, Angeles Ivon/0000-0001-7563-5113; Trejo-Soto, Claudia Andrea/0000-0003-0267-3359; Alarcon, Tomas/0000-0002-8566-3676; Hernandez-Machado, Aurora/0000-0002-0397-5255; Cid, Joan/0000-0001-5445-4508; Alarcon, Tomas/0000-0002-8566-3676; Hernandez-Machado, Aurora/0000-0002-0397-5255; Costa-Miracle, Enric/0000-0001-8238-1422	Spanish Ministry for Science and Innovation (MICINN) [MTM2011-29342]; Generalitat de Catalunya [2014SGR1307]; MINECO [FIS2013-47949-C2-1-P]; DURSI [2014SGR878]; CONICYT the Chilean Ministry of Education; ICREA Funding Source: Custom	Spanish Ministry for Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); MINECO(Spanish Government); DURSI; CONICYT the Chilean Ministry of Education; ICREA(ICREA)	IRV and TA acknowledge the Spanish Ministry for Science and Innovation (MICINN) for funding MTM2011-29342 and Generalitat de Catalunya for funding under grant 2014SGR1307. AHM gratefully acknowledges partial financial support from MINECO for funding under grant FIS2013-47949-C2-1-P and DURSI for funding under grant 2014SGR878. CTS acknowledges CONICYT the Chilean Ministry of Education for funding PhD fellowship, Becas Chile.	Abate AR, 2010, P NATL ACAD SCI USA, V107, P19163, DOI 10.1073/pnas.1006888107; Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Al-Housseiny TT, 2012, NAT PHYS, V8, P747, DOI [10.1038/NPHYS2396, 10.1038/nphys2396]; Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163; Bezagu M, 2014, J AM CHEM SOC, V136, P7205, DOI 10.1021/ja5019354; Bocquet L, 2014, LAB CHIP, V14, P3143, DOI 10.1039/c4lc00325j; Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z; Degre G, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2221501; Global M., 2008, ETHYLENEGLYCOL PRODU; Guillot P, 2006, LANGMUIR, V22, P6438, DOI 10.1021/la060131z; Ledesma-Aguilar R, 2011, NAT MATER, V10, P367, DOI [10.1038/NMAT2998, 10.1038/nmat2998]; Lee W, 2010, P NATL ACAD SCI USA, V107, P22413, DOI 10.1073/pnas.1010297107; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Meiselman H.J., 2007, HDB HEMORHEOLOGY HEM; Queralt-Martin M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.194501; Quere D, 1997, EUROPHYS LETT, V39, P533, DOI 10.1209/epl/i1997-00389-2; Reyssat M, 2008, J FLUID MECH, V615, P335, DOI 10.1017/S0022112008003996; Rodriguez-Villarreal I, 2011, THESIS; Srivastava N, 2005, ANAL CHEM, V77, P383, DOI 10.1021/ac0494681; Tabeling P, 2005, INTRO MICROFLUIDICS; Tas NR, 2004, APPL PHYS LETT, V85, P3274, DOI 10.1063/1.1804602; Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273; Yu FQ, 2013, LAB CHIP, V13, P1911, DOI 10.1039/c3lc41394b	23	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153559	10.1371/journal.pone.0153559	http://dx.doi.org/10.1371/journal.pone.0153559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104734	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100013
J	Arvanitis, M; Li, G; Li, DD; Cotnoir, D; Ganley-Leal, L; Carney, DW; Sello, JK; Mylonakis, E				Arvanitis, Marios; Li, Gang; Li, De-Dong; Cotnoir, Daniel; Ganley-Leal, Lisa; Carney, Daniel W.; Sello, Jason K.; Mylonakis, Eleftherios			A Conformationally Constrained Cyclic Acyldepsipeptide Is Highly Effective in Mice Infected with Methicillin-Susceptible and -Resistant Staphylococcus aureus	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; ANTIBIOTICS; CLPP; FUTURE; MODEL	Background Cyclic acyldepsipeptides (ADEPs) are a novel class of antibacterial agents, some of which (e.g., ADEP 4) are highly active against Gram-positive bacteria. The focus of these in vivo studies is ADEP B315, a rationally designed compound that has the most potent in vitro activity of any ADEP analog reported to date. Methods In vivo efficacy experiments were performed using lethal intraperitoneal mice infection models with a methicillin-sensitive S. aureus (MSSA) and a methicillin-resistant (MRSA) strain. The infected mice were treated with ADEP B315, a des-methyl analog of ADEP 4, vancomycin, or the vehicle used for the ADEPs and their survival was assessed daily. A subset of MSSA-infected mice was sacrificed soon after inoculation and the bacterial burden was measured in their livers and spleens. The toxicity of ADEP B315 was assessed in viability assays using human whole blood cultures. Results In the MSSA experiments, all mice treated with the vehicle succumbed to the infection within 24 hours. All tested compounds were effective in prolonging survival of infected mice (p<0.001). Mice treated with ADEP B315 had a 39% survival rate by 10 days compared to 7% survival in mice treated with a des-methyl ADEP 4 analog (p = 0.017). Survival of the infected mice treated with ADEP B315 was comparable to those treated with vanocmycin (p = 0.12) at the same dose. Further, bacterial burden in the liver and spleen was significantly lower in mice treated with ADEP B315 compared to controls. In the MRSA experiments, ADEP B315 was able to significantly prolong survival compared to mice treated with either the vehicle (p = 0.001) or vancomycin (p = 0.007). ADEP B315 exhibited no significant toxicity in human whole blood cultures at concentrations up to 25 mu g/ml. Conclusions ADEP B315 is safe and can cure mice that have lethal infections of methicillin-sensitive and -resistant strains of S. aureus.	[Arvanitis, Marios; Li, Gang; Li, De-Dong; Mylonakis, Eleftherios] Rhode Isl Hosp, Div Infect Dis, Providence, RI USA; [Arvanitis, Marios; Li, Gang; Li, De-Dong; Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Cotnoir, Daniel; Ganley-Leal, Lisa] Brown Univ, Dept Pediat, Alpert Med Sch, Hasbro Childrens Hosp, Providence, RI 02912 USA; [Carney, Daniel W.; Sello, Jason K.] Brown Univ, Dept Chem, 324 Brook St, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Hasbro Children's Hospital; Brown University	Mylonakis, E (corresponding author), Rhode Isl Hosp, Div Infect Dis, Providence, RI USA.; Mylonakis, E (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.; Sello, JK (corresponding author), Brown Univ, Dept Chem, 324 Brook St, Providence, RI 02912 USA.	Jason_sello@brown.edu; emylonakis@lifespan.org	Li, Dedong/R-7044-2019		National Institutes of Health [P01 AI083214, R21 AI097684, U54 AI057159]; PharmLogic Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, P01AI083214, R21AI097684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PharmLogic Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant P01 AI083214 to EM, grant R21 AI097684 to LGL, grant U54 AI057159 to NERCE, and PharmLogic Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089984; Arvanitis M, 2013, BBA-MOL BASIS DIS, V1832, P1378, DOI 10.1016/j.bbadis.2013.03.008; Bionda N, 2012, CHEMMEDCHEM, V7, P871, DOI 10.1002/cmdc.201200016; Brotz-Oesterhelt H, 2014, INT J MED MICROBIOL, V304, P23, DOI 10.1016/j.ijmm.2013.09.001; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Carney DW, 2014, J AM CHEM SOC, V136, P1922, DOI 10.1021/ja410385c; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; FRIMODTMOLLER N, 1993, J ANTIMICROB CHEMOTH, V31, P55, DOI 10.1093/jac/31.suppl_D.55; Higgins PG, 2009, ANTIMICROB AGENTS CH, V53, P4556, DOI 10.1128/AAC.00395-09; Hinzen B, 2006, CHEMMEDCHEM, V1, P689, DOI 10.1002/cmdc.200600055; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; KOSHINO H, 1991, TETRAHEDRON LETT, V32, P7707, DOI 10.1016/0040-4039(91)80571-M; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Michel K.H., 1985, US Pat., Patent No. [4492650, 4,492,650]; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Schuch R, 2014, J INFECT DIS, V209, P1469, DOI 10.1093/infdis/jit637; Socha AM, 2010, BIOORGAN MED CHEM, V18, P7193, DOI 10.1016/j.bmc.2010.08.032; Spellberg B, 2013, NEW ENGL J MED, V368, P299, DOI 10.1056/NEJMp1215093; Vaudaux P, 2010, ANTIMICROB AGENTS CH, V54, P3861, DOI 10.1128/AAC.00269-10; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727	21	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153912	10.1371/journal.pone.0153912	http://dx.doi.org/10.1371/journal.pone.0153912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101010	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500093
J	Thomas, JT; Chhuy-Hy, L; Andrykovich, KR; Moos, M				Thomas, J. Terrig; Chhuy-Hy, Lina; Andrykovich, Kristin R.; Moos, Malcolm, Jr.			SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HEPARAN-SULFATE; IN-VITRO; PROTEIN; BMP; ACTIVATION; PRECURSOR; SERUM	In an attempt to identify the cell-associated protein(s) through which SMOC (Secreted Modular Calcium binding protein) induces mitogen-activated protein kinase (MAPK) signaling, the epidermal growth factor receptor (EGFR) became a candidate. However, although in 32D/EGFR cells, the EGFR was phosphorylated in the presence of a commercially available human SMOC-1 (hSMOC-1), only minimal phosphorylation was observed in the presence of Xenopus SMOC-1 (XSMOC-1) or human SMOC-2. Analysis of the commercial hSMOC-1 product demonstrated the presence of pro-EGF as an impurity. When the pro-EGF was removed, only minimal EGFR activation was observed, indicating that SMOC does not signal primarily through EGFR and its receptor remains unidentified. Investigation of SMOC/pro-EGF binding affinity revealed a strong interaction that does not require the C-terminal extracellular calcium-binding (EC) domain of SMOC or the EGF domain of pro-EGF. SMOC does not appear to potentiate or inhibit MAPK signaling in response to pro-EGF, but the interaction could provide a mechanism for retaining soluble pro-EGF at the cell surface.	[Thomas, J. Terrig; Chhuy-Hy, Lina; Andrykovich, Kristin R.; Moos, Malcolm, Jr.] US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Thomas, JT (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies, Silver Spring, MD USA.	john.thomas@fda.hhs.gov	Moos, Malcolm C/F-3673-2011	Moos, Malcolm C/0000-0002-9575-9938	FDA	FDA(United States Department of Health & Human Services)	All funding for this study was FDA intramural funding. No grants were received.	Abouzeid H, 2011, AM J HUM GENET, V88, P92, DOI 10.1016/j.ajhg.2010.12.002; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aybay C, 2006, CYTOKINE, V35, P36, DOI 10.1016/j.cyto.2006.07.005; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Deb TB, 2001, J BIOL CHEM, V276, P15554, DOI 10.1074/jbc.M100928200; Gurdon JB, 1967, METHODS DEV BIOL; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; JOHNSON GR, 1994, J BIOL CHEM, V269, P27149; Klemencic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056839; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Li QF, 2001, J BIOL CHEM, V276, P38068; Mummery RS, 2007, GLYCOBIOLOGY, V17, P1094, DOI 10.1093/glycob/cwm082; Novinec M, 2008, PROTEIN EXPRES PURIF, V62, P75, DOI 10.1016/j.pep.2008.07.009; Okada I, 2011, AM J HUM GENET, V88, P30, DOI 10.1016/j.ajhg.2010.11.012; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; PARRIES G, 1995, J BIOL CHEM, V270, P27954, DOI 10.1074/jbc.270.46.27954; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Prince RN, 2010, J CELL SCI, V123, P2308, DOI 10.1242/jcs.058321; Rainger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002114; Sive H, 2000, EARLY DEVELOPMENT OF; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Thomas JT, 2009, J BIOL CHEM, V284, P18994, DOI 10.1074/jbc.M807759200; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; Vuilleumier R, 2010, NAT CELL BIOL, V12, P611, DOI 10.1038/ncb2064; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yoshioka J, 2005, P NATL ACAD SCI USA, V102, P10622, DOI 10.1073/pnas.0501198102	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154294	10.1371/journal.pone.0154294	http://dx.doi.org/10.1371/journal.pone.0154294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101391	gold, Green Submitted, Green Published			2022-12-27	WOS:000374898500180
J	Parrish, RC; Penley, MJ; Morran, LT				Parrish, Raymond C., II; Penley, McKenna J.; Morran, Levi T.			The Integral Role of Genetic Variation in the Evolution of Outcrossing in the Caenorhabditis elegans-Serratia marcescens Host-Parasite System	PLOS ONE			English	Article							SELF-FERTILIZATION; EXPERIMENTAL COEVOLUTION; INBREEDING DEPRESSION; SEX; SELECTION; MAINTENANCE; ADVANTAGE; PLANTS; COST; PARTHENOGENESIS	Outcrossing is predicted to facilitate more rapid adaptation than self-fertilization as a result of genetic exchange between genetically variable individuals. Such genetic exchange may increase the efficacy of selection by breaking down Hill-Robertson interference, as well as promoting the maintenance of within-lineage genetic diversity. Experimental studies have demonstrated the selective advantage of outcrossing in novel environments. Here, we assess the specific role of genetic variation in the evolution of outcrossing. We experimentally evolved genetically variable and inbred populations of mixed mating (outcrossing and self-fertilizing) Caenorhabditis elegans nematodes under novel ecological conditions-specifically the presence of the virulent parasite Serratia marcescens. Outcrossing rates increased in genetically variable host populations evolved in the presence of the parasite, whereas parasite exposure in inbred populations resulted in reduced rates of host outcrossing. The host populations with genetic variation also exhibited increased fitness in the presence of the parasite over eight generations, whereas inbred populations did not. This increase in fitness was primarily the result of adaptation to the parasite, rather than recovery from initial inbreeding depression. Therefore, the benefits of outcrossing were only manifested in the presence of genetic variation, and outcrossing was favored over self-fertilization as a result. As predicted, the benefits of outcrossing under novel ecological conditions are a product of genetic exchange between genetically diverse lineages.	[Parrish, Raymond C., II; Morran, Levi T.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Penley, McKenna J.; Morran, Levi T.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Parrish, Raymond C., II] Harvard Univ, Sch Med, Boston, MA USA	Indiana University System; Indiana University Bloomington; Emory University; Harvard University; Harvard Medical School	Morran, LT (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN USA.; Morran, LT (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	levi.morran@emory.edu			National Institutes of Health [1F32GM096482]; Emory University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health 1F32GM096482 to LTM (http://www.nih.gov/) and Emory University to LTM (www.emory.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2010, J HERED, V101, pS62, DOI 10.1093/jhered/esq003; BARRETT SCH, 1991, NATURE, V352, P522, DOI 10.1038/352522a0; Becks L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001317; Becks L, 2010, NATURE, V468, P89, DOI 10.1038/nature09449; Bell G, 1982, MASTERPIECE NATURE E; BRENNER S, 1974, GENETICS, V77, P71; CHARLESWORTH B, 1980, J THEOR BIOL, V84, P655, DOI 10.1016/S0022-5193(80)80026-9; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; CROW JF, 1992, J HERED, V83, P169, DOI 10.1093/oxfordjournals.jhered.a111187; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fisher RA, 1930, GENETICAL THEORY NAT; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Goldberg EE, 2010, SCIENCE, V330, P493, DOI 10.1126/science.1194513; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Gray JC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-43; Hartfield M, 2012, INTEGR ZOOL, V7, P192, DOI 10.1111/j.1749-4877.2012.00284.x; Heller J., 1979, GENET RES, V8, P269; Jarne P, 2006, EVOLUTION, V60, P1816; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; King KC, 2009, CURR BIOL, V19, P1438, DOI 10.1016/j.cub.2009.06.062; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Lively CM, 2014, J EVOLUTION BIOL, V27, P1292, DOI 10.1111/jeb.12354; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; LIVELY CM, 1990, AM NAT, V135, P489, DOI 10.1086/285058; Lynch M., 1995, EVOLUTION, V47, P1744; Masri L, 2013, ECOL LETT, V16, P461, DOI 10.1111/ele.12068; Morran LT, 2014, AM NAT, V184, pS91, DOI 10.1086/676930; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Morran LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014473; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; ROSENBLUTH RE, 1983, MUTAT RES, V110, P39, DOI 10.1016/0027-5107(83)90016-7; Schulte RD, 2010, P NATL ACAD SCI USA, V107, P7359, DOI 10.1073/pnas.1003113107; SMITH JM, 1978, EVOLUTION SEX; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Stewart AD, 2002, GENETICS, V160, P975; Szovenyi P, 2014, GENOME BIOL EVOL, V6, P1238, DOI 10.1093/gbe/evu099; Teotonio H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035811; UYENOYAMA MK, 1984, EVOLUTION, V38, P87, DOI 10.1111/j.1558-5646.1984.tb00262.x; Vergara D, 2014, AM NAT, V184, pS22, DOI 10.1086/676886; Verhoeven KJF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-23; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; Zeyl C, 1997, NATURE, V388, P465, DOI 10.1038/41312	46	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154463	10.1371/journal.pone.0154463	http://dx.doi.org/10.1371/journal.pone.0154463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119159	gold, Green Submitted, Green Published			2022-12-27	WOS:000374976200080
J	Lacy, BE; Patel, H; Guerin, A; Dea, K; Scopel, JL; Alaghband, R; Wu, EQ; Mody, R				Lacy, Brian E.; Patel, Haridarshan; Guerin, Annie; Dea, Katherine; Scopel, Justin L.; Alaghband, Reza; Wu, Eric Qiong; Mody, Reema			Variation in Care for Patients with Irritable Bowel Syndrome in the United States	PLOS ONE			English	Article							COMMERCIALLY INSURED POPULATION; QUALITY-OF-LIFE; REGIONAL-VARIATION; HEALTH-CARE; GEOGRAPHIC-VARIATION; MYOCARDIAL-INFARCTION; CHRONIC CONSTIPATION; RETROSPECTIVE ANALYSIS; ECONOMIC BURDEN; COSTS	Objectives Irritable bowel syndrome (IBS) affects nearly one in seven Americans. Significant national variations in care may exist, due to a current lack of standardized diagnosis and treatment algorithms; this can translate into a substantial additional economic burden. The study examines healthcare resource utilization in patients with IBS and in the subset of IBS patients with constipation (IBS-C) and analyzes the variation of IBS care for these patients across the United States (US). Methods Healthcare resource use (HRU), including gastrointestinal (GI) procedures and tests, all-cause and intestinal-related medical visits, GI specialist visits, and constipation or diarrhea pharmacy prescriptions for IBS patients enrolled in a large US administrative claims database (2001-2012) were analyzed for the 24-month period surrounding first diagnosis. Multivariate regression models, adjusting for age, gender, year of first diagnosis, insurance type, and Charlson comorbidity index, compared HRU across states (each state vs. the average of all other states). Results Of 201,322 IBS patients included, 77.2% were female. Mean age was 49.4 years. One in three patients had >= 3 distinct GI medical procedures or diagnostic tests; 50.1% visited a GI specialist. Significant HRU differences were observed in individual states compared to the national average. IBS-C patients had more medical visits, procedures, and pharmacy prescriptions for constipation/diarrhea than IBS patients without constipation. Conclusions This study is the first to identify considerable regional variations in IBS healthcare across the US and to note a markedly higher HRU by IBS-C patients than by IBS patients without constipation. Identifying the reasons for these variations may improve quality of care and reduce the economic burden of IBS.	[Lacy, Brian E.] Dartmouth Hitchcock Med Ctr, Div Gastroenterol & Hepatol, Lebanon, NH 03766 USA; [Patel, Haridarshan] Immens Consulting Inc, Chicago, IL USA; [Guerin, Annie; Dea, Katherine; Alaghband, Reza] Anal Grp Inc, Montreal, PQ, Canada; [Scopel, Justin L.] Takeda Pharmaceut Int Inc, US Med Affairs, Deerfield, IL USA; [Wu, Eric Qiong] Anal Grp Inc, Boston, MA USA; [Mody, Reema] Takeda Pharmaceut Int Inc, Global Outcomes & Epidemiol Res, Deerfield, IL USA	Dartmouth College; Analysis Group Inc.; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.; Analysis Group Inc.; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	Guerin, A (corresponding author), Anal Grp Inc, Montreal, PQ, Canada.	Annie.Guerin@analysisgroup.com			Takeda Pharmaceuticals International; Takeda Pharmaceuticals International, Inc.; Immensity Consulting, Inc.; Analysis Group, Inc.	Takeda Pharmaceuticals International(Takeda Pharmaceutical Company Ltd); Takeda Pharmaceuticals International, Inc.(Takeda Pharmaceutical Company Ltd); Immensity Consulting, Inc.; Analysis Group, Inc.	Research for this article was funded by the sponsor, Takeda Pharmaceuticals International. The study was designed by the senior authors (BEL, AG, EQW) and the sponsor employees HP, RM, and JLS. Data were collected by Analysis Group authors KD and RA and analyzed and interpreted in collaboration with all authors. All authors participated in the design of the study and contributed to the manuscript development. Although sponsor employees HP, RM, and JLS were involved in the design, collection, analysis, and interpretation of information, the content of this manuscript, the ultimate interpretation, and the decision to submit it for publication were made by each of the authors independently. All the authors vouch for the accuracy and completeness of the data reported and for the adherence of the study to the protocol. Takeda Pharmaceuticals International, Inc., Immensity Consulting, Inc., and Analysis Group, Inc. provided support in the form of salaries for the authors employed as listed in the 'competing interests' section, but these companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; [Anonymous], 2009, Prescrire Int, V18, P75; Astegiano M, 2008, Minerva Gastroenterol Dietol, V54, P251; Cai Qian, 2014, J Med Econ, V17, P148, DOI 10.3111/13696998.2013.860375; Canavan C, 2014, ALIMENT PHARM THER, V40, P1023, DOI 10.1111/apt.12938; Cary KC, 2015, PROSTATE CANCER P D, V18, P149, DOI 10.1038/pcan.2015.3; Charlson ME, 2008, J CLIN EPIDEMIOL, V61, P1234, DOI 10.1016/j.jclinepi.2008.01.006; Clin Practice Comm, 2002, GASTROENTEROLOGY, V123, P2105, DOI 10.1053/gast.2002.37095; Creed F, 2001, ANN INTERN MED, V134, P860, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00010; Danielson Group, 2014, DAN GROUP; David G, 2013, GASTROENTEROLOGY, V144, pS647; DETSKY AS, 1995, NEW ENGL J MED, V333, P589, DOI 10.1056/NEJM199508313330911; DiBonaventura M, 2011, CURR MED RES OPIN, V27, P2213, DOI 10.1185/03007995.2011.623157; Doshi JA, 2014, J MANAG CARE SPEC PH, V20, P382, DOI 10.18553/jmcp.2014.20.4.382; Fitzgerald John D, 2013, J Hosp Adm, V2, DOI 10.5430/jha.v2n4p71; Gebreab SY, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001673; Guerin Annie, 2014, J Med Econ, V17, P577, DOI 10.3111/13696998.2014.919926; Hsu RK, 2013, CLIN J AM SOC NEPHRO, V8, P1476, DOI 10.2215/CJN.12611212; Hungin APS, 2005, ALIMENT PHARM THER, V21, P1365, DOI 10.1111/j.1365-2036.2005.02463.x; Jung HK, 2014, J NEUROGASTROENTEROL, V20, P242, DOI [10.5056/jnm.2014.20.2.242, 10.5056/jnm.20.2.242]; Kolte D, 2015, CIRCULATION, V131, P1415, DOI 10.1161/CIRCULATIONAHA.114.014542; Kolte D, 2014, CLIN CARDIOL, V37, P204, DOI 10.1002/clc.22250; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Longstreth GF, 2003, AM J GASTROENTEROL, V98, P600, DOI 10.1016/S0002-9270(02)06018-5; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Magner D, 2009, J VASC SURG, V49, P893, DOI 10.1016/j.jvs.2008.11.065; Mitra D, 2011, POSTGRAD MED, V123, P122, DOI 10.3810/pgm.2011.05.2290; Moayyedi P, 2007, AM J GASTROENTEROL, V102, P478, DOI 10.1111/j.1572-0241.2006.00973.x; [National Collaborating Centre for Nursing and Supportive Care National Collaborating Centre for Nursing and Supportive Care ( UK) National Institute for Health and Care Excellence], 2008, IRR BOWL SYNDR AD DI; Nellesen D, J MANAG CARE PHARM, V19, P755; Nyrop KA, 2007, ALIMENT PHARM THERAP, V26, P237, DOI 10.1111/j.1365-2036.2007.03370.x; Pisu M, 2012, EPILEPSIA, V53, P2186, DOI 10.1111/j.1528-1167.2012.03640.x; Reames BN, 2014, J CLIN ONCOL, V32, P3667, DOI 10.1200/JCO.2014.57.1588; Rubin G, 2006, FAM PRACT, V23, P687, DOI 10.1093/fampra/cml050; Sariego J, 2008, AM J SURG, V196, P572, DOI 10.1016/j.amjsurg.2008.06.017; Tillisch Kirsten, 2005, Curr Gastroenterol Rep, V7, P249, DOI 10.1007/s11894-005-0016-y; U. S. Department of Health and Human Services, 2014, DAT BANK NPDB STAT; Viskin S, 1996, NEW ENGL J MED, V334, P194; Wetmore JB, 2014, CLIN J AM SOC NEPHRO, V9, P756, DOI 10.2215/CJN.06980713	40	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154258	10.1371/journal.pone.0154258	http://dx.doi.org/10.1371/journal.pone.0154258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116612	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600053
J	Keller, CJ; Chen, C; Lado, FA; Khodakhah, K				Keller, Corey J.; Chen, Christopher; Lado, Fred A.; Khodakhah, Kamran			The Limited Utility of Multiunit Data in Differentiating Neuronal Population Activity	PLOS ONE			English	Article							LOCAL-FIELD POTENTIALS; GAMMA OSCILLATIONS; SPIKING ACTIVITY; MOVEMENT DIRECTION; VISUAL-CORTEX; FREQUENCY; TETRAPLEGIA; HIPPOCAMPUS; PRIMATE; DEVICES	To date, single neuron recordings remain the gold standard for monitoring the activity of neuronal populations. Since obtaining single neuron recordings is not always possible, high frequency or 'multiunit activity' (MUA) is often used as a surrogate. Although MUA recordings allow one to monitor the activity of a large number of neurons, they do not allow identification of specific neuronal subtypes, the knowledge of which is often critical for understanding electrophysiological processes. Here, we explored whether prior knowledge of the single unit waveform of specific neuron types is sufficient to permit the use of MUA to monitor and distinguish differential activity of individual neuron types. We used an experimental and modeling approach to determine if components of the MUA can monitor medium spiny neurons (MSNs) and fast-spiking interneurons (FSIs) in the mouse dorsal striatum. We demonstrate that when well-isolated spikes are recorded, the MUA at frequencies greater than 100Hz is correlated with single unit spiking, highly dependent on the waveform of each neuron type, and accurately reflects the timing and spectral signature of each neuron. However, in the absence of well-isolated spikes (the norm in most MUA recordings), the MUA did not typically contain sufficient information to permit accurate prediction of the respective population activity of MSNs and FSIs. Thus, even under ideal conditions for the MUA to reliably predict the moment-to-moment activity of specific local neuronal ensembles, knowledge of the spike waveform of the underlying neuronal populations is necessary, but not sufficient.	[Keller, Corey J.; Chen, Christopher; Lado, Fred A.; Khodakhah, Kamran] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Keller, Corey J.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Keller, Corey J.] Stanford Univ, Stanford Neurosci Inst, Stanford, CA 94305 USA; [Lado, Fred A.] Montefiore Med Ctr, Dept Neurol, 111 E 210th St, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Stanford University; Stanford University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Keller, CJ (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA.; Keller, CJ (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Keller, CJ (corresponding author), Stanford Univ, Stanford Neurosci Inst, Stanford, CA 94305 USA.	coreyjkeller@gmail.com	Keller, Corey/GON-5459-2022	Keller, Corey/0000-0003-0529-3490; Lado, Fred/0000-0003-3648-4812	 [NS079750];  [F31NS080357];  [T32-GM007288]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079750, F31NS080357] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grant numbers NS079750, F31NS080357, T32-GM007288. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; BUCHWALD JS, 1970, J NEUROPHYSIOL, V33, P148, DOI 10.1152/jn.1970.33.1.148; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cristianini N, 2000, INTRO SUPPORT VECTOR; David S.V., 2010, COMPUT INTEL NEUROSC, DOI DOI 10.1155/2010/393019; du Hoffmann J, 2011, J NEUROPHYSIOL, V106, P1054, DOI 10.1152/jn.00349.2011; GRAVELAND GA, 1985, BRAIN RES, V327, P307, DOI 10.1016/0006-8993(85)91524-0; Hangya B, 2010, J PHYSIOL-LONDON, V588, P4165, DOI 10.1113/jphysiol.2010.194274; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Jia XX, 2013, NEURON, V77, P762, DOI 10.1016/j.neuron.2012.12.036; Jia XX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001045; Kecman V., 2001, LEARNING SOFT COMPUT; LEGATT AD, 1980, J NEUROSCI METH, V2, P203, DOI 10.1016/0165-0270(80)90061-8; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Maynard EM, 1999, J NEUROSCI, V19, P8083; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Scheffer-Teixeira R, 2013, J NEUROSCI, V33, P1535, DOI 10.1523/JNEUROSCI.4217-12.2013; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Whittingstall K, 2009, NEURON, V64, P281, DOI 10.1016/j.neuron.2009.08.016; Wiltschko AB, 2008, J NEUROSCI METH, V173, P34, DOI 10.1016/j.jneumeth.2008.05.016; Zanos TP, 2011, J NEUROPHYSIOL, V105, P474, DOI 10.1152/jn.00642.2010	30	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153154	10.1371/journal.pone.0153154	http://dx.doi.org/10.1371/journal.pone.0153154			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111446	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600012
J	Li, W; Li, YC; Huang, QY; Ye, SQ; Rong, TH				Li, Wei; Li, Yongchun; Huang, Qingyuan; Ye, Shengquan; Rong, Tiehua			Short and Long-Term Outcomes of Epidural or Intravenous Analgesia after Esophagectomy: A Propensity-Matched Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; CONTROLLED-TRIAL; LYMPH-NODES; FOLLOW-UP; CANCER; COMPLICATIONS; CARCINOMA; SURVIVAL; SURGERY; RECURRENCE	Background and Objectives As a well-established technique for postoperative pain relief, the benefits of epidural analgesia (EDA) have been under debate recently. This study aimed to determine whether EDA could improve perioperative outcomes and survival in patients undergoing esophagectomy. Methods From January 2010 to December 2012, 587 consecutive cases undergoing McKeown-type esohpageactomy were retrospectively identified from a prospectively maintained database. Results After propensity-matching, incorporating baseline characteristics, 178 cases were included in each group, and patients characteristics distributions were well-balanced between two groups. Compared with intravenous analgesia, the use of EDA significantly decreased the incidence of pneumonia from 32% to 19.7%(P = 0.008), and anastomotic leakage from 23.0% to 14.0% (P = 0.029). The change in CRP level of EDA group was significantly decreased (preoperative, 6.2 vs. 6.2; POD 1, 108.1 vs. 121.3; POD 3, 131.5 vs. 137.8; POD 7, 69.3 vs. 82.1 mg/L; P = 0.044). EDA patients had a significantly longer duration of indwelling urinary catheter (P< 0.001), and lower levels in both systolic (P = 0.001) and diastolic blood pressure (P< 0.001). There weren't significant differences in overall survival (log-rank P = 0.47) and recurrence (Gray-test P = 0.46) between two groups. Conclusions These findings revealed that EDA could attenuate inflammatory response and reduce the incidence of pneumonia and anastomotic leakage after esophagectomy, at the price of delayed urinary catheter removal and lower blood pressure. EDA remains an important component of multimodal perioperative management after esophagectomy.	[Li, Wei; Li, Yongchun; Ye, Shengquan; Rong, Tiehua] Sun Yat Sen Univ, Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Li, Wei; Li, Yongchun; Ye, Shengquan; Rong, Tiehua] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Li, Wei; Li, Yongchun; Ye, Shengquan; Rong, Tiehua] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Huang, Qingyuan] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai 200030, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Shanghai Jiao Tong University	Li, W (corresponding author), Sun Yat Sen Univ, Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.; Li, W (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Li, W (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	liw@sysucc.org.cn	Huang, Qingyuan/AAC-7164-2019		Guangdong Science and Technology Program [2013B021800172]	Guangdong Science and Technology Program	This work was funded by Guangdong Science and Technology Program (grant number 2013B021800172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2010, BRIT J ANAESTH, V104, P292, DOI 10.1093/bja/aeq006; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Dignam JJ, 2012, CLIN CANCER RES, V18, P2301, DOI 10.1158/1078-0432.CCR-11-2097; Fares KM, 2014, PAIN PHYSICIAN, V17, P305; FOK M, 1994, WORLD J SURG, V18, P355, DOI 10.1007/BF00316814; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Huang QY, 2015, J SURG ONCOL, V111, P365, DOI 10.1002/jso.23837; Huang QY, 2014, CANCER SCI, V105, P1638, DOI 10.1111/cas.12552; Hubner M, 2015, ANN SURG, V261, P648, DOI 10.1097/SLA.0000000000000838; Hur C, 2013, CANCER-AM CANCER SOC, V119, P1149, DOI 10.1002/cncr.27834; Kamiyoshihara Mitsuhiro, 2010, Asian Cardiovasc Thorac Ann, V18, P464, DOI 10.1177/0218492310381817; Kusano C, 1997, BRIT J SURG, V84, P252, DOI 10.1046/j.1365-2168.1997.02542.x; Law S, 2004, ANN SURG, V240, P791, DOI 10.1097/01.sla.0000143123.24556.1c; Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc5704; Lotan Y, 2005, J CLIN ONCOL, V23, P6533, DOI 10.1200/JCO.2005.05.516; Luketich JD, 2012, ANN SURG, V256, P95, DOI 10.1097/SLA.0b013e3182590603; Michelet P, 2007, ACTA ANAESTH SCAND, V51, P587, DOI 10.1111/j.1399-6576.2007.01290.x; Michelet P, 2005, CHEST, V128, P3461, DOI 10.1378/chest.128.5.3461; Rawal N, 2012, REGION ANESTH PAIN M, V37, P310, DOI 10.1097/AAP.0b013e31825735c6; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; Rodriguez MAP, 2008, MINERVA ANESTESIOL, V74, P619; Rudin A, 2005, J CARDIOTHOR VASC AN, V19, P350, DOI 10.1053/j.jvca.2005.03.013; Saeki H, 2009, SURG TODAY, V39, P476, DOI 10.1007/s00595-008-3924-2; URSCHEL JD, 1995, AM J SURG, V169, P634, DOI 10.1016/S0002-9610(99)80238-4; Wang H, 2015, J THORAC CARDIOV SUR, V149, P1006, DOI 10.1016/j.jtcvs.2014.12.063; Wuethrich PY, 2010, ANESTHESIOLOGY, V113, P570, DOI 10.1097/ALN.0b013e3181e4f6ec; Yang H, 2016, DIS ESOPHAGUS, V29, P152, DOI 10.1111/dote.12318	29	25	27	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154380	10.1371/journal.pone.0154380	http://dx.doi.org/10.1371/journal.pone.0154380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110939	gold, Green Published, Green Submitted			2022-12-27	WOS:000374970600062
J	Berman, Y; Ben-Jacob, E; Shapira, Y				Berman, Yonatan; Ben-Jacob, Eshel; Shapira, Yoash			The Dynamics of Wealth Inequality and the Effect of Income Distribution	PLOS ONE			English	Article							KINETIC EXCHANGE MODELS	The rapid increase of wealth inequality in the past few decades is one of the most disturbing social and economic issues of our time. Studying its origin and underlying mechanisms is essential for policy aiming to control and even reverse this trend. In that context, controlling the distribution of income, using income tax or other macroeconomic policy instruments, is generally perceived as effective for regulating the wealth distribution. We provide a theoretical tool, based on the realistic modeling of wealth inequality dynamics, to describe the effects of personal savings and income distribution on wealth inequality. Our theoretical approach incorporates coupled equations, solved using iterated maps to model the dynamics of wealth and income inequality. Notably, using the appropriate historical parameter values we were able to capture the historical dynamics of wealth inequality in the United States during the course of the 20th century. It is found that the effect of personal savings on wealth inequality is substantial, and its major decrease in the past 30 years can be associated with the current wealth inequality surge. In addition, the effect of increasing income tax, though naturally contributing to lowering income inequality, might contribute to a mild increase in wealth inequality and vice versa. Plausible changes in income tax are found to have an insignificant effect on wealth inequality, in practice. In addition, controlling the income inequality, by progressive taxation, for example, is found to have a very small effect on wealth inequality in the short run. The results imply, therefore, that controlling income inequality is an impractical tool for regulating wealth inequality.	[Berman, Yonatan; Ben-Jacob, Eshel; Shapira, Yoash] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Tel Aviv University	Berman, Y; Shapira, Y (corresponding author), Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel.	yonatanb@post.tau.ac.il; yoashshapia@gmail.com		Berman, Yonatan/0000-0001-6969-271X				Alvarez-Cuadrado F., 2012, 7083 IZA; [Anonymous], 2015, OECD STATEXTRACTS DA; [Anonymous], 1998, GROWTH INEQUALITY GL; Atkinson A.B., 2015, INEQUALITY WHAT CAN, P25; Atkinson AB, 2011, J ECON LIT, V49, P3, DOI 10.1257/jel.49.1.3; Bagatella-Flores N, 2015, PHYSICA A, V417, P168, DOI 10.1016/j.physa.2014.07.081; Benhabib J, 2011, ECONOMETRICA, V79, P123, DOI 10.3982/ECTA8416; Benhabib Jess., 2007, DISTRIBUTION WEALTH; Berman Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130181; BOSWORTH B, 1991, BROOKINGS PAP ECO AC, P183; Boyce JK, 2000, DISASTERS, V24, P254, DOI 10.1111/1467-7717.00146; Budria S, 2002, Q REV FEDERAL RESERV, V26, P2; Cagetti M, 2008, MACROECON DYN, V12, P285, DOI 10.1017/S1365100507070150; CARROLL CD, 1994, CARN ROCH CONF SERIE, V40, P133, DOI 10.1016/0167-2231(94)90006-X; Chatterjee A, 2007, EUR PHYS J B, V60, P135, DOI 10.1140/epjb/e2007-00343-8; Davies JB, 2011, ECON J, V121, P223, DOI 10.1111/j.1468-0297.2010.02391.x; De Nardi M, 2004, REV ECON STUD, V71, P743, DOI 10.1111/j.1467-937X.2004.00302.x; Elgar FJ, 2011, EUR J PUBLIC HEALTH, V21, P241, DOI 10.1093/eurpub/ckq068; FISCHER S, 1993, J MONETARY ECON, V32, P485, DOI 10.1016/0304-3932(93)90027-D; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Heckman JJ, 1998, REV ECON DYNAM, V1, P1, DOI 10.1006/redy.1997.0008; Hurst Charles E, 2007, SOCIAL INEQUALITY FO; Ispolatov S, 1998, EUR PHYS J B, V2, P267, DOI 10.1007/s100510050249; Jones CI, 2014, W20742 NBER; Karen D, 2004, J POLIT ECON, V112, P397, DOI [10.1086/381475, DOI 10.1086/381475]; Keister LA, 2000, ANNU REV SOCIOL, V26, P63, DOI 10.1146/annurev.soc.26.1.63; Keister Lisa, 2000, WEALTH AM TRENDS WEA; Kopczuk W, 2015, J ECON PERSPECT, V29, P47, DOI 10.1257/jep.29.1.47; Kuhn M, 2014, 2013 UPDATE US EARNI; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lerman D. L., 1988, POLICY STUDIES REV, V7, P765, DOI DOI 10.1111/J.1541-1338.1988.TB00895.X; Levine R, 1998, AM ECON REV, V88, P537; LEVINE R, 1991, J FINANC, V46, P1445, DOI 10.2307/2328866; Maki DM, 2001, 200121 FEDS; NELSON RR, 1966, AM ECON REV, V56, P69; Ng YK., 2014, 201410 NAN TU EGC; Ohtake F, 2013, GINI PROJ REP; Patriarca M, 2013, AM J PHYS, V81, P618, DOI 10.1119/1.4807852; Peters O, 2015, SOLVING LINEAR UNPUB; Piketty T, 2003, Q J ECON, V118, P1, DOI 10.1162/00335530360535135; Piketty T., 2014, CAPITAL 21 CENTURY; Piketty T, 2007, J ECON PERSPECT, V21, P3, DOI 10.1257/jep.21.1.3; Piketty T, 2014, Q J ECON, V129, P1255, DOI 10.1093/qje/qju018; Piketty T, 2014, SCIENCE, V344, P838, DOI 10.1126/science.1251936; Plog S, 2010, P NATL ACAD SCI USA, V107, P19619, DOI 10.1073/pnas.1014985107; Reich RB, 2012, OUTRAGE WHAT HAS GON; Reynolds A., 2006, INCOME WEALTH; Saez E., 2014, W20625 NAT BUR EC RE; Sen A., 1973, EC INEQUALITY; SOLOW RM, 1956, Q J ECON, V70, P65, DOI 10.2307/1884513; Stiglitz JE, 2015, NATL TAX J, V68, P425, DOI 10.17310/ntj.2015.2.09; Stiglitz Joseph E., 2012, PRICE INEQUALITY TOD; Tavoni A, 2011, P NATL ACAD SCI USA, V108, P11825, DOI 10.1073/pnas.1102493108; Thornton DL, 2009, FEDERAL RESERVE BANK, V46; US Congressional Budget Office, 2014, DISTR HOUS INC FED T; Wolff, 2010, 589 LEC EC I; Wolff EN, 2014, OXFORD REV ECON POL, V30, P21, DOI 10.1093/oxrep/gru001; Wolff EN, 1996, REV INCOME WEALTH, P433; World Bank, 2015, WORLD BANK GINI IND; Zentner E, 2014, MORGAN STANLEY REPOR	60	24	25	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154196	10.1371/journal.pone.0154196	http://dx.doi.org/10.1371/journal.pone.0154196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27105224	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100053
J	Chen, YG; Chen, MQ; Guo, YY; Li, SC; Wu, JX; Xu, BH				Chen, Yuan-Gui; Chen, Ming-Qiu; Guo, Yu-Yan; Li, Si-Cong; Wu, Jun-Xin; Xu, Ben-Hua			Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy	PLOS ONE			English	Article							WEIGHTED MAGNETIC-RESONANCE; CHEMORADIATION THERAPY; RADIATION-THERAPY; RADIOCHEMOTHERAPY; CHEMOTHERAPY; MRI	Objective To evaluate the predictive value of the apparent diffusion coefficient (ADC) for pathologic complete response (pCR) to neoadjuvant chemoradiotherapy (NCRT) in locally advanced rectal cancer. Methods A total of 265 patients with rectal adenocarcinoma, whole Diffusion-Weighted MRI (DWI-MRI) images, clinically stage II to III (cT3-4 and/or cN+) and treated with NCRT followed by TME were screened. Fifty patients with pCR and another 50 patients without pCR with similar clinical charcacters and treatment regimens were selected for statistical analysis. All the patients' pre-CRT and post-CRT average ADC values were calculated from the coefficient maps created by DWI-MRI and recorded independently. The difference in the ADC values between the pCR and non-pCR was analyzed by the Mann-Whitney U test. The cut-off ADC value of the receiver operating characteristic (ROC) curve with pCR was then established. Results The mean pre- and post-ADC values in all patients, and in pCR patients and non-pCR patients were 0.879 +/- 0.06 and 1.383 +/- 0.11, 0.859 +/- 0.04 and 1.440 +/- 0.10, 0.899 +/- 0.07 and 1.325 +/- 0.09 (x10(-3)mm(2)/s), respectively. The difference between the pre-and post-ADC values in all patients, pCR patients, and non-pCR patients were considered to be statistically significant. The pre-ADC value was significantly lower in the pCR patients than in the non-pCR patients (p = 0.003), whereas the post-ADC values were significantly higher in the pCR patients than in the non-pCR patients. The percentage increase of the ADC value (Delta ADC%) in the pCR and non-pCR patients were 68% and 48% respectively (p<0.001). The ROC curves of the cut-off value of the pre-CRT patient ADC value was 0.866x10(-3)mm(2)/s. The AUC, sensitivity, specificity, PPV, NPV, and accuracy of diagnosing pCR were 0.670 (95% CI 0.563-0.777), 0.600, 0.640, 60%, 60%, and 60%, respectively. The cut-off value of Delta ADC% was 58%. The corresponding AUC, sensitivity, specificity, PPV, NPV, and accuracy of diagnosing pCR were 0.856 (95% CI 0.783-0.930), 0.800, 0.760, 76.9%, 79.2%, and 78%, respectively. Conclusions DWI-MRI technology can be efficient for predicting pCR for LARC after NCRT. Although the mean pre-CRT ADC value and the Delta ADC% are moderate predictors for pCR, the latter would be more accurate.	[Chen, Yuan-Gui; Chen, Ming-Qiu; Guo, Yu-Yan; Xu, Ben-Hua] Fujian Med Univ, Union Hosp, Dept Radiat Oncol, Fuzhou, Fujian Province, Peoples R China; [Li, Si-Cong] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA; [Wu, Jun-Xin] Fujian Prov Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University; University of Nebraska System; University of Nebraska Medical Center	Xu, BH (corresponding author), Fujian Med Univ, Union Hosp, Dept Radiat Oncol, Fuzhou, Fujian Province, Peoples R China.; Wu, JX (corresponding author), Fujian Prov Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian Province, Peoples R China.	junxinwu@126.com; benhuaxu@163.com						[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Cho SH, 2015, ACTA RADIOL, V56, P1042, DOI 10.1177/0284185114550193; Curvo-Semedo L, 2011, RADIOLOGY, V260, P734, DOI 10.1148/radiol.11102467; Dzik-Jurasz A, 2002, LANCET, V360, P307, DOI 10.1016/S0140-6736(02)09520-X; Elmi A, 2013, CLIN RADIOL, V68, pE524, DOI 10.1016/j.crad.2013.05.094; Genovesi D, 2013, EJSO-EUR J SURG ONC, V39, P1071, DOI 10.1016/j.ejso.2013.07.090; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Glimelius B, 2013, ANN ONCOL, V24, P81, DOI 10.1093/annonc/mdt240; Greene FL, 2009, AJCC CANC STAGING MA; Hosonuma Tomonori, 2006, Magn Reson Med Sci, V5, P173, DOI 10.2463/mrms.5.173; Intven M, 2013, STRAHLENTHER ONKOL, V189, P117, DOI 10.1007/s00066-012-0270-5; Joye I, 2014, RADIOTHER ONCOL, V113, P158, DOI 10.1016/j.radonc.2014.11.026; Jung SH, 2012, J MAGN RESON IMAGING, V35, P110, DOI 10.1002/jmri.22749; Kim SH, 2011, EUR RADIOL, V21, P987, DOI 10.1007/s00330-010-1989-y; Lambrecht M, 2012, INT J RADIAT ONCOL, V82, P863, DOI 10.1016/j.ijrobp.2010.12.063; Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8; Meng XJ, 2014, BIOSCI TRENDS, V8, P11, DOI 10.5582/bst.8.11; O'Neill BDP, 2007, LANCET ONCOL, V8, P625, DOI 10.1016/S1470-2045(07)70202-4; Rao SX, 2008, EUR J RADIOL, V65, P299, DOI 10.1016/j.ejrad.2007.04.001; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Stipa F, 2006, ANN SURG ONCOL, V13, P1047, DOI 10.1245/ASO.2006.03.053; Sun YS, 2010, RADIOLOGY, V254, P170, DOI 10.1148/radiol.2541082230; Xie HT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000517; Xu BH, 2014, TUMORI, V100, P149, DOI 10.1700/1491.16399; Yu E, 2015, PRACT RADIAT ONCOL, V5, pE451, DOI 10.1016/j.prro.2015.04.005; Yuangui C, 2015, CHINESE J RAD ONCOLO, V24, P5	28	25	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153944	10.1371/journal.pone.0153944	http://dx.doi.org/10.1371/journal.pone.0153944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100991	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500105
J	Harris, LG; Murray, S; Pascoe, B; Bray, J; Meric, G; Mageiros, L; Wilkinson, TS; Jeeves, R; Rohde, H; Schwarz, S; De Lencastre, H; Miragaia, M; Rolo, J; Bowden, R; Jolley, KA; Maiden, MCJ; Mack, D; Sheppard, SK				Harris, Llinos G.; Murray, Susan; Pascoe, Ben; Bray, James; Meric, Guillaume; Mageiros, Leonardos; Wilkinson, Thomas S.; Jeeves, Rose; Rohde, Holger; Schwarz, Stefan; De Lencastre, Herminia; Miragaia, Maria; Rolo, Joana; Bowden, Rory; Jolley, Keith A.; Maiden, Martin C. J.; Mack, Dietrich; Sheppard, Samuel K.			Biofilm Morphotypes and Population Structure among Staphylococcus epidermidis from Commensal and Clinical Samples (vol 11, e0151240, 2016)	PLOS ONE			English	Correction													Méric, Guillaume/R-3947-2017; Harris, Llinos/AAQ-9477-2021; Jolley, Keith/ABE-8587-2020; Maiden, Martin C J/C-5055-2014; Pascoe, Ben/C-2253-2009; Rolo, Joana/G-4447-2011; Méric, Guillaume/AAD-2364-2019; Pascoe, Ben/AAD-2728-2019; Wilkinson, Thomas/C-5237-2013; Miragaia, Maria/J-2704-2015	Méric, Guillaume/0000-0001-6288-9958; Jolley, Keith/0000-0002-0751-0287; Maiden, Martin C J/0000-0001-6321-5138; Pascoe, Ben/0000-0001-6376-5121; Rolo, Joana/0000-0002-5291-212X; Méric, Guillaume/0000-0001-6288-9958; /0000-0001-6816-8932; Wilkinson, Thomas/0000-0003-0397-6079; BRAY, JAMES/0000-0003-3554-4254; Miragaia, Maria/0000-0002-1323-7184; Bowden, Rory/0000-0001-8596-0366; Harris, Llinos/0000-0002-0295-3038	Medical Research Council [G0801929] Funding Source: Medline; MRC [G0801929] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Harris LG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151240	1	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154510	10.1371/journal.pone.0154510	http://dx.doi.org/10.1371/journal.pone.0154510			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101249	Green Published, gold			2022-12-27	WOS:000374898500191
J	Barratt, H; Rojas-Garcia, A; Clarke, K; Moore, A; Whittington, C; Stockton, S; Thomas, J; Pilling, S; Raine, R				Barratt, Helen; Rojas-Garcia, Antonio; Clarke, Katherine; Moore, Anna; Whittington, Craig; Stockton, Sarah; Thomas, James; Pilling, Stephen; Raine, Rosalind			Epidemiology of Mental Health Attendances at Emergency Departments: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PATIENTS BROUGHT; SERVICES; MANAGEMENT; DEMAND; PEOPLE	Background The characteristics of Emergency Department (ED) attendances due to mental or behavioural health disorders need to be described to enable appropriate development of services. We aimed to describe the epidemiology of mental health-related ED attendances within health care systems free at the point of access, including clinical reason for presentation, previous service use, and patient sociodemographic characteristics. Method Systematic review and meta-analysis of observational studies describing ED attendances by patients with common mental health conditions. Findings 18 studies from seven countries met eligibility criteria. Patients attending due to mental or behavioural health disorders accounted for 4% of ED attendances; a third were due to self-harm or suicidal ideation. 58.1% of attendees had a history of psychiatric illness and up to 58% were admitted. The majority of studies were single site and of low quality so results must be interpreted cautiously. Conclusions Prevalence studies of mental health-related ED attendances are required to enable the development of services to meet specific needs.	[Barratt, Helen; Rojas-Garcia, Antonio; Raine, Rosalind] UCL, Dept Appl Hlth Res, NIHR CLAHRC North Thames, London, England; [Clarke, Katherine; Whittington, Craig; Pilling, Stephen] UCL, CORE, Res Dept Clin Educ & Hlth Psychol, London, England; [Moore, Anna] UCL, Div Psychiat, London, England; [Stockton, Sarah] Univ Oxford, Dept Psychiat, Oxford, England; [Thomas, James] Inst Educ EPPI Ctr, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of Oxford; University of London; University College London; UCL Institute of Education	Barratt, H (corresponding author), UCL, Dept Appl Hlth Res, NIHR CLAHRC North Thames, London, England.	h.barratt@ucl.ac.uk	Garcia, Antonio Rojas/AAA-1422-2021; Rojas Garcia, Antonio/GPX-8129-2022	Rojas Garcia, Antonio/0000-0002-7792-4311; Raine, Rosalind/0000-0003-0904-749X; Moore, Anna/0000-0001-9614-3812; Barratt, Helen/0000-0002-1387-137X; Thomas, James/0000-0003-4805-4190	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care North Thames at Barts Health NHS Trust	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care North Thames at Barts Health NHS Trust	The research was supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care North Thames at Barts Health NHS Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Al-Khafaji K, 2014, INT J LAW PSYCHIAT, V37, P415, DOI 10.1016/j.ijlp.2014.02.013; Ananiadou S, 2006, TEXT MINING FOR BIOL; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Brierley S, 2010, EMERG MED AUSTRALAS, V22, P532, DOI 10.1111/j.1742-6723.2010.01350.x; Brunero S, 2007, AUST HEALTH REV, V31, P462, DOI 10.1071/AH070462; Brunton J., 2010, EPPI REVIEWER 4 0 SO; Care Quality Commission, 2015, RIGHT HERE RIGHT NOW; Cassar S, 2002, PSYCHIAT B, V26, P134, DOI [10.1192/pb.26.4.134, DOI 10.1192/PB.26.4.134]; Chaput YJA, 2007, PSYCHIAT SERV, V58, P335, DOI 10.1176/appi.ps.58.3.335; Department of Health, 2013, NHS MANDATE 2014 TO; Fernandes A., 2011, GUIDANCE FOR COMMISS; FRY M, 2004, AUSTRALASIAN EMERGEN, V7, P21, DOI DOI 10.1016/S1328-2743(05)80027-6; Health and Social Care Information Centre, 2014, ACCIDENT AND EMERGEN; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Himelhoch S, 2004, MED CARE, V42, P512, DOI 10.1097/01.mlr.0000127998.89246.ef; Johansen IH, 2009, SCAND J PRIM HEALTH, V27, P180, DOI 10.1080/02813430903075473; Joint Commissioning Panel for Mental Health, 2012, GUIDANCE FOR COMMISS; Kalucy R, 2005, AUST NZ J PSYCHIAT, V39, P74, DOI 10.1111/j.1440-1614.2005.01512.x; Kang H, 2014, CAN J EMERG MED, V16, pS94; Knott JC, 2007, AUST NZ J PSYCHIAT, V41, P759, DOI 10.1080/00048670701517934; Lee S, 2006, AUSTRALAS EMERG NURS, V9, P65, DOI 10.1016/j.aenj.2006.02.002; Milton Keynes Primary Care Trust, 2002, 11 QUESTIONS TO HELP; NHS Confederation, 2014, BRIEFING MENTAL HEAL; Okorie EF, 2011, PSYCHIATR BULL, V35, P60, DOI 10.1192/pb.bp.108.024455; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Pascual JC, 2007, PSYCHIAT SERV, V58, P1199, DOI 10.1176/appi.ps.58.9.1199; Pereira S, 2013, EUR NEUROPSYCHOPHARM, V23, pS307, DOI 10.1016/S0924-977X(13)70481-4; Perez-Rodriguez MM, 2006, EUR J PUBLIC HEALTH, V16, P383, DOI 10.1093/eurpub/ckl021; Prats L, 2011, EUR PSYCHIATRY SUPPL, V26, P834, DOI [10.1016/S0924-9338(11)72539-1, DOI 10.1016/S0924-9338(11)72539-1]; Publications.gov.uk, 2013, INVESTMENT IN MENTAL; Reijneveld SA, 1998, J EPIDEMIOL COMMUN H, V52, P2, DOI 10.1136/jech.52.1.2; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Shafiei T, 2011, J PSYCHIATR MENT HLT, V18, P9, DOI 10.1111/j.1365-2850.2010.01632.x; Tankel AS, 2011, EMERG MED AUSTRALAS, V23, P689, DOI 10.1111/j.1742-6723.2011.01468.x; Thomas J, 2011, RES SYNTH METHODS, V2, P1, DOI 10.1002/jrsm.27; Tyrer P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7457; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wallace B. C., 2010, P 16 ACM SIGKDD INT, P173, DOI DOI 10.1145/1835804.1835829; Wells GA, THE NEWCASTLE OTTAWA; White IR, 2005, CLIN TRIALS, V2, P141, DOI 10.1191/1740774505cn081oa	41	54	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154449	10.1371/journal.pone.0154449	http://dx.doi.org/10.1371/journal.pone.0154449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120350	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200078
J	Li, ZY; Zhang, ZP; Bi, LJ; Cui, ZQ; Deng, JY; Wang, DB; Zhang, XE				Li, ZhaoYang; Zhang, ZhiPing; Bi, LiJun; Cui, ZongQiang; Deng, JiaoYu; Wang, DianBing; Zhang, Xian-En			Mutagenesis of mNeptune Red-Shifts Emission Spectrum to 681-685 nm	PLOS ONE			English	Article							FLUORESCENT PROTEIN; IN-VIVO; CHROMOPHORE; ISOMERIZATION; VARIANT; WINDOW	GFP-like fluorescent proteins with diverse emission wavelengths have been developed through mutagenesis, offering many possible choices in cellular and tissue imaging, such as multi-targets imaging, deep tissue imaging that require longer emission wavelength. Here, we utilized a combined approach of random mutation and structure-based rational design to develop new NIR fluorescent proteins on the basis of a far-red fluorescent protein, mNeptune (Ex/Em: 600/650 nm). We created a number of new monomeric NIR fluorescent proteins with the emission range of 681-685 nm, which exhibit the largest Stocks shifts (77-80 nm) compared to other fluorescent proteins. Among them, mNeptune681 and mNeptune684 exhibit more than 30 nm redshift in emission relative to mNeptune, owing to the major role of the extensive hydrogen-bond network around the chromophore and contributions of individual mutations to the observed redshift. Furthermore, the two variants still maintain monomeric state in solution, which is a trait crucial for their use as protein tags. In conclusion, our results suggest that there is untapped potential for developing fluorescent proteins with desired properties.	[Bi, LiJun; Wang, DianBing; Zhang, Xian-En] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 10010, Peoples R China; [Li, ZhaoYang; Zhang, ZhiPing; Cui, ZongQiang; Deng, JiaoYu] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, DB; Zhang, XE (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 10010, Peoples R China.	wangdb@moon.ibp.ac.cn; zhangxe@ibp.ac.cn	ZHANG, Xian-En/AAJ-5579-2021; Wang, Dian-Bing/AFQ-6894-2022	Wang, Dian-Bing/0000-0001-6225-7010	Chinese Academy of Sciences [KJZD-EW-TZ-L04]; National High Technology Research and Development Program ("863" Program) of China [2011AA02A114, 2012AA022206]	Chinese Academy of Sciences(Chinese Academy of Sciences); National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China)	This work was supported by the Chinese Academy of Sciences grant KJZD-EW-TZ-L04 to XEZ, and the National High Technology Research and Development Program ("863" Program) of China (No. 2011AA02A114, 2012AA022206) grant to DBW.; The authors thank Dr. Xu-De Wang (Wuhan Institute of Virology, Chinese Academy of Sciences) for kindly providing the valuable suggestions and assistance on protein experiments, and Dr. Ding Gao (Wuhan Institute of Virology, Chinese Academy of Sciences) for his assistance in the protein photobleaching experiments and related analysis. Support of Chinese Academy of Sciences grant (NO. KJZD-EW-TZ-L04) is acknowledged.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chalfie MS, 2005, METHODS BIOCH ANAL G; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Li Z- Y, 2014, ACTA BIOCH BIOPH SIN; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Mena MA, 2006, NAT BIOTECHNOL, V24, P1569, DOI 10.1038/nbt1264; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Piatkevich KD, 2013, SCI REP-UK, V3, DOI 10.1038/srep01847; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Pletnev S, 2012, ACTA CRYSTALLOGR D, V68, P1088, DOI 10.1107/S0907444912020598; Pletneva NV, 2011, PROTEIN SCI, V20, P1265, DOI 10.1002/pro.654; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shu XK, 2009, PROTEIN SCI, V18, P460, DOI 10.1002/pro.66; Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123	26	10	11	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0148749	10.1371/journal.pone.0148749	http://dx.doi.org/10.1371/journal.pone.0148749			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119418	Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200002
J	Lim, KL; Hewitt, J; Sitabkhan, A; Eden, JS; Lun, J; Levy, A; Merif, J; Smith, D; Rawlinson, WD; White, PA				Lim, Kun Lee; Hewitt, Joanne; Sitabkhan, Alefiya; Eden, John-Sebastian; Lun, Jennifer; Levy, Avram; Merif, Juan; Smith, David; Rawlinson, William D.; White, Peter A.			A Multi-Site Study of Norovirus Molecular Epidemiology in Australia and New Zealand, 2013-2014	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; UNITED-STATES; GII.4 NOROVIRUS; OUTBREAKS; VARIANT; STRAIN; CHILDREN; RECOMBINATION; EMERGENCE; EVOLUTION	Background Norovirus (NoV) is the major cause of acute gastroenteritis across all age groups. In particular, variants of genogroup II, genotype 4 (GII.4) have been associated with epidemics globally, occurring approximately every three years. The pandemic GII.4 variant, Sydney 2012, was first reported in early 2012 and soon became the predominant circulating NoV strain globally. Despite its broad impact, both clinically and economically, our understanding of the fundamental diversity and mechanisms by which new NoV strains emerge remains limited. In this study, we describe the molecular epidemiological trends of NoV-associated acute gastroenteritis in Australia and New Zealand between January 2013 and June 2014. Methodology Overall, 647 NoV-positive clinical faecal samples from 409 outbreaks and 238 unlinked cases of acute gastroenteritis were examined by RT-PCR and sequencing. Phylogenetic analysis was then performed to identify NoV capsid genotypes and to establish the temporal dominance of circulating pandemic GII.4 variants. Recombinant viruses were also identified based on analysis of the ORF1/2 overlapping region. Findings Peaks in NoV activity were observed, however the timing of these epidemics varied between different regions. Overall, GII.4 NoVs were the dominant cause of both outbreaks and cases of NoV-associated acute gastroenteritis (63.1%, n = 408/647), with Sydney 2012 being the most common GII.4 variant identified (98.8%, n = 403/408). Of the 409 reported NoV outbreaks, aged-care facilities were the most common setting in both Western Australia (87%, n = 20/23) and New Zealand (58.1%, n = 200/344) while most of the NoV outbreaks were reported from hospitals (38%, n = 16/42) in New South Wales, Australia. An analysis of a subset of non-GII.4 viruses from all locations (125/239) showed the majority (56.8%, n = 71/125) were inter-genotype recombinants. These recombinants were surprisingly diverse and could be classified into 18 distinct recombinant types, with GII.P16/GII. 13 (24% of recombinants) the most common. Conclusion This study revealed that following its emergence in 2012, GII.4 Sydney 2012 variant continued to be the predominant cause of NoV-associated acute gastroenteritis in Australia and New Zealand between 2013 and 2014.	[Lim, Kun Lee; Sitabkhan, Alefiya; Lun, Jennifer; Rawlinson, William D.; White, Peter A.] Univ New S Wales, Fac Sci, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Lim, Kun Lee] Singapore Gen Hosp, Mol Lab, Dept Pathol, Singapore, Singapore; [Hewitt, Joanne] Kenepuru Sci Ctr, Inst Environm Sci & Res, Porirua, New Zealand; [Eden, John-Sebastian] Univ Sydney, Sch Biol Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Eden, John-Sebastian] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Levy, Avram; Smith, David] Queen Elizabeth II Med Ctr, PathWest Lab Med WA, Perth, WA, Australia; [Levy, Avram; Smith, David] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Merif, Juan; Rawlinson, William D.] Prince Wales Hosp, Div Virol, SESIAHS, Dept Microbiol, Sydney, NSW, Australia; [Rawlinson, William D.] Univ New S Wales, Sch Med Sci, Fac Med, Sydney, NSW, Australia	University of New South Wales Sydney; Singapore General Hospital; Institute of Environmental Science & Research (ESR) - New Zealand; University of Sydney; University of Sydney; University of Western Australia; University of Western Australia; University of New South Wales Sydney	White, PA (corresponding author), Univ New S Wales, Fac Sci, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	p.white@unsw.edu.au	White, Peter A/C-6573-2012	White, Peter A/0000-0002-6046-9631; Hewitt, Joanne/0000-0003-0370-6394; Smith, David/0000-0002-3107-5182; Levy, Avram/0000-0002-0934-2387; Eden, John-Sebastian/0000-0003-1374-3551	Australian NHMRC [APP1083139]; New Zealand Ministry of Health, as part of ESR's contract; Singapore General Hospital Pte. Ltd.; Australian Postgraduate Award; Water Research Australia Scholarship; NHMRC [1073466]	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); New Zealand Ministry of Health, as part of ESR's contract; Singapore General Hospital Pte. Ltd.; Australian Postgraduate Award(Australian Government); Water Research Australia Scholarship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This project is partially funded through an Australian NHMRC Project Grant APP1083139. The New Zealand component of this study was funded by the New Zealand Ministry of Health, as part of ESR's contract to provide disease surveillance services. KLL acknowledges support through an FY10 SGH Formal Education Scholarship from Singapore General Hospital Pte. Ltd. JL is supported by an Australian Postgraduate Award and a Water Research Australia Scholarship. JSE is supported by an NHMRC Early Career Fellowship (1073466). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER JL, 1969, J INFECT DIS, V119, P668, DOI 10.1093/infdis/119.6.668; Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Ahmed SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075922; [Anonymous], EURO SURVEILL; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Bull RA, 2012, J VIROL, V86, P3219, DOI 10.1128/JVI.06712-11; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; CAUL EO, 1994, LANCET, V343, P1240, DOI 10.1016/S0140-6736(94)92146-6; de Graaf M, 2015, EURO SURVEILL, V20; Debbink K, 2013, J INFECT DIS; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Eden JS, 2014, VIROLOGY, V450, P106, DOI 10.1016/j.virol.2013.12.005; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Eden JS, 2011, J VIROL, V85, P10894, DOI 10.1128/JVI.05562-11; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Estes MK, 2006, CURR OPIN INFECT DIS, V19, P467, DOI 10.1097/01.qco.0000244053.69253.3d; Fu J, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21157; Greening GE, 2012, J MED VIROL, V84, P1449, DOI 10.1002/jmv.23349; Hall AJ, 2013, EMERG INFECT DIS, V19, P1305, DOI 10.3201/eid1908.130482; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; KAPLAN JE, 1982, AM J EPIDEMIOL, V116, P940, DOI 10.1093/oxfordjournals.aje.a113496; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Koopmans M, 2009, J HOSP INFECT, V73, P331, DOI 10.1016/j.jhin.2009.06.028; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Lim KL, 2013, J MED VIROL, V85, P1842, DOI 10.1002/jmv.23669; Lindesmith LC, 2013, J VIROL, V87, P2803, DOI 10.1128/JVI.03106-12; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Mahar JE, 2011, J MED VIROL, V83, P2213, DOI 10.1002/jmv.22215; Marshall JA, 2005, J MED VIROL, V75, P321, DOI 10.1002/jmv.20274; Martella V, 2013, J CLIN MICROBIOL, V51, P3855, DOI 10.1128/JCM.01847-13; Mathijs E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-310; Mattison K, 2011, ADV FOOD NUTR RES, V62, P1, DOI 10.1016/B978-0-12-385989-1.00001-6; McAllister G, 2012, EPIDEMIOL INFECT, V140, P2273, DOI 10.1017/S0950268812000052; Medici MC, 2006, J MED VIROL, V78, P1486, DOI 10.1002/jmv.20723; Meijer A, 2012, EUROSURVEILLANCE, V17, P2; Nayak MK, 2009, J CLIN VIROL, V45, P223, DOI 10.1016/j.jcv.2009.04.018; Noel JS, 1999, J INFECT DIS, V179, P1334, DOI 10.1086/314783; Parra GI, 2015, EMERG INFECT DIS, V21, P1477, DOI 10.3201/eid2108.150652; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Svraka S, 2007, J CLIN MICROBIOL, V45, P1389, DOI 10.1128/JCM.02305-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran TNH, 2013, J CLIN VIROL, V56, P185, DOI 10.1016/j.jcv.2012.11.011; Tu ETV, 2008, J CLIN MICROBIOL, V46, P2119, DOI 10.1128/JCM.02198-07; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; Tu ETV, 2007, EMERG INFECT DIS, V13, P1128, DOI 10.3201/eid1307.060999; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Verhoef L, 2010, EMERG INFECT DIS, V16, P617, DOI 10.3201/eid1604.090723; Vidal R, 2006, J CLIN MICROBIOL, V44, P2271, DOI 10.1128/JCM.01890-05; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; White P, 2002, J MED VIROL, V68, P113, DOI 10.1002/jmv.10177; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Yoon JS, 2008, J CLIN MICROBIOL, V46, P1474, DOI 10.1128/JCM.02282-07; Yu Y, 2014, BIOMED RES INT, V2014; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	62	32	33	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0145254	10.1371/journal.pone.0145254	http://dx.doi.org/10.1371/journal.pone.0145254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116221	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600002
J	Tumati, S; Burger, H; Martens, S; van der Schouw, YT; Aleman, A				Tumati, Shankar; Burger, Huibert; Martens, Sander; van der Schouw, Yvonne T.; Aleman, Andre			Association between Cognition and Serum Insulin-Like Growth Factor-1 in Middle-Aged & Older Men: An 8 Year Follow-Up Study	PLOS ONE			English	Article							IGF-I; ALZHEIMERS-DISEASE; BINDING PROTEIN-3; SEX-HORMONES; DECLINE; BRAIN; IMPAIRMENT; COMMUNITY; DEMENTIA; PEOPLE	Low levels of insulin-like growth factor-1 (IGF-1), an essential neurotrophic factor, have been associated with worse cognitive function in older adults. However, few studies have assessed the prospective association of serum IGF-1 with cognitive function. We aimed to determine the association between serum IGF-1 on concurrent and prospective cognitive function in a population sample of men aged 40-80 years. Blood samples were assessed for IGF-1 levels at baseline and neuropsychological assessments were performed at baseline (n = 400) and at follow-up after a mean duration of 8.3 years (n = 286). Linear regression analyses were carried out to determine the associations between quintiles of IGF-1 and cognitive function at the baseline and follow-up visits. Results showed that those in the top quintile of IGF-1 had lower processing capacity and global cognition scores at follow-up after controlling for cognitive function at baseline and other confounding factors. Additional analyses exploring associations with IGF-1 separately in middle-aged and older participants, and with quartiles of IGF-1 produced similar results. In those older than 60 years, high IGF-1 levels were also associated with lower baseline processing capacity. These results suggest that high IGF-1 levels are associated with worse long-term cognition in men. Together with past studies, we suggest that both, high and low levels of IGF-1 may be associated with poor cognitive function and that optimum levels of IGF-1 (quintile 2 and 3 in current study) may be associated with better cognitive function.	[Tumati, Shankar; Martens, Sander; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9700 AB Groningen, Netherlands; [Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9713 AV Groningen, Netherlands; [Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, NL-9713 AV Groningen, Netherlands; [van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center	Tumati, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9700 AB Groningen, Netherlands.	s.tumati@umcg.nl	van der Schouw, Yvonne T./F-8327-2014; Tumati, Shankar/AAD-2092-2020	van der Schouw, Yvonne T./0000-0002-4605-435X; Tumati, Shankar/0000-0001-5703-2044; Martens, Sander/0000-0001-8237-7984	International Health Foundation, Geneva, Switzerland; Netherlands organization for health research and development (zonmw.nl) [60-61900-98-146]	International Health Foundation, Geneva, Switzerland; Netherlands organization for health research and development (zonmw.nl)	This work was supported by the International Health Foundation, Geneva, Switzerland; ( baseline measurements) to YTVDS and the Netherlands organization for health research and development (zonmw.nl), grant 60-61900-98-146, follow-up measurements to YTVDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Delaimy WK, 2009, J AM GERIATR SOC, V57, P1441, DOI 10.1111/j.1532-5415.2009.02343.x; Aleman A, 1999, J CLIN ENDOCR METAB, V84, P471, DOI 10.1210/jc.84.2.471; Aleman A, 2001, EXP AGING RES, V27, P283, DOI 10.1080/036107301300208718; Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Angelini A, 2009, ARCH GERONTOL GERIAT, V49, P5, DOI 10.1016/j.archger.2009.09.006; Arwert LI, 2005, GROWTH HORM IGF RES, V15, P416, DOI 10.1016/j.ghir.2005.09.001; Baker LD, 2012, ARCH NEUROL-CHICAGO, V69, P1420, DOI 10.1001/archneurol.2012.1970; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; Bayram F, 2011, ENDOCRINE, V40, P304, DOI 10.1007/s12020-011-9476-z; Bidlingmaier M, 2014, J CLIN ENDOCR METAB, V99, P1712, DOI 10.1210/jc.2013-3059; Davis C, 1999, BRIT J CLIN PSYCHOL, V38, P305, DOI 10.1348/014466599162881; de Bruijn RFAG, 2014, J ALZHEIMERS DIS, V42, P137, DOI 10.3233/JAD-140186; Deak F, 2012, J GERONTOL A-BIOL, V67, P611, DOI 10.1093/gerona/gls118; Deijen Jan Berend, 2011, ISRN Endocrinol, V2011, P249421, DOI 10.5402/2011/249421; Dik MG, 2003, NEUROBIOL AGING, V24, P573, DOI 10.1016/S0197-4580(02)00136-7; Doi T, 2015, NEUROBIOL AGING, V36, P942, DOI 10.1016/j.neurobiolaging.2014.10.035; Duron E, 2012, J CLIN ENDOCR METAB, V97, P4673, DOI 10.1210/jc.2012-2063; Euser SM, 2008, J GERONTOL A-BIOL, V63, P907, DOI 10.1093/gerona/63.9.907; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Johansson P, 2013, PSYCHONEUROENDOCRINO, V38, P1729, DOI 10.1016/j.psyneuen.2013.02.006; Kalmijn S, 2000, J CLIN ENDOCR METAB, V85, P4551, DOI 10.1210/jc.85.12.4551; Landi F, 2007, GROWTH HORM IGF RES, V17, P58, DOI 10.1016/j.ghir.2006.11.001; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Licht CMM, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/181327; Matousek RH, 2010, HORM BEHAV, V57, P352, DOI 10.1016/j.yhbeh.2010.01.004; Morley JE, 1997, P NATL ACAD SCI USA, V94, P7537, DOI 10.1073/pnas.94.14.7537; Muller M, 2005, NEUROLOGY, V64, P866, DOI 10.1212/01.WNL.0000153072.54068.E3; Muller M, 2003, EUR J ENDOCRINOL, V149, P583, DOI 10.1530/eje.0.1490583; Okereke OI, 2006, J CLIN ENDOCR METAB, V91, P4306, DOI 10.1210/jc.2006-1325; Rollero A, 1998, NEUROPSYCHOBIOLOGY, V38, P73, DOI 10.1159/000026520; Rubin DB, 2009, MULTIPLE IMPUTATION; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Sievers C, 2014, EUR NEUROPSYCHOPHARM, V24, P890, DOI 10.1016/j.euroneuro.2014.01.008; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Sun LY, 2005, NEUROBIOL AGING, V26, P929, DOI 10.1016/j.neurobiolaging.2004.07.010; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Exel E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.08.014; Vardy ERLC, 2007, J ALZHEIMERS DIS, V12, P285; Verhage F., 1964, ONDERZOEK BIJ NEDERL; VOORRIPS LE, 1991, MED SCI SPORT EXER, V23, P974, DOI 10.1249/00005768-199108000-00015; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Westwood AJ, 2014, NEUROLOGY, V82, P1613, DOI 10.1212/WNL.0000000000000382; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	45	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154450	10.1371/journal.pone.0154450	http://dx.doi.org/10.1371/journal.pone.0154450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27115487	Green Published, gold			2022-12-27	WOS:000374973600068
J	Zhou, HX; Han, B; Hou, LM; An, TT; Jia, G; Cheng, ZX; Ma, Y; Zhou, YN; Kong, R; Wang, SJ; Wang, YW; Sun, XJ; Pan, SH; Sun, B				Zhou, Hao-xin; Han, Bing; Hou, Li-Min; An, Ting-Ting; Jia, Guang; Cheng, Zhuo-Xin; Ma, Yong; Zhou, Yi-Nan; Kong, Rui; Wang, Shuang-Jia; Wang, Yong-Wei; Sun, Xue-Jun; Pan, Shang-Ha; Sun, Bei			Protective Effects of Hydrogen Gas on Experimental Acute Pancreatitis	PLOS ONE			English	Article							CERULEIN-INDUCED PANCREATITIS; OXIDATIVE STRESS; NITRIC-OXIDE; AR42J CELLS; RATS; INJURY; INHALATION; CYTOKINES; MODEL	Acute pancreatitis (AP) is an inflammatory disease mediated by damage to acinar cells and pancreatic inflammation. In patients with AP, subsequent systemic inflammatory responses and multiple organs dysfunction commonly occur. Interactions between cytokines and oxidative stress greatly contribute to the amplification of uncontrolled inflammatory responses. Molecular hydrogen (H-2) is a potent free radical scavenger that not only ameliorates oxidative stress but also lowers cytokine levels. The aim of the present study was to investigate the protective effects of H-2 gas on AP both in vitro and in vivo. For the in vitro assessment, AR42J cells were treated with cerulein and then incubated in H-2-rich or normal medium for 24 h, and for the in vivo experiment, AP was induced through a retrograde infusion of 5% sodium taurocholate into the pancreatobiliary duct (0.1 mL/100 g body weight). Wistar rats were treated with inhaled air or 2% H-2 gas and sacrificed 12 h following the induction of pancreatitis. Specimens were collected and processed to measure the amylase and lipase activity levels; the myeloperoxidase activity and production levels; the cytokine mRNA expression levels; the 8-hydroxydeoxyguanosine, malondialdehyde, and glutathione levels; and the cell survival rate. Histological examinations and immunohistochemical analyses were then conducted. The results revealed significant reductions in inflammation and oxidative stress both in vitro and in vivo. Furthermore, the beneficial effects of H-2 gas were associated with reductions in AR42J cell and pancreatic tissue damage. In conclusion, our results suggest that H-2 gas is capable of ameliorating damage to the pancreas and AR42J cells and that H-2 exerts protective effects both in vitro and in vivo on subjects with AP. Thus, the results obtained indicate that this gas may represent a novel therapy agent in the management of AP.	[Zhou, Hao-xin; Hou, Li-Min] Harbin Med Univ, Affiliated Hosp 1, Dept Emergency Surg, Harbin, Peoples R China; [Han, Bing; Jia, Guang; Cheng, Zhuo-Xin; Ma, Yong; Zhou, Yi-Nan; Kong, Rui; Wang, Shuang-Jia; Wang, Yong-Wei; Pan, Shang-Ha; Sun, Bei] Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China; [An, Ting-Ting] Harbin Med Univ, Affiliated Hosp 1, Dept Abdominal Ultrasound, Harbin, Peoples R China; [Sun, Xue-Jun] Second Mil Med Univ, Dept Diving Med, Shanghai, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Naval Medical University	Sun, B (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China.	sunbei70@tom.com	shuangjia, wang/AFX-8272-2022; sun, xuejun/A-5561-2010; Sun, Xuejun/GLR-4436-2022	sun, xuejun/0000-0003-2387-5531; Sun, Xuejun/0000-0003-2387-5531	National Natural Scientific Foundation of China [81170431, 81372613]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Scientific Foundation of China No: 81170431, No: 81372613 http://nsfc.biomart.cn/search?name=&applicationabstract=1&applicationkeyword=1& person=%E5%AD%99%E5%A4%87&participant=&company=&no=&subject=&type=&money1=&money2=&startTime=1955&endTime=2015&redract_url=&submit=advSearch. BS designed the study. This work was also supported by the National Natural Scientific Foundation of China No: 81101799 http://nsfc.biomart.cn/search?name=&applicationabstract= 1&applicationkeyword=1&person=%E5%AD%94%E7%91%9E&participant=&company=&no=&subject=&type=&money1=&money2=&startTime=1955&endTime=2015&redract_url=&submit=advSearch.RKcontributed reagents and collected data.	Bai XW, 2009, PANCREAS, V38, P515, DOI 10.1097/MPA.0b013e31819cac24; Bettaieb A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113019; Buchholz BM, 2008, AM J TRANSPLANT, V8, P2015, DOI 10.1111/j.1600-6143.2008.02359.x; Carvalho ACS, 2014, PANCREAS, V43, P82, DOI 10.1097/MPA.0b013e3182a63b9d; Chen HG, 2013, INT J SURG, V11, P1060, DOI 10.1016/j.ijsu.2013.10.007; Chen P, 2010, CYTOKINE, V49, P15, DOI 10.1016/j.cyto.2009.09.013; Cheng ZX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023752; Chu JT, 2013, MOL CELL BIOCHEM, V382, P1, DOI 10.1007/s11010-013-1603-0; Chu PY, 2012, HUM EXP TOXICOL, V31, P397, DOI 10.1177/0960327111426583; Escobar J, 2009, CURR PHARM DESIGN, V15, P3027, DOI 10.2174/138161209789058075; Esrefoglu M, 2006, WORLD J GASTROENTERO, V12, P259; Gomez-Cambronero L, 2000, J PHARMACOL EXP THER, V293, P670; Gomez-Cambronero L. G., 2002, Current Drug Targets - Inflammation and Allergy, V1, P393, DOI 10.2174/1568010023344544; Hartman H, 2012, BRIT J SURG, V99, P246, DOI 10.1002/bjs.7775; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Hsu DZ, 2006, SHOCK, V25, P528, DOI 10.1097/01.shk.0000209552.95839.43; Hwang JH, 2005, PANCREAS, V31, P332, DOI 10.1097/01.mpa.0000183377.04295.c3; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P11, DOI 10.1016/j.bbrc.2009.05.117; Li GM, 2013, J SURG RES, V181, P279, DOI 10.1016/j.jss.2012.06.058; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ozturk F, 2008, FREE RADICAL RES, V42, P289, DOI 10.1080/10715760801930730; Pereda J, 2008, FREE RADICAL BIO MED, V44, P1599, DOI 10.1016/j.freeradbiomed.2008.01.018; Pereda J, 2006, CURR MED CHEM, V13, P2775, DOI 10.2174/092986706778522011; Rakonczay Z, 2003, EUR J PHARMACOL, V464, P217, DOI 10.1016/S0014-2999(03)01380-3; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Sun HY, 2011, J HEPATOL, V54, P471, DOI 10.1016/j.jhep.2010.08.011; Wang F, 2011, J SURG RES, V167, pE339, DOI 10.1016/j.jss.2010.11.005; Wang G, 2013, APOPTOSIS, V18, P28, DOI 10.1007/s10495-012-0770-x; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040160; Xiang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115982; Xue DB, 2009, PANCREAS, V38, pE183, DOI 10.1097/MPA.0b013e3181b65dec; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52; Zyromski N, 2003, SURGERY, V133, P235, DOI 10.1067/msy.2003.87	33	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154483	10.1371/journal.pone.0154483	http://dx.doi.org/10.1371/journal.pone.0154483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115738	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600070
J	Korpela, K; Salonen, A; Virta, LJ; Kumpu, M; Kekkonen, RA; de Vos, WM				Korpela, Katri; Salonen, Anne; Virta, Lauri J.; Kumpu, Minna; Kekkonen, Riina A.; de Vos, Willem M.			Lactobacillus rhamnosus GG Intake Modifies Preschool Children's Intestinal Microbiota, Alleviates Penicillin-Associated Changes, and Reduces Antibiotic Use	PLOS ONE			English	Article							LONG-TERM IMPACTS; GUT MICROBIOTA; FECAL MICROBIOTA; DIARRHEA; METAANALYSIS; BACTEROIDES; PROBIOTICS; SUSCEPTIBILITY; DIFFERS; ECOLOGY	Antibiotic use is considered among the most severe causes of disturbance to children's developing intestinal microbiota, and frequently causes adverse gastrointestinal effects ranging from mild and transient diarrhoea to life-threatening infections. Probiotics are commonly advocated to help in preventing antibiotic-associated gastrointestinal symptoms. However, it is currently unknown whether probiotics alleviate the antibiotic-associated changes in children's microbiota. Furthermore, it is not known how long-term probiotic consumption influences the developing microbiota of children. We analysed the influence of long-term Lactobacillus rhamnosus GG intake on preschool children's antibiotic use, and antibiotic-associated gastrointestinal complaints in a double blind, randomized placebo-controlled trial with 231 children aged 2-7. In addition, we analysed the effect of L. rhanmosus GG on the intestinal microbiota in a subset of 88 children. The results show that long-term L. rhamnosus GG supplementation has an influence on the composition of the intestinal microbiota in children, causing an increase in the abundance of Prevotella, Lactococcus, and Ruminococcus, and a decrease in Escherichia. The treatment appeared to prevent some of the changes in the microbiota associated with penicillin use, but not those associated with macrolide use. The treatment, however, did reduce the frequency of gastrointestinal complaints after a macrolide course. Finally, the treatment appeared to prevent certain bacterial infections for up to 3 years after the trial, as indicated by reduced antibiotic use.	[Korpela, Katri; Salonen, Anne; de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Fac Med, Immunobiol Res Programme, Helsinki, Finland; [Virta, Lauri J.] Social Insurance Inst, Res Dept, Turku, Finland; [Kumpu, Minna; Kekkonen, Riina A.] Valio Ltd, R&D, Helsinki, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands	University of Helsinki; Valio; Wageningen University & Research	Korpela, K (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Fac Med, Immunobiol Res Programme, Helsinki, Finland.	katri.korpela@helsinki.fi	Salonen, Anne/AAW-1858-2020	Salonen, Anne/0000-0002-6960-7447	Doctoral Program in Biomedicine, University of Helsinki; Academy of Finland [137389, 141140, 1272870]; Valio Ltd.	Doctoral Program in Biomedicine, University of Helsinki; Academy of Finland(Academy of Finland); Valio Ltd.	This work was supported by the Doctoral Program in Biomedicine, University of Helsinki, (http://www.helsinki.fi/dpbm/) (KK) and the Academy of Finland, (http://www.aka.fi), grant numbers 137389, 141140 and 1272870) (WMdV). The funder (Valio Ltd.) provided support in the form of salaries for authors MK and RK but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahlroos T, 2009, J APPL MICROBIOL, V106, P506, DOI 10.1111/j.1365-2672.2008.04018.x; Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Antunes LCM, 2011, ANTIMICROB AGENTS CH, V55, P1494, DOI 10.1128/AAC.01664-10; Aureli P, 2011, PHARMACOL RES, V63, P366, DOI 10.1016/j.phrs.2011.02.006; Blaser M, 2011, NATURE, V476, P393, DOI 10.1038/476393a; Chai G, 2012, PEDIATRICS, V130, P23, DOI 10.1542/peds.2011-2879; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; De La Cochetiere MF, 2005, J CLIN MICROBIOL, V43, P5588, DOI 10.1128/JCM.43.11.5588-5592.2005; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Engelbrektson AL, 2006, FEMS MICROBIOL ECOL, V57, P239, DOI 10.1111/j.1574-6941.2006.00112.x; Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7; Gough EK, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2267; Hawrelak JA, 2005, DIGESTION, V72, P51, DOI 10.1159/000087637; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Horvath A, 2011, ALIMENT PHARM THER, V33, P1302, DOI 10.1111/j.1365-2036.2011.04665.x; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Johnston BC, 2011, COCHRANE DATABASE SY, V11; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kumpu M, 2012, EUR J CLIN NUTR, V66, P1020, DOI 10.1038/ejcn.2012.62; Lahti L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt229; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Manichanh C, 2014, GUT, V63, P401, DOI 10.1136/gutjnl-2012-303013; McFarland LV, 2008, FUTURE MICROBIOL, V3, P563, DOI 10.2217/17460913.3.5.563; Modi SR, 2014, J CLIN INVEST, V124, P4212, DOI 10.1172/JCI72333; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Penders J, 2011, EUR RESPIR J, V38, P295, DOI 10.1183/09031936.00105010; Pinheiro J, 2020, R PACKAGE VERSION 31; Plummer SF, 2005, INT J ANTIMICROB AG, V26, P69, DOI 10.1016/j.ijantimicag.2005.04.004; R Core Team, 2021, R LANGUAGE ENV STAT; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Saitoh S, 2002, CLIN DIAGN LAB IMMUN, V9, P54, DOI 10.1128/CDLI.9.1.54-59.2002; SANJOAQUIN VH, 1995, SCAND J INFECT DIS, V27, P211, DOI 10.3109/00365549509019011; Saxelin M, 2005, CURR OPIN BIOTECH, V16, P204, DOI 10.1016/j.copbio.2005.02.003; Scheepers L E J M, 2015, Int J Obes (Lond), V39, P16, DOI 10.1038/ijo.2014.178; Segarra-Newnham M, 2007, ANN PHARMACOTHER, V41, P1212, DOI 10.1345/aph.1K110; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Sepp E, 2005, CLIN EXP ALLERGY, V35, P1141, DOI 10.1111/j.1365-2222.2005.02315.x; Szajewska H, 2007, ALIMENT PHARM THER, V25, P871, DOI 10.1111/j.1365-2036.2007.03282.x; Szajewska H, 2011, ALIMENT PHARM THER, V34, P1079, DOI 10.1111/j.1365-2036.2011.04837.x; Therneau T.M., 2000, MODELING SURVIVAL DA; Thuny F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009074; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Venables WN., 2002, MODERN APPL STAT S, V4; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07	56	42	44	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154012	10.1371/journal.pone.0154012	http://dx.doi.org/10.1371/journal.pone.0154012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111772	gold, Green Published, Green Submitted			2022-12-27	WOS:000374970600026
J	Minto, K; Hornsey, MJ; Gillespie, N; Healy, K; Jetten, J				Minto, Kiara; Hornsey, Matthew J.; Gillespie, Nicole; Healy, Karen; Jetten, Jolanda			A Social Identity Approach to Understanding Responses to Child Sexual Abuse Allegations	PLOS ONE			English	Article							GROUP IDENTIFICATION; COMPETENCE; DEVIANCE; MEMBERS	Two studies investigated the role of group allegiances in contributing to the failure of institutions to appropriately respond to allegations of child sexual abuse. In Study 1, 601 participants read a news article detailing an allegation of child sexual abuse against a Catholic Priest. Catholics were more protective of the accused-and more skeptical of the accuserthan other participants, an effect that was particularly pronounced among strongly identified Catholics. In Study 2 (N = 404), the tendency for Catholics to be more protective of the accused and more skeptical of the accuser than non-Catholics was replicated. Moreover, these effects held independently of the objective likelihood that the accused was guilty. Overall, the data show that group loyalties provide a psychological motivation to disbelieve child abuse allegations. Furthermore, the people for whom this motivation is strongest are also the people who are most likely to be responsible for receiving and investigating allegations: highly identified ingroup members. The findings highlight the psychological mechanisms that may limit the ability of senior Church figures to conduct impartial investigations into allegations of child abuse within the Church.	[Minto, Kiara; Hornsey, Matthew J.; Jetten, Jolanda] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Gillespie, Nicole] Univ Queensland, UQ Business Sch, Brisbane, Qld, Australia; [Healy, Karen] Univ Queensland, Sch Nursing Midwifery & Social Work, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Hornsey, MJ (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	m.hornsey@uq.edu.au		Hornsey, Matthew/0000-0003-1275-3977; Gillespie, Nicole/0000-0002-6101-2123; Healy, Karen/0000-0002-7743-1699; Minto, Kiara/0000-0001-9758-5401	Research Collaboration Seeding Grant from the Faculty of Health and Behavioural Sciences, University of Queensland	Research Collaboration Seeding Grant from the Faculty of Health and Behavioural Sciences, University of Queensland	The research was supported by a Research Collaboration Seeding Grant from the Faculty of Health and Behavioural Sciences, University of Queensland, awarded to the 2nd, 3rd, and 4th authors.	Abrams D, 2000, J PERS SOC PSYCHOL, V78, P906, DOI 10.1037/0022-3514.78.5.906; [Anonymous], 2014, BBC NEWS; Australian Institute of Family Studies, 2014, I CHILD AB INQ 2002; Bryant J.K., 2009, PROFESSIONAL SCH COU, V12, P333, DOI [https://doi.org/10.5330/PSC.n.2010-12.333, DOI 10.5330/PSC.N.2010-12.333]; Crenshaw WB, 1994, J CHILD SEXUAL ABUSE, V2, P19; Doyle TP, 2006, PASTOR PSYCHOL, V54, P189, DOI 10.1007/s11089-006-6323-x; Eisbach SS, 2010, J SPEC PEDIATR NURS, V15, P317, DOI 10.1111/j.1744-6155.2010.00259.x; Esposo SR, 2013, BRIT J SOC PSYCHOL, V52, P386, DOI 10.1111/bjso.12024; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hornsey MJ, 2008, SOC PERSONAL PSYCHOL, V2, P204, DOI 10.1111/j.1751-9004.2007.00066.x; Hornsey MJ, 2004, PERS SOC PSYCHOL B, V30, P365, DOI 10.1177/0146167203261295; Hutchison P, 2008, J EXP SOC PSYCHOL, V44, P874, DOI 10.1016/j.jesp.2007.09.001; Iyer A, 2012, EUR J SOC PSYCHOL, V42, P141, DOI 10.1002/ejsp.864; Jetten J, 2014, ANNU REV PSYCHOL, V65, P461, DOI 10.1146/annurev-psych-010213-115151; Kurvilla C, 2014, NEW YORK DAILY NEWS; Leach CW, 2008, J PERS SOC PSYCHOL, V95, P144, DOI 10.1037/0022-3514.95.1.144; Leach CW, 2007, J PERS SOC PSYCHOL, V93, P234, DOI 10.1037/0022-3514.93.2.234; Marques J.M., 1994, EUR REV SOC PSYCHOL, V5, P37, DOI [10.1080/14792779543000011, DOI 10.1080/14792779543000011]; MARQUES JM, 1988, EUR J SOC PSYCHOL, V18, P1, DOI 10.1002/ejsp.2420180102; Pagliaro S, 2011, PERS SOC PSYCHOL B, V37, P1117, DOI 10.1177/0146167211406906; Schepher- Hughes Nancy, 2003, SEXUALITIES, V6, P15; Staller KM, 2012, CULT STUD-CRIT METHO, V12, P274, DOI 10.1177/1532708612446420; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; van Prooijen JW, 2006, PERS SOC PSYCHOL B, V32, P715, DOI 10.1177/0146167205284964; Vulliamy AP, 2000, CHILD ABUSE NEGLECT, V24, P1461, DOI 10.1016/S0145-2134(00)00199-X; Warner R, 2007, EUR J SOC PSYCHOL, V37, P1, DOI 10.1002/ejsp.332; Zellman GL, 1996, APSAC HDB CHILD MALT, P359	27	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153205	10.1371/journal.pone.0153205	http://dx.doi.org/10.1371/journal.pone.0153205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27111546	Green Published, gold			2022-12-27	WOS:000374970600013
J	Morgan, KK; Luu, P; Tucker, DM				Morgan, Kyle K.; Luu, Phan; Tucker, Don M.			Changes in P3b Latency and Amplitude Reflect Expertise Acquisition in a Football Visuomotor Learning Task	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; INTRACEREBRAL POTENTIALS; VISUAL-STIMULI; RARE TARGET; CONTEXT; P300; ASSOCIATIONS; MECHANISMS; RESPONSES; COMPONENT	Learning is not a unitary phenomenon. Rather, learning progresses through stages, with the stages reflecting different challenges that require the support of specific cognitive processes that reflect the functions of different brain networks. A theory of general learning proposes that learning can be divided into early and late stages controlled by corticolimbic networks located in frontal and posterior brain regions, respectively. Recent human studies using dense-array EEG (dEEG) support these results by showing progressive increases in P3b amplitude (an Event Related Potential with estimated sources in posterior cingulate cortex and hippocampus) as participants acquire a new visuomotor skill. In the present study, the P3b was used to track the learning and performance of participants as they identify defensive football formations and make an appropriate response. Participants acquired the task over three days, and P3b latency and amplitude significantly changed when participants learned the task. As participants demonstrated further proficiency with extensive training, amplitude and latency changes in the P3b continued to closely mirror performance improvements. Source localization results across all days suggest that an important source generator of the P3b is located in the posterior cingulate cortex. Results from the study support prior findings and further suggest that the careful analysis of covert learning mechanisms and their underlying electrical signatures are a robust index of task competency.	[Morgan, Kyle K.; Luu, Phan; Tucker, Don M.] Elect Geodes Inc, Eugene, OR USA; [Morgan, Kyle K.; Luu, Phan; Tucker, Don M.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon	Morgan, KK (corresponding author), Elect Geodes Inc, Eugene, OR USA.; Morgan, KK (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	kmorgan@egi.com			Electrical Geodesics, Inc. (EGI)	Electrical Geodesics, Inc. (EGI)	Electrical Geodesics, Inc. (EGI) provided support in the form of salaries for authors KKM, PL, and DMT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aderson JR, 1993, RULES OF MIND; Anderson J.R., 1983, ARCHITECTURE COGNITI; ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; Barcelo F, 2000, NEUROPSYCHOLOGIA, V38, P1342, DOI 10.1016/S0028-3932(00)00046-4; BAUDENA P, 1995, ELECTROEN CLIN NEURO, V94, P251, DOI 10.1016/0013-4694(95)98476-O; Bledowski C, 2006, J NEUROSCI, V26, P821, DOI 10.1523/JNEUROSCI.3542-05.2006; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Brankack J, 1996, HIPPOCAMPUS, V6, P475, DOI 10.1002/(SICI)1098-1063(1996)6:5<475::AID-HIPO1>3.0.CO;2-I; Brovelli A, 2008, CEREB CORTEX, V18, P1485, DOI 10.1093/cercor/bhm198; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Ebmeier KP, 1995, ELECTROEN CLIN NEURO, V95, P434, DOI 10.1016/0013-4694(95)00173-5; Ferree TC, 2000, IEEE T BIO-MED ENG, V47, P1584, DOI 10.1109/10.887939; Fitts PM., 1967, HUM PERFORM; FRIEDMAN D, 1993, PSYCHOPHYSIOLOGY, V30, P383, DOI 10.1111/j.1469-8986.1993.tb02060.x; Gabriel M., 2002, ENCY HUMAN BRAIN, P775; Grol MJ, 2006, J NEUROSCI, V26, P117, DOI 10.1523/JNEUROSCI.2786-05.2006; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P191, DOI 10.1016/0013-4694(94)00259-N; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P229, DOI 10.1016/0013-4694(95)98475-N; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1111/1469-8986.3510023; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KRAMER AF, 1988, BIOL PSYCHOL, V26, P231, DOI 10.1016/0301-0511(88)90022-1; Laberge D., 1981, ATTENTION PERFORM, P173; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Luft CD, 2014, J COGNITIVE NEUROSCI, V26, P1180, DOI 10.1162/jocn_a_00543; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Luu P, 2007, BRAIN RES, V1179, P89, DOI 10.1016/j.brainres.2007.03.092; Luu P, 2009, BRAIN RES, V1247, P100, DOI 10.1016/j.brainres.2008.09.084; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; NEWMAN JP, 1990, PERS INDIV DIFFER, V11, P1101, DOI 10.1016/0191-8869(90)90021-I; Luu P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00159; Pineda JA, 1997, INT J PSYCHOPHYSIOL, V27, P223, DOI 10.1016/S0167-8760(97)00061-5; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shin J, 2011, HIPPOCAMPUS, V21, P744, DOI 10.1002/hipo.20792; SMITH ME, 1990, ELECTROEN CLIN NEURO, V76, P235, DOI 10.1016/0013-4694(90)90018-F; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Toni I, 1999, EXP BRAIN RES, V127, P19, DOI 10.1007/s002210050770; Wise SP, 2000, TRENDS NEUROSCI, V23, P271, DOI 10.1016/S0166-2236(00)01570-8	43	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154021	10.1371/journal.pone.0154021	http://dx.doi.org/10.1371/journal.pone.0154021			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27111898	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600028
J	Gerl, MJ; Bittl, V; Kirchner, S; Sachsenheimer, T; Brunner, HL; Luchtenborg, C; Ozbalci, C; Wiedemann, H; Wegehingel, S; Nickel, W; Haberkant, P; Schultz, C; Kruger, M; Brugger, B				Gerl, Mathias J.; Bittl, Verena; Kirchner, Susanne; Sachsenheimer, Timo; Brunner, Hanna L.; Luechtenborg, Christian; Oezbalci, Cagakan; Wiedemann, Hannah; Wegehingel, Sabine; Nickel, Walter; Haberkant, Per; Schultz, Carsten; Krueger, Marcus; Bruegger, Britta			Sphingosine-1-Phosphate Lyase Deficient Cells as a Tool to Study Protein Lipid Interactions	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; CLICK CHEMISTRY; SPHINGOLIPID INTERACTIONS; QUANTITATIVE-ANALYSIS; MEMBRANE; CRISPR-CAS9; METABOLISM; LIVER; DEHYDROGENASE; PURIFICATION	Cell membranes contain hundreds to thousands of individual lipid species that are of structural importance but also specifically interact with proteins. Due to their highly controlled synthesis and role in signaling events sphingolipids are an intensely studied class of lipids. In order to investigate their metabolism and to study proteins interacting with sphingolipids, metabolic labeling based on photoactivatable sphingoid bases is the most straightforward approach. In order to monitor protein-lipid-crosslink products, sphingosine derivatives containing a reporter moiety, such as a radiolabel or a clickable group, are used. In normal cells, degradation of sphingoid bases via action of the checkpoint enzyme sphingosine-1-phosphate lyase occurs at position C2-C3 of the sphingoid base and channels the resulting hexadecenal into the glycerolipid biosynthesis pathway. In case the functionalized sphingosine looses the reporter moiety during its degradation, specificity towards sphingolipid labeling is maintained. In case degradation of a sphingosine derivative does not remove either the photoactivatable or reporter group from the resulting hexadecenal, specificity towards sphingolipid labeling can be achieved by blocking sphingosine-1-phosphate lyase activity and thus preventing sphingosine derivatives to be channeled into the sphingolipid-to-glycerolipid metabolic pathway. Here we report an approach using clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated nuclease Cas9 to create a sphingosine-1-phosphate lyase (SGPL1) HeLa knockout cell line to disrupt the sphingolipid-to-glycerolipid metabolic pathway. We found that the lipid and protein compositions as well as sphingolipid metabolism of SGPL1 knock-out HeLa cells only show little adaptations, which validates these cells as model systems to study transient protein-sphingolipid interactions.	[Gerl, Mathias J.; Bittl, Verena; Kirchner, Susanne; Sachsenheimer, Timo; Brunner, Hanna L.; Luechtenborg, Christian; Oezbalci, Cagakan; Wiedemann, Hannah; Wegehingel, Sabine; Nickel, Walter; Bruegger, Britta] Heidelberg Univ, Biochem Ctr, Heidelberg, Germany; [Haberkant, Per; Schultz, Carsten] European Mol Biol Lab, Heidelberg, Germany; [Krueger, Marcus] CECAD, Cologne, Germany; [Gerl, Mathias J.] Lipotype GmbH, Tatzberg 47, D-01307 Dresden, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); University of Cologne	Gerl, MJ; Brugger, B (corresponding author), Heidelberg Univ, Biochem Ctr, Heidelberg, Germany.; Gerl, MJ (corresponding author), Lipotype GmbH, Tatzberg 47, D-01307 Dresden, Germany.	Mathias.Gerl@bzh.uni-heidelberg.de; britta.bruegger@bzh.uni-heidelberg.de		Schultz, Carsten/0000-0002-5824-2171; Haberkant, Per/0000-0002-5608-9062; Gerl, Mathias/0000-0002-8074-7221	Deutsche Forschungsgemeinschaft [GE 2516/1-1, TRR 83]; CellNetworks Cluster of Excellence [EXC81]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CellNetworks Cluster of Excellence	MJG was funded by the Deutsche Forschungsgemeinschaft: GE 2516/1-1 (www.dfg.de/en/). BB is supported by a grant from the Deutsche Forschungsgemeinschaft within TRR 83 (http://www.trr83.de) and is investigator of the CellNetworks Cluster of Excellence: EXC81 (http://www.cellnetworks.uni-hd.de).	Aguilar Ana, 2012, Adv Biol Regul, V52, P17; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Bibikova M, 2002, GENETICS, V161, P1169; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Carlson M., 2015, R PACKAGE VERSION 3; Colie S, 2009, CANCER RES, V69, P9346, DOI 10.1158/0008-5472.CAN-09-2198; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Damen CWN, 2014, J LIPID RES, V55, P1772, DOI 10.1194/jlr.D047795; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Flores-Martin J, 2013, INT J MOL SCI, V14, P6170, DOI 10.3390/ijms14036170; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Haberkant P, 2008, J LIPID RES, V49, P251, DOI 10.1194/jlr.D700023-JLR200; Haberkant P, 2016, ACS CHEM BIOL, V11, P222, DOI 10.1021/acschembio.5b00810; Haberkant P, 2014, BBA-MOL CELL BIOL L, V1841, P1022, DOI 10.1016/j.bbalip.2014.01.003; Haberkant P, 2013, ANGEW CHEM INT EDIT, V52, P4033, DOI 10.1002/anie.201210178; Hagen N, 2011, CELL DEATH DIFFER, V18, P1356, DOI 10.1038/cdd.2011.7; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Hagen-Euteneuer N, 2012, J BIOL CHEM, V287, P9128, DOI 10.1074/jbc.M111.302380; Hahne F., 2013, R PACKAGE VERSION, V1, P4; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Heal WP, 2012, NAT PROTOC, V7, P105, DOI 10.1038/nprot.2011.425; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Hobo: [DRC, 2015, TEAM KAIST FULL VID; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kelson TL, 1997, BBA-GEN SUBJECTS, V1335, P99, DOI 10.1016/S0304-4165(96)00126-2; Kim R, 2013, J LIPID RES, V54, P265, DOI 10.1194/jlr.D029207; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Narayanaswamy P, 2014, ANAL CHEM, V86, P3043, DOI 10.1021/ac4039652; Ozbalci C, 2013, METHODS MOL BIOL, V1033, P3, DOI 10.1007/978-1-62703-487-6_1; PALTAUF F, 1994, PROG LIPID RES, V33, P239, DOI 10.1016/0163-7827(94)90028-0; R Development Core Team T, 2011, R LANG ENV STAT COMP; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rohlfing A, 2007, ANAL CHEM, V79, P5793, DOI 10.1021/ac070633x; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Shieh P, 2012, J AM CHEM SOC, V134, P17428, DOI 10.1021/ja308203h; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; STOFFEL W, 1967, H-S Z PHYSIOL CHEM, V348, P941; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Thiele C, 2012, ACS CHEM BIOL, V7, P2004, DOI 10.1021/cb300414v; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yamaji T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088124; Zacherl S, 2015, J BIOL CHEM, V290, P3654, DOI 10.1074/jbc.M114.590067	70	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153009	10.1371/journal.pone.0153009	http://dx.doi.org/10.1371/journal.pone.0153009			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100999	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500021
J	Jiang, L; Zhao, X; Wang, L				Jiang, Lei; Zhao, Xia; Wang, Lu			Long-Range Correlations of Global Sea Surface Temperature	PLOS ONE			English	Article							DETRENDED FLUCTUATION ANALYSIS; SCALING BEHAVIOR; TERM PERSISTENCE; AIR-TEMPERATURE; ATMOSPHERE; AVERAGE; MEMORY	Scaling behaviors of the global monthly sea surface temperature (SST) derived from 1870-2009 average monthly data sets of Hadley Centre Sea Ice and SST (HadISST) are investigated employing detrended fluctuation analysis (DFA). The global SST fluctuations are found to be strong positively long- range correlated at all pertinent time- intervals. The value of scaling exponent is larger in the tropics than those in the intermediate latitudes of the northern and southern hemispheres. DFA leads to the scaling exponent alpha = 0.87 over the globe (60 degrees S similar to 60 degrees N), northern hemisphere (0 degrees N similar to 60 degrees N), and southern hemisphere (0 degrees S similar to 60 degrees S), alpha = 0.84 over the intermediate latitude of southern hemisphere (30 degrees S similar to 60 degrees S), alpha = 0.81 over the intermediate latitude of northern hemisphere (30 degrees N similar to 60 degrees N) and alpha = 0.90 over the tropics 30 degrees-S similar to 30 degrees N [fluctuation F(s) similar to s(alpha)], which the fluctuations of monthly SST anomaly display longterm correlated behaviors. Furthermore, the larger the standard deviation is, the smaller long- range correlations (LRCs) of SST in the corresponding regions, especially in three distinct upwelling areas. After the standard deviation is taken into account, an index chi = alpha* sigma is introduced to obtain the spatial distributions of chi. There exists an obvious change of global SST in central east and northern Pacific and the northwest Atlantic. This may be as a clue on predictability of climate and ocean variabilities.	[Jiang, Lei] Nanjing Univ Informat Sci & Technol, Sch Marine Sci, Nanjing, Jiangsu, Peoples R China; [Jiang, Lei] Jiangsu Res Ctr Ocean Survey Technol, Nanjing, Jiangsu, Peoples R China; [Zhao, Xia] Chinese Acad Sci, Inst Oceanol, Lab Ocean Circulat & Waves, Qingdao, Peoples R China; [Wang, Lu] Minist Environm Protect, Nucl & Radiat Safety Ctr, Beijing, Peoples R China	Nanjing University of Information Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS	Jiang, L (corresponding author), Nanjing Univ Informat Sci & Technol, Sch Marine Sci, Nanjing, Jiangsu, Peoples R China.; Jiang, L (corresponding author), Jiangsu Res Ctr Ocean Survey Technol, Nanjing, Jiangsu, Peoples R China.	jianglei@nuist.edu.cn			Jiangsu Program of Entrepreneurship and Innovation Group; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA11010102]; 973 project [2012CB956001]; Startup Foundation for Introducing Talent of NUIST [2014r18]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Jiangsu Program of Entrepreneurship and Innovation Group; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); 973 project(National Basic Research Program of China); Startup Foundation for Introducing Talent of NUIST; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Many thanks are due to supports from the 2015 Jiangsu Program of Entrepreneurship and Innovation Group, the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA11010102), 973 project (2012CB956001), the Startup Foundation for Introducing Talent of NUIST (2014r18) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Alvarez-Ramirez J, 2008, PHYSICA A, V387, P3629, DOI 10.1016/j.physa.2008.02.051; Blender R, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017666; Bunde A, 2000, PHYS REV LETT, V85, P3736, DOI 10.1103/PhysRevLett.85.3736; Bunde A, 2002, PHYSICA A, V314, P15, DOI 10.1016/S0378-4371(02)01050-6; Chen X, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027755; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; DELWORTH T, 1993, J CLIMATE, V6, P1993, DOI 10.1175/1520-0442(1993)006<1993:IVOTTC>2.0.CO;2; Deser C, 2003, J CLIMATE, V16, P57, DOI 10.1175/1520-0442(2003)016<0057:UTPOSS>2.0.CO;2; Deser C, 2010, MARINE SCI, V2; Eichner JF, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046133; Fraedrich K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.108501; Frauen C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050520; Gan ZJ, 2007, J ATMOS OCEAN TECH, V24, P681, DOI 10.1175/JTECH1981.1; Goswami BN, 2006, GEOPHYS RES LETT, V33; Govindan RB, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.028501; HALPERN D, 1989, J GEOPHYS RES-OCEANS, V94, P8018, DOI 10.1029/JC094iC06p08018; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Jiang L, 2015, THEOR APPL CLIMATOL, V119, P25, DOI 10.1007/s00704-013-1080-0; Jiang L, 2012, THEOR APPL CLIMATOL, V109, P261, DOI 10.1007/s00704-011-0578-6; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; Kavasseri RG, 2005, CHAOS SOLITON FRACT, V24, P165, DOI 10.1016/j.chaos.2004.09.004; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Kiraly A, 2005, METEOROL ATMOS PHYS, V88, P119, DOI 10.1007/s00703-004-0078-7; Koscielny-Bunde E, 1998, PHYS REV LETT, V81, P729, DOI 10.1103/PhysRevLett.81.729; KoscielnyBunde E, 1996, PHYSICA A, V231, P393, DOI 10.1016/0378-4371(96)00187-2; Kurnaz ML, 2004, FRACTALS, V12, P365, DOI 10.1142/S0218348X04002665; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Liu YH, 1997, PHYSICA A, V245, P437, DOI 10.1016/S0378-4371(97)00368-3; Luo M, 2015, J CLIMATE, V28, P3122, DOI 10.1175/JCLI-D-13-00743.1; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Monetti RA, 2003, PHYSICA A, V320, P581, DOI 10.1016/S0378-4371(02)01662-X; Oppo DW, 2009, NATURE, V460, P1113, DOI 10.1038/nature08233; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Stanley HE, 1999, PHYSICA A, V270, P309, DOI 10.1016/S0378-4371(99)00230-7; Talkner P, 2000, PHYS REV E, V62, P150, DOI 10.1103/PhysRevE.62.150; Telesca L, 2005, PHYSICA A, V354, P629, DOI 10.1016/j.physa.2005.02.053; Varotsos C, 2005, INT J REMOTE SENS, V26, P3333, DOI 10.1080/01431160500076111; Varotsos C, 2009, ATMOS CHEM PHYS, V9, P677, DOI 10.5194/acp-9-677-2009; Varotsos CA, 2013, ATMOS CHEM PHYS, V13, P5243, DOI 10.5194/acp-13-5243-2013; Vyushin D, 2004, GEOPHYS RES LETT, V31; Weber RO, 2001, J GEOPHYS RES-ATMOS, V106, P20131, DOI 10.1029/2001JD000548; Zhang WF, 2015, PHYSICA A, V428, P314, DOI 10.1016/j.physa.2015.01.081; Zhang YZ, 2013, GLOBAL PLANET CHANGE, V100, P362, DOI 10.1016/j.gloplacha.2012.11.012; Zhu XH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027291; Zhu XH, 2010, J CLIMATE, V23, P5021, DOI 10.1175/2010JCLI3370.1	46	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153774	10.1371/journal.pone.0153774	http://dx.doi.org/10.1371/journal.pone.0153774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100397	Green Submitted, gold, Green Published			2022-12-27	WOS:000374898500065
J	Kang, YE; Kim, JM; Joung, KH; Lee, JH; You, BR; Choi, MJ; Ryu, MJ; Ko, YB; Lee, MA; Lee, J; Ku, BJ; Shong, M; Lee, KH; Kim, HJ				Kang, Yea Eun; Kim, Ji Min; Joung, Kyong Hye; Lee, Ju Hee; You, Bo Ram; Choi, Min Jeong; Ryu, Min Jeong; Ko, Young Bok; Lee, Min A.; Lee, Junguee; Ku, Bon Jeong; Shong, Minho; Lee, Ki Hwan; Kim, Hyun Jin			The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LEPTIN; INFLAMMATION; ADIPONECTIN; ACTIVATION; EXPRESSION; INFILTRATION; SENSITIVITY; PHENOTYPE; MONOCYTES	The roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance have been explored in both animal and human studies. However, our current understanding of obesity-associated insulin resistance relies on studies of artificial metabolic extremes. The purpose of this study was to explore the roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in human patients with modest obesity and early metabolic dysfunction. We obtained omental adipose tissue and fasting blood samples from 51 females undergoing gynecologic surgery. We investigated serum concentrations of proinflammatory cytokines and adipokines as well as the mRNA expression of proinflammatory and macrophage phenotype markers in visceral adipose tissue using ELISA and quantitative RT-PCR. We measured adipose tissue inflammation and macrophage infiltration using immunohistochemical analysis. Serum levels of adiponectin and leptin were significantly correlated with HOMA-IR and body mass index. The levels of expression of MCP-1 and TNF-alpha in visceral adipose tissue were also higher in the obese group (body mass index >= 25). The expression of mRNA MCP-1 in visceral adipose tissue was positively correlated with body mass index (r = 0.428, p = 0.037) but not with HOMA-IR, whereas TNF-alpha in visceral adipose tissue was correlated with HOMA-IR (r = 0.462, p = 0.035) but not with body mass index. There was no obvious change in macrophage phenotype or macrophage infiltration in patients with modest obesity or early metabolic dysfunction. Expression of mRNA CD163/CD68 was significantly related to mitochondrial-associated genes and serum inflammatory cytokine levels of resistin and leptin. These results suggest that changes in the production of inflammatory biomolecules precede increased immune cell infiltration and induction of a macrophage phenotype switch in visceral adipose tissue. Furthermore, serum resistin and leptin have specific roles in the regulation of adipose tissue macrophages in patients with modest obesity or early metabolic dysfunction.	[Kang, Yea Eun; Kim, Ji Min; Joung, Kyong Hye; Lee, Ju Hee; You, Bo Ram; Choi, Min Jeong; Ryu, Min Jeong; Ku, Bon Jeong; Shong, Minho; Kim, Hyun Jin] Chungnam Natl Univ Hosp, Dept Internal Med, Daejeon, South Korea; [Ko, Young Bok; Lee, Min A.; Lee, Ki Hwan] Chungnam Natl Univ, Sch Med, Dept Obstet & Gynecol, Daejeon, South Korea; [Lee, Junguee] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Pathol, Daejeon, South Korea; [Ku, Bon Jeong; Shong, Minho] Chungnam Natl Univ, Sch Med, Dept Internal Med, Daejeon, South Korea	Chungnam National University; Chungnam National University Hospital; Chungnam National University; Catholic University of Korea; Chungnam National University	Kim, HJ (corresponding author), Chungnam Natl Univ Hosp, Dept Internal Med, Daejeon, South Korea.	kimhj43@cnuh.co.kr	/H-7803-2012	shong, minho/0000-0002-0247-7115; Kim, Hyun Jin/0000-0002-6760-4963; Lee, Ju Hee/0000-0001-5976-7175	National Research Foundation of Korea (NRF) - Ministry of Science [2014R1A1A1006176]; Korea Otsuka Pharmaceuticals, Republic of Korea; Korea Otsuka Pharmaceuticals grant (BJK)	National Research Foundation of Korea (NRF) - Ministry of Science; Korea Otsuka Pharmaceuticals, Republic of Korea; Korea Otsuka Pharmaceuticals grant (BJK)	This research was supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Science (grant number: 2014R1A1A1006176), and financed with a grant from Korea Otsuka Pharmaceuticals, Republic of Korea. A Korea Otsuka Pharmaceuticals grant (BJK) provided support with lab equipment and reagents that greatly enhanced the initial phase of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Catalan V, 2007, OBES SURG, V17, P1464, DOI 10.1007/s11695-008-9424-z; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; D'souza AM, 2014, ENDOCRINOLOGY, V155, P1268, DOI 10.1210/en.2013-1523; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hoffmann A, 2014, ATHEROSCLEROSIS, V235, pE194, DOI 10.1016/j.atherosclerosis.2014.05.572; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kanazawa M, 2002, ASIA PAC J CLIN NUTR, V11, pS732, DOI 10.1046/j.1440-6047.11.s8.19.x; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Lim S, 2014, ENDOCRINOL METAB, V29, P1, DOI 10.3803/EnM.2014.29.1.1; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Makki K, 2013, ISRN INFLAMMATION, V2013; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; McArdle M. A, 2013, FRONTIERS ENDOCRINOL, V4; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; Noto H, 2013, J DIABETES INVEST, V4, P225, DOI 10.1111/jdi.12068; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Oguri S, 2002, CLIN DIAGN LAB IMMUN, V9, P1307, DOI 10.1128/CDLI.9.6.1307-1312.2002; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Sakai S, 2013, J SURG RES, V185, P353, DOI 10.1016/j.jss.2013.06.002; Sanchez-Pozo C, 2003, CLIN EXP IMMUNOL, V134, P464, DOI 10.1111/j.1365-2249.2003.02321.x; Santos-Alvarez J, 1999, CELL IMMUNOL, V194, P6, DOI 10.1006/cimm.1999.1490; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Segal KR, 1996, DIABETES, V45, P988, DOI 10.2337/diabetes.45.7.988; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Staiger H, 2003, OBES RES, V11, P368, DOI 10.1038/oby.2003.48; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	50	181	185	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154003	10.1371/journal.pone.0154003	http://dx.doi.org/10.1371/journal.pone.0154003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101398	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500120
J	Manuyakorn, W; Smart, DE; Noto, A; Bucchieri, F; Haitchi, HM; Holgate, ST; Howarth, PH; Davies, DE				Manuyakorn, Wiparat; Smart, David E.; Noto, Antonio; Bucchieri, Fabio; Haitchi, Hans Michael; Holgate, Stephen T.; Howarth, Peter H.; Davies, Donna E.			Mechanical Strain Causes Adaptive Change in Bronchial Fibroblasts Enhancing Profibrotic and Inflammatory Responses	PLOS ONE			English	Article							SMOOTH-MUSCLE; AIRWAY INFLAMMATION; DERMAL FIBROBLASTS; IN-VITRO; ASTHMA; CELL; STRETCH; PROLIFERATION; ACTIVATION; PHENOTYPES	Asthma is characterized by periodic episodes of bronchoconstriction and reversible airway obstruction; these symptoms are attributable to a number of factors including increased mass and reactivity of bronchial smooth muscle and extracellular matrix (ECM) in asthmatic airways. Literature has suggested changes in cell responses and signaling can be elicited via modulation of mechanical stress acting upon them, potentially affecting the microenvironment of the cell. In this study, we hypothesized that mechanical strain directly affects the (myo)fibroblast phenotype in asthma. Therefore, we characterized responses of bronchial fibroblasts, from 6 normal and 11 asthmatic non-smoking volunteers, exposed to cyclical mechanical strain using flexible silastic membranes. Samples were analyzed for proteoglycans, a-smooth muscle actin (alpha SMA), collagens I and III, matrix metalloproteinase (MMP) 2 & 9 and interleukin-8 (IL-8) by qRT-PCR, Western blot, zymography and ELISA. Mechanical strain caused a decrease in alpha SMA mRNA but no change in either alpha SMA protein or proteoglycan expression. In contrast the inflammatory mediator IL-8, MMPs and interstitial collagens were increased at both the transcriptional and protein level. The results demonstrate an adaptive response of bronchial fibroblasts to mechanical strain, irrespective of donor. The adaptation involves cytoskeletal rearrangement, matrix remodelling and inflammatory cytokine release. These results suggest that mechanical strain could contribute to disease progression in asthma by promoting inflammation and remodelling responses.	[Manuyakorn, Wiparat; Smart, David E.; Noto, Antonio; Haitchi, Hans Michael; Holgate, Stephen T.; Howarth, Peter H.; Davies, Donna E.] Univ Southampton, Southampton Gen Hosp, Sch Med, Clin & Expt Sci,Sir Henry Wellcome Labs, Southampton, Hants, England; [Haitchi, Hans Michael; Holgate, Stephen T.; Howarth, Peter H.; Davies, Donna E.] Southampton Gen Hosp, NIHR, Southampton Resp Biomed Res Unit, Southampton Ctr Biomed Res, Southampton SO9 4XY, Hants, England; [Noto, Antonio; Bucchieri, Fabio] Univ Palermo, BIONEC Dept, Palermo, Italy; [Noto, Antonio; Bucchieri, Fabio] IEMEST, Ist Euromediterraneo Sci & Tecnol, Palermo, Italy; [Manuyakorn, Wiparat] Mahidol Univ, Div Pediat Allergy, Bangkok 10700, Thailand	University of Southampton; University of Southampton; University of Palermo; Mahidol University	Smart, DE (corresponding author), Univ Southampton, Southampton Gen Hosp, Sch Med, Clin & Expt Sci,Sir Henry Wellcome Labs, Southampton, Hants, England.	d.smart@southampton.ac.uk	Manuyakorn, Wiparat/AAD-5413-2022; Bucchieri, Fabio/F-8877-2012	BUCCHIERI, Fabio/0000-0002-0209-8668; Howarth, Peter/0000-0003-0619-7927; smart, David/0000-0002-1411-723X; Davies, Donna/0000-0002-5117-2991; Haitchi, Hans Michael/0000-0001-8603-302X; Manuyakorn, Wiparat/0000-0003-4278-1186	Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Medical Research Council (UK) [G0900453]; Asthma Allergy and Inflammation Research (AAIR) Charity; Asthma UK; MRC [G0400473, G1001367, G19/34, G0800649, G0900453] Funding Source: UKRI; Medical Research Council [G0900453, G0800649, G0400473, G1001367, G19/34] Funding Source: researchfish	Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma Allergy and Inflammation Research (AAIR) Charity; Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Studentship for WM was provided by Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. This work was funded by the Medical Research Council (UK) Grant number G0900453 (STH, DED, DES, PHH), http://www.mrc.ac.uk/; Asthma Allergy and Inflammation Research (AAIR) Charity (DED FB), http://www.aaircharity.org/; and Asthma UK (DED STH), http://www.asthma.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; AWOLESI MA, 1995, J CLIN INVEST, V96, P1449, DOI 10.1172/JCI118181; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Berry CC, 2003, BIORHEOLOGY, V40, P337; BISHOP JE, 1993, AM J RESP CELL MOL, V9, P126, DOI 10.1165/ajrcmb/9.2.126; BISHOP JE, 1993, EUR RESP REV VOL 3, P613; Blaauboer ME, 2011, BIOCHEM BIOPH RES CO, V404, P23, DOI 10.1016/j.bbrc.2010.11.033; Bonsignore MR, 2001, AM J PHYSIOL-LUNG C, V281, pL668, DOI 10.1152/ajplung.2001.281.3.L668; Breen EC, 2000, J APPL PHYSIOL, V88, P203; Cai L, 2010, J MOL BIOL, V395, P309, DOI 10.1016/j.jmb.2009.11.020; Carlsen KH, 2008, ALLERGY, V63, P387, DOI 10.1111/j.1398-9995.2008.01662.x; Choe MM, 2006, AM J RESP CELL MOL, V35, P306, DOI 10.1165/rcmb.2005-0443OC; Corry DB, 2004, FASEB J, V18, P995, DOI 10.1096/fj.03-1412fje; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Grymes RA, 1997, IN VITRO CELL DEV-AN, V33, P392, DOI 10.1007/s11626-997-0011-8; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Iba T, 1992, Cell Transplant, V1, P43; Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7; Jakkaraju S, 2003, TRENDS CARDIOVAS MED, V13, P330, DOI 10.1016/j.tcm.2003.08.004; James AL, 2005, EUR RESPIR J, V26, P429, DOI 10.1183/09031936.05.00146404; Kistemaker LEM, 2015, TRENDS PHARMACOL SCI, V36, P164, DOI 10.1016/j.tips.2014.11.005; Bellego F, 2009, ALLERGY, V64, P32, DOI 10.1111/j.1398-9995.2008.01814.x; Ludwig MS, 2004, CLIN EXP ALLERGY, V34, P926, DOI 10.1111/j.1365-2222.2004.01980.x; Niimi A, 2003, AM J RESP CRIT CARE, V168, P983, DOI 10.1164/rccm.200211-1268OC; Niimi A, 2005, J ALLERGY CLIN IMMUN, V116, P565, DOI 10.1016/j.jaci.2005.07.010; Nishimura K, 2007, WOUND REPAIR REGEN, V15, P646, DOI 10.1111/j.1524-475X.2007.00295.x; PETERKOF.B, 1972, ARCH BIOCHEM BIOPHYS, V152, P318, DOI 10.1016/0003-9861(72)90221-4; Peters AS, 2012, EXP DERMATOL, V21, P765, DOI 10.1111/exd.12010; Rodriguez JA, 2007, REV ESP CARDIOL, V60, P959, DOI 10.1157/13109649; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wells JM, 2015, MATRIX BIOL, V44-46, P122, DOI 10.1016/j.matbio.2015.01.016; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Westermann D, 2011, CIRCULATION, V124, P2082, DOI 10.1161/CIRCULATIONAHA.111.035964; Wicks J, 2006, THORAX, V61, P313, DOI 10.1136/thx.2005.050005; Yang Y, 2000, J CLIN INVEST, V106, P1321, DOI 10.1172/JCI8893	43	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153926	10.1371/journal.pone.0153926	http://dx.doi.org/10.1371/journal.pone.0153926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101406	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500096
J	Varnet, L; Meunier, F; Trolle, G; Hoen, M				Varnet, Leo; Meunier, Fanny; Trolle, Gwendoline; Hoen, Michel			Direct Viewing of Dyslexics' Compensatory Strategies in Speech in Noise Using Auditory Classification Images	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; ALLOPHONIC MODE; PHONOLOGICAL DEFICIT; FAMILY RISK; PERCEPTION; CHILDREN; ADULTS; ABILITIES; LITERACY; DISCRIMINATION	A vast majority of dyslexic children exhibit a phonological deficit, particularly noticeable in phonemic identification or discrimination tasks. The gap in performance between dyslexic and normotypical listeners appears to decrease into adulthood, suggesting that some individuals with dyslexia develop compensatory strategies. Some dyslexic adults however remain impaired in more challenging listening situations such as in the presence of background noise. This paper addresses the question of the compensatory strategies employed, using the recently developed Auditory Classification Image (ACI) methodology. The results of 18 dyslexics taking part in a phoneme categorization task in noise were compared with those of 18 normotypical age-matched controls. By fitting a penalized Generalized Linear Model on the data of each participant, we obtained his/her ACI, a map of the time-frequency regions he/she relied on to perform the task. Even though dyslexics performed significantly less well than controls, we were unable to detect a robust difference between the mean ACIs of the two groups. This is partly due to the considerable heterogeneity in listening strategies among a subgroup of 7 low-performing dyslexics, as confirmed by a complementary analysis. When excluding these participants to restrict our comparison to the 11 dyslexics performing as well as their average-reading peers, we found a significant difference in the F3 onset of the first syllable, and a tendency of difference on the F4 onset, suggesting that these listeners can compensate for their deficit by relying upon additional allophonic cues.	[Varnet, Leo; Trolle, Gwendoline; Hoen, Michel] CNRS UMR 5292, INSERM U1028, Lyon Neurosci Res Ctr, Auditory Language Proc ALP Res Grp, Lyon, France; [Varnet, Leo; Meunier, Fanny] CNRS UMR 5304, Lab Langage Cerveau & Cognit, Auditory Language Proc ALP Res Grp, Lyon, France; [Varnet, Leo; Meunier, Fanny; Trolle, Gwendoline; Hoen, Michel] Univ Lyon 1, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Varnet, L (corresponding author), CNRS UMR 5292, INSERM U1028, Lyon Neurosci Res Ctr, Auditory Language Proc ALP Res Grp, Lyon, France.; Varnet, L (corresponding author), CNRS UMR 5304, Lab Langage Cerveau & Cognit, Auditory Language Proc ALP Res Grp, Lyon, France.; Varnet, L (corresponding author), Univ Lyon 1, F-69365 Lyon, France.	leo.varnet@isc.cnrs.fr	Varnet, Léo/GQQ-5522-2022; Hoen, Michel/C-7721-2012	Varnet, Léo/0000-0002-9702-2649; Hoen, Michel/0000-0003-2099-8130	Ecole Doctorale Neurosciences et Cognition, Lyon-1 University, France; European Research Council [209234]; French National Research Agency (ANR) [ANR-10-LABX-0083]	Ecole Doctorale Neurosciences et Cognition, Lyon-1 University, France; European Research Council(European Research Council (ERC)European Commission); French National Research Agency (ANR)(French National Research Agency (ANR))	LV is funded by a PhD grant from the Ecole Doctorale Neurosciences et Cognition (http://nsco.universite-lyon.fr/), Lyon-1 University, France. This research was partially supported by a European Research Council (http://erc.europa.eu/) grant for the SpiN project (No. 209234) attributed to FM and by a public grant overseen by the French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (reference: ANR-10-LABX-0083).	Banai K, 2005, J NEUROSCI, V25, P9850, DOI 10.1523/JNEUROSCI.2373-05.2005; Boets B, 2006, BRAIN LANG, V97, P64, DOI 10.1016/j.bandl.2005.07.026; Boets B, 2007, BRAIN LANG, V101, P19, DOI 10.1016/j.bandl.2006.06.009; Boets B, 2013, SCIENCE, V342, P1251, DOI 10.1126/science.1244333; Boets B, 2010, BRIT J DEV PSYCHOL, V28, P5, DOI 10.1348/026151010X485223; Bogliotti C, 2008, J EXP CHILD PSYCHOL, V101, P137, DOI 10.1016/j.jecp.2008.03.006; BRADY S, 1983, J EXP CHILD PSYCHOL, V35, P345, DOI 10.1016/0022-0965(83)90087-5; Calabrese A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016104; CASTLES A, 1993, COGNITION, V47, P149, DOI 10.1016/0010-0277(93)90003-E; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; Dole M, 2014, NEUROPSYCHOLOGIA, V60, P103, DOI 10.1016/j.neuropsychologia.2014.05.016; Dole M, 2012, NEUROPSYCHOLOGIA, V50, P1543, DOI 10.1016/j.neuropsychologia.2012.03.007; Elbro C, 1996, READ WRIT, V8, P453, DOI 10.1007/BF00577023; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fawcett AJ, 1996, ANN DYSLEXIA, V46, P259, DOI 10.1007/BF02648179; Gola-Asmussen C., 2010, ECLA 16 EVALUATION C; Gold JM, 2000, CURR BIOL, V10, P663, DOI 10.1016/S0960-9822(00)00523-6; Hornickel J, 2009, P NATL ACAD SCI USA, V106, P13022, DOI 10.1073/pnas.0901123106; Knoblauch K., 2012, MODELING PSYCHOPHYSI; Knoblauch K, 2008, J VISION, V8, DOI 10.1167/8.16.10; Law JM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00482; Lefavrais P, 2005, LE TEST DE LALOUETTE; Lehongre K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00454; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Manis FR, 1997, J EXP CHILD PSYCHOL, V66, P211, DOI 10.1006/jecp.1997.2383; MANN VA, 1980, PERCEPT PSYCHOPHYS, V28, P407, DOI 10.3758/BF03204884; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Messaoud-Galusi S, 2011, J SPEECH LANG HEAR R, V54, P1682, DOI 10.1044/1092-4388(2011/09-0261); Mineault PJ, 2009, J VISION, V9, DOI 10.1167/9.10.17; Murray RF, 2011, J VISION, V11, DOI 10.1167/11.5.2; Nagai M, 2013, VISION RES, V79, P27, DOI 10.1016/j.visres.2013.01.001; Noordenbos MW, 2012, RES DEV DISABIL, V33, P1469, DOI 10.1016/j.ridd.2012.03.021; Noordenbos MW, 2013, CLIN NEUROPHYSIOL, V124, P1151, DOI 10.1016/j.clinph.2012.12.044; Pritchett LM, 2015, P NATL ACAD SCI USA, V112, P7321, DOI 10.1073/pnas.1422169112; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Ramus F, 2014, TRENDS COGN SCI, V18, P274, DOI 10.1016/j.tics.2014.01.009; Schonfelder VH, 2012, J ACOUST SOC AM, V131, P3953, DOI 10.1121/1.3701832; Sekuler AB, 2004, CURR BIOL, V14, P391, DOI 10.1016/j.cub.2004.02.028; Serniclaes W., 1995, VERBUM, P131; Serniclaes WI, 2004, J EXP CHILD PSYCHOL, V87, P336, DOI 10.1016/j.jecp.2004.02.001; Stein John, 2014, Curr Dev Disord Rep, V1, P267; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; TALLAL P, 1981, J ACOUST SOC AM, V69, P568, DOI 10.1121/1.385431; Varnet L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00865; Varnet L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14489; Varnet L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118009; Viswanathan N, 2010, J EXP PSYCHOL HUMAN, V36, P1005, DOI 10.1037/a0018391; White-Schwoch T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002196; Woolley SMN, 2009, J NEUROSCI, V29, P2780, DOI 10.1523/JNEUROSCI.2042-08.2009; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Ziegler JC, 2008, COGNITION, V107, P151, DOI 10.1016/j.cognition.2007.09.004; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x	55	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153781	10.1371/journal.pone.0153781	http://dx.doi.org/10.1371/journal.pone.0153781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100662	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500066
J	Veitonmaki, T; Murtola, TJ; Talala, K; Taari, K; Tammela, T; Auvinen, A				Veitonmaki, Thea; Murtola, Teemu J.; Talala, Kirsi; Taari, Kimmo; Tammela, Teuvo; Auvinen, Anssi			Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial	PLOS ONE			English	Article							COLORECTAL-CANCER; ASPIRIN USE; MORTALITY; CYCLOOXYGENASE-2; EXPRESSION; RISK; INFLAMMATION; SURVIVAL; CERTIFICATION; VALIDATION	Non-steroidal anti-inflammatory drugs (NSAIDs), especially aspirin, have been associated with lowered cancer incidence and mortality. We examined overall cancer mortality and mortality from specific cancer sites among the 80,144 men in the Finnish Prostate Cancer Screening Trial. Information on prescription drug use was acquired from the national drug reimbursement database. Over-the-counter use information was gathered by a questionnaire. Hazard ratios (HR) and 95% confidence intervals (CI) by prescription and over-the-counter NSAID use for overall and specific cancer deaths were calculated using Cox regression. During the median follow-up time of 15 years, 7,008 men died from cancer. Men with prescription NSAID use had elevated cancer mortality (HR 2.02 95% CI 1.91-2.15) compared to non-users. The mortality risk was increased for lung, colorectal and pancreas cancer mortality (HR 2.68, 95% CI 2.40-2.99, HR 1.91, 95% CI 1.57-2.32 and HR 1.93, 95% CI 1.58-2.37, respectively). The increased risk remained in competing risks regression (HR 1.11, 95% CI 1.05-1.18). When the usage during the last three years of follow-up was excluded, the effect was reversed (HR 0.69, 95% CI 0.65-0.73). Cancer mortality was not decreased for prescription or over-the-counter aspirin use. However, in the competing risk regression analysis combined prescription and over-the-counter aspirin use was associated with decreased overall cancer mortality (HR 0.76, 95% CI 0.70-0.82). Cancer mortality was increased for NSAID users. However, the risk disappeared when the last 3 years were excluded.	[Veitonmaki, Thea; Murtola, Teemu J.; Tammela, Teuvo] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Veitonmaki, Thea; Auvinen, Anssi] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Murtola, Teemu J.; Tammela, Teuvo] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Talala, Kirsi] Finnish Canc Registry, FIN-00170 Helsinki, Finland; [Taari, Kimmo] Univ Helsinki, Dept Urol, Helsinki, Finland; [Taari, Kimmo] Helsinki Univ Hosp, Helsinki, Finland	Tampere University; Tampere University Hospital; Tampere University; Tampere University; Finnish Cancer Registry; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Veitonmaki, T (corresponding author), Tampere Univ Hosp, Dept Urol, Tampere, Finland.; Veitonmaki, T (corresponding author), Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland.	veitonmaki.thea.p@student.uta.fi	Auvinen, Anssi/AAL-2111-2020; Auvinen, Anssi/AAD-9311-2020	Auvinen, Anssi/0000-0003-1125-4818; Taari, Kimmo/0000-0002-0077-4896	Seppo Nieminen Testament Fund; Finnish Cancer Society; Academy of Finland [132385, 260 931]; Competitive State Research Financing of Tampere University Hospital [9P053]	Seppo Nieminen Testament Fund; Finnish Cancer Society; Academy of Finland(Academy of Finland); Competitive State Research Financing of Tampere University Hospital	This study has been supported by grants from the Seppo Nieminen Testament Fund (T. Veitonmaki), Finnish Cancer Society, Academy of Finland (grant 132385 and 260 931) (A. Auvinen) and the Competitive State Research Financing of Tampere University Hospital (grant No. 9P053) (T. Murtola). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Bastiaannet E, 2012, BRIT J CANCER, V106, P1564, DOI 10.1038/bjc.2012.101; Brasky TM, 2012, J THORAC ONCOL, V7, P1503, DOI 10.1097/JTO.0b013e3182641bdc; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Daugherty SE, 2011, AM J EPIDEMIOL, V173, P721, DOI 10.1093/aje/kwq437; De Koning HJ, 2003, BJU INT, V92, P71, DOI 10.1111/j.1465-5101.2003.04402.x; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Gonzalez-Perez A, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-28; Goubran HA, 2014, SEMIN ONCOL, V41, P359, DOI 10.1053/j.seminoncol.2014.04.006; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G; Gurpinar E, 2014, CLIN CANCER RES, V20, P1104, DOI 10.1158/1078-0432.CCR-13-1573; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Jacobs EJ, 2004, J NATL CANCER I, V96, P524, DOI 10.1093/jnci/djh084; Kilpelainen TP, 2013, JNCI-J NATL CANCER I, V105, P719, DOI 10.1093/jnci/djt038; Kokawa A, 2001, CANCER, V91, P333, DOI 10.1002/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N; Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035; Lahti RA, 2003, FORENSIC SCI INT, V131, P113, DOI 10.1016/S0379-0738(02)00418-8; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Macfarlane TV, 2014, BRIT J CANCER, V111, P1852, DOI 10.1038/bjc.2014.473; Makinen T, 2008, INT J CANCER, V122, P413, DOI 10.1002/ijc.23126; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martikainen J, 2002, SOCIAL SECURITY HLTH, V54; Pelucchi C, 2011, ANN ONCOL, V22, P1487, DOI 10.1093/annonc/mdq610; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Ratnasinghe LD, 2004, ANTICANCER RES, V24, P3177; Ristimaki A, 1997, CANCER RES, V57, P1276; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Sahin IH, 2014, CANCER LETT, V345, P249, DOI 10.1016/j.canlet.2013.09.001; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Shebl FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114633; Walker AJ, 2012, BRIT J CANCER, V107, P1602, DOI 10.1038/bjc.2012.427; World Health Organization, ATC DDD IND DAT; Zimmermann KC, 1999, CANCER RES, V59, P198	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153413	10.1371/journal.pone.0153413	http://dx.doi.org/10.1371/journal.pone.0153413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100876	Green Published, gold			2022-12-27	WOS:000374898500032
J	Altamura, E; Borgatti, M; Finotti, A; Gasparello, J; Gambari, R; Spinelli, M; Castaldo, R; Altamura, N				Altamura, Emiliano; Borgatti, Monica; Finotti, Alessia; Gasparello, Jessica; Gambari, Roberto; Spinelli, Mariangela; Castaldo, Rosa; Altamura, Nicola			Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae	PLOS ONE			English	Article							NONSENSE-MEDIATED DECAY; MESSENGER-RNA DECAY; MPS I-H; STOP CODONS; SACCHAROMYCES-CEREVISIAE; REPORTER SYSTEM; UPF PROTEINS; HUMAN-CELLS; READTHROUGH; MUTATIONS	Nonsense mutations generate in-frame stop codons in mRNA leading to a premature arrest of translation. Functional consequences of premature termination codons (PTCs) include the synthesis of truncated proteins with loss of protein function causing severe inherited or acquired diseases. A therapeutic approach has been recently developed that is based on the use of chemical agents with the ability to suppress PTCs (read-through) restoring the synthesis of a functional full-length protein. Research interest for compounds able to induce read-through requires an efficient high throughput large scale screening system. We present a rapid, sensitive and quantitative method based on a dual-fluorescence reporter expressed in the yeast Saccharomyces cerevisiae to monitor and quantitate read-through at PTCs. We have shown that our novel system works equally well in detecting read-through at all three PTCs UGA, UAG and UAA.	[Altamura, Emiliano] Univ Bari, Dept Chem, Bari, Italy; [Borgatti, Monica; Finotti, Alessia; Gasparello, Jessica; Gambari, Roberto] Univ Ferrara, Biochem & Mol Biol Sect, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Spinelli, Mariangela; Castaldo, Rosa; Altamura, Nicola] CNR, Inst Biomembranes & Bioenerget, Bari, Italy	Universita degli Studi di Bari Aldo Moro; University of Ferrara; Consiglio Nazionale delle Ricerche (CNR)	Altamura, E (corresponding author), Univ Bari, Dept Chem, Bari, Italy.; Altamura, N (corresponding author), CNR, Inst Biomembranes & Bioenerget, Bari, Italy.	emiliano.altamura@uniba.it; n.altamura@ibbe.cnr.it	Gasparello, Jessica/N-6975-2018; Finotti, Alessia/C-6268-2012; Borgatti, Monica/G-2611-2015; Altamura, Emiliano/AAN-2309-2020	Gasparello, Jessica/0000-0001-8557-0739; Finotti, Alessia/0000-0002-7638-515X; Borgatti, Monica/0000-0001-8470-2496; Altamura, Emiliano/0000-0003-3171-6645	Italian Cystic Fibrosis Research Foundation [2/2010, 1/2012]; Fondazione Cariparo (Cassa di Risparmio di Padova e Rovigo); UE THALAMOSS Project (Thalassemia Modular Stratification System for Personalized Therapy of B-Thalassemia) [306201-FP7-HEALTH-2012-INNOVATION-1]; Telethon [GGP10124]; Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo; LABORATORIO SISTEMA [PONa300369 MIUR]; Ministero della Salute, Italy [098/GR-2009-1596647]	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Fondazione Cariparo (Cassa di Risparmio di Padova e Rovigo)(Fondazione Cariparo); UE THALAMOSS Project (Thalassemia Modular Stratification System for Personalized Therapy of B-Thalassemia); Telethon(Fondazione Telethon); Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo; LABORATORIO SISTEMA; Ministero della Salute, Italy(Ministry of Health, Italy)	Nicola Altamura was funded by Italian Cystic Fibrosis Research Foundation (FFC#2/2010 and FFC#1/2012). Roberto Gambari is funded by Fondazione Cariparo (Cassa di Risparmio di Padova e Rovigo), UE THALAMOSS Project (Thalassemia Modular Stratification System for Personalized Therapy of B-Thalassemia; n. 306201-FP7-HEALTH-2012-INNOVATION-1) and Telethon (contract GGP10124). This research activity has been also supported by Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo. Emiliano Altamura was supported by LABORATORIO SISTEMA (PONa300369 MIUR) facilities and the Center for Colloid and Surface Science (CSGI). Monica Borgatti was funded by Ministero della Salute, Italy (contract 098/GR-2009-1596647) and Italian Cystic Fibrosis Research Foundation (FFC#2/2010 and FFC#1/2012). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura N, 2013, J CYST FIBROS, V12, P806, DOI 10.1016/j.jcf.2013.02.007; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Bedwell DM, 1997, NAT MED, V3, P1280, DOI 10.1038/nm1197-1280; Bhuvanagiri M, 2014, EMBO MOL MED, V6, P1593, DOI 10.15252/emmm.201404461; Bidou L, 2004, GENE THER, V11, P619, DOI 10.1038/sj.gt.3302211; Bidou L, 2000, RNA, V6, P952, DOI 10.1017/S1355838200000443; Bidou L, 2012, TRENDS MOL MED, V18, P679, DOI 10.1016/j.molmed.2012.09.008; Bidou L, 2010, FEMS YEAST RES, V10, P1070, DOI 10.1111/j.1567-1364.2010.00684.x; Du LT, 2013, MOL THER, V21, P1653, DOI 10.1038/mt.2013.150; Du LT, 2009, J EXP MED, V206, P2285, DOI 10.1084/jem.20081940; Floquet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024125; Floquet C, 2011, NUCLEIC ACIDS RES, V39, P3350, DOI 10.1093/nar/gkq1277; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Goldmann T, 2012, EMBO MOL MED, V4, P1186, DOI 10.1002/emmm.201201438; Gonzalez-Hilarion S, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-58; Grentzmann G, 1998, RNA, V4, P479; Gunn G, 2014, MOL GENET METAB, V111, P374, DOI 10.1016/j.ymgme.2013.12.007; Halvey PJ, 2012, FEBS OPEN BIO, V2, P56, DOI 10.1016/j.fob.2012.04.004; Harger JW, 2004, RNA, V10, P1721, DOI 10.1261/rna.7120504; He F, 2001, MOL CELL BIOL, V21, P1515, DOI 10.1128/MCB.21.5.1515-1530.2001; He F, 2015, ANNU REV GENET, V49, P339, DOI 10.1146/annurev-genet-112414-054639; He F, 2013, MOL CELL BIOL, V33, P4672, DOI 10.1128/MCB.01136-13; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Keeling KM, 2012, CRIT REV BIOCHEM MOL, V47, P444, DOI 10.3109/10409238.2012.694846; Keeling KM, 2004, RNA, V10, P691, DOI 10.1261/rna.5147804; Keppler-Ross S, 2008, GENETICS, V179, P705, DOI 10.1534/genetics.108.087080; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Langedijk J, 2015, DRUG DISCOVERY TODAY; Lee HLR, 2012, PHARMACOL THERAPEUT, V136, P227, DOI 10.1016/j.pharmthera.2012.07.007; Lentini L, 2014, MOL PHARMACEUT, V11, P653, DOI 10.1021/mp400230s; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; McElroy SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001593; Namy O, 2001, EMBO REP, V2, P787, DOI 10.1093/embo-reports/kve176; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Rakauskaite R, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr382; Salvatori F, 2009, AM J HEMATOL, V84, P720, DOI 10.1002/ajh.21539; Shulman E, 2014, J BIOL CHEM, V289, P2318, DOI 10.1074/jbc.M113.533588; Swan SK, 1997, SEMIN NEPHROL, V17, P27; Taguchi A, 2014, CHEMMEDCHEM, V9, P2233, DOI 10.1002/cmdc.201402208; Wang D, 2012, MOL GENET METAB, V105, P116, DOI 10.1016/j.ymgme.2011.10.005; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Xue XP, 2014, AM J RESP CELL MOL, V50, P805, DOI 10.1165/rcmb.2013-0282OC	46	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154260	10.1371/journal.pone.0154260	http://dx.doi.org/10.1371/journal.pone.0154260			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119736	Green Published, gold			2022-12-27	WOS:000374976200054
J	Altmaier, E; Menni, C; Heier, M; Meisinger, C; Thorand, B; Quell, J; Kobl, M; Romisch-Margl, W; Valdes, AM; Mangino, M; Waldenberger, M; Strauch, K; Illig, T; Adamski, J; Spector, T; Gieger, C; Suhre, K; Kastenmuller, G				Altmaier, Elisabeth; Menni, Cristina; Heier, Margit; Meisinger, Christa; Thorand, Barbara; Quell, Jan; Kobl, Michael; Roemisch-Margl, Werner; Valdes, Ana M.; Mangino, Massimo; Waldenberger, Melanie; Strauch, Konstantin; Illig, Thomas; Adamski, Jerzy; Spector, Tim; Gieger, Christian; Suhre, Karsten; Kastenmuller, Gabi			The Pharmacogenetic Footprint of ACE Inhibition: A Population-Based Metabolomics Study	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; COMPLEMENT C3; HUMAN PLASMA; SYSTEM; HYPERTENSION; ASSOCIATION; DEGRADATION; HYDROLYSIS; ACTIVATION; PEPTIDES	Angiotensin-I-converting enzyme (ACE) inhibitors are an important class of antihypertensives whose action on the human organism is still not fully understood. Although it is known that ACE especially cleaves COOH-terminal dipeptides from active polypeptides, the whole range of substrates and products is still unknown. When analyzing the action of ACE inhibitors, effects of genetic variation on metabolism need to be considered since genetic variance in the ACE gene locus was found to be associated with ACE-concentration in blood as well as with changes in the metabolic profiles of a general population. To investigate the interactions between genetic variance at the ACE-locus and the influence of ACE-therapy on the metabolic status we analyzed 517 metabolites in 1,361 participants from the KORA F4 study. We replicated our results in 1,964 individuals from TwinsUK. We observed differences in the concentration of five dipeptides and three ratios of di- and oligopeptides between ACE inhibitor users and non-users that were genotype dependent. Such changes in the concentration affected major homozygotes, and to a lesser extent heterozygotes, while minor homozygotes showed no or only small changes in the metabolite status. Two of these resulting dipeptides, namely aspartylphenylalanine and phenylalanylserine, showed significant associations with blood pressure which qualifies them-and perhaps also the other dipeptides-as readouts of ACE-activity. Since so far ACE activity measurement is substrate specific due to the usage of only one oligopeptide, taking several dipeptides as potential products of ACE into account may provide a broader picture of the ACE activity.	[Altmaier, Elisabeth; Waldenberger, Melanie; Illig, Thomas; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Menni, Cristina; Valdes, Ana M.; Mangino, Massimo; Spector, Tim; Kastenmuller, Gabi] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Heier, Margit; Meisinger, Christa; Thorand, Barbara; Waldenberger, Melanie] German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Quell, Jan; Roemisch-Margl, Werner; Suhre, Karsten; Kastenmuller, Gabi] German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Kobl, Michael; Strauch, Konstantin] German Res Ctr Environm Hlth, Inst Genet Epidemiol, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Strauch, Konstantin] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Genet Epidemiol, Marchionistr 15, D-81377 Munich, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Illig, Thomas] Hannover Med Sch, Inst Human Genet, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Adamski, Jerzy] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Genome Anal Ctr, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Inst Expt Genet, Life & Food Sci Ctr Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Adamski, Jerzy; Kastenmuller, Gabi] German Ctr Diabet Res DZD eV, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Suhre, Karsten] Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Educ City, POB 24144, Doha, Qatar	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; King's College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Hannover Medical School; Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Kastenmuller, G (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England.; Kastenmuller, G (corresponding author), German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.; Kastenmuller, G (corresponding author), German Ctr Diabet Res DZD eV, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	g.kastenmueller@helmholtz-muenchen.de	Kastenmüller, Gabi/ABF-5987-2020; Waldenberger, Melanie/B-5355-2014; Thorand, Barbara/B-5349-2014; Heier, Margit/AAT-5280-2020; Suhre, Karsten/AAF-1778-2020; Mangino, Massimo/F-5134-2011; Meisinger, Christine/B-5358-2014	Waldenberger, Melanie/0000-0003-0583-5093; Thorand, Barbara/0000-0002-8416-6440; Suhre, Karsten/0000-0001-9638-3912; Mangino, Massimo/0000-0002-2167-7470; Kastenmuller, Gabi/0000-0002-2368-7322; Meisinger, Christa/0000-0002-9026-6544; Valdes, Ana M./0000-0003-1141-4471; Gieger, Christian/0000-0001-6986-9554; Menni, Cristina/0000-0001-9790-0571; Adamski, Jerzy/0000-0001-9259-0199; Quell, Jan D./0000-0003-2620-1532	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH) - German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Federal Ministry of Education and Research (BMBF); Helmholtz Cross Program Initiative "Personalized Medicine (iMed)"; European Union [305280]; German Federal Ministry of Education and Research (BMBF) [01ZX1313A-2014]; "Biomedical Research Program" funds at Weill Cornell Medical College in Qatar - Qatar Foundation; Wellcome Trust; European Community; National Institute for Health Research (NIHR); King's College London; Pfizer; Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH) - German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Cross Program Initiative "Personalized Medicine (iMed)"; European Union(European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); "Biomedical Research Program" funds at Weill Cornell Medical College in Qatar - Qatar Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); King's College London; Pfizer(Pfizer); Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust	The KORA research platform is financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF; http://www.bmbf.de/) to the German Center for Diabetes Research (DZD e.V.; http://www.dzd-ev.de/) and by the Helmholtz Cross Program Initiative "Personalized Medicine (iMed)". The research leading to these results has partly received funding from the European Union's Seventh Framework Programme (FP7-Health-F5-2012) under grant agreement no 305280 (MIMOmics; http://www.mimomics.eu/). It was also supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (grant 01ZX1313A-2014; http://www.sys-med.de/de/konsortien/eatherosysmed/). K.S. is supported by "Biomedical Research Program" funds at Weill Cornell Medical College in Qatar, a program funded by the Qatar Foundation (http://www.qf.org.qa/). TwinsUK was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013; https://ec.europa.eu/research/fp7/index_en.cfm). The study also receives support from the National Institute for Health Research (NIHR; http://www.nihr.ac.uk/) - funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. SNP Genotyping was performed by The Wellcome Trust Sanger Institute (http://www.sanger.ac.uk/) and National Eye Institute (https://nei.nih.gov/) via NIH/CIDR. Metabolomic analysis was funded by Pfizer (http://www.pfizer.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2000, J CLIN ENDOCR METAB, V85, P1043, DOI 10.1210/jc.85.3.1043; Altmaier E, 2014, EUR J EPIDEMIOL, V29, P325, DOI 10.1007/s10654-014-9910-7; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Arnold M, 2015, BIOINFORMATICS, V31, P1334, DOI 10.1093/bioinformatics/btu779; Barron BA, 1999, CARDIOVASC RES, V43, P13, DOI 10.1016/S0008-6363(99)00112-1; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; Cyr M, 2001, AM J PHYSIOL-HEART C, V281, pH275, DOI 10.1152/ajpheart.2001.281.1.H275; Dousset B, 1998, BIOCHEM BIOPH RES CO, V247, P587, DOI 10.1006/bbrc.1998.8834; DUBREUIL P, 1989, BIOCHEM J, V262, P125, DOI 10.1042/bj2620125; Engstrom G, 2007, J HUM HYPERTENS, V21, P276, DOI 10.1038/sj.jhh.1002129; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; GANU VS, 1989, MOL IMMUNOL, V26, P939, DOI 10.1016/0161-5890(89)90112-0; Guang C, 2012, ARCH CARDIOVASC DIS, V105, P373, DOI 10.1016/j.acvd.2012.02.010; HARRISON RA, 1988, COMPLEMENT INFLAMMAT, V5, P27, DOI 10.1159/000463028; Krumsiek J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003005; Li GH, 2004, NUTR RES, V24, P469, DOI [10.1016/S0271-5317(04)00058-2, 10.1016/j.nutres.2003.10.014]; Lu┬ffle M., 2003, INFORM BIOMETRIE EPI, P601; MELZIG MF, 1995, PHARMAZIE, V50, P139; MUSCARI A, 1995, AM J MED, V98, P357, DOI 10.1016/S0002-9343(99)80314-3; Nadar SK, 2007, J HUM HYPERTENS, V21, P261, DOI 10.1038/sj.jhh.1002160; Petersen AK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-120; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; SKIDGEL RA, 1985, P NATL ACAD SCI USA, V82, P1025, DOI 10.1073/pnas.82.4.1025; SKIDGEL RA, 1987, CLIN EXP HYPERTENS A, V9, P243, DOI 10.3109/10641968709164184; SKIDGEL RA, 1984, PEPTIDES, V5, P769, DOI 10.1016/0196-9781(84)90020-2; Smith RET, 2007, NAT REV DRUG DISCOV, V6, P597, DOI 10.1038/nrd2354; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Tichaczek-Goska D, 2012, ADV CLIN EXP MED, V21, P105; Turner AJ, 2002, TRENDS PHARMACOL SCI, V23, P177, DOI 10.1016/S0165-6147(00)01994-5; ULRICH C, 1985, PEPTIDES, V6, P475, DOI 10.1016/0196-9781(85)90113-5; Yu B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004212; Zhou XL, 2013, AM J PHYSIOL-RENAL, V305, pF957, DOI 10.1152/ajprenal.00344.2013	32	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153163	10.1371/journal.pone.0153163	http://dx.doi.org/10.1371/journal.pone.0153163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120469	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200019
J	Mama, SK; Li, YS; Basen-Engquist, K; Lee, RE; Thompson, D; Wetter, DW; Nguyen, NT; Reitzel, LR; McNeill, LH				Mama, Scherezade K.; Li, Yisheng; Basen-Engquist, Karen; Lee, Rebecca E.; Thompson, Deborah; Wetter, David W.; Nguyen, Nga T.; Reitzel, Lorraine R.; McNeill, Lorna H.			Psychosocial Mechanisms Linking the Social Environment to Mental Health in African Americans	PLOS ONE			English	Article							SELF-RATED HEALTH; PERCEIVED RACIAL-DISCRIMINATION; QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; PHYSICAL-ACTIVITY; SHORT-FORM; SOCIOECONOMIC POSITION; HOST-RESISTANCE; RISK-FACTORS; SUPPORT	Resource-poor social environments predict poor health, but the mechanisms and processes linking the social environment to psychological health and well-being remain unclear. This study explored psychosocial mediators of the association between the social environment and mental health in African American adults. African American men and women (n = 1467) completed questionnaires on the social environment, psychosocial factors (stress, depressive symptoms, and racial discrimination), and mental health. Multiplemediator models were used to assess direct and indirect effects of the social environment on mental health. Low social status in the community (p < .001) and U.S. (p < .001) and low social support (p < .001) were associated with poor mental health. Psychosocial factors significantly jointly mediated the relationship between the social environment and mental health in multiple-mediator models. Low social status and social support were associated with greater perceived stress, depressive symptoms, and perceived racial discrimination, which were associated with poor mental health. Results suggest the relationship between the social environment and mental health is mediated by psychosocial factors and revealed potential mechanisms through which social status and social support influence the mental health of African American men and women. Findings from this study provide insight into the differential effects of stress, depression and discrimination on mental health. Ecological approaches that aim to improve the social environment and psychosocial mediators may enhance health-related quality of life and reduce health disparities in African Americans.	[Mama, Scherezade K.] Penn State Univ, Coll Hlth & Human Dev, Dept Kinesiol, University Pk, PA 16802 USA; [Li, Yisheng; Nguyen, Nga T.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Basen-Engquist, Karen] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA; [Lee, Rebecca E.] Arizona State Univ, Coll Nursing & Hlth Innovat, Phoenix, AZ USA; [Thompson, Deborah] Baylor Coll Med, Childrens Nutr Res Ctr, USDA, ARS, Houston, TX 77030 USA; [Wetter, David W.] Rice Univ, Dept Psychol, Houston, TX 77251 USA; [Reitzel, Lorraine R.] Univ Houston, Coll Educ, Dept Psychol Hlth & Learning Sci, Houston, TX USA; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Arizona State University; Arizona State University-Downtown Phoenix; Baylor College of Medicine; United States Department of Agriculture (USDA); Rice University; University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center	Mama, SK (corresponding author), Penn State Univ, Coll Hlth & Human Dev, Dept Kinesiol, University Pk, PA 16802 USA.	skmama@psu.edu	Thompson, Debbe/GOV-5741-2022; Basen-Engquist, Karen/G-7817-2017; Reitzel, Lorraine/A-4843-2014	Thompson, Debbe/0000-0002-5491-8816; Basen-Engquist, Karen/0000-0001-7299-0646; Wetter, David/0000-0002-6366-0108; LI, Yisheng/0000-0001-9847-8544; Mama, Scherezade/0000-0003-1935-7707; Reitzel, Lorraine/0000-0002-7165-5720	University Cancer Foundation; Duncan Family Institute through the Center for Community-Engaged Translational Research; Ms. Regina J. Rogers Gift: Health Disparities Research Program; Cullen Trust for Health Care Endowed Chair Funds for Health Disparities Research; Morgan Foundation Funds for Health Disparities Research and Educational Programs; Center for Energy Balance in Cancer Prevention and Survivorship, Duncan Family Institute for Cancer Prevention and Risk Assessment; MD Anderson Cancer Center's Cancer Prevention Research Training Program; National Cancer Institute [R25T CA057730, P30 CA016672]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R13HD080934] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; ARS [ARS-0426345] Funding Source: Federal RePORTER	University Cancer Foundation; Duncan Family Institute through the Center for Community-Engaged Translational Research; Ms. Regina J. Rogers Gift: Health Disparities Research Program; Cullen Trust for Health Care Endowed Chair Funds for Health Disparities Research; Morgan Foundation Funds for Health Disparities Research and Educational Programs; Center for Energy Balance in Cancer Prevention and Survivorship, Duncan Family Institute for Cancer Prevention and Risk Assessment; MD Anderson Cancer Center's Cancer Prevention Research Training Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Project CHURCH was generously supported by funding from the University Cancer Foundation; the Duncan Family Institute through the Center for Community-Engaged Translational Research; the Ms. Regina J. Rogers Gift: Health Disparities Research Program; the Cullen Trust for Health Care Endowed Chair Funds for Health Disparities Research; and the Morgan Foundation Funds for Health Disparities Research and Educational Programs. Support was also provided by the Center for Energy Balance in Cancer Prevention and Survivorship, Duncan Family Institute for Cancer Prevention and Risk Assessment. Scherezade K. Mama was supported in part by a cancer prevention fellowship through MD Anderson Cancer Center's Cancer Prevention Research Training Program, funded by the National Cancer Institute (R25T CA057730 and P30 CA016672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Bean Melanie K, 2009, Prog Cardiovasc Nurs, V24, P131, DOI 10.1111/j.1751-7117.2009.00051.x; Bennett GG, 2004, PSYCHOL HEALTH, V19, P369, DOI 10.1080/0887044042000193505; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Bradley Kristina L, 2010, Issues Ment Health Nurs, V31, P408, DOI 10.3109/01612840903484105; Broman Clifford L., 1996, Ethnicity and Disease, V6, P148; Brummett BH, 2005, PSYCHOSOM MED, V67, P40, DOI 10.1097/01.psy.0000149257.74854.b7; Brunet J, 2014, SUPPORT CARE CANCER, V22, P689, DOI 10.1007/s00520-013-2023-0; CASSEL J, 1976, AM J EPIDEMIOL, V104, P107, DOI 10.1093/oxfordjournals.aje.a112281; Chen HJ, 2014, INT PSYCHOGERIATR, V26, P49, DOI 10.1017/S1041610213001701; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Cuevas AG, 2014, AM J HEALTH BEHAV, V38, P31, DOI [10.5993/AJHB.38.1.4, 10.599]; Cuevas AG, 2013, AM J HEALTH BEHAV, V37, P745, DOI 10.5993/AJHB.37.6.3; Gan YQ, 2015, STRESS HEALTH, V31, P336, DOI 10.1002/smi.2572; Garey L, 2016, BEHAV MODIF, V40, P303, DOI 10.1177/0145445515612396; Gibbons FX, 2014, HEALTH PSYCHOL, V33, P11, DOI 10.1037/a0033857; Hawkes AL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-560; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hudson DL, 2013, SOC SCI MED, V97, P7, DOI 10.1016/j.socscimed.2013.07.031; JAMES SA, 1994, CULT MED PSYCHIAT, V18, P163, DOI 10.1007/BF01379448; Klonoff EA, 2014, HEALTH PSYCHOL, V33, P1, DOI 10.1037/hea0000070; Klonoff EA, 2009, J BEHAV MED, V32, P48, DOI 10.1007/s10865-008-9192-1; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Kuehner C, 2005, J AFFECT DISORDERS, V86, P205, DOI 10.1016/j.jad.2005.01.014; Larson CO, 2008, PREV CHRONIC DIS, V5, pA44; LeBron AMW, 2015, ETHNIC DIS, V25, P24; MacKinnon DP, 2008, HEALTH PSYCHOL, V27, pS99, DOI 10.1037/0278-6133.27.2(Suppl.).S99; McacKinnon DP, 2008, INTRO STAT MEDIATION; McNeil SN, 2014, FAM PROCESS, V53, P109, DOI 10.1111/famp.12054; McNeill LH, 2006, SOC SCI MED, V63, P1011, DOI 10.1016/j.socscimed.2006.03.012; Merz EL, 2014, PSYCHOL ASSESSMENT, V26, P384, DOI 10.1037/a0035248; Modie-Moroka T, 2014, SOC PSYCH PSYCH EPID, V49, P1269, DOI 10.1007/s00127-013-0806-8; Moisiuc A, 2015, AM J HEALTH BEHAV, V39, P148, DOI 10.5993/AJHB.39.1.16; Nabi RL, 2013, CYBERPSYCH BEH SOC N, V16, P721, DOI 10.1089/cyber.2012.0521; Neighbors Harold W., 1996, Ethnicity and Disease, V6, P167; Operario D, 2004, PSYCHOL HEALTH, V19, P237, DOI 10.1080/08870440310001638098; OXMAN TE, 1992, AM J EPIDEMIOL, V135, P356, DOI 10.1093/oxfordjournals.aje.a116297; Pew Research Center, 2016, AM CHANG REL LANDSC; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reitzel LR, 2014, AM J PUBLIC HEALTH, V104, P110, DOI 10.2105/AJPH.2012.301140; Reitzel LR, 2013, AM J HEALTH BEHAV, V37, P104, DOI 10.5993/AJHB.37.1.12; Reitzel LR, 2010, ADDICTION, V105, P928, DOI 10.1111/j.1360-0443.2009.02875.x; Richter DL, 2002, WOMEN HEALTH, V36, P91; Sadana R, 2013, PUBLIC HEALTH REP, V128, P12, DOI 10.1177/00333549131286S303; Sallis JF, 2008, HLTH BEHAV HLTH ED T, DOI DOI 10.1111/J.1442-9993.2008.01952.X; Sorensen G, 2003, PREV MED, V37, P188, DOI 10.1016/S0091-7435(03)00111-7; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 1995, SF 12 HOW TO SCORE T; Wolff LS, 2010, SOC SCI MED, V70, P2019, DOI 10.1016/j.socscimed.2010.02.033	60	20	20	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154035	10.1371/journal.pone.0154035	http://dx.doi.org/10.1371/journal.pone.0154035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119366	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200042
J	Nalbant, A; Saygili, T				Nalbant, Ayten; Saygili, Tahsin			IL12, IL10, IFN gamma and TNF alpha Expression in Human Primary Monocytes Stimulated with Bacterial Heat Shock GroEL (Hsp64) Protein	PLOS ONE			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PROINFLAMMATORY CYTOKINE; INTERFERON-GAMMA; MACROPHAGES; CELLS; DIFFERENTIATION; LOCALIZATION; INFECTION; RESPONSES; CONTAINS	Actinobacillus (Aggregatibacter) actinomycetemicomitans (Aa) is a bacterium that lives in the oral cavity and plays an important role in periodontal diseases. The effect of A. actinomycetemcomitans's heat shock family protein GroEL on host or immune cells including monocytes is quite limited. In this study, the recombinant A. actinomycetemcomitans's GroEL protein (rAaGroEL) was used as an antigen and its effects on monocytes of peripheral blood mononuclear cells (PBMCs) was investigated. To do that, PBMCs were stimulated with rAaGroEL protein at different time points (16h to 96h) and the cytokines of CD14+ monocytes were detected with intracellular cytokine staining by Flow cytometry. Data showed that AaGroEL protein has an antigenic effect on human primary monocytes. AaGroEL protein responsive CD14 monocytes stimulates the expression of IL12, IL10, IFN gamma and TNF alpha cytokines with different kinetics and expression profile. Therefore, A. actinomycetemcomitans's heat shock GroEL protein can modulate innate and adaptive immune responses and contribute to an inflammatory diseases pathology.	[Nalbant, Ayten; Saygili, Tahsin] Izmir Inst Technol, Dept Mol Biol & Genet, Mol Immunol & Gene Regulat Lab, TR-35430 Izmir, Turkey; [Saygili, Tahsin] Alex Ilac Ticaret Ltd Sti, Buyukdere Cad 100-102 B Blok Kat 1, TR-34394 Istanbul, Turkey	Izmir Institute of Technology; Alexion Pharmaceuticals in Turkey	Nalbant, A (corresponding author), Izmir Inst Technol, Dept Mol Biol & Genet, Mol Immunol & Gene Regulat Lab, TR-35430 Izmir, Turkey.	aytennalbant@iyte.edu.tr	Ramalho, Lais Vieira/AAH-1596-2019	Ramalho, Lais Vieira/0000-0003-1459-3954	Scientific and Technological Research Council of Turkey (TUBITAK) [106T417]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by a grant from the Scientific and Technological Research Council of Turkey (TUBITAK) (Project# 106T417 to Dr. Ayten Nalbant). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg CH, 2015, VIRULENCE, V6, P188, DOI 10.4161/21505594.2014.982428; Boesze-Battaglia K, 2015, INFECT IMMUN, V83, P4042, DOI 10.1128/IAI.00788-15; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Delneste Y, 2003, BLOOD, V101, P143, DOI 10.1182/blood-2002-04-1164; Gobert AP, 2004, J BIOL CHEM, V279, P245, DOI 10.1074/jbc.M307858200; Goulhen F, 1998, INFECT IMMUN, V66, P5307, DOI 10.1128/IAI.66.11.5307-5313.1998; Graham GM, 2004, BRIT J DERMATOL, V150, P421, DOI 10.1046/j.1365-2133.2004.05762.x; Guerra-Laso JM, 2015, IMMUNOLOGY, V144, P291, DOI 10.1111/imm.12371; Hu YM, 2008, INFECT IMMUN, V76, P1535, DOI 10.1128/IAI.01078-07; KIRBY AC, 1995, J CLIN INVEST, V96, P1185, DOI 10.1172/JCI118150; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Leclerq S, 2002, J MED MICROBIOL, V51, P20, DOI 10.1099/0022-1317-51-1-20; Lewthwaite JC, 2001, INFECT IMMUN, V69, P7349, DOI 10.1128/IAI.69.12.7349-7355.2001; Lin SN, 2005, J MED MICROBIOL, V54, P225, DOI 10.1099/jmm.0.45871-0; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Melton DW, 2015, AUTOIMMUNITY, V48, P161, DOI 10.3109/08916934.2015.1027816; Paju S, 2000, FEMS MICROBIOL LETT, V182, P231, DOI 10.1016/S0378-1097(99)00595-9; RETZLAFF C, 1994, INFECT IMMUN, V62, P5689, DOI 10.1128/IAI.62.12.5689-5693.1994; Saygili T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049252; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sharma SA, 1997, CLIN DIAGN LAB IMMUN, V4, P440, DOI 10.1128/CDLI.4.4.440-446.1997; Shenker BJ, 2000, J IMMUNOL, V165, P2612, DOI 10.4049/jimmunol.165.5.2612; Shenker BJ, 2014, CELL MICROBIOL, V16, P1391, DOI 10.1111/cmi.12299; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Ueki K, 2002, CLIN EXP IMMUNOL, V127, P72, DOI 10.1046/j.1365-2249.2002.01723.x	25	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154085	10.1371/journal.pone.0154085	http://dx.doi.org/10.1371/journal.pone.0154085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119521	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200043
J	Tsai, CA; Lee, KT; Liu, JP				Tsai, Chen-An; Lee, Kuan-Ting; Liu, Jen-pei			Addressing Loss of Efficiency Due to Misclassification Error in Enriched Clinical Trials for the Evaluation of Targeted Therapies Based on the Cox Proportional Hazards Model	PLOS ONE			English	Article							DESIGN; REGRESSION; INFERENCE	A key feature of precision medicine is that it takes individual variability at the genetic or molecular level into account in determining the best treatment for patients diagnosed with diseases detected by recently developed novel biotechnologies. The enrichment design is an efficient design that enrolls only the patients testing positive for specific molecular targets and randomly assigns them for the targeted treatment or the concurrent control. However there is no diagnostic device with perfect accuracy and precision for detecting molecular targets. In particular, the positive predictive value (PPV) can be quite low for rare diseases with low prevalence. Under the enrichment design, some patients testing positive for specific molecular targets may not have the molecular targets. The efficacy of the targeted therapy may be underestimated in the patients that actually do have the molecular targets. To address the loss of efficiency due to misclassification error, we apply the discrete mixture modeling for time-to-event data proposed by Eng and Hanlon [8] to develop an inferential procedure, based on the Cox proportional hazard model, for treatment effects of the targeted treatment effect for the true-positive patients with the molecular targets. Our proposed procedure incorporates both inaccuracy of diagnostic devices and uncertainty of estimated accuracy measures. We employed the expectation-maximization algorithm in conjunction with the bootstrap technique for estimation of the hazard ratio and its estimated variance. We report the results of simulation studies which empirically investigated the performance of the proposed method. Our proposed method is illustrated by a numerical example.	[Tsai, Chen-An; Lee, Kuan-Ting; Liu, Jen-pei] Natl Taiwan Univ, Dept Agron, Div Biometry, Taipei, Taiwan; [Liu, Jen-pei] Natl Taiwan Univ, Inst Epidemiol, Taipei 10764, Taiwan; [Liu, Jen-pei] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Taiwan	National Taiwan University; National Taiwan University; National Health Research Institutes - Taiwan	Liu, JP (corresponding author), Natl Taiwan Univ, Dept Agron, Div Biometry, Taipei, Taiwan.; Liu, JP (corresponding author), Natl Taiwan Univ, Inst Epidemiol, Taipei 10764, Taiwan.; Liu, JP (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Taiwan.	jpliu@ntu.edu.tw			Taiwan Ministry of Science and Technology [MOST 103-2118-M-002-003-MY2]	Taiwan Ministry of Science and Technology	This research is partially supported by the Taiwan Ministry of Science and Technology grant MOST 103-2118-M-002-003-MY2 to Jen-pei Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams Jeffrey, 2014, Am Soc Clin Oncol Educ Book, P71, DOI 10.14694/EdBook_AM.2014.34.71; Breslow NE, 1972, J R STAT SOC B, V34, P216, DOI DOI 10.1111/J.2517-6161.1972.TB00900.X; Chen CF, 2013, PHARM STAT, V12, P165, DOI 10.1002/pst.1568; Chow SC, 2014, DESIGN ANAL CLIN TRI, P191; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; COX DR, 1972, J R STAT SOC B, V34, P187; EFRON B, 1993, INTRO BOOTSTRAP, P45; Eng KH, 2014, BIOINFORMATICS, V30, P1690, DOI 10.1093/bioinformatics/btu065; Liu JP, 2009, PHARM STAT, V8, P356, DOI 10.1002/pst.364; Liu JP, 2008, J FORMOS MED ASSOC, V107, pS35, DOI 10.1016/S0929-6646(09)60007-3; Pepe M, 2003, STAT EVALUATION MED, P14; *US FDA, 2006, ANN REDL DRAFT PACK; *US FDA, 2005, DRAFT CONC PAP DRUG	13	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153525	10.1371/journal.pone.0153525	http://dx.doi.org/10.1371/journal.pone.0153525			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120450	Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200029
J	Mans, J; Armah, GE; Steele, AD; Taylor, MB				Mans, Janet; Armah, George E.; Steele, A. Duncan; Taylor, Maureen B.			Norovirus Epidemiology in Africa: A Review	PLOS ONE			English	Review							SOUTH-AFRICA; ENTERIC VIRUSES; MOLECULAR CHARACTERIZATION; HOSPITALIZED CHILDREN; ACUTE GASTROENTERITIS; HUMAN CALICIVIRUSES; ACUTE DIARRHEA; CLINICAL CHARACTERISTICS; DEVELOPING-COUNTRIES; GREATER CAIRO	Norovirus (NoV) is recognised as a leading cause of gastroenteritis worldwide across all age groups. The prevalence and diversity of NoVs in many African countries is still unknown, although early sero-prevalence studies indicated widespread early infection. Reports on NoVs in Africa vary widely in terms of study duration, population groups and size, inclusion of asymptomatic controls, as well as genotyping information. This review provides an estimate of NoV prevalence and distribution of genotypes of NoVs in Africa. Inclusion criteria for the review were study duration of at least 6 months, population size of > 50 and diagnosis by RT-PCR. As regions used for genotyping varied, or genotyping was not always performed, this was not considered as an inclusion criteria. A literature search containing the terms norovirus+Africa yielded 74 publications. Of these 19 studies from 14 out of the 54 countries in Africa met the inclusion criteria. Data from studies not meeting the inclusion criteria, based on sample size or short duration, were included as discussion points. The majority of studies published focused on children, under five years of age, hospitalised with acute gastroenteritis. The mean overall prevalence was 13.5% (range 0.825.5%) in children with gastroenteritis and 9.7% (range 7-31%) in asymptomatic controls, where tested. NoV GII.4 was the predominant genotype identified in most of the studies that presented genotyping data. Other prevalent genotypes detected included GII.3 and GII.6. In conclusion, NoV is a common pathogen in children with diarrhoea in Africa, with considerable carriage in asymptomatic children. There is however, a paucity of data on NoV infection in adults.	[Mans, Janet; Taylor, Maureen B.] Univ Pretoria, Dept Med Virol, ZA-0001 Pretoria, South Africa; [Armah, George E.] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Steele, A. Duncan] Univ Limpopo, MRC Diarrhoeal Pathogens Res Unit, Pretoria, South Africa; [Steele, A. Duncan] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Pretoria; University of Ghana; University of Limpopo; Bill & Melinda Gates Foundation	Mans, J (corresponding author), Univ Pretoria, Dept Med Virol, ZA-0001 Pretoria, South Africa.	janet.mans@up.ac.za	Taylor, Maureen B/D-2171-2017	Taylor, Maureen B/0000-0002-2780-5795; Steele, Andrew Duncan/0000-0002-4946-037X; Mans, Janet/0000-0001-6721-1177				Abugalia M, 2011, J MED VIROL, V83, P1849, DOI 10.1002/jmv.22141; Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Armah GE, 2006, J MED VIROL, V78, P1480, DOI 10.1002/jmv.20722; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Ayukekbong J, 2011, J MED VIROL, V83, P2135, DOI 10.1002/jmv.22243; Benmessaoud R, 2015, J MED MICROBIOL, V64, P84, DOI 10.1099/jmm.0.079830-0; Bruggink LD, 2012, J MED VIROL, V84, P1437, DOI 10.1002/jmv.23342; Bucardo F, 2008, J CLIN MICROBIOL, V46, P2573, DOI 10.1128/JCM.00505-08; de la Noue AC, 2014, APPL ENVIRON MICROB, V80, P7196, DOI 10.1128/AEM.01871-14; Dove W, 2005, J MED VIROL, V77, P522, DOI 10.1002/jmv.20488; Eden JS, 2014, VIROLOGY, V450, P106, DOI 10.1016/j.virol.2013.12.005; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; El Qazoui M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-300; Fu J, 2015, EUROSURVEILLANCE, P20; Green K., 2013, FIELDS VIROLOGY, V1, P583; Junquera CG, 2009, PEDIATR INFECT DIS J, V28, P604, DOI 10.1097/INF.0b013e318197c3ca; Hassine-Zaafrane M, 2014, FOOD ENVIRON VIROL, V6, P125, DOI 10.1007/s12560-014-9147-3; Hassine-Zaafrane M, 2013, J MED VIROL, V85, P1100, DOI 10.1002/jmv.23552; Huynen P, 2013, J CLIN VIROL, V58, P515, DOI 10.1016/j.jcv.2013.08.013; Kamel AH, 2010, J APPL MICROBIOL, V108, P1620, DOI 10.1111/j.1365-2672.2009.04562.x; Kamel AH, 2009, J CLIN MICROBIOL, V47, P1037, DOI 10.1128/JCM.01381-08; Kaufman SS, 2014, ANTIVIR RES, V105, P80, DOI 10.1016/j.antiviral.2014.02.012; Kiulia NM, 2014, FOOD ENVIRON VIROL, V6, P221, DOI 10.1007/s12560-014-9160-6; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Krumkamp R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003568; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Mans J, 2016, EPIDEMIOL INFECT, V144, P907, DOI 10.1017/S0950268815002150; Mans J, 2013, EPIDEMIOL INFECT, V141, P303, DOI 10.1017/S0950268812000490; Mans J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-168; Mans J, 2014, J MED VIROL, V86, P75, DOI 10.1002/jmv.23784; Mans J, 2010, J CLIN VIROL, V49, P258, DOI 10.1016/j.jcv.2010.08.011; Maslin J, 2008, AM J TROP MED HYG, V78, P522, DOI 10.4269/ajtmh.2008.78.522; Mattison K, 2010, J MED VIROL, V82, P321, DOI 10.1002/jmv.21682; Siqueira JAM, 2013, J MED VIROL, V85, P737, DOI 10.1002/jmv.23506; Moyo S, 2014, INFECT GENET EVOL, V26, P340, DOI 10.1016/j.meegid.2014.06.013; Murata T, 2007, PEDIATR INFECT DIS J, V26, P46, DOI 10.1097/01.inf.0000247102.04997.e0; Murray TY, 2013, J APPL MICROBIOL, V114, P1843, DOI 10.1111/jam.12167; Nordgren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069557; O'Ryan ML, 2010, PEDIATR INFECT DIS J, V29, P855, DOI 10.1097/INF.0b013e3181e8b346; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Rackoff LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059394; Sdiri-Loulizi K, 2010, J APPL MICROBIOL, V109, P1093, DOI 10.1111/j.1365-2672.2010.04772.x; Sdiri-Loulizi K, 2009, J CLIN MICROBIOL, V47, P421, DOI 10.1128/JCM.01852-08; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Silva PA, 2008, J MED VIROL, V80, P1790, DOI 10.1002/jmv.21231; Smit TK, 1999, J MED VIROL, V59, P227, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;227::AID-JMV17&gt;3.0.CO;2-8; Taylor MB, 1996, EPIDEMIOL INFECT, V116, P203, DOI 10.1017/S0950268800052444; Trainor E, 2013, J MED VIROL, V85, P1299, DOI 10.1002/jmv.23589; UNAIDS, 2015, AIDS CHANG EV MDG 6; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Yassin MA, 2012, PAEDIATR INT CHILD H, V32, P51, DOI 10.1179/1465328111Y.0000000047	56	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0146280	10.1371/journal.pone.0146280	http://dx.doi.org/10.1371/journal.pone.0146280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116615	Green Submitted, gold, Green Published			2022-12-27	WOS:000374973600005
J	Narciso, FV; Barela, JA; Aguiar, SA; Carvalho, ANS; Tufik, S; de Mello, MT				Narciso, Fernanda Veruska; Barela, Jose A.; Aguiar, Stefane A.; Carvalho, Adriana N. S.; Tufik, Sergio; de Mello, Marco Tulio			Effects of Shift Work on the Postural and Psychomotor Performance of Night Workers	PLOS ONE			English	Article							VIGILANCE TEST PVT; SLEEP-DEPRIVATION; COGNITIVE PERFORMANCE; BALANCE CONTROL; TIME AWAKE; COMPONENTS; ALERTNESS; FATIGUE; NURSES; POSTUROGRAPHY	The purpose of the study was to investigate the effects of shift work on the psychomotor and postural performance of night workers. The study included 20 polysomnography technicians working schedule of 12-h night shift by 36-h off. On the first day of protocol, the body mass and height were measured, and an actigraph was placed on the wrist of each participant. On the second day of protocol, sleepiness by Karolinska Sleepiness Scale, postural control by force platform (30 seconds) and psychomotor performance by Psychomotor Vigilance Task (10 minutes) were measured before and after 12-h night work. Results showed that after 12-h night work, sleepiness increased by 59% (p<0.001), postural control variables increased by 9% (p = 0.048), and 14% (p = 0.006). Mean reaction time, and the number of lapses of attention increased by 13% (p = 0.006) and 425% (p = 0.015), respectively, but the mean reciprocal reaction time decreased by 7%. In addition, there were correlations between sleepiness and postural control variables with opened eyes (r = 0.616, 95% confidence interval [CI] = 0.361-0.815; r = 0.538; 95% CI = 0.280-0.748) and closed eyes (r = 0.557; 95% CI = 0.304-0.764, r = 0497; 95% CI = 0.325-0.715) and a pronounced effect of sleepiness on postural sway (R-2 = 0.393; 95% CI = 0.001-0.03). Therefore, 12-h night work system and sleepiness showed a negative impact in postural and psychomotor vigilance performance of night workers. As unexpected, the force platform was feasibility to detect sleepiness in this population, underscoring the possibility of using this method in the workplace to prevent occupational injuries and accidents.	[Narciso, Fernanda Veruska; Tufik, Sergio; de Mello, Marco Tulio] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil; [Barela, Jose A.; Aguiar, Stefane A.] Univ Cruzeiro Sul, Sao Paulo, SP, Brazil; [Carvalho, Adriana N. S.] Assoc Fundo Incent Pesquisa, Sao Paulo, SP, Brazil; [de Mello, Marco Tulio] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Cruzeiro do Sul; Universidade Federal de Minas Gerais	de Mello, MT (corresponding author), Univ Fed Sao Paulo, Sao Paulo, SP, Brazil.; de Mello, MT (corresponding author), Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.	tmello@demello.net.br	Barela, José A/F-4284-2012; Narciso, Fernanda Veruska FVN/O-9869-2015; de Mello, Marco Tulio/G-3237-2010	Barela, José A/0000-0003-0951-254X; de Mello, Marco Tulio/0000-0003-3896-2208; Veruska Narciso, Fernanda/0000-0001-6863-8252				Aguiar SA, 2014, NEUROSCI LETT, V574, P47, DOI 10.1016/j.neulet.2014.05.028; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Avni N, 2006, PSYCHIAT CLIN NEUROS, V60, P340, DOI 10.1111/j.1440-1819.2006.01511.x; Basner M, 2011, ACTA ASTRONAUT, V69, P949, DOI 10.1016/j.actaastro.2011.07.015; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Bougard C, 2011, EXP BRAIN RES, V209, P109, DOI 10.1007/s00221-010-2524-8; de Mello MT, 2008, BRAZ J MED BIOL RES, V41, P1129, DOI 10.1590/S0100-879X2008001200014; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Folkard S, 2006, AM J IND MED, V49, P953, DOI 10.1002/ajim.20307; Forsman P, 2008, IEEE ENG MED BIO, P686, DOI 10.1109/IEMBS.2008.4649245; Forsman P, 2008, J BIOMECH, V41, P2892, DOI 10.1016/j.jbiomech.2008.07.003; Forsman P, 2014, ACCIDENT ANAL PREV, V62, P186, DOI 10.1016/j.aap.2013.09.015; Forsman P, 2010, GAIT POSTURE, V32, P419, DOI 10.1016/j.gaitpost.2010.06.012; Geiger-Brown J, 2012, CHRONOBIOL INT, V29, P211, DOI 10.3109/07420528.2011.645752; Goncalves M, 2015, J SLEEP RES, V24, P242, DOI 10.1111/jsr.12267; Harma M, 2002, J SLEEP RES, V11, P141, DOI 10.1046/j.1365-2869.2002.00294.x; Jackson ML, 2013, ACCIDENT ANAL PREV, V50, P438, DOI 10.1016/j.aap.2012.05.020; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Karhula K, 2013, IND HEALTH, V51, P406; Karita K, 2006, J OCCUP HEALTH, V48, P65, DOI 10.1539/joh.48.65; Lamond N, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.11.e13; Liviya W, 2014, J OCCUP ENVIRON MED, V56, P935, DOI 10.1097/JOM.0000000000000150; Lombardi DA, 2010, CHRONOBIOL INT, V27, P1013, DOI 10.3109/07420528.2010.489466; Morad Y, 2007, AVIAT SPACE ENVIR MD, V78, P859; Niu SF, 2013, BIOL RES NURS, V15, P273, DOI 10.1177/1099800412439459; Patel M, 2008, EXP BRAIN RES, V185, P165, DOI 10.1007/s00221-007-1143-5; Pham Quang-Cuong, 2014, Rev. Bras. Eng. Bioméd., V30, P322, DOI 10.1590/1517-3151.0611; Roach GD, 2006, CHRONOBIOL INT, V23, P1379, DOI 10.1080/07420520601067931; Robillard R, 2011, CLIN NEUROPHYSIOL, V122, P1771, DOI 10.1016/j.clinph.2011.02.010; Roca J, 2012, ACTA PSYCHOL, V140, P164, DOI 10.1016/j.actpsy.2012.03.007; Roge J, 2009, PERCEPT MOTOR SKILL, V109, P270, DOI 10.2466/PMS.109.1.270-284; Sallinen M, 2004, J SLEEP RES, V13, P285, DOI 10.1111/j.1365-2869.2004.00425.x; Sargent C, 2012, ACCIDENT ANAL PREV, V45, P74, DOI 10.1016/j.aap.2011.09.030; Scott LD, 2006, AM J CRIT CARE, V15, P30; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Thomas Maria L., 2003, Thalamus & Related Systems, V2, P199, DOI 10.1017/S1472928803000207; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; Van Dongen HPA, 2005, CLIN SPORT MED, V24, P237, DOI 10.1016/j.csm.2004.12.007; Vetter C, 2012, CHRONOBIOL INT, V29, P1127, DOI 10.3109/07420528.2012.707999; Wehrens SMT, 2012, CHRONOBIOL INT, V29, P537, DOI 10.3109/07420528.2012.675258	40	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0151609	10.1371/journal.pone.0151609	http://dx.doi.org/10.1371/journal.pone.0151609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27115868	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600011
J	Cacao, E; Hada, M; Saganti, PB; George, KA; Cucinotta, FA				Cacao, Eliedonna; Hada, Megumi; Saganti, Premkumar B.; George, Kerry A.; Cucinotta, Francis A.			Relative Biological Effectiveness of HZE Particles for Chromosomal Exchanges and Other Surrogate Cancer Risk Endpoints	PLOS ONE			English	Article							SISTER-CHROMATID EXCHANGES; VERY-LOW FLUENCES; ALPHA-PARTICLES; TRACK STRUCTURE; ACCELERATED PARTICLES; MUTATION-INDUCTION; RADIATION QUALITY; ENERGY PROTONS; SPACE; CELLS	The biological effects of high charge and energy (HZE) particle exposures are of interest in space radiation protection of astronauts and cosmonauts, and estimating secondary cancer risks for patients undergoing Hadron therapy for primary cancers. The large number of particles types and energies that makeup primary or secondary radiation in HZE particle exposures precludes tumor induction studies in animal models for all but a few particle types and energies, thus leading to the use of surrogate endpoints to investigate the details of the radiation quality dependence of relative biological effectiveness (RBE) factors. In this report we make detailed RBE predictions of the charge number and energy dependence of RBE's using a parametric track structure model to represent experimental results for the low dose response for chromosomal exchanges in normal human lymphocyte and fibroblast cells with comparison to published data for neoplastic transformation and gene mutation. RBE's are evaluated against acute doses of.-rays for doses near 1 Gy. Models that assume linear or non-targeted effects at low dose are considered. Modest values of RBE (<10) are found for simple exchanges using a linear dose response model, however in the non-targeted effects model for fibroblast cells large RBE values (>10) are predicted at low doses <0.1 Gy. The radiation quality dependence of RBE's against the effects of acute doses.-rays found for neoplastic transformation and gene mutation studies are similar to those found for simple exchanges if a linear response is assumed at low HZE particle doses. Comparisons of the resulting model parameters to those used in the NASA radiation quality factor function are discussed.	[Cacao, Eliedonna; Cucinotta, Francis A.] Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA; [Hada, Megumi; Saganti, Premkumar B.] Prairie View A&M Univ, Radiat Inst Sci & Engn, Prairie View, TX USA; [George, Kerry A.] Wyle, Houston, TX USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Texas A&M University System; Prairie View A&M University	Cucinotta, FA (corresponding author), Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA.	Francis.Cucinotta@unlv.edu	Cucinotta, Francis/AAZ-5941-2020	Saganti, Premkumar/0000-0002-2456-210X	DOE Low Dose Program [DE-AI02-10ER64969]; University of Nevada, Las Vegas	DOE Low Dose Program; University of Nevada, Las Vegas	This work was supported by the DOE Low Dose Program (grant number DE-AI02-10ER64969) to FAC, and the University of Nevada, Las Vegas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALPEN EL, 1993, RADIAT RES, V136, P382, DOI 10.2307/3578551; [Anonymous], 2006, HLTH RISKS EXPOSURE; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; BELLI M, 1992, INT J RADIAT BIOL, V61, P625, DOI 10.1080/09553009214551431; BELLI M, 1993, INT J RADIAT BIOL, V63, P331, DOI 10.1080/09553009314550441; Buonanno M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021540; Burns FJ, 2007, RADIAT ENVIRON BIOPH, V46, P195, DOI 10.1007/s00411-007-0106-3; Chang PY, 2016, RAD RES IN PRESS; Cucinotta FA, 1998, RADIAT RES, V150, P115, DOI 10.2307/3579651; Cucinotta FA, 1996, INT J RADIAT BIOL, V69, P593, DOI 10.1080/095530096145607; Cucinotta FA, 1998, RADIAT ENVIRON BIOPH, V37, P259, DOI 10.1007/s004110050127; Cucinotta FA, 2013, 2013217375 NASA TP; Cucinotta FA, 2016, HEALTH PHYS, V110, P262, DOI 10.1097/HP.0000000000000442; Cucinotta FA, 2015, LIFE SCI SPACE RES, V5, P31, DOI 10.1016/j.lssr.2015.04.002; Cucinotta FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120717; Cucinotta FA, 2014, LIFE SCI SPACE RES, V2, P54, DOI 10.1016/j.lssr.2014.06.003; Cucinotta FA, 2010, MUTAT RES-FUND MOL M, V687, P49, DOI 10.1016/j.mrfmmm.2010.01.012; Dicello JF, 2004, PHYS MED BIOL, V49, P3817, DOI 10.1088/0031-9155/49/16/024; Edwards A. A., 1999, Journal of Radiological Protection, V19, P93, DOI 10.1088/0952-4746/19/2/201; Edwards AA, 2001, PHYS MEDICA, V17, P147; FRY RJM, 1985, RADIAT RES, V104, pS188, DOI 10.2307/3576646; George K, 2007, ADV SPACE RES, V39, P1076, DOI 10.1016/j.asr.2007.01.004; George KA, 2013, RADIAT RES, V180, P25, DOI 10.1667/RR3291.1; GOODHEAD DT, 1989, NUCL TRACKS RAD MEAS, V16, P177; Hada M, 2014, RADIAT RES, V182, P368, DOI 10.1667/RR13721.1; Huo LH, 2001, RADIAT RES, V156, P521, DOI 10.1667/0033-7587(2001)156[0521:HMIIBC]2.0.CO;2; ICRP, 2003, ICRP PUBL; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; KATZ R, 1994, RADIAT RES, V140, P356, DOI 10.2307/3579113; Kawata T, 2001, INT J RADIAT BIOL, V77, P165, DOI 10.1080/09553000010007686; Kiefer J, 2001, RADIAT RES, V156, P607, DOI 10.1667/0033-7587(2001)156[0607:MIMCIB]2.0.CO;2; Kim MHY, 2014, J GEOPHYS RES-PLANET, V119, P1311, DOI 10.1002/2013JE004549; Lehnert BE, 1997, CANCER RES, V57, P2164; Liber HL, 2014, RADIAT RES, V182, P390, DOI 10.1667/RR13817.1; Little JB, 2003, RADIAT RES, V159, P262, DOI 10.1667/0033-7587(2003)159[0262:IOTNEJ]2.0.CO;2; Nagasawa H, 2002, MUTAT RES-FUND MOL M, V508, P121, DOI 10.1016/S0027-5107(02)00193-8; NAGASAWA H, 1992, CANCER RES, V52, P6394; NAS (National Academy of Sciences Space Science Board), 1996, REP TASK GROUP BIOL; NAS/NRC, 2012, TECHNICAL EVALUATION; NCRP, 2014, RAD PROT SPAC ACT SU; NCRP, 1990, 104 NCRP; NCRP, 2006, 153 NCRP NAT COUNC R; Plante I, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125020; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Suman S, 2016, INT J RADIAT ONCOL, V95, P131, DOI 10.1016/j.ijrobp.2015.10.057; Terasawa T, 2009, ANN INTERN MED, V151, P556, DOI 10.7326/0003-4819-151-8-200910200-00145; THACKER J, 1979, INT J RADIAT BIOL, V36, P137, DOI 10.1080/09553007914550891; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, SOURC EFF ION RAD UN; WALIGORSKI MPR, 1987, RADIAT RES, V111, P424, DOI 10.2307/3576928; Weil MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104819; WILSON JW, 1993, NATO ADV SCI INST SE, V243, P295; Yang H, 2011, RADIAT RES, V176, P695, DOI 10.1667/RR2674.1; YANG TCH, 1985, RADIAT RES, V104, pS177, DOI 10.2307/3576645; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989	56	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153998	10.1371/journal.pone.0153998	http://dx.doi.org/10.1371/journal.pone.0153998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111667	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600025
J	Harle, A; Salleron, J; Franczak, C; Dubois, C; Filhine-Tressarieu, P; Leroux, A; Merlin, JL				Harle, Alexandre; Salleron, Julia; Franczak, Claire; Dubois, Cindy; Filhine-Tressarieu, Pierre; Leroux, Agnes; Merlin, Jean-Louis			Detection of BRAF Mutations Using a Fully Automated Platform and Comparison with High Resolution Melting, Real-Time Allele Specific Amplification, Immunohistochemistry and Next Generation Sequencing Assays, for Patients with Metastatic Melanoma	PLOS ONE			English	Article							CLINICAL-RESPONSE; VEMURAFENIB; DABRAFENIB; SURVIVAL; P.V600E; RARE; TOOL	Background Metastatic melanoma is a severe disease with one of the highest mortality rate in skin diseases. Overall survival has significantly improved with immunotherapy and targeted therapies. Kinase inhibitors targeting BRAF V600 showed promising results. BRAF genotyping is mandatory for the prescription of anti-BRAF therapies. Methods Fifty-nine formalin-fixed paraffin-embedded melanoma samples were assessed using High-Resolution-Melting (HRM) PCR, Real-time allele-specific amplification (RT-ASA) PCR, Next generation sequencing (NGS), immunohistochemistry (IHC) and the fully-automated molecular diagnostics platform Idylla (TM). Sensitivity, specificity, positive predictive value and negative predictive value were calculated using NGS as the reference standard to compare the different assays. Results BRAF mutations were found in 28(47.5%), 29(49.2%), 31(52.5%), 29(49.2%) and 27 (45.8%) samples with HRM, RT-ASA, NGS, Idylla (TM) and IHC respectively. Twenty-six (81.2%) samples were found bearing a c. 1799T>A (p.Val600Glu) mutation, three (9.4%) with a c. 1798_1799delinsAA (p.Val600Lys) mutation and one with c. 1789_1790delinsTC (p.Leu597Ser) mutation. Two samples were found bearing complex mutations. Conclusions HRM appears the less sensitive assay for the detection of BRAF V600 mutations. The RT-ASA, Idylla (TM) and IHC assays are suitable for routine molecular diagnostics aiming at the prescription of anti-BRAF therapies. Idylla (TM) assay is fully-automated and requires less than 2 minutes for samples preparation and is the fastest of the tested assays.	[Harle, Alexandre; Merlin, Jean-Louis] Univ Lorraine, Fac Pharm, Nancy, France; [Harle, Alexandre; Leroux, Agnes; Merlin, Jean-Louis] CNRS UMR 7039 CRAN, Nancy, France; [Harle, Alexandre; Salleron, Julia; Franczak, Claire; Dubois, Cindy; Filhine-Tressarieu, Pierre; Leroux, Agnes; Merlin, Jean-Louis] Inst Cancerol Lorraine, Serv Biopathol, Vandoeuvre Les Nancy, France; [Salleron, Julia] Inst Cancerol Lorraine, Cellule Biostat, Vandoeuvre Les Nancy, France	Universite de Lorraine; UNICANCER; Institut de cancerologie de Lorraine (ICL); UNICANCER; Institut de cancerologie de Lorraine (ICL)	Harle, A (corresponding author), Univ Lorraine, Fac Pharm, Nancy, France.; Harle, A (corresponding author), CNRS UMR 7039 CRAN, Nancy, France.; Harle, A (corresponding author), Inst Cancerol Lorraine, Serv Biopathol, Vandoeuvre Les Nancy, France.	a.harle@nancy.unicancer.fr						Boyers LN, 2014, J AM ACAD DERMATOL, V71, P1137, DOI 10.1016/j.jaad.2014.08.022; Busser B, 2013, JAMA DERMATOL, V149, P1403, DOI 10.1001/jamadermatol.2013.8198; Capper D, 2011, ACTA NEUROPATHOL, V122, P11, DOI 10.1007/s00401-011-0841-z; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Dahlman KB, 2012, CANCER DISCOV, V2, P791, DOI 10.1158/2159-8290.CD-12-0097; Fisher KE, 2014, HUM PATHOL, V45, P2281, DOI 10.1016/j.humpath.2014.07.014; Harle A, 2015, TARGETED ONCOLOGY, DOI [10.1007/s11523-0150404-7, DOI 10.1007/S11523-0150404-7]; Harle A, 2013, VIRCHOWS ARCH, V462, P329, DOI 10.1007/s00428-013-1380-x; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Jarry A, 2004, MOL CELL PROBE, V18, P349, DOI 10.1016/j.mcp.2004.05.004; Long GV, 2013, AM J SURG PATHOL, V37, P61, DOI 10.1097/PAS.0b013e31826485c0; Lopez-Rios F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053733; Lovly CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035309; Mourah S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120232; Na JI, 2015, VIRCHOWS ARCH, V2015, P19; Pichler M, 2009, J MOL DIAGN, V11, P140, DOI 10.2353/jmoldx.2009.080100; Rahman A, 2014, LANCET ONCOL, V15, pE535, DOI 10.1016/S1470-2045(14)71023-X; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Trudel S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-727; Uguen A, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0359-0; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Willmore-Payne C, 2005, HUM PATHOL, V36, P486, DOI 10.1016/j.humpath.2005.03.015; Wilson MA, 2014, CANCER GENET-NY, V207, P272, DOI 10.1016/j.cancergen.2014.06.022	24	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153576	10.1371/journal.pone.0153576	http://dx.doi.org/10.1371/journal.pone.0153576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111917	Green Published, gold			2022-12-27	WOS:000374970600017
J	Huang, JC; Zhu, TT; Qu, Y; Mu, DZ				Huang, Jichong; Zhu, Tingting; Qu, Yi; Mu, Dezhi			Prenatal, Perinatal and Neonatal Risk Factors for Intellectual Disability: A Systemic Review and Meta-Analysis	PLOS ONE			English	Review							MENTAL-RETARDATION; PREGNANCY; CHILDREN; SMOKING; OUTCOMES; PRETERM; FETAL; BORN; BIAS; AGE	Background The etiology of non-genetic intellectual disability (ID) is not fully known, and we aimed to identify the prenatal, perinatal and neonatal risk factors for ID. Method PubMed and Embase databases were searched for studies that examined the association between pre-, peri-and neonatal factors and ID risk (keywords "intellectual disability" or "mental retardation" or "ID" or "MR" in combination with "prenatal" or "pregnancy" or "obstetric" or "perinatal" or "neonatal". The last search was updated on September 15, 2015. Summary effect estimates (pooled odds ratios) were calculated for each risk factor using random effects models, with tests for heterogeneity and publication bias. Results Seventeen studies with 55,344 patients and 5,723,749 control individuals were eligible for inclusion in our analysis, and 16 potential risk factors were analyzed. Ten prenatal factors (advanced maternal age, maternal black race, low maternal education, third or more parity, maternal alcohol use, maternal tobacco use, maternal diabetes, maternal hypertension, maternal epilepsy and maternal asthma), one perinatal factor (preterm birth) and two neonatal factors (male sex and low birth weight) were significantly associated with increased risk of ID. Conclusion This systemic review and meta-analysis provides a comprehensive evidence-based assessment of the risk factors for ID. Future studies are encouraged to focus on perinatal and neonatal risk factors and the combined effects of multiple factors.	[Huang, Jichong; Zhu, Tingting; Qu, Yi; Mu, Dezhi] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu 610041, Peoples R China; [Huang, Jichong; Zhu, Tingting; Qu, Yi; Mu, Dezhi] Sichuan Univ, Minist Educ, Key Lab Obstetr & Gynecol & Pediat Dis & Birth De, Chengdu 610041, Peoples R China; [Mu, Dezhi] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	Sichuan University; Sichuan University; University of California System; University of California San Francisco	Mu, DZ (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu 610041, Peoples R China.; Mu, DZ (corresponding author), Sichuan Univ, Minist Educ, Key Lab Obstetr & Gynecol & Pediat Dis & Birth De, Chengdu 610041, Peoples R China.; Mu, DZ (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	mudz@scu.edu.cn		Qu, Yi/0000-0002-9993-8810; Mu, Dezhi/0000-0002-2599-7041	National Science Foundation of China [81330016, 81300524, 81172174, 81270724, 81200462]; State Commission of Science Technology of China [2013CB967404, 2012BAI04B04]; Ministry of Education of China [IRT0935, 313037]; Science and Technology Bureau of Sichuan province [2014SZ0149, 2016TD0002]; Ministry of Health of China [1311200003303]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Commission of Science Technology of China; Ministry of Education of China(Ministry of Education, China); Science and Technology Bureau of Sichuan province; Ministry of Health of China	This work was supported by the National Science Foundation of China (No. 81330016, 81300524, 81172174, 81270724 and 81200462), grants from the State Commission of Science Technology of China (2013CB967404, 2012BAI04B04), grants from the Ministry of Education of China (IRT0935, 313037), grants from the Science and Technology Bureau of Sichuan province (2014SZ0149, 2016TD0002), and a grant of clinical discipline program (neonatology) from the Ministry of Health of China (1311200003303).	ADAMS MM, 1993, OBSTET GYNECOL, V82, P955; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson JE, 2006, MATERN CHILD HLTH J, V10, pS101, DOI 10.1007/s10995-006-0093-z; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bilder DA, 2013, AJIDD-AM J INTELLECT, V118, P156, DOI 10.1352/1944-7558-118.2.156; Boyle CA, 1995, ANN EPIDEMIOL, P347; Croen LA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e86; Curry CJ, 1997, AM J MED GENET, V72, P468, DOI 10.1002/(SICI)1096-8628(19971112)72:4<468::AID-AJMG18>3.0.CO;2-P; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DREWS CD, 1995, AM J PUBLIC HEALTH, V85, P329, DOI 10.2105/AJPH.85.3.329; Drews CD, 1996, PEDIATRICS, V97, P547; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekblad M, 2015, ACTA PAEDIATR, V104, P12, DOI 10.1111/apa.12791; Elyasi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133918; Griffith MI, 2011, HYPERTENS PREGNANCY, V30, P108, DOI 10.3109/10641955.2010.507837; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kerr-Wilson CO, 2012, J PUBLIC HEALTH-UK, V34, P209, DOI 10.1093/pubmed/fdr024; Khoshdel A, 2006, INT J CLIN PRACT, V60, P1287, DOI 10.1111/j.1742-1241.2006.01078.x; Langridge AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050963; Leonard H, 2006, ANN EPIDEMIOL, V16, P448, DOI 10.1016/j.annepidem.2005.05.002; Lyall K, 2011, J AUTISM DEV DISORD, V41, P618, DOI 10.1007/s10803-010-1079-7; Mann JR, 2013, BJOG-INT J OBSTET GY, V120, P309, DOI 10.1111/1471-0528.12052; Mann JR, 2013, MATERN CHILD HLTH J, V17, P928, DOI 10.1007/s10995-012-1072-1; Mann JR, 2009, ANN EPIDEMIOL, V19, P891, DOI 10.1016/j.annepidem.2009.08.004; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; McDermott S, 1993, Paediatr Perinat Epidemiol, V7, P195, DOI 10.1111/j.1365-3016.1993.tb00393.x; O'Leary C, 2013, DEV MED CHILD NEUROL, V55, P271, DOI 10.1111/dmcn.12029; Onicescu G, 2014, ENVIRON SCI POLLUT R, V21, P10775, DOI 10.1007/s11356-014-3072-8; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Rindfuss RR, 1996, DEMOGRAPHY, V33, P277, DOI 10.2307/2061761; Robinson M, 2009, J PEDIATR-US, V154, P218, DOI 10.1016/j.jpeds.2008.07.061; ROELEVELD N, 1992, PREV MED, V21, P110, DOI 10.1016/0091-7435(92)90010-F; Rojahn J.A.M., 2007, HDB INTELLECTUAL DEV, P1, DOI DOI 10.1007/0-387-32931-5_1; Takkouche B, 1999, AM J EPIDEMIOL, V150, P206; Wells BS GA, 2015, NEWCASTLE OTTAWA SCO; Williams LO, 1999, AM J EPIDEMIOL, V149, P814; YEARGINALLSOPP M, 1995, AM J PUBLIC HEALTH, V85, P324, DOI 10.2105/AJPH.85.3.324	39	65	66	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153655	10.1371/journal.pone.0153655	http://dx.doi.org/10.1371/journal.pone.0153655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27110944	gold, Green Published, Green Submitted			2022-12-27	WOS:000374970600019
J	Ameratunga, M; Asadi, K; Lin, XH; Walkiewicz, M; Murone, C; Knight, S; Mitchell, P; Boutros, P; John, T				Ameratunga, Malaka; Asadi, Khashayar; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel; Knight, Simon; Mitchell, Paul; Boutros, Paul; John, Thomas			PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC	PLOS ONE			English	Article							CELL LUNG-CANCER; CD8(+) T-CELLS; LIGAND 1; EXPRESSION; SURVIVAL; RECURRENCE; CD4(+); ADENOCARCINOMA; MUTATIONS; BLOCKADE	Introduction Immune checkpoint inhibition has shifted treatment paradigms in non-small cell lung cancer (NSCLC). Conflicting results have been reported regarding the immune infiltrate and programmed death-ligand 1 (PD-L1) as a prognostic marker. We correlated the immune infiltrate and PD-L1 expression with clinicopathologic characteristics in a cohort of resected NSCLC. Methods A tissue microarray was constructed using triplicate cores from consecutive resected NSCLC. Immunohistochemistry was performed for CD8, FOXP3 and PD-L1. Strong PD-L1 expression was predefined as greater than 50% tumor cell positivity. Matched nodal samples were assessed for concordance of PD-L1 expression. Results Of 522 patients, 346 were node-negative (N0), 72 N1 and 109 N2; 265 were adenocarcinomas (AC), 182 squamous cell cancers (SCC) and 75 other. Strong PD-L1 expression was found in 24% cases. In the overall cohort, PD-L1 expression was not associated with survival. In patients with N2 disease, strong PD-L1 expression was associated with significantly improved disease-free (DFS) and overall survival (OS) in multivariate analysis (HR 0.49, 95% CI 0.36-0.94, p = 0.031; HR 0.46, 95% CI 0.26-0.80, p = 0.006). In this resected cohort only 5% harboured EGFR mutations, whereas 19% harboured KRAS and 23% other. KRAS mutated tumors were more likely to highly express PD-L1 compared to EGFR (22% vs 3%). A stromal CD8 infiltrate was associated with significantly improved DFS in SCC (HR 0.70, 95% CI 0.50-0.97, p = 0.034), but not AC, whereas FOXP3 was not prognostic. Matched nodal specimens (N = 53) were highly concordant for PD-L1 expression (89%). Conclusion PD-L1 expression was not prognostic in the overall cohort. PD-L1 expression in primary tumor and matched nodal specimens were highly concordant. The observed survival benefit in N2 disease requires confirmation.	[Ameratunga, Malaka; Mitchell, Paul; John, Thomas] Austin Hlth, Dept Med Oncol, Olivia Newton John Canc & Wellness Ctr, Heidelberg, Vic, Australia; [Asadi, Khashayar; Murone, Carmel] Austin Hlth, Dept Pathol, Heidelberg, Vic, Australia; [Lin, Xihui; Boutros, Paul] Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada; [Walkiewicz, Marzena; Murone, Carmel; John, Thomas] Olivia Newton John Canc Res Inst, Hawthorn, Vic, Australia; [Knight, Simon] Austin Hlth, Dept Thorac, Hawthorn, Vic, Australia; [Boutros, Paul] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Boutros, Paul] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [John, Thomas] La Trobe Univ, Sch Canc Med, Bundoora, Vic 3086, Australia; [John, Thomas] Univ Melbourne, Melbourne, Vic 3010, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; La Trobe University; Olivia Newton-John Cancer Research Institute; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ontario Institute for Cancer Research; La Trobe University; Olivia Newton-John Cancer Research Institute; Florey Institute of Neuroscience & Mental Health; University of Toronto; University of Toronto; La Trobe University; University of Melbourne	John, T (corresponding author), Austin Hlth, Dept Med Oncol, Olivia Newton John Canc & Wellness Ctr, Heidelberg, Vic, Australia.; John, T (corresponding author), Olivia Newton John Canc Res Inst, Hawthorn, Vic, Australia.; John, T (corresponding author), La Trobe Univ, Sch Canc Med, Bundoora, Vic 3086, Australia.; John, T (corresponding author), Univ Melbourne, Melbourne, Vic 3010, Australia.	tom.john@onjcri.org.au		John, Thomas/0000-0003-3399-5342; Boutros, Paul/0000-0003-0553-7520; Ameratunga, Malaka/0000-0002-7171-6781	National Health and Medical Research Council (NHMRC); Ontario Institute for Cancer Research by the Government of Ontario; Terry Fox Research Institute; Canadian Institutes of Health Research (CIHR); Victorian Government; Cancer Council Victoria	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ontario Institute for Cancer Research by the Government of Ontario; Terry Fox Research Institute; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Victorian Government; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	Thomas John received funding from the National Health and Medical Research Council (NHMRC). This study was conducted with the support of the Ontario Institute for Cancer Research to PCB through funding provided by the Government of Ontario. Dr. Boutros was supported by a Terry Fox Research Institute New Investigator Award and by a Canadian Institutes of Health Research (CIHR) New Investigator Award. The Victorian Cancer Biobank is supported by the Victorian Government. Assoc Prof John is an NHMRC Early Career Scholar and receives funding from the Cancer Council Victoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Andtbacka RH, 2015, J CLIN ONCOLOGY; Antonia SJ, 2014, J CLIN ONCOLOGY, V32; Azuma K, 2014, ANN ONCOL, V25, P1935, DOI 10.1093/annonc/mdu242; Boland JM, 2013, CLIN LUNG CANCER, V14, P157, DOI 10.1016/j.cllc.2012.05.006; Cedres S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121071; Cooper WA, LUNG CANC; D'Incecco A, 2015, BRIT J CANCER, V112, P95, DOI 10.1038/bjc.2014.555; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Donnem T, 2015, CLIN CANC RES; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-1; Garon EB, 2015, NEW ENGLAND J MED; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Horne ZD, 2011, J SURG RES, V171, P1, DOI 10.1016/j.jss.2011.03.068; Ishibashi Y, 2006, ONCOL REP, V15, P1315; John T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067876; Kawai O, 2008, CANCER-AM CANCER SOC, V113, P1387, DOI 10.1002/cncr.23712; Kerr KM, 2015, J THORAC ONCOL, V10, P985, DOI 10.1097/JTO.0000000000000526; Kilic A, 2011, J SURG RES, V167, P207, DOI 10.1016/j.jss.2009.08.029; Kim MY, 2015, LUNG CANCER, V88, P24, DOI 10.1016/j.lungcan.2015.01.016; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Liu H, 2012, CANCER IMMUNOL IMMUN, V61, P1849, DOI 10.1007/s00262-012-1231-7; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Mori M, 2000, TOHOKU J EXP MED, V191, P113, DOI 10.1620/tjem.191.113; Pan ZK, 2015, J THORAC DIS, V7, P462, DOI 10.3978/j.issn.2072-1439.2015.02.13; Petersen RP, 2006, CANCER-AM CANCER SOC, V107, P2866, DOI 10.1002/cncr.22282; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Schalper KA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju435; Schmidt LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136023; Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Tao H, 2014, ANN THORACIC CARDIOV; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Tian CT, 2015, CHINESE MED J-PEKING, V128, P105, DOI 10.4103/0366-6999.147828; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Wakabayashi O, 2003, CANCER SCI, V94, P1003, DOI 10.1111/j.1349-7006.2003.tb01392.x; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yang CY, 2014, EUR J CANCER, V50, P1361, DOI 10.1016/j.ejca.2014.01.018; Zhang GQ, 2012, ASIAN PAC J CANCER P, V13, P3955, DOI 10.7314/APJCP.2012.13.8.3955; Zhang Y, 2010, CELL MOL IMMUNOL, V7, P389, DOI 10.1038/cmi.2010.28; Zhang Y, 2014, ONCOTARGETS THER, V7, P567, DOI 10.2147/OTT.S59959; Zhang YX, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000515; Zhuang XW, 2010, APPL IMMUNOHISTO M M, V18, P24, DOI 10.1097/PAI.0b013e3181b6a741	48	53	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153954	10.1371/journal.pone.0153954	http://dx.doi.org/10.1371/journal.pone.0153954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104612	Green Published, gold			2022-12-27	WOS:000374565100030
J	Marton, S; Cleto, F; Krieger, MA; Cardoso, J				Marton, Soledad; Cleto, Fernanda; Krieger, Marco Aurelio; Cardoso, Josiane			Isolation of an Aptamer that Binds Specifically to E. coli	PLOS ONE			English	Article							IN-VITRO SELECTION; WHOLE-CELL SELEX; DNA APTAMERS; SALMONELLA-TYPHIMURIUM; EXPONENTIAL ENRICHMENT; STAPHYLOCOCCUS-AUREUS; SYSTEMATIC EVOLUTION; SSDNA APTAMERS; RNA LIGANDS; IDENTIFICATION	Escherichia coli is a bacterial species found ubiquitously in the intestinal flora of animals, although pathogenic variants cause major public health problems. Aptamers are short oligo-nucleotides that bind to targets with high affinity and specificity, and have great potential for use in diagnostics and therapy. We used cell-based Systematic Evolution of Ligands by EXponential enrichment (cell-SELEX) to isolate four single stranded DNA (ssDNA) aptamers that bind strongly to E. coli cells (ATCC generic strain 25922), with Kd values in the nanomolar range. Fluorescently labeled aptamers label the surface of E. coli cells, as viewed by fluorescent microscopy. Specificity tests with twelve different bacterial species showed that one of the aptamers-called P12-31-is highly specific for E. coli. Importantly, this aptamer binds to Meningitis/sepsis associated E. coli (MNEC) clinical isolates, and is the first aptamer described with potential for use in the diagnosis of MNEC-borne pathologies.	[Marton, Soledad; Cleto, Fernanda; Krieger, Marco Aurelio; Cardoso, Josiane] Inst Biol Mol Parana, Dept Res & Dev, 3375 Prof Algacyr Munhoz Mader St, Curitiba, Parana, Brazil; [Krieger, Marco Aurelio] Inst Carlos Chagas, Lab Genom Funct, 3375 Prof Algacyr Munhoz Mader St, Curitiba, Parana, Brazil		Cardoso, J (corresponding author), Inst Biol Mol Parana, Dept Res & Dev, 3375 Prof Algacyr Munhoz Mader St, Curitiba, Parana, Brazil.	josianec@gmail.com	Krieger, Marco/AAE-8611-2020	Krieger, Marco Aurelio/0000-0003-0030-3952	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP); Coordenacao de aperfeicoamento de pessoal de nivel superior (CAPES); Fundacao Oswaldo Cruz (FIOCRUZ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de aperfeicoamento de pessoal de nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Cruz (FIOCRUZ)	This investigation received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora de Estudos e Projetos (FINEP), Coordenacao de aperfeicoamento de pessoal de nivel superior (CAPES) and Fundacao Oswaldo Cruz (FIOCRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Bruno JG, 2008, FOLIA MICROBIOL, V53, P295, DOI 10.1007/s12223-008-0046-6; Bruno JG, 2010, J FLUORESC, V20, P1211, DOI 10.1007/s10895-010-0670-9; Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007; Dua P, 2013, CANCER RES, V73, P1934, DOI 10.1158/0008-5472.CAN-12-3682; Duan N, 2013, ANAL CHIM ACTA, V804, P151, DOI 10.1016/j.aca.2013.09.047; Duan N, 2013, J MICROBIOL METH, V94, P170, DOI 10.1016/j.mimet.2013.06.016; Duan N, 2013, J AGR FOOD CHEM, V61, P3229, DOI 10.1021/jf400767d; Duan N, 2012, J AGR FOOD CHEM, V60, P4034, DOI 10.1021/jf300395z; Duan N, 2012, ANAL CHIM ACTA, V723, P1, DOI 10.1016/j.aca.2012.02.011; Dwivedi HP, 2013, APPL MICROBIOL BIOT, V97, P3677, DOI 10.1007/s00253-013-4766-4; Dwivedi HP, 2010, APPL MICROBIOL BIOT, V87, P2323, DOI 10.1007/s00253-010-2728-7; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fang ZY, 2014, BIOSENS BIOELECTRON, V56, P192, DOI 10.1016/j.bios.2014.01.015; Ferreira IM, 2014, APPL BIOCHEM BIOTECH, V174, P2548, DOI 10.1007/s12010-014-1206-6; Gopinath SC, 2011, BIOSENS BIOELECTRON, V60, P332; GREEN R, 1990, NATURE, V347, P406, DOI 10.1038/347406a0; Hamula CLA, 2011, ANAL CHEM, V83, P3640, DOI 10.1021/ac200575e; Hernandez R, 2014, BIOSENS BIOELECTRON, V54, P553, DOI 10.1016/j.bios.2013.11.053; Homann M, 1999, NUCLEIC ACIDS RES, V27, P2006, DOI 10.1093/nar/27.9.2006; Hong KL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/419318; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kim SE, 2012, ANAL BIOCHEM, V424, P12, DOI 10.1016/j.ab.2012.02.016; Kim YS, 2014, BIOSENS BIOELECTRON, V54, P195, DOI 10.1016/j.bios.2013.11.003; Kim YS, 2013, ANAL BIOCHEM, V436, P22, DOI 10.1016/j.ab.2013.01.014; Kolovskaya OS, 2013, J MED CHEM, V56, P1564, DOI 10.1021/jm301856j; Labib M, 2012, ANAL CHEM, V84, P8114, DOI 10.1021/ac302217u; Lee YJ, 2012, BIOCHEM BIOPH RES CO, V417, P414, DOI 10.1016/j.bbrc.2011.11.130; Li H, 2011, CAN J MICROBIOL, V57, P453, DOI [10.1139/w11-030, 10.1139/W11-030]; Liu Zhong-Cheng, 2012, Yao Xue Xue Bao, V47, P1605; Ma XY, 2014, J MICROBIOL METH, V98, P94, DOI 10.1016/j.mimet.2014.01.003; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Marton S, 2013, J VIRAL HEPATITIS, V20, P103, DOI 10.1111/j.1365-2893.2012.01629.x; Marton S, 2010, MOLECULES, V15, P4610, DOI 10.3390/molecules15074610; Mayer G, 2010, NAT PROTOC, V5, P1993, DOI 10.1038/nprot.2010.163; Moon J, 2013, J MICROBIOL METH, V95, P162, DOI 10.1016/j.mimet.2013.08.005; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Nagarkatti R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043533; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nutiu R, 2005, METHODS, V37, P16, DOI 10.1016/j.ymeth.2005.07.001; Park HC, 2014, APPL BIOCHEM BIOTECH, V174, P793, DOI 10.1007/s12010-014-1103-z; Park Jinah, 2014, Int J Cell Biol, V2014, P715867, DOI 10.1155/2014/715867; Peng ZH, 2014, J FLUORESC, V24, P1159, DOI 10.1007/s10895-014-1396-x; Pestourie C, 2006, OLIGONUCLEOTIDES, V16, P323, DOI 10.1089/oli.2006.16.323; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Ray P, 2012, J CLIN INVEST, V122, P1734, DOI 10.1172/JCI62385; Savory N, 2014, J MICROBIOL METH, V104, P94, DOI 10.1016/j.mimet.2014.06.016; Savory N, 2013, BIOTECHNOL BIOENG, V110, P2573, DOI 10.1002/bit.24922; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Shamah SM, 2008, ACCOUNTS CHEM RES, V41, P130, DOI 10.1021/ar700142z; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; So HM, 2008, SMALL, V4, P197, DOI 10.1002/smll.200700664; Suh SH, 2014, ANAL BIOCHEM, V459, P39, DOI 10.1016/j.ab.2014.05.006; Suh SH, 2013, J BIOTECHNOL, V167, P454, DOI 10.1016/j.jbiotec.2013.07.027; Sullenger BA, 2003, E SCHERING RES FDN W, V43, P217; Tang XM, 2013, BIOTECHNOL LETT, V35, P909, DOI 10.1007/s10529-013-1154-1; Thiel KW, 2009, OLIGONUCLEOTIDES, V19, P209, DOI 10.1089/oli.2009.0199; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ulrich H, 2006, COMB CHEM HIGH T SCR, V9, P619, DOI 10.2174/138620706778249695; Vivekananda J, 2006, LAB INVEST, V86, P610, DOI 10.1038/labinvest.3700417; Wang KY, 2011, EUR J CLIN MICROBIOL, V30, P273, DOI 10.1007/s10096-010-1074-0; Weigand JE, 2009, APPL MICROBIOL BIOT, V85, P229, DOI 10.1007/s00253-009-2194-2; White RR, 2000, J CLIN INVEST, V106, P929, DOI 10.1172/JCI11325; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x; Wu SJ, 2015, ANAL BIOANAL CHEM, V407, P1303, DOI 10.1007/s00216-014-8378-3; Wu WH, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-658; Wu WH, 2014, ACS APPL MATER INTER, V6, P16974, DOI 10.1021/am5045828; Yang M, 2013, SENSORS-BASEL, V13, P6865, DOI 10.3390/s130506865; Yuan JL, 2014, TALANTA, V127, P163, DOI 10.1016/j.talanta.2014.04.013; Zelada-Guillen GA, 2012, BIOSENS BIOELECTRON, V31, P226, DOI 10.1016/j.bios.2011.10.021; Zelada-Guillen GA, 2010, ANAL CHEM, V82, P9254, DOI 10.1021/ac101739b; Zimbres FM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/731516; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	76	47	48	11	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153637	10.1371/journal.pone.0153637	http://dx.doi.org/10.1371/journal.pone.0153637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104834	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100014
J	Cuperlovic-Culf, M; Wang, LP; Forseille, L; Boyle, K; Merkley, N; Burton, I; Fobert, PR				Cuperlovic-Culf, Miroslava; Wang, Lipu; Forseille, Lily; Boyle, Kerry; Merkley, Nadine; Burton, Ian; Fobert, Pierre R.			Metabolic Biomarker Panels of Response to Fusarium Head Blight Infection in Different Wheat Varieties	PLOS ONE			English	Article							SPECTROMETRY-BASED METABOLOMICS; RESISTANCE-RELATED METABOLITES; RESOLVED NMR-SPECTRA; RED SPRING WHEAT; MASS-SPECTROMETRY; QUANTITATIVE RESISTANCE; GENE-EXPRESSION; GRAMINEARUM; BARLEY; IDENTIFICATION	Metabolic changes in spikelets of wheat varieties FL62R1, Stettler, Muchmore and Sumai3 following Fusarium graminearum infection were explored using NMR analysis. Extensive 1D and 2D H-1 NMR measurements provided information for detailed metabolite assignment and quantification leading to possible metabolic markers discriminating resistance level in wheat subtypes. In addition, metabolic changes that are observed in all studied varieties as well as wheat variety specific changes have been determined and discussed. A new method for metabolite quantification from NMR data that automatically aligns spectra of standards and samples prior to quantification using multivariate linear regression optimization of spectra of assigned metabolites to samples' 1D spectra is described and utilized. Fusarium infection-induced metabolic changes in different wheat varieties are discussed in the context of metabolic network and resistance.	[Cuperlovic-Culf, Miroslava] Natl Res Council Canada, Ottawa, ON, Canada; [Wang, Lipu; Forseille, Lily; Boyle, Kerry; Fobert, Pierre R.] Natl Res Council Canada, Saskatoon, SK, Canada; [Merkley, Nadine; Burton, Ian] Natl Res Council Canada, Halifax, NS, Canada	National Research Council Canada; National Research Council Canada; International Business Machines (IBM); National Research Council Canada	Cuperlovic-Culf, M (corresponding author), Natl Res Council Canada, Ottawa, ON, Canada.	miroslava.cuperlovic-culf@nrc-cnrc.gc.ca	Cuperlovic-Culf, Miroslava/C-7876-2016	Cuperlovic-Culf, Miroslava/0000-0002-9483-8159	Canadian Goverment through National Research Council	Canadian Goverment through National Research Council	The authors received no specific funding for this work other than regular funding of the Canadian Goverment through National Research Council Programs and Projects.	Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Boenisch MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-110; Bollina V, 2011, PLANT MOL BIOL, V77, P355, DOI 10.1007/s11103-011-9815-8; Bollina V, 2010, MOL PLANT PATHOL, V11, P769, DOI 10.1111/j.1364-3703.2010.00643.x; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Boutigny AL, 2008, EUR J PLANT PATHOL, V121, P411, DOI 10.1007/s10658-007-9266-x; Brown NA, 2010, FUNGAL BIOL-UK, V114, P555, DOI 10.1016/j.funbio.2010.04.006; Chamarthi SK, 2014, EUR J PLANT PATHOL, V138, P67, DOI 10.1007/s10658-013-0302-8; Comeau A., 2011, Plant Breeding and Seed Science, V63, P39, DOI 10.2478/v10129-011-0014-1; Crampton BG, 2009, MOL PLANT PATHOL, V10, P291, DOI 10.1111/j.1364-3703.2008.00532.x; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Cuperlovic-Culf M, 2012, J BIOL CHEM, V287, P20164, DOI 10.1074/jbc.M111.337196; DePauw RM, 2011, CAN J PLANT SCI, V91, P797, DOI [10.4141/cjps10188, 10.4141/CJPS10188]; DePauw RM, 2009, CAN J PLANT SCI, V89, P945, DOI 10.4141/CJPS08227; Gonzalez-Lamothe R, 2009, INT J MOL SCI, V10, P3400, DOI 10.3390/ijms10083400; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Gunnaiah R, 2014, PLANT PHYSIOL BIOCH, V83, P40, DOI 10.1016/j.plaphy.2014.07.002; Hamzehzarghani H, 2005, PHYSIOL MOL PLANT P, V66, P119, DOI 10.1016/j.pmpp.2005.05.005; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Kumaraswamy KG, 2011, J CHEM ECOL, V37, P846, DOI 10.1007/s10886-011-9989-1; Lefort N, 2013, J PHARM BIOMED ANAL, V93, P77, DOI DOI 10.1016/J.JPBA.2013.08.017; Ludwig C, 2012, METABOLOMICS, V8, P8, DOI 10.1007/s11306-011-0347-7; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Morin PJ, 2013, J PROTEOME RES, V12, P2165, DOI 10.1021/pr400026q; Paranidharan V, 2008, BOTANY, V86, P1168, DOI 10.1139/B08-052; Parsons HM, 2009, MAGN RESON CHEM, V47, pS86, DOI 10.1002/mrc.2501; Pasquet JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-629; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Scharf DH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003859; Shanker AK, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, pIX; Shelp BJ, 2012, PLANT SCI, V193, P130, DOI 10.1016/j.plantsci.2012.06.001; Shimizu M, 2010, APPL ENVIRON MICROB, V76, P1507, DOI 10.1128/AEM.02135-09; Smolinska A, 2012, ANAL CHIM ACTA, V750, P82, DOI 10.1016/j.aca.2012.05.049; Taylor NL, 2004, PLANT PHYSIOL, V134, P838, DOI 10.1104/pp.103.035675; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Walter S, 2010, NEW PHYTOL, V185, P54, DOI 10.1111/j.1469-8137.2009.03041.x; Wong JWH, 2005, ANAL CHEM, V77, P5655, DOI 10.1021/ac050619p	37	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153642	10.1371/journal.pone.0153642	http://dx.doi.org/10.1371/journal.pone.0153642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101152	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500046
J	Mamedov, T; Chichester, JA; Jones, RM; Ghosh, A; Coffin, MV; Herschbach, K; Prokhnevsky, AI; Streatfield, SJ; Yusibov, V				Mamedov, Tarlan; Chichester, Jessica A.; Jones, R. Mark; Ghosh, Ananya; Coffin, Megan V.; Herschbach, Kristina; Prokhnevsky, Alexey I.; Streatfield, Stephen J.; Yusibov, Vidadi			Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; INHALATION ANTHRAX; VACCINE; CHALLENGE; EFFICACY; IMMUNITY; RABBITS; MICE; EXPRESSION; CORRELATE	Bacillus anthracis has long been considered a potential biological warfare agent, and therefore, there is a need for a safe, low-cost and highly efficient anthrax vaccine with demonstrated long-term stability for mass vaccination in case of an emergency. Many efforts have been made towards developing an anthrax vaccine based on recombinant protective antigen (rPA) of B. anthracis, a key component of the anthrax toxin, produced using different expression systems. Plants represent a promising recombinant protein production platform due to their relatively low cost, rapid scalability and favorable safety profile. Previous studies have shown that full-length rPA produced in Nicotiana benthamiana (pp-PA83) is immunogenic and can provide full protection against lethal spore challenge; however, further improvement in the potency and stability of the vaccine candidate is necessary. PA of B. anthracis is not a glycoprotein in its native host; however, this protein contains potential N-linked glycosylation sites, which can be aberrantly glycosylated during expression in eukaryotic systems including plants. This glycosylation could affect the availability of certain key epitopes either due to masking or misfolding of the protein. Therefore, a non-glycosylated form of pp-PA83 was engineered and produced in N. benthamiana using an in vivo deglycosylation approach based on co-expression of peptide-N-glycosidase F (PNGase F) from Flavobacterium meningosepticum. For comparison, versions of pp-PA83 containing point mutations in six potential N-glycosylation sites were also engineered and expressed in N. benthamiana. The in vivo deglycosylated pp-PA83 (pp-dPA83) was shown to have in vitro activity, in contrast to glycosylated pp-PA83, and to induce significantly higher levels of toxin-neutralizing antibody responses in mice compared with glycosylated pp-PA83, in vitro deglycosylated pp-PA83 or the mutated versions of pp-PA83. These results suggest that pp-dPA83 may offer advantages in terms of dose sparing and enhanced immunogenicity as a promising candidate for a safe, effective and low-cost subunit vaccine against anthrax.	[Mamedov, Tarlan; Chichester, Jessica A.; Jones, R. Mark; Ghosh, Ananya; Coffin, Megan V.; Herschbach, Kristina; Prokhnevsky, Alexey I.; Streatfield, Stephen J.; Yusibov, Vidadi] Fraunhofer USA Ctr Mol Biotechnol, Newark, DE USA; [Mamedov, Tarlan] Akdeniz Univ, Dept Agr Biotechnol, TR-07985 Antalya, Turkey; [Ghosh, Ananya] Siemens Healthcare, 500 Gbc Dr, Newark, DE 19702 USA; [Herschbach, Kristina] Merck Millipore, Frankfurter Str 250, D-64293 Darmstadt, Germany	Akdeniz University; Siemens AG; Merck KGaA; MilliporeSigma	Mamedov, T (corresponding author), Fraunhofer USA Ctr Mol Biotechnol, Newark, DE USA.; Mamedov, T (corresponding author), Akdeniz Univ, Dept Agr Biotechnol, TR-07985 Antalya, Turkey.	tmammedov@gmail.com; Vidadi.Yusibov@fhcmb.org	Yusibov, Vidadi/AAA-7408-2019; Mammedov, Tarlan/J-3853-2013		Fraunhofer USA Center for Molecular Biotechnology	Fraunhofer USA Center for Molecular Biotechnology	This study was supported by Fraunhofer USA Center for Molecular Biotechnology.	Aziz MA, 2002, BIOCHEM BIOPH RES CO, V299, P345, DOI 10.1016/S0006-291X(02)02625-6; BRACHMAN PS, 1960, AM J HYG, V72, P6, DOI 10.1093/oxfordjournals.aje.a120135; Campbell JD, 2007, HUM VACCINES, V3, P205, DOI 10.4161/hv.3.5.4459; Chichester JA, 2007, VACCINE, V25, P3111, DOI 10.1016/j.vaccine.2007.01.068; Chichester JA, 2013, HUM VACC IMMUNOTHER, V9, P544, DOI 10.4161/hv.23233; Fellows PF, 2001, VACCINE, V19, P3241, DOI 10.1016/S0264-410X(01)00021-4; Fowler K, 1999, J APPL MICROBIOL, V87, P305, DOI 10.1046/j.1365-2672.1999.00898.x; Friedlander AM, 1999, JAMA-J AM MED ASSOC, V282, P2104, DOI 10.1001/jama.282.22.2104; Gomord V, 2004, CURR OPIN PLANT BIOL, V7, P171, DOI 10.1016/j.pbi.2004.01.015; Gorantala J, 2011, VACCINE, V29, P4521, DOI 10.1016/j.vaccine.2011.03.082; Gorse GJ, 2006, VACCINE, V24, P5950, DOI 10.1016/j.vaccine.2006.05.044; Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X; Hepler RW, 2006, VACCINE, V24, P1501, DOI 10.1016/j.vaccine.2005.10.018; Hull AK, 2005, VACCINE, V23, P2082, DOI 10.1016/j.vaccine.2005.01.013; Ivins BE, 1998, VACCINE, V16, P1141, DOI 10.1016/S0264-410X(98)80112-6; Keitel WA, 2006, EXPERT REV VACCINES, V5, P417, DOI 10.1586/14760584.5.4.417; Klimyuk V, 2014, CURR TOP MICROBIOL, V375, P127, DOI 10.1007/82_2012_212; Koya V, 2005, INFECT IMMUN, V73, P8266, DOI 10.1128/IAI.73.12.8266-8274.2005; Krenek P, 2015, BIOTECHNOL ADV, V33, P1024, DOI 10.1016/j.biotechadv.2015.03.012; Laird MW, 2004, PROTEIN EXPRES PURIF, V38, P145, DOI 10.1016/j.pep.2004.08.007; Little SF, 2006, VACCINE, V24, P2530, DOI 10.1016/j.vaccine.2005.12.028; Little SF, 2004, VACCINE, V22, P422, DOI 10.1016/j.vaccine.2003.07.004; Mamedov T, 2012, PLANT BIOTECHNOL J, V10, P773, DOI 10.1111/j.1467-7652.2012.00694.x; Mett V, 2011, HUM VACCINES, V7, P183, DOI 10.4161/hv.7.0.14586; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Musiychuk K, 2007, INFLUENZA OTHER RESP, V1, P19, DOI 10.1111/j.1750-2659.2006.00005.x; Pitt MLM, 2001, VACCINE, V19, P4768, DOI 10.1016/S0264-410X(01)00234-1; Prokhnevsky A, 2015, MOL BIOTECHNOL, V57, P101, DOI 10.1007/s12033-014-9806-5; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Schneemann A, 2009, FUTURE MICROBIOL, V4, P35, DOI 10.2217/17460913.4.1.35; Shamloul M, 2014, JOVE-J VIS EXP   APR, V86, DOI DOI 10.3791/51204; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Skoble J, 2009, INFECT IMMUN, V77, P1649, DOI 10.1128/IAI.00530-08; Thuenemann EC, 2013, CURR PHARM DESIGN, V19, P5564, DOI 10.2174/1381612811319310011; Wang Julia Y, 2005, Med Immunol, V4, P4, DOI 10.1186/1476-9433-4-4; Williamson ED, 2005, INFECT IMMUN, V73, P5978, DOI 10.1128/IAI.73.9.5978-5987.2005; Yusibov V, 2015, EXPERT REV VACCINES, V14, P519, DOI 10.1586/14760584.2015.989988; Yusibov V, 2013, CURR PHARM DESIGN, V19, P5574, DOI 10.2174/13816128113199990335; Yusibov V, 2011, HUM VACCINES, V7, P313, DOI 10.4161/hv.7.3.14207	39	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153956	10.1371/journal.pone.0153956	http://dx.doi.org/10.1371/journal.pone.0153956			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101370	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500108
J	Niu, CT; Zhu, LJ; Xu, X; Li, Q				Niu, Chengtuo; Zhu, Linjiang; Xu, Xin; Li, Qi			Rational Design of Disulfide Bonds Increases Thermostability of a Mesophilic 1,3-1,4-beta-Glucanase from Bacillus terquilensis	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; MOLECULAR-DYNAMICS; HYBRID (1-3,1-4)-BETA-GLUCANASES; CLOSTRIDIUM-THERMOCELLUM; PROTEIN THERMOSTABILITY; ALPHA-AMYLASE; STABILITY; ENZYME; BETA-1,3-1,4-GLUCANASE; STABILIZATION	1,3-1,4-beta-glucanase is an important biocatalyst in brewing industry and animal feed industry, while its low thermostability often reduces its application performance. In this study, the thermostability of a mesophilic beta-glucanase from Bacillus terquilensis was enhanced by rational design and engineering of disulfide bonds in the protein structure. Protein spatial configuration was analyzed to pre-exclude the residues pairs which negatively conflicted with the protein structure and ensure the contact of catalytic center. The changes in protein overall and local flexibility among the wild-type enzyme and the designated mutants were predicted to select the potential disulfide bonds for enhancement of thermostability. Two residue pairs (N31C-T187C and P102C-N125C) were chosen as engineering targets and both of them were proved to significantly enhance the protein thermostability. After combinational mutagenesis, the double mutant N31C-T187C/P102C-N125C showed a 48.3% increase in half-life value at 60 degrees C and a 4.1 degrees C rise in melting temperature (T-m) compared to wild-type enzyme. The catalytic property of N31C-T187C/P102C-N125C mutant was similar to that of wild-type enzyme. Interestingly, the optimal pH of double mutant was shifted from pH6.5 to pH6.0, which could also increase its industrial application. By comparison with mutants with single-Cys substitutions, the introduction of disulfide bonds and the induced new hydrogen bonds were proved to result in both local and overall rigidification and should be responsible for the improved thermostability. Therefore, the introduction of disulfide bonds for thermostability improvement could be rationally and highly-effectively designed by combination with spatial configuration analysis and molecular dynamics simulation.	[Niu, Chengtuo; Zhu, Linjiang; Xu, Xin; Li, Qi] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Li, Qi] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University	Li, Q (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China.; Li, Q (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	liqi@jiangnan.edu.cn		Zhu, Linjiang/0000-0001-7077-160X	National Science Foundation [31271919]; Fundamental Research Funds for the Central Universities [JUSRP51504, JUDCF13008, JUSRP51402A]; National High Technology Research Program of China [2013AA102106]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program of Introducing Talents of Discipline to Universities [111-2-06]	National Science Foundation(National Science Foundation (NSF)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National High Technology Research Program of China(National High Technology Research and Development Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions; Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was financially supported by the program for National Science Foundation (No. 31271919)(http://www.nsfc.gov.cn/), the Fundamental Research Funds for the Central Universities (JUSRP51504 & JUDCF13008 & JUSRP51402A)(http://yjsb.jiangnan.edu.cn/, http://www.moe.gov.cn/), the National High Technology Research Program of China (2013AA102106), the Priority Academic Program Development of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn/default.aspx), and Program of Introducing Talents of Discipline to Universities (No. 111-2-06)(http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badieyan S, 2012, BIOTECHNOL BIOENG, V109, P31, DOI 10.1002/bit.23280; Beck DAC, 2004, METHODS, V34, P112, DOI 10.1016/j.ymeth.2004.03.008; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brissos V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087209; Chaari F, 2014, PROCESS BIOCHEM, V49, P1040, DOI 10.1016/j.procbio.2014.02.023; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; Dodson G, 2006, CELL MOL LIFE SCI, V63, P207, DOI 10.1007/s00018-005-5236-7; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Eijsink VGH, 2001, BIOCATAL BIOTRANSFOR, V19, P443, DOI 10.3109/10242420108992029; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fernandes AT, 2011, J BIOL INORG CHEM, V16, P641, DOI 10.1007/s00775-011-0768-9; HAHN M, 1995, FEBS LETT, V374, P221, DOI 10.1016/0014-5793(95)01111-Q; Han ZL, 2009, APPL MICROBIOL BIOT, V85, P117, DOI 10.1007/s00253-009-2067-8; Hwa KY, 2014, APPL MICROBIOL BIOT, V98, P7825, DOI 10.1007/s00253-014-5731-6; Kumar S, 2000, J BIOMOL STRUCT DYN, P79, DOI 10.1080/07391102.2000.10506606; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu L, 2014, APPL ENVIRON MICROB, V80, P798, DOI 10.1128/AEM.03045-13; Liu YH, 2008, APPL MICROBIOL BIOT, V80, P795, DOI 10.1007/s00253-008-1580-5; Luo ZC, 2014, APPL BIOCHEM BIOTECH, V173, P562, DOI 10.1007/s12010-014-0863-9; Mansfeld J, 1997, J BIOL CHEM, V272, P11152, DOI 10.1074/jbc.272.17.11152; Michael J., 2013, BREWING; Michaux C, 2010, BIOCHIMIE, V92, P1407, DOI 10.1016/j.biochi.2010.07.003; Niu CT, 2015, J AGR FOOD CHEM, V63, P5249, DOI 10.1021/acs.jafc.5b00480; Niu CT, 2014, BIOTECHNOL LETT, V36, P2453, DOI 10.1007/s10529-014-1616-0; OLSEN O, 1991, MOL GEN GENET, V225, P177, DOI 10.1007/BF00269845; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Planas N, 2000, BBA-PROTEIN STRUCT M, V1543, P361, DOI 10.1016/S0167-4838(00)00231-4; POLITZ O, 1993, EUR J BIOCHEM, V216, P829, DOI 10.1111/j.1432-1033.1993.tb18204.x; Quang ATL, 2012, BIOTECHNOL BIOENG, V109, P867, DOI 10.1002/bit.24371; Rader AJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016002; Radestock S, 2011, PROTEINS, V79, P1089, DOI 10.1002/prot.22946; SCHIMMING S, 1991, BIOCHEM BIOPH RES CO, V177, P447, DOI 10.1016/0006-291X(91)92004-4; Siadat Omid Ranaei, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-12; Spring P, 1996, POULTRY SCI, V75, P357, DOI 10.3382/ps.0750357; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Umemoto H, 2009, BIOSCI BIOTECH BIOCH, V73, P965, DOI 10.1271/bbb.80869; Wang JJ, 2014, APPL BIOCHEM BIOTECH, V173, P826, DOI 10.1007/s12010-014-0900-8; WELFLE K, 1994, J BIOMOL STRUCT DYN, V11, P1417, DOI 10.1080/07391102.1994.10508076; WELLS JA, 1986, J BIOL CHEM, V261, P6564; WETZEL R, 1988, P NATL ACAD SCI USA, V85, P401, DOI 10.1073/pnas.85.2.401; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yin X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126864; Yu HR, 2014, BIOTECHNOL ADV, V32, P308, DOI 10.1016/j.biotechadv.2013.10.012; Zhang ZG, 2010, BIORESOURCE TECHNOL, V101, P9272, DOI 10.1016/j.biortech.2010.07.060	57	24	27	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154036	10.1371/journal.pone.0154036	http://dx.doi.org/10.1371/journal.pone.0154036			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100881	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500128
J	Rasoulzadeh, Z; Ghods, R; Kazemi, T; Mirzadegan, E; Ghaffari-Tabrizi-Wizsy, N; Rezania, S; Kazemnejad, S; Arefi, S; Ghasemi, J; Vafaei, S; Mahmoudi, AR; Zarnani, AH				Rasoulzadeh, Zahra; Ghods, Roya; Kazemi, Tohid; Mirzadegan, Ebrahim; Ghaffari-Tabrizi-Wizsy, Nassim; Rezania, Simin; Kazemnejad, Somaieh; Arefi, Soheila; Ghasemi, Jamileh; Vafaei, Sedigheh; Mahmoudi, Ahmad-Reza; Zarnani, Amir-Hassan			Placental Kisspeptins Differentially Modulate Vital Parameters of Estrogen Receptor-Positive and -Negative Breast Cancer Cells	PLOS ONE			English	Article							METASTASIS-SUPPRESSOR GENE; PROTEIN-COUPLED RECEPTOR; MONOCLONAL-ANTIBODIES; TROPHOBLAST INVASION; GROWTH-FACTOR; STEM-CELLS; EXPRESSION; KISS-1; MIGRATION; MOTILITY	Kisspeptins (KPs) are major regulators of trophoblast and cancer invasion. Thus far, limited and conflicting data are available on KP-mediated modulation of breast cancer (BC) metastasis; mostly based on synthetic KP-10, the most active fragment of KP. Here, we report for the first time comprehensive functional effects of term placental KPs on proliferation, adhesion, Matrigel invasion, motility, MMP activity and pro-inflammatory cytokine production in MDA-MB-231 (estrogen receptor-negative) and MCF-7 (estrogen receptor-positive). KPs were expressed at high level by term placental syncytiotrophoblasts and released in soluble form. Placental explant conditioned medium containing KPs (CM) significantly reduced proliferation of both cell types compared to CM without (w/o) KP (CM-w/o KP) in a dose-and time-dependent manner. In MDA-MB-231 cells, placental KPs significantly reduced adhesive properties, while increased MMP9 and MMP2 activity and stimulated invasion. Increased invasiveness of MDA-MB-231 cells after CM treatment was inhibited by KP receptor antagonist, P-234. CM significantly reduced motility of MCF-7 cells at all time points (2-30 hr), while it stimulated motility of MDA-MB-231 cells. These effects were reversed by P-234. Co-treatment with selective ER modulators, Tamoxifen and Raloxifene, inhibited the effect of CM on motility of MCF-7 cells. The level of IL-6 in supernatant of MCF-7 cells treated with CM was higher compared to those treated with CM-w/o KP. Both cell types produced more IL-8 after treatment with CM compared to those treated with CM-w/o KP. Taken together, our observations suggest that placental KPs differentially modulate vital parameters of estrogen receptor-positive and -negative BC cells possibly through modulation of pro-inflammatory cytokine production.	[Rasoulzadeh, Zahra; Kazemi, Tohid] Tabriz Univ Med Sci, Dept Immunol, Tabriz 5165683146, Iran; [Rasoulzadeh, Zahra; Kazemi, Tohid] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz 5165683146, Iran; [Ghods, Roya] Iran Univ Med Sci, Fac Adv Technol Med, Dept Mol Med, Tehran 1449614535, Iran; [Ghods, Roya] Iran Univ Med Sci, Oncopathol Res Ctr, Tehran 1449614535, Iran; [Mirzadegan, Ebrahim] ACECR, Avicenna Res Inst, Immunobiol Res Ctr, Tehran 117719615, Iran; [Ghaffari-Tabrizi-Wizsy, Nassim] Med Univ Graz, Inst Pathophysiol & Immunol, SFL Chicken CAM Lab, A-8010 Graz, Austria; [Rezania, Simin] Med Univ Graz, Inst Biophys, A-8010 Graz, Austria; [Kazemnejad, Somaieh; Arefi, Soheila] ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran 117719615, Iran; [Kazemnejad, Somaieh; Arefi, Soheila; Ghasemi, Jamileh; Vafaei, Sedigheh; Zarnani, Amir-Hassan] ACECR, Avicenna Res Inst, Nanobiotechnol Res Ctr, Tehran 117719615, Iran; [Mahmoudi, Ahmad-Reza] ACECR, Avicenna Res Inst, Monoclonal Antibody Res Ctr, Tehran 117719615, Iran; [Zarnani, Amir-Hassan] Iran Univ Med Sci, Immunol Res Ctr, Tehran 8174673461, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Iran University of Medical Sciences; Iran University of Medical Sciences; Academic Center for Education, Culture & Research (ACECR); Medical University of Graz; Medical University of Graz; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Iran University of Medical Sciences	Kazemi, T (corresponding author), Tabriz Univ Med Sci, Dept Immunol, Tabriz 5165683146, Iran.; Kazemi, T (corresponding author), Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz 5165683146, Iran.; Zarnani, AH (corresponding author), ACECR, Avicenna Res Inst, Nanobiotechnol Res Ctr, Tehran 117719615, Iran.; Zarnani, AH (corresponding author), Iran Univ Med Sci, Immunol Res Ctr, Tehran 8174673461, Iran.	tohid_kazemi@yahoo.com; zarnani@avicenna.ac.ir	Kazemi, Tohid/A-8391-2013; Kazemnejad, Somaieh/O-6577-2018; Kazemi, Tohid/AAF-2444-2019; Ghaffari-Tabrizi-Wizsy, Nassim/J-7333-2017; Kazemnejad, Somaieh/AAD-7963-2019	Kazemi, Tohid/0000-0002-8583-1270; Kazemnejad, Somaieh/0000-0003-1808-8357; Kazemi, Tohid/0000-0002-8583-1270; Ghaffari-Tabrizi-Wizsy, Nassim/0000-0001-6696-8717; 	National Elites Foundation [910112-039]	National Elites Foundation	This research work was supported by a grant (910112-039) from National Elites Foundation. URL: http://en.bmn.ir/. AHZ received the funding.; The results presented here were extracted from MSc. thesis of Mrs. Z. Rasoulzadeh. This research work was supported by a grant (910112-039) from National Elites Foundation and conducted in Avicenna Research Institute.	Arihiro K, 2000, Breast Cancer, V7, P221, DOI 10.1007/BF02967464; Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO;2-A; Chiu JJ, 1996, CLIN CANCER RES, V2, P215; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Cohen M, 2007, GYNECOL OBSTET INVES, V64, P126, DOI 10.1159/000101734; Cvetkovic D, 2013, ENDOCRINOLOGY, V154, P1999, DOI 10.1210/en.2012-2164; Delbandi AA, 2013, FERTIL STERIL, V100, P761, DOI 10.1016/j.fertnstert.2013.04.041; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; FISHER SJ, 1989, J CELL BIOL, V109, P891, DOI 10.1083/jcb.109.2.891; Freund A, 2003, ONCOGENE, V22, P256, DOI 10.1038/sj.onc.1206113; Galien R, 1997, NUCLEIC ACIDS RES, V25, P2424, DOI 10.1093/nar/25.12.2424; Ghods R, 2014, BIOTECHNOL APPL BIOC, V61, P363, DOI 10.1002/bab.1177; Harms JF, 2003, CLIN EXP METASTAS, V20, P11, DOI 10.1023/A:1022530100931; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Ji K, 2013, INT J MOL MED, V32, P747, DOI 10.3892/ijmm.2013.1472; Kostadima L, 2007, ANTICANCER RES, V27, P2499; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Le Bellego F, 2009, ISOLATION CULTURE TE, P73; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; LIPPMAN M, 1976, CANCER RES, V36, P4595; Makri A, 2008, CANCER TREAT REV, V34, P682, DOI 10.1016/j.ctrv.2008.05.007; Marot D, 2007, ENDOCR-RELAT CANCER, V14, P691, DOI 10.1677/ERC-07-0012; Martin TA, 2005, CLIN EXP METASTAS, V22, P503, DOI 10.1007/s10585-005-4180-0; Mooez S, 2011, ASIAN PAC J CANCER P, V12, P2785; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; Nikoo S, 2014, MOL HUM REPROD, V20, P905, DOI 10.1093/molehr/gau044; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Olbrich T, 2010, GYNECOL ONCOL, V119, P571, DOI 10.1016/j.ygyno.2010.08.018; PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Rahimi M, 2014, J BIOMATER APPL, V29, P199, DOI 10.1177/0885328213519835; Rajah TT, 2012, ANTICANCER RES, V32, P1181; Rama S, 2004, MOL CELL ENDOCRINOL, V218, P79, DOI 10.1016/j.mce.2003.12.016; Rashidi Nesa, 2015, J Reprod Infertil, V16, P72; Rezania S, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-54; Rochefort H, 1998, J STEROID BIOCHEM, V65, P163, DOI 10.1016/S0960-0760(98)00010-7; Roy SS, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/654698; Shochet GE, 2015, BREAST CANCER RES TR, V149, P645, DOI 10.1007/s10549-015-3266-x; Shochet GE, 2012, HUM REPROD, V27, P73, DOI 10.1093/humrep/der365; Shojaeian S, 2010, IMMUNOL INVEST, V39, P114, DOI 10.3109/08820130903496785; Sitras V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033294; Taylor AP, 2010, BRIT J CANCER, V103, P82, DOI 10.1038/sj.bjc.6605746; Xie F, 2012, SENSORS-BASEL, V12, P9936, DOI 10.3390/s120709936; Zajac M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021599; Ziegler E, 2013, ONCOL REP, V29, P549, DOI 10.3892/or.2012.2135	49	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153684	10.1371/journal.pone.0153684	http://dx.doi.org/10.1371/journal.pone.0153684			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101408	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500048
J	Wei, M; Zhao, X; Liu, M; Niu, MJ; Seif, E; Kleiman, L				Wei, Min; Zhao, Xia; Liu, Mi; Niu, Meijuan; Seif, Elias; Kleiman, Lawrence			Export of Precursor tRNA(Ile) from the Nucleus to the Cytoplasm in Human Cells	PLOS ONE			English	Article							TRANSFER-RNA; IDENTIFICATION; TRANSCRIPTION; TRNA(LYS3); IMPORT	In the current concept, tRNA maturation in vertebrate cells, including splicing of introns, trimming of 5' leader and 3' trailer, and adding of CCA, is thought to occur exclusively in the nucleus. Here we provide evidence to challenge this concept. Unspliced intron-containing precursor tRNAIle was identified in Human Immunodeficiency Virus type 1 (HIV-1) virions, which are synthesized in the cytoplasm. Northern blot, confocal microscopy and quantitative RT-PCR further verified enrichment of this unspliced tRNAIle within the cytoplasm in human cells. In addition to containing an intron, the cytoplasmic precursor tRNAIle also contains a short incompletely processed 5' leader and a 3' trailer, which abundance is around 1000 fold higher than the nuclear precursor tRNAIle with long 5' leader and long 3' trailer. In vitro data also suggest that the cytoplasmic unspliced end-immature precursor tRNAIle could be processed by short isoform of RNase Z, but not long isoform of RNase Z. These data suggest that precursor tRNAs could export from the nucleus to the cytoplasm in human cells, instead of be processed only in the nucleus.	[Wei, Min] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Wei, Min; Zhao, Xia; Niu, Meijuan; Seif, Elias; Kleiman, Lawrence] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3A 2T5, Canada; [Liu, Mi] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Nankai University; Lady Davis Institute; McGill University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wei, M (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.; Wei, M (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3A 2T5, Canada.	weimin@nankai.edu.cn			Canadian Institutes of Health Research (CIHR) [HOP 81389]; Nankai University [ZB15006101]; National Natural Science Foundation of China [81571991]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Nankai University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the Canadian Institutes of Health Research (CIHR, HOP 81389 to L.K.), Nankai University starting fund (ZB15006101 to M. W.), and National Natural Science Foundation of China (81571991 to M. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Eckwahl MJ, 2015, GENE DEV, V29, P646, DOI 10.1101/gad.258731.115; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Hopper AK, 2008, TRENDS CELL BIOL, V18, P98, DOI 10.1016/j.tcb.2008.01.001; Hopper AK, 2013, GENETICS, V194, P43, DOI 10.1534/genetics.112.147470; Hopper AK, 2010, FEBS LETT, V584, P310, DOI 10.1016/j.febslet.2009.11.053; JIANG M, 1993, J VIROL, V67, P3246, DOI 10.1128/JVI.67.6.3246-3253.1993; Kleiman L, 2004, CURR HIV RES, V2, P163, DOI 10.2174/1570162043484988; Kleiman L, 2002, IUBMB LIFE, V53, P107, DOI 10.1080/15216540211469; Kramer EB, 2013, P NATL ACAD SCI USA, V110, P21042, DOI 10.1073/pnas.1316579110; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Nashimoto M, 1999, NUCLEIC ACIDS RES, V27, P2770, DOI 10.1093/nar/27.13.2770; Negri ED, 1997, CELL, V89, P859, DOI 10.1016/S0092-8674(00)80271-8; Ohira T, 2011, P NATL ACAD SCI USA, V108, P10502, DOI 10.1073/pnas.1105645108; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Rossmanith W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019152; Schiffer SP, 2002, COMPARATIVE MED, V52, P305; Shaheen HH, 2005, P NATL ACAD SCI USA, V102, P11290, DOI 10.1073/pnas.0503836102; Takahashi M, 2008, FEBS LETT, V582, P2532, DOI 10.1016/j.febslet.2008.06.020; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Takano A, 2005, SCIENCE, V309, P140, DOI 10.1126/science.1113346; Wei M, 2005, J VIROL, V79, P9081, DOI 10.1128/JVI.79.14.9081-9087.2005; Xing L, 2011, J VIROL, V85, P1847, DOI 10.1128/JVI.02010-10; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757	28	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154044	10.1371/journal.pone.0154044	http://dx.doi.org/10.1371/journal.pone.0154044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101286	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500131
J	Peter, B; Wijsman, EM; Nato, AQ; Matsushita, MM; Chapman, KL; Stanaway, IB; Wolff, J; Oda, K; Gabo, VB; Raskind, WH				Peter, Beate; Wijsman, Ellen M.; Nato, Alejandro Q., Jr.; Matsushita, Mark M.; Chapman, Kathy L.; Stanaway, Ian B.; Wolff, John; Oda, Kaori; Gabo, Virginia B.; Raskind, Wendy H.		University Washington Ctr	Genetic Candidate Variants in Two Multigenerational Families with Childhood Apraxia of Speech	PLOS ONE			English	Article							RECOGNIZED MICRODELETION SYNDROME; AUTISM SPECTRUM DISORDER; COMPARATIVE GENOMIC HYBRIDIZATION; NUMBER VARIATION DETECTION; SOUND DISORDERS; LINKAGE ANALYSIS; LANGUAGE IMPAIRMENT; EXOME SEQUENCE; LARGE PEDIGREE; CHILDREN	Childhood apraxia of speech (CAS) is a severe and socially debilitating form of speech sound disorder with suspected genetic involvement, but the genetic etiology is not yet well understood. Very few known or putative causal genes have been identified to date, e.g., FOXP2 and BCL11A. Building a knowledge base of the genetic etiology of CAS will make it possible to identify infants at genetic risk and motivate the development of effective very early intervention programs. We investigated the genetic etiology of CAS in two large multi-generational families with familial CAS. Complementary genomic methods included Markov chain Monte Carlo linkage analysis, copy-number analysis, identity-by-descent sharing, and exome sequencing with variant filtering. No overlaps in regions with positive evidence of linkage between the two families were found. In one family, linkage analysis detected two chromosomal regions of interest, 5p15.1-p14.1, and 17p13.1-q11.1, inherited separately from the two founders. Single-point linkage analysis of selected variants identified CDH18 as a primary gene of interest and additionally, MYO10, NIPBL, GLP2R, NCOR1, FLCN, SMCR8, NEK8, and ANKRD12, possibly with additive effects. Linkage analysis in the second family detected five regions with LOD scores approaching the highest values possible in the family. A gene of interest was C4orf21 (ZGRF1) on 4q25-q28.2. Evidence for previously described causal copy-number variations and validated or suspected genes was not found. Results are consistent with a heterogeneous CAS etiology, as is expected in many neurogenic disorders. Future studies will investigate genome variants in these and other families with CAS.	[Peter, Beate] Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85287 USA; [Peter, Beate] St Louis Univ, Dept Commun Sci & Disorders, St Louis, MO 63103 USA; [Peter, Beate] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Wijsman, Ellen M.; Nato, Alejandro Q., Jr.; Matsushita, Mark M.; Wolff, John; Oda, Kaori; Gabo, Virginia B.; Raskind, Wendy H.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Wijsman, Ellen M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Chapman, Kathy L.] Univ Utah, Dept Commun Sci & Disorders, Salt Lake City, UT USA; [Stanaway, Ian B.] Univ Washington, Dept Environm & Occupat Hlth, Environm Toxicol, Seattle, WA 98195 USA; [Raskind, Wendy H.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Arizona State University; Arizona State University-Tempe; Saint Louis University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Peter, B (corresponding author), Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85287 USA.; Peter, B (corresponding author), St Louis Univ, Dept Commun Sci & Disorders, St Louis, MO 63103 USA.; Peter, B (corresponding author), Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA.	Beate.Peter@asu.edu	Nato, Alejandro Q/D-9276-2012	Nato, Alejandro Q/0000-0002-8745-9046; Blue, Elizabeth/0000-0002-0633-0305; Peter, Beate/0000-0002-9083-8522	American Speech Language-Hearing Foundation New Century Scholars Research Grant; NIDCD [T32DC00033, R03DC010886, R01HD054562, R01MH094293]; National Human Genome Research Institute; NIH [1U54HG006493]; Environmental Health Sciences of the National Institutes of Health [T32ES015459, 5P01 ES009601]; EPA [RD-83451401]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054562] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, R25HG007153, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009601, T32ES015459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000033, R03DC010886] Funding Source: NIH RePORTER	American Speech Language-Hearing Foundation New Century Scholars Research Grant; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Environmental Health Sciences of the National Institutes of Health; EPA(United States Environmental Protection Agency); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The following funding sources are gratefully acknowledged: American Speech Language-Hearing Foundation New Century Scholars Research Grant (B. Peter), NIDCD T32DC00033 (B. Peter), NIDCD R03DC010886 (B. Peter), R01HD054562 (W. H. Raskind), and R01MH094293 (E. Wijsman). SNP genotyping and exome sequencing were provided by the University of Washington Center for Mendelian Genomics (UW CMG) and was funded by the National Human Genome Research Institute and NIH grant 1U54HG006493 to the three UW CMG members, Drs. M. Bamshad, D. Nickerson and J. Shendure. I. Stanaway was supported under grants from the Environmental Health Sciences of the National Institutes of Health (T32ES015459 and 5P01 ES009601) and the EPA (RD-83451401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; BALSAMO J, 1995, J CELL BIOL, V129, P1391, DOI 10.1083/jcb.129.5.1391; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Button L, 2013, CLIN LINGUIST PHONET, V27, P192, DOI 10.3109/02699206.2012.744097; Can DD, 2013, BRAIN LANG, V124, P34, DOI 10.1016/j.bandl.2012.10.007; Chabchoub E, 2008, J MED GENET, V45, P189, DOI 10.1136/jmg.2007.056176; Chapman NH, 2015, HUM GENET, V134, P1055, DOI 10.1007/s00439-015-1585-y; Coin LJM, 2010, NAT METHODS, V7, P541, DOI [10.1038/NMETH.1466, 10.1038/nmeth.1466]; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; Crowe Hall B.J., 1991, LANG SPEECH HEAR SER, V22, P334, DOI DOI 10.1044/0161-1461.2201.334; Dawson J. I., 2001, STRUCTURED PHOTOGRAP; De Leeuw N, 2008, J MED GENET, V45, P122, DOI 10.1136/jmg.2007.054049; Dollaghan C, 1998, J SPEECH LANG HEAR R, V41, P1136, DOI 10.1044/jslhr.4105.1136; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; ELSAS LJ, 1995, EUR J PEDIATR, V154, pS21, DOI 10.1007/BF02143798; Felix TM, 2010, AM J MED GENET A, V152A, P2604, DOI 10.1002/ajmg.a.33612; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fisher SE, 2003, ANNU REV NEUROSCI, V26, P57, DOI 10.1146/annurev.neuro.26.041002.131144; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; FLETCHER SG, 1972, J SPEECH HEAR RES, V15, P763, DOI 10.1044/jshr.1504.763; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Frank V, 2013, HUM MOL GENET, V22, P2177, DOI 10.1093/hmg/ddt070; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hancarova M, 2013, AM J MED GENET A, V161A, P865, DOI 10.1002/ajmg.a.35783; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Kim S, 2012, GENET EPIDEMIOL, V36, P488, DOI 10.1002/gepi.21643; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kleensang A, 2010, HUM HERED, V69, P202, DOI 10.1159/000289596; Konig IR, 2011, AM J MED GENET B, V156B, P36, DOI 10.1002/ajmg.b.31135; Korvatska O, 2015, JAMA NEUROL, V72, P920, DOI 10.1001/jamaneurol.2015.0979; Korvatska O, 2013, HUM MOL GENET, V22, P3259, DOI 10.1093/hmg/ddt180; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Laffin JJS, 2012, GENET MED, V14, P928, DOI 10.1038/gim.2012.72; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lewis BA, 2006, J COMMUN DISORD, V39, P139, DOI 10.1016/j.jcomdis.2005.11.003; Lewis BA, 2004, LANG SPEECH HEAR SER, V35, P122, DOI 10.1044/0161-1461(2004/014); Liang JS, 2009, J MED GENET, V46, P645, DOI 10.1136/jmg.2008.059220; Liegeois F, 2011, EUR J PAEDIATR NEURO, V15, P283, DOI 10.1016/j.ejpn.2011.04.006; Liu KC, 2012, MOL BIOL CELL, V23, P1675, DOI 10.1091/mbc.E11-04-0358; Lousada M, 2014, INT J LANG COMM DIS, V49, P584, DOI 10.1111/1460-6984.12095; Marchani EE, 2012, HUM HERED, V74, P153, DOI 10.1159/000346560; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Morris CA, 2015, AM J MED GENET A, V167, P2916, DOI 10.1002/ajmg.a.37340; MORTON NE, 1955, AM J HUM GENET, V7, P277; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Murray E, 2014, AM J SPEECH-LANG PAT, V23, P486, DOI 10.1044/2014_AJSLP-13-0035; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; Namasivayam AK, 2015, INT J LANG COMM DIS, V50, P529, DOI 10.1111/1460-6984.12154; Nathan L, 2004, BRIT J EDUC PSYCHOL, V74, P173, DOI 10.1348/000709904773839824; Nato AQ, 2015, BIOINFORMATICS, V31, P3790, DOI 10.1093/bioinformatics/btv444; Newbury DF, 2013, EUR J HUM GENET, V21, P361, DOI 10.1038/ejhg.2012.166; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Pal DK, 2010, GENES BRAIN BEHAV, V9, P1004, DOI 10.1111/j.1601-183X.2010.00648.x; Peter B, 2014, AM J MED GENET A, V164, P2091, DOI 10.1002/ajmg.a.36599; Peter B, 2013, CLIN LINGUIST PHONET, V27, P163, DOI 10.3109/02699206.2012.736011; Peter B, 2012, PSYCHIAT GENET, V22, P226, DOI 10.1097/YPG.0b013e328353ae92; Peter B, 2011, TOP LANG DISORD, V31, P145, DOI 10.1097/TLD.0b013e318217b855; Peter B, 2011, J NEURODEV DISORD, V3, P39, DOI 10.1007/s11689-010-9065-0; Piccione M, 2012, EUR J MED GENET, V55, P238, DOI 10.1016/j.ejmg.2012.01.014; Pliatsikas C, 2014, CEREBELLUM, V13, P55, DOI 10.1007/s12311-013-0515-6; Pourcain BS, 2010, AM J PSYCHIAT, V167, P1364, DOI 10.1176/appi.ajp.2010.09121789; Prontera P, 2011, AM J MED GENET A, V155A, P2473, DOI 10.1002/ajmg.a.33875; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raca G, 2013, EUR J HUM GENET, V21, P455, DOI 10.1038/ejhg.2012.165; Rajcan-Separovic E, 2007, J MED GENET, V44, P269, DOI 10.1136/jmg.2006.045013; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; ROBBINS J, 1987, J SPEECH HEAR DISORD, V52, P271, DOI 10.1044/jshd.5203.271; Shibata T, 1997, J BIOL CHEM, V272, P5236, DOI 10.1074/jbc.272.8.5236; Shriberg LD, 2011, J SPEECH LANG HEAR R, V54, P487, DOI 10.1044/1092-4388(2010/10-0068); Shriberg LD, 2009, J SPEECH LANG HEAR R, V52, P1189, DOI 10.1044/1092-4388(2009/08-0047); Shriberg LD, 2005, J SPEECH LANG HEAR R, V48, P834, DOI 10.1044/1092-4388(2005/058); Shriberg LD, 1997, J SPEECH LANG HEAR R, V40, P273, DOI 10.1044/jslhr.4002.273; Sices L, 2007, J DEV BEHAV PEDIATR, V28, P438, DOI 10.1097/DBP.0b013e31811ff8ca; Thevenon J, 2013, EUR J HUM GENET, V21, P82, DOI 10.1038/ejhg.2012.116; THOMPSON EA, 1993, GENET EPIDEMIOL, V10, P677, DOI 10.1002/gepi.1370100658; Thompson E, 2011, HUM HERED, V71, P86, DOI 10.1159/000313555; Tierney C, 2015, J DEV BEHAV PEDIATR, V36, P569, DOI 10.1097/DBP.0000000000000189; Tong LP, 2008, HUM HERED, V65, P142, DOI 10.1159/000109731; Torgesen J.K., 1999, TOWRE TEST WORD READ; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Velleman Shelley L, 2011, Perspect Lang Learn Educ, V18, P108; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vick JC, 2014, J SPEECH LANG HEAR R, V57, P2033, DOI 10.1044/2014_JSLHR-S-12-0193; Wagner RK, 1999, COMPREHENSIVE TEST O; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Wechsler D., 2002, WECHSLER INDIVIDUAL; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Wiig E., 1992, CLIN EVALUATION LANG; Wolf M, 2004, TEST OF RAPID AUTOMA; Woodcock R, 2001, WOODCOCK JOHNSON TES; Woodcock R.W., 2011, WOODCOCK READING MAS; Worthey EA, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-29; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036988; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Ziegler A, 2010, STAT APPROACH GENETI, Vxxiv	111	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153864	10.1371/journal.pone.0153864	http://dx.doi.org/10.1371/journal.pone.0153864			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120335	Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200038
J	Shah, A; Eikmanns, BJ				Shah, Adnan; Eikmanns, Bernhard J.			Transcriptional Regulation of the beta-Type Carbonic Anhydrase Gene bca by RamA in Corynebacterium glutamicum	PLOS ONE			English	Article							L-VALINE; RIBOSOMAL RECRUITMENT; ACETATE METABOLISM; RALSTONIA-EUTROPHA; ESCHERICHIA-COLI; L-LYSINE; EXPRESSION; GROWTH; INSIGHTS; ETHANOL	Carbonic anhydrase catalyzes the reversible hydration of carbon dioxide to bicarbonate and maintains the balance of CO2/HCO3- in the intracellular environment, specifically for carboxylation/decarboxylation reactions. In Corynebacterium glutamicum, two putative genes, namely the bca (cg2954) and gca (cg0155) genes, coding for beta-type and gamma-type carbonic anhydrase, respectively, have been identified. We here analyze the transcriptional organization of these genes. The transcriptional start site (TSS) of the bca gene was shown to be the first nucleotide "A" of its putative translational start codon (ATG) and thus, bca codes for a leaderless transcript. The TSS of the gca gene was identified as an "A" residue located at position -20 relative to the first nucleotide of the annotated translational start codon of the cg0154 gene, which is located immediately upstream of gca. Comparative expression analysis revealed carbon source-dependent regulation of the bca gene, with 1.5- to 2-fold lower promoter activity in cells grown on acetate as compared to glucose as sole carbon source. Based on higher expression of bca in a mutant deficient of the regulator of acetate metabolism RamA as compared to the wild-type of C. glutamicum and based on the binding of His-tagged RamA protein to the bca promoter region, we here present evidence that RamA negatively regulates expression of bca in C. glutamicum. Functional characterization of a gca deletion mutant of C. glutamicum revealed the same growth characteristics of C. glutamicum Delta gca as that of wild-type C. glutamicum and no effect on expression of the bca gene.	[Shah, Adnan; Eikmanns, Bernhard J.] Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany	Ulm University	Eikmanns, BJ (corresponding author), Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany.	bernhard.eikmanns@uni-ulm.de		Eikmanns, Bernhard/0000-0002-3069-431X	German Academic Exchange Service (DAAD); Higher Education Commission (HEC) Pakistan	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan)	AS obtained a scholarship grant by German Academic Exchange Service (DAAD) and Higher Education Commission (HEC) Pakistan.	Arndt A, 2008, J MOL MICROB BIOTECH, V15, P222, DOI 10.1159/000107370; Auchter M, 2011, J BIOTECHNOL, V154, P126, DOI 10.1016/j.jbiotec.2010.07.001; Auchter M, 2011, J BIOTECHNOL, V152, P77, DOI 10.1016/j.jbiotec.2011.02.003; Blombach B, 2008, APPL MICROBIOL BIOT, V79, P471, DOI 10.1007/s00253-008-1444-z; Blombach B, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00108; Blombach B, 2013, J BIOTECHNOL, V168, P331, DOI 10.1016/j.jbiotec.2013.10.005; Blombach B, 2011, APPL ENVIRON MICROB, V77, P3300, DOI 10.1128/AEM.02972-10; Blombach B, 2009, APPL ENVIRON MICROB, V75, P419, DOI 10.1128/AEM.01844-08; Bott M., 2012, MICROBIOLOGY MONOGRA, P281; Buchholz J, 2013, APPL ENVIRON MICROB, V79, P5566, DOI 10.1128/AEM.01741-13; Buckle-Vallant V, 2014, APPL MICROBIOL BIOT, V98, P297, DOI 10.1007/s00253-013-5310-2; Burghout P, 2010, J BACTERIOL, V192, P4054, DOI 10.1128/JB.00151-10; Cheng YS, 2013, BIOTECHNOL LETT, V35, P735, DOI 10.1007/s10529-013-1138-1; Cottier F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002485; Cramer A, 2006, J BACTERIOL, V188, P2554, DOI 10.1128/JB.188.7.2554-2567.2006; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Eggeling L, 2015, APPL MICROBIOL BIOT, V99, P3387, DOI 10.1007/s00253-015-6508-2; Eikmanns BJ, 2015, CORYNEBACTERIUM GLUTAMICUM: FROM SYSTEMS BIOLOGY TO BIOTECHNOLOGICAL APPLICATIONS, P111; Eikmanns BJ, 2014, BIOPROCESSING OF RENEWABLE RESOURCES TO COMMODITY BIOPRODUCTS, P327; EIKMANNS BJ, 1991, APPL MICROBIOL BIOT, V34, P617, DOI 10.1007/BF00167910; Emmett DH, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI DOI 10.1006/MPEV.1996.0006; Follonier S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-30; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gai CS, 2014, AMB EXPRESS, V4, DOI 10.1186/2191-0855-4-2; Gerstmeir R, 2004, J BACTERIOL, V186, P2798, DOI 10.1128/JB.186.9.2798-2809.2004; Gotz R, 1999, YEAST, V15, P855, DOI 10.1002/(SICI)1097-0061(199907)15:10A<855::AID-YEA425>3.0.CO;2-C; Green MR, 2012, MOL CLONING LAB MANU, V1; Grill S, 2001, FEBS LETT, V495, P167, DOI 10.1016/S0014-5793(01)02378-X; GUILLOTON MB, 1993, J BACTERIOL, V175, P1443, DOI 10.1128/JB.175.5.1443-1451.1993; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hasegawa S, 2013, APPL ENVIRON MICROB, V79, P1250, DOI 10.1128/AEM.02806-12; Heider SAE, 2015, BIOTECHNOL J, V10, P1170, DOI 10.1002/biot.201400590; Heider SAE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-198; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huser AT, 2005, APPL ENVIRON MICROB, V71, P3255, DOI 10.1128/AEM.71.6.3255-3268.2005; Inui M, 2004, J MOL MICROB BIOTECH, V8, P243, DOI 10.1159/000086705; Jensen JVK, 2015, J BIOTECHNOL, V214, P85, DOI 10.1016/j.jbiotec.2015.09.017; Jo SJ, 2006, J BIOSCI BIOENG, V102, P233, DOI 10.1263/jbb.102.233; Jojima T, 2015, APPL MICROBIOL BIOT, V99, P1165, DOI 10.1007/s00253-014-6223-4; Kaldenhoff R, 2014, BBA-GEN SUBJECTS, V1840, P1592, DOI 10.1016/j.bbagen.2013.09.037; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kaur S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-184; Kaur S, 2009, FEMS MICROBIOL LETT, V299, P149, DOI 10.1111/j.1574-6968.2009.01736.x; Kern D.M., 1960, J CHEM EDUC, V37, P14, DOI [10.1021/ed037p14, DOI 10.1021/ED037P14]; Kind S, 2011, APPL MICROBIOL BIOT, V91, P1287, DOI 10.1007/s00253-011-3457-2; Kinoshita S., 1957, J GEN APPL MICROBIOL, V3, P193, DOI [10.2323/jgam.3.193, DOI 10.2323/JGAM.3.193]; Krause FS, 2010, APPL ENVIRON MICROB, V76, P8053, DOI 10.1128/AEM.01710-10; Kulis-Horn RK, 2014, MICROB BIOTECHNOL, V7, P5, DOI 10.1111/1751-7915.12055; Kumar RSS, 2013, J BACTERIOL, V195, P2262, DOI 10.1128/JB.02288-12; Kusian B, 2002, J BACTERIOL, V184, P5018, DOI 10.1128/JB.184.18.5018-5026.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liebl W, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P796, DOI 10.1007/0-387-30743-5_30; Litsanov B, 2012, MICROB BIOTECHNOL, V5, P116, DOI [10.1111/j.1751-7915.2011.00310.x, 10.1111/j.1751-7915.2012.00347.x]; Lotlikar SR, 2013, MICROBIOL-SGM, V159, P1748, DOI 10.1099/mic.0.066357-0; Merlin C, 2003, J BACTERIOL, V185, P6415, DOI 10.1128/JB.185.21.6415-6424.2003; Mimitsuka T, 2007, BIOSCI BIOTECH BIOCH, V71, P2130, DOI 10.1271/bbb.60699; Mitsuhashi S, 2004, APPL MICROBIOL BIOT, V63, P592, DOI 10.1007/s00253-003-1402-8; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nguyen AQD, 2015, METABOLITES, V5, P211, DOI 10.3390/metabo5020211; Nishimori I, 2008, CURR PHARM DESIGN, V14, P622, DOI 10.2174/138161208783877875; Okino S, 2008, APPL MICROBIOL BIOT, V81, P459, DOI 10.1007/s00253-008-1668-y; Oldiges M, 2014, APPL MICROBIOL BIOT, V98, P5859, DOI 10.1007/s00253-014-5782-8; Park SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5618; Patek M, 2003, J BIOTECHNOL, V104, P311, DOI 10.1016/S0168-1656(03)00155-X; Peters-Wendisch PG, 1998, MICROBIOL-UK, V144, P915, DOI 10.1099/00221287-144-4-915; Pfeifer-Sancar K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-888; Rowlett RS, 2010, BBA-PROTEINS PROTEOM, V1804, P362, DOI 10.1016/j.bbapap.2009.08.002; Ruckert C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-483; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schneider J, 2011, APPL MICROBIOL BIOT, V91, P17, DOI 10.1007/s00253-011-3252-0; Schneider J, 2010, APPL MICROBIOL BIOT, V88, P859, DOI 10.1007/s00253-010-2778-x; Siebert D, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0269-0; Smith KS, 1999, P NATL ACAD SCI USA, V96, P15184, DOI 10.1073/pnas.96.26.15184; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; Song YY, 2012, APPL MICROBIOL BIOT, V93, P1917, DOI 10.1007/s00253-011-3718-0; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Supuran CT, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00034; Takors R, 2007, J BIOTECHNOL, V129, P181, DOI 10.1016/j.jbiotec.2007.01.031; TASHIAN RE, 1989, BIOESSAYS, V10, P186, DOI 10.1002/bies.950100603; Teramoto H, 2011, J BIOTECHNOL, V154, P114, DOI 10.1016/j.jbiotec.2011.01.016; Toyoda K, 2016, APPL MICROBIOL BIOT, V100, P45, DOI 10.1007/s00253-015-7074-3; Toyoda K, 2013, J BACTERIOL, V195, P1718, DOI 10.1128/JB.00016-13; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200; Ueda Kenji, 2012, Int J Evol Biol, V2012, P324549, DOI 10.1155/2012/324549; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Vasicova P, 1998, BIOTECHNOL TECH, V12, P743, DOI 10.1023/A:1008827609914; Vertes AA, 2012, ANNU REV MICROBIOL, V66, P521, DOI 10.1146/annurev-micro-010312-105506; Vogt M, 2015, MICROB BIOTECHNOL, V8, P351, DOI 10.1111/1751-7915.12237; Wendisch VF, 2000, J BACTERIOL, V182, P3088, DOI 10.1128/JB.182.11.3088-3096.2000; Wendisch VF, 2015, J BIOTECHNOL, V201, P1, DOI 10.1016/j.jbiotec.2015.02.010; Wieschalka S, 2013, MICROB BIOTECHNOL, V6, P87, DOI 10.1111/1751-7915.12013; Yamamoto S, 2013, BIOTECHNOL BIOENG, V110, P2938, DOI 10.1002/bit.24961; Youn JW, 2008, J BACTERIOL, V190, P6458, DOI 10.1128/JB.00780-08; Zimmerman SA, 2008, CURR PHARM DESIGN, V14, P716, DOI 10.2174/138161208783877929	95	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154382	10.1371/journal.pone.0154382	http://dx.doi.org/10.1371/journal.pone.0154382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119954	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200065
J	Barth, S; Haas, JP; Schlichtiger, J; Molz, J; Bisdorff, B; Michels, H; Hugle, B; Radon, K				Barth, Swaantje; Haas, Johannes-Peter; Schlichtiger, Jenny; Molz, Johannes; Bisdorff, Betty; Michels, Hartmut; Huegle, Boris; Radon, Katja			Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PEDIATRIC RHEUMATOLOGY; EQ-5D QUESTIONNAIRE; FOLLOW-UP; PREDICTORS; CHILDREN; ADULTS; PREVALENCE; MANAGEMENT; OUTCOMES	Objective Aims of the study were to investigate health-related quality of life (HRQOL) in adult patients with former diagnosis of Juvenile Idiopathic Arthritis (JIA), to compare their HRQOL with the general population and to identify factors related to a poor outcome. Methods In 2012, a cross-sectional survey was performed by mailing a questionnaire to a large cohort of former and current patients of the German Centre for Rheumatology in Children and Adolescents. Only adult patients (>= 18 years) with a diagnosis compatible with JIA were included (n = 2592; response 66%). The questionnaire included information about HRQOL (EQ5D), disease-related questions and socio-demographics. Prevalence and 95% confidence intervals (CI) of problems with mobility, self-care, usual activities, pain and anxiety/depression were standardized to the German general population. Factors associated with low HRQOL in JIA patients were identified using logistic regression models. Results Sixty-two percent of the study population was female; age range was 18-73 years. In all dimensions, JIA patients reported statistically significantly more problems than the general population with largest differences in the pain dimension (JIA patients 56%; 95% CI 55-58%; general population 28%; 26-29%) and the anxiety/ depression dimension (28%; 27-29% vs. 4%; 4-5%). Lower HRQOL in JIA patients was associated with female sex, older age, lower level of education, still being under rheumatic treatment and disability. Conclusions HRQOL in adult JIA patients is considerably lower than in the general population. As this cohort includes historic patients the new therapeutic schemes available today are expected to improve HRQOL in future.	[Barth, Swaantje; Schlichtiger, Jenny; Molz, Johannes; Bisdorff, Betty; Radon, Katja] Univ Hosp Munich LMU, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Haas, Johannes-Peter; Michels, Hartmut; Huegle, Boris] German Ctr Rheumatol Children & Adolescents, Garmisch Partenkirchen, Germany	University of Munich	Barth, S (corresponding author), Univ Hosp Munich LMU, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany.	sekretariat-radon@uni-muenchen.de	Hügle, Boris/AAN-3064-2020		Verein Hilfe fur das rheumakranke Kind	Verein Hilfe fur das rheumakranke Kind	The "Verein Hilfe fur das rheumakranke Kind" has provided financial support for this study (http://www.kinderrheuma.info/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison, 2001, LOGISTIC REGRESSION; Amine B, 2009, RHEUMATOL INT, V29, P275, DOI 10.1007/s00296-008-0672-y; Arkela-Kautiainen M, 2005, ANN RHEUM DIS, V64, P875, DOI 10.1136/ard.2004.026591; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brunner HI, 2004, ARTHRIT RHEUM-ARTHR, V51, P763, DOI 10.1002/art.20689; Brunner HI, 2003, CURR OPIN RHEUMATOL, V15, P602, DOI 10.1097/00002281-200309000-00014; Claes C, 1999, P 15 PLEN M EUROQOL, P13; Dannecker G, 2014, PADIATRISCHE RHEUMAT; Davidson J, 2000, EUR J RADIOL, V33, P128, DOI 10.1016/S0720-048X(99)00161-8; Dueckers G, 2011, KLIN PADIATR, V223, P386, DOI 10.1055/s-0031-1287837; Duffy CM, 2005, ARTHRITIS RHEUM-US, V52, P382, DOI 10.1002/art.20815; EULAR, 1977, EULAR B, V4; Flato B, 2003, J RHEUMATOL, V30, P386; Foster HE, 2003, ARTHRITIS RHEUM-US, V48, P767, DOI 10.1002/art.10863; Greiner W, 2005, Eur J Health Econ, V6, P124, DOI 10.1007/s10198-004-0264-z; Gutierrez-Suarez R, 2007, RHEUMATOLOGY, V46, P314, DOI 10.1093/rheumatology/kel218; Haverman L, 2012, ARTHRIT CARE RES, V64, P694, DOI 10.1002/acr.21609; Hinz A, 2006, PSYCHOTHER PSYCH MED, V56, P42, DOI 10.1055/s-2005-867061; Hugle B, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-3; Hurst NP, 1997, BRIT J RHEUMATOL, V36, P551; Ilowite NT, 2002, PEDIATRICS, V109, P109, DOI 10.1542/peds.109.1.109; J.-Matthias Graf von der Schulenburg CC, 1998, Z GESUNDHEITSWESEN; Konig HH, 2009, MED CARE, V47, P255, DOI 10.1097/MLR.0b013e318184759e; Krumpey-Langkammerer M, 2001, J RHEUMATOL, V28, P2544; Manners PJ, 2002, J RHEUMATOL, V29, P1520; Marra CA, 2005, SOC SCI MED, V60, P1571, DOI 10.1016/j.socscimed.2004.08.034; Minden K, 2002, ARTHRITIS RHEUM-US, V46, P2392, DOI 10.1002/art.10444; Minden K, 2000, J RHEUMATOL, V27, P2256; Moock J, 2008, PHYS MED REHAB KUROR, V18, P245, DOI 10.1055/s-0028-1082329; Oen K, 2002, BEST PRACT RES CL RH, V16, P347, DOI 10.1053/berh.2002.0233; Ostile IL, 2009, CLIN EXP RHEUMATOL, V27, P1039; Oliveira S, 2007, ARTHRIT RHEUM-ARTHR, V57, P35, DOI 10.1002/art.22473; Packham JC, 2002, RHEUMATOLOGY, V41, P1428, DOI 10.1093/rheumatology/41.12.1428; Peterson LS, 1997, ARTHRITIS RHEUM, V40, P2235, DOI 10.1002/art.1780401219; Petty RE, 2001, J RHEUMATOL, V2004, P390, DOI DOI 10.1002/ACR.20460; Prince FHM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6434; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Stevanovic D, 2013, QUAL LIFE RES, V22, P607, DOI 10.1007/s11136-012-0172-0; Stinson JN, 2012, PAIN RES MANAG, V17, P391, DOI 10.1155/2012/237258; Strand CV, 1997, WHO ILAR TASKFORCE Q; von Koskull S, 2001, ANN RHEUM DIS, V60, P940, DOI 10.1136/ard.60.10.940; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303; Wille N, 2010, QUAL LIFE RES, V19, P875, DOI 10.1007/s11136-010-9648-y; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zak M, 2000, RHEUMATOLOGY, V39, P198, DOI 10.1093/rheumatology/39.2.198	45	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153267	10.1371/journal.pone.0153267	http://dx.doi.org/10.1371/journal.pone.0153267			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27115139	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600018
J	Ahmed, RH; Huri, HZ; Al-Hamodi, Z; Salem, SD; Al-absi, B; Muniandy, S				Ahmed, Radwan H.; Huri, Hasniza Zaman; Al-Hamodi, Zaid; Salem, Sameer D.; Al-absi, Boshra; Muniandy, Sekaran			Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; APOLIPOPROTEIN-B; INSULIN-RESISTANCE; RISK-FACTORS; RHEUMATOID-ARTHRITIS; METABOLIC SYNDROME; LINKING OBESITY; DISEASE; INFLAMMATION; INHIBITOR	Background Genetic polymorphisms of the Dipeptidyl Peptidase 4 (DPP4) gene may play a role in the etiology of type 2 diabetes mellitus (T2DM). This study aimed to investigate the possible association of single nucleotide polymorphisms (SNPs) of the DPP4 gene in Malaysian subjects with T2DM and evaluated whether they had an effect on the serum levels of soluble dipeptidyl peptidase 4 (sDPP-IV). Method Ten DPP4 SNPs were genotyped by TaqMan genotyping assays in 314 subjects with T2DM and 235 controls. Of these, 71 metabolic syndrome (MetS) subjects were excluded from subsequent analysis. The odds ratios (ORs) and their 95% confidence interval (CIs) were calculated using multiple logistic regression for the association between the SNPs of DPP4 and T2DM. In addition, the serum levels of sDPP-IV were investigated to evaluate the association of the SNPs of DPP4 with the sDPP-IV levels. Results Dominant, recessive, and additive genetic models were employed to test the association of DPP4 polymorphisms with T2DM, after adjusting for age, race, gender and BMI. The rs12617656 was associated with T2DM in Malaysian subjects in the recessive genetic model (OR = 1.98, p = 0.006), dominant model (OR = 1.95, p = 0.008), and additive model (OR = 1.63, p = 0.001). This association was more pronounced among Malaysian Indians, recessive (OR = 3.21, p = 0.019), dominant OR = 3.72, p = 0.003) and additive model (OR = 2.29, p = 0.0009). The additive genetic model showed that DPP4 rs4664443 and rs7633162 polymorphisms were associated with T2DM (OR = 1.53, p = 0.039), and (OR = 1.42, p = 0.020), respectively. In addition, the rs4664443 G>A polymorphism was associated with increased sDPP-IV levels (p = 0.042) in T2DM subjects. Conclusions DPP4 polymorphisms were associated with T2DM in Malaysian subjects, and linked to variations in sDPP-IV levels. In addition, these associations were more pronounced among Malaysian Indian subjects.	[Ahmed, Radwan H.; Al-absi, Boshra; Muniandy, Sekaran] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Huri, Hasniza Zaman] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Huri, Hasniza Zaman] Univ Malaya Med Ctr, Clin Invest Ctr, Kuala Lumpur, Malaysia; [Al-Hamodi, Zaid; Salem, Sameer D.] Sanaa Univ, Dept Biochem & Mol Biol, Fac Med, Sanaa, Yemen	Universiti Malaya; Universiti Malaya; Universiti Malaya	Ahmed, RH; Muniandy, S (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	radwanalhamody@yahoo.com; sekaran@um.edu.my	MUNIANDY, SEKARAN/B-5345-2010; HURI, HASNIZA ZAMAN/B-8612-2010; ahmed, radwan/O-3803-2018	MUNIANDY, SEKARAN/0000-0003-1310-3634; HURI, HASNIZA ZAMAN/0000-0002-6423-8515; ahmed, radwan/0000-0003-1398-6772	University of Malaya [PG035-2014A, HIR/420001-E000046]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106754] Funding Source: NIH RePORTER	University of Malaya(Universiti Malaya); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the research grants from the University of Malaya, (PPP Grant No. PG035-2014A and HIR/420001-E000046).	Aghili N, 2012, NEUROPEPTIDES, V46, P367, DOI 10.1016/j.npep.2012.10.001; Ahmed RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140618; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Bailey S, 2014, DIABETOLOGIA, V57, P738, DOI 10.1007/s00125-013-3142-3; Basile KJ, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/769671; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouchard L, 2009, ACTA DIABETOL, V46, P13, DOI 10.1007/s00592-008-0049-4; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chung SJ, 2011, YONSEI MED J, V52, P113, DOI 10.3349/ymj.2011.52.1.113; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Deacon CF, 2009, ADV THER, V26, P488, DOI 10.1007/s12325-009-0030-9; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; DF I, 2013, DIABETES ATLAS; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Faraj M, 2006, DIABETOLOGIA, V49, P1637, DOI 10.1007/s00125-006-0259-7; Horng T, 2011, NAT MED, V17, P164, DOI 10.1038/nm0211-164; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jiang L, 2014, ARTHRITIS RHEUMATOL, V66, P1121, DOI 10.1002/art.38353; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lee SA, 2013, J CLIN ENDOCR METAB, V98, P2553, DOI 10.1210/jc.2012-4288; Ley SH, 2010, CLIN CHEM, V56, P666, DOI 10.1373/clinchem.2009.136994; Lu MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101528; Moonesinghe R, 2012, EUR J HUM GENET, V20, P831, DOI 10.1038/ejhg.2012.15; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Ohnuma K, 2001, J IMMUNOL, V167, P6745, DOI 10.4049/jimmunol.167.12.6745; Ohnuma K, 2008, FRONT BIOSCI-LANDMRK, V13, P2299, DOI 10.2741/2844; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; Organization WH, 2006, DEF DIAGN DIAB MELL, P50; Pacheco R, 2005, P NATL ACAD SCI USA, V102, P9583, DOI 10.1073/pnas.0501050102; Rohrborn D, 2014, FEBS LETT, V588, P3870, DOI 10.1016/j.febslet.2014.08.029; Rohrborn D, 2015, FRONTIERS IMMUNOLOGY, P6; Ryoo JH, 2013, ATHEROSCLEROSIS, V226, P496, DOI 10.1016/j.atherosclerosis.2012.11.024; Sanghera DK, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000198; Sattar N, 2004, CIRCULATION, V110, P2687, DOI 10.1161/01.CIR.0000145660.60487.94; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Silva Junior WSd, 2015, BIOMED RES INT, V2015; Sung KC, 2005, ATHEROSCLEROSIS, V180, P161, DOI 10.1016/j.atherosclerosis.2004.11.009; TORIMOTO Y, 1991, J IMMUNOL, V147, P2514; Turcot V, 2011, OBESITY, V19, P388, DOI 10.1038/oby.2010.198; Vazquez AI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123818; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Wilson MJ, 2000, J ANDROL, V21, P220; Woodard-Grice AV, 2010, FASEB J, V24; Yang F., 2014, PLOS ONE, V9; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhong JX, 2015, CIRC RES, V116, P1491, DOI 10.1161/CIRCRESAHA.116.305665; Zhong JX, 2014, DIABETES, V63, P1289, DOI 10.2337/db13-1094	53	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154369	10.1371/journal.pone.0154369	http://dx.doi.org/10.1371/journal.pone.0154369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111895	gold, Green Published			2022-12-27	WOS:000374970600060
J	Lee, EC; Kim, H; Ditano, J; Manion, D; King, BL; Strange, K				Lee, Elaine C.; Kim, Heejung; Ditano, Jennifer; Manion, Dacie; King, Benjamin L.; Strange, Kevin			Abnormal Osmotic Avoidance Behavior in C-elegans Is Associated with Increased Hypertonic Stress Resistance and Improved Proteostasis	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; CAENORHABDITIS-ELEGANS; EXPRESSION ANALYSIS; PROTEIN DAMAGE; AGGREGATION; REGULATOR; FAMILY; GENES; BETA; RNAI	Protein function is controlled by the cellular proteostasis network. Proteostasis is energetically costly and those costs must be balanced with the energy needs of other physiological functions. Hypertonic stress causes widespread protein damage in C. elegans. Suppression and management of protein damage is essential for optimal survival under hypertonic conditions. ASH chemosensory neurons allow C. elegans to detect and avoid strongly hypertonic environments. We demonstrate that mutations in osm-9 and osm-12 that disrupt ASH mediated hypertonic avoidance behavior or genetic ablation of ASH neurons are associated with enhanced survival during hypertonic stress. Improved survival is not due to altered systemic volume homeostasis or organic osmolyte accumulation. Instead, we find that osm-9(ok1677) mutant and osm-9(RNAi) worms exhibit reductions in hypertonicity induced protein damage in non-neuronal cells suggesting that enhanced proteostasis capacity may account for improved hypertonic stress resistance in worms with defects in osmotic avoidance behavior. RNA-seq analysis revealed that genes that play roles in managing protein damage are upregulated in osm-9(ok1677) worms. Our findings are consistent with a growing body of work demonstrating that intercellular communication between neuronal and non-neuronal cells plays a critical role in integrating cellular stress resistance with other organismal physiological demands and associated energy costs.	[Lee, Elaine C.; Kim, Heejung; Ditano, Jennifer; Manion, Dacie; King, Benjamin L.; Strange, Kevin] Mt Desert Isl Biol Lab, Salsbury Cove, ME 04672 USA; [Lee, Elaine C.] Univ Connecticut, Storrs, CT 06269 USA	Mount Desert Island Biological Laboratory; University of Connecticut	Strange, K (corresponding author), Mt Desert Isl Biol Lab, Salsbury Cove, ME 04672 USA.	kstrange@mdibl.org	King, Benjamin/AAI-1492-2019	King, Benjamin/0000-0001-6463-1336	National Institutes of Health from the National Institute of Diabetes, Digestive and Kidney Diseases [R01 DK61168]; Institutional Development Award (IDeA) grant [P20 GM103423]; Center of Biomedical Research Excellence (COBRE) grant from the National Institute of General Medical Sciences [P20 GM104318]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104318, P20GM103423] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Diabetes, Digestive and Kidney Diseases; Institutional Development Award (IDeA) grant; Center of Biomedical Research Excellence (COBRE) grant from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant R01 DK61168 to K.S. from the National Institute of Diabetes, Digestive and Kidney Diseases, and by Institutional Development Award (IDeA) grant P20 GM103423 and Center of Biomedical Research Excellence (COBRE) grant P20 GM104318 from the National Institute of General Medical Sciences. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; [Anonymous], 1988, NEMATODE CAENORHABDI; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bargmann C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Beverly M, 2011, J NEUROSCI, V31, P11718, DOI 10.1523/JNEUROSCI.1098-11.2011; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; BRENNER S, 1974, GENETICS, V77, P71; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Burkewitz K, 2011, AM J PHYSIOL-CELL PH, V301, pC566, DOI 10.1152/ajpcell.00030.2011; Burkewitz K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034153; Calahorro Fernando, 2009, J Vis Exp, DOI 10.3791/1616; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chandler-Brown D, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00316; Choe KP, 2008, AM J PHYSIOL-CELL PH, V295, pC1488, DOI 10.1152/ajpcell.00450.2008; Choi S, 2013, NEURON, V78, P869, DOI 10.1016/j.neuron.2013.04.002; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dubey K, 2014, BIOCHEM BIOPH RES CO, V448, P480, DOI 10.1016/j.bbrc.2014.04.135; Dzamko N, 2014, FRONT MOL NEUROSCI, V7, P57; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Ghosh K, 2010, BIOPHYS J, V99, P3996, DOI 10.1016/j.bpj.2010.10.036; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Harris TW, 2014, NUCLEIC ACIDS RES, V42, pD789, DOI 10.1093/nar/gkt1063; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kakuyama H, 2005, BIOCHEMISTRY-US, V44, P15602, DOI 10.1021/bi051263e; Kim H, 2013, AM J PHYSIOL-CELL PH, V305, pC1257, DOI 10.1152/ajpcell.00176.2013; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Labbadia John, 2014, F1000Prime Rep, V6, P7, DOI 10.12703/P6-7; Lamitina ST, 2004, AM J PHYSIOL-CELL PH, V286, pC785, DOI 10.1152/ajpcell.00381.2003; LAMITINA ST, 2004, AM J PHYSIOL, V288, P467; Lamitina T, 2006, P NATL ACAD SCI USA, V103, P12173, DOI 10.1073/pnas.0602987103; Lee ECH, 2012, AM J PHYSIOL-CELL PH, V303, pC1269, DOI 10.1152/ajpcell.00294.2012; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Luo JH, 2014, J BIOL CHEM, V289, P27766, DOI 10.1074/jbc.M114.574947; Mancuso VP, 2012, DEVELOPMENT, V139, P979, DOI 10.1242/dev.075135; Matilainen O, 2013, CELL REP, V3, P1980, DOI 10.1016/j.celrep.2013.05.012; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muniz JRC, 2013, J MOL BIOL, V425, P3166, DOI 10.1016/j.jmb.2013.06.015; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Oh KH, 2013, P NATL ACAD SCI USA, V110, P19024, DOI 10.1073/pnas.1308866110; Parmar AS, 2012, BIOPOLYMERS, V97, P795, DOI 10.1002/bip.22070; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohlfing AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001267; Rohlfing AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009010; Spaich S, 2012, CIRC RES, V111, P1504, DOI 10.1161/CIRCRESAHA.112.271007; Stanyon HF, 2012, J BIOL CHEM, V287, P28163, DOI 10.1074/jbc.C112.360800; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Wang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000350; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; Wheeler JM, 2006, GENETICS, V174, P1327, DOI 10.1534/genetics.106.059089; Wolff S, 2006, EXP GERONTOL, V41, P894, DOI 10.1016/j.exger.2006.06.054; Yamanaka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093891; Yoshida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1750	73	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154156	10.1371/journal.pone.0154156	http://dx.doi.org/10.1371/journal.pone.0154156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111894	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600038
J	Olsen, JA; Kenna, LA; Spelios, MG; Hessner, MJ; Akirav, EM				Olsen, John A.; Kenna, Lauren A.; Spelios, Michael G.; Hessner, Martin J.; Akirav, Eitan M.			Circulating Differentially Methylated Amylin DNA as a Biomarker of beta- Cell Loss in Type 1 Diabetes	PLOS ONE			English	Article							ISLET AMYLOID POLYPEPTIDE; MICROSATELLITE ALTERATIONS; INSULIN-SECRETION; PANCREATIC-ISLETS; CANCER PATIENTS; PRAMLINTIDE; MELLITUS; EXPRESSION; THERAPY; DEATH	In type 1 diabetes (T1D), beta-cell loss is silent during disease progression. Methylation-sensitive quantitative real-time PCR (qPCR) of beta-cell-derived DNA in the blood can serve as a biomarker of beta-cell death in T1D. Amylin is highly expressed by beta-cells in the islet. Here we examined whether demethylated circulating free amylin DNA (cfDNA) may serve as a biomarker of beta-cell death in T1D. beta-cells showed unique methylation patterns within the amylin coding region that were not observed with other tissues. The design and use of methylation-specific primers yielded a strong signal for demethylated amylin in purified DNA from murine islets when compared with other tissues. Similarly, methylation-specific primers detected high levels of demethylated amylin DNA in human islets and enriched human beta-cells. In vivo testing of the primers revealed an increase in demethylated amylin cfDNA in sera of non-obese diabetic (NOD) mice during T1D progression and following the development of hyperglycemia. This increase in amylin cfDNA did not mirror the increase in insulin cfDNA, suggesting that amylin cfDNA may detect beta-cell loss in serum samples where insulin cfDNA is undetected. Finally, purified cfDNA from recent onset T1D patients yielded a high signal for demethylated amylin cfDNA when compared with matched healthy controls. These findings support the use of demethylated amylin cfDNA for detection of beta-cell-derived DNA. When utilized in conjunction with insulin, this latest assay provides a comprehensive multi-gene approach for the detection of beta-cell loss.	[Olsen, John A.; Kenna, Lauren A.; Spelios, Michael G.; Akirav, Eitan M.] Winthrop Univ Hosp, Res Inst, Islet Biol, Mineola, NY 11501 USA; [Hessner, Martin J.] Childrens Hosp Wisconsin, Childrens Res Inst, Max McGee Natl Res Ctr Juvenile Diabet, Milwaukee, WI 53201 USA; [Hessner, Martin J.] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Akirav, Eitan M.] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA	Winthrop University Hospital; Children's Hospital of Wisconsin; Medical College of Wisconsin; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Akirav, EM (corresponding author), Winthrop Univ Hosp, Res Inst, Islet Biol, Mineola, NY 11501 USA.; Akirav, EM (corresponding author), SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA.	eakirav@winthrop.org			Juvenile Diabetes Research Foundation [17-2012-588, 1-PNF-2014-96-Q-R]; National Institutes of Health, National Center for Advancing Translational Sciences [8UL1TR000055]; Winthrop University Hospital Pilot Award; Children's Hospital of Wisconsin Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health, National Center for Advancing Translational Sciences; Winthrop University Hospital Pilot Award; Children's Hospital of Wisconsin Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by 1) Juvenile Diabetes Research Foundation (Grant No. 17-2012-588 and 1-PNF-2014-96-Q-R), www.jdrf.org; 2) National Institutes of Health, National Center for Advancing Translational Sciences (8UL1TR000055), www.nih.gov; 3) Winthrop University Hospital Pilot Award, www.winthrop.org; 4) The Children's Hospital of Wisconsin Foundation, www.chw.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav E, 2008, DIABETES, V57, P2883, DOI 10.2337/db07-1817; Akirav EM, 2011, P NATL ACAD SCI USA, V108, P19018, DOI 10.1073/pnas.1111008108; Akirav EM, 2011, DIABETES, V60, P876, DOI 10.2337/db10-0793; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Banerjee M, 2009, DIABETOLOGIA, V52, P621, DOI 10.1007/s00125-009-1259-1; Bassi EJ, 2012, DIABETES, V61, P2534, DOI 10.2337/db11-0844; Bonifacio E, 1999, J IMMUNOL, V163, P525; BrethertonWatt D, 1996, BIOCHEM J, V313, P495, DOI 10.1042/bj3130495; Chen XQ, 1996, NAT MED, V2, P1033; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Fineman M, 2002, HORM METAB RES, V34, P504, DOI 10.1055/s-2002-34790; Fisher MM, 2015, DIABETES, V64, P3867, DOI 10.2337/db15-0430; GERMAN MS, 1992, MOL CELL BIOL, V12, P1777, DOI 10.1128/MCB.12.4.1777; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Herold KC, 2015, J CLIN INVEST, V125, P1163, DOI 10.1172/JCI78142; Hollander PA, 2003, DIABETES CARE, V26, P784, DOI 10.2337/diacare.26.3.784; Husseiny MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047942; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Lebastchi J, 2013, DIABETES, V62, P1676, DOI 10.2337/db12-1207; LEFFERT JD, 1989, P NATL ACAD SCI USA, V86, P3127, DOI 10.1073/pnas.86.9.3127; Ludvik B, 2003, EUR J CLIN INVEST, V33, P316, DOI 10.1046/j.1365-2362.2003.01142.x; LUKINIUS A, 1989, DIABETOLOGIA, V32, P240, DOI 10.1007/BF00285291; MOSSELMAN S, 1990, FEBS LETT, V271, P33, DOI 10.1016/0014-5793(90)80365-P; Nawroz H, 1996, NAT MED, V2, P1035, DOI 10.1038/nm0996-1035; OBRIEN TD, 1991, DIABETES, V40, P1701, DOI 10.2337/diabetes.40.12.1701; Paulsson JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093053; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Reidelberger RD, 2004, AM J PHYSIOL-REG I, V287, pR568, DOI 10.1152/ajpregu.00213.2004; Riediger T, 2004, AM J PHYSIOL-REG I, V286, pR114, DOI 10.1152/ajpregu.00333.2003; Ryan GJ, 2005, CLIN THER, V27, P1500, DOI 10.1016/j.clinthera.2005.10.009; Spelios MG, 2015, J BIOL CHEM, V290, P15250, DOI 10.1074/jbc.M114.628784; Spelios MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072260; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WESTERMARK P, 1987, DIABETOLOGIA, V30, P887; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Whitehouse F, 2002, DIABETES CARE, V25, P724, DOI 10.2337/diacare.25.4.724	39	36	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152662	10.1371/journal.pone.0152662	http://dx.doi.org/10.1371/journal.pone.0152662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111653	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600003
J	Chen, XF; Rateri, DL; Howatt, DA; Balakrishnan, A; Moorleghen, JJ; Cassis, LA; Daugherty, A				Chen, Xiaofeng; Rateri, Debra L.; Howatt, Deborah A.; Balakrishnan, Anju; Moorleghen, Jessica J.; Cassis, Lisa A.; Daugherty, Alan			TGF-beta Neutralization Enhances AngII-Induced Aortic Rupture and Aneurysm in Both Thoracic and Abdominal Regions	PLOS ONE			English	Article							ANGIOTENSIN-II; GROWTH; RECEPTOR; HYPERPLASIA; ATHEROSCLEROSIS; HYPERTROPHY; PROGRESSION; DISRUPTION; EXPRESSION; GAMMA	AngII and TGF-beta interact in development of thoracic and abdominal aortic diseases, although there are many facets of this interaction that have not been clearly defined. The aim of the present study was to determine the effects of TGF-beta neutralization on AngII induced-aortic pathologies. Male C57BL/6J mice were administered with either a rabbit or mouse TGF-beta neutralizing antibody and then infused with AngII. The rabbit TGF-beta antibody modestly reduced serum TGF-beta concentrations, with no significant enhancements to AngII-induced aneurysm or rupture. Administration of this rabbit TGF-beta antibody in mice led to high serum titers against rabbit IgG that may have attenuated the neutralization. In contrast, a mouse TGF-beta antibody (1D11) significantly increased rupture in both the ascending and suprarenal aortic regions, but only at doses that markedly decreased serum TGF-beta concentrations. High doses of 1D11 antibody significantly increased AngII-induced ascending and suprarenal aortic dilatation. To determine whether TGF-beta neutralization had effects in mice previously infused with AngII, the 1D11 antibody was injected into mice that had been infused with AngII for 28 days and were observed during continued infusion for a further 28 days. Despite near ablations of serum TGF-beta concentrations, the mouse TGF-beta antibody had no effect on aortic rupture or dimensions in either ascending or suprarenal region. These data provide further evidence that AngII-induced aortic rupture is enhanced greatly by TGF-beta neutralization when initiated before pathogenesis.	[Chen, Xiaofeng] Wenzhou Med Univ, Taizhou Hosp, Dept Cardiol, Lab Cardiovasc Dis, Wenzhou, Zhejiang, Peoples R China; [Chen, Xiaofeng; Rateri, Debra L.; Howatt, Deborah A.; Balakrishnan, Anju; Moorleghen, Jessica J.; Daugherty, Alan] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA; [Cassis, Lisa A.] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Daugherty, Alan] Univ Kentucky, Dept Physiol, Lexington, KY USA	Wenzhou Medical University; University of Kentucky; University of Kentucky; University of Kentucky	Daugherty, A (corresponding author), Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA.; Daugherty, A (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY USA.	Alan.Daugherty@uky.edu	Daugherty, Alan/C-8282-2009	Daugherty, Alan/0000-0003-2093-3775	National Marfan Foundation; National Institutes of Health [HL 107319]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107319] Funding Source: NIH RePORTER	National Marfan Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Marfan Foundation: http://www.marfan.org/?gclid=CNKUmZ3frMoCFYwvgQodAqMGTQ, National Institutes of Health - HL 107319 http://www.nih.gov/.	Bush E, 2000, HYPERTENSION, V36, P360, DOI 10.1161/01.HYP.36.3.360; Campbell SE, 1997, J MOL CELL CARDIOL, V29, P1947, DOI 10.1006/jmcc.1997.0435; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Chen XF, 2013, CURR OPIN PHARMACOL, V13, P180, DOI 10.1016/j.coph.2013.01.002; Cook JR, 2015, ARTERIOSCL THROM VAS, V35, P911, DOI 10.1161/ATVBAHA.114.305150; Dai JP, 2005, CIRCULATION, V112, P1008, DOI 10.1161/CIRCULATIONAHA.104.523357; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; Davis FM, 2014, HEART, V100, P1498, DOI 10.1136/heartjnl-2014-305648; Gahllo EM, 2014, J CLIN INVEST, V124, P448, DOI 10.1172/JCI69666; GIBBONS GH, 1992, J CLIN INVEST, V90, P456, DOI 10.1172/JCI115881; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hu JH, 2015, ARTERIOSCL THROM VAS, V35, P2647, DOI 10.1161/ATVBAHA.115.306573; King VL, 2009, CIRCULATION, V119, P426, DOI 10.1161/CIRCULATIONAHA.108.785949; Li W, 2014, J CLIN INVEST, V124, P755, DOI 10.1172/JCI69942; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Liu J, 2015, ARTERIOSCL THROM VAS, V35, P1826, DOI 10.1161/ATVBAHA.115.305482; Lu H, 2015, JOVE-J VIS EXP, DOI 10.3791/53191; Lu H, 2012, CLIN SCI, V123, P531, DOI 10.1042/CS20120097; Owens AP, 2010, CIRC RES, V106, P611, DOI 10.1161/CIRCRESAHA.109.212837; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Poduri A, 2015, ARTERIOSCL THROM VAS, V35, P1995, DOI 10.1161/ATVBAHA.115.305995; Rateri DL, 2014, AM J PATHOL, V184, P2586, DOI 10.1016/j.ajpath.2014.05.014; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Spin JM, 2011, PHYSIOL GENOMICS, V43, P993, DOI 10.1152/physiolgenomics.00044.2011; Subramanian V, 2012, ARTERIOSCL THROM VAS, V32, P397, DOI 10.1161/ATVBAHA.111.239897; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Topouzis S, 1996, DEV BIOL, V178, P430, DOI 10.1006/dbio.1996.0229; Wang Y. X., 2006, HDB MOUSE MODELS CAR, V125; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Zhou YB, 2003, AM J PHYSIOL-HEART C, V285, pH2797, DOI 10.1152/ajpheart.00466.2003	34	50	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153811	10.1371/journal.pone.0153811	http://dx.doi.org/10.1371/journal.pone.0153811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104863	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100023
J	Gallego, A; Mele, M; Balcells, I; Garcia-Ramallo, E; Torruella-Loran, I; Fernandez-Bellon, H; Abello, T; Kondova, I; Bontrop, R; Hvilsom, C; Navarro, A; Marques-Bonet, T; Espinosa-Parrilla, Y				Gallego, Alicia; Mele, Marta; Balcells, Ingrid; Garcia-Ramallo, Eva; Torruella-Loran, Ignasi; Fernandez-Bellon, Hugo; Abello, Teresa; Kondova, Ivanela; Bontrop, Ronald; Hvilsom, Christina; Navarro, Arcadi; Marques-Bonet, Tomas; Espinosa-Parrilla, Yolanda			Functional Implications of Human-Specific Changes in Great Ape microRNAs	PLOS ONE			English	Article							EVOLUTION; GENE; BIOGENESIS; EXPRESSION; CLUSTER; POLYMORPHISM; DIVERSITY; ELEMENTS; ORIGIN; MIRNAS	microRNAs are crucial post-transcriptional regulators of gene expression involved in a wide range of biological processes. Although microRNAs are highly conserved among species, the functional implications of existing lineage-specific changes and their role in determining differences between humans and other great apes have not been specifically addressed. We analyzed the recent evolutionary history of 1,595 human microRNAs by looking at their intra-and inter-species variation in great apes using high-coverage sequenced genomes of 82 individuals including gorillas, orangutans, bonobos, chimpanzees and humans. We explored the strength of purifying selection among microRNA regions and found that the seed and mature regions are under similar and stronger constraint than the precursor region. We further constructed a comprehensive catalogue of microRNA species-specific nucleotide substitutions among great apes and, for the first time, investigated the biological relevance that human-specific changes in microRNAs may have had in great ape evolution. Expression and functional analyses of four microRNAs (miR-299-3p, miR-503-3p, miR508-3p and miR-541-3p) revealed that lineage-specific nucleotide substitutions and changes in the length of these microRNAs alter their expression as well as the repertoires of target genes and regulatory networks. We suggest that the studied molecular changes could have modified crucial microRNA functions shaping phenotypes that, ultimately, became human-specific. Our work provides a frame to study the impact that regulatory changes may have in the recent evolution of our species.	[Gallego, Alicia; Balcells, Ingrid; Garcia-Ramallo, Eva; Torruella-Loran, Ignasi; Navarro, Arcadi; Marques-Bonet, Tomas; Espinosa-Parrilla, Yolanda] Univ Pompeu Fabra, CSIC, IBE, Dept Expt & Hlth Sci, Barcelona, Catalonia, Spain; [Mele, Marta; Navarro, Arcadi] CRG, Barcelona, Catalonia, Spain; [Mele, Marta] Harvard Univ, Dept Stem Cells & Regenerat Biol, Cambridge, MA 02138 USA; [Mele, Marta] Broad Inst MIT & Harvard, Cambridge, MA USA; [Balcells, Ingrid] Univ Helsinki, Dept Biosci, Viikki Bioctr, Helsinki, Finland; [Fernandez-Bellon, Hugo; Abello, Teresa] Parc Zool Barcelona, Barcelona, Catalonia, Spain; [Fernandez-Bellon, Hugo] Univ Autonoma Barcelona, Bellaterra, Catalonia, Spain; [Kondova, Ivanela; Bontrop, Ronald] Biomed Primate Res Ctr, Rijswijk, Netherlands; [Hvilsom, Christina] Copenhagen Zoo, Frederiksberg, Denmark; [Navarro, Arcadi] INB, Barcelona, Catalonia, Spain; [Navarro, Arcadi] Catalan Inst Res & Adv Studies, ICREA, Barcelona, Catalonia, Spain; [Marques-Bonet, Tomas] CNAG, Barcelona, Catalonia, Spain; [Espinosa-Parrilla, Yolanda] Univ Magallanes, Sch Med, Punta Arenas, Chile	Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Autonomous University of Barcelona; ICREA; Universidad de Magallanes	Espinosa-Parrilla, Y (corresponding author), Univ Pompeu Fabra, CSIC, IBE, Dept Expt & Hlth Sci, Barcelona, Catalonia, Spain.; Espinosa-Parrilla, Y (corresponding author), Univ Magallanes, Sch Med, Punta Arenas, Chile.	yolespinosa@gmail.com	Espinosa-Parrilla, Yolanda/GSN-8107-2022; Marques-Bonet, Tomas/ABF-3734-2020; Espinosa-Parrilla, Yolanda/E-6368-2013; Bontrop, Ronald E/J-3628-2012; Fernández-Bellon, Hugo/M-5925-2019; Gallego, Alicia/L-6653-2017	Espinosa-Parrilla, Yolanda/0000-0002-5441-3113; Marques-Bonet, Tomas/0000-0002-5597-3075; Bontrop, Ronald E/0000-0003-0874-6467; Fernández-Bellon, Hugo/0000-0001-6071-1435; Hvilsom, Christina/0000-0001-7870-6888; Gallego Jimenez, Alicia/0000-0002-2936-7311; mele, marta/0000-0001-8874-6453	Spanish National Institute for Bioinformatics; Ministerio de Ciencia e Innovacion de Espana [BFU2012-38236, BFU2010-18477, BFU2009-06974, CGL2009-09013]; Ministerio de Ciencia e Innovacion de Espana [FPI-MINECO]; Direccio General de Recerca de la Generalitat de Catalunya [2009SGR-1101, 2014SGR-866, SGR2014-1311]; European Union [PIOF-GA-2009-236836, PIRSES-GA-2013-612583]; Ministerio de Educacion, Cultura y Deporte de Espana; FEDER European Regional Development Fund; Parc Zoologic de Barcelona; Copenhagen Zoo; ICREA Funding Source: Custom	Spanish National Institute for Bioinformatics; Ministerio de Ciencia e Innovacion de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Ciencia e Innovacion de Espana [FPI-MINECO]; Direccio General de Recerca de la Generalitat de Catalunya(Generalitat de Catalunya); European Union(European Commission); Ministerio de Educacion, Cultura y Deporte de Espana(Spanish Government); FEDER European Regional Development Fund(European Commission); Parc Zoologic de Barcelona; Copenhagen Zoo; ICREA(ICREA)	This work was funded by Spanish National Institute for Bioinformatics (www.inab.org); "Ministerio de Ciencia e Innovacion de Espana" [grant numbers BFU2012-38236, BFU2010-18477, BFU2009-06974, CGL2009-09013 and FPI-MINECO to ITL]; "Direccio General de Recerca de la Generalitat de Catalunya" [2009SGR-1101, 2014SGR-866 and SGR2014-1311]; European Union Seventh Framework Programme [grant number PIOF-GA-2009-236836 and PIRSES-GA-2013-612583]; "Ministerio de Educacion, Cultura y Deporte de Espana" [grant FPU-MEC to AG]; FEDER European Regional Development Fund "A way to build Europe". Three authors of this work were employed by the funding organizations of either the "Parc Zoologic de Barcelona" or the Copenhagen Zoo. The funder "Parc Zoologic de Barcelona" provided support in the form of salaries for authors HFB and TA and the funder Copenhagen Zoo for author CH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The unique role of "Parc Zoologic de Barcelona" and Copenhagen Zoo was to provide support in the form of salaries for authors HFB, TA and CH. These funders did not have any additional role in the study design, data collection and analysis, decisionto publish, or preparation of the manuscript.	Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Brameier Markus, 2010, BMC Res Notes, V3, P64, DOI 10.1186/1756-0500-3-64; Campo-Paysaa F, 2011, EVOL DEV, V13, P15, DOI 10.1111/j.1525-142X.2010.00452.x; Dannemann M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-116; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Durbin RM, 2010, MAP HUMAN GENOME VAR, DOI [10.1038/nature09534, DOI 10.1038/NATURE09534]; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Friedlander MR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r57; Gallo R, 2002, J CELL BIOL, V158, P731, DOI 10.1083/jcb.200202024; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Guo L, 2014, GENE, V534, P24, DOI 10.1016/j.gene.2013.10.037; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heimberg AM, 2008, P NATL ACAD SCI US; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Iwama H, 2013, MOL BIOL EVOL, V30, P613, DOI 10.1093/molbev/mss262; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Lin S, 2010, COMPUT BIOL CHEM, V34, P232, DOI 10.1016/j.compbiolchem.2010.08.001; Llobet-Navas D, 2014, GENE DEV, V28, P765, DOI 10.1101/gad.237404.114; Londin E, 2015, P NATL ACAD SCI USA, V112, pE1106, DOI 10.1073/pnas.1420955112; Lopez-Valenzuela M, 2012, MOL BIOL EVOL, V29, P1797, DOI 10.1093/molbev/mss023; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Mu XJ, 2011, NUCLEIC ACIDS RES, V39, P7058, DOI 10.1093/nar/gkr342; Muinos-Gimeno M, 2011, BIOL PSYCHIAT, V69, P526, DOI 10.1016/j.biopsych.2010.10.010; Nei M., 1987, MOL EVOLUTIONARY GEN; Nowick K, 2009, P NATL ACAD SCI USA, V106, P22358, DOI 10.1073/pnas.0911376106; Perdomo-Sabogal A, 2014, CURR OPIN GENET DEV, V29, P60, DOI 10.1016/j.gde.2014.08.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Quach H, 2009, AM J HUM GENET, V84, P316, DOI 10.1016/j.ajhg.2009.01.022; Saba R, 2010, BRAIN RES, V1338, P3, DOI 10.1016/j.brainres.2010.03.107; Salin-Cantegrel A, 2011, J BIOL CHEM, V286, P28456, DOI 10.1074/jbc.M111.226894; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shen Y, 2011, P NATL ACAD SCI USA, V108, P15942, DOI 10.1073/pnas.1110098108; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smit A.F.A., 2015, REPEATMASKER OPEN 4; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Yang JS, 2010, CELL CYCLE, V9, P4455, DOI 10.4161/cc.9.22.13958; Zhang J, 2011, CELL BIOCHEM FUNCT, V29, P279, DOI 10.1002/cbf.1747; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhu Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-718	55	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154194	10.1371/journal.pone.0154194	http://dx.doi.org/10.1371/journal.pone.0154194			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105073	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100052
J	Godongwana, B				Godongwana, Buntu			Effectiveness Factors and Conversion in a Biocatalytic Membrane Reactor	PLOS ONE			English	Article							BIOREACTOR DESIGN EQUATIONS; SUBSTRATE CONSUMPTION; HOLLOW; TRANSPORT; MASS	Analytical expressions of the effectiveness factor of a biocatalytic membrane reactor, and its asymptote as the Thiele modulus becomes large, are presented. The evaluation of the effectiveness factor is based on the solution of the governing equations for solute transport in the two regions of the reactor, i.e. the lumen and the matrix (with the biofilm immobilized in the matrix). The lumen solution accounts for both axial diffusion and radial convective flow, while the matrix solution is based on Robin-type boundary conditions. The effectiveness factor is shown to be a function of the Thiele modulus, the partition coefficient, the Sherwood number, the Peclet number, and membrane thickness. Three regions of Thiele moduli are defined in the effectiveness factor graphs. These correspond with reaction rate limited, internal-diffusion limited, and external mass transfer limited solute transport. Radial convective flows were shown to only improve the effectiveness factor in the region of internal diffusion limitation. The assumption of first order kinetics is shown to be applicable only in the Thiele modulus regions of internal and external mass transfer limitation. An iteration scheme is also presented for estimating the effectiveness factor when the solute fractional conversion is known. The model is validated with experimental data from a membrane gradostat reactor immobilised with Phanerochaete chrysosporium for the production of lignin and manganese peroxidases. The developed model and experimental data allow for the determination of the Thiele modulus at which the effectiveness factor and fractional conversion are optimal.	[Godongwana, Buntu] Cape Peninsula Univ Technol, Dept Chem Engn, Cape Town, South Africa	Cape Peninsula University of Technology	Godongwana, B (corresponding author), Cape Peninsula Univ Technol, Dept Chem Engn, Cape Town, South Africa.	godongwanab@cput.ac.za		Godongwana, Buntu/0000-0002-5921-0032	National Research Foundation of South Africa [87845]; National Research Foundation (RSA)	National Research Foundation of South Africa(National Research Foundation - South Africa); National Research Foundation (RSA)	The study was funded by the National Research Foundation of South Africa (http://www.nrf.ac.za/), grant number 87845. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank the National Research Foundation (RSA) for supporting this work. Special thanks to Dr S.K. Ntwampe and Dr M.S. Sheldon for making available the data used in Fig 3.	Abramowitz M., 1965, HDB MATH FUNCTIONS; [Anonymous], 1975, MATH THEORY DIFFUSIO; Calabro V, 2002, J MEMBRANE SCI, V206, P217, DOI 10.1016/S0376-7388(01)00766-9; Chang H N, 1991, Adv Biochem Eng Biotechnol, V44, P27; Charcosset C, 2006, BIOTECHNOL ADV, V24, P482, DOI 10.1016/j.biotechadv.2006.03.002; Curcio S, 2006, J MEMBRANE SCI, V273, P129, DOI 10.1016/j.memsci.2005.10.006; DALLBAUMAN L, 1990, BIOTECHNOL BIOENG, V35, P837, DOI 10.1002/bit.260350812; Girono L, 2000, TRENDS BIOTECHNOL, V18, P339, DOI 10.1016/S0167-7799(00)01472-4; Godongwana B, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/810843; Godongwana B, 2010, INT J CHEM ENG, V2010, DOI 10.1155/2010/738482; Gonzo EE, 2007, BIOCHEM ENG J, V37, P80, DOI 10.1016/j.bej.2007.03.011; Jayaraman VK, 1997, CHEM ENG J, V65, P77; JAYARAMAN VK, 1992, BIOTECHNOL PROGR, V8, P462, DOI 10.1021/bp00017a014; Lewandowski Z., 2007, FUNDAMENTALS BIOFILM; Lieb T, 2007, PERRYS CHEM ENG HDB; Nagy E, 2012, ELSEV INSIGHT, P1; Nagy E, 2015, J MEMBRANE SCI, V482, P144, DOI 10.1016/j.memsci.2014.11.060; Ntwampe SKO, 2006, BIOCHEM ENG J, V30, P147, DOI 10.1016/j.bej.2006.03.001; Tanyolac A, 1996, CHEM ENG J BIOCH ENG, V62, P149, DOI 10.1016/0923-0467(95)03066-2; WATERLAND LR, 1974, AICHE J, V20, P50, DOI 10.1002/aic.690200106; WEBSTER IA, 1978, BIOTECHNOL BIOENG, V20, P1541, DOI 10.1002/bit.260201004; WEBSTER IA, 1979, BIOTECHNOL BIOENG, V21, P1725, DOI 10.1002/bit.260211004; Wickramasinghe SR, 2002, J MEMBRANE SCI, V208, P247, DOI 10.1016/S0376-7388(02)00281-8; Willaert R, 1999, BIOTECHNOL TECH, V13, P317, DOI 10.1023/A:1008907024434; Ye H, 2006, J MEMBRANE SCI, V272, P169, DOI 10.1016/j.memsci.2005.07.040	25	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153000	10.1371/journal.pone.0153000	http://dx.doi.org/10.1371/journal.pone.0153000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104954	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100006
J	Chowdhury, B; Porter, EG; Stewart, JC; Ferreira, CR; Schipma, MJ; Dykhuizen, EC				Chowdhury, Basudev; Porter, Elizabeth G.; Stewart, Jane C.; Ferreira, Christina R.; Schipma, Matthew J.; Dykhuizen, Emily C.			PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENRICHMENT ANALYSIS; MASS-SPECTROMETRY; CHOLESTEROL; MECHANISMS; INDUCTION; DYNAMICS; REVEALS; CANCER; ROLES	Polybromo-1 (PBRM1) is a component of the PBAF (Polybromo-associated-BRG1- or BRM-associated factors) chromatin remodeling complex and is the second most frequently mutated gene in clear-cell renal cell Carcinoma (ccRCC). Mutation of PBRM1 is believed to be an early event in carcinogenesis, however its function as a tumor suppressor is not understood. In this study, we have employed Next Generation Sequencing to profile the differentially expressed genes upon PBRM1 re-expression in a cellular model of ccRCC. PBRM1 re-expression led to upregulation of genes involved in cellular adhesion, carbohydrate metabolism, apoptotic process and response to hypoxia, and a downregulation of genes involved in different stages of cell division. The decrease in cellular proliferation upon PBRM1 re-expression was confirmed, validating the functional role of PBRM1 as a tumor suppressor in a cell-based model. In addition, we identified a role for PBRM1 in regulating metabolic pathways known to be important for driving ccRCC, including the regulation of hypoxia response genes, PI3K signaling, glucose uptake, and cholesterol homeostasis. Of particular novelty is the identification of cell adhesion as a major downstream process uniquely regulated by PBRM1 expression. Cytoskeletal reorganization was induced upon PBRM1 reexpression as evidenced from the increase in the number of cells displaying cortical actin, a hallmark of epithelial cells. Genes involved in cell adhesion featured prominently in our transcriptional dataset and overlapped with genes uniquely regulated by PBRM1 in clinical specimens of ccRCC. Genes involved in cell adhesion serve as tumor suppressor and maybe involved in inhibiting cell migration. Here we report for the first time genes linked to cell adhesion serve as downstream targets of PBRM1, and hope to lay the foundation of future studies focusing on the role of chromatin remodelers in bringing about these alterations during malignancies.	[Chowdhury, Basudev; Porter, Elizabeth G.; Stewart, Jane C.; Dykhuizen, Emily C.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Ferreira, Christina R.] Purdue Univ, Metabolite Profiling Facil, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Schipma, Matthew J.] Northwestern Univ, Ctr Genet Med, NUSeq Core Facil, Chicago, IL 60611 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Northwestern University	Dykhuizen, EC (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	edykhui@purdue.edu	Ferreira, Christina Ramires/F-4744-2012	Ferreira, Christina Ramires/0000-0003-3988-6454; dykhuizen, emily/0000-0003-3072-1469	V scholar award from the V foundation [14109042]; NIH Shared Instrumentation Grant; NCRR [1 S10 RR023734-01A1]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023734] Funding Source: NIH RePORTER	V scholar award from the V foundation; NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Sanger sequencing and Cell cycle/apoptosis data were acquired by the Purdue Genomics Facility and Flow Cytometry Facility supported by P30 CA023168. ECD is supported by a V scholar award (14109042) from the V foundation. NIH Shared Instrumentation Grant, NCRR 1 S10 RR023734-01A1 supported the imaging using Zeiss LSM 710 confocal microscope.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; Butz H, 2014, CLIN CHEM, V60, P1314, DOI 10.1373/clinchem.2014.225854; Cairns P, 2011, CANCER BIOMARK, V9, P461, DOI 10.3233/CBM-2011-0176; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Cho DC, 2013, CURR CANCER DRUG TAR, V13, P126; CLAYMAN RV, 1983, J UROLOGY, V129, P621, DOI 10.1016/S0022-5347(17)52265-X; COTTLERFOX M, 1980, INT J CANCER, V26, P689, DOI 10.1002/ijc.2910260523; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duns G, 2012, HUM MUTAT, V33, P1059, DOI 10.1002/humu.22090; Ferreira CR, 2015, REPROD FERT DEVELOP, V27, P621, DOI 10.1071/RD14310; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; GEBHARD RL, 1987, J LIPID RES, V28, P1177; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Ilatovskaya DV, 2013, CELL TISSUE RES, V354, P783, DOI 10.1007/s00441-013-1710-y; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kalo P, 2001, J CHROMATOGR A, V935, P237, DOI 10.1016/S0021-9673(01)01315-2; Kenneth NS, 2009, J BIOL CHEM, V284, P4123, DOI 10.1074/jbc.M808491200; Klingner C, 2014, J CELL BIOL, V207, P107, DOI 10.1083/jcb.201402037; KORHONEN M, 1994, CANCER RES, V54, P4532; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Lin A, 2014, ONCOGENE, V33, P3183, DOI 10.1038/onc.2013.273; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Motzer Robert J, 2015, J Natl Compr Canc Netw, V13, P151; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pawlowski R, 2013, INT J CANCER, V132, pE11, DOI 10.1002/ijc.27822; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Sena JA, 2013, MOL CELL BIOL, V33, P3849, DOI 10.1128/MCB.00731-13; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shankar J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119954; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sundelin JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048694; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Zeng ZS, 2014, EXP THER MED, V7, P121, DOI 10.3892/etm.2013.1392	56	44	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153718	10.1371/journal.pone.0153718	http://dx.doi.org/10.1371/journal.pone.0153718			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100670	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500054
J	Guo, WH; Feng, XY				Guo, Weihua; Feng, Xueyang			OM-FBA: Integrate Transcriptomics Data with Flux Balance Analysis to Decipher the Cell Metabolism	PLOS ONE			English	Article							EUKARYOTIC GENE-EXPRESSION; HIGH-THROUGHPUT PROTEOMICS; GENOME-SCALE MODELS; NCBI GEO ARCHIVE; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; FUNCTIONAL GENOMICS; SYSTEMS BIOLOGY; OMICS DATA; RECONSTRUCTION	Constraint-based metabolic modeling such as flux balance analysis (FBA) has been widely used to simulate cell metabolism. Thanks to its simplicity and flexibility, numerous algorithms have been developed based on FBA and successfully predicted the phenotypes of various biological systems. However, their phenotype predictions may not always be accurate in FBA because of using the objective function that is assumed for cell metabolism. To overcome this challenge, we have developed a novel computational framework, namely omFBA, to integrate multi-omics data (e.g. transcriptomics) into FBA to obtain omics-guided objective functions with high accuracy. In general, we first collected transcriptomics data and phenotype data from published database (e.g. GEO database) for different microorganisms such as Saccharomyces cerevisiae. We then developed a "Phenotype Match" algorithm to derive an objective function for FBA that could lead to the most accurate estimation of the known phenotype (e.g. ethanol yield). The derived objective function was next correlated with the transcriptomics data via regression analysis to generate the omics-guided objective function, which was next used to accurately simulate cell metabolism at unknown conditions. We have applied omFBA in studying sugar metabolism of S. cerevisiae and found that the ethanol yield could be accurately predicted in most of the cases tested (>80%) by using transcriptomics data alone, and revealed valuable metabolic insights such as the dynamics of flux ratios. Overall, omFBA presents a novel platform to potentially integrate multi-omics data simultaneously and could be incorporated with other FBA-derived tools by replacing the arbitrary objective function with the omics-guided objective functions.	[Guo, Weihua; Feng, Xueyang] Virginia Polytech Inst & State Univ, Dept Biol Syst Engn, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Feng, XY (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.	xueyang@vt.edu	Guo, Weihua/AGF-9090-2022	Feng, Xueyang/0000-0003-4426-5732	Virginia Tech [175323]	Virginia Tech	This study was supported by start-up fund (#175323) from Virginia Tech.; We thank the writing center in Virginia Tech for improving the language of the paper. This study was supported by start-up fund (#175323) from Virginia Tech.	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Celton M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-317; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; de Jong B, 2012, CURR OPIN BIOTECH, V23, P624, DOI 10.1016/j.copbio.2011.11.021; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Edgar R, 2006, NAT BIOTECHNOL, V24, P1471, DOI 10.1038/nbt1206-1471; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12; Feng XY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002376; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Frick O, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-30; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Hoppe A, 2012, METABOLITES, V2, P614, DOI 10.3390/metabo2030614; Hyduke DR, 2013, MOL BIOSYST, V9, P167, DOI 10.1039/c2mb25453k; Kenny J, 1962, THE STANDARD DEVIATI, V3, P77; Kim J, 2014, CURR OPIN BIOTECH, V29, P34, DOI 10.1016/j.copbio.2014.02.009; Kim MK, 2014, COMPUT STRUCT BIOTEC, V11, P59, DOI 10.1016/j.csbj.2014.08.009; King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049; Lakshmanan M, 2014, BRIEF BIOINFORM, V15, P108, DOI 10.1093/bib/bbs069; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Moxley JF, 2009, P NATL ACAD SCI USA, V106, P6477, DOI 10.1073/pnas.0811091106; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; Nogales J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79; O'Brien EJ, 2015, CURR OPIN BIOTECH, V34, P125, DOI 10.1016/j.copbio.2014.12.017; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Ott R, 2008, AN INTRODUCTION TO S; Poskar CH, 2014, METHODS MOL BIOL, V1090, P223, DOI 10.1007/978-1-62703-688-7_14; Raghevendran V, 2004, YEAST, V21, P769, DOI 10.1002/yea.1136; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; RodriguezTome P, 1996, NUCLEIC ACIDS RES, V24, P6, DOI 10.1093/nar/24.1.6; Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103; Saha R, 2014, CURR OPIN BIOTECH, V29, P39, DOI 10.1016/j.copbio.2014.02.011; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Schuetz R, SYSTEMATIC EVALUATIO; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Sundararaman Niveda, 2015, BMC Res Notes, V8, P771, DOI 10.1186/s13104-015-1759-7; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wiechert W, 2007, CURR OPIN PLANT BIOL, V10, P323, DOI 10.1016/j.pbi.2007.04.015; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0; Zhang ZR, 2014, ANNU REV ANAL CHEM, V7, P427, DOI 10.1146/annurev-anchem-071213-020216; Zur H, 2010, BIOINFORMATICS, V26, P3140, DOI 10.1093/bioinformatics/btq602	53	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154188	10.1371/journal.pone.0154188	http://dx.doi.org/10.1371/journal.pone.0154188			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100883	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500164
J	Li, YG; Han, BB; Li, F; Yu, JW; Dong, ZF; Niu, GM; Qing, YW; Li, JB; Wei, M; Zhu, W				Li, Yong-Guang; Han, Bei-Bei; Li, Feng; Yu, Jian-Wu; Dong, Zhi-Feng; Niu, Geng-Ming; Qing, Yan-Wei; Li, Jing-Bo; Wei, Meng; Zhu, Wei			High Glucose Induces Down-Regulated GRIM-19 Expression to Activate STAT3 Signaling and Promote Cell Proliferation in Cell Culture	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CANCER-CELLS; HEPG2 CELLS; COMPLEX-I; AMPK; PROTEIN; PHOSPHORYLATION; PATHWAY; RISK; TUMORIGENESIS	Recent studies indicated that Gene Associated with Retinoid-IFN-Induced Mortality 19 (GRIM-19), a newly discovered mitochondria-related protein, can regulate mitochondrial function and modulate cell viability possibly via interacting with STAT3 signal. In the present study we sought to test: 1) whether GRIM-19 is involved in high glucose (HG) induced altered cell metabolism in both cancer and cardiac cells, 2) whether GRIM-19/STAT3 signaling pathway plays a role in HG induced biological effects, especially whether AMPK activity could be involved. Our data showed that HG enhanced cell proliferation of both HeLa and H9C2 cells, which was closely associated with down-regulated GRIM-19 expression and increased phosphorylated STAT3 level. We showed that GRIM-19 knock-down alone in normal glucose cultured cells can also result in an increase in phosphorylated STAT3 level and enhanced proliferation capability, whereas GRIM-19 over-expression can abolished HG induced STAT3 activation and enhanced cell proliferation. Importantly, both down-regulated or over-expression of GRIM-19 increased lactate production in both HeLa and H9C2 cells. The activated STAT3 was responsible for increased cell proliferation as either AG-490, an inhibitor of JAK2, or siRNA targeting STAT3 can attenuate cell proliferation increased by HG. In addition, HG increased lactate acid levels in HeLa cells, which was also observed when GRIM-19 was genetically manipulated. However, HG did not affect the lactate levels in H9C2 cells. Of note, over-expression of GRIM-19 and silencing of STAT3 both increased lactate production in H9C2 cells. As expected, HG resulted in significant decreases in phosphorylated AMPKa levels in H9C2 cells, but not in HeLa cells. Interestingy, activation of AMPKa by metformin was associated with a reversal of the suppressed GRIM-19 expression in H9C2 cells, the fold of changes in GRIM-19 expression by metformin were much less in HeLa cells. Metformin did not affect the phosphorylated STAT3 lelvels, however, decreased its levels in H9C2, especially in the setting of HG culture. Not like HG alone which resulted in no changes in lactate acid in H9C2 cells, metformin can increase lactate acid levels in H9C2 cells. Increased lactate induced by metformin was also observed in HeLa cells.	[Li, Yong-Guang; Han, Bei-Bei; Li, Feng; Dong, Zhi-Feng; Niu, Geng-Ming; Qing, Yan-Wei; Li, Jing-Bo; Wei, Meng; Zhu, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Heart, State Key Discipline Div, Shanghai 200030, Peoples R China; [Yu, Jian-Wu] Zhejiang Prov Peoples Hosp, Div Cardiol, Hangzhou, Zhejiang, Peoples R China; [Zhu, Wei] Zhejiang Univ, Prov Key Lab Cardiovasc Res, Dept Cardiol, Sch Med,Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Zhejiang Provincial People's Hospital; Zhejiang University	Wei, M; Zhu, W (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Heart, State Key Discipline Div, Shanghai 200030, Peoples R China.; Zhu, W (corresponding author), Zhejiang Univ, Prov Key Lab Cardiovasc Res, Dept Cardiol, Sch Med,Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	weim.sjtu6h@hotmail.com; weizhu65@zju.edu.cn	NIU, NIU/AAA-1523-2022		National Natural Science Foundation of China [81070110, 81370346]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (#81070110 to M. Wei, #81370346 to W. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (#81070110 to M. Wei, #81370346 to W. Zhu).	Biasutto L, 2010, MITOCHONDRION, V10, P670, DOI 10.1016/j.mito.2010.06.004; Bu XM, 2013, GENE, V512, P198, DOI 10.1016/j.gene.2012.10.057; Chen Y, 2012, J BIOL CHEM, V287, P27227, DOI 10.1074/jbc.M112.340315; Garcia-Jimenez C, 2014, J MOL ENDOCRINOL, V52, pR51, DOI 10.1530/JME-13-0152; Gorgani-Firuzjaee S, 2015, FREE RADICAL BIO MED, V89, P679, DOI 10.1016/j.freeradbiomed.2015.10.036; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Guo YL, 2015, BBA-MOL BASIS DIS, V1852, P319, DOI 10.1016/j.bbadis.2014.05.017; He CY, 2013, DIABETES, V62, P1270, DOI 10.2337/db12-0533; Hervouet E, 2005, CARCINOGENESIS, V26, P531, DOI 10.1093/carcin/bgi001; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kalakonda S, 2013, P NATL ACAD SCI USA, V110, pE4213, DOI 10.1073/pnas.1303760110; Kalvakolanu DV, 2010, CYTOKINE, V52, P128, DOI 10.1016/j.cyto.2010.03.009; Kim JE, 2014, CANCERS, V6, P376, DOI 10.3390/cancers6010376; Kostromina E, 2010, ENDOCRINOLOGY, V151, P2050, DOI 10.1210/en.2009-1199; LeRoith D, 2008, EXP CLIN ENDOCR DIAB, V116, pS4, DOI 10.1055/s-2008-1081488; Li YG, 2013, ONCOL REP, V30, P2820, DOI 10.3892/or.2013.2748; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Liu Q, 2013, CARCINOGENESIS, V34, P1728, DOI 10.1093/carcin/bgt125; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Mackenzie GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061532; Mashili F, 2013, DIABETES, V62, P457, DOI 10.2337/db12-0337; Do MT, 2013, TOXICOL APPL PHARM, V271, P229, DOI 10.1016/j.taap.2013.05.010; Moon YM, 2014, ARTHRITIS RHEUMATOL, V66, P569, DOI 10.1002/art.38267; Nallar SC, 2013, J BIOL CHEM, V288, P7930, DOI 10.1074/jbc.M112.440610; Okamoto T, 2010, MOL CANCER THER, V9, P2333, DOI 10.1158/1535-7163.MCT-09-1147; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Rapp K, 2006, DIABETOLOGIA, V49, P945, DOI 10.1007/s00125-006-0207-6; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225; Vieira E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069939; Zhang QF, 2013, J BIOL CHEM, V288, P31280, DOI 10.1074/jbc.M113.505057	33	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153659	10.1371/journal.pone.0153659	http://dx.doi.org/10.1371/journal.pone.0153659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101310	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500047
J	van Loon, EPM; Little, R; Prehar, S; Bindels, RJM; Cartwright, EJ; Hoenderop, JGJ				van Loon, Ellen P. M.; Little, Robert; Prehar, Sukhpal; Bindels, Rene J. M.; Cartwright, Elizabeth J.; Hoenderop, Joost G. J.			Calcium Extrusion Pump PMCA4: A New Player in Renal Calcium Handling?	PLOS ONE			English	Article							ACTIVE CA2+ REABSORPTION; EPITHELIAL CA2+; KNOCKOUT MICE; VITAMIN-D; PARATHYROID-HORMONE; COORDINATED CONTROL; TRANSPORT PROTEINS; SPERM MOTILITY; MALE-FERTILITY; KIDNEY	Calcium (Ca2+) is vital for multiple processes in the body, and maintenance of the electrolyte concentration is required for everyday physiological function. In the kidney, and more specifically, in the late distal convoluted tubule and connecting tubule, the fine-tuning of Ca2+ reabsorption from the pro-urine takes place. Here, Ca2+ enters the epithelial cell via the transient receptor potential vanilloid receptor type 5 (TRPV5) channel, diffuses to the basolateral side bound to calbindin-D-28k and is extruded to the blood compartment via the Na+/Ca2+ exchanger 1 (NCX1) and the plasma membrane Ca2+ ATPase (PMCA). Traditionally, PMCA1 was considered to be the primary Ca2+ pump in this process. However, in recent studies TRPV5-expressing tubules were shown to highly express PMCA4. Therefore, PMCA4 may have a predominant role in renal Ca2+ handling. This study aimed to elucidate the role of PMCA4 in Ca2+ homeostasis by characterizing the Ca2+ balance, and renal and duodenal Ca2+-related gene expression in PMCA4 knockout mice. The daily water intake of PMCA4 knockout mice was significantly lower compared to wild type littermates. There was no significant difference in serum Ca2+ level or urinary Ca2+ excretion between groups. In addition, renal and duodenal mRNA expression levels of Ca2+-related genes, including TRPV5, TRPV6, calbindin-D-28k, calbindin-D-9k, NCX1 and PMCA1 were similar in wild type and knockout mice. Serum FGF23 levels were significantly increased in PMCA4 knockout mice. In conclusion, PMCA4 has no discernible role in normal renal Ca2+ handling as no urinary Ca2+ wasting was observed. Further investigation of the exact role of PMCA4 in the distal convoluted tubule and connecting tubule is required.	[van Loon, Ellen P. M.; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Dept Physiol, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Little, Robert; Prehar, Sukhpal; Cartwright, Elizabeth J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Cardiovasc Sci, Manchester, Lancs, England	Radboud University Nijmegen; University of Manchester	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Dept Physiol, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	Joost.Hoenderop@radboudumc.nl	Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; Cartwright, Elizabeth/0000-0002-6836-7795	Dutch Kidney Foundation [CP10.11]; Medical Research Council UK [G1002082]; MRC [G0802004, G1002082] Funding Source: UKRI; Medical Research Council [G1002082, G0802004] Funding Source: researchfish	Dutch Kidney Foundation; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project is part of the NIGRAM consortium, financially supported by the Dutch Kidney Foundation (CP10.11). EPML, RJMB and JGJH received this funding. This project was also funded by the Medical Research Council (G1002082) UK. RL, SP and EJC received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RT, 2015, AM J PHYSIOL-RENAL, V309, pF604, DOI 10.1152/ajprenal.00651.2014; Alexander RT, 2009, J AM SOC NEPHROL, V20, P2371, DOI 10.1681/ASN.2008121273; Bai XY, 2004, ENDOCRINOLOGY, V145, P5269, DOI 10.1210/en.2004-0233; BODEN SD, 1990, ORTHOP CLIN N AM, V21, P31; Bouillon R, 2003, J CELL BIOCHEM, V88, P332, DOI 10.1002/jcb.10360; Brini M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004168; Buch MH, 2005, J BIOL CHEM, V280, P29479, DOI 10.1074/jbc.M501326200; Bushinsky DA, 2010, CLIN J AM SOC NEPHRO, V5, pS12, DOI 10.2215/CJN.05970809; Cartwright EJ, 2011, SCI CHINA LIFE SCI, V54, P691, DOI 10.1007/s11427-011-4199-1; Chen J, 2004, NAT IMMUNOL, V5, P651, DOI 10.1038/ni1072; Cho CH, 2000, MOL CELLS, V10, P712; Dimke H, 2010, CLIN SCI, V118, P1, DOI 10.1042/CS20090086; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Gkika D, 2006, J AM SOC NEPHROL, V17, P3020, DOI 10.1681/ASN.2006060676; Hoenderop JGJ, 2000, AM J PHYSIOL-RENAL, V278, pF352, DOI 10.1152/ajprenal.2000.278.3.F352; Hoenderop JGJ, 2000, J AM SOC NEPHROL, V11, P1171, DOI 10.1681/ASN.V1171171; Hoenderop JGJ, 2005, J AM SOC NEPHROL, V16, P15, DOI 10.1681/ASN.2004070523; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Hoenderop JGJ, 2002, ANNU REV PHYSIOL, V64, P529, DOI 10.1146/annurev.physiol.64.081501.155921; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Hoorn EJ, 2013, PEDIATR NEPHROL, V28, P1195, DOI 10.1007/s00467-012-2350-2; HOWARD A, 1993, AM J PHYSIOL, V265, pG917, DOI 10.1152/ajpgi.1993.265.5.G917; Huybers S, 2008, INFLAMM BOWEL DIS, V14, P803, DOI 10.1002/ibd.20385; Kim HJ, 2012, J CELL BIOL, V199, P1145, DOI 10.1083/jcb.201204067; Lambers TT, 2006, KIDNEY INT, V69, P650, DOI 10.1038/sj.ki.5000169; Lameris AL, 2015, AM J PHYSIOL-GASTR L, V308, pG206, DOI 10.1152/ajpgi.00093.2014; Lee CT, 2002, KIDNEY INT, V62, P2055, DOI 10.1046/j.1523-1755.2002.00670.x; Mohamed TMA, 2011, J BIOL CHEM, V286, P41520, DOI 10.1074/jbc.M111.290411; Nilius B, 2002, J BIOL CHEM, V277, P30852, DOI 10.1074/jbc.M202418200; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Pulskens WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142510; Renkema KY, 2008, ANN MED, V40, P82, DOI 10.1080/07853890701689645; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; Renkema KY, 2005, J AM SOC NEPHROL, V16, P3188, DOI 10.1681/ASN.2005060632; Ryan ZC, 2015, BIOCHEM BIOPH RES CO, V467, P152, DOI 10.1016/j.bbrc.2015.09.087; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Sooy K, 2000, CURR OPIN NEPHROL HY, V9, P341, DOI 10.1097/00041552-200007000-00004; STAUFFER TP, 1993, J BIOL CHEM, V268, P25993; van Abel M, 2005, KIDNEY INT, V68, P1708, DOI 10.1111/j.1523-1755.2005.00587.x; van der Hagen EAE, 2014, PFLUG ARCH EUR J PHY, V466, P2077, DOI 10.1007/s00424-014-1470-x; van Loon EPM, 2015, AM J PHYSIOL-RENAL, V309, pF359, DOI 10.1152/ajprenal.00240.2014; VanBaal J, 1996, AM J PHYSIOL-RENAL, V271, pF985, DOI 10.1152/ajprenal.1996.271.5.F985; White KE, 1997, J GEN PHYSIOL, V109, P217, DOI 10.1085/jgp.109.2.217; Woudenberg-Vrenken TE, 2009, NAT REV NEPHROL, V5, P441, DOI 10.1038/nrneph.2009.100; Zheng W, 2004, J BIOL CHEM, V279, P52406, DOI 10.1074/jbc.M405562200	46	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153483	10.1371/journal.pone.0153483	http://dx.doi.org/10.1371/journal.pone.0153483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101128	gold, Green Submitted, Green Published			2022-12-27	WOS:000374898500034
J	Zhang, YJ; Thas, O				Zhang, Yingjie; Thas, Olivier			Constrained Ordination Analysis with Enrichment of Bell-Shaped Response Functions	PLOS ONE			English	Article							CANONICAL CORRESPONDENCE-ANALYSIS; GENERALIZED LINEAR-MODELS; SPECIES DISTRIBUTION; GAUSSIAN ORDINATION; GRADIENT ANALYSIS; ECOLOGICAL THEORY; BETA-FUNCTION; VEGETATION; SKEWNESS	Constrained ordination methods aims at finding an environmental gradient along which the species abundances are maximally separated. The species response functions, which describe the expected abundance as a function of the environmental score, are according to the ecological fundamental niche theory only meaningful if they are bell-shaped. Many classical model-based ordination methods, however, use quadratic regression models without imposing the bell-shape and thus allowing for meaningless U-shaped response functions. The analysis output (e.g. a biplot) may therefore be potentially misleading and the conclusions are prone to errors. In this paper we present a log-likelihood ratio criterion with a penalisation term to enforce more bell-shaped response shapes. We report the results of a simulation study and apply our method to metagenomics data from microbial ecology.	[Zhang, Yingjie; Thas, Olivier] Univ Ghent, Dept Math Modelling Stat & Bioinformat, Coupure Links 653, B-9000 Ghent, Belgium; [Thas, Olivier] Univ Wollongong, Sch Math & Appl Stat, NIASRA, Northfields Ave, Wollongong, NSW 2522, Australia	Ghent University; University of Wollongong	Zhang, YJ (corresponding author), Univ Ghent, Dept Math Modelling Stat & Bioinformat, Coupure Links 653, B-9000 Ghent, Belgium.	Yingjie.Zhang@UGent.be	Zhang, Yingjie/HHM-3016-2022	Thas, Olivier/0000-0001-6442-4089	IAP research network grant of the Belgian Science Policy [P7/06]; Ghent University	IAP research network grant of the Belgian Science Policy; Ghent University(Ghent University)	This research was supported by IAP research network grant P7/06 of the Belgian Science Policy and by the Multidisciplinary Research Partnership Bioinformatics: from nucleotides to networks of Ghent University.	[Anonymous], 1988, ADV ECOL RES; Antoniadis A, 2011, ANN I STAT MATH, V63, P585, DOI 10.1007/s10463-009-0242-4; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Austin MP, 1999, OIKOS, V86, P170, DOI 10.2307/3546582; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Ellers PHC, 2005, J CHEMOMETR, V19, P317, DOI 10.1002/cem.935; GAUCH HG, 1974, ECOLOGY, V55, P1382, DOI 10.2307/1935466; Greenacre M., 2007, CORRES ANAL PRACTICE; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; HUISMAN J, 1993, J VEG SCI, V4, P37, DOI 10.2307/3235732; Johnson KW, 1999, ENVIRONMETRICS, V10, P39, DOI 10.1002/(SICI)1099-095X(199901/02)10:1<39::AID-ENV334>3.3.CO;2-V; Karadzic B, 2003, J VEG SCI, V14, P799, DOI 10.1111/j.1654-1103.2003.tb02212.x; Li ZL, 2012, CAN J STAT, V40, P745, DOI 10.1002/cjs.11165; Oksanen J, 1997, J VEG SCI, V8, P147, DOI 10.2307/3237252; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rosset S, 2007, ANN STAT, V35, P1012, DOI 10.1214/009053606000001370; ter Braak CJF, 2014, COMP SCI DATA ANAL S, P61; ter Braak CJF, 2015, PLANT ECOL, V216, P683, DOI 10.1007/s11258-014-0356-5; ter Braak CJF, 2010, GENETICS, V185, P1045, DOI 10.1534/genetics.110.117390; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Verleyen E, 2012, ANTARCT SCI, V24, P23, DOI 10.1017/S0954102011000642; WHITTAKER RH, 1967, BIOL REV, V42, P207, DOI 10.1111/j.1469-185X.1967.tb01419.x; Yee TW, 2004, ECOL MONOGR, V74, P685, DOI 10.1890/03-0078; Yee TW, 2003, STAT MODEL, V3, P15, DOI 10.1191/1471082X03st045oa; Zhang YJ, 2012, STAT MODEL, V12, P463, DOI 10.1177/1471082X12460129; Zhu M, 2005, ECOL MODEL, V187, P524, DOI 10.1016/j.ecolmodel.2005.01.049	26	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154079	10.1371/journal.pone.0154079	http://dx.doi.org/10.1371/journal.pone.0154079			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100464	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500137
J	Lamb, F; Ploner, A; Fink, K; Maeurer, M; Bergman, P; Piehl, F; Weibel, D; Sparen, P; Arnheim-Dahlstrom, L				Lamb, Favelle; Ploner, Alexander; Fink, Katharina; Maeurer, Markus; Bergman, Peter; Piehl, Fredrik; Weibel, Daniel; Sparen, Par; Arnheim-Dahlstrom, Lisen			No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination	PLOS ONE			English	Article							PANDEMRIX VACCINATION; H1N1 INFECTION; INFLUENZA; ONSET; ASSOCIATION; ANTIBODIES; DISORDER; CHILDREN	Objectives To investigate disease history before A(H1N1)pdm09 vaccination as a risk factor for narcolepsy. Methods Case-control study in Sweden. Cases included persons referred for a Multiple Sleep Latency Test between 2009 and 2010, identified through diagnostic sleep centres and confirmed through independent review of medical charts. Controls, selected from the total population register, were matched to cases on age, gender, MSLT-referral date and county of residence. Disease history (prescriptions and diagnoses) and vaccination history was collected through telephone interviews and population-based healthcare registers. Conditional logistic regression was used to investigate disease history before A(H1N1)pdm09 vaccination as a risk-factor for narcolepsy. Results In total, 72 narcolepsy cases and 251 controls were included (range 3-69 years mean 19-years). Risk of narcolepsy was increased in individuals with a disease history of nervous system disorders (OR range = 3.6-8.8) and mental and behavioural disorders (OR = 3.8, 95% CI 1.6-8.8) before referral. In a second analysis of vaccinated individuals only, nearly all initial associations were no longer statistically significant and effect sizes were smaller (OR range = 1.3-2.6). A significant effect for antibiotics (OR = 0.4, 95% CI 0.2-0.8) and a marginally significant effect for nervous system disorders was observed. In a third case-only analysis, comparing cases referred before vaccination to those referred after; prescriptions for nervous system disorders (OR = 26.0 95% CI 4.0-170.2) and ADHD (OR = 35.3 95% CI 3.4-369.9) were statistically significant during the vaccination period, suggesting initial associations were due to confounding by indication. Conclusion The findings of this study do not support disease history before A(H1N1)pdm09 vaccination as a risk factor for narcolepsy.	[Lamb, Favelle; Ploner, Alexander; Sparen, Par; Arnheim-Dahlstrom, Lisen] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Fink, Katharina; Piehl, Fredrik] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Maeurer, Markus] Karolinska Hosp, CAST Ctr Allogen Stem Cell Transplantat, Stockholm, Sweden; [Maeurer, Markus] LabMed Karolinska Inst, Div Therapeut Immunol TIM, Stockholm, Sweden; [Bergman, Peter] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Huddinge, Sweden; [Bergman, Peter] Karolinska Univ Hosp, Huddinge, Sweden; [Weibel, Daniel] Erasmus Univ, Dept Med Informat, Med Ctr, NL-3000 DR Rotterdam, Netherlands	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Erasmus University Rotterdam; Erasmus MC	Arnheim-Dahlstrom, L (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	lisen.arnheim.dahlstrom@ki.se		Ploner, Alexander/0000-0002-5042-8326; Bergman, Peter/0000-0003-3306-3713; Sparen, Par/0000-0002-5184-8971; Maeurer, Markus/0000-0002-8436-8077	Biogen Idec; GlaxoSmithKline; MSD Sanofi Pasteur; Merck Sharp Dome	Biogen Idec(Biogen); GlaxoSmithKline(GlaxoSmithKline); MSD Sanofi Pasteur; Merck Sharp Dome	The authors of this manuscript have the following competing interests: Favelle Lamb and Alexander Ploner have no conflicts of interest, Katharina Fink has received funding for a fellowship in multiple sclerosis research from Biogen Idec, GlaxoSmithKline for studies other than the study presented here. Markus Maeurer, Peter Bergman, Fredrik Piehl and Daniel Weibel have no conflicts of interest. Par Sparen has received funding from GlaxoSmithKline for a register-based study on H1N1 vaccinations and risk of epilepsy and Lisen Arnheim-Dahlstrom has received funding from MSD Sanofi Pasteur, Merck Sharp & Dome and GlaxoSmithKline for studies other than the study presented here. The authors confirm that the information included in the competing interest section does not alter their adherence to PLOS ONE policies on sharing data and materials.	Ahmed SS, 2014, J AUTOIMMUN, V50, P1, DOI 10.1016/j.jaut.2014.01.033; Ambati A, 2015, J INTERN MED, V278, P264, DOI 10.1111/joim.12355; Ambati A, 2015, IMMUNOLOGY, V145, P357, DOI 10.1111/imm.12448; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bonhoeffer J, 2002, VACCINE, V21, P298, DOI 10.1016/S0264-410X(02)00449-8; European Centre for Disease Prevention and Control, NARC ASS PAND INFL V; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Fitzgerald KT, 2013, TOP COMPANION ANIM M, V28, P2, DOI 10.1053/j.tcam.2013.03.002; GREENLAND S, 1982, AM J EPIDEMIOL, V116, P547, DOI 10.1093/oxfordjournals.aje.a113439; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Han F, 2013, ANN NEUROL, V73, P560, DOI 10.1002/ana.23799; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Heier MS, 2013, SLEEP MED, V14, P867, DOI 10.1016/j.sleep.2013.03.020; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Lakemedelsverket, 2011, OCC NARC CAT CHILDR; Lakemedelsverket, 2011, REG BAS COMP COH STU; Lind A, 2014, J AUTOIMMUN, V50, P99, DOI 10.1016/j.jaut.2014.01.031; Ludvigsson JF, 2016, EUROPEAN J EPIDEMIOL; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Modestino EJ, 2013, J ATTEN DISORD, V17, P574, DOI 10.1177/1087054713480033; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Oosterloo M, 2006, PSYCHIAT RES, V143, P293, DOI 10.1016/j.psychres.2006.02.009; Partinen M, 2014, LANCET NEUROL, V13, P600, DOI 10.1016/S1474-4422(14)70075-4; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Picchioni D, 2007, NEUROEPIDEMIOLOGY, V29, P185, DOI 10.1159/000111581; SCB, 2014, POP STAT; SCB, 2015, STAT DAT; Singh AK, 2013, J AUTOIMMUN, V43, P26, DOI 10.1016/j.jaut.2013.02.003; Socialstyrelsen, 2015, NAT PAT REG NPR INF; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thebault S, 2013, CURR OPIN PULM MED, V19, P587, DOI 10.1097/MCP.0b013e328365af97; Vaarala O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114361	35	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154296	10.1371/journal.pone.0154296	http://dx.doi.org/10.1371/journal.pone.0154296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120092	Green Published, gold			2022-12-27	WOS:000374976200056
J	Liu, S; Wang, YY; Fan, X; Ma, J; Ma, WB; Wang, RZ; Jiang, T				Liu, Shuai; Wang, Yinyan; Fan, Xing; Ma, Jun; Ma, Wenbin; Wang, Renzhi; Jiang, Tao			Anatomical Involvement of the Subventricular Zone Predicts Poor Survival Outcome in Low-Grade Astrocytomas	PLOS ONE			English	Article							NEURAL STEM-CELLS; AVIAN-SARCOMA VIRUS; GLIOBLASTOMA-MULTIFORME; SUBEPENDYMAL PLATE; ADULT BRAIN; GLIOMA; HETEROGENEITY; IRRADIATION; PRECURSORS; INDUCTION	The subventricular zone (SVZ) has been implicated in the origination, development, and biological behavior of gliomas. Tumor-SVZ contact is also postulated to be a poor prognostic factor in glioblastomas. We aimed to evaluate the prognostic consequence of the anatomical involvement of low-grade gliomas with the SVZ. To that end, we reviewed 143 patients with diffuse astrocytomas, and tumor lesions were manually delineated on magnetic resonance images. We initially investigated the prognostic role of SVZ contact in all patients. Additionally, we investigated the influence of the anatomical proximity of the tumor lesion centroids to the SVZ in the SVZ-involved patient cohorts, as well as location within the SVZ. We found SVZ contact with tumors to be a significant prognostic factor of overall survival in all patients with diffuse astrocytomas (p = 0.027). In the SVZ-involved cohort, a shorter distance from the tumor centroid to the SVZ (<= 30 mm) correlated with shorter overall survival (p = 0.022) on univariate analysis. However, there was no significant difference in overall survival with respect to the SVZ region involved with the tumor (p = 0.930). Multivariate analysis showed that a shorter distance between the tumor centroid and the SVZ (p = 0.039) was significantly associated with poor overall survival in SVZ-involved patients. Hence, this study helps establish the prognostic role of the anatomical interaction of tumors with the SVZ in low-grade astrocytomas.	[Liu, Shuai; Ma, Wenbin; Wang, Renzhi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100730, Peoples R China; [Liu, Shuai; Ma, Wenbin; Wang, Renzhi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Yinyan; Fan, Xing; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Wang, Yinyan; Jiang, Tao] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Ma, Jun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China; [Jiang, Tao] Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Beijing Neurosurgical Institute; Capital Medical University; Capital Medical University	Wang, RZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100730, Peoples R China.; Wang, RZ (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.; Jiang, T (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Jiang, T (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China.; Jiang, T (corresponding author), Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing, Peoples R China.	wangrz@126.com; taojiang1964@163.com	jiang, tao/GWC-7108-2022; Wang, Yinyan/AAJ-1160-2020	Fan, Xing/0000-0003-2622-2210; Liu, Shuai/0000-0001-6233-4055	National 973 Program [2015CB755500]; Research Special Fund for Public Welfare industry of health [201402008]	National 973 Program(National Basic Research Program of China); Research Special Fund for Public Welfare industry of health	Funding for this work was provided by the National 973 Program (No. 2015CB755500) [Tao Jiang], http://www.973.gov.cn; and the Research Special Fund for Public Welfare industry of health (No. 201402008) [Wenbin Ma], http://www.shenjingzhongliu.org.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Adeberg S, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-95; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; Barami K, 2009, J CLIN NEUROSCI, V16, P195, DOI 10.1016/j.jocn.2008.03.006; Bohman LE, 2010, NEUROSURGERY, V67, P1319, DOI 10.1227/NEU.0b013e3181f556ab; Bourkoula E, 2014, STEM CELLS, V32, P1239, DOI 10.1002/stem.1605; Chaichana KL, 2013, J CLIN NEUROSCI, V20, P1422, DOI 10.1016/j.jocn.2013.02.007; Chen LD, 2013, INT J RADIAT ONCOL, V86, P616, DOI 10.1016/j.ijrobp.2013.02.014; COPELAND DD, 1977, ACTA NEUROPATHOL, V38, P1, DOI 10.1007/BF00691268; COPELAND DD, 1975, J NEUROPATH EXP NEUR, V34, P340, DOI 10.1097/00005072-197507000-00004; Ellingson BM, 2012, NEUROIMAGE, V59, P908, DOI 10.1016/j.neuroimage.2011.09.076; Evers P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-384; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Filatova A, 2013, BBA-GEN SUBJECTS, V1830, P2496, DOI 10.1016/j.bbagen.2012.10.008; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Giachino C, 2014, STEM CELLS, V32, P70, DOI 10.1002/stem.1520; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Goffart Nicolas, 2013, Cancers (Basel), V5, P1049, DOI 10.3390/cancers5031049; Gupta T, 2012, J NEURO-ONCOL, V109, P195, DOI 10.1007/s11060-012-0887-3; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; Holland EC, 2001, CURR OPIN NEUROL, V14, P683, DOI 10.1097/00019052-200112000-00002; Jafri NF, 2013, NEURO-ONCOLOGY, V15, P91, DOI 10.1093/neuonc/nos268; Jeon JY, 2008, EXP MOL MED, V40, P84, DOI 10.3858/emm.2008.40.1.84; Kelsch W, 2007, PLOS BIOL, V5, P2501, DOI 10.1371/journal.pbio.0050300; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Nabilsi NH, 2014, GENOME RES, V24, P329, DOI 10.1101/gr.161737.113; Pallud J, 2012, NEUROSURGERY, V71, P729, DOI 10.1227/NEU.0b013e31826213de; Rhoton AL, 2002, NEUROSURGERY, V51, pS207, DOI 10.1227/01.NEU.0000028161.91504.4F; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; VICK NA, 1977, ACTA NEUROPATHOL, V40, P63, DOI 10.1007/BF00688574; Young GS, 2011, J NEURO-ONCOL, V104, P261, DOI 10.1007/s11060-010-0477-1; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	39	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154539	10.1371/journal.pone.0154539	http://dx.doi.org/10.1371/journal.pone.0154539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120204	Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200087
J	Kooi, IE; Mol, BM; Massink, MPG; de Jong, MC; de Graaf, P; van der Valk, P; Meijers-Heijboer, H; Kaspers, GJL; Moll, AC; te Riele, H; Cloos, J; Dorsman, JC				Kooi, Irsan E.; Mol, Berber M.; Massink, Maarten P. G.; de Jong, Marcus C.; de Graaf, Pim; van der Valk, Paul; Meijers-Heijboer, Hanne; Kaspers, Gertjan J. L.; Moll, Annette C.; te Riele, Hein; Cloos, Jacqueline; Dorsman, Josephine C.			A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CHILDHOOD-CANCER; IN-VITRO; SOX4; EXPRESSION; RETINOMA; SEGMENTATION; IMBALANCES; KARYOTYPE; SURVIVAL	Background While RB1 loss initiates retinoblastoma development, additional somatic copy number alterations (SCNAs) can drive tumor progression. Although SCNAs have been identified with good concordance between studies at a cytoband resolution, accurate identification of single genes for all recurrent SCNAs is still challenging. This study presents a comprehensive meta-analysis of genome-wide SCNAs integrated with gene expression profiling data, narrowing down the list of plausible retinoblastoma driver genes. Methods We performed SCNA profiling of 45 primary retinoblastoma samples and eight retinoblastoma cell lines by high-resolution microarrays. We combined our data with genomic, clinical and histopathological data of ten published genome-wide SCNA studies, which strongly enhanced the power of our analyses (N = 310). Results Comprehensive recurrence analysis of SCNAs in all studies integrated with gene expression data allowed us to reduce candidate gene lists for 1q, 2p, 6p, 7q and 13q to a limited gene set. Besides the well-established driver genes RB1 (13q-loss) and MYCN (2p-gain) we identified CRB1 and NEK7 (1q-gain), SOX4 (6p-gain) and NUP205 (7q-gain) as novel retinoblastoma driver candidates. Depending on the sample subset and algorithms used, alternative candidates were identified including MIR181 (1q-gain) and DEK (6p gain). Remarkably, our study showed that copy number gains rarely exceeded change of one copy, even in pure tumor samples with 100% homozygosity at the RB1 locus (N = 34), which is indicative for intra-tumor heterogeneity. In addition, profound between-tumor variability was observed that was associated with age at diagnosis and differentiation grades. Interpretation Since focal alterations at commonly altered chromosome regions were rare except for 2p24.3 (MYCN), further functional validation of the oncogenic potential of the described candidate genes is now required. For further investigations, our study provides a refined and revised set of candidate retinoblastoma driver genes.	[Kooi, Irsan E.; Mol, Berber M.; Meijers-Heijboer, Hanne; Dorsman, Josephine C.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Massink, Maarten P. G.] Univ Med Ctr Utrecht, Dept Biomed Genet, Utrecht, Netherlands; [de Jong, Marcus C.; de Graaf, Pim] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [van der Valk, Paul] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Kaspers, Gertjan J. L.; Cloos, Jacqueline] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Oncol Hematol, Amsterdam, Netherlands; [Moll, Annette C.] Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [te Riele, Hein] Netherlands Canc Inst, Div Biol Stress Response, Amsterdam, Netherlands; [Cloos, Jacqueline] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Netherlands Cancer Institute; Vrije Universiteit Amsterdam	Dorsman, JC (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands.	jc.dorsman@vumc.nl	Kaspers, Gertjan/ABC-5334-2020	Kaspers, Gertjan/0000-0001-7716-8475; Massink, Maarten/0000-0002-7845-6038; Cloos, Jacqueline/0000-0001-9150-8026	VUmc CCA (VU University Medical Center Cancer Center Amsterdam foundation) [CCA20083-05]; KIKA (Dutch Children Cancer-Free foundation) [98]	VUmc CCA (VU University Medical Center Cancer Center Amsterdam foundation); KIKA (Dutch Children Cancer-Free foundation)	The research was supported by grants from VUmc CCA (VU University Medical Center Cancer Center Amsterdam foundation) grant number CCA20083-05 and KIKA (Dutch Children Cancer-Free foundation) grant number 98. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2009, BRIT J CANCER, V100, P511, DOI 10.1038/sj.bjc.6604884; Chen DN, 2001, CANCER GENET CYTOGEN, V129, P57, DOI 10.1016/S0165-4608(01)00427-7; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Eagle RC, 2009, ARCH PATHOL LAB MED, V133, P1203, DOI 10.1043/1543-2165-133.8.1203; Fujitomo T, 2012, CANCER RES, V72, P4110, DOI 10.1158/0008-5472.CAN-12-0159; Ganguly A, 2009, RETINA-J RET VIT DIS, V29, P1002, DOI 10.1097/IAE.0b013e3181a0be05; Gratias S, 2007, CANCER RES, V67, P408, DOI 10.1158/0008-5472.CAN-06-1317; Herzog S, 2001, HUM GENET, V108, P98, DOI 10.1007/s004390000450; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Hur W, 2010, CARCINOGENESIS, V31, P1298, DOI 10.1093/carcin/bgq072; Jacobson SG, 2003, HUM MOL GENET, V12, P1073, DOI 10.1093/hmg/ddg117; Jee HJ, 2010, CELL CYCLE, V9, P4703, DOI 10.4161/cc.9.23.14059; Kapatai G, 2013, BRIT J CANCER, V109, P512, DOI 10.1038/bjc.2013.283; Karolchik Donna, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s40; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kooi IE, 2015, EBIOMEDICINE, V2, P660, DOI 10.1016/j.ebiom.2015.06.022; Lillington DM, 2003, GENE CHROMOSOME CANC, V36, P121, DOI 10.1002/gcc.10149; Lin BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010210; Linabery AM, 2008, CANCER, V112, P416, DOI 10.1002/cncr.23169; Mairal A, 2000, GENE CHROMOSOME CANC, V28, P370, DOI 10.1002/1098-2264(200008)28:4<370::AID-GCC2>3.0.CO;2-8; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Mol BM, 2014, GENE CHROMOSOME CANC, V53, P1, DOI 10.1002/gcc.22111; Nassirpour R, 2010, MOL CANCER RES, V8, P717, DOI 10.1158/1541-7786.MCR-09-0291; Natrajan Rachael, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P627; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Paderova JA, 2007, CANCER GENET CYTOGEN, V179, P102, DOI 10.1016/j.cancergencyto.2007.08.014; PARKIN DM, 1988, INT J CANCER, V42, P511, DOI 10.1002/ijc.2910420408; Ramezani-Rad P, 2013, BLOOD, V121, P148, DOI 10.1182/blood-2012-05-428938; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Saloura V, 2015, MOL CANCER RES, V13, P293, DOI 10.1158/1541-7786.MCR-14-0292-T; Sampieri K, 2008, ACTA ONCOL, V47, P1483, DOI 10.1080/02841860802342382; Sampieri K, 2009, CANCER SCI, V100, P465, DOI 10.1111/j.1349-7006.2008.01070.x; Schwienbacher C, 2010, IMMUNOGENETICS, V62, P561, DOI 10.1007/s00251-010-0459-7; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; van der Wal JE, 2003, J CLIN PATHOL, V56, P26, DOI 10.1136/jcp.56.1.26; Wang R, 2013, CLIN TRANSL ONCOL, V15, P626, DOI 10.1007/s12094-012-0978-9; Xu XLL, 2014, NATURE, V514, P385, DOI 10.1038/nature13813; Xu XL, 2010, AM J PATHOL, V177, P424, DOI 10.2353/ajpath.2010.090512; Yeh YM, 2013, INT J CANCER, V133, P867, DOI 10.1002/ijc.28086; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zielinski B, 2005, GENE CHROMOSOME CANC, V43, P294, DOI 10.1002/gcc.20186	47	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153323	10.1371/journal.pone.0153323	http://dx.doi.org/10.1371/journal.pone.0153323			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115612	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600021
J	Munoz-Moreno, R; Cuesta-Geijo, MA; Martinez-Romero, C; Barrado-Gil, L; Galindo, I; Garcia-Sastre, A; Alonso, C				Munoz-Moreno, Raquel; Cuesta-Geijo, Miguel Angel; Martinez-Romero, Carles; Barrado-Gil, Lucia; Galindo, Inmaculada; Garcia-Sastre, Adolfo; Alonso, Covadonga			Antiviral Role of IFITM Proteins in African Swine Fever Virus Infection	PLOS ONE			English	Article							DEPENDENT ENDOCYTOSIS; DENGUE VIRUS; VIRAL ENTRY; CELLS; REPLICATION; MACROPHAGES; INHIBITION; PATHWAY; TARGET; ALPHA	The interferon-induced transmembrane (IFITM) protein family is a group of antiviral restriction factors that impair flexibility and inhibit membrane fusion at the plasma or the endosomal membrane, restricting viral progression at entry. While IFITMs are widely known to inhibit several single-stranded RNA viruses, there are limited reports available regarding their effect in double-stranded DNA viruses. In this work, we have analyzed a possible antiviral function of IFITMs against a double stranded DNA virus, the African swine fever virus (ASFV). Infection with cell-adapted ASFV isolate Ba71V is IFN sensitive and it induces IFITMs expression. Interestingly, high levels of IFITMs caused a collapse of the endosomal pathway to the perinuclear area. Given that ASFV entry is strongly dependent on endocytosis, we investigated whether IFITM expression could impair viral infection. Expression of IFITM1, 2 and 3 reduced virus infectivity in Vero cells, with IFITM2 and IFITM3 having an impact on viral entry/uncoating. The role of IFITM2 in the inhibition of ASFV in Vero cells could be related to impaired endocytosis-mediated viral entry and alterations in the cholesterol efflux, suggesting that IFITM2 is acting at the late endosome, preventing the decapsidation stage of ASFV.	[Munoz-Moreno, Raquel; Cuesta-Geijo, Miguel Angel; Barrado-Gil, Lucia; Galindo, Inmaculada; Alonso, Covadonga] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain; [Munoz-Moreno, Raquel; Martinez-Romero, Carles; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Martinez-Romero, Carles; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Cuesta-Geijo, Miguel Angel] Kings Coll London, Sch Med, Guys Hosp, Dept Infect Dis, London WC2R 2LS, England	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Alonso, C (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.	calonso@inia.es	Alonso, Covadonga/A-8000-2011; Geijo, Miguel Ángel Cuesta/Q-5450-2018; Barrado-Gil, Lucía/H-4691-2015; Galindo, inmaculada/Q-6603-2018	Alonso, Covadonga/0000-0002-0862-6177; Geijo, Miguel Ángel Cuesta/0000-0003-4694-1968; Barrado-Gil, Lucía/0000-0002-1053-2997; Galindo, inmaculada/0000-0001-8257-9797; Martinez-Romero, Carles/0000-0001-8888-7715; Munoz-Moreno, Raquel/0000-0002-4521-0488; Garcia-Sastre, Adolfo/0000-0002-6551-1827	Ministerio de Economia y Competitividad (ES) [AGL2012-34533, AGL2015-69598-R]; National Institute for Allergy and Infectious Diseases (NIAID) [U19AI106754]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106754] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad (ES); National Institute for Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding sources for CA were: Ministerio de Economia y Competitividad (ES); http://www.mineco.gob.es/portal/site/mineco/idi; AGL2012-34533 and AGL2015-69598-R. Funding sources for AG-S were: National Institute for Allergy and Infectious Diseases (NIAID); http://www.niaid.nih.gov/; U19AI106754.	Alonso C, 2013, VIRUS RES, V173, P42, DOI 10.1016/j.virusres.2012.12.006; Altan-Bonnet N, 2012, TRENDS BIOCHEM SCI, V37, P293, DOI 10.1016/j.tibs.2012.03.004; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Cuesta-Geijo MA, 2016, J VIROL, V90, P1534, DOI 10.1128/JVI.02694-15; [Anonymous], 2014, VET REC, V175, P59, DOI 10.1136/vr.g4627; [Anonymous], 2014, AN DIS NOT SYST OUTB; Appelqvist H, 2011, AM J PATHOL, V178, P629, DOI 10.1016/j.ajpath.2010.10.030; BRADBURY LE, 1992, J IMMUNOL, V149, P2841; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Compton AA, 2014, CELL HOST MICROBE, V16, P736, DOI 10.1016/j.chom.2014.11.001; Correia S, 2013, VIRUS RES, V173, P87, DOI 10.1016/j.virusres.2012.10.013; Cuesta-Geijo MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048853; de Oliveira VL, 2011, ARCH VIROL, V156, P597, DOI 10.1007/s00705-010-0894-7; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; ENJUANES L, 1976, J GEN VIROL, V32, P471, DOI 10.1099/0022-1317-32-3-471; ESPARZA I, 1988, J GEN VIROL, V69, P2973, DOI 10.1099/0022-1317-69-12-2973; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Galindo I, 2015, VIRUS RES, V200, P45, DOI 10.1016/j.virusres.2015.01.022; Hernaez B, 2006, VIROLOGY, V350, P1, DOI 10.1016/j.virol.2006.01.021; Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; King DP, 2003, J VIROL METHODS, V107, P53, DOI 10.1016/S0166-0934(02)00189-1; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li D, 2013, INT J MOL SCI, V14, P24242, DOI 10.3390/ijms141224242; Netherton CL, 2009, J VIROL, V83, P2310, DOI 10.1128/JVI.00781-08; PAEZ E, 1990, ARCH VIROL, V112, P115, DOI 10.1007/BF01348989; Pejsak Z, 2014, POL J VET SCI, V17, P665, DOI 10.2478/pjvs-2014-0097; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Salas ML, 2013, VIRUS RES, V173, P29, DOI 10.1016/j.virusres.2012.09.016; Sanchez EG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002754; Warren CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096579; Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066; Zhu R, 2013, FISH SHELLFISH IMMUN, V35, P918, DOI 10.1016/j.fsi.2013.07.002	39	40	43	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154366	10.1371/journal.pone.0154366	http://dx.doi.org/10.1371/journal.pone.0154366			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116236	Green Published, gold, Green Submitted			2022-12-27	WOS:000374973600062
J	Shioda, K; Cosmas, L; Audi, A; Gregoricus, N; Vinje, J; Parashar, UD; Montgomery, JM; Feikin, DR; Breiman, RF; Hall, AJ				Shioda, Kayoko; Cosmas, Leonard; Audi, Allan; Gregoricus, Nicole; Vinje, Jan; Parashar, Umesh D.; Montgomery, Joel M.; Feikin, Daniel R.; Breiman, Robert F.; Hall, Aron J.			Population-Based Incidence Rates of Diarrheal Disease Associated with Norovirus, Sapovirus, and Astrovirus in Kenya	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; HOSPITAL-BASED SURVEILLANCE; HUMAN ROTAVIRUS VACCINE; UNITED STATES; GASTROENTERITIS; CHILDREN; BURDEN; COMMUNITY; PREVALENCE; ASSAY	Background Diarrheal diseases remain a major cause of mortality in Africa and worldwide. While the burden of rotavirus is well described, population-based rates of disease caused by norovirus, sapovirus, and astrovirus are lacking, particularly in developing countries. Methods Data on diarrhea cases were collected through a population-based surveillance platform including healthcare encounters and household visits in Kenya. We analyzed data from June 2007 to October 2008 in Lwak, a rural site in western Kenya, and from October 2006 to February 2009 in Kibera, an urban slum. Stool specimens from diarrhea cases of all ages who visited study clinics were tested for norovirus, sapovirus, and astrovirus by RT-PCR. Results Of 334 stool specimens from Lwak and 524 from Kibera, 85 (25%) and 159 (30%) were positive for norovirus, 13 (4%) and 31 (6%) for sapovirus, and 28 (8%) and 18 (3%) for astrovirus, respectively. Among norovirus-positive specimens, genogroup II predominated in both sites, detected in 74 (87%) in Lwak and 140 (88%) in Kibera. The adjusted community incidence per 100,000 person-years was the highest for norovirus (Lwak: 9,635; Kibera: 4,116), followed by astrovirus (Lwak: 3,051; Kibera: 440) and sapovirus (Lwak: 1,445; Kibera: 879). For all viruses, the adjusted incidence was higher among children aged <5 years (norovirus: 22,225 in Lwak and 17,511 in Kibera; sapovirus: 5,556 in Lwak and 4,378 in Kibera; astrovirus: 11,113 in Lwak and 2,814 in Kibera) compared to cases aged >= 5 years. Conclusion Although limited by a lack of controls, this is the first study to estimate the outpatient and community incidence rates of norovirus, sapovirus, and astrovirus across the age spectrum in Kenya, suggesting a substantial disease burden imposed by these viruses. By applying adjusted rates, we estimate approximately 2.8-3.3 million, 0.45-0.54 million, and 0.77-0.95 million people become ill with norovirus, sapovirus, and astrovirus, respectively, every year in Kenya.	[Shioda, Kayoko; Gregoricus, Nicole; Vinje, Jan; Parashar, Umesh D.; Feikin, Daniel R.; Hall, Aron J.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Shioda, Kayoko] Oak Ridge Inst Sci & Technol, Oak Ridge, TN USA; [Cosmas, Leonard; Montgomery, Joel M.; Feikin, Daniel R.; Breiman, Robert F.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Nairobi, Kenya; [Audi, Allan] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Nairobi, Kenya; [Breiman, Robert F.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Kenya Medical Research Institute; Emory University	Shioda, K (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.; Shioda, K (corresponding author), Oak Ridge Inst Sci & Technol, Oak Ridge, TN USA.	yji4@cdc.gov	Vinje, Jan/ABE-6336-2020	Vinje, Jan/0000-0002-1530-3675; Audi, Allan/0000-0003-1683-554X				Abebe A, 2014, PEDIATR INFECT DIS J, V33, pS28, DOI 10.1097/INF.0000000000000048; Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Becker-Dreps S, 2014, PEDIATR INFECT DIS J, V33, P1156, DOI 10.1097/INF.0000000000000427; Breiman RF, 2014, PEDIATR INFECT DIS J, V33, pS54, DOI 10.1097/INF.0000000000000094; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Dennehy PH, 2001, J INFECT DIS, V184, P10, DOI 10.1086/321007; DENNEHY PH, 1990, J CLIN MICROBIOL, V28, P1280, DOI 10.1128/JCM.28.6.1280-1283.1990; Feikin DR, 2012, VACCINE, V30, pA52, DOI 10.1016/j.vaccine.2011.08.043; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Groome MJ, 2014, LANCET INFECT DIS, V14, P1096, DOI 10.1016/S1473-3099(14)70940-5; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Hemming M, 2013, EUR J PEDIATR, V172, P739, DOI 10.1007/s00431-013-1945-3; Hill VR, 2010, FOOD ENVIRON VIROL, V2, P218, DOI 10.1007/s12560-010-9049-y; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kenya National Bureau of Statistics, 2010, 2009 KEN POP HOUS CE; Khagayi S, 2014, PEDIATR INFECT DIS J, V33, pS34, DOI 10.1097/INF.0000000000000049; Krieg NR, 1984, BERGEYS MANUAL SYSTE, V1; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Mwenda JM, 2014, PEDIATR INFECT DIS J, V33, pS6, DOI 10.1097/INF.0000000000000174; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ogilvie I, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-62; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021; Podkolzin AT, 2009, J INFECT DIS, V200, pS228, DOI 10.1086/605054; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Trujillo AA, 2006, J CLIN MICROBIOL, V44, P1405, DOI 10.1128/JCM.44.4.1405-1412.2006; Tsolenyanu E, 2014, PEDIATR INFECT DIS J, V33, pS14, DOI 10.1097/INF.0000000000000046; Verhoef L, 2013, EPIDEMIOL INFECT, V141, P496, DOI 10.1017/S0950268812000799; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220	34	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0145943	10.1371/journal.pone.0145943	http://dx.doi.org/10.1371/journal.pone.0145943			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116458	Green Published, gold, Green Submitted			2022-12-27	WOS:000374973600004
J	Caldwell, ZR; Zgliczynski, BJ; Williams, GJ; Sandin, SA				Caldwell, Zachary R.; Zgliczynski, Brian J.; Williams, Gareth J.; Sandin, Stuart A.			Reef Fish Survey Techniques: Assessing the Potential for Standardizing Methodologies	PLOS ONE			English	Article							UNDERWATER VISUAL CENSUS; STRIP TRANSECT; VIDEO SYSTEM; CORAL; DENSITY; ASSEMBLAGES; ISLANDS; ABUNDANCE; TRAJECTORIES; COLLAPSE	Dramatic changes in populations of fishes living on coral reefs have been documented globally and, in response, the research community has initiated efforts to assess and monitor reef fish assemblages. A variety of visual census techniques are employed, however results are often incomparable due to differential methodological performance. Although comparability of data may promote improved assessment of fish populations, and thus management of often critically important nearshore fisheries, to date no standardized and agreed-upon survey method has emerged. This study describes the use of methods across the research community and identifies potential drivers of method selection. An online survey was distributed to researchers from academic, governmental, and non-governmental organizations internationally. Although many methods were identified, 89% of survey-based projects employed one of three methods-belt transect, stationary point count, and some variation of the timed swim method. The selection of survey method was independent of the research design (i.e., assessment goal) and region of study, but was related to the researcher's home institution. While some researchers expressed willingness to modify their current survey protocols to more standardized protocols (76%), their willingness decreased when methodologies were tied to long-term datasets spanning five or more years. Willingness to modify current methodologies was also less common among academic researchers than resource managers. By understanding both the current application of methods and the reported motivations for method selection, we hope to focus discussions towards increasing the comparability of quantitative reef fish survey data.	[Caldwell, Zachary R.; Zgliczynski, Brian J.; Williams, Gareth J.; Sandin, Stuart A.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Caldwell, Zachary R.] Nature Conservancy, Honolulu, HI USA; [Williams, Gareth J.] Bangor Univ, Sch Ocean Sci, Menai Bridge Anglesey, Wales	University of California System; University of California San Diego; Scripps Institution of Oceanography; Nature Conservancy; Bangor University	Caldwell, ZR (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.; Caldwell, ZR (corresponding author), Nature Conservancy, Honolulu, HI USA.	zcaldwell@tnc.org		Williams, Dr Gareth J./0000-0001-7837-1619				Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; [Anonymous], ARCGIS; Barea-Azcon JM, 2007, BIODIVERS CONSERV, V16, P1213, DOI 10.1007/s10531-006-9114-x; BELL JD, 1985, CORAL REEFS, V4, P41, DOI 10.1007/BF00302203; BELLWOOD DR, 1988, CORAL REEFS, V7, P23, DOI 10.1007/BF00301978; Bibby C, 1998, EXPEDITION FIELD TEC; Bohnsack JA, 1999, BASELINE DATA EVALUA; Bohnsack JA, 1986, STATIONARY VISUAL CE; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; Branden KL, 1986, T ROYAL SOC S AUSTR; Brock RE, 1982, CRITIQUE VISUAL CENS; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Cappo M, 2003, POTENTIAL VIDEO TECH; CHAPMAN CJ, 1974, MAR BIOL, V27, P357, DOI 10.1007/BF00394372; Cheung WWL, 2008, FISH RES, V92, P28, DOI 10.1016/j.fishres.2007.12.018; Colbert KC, 2002, NORTH J APPL FOR, V19, P171, DOI 10.1093/njaf/19.4.171; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; Colvocoresses J, 2007, FISH RES, V85, P130, DOI 10.1016/j.fishres.2007.01.012; Curtis RO, 1967, HEIGHT DIAMETER HEIG; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Done TJ, 1981, RAPID LARGE AREA REE; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Guidetti P, 2005, MAR ENVIRON RES, V59, P333, DOI 10.1016/j.marenvres.2004.05.008; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Halford A. R., 1994, VISUAL CENSUS SURVEY; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Hann DW, 1987, HEIGHT DIAM EQ 17 TR; Harvey E, 2004, MAR FRESHWATER RES, V55, P573, DOI 10.1071/MF03130; Hawkins JP, 2007, AQUAT CONSERV, V17, P111, DOI 10.1002/aqc.784; Heenan A, 2016, J APPL ECOL, V53, P699, DOI 10.1111/1365-2664.12633; Helfman GS, 2009, DIVERSITY FISHES, DOI DOI 10.1890/070156; Hill JJ, 2004, METHODS ECOLOGICAL M; Holzwarth SR, 2006, ATOLL RES; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S., 2001, MARINE FISHERIES ECO; Johnson AE, 2010, MAR ECOL PROG SER, V415, P201, DOI 10.3354/meps08762; Kaiser MJ, 1998, EFFECTS FISHING MARI, P201; Kenyon JC, 2006, COAST MANAGE, V34, P339, DOI 10.1080/08920750600686711; King M, 2013, FISHERIES MANAGEMENT, P273, DOI [10.1002/9781118688038, DOI 10.1002/9781118688038.CH6]; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Kulbicki M, 1999, AQUAT LIVING RESOUR, V12, P315, DOI 10.1016/S0990-7440(99)00116-3; Kulbicki M, 2010, J EXP MAR BIOL ECOL, V387, P15, DOI 10.1016/j.jembe.2010.03.003; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Lindfield SJ, 2014, METHODS ECOL EVOL, V5, P1061, DOI 10.1111/2041-210X.12262; Mallet D, 2014, FISH RES, V154, P44, DOI 10.1016/j.fishres.2014.01.019; Mapstone B. D., 1998, INVESTIGATION OPTIMU; McCauley DJ, 2012, ECOL APPL, V22, P385, DOI 10.1890/11-1059.1; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; Menza CW, 2006, GUIDE MONITORING REE; Minte-Vera CV, 2008, MAR ECOL PROG SER, V367, P283, DOI 10.3354/meps07511; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Nevill J, 2005, IMPACTS SPEARFISHING; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Richards BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031374; Richards BL, 2011, B MAR SCI, V87, P55, DOI 10.5343/bms.2010.1019; Rizzari JR, 2014, BIOL CONSERV, V176, P39, DOI 10.1016/j.biocon.2014.05.003; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Semmens BX, 1998, J GULF MEXICO SCI; Smith SG, 2011, FISH RES, V109, P25, DOI 10.1016/j.fishres.2011.01.012; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Thomson MJ, 1978, BMS, V28, P179; THRESHER RE, 1986, ENVIRON BIOL FISH, V17, P93, DOI 10.1007/BF00001740; Tissot BN, 2003, CONSERV BIOL, V17, P1759, DOI 10.1111/j.1523-1739.2003.00379.x; Usseglio Paolo, 2015, P270; Wantiez L, 1997, CORAL REEFS, V16, P215, DOI 10.1007/s003380050077; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Williams I. D., 2011, J MAR BIOL, V2011, P14, DOI DOI 10.1155/2011/826234; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2003, MAR ECOL PROG SER, V257, P209, DOI 10.3354/meps257209; Willis TJ, 2001, J FISH BIOL, V59, P1408, DOI 10.1006/jfbi.2001.1721; Zgliczynski BJ, 2013, CORAL REEFS, V32, P637, DOI 10.1007/s00338-013-1018-0	82	42	43	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153066	10.1371/journal.pone.0153066	http://dx.doi.org/10.1371/journal.pone.0153066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111085	gold, Green Submitted, Green Published			2022-12-27	WOS:000374970600009
J	Cong, XM; Xu, WL; Janton, S; Henderson, WA; Matson, A; McGrath, JM; Maas, K; Graf, J				Cong, Xiaomei; Xu, Wanli; Janton, Susan; Henderson, Wendy A.; Matson, Adam; McGrath, Jacqueline M.; Maas, Kendra; Graf, Joerg			Gut Microbiome Developmental Patterns in Early Life of Preterm Infants: Impacts of Feeding and Gender	PLOS ONE			English	Article							NEONATAL RESEARCH NETWORK; NECROTIZING ENTEROCOLITIS; INTESTINAL MICROBIOTA; MILK OLIGOSACCHARIDES; OUTCOMES; AUTOIMMUNITY; LACTATION; DIVERSITY; INFECTION; SEVERITY	Gut microbiota plays a key role in multiple aspects of human health and disease, particularly in early life. Distortions of the gut microbiota have been found to correlate with fatal diseases in preterm infants, however, developmental patterns of gut microbiome and factors affecting the colonization progress in preterm infants remain unclear. The purpose of this prospective longitudinal study was to explore day-to-day gut microbiome patterns in preterm infants during their first 30 days of life in the neonatal intensive care unit (NICU) and investigate potential factors related to the development of the infant gut microbiome. A total of 378 stool samples were collected daily from 29 stable/healthy preterm infants. DNA extracted from stool was used to sequence the V4 region of the 16S rRNA gene region for community analysis. Operational taxonomic units (OTUs) and alpha-diversity of the community were determined using QIIME software. Proteobacteria was the most abundant phylum, accounting for 54.3% of the total reads. Result showed shift patterns of increasing Clostridium and Bacteroides, and decreasing Staphylococcus and Haemophilus over time during early life. Alpha-diversity significantly increased daily in preterm infants after birth and linear mixe-deffects models showed that postnatal days, feeding types and gender were associated with the a-diversity, p< 0.05-0.01. Male infants were found to begin with a low a-diversity, whereas females tended to have a higher diversity shortly after birth. Female infants were more likely to have higher abundance of Clostridiates, and lower abundance of Enterobacteriales than males during early life. Infants fed mother's own breastmilk (MBM) had a higher diversity of gut microbiome and significantly higher abundance in Clostridiales and Lactobacillales than infants fed non-MBM. Permanova also showed that bacterial compositions were different between males and females and between MBM and non-MBM feeding types. In conclusion, infant postnatal age, gender and feeding type significantly contribute to the dynamic development of the gut microbiome in preterm infants.	[Cong, Xiaomei; Xu, Wanli; McGrath, Jacqueline M.] Univ Connecticut, Sch Nursing, Storrs, CT USA; [Cong, Xiaomei; Graf, Joerg] Univ Connecticut, Inst Syst Genom, Farmington, CT USA; [Janton, Susan; Graf, Joerg] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Henderson, Wendy A.] NINR, Digest Disorders Unit, Biobehav Branch, NIH, Bethesda, MD 20892 USA; [Matson, Adam; McGrath, Jacqueline M.] Connecticut Childrens Med Ctr, Hartford, CT USA; [Maas, Kendra] Univ Connecticut, Microbial Anal Resources & Serv, Storrs, CT USA	University of Connecticut; University of Connecticut; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); Connecticut Children's Medical Center; University of Connecticut	Cong, XM (corresponding author), Univ Connecticut, Sch Nursing, Storrs, CT USA.; Cong, XM (corresponding author), Univ Connecticut, Inst Syst Genom, Farmington, CT USA.	xiaomei.cong@uconn.edu	Henderson, Wendy A./F-1171-2018; Graf, Joerg/ABI-2447-2020	Henderson, Wendy A./0000-0003-3924-7118; Graf, Joerg/0000-0001-5320-2712; Matson, Adam/0000-0003-4080-0013; Cong, Xiaomei/0000-0002-4992-199X; McGrath, Jacqueline/0000-0002-1731-7181	National Institute of Nursing Research of the National Institutes of Health (NIH-NINR) [K23NR014674]; Affinity Research Collaboratives award through University of Connecticut Institute for Systems Genomics; NATIONAL INSTITUTE OF NURSING RESEARCH [K23NR014674, ZIANR000018] Funding Source: NIH RePORTER	National Institute of Nursing Research of the National Institutes of Health (NIH-NINR); Affinity Research Collaboratives award through University of Connecticut Institute for Systems Genomics; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This publication was supported by the National Institute of Nursing Research of the National Institutes of Health (NIH-NINR) under award number K23NR014674 and Affinity Research Collaboratives award through University of Connecticut Institute for Systems Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleya S, 2012, ANAEROBE; Arboleya S, 2013, ANAEROBE, V19, P9, DOI 10.1016/j.anaerobe.2012.11.001; Arboleya S, 2012, GUT MICROBES, V3, P583, DOI 10.4161/gmic.21942; Arboleya S, 2012, FEMS MICROBIOL ECOL, V79, P763, DOI 10.1111/j.1574-6941.2011.01261.x; Arboleya S, 2011, INT J FOOD MICROBIOL, V149, P28, DOI 10.1016/j.ijfoodmicro.2010.10.036; Aujoulat F, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0325-0; Berrington JE, 2014, CURR OPIN INFECT DIS, V27, P236, DOI 10.1097/QCO.0000000000000061; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; Cong X, 2015, ADV NEONATAL CARE; Dinan TG, 2012, PSYCHONEUROENDOCRINO, V37, P1369, DOI 10.1016/j.psyneuen.2012.03.007; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Dominianni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124599; El Aidy S, 2016, ADV EXP MED BIOL, V874, P301, DOI 10.1007/978-3-319-20215-0_15; Fanaroff AA, 2003, SEMIN PERINATOL, V27, P281, DOI 10.1016/S0146-0005(03)00055-7; Gabrielli O, 2011, PEDIATRICS, V128, pE1520, DOI 10.1542/peds.2011-1206; Gomez A, 2015, CLIN IMMUNOL, V159, P154, DOI 10.1016/j.clim.2015.04.016; Gritz EC, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00017; Groer MW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-38; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Karunasena E, 2014, APPL ENVIRON MICROB, V80, P4481, DOI 10.1128/AEM.01229-14; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kozyrskyj AL, 2015, J DEV ORIG HLTH DIS, P1; LaTuga MS, 2014, SEMIN REPROD MED, V32, P68, DOI 10.1055/s-0033-1361824; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; McMurtry VE, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0075-8; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Nelson MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094249; Poroyko V, 2011, NUTR HOSP, V26, P1283, DOI [10.3305/nh.2011.26.6.5362, 10.1590/S0212-16112011000600015]; Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608; Rouge C, 2010, ANAEROBE, V16, P362, DOI 10.1016/j.anaerobe.2010.06.002; Shastri P, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0031-0; Sherman MP, 2015, PEDIATR RES, V77, P127, DOI 10.1038/pr.2014.161; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Underwood M. A, 2015, PEDIATR RES; Unger S, 2015, PEDIATR RES, V77, P205, DOI 10.1038/pr.2014.162; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Yu ZT, 2013, GLYCOBIOLOGY, V23, P1281, DOI 10.1093/glycob/cwt065; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zhou YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118632	50	118	123	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152751	10.1371/journal.pone.0152751	http://dx.doi.org/10.1371/journal.pone.0152751			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111847	gold, Green Published			2022-12-27	WOS:000374970600005
J	Sei, H; Oshima, T; Shan, J; Wu, LP; Yamasaki, T; Okugawa, T; Kondo, T; Tomita, T; Fukui, H; Watari, J; Miwa, H				Sei, Hiroo; Oshima, Tadayuki; Shan, Jing; Wu, Liping; Yamasaki, Takahisa; Okugawa, Takuya; Kondo, Takashi; Tomita, Toshihiko; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroto			Esophageal Epithelial-Derived IL-33 Is Upregulated in Patients with Heartburn	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; PROTON-PUMP INHIBITORS; FACTOR-KAPPA-B; INTERLEUKIN-8 EXPRESSION; INTERCELLULAR SPACES; DIAGNOSTIC-VALUE; CYTOKINE IL-33; ACID; GERD; HISTOLOGY	Background Interleukin-33 (IL-33) is a tissue-derived cytokine that is constitutively expressed in epithelial cells of tissues exposed to the environment and plays a role in sensing damage caused by inflammatory diseases. IL-33 acts as both a traditional cytokine and as a chromatin-associated nuclear factor in both innate and adaptive immunity. We recently showed that IL-33 in esophageal mucosa is upregulated in reflux esophagitis. However, IL-33 expression in patients with heartburn without mucosal injury and its relationship with intercellular space (ICS) have never been examined. We therefore examined the expression of cytokines and ICS in patients with heartburn. Methods The expression of IL-33 in the middle and distal esophageal mucosa of patients with heartburn without mucosal break and control samples was examined using real-time RT-PCR and immunofluorescence. The mRNA expression of IL-6, IL-8, MCP-1, and RANTES, and ICS was also analyzed. Results IL-33 expression and the mean ICS were significantly increased in the mucosa of patients with heartburn compared to that of the control. IL-33 and ICS were not different between the patients who were taking a PPI and those who were not. The upregulated IL-33 expression in the heartburn group was located in the nuclei of the basal cell layer. Although IL-6, IL-8, MCP-1 and RANTES levels were not different between control and patients with heartburn samples, IL-33 mRNA levels were still significantly correlated with IL-6, IL-8, or MCP-1 mRNA levels. Conclusion Nuclear IL-33 is upregulated in patients with heartburn. Upregulated IL-33 in heartburn patients is related to the symptoms.	[Sei, Hiroo; Oshima, Tadayuki; Shan, Jing; Wu, Liping; Yamasaki, Takahisa; Okugawa, Takuya; Kondo, Takashi; Tomita, Toshihiko; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroto] Hyogo Coll Med, Div Gastroenterol, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan; [Shan, Jing; Wu, Liping] Third Peoples Hosp Chengdu, Depertment Gastroenterol, Chengdu, Peoples R China	Hyogo College of Medicine	Oshima, T (corresponding author), Hyogo Coll Med, Div Gastroenterol, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan.	t-oshima@hyo-med.ac.jp		Yamasaki, Takahisa/0000-0002-0679-2147	Japan Society for the Promotion of Science (JSPS) [25460939]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) (25460939 to TO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Altomare A, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01963.x; Arul P, 2014, MALAYS J PATHOL, V36, P181; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Balato A, 2014, ARCH DERMATOL RES, V306, P299, DOI 10.1007/s00403-014-1447-9; Bytzer P, 2012, CLIN GASTROENTEROL H, V10, P1360, DOI 10.1016/j.cgh.2012.06.030; Calabrese C, 2005, AM J GASTROENTEROL, V100, P537, DOI 10.1111/j.1572-0241.2005.40476.x; Caviglia R, 2007, ALIMENT PHARM THER, V25, P629, DOI 10.1111/j.1365-2036.2006.03237.x; Cui R, 2011, DIS ESOPHAGUS, V24, P1, DOI 10.1111/j.1442-2050.2010.01083.x; Dent J, 2007, CLIN GASTROENTEROL H, V5, P4, DOI 10.1016/j.cgh.2006.08.006; Farre R, 2010, GUT, V59, P164, DOI 10.1136/gut.2009.194191; Fiocca R, 2010, AM J GASTROENTEROL, V105, P1015, DOI 10.1038/ajg.2009.631; Fujiwara Y, 2012, INTERNAL MED, V51, P3235, DOI 10.2169/internalmedicine.51.8670; Hershcovici T, 2010, CURR OPIN GASTROEN, V26, P367, DOI 10.1097/MOG.0b013e32833ae2be; Huo XF, 2014, GUT, V63, P1042, DOI 10.1136/gutjnl-2013-305533; Isomoto H, 2004, AM J GASTROENTEROL, V99, P589, DOI 10.1111/j.1572-0241.2004.04110.x; Isomoto H, 2003, AM J GASTROENTEROL, V98, P551, DOI 10.1016/S0002-9270(02)06025-2; Kahrilas PJ, 2015, NEUROGASTROENT MOTIL, V27, P1195, DOI 10.1111/nmo.12644; Kandulski A, 2013, ALIMENT PHARM THER, V38, P643, DOI 10.1111/apt.12428; Knowles CH, 2008, GUT, V57, P674, DOI 10.1136/gut.2007.127886; Kondo T, 2015, CLIN GASTROENTEROL H, V13, P1249, DOI 10.1016/j.cgh.2015.01.014; Krugmann J, 2013, BEST PRACT RES CL GA, V27, P373, DOI 10.1016/j.bpg.2013.06.010; Kusano M, 2015, J GASTROENTEROL, V50, P298, DOI 10.1007/s00535-014-0972-9; Lin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060963; Miwa H, 2013, J GASTROEN HEPATOL, V28, P479, DOI 10.1111/j.1440-1746.2012.07266.x; Miwa Hiroto, 2010, J Neurogastroenterol Motil, V16, P353, DOI 10.5056/jnm.2010.16.4.353; Miwa H, 2008, CLIN J GASTROENTEROL, V1, P133, DOI 10.1007/s12328-008-0039-7; Miwa H, 2010, J GASTROENTEROL, V45, P478, DOI 10.1007/s00535-009-0180-1; Monkemuller K, 2009, DIGESTION, V79, P186, DOI 10.1159/000211714; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Numans ME, 2004, ANN INTERN MED, V140, P518, DOI 10.7326/0003-4819-140-7-200404060-00011; Oh DS, 2007, ARCH SURG-CHICAGO, V142, P554, DOI 10.1001/archsurg.142.6.554; Schindlbeck NE, 1996, GUT, V39, P151, DOI 10.1136/gut.39.2.151; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seidelin JB, 2015, J GASTROENTEROL, V50, P180, DOI 10.1007/s00535-014-0982-7; Shan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151701; Shan J, 2015, J GASTROENTEROL, V50, P414, DOI 10.1007/s00535-014-0988-1; Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055; Tominaga K, 2014, J GASTROENTEROL, V49, P1392, DOI 10.1007/s00535-013-0896-9; Wu LP, 2015, AM J PHYSIOL-GASTR L, V309, pG695, DOI 10.1152/ajpgi.00162.2015; Yoshida N, 2004, SCAND J GASTROENTERO, V39, P816, DOI 10.1080/00365520410006729; Yoshida N, 2007, J CLIN BIOCHEM NUTR, V40, P13, DOI 10.3164/jcbn.40.13; Zentilin P, 2005, AM J GASTROENTEROL, V100, P2299, DOI 10.1111/j.1572-0241.2005.50209.x; Zhong CJ, 2013, J GASTROENTEROL, V48, P601, DOI 10.1007/s00535-012-0689-6	44	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154234	10.1371/journal.pone.0154234	http://dx.doi.org/10.1371/journal.pone.0154234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111066	gold, Green Published			2022-12-27	WOS:000374970600052
J	Klapper, R; Kochmann, J; O'Hara, RB; Karl, H; Kuhn, T				Klapper, Regina; Kochmann, Judith; O'Hara, Robert B.; Karl, Horst; Kuhn, Thomas			Parasites as Biological Tags for Stock Discrimination of Beaked Redfish (Sebastes mentella): Parasite Infra-Communities vs. Limited Resolution of Cytochrome Markers	PLOS ONE			English	Article							MACKEREL TRACHURUS-TRACHURUS; ATLANTIC HORSE MACKEREL; DEEP-WATER REDFISH; GENETIC-STRUCTURE; ANISAKIS SPP.; TAXONOMIC DISTINCTNESS; HOLISTIC APPROACH; MEDITERRANEAN SEA; NORTH-ATLANTIC; HOST	The use of parasites as biological tags for discrimination of fish stocks has become a commonly used approach in fisheries management. Metazoan parasite community analysis and anisakid nematode population genetics based on a mitochondrial cytochrome marker were applied in order to assess the usefulness of the two parasitological methods for stock discrimination of beaked redfish Sebastes mentella of three fishing grounds in the North East Atlantic. Multivariate, model-based approaches demonstrated that the metazoan parasite fauna of beaked redfish from East Greenland differed from Tampen, northern North Sea, and Bear Island, Barents Sea. A joint model (latent variable model) was used to estimate the effects of covariates on parasite species and identified four parasite species as main source of differences among fishing grounds; namely Chondracanthus nodosus, Anisakis simplex s.s., Hysterothylacium aduncum, and Bothriocephalus scorpii. Due to its high abundance and differences between fishing grounds, Anisakis simplex s.s. was considered as a major biological tag for host stock differentiation. Whilst the sole examination of Anisakis simplex s.s. on a population genetic level is only of limited use, anisakid nematodes (in particular, A. simplex s.s.) can serve as biological tags on a parasite community level. This study confirmed the use of multivariate analyses as a tool to evaluate parasite infra-communities and to identify parasite species that might serve as biological tags. The present study suggests that S. mentella in the northern North Sea and Barents Sea is not sub-structured.	[Klapper, Regina; Karl, Horst] Max Rubner Inst, Dept Safety & Qual Milk & Fish Prod, Fed Res Inst Nutr & Food, Hamburg, Germany; [Klapper, Regina; Kochmann, Judith; Kuhn, Thomas] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, D-60054 Frankfurt, Germany; [Klapper, Regina; Kochmann, Judith; O'Hara, Robert B.; Kuhn, Thomas] Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr, Frankfurt, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Klapper, R (corresponding author), Max Rubner Inst, Dept Safety & Qual Milk & Fish Prod, Fed Res Inst Nutr & Food, Hamburg, Germany.; Klapper, R (corresponding author), Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, D-60054 Frankfurt, Germany.; Klapper, R (corresponding author), Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr, Frankfurt, Germany.	R.Klapper@em.uni-frankfurt.de	O'Hara, Bob/A-7499-2008; Kochmann, Judith/AAG-3574-2021	O'Hara, Bob/0000-0001-9737-3724; Kochmann, Judith/0000-0001-6312-7859	Goethe University Frankfurt/Main, Institute of Ecology, Evolution and Diversity	Goethe University Frankfurt/Main, Institute of Ecology, Evolution and Diversity	This work was supported by the Goethe University Frankfurt/Main, Institute of Ecology, Evolution and Diversity. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaunza P, 2008, FISH RES, V89, P196, DOI 10.1016/j.fishres.2007.09.022; Abaunza P, 2008, FISH RES, V89, P104, DOI 10.1016/j.fishres.2007.09.020; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Bakay Yu. I., 2011, Journal of Ichthyology, V51, P90, DOI 10.1134/S0032945211010036; Baldwin RE, 2011, J PARASITOL, V97, P545, DOI 10.1645/GE-2690.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017; Begg GA, 1999, FISH RES, V43, P1, DOI 10.1016/S0165-7836(99)00062-4; Begg GA, 1999, FISH RES, V43, P35, DOI 10.1016/S0165-7836(99)00065-X; Blasco-Costa I, 2012, MOL ECOL, V21, P207, DOI 10.1111/j.1365-294X.2011.05374.x; Blazekovic K, 2015, INT J PARASITOL, V45, P17, DOI 10.1016/j.ijpara.2014.07.012; BLOUIN MS, 1995, GENETICS, V141, P1007; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Cadrin SX, 2010, ICES J MAR SCI, V67, P1617, DOI 10.1093/icesjms/fsq046; Catalano Sarah R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P220, DOI 10.1016/j.ijppaw.2013.11.001; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Criscione CD, 2006, ECOLOGY, V87, P823, DOI 10.1890/0012-9658(2006)87[823:PGISPO]2.0.CO;2; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Cross MA, 2007, MAR BIOL, V151, P695, DOI 10.1007/s00227-006-0509-8; Ellingsen KE, 2005, J ANIM ECOL, V74, P1069, DOI 10.1111/j.1365-2656.2005.01004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Froese R., 2015, FISHBASE; FU YX, 1993, GENETICS, V133, P693; Gibson DI, 2005, KEYS TREMATODA; Gonzalez C., 2000, Northwest Atlantic Fisheries Organization Scientific Council Studies, V33, P89; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Herrington WC, 1939, 5 US BUR FISH; Hui FK, 2016, METHODS ECOL EVOL; ICES C, 2009, WORKSH REDF STOCK ST, P67; Jones A., 2005, KEYS TREMATODA, V2; KARL H, 1993, ARCH LEBENSMITTELHYG, V44, P124; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Khalil LF, 1994, KEYS CESTODE PARASIT; Klapper R, 2015, VET PARASITOL, V207, P72, DOI 10.1016/j.vetpar.2014.11.017; Klimpel S, 2004, PARASITOL RES, V94, P1, DOI 10.1007/s00436-004-1154-0; Klimpel Sven, 2009, Bulletin of Fish Biology, V10, P25; Kuhn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028642; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Love M. S., 2002, ROCKFISHES NE PACIFI; Luque JL, 2008, J FISH BIOL, V72, P189, DOI 10.1111/j.1095-8649.2007.01695.x; Luque JL, 2004, PARASITOLOGY, V128, P671, DOI 10.1017/S0031182004005050; MacKenzie K, 2008, FISH RES, V89, P136, DOI 10.1016/j.fishres.2007.09.031; Mackenzie K, 2015, PARASITOLOGY, V142, P54, DOI 10.1017/S0031182014000341; MacKenzie K, 2002, PARASITOLOGY, V124, pS153, DOI 10.1017/S0031182002001518; MACKENZIE K, 1987, INT J PARASITOL, V17, P345, DOI 10.1016/0020-7519(87)90109-3; MacKenzie K, 1998, FISH RES, V38, P45, DOI 10.1016/S0165-7836(98)00116-7; Magnusson J, 1996, J FISH BIOL, V49, P182, DOI 10.1111/j.1095-8649.1996.tb06075.x; Magurran A.E, 1988, ECOLOGICAL DIVERSITY, DOI DOI 10.1007/978-94-015-7358-0_4; Marcogliese DJ, 2015, PARASITOLOGY, V142, P68, DOI 10.1017/S0031182014000110; Marcogliese DJ, 2003, FISH B-NOAA, V101, P183; Mattiucci S, 2008, FISH RES, V89, P146, DOI 10.1016/j.fishres.2007.09.032; Mattiucci S, 2015, PARASITOLOGY, V142, P90, DOI 10.1017/S0031182014001103; Mattiucci S, 2008, ADV PARASIT, V66, P47, DOI 10.1016/S0065-308X(08)00202-9; Mes THM, 2003, MOL ECOL, V12, P1555, DOI 10.1046/j.1365-294X.2003.01846.x; Mladineo I, 2014, APPL ENVIRON MICROB, V80, P1281, DOI 10.1128/AEM.03561-13; Mladineo I, 2010, VET PARASITOL, V174, P131, DOI 10.1016/j.vetpar.2010.08.015; Moran JDW, 1996, CAN J FISH AQUAT SCI, V53, P1821, DOI 10.1139/cjfas-53-8-1821; MULVEY M, 1991, EVOLUTION, V45, P1628, DOI [10.2307/2409784, 10.1111/j.1558-5646.1991.tb02668.x]; Munster J, 2015, PARASITOL RES, V114, P2723, DOI 10.1007/s00436-015-4479-y; Nadler SA, 2000, J PARASITOL, V86, P380, DOI 10.1645/0022-3395(2000)086[0380:POTANA]2.0.CO;2; Oliva ME, 2005, FISH RES, V71, P71, DOI 10.1016/j.fishres.2004.07.009; Petursdottir H, 2008, DEEP-SEA RES PT II, V55, P83, DOI 10.1016/j.dsr2.2007.09.003; Planque B, 2013, AQUAT LIVING RESOUR, V26, P293, DOI 10.1051/alr/2013062; Poulin R, 2015, PARASITOLOGY, V142, P145, DOI 10.1017/S0031182013001534; Roques S, 2002, MAR BIOL, V140, P297, DOI 10.1007/s002270100705; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLEMAN W, 1960, J FISH RES BOARD CAN, V17, P9, DOI 10.1139/f60-002; Templeman W, 1959, REDFISH DISTRIBUTION; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Warton DI, 2015, TRENDS ECOL EVOL, V30, P766, DOI 10.1016/j.tree.2015.09.007; Williams H.H., 1992, Reviews in Fish Biology and Fisheries, V2, P144, DOI 10.1007/BF00042882; WILLIAMS IC, 1963, PARASITOLOGY, V53, P501, DOI 10.1017/S0031182000073959	75	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153964	10.1371/journal.pone.0153964	http://dx.doi.org/10.1371/journal.pone.0153964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104735	gold, Green Published, Green Submitted			2022-12-27	WOS:000374565100031
J	Ng, TM; Khong, WX; Harris, PNA; De, PP; Chow, A; Tambyah, PA; Lye, DC				Ng, Tat Ming; Khong, Wendy X.; Harris, Patrick N. A.; De, Partha P.; Chow, Angela; Tambyah, Paul A.; Lye, David C.			Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; RESISTANT ENTEROBACTERIACEAE; NOSOCOMIAL INFECTIONS; ANTIMICROBIAL THERAPY; RISK-FACTORS; SPREAD; PREVALENCE; ORGANISMS	Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are a common cause of bacteraemia in endemic countries and may be associated with high mortality; carbapenems are considered the drug of choice. Limited data suggest piperacillin-tazobactam could be equally effective. We aimed to compare 30-day mortality of patients treated empirically with piperacillin-tazobactam versus a carbapenem in a multi-centre retrospective cohort study in Singapore. Only patients with active empiric monotherapy with piperacillin-tazobactam or a carbapenem were included. A propensity score for empiric carbapenem therapy was derived and an adjusted multivariate analysis of mortality was conducted. A total of 394 patients had ESBL-Escherichia. coli and ESBL-Klebsiella pneumoniae bacteraemia of which 23.1% were community acquired cases. One hundred and fifty-one received initial active monotherapy comprising piperacillin-tazobactam (n = 94) or a carbapenem (n = 57). Patients who received carbapenems were less likely to have health-care associated risk factors and have an unknown source of bacteraemia, but were more likely to have a urinary source. Thirty-day mortality was comparable between those who received empiric piperacillin-tazobactam and a carbapenem (29 [30.9%] vs. 17 [29.8%]), P = 0.89). Those who received empiric piperacillin-tazobactam had a lower 30-day acquisition of multi-drug resistant and fungal infections (7 [7.4%] vs. 14 [24.6%]), P<0.01). After adjusting for con-founders, use of empiric piperacillin-tazobactam was not associated with increased 30-day mortality (OR 1.00, 95% CI; 0.45-2.17). Empiric piperacillin-tazobactam was not associated with increased 30-day mortality and may result in fewer multi-drug resistant and fungal infections when compared with a carbapenem.	[Ng, Tat Ming; Khong, Wendy X.] Tan Tock Seng Hosp, Dept Pharm, Singapore, Singapore; [Harris, Patrick N. A.] Natl Univ Singapore Hosp, Univ Med Cluster, Div Infect Dis, Singapore 117548, Singapore; [Harris, Patrick N. A.; Lye, David C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Harris, Patrick N. A.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [De, Partha P.] Tan Tock Seng Hosp, Dept Lab Med, Singapore, Singapore; [Chow, Angela] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Dept Clin Epidemiol, Singapore, Singapore; [Chow, Angela] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Tambyah, Paul A.] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Lye, David C.] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Dept Infect Dis, Singapore, Singapore	Tan Tock Seng Hospital; National University of Singapore; National University of Singapore; University of Queensland; Tan Tock Seng Hospital; Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Tan Tock Seng Hospital	Ng, TM (corresponding author), Tan Tock Seng Hosp, Dept Pharm, Singapore, Singapore.	ngtatming@gmail.com	Harris, Patrick/P-3813-2014; Lye, David/ABF-4402-2021; Ng, Tat Ming/AAI-3040-2021	Harris, Patrick/0000-0002-2895-0345; Lye, David/0000-0003-0324-0205; ng, tat ming/0000-0002-4570-3266; Chow, Angela/0000-0002-4063-736X				Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chaubey Vikas P, 2010, BMC Res Notes, V3, P116, DOI 10.1186/1756-0500-3-116; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Harris PNA, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0541-9; Hsu LY, 2007, EMERG INFECT DIS, V13, P1944, DOI 10.3201/eid1312.070299; Kang CI, 2012, J INFECTION, V64, P533, DOI 10.1016/j.jinf.2012.01.008; Kang CI, 2004, ANTIMICROB AGENTS CH, V48, P4574, DOI 10.1128/AAC.48.12.4574-4581.2004; Kanj SS, 2011, MAYO CLIN PROC, V86, P250, DOI 10.4065/mcp.2010.0674; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Leibovici L, 1998, J INTERN MED, V244, P379; Lopez-Cerero L, 2010, CLIN MICROBIOL INFEC, V16, P132, DOI 10.1111/j.1469-0691.2009.02893.x; Melzer M, 2007, J INFECTION, V55, P254, DOI 10.1016/j.jinf.2007.04.007; Nguyen HM, 2014, J ANTIMICROB CHEMOTH, V69, P871, DOI 10.1093/jac/dkt450; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Ofer-Friedman H, 2015, INFECT CONT HOSP EP, V36, P981, DOI 10.1017/ice.2015.101; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Paterson DL, 2004, CLIN INFECT DIS, V39, P31, DOI 10.1086/420816; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Rodriguez-Bano J, 2012, CLIN INFECT DIS, V54, P167, DOI 10.1093/cid/cir790; Rogers BA, 2011, CLIN INFECT DIS, V53, P49, DOI 10.1093/cid/cir273; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Tamma PD, 2015, CLIN INFECT DIS, V60, P1319, DOI 10.1093/cid/civ003; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Yang K, 2007, ANN PHARMACOTHER, V41, P1427, DOI 10.1345/aph.1K213; Young BE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-298	32	78	83	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153696	10.1371/journal.pone.0153696	http://dx.doi.org/10.1371/journal.pone.0153696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104951	gold, Green Published, Green Submitted			2022-12-27	WOS:000374565100015
J	Park, HS; Lim, SM; Kim, S; Kim, S; Kim, HR; Kwack, K; Lee, MG; Kim, JH; Moon, YW				Park, Hyung Soon; Lim, Sun Min; Kim, Sora; Kim, Sangwoo; Kim, Hye Ryun; Kwack, KyuBum; Lee, Min Goo; Kim, Joo-Hang; Moon, Yong Wha			Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution	PLOS ONE			English	Article							CELL LUNG-CANCER; PRECISION MEDICINE; CLINICAL-TRIALS; MUTATIONS; KINASE; SORAFENIB; SHIVA	We evaluated the preliminary efficacy and feasibility of a next-generation sequencing (NGS)based targeted anticancer therapy in refractory solid tumors at a Korean institution. Thirty-six patients with advanced cancer underwent molecular profiling with NGS with the intent of clinical application of available matched targeted agents. Formalin-fixed paraffin-embedded (FFPE) tumors were sequenced using the Comprehensive Cancer Panel (CCP) or FoundationOne in the Clinical Laboratory Improvement Amendments-certified laboratory in the USA. Response evaluations were performed according to RECIST v1.1. Four specimens did not pass the DNA quality test and 32 specimens were successfully sequenced with CCP (n = 31) and FoundationOne (n = 1). Of the 32 sequenced patients, 10 (31.3%) were <= 40 years. Twelve patients (37.5%) had received <= 3 types of prior systemic therapies. Of 24 patients with actionable mutations, five were given genotype-matched drugs corresponding to actionable mutations: everolimus to PIK3CA mutation in parotid carcinosarcoma (partial response) and tracheal squamous cell carcinoma (stable disease; 21% reduction), sorafenib to PDGFRA mutation in auditory canal adenocarcinoma (partial response), sorafenib to BRAF mutation in microcytic adnexal carcinoma (progressive disease), and afatinib to ERBB2 mutation in esophageal adenocarcinoma (progressive disease). Nineteen of 24 patients with actionable mutations could not undergo targeted therapy based on genomic testing because of declining performance status (10/24, 41.7%), stable disease with previous treatment (5/24, 20.8%), and lack of access to targeted medication (4/24, 16.7%). NGS-based targeted therapy may be a good option in selected patients with refractory solid tumors. To pursue this strategy in Korea, lack of access to clinical-grade NGS assays and a limited number of genotype-matched targeted medications needs to be addressed and resolved.	[Park, Hyung Soon; Lee, Min Goo] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Park, Hyung Soon; Kim, Sora; Kim, Sangwoo; Lee, Min Goo] Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Seoul, South Korea; [Park, Hyung Soon; Kim, Hye Ryun] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea; [Lim, Sun Min; Kim, Joo-Hang; Moon, Yong Wha] CHA Univ, Dept Internal Med, CHA Bundang Med Ctr, Med Oncol, Songnam, South Korea; [Kim, Sora; Kim, Sangwoo] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Kwack, KyuBum] CHA Univ, Dept Biomed Sci, Coll Life Sci, Songnam, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System; Pochon Cha University	Moon, YW (corresponding author), CHA Univ, Dept Internal Med, CHA Bundang Med Ctr, Med Oncol, Songnam, South Korea.	ymoon@cha.ac.kr	Lee, Min Goo/D-5635-2012; Lee, Min Goo/AAS-4636-2020	Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X; Kim, Sangwoo/0000-0001-5356-0827; Kim, Hye Ryun/0000-0002-1842-9070				1000 Genomes Project Consortium, 2012, Nature, V491, P56, DOI 10.1038/nature11632; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Jardim DLF, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv253; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gronych J, 2011, J CLIN INVEST, V121, P1344, DOI 10.1172/JCI44656; Heinrich MC, 2012, MOL CANCER THER, V11, P1770, DOI 10.1158/1535-7163.MCT-12-0223; Herter-Sprie GS, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00086; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Janku F, 2014, CELL REP, V6, P377, DOI 10.1016/j.celrep.2013.12.035; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Janku F, 2012, CLIN CANCER RES, V18, P6356, DOI 10.1158/1078-0432.CCR-12-0178; Jones S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7161; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Le Tourneau C, 2015, LANCET ONCOL, V16, P1324, DOI 10.1016/S1470-2045(15)00188-6; Lee KS, 2015, CANCER RES TREAT, V47, P387, DOI 10.4143/crt.2014.001; Munoz Javier, 2013, Am Soc Clin Oncol Educ Book, P127, DOI 10.1200/EdBook_AM.2013.33.127; Pant S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00078; Parkinson DR, 2012, CLIN CANCER RES, V18, P619, DOI 10.1158/1078-0432.CCR-11-2017; Prat A, 2008, NAT CLIN PRACT ONCOL, V5, P531, DOI 10.1038/ncponc1179; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Roubaud G, 2012, ANN ONCOL, V23, P804, DOI 10.1093/annonc/mdr631; Schwaederle M, 2015, J CLIN ONCOL, V33, P3817, DOI 10.1200/JCO.2015.61.5997; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh RR, 2014, BRIT J CANCER, V111, P2014, DOI 10.1038/bjc.2014.518; Skinner MA, 2003, ANTICANCER RES, V23, P3601; Tsimberidou AM, 2015, LANCET ONCOL, V16, pE579, DOI 10.1016/S1470-2045(15)00397-6; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LH, 2014, NATURE, V511, P241, DOI 10.1038/nature13296; Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287	36	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154133	10.1371/journal.pone.0154133	http://dx.doi.org/10.1371/journal.pone.0154133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105424	Green Submitted, gold, Green Published			2022-12-27	WOS:000374565100046
J	Rappaport, SM				Rappaport, Stephen M.			Genetic Factors Are Not the Major Causes of Chronic Diseases	PLOS ONE			English	Article							GLOBAL BURDEN; ENVIRONMENTAL-INFLUENCES; HEART-DISEASE; RISK-FACTORS; CANCER-RISK; FOLLOW-UP; HERITABILITY; SWEDISH; TWIN; METABOLISM	The risk of acquiring a chronic disease is influenced by a person's genetics (G) and exposures received during life (the 'exposome', E) plus their interactions (GxE). Yet, investigators use genome-wide association studies (GWAS) to characterize G while relying on self-reported information to classify E. If E and GxE dominate disease risks, this imbalance obscures important causal factors. To estimate proportions of disease risk attributable to G (plus shared exposures), published data from Western European monozygotic (MZ) twins were used to estimate population attributable fractions (PAFs) for 28 chronic diseases. Genetic PAFs ranged from 3.4% for leukemia to 48.6% for asthma with a median value of 18.5%. Cancers had the lowest PAFs (median = 8.26%) while neurological (median = 26.1%) and lung (median = 33.6%) diseases had the highest PAFs. These PAFs were then linked with Western European mortality statistics to estimate deaths attributable to G for heart disease and nine cancer types. Of 1.53 million Western European deaths in 2000, 0.25 million (16.4%) could be attributed to genetics plus shared exposures. Given the modest influences of G-related factors on the risks of chronic diseases in MZ twins, the disparity in coverage of G and E in etiological research is problematic. To discover causes of disease, GWAS should be complemented with exposome-wide association studies (EWAS) that profile chemicals in biospecimens from incident disease cases and matched controls.	[Rappaport, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Rappaport, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	srappaport@berkeley.edu			National Institute for Environmental Health Sciences [P42ES05948, P42ES0470518]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705, P42ES005948] Funding Source: NIH RePORTER	National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Partial funding was received from grants P42ES05948 and P42ES0470518 from the National Institute for Environmental Health Sciences.	Algovik M, 2004, ACTA OBSTET GYN SCAN, V83, P832, DOI 10.1111/j.0001-6349.2004.00544.x; Altman D, 2008, EUR UROL, V54, P918, DOI 10.1016/j.eururo.2007.12.004; Bae S, 2014, CANCER RES, V74, P7442, DOI 10.1158/0008-5472.CAN-14-1835; Bak S, 2002, STROKE, V33, P769, DOI 10.1161/hs0302.103619; Bengtson MB, 2006, GUT, V55, P1754, DOI 10.1136/gut.2006.097287; Cameron AJ, 2002, GASTROENTEROLOGY, V122, P55, DOI 10.1053/gast.2002.30301; Chakravarti A, 2003, NATURE, V421, P412, DOI 10.1038/nature01401; Chang CQ, 2014, EUR J HUM GENET, V22, P402, DOI 10.1038/ejhg.2013.161; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Gannett L, 1999, BIOL PHILOS, V14, P349, DOI 10.1023/A:1006583215835; Gatz M, 1997, J GERONTOL A-BIOL, V52, pM117, DOI 10.1093/gerona/52A.2.M117; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Haga SB, 2003, NAT GENET, V34, P347, DOI 10.1038/ng0803-347; Hansen PS, 2006, EUR J ENDOCRINOL, V154, P29, DOI 10.1530/eje.1.02060; Hemminki K, 2002, CANCER EPIDEM BIOMAR, V11, P1638; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Ingebrigtsen T, 2010, RESP MED, V104, P1890, DOI 10.1016/j.rmed.2010.05.004; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Mulder EJ, 2003, TWIN RES, V6, P422, DOI 10.1375/twin.6.5.422; Rappaport SM, 2014, ENVIRON HEALTH PERSP, V122, P769, DOI 10.1289/ehp.1308015; Rappaport SM, 2012, BIOMARKERS, V17, P483, DOI 10.3109/1354750X.2012.691553; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Roberts NJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003380; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Sullivan PF, 2005, PSYCHOL MED, V35, P1327, DOI 10.1017/S0033291705005222; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Thomsen SF, 2010, CLIN EXP ALLERGY, V40, P1054, DOI 10.1111/j.1365-2222.2010.03525.x; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Vineis P, 2006, ANN NY ACAD SCI, V1076, P163, DOI 10.1196/annals.1371.060; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wild CP, 2013, ENVIRON MOL MUTAGEN, V54, P480, DOI 10.1002/em.21777; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Wirdefeldt K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.02.017; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x	45	120	123	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154387	10.1371/journal.pone.0154387	http://dx.doi.org/10.1371/journal.pone.0154387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105432	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100073
J	Roth, C; Gangl, C; Dalos, D; Krenn, L; Scherzer, S; Gerken, A; Reinwein, M; Zhang, C; Hagmann, M; Wrba, T; Delle-Karth, G; Neunteufl, T; Maurer, G; Vock, P; Mayr, H; Frey, B; Berger, R				Roth, Christian; Gangl, Clemens; Dalos, Daniel; Krenn, Lisa; Scherzer, Sabine; Gerken, Anna; Reinwein, Martin; Zhang, Chao; Hagmann, Michael; Wrba, Thomas; Delle-Karth, Georg; Neunteufl, Thomas; Maurer, Gerald; Vock, Paul; Mayr, Harald; Frey, Bernhard; Berger, Rudolf			Outcome after Elective Percutaneous Coronary Intervention Depends on Age in Patients with Stable Coronary Artery Disease - An Analysis of Relative Survival in a Multicenter Cohort and an OCT Substudy	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OPTIMAL MEDICAL THERAPY; LONG-TERM OUTCOMES; MYOCARDIAL-INFARCTION; PLAQUE COMPOSITION; ELDERLY-PATIENTS; INTRAVASCULAR ULTRASOUND; INVASIVE MANAGEMENT; VIRTUAL HISTOLOGY; CLINICAL-OUTCOMES	Background Age is a strong predictor of survival in patients with coronary artery disease. In elder patients with increasing co-morbidities percutaneous coronary intervention (PCI) is associated with more complications and worse outcome. The calculation of relative survival rates adjusts for the "background" mortality in the general population by correcting for age and gender. We analyzed if elder patients after elective PCI have a worse relative survival compared to younger patient groups. Methods A total of 8,342 patients who underwent elective PCI at two high volume centers between 1998 and 2009 were analyzed. Results The survival of our patients after PCI (observed survival) was slightly lower compared to the general population (expected survival) resulting in a slightly decreasing relative survival curve. In a multivariate Cox regression model age amongst others was a strong predictor of survival. Stratifying patients according to their age the relative survival curves of younger patients (Quartile 1: <58 years; 2,046 patients), elder patients (Quartile 3: 66-73 years; 2,090 patients) and very old patients (Quartile 4: >73 years; 2,307 patients) were similar. The relative survival of mid-aged patients (Quartile 2: 58-65 years; 1,899 patients) was better than that of all other patient groups. The profile of cardiovascular risk factors differs between the various groups resulting in different composition and burden of coronary plaques in an optical coherence tomography sub-study. Conclusion Patients after elective PCI have a slightly worse long-term survival compared to the age- and sex-matched general population. This is also true for different groups of age except for mid-aged patients between 58 and 63 years. Elder patients between 66 and 73 years and above 73 years have a similar relative survival compared to younger patients below 58 years, and might therefore have similar benefit from elective PCI.	[Roth, Christian; Gangl, Clemens; Dalos, Daniel; Krenn, Lisa; Scherzer, Sabine; Gerken, Anna; Reinwein, Martin; Zhang, Chao; Delle-Karth, Georg; Neunteufl, Thomas; Maurer, Gerald; Frey, Bernhard; Berger, Rudolf] Med Univ Vienna, Dept Internal Med 2, Cardiol, Vienna, Austria; [Hagmann, Michael] Med Univ Vienna, Sect Med Stat, Vienna, Austria; [Wrba, Thomas] Med Univ Vienna, Sect Med Informat & Retrieval Syst, Dept Informat & Intelligent Syst, Vienna, Austria; [Delle-Karth, Georg] Hosp Hietzing, Cardiol, Dept Internal Med 4, Vienna, Austria; [Neunteufl, Thomas] Univ Hosp Krems, Dept Internal Med 1, Cardiol, Krems An Der Donau, Austria; [Neunteufl, Thomas] Karl Landsteiner Private Univ Hlth Sci, Krems An Der Donau, Austria; [Vock, Paul; Mayr, Harald; Frey, Bernhard] Univ Hosp St Polten, Dept Internal Med 3, Cardiol, St Polten, Austria; [Berger, Rudolf] Hosp St John God, Dept Internal Med 1, Cardiol & Nephrol, Eisenstadt, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Hietzing Hospital	Berger, R (corresponding author), Med Univ Vienna, Dept Internal Med 2, Cardiol, Vienna, Austria.; Berger, R (corresponding author), Hosp St John God, Dept Internal Med 1, Cardiol & Nephrol, Eisenstadt, Austria.	rudolf.berger@meduniwien.ac.at		Dalos, Daniel/0000-0002-9597-5745; Maurer, Gerald/0000-0002-9043-7657				ANDERSON HV, 1995, J AM COLL CARDIOL, V26, P1643, DOI 10.1016/0735-1097(95)00404-1; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Baber U, 2012, JACC-CARDIOVASC IMAG, V5, pS53, DOI 10.1016/j.jcmg.2011.12.008; Bach RG, 2004, ANN INTERN MED, V141, P186, DOI 10.7326/0003-4819-141-3-200408030-00007; Bagnall AJ, 2009, AM J CARDIOL, V103, P1530, DOI 10.1016/j.amjcard.2009.01.369; Bangalore S, 2013, CIRCULATION, V127, P769, DOI 10.1161/CIRCULATIONAHA.112.131961; Bassand Jean-Pierre, 2008, Rev Port Cardiol, V27, P1063; Batchelor WB, 2000, J AM COLL CARDIOL, V36, P723, DOI 10.1016/S0735-1097(00)00777-4; Bauer T, 2007, EUR HEART J, V28, P2873, DOI 10.1093/eurheartj/ehm464; Bauer T, 2011, INT J CARDIOL, V151, P164, DOI 10.1016/j.ijcard.2010.05.006; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bortnick AE, 2014, AM J CARDIOL, V113, P573, DOI 10.1016/j.amjcard.2013.10.039; Brown AJ, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003487; Buljubasic N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141093; Chauhan MS, 2001, J AM COLL CARDIOL, V37, P856, DOI 10.1016/S0735-1097(00)01170-0; Cheng JM, 2010, AM J CARDIOL, V106, P1376, DOI 10.1016/j.amjcard.2010.07.007; Cole Jason H, 2004, Curr Atheroscler Rep, V6, P121, DOI 10.1007/s11883-004-0100-z; Davidson L, 2014, AM J MED, V127, P140, DOI 10.1016/j.amjmed.2013.09.025; Deckers JW, 2013, INT J CARDIOL, V167, P2387, DOI 10.1016/j.ijcard.2013.01.008; Ertelt K, 2014, CARDIOVASC REVASCULA, V15, P375, DOI 10.1016/j.carrev.2014.09.002; Garcia-Garcia HM, 2009, JACC-CARDIOVASC IMAG, V2, P629, DOI 10.1016/j.jcmg.2009.01.008; Hou XW, 2015, GENE, V565, P39, DOI 10.1016/j.gene.2015.03.062; Johnman C, 2010, CIRC-CARDIOVASC INTE, V3, P341, DOI 10.1161/CIRCINTERVENTIONS.109.928705; Kataoka Y, 2015, ATHEROSCLEROSIS, V242, P490, DOI 10.1016/j.atherosclerosis.2015.08.005; Kataoka Y, 2015, EUR J PREV CARDIOL, V22, P1331, DOI 10.1177/2047487315598711; KELSEY SF, 1990, AM J CARDIOL, V66, P1033, DOI 10.1016/0002-9149(90)90500-Z; Klein LW, 2002, J AM COLL CARDIOL, V40, P394, DOI 10.1016/S0735-1097(02)01992-7; Kobayashi Y, 2003, AM J CARDIOL, V92, P443, DOI 10.1016/S0002-9149(03)00663-5; Kyto V, 2014, EUR J CLIN INVEST, V44, P902, DOI 10.1111/eci.12321; Lee MS, 2008, CATHETER CARDIO INTE, V71, P526, DOI 10.1002/ccd.21382; Marcohno MS, 2012, EUROINTERVENTION, V8, P920, DOI 10.4244/EIJV8I8A141; Marso SP, 2012, JACC-CARDIOVASC IMAG, V5, pS42, DOI 10.1016/j.jcmg.2012.01.008; Mintz GS, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.004045; Miyamoto Y, 2011, JACC-CARDIOVASC IMAG, V4, P638, DOI 10.1016/j.jcmg.2011.03.014; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Munoz JC, 2002, AM HEART J, V143, P620, DOI 10.1067/mhj.2002.120966; Obaid DR, 2013, CIRC-CARDIOVASC IMAG, V6, P655, DOI 10.1161/CIRCIMAGING.112.000250; Park SJ, 2012, CARDIOVASC INTERV TH, V27, P1, DOI 10.1007/s12928-011-0085-9; Ranchord AM, 2010, J INVASIVE CARDIOL, V22, P301; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Roe MT, 2013, CIRC-CARDIOVASC QUAL, V6, P323, DOI 10.1161/CIRCOUTCOMES.113.000120; Ruiz-Garcia J, 2012, EUROINTERVENTION, V8, P929, DOI 10.4244/EIJV8I8A142; Stone GW, 2016, LANCET; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Thim T, 2010, CIRC-CARDIOVASC IMAG, V3, P384, DOI 10.1161/CIRCIMAGING.109.919357; Thompson RC, 1996, J AM COLL CARDIOL, V27, P8, DOI 10.1016/0735-1097(95)00436-X; Verschuren JJW, 2013, NETH HEART J, V21, P101, DOI 10.1007/s12471-012-0370-y; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Windecker S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3859; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Zamorano JL, 2014, REV ESP CARDIOL, V67, P538, DOI 10.1016/j.rec.2013.10.020	52	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154025	10.1371/journal.pone.0154025	http://dx.doi.org/10.1371/journal.pone.0154025			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105207	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100035
J	Su, B; Liu, TS; Fan, HJ; Chen, F; Ding, H; Wu, ZW; Wang, HW; Hou, SK				Su, Bin; Liu, Tiansheng; Fan, Haojun; Chen, Feng; Ding, Hui; Wu, Zhouwei; Wang, Hongwu; Hou, Shike			Inflammatory Markers and the Risk of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							C-REACTIVE PROTEIN; SMOKING-CESSATION INTERVENTIONS; INDUCED SPUTUM; COPD; OUTCOMES	Systemic inflammatory factors are inconsistently associated with the pathogenesis of chronic obstructive pulmonary disease (COPD). We conducted a systematic review and meta-analysis to summarize the evidence supporting the association between systemic inflammation and the risk of COPD. Pertinent studies were retrieved from PubMed, EmBase, and the Cochrane Library until April 2015. A random-effects model was used to process the data, and the analysis was further stratified by factors affecting these associations. Sensitivity analyses for publication bias were performed. We included 24 observational studies reporting data on 10,677 COPD patients and 28,660 controls. Overall, we noted that COPD was associated with elevated serum CRP (SMD: 1.21; 95% CI: 0.92-1.50; P < 0.001), leukocytes (SMD: 1.07; 95%: 0.25-1.88; P = 0.010), IL-6 (SMD: 0.90; 95% CI: 0.48-1.31; P < 0.001), IL-8 (SMD: 2.34; 95% CI: 0.69-4.00; P = 0.006), and fibrinogen levels (SMD: 0.87; 95% CI: 0.44-1.31; P < 0.001) when compared with control. However, COPD was not significantly associated with TNF-alpha levels when compared with control (SMD: 0.60; 95% CI: -0.46 to 1.67; P = 0.266). Our findings suggested that COPD was associated with elevated serum CRP, leukocytes, IL-6, IL-8, and fibrinogen, without any significant relationship with TNF-alpha.	[Su, Bin] Chinese Peoples Armed Police Forces, Logist Univ, Affiliated Hosp, Med Simulat Teaching Base, Tianjin, Peoples R China; [Liu, Tiansheng] Chinese Peoples Armed Police Forces, Logist Univ, Affiliated Hosp, Dept Orthoped, Tianjin, Peoples R China; [Fan, Haojun; Chen, Feng; Ding, Hui; Wu, Zhouwei; Hou, Shike] Chinese Peoples Armed Police Forces, Logist Univ, Affiliated Hosp, Tianjin, Peoples R China; [Su, Bin; Wang, Hongwu] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine	Su, B (corresponding author), Chinese Peoples Armed Police Forces, Logist Univ, Affiliated Hosp, Med Simulat Teaching Base, Tianjin, Peoples R China.; Su, B (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China.	subin150@sina.com			Tianjin Municipal Natural Science Foundation [15JCYBJC28500]; key cultivated academic construction project of state administrative bureau for prophylactic medicine of traditional Chinese medicine [2012]	Tianjin Municipal Natural Science Foundation(Natural Science Foundation of Tianjin); key cultivated academic construction project of state administrative bureau for prophylactic medicine of traditional Chinese medicine	This work was supported by Tianjin Municipal Natural Science Foundation (15JCYBJC28500). This work was also supported by key cultivated academic construction project of state administrative bureau for prophylactic medicine of traditional Chinese medicine (NO. 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-41; Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Agusti Alvar G N, 2005, Proc Am Thorac Soc, V2, P367, DOI 10.1513/pats.200504-026SR; Barbaro MPF, 2007, INT J IMMUNOPATH PH, V20, P753, DOI 10.1177/039463200702000411; Barreiro E, 2008, THORAX, V63, P100, DOI 10.1136/thx.2007.078030; Bartlett YK, 2014, BRIT J HEALTH PSYCH, V19, P181, DOI 10.1111/bjhp.12071; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bircan A, 2008, MED PRIN PRACT, V17, P202, DOI 10.1159/000117793; Bucchioni E, 2003, RESP MED, V97, P1299, DOI 10.1016/j.rmed.2003.07.008; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fattouh M, 2014, EGYPT J CHEST DIS TU, V63, P799, DOI 10.1016/j.ejcdt.2014.06.011; Feng EZ, 2013, EXP THER MED, V6, P747, DOI 10.3892/etm.2013.1192; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Garcia-Rio F, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-63; Hacker S, 2009, CLIN LAB, V55, P31; Harting JR, 2012, J TOXICOL ENV HEAL A, V75, P1456, DOI 10.1080/15287394.2012.722186; He ZH, 2010, RESPIROLOGY, V15, P478, DOI 10.1111/j.1440-1843.2010.01709.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Karadag F, 2008, EUR J INTERN MED, V19, P104, DOI 10.1016/j.ejim.2007.04.026; Kersul AL, 2011, ARCH BRONCONEUMOL, V47, P176, DOI 10.1016/j.arbres.2010.12.003; Liu XJ, 2009, NUTRITION, V25, P373, DOI 10.1016/j.nut.2008.09.008; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Petersen AMW, 2008, SCAND J MED SCI SPOR, V18, P557, DOI 10.1111/j.1600-0838.2007.00727.x; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; Strassmann R, 2009, EUR RESPIR J, V34, P634, DOI 10.1183/09031936.00167708; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Undas A, 2009, THROMB HAEMOSTASIS, V102, P1176, DOI 10.1160/TH09-02-0118; Valvi D, 2012, INT J CHRONIC OBSTR, V7, P173, DOI 10.2147/COPD.S29892; van den Borst B, 2011, AM J CLIN NUTR, V94, P1504, DOI 10.3945/ajcn.111.023911; Van Helvoort HAC, 2006, MED SCI SPORT EXER, V38, P1543, DOI 10.1249/01.mss.0000228331.13123.53; Vernooy JH, 2002, AM J RESP CRIT CARE, V166, P1218, DOI 10.1164/rccm.2202023; Wang XR, 2014, INT J CHRONIC OBSTR, V9, P543, DOI 10.2147/COPD.S62700; Wells G, 2000, NEWCASTLE OTTAWA SCA; Yasuda N, 1998, RESP MED, V92, P993, DOI 10.1016/S0954-6111(98)90343-2	42	58	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0150586	10.1371/journal.pone.0150586	http://dx.doi.org/10.1371/journal.pone.0150586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104349	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100002
J	Kiregu, J; Murindahabi, NK; Tumusiime, D; Thomson, DR; Hedt-Gauthier, BL; Ahayo, A				Kiregu, Joshua; Murindahabi, Nathalie K.; Tumusiime, David; Thomson, Dana R.; Hedt-Gauthier, Bethany L.; Ahayo, Anita			Socioeconomics and Major Disabilities: Characteristics of Working-Age Adults in Rwanda	PLOS ONE			English	Article							DIFFERENCE	Background Disability affects approximately 15% of the world's population, and has adverse socio-economic effects, especially for the poor. In Rwanda, there are a number of government compensation programs that support the poor, but not specifically persons with disability (PWDs). This study investigates the relationship between poverty and government compensation on disability among working-age adults in Rwanda. Methods This was a secondary analysis of 35,114 adults aged 16 to 65 interviewed in the 2010/2011 Rwanda Household Wealth and Living Conditions survey, a national cross-sectional two-stage cluster survey, stratified by district. This study estimated self-reported major disability, and used chi-square tests to estimate associations (p< 0.1) with income, government compensation, occupation type, participation in public works programs, and household poverty status. Non-collinear economic variables were included in a multivariate logistic regression, along with socio-demographic confounders that modified the relationship between any economic predictor and the outcome by 10% or more. All analyses adjusted for sampling weights, stratification, and clustering of households. Results Over 4% of working-age adults reported having a major disability and the most prevalent types of disability in order were physical, mental, and then sensory disability. In bivariate analysis, annual income, occupation type, and poverty status were associated with major disability (p< 0.001 for all). Occupation type was dropped because it was collinear with income. Age, education, and urban/rural residence were confounders. In the multivariate analysis, adults in all income groups had about half the odds of disability compared to adults with no income (Rwf1-120,000 OR = 0.57; Rwf120,000-250,000 OR = 0.61; Rwf250,000-1,000,000 OR = 0.59; Rwf1,000,000+ OR = 0.66; p< 0.05 for all), and non-poor adults had 0.77 the odds of disability compared to poor adults (p = 0.001). Conclusion Given that personal income rather than government programming is associated with disability in Rwanda, we recommend deliberately targeted services to those with disability via cash transfers, placements in disability-appropriate employment, and micro-savings programs.	[Kiregu, Joshua; Murindahabi, Nathalie K.; Tumusiime, David; Thomson, Dana R.; Hedt-Gauthier, Bethany L.] Univ Rwanda, Coll Med & Hlth Sci, Kigali, Rwanda; [Hedt-Gauthier, Bethany L.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Ahayo, Anita] Rwanda Biomed Ctr, Injuries & Disabil Unit, Kigali, Rwanda	University of Rwanda; Harvard University; Harvard Medical School; Rwanda Biomedical Center	Kiregu, J (corresponding author), Univ Rwanda, Coll Med & Hlth Sci, Kigali, Rwanda.	Jkiregu@nursph.org		Thomson, Dana Renee/0000-0002-9507-9123				Abbott P, 2012, LEGAL POLICY FRAMEWO; Amosun SL, 2005, DISABIL REHABIL, V27, P837, DOI 10.1080/09638280400018676; Barrett CB, 2008, 0804 WORLD BANK; Berkman L, 2000, HIST FRAMEWORK SOCIA; Blaser Art, 2002, DISABIL STUD Q, V22, P53; Braithwaite J., 2008, DISABILITY POVERTY S; Colleta Nat J., 2000, VIOLENT CONFLICT TRA; Des Forges, 1999, LEAVE NONE TELL STOR; Dupas P, 2013, AM ECON J-APPL ECON, V5, P163, DOI 10.1257/app.5.1.163; Government of Rwanda, 2007, VIS 2020 UM INT LOC; GRAMMENOS S, 2003, ILLNESS DISABILITY S; Johannsmeier C, 2007, SOCIAL EC EFFECTS EF; Lang R., 2009, DISABILITY SCOPING S; Leonard Cheshire Disability, 2014, ACC LIV; Leonardi M, 2006, LANCET, V368, P1219, DOI 10.1016/S0140-6736(06)69498-1; MINALOC and ADPD/RNDSC, 2010, CENS PEOPL DIS RWAND; Ministry of Finance and Economic Planning-Rwanda (MINECOFIN), 2009, NAT SOC SEC POL; Mizunoya S, 2012, 201203 FORDH U; National Institute of Statistics of Rwanda, 2014, SOC CHAR PERS DIS TH; National Institute of Statistics of Rwanda, 2014, 4 POP HOUS CENS RWAN; National Institute of Statistics of Rwanda (NISR), 2013, EICV3 THEM REP SOC P; National Institute of Statistics of Rwanda (NISR), 2014, ENQ INT COND VIE MEN; National Institute of Statistics of Rwanda (NISR) MoHMR ICF International, 2012, RWAND DEM HLTH SURV; NISR, 2012, EV POV RWAND 2000 20; NISR, 2014, POP SIZ STRUCT DISTR; Pretoria University Law Press (PULP), 2014, AFRICAN DISABILITY R, V2; Rieder Heide, 2013, CONFL HEALTH, V7, P1; Samson M, 2004, SOCIAL EC IMPACT S A; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Schneider M., 2006, DISABILITY SOCIAL CH, P8; Schneider M, 2009, ALTER, V3, P245, DOI 10.1016/j.alter.2009.04.002; Schneider M, 2009, DISABIL REHABIL, V31, P42, DOI 10.1080/09638280802280338; Schur L, 2002, J ECON ISSUES, V36, P339, DOI 10.1080/00213624.2002.11506476; Sen A., 2010, IDEA JUSTICE, DOI DOI 10.2307/J.CTVJNRV7N; Statistics South Africa, 2013, CENS 2011 HIGHL KEY; Straus S., 2004, J GENOCIDE RES, V6, P85, DOI DOI 10.1080/1462352042000194728; The Global Alliance on Accessible Technologies and Environments (GAATES), 2012, GLOBAL ACCESSIB 0617; Vision 2020 Umurenge Programme, 2011, VIS 2020 UM PROGR AN; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Williamson C, 2012, ENQUIRE, V5, P3; World Bank, 2015, WORLD DEV INDICATORS; World Health Organization, 2002, COMMON LANGUAGE FUNC	42	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153741	10.1371/journal.pone.0153741	http://dx.doi.org/10.1371/journal.pone.0153741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27101377	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000374898500060
J	Leshkowitz, D; Feldmesser, E; Friedlander, G; Jona, G; Ainbinder, E; Parmet, Y; Horn-Saban, S				Leshkowitz, Dena; Feldmesser, Ester; Friedlander, Gilgi; Jona, Ghil; Ainbinder, Elena; Parmet, Yisrael; Horn-Saban, Shirley			Using Synthetic Mouse Spike-In Transcripts to Evaluate RNA-Seq Analysis Tools	PLOS ONE			English	Article							EXPRESSION ANALYSIS; DIFFERENTIAL GENE; QUANTIFICATION; INFERENCE; ALIGNMENT; TOPHAT	One of the key applications of next-generation sequencing (NGS) technologies is RNA-Seq for transcriptome genome-wide analysis. Although multiple studies have evaluated and benchmarked RNA-Seq tools dedicated to gene level analysis, few studies have assessed their effectiveness on the transcript-isoform level. Alternative splicing is a naturally occurring phenomenon in eukaryotes, significantly increasing the biodiversity of proteins that can be encoded by the genome. The aim of this study was to assess and compare the ability of the bioinformatics approaches and tools to assemble, quantify and detect differentially expressed transcripts using RNA-Seq data, in a controlled experiment. To this end, in vitro synthesized mouse spike-in control transcripts were added to the total RNA of differentiating mouse embryonic bodies, and their expression patterns were measured. This novel approach was used to assess the accuracy of the tools, as established by comparing the observed results versus the results expected of the mouse controlled spiked-in transcripts. We found that detection of differential expression at the gene level is adequate, yet on the transcript-isoform level, all tools tested lacked accuracy and precision.	[Leshkowitz, Dena; Feldmesser, Ester; Jona, Ghil; Ainbinder, Elena; Horn-Saban, Shirley] Weizmann Inst Sci, Biol Serv Dept, IL-76100 Rehovot, Israel; [Friedlander, Gilgi] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, IL-76100 Rehovot, Israel; [Parmet, Yisrael] Ben Gurion Univ Negev, Ind Engn & Management Dept, IL-84105 Beer Sheva, Israel; [Horn-Saban, Shirley] Galil Genet Anal Ltd, Katsrin, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Ben Gurion University	Leshkowitz, D (corresponding author), Weizmann Inst Sci, Biol Serv Dept, IL-76100 Rehovot, Israel.	Dena.Leshkowitz@weizmann.ac.il	PARMET, YISRAEL/F-1982-2012	PARMET, YISRAEL/0000-0002-2071-7338; Jona, Ghil/0000-0002-4526-6182	Weizmann-Staff Scientists Internal Grant Program	Weizmann-Staff Scientists Internal Grant Program	This project was supported by a grant from Weizmann-Staff Scientists Internal Grant Program (D.L., E.F. and S.H.S.) [http://www.weizmann.ac.il/RGP/proposal/100]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Angelini C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-135; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Busby MA, 2013, BIOINFORMATICS, V29, P656, DOI 10.1093/bioinformatics/btt015; Chandramohan R, 2013, IEEE ENG MED BIO, P647, DOI 10.1109/EMBC.2013.6609583; Estivill X, 2015, NAT BIOTECHNOL, V33, P357, DOI 10.1038/nbt.3195; Feng HJ, 2013, CANCER LETT, V340, P179, DOI 10.1016/j.canlet.2012.11.010; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hart SN, 2013, J COMPUT BIOL, V20, P970, DOI 10.1089/cmb.2012.0283; Hooper JE, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-3; Kanitz A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0702-5; Ken K, 2012, PACKAGE MBESS; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Singh P, 2009, CANCER RES, V69, P9422, DOI 10.1158/0008-5472.CAN-09-2236; Smith-Unna RD, TRANSRATE REFERENCE; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Jianbo, 2015, BioMolecular Concepts, V6, P59, DOI 10.1515/bmc-2014-0040; Xu J, 2012, MOL BIOL REP, V39, P789, DOI 10.1007/s11033-011-0800-8	43	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153782	10.1371/journal.pone.0153782	http://dx.doi.org/10.1371/journal.pone.0153782			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100792	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500067
J	Malfait, B; Dingenen, B; Smeets, A; Staes, F; Pataky, T; Robinson, MA; Vanrenterghem, J; Verschueren, S				Malfait, Bart; Dingenen, Bart; Smeets, Annemie; Staes, Filip; Pataky, Todd; Robinson, Mark A.; Vanrenterghem, Jos; Verschueren, Sabine			Knee and Hip Joint Kinematics Predict Quadriceps and Hamstrings Neuromuscular Activation Patterns in Drop Jump Landings	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; SCORING SYSTEM LESS; INJURY RISK; MUSCLE ACTIVATION; IMPACT FORCES; VERTICAL JUMP; FEMALE; COCONTRACTION; BIOMECHANICS; BASKETBALL	Purpose The purpose was to assess if variation in sagittal plane landing kinematics is associated with variation in neuromuscular activation patterns of the quadriceps-hamstrings muscle groups during drop vertical jumps (DVJ). Methods Fifty female athletes performed three DVJ. The relationship between peak knee and hip flexion angles and the amplitude of four EMG vectors was investigated with trajectory-level canonical correlation analyses over the entire time period of the landing phase. EMG vectors consisted of the {vastus medialis(VM), vastus lateralis(VL)}, {vastus medialis(VM), hamstring medialis(HM)}, {hamstring medialis(HM), hamstring lateralis(HL)} and the {vastus lateralis(VL), hamstring lateralis(HL)}. To estimate the contribution of each individual muscle, linear regressions were also conducted using one-dimensional statistical parametric mapping. Results The peak knee flexion angle was significantly positively associated with the amplitudes of the {VM, HM} and {HM, HL} during the preparatory and initial contact phase and with the {VL, HL} vector during the peak loading phase (p< 0.05). Small peak knee flexion angles were significantly associated with higher HM amplitudes during the preparatory and initial contact phase (p< 0.001). The amplitudes of the {VM, VL} and {VL, HL} were significantly positively associated with the peak hip flexion angle during the peak loading phase (p< 0.05). Small peak hip flexion angles were significantly associated with higher VL amplitudes during the peak loading phase (p = 0.001). Higher external knee abduction and flexion moments were found in participants landing with less flexed knee and hip joints (p< 0.001). Conclusion This study demonstrated clear associations between neuromuscular activation patterns and landing kinematics in the sagittal plane during specific parts of the landing. These findings have indicated that an erect landing pattern, characterized by less hip and knee flexion, was significantly associated with an increased medial and posterior neuromuscular activation (dominant hamstrings medialis activity) during the preparatory and initial contact phase and an increased lateral neuromuscular activation (dominant vastus lateralis activity) during the peak loading phase.	[Malfait, Bart; Dingenen, Bart; Smeets, Annemie; Staes, Filip; Verschueren, Sabine] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Rehabil Sci & Physiotherapy, Musculoskeletal Rehabil Res Grp, Leuven, Belgium; [Robinson, Mark A.; Vanrenterghem, Jos] Liverpool John Moores Univ, Fac Sci, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England; [Pataky, Todd] Shinshu Univ, Dept Bioengn, Ueda, Nagano, Japan	KU Leuven; Liverpool John Moores University; Shinshu University	Verschueren, S (corresponding author), Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Rehabil Sci & Physiotherapy, Musculoskeletal Rehabil Res Grp, Leuven, Belgium.	sabine.verschueren@faber.kuleuven.be	Smeets, Annemie/ACW-6678-2022; Robinson, Mark A./H-7108-2019; Verschueren, Sabine/K-4213-2015	Smeets, Annemie/0000-0003-4569-8652; Robinson, Mark A./0000-0002-5627-492X; Dingenen, Bart/0000-0002-8684-9931; Vanrenterghem, Jos/0000-0002-1682-8430; Verschueren, Sabine/0000-0003-2592-494X				Adler R., 2007, RANDOM FIELDS GEOMET; BARATTA R, 1988, AM J SPORT MED, V16, P113, DOI 10.1177/036354658801600205; Barendrecht M, 2011, J STRENGTH COND RES, V25, P575, DOI 10.1519/JSC.0b013e3182023bc7; Bates NA, 2013, J BIOMECH, V46, P1237, DOI 10.1016/j.jbiomech.2013.02.024; BEARD DJ, 1994, J BONE JOINT SURG BR, V76B, P654, DOI 10.1302/0301-620X.76B4.8027158; Beaulieu ML, 2009, KNEE SURG SPORT TR A, V17, P968, DOI 10.1007/s00167-009-0821-1; Besier TF, 2003, J BIOMECH, V36, P1159, DOI 10.1016/S0021-9290(03)00087-3; BEYNNON B, 1992, INT ORTHOP, V16, P1; Bisseling RW, 2006, J BIOMECH, V39, P2438, DOI 10.1016/j.jbiomech.2005.07.021; Blackburn JT, 2008, CLIN BIOMECH, V23, P313, DOI 10.1016/j.clinbiomech.2007.10.003; Blackburn JT, 2009, J ATHL TRAINING, V44, P174, DOI 10.4085/1062-6050-44.2.174; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Colby S, 2000, AM J SPORT MED, V28, P234, DOI 10.1177/03635465000280021501; Dingenen B, 2015, KNEE, V22, P73, DOI 10.1016/j.knee.2014.12.006; Elias JJ, 2003, AM J SPORT MED, V31, P241, DOI 10.1177/03635465030310021401; Ford KR, 2005, J STRENGTH COND RES, V19, P394, DOI 10.1519/15834.1; Ford KR, 2003, MED SCI SPORT EXER, V35, P1745, DOI 10.1249/01.MSS.0000089346.85744.D9; Gottlob C A, 2000, Am J Orthop (Belle Mead NJ), V29, P472; Griffin LY, 2006, AM J SPORT MED, V34, P1512, DOI 10.1177/0363546506286866; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hewett TE, 1996, AM J SPORT MED, V24, P765, DOI 10.1177/036354659602400611; HIROKAWA S, 1991, J ELECTROMYOGR KINES, V1, P199, DOI 10.1016/1050-6411(91)90035-4; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Li G, 1999, J BIOMECH, V32, P395, DOI 10.1016/S0021-9290(98)00181-X; Lloyd DG, 2001, J BIOMECH, V34, P1257, DOI 10.1016/S0021-9290(01)00095-1; Malfait B, 2014, MED SCI SPORT EXER, V46, P678, DOI 10.1249/MSS.0000000000000170; Myer GD, 2005, J ELECTROMYOGR KINES, V15, P181, DOI 10.1016/j.jelekin.2004.08.006; Myer GD, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-39; NOYES FR, 1983, J BONE JOINT SURG AM, V65, P154, DOI 10.2106/00004623-198365020-00003; Padua DA, 2009, AM J SPORT MED, V37, P1996, DOI 10.1177/0363546509343200; Palmieri-Smith RM, 2009, J ATHL TRAINING, V44, P256, DOI 10.4085/1062-6050-44.3.256; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Pataky TC, 2012, COMPUT METHOD BIOMEC, V15, P295, DOI 10.1080/10255842.2010.527837; Pflum MA, 2004, MED SCI SPORT EXER, V36, P1949, DOI 10.1249/01.MSS.0000145467.79916.46; Pollard CD, 2010, CLIN BIOMECH, V25, P142, DOI 10.1016/j.clinbiomech.2009.10.005; Robinson MA, 2015, J ELECTROMYOGR KINES, V25, P14, DOI 10.1016/j.jelekin.2014.10.018; Robinson MA, 2012, J BIOMECH, V45, P1941, DOI 10.1016/j.jbiomech.2012.05.017; Sell TC, 2007, J ORTHOP RES, V25, P1589, DOI 10.1002/jor.20459; Shimokochi Y, 2009, J ATHL TRAINING, V44, P33, DOI 10.4085/1062-6050-44.1.33; Smith HC, 2012, AM J SPORT MED, V40, P521, DOI 10.1177/0363546511429776; Sugimoto D, 2015, BRIT J SPORT MED, V49, P282, DOI 10.1136/bjsports-2014-093461; Vanrenterghem J, 2012, J BIOMECH, V45, P2444, DOI 10.1016/j.jbiomech.2012.06.029; Walsh M, 2012, J ATHL TRAINING, V47, P406, DOI 10.4085/1062-6050-47.4.17; Wikstrom EA, 2006, SPORTS MED, V36, P393, DOI 10.2165/00007256-200636050-00003; Yu B, 2006, CLIN BIOMECH, V21, P297, DOI 10.1016/j.clinbiomech.2005.11.003; Zebis MK, 2009, AM J SPORT MED, V37, P1967, DOI 10.1177/0363546509335000; Zhang LQ, 2001, J BIOMECH, V34, P1107, DOI 10.1016/S0021-9290(01)00080-X	49	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153737	10.1371/journal.pone.0153737	http://dx.doi.org/10.1371/journal.pone.0153737			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101130	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000374898500058
J	Pandey, MS; Miller, CM; Harris, EN; Weigel, PH				Pandey, Madhu S.; Miller, Colton M.; Harris, Edward N.; Weigel, Paul H.			Activation of ERK and NF-kappa B during HARE-Mediated Heparin Uptake Require Only One of the Four Endocytic Motifs	PLOS ONE			English	Article							LIVER ENDOTHELIAL-CELLS; LOW-DENSITY-LIPOPROTEIN; MOLECULAR-WEIGHT HEPARINS; HUMAN HYALURONAN RECEPTOR; CHONDROITIN SULFATE; DERMATAN SULFATE; GENE-EXPRESSION; IN-VITRO; CYTOPLASMIC DOMAIN; CORPSE CLEARANCE	Fifteen different ligands, including heparin (Hep), are cleared from lymph and blood by the Hyaluronan (HA) Receptor for Endocytosis (HARE; derived from Stabilin-2 by proteolysis), which contains four endocytic motifs (M1-M4). Endocytosis of HARE.Hep complexes is targeted to coated pits by M1, M2, and M3 (Pandey et al, Int. J. Cell Biol. 2015, article ID 524707), which activates ERK1/2 and NF-kappa B (Pandey et al J. Biol. Chem. 288, 14068-79, 2013). Here, we used a NF-kappa B promoter-driven luciferase gene assay and cell lines expressing different HARE cytoplasmic domain mutants to identify motifs needed for Hep-mediated signaling. Deletion of M1, M2 or M4 singly had no effect on Hep-mediated ERK1/2 activation, whereas signaling (but not uptake) was eliminated in HARE(Delta M3) cells lacking NPLY2519. ERK1/2 signaling in cells expressing WT HARE(Y2519A) or HARE(Y2519A) lacking M1, M2 and M4 (containing M3-only) was decreased by 75% or eliminated, respectively. Deletion of M3 (but not M1, M2 or M4) also inhibited the formation of HARE.Hep.ERK1/2 complexes by 67%. NF-kappa B activation by HARE-mediated uptake of Hep, HA, dermatan sulfate or acetylated LDL was unaffected in single-motif deletion mutants lacking M1, M2 or M4. In contrast, cells expressing HARE(Delta M3) showed loss of HARE-mediated NF-kappa B activation during uptake of each of these four ligands. NF-kappa B activation by the four signaling ligands was also eliminated in HARE(Y2519A) or HARE(M3-only; Y2519A) cells. We conclude that the HARE NPLY2519 motif is necessary for both ERK1/2 and NF-kappa B signaling and that Tyr(2519) is critical for these functions.	[Pandey, Madhu S.; Weigel, Paul H.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Miller, Colton M.; Harris, Edward N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Nebraska System; University of Nebraska Lincoln	Weigel, PH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA.	paul-weigel@ouhsc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130864] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL130864] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Castelli R, 2004, VASC MED, V9, P205, DOI 10.1191/1358863x04vm566ra; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Easton JB, 2006, J NEUROCHEM, V97, P834, DOI 10.1111/j.1471-4159.2006.03789.x; Eberlein M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-20; ERIKSSON S, 1983, EXP CELL RES, V144, P223, DOI 10.1016/0014-4827(83)90458-5; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; FILARDO EJ, 1995, J CELL BIOL, V130, P441, DOI 10.1083/jcb.130.2.441; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Hare AK, 2015, BIOCHEM BIOPH RES CO, V456, P257, DOI 10.1016/j.bbrc.2014.11.068; Harris E. N., 2009, HEPATIC ENDOCYTOSIS, P210; Harris EN, 2008, GLYCOBIOLOGY, V18, P638, DOI 10.1093/glycob/cwn045; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2009, AM J PHYSIOL-GASTR L, V296, pG1191, DOI 10.1152/ajpgi.90717.2008; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; JACKSON RL, 1985, FEBS LETT, V190, P297, DOI 10.1016/0014-5793(85)81304-1; Jung MY, 2007, J LEUKOCYTE BIOL, V82, P1156, DOI 10.1189/jlb.0107052; Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laurent T.C., 1991, DEGRADATION BIOACTIV, P249; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LAURENT TC, 1986, BIOCHEM J, V234, P653, DOI 10.1042/bj2340653; LEBEL L, 1994, EUR J CLIN INVEST, V24, P621, DOI 10.1111/j.1365-2362.1994.tb01114.x; Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641; MARENGERE LEM, 1994, J CELL SCI, P97; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; Miller C. M., 2016, NUCL ACIDS RES; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Pandey MS, 2008, J BIOL CHEM, V283, P21453, DOI 10.1074/jbc.M800886200; Pandey Madhu S, 2015, Int J Cell Biol, V2015, P524707, DOI 10.1155/2015/524707; Pandey MS, 2014, J BIOL CHEM, V289, P21807, DOI 10.1074/jbc.M114.565846; Pandey MS, 2014, J BIOL CHEM, V289, P1756, DOI 10.1074/jbc.M113.510339; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Park SY, 2008, MOL CELL BIOL, V28, P5288, DOI 10.1128/MCB.01993-07; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Qian H, 2009, BIOCHEM BIOPH RES CO, V390, P883, DOI 10.1016/j.bbrc.2009.10.068; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Saito A, 2007, BBA-GEN SUBJECTS, V1770, P241, DOI 10.1016/j.bbagen.2006.10.015; Sauer Brian, 1994, Current Opinion in Biotechnology, V5, P521, DOI 10.1016/0958-1669(94)90068-X; Simpson MA, 2012, INT J CANCER, V131, pE836, DOI 10.1002/ijc.27427; SMEDSROD B, 1988, COLLAGEN REL RES, V8, P375; SMEDSROD B, 1988, CELL TISSUE RES, V253, P39; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Weigel P. H., 2012, STRUCTURE FUNCTION B, P293; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; YOUNG E, 1994, THROMB HAEMOSTASIS, V71, P300; Zhang LJ, 2010, PROG MOL BIOL TRANSL, V93, P1, DOI 10.1016/S1877-1173(10)93001-9; Zhou B, 1999, J BIOL CHEM, V274, P33831, DOI 10.1074/jbc.274.48.33831; Zhou B, 2003, GLYCOBIOLOGY, V13, P339, DOI 10.1093/glycob/cwg029; Zhou B, 2002, MOL BIOL CELL, V13, P2853, DOI 10.1091/mbc.02-03-0048; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200; Ziakas PD, 2010, OBSTET GYNECOL, V115, P1256, DOI 10.1097/AOG.0b013e3181deba40	62	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154124	10.1371/journal.pone.0154124	http://dx.doi.org/10.1371/journal.pone.0154124			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100626	Green Published, gold			2022-12-27	WOS:000374898500150
J	Sahnoun, M; Jemli, S; Trabelsi, S; Ayadi, L; Bejar, S				Sahnoun, Mouna; Jemli, Sonia; Trabelsi, Sahar; Ayadi, Leila; Bejar, Samir			Aspergillus Oryzae S2 alpha-Amylase Domain C Involvement in Activity and Specificity: In Vivo Proteolysis, Molecular and Docking Studies	PLOS ONE			English	Article							ALKALINE PROTEASE; ESCHERICHIA-COLI; STARCH-BINDING; TAKA-AMYLASE; PURIFICATION; NIGER; OPTIMIZATION; CHYMOTRYPSIN; PROTEINASE; STABILITY	We previously reported that Aspergillus oryzae strain S2 had produced two alpha-amylase isoforms named AmyA and AmyB. The apparent molecular masses revealed by SDS-PAGE were 50 and 42 kDa, respectively. Yet AmyB has a higher catalytic efficiency. Based on a monitoring study of the alpha-amylase production in both the presence and absence of different protease inhibitors, a chymotrypsin proteolysis process was detected in vivo generating AmyB. A. oryzae S2 alpha-amylase gene was amplified, cloned and sequenced. The sequence analysis revealed nine exons, eight introns and an encoding open reading frame of 1500 bp corresponding to AmyA isoform. The amino-acid sequence analysis revealed aY371 potential chymotrypsin cleaving site, likely to be the AmyB C-Terminal end and two other potential sites at Y359, and F379. A zymogram with a high acrylamide concentration was used. It highlighted two other closed apparent molecular mass alpha-amylases termed AmyB(1) and AmyB(2) reaching40 kDa and 43 kDa. These isoforms could be possibly generated fromY359, and F379secondary cut, respectively. The molecular modeling study showed that AmyB preserved the (beta/alpha)(8) barrel domain and the domain B but lacked the C-terminal domain C. The contact map analysis and the docking studies strongly suggested a higher activity and substrate binding affinity for AmyB than AmyA which was previously experimentally exhibited. This could be explained by the easy catalytic cleft accessibility.	[Sahnoun, Mouna; Jemli, Sonia; Trabelsi, Sahar; Bejar, Samir] Univ Sfax, CBS, LMBEE, Sidi Mansour Rd Km 6,POB 1177, Sfax 3018, Tunisia; [Ayadi, Leila] Univ Sfax, Preparatory Inst Engn Studies IPEIS, MenzelChaker Rd Km 0-5,POB 3018, Sfax 3018, Tunisia	Centre de Biotechnologie de Sfax; Universite de Sfax; Universite de Sfax	Bejar, S (corresponding author), Univ Sfax, CBS, LMBEE, Sidi Mansour Rd Km 6,POB 1177, Sfax 3018, Tunisia.	samir.bejar@cbs.rnrt.tn		Jemli, Sonia/0000-0001-6265-581X	Tunisian Ministry of Higher Education and Scientific Research [LR15CBS06_2015-2018]	Tunisian Ministry of Higher Education and Scientific Research	This work was supported by a grant from the Tunisian Ministry of Higher Education and Scientific Research contract program CBSLMBEE/code: LR15CBS06_2015-2018. There was no additional external funding received for this study.	Adewale IO, 2009, CARBOHYD POLYM, V77, P105, DOI 10.1016/j.carbpol.2008.12.011; Anandan D, 2007, J IND MICROBIOL BIOT, V34, P339, DOI 10.1007/s10295-006-0201-5; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; BENDER H, 1990, CARBOHYD RES, V206, P257, DOI 10.1016/0008-6215(90)80065-B; BOEL E, 1984, EMBO J, V3, P1097, DOI 10.1002/j.1460-2075.1984.tb01935.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; D'Amico S, 2003, J MOL BIOL, V332, P981, DOI 10.1016/j.jmb.2003.07.014; DAVIDSON R, 1975, BIOCHEM J, V147, P45, DOI 10.1042/bj1470045; Goesaert H, 2009, J CEREAL SCI, V50, P345, DOI 10.1016/j.jcs.2009.04.010; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Housaindokht MR, 2013, J MOL CATAL B-ENZYM, V95, P36, DOI 10.1016/j.molcatb.2013.05.011; Iefuji H, 1996, BIOCHEM J, V318, P989, DOI 10.1042/bj3180989; Janecek S, 2003, EUR J BIOCHEM, V270, P635, DOI 10.1046/j.1432-1033.2003.03404.x; Janecek S, 1997, PROG BIOPHYS MOL BIO, V67, P67, DOI 10.1016/S0079-6107(97)00015-1; Janecek S, 2014, CELL MOL LIFE SCI, V71, P1149, DOI 10.1007/s00018-013-1388-z; Janecek S, 2012, FEBS LETT, V586, P3360, DOI 10.1016/j.febslet.2012.07.020; Janecek S, 2011, PROTEIN J, V30, P429, DOI 10.1007/s10930-011-9348-7; Janecek Stefan, 2000, P19; Jemli S, 2015, CRIT REV BIOTECHNOL, V8, P1; JONES RL, 1991, INT REV CYTOL, V126, P49; Kammoun R, 2008, BIORESOURCE TECHNOL, V99, P5602, DOI 10.1016/j.biortech.2007.10.045; KIMURA K, 1989, BIOCHEM BIOPH RES CO, V161, P1273, DOI 10.1016/0006-291X(89)91380-6; KOLODZEJSKA MV, 1977, UKR BIOKHIM ZH+, V49, P42; KU HC, 1972, BIOCHIM BIOPHYS ACTA, V268, P225, DOI 10.1016/0005-2744(72)90219-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin LL, 1997, J APPL MICROBIOL, V82, P325, DOI 10.1046/j.1365-2672.1997.00364.x; Mar SS, 2003, BIOSCI BIOTECH BIOCH, V67, P1080, DOI 10.1271/bbb.67.1080; Mehta D, 2014, APPL MICROBIOL BIOT, V98, P4503, DOI 10.1007/s00253-013-5459-8; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Monhemi H, 2012, J SUPERCRIT FLUID, V72, P161, DOI 10.1016/j.supflu.2012.08.020; Murakami S, 2008, ENZYME MICROB TECH, V43, P321, DOI 10.1016/j.enzmictec.2008.05.006; Nguyen QD, 2002, ENZYME MICROB TECH, V31, P345, DOI 10.1016/S0141-0229(02)00128-X; Nirmala M, 2003, PHYTOCHEMISTRY, V62, P21, DOI 10.1016/S0031-9422(02)00443-0; Ohdan K, 1999, APPL ENVIRON MICROB, V65, P4652; Prakash B, 2009, PROCESS BIOCHEM, V44, P210, DOI 10.1016/j.procbio.2008.10.013; Ravi-Kumar K, 2007, APPL MICROBIOL BIOT, V74, P1011, DOI 10.1007/s00253-006-0742-6; Ravi-Kumar K, 2004, FEBS LETT, V557, P239, DOI 10.1016/S0014-5793(03)01510-2; REICHARD U, 1990, J MED MICROBIOL, V33, P243, DOI 10.1099/00222615-33-4-243; Robert X, 2003, STRUCTURE, V11, P973, DOI 10.1016/S0969-2126(03)00151-5; ROGERS JC, 1985, J BIOL CHEM, V260, P3731; Sahnoun M, 2015, INT J BIOL MACROMOL, V75, P73, DOI 10.1016/j.ijbiomac.2015.01.026; Sahnoun M, 2012, PROCESS BIOCHEM, V47, P18, DOI 10.1016/j.procbio.2011.09.016; Sambrook J, 1989, MOL CLONING LAB MANU, P431; Sanoja RR, 2000, APPL ENVIRON MICROB, V66, P3350, DOI 10.1128/AEM.66.8.3350-3356.2000; SCHWERT GW, 1955, BIOCHIM BIOPHYS ACTA, V16, P570, DOI 10.1016/0006-3002(55)90280-8; SOGAARD M, 1991, P NATL ACAD SCI USA, V88, P8140, DOI 10.1073/pnas.88.18.8140; Suarez-Dieguez T, 2009, CARBOHYD POLYM, V75, P538, DOI 10.1016/j.carbpol.2008.09.015; SWIFT HJ, 1991, ACTA CRYSTALLOGR B, V47, P535, DOI 10.1107/S0108768191001970; Tremacoldi CR, 2007, WORLD J MICROB BIOT, V23, P295, DOI 10.1007/s11274-006-9211-8; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vujicic-Zagar A, 2006, ACTA CRYSTALLOGR F, V62, P716, DOI 10.1107/S1744309106024729; Wu AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100498; Xian L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121531; Yadav SK, 2015, BIOCATAL AGRIC BIOTE, V4, P667, DOI 10.1016/j.bcab.2015.08.007; YAMANE K, 1984, J BIOCHEM-TOKYO, V96, P1849, DOI 10.1093/oxfordjournals.jbchem.a135019; Yoshizaki Y, 2010, J BIOSCI BIOENG, V110, P670, DOI 10.1016/j.jbiosc.2010.07.005	59	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153868	10.1371/journal.pone.0153868	http://dx.doi.org/10.1371/journal.pone.0153868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101008	Green Published, gold			2022-12-27	WOS:000374898500081
J	El Zaatari, S; Grine, FE; Ungar, PS; Hublin, JJ				El Zaatari, Sireen; Grine, Frederick E.; Ungar, Peter S.; Hublin, Jean-Jacques			Neandertal versus Modern Human Dietary Responses to Climatic Fluctuations	PLOS ONE			English	Article							MICROWEAR TEXTURE ANALYSIS; ISOTOPIC EVIDENCE; GENOME SEQUENCE; CAVE; MIDDLE; REMAINS; EXPLOITATION; CHARENTE; COLLAGEN; EUROPE	The Neandertal lineage developed successfully throughout western Eurasia and effectively survived the harsh and severely changing environments of the alternating glacial/interglacial cycles from the middle of the Pleistocene until Marine Isotope Stage 3. Yet, towards the end of this stage, at the time of deteriorating climatic conditions that eventually led to the Last Glacial Maximum, and soon after modern humans entered western Eurasia, the Neandertals disappeared. Western Eurasia was by then exclusively occupied by modern humans. We use occlusal molar microwear texture analysis to examine aspects of diet in western Eurasian Paleolithic hominins in relation to fluctuations in food supplies that resulted from the oscillating climatic conditions of the Pleistocene. There is demonstrable evidence for differences in behavior that distinguish Upper Paleolithic humans from members of the Neandertal lineage. Specifically, whereas the Neandertals altered their diets in response to changing paleoecological conditions, the diets of Upper Paleolithic humans seem to have been less affected by slight changes in vegetation/climatic conditions but were linked to changes in their technological complexes. The results of this study also indicate differences in resource exploitation strategies between these two hominin groups. We argue that these differences in subsistence strategies, if they had already been established at the time of the first contact between these two hominin taxa, may have given modern humans an advantage over the Neandertals, and may have contributed to the persistence of our species despite habitat-related changes in food availabilities associated with climate fluctuations.	[El Zaatari, Sireen] Univ Tubingen, Paleoanthropol, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany; [El Zaatari, Sireen; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Grine, Frederick E.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY USA; [Grine, Frederick E.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY USA; [Ungar, Peter S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Max Planck Society; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Arkansas System; University of Arkansas Fayetteville	El Zaatari, S (corresponding author), Univ Tubingen, Paleoanthropol, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany.; El Zaatari, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	sireen.el-zaatari@uni.tuebingen.de	El-Zaatari, Sireen/AAE-7645-2020		Max Planck Society; Wenner Gren Foundation [8554]; National Science Foundation [0452155, 0315157]; LSB Leakey Foundation [800320]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Wenner Gren Foundation; National Science Foundation(National Science Foundation (NSF)); LSB Leakey Foundation	This study was supported by Max Planck Society, Wenner Gren Foundation through a Hunt Post-Doctoral Fellowship to SEZ (8554), the National Science Foundation to FEG and SEZ and PSU (0452155; 0315157), and the LSB Leakey Foundation to SEZ and FEG (800320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, HUNTERS GOLDEN AGE M; Antunes M.T., 2000, LAST NEANDERTHALS PO, V38, P259; Aranguren B, 2007, ANTIQUITY, V81, P845, DOI 10.1017/S0003598X00095946; Bailey S, 2002, THESIS ARIZONA STATE; Barton Nick, 2000, P211; Blasco R, 2012, CR PALEVOL, V11, P265, DOI 10.1016/j.crpv.2012.01.003; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; Bocherens H, 2005, J HUM EVOL, V49, P71, DOI 10.1016/j.jhevol.2005.03.003; BOCHERENS H, 1991, J HUM EVOL, V20, P481, DOI 10.1016/0047-2484(91)90021-M; Bocherens Herve, 2003, BAR International Series, V1105, P1; Bocherens H, 2014, QUATERN INT, V339, P112, DOI 10.1016/j.quaint.2013.06.026; Bocherens H, 2014, J HUM EVOL, V69, P31, DOI 10.1016/j.jhevol.2013.12.015; Bright J, 2002, WORLD ARCHAEOL, V34, P164, DOI 10.1080/00438240220134304; Brown K, 2011, INTERD CONTRIB ARCH, P247, DOI 10.1007/978-1-4419-8219-3_10; Cook RJ, 1996, J ROY STAT SOC A STA, V159, P93, DOI 10.2307/2983471; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; El Zaatari S, 2013, SUBSISTENCE EC SOC G, P55; El Zaatari S, 2014, CAM S BIO EVOL ANTHR, V68, P120; El Zaatari S, 2014, AM J PHYS ANTHROPOL, V153, P570, DOI 10.1002/ajpa.22457; El Zaatari S, 2011, J HUM EVOL, V61, P411, DOI 10.1016/j.jhevol.2011.05.004; El-Zaatari S, 2010, INT J OSTEOARCHAEOL, V20, P67, DOI 10.1002/oa.1027; Elefanti P, 2008, EURASIAN PREHISTORY, V5, P77; Finlayson C., 2001, PREMIERS HOMES MODER, P117; Finlayson C., 2004, NEANDERTHALS MODERN; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Fiorenza L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014769; FIZET M, 1995, J ARCHAEOL SCI, V22, P67, DOI 10.1016/S0305-4403(95)80163-4; Freidline SE, 2012, J HUM EVOL, V63, P723, DOI 10.1016/j.jhevol.2012.08.002; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gilpin W, 2016, P NATL ACAD SCI USA, V113, P2134, DOI 10.1073/pnas.1524861113; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Harvati K, 2013, J HUM EVOL, V64, P486, DOI 10.1016/j.jhevol.2013.02.002; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Hockett B, 2005, QUATERN INT, V137, P21, DOI 10.1016/j.quaint.2004.11.017; Hua LC, 2015, AM J PHYS ANTHROPOL, V158, P769, DOI 10.1002/ajpa.22823; Hublin JJ, 2015, QUATERNARY SCI REV, V118, P194, DOI 10.1016/j.quascirev.2014.08.011; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P13471, DOI 10.1073/pnas.1211082109; KEELEY LH, 1988, J ANTHROPOL ARCHAEOL, V7, P373, DOI 10.1016/0278-4165(88)90003-7; Lowe J, 2015, RECONSTRUCTING QUATERNARY ENVIRONMENTS, 3RD EDITION; MASON SLR, 1994, ANTIQUITY, V68, P48, DOI 10.1017/S0003598X00046184; Merceron G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009542; Michel V, 2013, QUAT GEOCHRONOL, V15, P20, DOI 10.1016/j.quageo.2012.12.008; Neff N. A., 1980, SURVEY MULTIVARIATE; O'Connell James F., 2006, P43; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Revedin A, 2015, QUATERN INT, V359, P77, DOI 10.1016/j.quaint.2014.09.066; Richards MP, 2008, J HUM EVOL, V55, P179, DOI 10.1016/j.jhevol.2008.02.007; Richards MP, 2008, ANTIQUITY, V82, P553, DOI 10.1017/S0003598X00097210; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Richards MP, 2000, P NATL ACAD SCI USA, V97, P7663, DOI 10.1073/pnas.120178997; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; Rougier H., 2003, THESIS U BORDEAUX 1; Salazar-Garcia DC, 2013, QUATERN INT, V318, P3, DOI 10.1016/j.quaint.2013.06.007; Schubert BW, 2010, J ZOOL, V280, P257, DOI 10.1111/j.1469-7998.2009.00656.x; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2012, AM J PHYS ANTHROPOL, V147, P551, DOI 10.1002/ajpa.22007; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Sokal R.R., 2012, BIOMETRY; Stiner MC, 2010, FARMING, V3, P1; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P73, DOI 10.1002/ajpa.1330800109; Ungar Peter S., 2007, Journal of Mammalian Evolution, V14, P163, DOI 10.1007/s10914-007-9050-x; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5; Withnell CB, 2014, MAMMALIA, V78, P409, DOI 10.1515/mammalia-2013-0121; Wood RE, 2013, ARCHAEOMETRY, V55, P148, DOI 10.1111/j.1475-4754.2012.00671.x; Zilhao J, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P407, DOI 10.1007/978-0-387-76487-0_27	70	47	47	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153277	10.1371/journal.pone.0153277	http://dx.doi.org/10.1371/journal.pone.0153277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DK5QZ	27119336	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200021
J	Fayssoil, A; Ogna, A; Chaffaut, C; Chevret, S; Guimaraes-Costa, R; Leturcq, F; Wahbi, K; Prigent, H; Lofaso, F; Nardi, O; Clair, B; Behin, A; Stojkovic, T; Laforet, P; Orlikowski, D; Annane, D				Fayssoil, Abdallah; Ogna, Adam; Chaffaut, Cendrine; Chevret, Sylvie; Guimaraes-Costa, Raquel; Leturcq, France; Wahbi, Karim; Prigent, Helene; Lofaso, Frederic; Nardi, Olivier; Clair, Bernard; Behin, Anthony; Stojkovic, Tanya; Laforet, Pascal; Orlikowski, David; Annane, Djillali			Natural History of Cardiac and Respiratory Involvement, Prognosis and Predictive Factors for Long-Term Survival in Adult Patients with Limb Girdle Muscular Dystrophies Type 2C and 2D	PLOS ONE			English	Article							GAMMA-SARCOGLYCANOPATHY; HEART-FAILURE; MUTATIONS; SLEEP; SPECTRUM; IMPACT; VENTILATION; DISEASE; TESTS	Background Type 2C and 2D limb girdle muscular dystrophies (LGMD) are a group of autosomal recessive limb girdle muscular dystrophies manifested by proximal myopathy, impaired respiratory muscle function and cardiomyopathy. The correlation and the prognostic impact of respiratory and heart impairment are poorly described. We aimed to describe the long-term cardiac and respiratory follow-up of these patients and to determine predictive factors of cardio-respiratory events and mortality in LGMD 2C and 2D. Methods We reviewed the charts of 34 LGMD patients, followed from 2005 to 2015, to obtain echo-cardiographic, respiratory function and sleep recording data. We considered respiratory events (acute respiratory failure, pulmonary sepsis, atelectasis or pneumothorax), cardiac events (acute heart failure, significant cardiac arrhythmia or conduction block, ischemic stroke) and mortality as outcomes of interest for the present analysis. Results A total of 21 patients had type 2C LGMD and 13 patients had type 2D. Median age was 30 years [IQR 24-38]. At baseline, median pulmonary vital capacity (VC) was 31% of predicted value [20-40]. Median maximal inspiratory pressure (MIP) was 31 cmH(2)O [IQR 20.25-39.75]. Median maximal expiratory pressure (MEP) was 30 cm H2O [20-36]. Median left ventricular ejection fraction (LVEF) was 55% [45-64] with 38% of patients with LVEF <50%. Over a median follow-up of 6 years, we observed 38% respiratory events, 14% cardiac events and 20% mortality. Among baseline characteristics, LVEF and left ventricular end diastolic diameter (LVEDD) were associated with mortality, whilst respiratory parameters (VC, MIP, MEP) and the need for home mechanical ventilation (HMV) were associated with respiratory events. Conclusion In our cohort of severely respiratory impaired type 2C and 2D LGMD, respiratory morbidity was high. Cardiac dysfunction was frequent in particular in LGMD 2C and had an impact on long-term mortality.	[Fayssoil, Abdallah; Ogna, Adam; Nardi, Olivier; Clair, Bernard; Orlikowski, David; Annane, Djillali] Univ Versailles St Quentin Yvelines, CHU Raymond Poincare, APHP, Serv Reanimat Med,GNHM,Ctr Reference neuromuscula, Garches, France; [Fayssoil, Abdallah; Ogna, Adam; Nardi, Olivier; Clair, Bernard; Orlikowski, David; Annane, Djillali] Univ Versailles St Quentin Yvelines, CHU Raymond Poincare, APHP, Unite Ventilat Domicile,GNHM,Ctr Reference Neurom, Garches, France; [Fayssoil, Abdallah; Ogna, Adam; Orlikowski, David] INSERM, Ctr Invest Clin & Innovat Technol CIC 14 29, Garches, France; [Fayssoil, Abdallah; Guimaraes-Costa, Raquel; Behin, Anthony; Stojkovic, Tanya; Laforet, Pascal] Univ Paris 06, CHU Pitie Salpetriere, Inst Myol, Ctr Reference Neuro Musculaire Paris Est, Paris, France; [Chevret, Sylvie] Univ Paris Diderot, SBIM, CHU St Louis, APHP, Paris, France; [Prigent, Helene; Lofaso, Frederic] Univ Versailles St Quentin Yvelines, Serv Physiol Explorat Fonct, CHU Raymond Poincare, APHP, Garches, France; [Wahbi, Karim] Univ Paris 05, Hop Cochin, APHP, Serv Cardiol,Sorbonne Paris Cite, Paris, France; [Leturcq, France] Univ Paris 05, Hop Cochin, APHP, Lab Biochim & Genet Mol,Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Fayssoil, A (corresponding author), Univ Versailles St Quentin Yvelines, CHU Raymond Poincare, APHP, Serv Reanimat Med,GNHM,Ctr Reference neuromuscula, Garches, France.; Fayssoil, A (corresponding author), Univ Versailles St Quentin Yvelines, CHU Raymond Poincare, APHP, Unite Ventilat Domicile,GNHM,Ctr Reference Neurom, Garches, France.; Fayssoil, A (corresponding author), INSERM, Ctr Invest Clin & Innovat Technol CIC 14 29, Garches, France.; Fayssoil, A (corresponding author), Univ Paris 06, CHU Pitie Salpetriere, Inst Myol, Ctr Reference Neuro Musculaire Paris Est, Paris, France.	abdallah.fayssoil@aphp.fr	orlikowski, david/R-2162-2019; PRIGENT, HELENE/S-7445-2018; Lofaso, Frédéric/R-6100-2018; Annane, Djillali/R-7947-2019; STOJKOVIC, Tanya/AAA-3967-2021	fayssoil, abdallah/0000-0003-3844-5438; wahbi, karim/0000-0001-7682-7387; Nardi, Olivier/0000-0003-4086-9766; chevret, sylvie/0000-0001-6449-4730; Behin, Anthony/0000-0001-7179-5152; GUIMARAES-COSTA, Raquel/0000-0001-6799-022X				Annane D, 2014, COCHRANE DB SYST REV, P12; Bach JR, 2011, RESP CARE, V56, P744, DOI 10.4187/respcare.00831; Boito CA, 2005, ARCH NEUROL-CHICAGO, V62, P1894, DOI 10.1001/archneur.62.12.1894; Bourke SC, 2002, EUR RESPIR J, V19, P1194, DOI 10.1183/09031936.02.01302001a; Calvert LD, 2006, RESP MED, V100, P1058, DOI 10.1016/j.rmed.2005.09.030; Calvo F, 2000, NEUROMUSCULAR DISORD, V10, P560, DOI 10.1016/S0960-8966(00)00147-4; Cheitlin MD, 2003, J AM SOC ECHOCARDIOG, V16, P1091, DOI 10.1016/S0894-7317(03)00685-0; Chen Chih-Hao, 2013, BMC Res Notes, V6, P32, DOI 10.1186/1756-0500-6-32; Duggan DJ, 1997, NEW ENGL J MED, V336, P618, DOI 10.1056/NEJM199702273360904; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Fanin M, 2003, NEUROMUSCULAR DISORD, V13, P303, DOI 10.1016/S0960-8966(02)00280-8; Fayssoil A, 2014, ACTA NEUROL BELG, V114, P257, DOI 10.1007/s13760-013-0276-5; Finder JD, 2004, AM J RESP CRIT CARE, V170, P456, DOI 10.1164/rccm.200307-885ST; GIGLIOTTI F, 1995, THORAX, V50, P962, DOI 10.1136/thx.50.9.962; Green M, 2002, AM J RESP CRIT CARE, V166, P528; Hukins CA, 2000, AM J RESP CRIT CARE, V161, P166, DOI 10.1164/ajrccm.161.1.9901057; Kohler M, 2009, J NEUROL NEUROSUR PS, V80, P320, DOI 10.1136/jnnp.2007.141721; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; NAGAI T, 1989, JPN CIRC J, V53, P406, DOI 10.1253/jcj.53.406; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; Oskoui M, 2007, NEUROLOGY, V69, P1931, DOI 10.1212/01.wnl.0000290830.40544.b9; Passamano Luigia, 2012, Acta Myol, V31, P121; Perrin C, 2004, MUSCLE NERVE, V29, P5, DOI 10.1002/mus.10487; Petri H, 2015, INT J CARDIOL, V182, P403, DOI 10.1016/j.ijcard.2014.12.090; Phillips MF, 1999, AM J RESP CRIT CARE, V160, P198, DOI 10.1164/ajrccm.160.1.9805055; Politano L, 2001, NEUROMUSCULAR DISORD, V11, P178, DOI 10.1016/S0960-8966(00)00174-7; Poppe M, 2004, ANN NEUROL, V56, P738, DOI 10.1002/ana.20283; Ragette R, 2002, THORAX, V57, P724, DOI 10.1136/thorax.57.8.724; Rideau Y, 1983, Acta Neurol (Napoli), V5, P118; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; Sandona D, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001203; Semplicini C, 2015, NEUROLOGY, V84, P1772, DOI 10.1212/WNL.0000000000001519; Simonds AK, 1998, THORAX, V53, P949, DOI 10.1136/thx.53.11.949; Suresh S, 2005, J PAEDIATR CHILD H, V41, P500, DOI 10.1111/j.1440-1754.2005.00691.x; Sveen ML, 2008, ARCH NEUROL-CHICAGO, V65, P1196, DOI 10.1001/archneur.65.9.1196; Toussaint M, 2007, CHEST, V131, P368, DOI 10.1378/chest.06-1265; Trabelsi M, 2008, EUR J HUM GENET, V16, P793, DOI 10.1038/ejhg.2008.9; van Westrum SMS, 2014, MUSCLE NERVE, V50, P909, DOI 10.1002/mus.24233	39	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153095	10.1371/journal.pone.0153095	http://dx.doi.org/10.1371/journal.pone.0153095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120200	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200017
J	Qualai, J; Li, LX; Cantero, J; Tarrats, A; Fernandez, MA; Sumoy, L; Rodolosse, A; McSorley, SJ; Genesca, M				Qualai, Jamal; Li, Lin-Xi; Cantero, Jon; Tarrats, Antoni; Antonio Fernandez, Marco; Sumoy, Lauro; Rodolosse, Annie; McSorley, Stephen J.; Genesca, Meritxell			Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential	PLOS ONE			English	Article							INDUCTION	CD11c is an a integrin classically employed to define myeloid dendritic cells. Although there is little information about CD11c expression on human T cells, mouse models have shown an association of CD11c expression with functionally relevant T cell subsets. In the context of genital tract infection, we have previously observed increased expression of CD11c in circulating T cells from mice and women. Microarray analyses of activated effector T cells expressing CD11c derived from naive mice demonstrated enrichment for natural killer (NK) associated genes. Here we find that murine CD11c(+) T cells analyzed by flow cytometry display markers associated with non-conventional T cell subsets, including gamma delta T cells and invariant natural killer T (iNKT) cells. However, in women, only gamma delta T cells and CD8(+) T cells were enriched within the CD11c fraction of blood and cervical tissue. These CD11c+ cells were highly activated and had greater interferon (IFN)-gamma secretory capacity than CD11c(-) T cells. Furthermore, circulating CD11c(+) T cells were associated with the expression of multiple adhesion molecules in women, suggesting that these cells have high tissue homing potential. These data suggest that CD11c expression distinguishes a population of circulating T cells during bacterial infection with innate capacity and mucosal homing potential.	[Qualai, Jamal; Cantero, Jon; Genesca, Meritxell] AIDS Res Inst IrsiCaixa HIVACAT, Mucosal Immunol Unit, Inst Invest Ciencies Salut Germans Trias & Pujol, Can Ruti Campus, Badalona, Spain; [Li, Lin-Xi] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Tarrats, Antoni] Univ Hosp Germans Trias & Pujol, Dept Obstet & Gynecol, Can Ruti Campus, Badalona, Spain; [Antonio Fernandez, Marco] Inst Invest Ciencies Salut Germans Trias & Pujol, Flow Cytometry Unit, Badalona, Spain; [Sumoy, Lauro] IMPPC, Genom & Bioinformat Grp, Can Ruti Campus, Badalona, Spain; [Rodolosse, Annie] Inst Res Biomed IRB Barcelona, Funct Genom Core, Barcelona, Spain; [McSorley, Stephen J.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Ctr Comparat Med, Davis, CA 95616 USA	Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Institut de Recerca de la Sida - IrsiCaixa; University of Arkansas System; University of Arkansas Medical Sciences; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of California System; University of California Davis	Genesca, M (corresponding author), AIDS Res Inst IrsiCaixa HIVACAT, Mucosal Immunol Unit, Inst Invest Ciencies Salut Germans Trias & Pujol, Can Ruti Campus, Badalona, Spain.	mgenesca@igtp.cat	Fernandez, Marco/R-3964-2019; Genescà, Meritxell/AFT-2336-2022; Sumoy, Lauro/AGZ-3186-2022; Sumoy, Lauro/K-1680-2013; Genescà, Meritxell/AAF-9074-2020	Fernandez, Marco/0000-0002-3921-2209; Genescà, Meritxell/0000-0001-6413-3812; Sumoy, Lauro/0000-0003-0005-4618; Sumoy, Lauro/0000-0003-0005-4618; Li, Lin-Xi/0000-0002-5526-8966; McSorley, Stephen/0000-0002-6363-3222; Cantero, Jon/0000-0003-4844-6143	Marie Curie Career Integration Grant (CIG); European Commission; Dexeus foundation for women's health research; Ramon y Cajal contract from the Spanish Ministry for Science and Innovation (MICINN); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117303, R01AI103422] Funding Source: NIH RePORTER	Marie Curie Career Integration Grant (CIG); European Commission(European CommissionEuropean Commission Joint Research Centre); Dexeus foundation for women's health research; Ramon y Cajal contract from the Spanish Ministry for Science and Innovation (MICINN); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Marie Curie Career Integration Grant (CIG), from the European Commission and a fellowship award, from the Dexeus foundation for women's health research. MG is currently supported by a Ramon y Cajal contract from the Spanish Ministry for Science and Innovation (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakelyan A, 2014, METHODS MOL BIOL, V1087, P233, DOI 10.1007/978-1-62703-670-2_19; Beyer M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-70; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Bullard DC, 2007, AM J PATHOL, V170, P2001, DOI 10.2353/ajpath.2007.061016; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Chen ZB, 2013, J IMMUNOL, V190, P6145, DOI 10.4049/jimmunol.1300060; Cooney LA, 2013, INFECT IMMUN, V81, P4171, DOI 10.1128/IAI.00871-13; Del Campo J, 2010, VACCINE, V28, P1193, DOI 10.1016/j.vaccine.2009.11.035; DeNucci CC, 2009, CRIT REV IMMUNOL, V29, P87, DOI 10.1615/CritRevImmunol.v29.i2.10; Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6; Egan CE, 2009, MUCOSAL IMMUNOL, V2, P527, DOI 10.1038/mi.2009.105; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Fujiwara D, 2011, AM J PHYSIOL-GASTR L, V300, pG939, DOI 10.1152/ajpgi.00032.2010; Fuller JM, 2013, J AM CHEM SOC, V135, P8947, DOI 10.1021/ja402019c; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gonzalez-Roca E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014418; Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Kim YH, 2005, CELL IMMUNOL, V238, P76, DOI 10.1016/j.cellimm.2006.01.004; Kubota K, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00026; Kuka M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2223; Li LX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003707; Ljutic B, 2005, J IMMUNOL, V174, P4789, DOI 10.4049/jimmunol.174.8.4789; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Paul S, 2015, J LEUKOCYTE BIOL, V97, P259, DOI 10.1189/jlb.3RU0914-443R; Pennington DJ, 2005, ADV IMMUNOL, V87, P27, DOI 10.1016/S0065-2776(05)87002-6; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Romagnoli PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056999; Sadhu C, 2007, J LEUKOCYTE BIOL, V81, P1395, DOI 10.1189/jlb.1106680; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Trifonova RT, 2014, AM J REPROD IMMUNOL, V71, P252, DOI 10.1111/aji.12198; Tsai S, 2011, CELL MOL LIFE SCI, V68, P3781, DOI 10.1007/s00018-011-0738-y; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Williams DM, 1996, INFECT IMMUN, V64, P3916, DOI 10.1128/IAI.64.9.3916-3919.1996	42	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154253	10.1371/journal.pone.0154253	http://dx.doi.org/10.1371/journal.pone.0154253			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119555	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200053
J	Rabovsky, M; Stein, T; Rahman, RA				Rabovsky, Milena; Stein, Timo; Rahman, Rasha Abdel			Access to Awareness for Faces during Continuous Flash Suppression Is Not Modulated by Affective Knowledge	PLOS ONE			English	Article							PERSONALITY; EXPRESSIONS; SEE	It is a controversially debated topic whether stimuli can be analyzed up to the semantic level when they are suppressed from visual awareness during continuous flash suppression (CFS). Here, we investigated whether affective knowledge, i.e., affective biographical information about faces, influences the time it takes for initially invisible faces with neutral expressions to overcome suppression and break into consciousness. To test this, we used negative, positive, and neutral famous faces as well as initially unfamiliar faces, which were associated with negative, positive or neutral biographical information. Affective knowledge influenced ratings of facial expressions, corroborating recent evidence and indicating the success of our affective learning paradigm. Furthermore, we replicated shorter suppression durations for upright than for inverted faces, demonstrating the suitability of our CFS paradigm. However, affective biographical information did not modulate suppression durations for newly learned faces, and even though suppression durations for famous faces were influenced by affective knowledge, these effects did not differ between upright and inverted faces, indicating that they might have been due to low-level visual differences. Thus, we did not obtain unequivocal evidence for genuine influences of affective biographical information on access to visual awareness for faces during CFS.	[Rabovsky, Milena; Rahman, Rasha Abdel] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Rabovsky, Milena] Stanford Univ, Dept Psychol, Stanford, CA USA; [Stein, Timo] Univ Trento, Ctr Mind Brain Sci, Trento, Italy	Humboldt University of Berlin; Stanford University; University of Trento	Rabovsky, M (corresponding author), Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany.; Rabovsky, M (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA USA.	rabovsky@stanford.edu	; Abdel Rahman, Rasha/J-4687-2015	Stein, Timo/0000-0002-8484-0933; Rabovsky, Milena/0000-0001-7729-1027; Abdel Rahman, Rasha/0000-0002-8438-1570	German Research Foundation grant [AB 277-6, STE 2239/1-1]; European Union [329363]	German Research Foundation grant; European Union(European Commission)	This work was funded by the German Research Foundation grant AB 277-6 to RAR and grant STE 2239/1-1 to TS (http://www.dfg.de/). In addition, the research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA Grant Agreement 329363 (http://ec.europa.eu/research/mariecurieactions/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E, 2011, SCIENCE, V332, P1446, DOI 10.1126/science.1201574; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Bates D, 2012, LME4 LINEAR MIXED EF; Baumeister RF, 2004, REV GEN PSYCHOL, V8, P111, DOI 10.1037/1089-2680.8.2.111; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bliss-Moreau E, 2008, EMOTION, V8, P479, DOI 10.1037/1528-3542.8.4.479; Borkenau P., 2008, NEOFUNF FAKTOREN INV, V2nd; Chen YC, 2012, CONSCIOUS COGN, V21, P1703, DOI 10.1016/j.concog.2012.10.001; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Costello P, 2009, CONSCIOUS COGN, V18, P375, DOI 10.1016/j.concog.2009.02.003; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Gayet S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00460; Gobbini MI, 2013, CONSCIOUS COGN, V22, P765, DOI 10.1016/j.concog.2013.05.002; Gobbini MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066620; Gray KLH, 2013, EMOTION, V13, P537, DOI 10.1037/a0031403; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; Heyman T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104719; Jensen-Campbell LA, 2003, J PERS, V71, P1059, DOI 10.1111/1467-6494.7106007; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; LARSEN RJ, 1991, J PERS SOC PSYCHOL, V61, P132, DOI 10.1037/0022-3514.61.1.132; Lupyan G, 2013, P NATL ACAD SCI USA, V110, P14196, DOI 10.1073/pnas.1303312110; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Mudrik L, 2011, PSYCHOL SCI, V22, P764, DOI 10.1177/0956797611408736; Pinto Y, 2015, J VISION, V15, DOI 10.1167/15.8.13; Rahman RA, 2011, EMOTION, V11, P1397, DOI 10.1037/a0024717; Shimaoka D, 2011, VISION RES, V51, P521, DOI 10.1016/j.visres.2011.01.009; Sklar AY, 2012, P NATL ACAD SCI USA, V109, P19614, DOI 10.1073/pnas.1211645109; Stein T, 2015, J VISION, V15; Stein T, 2015, J EXP PSYCHOL GEN, V144, P1089, DOI 10.1037/xge0000109; Stein T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00582; Stein T, 2014, PSYCHOL SCI, V25, P566, DOI 10.1177/0956797613512509; Stein T, 2012, EMOTION, V12, P988, DOI 10.1037/a0026944; Stein T, 2012, COGNITION, V125, P64, DOI 10.1016/j.cognition.2012.06.005; Stein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029361; Stein T, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00167; Stein T, 2011, COGNITION, V119, P307, DOI 10.1016/j.cognition.2011.01.008; Stewart LH, 2012, J EXP PSYCHOL GEN, V141, P715, DOI 10.1037/a0027950; Suess F, 2014, SOC COGN AFFECT NEUR; Tobin RM, 2000, J PERS SOC PSYCHOL, V79, P656, DOI 10.1037//0022-3514.79.4.656; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P195, DOI 10.1093/scan/nsn013; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882; Yang E, 2012, J VISION, V12, DOI 10.1167/12.3.8; Yang YH, 2011, CONSCIOUS COGN, V20, P223, DOI 10.1016/j.concog.2010.07.005; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	48	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0150931	10.1371/journal.pone.0150931	http://dx.doi.org/10.1371/journal.pone.0150931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119743	gold, Green Published			2022-12-27	WOS:000374976200004
J	Selwyn, JD; Hogan, JD; Downey-Wall, AM; Gurski, LM; Portnoy, DS; Heath, DD				Selwyn, Jason D.; Hogan, J. Derek; Downey-Wall, Alan M.; Gurski, Lauren M.; Portnoy, David S.; Heath, Daniel D.			Kin-Aggregations Explain Chaotic Genetic Patchiness, a Commonly Observed Genetic Pattern, in a Marine Fish	PLOS ONE			English	Article							R-PACKAGE; POPULATIONS; REEF; RELATEDNESS; DISPERSAL; PARENTAGE; DRIVERS	The phenomenon of chaotic genetic patchiness is a pattern commonly seen in marine organisms, particularly those with demersal adults and pelagic larvae. This pattern is usually associated with sweepstakes recruitment and variable reproductive success. Here we investigate the biological underpinnings of this pattern in a species of marine goby Coryphopterus personatus. We find that populations of this species show tell-tale signs of chaotic genetic patchiness including: small, but significant, differences in genetic structure over short distances; a non-equilibrium or "chaotic" pattern of differentiation among locations in space; and within locus, within population deviations from the expectations of Hardy-Weinberg equilibrium (HWE). We show that despite having a pelagic larval stage, and a wide distribution across Caribbean coral reefs, this species forms groups of highly related individuals at small spatial scales (<10 metres). These spatially clustered family groups cause the observed deviations from HWE and local population differentiation, a finding that is rarely demonstrated, but could be more common than previously thought.	[Selwyn, Jason D.; Hogan, J. Derek; Gurski, Lauren M.] Texas A&M Univ, Dept Life Sci, HoBi Lab, Corpus Christi, TX USA; [Downey-Wall, Alan M.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA; [Portnoy, David S.] Texas A&M Univ, Dept Life Sci, Marine Genom Lab, Corpus Christi, TX USA; [Heath, Daniel D.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada	Texas A&M University System; Northeastern University; Texas A&M University System; University of Windsor	Selwyn, JD (corresponding author), Texas A&M Univ, Dept Life Sci, HoBi Lab, Corpus Christi, TX USA.	jason.selwyn@tamucc.edu		Selwyn, Jason/0000-0002-9100-217X	Natural Sciences and Engineering Research Council of Canada CRO grant [227965]; Natural Sciences and Engineering Research Council Tier I Canada Research Chair grant; University of Windsor; Texas A&M University - Corpus Christi start-up funds; NSF [1429518]	Natural Sciences and Engineering Research Council of Canada CRO grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council Tier I Canada Research Chair grant; University of Windsor; Texas A&M University - Corpus Christi start-up funds; NSF(National Science Foundation (NSF))	This work was supported by the Natural Sciences and Engineering Research Council of Canada CRO grant# 227965 awarded to P.F. Sale, a Global Environment Facility Coral Reef Targeted Research project and by a Natural Sciences and Engineering Research Council Tier I Canada Research Chair grant to DDH; a Great Lakes Institute for Environmental Research post-doctoral fellowship from the University of Windsor and Texas A&M University - Corpus Christi start-up funds to JDH.; We thank K. Pennoyer, S. Furiness, and C. van Slyck for manuscript edits. P. Sale, R. Hepburn, J. Kritzer, S. Ludsin, P. Chittaro, C. Mora and P. Usseglio for field collections. G. Nanninga and two anonymous reviewers for helpful comments to improve the manuscript. The Institute of Marine Studies at the University of Belize for field support. NSF Award 1429518 for high power computing services.	Bernardi G, 2004, MAR BIOL, V145, P803, DOI 10.1007/s00227-004-1355-1; Broquet T, 2013, EVOLUTION, V67, P1660, DOI 10.1111/j.1558-5646.2012.01826.x; Buston PM, 2009, MOL ECOL, V18, P4707, DOI 10.1111/j.1365-294X.2009.04383.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dyer R. J., 2014, GSTUDIO ANAL FUNCTIO; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Engels B., 2014, HWXTEST EXACT TESTS; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HAMNER WM, 1988, B MAR SCI, V42, P459; HEDGECOCK D, 1994, CAL COOP OCEAN FISH, V35, P73; Hepburn RI, 2005, CONSERV GENET, V6, P1059, DOI 10.1007/s10592-005-9088-3; Hewitt R.P., 1981, CONSEIL INT EXPLORAT, V178, P229; Hogan JD, 2010, MAR ECOL PROG SER, V417, P263, DOI 10.3354/meps08793; Hogan JD, 2010, MOL ECOL RESOUR; Hunter J. R, 1980, FISH BEHAV ITS USE C, V5, P287; Iacchei M, 2013, MOL ECOL, V22, P3476, DOI 10.1111/mec.12341; JOHNSON MS, 1984, EVOLUTION, V38, P1371, DOI 10.1111/j.1558-5646.1984.tb05658.x; Jolly MT, 2003, HELGOLAND MAR RES, V56, P238, DOI 10.1007/s10152-002-0123-1; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kolaczyk ED., 2014, STAT ANAL NETWORK DA; Larson RJ, 1999, CAL COOP OCEAN FISH, V40, P94; Marino IAM, 2010, ESTUAR COAST SHELF S, V87, P135, DOI 10.1016/j.ecss.2010.01.003; Medvinsky AB, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021915; Pew J, 2015, MOL ECOL RESOUR, V15, P557, DOI 10.1111/1755-0998.12323; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Renyi Alfred, 1959, PUBL MATH, V6, P5; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Shapiro D.Y., 1983, Symposia Series for Undersea Research, V1, P39; Thresher RE, 1984, REPROD REEF FISHES; Wang J, 2007, HEREDITY, V99, P205, DOI 10.1038/sj.hdy.6800984; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798	39	37	37	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153381	10.1371/journal.pone.0153381	http://dx.doi.org/10.1371/journal.pone.0153381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119659	Green Published, gold			2022-12-27	WOS:000374976200024
J	Xie, F; Li, ZP; Wang, HW; Fei, X; Jiao, ZY; Tang, WB; Tang, J; Luo, YK				Xie, Fang; Li, Zhi-Ping; Wang, Hong-Wei; Fei, Xiang; Jiao, Zi-Yu; Tang, Wen-Bo; Tang, Jie; Luo, Yu-Kun			Evaluation of Liver Ischemia-Reperfusion Injury in Rabbits Using a Nanoscale Ultrasound Contrast Agent Targeting ICAM-1	PLOS ONE			English	Article							SINUSOIDAL ENDOTHELIAL-CELL; ENHANCED ULTRASOUND; ADHESION MOLECULE-1; P-SELECTIN; SHEAR-FLOW; TRANSPLANTATION; MICROBUBBLES; DIAGNOSIS; INFLAMMATION; STORAGE	Objective To assess the feasibility of ultrasound molecular imaging in the early diagnosis of liver ischemia-reperfusion injury (IRI) using a nanoscale contrast agent targeting anti-intracellular adhesion molecule-1 (anti-ICAM-1). Methods The targeted nanobubbles containing anti-ICAM-1 antibody were prepared using the avidin-biotin binding method. Human hepatic sinusoidal endothelial cells (HHSECs) were cultured at the circumstances of hypoxia/reoxygenation (H/R) and low temperature. The rabbit liver IRI model (I/R group) was established using the Pringle's maneuver. The time-intensity curve of the liver contrast ultrasonographic images was plotted and the peak intensity, time to peak, and time of duration were calculated. Results The size of the targeted nanobubbles were 148.15 +/- 39.75 nm and the concentration was 3.6-7.4 x 10(9)/ml, and bound well with the H/R HHSECs. Animal contrast enhanced ultrasound images showed that the peak intensity and time of duration of the targeted nanobubbles were significantly higher than that of common nanobubbles in the I/R group, and the peak intensity and time of duration of the targeted nanobubbles in the I/R group were also significantly higher than that in the SO group. Conclusion The targeted nanobubbles have small particle size, stable characteristic, and good targeting ability, which can assess hepatic ischemia-reperfusion injury specifically, noninvasively, and quantitatively at the molecular level.	[Xie, Fang; Wang, Hong-Wei; Fei, Xiang; Jiao, Zi-Yu; Tang, Wen-Bo; Tang, Jie; Luo, Yu-Kun] Chinese Peoples Liberat Army Gen Hosp, Dept Ultrasound, Beijing 100853, Peoples R China; [Xie, Fang] North China Univ Sci & Technol, Affiliated Hosp, Dept Ultrasound, Tangshan, Peoples R China; [Li, Zhi-Ping] Beijing Inst Pharmacol & Toxicol, Pharmacol Res Dept, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; North China University of Science & Technology; Academy of Military Medical Sciences - China	Tang, J; Luo, YK (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Ultrasound, Beijing 100853, Peoples R China.	txiner@vip.sina.com; lyk301@163.com		Luo, Yukun/0000-0002-5944-8198	National Natural Science Foundation of China [81271588]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81271588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann C, 2006, GASTROENTEROLOGY, V130, P8, DOI 10.1053/j.gastro.2005.11.009; CALDWELLKENKEL JC, 1989, HEPATOLOGY, V10, P292, DOI 10.1002/hep.1840100307; Caraceni P, 2005, J SURG RES, V124, P160, DOI 10.1016/j.jss.2004.10.007; Corbitt N, 2013, AM J PATHOL, V182, P180, DOI 10.1016/j.ajpath.2012.09.010; Correas JM, 2000, INVEST RADIOL, V35, P72, DOI 10.1097/00004424-200001000-00008; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Deshpande N, 2010, CLIN RADIOL, V65, P567, DOI 10.1016/j.crad.2010.02.013; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Garcia-Criado A, 2015, EUR RADIOL, V25, P196, DOI 10.1007/s00330-014-3377-5; Gorce JM, 2000, INVEST RADIOL, V35, P661, DOI 10.1097/00004424-200011000-00003; Gorina R, 2014, J IMMUNOL, V192, P324, DOI 10.4049/jimmunol.1300858; Gracia-Sancho J, 2010, TRANSPLANTATION, V90, P142, DOI 10.1097/TP.0b013e3181e228db; Harvey CJ, 2001, EUR RADIOL, V11, P675, DOI 10.1007/s003300000624; Huet PM, 2004, HEPATOLOGY, V39, P1110, DOI 10.1002/hep.20157; Imamura H, 2002, LANCET, V360, P2049, DOI 10.1016/S0140-6736(02)11995-7; Ivanov A. N., 2014, Uspekhi Fiziologicheskikh Nauk, V45, P34; Jacobs W, 1997, PARASITOL RES, V83, P405, DOI 10.1007/s004360050273; Kaufmann BA, 2007, EUR HEART J, V28, P2011, DOI 10.1093/eurheartj/ehm176; Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738; Langer K, 2000, EUR J PHARM BIOPHARM, V49, P303, DOI 10.1016/S0939-6411(00)00068-0; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee SJ, 2013, J CLIN ULTRASOUND, V41, P305, DOI 10.1002/jcu.22044; Lindner JR, 2001, CIRCULATION, V104, P2107, DOI 10.1161/hc4201.097061; Lu Q, 2012, EUR J RADIOL, V81, pE338, DOI 10.1016/j.ejrad.2011.11.015; Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015; Park YS, 2012, RADIOLOGY, V265, P617, DOI 10.1148/radiol.12112042; Rennert J, 2012, J GASTROINTEST LIVER, V21, P407; Suzuki R, 2010, J CONTROL RELEASE, V142, P245, DOI 10.1016/j.jconrel.2009.10.027; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Takalkar AM, 2004, J CONTROL RELEASE, V96, P473, DOI 10.1016/j.jconrel.2004.03.002; Tazaki T, 2010, HEPATOLOGY, V52, P1089, DOI 10.1002/hep.23767; Theruvath TP, 2006, TRANSPL P, V38, P3351, DOI 10.1016/j.transproceed.2006.10.171; Yang H, 2011, INT J NANOMED, V6, P2043, DOI 10.2147/IJN.S24808	33	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153805	10.1371/journal.pone.0153805	http://dx.doi.org/10.1371/journal.pone.0153805			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120181	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200037
J	Charles, JP; Cappellari, O; Spence, AJ; Hutchinson, JR; Wells, DJ				Charles, James P.; Cappellari, Ornella; Spence, Andrew J.; Hutchinson, John R.; Wells, Dominic J.			Musculoskeletal Geometry, Muscle Architecture and Functional Specialisations of the Mouse Hindlimb	PLOS ONE			English	Article							SOFT-TISSUE ANATOMY; PELVIC LIMB; SKELETAL-MUSCLE; COMPUTED-TOMOGRAPHY; MUSCULAR-DYSTROPHY; ENHANCED MICROCT; RABBIT HINDLIMB; UNIQUE ACTION; MOMENT ARMS; FIBER TYPES	Mice are one of the most commonly used laboratory animals, with an extensive array of disease models in existence, including for many neuromuscular diseases. The hindlimb is of particular interest due to several close muscle analogues/homologues to humans and other species. A detailed anatomical study describing the adult morphology is lacking, however. This study describes in detail the musculoskeletal geometry and skeletal muscle architecture of the mouse hindlimb and pelvis, determining the extent to which the muscles are adapted for their function, as inferred from their architecture. Using I2KI enhanced microCT scanning and digital segmentation, it was possible to identify 39 distinct muscles of the hindlimb and pelvis belonging to nine functional groups. The architecture of each of these muscles was determined through microdissections, revealing strong architectural specialisations between the functional groups. The hip extensors and hip adductors showed significantly stronger adaptations towards high contraction velocities and joint control relative to the distal functional groups, which exhibited larger physiological cross sectional areas and longer tendons, adaptations for high force output and elastic energy savings. These results suggest that a proximo-distal gradient in muscle architecture exists in the mouse hindlimb. Such a gradient has been purported to function in aiding locomotor stability and efficiency. The data presented here will be especially valuable to any research with a focus on the architecture or gross anatomy of the mouse hindlimb and pelvis musculature, but also of use to anyone interested in the functional significance of muscle design in relation to quadrupedal locomotion.	[Charles, James P.; Cappellari, Ornella; Wells, Dominic J.] Univ London Royal Vet Coll, Neuromuscular Dis Grp, Comparat Biomed Sci, 4 Royal Coll St, London NW1 0TU, England; [Cappellari, Ornella; Spence, Andrew J.; Hutchinson, John R.] Univ London Royal Vet Coll, Struct & Mot Lab, Comparat Biomed Sci, Hawkshead Lane, Hatfield AL9 7TA, Herts, England; [Spence, Andrew J.] Temple Univ, Coll Engn, Dept Bioengn, 1947 N 12th St, Philadelphia, PA 19122 USA	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Wells, DJ (corresponding author), Univ London Royal Vet Coll, Neuromuscular Dis Grp, Comparat Biomed Sci, 4 Royal Coll St, London NW1 0TU, England.	dwells@rvc.ac.uk	Hutchinson, John/AAH-1593-2020; Cappellari, Ornella/ABD-6840-2020	Cappellari, Ornella/0000-0002-1882-3502; Hutchinson, John/0000-0002-6767-7038; Wells, Dominic/0000-0002-1425-6344	Biotechnology and Biological Sciences Research Council [BB/J021504/1]; US Army Research Office [64929EG]; BBSRC [BB/J021504/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US Army Research Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) BB/J021504/1 and US Army Research Office (http://www.arl.army.mil/) 64929EG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1991, J EXP BIOL, V160, P55; Allen V, 2014, J ANAT, V225, P569, DOI 10.1111/joa.12245; Allen V, 2010, J ANAT, V216, P423, DOI 10.1111/j.1469-7580.2009.01202.x; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; BARNETT C H, 1953, Ann Phys Med, V1, P177; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Biewener AA, 1998, J EXP BIOL, V201, P1681; Biewener AA, 2007, J EXP BIOL, V210, P2949, DOI 10.1242/jeb.005801; BODINE SC, 1982, J NEUROPHYSIOL, V48, P192, DOI 10.1152/jn.1982.48.1.192; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Charles JP, J ANAT IN PRESS; Cox PG, 2011, ANAT REC, V294, P915, DOI 10.1002/ar.21381; Daley MA, 2007, J EXP BIOL, V210, P383, DOI 10.1242/jeb.02668; DeLaurier A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-83; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; During DN, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-1; Eng CM, 2008, J EXP BIOL, V211, P2336, DOI 10.1242/jeb.017640; FEDAK MA, 1982, J EXP BIOL, V97, P23; FRIEDERICH JA, 1990, J BIOMECH, V23, P91, DOI 10.1016/0021-9290(90)90373-B; Gignac PM, 2014, J EXP ZOOL PART B, V322, P166, DOI 10.1002/jez.b.22561; Gillis GB, 2005, J EXP BIOL, V208, P4599, DOI 10.1242/jeb.01940; Gillis GB, 2002, J APPL PHYSIOL, V93, P1731, DOI 10.1152/japplphysiol.00489.2002; GRIFFITHS RI, 1991, J PHYSIOL-LONDON, V436, P219, DOI 10.1113/jphysiol.1991.sp018547; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Heier CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112477; Henriques A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015445; Herdina AN, 2015, J ANAT, V226, P229, DOI 10.1111/joa.12274; Herdina AN, 2010, ANAT REC, V293, P1248, DOI 10.1002/ar.21148; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Lamas LP, 2014, PEERJ, V2, DOI 10.7717/peerj.716; Lautenschlager S, 2014, J ANAT, V224, P412, DOI 10.1111/joa.12153; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M; LIEBER RL, 1989, J MORPHOL, V199, P93, DOI 10.1002/jmor.1051990108; Malerba A, 2011, MOL THER, V19, P345, DOI 10.1038/mt.2010.261; Mathewson MA, 2012, J ANAT, V221, P443, DOI 10.1111/j.1469-7580.2012.01559.x; MENDEZ J, 1960, METABOLISM, V9, P184; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Partridge TA, 2013, FEBS J, V280, P4177, DOI 10.1111/febs.12267; Paxton H, 2010, J ANAT, V217, P153, DOI 10.1111/j.1469-7580.2010.01251.x; Payne RC, 2005, J ANAT, V206, P557, DOI 10.1111/j.1469-7580.2005.00420.x; Payne RC, 2005, J ANAT, V206, P193, DOI 10.1111/j.1469-7580.2005.00353.x; POWELL PL, 1984, J APPL PHYSIOL, V57, P1715, DOI 10.1152/jappl.1984.57.6.1715; Reeves ND, 2003, J APPL PHYSIOL, V95, P1090, DOI 10.1152/japplphysiol.01046.2002; SACKS RD, 1982, J MORPHOL, V173, P185, DOI 10.1002/jmor.1051730206; SCHENAU GJV, 1989, HUM MOVEMENT SCI, V8, P301; SCHENAU GJV, 1987, J ANAT, V155, P1; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; Smith NC, 2006, J ANAT, V209, P765, DOI 10.1111/j.1469-7580.2006.00658.x; Spence AJ, 2012, CURR BIOL, V22, pR309, DOI 10.1016/j.cub.2012.03.017; Spence AJ, 2009, CURR BIOL, V19, pR57, DOI 10.1016/j.cub.2008.10.042; Vickerton P, 2013, J ANAT, V223, P185, DOI 10.1111/joa.12068; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; Ward SR, 2005, J BIOMECH, V38, P2317, DOI 10.1016/j.jbiomech.2004.10.001; Wickiewicz TL, 1983, CLIN ORTHOP RELAT RE, P275; Williams SB, 2008, J ANAT, V213, P361, DOI [10.1111/j.1469-7580.2008.00961.x, 10.1111/j.1469-7580.2008.00962.x]; Williams SB, 2007, J ANAT, V210, P472, DOI 10.1111/j.1469-7580.2007.00704.x; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015; Winters TM, 2011, J BIOMECH, V44, P109, DOI 10.1016/j.jbiomech.2010.08.033; YOUNG RP, 1993, EXP BRAIN RES, V96, P141, DOI 10.1007/BF00230447; ZAJAC FE, 1989, EXERCISE SPORT SCI R, V17, P187	64	64	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0147669	10.1371/journal.pone.0147669	http://dx.doi.org/10.1371/journal.pone.0147669			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115354	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600007
J	Lyngwi, NA; Nongkhlaw, M; Kalita, D; Joshi, SR				Lyngwi, Nathaniel A.; Nongkhlaw, Macmillan; Kalita, Debajit; Joshi, Santa Ram			Bioprospecting of Plant Growth Promoting Bacilli and Related Genera Prevalent in Soils of Pristine Sacred Groves: Biochemical and Molecular Approach	PLOS ONE			English	Article							PHOSPHATE SOLUBILIZING BACTERIA; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE; ACC DEAMINASE; GENOME SEQUENCE; KEY ENZYME; RHIZOBACTERIA; BIOSYNTHESIS; PETROBACTIN; EVOLUTION; GENETICS	Bacillus spp. and related genera native to soils of the pristine sacred groves from Meghalaya, India were characterized using biochemical and 16S rRNA gene analysis which revealed dominance of Bacillus, Paenibacillus, Lysinibacillus and Viridibacillus in the groves. Biochemical estimation was carried out for in vitro testing of plant growth promoting traits present in these isolates. PCR screening were performed for plant growth-promoting related genes involved in the biosynthesis of acid phosphatase (AcPho), indolepyruvate decarboxylase (ipdC), 1-aminocyclopropane-1-carboxylate deaminase (accd) and siderophore biosynthesis protein (asbA). 76% of the sacred grove isolates gave an amplified fragment for AcPho. Three of the isolates gave an amplified fragment for IpdC gene. Apart from 2 isolates, all the other isolates including the reference strains were positive for the amplification of the accd gene indicating their potential to produce ACC deaminase enzyme. 42% of the isolates gave an amplified fragment for asbA gene indicating the potential ability of these isolates to produce the catechol type siderophore, petrobactin. Overall findings indicated multiple PGP genetic traits present in these isolates which suggested that these isolates are capable of expressing multiple PGP traits. Phylogenetic and sequence analysis of accd and asbA genes from the isolates revealed that asbA genes from Paenibacillus taichungiensis SG3 and Paenibacillus tylopili SG24 indicated the occurrence of intergeneric horizontal transfer between Paenibacillus and Bacillus.	[Lyngwi, Nathaniel A.; Nongkhlaw, Macmillan; Kalita, Debajit; Joshi, Santa Ram] North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Microbiol Lab, Shillong, Meghalaya, India	North Eastern Hill University	Joshi, SR (corresponding author), North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Microbiol Lab, Shillong, Meghalaya, India.	srjoshi2006@yahoo.co.in	Kalita, Debajit/H-9488-2014; Joshi/F-2097-2015	Joshi, Santa Ram/0000-0001-8080-484X	North Eastern Council, Government of India [NEC.ST/MG/693/2013]; DST-INSPIRE	North Eastern Council, Government of India(North Eastern Council, Government of India); DST-INSPIRE(Department of Science & Technology (India))	The authors thank North Eastern Council, Government of India for the financial support to carry out the study (Sanction No. NEC.ST/MG/693/2013 dated 22nd March 2013). MN thanks DST-INSPIRE for fellowship support.	Abeles F, 1992, ETHYLENE PLANT BIOL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnow LE, 1937, J BIOL CHEM, V118, P531; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Belimov AA, 2005, SOIL BIOL BIOCHEM, V37, P241, DOI 10.1016/j.soilbio.2004.07.033; Bhagobaty RK, 2011, FOR SCI TECHNOL, V7, P151, DOI 10.1080/21580103.2011.621381; BISHOP ML, 1994, SOIL SCI, V157, P238, DOI 10.1097/00010694-199404000-00006; BROWN ME, 1974, ANNU REV PHYTOPATHOL, V12, P181, DOI 10.1146/annurev.py.12.090174.001145; Bruto M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06261; Carney KM, 2006, MICROB ECOL, V52, P226, DOI 10.1007/s00248-006-9115-z; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen YP, 2006, APPL SOIL ECOL, V34, P33, DOI 10.1016/j.apsoil.2005.12.002; Clark FE, 1997, SOIL MICROBIOLOGY BI, P340; Collins CH, 2001, MICROBIOLOGICAL METH, P98; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; CSAKY TZ, 1948, ACTA CHEM SCAND, V2, P450, DOI 10.3891/acta.chem.scand.02-0450; DWORKIN M, 1958, J BACTERIOL, V75, P592, DOI 10.1128/JB.75.5.592-603.1958; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; El-Sawah M.M.A., 1993, J AGR SCI, V18, P2775; FELLER C, 1994, CAN J SOIL SCI, V74, P121, DOI 10.4141/cjss94-019; Fujino A, 2004, J MOL BIOL, V341, P999, DOI 10.1016/j.jmb.2004.06.062; Gamalero E, 2011, BACTERIA IN AGROBIOLOGY: PLANT NUTRIENT MANAGEMENT, P17, DOI 10.1007/978-3-642-21061-7_2; GARCIA C, 1992, SOIL BIOL BIOCHEM, V25, P361; Glick BR, 2014, MICROBIOL RES, V169, P30, DOI 10.1016/j.micres.2013.09.009; GLICK BR, 1999, BIOCH GENETIC MECH U, P45; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Grichko VP, 2001, PLANT PHYSIOL BIOCH, V39, P11, DOI 10.1016/S0981-9428(00)01212-2; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Holt J, 1994, BERGEYS MANUAL DETER, V9th; HONMA M, 1978, AGR BIOL CHEM TOKYO, V42, P1825, DOI 10.1080/00021369.1978.10863261; Hontzeas N, 2005, APPL ENVIRON MICROB, V71, P7556, DOI 10.1128/AEM.71.11.7556-7558.2005; Hontzeas N, 2004, BBA-PROTEINS PROTEOM, V1703, P11, DOI 10.1016/j.bbapap.2004.09.015; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Joung KB, 2002, J APPL MICROBIOL, V92, P97, DOI 10.1046/j.1365-2672.2002.01507.x; Kawaguchi M, 1996, PLANT CELL PHYSIOL, V37, P1043, DOI 10.1093/oxfordjournals.pcp.a029051; Kayang H., 2006, ASIAN J MICROBIOLOGY, V8, P521; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KNUDSEN D, 1988, N CENTRAL REGIONAL P, V221, P12; Koppisch AT, 2008, BIOMETALS, V21, P581, DOI 10.1007/s10534-008-9144-9; Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X; Lee JC, 2008, INT J SYST EVOL MICR, V58, P612, DOI 10.1099/ijs.0.65350-0; Lee JY, 2007, J BACTERIOL, V189, P1698, DOI 10.1128/JB.01526-06; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lynch J. M., 1990, The rhizosphere., P177; Lyngwi NA, 2015, INDIAN J TRADIT KNOW, V14, P474; Lyngwi NA, 2013, REV BIOL TROP, V61, P467; MarekKozaczuk M, 1996, PLANT SOIL, V179, P269, DOI 10.1007/BF00009337; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; MAYAK S, 2004, PLANT PHYSIOL BIOCH, V167, P650; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Nongkhlaw M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048199; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Patten CL, 1996, CAN J MICROBIOL, V42, P207, DOI 10.1139/m96-032; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Prescott LM, 2002, MICROBIOLOGY, P34; Raddadi N, 2008, ANN MICROBIOL, V58, P47, DOI 10.1007/BF03179444; Ragan MA, 2001, CURR OPIN GENET DEV, V11, P620, DOI 10.1016/S0959-437X(00)00244-6; Rodriguez H, 2006, PLANT SOIL, V287, P15, DOI 10.1007/s11104-006-9056-9; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Schutz A, 2003, EUR J BIOCHEM, V270, P2322, DOI 10.1046/j.1432-1033.2003.03602.x; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Seshadri R, 2015, SCI REP-UK, V5, DOI 10.1038/srep16825; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Wahyudi A. T., 2011, Journal of Microbiology and Antimicrobials, V3, P34; Wang CX, 2000, CAN J MICROBIOL, V46, P898, DOI 10.1139/cjm-46-10-898; Wilson MK, 2010, BIOMETALS, V23, P129, DOI 10.1007/s10534-009-9272-x; XU JG, 1995, PLANT SOIL, V173, P3, DOI 10.1007/BF00155512	69	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152951	10.1371/journal.pone.0152951	http://dx.doi.org/10.1371/journal.pone.0152951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111883	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600006
J	Wong, KK; Zhu, F; Khatri, I; Huo, Q; Spaner, DE; Gorczynski, RM				Wong, Karrie K.; Zhu, Fang; Khatri, Ismat; Huo, Qiang; Spaner, David E.; Gorczynski, Reginald M.			Characterization of CD200 Ectodomain Shedding	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; L-SELECTIN CD62L; SOLUBLE CD200; CLEAVAGE; CELLS; INHIBITOR; RECEPTOR; FORM; PROTEASES; PATHWAYS	We have previously reported the existence of a soluble form of CD200 (sCD200) in human plasma, and found sCD200 to be elevated in the plasma of Chronic Lymphocytic Leukemia (CLL) patients. CLL cells release CD200 at a constitutive level, which could be attenuated partially by ADAM28 silencing. In this study, we further explored mechanisms of CD200 shedding beyond that of ADAM28, and performed biochemical analysis of sCD200 using materials derived from purified CLL cells and Hek293 cells stably transfected with CD200, and antibodies generated specifically against either the extracellular or cytoplasmic regions of CD200. CD200 shedding was enhanced by PMA stimulation, and the loss of cell surface CD200 could be monitored as a reduction in CD200 cell surface expression by flow cytometry, in parallel with an increase in the detection of sCD200 in the supernatant. Western blot analyses and functional studies using CD200R1 expressing Hek293 cells showed that the shed CD200 detected in CLL and Hek293-hCD200 supernatants lacked the cytoplasmic domain of CD200 but retained the functional extracellular domain required for binding to, and phosphorylation of, CD200R. These data confirms that a functionally active CD200 extracellular moiety can be cleaved from the surface of CD200 expressing cells following ectodomain shedding.	[Wong, Karrie K.; Zhu, Fang; Gorczynski, Reginald M.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Zhu, Fang; Khatri, Ismat; Huo, Qiang; Gorczynski, Reginald M.] Univ Hlth Network, Transplant Res Div, Toronto, ON, Canada; [Zhu, Fang; Khatri, Ismat; Huo, Qiang; Gorczynski, Reginald M.] Univ Toronto, Toronto, ON, Canada; [Spaner, David E.] Univ Toronto, Sunnybrook Res Inst, Div Mol & Cellular Biol, Toronto, ON, Canada; [Wong, Karrie K.] Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Gorczynski, RM (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Gorczynski, RM (corresponding author), Univ Hlth Network, Transplant Res Div, Toronto, ON, Canada.; Gorczynski, RM (corresponding author), Univ Toronto, Toronto, ON, Canada.	rgorczynski@uhnres.utoronto.ca	Wong, Karrie/F-8105-2017; Zhu, Fang/L-3411-2016; Gorczynski, Reginald/AAA-1435-2019	Wong, Karrie/0000-0002-3192-6872; 	Canadian Institutes of Health Research (CIHR) [190633]; Canadian Institutes of Health Research Regenerative Medicine Graduate Fellowship; CIHR [190633]; Leukemia and Lymphoma Society of Canada (LLSC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087746] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Regenerative Medicine Graduate Fellowship(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society of Canada (LLSC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the Canadian Institutes of Health Research (CIHR) (#190633) for RG, the Canadian Institutes of Health Research Regenerative Medicine Graduate Fellowship for KW, CIHR (#190633) and the Leukemia and Lymphoma Society of Canada (LLSC) (to DES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Ashiru O, 2010, CANCER RES, V70, P481, DOI 10.1158/0008-5472.CAN-09-1688; Borland G, 1999, J BIOL CHEM, V274, P2810, DOI 10.1074/jbc.274.5.2810; Brenneman F., 2011, SOLUBLE CD200 UNPUB; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chen ZQ, 2008, TRANSPLANTATION, V86, P1116, DOI 10.1097/TP.0b013e318186fec2; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Fourie AM, 2003, J BIOL CHEM, V278, P30469, DOI 10.1074/jbc.M213157200; Frigola X, 2011, CLIN CANCER RES, V17, P1915, DOI 10.1158/1078-0432.CCR-10-0250; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gasbarri A, 2003, MELANOMA RES, V13, P325, DOI 10.1097/00008390-200308000-00001; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Gorczynski Reginald M, 2005, Curr Opin Investig Drugs, V6, P483; Gu B, 1998, BLOOD, V92, P946; Hargreaves PG, 1998, BRIT J HAEMATOL, V101, P694, DOI 10.1046/j.1365-2141.1998.00754.x; Khatri Ismat B I, 2012, OPEN J IMMUNOLOGY, V2, P15; Kos O, 2014, BONE, V60, P33, DOI 10.1016/j.bone.2013.12.004; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lesesve J F, 2001, Hematol J, V2, P355, DOI 10.1038/sj.thj.6200129; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Moreaux J, 2008, BIOCHEM BIOPH RES CO, V366, P117, DOI 10.1016/j.bbrc.2007.11.103; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Nuckel H, 2010, LEUKEMIA, V24, P1152, DOI 10.1038/leu.2010.74; Oaks MK, 2000, CELL IMMUNOL, V201, P144, DOI 10.1006/cimm.2000.1649; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schwager SLU, 1999, BIOCHEMISTRY-US, V38, P10388, DOI 10.1021/bi990357j; Schwarzmeier JD, 2002, LEUKEMIA LYMPHOMA, V43, P549, DOI 10.1080/10428190210323; Seiffert M, 2010, BLOOD, V116, P4223, DOI 10.1182/blood-2010-05-284505; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Stumpfova M, 2010, CANCER RES, V70, P2962, DOI 10.1158/0008-5472.CAN-09-4380; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Twito T, 2013, LEUKEMIA RES, V37, P816, DOI 10.1016/j.leukres.2013.04.014; Walker DG, 2013, FUTUR NEUROL, V8, P321, DOI [10.2217/fnl.13.14, 10.2217/FNL.13.14]; Wong KK, 2012, CANCER RES, V72, P4931, DOI 10.1158/0008-5472.CAN-12-1390; Wong KK, 2010, J LEUKOCYTE BIOL, V88, P361, DOI 10.1189/jlb.1009686; Zhang GB, 2009, LUNG CANCER, V66, P245, DOI 10.1016/j.lungcan.2009.01.017; Zhao LC, 2001, J BIOL CHEM, V276, P30631, DOI 10.1074/jbc.M103748200	49	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152073	10.1371/journal.pone.0152073	http://dx.doi.org/10.1371/journal.pone.0152073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111430	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600001
J	Mercier, A; Sun, Z; Parrish, CC; Hamel, JF				Mercier, Annie; Sun, Zhao; Parrish, Christopher C.; Hamel, Jean-Francois			Remarkable Shifts in Offspring Provisioning during Gestation in a Live-Bearing Cnidarian	PLOS ONE			English	Article							PARENTAL CARE; FETAL NUTRITION; SIZE; EVOLUTION; VIVIPARITY; CONFLICT; FISH; SPECIALIZATIONS; PLACENTOTROPHY; MATROTROPHY	Animals display diverse means of producing and provisioning offspring, from eggs to embryos and juveniles. While external development predominates, many forms of embryonic incubation have evolved, including placentation in mammals and a number of understudied variants in basal metazoans that could help understand evolutionary diversification. Here we studied the brooding sea anemone Aulactinia stella, using behavioural, morphological and biochemical indicators of offspring phenotype to characterize gestation and elucidate parental and sibling relationships. The pronounced variance in juvenile weight within broods was not strongly related to any of the typical external predictors (adult weight, clutch size, sampling date, environmental conditions). Lipid concentration was significantly higher in the tissues of the small juveniles than in those of large juveniles or adult, and fatty acid profiles tended to set small juveniles apart. Finally, intra-brood feeding on external resources was documented in larger juveniles. These results are consistent with ontogenetic shifts in nutrition, from vitellogenic provisioning to post-zygotic nourishment to a prenatal form of nursing upon acquisition of feeding organs, highlighting matrotrophic and conflict-driven mechanisms acting on offspring phenotype during gestation.	[Mercier, Annie; Sun, Zhao; Parrish, Christopher C.] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada; [Hamel, Jean-Francois] SEVE, Portugal Cove St Philips, NF, Canada	Memorial University Newfoundland	Mercier, A (corresponding author), Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada.	amercier@mun.ca	Mercier, Annie/B-4254-2012		Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This research was supported by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) and Canada Foundation for Innovation (http://www.innovation.ca/) grants to AM and CCP.	Ala-Honkola O, 2011, J EVOLUTION BIOL, V24, P2600, DOI 10.1111/j.1420-9101.2011.02383.x; Avise JC, 2011, P NATL ACAD SCI USA, V108, P11512, DOI 10.1073/pnas.1109216108; Beekey MA, 2000, CAN J ZOOL, V78, P1697, DOI 10.1139/cjz-78-10-1697; Blackburn DG, 2015, J MORPHOL, V276, P961, DOI 10.1002/jmor.20272; BLACKBURN DG, 1992, AM ZOOL, V32, P313; Bocharova ES, 2015, HYDROBIOLOGIA, V759, P27, DOI 10.1007/s10750-015-2250-0; Brante A, 2003, MAR ECOL PROG SER, V251, P221, DOI 10.3354/meps251221; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Collin R, 2012, BIOL BULL-US, V223, P268, DOI 10.1086/BBLv223n3p268; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Fernandez M, 2000, ECOL LETT, V3, P487, DOI 10.1046/j.1461-0248.2000.00172.x; Guralnick R, 2004, J MOLLUS STUD, V70, P341, DOI 10.1093/mollus/70.4.341; HALL SJ, 1986, J MOLLUS STUD, V52, P193, DOI 10.1093/mollus/52.3.193; Heras H, 2000, LIPIDS, V35, P645, DOI 10.1007/s11745-000-0569-z; Jacobs MW, 2010, INTEGR COMP BIOL, V50, P630, DOI 10.1093/icb/icq091; Jorgensen C, 2011, AM NAT, V177, pE119, DOI 10.1086/659622; Kalinka AT, 2015, BIOESSAYS, V37, P721, DOI 10.1002/bies.201400200; Kaliszewicz A, 2012, POLAR BIOL, V35, P1911, DOI 10.1007/s00300-012-1232-1; Kamel SJ, 2010, INTEGR COMP BIOL, V50, P619, DOI 10.1093/icb/icq104; Kamel SJ, 2010, TRENDS ECOL EVOL, V25, P442, DOI 10.1016/j.tree.2010.05.008; Kolliker M, 2012, EVOLUTION OF PARENTAL CARE, P285; Lode T, 2012, REPROD BIOL, V12, P259, DOI 10.1016/j.repbio.2012.09.001; Marshall DJ, 2008, ADV MAR BIOL, V53, P1, DOI 10.1016/S0065-2881(07)53001-4; Mercier A, 2011, P ROY SOC B-BIOL SCI, V278, P3517, DOI 10.1098/rspb.2011.0605; Mercier A, 2010, BEHAV ECOL SOCIOBIOL, V64, P1749, DOI 10.1007/s00265-010-0987-z; Mock D. W., 1997, EVOLUTION SIBLING RI; Monteith KM, 2012, J EVOLUTION BIOL, V25, P1815, DOI 10.1111/j.1420-9101.2012.02567.x; Ostrovsky AN, 2016, BIOL REV, V91, P673, DOI 10.1111/brv.12189; Ostrovsky AN, 2013, EVOLUTION, V67, P1368, DOI 10.1111/evo.12039; Ostrovsky AN, 2009, MAR ECOL PROG SER, V378, P113, DOI 10.3354/meps07850; Parrish CC, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P4; Parrish CC, 2009, MAR ECOL PROG SER, V391, P33, DOI 10.3354/meps08148; Pollux BJA, 2014, NATURE, V513, P233, DOI 10.1038/nature13451; Pollux BJA, 2011, FUNCT ECOL, V25, P747, DOI 10.1111/j.1365-2435.2011.01831.x; Rollinson N, 2011, OECOLOGIA, V166, P889, DOI 10.1007/s00442-011-1945-9; Rosa R, 2003, AQUACULTURE, V221, P507, DOI 10.1016/S0044-8486(03)00117-0; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Schrader M, 2005, COPEIA, P649; Schrader M, 2012, EVOLUTION, V66, P272, DOI 10.1111/j.1558-5646.2011.01422.x; SHINE R, 1989, AM NAT, V134, P311, DOI 10.1086/284982; SHINE R, 1978, J THEOR BIOL, V75, P417, DOI 10.1016/0022-5193(78)90353-3; Simons AM, 2011, P ROY SOC B-BIOL SCI, V278, P1601, DOI 10.1098/rspb.2011.0176; Smiseth PT, 2007, EVOLUTION, V61, P2331, DOI 10.1111/j.1558-5646.2007.00192.x; Sun Z, 2015, ECOL EVOL, V5, P1117, DOI 10.1002/ece3.1320; Sun Z, 2012, AM NAT, V180, pE151, DOI 10.1086/667862; Trexler JC, 2003, AM NAT, V162, P574, DOI 10.1086/378822; TRIVERS RL, 1974, AM ZOOL, V14, P249; Trumbo Stephen T., 1996, Advances in the Study of Behavior, V25, P3; Van Dyke JU, 2014, AM NAT, V184, P198, DOI 10.1086/677138; Wehrtmann IS, 1998, COMP BIOCHEM PHYS B, V121, P457, DOI 10.1016/S0305-0491(98)10141-4	52	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154051	10.1371/journal.pone.0154051	http://dx.doi.org/10.1371/journal.pone.0154051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104375	Green Published, gold			2022-12-27	WOS:000374565100039
J	Ramjee, G; Moonsamy, S; Abbai, NS; Wand, H				Ramjee, Gita; Moonsamy, Suri; Abbai, Nathlee Samantha; Wand, Handan			Individual and Population Level Impact of Key HIV Risk Factors on HIV Incidence Rates in Durban, South Africa	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PREEXPOSURE PROPHYLAXIS; GENITAL-TRACT; WOMEN; PREVENTION	We aimed to estimate the individual and joint impact of age, marital status and diagnosis with sexually transmitted infections (STIs) on HIV acquisition among young women at a population level in Durban, KwaZulu-Natal, South Africa. A total of 3,978 HIV seronegative women were recruited for four biomedical intervention trials from 2002-2009. Point and interval estimates of partial population attributable risk (PAR) were used to quantify the proportion of HIV seroconversions which can be prevented if a combination of risk factors is eliminated from a target population. More than 70% of the observed HIV acquisitions were collectively attributed to the three risk factors: younger age (<25 years old), unmarried and not cohabiting with a stable/regular partner and diagnosis with STIs. Addressing these risks requires targeted structural, behavioural, biomedical and cultural interventions in order to impact on unacceptably high HIV incidence rates among young women and the population as a whole.	[Ramjee, Gita; Moonsamy, Suri; Abbai, Nathlee Samantha] MRC, HIV Prevent Res Unit, Durban, South Africa; [Ramjee, Gita] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Ramjee, Gita] Univ Washington, Sch Med, Dept Global Hlth, Washington, DC USA; [Wand, Handan] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	University of London; London School of Hygiene & Tropical Medicine; University of Washington; University of New South Wales Sydney; Kirby Institute	Ramjee, G (corresponding author), MRC, HIV Prevent Res Unit, Durban, South Africa.; Ramjee, G (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.; Ramjee, G (corresponding author), Univ Washington, Sch Med, Dept Global Hlth, Washington, DC USA.	Gita.Ramjee@mrc.ac.za	abbai, nathlee/Q-5097-2019	Abbai, Nathlee/0000-0003-2392-0574				Balkus JE, 2015, JAIDS-J ACQ IMM DEF, V70, P212, DOI 10.1097/QAI.0000000000000715; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Corneli A, 2014, JAIDS-J ACQ IMM DEF, V67, P555, DOI 10.1097/QAI.0000000000000362; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Fichorova RN, 2015, MBIO, V6, DOI 10.1128/mBio.00221-15; Jewkes R, 2015, LANCET, V385, P1580, DOI 10.1016/S0140-6736(14)61683-4; Karim Q, 2015, IMPACT CONDITIONAL C; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kleppa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098593; Losina E., 2010, PLOS ONE, V5, P1; Mabala R, 2006, ENVIRON URBAN, V18, P407, DOI 10.1177/0956247806069624; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mlisana K, 2012, J INFECT DIS, V206, P6, DOI 10.1093/infdis/jis298; Naicker N, 2015, AIDS BEHAV, V19, P1305, DOI 10.1007/s10461-015-1002-5; Naidoo S, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-31; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; Pettifor A, 2015, HPTN 068 CONDITIONAL; Plan NS, 2011, NATL STRATEGIC PLAN; Ramjee G, 2005, JAIDS-J ACQ IMM DEF, V39, P333, DOI 10.1097/01.qai.0000144445.44518.ea; Ramjee G, 2012, B WORLD HEALTH ORGAN, V90, P785; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Ramjee G, 2012, AIDS BEHAV, V16, P2062, DOI 10.1007/s10461-011-0043-7; Reddy BS, 2004, CLIN EXP IMMUNOL, V137, P552, DOI 10.1111/j.1365-2249.2004.02564.x; Rees H, 2015, C RETR OPP INF SEATT, p26LB; Santelli JS, 2013, JAIDS-J ACQ IMM DEF, V63, P393, DOI 10.1097/QAI.0b013e3182926795; Shisana O, 2009, S AFRICAN NATL HIV P; Shisana O, 2014, S AFRICAN NATL HIV P; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Sperling R, 2013, J REPROD IMMUNOL, V99, P80, DOI 10.1016/j.jri.2013.07.003; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Street RA, 2016, INT J STD AIDS, V27, P746, DOI 10.1177/0956462415592325; UNAIDS, 2012, EV MIN YOUNG WOM IS; UNAIDS, 2016, GLOB REP GLOB AIDS E; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Wand Handan, 2015, J Int AIDS Soc, V18, P19866, DOI 10.7448/IAS.18.1.19866; Wand H, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000285; Wand H, 2011, AIDS BEHAV, V15, P479, DOI 10.1007/s10461-010-9845-2; Wilkinson D, 1998, SEX TRANSM DIS, V25, P20, DOI 10.1097/00007435-199801000-00005	40	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153969	10.1371/journal.pone.0153969	http://dx.doi.org/10.1371/journal.pone.0153969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104835	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100032
J	Come, C; Cvrljevic, A; Khan, MM; Treise, I; Adler, T; Aguilar-Pimentel, JA; Au-Yeung, B; Sittig, E; Laajala, TD; Chen, YL; Oeder, S; Calzada-Wack, J; Horsch, M; Aittokallio, T; Busch, DH; Ollert, MW; Neff, F; Beckers, J; Gailus-Durner, V; Fuchs, H; de Angelis, MH; Chen, Z; Lahesmaa, R; Westermarck, J				Come, Christophe; Cvrljevic, Anna; Khan, Mohd Moin; Treise, Irina; Adler, Thure; Aguilar-Pimentel, Juan Antonio; Au-Yeung, Byron; Sittig, Eleonora; Laajala, Teemu Daniel; Chen, Yiling; Oeder, Sebastian; Calzada-Wack, Julia; Horsch, Marion; Aittokallio, Tero; Busch, Dirk H.; Ollert, Markus W.; Neff, Frauke; Beckers, Johannes; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Chen, Zhi; Lahesmaa, Riitta; Westermarck, Jukka			CIP2A Promotes T-Cell Activation and Immune Response to Listeria monocytogenes Infection	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; CATALYTIC-ACTIVITY; CANCER; APOPTOSIS; PP2A; ONCOPROTEIN; INHIBITOR; KINASE; ZAP70	The oncoprotein Cancerous Inhibitor of Protein Phosphatase 2A ( CIP2A) is overexpressed in most malignancies and is an obvious candidate target protein for future cancer therapies. However, the physiological importance of CIP2A-mediated PP2A inhibition is largely unknown. As PP2A regulates immune responses, we investigated the role of CIP2A in normal immune system development and during immune response in vivo. We show that CIP2A-deficient mice (CIP2A(HOZ)) present a normal immune system development and function in unchallenged conditions. However when challenged with Listeria monocytogenes, CIP2A(HOZ) mice display an impaired adaptive immune response that is combined with decreased frequency of both CD4(+) T-cells and CD8(+) effector T-cells. Importantly, the cell autonomous effect of CIP2A deficiency for T-cell activation was confirmed. Induction of CIP2A expression during T-cell activation was dependent on Zap70 activity. Thus, we reveal CIP2A as a hitherto unrecognized mediator of T-cell activation during adaptive immune response. These results also reveal CIP2A(HOZ) as a possible novel mouse model for studying the role of PP2A activity in immune regulation. On the other hand, the results also indicate that CIP2A targeting cancer therapies would not cause serious immunological side-effects.	[Come, Christophe; Cvrljevic, Anna; Khan, Mohd Moin; Sittig, Eleonora; Laajala, Teemu Daniel; Chen, Zhi; Lahesmaa, Riitta; Westermarck, Jukka] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Come, Christophe; Cvrljevic, Anna; Khan, Mohd Moin; Sittig, Eleonora; Laajala, Teemu Daniel; Chen, Zhi; Lahesmaa, Riitta; Westermarck, Jukka] Abo Akad Univ, Turku, Finland; [Khan, Mohd Moin] Univ Turku, Turku Doctoral Programme Mol Med TuDMM, Fac Med, Turku, Finland; [Treise, Irina; Adler, Thure; Aguilar-Pimentel, Juan Antonio; Calzada-Wack, Julia; Horsch, Marion; Neff, Frauke; Beckers, Johannes; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, German Mouse Clin, Neuherberg, Germany; [Treise, Irina; Adler, Thure; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Aguilar-Pimentel, Juan Antonio] Tech Univ Munich, Klinikum Rechts Isar, Biederstein, Dept Dermatol & Allergy, D-80290 Munich, Germany; [Au-Yeung, Byron; Chen, Yiling] Univ Calif San Francisco, Dept Med, Dept Microbiol & Immunol, Howard Hughes Med Inst,Rosalind Russell Med Res C, San Francisco, CA USA; [Laajala, Teemu Daniel] Univ Turku, Dept Math & Stat, Turku, Finland; [Oeder, Sebastian] Tech Univ Munich, Ctr Allergy & Environm Munich ZAUM, D-80290 Munich, Germany; [Oeder, Sebastian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Allergy Res, Munich, Germany; [Oeder, Sebastian] Kuhne Fdn, Christine Kuhne Ctr Allergy Res & Educ CKCARE, Munich, Germany; [Calzada-Wack, Julia; Neff, Frauke] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Treise, Irina; Horsch, Marion; Beckers, Johannes; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany; [Aittokallio, Tero] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Ollert, Markus W.] Tech Univ Munich, Ctr Allergy & Environm Munich ZAUM, Clin Res Grp Mol Allergol, D-80290 Munich, Germany; [Ollert, Markus W.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Allergy Res, Munich, Germany; [Beckers, Johannes] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany; [Westermarck, Jukka] Univ Turku, Dept Pathol, Turku, Finland	University of Turku; Abo Akademi University; University of Turku; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Turku; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Helsinki; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Turku	Come, C (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.; Come, C (corresponding author), Abo Akad Univ, Turku, Finland.	christophe.come@bric.ku.dk	Chen, Yi/HIR-2608-2022; Westermarck, Jukka/AAL-6464-2020; de Angelis, Martin Hrabe/F-5531-2012; Aittokallio, Tero/B-6583-2009; Beckers, Johannes/K-7237-2012; Khan, Mohd Moin/GYQ-7170-2022; Gailus-Durner, Valerie/M-7337-2014; Come, Christophe/E-8395-2016	Westermarck, Jukka/0000-0001-7478-3018; de Angelis, Martin Hrabe/0000-0002-7898-2353; Aittokallio, Tero/0000-0002-0886-9769; Beckers, Johannes/0000-0001-7874-3822; Au-Yeung, Byron/0000-0002-6446-9102; Chen, Zhi/0000-0002-4658-7463; Calzada, Julia/0000-0003-0816-9305; Cvrljevic, Anna/0000-0003-2851-8701; Ollert, Markus W./0000-0002-8055-0103; Laajala, Teemu Daniel/0000-0002-7016-7354; Come, Christophe/0000-0001-5229-4440	Academy of Finland [121413, 122546, 258313, 137687, 133227, 140880, 269862, 272437]; Sigrid Juselius Foundation; Turku Doctoral Programme of Molecular Medicine (TuDMM); Foundation for the Finnish Cancer Institute; German Federal Ministry of Education and Research; Infrafrontier [01KX1012]; German National Genome Research Network (BMBF-NGFN project) [01GS0868]; Seventh Framework Programme of the European Commission [FP7-SYBILLA-201106]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR065481] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku Doctoral Programme of Molecular Medicine (TuDMM); Foundation for the Finnish Cancer Institute; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Infrafrontier; German National Genome Research Network (BMBF-NGFN project); Seventh Framework Programme of the European Commission(European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the Academy of Finland (http://www.aka.fi/fi/; grants 121413, 122546, 258313 and 137687, 133227, 140880, 269862, 272437), Sigrid Juselius Foundation (http://sigridjuselius.net/), Turku Doctoral Programme of Molecular Medicine (TuDMM; http://www.utu.fi/en/units/med/studying/postgrad/doctoral/doctoralprogrammes/ tudmm/Pages/home.aspx), Foundation for the Finnish Cancer Institute (http://syopasaatio.fi/), the German Federal Ministry of Education and Research (http://www.bmbf.de/; Infrafrontier grant 01KX1012), German National Genome Research Network (BMBF-NGFN project 01GS0868 to MO) and the Seventh Framework Programme of the European Commission (http://cordis.europa.eu/fp7/home_en.html; FP7-SYBILLA-201106).	Apostolidis SA, 2013, J BIOL CHEM, V288, P26775, DOI 10.1074/jbc.M113.483743; Au-Yeung BB, 2014, NATURE IMMUNOL UNPUB; Au-Yeung BB, 2014, NAT IMMUNOL, V15, P687, DOI 10.1038/ni.2918; Au-Yeung BB, 2010, NAT IMMUNOL, V11, P1085, DOI 10.1038/ni.1955; Bandukwala HS, 2012, P NATL ACAD SCI USA, V109, P14532, DOI 10.1073/pnas.1212264109; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Collison A, 2013, NAT MED, V19, P232, DOI 10.1038/nm.3049; Crispin JC, 2012, J IMMUNOL, V188, P3567, DOI 10.4049/jimmunol.1200143; Crispin JC, 2011, P NATL ACAD SCI USA, V108, P12443, DOI 10.1073/pnas.1103915108; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Guenebeaud C, 2010, MOL CELL, V40, P863, DOI 10.1016/j.molcel.2010.11.021; Homsi J, SUPPORTIVE CARE CANC, V8, P487; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Khanna A, 2013, CANCER RES, V73, P6548, DOI 10.1158/0008-5472.CAN-13-1994; Kugler JE, 2013, J BIOL CHEM, V288, P16690, DOI 10.1074/jbc.M113.463315; Laine A, 2013, CANCER DISCOV, V3, P182, DOI 10.1158/2159-8290.CD-12-0292; LANGERMANS JAM, 1994, IMMUNOLOGY, V81, P192; Niemela M, 2012, ONCOGENE, V31, P4266, DOI 10.1038/onc.2011.599; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Peng B, 2015, MOL BIOSYST, V11, P105, DOI 10.1039/c4mb00513a; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Puustinen P, 2014, AUTOPHAGY, V10, P1352, DOI 10.4161/auto.29076; Puustinen P, 2014, J CELL BIOL, V204, P713, DOI 10.1083/jcb.201304012; Roncagalli R, 2014, NAT IMMUNOL, V15, P384, DOI 10.1038/ni.2843; Stosor V, 2014, INFECT COMPLICATIONS; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Ventela S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033209; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wang J, 2011, INT J LAB HEMATOLOGY; Weaver JL, 2002, TOXICOL MECH METHOD, V12, P95, DOI 10.1080/10517230290075341; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; Zembower TR, 2014, CANCER TREAT RES, V161, P43, DOI 10.1007/978-3-319-04220-6_2; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	38	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152996	10.1371/journal.pone.0152996	http://dx.doi.org/10.1371/journal.pone.0152996			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100879	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500020
J	Lin, CS; Wu, SY; Huang, HY; Lai, YL				Lin, Chia-Shu; Wu, Shih-Yun; Huang, Hsin-Yi; Lai, Yu-Lin			Systematic Review and Meta-Analysis on Incidence of Altered Sensation of Mandibular Implant Surgery	PLOS ONE			English	Review							2 ENDOSTEAL IMPLANTS; CREST ONLAY GRAFTS; DENTAL IMPLANTS; BONE AUGMENTATION; NERVE INJURIES; MENTAL NERVE; COMPLICATIONS; PLACEMENT; DENTISTRY; PAIN	Altered sensation (including paresthesia, dysesthesia and hypoesthesia) after mandibular implant surgery may indicate transient or permanent injury of the inferior alveolar nerve and the mental branch, and considerably lower patients' satisfaction about the therapy. Previous studies have shown a great degree of variability on the incidence of altered sensation. We here reported the incidence of altered sensation after mandibular implant surgery based on a meta-analysis of 26 articles published between 1990.1.1 and 2016.1.1. Study quality and risk of bias was assessed and the studies with a lower score were excluded in the meta-analysis. Data synthesis was performed using the logistic-normal random-effect model. The meta-analyses revealed that the short-term (10 days after implant placement) and long-term (1 year after implant placement) incidence was 13% (95% CI, 6%-25%) and 3% (95% CI, 1%-7%), respectively. (2) For the patients who initially reported altered sensation, 80% (95% CI, 52%-94%) of them would return to normal sensation within 6 months after surgery, and 91% (95% CI, 78%-96%) of them would return to normal sensation one year after surgery. We concluded that dentist-patient communication about the risk of altered sensation is critical to treatment planning, since the short-term incidence of altered sensation is substantial (13%). When a patient reports altered sensation, regular assessment for 6 months would help tracing the changes of symptoms. In terms of long-term follow-up (1 year after surgery), the incidence is much lower (3%) and most patients (91%) would return to normal sensation.	[Lin, Chia-Shu; Wu, Shih-Yun; Lai, Yu-Lin] Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei 112, Taiwan; [Wu, Shih-Yun] Taipei Vet Gen Hosp, Dept Stomatol, Div Family Dent, Taipei, Taiwan; [Huang, Hsin-Yi] Taipei Vet Gen Hosp, Biostat Task Force, Taipei, Taiwan; [Lai, Yu-Lin] Taipei Vet Gen Hosp, Dept Stomatol, Div Endodont & Periodontol, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Lin, CS (corresponding author), Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei 112, Taiwan.	winzlin@ym.edu.tw	Lin, Chia-shu/AAA-5143-2019; Lin, Chia-Shu/HGD-7267-2022	Lin, Chia-Shu/0000-0002-6575-0887	Ministry of Science and Technology of Taiwan [103-2314-B-010-025-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by the Ministry of Science and Technology of Taiwan (103-2314-B-010-025-MY3).	Abarca M, 2006, CLIN ORAL INVEST, V10, P269, DOI 10.1007/s00784-006-0065-0; Akal UK, 2000, INT J ORAL MAX SURG, V29, P331, DOI 10.1016/S0901-5027(00)80046-6; Al-Sabbagh Mohanad, 2015, Dent Clin North Am, V59, P131, DOI 10.1016/j.cden.2014.08.004; Al-Sabbagh Mohanad, 2015, Dent Clin North Am, V59, P143, DOI 10.1016/j.cden.2014.08.005; Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11; Allen PF, 1997, BRIT DENT J, V182, P298, DOI 10.1038/sj.bdj.4809371; ASTRAND P, 1991, International Journal of Oral and Maxillofacial Implants, V6, P305; Bagheri SC, 2014, J AM DENT ASSOC, V145, P859, DOI 10.14219/jada.2014.45; Bartling R, 1999, J ORAL MAXIL SURG, V57, P1408, DOI 10.1016/S0278-2391(99)90720-6; BATENBURG RHK, 1994, CLIN ORAL IMPLAN RES, V5, P207, DOI 10.1034/j.1600-0501.1994.050403.x; Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x; Bormann KH, 2010, INT J ORAL MAX SURG, V39, P554, DOI 10.1016/j.ijom.2010.03.002; Bornstein MM, 2014, INT J ORAL MAX IMPL, V29, P78, DOI 10.11607/jomi.2013.g1; Boven GC, 2014, INT J ORAL MAX SURG, V43, P626, DOI 10.1016/j.ijom.2013.11.003; Burstein Jeffrey, 2008, J Oral Implantol, V34, P34, DOI 10.1563/1548-1336(2008)34[34:AITTIA]2.0.CO;2; CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X; Chaushu G, 2002, INT J ORAL MAX IMPL, V17, P413; Chrcanovic BR, 2014, J DENT RES, V93, P859, DOI 10.1177/0022034514538820; Chrcanovic BR, 2014, J ORAL REHABIL, V41, P443, DOI 10.1111/joor.12157; Coulthard P, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005293.pub2; Delcanho R, 2014, J AM DENT ASSOC, V145, P1268, DOI 10.14219/jada.2014.210; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellies L G, 1993, Int J Oral Maxillofac Implants, V8, P674; ELLIES LG, 1992, J PROSTHET DENT, V68, P664, DOI 10.1016/0022-3913(92)90384-M; Felice P, 2009, EUR J ORAL IMPLANTOL, V2, P267; Felice P, 2009, EUR J ORAL IMPLANTOL, V2, P7; Figgener L, 2004, INT J ORAL MAX IMPL, V19, P382; Frei C, 2004, CLIN ORAL IMPLAN RES, V15, P490, DOI 10.1111/j.1600-0501.2004.01032.x; FRIBERG B, 1992, International Journal of Oral and Maxillofacial Implants, V7, P80; Geckili O, 2011, QUINTESSENCE INT, V42, P721; Hegedus F, 2006, INT J ORAL MAX IMPL, V21, P111; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Johns R B, 1992, Int J Oral Maxillofac Implants, V7, P513; Juodzbalys Gintaras, 2013, J Oral Maxillofac Res, V4, pe2, DOI 10.5037/jomr.2013.4202; KIYAK H A, 1990, International Journal of Oral and Maxillofacial Implants, V5, P61; Klit H, 2014, PAIN, V155, P2699, DOI 10.1016/j.pain.2014.09.037; Kutuk N, 2013, J CRANIOFAC SURG, V24, pE405, DOI 10.1097/SCS.0b013e318292c7d5; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Mijiritsky E, 2013, IMPLANT DENT, V22, P394, DOI 10.1097/ID.0b013e31829afac0; Moher D, 2015, SYST REV, V4, DOI [10.1186/s13643-015-0087-2, 10.1186/2046-4053-4-1]; Neto PT, 2004, QUINTESSENCE INT, V35, P717; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Pabbidi RM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-9; Papaspyridakos P, 2012, J DENT RES, V91, P242, DOI 10.1177/0022034511431252; Poort LJ, 2009, J ORAL MAXIL SURG, V67, P292, DOI 10.1016/j.joms.2008.06.076; Porter Judith A, 2005, Gen Dent, V53, P423; Raghoebar GM, 2011, INT J ORAL MAX IMPL, V26, P607; Renton Tara, 2010, Dent Update, V37, P350; Seddon HJ, 1942, BRIT MED J, V1942, P237, DOI 10.1136/bmj.2.4260.237; Shavit Ilana, 2014, J Oral Maxillofac Res, V5, pe2, DOI 10.5037/jomr.2014.5402; Smith JG, 2013, J OROFAC PAIN, V27, P293, DOI 10.11607/jop.1056; Stellingsma C, 2004, CRIT REV ORAL BIOL M, V15, P240, DOI 10.1177/154411130401500406; T A, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X; van der Meij EH, 2005, INT J ORAL MAX SURG, V34, P152, DOI 10.1016/j.ijom.2004.05.007; van Steenberghe D, 1990, Int J Oral Maxillofac Implants, V5, P272; Vazquez L, 2008, CLIN ORAL IMPLAN RES, V19, P81, DOI 10.1111/j.1600-0501.2007.01402.x; Vetromilla BM, 2014, INT J ORAL MAX SURG, V43, P1360, DOI 10.1016/j.ijom.2014.07.010; Visser A, 2005, CLIN ORAL IMPLAN RES, V16, P19, DOI 10.1111/j.1600-0501.2004.01085.x; Walton JN, 2000, J PROSTHET DENT, V83, P443, DOI 10.1016/S0022-3913(00)70039-4; Wells G, 2000, NEWCASTLE OTTAWA SCA; Wismeijer D, 1997, BRIT J ORAL MAX SURG, V35, P254, DOI 10.1016/S0266-4356(97)90043-7; ZARB GA, 1990, J PROSTHET DENT, V64, P185, DOI 10.1016/0022-3913(90)90177-E	63	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154082	10.1371/journal.pone.0154082	http://dx.doi.org/10.1371/journal.pone.0154082			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100832	Green Published, gold			2022-12-27	WOS:000374898500139
J	Mohan, A; Singh, RS; Kumari, M; Garg, D; Upadhyay, A; Ecelbarger, CM; Tripathy, S; Tiwari, S				Mohan, Aradhana; Singh, Ravi Shankar; Kumari, Manju; Garg, Devika; Upadhyay, Aditya; Ecelbarger, Carolyn M.; Tripathy, Sucheta; Tiwari, Swasti			Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; MATRIX METALLOPROTEINASES; MESANGIAL CELLS; NONCODING RNAS; EXPRESSION; EXOSOMES/MICROVESICLES; PROLIFERATION; SEQUENCES; MIR-451; MIRNAS	Non-invasive renal signatures can help in serial monitoring of diabetic patients. We tested whether urinary exosomal (UE) microRNA (miR) analysis could non-invasively predict renal pathology in diabetic rats during the course of diabetes. Diabetes mellitus (DM) was induced in male Wistar rats by a single intraperitoneal injection of streptozotocin (STZ, 50 mg/kg body weight). Non-diabetic control (CTRL) rats were injected with vehicle. Insulin (INS) treatment (5U/d, s.c.) was provided to 50% of the DM rats. Urine samples were collected at weeks 3, 6, and 9 following injections and UE prepared. An increase in miR-451-5p and miR-16, observed by pilot small RNA sequencing of UE RNA, was confirmed by quantitative real-time polymerase chain reaction (qPCR) and selected for further study. Subsets of rats were euthanized after 3, 6, and 9 weeks of diabetes for renal pathology analysis, including determination of the tubulointerstitial fibrotic index (TFI) and glomerulosclerotic index (GI) scores. qPCR showed a substantial rise in miR-451-5p in UE from DM rats during the course of diabetes, with a significant rise (median fold change >1000) between 3 and 6 weeks. Moreover, UE miR-451-5p at 6 weeks predicted urine albumin at 9 weeks (r = 0.76). A delayed but significant rise was also observed for miR-16. In contrast, mean urine albumin only increased 21% between 3 and 6 weeks (non-significant rise), and renal TFI and GI were unchanged till 9 weeks. Renal expression of miR-451-5p and miR-16 (at 10 weeks) did not correlate with urine levels, and moreover, was negatively associated with indices of renal pathology (r >= -0.70, p = 0.005 for TFI and r >= -0.6, p <= 0.02 for GI). Overall, a relative elevation in renal miR-451-5p and miR-16 in diabetes appeared protective against diabetes-induced kidney fibrosis; while UE miR-451-5p may hold prognostic value as an early and sensitive non-invasive indicator of renal disease.	[Mohan, Aradhana; Singh, Ravi Shankar; Kumari, Manju; Garg, Devika; Upadhyay, Aditya; Tiwari, Swasti] Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, Lucknow, Uttar Pradesh, India; [Ecelbarger, Carolyn M.] Georgetown Univ, Dept Med, Washington, DC USA; [Tripathy, Sucheta] Indian Inst Chem Biol, CSIR, Struct Biol & Bioinformat Div, Kolkata, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Georgetown University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Tiwari, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, Lucknow, Uttar Pradesh, India.	tiwaris@sgpgi.ac.in	Tripathy, Sucheta/N-3097-2019; Singh, Ravi Shankar/ADM-2908-2022	Tripathy, Sucheta/0000-0003-0611-8088; Singh, Ravi Shankar/0000-0001-8698-4562	Department of Biotechnology, India [BT/PR2698/AGR/36/705/2011]; University Grant Commission, India [F 2-89/98]; Indian Council of Medical Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); University Grant Commission, India(University Grants Commission, India); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This work was supported by grant to S. Tiwari from Department of Biotechnology, India (BT/PR2698/AGR/36/705/2011) (http://www.dbtindia.nic.in/). AM was supported by a Senior Research Fellowship from University Grant Commission, India (F 2-89/98; SA I) (http://www.ugc.ac.in/). RSS was supported by a Senior Research Fellowship from Indian Council of Medical Research, India (http://www.icmr.nic.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur RB, 2010, NEPHROL DIAL TRANSPL, V25, P2866, DOI 10.1093/ndt/gfq258; Barutta F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073798; Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399; Chavali V, 2014, CELL BIOCHEM BIOPHYS, V68, P25, DOI 10.1007/s12013-013-9679-4; Chen YQ, 2012, J NEPHROL, V25, P566, DOI 10.5301/jn.5000034; Cheng L, 2014, KIDNEY INT, V86, P433, DOI 10.1038/ki.2013.502; Cheng YH, 2012, J MOL CELL CARDIOL, V53, P668, DOI 10.1016/j.yjmcc.2012.08.010; Ecelbarger CM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/841343; Gajdosik A, 1999, GEN PHYSIOL BIOPHYS, V18, P54; Gezer U, 2014, CELL BIOL INT, V38, P1076, DOI 10.1002/cbin.10301; Gits CMM, 2014, INT J CANCER, V135, P348, DOI 10.1002/ijc.28694; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; Hovind P, 2001, KIDNEY INT, V59, P702, DOI 10.1046/j.1523-1755.2001.059002702.x; Kalani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060177; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Klein Janet D, 2009, J Epithel Biol Pharmacol, V2, P23; Kort EJ, 2008, CANCER RES, V68, P4034, DOI 10.1158/0008-5472.CAN-08-0592; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SO, 2008, J CLIN INVEST, V118, P3714, DOI 10.1172/JCI34922; Li CL, 2006, J AM SOC NEPHROL, V17, P1657, DOI 10.1681/ASN.2005121381; Li HY, 2013, ASIAN PAC J CANCER P, V14, P3631, DOI 10.7314/APJCP.2013.14.6.3631; Li SY, 2014, KIDNEY INT, V86, P358, DOI 10.1038/ki.2014.67; Liang Y, 2015, CELL PHYSIOL BIOCHEM, V36, P1793, DOI 10.1159/000430151; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lv LL, 2013, INT J BIOL SCI, V9, P1021, DOI 10.7150/ijbs.6100; Maric C, 2004, J AM SOC NEPHROL, V15, P1546, DOI 10.1097/01.ASN.0000128219.65330.EA; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; Mohan A, 2015, J DIABETES METAB, V6, DOI 10.4172/2155-6156.1000510; Musante L, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00149; Pandey G, 2015, J BIOL CHEM, V290, P5582, DOI 10.1074/jbc.M114.592741; PARK IS, 1994, PANCREAS, V9, P566, DOI 10.1097/00006676-199409000-00005; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Rosenberger CM, 2012, J IMMUNOL, V189, P5965, DOI 10.4049/jimmunol.1201437; Sato-Kuwabara Y, 2015, INT J ONCOL, V46, P17, DOI 10.3892/ijo.2014.2712; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Sekiuchi M, 2012, CLIN EXP NEPHROL, V16, P863, DOI 10.1007/s10157-012-0633-3; SUZUKI D, 1995, DIABETES, V44, P1233, DOI 10.2337/diabetes.44.10.1233; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Tiwari S, 2013, J AM SOC NEPHROL, V24, P1209, DOI 10.1681/ASN.2012060628; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051140; Wu H, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/920134; Xu X, 2014, CURR MED CHEM, V21, P3244, DOI 10.2174/0929867321666140716092052; Zhang Z, 2012, FEBS LETT, V586, P20, DOI 10.1016/j.febslet.2011.07.042; Zhang Z, 2009, FEBS LETT, V583, P2009, DOI 10.1016/j.febslet.2009.05.021	57	58	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154055	10.1371/journal.pone.0154055	http://dx.doi.org/10.1371/journal.pone.0154055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101382	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500132
J	Tessem, MB; Bertilsson, H; Angelsen, A; Bathen, TF; Drablos, F; Rye, MB				Tessem, May-Britt; Bertilsson, Helena; Angelsen, Anders; Bathen, Tone F.; Drablos, Finn; Rye, Morten Beck			A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; INHIBITION; DECONVOLUTION; VALIDATION; DISCOVERY; ONCOGENE; SUBTYPES	Molecular analysis of patient tissue samples is essential to characterize the in vivo variability in human cancers which are not accessible in cell-lines or animal models. This applies particularly to studies of tumor metabolism. The challenge is, however, the complex mixture of various tissue types within each sample, such as benign epithelium, stroma and cancer tissue, which can introduce systematic biases when cancers are compared to normal samples. In this study we apply a simple strategy to remove such biases using sample selections where the average content of stroma tissue is balanced between the sample groups. The strategy is applied to a prostate cancer patient cohort where data from MR spectroscopy and gene expression have been collected from and integrated on the exact same tissue samples. We reveal in vivo changes in cancer-relevant metabolic pathways which are otherwise hidden in the data due to tissue confounding. In particular, lowered levels of putrescine are connected to increased expression of SRM, reduced levels of citrate are attributed to upregulation of genes promoting fatty acid synthesis, and increased succinate levels coincide with reduced expression of SUCLA2 and SDHD. In addition, the strategy also highlights important metabolic differences between the stroma, epithelium and prostate cancer. These results show that important in vivo metabolic features of cancer can be revealed from patient data only if the heterogeneous tissue composition is properly accounted for in the analysis.	[Tessem, May-Britt; Rye, Morten Beck] Univ Trondheim Hosp, St Olavs Hosp, Trondheim, Norway; [Tessem, May-Britt; Angelsen, Anders; Bathen, Tone F.] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, MI Lab, Trondheim, Norway; [Bertilsson, Helena; Drablos, Finn; Rye, Morten Beck] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Bertilsson, Helena; Angelsen, Anders] Univ Trondheim Hosp, St Olavs Hosp, Dept Urol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Rye, MB (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Trondheim, Norway.; Rye, MB (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway.	morten.rye@ntnu.no	Drablos, Finn/L-4970-2019	Drablos, Finn/0000-0001-5794-828X	Liaison Committee	Liaison Committee	This work was funded by research grants to MBR and MBT from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Bathen TF, 2010, CANCER RES, V70, P6692, DOI 10.1158/0008-5472.CAN-10-0437; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertilsson H, 2012, CLIN CANCER RES, V18, P3261, DOI 10.1158/1078-0432.CCR-11-2929; Bertilsson H, 2011, PROSTATE, V71, P461, DOI 10.1002/pros.21260; Bettuzzi S, 2000, CANCER RES, V60, P1472; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Forshell TP, 2010, CANCER PREV RES, V3, P140, DOI 10.1158/1940-6207.CAPR-09-0166; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Giskeodegard GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062375; Jia ZY, 2011, CANCER RES, V71, P2476, DOI 10.1158/0008-5472.CAN-10-2585; Keshari KR, 2013, PROSTATE, V73, P1171, DOI 10.1002/pros.22665; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Lahdesmaki H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-54; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Repsilber D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-27; Rhodes DR, 2002, CANCER RES, V62, P4427; Schoenborn JR, 2013, CLIN CANCER RES, V19, P4058, DOI 10.1158/1078-0432.CCR-12-3606; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soda K, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-95; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Swanson MG, 2003, MAGN RESON MED, V50, P944, DOI 10.1002/mrm.10614; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Valkenburg KC, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/895238; Venet D, 2001, Bioinformatics, V17 Suppl 1, pS279; Wang M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-328; Wang YP, 2010, CANCER RES, V70, P6448, DOI 10.1158/0008-5472.CAN-10-0021; Wu XY, 2014, AM J CLIN EXP UROL, V2, P111; Zhao YD, 2010, GENOME MED, V2, DOI 10.1186/gm214; Zhong Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-89	39	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153727	10.1371/journal.pone.0153727	http://dx.doi.org/10.1371/journal.pone.0153727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100877	gold, Green Published			2022-12-27	WOS:000374898500056
J	Xie, F; Zemlin, CW				Xie, Fei; Zemlin, Christian W.			Effect of Twisted Fiber Anisotropy in Cardiac Tissue on Ablation with Pulsed Electric Fields	PLOS ONE			English	Article							CATHETER ABLATION; ATRIAL-FIBRILLATION; LEFT-VENTRICLE; THERAPY; ELECTROPORATION; COMPLICATIONS; FEASIBILITY; ORIENTATION; PLATFORM; RABBIT	Background Ablation of cardiac tissue with pulsed electric fields is a promising alternative to current thermal ablation methods, and it critically depends on the electric field distribution in the heart. Methods We developed a model that incorporates the twisted anisotropy of cardiac tissue and computed the electric field distribution in the tissue. We also performed experiments in rabbit ventricles to validate our model. We find that the model agrees well with the experimentally determined ablation volume if we assume that all tissue that is exposed to a field greater than 3 kV/cm is ablated. In our numerical analysis, we considered how tissue thickness, degree of anisotropy, and electrode configuration affect the geometry of the ablated volume. We considered two electrode configurations: two parallel needles inserted into the myocardium ("penetrating needles" configuration) and one circular electrode each on epi- and endocardium, opposing each other ("epi-endo" configuration). Results For thick tissues (10 mm) and moderate anisotropy ratio (a = 2), we find that the geometry of the ablated volume is almost unaffected by twisted anisotropy, i.e. it is approximately translationally symmetric from epi- to endocardium, for both electrode configurations. Higher anisotropy ratio (a = 10) leads to substantial variation in ablation width across the wall; these variations were more pronounced for the penetrating needle configuration than for the epi- endo configuration. For thinner tissues (4 mm, typical for human atria) and higher anisotropy ratio (a = 10), the epi- endo configuration yielded approximately translationally symmetric ablation volumes, while the penetrating electrodes configuration was much more sensitive to fiber twist. Conclusions These results suggest that the epi-endo configuration will be reliable for ablation of atrial fibrillation, independently of fiber orientation, while the penetrating electrode configuration may experience problems when the fiber orientation is not consistent across the atrial wall.	[Xie, Fei; Zemlin, Christian W.] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA USA; [Xie, Fei; Zemlin, Christian W.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA	Old Dominion University; Old Dominion University	Zemlin, CW (corresponding author), Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA USA.; Zemlin, CW (corresponding author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA.	czemlin@odu.edu						Arena CB, 2012, BIOPHYS J, V103, P2033, DOI 10.1016/j.bpj.2012.09.017; Beebe SJ, 2011, IEEE ENG MED BIO, P6861, DOI 10.1109/IEMBS.2011.6091692; Bello O, 2009, AFRICAN J PHYS SCI, V2; Bertaglia E, 2007, HEART RHYTHM, V4, P1265, DOI 10.1016/j.hrthm.2007.06.016; Bishop MJ, 2011, IEEE T BIO-MED ENG, V58, P1066, DOI 10.1109/TBME.2010.2096425; Chen X, 2012, TECHNOL CANCER RES T, V11, P83, DOI 10.7785/tcrt.2012.500237; Chen XH, 2010, PIGM CELL MELANOMA R, V23, P554, DOI 10.1111/j.1755-148X.2010.00704.x; Colman MA, 2014, EUROPACE, V16, P416, DOI 10.1093/europace/eut349; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Healy LJ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-74; Ho SY, 2002, CARDIOVASC RES, V54, P325, DOI 10.1016/S0008-6363(02)00226-2; Kearney K, 2014, ANN CARDIOTHORAC SUR, V3, P15, DOI 10.3978/j.issn.2225-319X.2014.01.03; Khan AR, 2014, CIRC-ARRHYTHMIA ELEC, V7, P853, DOI 10.1161/CIRCEP.114.001853; Kim DH, 2012, P NATL ACAD SCI USA, V109, P19910, DOI 10.1073/pnas.1205923109; Lavee J, 2007, HEART SURG FORUM, V10, pE162, DOI 10.1532/HSF98.20061202; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; Mankowski J, 2000, IEEE T PLASMA SCI, V28, P102, DOI 10.1109/27.842875; Neven K, 2014, CIRC-ARRHYTHMIA ELEC, V7, P913, DOI 10.1161/CIRCEP.114.001607; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Pravdin SF, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-54; Santangeli P, 2014, CIRC-ARRHYTHMIA ELEC, V7, P739, DOI 10.1161/CIRCEP.113.000629; Schwab BC, 2013, IEEE T MED IMAGING, V32, P862, DOI 10.1109/TMI.2013.2240693; Seemann G., 2006, COMP CARDIOL, V33, P801; SEGAL SS, 1986, AM J PHYSIOL, V250, pC474, DOI 10.1152/ajpcell.1986.250.3.C474; Spragg DD, 2008, J CARDIOVASC ELECTR, V19, P627, DOI 10.1111/j.1540-8167.2008.01181.x; STREETER D, 1979, HDB PHYSL; STREETER DD, 1966, ANAT REC, V155, P503, DOI 10.1002/ar.1091550403; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; Thiriet M, 2015, DIS CARDIAC PUMP; Wang YT, 2012, AM J PHYSIOL-HEART C, V303, pH439, DOI 10.1152/ajpheart.01121.2011; Winkle RA, 2014, HEART RHYTHM, V11, P963, DOI 10.1016/j.hrthm.2014.03.013; Wittkampf FH, 2011, J CARDIOVASC ELECTR, V22, P302, DOI 10.1111/j.1540-8167.2010.01863.x; Xie F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144833; Zhao JC, 2015, INT J MOL SCI, V16, P10834, DOI 10.3390/ijms160510834; Zhao JC, 2013, IEEE T MED IMAGING, V32, P18, DOI 10.1109/TMI.2012.2227776	36	13	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152262	10.1371/journal.pone.0152262	http://dx.doi.org/10.1371/journal.pone.0152262			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101250	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500011
J	Andersen, T; Baranov, V; Hagenlund, LK; Ivkovic, M; Kvifte, GM; Pavlek, M				Andersen, Trond; Baranov, Viktor; Hagenlund, Linn Katrine; Ivkovic, Marija; Kvifte, Gunnar Mikalsen; Pavlek, Martina			Blind Flight? A New Troglobiotic Orthoclad (Diptera, Chironomidae) from the Lukina Jama - Trojama Cave in Croatia	PLOS ONE			English	Article							BLOCKS; SYSTEM	The genus Troglocladius Andersen, Baranov et Hagenlund, gen. n. is erected based on T. hajdi Andersen, Baranov et Hagenlund, sp. n. collected at 980 m depth in the Lukina jama-Trojama cave system in Croatia. Morphological features such as pale color, strongly reduced eyes and very long legs make it a typical cave animal. Surprisingly, it has also retained large wings and appears to be capable of flight which would make T. hajdi the first flying troglobiont worldwide, disproving previous beliefs that bats are the only animals capable of flying in complete darkness. Morphologically the new species does not readily fit within any described genus, but shares characteristics with genera both in the tribes "Metriocnemini" and "Orthocladiini". Bayesian molecular phylogenetic analysis using the markers COI, 18S rDNAs, 28S rDNA, CADI, and CADIV groups it with the genera Tvetenia, Cardiocladius and Eukiefferiella in the tribe "Metriocnemini". Troglocladius hajdi may be parthenogenetic, as only females were collected. The discovery confirms the position of the Dinaric arch as a highly important hotspot of subterranean biodiversity.	[Andersen, Trond; Hagenlund, Linn Katrine; Kvifte, Gunnar Mikalsen] Univ Bergen, Univ Museum Bergen, Dept Nat Hist, Bergen, Norway; [Baranov, Viktor] Lebniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Ivkovic, Marija] Univ Zagreb, Fac Sci, Div Biol, Dept Zool, Zagreb 41000, Croatia; [Kvifte, Gunnar Mikalsen] Univ Kassel, Inst Biol, Dept Zool, D-34125 Kassel, Germany; [Pavlek, Martina] Rudjer Boskovic Inst, Zagreb, Croatia; [Pavlek, Martina] Croatian Biospeleol Soc, Zagreb, Croatia	University of Bergen; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Zagreb; Universitat Kassel; Rudjer Boskovic Institute	Hagenlund, LK (corresponding author), Univ Bergen, Univ Museum Bergen, Dept Nat Hist, Bergen, Norway.	linn.hagenlund@uib.no	Pavlek, Martina/AAD-9359-2019; Baranov, Viktor/H-5733-2019; Ivković, Marija/AAB-1756-2020	Baranov, Viktor/0000-0003-1893-3215; Ivkovic, Marija/0000-0003-3188-5676; Kvifte, Gunnar Mikalsen/0000-0002-3210-5857; Pavlek, Martina/0000-0001-6710-0581				Armitage P.D., 1995, P194; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Copeland RS, 2011, AFR INVERTEBR, V52, P363, DOI 10.5733/afin.052.0211; Cranston P., 1985, BRIT ANTARCTIC SURVE, V66, P35; Cranston PS, 2012, SYST ENTOMOL, V37, P172, DOI 10.1111/j.1365-3113.2011.00603.x; Cukovic T, 2014, SUBTERRANEA CROATICA, V16, P13; Donato M, 2008, AQUAT INSECT, V30, P51, DOI 10.1080/01650420701829633; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FREEMAN PAUL, 1962, PACIFIC INSECTS, V4, P129; Gibert J, 2012, ENCY CAVES, P219; Gunn J, 2000, AQUAT CONSERV, V10, P353, DOI 10.1002/1099-0755(200009/10)10:5<353::AID-AQC413>3.0.CO;2-S; Juberthie C., 1994, ENCY BIOSPEOLOGICA, VI; Matile Loic, 1994, P341; Paar D, 2013, P 16 INT C SPEL, V2, P442; PECK SB, 1988, CAN J ZOOL, V66, P1197, DOI 10.1139/z88-176; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pricop Emilian, 2009, ELBA Bioflux, V1, P41; Reeves Will K., 2000, Journal of the Elisha Mitchell Scientific Society, V116, P334; Reeves Will K., 2000, Journal of Cave and Karst Studies, V62, P169; Rohacek J., 2000, Annales Historico-Naturales Musei Nationalis Hungarici, V92, P215; Rohacek Jindrich, 2014, Casopis Slezskeho Zemskeho Muzea Serie A Vedy Prirodni, V63, P97; Saether O. A., 1969, Bulletin Fisheries Research Board of Canada, V170, P1; Saether O.A., 1977, B FISHERIES RES BOAR, V197, P1, DOI DOI 10.11646/ZOOTAXA.1806.1.1; Saether O. A., 1980, ENTOMOL SCAND, V14, P1; Saether OA, 2011, ZOOTAXA, P1; Sket B, 2004, BALKAN BIODIVERSITY: PATTERN AND PROCESS IN THE EUROPEAN HOTSPOT, P309; Sket B, 2001, ZOOL SCR, V30, P223, DOI 10.1046/j.1463-6409.2001.00065.x; Sket B., 2012, ENCY CAVES, P228, DOI [DOI 10.1016/B978-0-12-383832-2.00031-1, 10.1016/b978-0-12-383832-2.00031-1]; Sket B, 2008, J NAT HIST, V42, P1549, DOI 10.1080/00222930801995762; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trajano Eleonora, 1992, Revista Brasileira de Zoologia, V7, P383, DOI 10.1590/S0101-81751990000300017; Vandel A, 1966, BIOSPELEOLOGY BIOL C; Weber D, 2013, HOHLENFAUNA LUXEMBUR, V69; Weigand Alexander M., 2013, Subterranean Biology, V11, P45, DOI 10.3897/subtbiol.11.5966; Zavrel Jan, 1943, ARCH HYDRO BIOL, V40, P250	38	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152884	10.1371/journal.pone.0152884	http://dx.doi.org/10.1371/journal.pone.0152884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119557	Green Published, gold			2022-12-27	WOS:000374976200013
J	Witkowski, O; Ikegami, T				Witkowski, Olaf; Ikegami, Takashi			Emergence of Swarming Behavior: Foraging Agents Evolve Collective Motion Based on Signaling	PLOS ONE			English	Article							SYSTEM	Swarming behavior is common in biology, from cell colonies to insect swarms and bird flocks. However, the conditions leading to the emergence of such behavior are still subject to research. Since Reynolds' boids, many artificial models have reproduced swarming behavior, focusing on details ranging from obstacle avoidance to the introduction of fixed leaders. This paper presents a model of evolved artificial agents, able to develop swarming using only their ability to listen to each other's signals. The model simulates a population of agents looking for a vital resource they cannot directly detect, in a 3D environment. Instead of a centralized algorithm, each agent is controlled by an artificial neural network, whose weights are encoded in a genotype and adapted by an original asynchronous genetic algorithm. The results demonstrate that agents progressively evolve the ability to use the information exchanged between each other via signaling to establish temporary leader-follower relations. These relations allow agents to form swarming patterns, emerging as a transient behavior that improves the agents' ability to forage for the resource. Once they have acquired the ability to swarm, the individuals are able to outperform the non-swarmers at finding the resource. The population hence reaches a neutral evolutionary space which leads to a genetic drift of the genotypes. This reductionist approach to signal-based swarming not only contributes to shed light on the minimal conditions for the evolution of a swarming behavior, but also more generally it exemplifies the effect communication can have on optimal search patterns in collective groups of individuals.	[Witkowski, Olaf; Ikegami, Takashi] Univ Tokyo, Dept Interdisciplinary Studies, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan; [Witkowski, Olaf] Tokyo Inst Technol, ELSI Origins Network, Earth Life Sci Inst, 2-12-1-IE-1 Ookayama, Tokyo 1528550, Japan	University of Tokyo; Tokyo Institute of Technology	Witkowski, O (corresponding author), Univ Tokyo, Dept Interdisciplinary Studies, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.; Witkowski, O (corresponding author), Tokyo Inst Technol, ELSI Origins Network, Earth Life Sci Inst, 2-12-1-IE-1 Ookayama, Tokyo 1528550, Japan.	olaf@sacral.c.u-tokyo.ac.jp	Witkowski, Olaf/AGP-5019-2022	Witkowski, Olaf/0000-0002-2101-2428				Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Berdahl A, 2016, FISH FISH, V17, P525, DOI 10.1111/faf.12084; Blondel VD, 2005, IEEE DECIS CONTR P, P2996; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Bremermann HJ, 1962, SELF ORG SYSTEMS, P93; BUDRENE EO, 1991, NATURE, V349, P630, DOI 10.1038/349630a0; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Cucker F., 2008, MATHS ACTION, V1, P1, DOI DOI 10.5802/MSIA.1; Czirok A., 1997, CONDMAT9712154 ARXIV; D'Orsogna MR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.104302; Eberhart R., 1995, P 6 INT S MICR MACH, P39; FRASER A. S., 1960, AUSTRALIAN JOUR BIOL SCI, V13, P344; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; Haldane J. B. S., 1990, CAUSES EVOLUTION; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hartman C, 2006, COMPUT ANIMAT VIRT W, V17, P199, DOI 10.1002/cav.123; Hidalgo J, 2014, P NATL ACAD SCI USA, V111, P10095, DOI 10.1073/pnas.1319166111; Holland J.H., 1975, ADAPTATION NATURAL A; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Lizier JT, 2011, J COMPUT NEUROSCI, V30, P85, DOI 10.1007/s10827-010-0271-2; MATARIC MJ, 1992, IEEE T ROBOTIC AUTOM, V8, P304, DOI 10.1109/70.143349; Mueller T, 2013, SCIENCE, V341, P999, DOI 10.1126/science.1237139; Nishimura Shin I., 1997, Artificial Life, V3, P243, DOI 10.1162/artl.1997.3.4.243; Olson RS, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0305; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; PARTRIDGE BL, 1982, SCI AM, V246, P114, DOI 10.1038/scientificamerican0682-114; Pearson K, 1901, LONDON EDINBURGH DUB, V6, P559, DOI [10.1080/14786440109462720, DOI 10.1080/14786440109462720]; PITCHER TJ, 1979, MAR BIOL, V54, P383, DOI 10.1007/BF00395444; Polin M, 2009, SCIENCE, V325, P487, DOI 10.1126/science.1172667; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Sayama H, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P577, DOI 10.1145/2330163.2330245; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shimoyama N, 1996, PHYS REV LETT, V76, P3870, DOI 10.1103/PhysRevLett.76.3870; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Su HS, 2009, IEEE T AUTOMAT CONTR, V54, P293, DOI 10.1109/TAC.2008.2010897; Syswerda G., 1991, FDN GENETIC ALGORITH, V1, P94, DOI DOI 10.1016/B978-0-08-050684-5.50009-4; Torney CJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002194; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Ward CR, 2001, ARTIF LIFE, V7, P191, DOI 10.1162/106454601753139005; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Wright S ., 1932, ROLES MUTATION INBRE, V1; Xiaoyuan Tu, 1994, Computer Graphics Proceedings. Annual Conference Series 1994. SIGGRAPH 94 Conference Proceedings, P43; Yu WW, 2010, SYST CONTROL LETT, V59, P543, DOI 10.1016/j.sysconle.2010.06.014; Zaera N., 1996, P INT C SIM AD BEH C	50	20	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152756	10.1371/journal.pone.0152756	http://dx.doi.org/10.1371/journal.pone.0152756			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119340	gold, Green Submitted, Green Published			2022-12-27	WOS:000374976200011
J	Brencic, M				Brencic, Mihael			Statistical Analysis of Categorical Time Series of Atmospheric Elementary Circulation Mechanisms - Dzerdzeevski Classification for the Northern Hemisphere	PLOS ONE			English	Article							PATTERNS	Northern hemisphere elementary circulation mechanisms, defined with the Dzerdzeevski classification and published on a daily basis from 1899-2012, are analysed with statistical methods as continuous categorical time series. Classification consists of 41 elementary circulation mechanisms (ECM), which are assigned to calendar days. Empirical marginal probabilities of each ECM were determined. Seasonality and the periodicity effect were investigated with moving dispersion filters and randomisation procedure on the ECM categories as well as with the time analyses of the ECM mode. The time series were determined as being non-stationary with strong time-dependent trends. During the investigated period, periodicity interchanges with periods when no seasonality is present. In the time series structure, the strongest division is visible at the milestone of 1986, showing that the atmospheric circulation pattern reflected in the ECM has significantly changed. This change is result of the change in the frequency of ECM categories; before 1986, the appearance of ECM was more diverse, and afterwards fewer ECMs appear. The statistical approach applied to the categorical climatic time series opens up new potential insight into climate variability and change studies that have to be performed in the future.	[Brencic, Mihael] Univ Ljubljana, Fac Nat Sci & Engn, Dept Geol, Ljubljana, Slovenia; [Brencic, Mihael] Geol Survey Slovenia, Ljubljana, Slovenia	University of Ljubljana	Brencic, M (corresponding author), Univ Ljubljana, Fac Nat Sci & Engn, Dept Geol, Ljubljana, Slovenia.; Brencic, M (corresponding author), Geol Survey Slovenia, Ljubljana, Slovenia.	mihael.brencic@ntf.uni-lj.si			research programme "Groundwater and Geochemistry" of the Geological Survey of Slovenia of Republic of Slovenia [P 0020]; Slovenia Federation [BI-RU/12-13-024, BI-RU/14-15-040]; Russia Federation [BI-RU/12-13-024, BI-RU/14-15-040]; Slovenian Research Agency	research programme "Groundwater and Geochemistry" of the Geological Survey of Slovenia of Republic of Slovenia; Slovenia Federation; Russia Federation; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The results were obtained through the research programme "Groundwater and Geochemistry" (P 0020) of the Geological Survey of Slovenia of Republic of Slovenia and through the bilateral project between Slovenia and Russia Federation BI-RU/12-13-024 and BI-RU/14-15-040 lead by Polona Vreca - Jozef Stefan Institute. All activities were financially supported by the Slovenian Research Agency.	Brencic M., ACTA GEOPHY IN PRESS; Brencic M, 2015, J HYDROL, V529, P1422, DOI 10.1016/j.jhydrol.2015.08.040; DZERDZEEVSKII B, 1962, TELLUS, V14, P328; Dzerdzeevskii BL, 1946, CLASSIFICATION CIRCU; Girs AA, 1972, MACROCIRCULATION MET; Huth R, 2008, ANN NY ACAD SCI, V1146, P105, DOI 10.1196/annals.1446.019; Johnson NL, 1994, CONTINOUS UNIVARIATE, V1; Kader GD, 2007, J STAT EDUC, V15, DOI 10.1080/10691898.2007.11889465; Kononova N, 2013, NO HEMISPHERE ATMOSP; Kononova N.K., 2009, CLASSIFICATION CIRCU; Kononova Nina, 2010, [Geography, Environment, Sustainability, Geography, Environment, Sustainability], V3, P25; R Core Team, LANG ENV STAT COMP; Sepp M, 2002, BOREAL ENVIRON RES, V7, P273; Stanojevic G, 2010, J GEOGR INST JOVAN C, V60, P27, DOI 10.2298/IJGI1002027S; SWANSON DA, 1976, SOC FORCES, V55, P182, DOI 10.2307/2577102; Wei&beta;, 2009, CATEGORICAL TIME SER; Wei8 CH, 2008, STAT METHODOL, V5, P56, DOI [10.1016/j.stamet.2007.05.001, DOI 10.1016/J.STAMET.2007.05.001]; Weiss CH, 2008, ASTA-ADV STAT ANAL, V92, P71, DOI 10.1007/s10182-008-0055-4; Wilks A. A., 1995, STAT METHODS ATMOSPH	19	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154368	10.1371/journal.pone.0154368	http://dx.doi.org/10.1371/journal.pone.0154368			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116375	gold, Green Published, Green Submitted			2022-12-27	WOS:000374973600063
J	Ning, X; Zhang, T; Wu, YF; Zhang, PH; Zhang, JW; Li, S; Yue, XK; Yuan, JP				Ning, Xin; Zhang, Teng; Wu, Yaofa; Zhang, Pihui; Zhang, Jiawei; Li, Shuai; Yue, Xiaokui; Yuan, Jianping			Coordinated Parameter Identification Technique for the Inertial Parameters of Non-Cooperative Target	PLOS ONE			English	Article								Space operations will be the main space missions in the future. This paper focuses on the precise operations for non-cooperative target, and researches of coordinated parameter identification (CPI) which allows the motion of multi- joints. The contents of this paper are organized: (1) Summarize the inertial parameters identification techniques which have been conducted now, and the technique based on momentum conservation is selected for reliability and realizability; (2) Elaborate the basic principles and primary algorithm of coordinated parameter identification, and analyze some special problems in calculation (3) Numerical simulation of coordinated identification technique by an case study on non-cooperative target of spacecraft mounting dual-arm with six joints is done. The results show that the coordinated parameter identification technique could get all the inertial parameters of the target in 3D by one-time identification, and does not need special configuration or driven joints, moreover the results are highly precise and save much more time than traditional ones.	[Ning, Xin; Zhang, Teng; Wu, Yaofa; Zhang, Pihui; Zhang, Jiawei; Li, Shuai; Yue, Xiaokui; Yuan, Jianping] Northwestern Polytech Univ, Coll Astronaut, Xian 710072, Shaan Xi, Peoples R China; [Ning, Xin] Univ Calgary, Dept Mech & Mfg Engn, Schulich Sch Engn, Calgary, AB, Canada	Northwestern Polytechnical University; University of Calgary	Ning, X (corresponding author), Northwestern Polytech Univ, Coll Astronaut, Xian 710072, Shaan Xi, Peoples R China.; Ning, X (corresponding author), Univ Calgary, Dept Mech & Mfg Engn, Schulich Sch Engn, Calgary, AB, Canada.	ning_nwpu@126.com			National Science Foundation of China [11402200]; Key Laboratory of Precision Navigation and Timing Technology [2014PNTT02]; Fundamental Research Funds for the Central Universities; China Aerospace Science and Industry Corporation [2015-HT-XGD]; China Aerospace Science and Technology Corporation [GSR1572001]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Precision Navigation and Timing Technology; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Aerospace Science and Industry Corporation; China Aerospace Science and Technology Corporation	The authors are grateful for the support and funding from National Science Foundation of China (No. 11402200, XN); Open Fund of Key Laboratory of Precision Navigation and Timing Technology (No. 2014PNTT02, XN); Fundamental Research Funds for the Central Universities; Space Supporting Fund from China Aerospace Science and Industry Corporation (No. 2015-HT-XGD, XN); Innovation Fund from China Aerospace Science and Technology Corporation (No. GSR1572001, XN).	Chen E-W, 2006, 2006 IEEE INT C IEEE; [干方建 Gan Fangjian], 2002, [中国科学技术大学学报, Journal of University of Science and Technology of China], V32, P353; Goncalves J., 2002, Computer Assisted Mechanics and Engineering Sciences, V9, P373; MUROTSU Y, 1994, J GUID CONTROL DYNAM, V17, P488, DOI 10.2514/3.21225; Sun G. Q., 2015, SCI REPORTS, V5; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Nguyen-Huynh TC, 2013, J GUID CONTROL DYNAM, V36, P404, DOI 10.2514/1.57856; Nguyen-Huynh TC, 2011, IEEE INT CONF ROBOT; Yoshida K, 2000, ROBOTICS RESEARCH, P449; Yoshida K., 2002, P AIAA GUID NAV CONT	11	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153604	10.1371/journal.pone.0153604	http://dx.doi.org/10.1371/journal.pone.0153604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116187	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600025
J	Matthews, LJ; Passmore, S; Richard, PM; Gray, RD; Atkinson, QD				Matthews, Luke J.; Passmore, Sam; Richard, Paul M.; Gray, Russell D.; Atkinson, Quentin D.			Shared Cultural History as a Predictor of Political and Economic Changes among Nation States	PLOS ONE			English	Article							NETWORK AUTOCORRELATION; EVOLUTION; EXPANSION; DIFFUSION; SUPPORT	Political and economic risks arise from social phenomena that spread within and across countries. Regime changes, protest movements, and stock market and default shocks can have ramifications across the globe. Quantitative models have made great strides at predicting these events in recent decades but incorporate few explicitly measured cultural variables. However, in recent years cultural evolutionary theory has emerged as a major paradigm to understand the inheritance and diffusion of human cultural variation. Here, we combine these two strands of research by proposing that measures of socio-linguistic affiliation derived from language phylogenies track variation in cultural norms that influence how political and economic changes diffuse across the globe. First, we show that changes over time in a country's democratic or autocratic character correlate with simultaneous changes among their socio-linguistic affiliations more than with changes of spatially proximate countries. Second, we find that models of changes in sovereign default status favor including socio-linguistic affiliations in addition to spatial data. These findings suggest that better measurement of cultural networks could be profoundly useful to policy makers who wish to diversify commercial, social, and other forms of investment across political and economic risks on an international scale.	[Matthews, Luke J.] RAND Corp, 20 Pk Plaza,Suite 920, Boston, MA 02116 USA; [Passmore, Sam; Gray, Russell D.; Atkinson, Quentin D.] Univ Auckland, Sch Psychol, Private Bag 92019, Auckland 1142, New Zealand; [Matthews, Luke J.; Richard, Paul M.] Activate Networks Inc, 1 Newton Execut Pk,Suite 100, Newton, MA 02462 USA; [Gray, Russell D.; Atkinson, Quentin D.] Max Planck Inst Sci Human Hist, Kahlaische Str 10, D-07745 Jena, Germany	RAND Corporation; University of Auckland	Matthews, LJ (corresponding author), RAND Corp, 20 Pk Plaza,Suite 920, Boston, MA 02116 USA.; Matthews, LJ (corresponding author), Activate Networks Inc, 1 Newton Execut Pk,Suite 100, Newton, MA 02462 USA.	lmatthew@rand.org	Passmore, Sam/Q-6645-2019	Passmore, Sam/0000-0002-5302-356X; Atkinson, Quentin/0000-0002-8499-7535	Rutherford Discovery Fellowship [RDF-UOA1101]; Activate Networks, Inc.	Rutherford Discovery Fellowship; Activate Networks, Inc.	QDA and SP were supported by a Rutherford Discovery Fellowship (RDF-UOA1101) to QDA. Activate Networks, Inc. provided support in the form of salaries for authors [LJM, PMR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acemoglu D., 2012, FOREIGN POLICY, P85; Asgharian H, 2013, J BANK FINANC, V37, P4738, DOI 10.1016/j.jbankfin.2013.08.015; Atkinson QD, 2005, SYST BIOL, V54, P513, DOI 10.1080/10635150590950317; Atkinson QD, 2008, SCIENCE, V319, P588, DOI 10.1126/science.1149683; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Bowern C, 2012, LANGUAGE, V88, P817, DOI 10.1353/lan.2012.0081; Butts CT, 2010, SNA TOOLS SCIAL NETW; Central Intelligence Agency (CIA), 2013, WORLD FACTB 2013 201; Ciccarelli M, 2013, PANEL VECTO IN PRESS; Collard M, 2006, EVOL HUM BEHAV, V27, P169, DOI 10.1016/j.evolhumbehav.2005.07.003; Collier D., 2010, RETHINKING SOCIAL IN; Corrado L, 2011, IS EC SPATIAL ECONOM; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; Dow MM, 2007, CROSS-CULT RES, V41, P336, DOI 10.1177/1069397107305452; Felsenstein D, 2007, SPAT ECON ANAL, V2, P1742; Gachter S, CUTURE COOPERATIONS; Goldstone JA, 2008, USING QUANTITATIVE Q; Goldstone JA, 2010, AM J POLIT SCI, V54, P190, DOI 10.1111/j.1540-5907.2009.00426.x; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Gray RD, 2005, SCIENCE, V209, P307; Grollemund R, 2015, P NATL ACAD SCI USA, V112, P13296, DOI 10.1073/pnas.1503793112; Hasegawa T, 2011, P ROYAL SOC B; HEAGERTY P, 2002, POLITICAL, V0010; Henisz WJ, 2009, NETWORK CHALLENGE ST, P433; Honkola T, 2013, J EVOLUTION BIOL, V26, P1244, DOI 10.1111/jeb.12107; Hoti S., 2003, INT COUNTRY IN PRESS; HUNTINGTON SP, 1993, FOREIGN AFF, V72, P22, DOI 10.2307/20045621; Jordan FM, 2011, PHILOS T ROYAL SOC B; Jordan FM, 2009, P ROYAL SOC B; Kalinina OI, 2013, SOVEREIGN GOVT RATIN; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; King G, 2001, WORLD POLIT, V53, P623, DOI 10.1353/wp.2001.0018; Kitchen A, 2009, P BIOL SCI; Leenders RTAJ, 2002, SOC NETWORKS, V24, P21, DOI 10.1016/S0378-8733(01)00049-1; Mace R, 2005, TRENDS ECOL EVOL, V20, P116, DOI 10.1016/j.tree.2004.12.002; Marshall M., 2014, POLITY 4 REGIME TREN; Matthews LJ, 2011, PLOSONE; Matthews LJ, 2012, HUM NATURE-INT BIOS, V23, P218, DOI 10.1007/s12110-012-9138-8; Matthews LJ, 2011, AM J PHYS ANTHROPOL, V145, P382, DOI 10.1002/ajpa.21507; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mesoudi A, 2004, EVOLUTION, V58, P1; Mesoudi A, 2006, BEHAV BRAIN SCI, V29, P329, DOI 10.1017/S0140525X06009083; Miguel E, 2008, 13968 NBER; Mizruchi MS, 2008, SOC NETWORKS, V30, P190, DOI 10.1016/j.socnet.2008.02.002; Neuman EJ, 2010, SOC NETWORKS, V32, P290, DOI 10.1016/j.socnet.2010.04.003; O'Brien SP, 2010, INT STUD REV, V12, P87, DOI 10.1111/j.1468-2486.2009.00914.x; O'Loughlin J, 1998, ANN ASSOC AM GEOGR, V88, P545, DOI 10.1111/0004-5608.00112; O'Malley AJ, 2008, HEALTH SERV OUTCOME, V8, P222, DOI 10.1007/s10742-008-0041-z; Pagel M, 2004, NATURE, V428, P275, DOI 10.1038/428275a; Pagel M, 2009, NAT REV GENET, V10, P405, DOI 10.1038/nrg2560; Reinhart CM, 2011, AM ECON REV, V101, P1676, DOI 10.1257/aer.101.5.1676; Rogoff KS, NBER WORKING PAPER S, V2008; Rohlf FJ, 2006, EVOLUTION, V60, P1509, DOI 10.1111/j.0014-3820.2006.tb01229.x; Ross Malcolm D., 1996, COMP METHOD REV REGU, p180 217; Schrodt PA, 2014, J PEACE RES, V51, P287, DOI 10.1177/0022343313499597; Serra D, 2006, PUBLIC CHOICE, V126, P225, DOI 10.1007/s11127-006-0286-4; Spolaore E, 2013, J ECON LIT, V51, P325, DOI 10.1257/jel.51.2.325; Spolaore E, 2009, Q J ECON, V124, P469, DOI 10.1162/qjec.2009.124.2.469; State B, 2013, MESH CIVILI IN PRESS; Takhteyev Y, 2012, SOC NETWORKS, V34, P73, DOI 10.1016/j.socnet.2011.05.006; TEAM RC, 2010, R LANG ENV STAT COMP; Thurston W. R., 1989, VICAL, P555; Turchin P, 2013, P NATL ACAD SCI USA, V110, P16384, DOI 10.1073/pnas.1308825110; Venables WN, 2002, MODERN APPL STAT S, V4th, P211, DOI [10.1007/978-0-387-21706-2_8, DOI 10.1007/978-0-387-21706-2]; Walker RS, 2011, P ROY SOC B-BIOL SCI, V278, P2562, DOI 10.1098/rspb.2010.2579; Wallerstein I., 1974, MODERN WORLD SYSTEM; Ward M.D., 2008, SPATIAL REGRESSION M; WARD MD, 2002, POLITICAL, V0010; Ward MD, 2012, LEARNING ST IN PRESS; Ward MD, 2010, J PEACE RES, V47, P363, DOI 10.1177/0022343309356491; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	73	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152979	10.1371/journal.pone.0152979	http://dx.doi.org/10.1371/journal.pone.0152979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DK5OX	27110713	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600007
J	Wigg, S; Stafford, LD				Wigg, Sophie; Stafford, Lorenzo D.			Health Warnings on Alcoholic Beverages: Perceptions of the Health Risks and Intentions towards Alcohol Consumption	PLOS ONE			English	Article							PICTORIAL WARNINGS; FEAR APPEALS; LABELS; IMPACT	Objectives Research has demonstrated that packaging which includes pictorial health warnings are more effective in altering smokers' perceptions and intentions as well as changing smoking behaviours compared to text-only health warnings. However, very few studies have investigated the effectiveness of health warnings on alcoholic beverages Methods Participants (N = 60) viewed alcoholic beverages presenting one of three health warnings (No health warning, Text-only, Pictorial) and then responded to questions relating to level of fear arousal and their perceptions toward alcohol use. Results We found that pictorial health warnings were associated with significantly higher fear arousal, increased perceptions of the health risks of consuming alcohol as well as greater intentions to reduce and quit alcohol consumption compared to the control. Conclusions These novel findings suggest pictorial health warnings on alcoholic beverages may be an important way of making the public aware of the health risks of alcohol consumption.	[Wigg, Sophie; Stafford, Lorenzo D.] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England	University of Portsmouth	Stafford, LD (corresponding author), Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England.	lorenzo.Stafford@port.ac.uk		Stafford, Lorenzo Dante/0000-0002-8791-204X				Al-hamdani M, 2015, CANADIAN J PUBLIC HL, V106; [Anonymous], 2012, UK GOVT ALCOHOL STRA; Borland R, 2009, ADDICTION, V104, P669, DOI 10.1111/j.1360-0443.2009.02508.x; de Hoog N, 2007, REV GEN PSYCHOL, V11, P258, DOI 10.1037/1089-2680.11.3.258; Faculty of Public Health, 2008, ALC PUBL HLTH 2008; Glock S, 2013, APPL PSYCHOL-HLTH WE, V5, P332, DOI 10.1111/aphw.12013; Goodall C, 2008, HEALTH COMMUN, V23, P117, DOI 10.1080/10410230801967825; Hammond D, 2004, AM J PUBLIC HEALTH, V94, P1442, DOI 10.2105/AJPH.94.8.1442; Hammond D, 2003, TOB CONTROL, V12, P391, DOI 10.1136/tc.12.4.391; Hammond D, 2011, TOBACCO CONTROL; Health Canada. Tandemar Research Inc, 1996, CIG PACK STUD EV NEW; Hitchman SC, 2013, NICOTINE TOB RES; International Center for Alcohol Policies (ICAP), 2011, HLTH WARN LAB; ITC Project, HLTH WARN TOB PACK I; Kees J, 2010, J PUBLIC POLICY MARK, V29, P265, DOI 10.1509/jppm.29.2.265; Lang P.J., 1988, INT AFFECTIVE PICTUR; Li L, 2014, HLTH ED RES; MEHRABIAN A, 1978, PSYCHOL REP, V43, P803, DOI 10.2466/pr0.1978.43.3.803; NHS, 2013, ALC MIS 2013; Schneider S, 2012, PATIENT EDUC COUNS, V86, P77, DOI 10.1016/j.pec.2011.03.005; Scholes-Balog KE, 2012, AUST NZ J PUBL HEAL, V36, P524, DOI 10.1111/j.1753-6405.2012.00934.x; Services H, 2014, HLTH CONSEQUENCES SM, P17; Stockley C S., 2001, Int J Drug Policy, V12, P153, DOI 10.1016/S0955-3959(01)00077-9; Stockwell T., 2006, REV RES  IMPACTS ALC; Strahan EJ, 2002, TOB CONTROL, V11, P183, DOI 10.1136/tc.11.3.183; Thomas SL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-151; Tobacco Free Center, 2011, PICT WARN LAB COUNTR; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Tversky A, 1989, RATIONAL CHOICE FRAM; UK Department of Health, 2016, UK CHIEF MED OFF LOW; Walker RK, 2013, ALCOHOL CLIN EXP RES, V37, P1253, DOI 10.1111/acer.12109; WHO, 2014, GLOB STAT REP ALC HL; Wilkinson C, 2009, DRUG ALCOHOL REV, V28, P426, DOI 10.1111/j.1465-3362.2009.00055.x; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Yong H-H, 2013, ADULT SMOKERS REACTI; Younie S, 2005, PREVENTING HARMFUL SUBSTANCE USE: THE EVIDENCE BASE FOR POLICY AND PRACTICE, P337, DOI 10.1002/9780470713624.ch28	37	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153027	10.1371/journal.pone.0153027	http://dx.doi.org/10.1371/journal.pone.0153027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27105210	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100008
J	Xu, J; Nakamura, S; Islam, MS; Guo, YJ; Ihara, K; Tomioka, R; Masuda, M; Yoneyama, H; Isogai, E				Xu, Jun; Nakamura, Shuichi; Islam, Md. Shafiqul; Guo, Yijie; Ihara, Kohei; Tomioka, Rintaro; Masuda, Mizuki; Yoneyama, Hiroshi; Isogai, Emiko			Mannose-Binding Lectin Inhibits the Motility of Pathogenic Salmonella by Affecting the Driving Forces of Motility and the Chemotactic Response	PLOS ONE			English	Article							BACTERIAL FLAGELLAR MOTORS; MEMBRANE-POTENTIAL CHANGES; SPIROCHAETA-AURANTIA; PROTEIN FUNCTIONS; INTRACELLULAR PH; ROTARY MOTOR; TYPHIMURIUM; INFECTION; CELL; DISEASE	Mannose-binding lectin (MBL) is a key pattern recognition molecule in the lectin pathway of the complement system, an important component of innate immunity. MBL functions as an opsonin which enhances the sequential immune process such as phagocytosis. We here report an inhibitory effect of MBL on the motility of pathogenic bacteria, which occurs by affecting the energy source required for motility and the signaling pathway of chemotaxis. When Salmonella cells were treated with a physiological concentration of MBL, their motile fraction and free-swimming speed decreased. Rotation assays of a single flagellum showed that the flagellar rotation rate was significantly reduced by the addition of MBL. Measurements of the intracellular pH and membrane potential revealed that MBL affected a driving force for the Salmonella flagellum, the electrochemical potential difference of protons. We also found that MBL treatment increased the reversal frequency of Salmonella flagellar rotation, which interfered with the relative positive chemotaxis toward an attractive substrate. We thus propose that the motility inhibition effect of MBL may be secondarily involved in the attack against pathogens, potentially facilitating the primary role of MBL in the complement system.	[Xu, Jun; Ihara, Kohei; Tomioka, Rintaro; Masuda, Mizuki; Yoneyama, Hiroshi; Isogai, Emiko] Tohoku Univ, Grad Sch Agr Sci, Dept Anim Microbiol, Sendai, Miyagi 980, Japan; [Nakamura, Shuichi; Islam, Md. Shafiqul] Tohoku Univ, Dept Appl Phys, Grad Sch Engn, Sendai, Miyagi 980, Japan; [Guo, Yijie] Xi An Jiao Tong Univ, Dept Immunobiol & Pathogen Biol, Xian 710049, Peoples R China	Tohoku University; Tohoku University; Xi'an Jiaotong University	Xu, J (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Anim Microbiol, Sendai, Miyagi 980, Japan.; Nakamura, S (corresponding author), Tohoku Univ, Dept Appl Phys, Grad Sch Engn, Sendai, Miyagi 980, Japan.	xu.jun.r4@dc.tohoku.ac.jp; naka@bp.apph.tohoku.ac.jp	Ihara, Kohei/AFS-0038-2022; Islam, Shafiqul/AAT-3046-2021	GUO, YIJIE/0000-0002-4949-2048; Xu, Jun/0000-0002-1503-5623; Ihara, Kohei/0000-0002-4389-4599; Nakamura, Shuichi/0000-0003-3972-7779	Grants-in-Aid for Scientific Research [16H05036] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bai F, 2009, BIOPHYS J, V96, P3154, DOI 10.1016/j.bpj.2009.01.023; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1995, BIOPHYS J, V68, pS163; Berg HC, 1995, BIOPHYS J S1, V68, p166S; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; COHEN HJ, 1981, BLOOD, V58, P975; Devyatyrova-Johnson M, 2000, INFECT IMMUN, V68, P3894, DOI 10.1128/IAI.68.7.3894-3899.2000; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Faine S., 1982, GUIDELINES CONTROL L; GOULBOURNE EA, 1981, J BACTERIOL, V148, P837, DOI 10.1128/JB.148.3.837-844.1981; GOULBOURNE EA, 1983, J BACTERIOL, V153, P916, DOI 10.1128/JB.153.2.916-920.1983; GROISMAN EA, 1993, P NATL ACAD SCI USA, V90, P1033, DOI 10.1073/pnas.90.3.1033; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; Islam MS, 2014, FEMS MICROBIOL LETT, V356, P39, DOI 10.1111/1574-6968.12495; Isogai E, 2005, COMP IMMUNOL MICROB, V28, P363, DOI 10.1016/j.cimid.2005.10.001; JEPRAS RI, 1995, APPL ENVIRON MICROB, V61, P2696, DOI 10.1128/AEM.61.7.2696-2701.1995; JONES BD, 1992, INFECT IMMUN, V60, P2475, DOI 10.1128/IAI.60.6.2475-2480.1992; KAWAKAMI M, 1984, J IMMUNOL, V132, P2578; KIHARA M, 1981, J BACTERIOL, V145, P1209, DOI 10.1128/JB.145.3.1209-1221.1981; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Kumariya R, 2015, BBA-BIOMEMBRANES, V1848, P1367, DOI 10.1016/j.bbamem.2015.03.007; LANDSPERGER WJ, 1994, INFECT IMMUN, V62, P4825, DOI 10.1128/IAI.62.11.4825-4830.1994; LIU SL, 1988, INFECT IMMUN, V56, P1967, DOI 10.1128/IAI.56.8.1967-1973.1988; Luty AJF, 1998, J INFECT DIS, V178, P1221, DOI 10.1086/515690; MACNAB RM, 1977, P NATL ACAD SCI USA, V74, P221, DOI 10.1073/pnas.74.1.221; MAGARIYAMA Y, 1990, J BACTERIOL, V172, P4359, DOI 10.1128/jb.172.8.4359-4369.1990; Matsuo K, 2000, CARBOHYD RES, V328, P517, DOI 10.1016/S0008-6215(00)00143-9; MATSUSHITA M, 1992, BIOCHEM BIOPH RES CO, V183, P645, DOI 10.1016/0006-291X(92)90531-O; MELTON T, 1978, J BACTERIOL, V133, P708, DOI 10.1128/JB.133.2.708-716.1978; Minamino T, 2003, J BACTERIOL, V185, P1190, DOI 10.1128/JB.185.4.1190-1194.2003; Minamino T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1488; Mowbray SL, 1998, J STRUCT BIOL, V124, P257, DOI 10.1006/jsbi.1998.4043; Nakamura S, 2006, BIOPHYS J, V90, P3019, DOI 10.1529/biophysj.105.074336; Nakamura S, 2009, J MOL BIOL, V386, P332, DOI 10.1016/j.jmb.2008.12.034; NATHAN P, 1986, J MOL BIOL, V191, P433, DOI 10.1016/0022-2836(86)90138-5; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; POOLE PS, 1988, ANAL BIOCHEM, V175, P52, DOI 10.1016/0003-2697(88)90359-4; RAVID S, 1984, J BACTERIOL, V158, P222, DOI 10.1128/JB.158.1.222-230.1984; REPASKE DR, 1981, J BACTERIOL, V145, P1196, DOI 10.1128/JB.145.3.1196-1208.1981; SAGIEISENBERG R, 1983, J MEMBRANE BIOL, V75, P97, DOI 10.1007/BF01995629; SAMUEL ADT, 1995, P NATL ACAD SCI USA, V92, P3502, DOI 10.1073/pnas.92.8.3502; SIITONEN A, 1992, INFECT IMMUN, V60, P3918, DOI 10.1128/IAI.60.9.3918-3920.1992; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Sze CW, 2012, INFECT IMMUN, V80, P2485, DOI 10.1128/IAI.00145-12; Terry K, 2005, INFECT IMMUN, V73, P803, DOI 10.1128/IAI.73.2.803-811.2005; Troelsen LN, 2007, ARTHRITIS RHEUM, V56, P21, DOI 10.1002/art.22302; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Xu J, 2015, MICROBIOL RES, V171, P21, DOI 10.1016/j.micres.2014.12.010	52	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154165	10.1371/journal.pone.0154165	http://dx.doi.org/10.1371/journal.pone.0154165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104738	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100049
J	Longobardi, P; Montenegro, A; Beltrami, H; Eby, M				Longobardi, Patrick; Montenegro, Alvaro; Beltrami, Hugo; Eby, Michael			Deforestation Induced Climate Change: Effects of Spatial Scale	PLOS ONE			English	Article							CARBON-CYCLE; COVER CHANGES; VEGETATION; MODEL; FEEDBACKS; AMAZON; TEMPERATURE; DYNAMICS; IMPACT	Deforestation is associated with increased atmospheric CO2 and alterations to the surface energy and mass balances that can lead to local and global climate changes. Previous modelling studies show that the global surface air temperature (SAT) response to deforestation depends on latitude, with most simulations showing that high latitude deforestation results in cooling, low latitude deforestation causes warming and that the mid latitude response is mixed. These earlier conclusions are based on simulated large scal land cover change, with complete removal of trees from whole latitude bands. Using a global climate model we examine the effects of removing fractions of 5% to 100% of forested areas in the high, mid and low latitudes. All high latitude deforestation scenarios reduce mean global SAT, the opposite occurring for low latitude deforestation, although a decrease in SAT is simulated over low latitude deforested areas. Mid latitude SAT response is mixed. In all simulations deforested areas tend to become drier and have lower SAT, although soil temperatures increase over deforested mid and low latitude grid cells. For high latitude deforestation fractions of 45% and above, larger net primary productivity, in conjunction with colder and drier conditions after deforestation cause an increase in soil carbon large enough to produce a net decrease of atmospheric CO2. Our results reveal the complex interactions between soil carbon dynamics and other climate subsystems in the energy partition responses to land cover change.	[Longobardi, Patrick; Montenegro, Alvaro; Beltrami, Hugo] St Francis Xavier Univ, CASI, Antigonish, NS B2G 1C0, Canada; [Longobardi, Patrick; Beltrami, Hugo] St Francis Xavier Univ, Dept Earth Sci, Antigonish, NS B2G 1C0, Canada; [Montenegro, Alvaro] Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; [Eby, Michael] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Montenegro, Alvaro] Univ Estadual Paulista, Campus Litoral Paulista, Sao Vicente, SP, Brazil	Saint Francis Xavier University - Canada; Saint Francis Xavier University - Canada; University System of Ohio; Ohio State University; University of Victoria; Universidade Estadual Paulista	Montenegro, A (corresponding author), St Francis Xavier Univ, CASI, Antigonish, NS B2G 1C0, Canada.; Montenegro, A (corresponding author), Ohio State Univ, Dept Geog, Columbus, OH 43210 USA.; Montenegro, A (corresponding author), Univ Estadual Paulista, Campus Litoral Paulista, Sao Vicente, SP, Brazil.	montenegro.8@OSU.edu	Eby, Michael/H-5278-2013; Montenegro, Alvaro/B-4744-2013	Montenegro, Alvaro/0000-0001-6848-1996	NSERC; Natural Sciences and Engineering Research Council of Canada Discovery Grant (NSERC) [DG 140576948]; Canada Research Program; Canadian Foundation for Innovation; NSERC-CREATE Training Program in Climate Sciences based at St. Francis Xavier University; ACENET; Univ Estadual Paulista	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada Discovery Grant (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Program; Canadian Foundation for Innovation(Canada Foundation for Innovation); NSERC-CREATE Training Program in Climate Sciences based at St. Francis Xavier University; ACENET; Univ Estadual Paulista	This work was supported by NSERC (http://www.nserc-crsng.gc.ca/).; This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada Discovery Grant (NSERC DG 140576948), The Canada Research Program (c) to H. Beltrami. Computational facilities provided by the Atlantic Computational Excellence Network (ACEnet-Compute Canada) with support from the Canadian Foundation for Innovation. H. Beltrami holds a Canada Research Chair in Climate Dynamics. P.L was funded by graduate fellowships from a NSERC-CREATE Training Program in Climate Sciences based at St. Francis Xavier University and by ACENET. AM was partially supported by the Univ Estadual Paulista International Visiting Professor Fellowship.	Arora VK, 2011, NAT GEOSCI, V4, P514, DOI [10.1038/ngeo1182, 10.1038/NGEO1182]; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Bathiany S, 2010, BIOGEOSCIENCES, V7, P1383, DOI 10.5194/bg-7-1383-2010; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Bonan GB, 2001, J CLIMATE, V14, P2430, DOI 10.1175/1520-0442(2001)014&lt;2430:OEFROD&gt;2.0.CO;2; Bounoua L, 2002, CLIMATIC CHANGE, V52, P29, DOI 10.1023/A:1013051420309; Brovkin V, 1999, GLOBAL ECOL BIOGEOGR, V8, P509, DOI 10.1046/j.1365-2699.1999.00169.x; Brovkin V, 2006, CLIM DYNAM, V26, P587, DOI 10.1007/s00382-005-0092-6; Brovkin V, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037543; Butler R, 2006, AMAZON WORLDS LARGES; Chagnon FJF, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021188; Claussen M, 2001, GEOPHYS RES LETT, V28, P1011, DOI 10.1029/2000GL012471; Cox P. M., 2001, HADLEY CTR TECH NOTE, V24, P1; Cox PM, 1998, J HYDROL, V212, P79, DOI 10.1016/S0022-1694(98)00203-0; Cox PM, 2001, 23 MET OFF HARDL CTR, P1; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567, DOI 10.1080/01431169408954345; Diochon A, 2009, FOREST ECOL MANAG, V257, P413, DOI 10.1016/j.foreco.2008.09.015; Durieux L, 2003, REMOTE SENS ENVIRON, V86, P132, DOI 10.1016/S0034-4257(03)00095-6; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food of the United Nations AO, 2010, GLOB FOR RES ASS 201; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Friedlingstein P, 2010, CURR OPIN ENV SUST, V2, P251, DOI 10.1016/j.cosust.2010.06.002; Friedlingstein P, 1999, GLOBAL CHANGE BIOL, V5, P755, DOI 10.1046/j.1365-2486.1999.00269.x; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gotelli NJ, 2003, PRIMER ECOLOGY; Govindasamy B, 2001, GEOPHYS RES LETT, V28, P291, DOI 10.1029/2000GL006121; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; Kleidon A, 2000, CLIMATIC CHANGE, V44, P471, DOI 10.1023/A:1005559518889; Larcher W, 2001, PHYSIOLOGICAL PLANT; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Magrin G, 2007, CLIMATE CHANGE 2007, P581; MARLAND G, 2002, NDP030 CDIAC ORNL; Matthews HD, 2004, CLIM DYNAM, V22, P461, DOI 10.1007/s00382-004-0392-2; Meissner KJ, 2003, CLIM DYNAM, V21, P515, DOI 10.1007/s00382-003-0352-2; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Montenegro A, 2009, GLOBAL PLANET CHANGE, V69, P195, DOI 10.1016/j.gloplacha.2009.08.005; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Nave LE, 2010, FOREST ECOL MANAG, V259, P857, DOI 10.1016/j.foreco.2009.12.009; Oschlies A, 1999, GLOBAL BIOGEOCHEM CY, V13, P135, DOI 10.1029/98GB02811; Poeplau C, 2011, GLOBAL CHANGE BIOL, V17, P2415, DOI 10.1111/j.1365-2486.2011.02408.x; Pongratz J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047848; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Roy J., 2001, TERRESTRIAL GLOBAL P, DOI 10.1016/b978-012505290-0/50024-7; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schmittner A, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002283; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Walker IJ, 2007, IMPACTS ADAPTATION C, P329; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Weaver AJ, 2001, ATMOS OCEAN, V39, P361, DOI 10.1080/07055900.2001.9649686; Zhang H, 2001, CLIMATIC CHANGE, V49, P309, DOI 10.1023/A:1010662425950	55	33	33	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153357	10.1371/journal.pone.0153357	http://dx.doi.org/10.1371/journal.pone.0153357			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100667	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500030
J	Pavan, ALM; Dela Rosa, ME; Giacomini, G; Neto, FAB; Yamashita, S; Vulcano, LC; Duarte, SB; Miranda, JRD; de Pina, DR				Menegatti Pavan, Ana Luiza; Dela Rosa, Maria Eugenia; Giacomini, Guilherme; Bacchim Neto, Fernando Antonio; Yamashita, Seizo; Vulcano, Luiz Carlos; Duarte, Sergio Barbosa; de Arruda Miranda, Jose Ricardo; de Pina, Diana Rodrigues			Homogeneous Canine Chest Phantom Construction: A Tool for Image Quality Optimization	PLOS ONE			English	Article							STANDARD PATIENT; SKULL; RADIATION	Digital radiographic imaging is increasing in veterinary practice. The use of radiation demands responsibility to maintain high image quality. Low doses are necessary because workers are requested to restrain the animal. Optimizing digital systems is necessary to avoid unnecessary exposure, causing the phenomenon known as dose creep. Homogeneous phantoms are widely used to optimize image quality and dose. We developed an automatic computational methodology to classify and quantify tissues (i.e., lung tissue, adipose tissue, muscle tissue, and bone) in canine chest computed tomography exams. The thickness of each tissue was converted to simulator materials (i.e., Lucite, aluminum, and air). Dogs were separated into groups of 20 animals each according to weight. Mean weights were 6.5 +/- 2.0 kg, 15.0 +/- 5.0 kg, 32.0 +/- 5.5 kg, and 50.0 +/- 12.0 kg, for the small, medium, large, and giant groups, respectively. The one-way analysis of variance revealed significant differences in all simulator material thicknesses (p < 0.05) quantified between groups. As a result, four phantoms were constructed for dorsoventral and lateral views. In conclusion, the present methodology allows the development of phantoms of the canine chest and possibly other body regions and/or animals. The proposed phantom is a practical tool that may be employed in future work to optimize veterinary X-ray procedures.	[Menegatti Pavan, Ana Luiza; Dela Rosa, Maria Eugenia; Giacomini, Guilherme; Bacchim Neto, Fernando Antonio; de Arruda Miranda, Jose Ricardo] Sao Paulo State Univ, Dept Phys & Biophys, Biosci Inst Botucatu, Sao Paulo, Brazil; [Yamashita, Seizo; de Pina, Diana Rodrigues] Sao Paulo State Univ, Dept Trop Dis & Diagnost Imaging, Botucatu Med Sch, Sao Paulo, Brazil; [Vulcano, Luiz Carlos] Sao Paulo State Univ, Sch Vet Med & Anim Sci, Dept Anim Reprod & Vet Radiol, Sao Paulo, Brazil; [Duarte, Sergio Barbosa] Brasilian Ctr Phys Res, Rio De Janeiro, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	de Pina, DR (corresponding author), Sao Paulo State Univ, Dept Trop Dis & Diagnost Imaging, Botucatu Med Sch, Sao Paulo, Brazil.	drpina@fmb.unesp.br	Miranda, Jose/HCI-6099-2022; /AAD-1785-2020; Pina, Diana rodrigues/AAL-2422-2020; miranda, jose ricardo arruda/C-2300-2012; Duarte, Sergio/P-3623-2019	Pina, Diana rodrigues/0000-0003-1967-1990; Menegatti Pavan, Ana Luiza/0000-0002-6039-1985; miranda, jose ricardo de arruda/0000-0002-8306-8056	Brazilian agency CAPES; Brazilian agency CNPQ; Brazilian agency FAPESP	Brazilian agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian agency CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by to the Brazilian agencies CAPES, CNPQ, and FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all of the clinical and technical personnel of our institution radiodiagnostic facility. The authors are also grateful to the Brazilian agencies CAPES, CNPQ, and FAPESP for their financial support.	Barber J, 2012, J SMALL ANIM PRACT, V53, P578, DOI 10.1111/j.1748-5827.2012.01257.x; Chu RYL, 1990, 31 AAPM; Copple C, 2013, VET RADIOL ULTRASOUN, V54, P9, DOI 10.1111/j.1740-8261.2012.01989.x; Alves AFF, 2015, EUR J RADIOL, V84, P1579, DOI 10.1016/j.ejrad.2015.05.015; Flynn M, 2009, EXPOSURE INDICATOR D, V0271-7344; Gibson DJ, 2012, ACAD RADIOL, V19, P458, DOI 10.1016/j.acra.2011.12.003; GOLDSTON RT, 1995, GERIATRICS GERONTOLO; Gray JE, 1983, QUALITY CONTROL DIAG; Hernandez-Ruiz L, 2012, APPL RADIAT ISOTOPES, V71, P44, DOI 10.1016/j.apradiso.2012.06.023; Hupe O, 2011, RADIAT PROT DOSIM, V144, P478, DOI 10.1093/rpd/ncq351; JENNINGS RJ, 1988, MED PHYS, V15, P588, DOI 10.1118/1.596210; Ma WK, 2013, RADIOGRAPHY, V19, P85, DOI [10.1016/j.radi.2012.11.007, 10.1016/j.radi.2013.04.002]; Pavan ALM, 2015, PHYS MEDICA, V31, P1065, DOI 10.1016/j.ejmp.2015.06.010; Pavan ALM, 2014, 6 LAT AM C BIOM ENG; Pina DR, 2006, APPL RADIAT ISOTOPES, V64, P1623, DOI 10.1016/j.apradiso.2006.05.006; Pina DR, 2012, MED PHYS, V39, P1357, DOI 10.1118/1.3685588; Pina DR, 2009, APPL RADIAT ISOTOPES, V67, P61, DOI 10.1016/j.apradiso.2008.07.018; Pina DR, 2004, PHYS MED BIOL, V49, pN215, DOI 10.1088/0031-9155/49/14/N02; Precht H, 2014, J DIGIT IMAGING, V27, P68, DOI 10.1007/s10278-013-9635-2; Ranger NT, 2007, RADIOLOGY, V243, P785, DOI 10.1148/radiol.2433060485; Samei E, 2005, RADIAT PROT DOSIM, V114, P220, DOI 10.1093/rpd/nch562; Uffmann M, 2009, EUR J RADIOL, V72, P202, DOI 10.1016/j.ejrad.2009.05.060; Veneziani GR, 2010, RADIAT MEAS, V45, P733, DOI 10.1016/j.radmeas.2010.02.020; WHITE D R, 1978, Medical Physics (Woodbury), V5, P467, DOI 10.1118/1.594456	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154193	10.1371/journal.pone.0154193	http://dx.doi.org/10.1371/journal.pone.0154193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101001	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500165
J	Nel, I; Gauler, TC; Bublitz, K; Lazaridis, L; Goergens, A; Giebel, B; Schuler, M; Hoffmann, AC				Nel, Ivonne; Gauler, Thomas C.; Bublitz, Kira; Lazaridis, Lazaros; Goergens, Andre; Giebel, Bernd; Schuler, Martin; Hoffmann, Andreas-Claudius			Circulating Tumor Cell Composition in Renal Cell Carcinoma	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN PERIPHERAL-BLOOD; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; VECTOR SYSTEMS; SOLID TUMORS; LUNG-CANCER; BONE-MARROW; TRANSITION	Purpose Due to their minimal-invasive yet potentially current character circulating tumor cells (CTC) might be useful as a "liquid biopsy" in solid tumors. However, successful application in metastatic renal cell carcinoma (mRCC) has been very limited so far. High plasticity and heterogeneity of CTC morphology challenges currently available enrichment and detection techniques with EpCAM as the usual surface marker being underrepresented in mRCC. We recently described a method that enables us to identify and characterize non-hematopoietic cells in the peripheral blood stream with varying characteristics and define CTC subgroups that distinctly associate to clinical parameters. With this pilot study we wanted to scrutinize feasibility of this approach and its potential usage in clinical studies. Experimental Design Peripheral blood was drawn from 14 consecutive mRCC patients at the West German Cancer Center and CTC profiles were analyzed by Multi-Parameter Immunofluorescence Microscopy (MPIM). Additionally angiogenesis-related genes were measured by quantitative RT-PCR analysis. Results We detected CTC with epithelial, mesenchymal, stem cell-like or mixed-cell characteristics at different time-points during anti-angiogenic therapy. The presence and quantity of N-cadherin-positive or CD133-positive CTC was associated with inferior PFS. There was an inverse correlation between high expression of HIF1A, VEGFA, VEGFR and FGFR and the presence of N-cadherin-positive and CD133-positive CTC. Conclusions Patients with mRCC exhibit distinct CTC profiles that may implicate differences in therapeutic outcome. Prospective evaluation of phenotypic and genetic CTC profiling as prognostic and predictive biomarker in mRCC is warranted.	[Nel, Ivonne; Gauler, Thomas C.; Bublitz, Kira; Lazaridis, Lazaros; Hoffmann, Andreas-Claudius] Univ Duisburg Essen, Mol Oncol Risk Profile Evaluat, Dept Med Oncol, West German Canc Ctr, Essen, Germany; [Nel, Ivonne] ABA GmbH & Co KG, BMZ2, Dortmund, Germany; [Gauler, Thomas C.; Schuler, Martin] Univ Duisburg Essen, Dept Radiotherapy, Essen, Germany; [Goergens, Andre; Giebel, Bernd] Univ Duisburg Essen, Univ Hosp Essen, Inst Transfus Med, Essen, Germany; [Schuler, Martin; Hoffmann, Andreas-Claudius] Univ Duisburg Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Hoffmann, AC (corresponding author), Univ Duisburg Essen, Mol Oncol Risk Profile Evaluat, Dept Med Oncol, West German Canc Ctr, Essen, Germany.; Hoffmann, AC (corresponding author), Univ Duisburg Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany.	hoffmann@more-oncology.com	Görgens, André/C-3835-2016; Giebel, Bernd/AAH-1083-2021	Görgens, André/0000-0001-9198-0857; Giebel, Bernd/0000-0003-2446-948X	Central European Society for Anticancer Drug Research - EWIV (CESAR)	Central European Society for Anticancer Drug Research - EWIV (CESAR)	The method described in this manuscript is part of the translational program in two multicenter trials in mRCC, C-II-008 Inhibitors (TKI) in Metastatic Renal Cell Carcinoma (mRCC) (BERAT) Trial, NCT01731158; FLIPPER Phase IV study, NCT01521715, and is sponsored by a grant from the Central European Society for Anticancer Drug Research - EWIV (CESAR).	Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Bitting RL, 2013, METHODS, V64, P129, DOI 10.1016/j.ymeth.2013.06.034; Bluemke K, 2009, CANCER EPIDEM BIOMAR, V18, P2190, DOI 10.1158/1055-9965.EPI-08-1178; Cesselli D, 2009, CIRC RES, V104, P1225, DOI 10.1161/CIRCRESAHA.109.195859; Chen S, 2013, J SURG ONCOL, V107, P799, DOI 10.1002/jso.23337; Chong PP, 2012, J ORTHOP RES, V30, P634, DOI 10.1002/jor.21556; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gorgens A, 2014, STEM CELL REP, V3, P1058, DOI 10.1016/j.stemcr.2014.09.016; Gradilone A, 2011, ANTICANCER RES, V31, P4219; Gradilone A, 2011, J CELL MOL MED, V15, P1066, DOI 10.1111/j.1582-4934.2011.01285.x; Gruenwald V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-695; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hernandez-Yanez M, 2012, CURR ONCOL REP, V14, P221, DOI 10.1007/s11912-012-0231-2; Hoffman AC, 2009, CLIN CANCER RES, V15, P5191, DOI 10.1158/1078-0432.CCR-08-2534; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Hoffmann AC, 2010, NEOPLASIA, V12, P628, DOI 10.1593/neo.10402; Jiang YS, 2013, MED HYPOTHESES, V81, P73, DOI 10.1016/j.mehy.2013.03.020; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kassis I, 2006, BONE MARROW TRANSPL, V37, P967, DOI 10.1038/sj.bmt.1705358; Klopp AH, 2007, CANCER RES, V67, P11687, DOI 10.1158/0008-5472.CAN-07-1406; Leurs C, 2003, HUM GENE THER, V14, P509, DOI 10.1089/104303403764539305; Lianidou ES, 2011, CLIN CHEM LAB MED, V49, P1579, DOI 10.1515/CCLM.2011.628; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; Mullers E, 2011, J VIROL, V85, P1452, DOI 10.1128/JVI.01731-10; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Nel I, 2014, TRANSL LUNG CANCER R, V3, P100, DOI 10.3978/j.issn.2218-6751.2014.03.05; Nel I, 2014, HEPATOL INT, V8, P321, DOI 10.1007/s12072-014-9539-3; Nel I, 2014, BIOMARK MED, V8, P687, DOI [10.2217/BMM.14.23, 10.2217/bmm.14.23]; Nel I, 2014, INT J CLIN PHARM TH, V52, P74, DOI 10.5414/CPXCES13EA01; Nel I, 2013, TRANSL ONCOL, V6, P420, DOI 10.1593/tlo.13271; O'Flaherty JD, 2012, LUNG CANCER, V76, P19, DOI 10.1016/j.lungcan.2011.10.018; Pirozzi G, 2013, ONCOL REP, V29, P1763, DOI 10.3892/or.2013.2294; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Roufosse CA, 2004, INT J BIOCHEM CELL B, V36, P585, DOI 10.1016/j.biocel.2003.10.007; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Weller P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113706; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Yang FC, 1998, BLOOD, V92, P4632, DOI 10.1182/blood.V92.12.4632.424k28_4632_4640; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	45	29	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153018	10.1371/journal.pone.0153018	http://dx.doi.org/10.1371/journal.pone.0153018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101285	gold, Green Submitted, Green Published			2022-12-27	WOS:000374898500023
J	Omodaka, K; Takahashi, S; Matsumoto, A; Maekawa, S; Kikawa, T; Himori, N; Takahashi, H; Maruyama, K; Kunikata, H; Akiba, M; Nakazawa, T				Omodaka, Kazuko; Takahashi, Seri; Matsumoto, Akiko; Maekawa, Shigeto; Kikawa, Tsutomu; Himori, Noriko; Takahashi, Hidetoshi; Maruyama, Kazuichi; Kunikata, Hiroshi; Akiba, Masahiro; Nakazawa, Toru			Clinical Factors Associated with Lamina Cribrosa Thickness in Patients with Glaucoma, as Measured with Swept Source Optical Coherence Tomography	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OCULAR PERFUSION-PRESSURE; CENTRAL CORNEAL THICKNESS; HEAD BLOOD-FLOW; LASER SPECKLE; DEPTH; RISK; CIRCULATION; POPULATION; ANTERIOR	Purpose To investigate the influence of various risk factors on thinning of the lamina cribrosa (LC), as measured with swept-source optical coherence tomography (SS-OCT; Topcon). Methods This retrospective study comprised 150 eyes of 150 patients: 22 normal subjects, 28 pre-perimetric glaucoma (PPG) patients, and 100 open-angle glaucoma patients. Average LC thickness was determined in a 3 x 3 mm cube scan of the optic disc, over which a 4 x 4 grid of 16 points was superimposed (interpoint distance: 175 mu m), centered on the circular Bruch's membrane opening. The borders of the LC were defined as the visible limits of the LC pores. The correlation of LC thickness with Humphrey field analyzer-measured mean deviation (MD; SITA standard 24-2), circumpapillary retinal nerve fiber layer thickness (cpRNFLT), the vertical cup-to-disc (C/D) ratio, and tissue mean blur rate (MBR) was determined with Spearman's rank correlation coefficient. The relationship of LC thickness with age, axial length, intraocular pressure (IOP), MD, the vertical C/D ratio, central corneal thickness (CCT), and tissue MBR was determined with multiple regression analysis. Average LC thickness and the correlation between LC thickness and MD were compared in patients with the glaucomatous enlargement (GE) optic disc type and those with non-GE disc types, as classified with Nicolela's method. Results We found that average LC thickness in the 16 grid points was significantly associated with overall LC thickness (r = 0.77, P < 0.001). The measurement time for this area was 12.4 +/- 2.4 minutes. Average LC thickness in this area had a correlation coefficient of 0.57 with cpRNFLT (P < 0.001) and 0.46 (P < 0.001) with MD. Average LC thickness differed significantly between the groups (normal: 268 +/- 23 mu m, PPG: 248 +/- 13 mu m, OAG: 233 +/- 20 mu m). Multiple regression analysis showed that MD (beta = 0.29, P = 0.013), vertical C/D ratio (beta = -0.25, P = 0.020) and tissue MBR (beta = 0.20, P = 0.034) were independent variables significantly affecting LC thickness, but age, axial length, IOP, and CCT were not. LC thickness was significantly lower in the GE patients (233.9 +/- 17.3 mu m) than the non-GE patients (243.6 +/- 19.5 mu m, P = 0.040). The correlation coefficient between MD and LC thickness was 0.58 (P < 0.001) in the GE patients and 0.39 (P = 0.013) in the non-GE patients. Conclusion Cupping formation and tissue blood flow were independently correlated to LC thinning. Glaucoma patients with the GE disc type, who predominantly have large cupping, had lower LC thickness even with similar glaucoma severity.	[Omodaka, Kazuko; Takahashi, Seri; Maekawa, Shigeto; Himori, Noriko; Takahashi, Hidetoshi; Maruyama, Kazuichi; Kunikata, Hiroshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan; [Matsumoto, Akiko; Kikawa, Tsutomu; Akiba, Masahiro] Topcon Corp, Tokyo, Japan; [Kunikata, Hiroshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi 980, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi 980, Japan	Tohoku University; Topcon Corporation; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi 980, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi 980, Japan.	ntoru@oph.med.tohoku.ac.jp	Maruyama, Kazuichi/GRX-8129-2022	Maruyama, Kazuichi/0000-0001-6283-5466	Topcon Corporation; JST grant from JSPS KAKENHI [TN 26293372, TN 26670751]; JST Center for Revitalization Promotion	Topcon Corporation; JST grant from JSPS KAKENHI; JST Center for Revitalization Promotion	Topcon Corporation provided support in the form of salaries for authors AM, TK, and MA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This paper was supported in part by a JST grant from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (TN 26293372) and for Exploratory Research (TN 26670751), and by the JST Center for Revitalization Promotion.	Aizawa N, 2014, INVEST OPHTH VIS SCI, V55, P7991, DOI 10.1167/iovs.14-15373; Aizawa N, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-113; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Anderson DR., 1999, AUTOMATED STATIC PER; Faridi OS, 2014, OPHTHALMOLOGY, V121, P1524, DOI 10.1016/j.ophtha.2014.02.017; Gherghel D, 2000, AM J OPHTHALMOL, V130, P597, DOI 10.1016/S0002-9394(00)00766-2; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P7738, DOI 10.1167/iovs.10-6925; Himori N, 2015, GRAEFES ARCH CLIN EX; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Jonas JB, 2005, INVEST OPHTH VIS SCI, V46, P1275, DOI 10.1167/iovs.04-0851; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Kim S, 2013, OPHTHALMOLOGY, V120, P1798, DOI 10.1016/j.ophtha.2013.02.015; Lee DS, 2015, INVEST OPHTH VIS SCI, V56, P2833, DOI 10.1167/iovs.14-15869; Lee EJ, 2015, OPHTHALMOLOGY, V122, P721, DOI 10.1016/j.ophtha.2014.10.007; Lee EJ, 2013, GRAEF ARCH CLIN EXP, V251, P847, DOI 10.1007/s00417-012-2145-y; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leske MC, 2009, CURR OPIN OPHTHALMOL, V20, P73, DOI 10.1097/ICU.0b013e32831eef82; Lin CC, 2013, OPHTHALMOLOGY, V120, P1559, DOI 10.1016/j.ophtha.2013.01.006; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Mohamed-Noor J, 2009, J GLAUCOMA, V18, P32, DOI 10.1097/IJG.0b013e31816b2fd1; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P640, DOI 10.1016/S0161-6420(96)30640-4; Omodaka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122347; Omodaka K, 2010, CLIN OPHTHALMOL, V4, P765; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; Sawada Y, 2015, INVEST OPHTH VIS SCI, V56, P5777, DOI 10.1167/iovs.14-15942; Shiga Y, 2016, CURR EYE RE IN PRESS; Shin HY, 2014, OPHTHALMOLOGY, V121, P1990, DOI 10.1016/j.ophtha.2014.04.030; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Takayama S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/586857; Takayama S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/157090; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; TIELSCH JM, 1994, ARCH OPHTHALMOL-CHIC, V112, P69, DOI 10.1001/archopht.1994.01090130079022; Tsuda S, 2013, J GLAUCOMA, V22, P398, DOI 10.1097/IJG.0b013e318237c8b3; Vohra R, 2013, SURV OPHTHALMOL, V58, P311, DOI 10.1016/j.survophthal.2012.08.010; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Wu ZH, 2015, OPHTHALMOLOGY, V122, P1317, DOI 10.1016/j.ophtha.2015.02.035	39	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153707	10.1371/journal.pone.0153707	http://dx.doi.org/10.1371/journal.pone.0153707			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100404	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500053
J	Parr, EB; Camera, DM; Burke, LM; Phillips, SM; Coffey, VG; Hawley, JA				Parr, Evelyn B.; Camera, Donny M.; Burke, Louise M.; Phillips, Stuart M.; Coffey, Vernon G.; Hawley, John A.			Circulating MicroRNA Responses between 'High' and 'Low' Responders to a 16-Wk Diet and Exercise Weight Loss Intervention	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE	Background Interactions between diet, physical activity and genetic predisposition contribute to variable body mass changes observed in response to weight loss interventions. Circulating microRNAs (c-miRNAs) may act as 'biomarkers' that are associated with the rate of change in weight loss, and/or play a role in regulating the biological variation, in response to energy restriction. Objective To quantify targeted c-miRNAs with putative roles in energy metabolism and exercise adaptations following a 16 wk diet and exercise intervention in individuals with large (high responders; HiRes) versus small (low responders; LoRes) losses in body mass. Methods From 89 male and female overweight/obese participants who completed the intervention (energy restriction from diet, 250 kcal/d, and exercise, 250 kcal/d), subgroups of HiRes (>10% body mass loss, n = 22) and LoRes (<5% body mass loss, n = 18) were identified. From resting plasma samples collected after an overnight fast pre and post intervention, RNA was extracted, quantified and reverse transcribed. Thirteen c-miRNA selected a priori were analysed using a customised 96-well miScript miRNA PCR Array. Results Loss of body mass (-11.0 +/- 2.3 kg vs. -3.0 +/- 1.3 kg; P<0.01) and fat mass (-11.1 +/- 2.6 kg vs. -3.9 +/- 1.6 kg; P<0.01) was greater for HiRes than LoRes (P<0.001). Expression of c-miR-935 was higher in LoRes compared to HiRes pre-(similar to 47%; P = 0.025) and post-(similar to 100%; P<0.01) intervention and was the only c-miRNA differentially expressed at baseline between groups. The abundance of c-miR-221-3p and -223-3p increased pre- to post-intervention in both groups (similar to 57-69% and similar to 25-90%, P<0.05). There was a post-intervention increase in c-miR-140 only in LoRes compared to HiRes (similar to 23%, P = 0.016). Conclusion The differential expression and responses of selected c- miRNAs in overweight/obese individuals to an exercise and diet intervention suggests a putative role for these 'biomarkers' in the prediction or detection of individual variability to weight loss interventions.	[Parr, Evelyn B.; Camera, Donny M.; Burke, Louise M.; Hawley, John A.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Exercise & Nutr, Melbourne, Vic, Australia; [Burke, Louise M.] Australian Inst Sport, Dept Sports Nutr, Canberra, ACT, Australia; [Phillips, Stuart M.] McMaster Univ, Exercise Metab Res Grp, Dept Kinesiol, Hamilton, ON, Canada; [Coffey, Vernon G.] Bond Univ, Bond Inst Hlth & Sport, Gold Coast, Qld, Australia; [Coffey, Vernon G.] Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld, Australia; [Hawley, John A.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England	Australian Catholic University; Australian Institute of Sport; McMaster University; Bond University; Bond University; Liverpool John Moores University	Hawley, JA (corresponding author), Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Exercise & Nutr, Melbourne, Vic, Australia.; Hawley, JA (corresponding author), Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England.	john.hawley@acu.edu.au	Hawley, John A/U-3814-2018; Camera, Donny/J-1571-2018; Phillips, Stuart/B-2343-2009; Parr, Evelyn/J-1576-2018; Burke, Louise/X-3127-2019; Burke, Louise/ABC-5691-2020	Hawley, John A/0000-0002-0886-9881; Camera, Donny/0000-0002-6494-9472; Phillips, Stuart/0000-0002-1956-4098; Parr, Evelyn/0000-0003-1710-6381; Burke, Louise/0000-0001-8866-5637; 	Dairy Health and Nutrition Consortium, Dairy Innovation Australia Ltd [201134D]	Dairy Health and Nutrition Consortium, Dairy Innovation Australia Ltd	Supported by a grant from the Dairy Health and Nutrition Consortium, Dairy Innovation Australia Ltd (ID# 201134D) to JAH, VGC, SMP and LMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi W, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00495; Aoi W, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00080; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bouchard L, 2010, AM J CLIN NUTR, V91, P309, DOI 10.3945/ajcn.2009.28085; Campion J, 2009, OBES REV, V10, P383, DOI 10.1111/j.1467-789X.2009.00595.x; Capuano Melissa M, 2013, BMC Res Notes, V6, P235, DOI 10.1186/1756-0500-6-235; Frankenfield D, 2005, J AM DIET ASSOC, V105, P775, DOI 10.1016/j.jada.2005.02.005; Guzman-Ruiz R, 2014, INT J OBESITY, V38, P1545, DOI 10.1038/ijo.2014.36; Hainer V, 2008, PHYSIOL RES, V57, pS17, DOI 10.33549/physiolres.931486; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Kilic ID, 2015, GENE, V560, P140, DOI 10.1016/j.gene.2015.01.048; King NA, 2012, BRIT J SPORT MED, V46, P315, DOI 10.1136/bjsm.2010.082495; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Li YP, 2014, INT J MED SCI, V11, P522, DOI 10.7150/ijms.8206; Liu Y, 2014, INT J MOL SCI, V15, P10567, DOI 10.3390/ijms150610567; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Milagro FI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054319; Milagro FI, 2011, FASEB J, V25, P1378, DOI 10.1096/fj.10-170365; Moleres A, 2013, FASEB J, V27, P2504, DOI 10.1096/fj.12-215566; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; Parr EB, OBES SILVER IN PRESS; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Sawada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070823; Wen DZ, 2015, OBES RES CLIN PRACT, V9, P398, DOI 10.1016/j.orcp.2015.01.006; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323	30	42	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152545	10.1371/journal.pone.0152545	http://dx.doi.org/10.1371/journal.pone.0152545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101373	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500012
J	Wang, LJ; Xu, XY; Kang, LN; Xiang, WP				Wang, Lingjuan; Xu, Xiaoyan; Kang, Lina; Xiang, Wenpei			Bone Marrow Mesenchymal Stem Cells Attenuate Mitochondria Damage Induced by Hypoxia in Mouse Trophoblasts	PLOS ONE			English	Article							MEDIATED APOPTOSIS; EXPRESSION; STRESS; DEATH; ACTIVATION; PREGNANCY; ISCHEMIA; RESCUE; MODEL	Objective We aimed to observe the change of mitochondrial function and structure as well as the cell function induced by hypoxia in mouse trophoblasts, and moreover, to validate the restoration of these changes after co-culture with bone marrow mesenchymal stem cells (hereinafter referred to as "MSCs"). Further, we explored the mechanism of MSCs attenuating the functional damage of trophoblasts caused by hypoxia. Methods Cells were divided into two groups, trophoblasts and MSCs+ trophoblasts respectively, and the two groups of cells were incubated with normoxia or hypoxia. Chemiluminescence was used to assay the beta-HCG and progesterone in cell culture supernatants quantitatively. Western blotting and PCR were applied to detect the expression of Mfn2, MMP-2, MMP-9 and integrin beta 1 in the two groups. The mitochondrial membrane potential of each group of cells was detected with JC-1 dye and the ATP content was measured by the phosphomolybdic acid colorimetric method. We utilized transmission electron microscopy for observing the ultrastructure of mitochondria in trophoblasts. Finally, we assessed the cell apoptosis with flow cytometry (FCM) and analyzed the expression of the apoptosis related genes-Bcl-2, Bax, Caspase3 and Caspase9 by western blotting. Results The results showed that the Mfn2 expression was reduced after 4 h in hypoxia compared with that in normoxia, but increased in the co-culture group when compared with that in the separated-culture group (p< 0.05). In addition, compared with the separated-culture group, the beta-HCG and progesterone levels in the co-culture group were significantly enhanced (p< 0.05), and so were the expressions of MMP-2, MMP-9 and integrin beta 1 (p< 0.05). Moreover, it exhibited significantly higher in ATP levels and intensified about the mitochondrial membrane potential in the co-culture group. TEM revealed disorders of the mitochondrial cristae and presented short rod-like structure and spheroids in hypoxia, however, in the co-culture group, the mitochondrial cristae had a relatively regular arrangement and the mitochondrial ultrastructure showed hyperfusion. The expression of Bax, Caspase3 and Caspase9 was decreased in the co-culture group when compared with that in trophoblast cells cultured alone (p< 0.05), while the Bcl-2 levels and the Apoptosis Index (AI) were markedly increased in the co-culture group (p< 0.05). Conclusion Bone marrow mesenchymal stem cells can attenuate mitochondria damage and cell apoptosis induced by hypoxia; the mechanism could be upregulating the expression of Mfn2 in mouse trophoblasts and changing mitochondrial structure.	[Wang, Lingjuan; Kang, Lina; Xiang, Wenpei] Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan 430074, Peoples R China; [Xu, Xiaoyan] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xiang, WP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan 430074, Peoples R China.	wpxiang2010@gmail.com			Fundamental Research Funds for the Central Universities	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the Fundamental Research Funds for the Central Universities. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuk PTY, 2006, MED HYPOTHESES, V67, P792, DOI 10.1016/j.mehy.2006.04.026; Borbely AU, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-7; Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050; Cai XH, 2014, EXP NEUROL, V257, P148, DOI 10.1016/j.expneurol.2014.04.029; Chen RL, 2015, IND HEALTH, V53, P222, DOI 10.2486/indhealth.2014-0182; Chen WQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136421; Chu PPY, 2012, CYTOTHERAPY, V14, P1064, DOI 10.3109/14653249.2012.697146; Creagh EM, 2014, TRENDS IMMUNOL, V35, P631, DOI 10.1016/j.it.2014.10.004; de Windt TS, 2014, STEM CELL TRANSL MED, V3, P723, DOI 10.5966/sctm.2013-0207; Escobar-Henriques M, 2013, BBA-MOL CELL RES, V1833, P162, DOI 10.1016/j.bbamcr.2012.07.016; Fu X, 2008, CYTOTHERAPY, V10, P353, DOI 10.1080/14653240802035926; Gultice AD, 2006, BIOL REPROD, V74, P1041, DOI 10.1095/biolreprod.105.047845; Guo JQ, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-18; Handschuh K, 2007, PLACENTA, V28, P175, DOI 10.1016/j.placenta.2006.01.019; He Yun-Yun, 2011, Sheng Li Ke Xue Jin Zhan, V42, P419; Hedskog L, 2012, ANTIOXID REDOX SIGN, V16, P1476, DOI 10.1089/ars.2011.4259; Hong JY, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-122; Hou M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085808; Hu JQ, 2015, MOL MED REP, V12, P5701, DOI 10.3892/mmr.2015.4139; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Kim SM, 2008, EXP MOL MED, V40, P261, DOI 10.3858/emm.2008.40.3.261; Lee HJ, 2007, J CLIN ONCOL, V25, P3198, DOI 10.1200/JCO.2006.10.3028; Li H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15271; Li ML, 2014, CELL SIGNAL, V26, P1539, DOI 10.1016/j.cellsig.2014.03.026; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Liu KM, 2014, MICROVASC RES, V92, P10, DOI 10.1016/j.mvr.2014.01.008; Lopez J, 2015, BRIT J CANCER, V112, P957, DOI 10.1038/bjc.2015.85; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Pang W, 2013, PLACENTA, V34, P613, DOI 10.1016/j.placenta.2013.03.013; Park JY, 2011, ARCH TOXICOL, V85, P1057, DOI 10.1007/s00204-011-0645-x; Rasstrigina I. M., 2014, Arkhiv Patologii, V76, P24; Rau TF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047877, 10.1371/journal.pone.0040881]; ROSENBAUM DM, 1994, ANN NEUROL, V36, P864, DOI 10.1002/ana.410360610; Tessier DR, 2015, AM J REPROD IMMUNOL, V74, P1, DOI 10.1111/aji.12345; Tuuli MG, 2011, PLACENTA, V32, pS109, DOI 10.1016/j.placenta.2010.12.013; Xiong SB, 2014, PROTEIN CELL, V5, P737, DOI 10.1007/s13238-014-0089-1; Yu B, 2015, INT J CARDIOL, V182, P349, DOI 10.1016/j.ijcard.2014.12.043; Zheng X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.66	38	5	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153729	10.1371/journal.pone.0153729	http://dx.doi.org/10.1371/journal.pone.0153729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100996	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500057
J	Wolf, KJ; Emerson, RO; Pingel, J; Buller, RM; DiPaolo, RJ				Wolf, Kyle J.; Emerson, Ryan O.; Pingel, Jeanette; Buller, R. Mark; DiPaolo, Richard J.			Conventional and Regulatory CD4(+) T Cells That Share Identical TCRs Are Derived from Common Clones	PLOS ONE			English	Article							SELF-ANTIGEN; IN-VIVO; GENERATION; RECOGNITION; EXPRESSION; RESPONSES; SELECTION; MICE	Results from studies comparing the diversity and specificity of the TCR repertoires expressed by conventional (Tconv) and regulatory (Treg) CD4(+) T cell have varied depending on the experimental system employed. We developed a new model in which T cells express a single fixed TCR alpha chain, randomly rearranged endogenous TCR beta chains, and a Foxp3-GFP reporter. We purified CD4(+) Foxp3(-) and CD4(+) Foxp3(+) cells, then performed biased controlled multiplex PCR and high throughput sequencing of endogenous TCR beta chains. We identified > 7,000 different TCR beta sequences in the periphery of 5 individual mice. On average, similar to 12% of TCR sequences were expressed by both conventional and regulatory populations within individual mice. The CD4(+) T cells that expressed shared TCR sequences were present at higher frequencies compared to T cells expressing non-shared TCRs. Furthermore, nearly all (> 90%) of the TCR sequences that were shared within mice were identical at the DNA sequence level, indicating that conventional and regulatory T cells that express shared TCRs are derived from common clones. Analysis of TCR repertoire overlap in the thymus reveals that a large proportion of Tconv and Treg sharing observed in the periphery is due to clonal expansion in the thymus. Together these data show that there are a limited number of TCR sequences shared between Tconv and Tregs. Also, Tconv and Tregs sharing identical TCRs are found at relatively high frequencies and are derived from common progenitors, of which a large portion are generated in the thymus.	[Wolf, Kyle J.; Pingel, Jeanette; Buller, R. Mark; DiPaolo, Richard J.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA; [Emerson, Ryan O.] Adapt Biotechnol Corp, Seattle, WA USA; [Pingel, Jeanette] Washington Univ, Sch Med, Dept Pediat Rheumatol, St Louis, MO USA	Saint Louis University; Washington University (WUSTL)	DiPaolo, RJ (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA.	rdipaolo@slu.edu		Wolf, Kyle/0000-0003-4874-2911	Saint Louis University School of Medicine; Adaptive Biotechnologies	Saint Louis University School of Medicine; Adaptive Biotechnologies	This project was funded by a seed grant from the Saint Louis University School of Medicine. Adaptive Biotechnologies provided support in the form of salaries for author (ROE), but did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2007, INT IMMUNOL, V19, P557, DOI 10.1093/intimm/dxm021; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Arnold PY, 2004, J IMMUNOL, V173, P3103, DOI 10.4049/jimmunol.173.5.3103; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bettini M, 2014, J IMMUNOL, V193, P571, DOI 10.4049/jimmunol.1400043; Bettini ML, 2013, NAT PROTOC, V8, P1837, DOI 10.1038/nprot.2013.111; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Clemens EB, 2015, J IMMUNOL, V194, P898, DOI 10.4049/jimmunol.1401792; DiPaolo RJ, 2009, EUR J IMMUNOL, V39, P234, DOI 10.1002/eji.200838772; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Geiger TL, 2012, HUM IMMUNOL, V73, P232, DOI 10.1016/j.humimm.2011.12.012; Haeryfar SMM, 2005, J IMMUNOL, V174, P3344, DOI 10.4049/jimmunol.174.6.3344; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Lefranc Marie-Paule, 2004, In Silico Biology, V4, P17; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liu X, 2009, IMMUNITY, V31, P909, DOI 10.1016/j.immuni.2009.09.023; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Ochando JC, 2005, J IMMUNOL, V174, P6993, DOI 10.4049/jimmunol.174.11.6993; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032	38	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153705	10.1371/journal.pone.0153705	http://dx.doi.org/10.1371/journal.pone.0153705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100298	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500052
J	Aloric, A; Sollich, P; McBurney, P; Galla, T				Aloric, Aleksandra; Sollich, Peter; McBurney, Peter; Galla, Tobias			Emergence of Cooperative Long-Term Market Loyalty in Double Auction Markets	PLOS ONE			English	Article							INFORMATION; SEGREGATION	Loyal buyer-seller relationships can arise by design, e.g. when a seller tailors a product to a specific market niche to accomplish the best possible returns, and buyers respond to the dedicated efforts the seller makes to meet their needs. We ask whether it is possible, instead, for loyalty to arise spontaneously, and in particular as a consequence of repeated interaction and co-adaptation among the agents in a market. We devise a stylized model of double auction markets and adaptive traders that incorporates these features. Traders choose where to trade (which market) and how to trade (to buy or to sell) based on their previous experience. We find that when the typical scale of market returns (or, at fixed scale of returns, the intensity of choice) become higher than some threshold, the preferred state of the system is segregated: both buyers and sellers are segmented into subgroups that are persistently loyal to one market over another. We characterize the segregated state analytically in the limit of large markets: it is stabilized by some agents acting cooperatively to enable trade, and provides higher rewards than its unsegregated counterpart both for individual traders and the population as a whole.	[Aloric, Aleksandra; Sollich, Peter] Kings Coll London, Dept Math, London WC2R 2LS, England; [McBurney, Peter] Kings Coll London, Dept Informat, London WC2R 2LS, England; [Galla, Tobias] Univ Manchester, Sch Phys & Astron, Theoret Phys, Manchester, Lancs, England	University of London; King's College London; University of London; King's College London; University of Manchester	Aloric, A (corresponding author), Kings Coll London, Dept Math, London WC2R 2LS, England.	aleksandra.aloric@gmail.com	Sollich, Peter/H-2174-2011; Sollich, Peter/ABC-2993-2020; Aloric, Aleksandra/J-2816-2019; Galla, Tobias/R-1718-2018	Sollich, Peter/0000-0003-0169-7893; Aloric, Aleksandra/0000-0002-7278-599X; McBurney, Peter/0000-0001-5547-5239	Engineering and Physical Sciences Council EPSRC 896 (UK) [EP/K000632/1]; EPSRC [EP/K000632/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K000632/1] Funding Source: researchfish	Engineering and Physical Sciences Council EPSRC 896 (UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge funding by the Engineering and Physical Sciences Council EPSRC 896 (UK), grant reference EP/K000632/1 (Network Plus, Towards consensus on a unifying 897 treatment of emergence and systems far from equilibrium). PS acknowledges the 898 stimulating research environment provided by the EPSRC Centre for Doctoral Training 899 in Cross-Disciplinary Approaches to Non-Equilibrium Systems (CANES, 900 EP/L015854/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloric A, 2015, LECT NOTES ECON MATH, V676, P79, DOI 10.1007/978-3-319-09578-3_7; BINDER K, 1981, PHYS REV LETT, V47, P693, DOI 10.1103/PhysRevLett.47.693; Bloembergen D, 2015, CONNECT SCI, V27, P253, DOI 10.1080/09540091.2015.1039492; Camerer C, 1999, ECONOMETRICA, V67, P827, DOI 10.1111/1468-0262.00054; Cheung YW, 1997, GAME ECON BEHAV, V19, P46, DOI 10.1006/game.1997.0544; Eilers PHC, 2004, BIOINFORMATICS, V20, P623, DOI 10.1093/bioinformatics/btg454; Foresight, 2012, FOR FUT COMP TRAD FI; Freidlin M. I., 1984, RANDOM PERTURBATIONS; GODE DK, 1993, J POLIT ECON, V101, P119, DOI 10.1086/261868; Goeree JK, 2000, J ECON DYN CONTROL, V24, P761, DOI 10.1016/S0165-1889(99)00025-1; Gordon MJ, 1962, IRWIN SERIES EC; Hanaki N, 2011, J ECON BEHAV ORGAN, V77, P382, DOI 10.1016/j.jebo.2010.11.009; Ho TH, 2007, J ECON THEORY, V133, P177, DOI 10.1016/j.jet.2005.12.008; Hotelling H, 1929, ECON J, V39, P41, DOI 10.2307/2224214; Huang ZG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00703; Huber J, 2008, J ECON BEHAV ORGAN, V65, P86, DOI 10.1016/j.jebo.2005.05.012; Huber J, 2007, J ECON DYN CONTROL, V31, P2536, DOI 10.1016/j.jedc.2006.09.003; Johnson NF, 1999, PHYS REV LETT, V82, P3360, DOI 10.1103/PhysRevLett.82.3360; Kampen NGv, 1997, STOCHASTIC PROCESSES; Kirman AP, 2000, LECT NOTES ECON MATH, V484, P33; Krumme C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01645; Ladley D, 2004, KNOWL ENG REV, P1; Lillo F, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043019; NAGARAJAN G, 1995, AGR ECON, V12, P171, DOI 10.1016/0169-5150(95)01135-8; Nicole R, MEAN FIELD APP UNPUB; Niu J, 2010, WHAT 2007 TAC MARKET; Parsons S, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1883612.1883617; Robinson Edward, 2012, Adaptive and Learning Agents. International Workshop, ALA 2011 Held at AAMAS 2011. Revised Selected Papers, P1, DOI 10.1007/978-3-642-28499-1_1; Sato Y, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.015206; Smith A, 1904, LIB EC LIBERTY 1904; Toth B, 2007, EUR PHYS J B, V55, P115, DOI 10.1140/epjb/e2007-00046-2; Toth B, 2015, J ECON DYN CONTROL, V51, P218, DOI 10.1016/j.jedc.2014.10.007; Wu RS, 2011, ELECTRON COMMER R A, V10, P331, DOI 10.1016/j.elerap.2010.11.002; Zwanzig R., 2001, NONEQUILIBRIUM STAT	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154606	10.1371/journal.pone.0154606	http://dx.doi.org/10.1371/journal.pone.0154606			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120473	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200089
J	Bennie, JA; Pedisic, Z; van Uffelen, JGZ; Charity, MJ; Harvey, JT; Banting, LK; Vergeer, I; Biddle, SJH; Eime, RM				Bennie, Jason A.; Pedisic, Zeljko; van Uffelen, Jannique G. Z.; Charity, Melanie J.; Harvey, Jack T.; Banting, Lauren K.; Vergeer, Ineke; Biddle, Stuart J. H.; Eime, Rochelle M.			Pumping Iron in Australia: Prevalence, Trends and Sociodemographic Correlates of Muscle Strengthening Activity Participation from a National Sample of 195,926 Adults	PLOS ONE			English	Article							RISK; METAANALYSIS; BEHAVIOR; IMPACT; SPORT	Objective The current Australian Physical Activity Guidelines recommend that adults engage in regular muscle-strengthening activity (e.g. strength or resistance training). However, public health surveillance studies describing the patterns and trends of population-level muscle-strengthening activity participation are sparse. The aim of this study is to examine the prevalence, trends and sociodemographic correlates of muscle-strengthening activity participation in a national-representative sample of Australians aged 15 years and over. Methods Between 2001 and 2010, quarterly cross-sectional national telephone surveys were conducted as part of the Australian Sports Commission's 'Exercise, Recreation and Sport Survey'. Pooled population-weighted proportions were calculated for reporting: [i] no muscle-strengthening activity; [ii] insufficient muscle-strengthening activity, and [iii] sufficient muscle-strengthening activity. Associations with sociodemographic variables were assessed using multiple logistic regression analyses. Results Out of 195,926 participants, aged 15-98 years, only 10.4%(95% CI: 10.1-10.7) and 9.3% (95% CI: 9.1-9.5) met the muscle-strengthening activity recommendations in the past two weeks and in the past year, respectively. Older adults (50+ years), and those living in socio-economically disadvantaged, outer regional/remote areas and with lower education were less likely to report sufficient muscle-strengthening activity (p<0.001). Over the 10-year monitoring period, there was a significant increase in the prevalence of sufficient muscle-strengthening activity (6.4% to 12.0%, p-value for linear trend <0.001). Conclusions A vast majority of Australian adults did not engage in sufficient muscle-strengthening activity. There is a need for public health strategies to support participation in muscle-strengthening activity in this population. Such strategies should target older and lower educated adults, and those living in socioeconomically disadvantaged, outer regional/remote and areas.	[Bennie, Jason A.; Pedisic, Zeljko; van Uffelen, Jannique G. Z.; Charity, Melanie J.; Harvey, Jack T.; Banting, Lauren K.; Vergeer, Ineke; Biddle, Stuart J. H.; Eime, Rochelle M.] Victoria Univ, ISEAL, Act Living & Publ Hlth Program, Melbourne, Vic 8001, Australia; [Charity, Melanie J.; Harvey, Jack T.; Eime, Rochelle M.] Federat Univ Australia, Fac Hlth, Ballarat, Vic, Australia	Victoria University; Federation University Australia	Bennie, JA (corresponding author), Victoria Univ, ISEAL, Act Living & Publ Hlth Program, Melbourne, Vic 8001, Australia.	jason.bennie@vu.edu.au	van Uffelen, Jannique/AAI-8216-2020; Bennie, Jason/AAY-2915-2020; van Uffelen, Jannique/C-3392-2008	van Uffelen, Jannique/0000-0001-7253-5766; Bennie, Jason/0000-0002-8668-8998; van Uffelen, Jannique/0000-0001-7253-5766; Biddle, Stuart/0000-0002-7663-6895; Vergeer, Ineke/0000-0002-6560-9023; Pedisic, Zeljko/0000-0003-2886-3556; Harvey, Jack/0000-0001-6927-6580; Eime, Rochelle/0000-0002-8614-2813	Fitness Australia; Australia Sports Commission-ISEAL Victoria University Senior Research Fellowship; ISEAL Research Program Strategic Project Grant (project title: Epidemiological assessment of muscle strengthening exercise participation in Australia)	Fitness Australia; Australia Sports Commission-ISEAL Victoria University Senior Research Fellowship; ISEAL Research Program Strategic Project Grant (project title: Epidemiological assessment of muscle strengthening exercise participation in Australia)	JAB declares he has a research fellowship part-funded by Fitness Australia, a not-for-profit, member-based industry association representing the interests of over 30,000 Australian registered exercise professionals, fitness service providers and industry suppliers. SJHB declares he has been a consultant to Fitness First. JGZvU declares she is supported by an Australia Sports Commission-ISEAL Victoria University Senior Research Fellowship. JAB and ZP declare that this study was partially funded by the ISEAL Research Program Strategic Project Grant (project title: Epidemiological assessment of muscle strengthening exercise participation in Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2011, IND REL SOC ADV DIS; [Anonymous], 2014, AUSTR PHYS ACT SED B; Australian Institute of Health and Welfare, 2003, RUR REG REM HLTH GUI; Australian Institute of Health and Welfare, 2014, AUSTR HLTH SER, V14; Australian Sports Commission, 2010, RECR SPORT SURV ERAS; Bennie JA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2736-3; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Churilla JR, 2012, J DIABETES, V4, P77, DOI 10.1111/j.1753-0407.2011.00172.x; Cornelissen VA, 2011, HYPERTENSION, V58, P950, DOI 10.1161/HYPERTENSIONAHA.111.177071; Eime RM, 2015, SPORT MANAGEMENT REV; Eime RM, 2013, RES Q EXERCISE SPORT, V84, P157, DOI 10.1080/02701367.2013.784846; Fitness Australia, 2012, FITN IND WORKF REP; Global Observatory for Physical Activity, 2016, GLOB OBS PHYS ACT CO; Grontved A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001587; Grontved A, 2012, ARCH INTERN MED, V172, P1306, DOI 10.1001/archinternmed.2012.3138; Harada K, 2011, J AGING PHYS ACTIV, V19, P262, DOI 10.1123/japa.19.3.262; Harris CD, 2013, MMWR-MORBID MORTAL W, V62, P326; Kazuhiro H., 2008, International Journal of Sport and Health Science, V6, P66, DOI 10.5432/ijshs.6.66; Kelley GA, 2009, PREV MED, V48, P9, DOI 10.1016/j.ypmed.2008.10.010; Loustalot F, 2013, RES Q EXERCISE SPORT, V84, P30, DOI 10.1080/02701367.2013.762289; Merom D, 2004, J SCI MED SPORT, V7, P32, DOI 10.1016/S1440-2440(04)80041-0; Merom D, 2012, J SCI MED SPORT, V15, pS44; Merom D, 2012, PREV MED, V55, P613, DOI 10.1016/j.ypmed.2012.10.001; Nakamura Y., 2015, PHYS ACTIVITY EXERCI, P29; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Schoenborn Charlotte A, 2013, Vital Health Stat 10, P1; Westcott WL, 2012, CURR SPORT MED REP, V11, P209, DOI 10.1249/JSR.0b013e31825dabb8; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yore MM, 2007, MED SCI SPORT EXER, V39, P1267, DOI 10.1249/mss.0b013e3180618bbe	34	62	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153225	10.1371/journal.pone.0153225	http://dx.doi.org/10.1371/journal.pone.0153225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119145	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000374976200020
J	Thomas, GO; Poortinga, W; Sautkina, E				Thomas, Gregory Owen; Poortinga, Wouter; Sautkina, Elena			Habit Discontinuity, Self-Activation, and the Diminishing Influence of Context Change: Evidence from the UK Understanding Society Survey	PLOS ONE			English	Article							TRAVEL BEHAVIOR; MODE CHOICE; METAANALYSIS; VALUES; LIFE	Repeated behaviours in stable contexts can become automatic habits. Habits are resistant to information-based techniques to change behaviour, but are contextually cued, so a change in behaviour context (e.g., location) weakens habit strength and can facilitate greater consideration of the behaviour. This idea was demonstrated in previous work, whereby people with strong environmental attitudes have lower car use, but only after recently moving home. We examine the habit discontinuity hypothesis by analysing the Understanding Society dataset with 18,053 individuals representative of the UK population, measuring time since moving home, travel mode to work, and strength of environmental attitudes. Results support previous findings where car use is significantly lower among those with stronger environmental views (but only after recently moving home), and in addition, demonstrate a trend where this effects decays as the time since moving home increases. We discuss results in light of moving into a new home being a potential 'window of opportunity' to promote pro-environmental behaviours.	[Thomas, Gregory Owen; Poortinga, Wouter; Sautkina, Elena] Cardiff Univ, Welsh Sch Architecture, Bute Bldg,King Edward VII Ave, Cardiff CF10 3NB, S Glam, Wales	Cardiff University	Thomas, GO (corresponding author), Cardiff Univ, Welsh Sch Architecture, Bute Bldg,King Edward VII Ave, Cardiff CF10 3NB, S Glam, Wales.	ThomasG37@cardiff.ac.uk	Sautkina, Elena/U-6408-2018; Sautkina, Elena/O-9156-2019; Poortinga, Wouter/A-1802-2010	Sautkina, Elena/0000-0002-9043-0906; Sautkina, Elena/0000-0002-9043-0906; Poortinga, Wouter/0000-0002-6926-8545; Thomas, Gregory/0000-0002-5566-4416	UK Economic and Social Research Council (ESRC) [ES/M00385X/1]; Economic and Social Research Council [ES/M00385X/1] Funding Source: researchfish; ESRC [ES/M00385X/1] Funding Source: UKRI	UK Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The research was funded by the UK Economic and Social Research Council (ESRC), grant reference number ES/M00385X/1. Details of the funding may be found online at: http://gtr.rcuk.ac. uk/project/2F02609D-27F5-46CB-BA70-A4FBD17A645B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Aarts H, 1997, ACTA PSYCHOL, V96, P1, DOI 10.1016/S0001-6918(97)00008-5; Aiken L. S., 1991, MULTIPLE REGRESSION; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bamberg S, 2006, ENVIRON BEHAV, V38, P820, DOI 10.1177/0013916505285091; Betsch T, 2001, ORGAN BEHAV HUM DEC, V84, P23, DOI 10.1006/obhd.2000.2916; Betsch T, 1999, SWISS J PSYCHOL, V58, P151, DOI 10.1024//1421-0185.58.3.151; Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383; Chorus C.G., 2006, EUR J TRANSP INFRAST, V6, P335; Clark B, 2014, TRANSPORT RES REC, P54, DOI 10.3141/2413-06; de Groot JIM, 2008, ENVIRON BEHAV, V40, P330, DOI 10.1177/0013916506297831; [DECC Change DoEaC], 2015, 2013 UK GREENH GAS E; [DfT Transport Df], 2011, TRANSP EN ENV STAT 2; [DfT DfT], 2011, CLIM CHANG TRANSP CH; Gardner B, 2008, TRANSPORT RES F-TRAF, V11, P300, DOI 10.1016/j.trf.2008.01.004; Gardner B, 2011, ANN BEHAV MED, V42, P174, DOI 10.1007/s12160-011-9282-0; Gardner B, 2009, TRANSPORT RES F-TRAF, V12, P68, DOI 10.1016/j.trf.2008.08.001; Jones CHD, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-109; Knies G., 2014, UNDERSTANDING SOC UK; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Marsden G, 2013, TRANSPORT RES A-POL, V51, P46, DOI 10.1016/j.tra.2013.03.004; Meyers LS, 2012, APPL MULTIVARIATE RE; Neal DT, 2011, PERSONALITY SOCIAL P; ONS, 2010, STAND OCC CLASS 2010, V3; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; Rodriguez DA, 2004, TRANSPORT RES D-TR E, V9, P151, DOI 10.1016/j.trd.2003.11.001; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Stanbridge K, 2006, 11 INT C TRAV BEH RE; Steg L, 2011, SOC NATUR RESOUR, V24, P349, DOI 10.1080/08941920903214116; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Thomas GO, 2014, ENV BEHAV; University of Essex. Institute for Social and Economic Research and NatCen Social Research Understanding Society, 2009, UND SOC WAV 1 4 2009; Verplanken B, 1997, EUR J SOC PSYCHOL, V27, P539, DOI 10.1002/(SICI)1099-0992(199709/10)27:5<539::AID-EJSP831>3.3.CO;2-1; Verplanken B, 2002, J PERS SOC PSYCHOL, V82, P434, DOI 10.1037/0022-3514.82.3.434; Verplanken B, 2008, J ENVIRON PSYCHOL, V28, P121, DOI 10.1016/j.jenvp.2007.10.005; Verplanken B, 2006, J PUBLIC POLICY MARK, V25, P90, DOI 10.1509/jppm.25.1.90; Walker I, 2014, ENV BEHAV; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843; Yong E, 2012, NATURE, V485, P298, DOI 10.1038/485298a	40	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153490	10.1371/journal.pone.0153490	http://dx.doi.org/10.1371/journal.pone.0153490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120333	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200028
J	Nothstein, AK; Eiche, E; Riemann, M; Nick, P; Winkel, LHE; Gottlicher, J; Steininger, R; Brendel, R; von Brasch, M; Konrad, G; Neumann, T				Nothstein, Alexandra K.; Eiche, Elisabeth; Riemann, Michael; Nick, Peter; Winkel, Lenny H. E.; Gottlicher, Jorg; Steininger, Ralph; Brendel, Rita; von Brasch, Matthias; Konrad, Gabriele; Neumann, Thomas			Tracking Se Assimilation and Speciation through the Rice Plant - Nutrient Competition, Toxicity and Distribution	PLOS ONE			English	Article							ORYZA-SATIVA L.; SELENIUM ACCUMULATION; SELENATE; SPECTROSCOPY; FRACTIONS; SULFATE; ROOTS; CHAIN; WHEAT; GRAIN	Up to 1 billion people are affected by low intakes of the essential nutrient selenium (Se) due to low concentrations in crops. Biofortification of this micronutrient in plants is an attractive way of increasing dietary Se levels. We investigated a promising method of Se biofortification of rice seedlings, as rice is the primary staple for 3 billion people, but naturally contains low Se concentrations. We studied hydroponic Se uptake for 0-2500 ppb Se, potential phyto-toxicological effects of Se and the speciation of Se along the shoots and roots as a function of added Se species, concentrations and other nutrients supplied. We found that rice germinating directly in a Se environment increased plant-Se by factor 2-16, but that nutrient supplementation is required to prevent phyto-toxicity. XANES data showed that selenite uptake mainly resulted in the accumulation of organic Se in roots, but that selenate uptake resulted in accumulation of selenate in the higher part of the shoot, which is an essential requirement for Se to be transported to the grain. The amount of organic Se in the plant was positively correlated with applied Se concentration. Our results indicate that biofortification of seedlings with selenate is a successful method to increase Se levels in rice.	[Nothstein, Alexandra K.; Eiche, Elisabeth; von Brasch, Matthias; Konrad, Gabriele; Neumann, Thomas] Karlsruhe Inst Technol, Inst Appl Geosci AGW, Adenauerring 20b, D-76131 Karlsruhe, Germany; [Riemann, Michael; Nick, Peter; Brendel, Rita] Karlsruhe Inst Technol, Mol Cell Biol, Inst Bot, Kaiserstr 2, D-76131 Karlsruhe, Germany; [Riemann, Michael; Nick, Peter; Brendel, Rita] Karlsruhe Inst Technol, Ctr Funct Nanostruct, Kaiserstr 2, D-76131 Karlsruhe, Germany; [Winkel, Lenny H. E.] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Winkel, Lenny H. E.] ETH, Inst Biogeochem & Pollutant Dynam, Univ Str 16, CH-8092 Zurich, Switzerland; [Gottlicher, Jorg; Steininger, Ralph] Karlsruhe Inst Technol, ANKA Synchrotron Radiat Facil, Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Karlsruhe Institute of Technology	Nothstein, AK (corresponding author), Karlsruhe Inst Technol, Inst Appl Geosci AGW, Adenauerring 20b, D-76131 Karlsruhe, Germany.	a.nothstein@kit.edu	Eiche, Elisabeth/G-3768-2011	Riemann, Michael/0000-0003-0287-2112; Winkel, Lenny/0000-0001-7586-7256; Eiche, Elisabeth/0000-0002-1493-9161	Landesgraduiertenfoderung Baden-Wurrtemberg through the Kalrsruhe Institute of Technology Council for Research and Promotion of Young Scientists (CRYS, KIT); Helmholtz Graduate School GRACE (KIT); Graduate School of Climate and Environment at the Karlsruhe Institute of Technology; Young Investigator Group for Selenium Isotopes - Karlsruhe Institute of Technology; Graduate School for Climate and Environment at the Karlsruhe Institute for Technology; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Karlsruhe Institute of Technology	Landesgraduiertenfoderung Baden-Wurrtemberg through the Kalrsruhe Institute of Technology Council for Research and Promotion of Young Scientists (CRYS, KIT); Helmholtz Graduate School GRACE (KIT); Graduate School of Climate and Environment at the Karlsruhe Institute of Technology; Young Investigator Group for Selenium Isotopes - Karlsruhe Institute of Technology; Graduate School for Climate and Environment at the Karlsruhe Institute for Technology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology	This study, which was part of a PhD study, was funded for 2 years by a graduate student grant from the Landesgraduiertenfoderung Baden-Wurrtemberg through the Kalrsruhe Institute of Technology Council for Research and Promotion of Young Scientists (CRYS, KIT) for financial support via Dr. Monika Stelling's YIG and the Helmholtz Graduate School GRACE (KIT). The third year of this PhD study was funded by a graduate student grant from the Graduate School of Climate and Environment at the Karlsruhe Institute of Technology. Lab material was made available through funding by the Young Investigator Group for Selenium Isotopes funded by the Karlsruhe Institute of Technology and the Graduate School for Climate and Environment at the Karlsruhe Institute for Technology. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banuelos GS, 2015, FOOD CHEM, V166, P603, DOI 10.1016/j.foodchem.2014.06.071; BELL PF, 1992, SOIL SCI SOC AM J, V56, P1818, DOI 10.2136/sssaj1992.03615995005600060035x; Brozmanova J, 2010, ARCH TOXICOL, V84, P919, DOI 10.1007/s00204-010-0595-8; Cantrell RP, 2002, SCIENCE, V296, P53, DOI 10.1126/science.1070721; Carey AM, 2012, ENVIRON SCI TECHNOL, V46, P5557, DOI 10.1021/es203871j; Eiche E, 2015, SCI TOTAL ENVIRON, V505, P952, DOI 10.1016/j.scitotenv.2014.10.080; Finley JW, 2005, NUTR REV, V63, P196, DOI 10.1111/j.1753-4887.2005.tb00137.x; Hartikainen H, 2005, J TRACE ELEM MED BIO, V18, P309, DOI 10.1016/j.jtemb.2005.02.009; Hopper JL, 1999, PLANT SOIL, V210, P199, DOI 10.1023/A:1004639906245; Keskinen R, 2011, NUTR CYCL AGROECOSYS, V91, P17, DOI 10.1007/s10705-011-9435-3; Khan MS, 2014, PLANT CELL MONOGR, V22, P247, DOI 10.1007/978-3-642-41787-0_8; Kikkert J, 2013, PLANT SOIL, V372, P629, DOI 10.1007/s11104-013-1773-2; LAUCHLI A, 1993, BOT ACTA, V106, P455; LeDuc DL, 2004, PLANT PHYSIOL, V135, P377, DOI 10.1104/pp.103.026989; Li HF, 2008, NEW PHYTOL, V178, P92, DOI 10.1111/j.1469-8137.2007.02343.x; Liu KL, 2009, J AGR FOOD CHEM, V57, P695, DOI 10.1021/jf802948k; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pickering IJ, 1999, J BIOL INORG CHEM, V4, P791, DOI 10.1007/s007750050352; Rayman M, 2002, LANCET, V379, P1256; Sun GX, 2010, ENVIRON SCI TECHNOL, V44, P6706, DOI 10.1021/es101843x; Terry N, 2000, ANNU REV PLANT PHYS, V51, P401, DOI 10.1146/annurev.arplant.51.1.401; Wang P, 2015, J EXP BOT, V66, P4795, DOI 10.1093/jxb/erv254; Wang P, 2013, PLANT PHYSIOL, V163, P407, DOI 10.1104/pp.113.222299; Williams PN, 2009, ENVIRON SCI TECHNOL, V43, P6024, DOI 10.1021/es900671m; Zayed A, 1998, PLANTA, V206, P284, DOI 10.1007/s004250050402; Zhao XQ, 2010, PLANT PHYSIOL, V153, P1871, DOI 10.1104/pp.110.157867; Zhu YG, 2009, TRENDS PLANT SCI, V14, P436, DOI 10.1016/j.tplants.2009.06.006	28	25	25	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0152081	10.1371/journal.pone.0152081	http://dx.doi.org/10.1371/journal.pone.0152081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116220	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600014
J	Mo, SS; Slettemeas, JS; Berg, ES; Norstrom, M; Sunde, M				Mo, Solveig Solverod; Slettemeas, Jannice Schau; Berg, Einar Sverre; Norstrom, Madelaine; Sunde, Marianne			Plasmid and Host Strain Characteristics of Escherichia coli Resistant to Extended-Spectrum Cephalosporins in the Norwegian Broiler Production	PLOS ONE			English	Article							BETA-LACTAMASE GENES; CHICKEN MEAT; SALMONELLA-ENTERICA; POULTRY-MEAT; RETAIL MEAT; VIRULENCE; INFECTIONS; ANIMALS; SWEDEN; OVEREXPRESSION	Escherichia coli resistant to extended-spectrum cephalosporins have been detected in the Norwegian broiler production, despite the fact that antimicrobial agents are rarely used. The genetic mechanism responsible for cephalosporin resistance is mainly attributed to the presence of the bla(CMY-2) gene encoding a plasmid-mediated AmpC-beta-lactamase (pAmpC). The aim of this study was to characterize and compare bla(CMY-2) containing Escherichia coli isolated from the intestinal flora of broilers and retail chicken meat (fillets) to identify possible successful clones and/or resistance plasmids widespread in the Norwegian broiler production. Methods used included PCR based phylotyping, conjugation experiments, plasmid replicon typing, pulsed-field gel electrophoresis, multiple locus variable-number tandem-repeats analysis and whole genome sequencing. The nucleotide sequence of an IncK plasmid carrying bla(CMY-2) was determined. Intestinal isolates displayed a higher degree of genetic diversity than meat isolates. A cluster of genetically related isolates belonging to ST38, phylogroup D, carrying bla(CMY-2) containing IncK plasmids was identified. Furthermore, genes encoding plasmid stability systems (relBE/stbDE and pndAC) were identified on the IncK plasmid. Single nucleotide polymorphism (SNP) analysis of a subset of isolates confirmed a close genetic relationship within the two most prevalent STs. The IncK plasmids within these two STs also shared a high degree of similarity. Cephalosporin-resistant E. coli with the same genetic characteristics have been identified in the broiler production in other European countries, and the IncK plasmid characterized in this study showed close homology to a plasmid isolated from retail chicken meat in the Netherlands. The results indicate that both clonal expansion and horizontal transfer of bla(CMY-2) containing plasmids contribute to dissemination of cephalosporin resistant E. coli in the broiler production. The presence of plasmid stability systems may explain why the IncK plasmid containing bla(CMY-2) is maintained and disseminated in the Norwegian broiler production in absence of selection pressure from the use of antimicrobial agents.	[Mo, Solveig Solverod; Slettemeas, Jannice Schau; Sunde, Marianne] Norwegian Vet Inst, Dept Diagnost Serv, Oslo, Norway; [Berg, Einar Sverre] Norwegian Inst Publ Hlth, Dept Foodborne Infect, Oslo, Norway; [Norstrom, Madelaine] Norwegian Vet Inst, Dept Hlth Surveillance, Oslo, Norway; [Sunde, Marianne] Norwegian Inst Publ Hlth, Dept Bacteriol & Immunol, Oslo, Norway	Norwegian Veterinary Institute; Norwegian Institute of Public Health (NIPH); Norwegian Veterinary Institute; Norwegian Institute of Public Health (NIPH)	Mo, SS (corresponding author), Norwegian Vet Inst, Dept Diagnost Serv, Oslo, Norway.	solveig.mo@vetinst.no		Slettemeas, Jannice Schau/0000-0003-2542-6991; Mo, Solveig Solverod/0000-0003-4532-9857; Sunde, Marianne/0000-0002-2326-4338	Research Council of Norway [225165/E40]	Research Council of Norway(Research Council of Norway)	The study was funded by a grant from the Research Council of Norway, www.forskningsradet.no, grant no. 225165/E40. The funders had no role in study design, data collection and analysis, descision to publish, or preparation of the manuscript.	Agerso Y, 2014, FOODBORNE PATHOG DIS, V11, P740, DOI 10.1089/fpd.2014.1742; Animalia, 2016, FORTS NEDG FOR RES B; Anjum MF, 2007, APPL ENVIRON MICROB, V73, P5692, DOI 10.1128/AEM.00419-07; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Berg ES, 2015, HIGHLY SIMILAR CEPHA; Bishop RE, 2000, BBA-PROTEIN STRUCT M, V1482, P73, DOI 10.1016/S0167-4838(00)00138-2; Borjesson S, 2013, CLIN MICROBIOL INFEC, V19, pE309, DOI 10.1111/1469-0691.12192; Borjesson S, 2013, APPL ENVIRON MICROB, V79, P2463, DOI 10.1128/AEM.03893-12; Brolund A, 2014, CLIN MICROBIOL INFEC, V20, pO344, DOI 10.1111/1469-0691.12413; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chattaway MA, 2014, EMERG INFECT DIS, V20, P1935, DOI 10.3201/eid2011.131845; Chung YJ, 2002, J BACTERIOL, V184, P2543, DOI 10.1128/JB.184.9.2543-2545.2002; Coque T M, 2008, Euro Surveill, V13; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Cortes P, 2010, APPL ENVIRON MICROB, V76, P2799, DOI 10.1128/AEM.02421-09; Dale AP, 2015, J INFECTION, V71, P615, DOI 10.1016/j.jinf.2015.09.009; de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Doi Y, 2010, CLIN MICROBIOL INFEC, V16, P33, DOI 10.1111/j.1469-0691.2009.03001.x; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; Egervarn M, 2014, INT J FOOD MICROBIOL, V171, P8, DOI 10.1016/j.ijfoodmicro.2013.11.005; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Hammerum AM, 2014, J ANTIMICROB CHEMOTH, V69, P2650, DOI 10.1093/jac/dku180; Hossain A, 2004, J ANTIMICROB CHEMOTH, V53, P964, DOI 10.1093/jac/dkh240; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Kang MS, 2006, ANTIMICROB AGENTS CH, V50, P1590, DOI 10.1128/AAC.50.4.1590-1593.2006; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Lazarus B, 2015, CLIN INFECT DIS, V60, P439, DOI 10.1093/cid/ciu785; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; Manges AR, 2016, CLIN MICROBIOL INFEC, V22, P122, DOI 10.1016/j.cmi.2015.11.010; Mo SS, 2014, VET MICROBIOL, V171, P315, DOI 10.1016/j.vetmic.2014.02.002; Naseer U, 2010, CLIN MICROBIOL INFEC, V16, P171, DOI 10.1111/j.1469-0691.2009.02861.x; [NORM/NORM-VET NORM/NORM-VET], 2012, NORM NORM VET 2012 U; [NORM/NORM-VET NORM/NORM-VET], 2013, NORM NORM VET 2013 U; [NORM/NORM-VET NORM/NORM-VET], 2006, NORM NORM VET 2006 U; [NORM/NORM-VET NORM/NORM-VET], 2011, NORM NORM VET 2011 U; NORM/NORM-VET. NORM/NORM-VET, 2014, NORM NORM VET 2014 U; NorwegianAgricultureAgency, MARK 2015 PRIS MARK; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Pitout JDD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00009; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P447, DOI 10.1128/AAC.49.1.447-450.2005; Refsum T, 2015, GO MORNING; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Schmidt GV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131672; Sunde M, 2009, J ANTIMICROB CHEMOTH, V63, P215, DOI 10.1093/jac/dkn445; Sunde M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128797; Unterholzner Simon J, 2013, Mob Genet Elements, V3, pe26219; Voets GM, 2013, INT J FOOD MICROBIOL, V167, P359, DOI 10.1016/j.ijfoodmicro.2013.10.001; Vogt D, 2014, MICROB DRUG RESIST, V20, P485, DOI 10.1089/mdr.2013.0210; WHO-AGISAR, 2011, CRIT IMP ANT HUM MED; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13	58	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154019	10.1371/journal.pone.0154019	http://dx.doi.org/10.1371/journal.pone.0154019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111852	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600027
J	Wu, YA; Zhou, YM; Lu, CH; Ahmad, H; Zhang, H; He, JT; Zhang, LL; Wang, T				Wu, Yanan; Zhou, Yanmin; Lu, Changhui; Ahmad, Hussain; Zhang, Hao; He, Jintian; Zhang, Lili; Wang, Tian			Influence of Butyrate Loaded Clinoptilolite Dietary Supplementation on Growth Performance, Development of Intestine and Antioxidant Capacity in Broiler Chickens	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SODIUM-BUTYRATE; NITRIC-OXIDE; NATURAL CLINOPTILOLITE; GASTROINTESTINAL-TRACT; ENZYME-ACTIVITIES; MORPHOLOGY; EXPRESSION; 5-FLUOROURACIL; DEALUMINATION	The study was conducted to evaluate the effects of dietary butyrate loaded clinoptilolite (CLI-B) on growth performance, pancreatic digestive enzymes, intestinal development and histomorphology, as well as antioxidant capacity of serum and intestinal mucosal in chickens. Two hundred forty 1-day-old commercial Arbor Acres broilers were randomly assigned to 4 groups: CON group (fed basal diets), SB group (fed basal diet with 0.05% sodium butyrate), CLI group (fed basal diet with 1% clinoptilolite), and CLI-B group (fed basal diet with 1% CLI-B). The results showed that supplementation of CLI-B significantly decreased (P < 0.05) feed conservation ratio at both 21 and 42 days of age, improved the pancreatic digestive enzymes activities (P < 0.05), increased the villus length and villus/crypt ratio (P < 0.05), and decreased the crypt depth of intestine (P < 0.05) as compared to the other experimental groups. Furthermore, the CLI-B environment improved the antioxidant capacity by increasing the antioxidant enzyme activities (P < 0.05) in intestine mucosal, and decreasing the NO content and iNOS activity (P < 0.05) in serum. In addition, CLI-B supplementation had improved the development of intestine and antioxidant capacity of broilers than supplementation with either clinoptilolite or butyrate sodium alone. In conclusion, 1% CLI-B supplementation improved the health status, intestine development and antioxidant capacity in broiler chickens, thus appearing as an important feed additive for the poultry industry.	[Wu, Yanan; Zhou, Yanmin; Lu, Changhui; Ahmad, Hussain; Zhang, Hao; He, Jintian; Zhang, Lili; Wang, Tian] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, T (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	tianwangnjau@163.com	Ahmad, hussain/AAP-9386-2020					Ahmad H, 2012, J AGR FOOD CHEM, V60, P7111, DOI 10.1021/jf3017207; Armbruster T., 2001, STUDIES SURFACE SCI, VVolume 135, P13, DOI DOI 10.1016/S0167-2991(01)81183-6; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Cao M, 2014, NUTRITION, V30, P1442, DOI 10.1016/j.nut.2014.04.016; Carraro A, 2014, APPL CLAY SCI, V88-89, P92, DOI 10.1016/j.clay.2013.11.028; Choct M, 2009, BRIT POULTRY SCI, V50, P9, DOI 10.1080/00071660802538632; Dong L, 2014, J HISTOCHEM CYTOCHEM, V62, P510, DOI 10.1369/0022155414532655; Evans M, 1989, ZEOLITES DO THEY HAV; FURUSE M, 1991, BRIT POULTRY SCI, V32, P159, DOI 10.1080/00071669108417337; GALFI P, 1990, ACTA VET HUNG, V38, P3; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Garcia-Basabe Y, 2010, MICROPOR MESOPOR MAT, V135, P187, DOI 10.1016/j.micromeso.2010.07.008; Guilloteau P, 2009, J DAIRY SCI, V92, P1038, DOI 10.3168/jds.2008-1213; Halliwell B, 2000, FREE RADICAL RES, V33, P819, DOI 10.1080/10715760000301341; Hu CH, 2012, ANIM FEED SCI TECH, V177, P108, DOI 10.1016/j.anifeedsci.2012.07.028; Hu CH, 2012, BIOL TRACE ELEM RES, V149, P190, DOI 10.1007/s12011-012-9422-9; Hu ZH, 2007, ANIM FEED SCI TECH, V132, P240, DOI 10.1016/j.anifeedsci.2006.03.017; HUME ME, 1993, POULTRY SCI, V72, P786, DOI 10.3382/ps.0720786; HWANG PP, 1993, MAR BIOL, V117, P551, DOI 10.1007/BF00349765; Incharoen T, 2011, J AGR SCI TECHNOLO A, P1284; Jahns F, 2015, MOL CARCINOGEN, V54, P249, DOI 10.1002/mc.22102; Jevtic S, 2012, MICROPOR MESOPOR MAT, V159, P30, DOI 10.1016/j.micromeso.2012.04.014; Jin L, 2014, J INTEGR AGR, V13, P2731, DOI 10.1016/S2095-3119(13)60729-7; Jung BG, 2010, VET MICROBIOL, V143, P117, DOI 10.1016/j.vetmic.2009.11.009; Kanika G, 2015, J BIOCHEM MOL TOXIC, V29, P349, DOI 10.1002/jbt.21698; Karpuzoglu E, 2006, NITRIC OXIDE-BIOL CH, V15, P177, DOI 10.1016/j.niox.2006.03.009; Koide N, 2003, MICROBIOL IMMUNOL, V47, P669, DOI 10.1111/j.1348-0421.2003.tb03430.x; Kotunia A, 2004, J Physiol Pharmacol, V55 Suppl 2, P59; Li ZX, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-30; Matis G, 2015, DOMEST ANIM ENDOCRIN, V50, P26, DOI 10.1016/j.domaniend.2014.07.004; MESSMER UK, 1995, MOL PHARMACOL, V47, P757; MILES RD, 1986, NUTR REP INT, V34, P1097; NABUURS MJA, 1993, RES VET SCI, V55, P78, DOI 10.1016/0034-5288(93)90038-H; Nezamzadeh-Ejhieh A, 2013, J CHEM, V2012; Oguz H., 2011, Eurasian Journal of Veterinary Sciences, V27, P1; Oliveira L, 2014, LIVEST SCI, V167, P227, DOI 10.1016/j.livsci.2014.05.013; Olukosi OA, 2014, J ANIM SCI, V92, P3945, DOI 10.2527/jas.2013-6368; OLVER MD, 1989, BRIT POULTRY SCI, V30, P115, DOI 10.1080/00071668908417130; Orchel Arkadiusz, 2006, Acta Pol Pharm, V63, P441; Papaioannou D, 2005, MICROPOR MESOPOR MAT, V84, P161, DOI 10.1016/j.micromeso.2005.05.030; Pavelic K, 2002, J CANCER RES CLIN, V128, P37, DOI 10.1007/s00432-001-0301-6; Qu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029641; Ricke SC, 2003, POULTRY SCI, V82, P632, DOI 10.1093/ps/82.4.632; ROLAND DA, 1990, POULTRY SCI, V69, P2157, DOI 10.3382/ps.0692157; Rozic M, 2005, J COLLOID INTERF SCI, V284, P48, DOI 10.1016/j.jcis.2004.09.061; SCHEPPACH W, 1992, JPEN-PARENTER ENTER, V16, P43, DOI 10.1177/014860719201600143; Spanakis M, 2014, NANOMED-NANOTECHNOL, V10, P197, DOI 10.1016/j.nano.2013.06.016; Sverko V, 2004, FOOD TECHNOL BIOTECH, V42, P189; Tang ZG, 2014, ANIM FEED SCI TECH, V189, P98, DOI 10.1016/j.anifeedsci.2013.12.014; Thompson JL, 1997, BRIT POULTRY SCI, V38, P59, DOI 10.1080/00071669708417941; Vilaca N, 2013, COLLOID SURFACE B, V112, P237, DOI 10.1016/j.colsurfb.2013.07.042; Wachtershauser A, 2000, EUR J NUTR, V39, P164, DOI 10.1007/s003940070020; Wang O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118135; Wen C, 2012, ANIM FEED SCI TECH, V172, P180, DOI 10.1016/j.anifeedsci.2011.11.012; Wu QJ, 2013, ASIAN AUSTRAL J ANIM, V26, P987, DOI 10.5713/ajas.2012.12545; Wu QJ, 2013, VET IMMUNOL IMMUNOP, V153, P70, DOI 10.1016/j.vetimm.2013.02.006; Wu YA, 2013, BIOL TRACE ELEM RES, V155, P228, DOI 10.1007/s12011-013-9777-6; Xiao M, 2014, BIOMED ENVIRON SCI, V27, P197, DOI 10.3967/bes2014.040; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zarkovic N, 2003, ANTICANCER RES, V23, P1589	60	36	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154410	10.1371/journal.pone.0154410	http://dx.doi.org/10.1371/journal.pone.0154410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104860	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100077
J	Meilinger, T; Watanabe, K				Meilinger, Tobias; Watanabe, Katsumi			Multiple Strategies for Spatial Integration of 2D Layouts within Working Memory	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; TEMPORAL INTEGRATION; VISUAL PERCEPTS; INFORMATION; ATTENTION; KNOWLEDGE; IMAGES; FRAMES; FORM	Prior results on the spatial integration of layouts within a room differed regarding the reference frame that participants used for integration. We asked whether these differences also occur when integrating 2D screen views and, if so, what the reasons for this might be. In four experiments we showed that integrating reference frames varied as a function of task familiarity combined with processing time, cues for spatial transformation, and information about action requirements paralleling results in the 3D case. Participants saw part of an object layout in screen 1, another part in screen 2, and reacted on the integrated layout in screen 3. Layout presentations between two screens coincided or differed in orientation. Aligning misaligned screens for integration is known to increase errors/latencies. The error/latency pattern was thus indicative of the reference frame used for integration. We showed that task familiarity combined with self-paced learning, visual updating, and knowing from where to act prioritized the integration within the reference frame of the initial presentation, which was updated later, and from where participants acted respectively. Participants also heavily relied on layout intrinsic frames. The results show how humans flexibly adjust their integration strategy to a wide variety of conditions.	[Meilinger, Tobias; Watanabe, Katsumi] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Meilinger, Tobias] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Spemannstr 38, D-72076 Tubingen, Germany; [Watanabe, Katsumi] Waseda Univ, Dept Intermedia Art & Sci, Tokyo, Japan	University of Tokyo; Max Planck Society; Waseda University	Meilinger, T (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan.; Meilinger, T (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Spemannstr 38, D-72076 Tubingen, Germany.	tobias.meilinger@tuebingen.mpg.de	Meilinger, Tobias/C-3969-2014	Meilinger, Tobias/0000-0002-1326-1213; Watanabe, Katsumi/0000-0003-1282-9994	Japanese Society for the Promotion of Science; Humboldt Foundation	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by the Japanese Society for the Promotion of Science and the Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraamides MN, 2012, SPATIAL COGNITION, P182; Brockmole JR, 2003, PSYCHON B REV, V10, P510, DOI 10.3758/BF03196514; Brockmole JR, 2002, J EXP PSYCHOL HUMAN, V28, P315, DOI 10.1037//0096-1523.28.2.315; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Deubel H, 2004, VIS COGN, V11, P173, DOI 10.1080/13506280344000284; GOLLEDGE RG, 1993, J ENVIRON PSYCHOL, V13, P293, DOI 10.1016/S0272-4944(05)80252-X; Greenauer N, 2013, PSYCHOL RES-PSYCH FO, V77, P540, DOI 10.1007/s00426-012-0452-x; Greenauer N, 2010, J EXP PSYCHOL LEARN, V36, P938, DOI 10.1037/a0019647; HANLEY GL, 1983, MEM COGNITION, V11, P415, DOI 10.3758/BF03202457; HAYHOE M, 1991, PERCEPTION, V20, P393, DOI 10.1068/p200393; Jiang Y, 2005, EXP PSYCHOL, V52, P1, DOI [10.1027/1618-3169.52.1.x, DOI 10.1027/1618-3169.52.1.X]; Jiang YH, 2004, EXP PSYCHOL, V51, P45, DOI 10.1027/1617-3169.51.1.45; JONIDES J, 1982, SCIENCE, V215, P192, DOI 10.1126/science.7053571; Kelly JW, 2013, COGNITION, V126, P459, DOI 10.1016/j.cognition.2012.11.007; Kelly JW, 2011, COGNITION, V118, P444, DOI 10.1016/j.cognition.2010.12.006; Kelly JW, 2010, COGNITION, V116, P409, DOI 10.1016/j.cognition.2010.06.002; Kelly JW, 2010, SPATIAL COGNITION, P222; McNamara TP, 2008, COGNITIVE PSYCHOL ME, P157; Meilinger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074177; Meilinger T, 2011, MEM COGNITION, V39, P1042, DOI 10.3758/s13421-011-0088-x; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Melcher D, 2007, NAT NEUROSCI, V10, P903, DOI 10.1038/nn1917; MONTELLO DR, 1993, ENVIRON BEHAV, V25, P457, DOI 10.1177/0013916593253002; Snijders T, 1999, MULTILEVEL ANAL; Yamamoto N, 2009, VIS COGN, V17, P457, DOI 10.1080/13506280701653644	25	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154088	10.1371/journal.pone.0154088	http://dx.doi.org/10.1371/journal.pone.0154088			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27101011	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500141
J	Bursley, JK; Nestor, A; Tarr, MJ; Creswell, JD				Bursley, James K.; Nestor, Adrian; Tarr, Michael J.; Creswell, J. David			Awake, Offline Processing during Associative Learning	PLOS ONE			English	Article							MEMORY CONSOLIDATION; PREFRONTAL CORTEX; POSTENCODING REST; SLEEP; PRECUNEUS; CONNECTIVITY; REACTIVATION; RETRIEVAL; PATTERNS; REPLAY	Offline processing has been shown to strengthen memory traces and enhance learning in the absence of conscious rehearsal or awareness. Here we evaluate whether a brief, two-minute offline processing period can boost associative learning and test a memory reactivation account for these offline processing effects. After encoding paired associates, subjects either completed a distractor task for two minutes or were immediately tested for memory of the pairs in a counterbalanced, within-subjects functional magnetic resonance imaging study. Results showed that brief, awake, offline processing improves memory for associate pairs. Moreover, multi-voxel pattern analysis of the neuroimaging data suggested reactivation of encoded memory representations in dorsolateral prefrontal cortex during offline processing. These results signify the first demonstration of awake, active, offline enhancement of associative memory and suggest that such enhancement is accompanied by the offline reactivation of encoded memory representations.	[Bursley, James K.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Bursley, James K.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Nestor, Adrian] Univ Toronto Scarborough, Dept Psychol, Toronto, ON, Canada; [Tarr, Michael J.; Creswell, J. David] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Tarr, Michael J.; Creswell, J. David] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Harvard University; Harvard University; University of Toronto; University Toronto Scarborough; Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bursley, JK (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.; Bursley, JK (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.; Creswell, JD (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.; Creswell, JD (corresponding author), Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA.	bursley@fas.harvard.edu; creswell@cmu.edu		Nestor, Adrian/0000-0002-2250-8759; Bursley, James/0000-0001-6543-4713	Rothberg Research Award in Human Brain Imaging	Rothberg Research Award in Human Brain Imaging	This work was supported by a Rothberg Research Award in Human Brain Imaging awarded to JKB and JDC, http://www.cmu.edu/news/archive/2011/July/july7_rothbergawards.shtml. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Bos MW, 2008, J EXP SOC PSYCHOL, V44, P1114, DOI 10.1016/j.jesp.2008.01.001; Brown RM, 2007, J NEUROSCI, V27, P10468, DOI 10.1523/JNEUROSCI.2799-07.2007; Brown RM, 2007, NAT NEUROSCI, V10, P148, DOI 10.1038/nn1836; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; Craig M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093915; Creswell JD, 2013, SOC COGN AFFECT NEUR; Deuker L, 2013, J NEUROSCI, V33, P19373, DOI 10.1523/JNEUROSCI.0414-13.2013; Dewar M, 2012, PSYCHOL SCI, V23, P955, DOI 10.1177/0956797612441220; Dijksterhuis A, 2006, PERSPECT PSYCHOL SCI, V1, P95, DOI 10.1111/j.1745-6916.2006.00007.x; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; Geuze E, 2007, PROG BRAIN RES, V167, P293, DOI 10.1016/S0079-6123(07)67026-5; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Groen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019985; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Krause BJ, 1999, BRAIN, V122, P255, DOI 10.1093/brain/122.2.255; Levy BJ, 2013, PERSPECT PSYCHOL SCI, V8, P72, DOI 10.1177/1745691612469031; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Mottaghy FM, 1999, EXP BRAIN RES, V128, P332, DOI 10.1007/s002210050853; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Peters J, 2009, HIPPOCAMPUS, V19, P141, DOI 10.1002/hipo.20490; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Sharon T, 2011, P NATL ACAD SCI USA, V108, P1146, DOI 10.1073/pnas.1005238108; SHEA JB, 1979, J EXP PSYCHOL-HUM L, V5, P179, DOI 10.1037/0278-7393.5.2.179; Staresina BP, 2006, J NEUROSCI, V26, P9162, DOI 10.1523/JNEUROSCI.2877-06.2006; Staresina BP, 2013, P NATL ACAD SCI USA, V110, P21159, DOI 10.1073/pnas.1311989110; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Summerfield C, 2006, PLOS BIOL, V4, P855, DOI 10.1371/journal.pbio.0040128; Tambini A, 2013, P NATL ACAD SCI USA, V110, P19591, DOI 10.1073/pnas.1308499110; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Turk-Browne NB, 2006, NEURON, V49, P917, DOI 10.1016/j.neuron.2006.01.030; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107	45	5	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0127522	10.1371/journal.pone.0127522	http://dx.doi.org/10.1371/journal.pone.0127522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119345	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200001
J	Dakin, R; McCrossan, O; Hare, JF; Montgomerie, R; Kane, SA				Dakin, Roslyn; McCrossan, Owen; Hare, James F.; Montgomerie, Robert; Kane, Suzanne Amador			Biomechanics of the Peacock's Display: How Feather Structure and Resonance Influence Multimodal Signaling	PLOS ONE			English	Article							COURTSHIP DISPLAYS; PERFORMANCE; FLUTTER; ARANEAE; SOUNDS	Courtship displays may serve as signals of the quality of motor performance, but little is known about the underlying biomechanics that determines both their signal content and costs. Peacocks (Pavo cristatus) perform a complex, multimodal "train-rattling" display in which they court females by vibrating the iridescent feathers in their elaborate train ornament. Here we study how feather biomechanics influences the performance of this display using a combination of field recordings and laboratory experiments. Using high-speed video, we find that train-rattling peacocks stridulate their tail feathers against the train at 25.6 Hz, on average, generating a broadband, pulsating mechanical sound at that frequency. Laboratory measurements demonstrate that arrays of peacock tail and train feathers have a broad resonant peak in their vibrational spectra at the range of frequencies used for train-rattling during the display, and the motion of feathers is just as expected for feathers shaking near resonance. This indicates that peacocks are able to drive feather vibrations energetically efficiently over a relatively broad range of frequencies, enabling them to modulate the feather vibration frequency of their displays. Using our field data, we show that peacocks with longer trains use slightly higher vibration frequencies on average, even though longer train feathers are heavier and have lower resonant frequencies. Based on these results, we propose hypotheses for future studies of the function and energetics of this display that ask why its dynamic elements might attract and maintain female attention. Finally, we demonstrate how the mechanical structure of the train feathers affects the peacock's visual display by allowing the colorful iridescent eyespots-which strongly influence female mate choice-to remain nearly stationary against a dynamic iridescent background.	[Dakin, Roslyn] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [McCrossan, Owen] Drexel Univ, Philadelphia, PA 19104 USA; [Hare, James F.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Montgomerie, Robert] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Kane, Suzanne Amador] Haverford Coll, Dept Phys, Haverford, PA 19041 USA	University of British Columbia; Drexel University; University of Manitoba; Queens University - Canada; Haverford College	Dakin, R (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.; Kane, SA (corresponding author), Haverford Coll, Dept Phys, Haverford, PA 19041 USA.	roslyn.dakin@gmail.com; samador@haverford.edu			National Sciences and Engineering Research Council of Canada (NSERC); NSERC [RGPIN-2349-08, RGPIN-1542-71]; Haverford College	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Haverford College	This research was supported by a National Sciences and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship (RD), NSERC grants to RM (RGPIN-2349-08) and JFH (RGPIN-1542-71), and funding from Haverford College (SAK).	Andersson Malte, 1994; Bachmann T, 2012, J EXP BIOL, V215, P405, DOI 10.1242/jeb.059451; Bostwick KS, 2010, P R SOC B, V277, P835, DOI 10.1098/rspb.2009.1576; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Clark CJ, 2013, J EXP BIOL, V216, P3395, DOI 10.1242/jeb.080317; Clark CJ, 2013, J EXP BIOL, V216, P3404, DOI 10.1242/jeb.085993; Clark CJ, 2009, P ROY SOC B-BIOL SCI, V276, P3047, DOI 10.1098/rspb.2009.0508; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Corfield JR, 2013, HEARING RES, V304, P111, DOI 10.1016/j.heares.2013.07.004; Dakin R, 2013, BEHAV ECOL, V24, P1048, DOI 10.1093/beheco/art045; Dakin R, 2011, ANIM BEHAV, V82, P21, DOI 10.1016/j.anbehav.2011.03.016; Dakin R, 2009, BEHAV ECOL SOCIOBIOL, V63, P825, DOI 10.1007/s00265-009-0717-6; Darwin C., 1871, P423; Dickerson AK, 2012, J R SOC INTERFACE, V9, P3208, DOI 10.1098/rsif.2012.0429; DOOLING RJ, 1981, J COMP PHYSIOL, V143, P383, DOI 10.1007/BF00611177; Elias DO, 2012, BIOL J LINN SOC, V105, P522, DOI 10.1111/j.1095-8312.2011.01817.x; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; Freeman AR, 2015, ANIM BEHAV, V102, P241, DOI 10.1016/j.anbehav.2015.01.029; Haller NK, 2014, VISION RES, V102, P19, DOI 10.1016/j.visres.2014.07.007; Healy K, 2013, ANIM BEHAV, V86, P685, DOI 10.1016/j.anbehav.2013.06.018; Hebets EA, 1999, ANIM BEHAV, V57, P865, DOI 10.1006/anbe.1998.1048; Iwata T, 2013, AQUATIC MAMMALS, V39; Jung R., 1973, HDB SENSORY PHYSL, VVII/3A, P455; Kleinebeckel D, 1990, THERMOREGULATION PHY, P235; Koch RE, 2015, AUK, V132, P349, DOI 10.1642/AUK-14-63.1; Kovalev A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0988; Liu ZQ, 2015, ACTA BIOMATER, V17, P137, DOI 10.1016/j.actbio.2015.01.035; Loyau A, 2007, BEHAV ECOL, V18, P1123, DOI 10.1093/beheco/arm088; Macho-Stadler E, 2015, EUR J PHYS, V36, DOI 10.1088/0143-0807/36/5/055007; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Neimark MA, 2003, J NEUROSCI, V23, P6499; Ha NS, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/046008; Ortega-Jimenez VM, 2012, J R SOC INTERFACE, V9, P1093, DOI 10.1098/rsif.2011.0608; PACHORI G N, 1970, Annals of Zoology (Agra), V6, P109; Petrie M, 1996, J ZOOL, V238, P365, DOI 10.1111/j.1469-7998.1996.tb05400.x; Potter M.C., 2002, MECH FLUIDS; Program BR, 2011, RAV PROINT SOUND AN; R Core Team, 2015, R LANG DEV ENV STAT; Ridley M.W., 1984, World Pheasant Association Journal, V9, P57; Ros AFH, 2009, J ETHOL, V27, P209, DOI 10.1007/s10164-008-0105-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitz A, 2015, J MORPHOL, V276, P33, DOI 10.1002/jmor.20317; Smith WF, 2010, WAVES OSCILLATIONS P; VINCENT JFV, 1986, J ZOOL, V210, P55, DOI 10.1111/j.1469-7998.1986.tb03620.x; Volterra E., 1965, DYNAMICS VIBRATIONS; Weiss IM, 2010, J EXP ZOOL PART A, V313A, P690, DOI 10.1002/jez.641; Williams CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008806; Yorzinski JL, 2013, J EXP BIOL, V216, P3035, DOI 10.1242/jeb.087338	49	12	12	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152759	10.1371/journal.pone.0152759	http://dx.doi.org/10.1371/journal.pone.0152759			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119380	gold, Green Submitted, Green Published			2022-12-27	WOS:000374976200012
J	Forsberg, V; Zhang, RY; Backstrom, J; Dahlstrom, C; Andres, B; Norgren, M; Andersson, M; Hummelgard, M; Olin, H				Forsberg, Viviane; Zhang, Renyun; Backstrom, Joakim; Dahlstrom, Christina; Andres, Britta; Norgren, Magnus; Andersson, Mattias; Hummelgard, Magnus; Olin, Hakan			Exfoliated MoS2 in Water without Additives	PLOS ONE			English	Article							LARGE-SCALE PRODUCTION; LIQUID EXFOLIATION; NANOSHEETS; GRAPHENE; INTERCALATION; DISPERSION; NANOTUBES; CHEMISTRY; RAMAN; MONO	Many solution processing methods of exfoliation of layered materials have been studied during the last few years; most of them are based on organic solvents or rely on surfactants and other funtionalization agents. Pure water should be an ideal solvent, however, it is generally believed, based on solubility theories that stable dispersions of water could not be achieved and systematic studies are lacking. Here we describe the use of water as a solvent and the stabilization process involved therein. We introduce an exfoliation method of molybdenum disulfide (MoS2) in pure water at high concentration (i.e., 0.14 +/- 0.01 g L-1). This was achieved by thinning the bulk MoS2 by mechanical exfoliation between sand papers and dispersing it by liquid exfoliation through probe sonication in water. We observed thin MoS2 nanosheets in water characterized by TEM, AFM and SEM images. The dimensions of the nanosheets were around 200 nm, the same range obtained in organic solvents. Electrophoretic mobility measurements indicated that electrical charges may be responsible for the stabilization of the dispersions. A probability decay equation was proposed to compare the stability of these dispersions with the ones reported in the literature. Water can be used as a solvent to disperse nanosheets and although the stability of the dispersions may not be as high as in organic solvents, the present method could be employed for a number of applications where the dispersions can be produced on site and organic solvents are not desirable.	[Forsberg, Viviane; Zhang, Renyun; Backstrom, Joakim; Dahlstrom, Christina; Andres, Britta; Norgren, Magnus; Andersson, Mattias; Hummelgard, Magnus; Olin, Hakan] Mid Sweden Univ, Dept Nat Sci, Sundsvall, Sweden	Mid-Sweden University	Forsberg, V (corresponding author), Mid Sweden Univ, Dept Nat Sci, Sundsvall, Sweden.	viviane.forsberg@gmail.com	Olin, Håkan/A-8175-2008; Zhang, Renyun/C-6617-2009; Backstrom, Joakim/E-2299-2011	Olin, Håkan/0000-0001-7329-3359; Andres, Britta/0000-0002-2393-3378; Zhang, Renyun/0000-0003-2873-7875; /0000-0003-3407-7973; Backstrom, Joakim/0000-0001-8868-4766	KKS foundation; European regional development fund; Swedish Energy Agency; County Government of Vasternorrland	KKS foundation; European regional development fund(European Commission); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); County Government of Vasternorrland	This work was supported by the KKS foundation, the European regional development fund, Swedish Energy Agency, and County Government of Vasternorrland.	Alecrim V, 2015, PROC NIP 31ST DIGITA, V2015, P192; Backes C, 2015, ANGEW CHEM, V127, P2676, DOI DOI 10.1002/ANGE.201409412; Benavente E, 2002, COORDIN CHEM REV, V224, P87, DOI 10.1016/S0010-8545(01)00392-7; Brauer HE, 1997, PHYS REV B, V55, P10022, DOI 10.1103/PhysRevB.55.10022; Chhowalla M, 2013, NAT CHEM, V5, P263, DOI [10.1038/NCHEM.1589, 10.1038/nchem.1589]; COEHOORN R, 1987, PHYS REV B, V35, P6203, DOI 10.1103/PhysRevB.35.6203; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Dumcenco D, 2015, ACS NANO, V9, P4611, DOI 10.1021/acsnano.5b01281; Eda G, 2012, ACS NANO, V6, P7311, DOI 10.1021/nn302422x; Hanlon D, 2014, CHEM MATER, V26, P1751, DOI 10.1021/cm500271u; Hansen C.M., 2007, HANSEN SOLUBILITY PA, V2nd, DOI [10.1201/9781420006834, DOI 10.1201/9781420006834]; Ibanez M, 2014, CLAY CLAY MINER, V62, P374, DOI 10.1346/CCMN.2014.0620502; ICDD, 2014, OWDER DIFRACTION FIL; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; JOENSEN P, 1986, MATER RES BULL, V21, P457, DOI 10.1016/0025-5408(86)90011-5; KAM KK, 1982, J PHYS CHEM-US, V86, P463, DOI 10.1021/j100393a010; Kuc A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245213; Lee YH, 2012, ADV MATER, V24, P2320, DOI 10.1002/adma.201104798; Lotya M, 2009, J AM CHEM SOC, V131, P3611, DOI 10.1021/ja807449u; MIREMADI BK, 1987, J CATAL, V103, P334, DOI 10.1016/0021-9517(87)90125-4; Niu LY, 2016, SMALL, V12, P272, DOI 10.1002/smll.201502207; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; O'Neill A, 2012, CHEM MATER, V24, P2414, DOI 10.1021/cm301515z; O'Neill A, 2011, J PHYS CHEM C, V115, P5422, DOI 10.1021/jp110942e; Paton KR, 2014, NAT MATER, V13, P624, DOI [10.1038/nmat3944, 10.1038/NMAT3944]; Pu J, 2012, NANO LETT, V12, P4013, DOI 10.1021/nl301335q; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Smith RJ, 2011, ADV MATER, V23, P3944, DOI 10.1002/adma.201102584; Smoluchowski Mv, 1921, HANDBUCH DER ELEKTRI, VII; Stephenson T, 2014, ENERG ENVIRON SCI, V7, P209, DOI 10.1039/c3ee42591f; Sun Z, 2008, J PHYS CHEM C, V112, P10692, DOI 10.1021/jp8021634; TRIBUTSCH H, 1980, FARADAY DISCUSS, V70, P189, DOI 10.1039/dc9807000189; Varrla E, 2015, CHEM MATER, V27, P1129, DOI 10.1021/cm5044864; Visic B, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-593; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/NNANO.2012.193, 10.1038/nnano.2012.193]; WEIMER M, 1988, PHYS REV B, V37, P4292, DOI 10.1103/PhysRevB.37.4292; WIETING TJ, 1971, PHYS REV B, V3, P4286, DOI 10.1103/PhysRevB.3.4286; Windom BC, 2011, TRIBOL LETT, V42, P301, DOI 10.1007/s11249-011-9774-x; Yao YG, 2012, J MATER CHEM, V22, P13494, DOI 10.1039/c2jm30587a; Yoffe A. D., 1973, 1973 Annual review of materials science, vol.3, P147; Yu Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02697; Zhang WT, 2015, NANOSCALE, V7, P10210, DOI 10.1039/c5nr02253c; Zhou KG, 2011, ANGEW CHEM INT EDIT, V50, P10839, DOI 10.1002/anie.201105364	43	74	74	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154522	10.1371/journal.pone.0154522	http://dx.doi.org/10.1371/journal.pone.0154522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120098	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200086
J	Oczkowski, SJ; Chung, HO; Hanvey, L; Mbuagbaw, L; You, JJ				Oczkowski, Simon J.; Chung, Han-Oh; Hanvey, Louise; Mbuagbaw, Lawrence; You, John J.			Communication Tools for End-of-Life Decision-Making in Ambulatory Care Settings: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; OBSTRUCTIVE PULMONARY-DISEASE; ADVANCE DIRECTIVES; CARDIOPULMONARY-RESUSCITATION; TREATMENT PREFERENCES; SUSTAINING TREATMENT; DIALYSIS PATIENTS; ADVANCED CANCER; VIDEO IMAGES; NURSING-HOME	Background Patients with serious illness, and their families, state that better communication and decision-making with healthcare providers is a high priority to improve the quality of end-of-life care. Numerous communication tools to assist patients, family members, and clinicians in end-of-life decision-making have been published, but their effectiveness remains unclear. Objectives To determine, amongst adults in ambulatory care settings, the effect of structured communication tools for end-of-life decision-making on completion of advance care planning. Methods We searched for relevant randomized controlled trials (RCTs) or non-randomized intervention studies in MEDLINE, EMBASE, CINAHL, ERIC, and the Cochrane Database of Randomized Controlled Trials from database inception until July 2014. Two reviewers independently screened articles for eligibility, extracted data, and assessed risk of bias. Grading of Recommendations Assessment, Development, and Evaluation (GRADE) was used to evaluate the quality of evidence for each of the primary and secondary outcomes. Results Sixty-seven studies, including 46 RCTs, were found. The majority evaluated communication tools in older patients (age > 50) with no specific medical condition, but many specifically evaluated populations with cancer, lung, heart, neurologic, or renal disease. Most studies compared the use of communication tools against usual care, but several compared the tools to less-intensive advance care planning tools. The use of structured communication tools increased: the frequency of advance care planning discussions/discussions about advance directives (RR 2.31, 95% CI 1.25-4.26, p = 0.007, low quality evidence) and the completion of advance directives (ADs) (RR 1.92, 95% CI 1.43-2.59, p<0.001, low quality evidence); concordance between AD preferences and subsequent medical orders for use or non-use of life supporting treatment (RR 1.19, 95% CI 1.01-1.39, p = 0.028, very low quality evidence, 1 observational study); and concordance between the care desired and care received by patients (RR 1.17, 95% CI 1.05-1.30, p = 0.004, low quality evidence, 2 RCTs). Conclusions The use of structured communication tools may increase the frequency of discussions about and completion of advance directives, and concordance between the care desired and the care received by patients. The use of structured communication tools rather than an ad-hoc approach to end-of-life decision-making should be considered, and the selection and implementation of such tools should be tailored to address local needs and context.	[Oczkowski, Simon J.; Chung, Han-Oh; You, John J.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Hanvey, Louise] Canadian Hosp Palliat Care Assoc, Ottawa, ON, Canada; [Mbuagbaw, Lawrence; You, John J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Mbuagbaw, Lawrence] St Josephs Healthcare Hamilton, Biostat Unit, Father Sean OSullivan Res Ctr, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Oczkowski, SJ (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	oczkowsj@mcmaster.ca	Oczkowski, Simon/AAL-6833-2020; Mbuagbaw, Lawrence/D-9381-2015	Oczkowski, Simon/0000-0002-2874-8948; Mbuagbaw, Lawrence/0000-0001-5855-5461	Technology Evaluation in the Elderly Network [KS 2014-06]	Technology Evaluation in the Elderly Network	This work was supported by a grant from the Technology Evaluation in the Elderly Network (http://www.tvn-nce.ca, #KS 2014-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au DH, 2012, CHEST, V141, P726, DOI 10.1378/chest.11-0362; Briggs LA, 2004, J PROF NURS, V20, P47, DOI 10.1016/j.profnurs.2003.12.001; Brown JB, 1999, J GEN INTERN MED, V14, P21, DOI 10.1046/j.1525-1497.1999.00276.x; Chan HYL, 2010, J CLIN NURS, V19, P3073, DOI 10.1111/j.1365-2702.2010.03353.x; Clayton JM, 2007, J CLIN ONCOL, V25, P715, DOI 10.1200/JCO.2006.06.7827; Deep KS, 2010, PATIENT EDUC COUNS, V81, P229, DOI 10.1016/j.pec.2010.02.004; Dexter PR, 1998, ANN INTERN MED, V128, P102, DOI 10.7326/0003-4819-128-2-199801150-00005; Ditto PH, 2001, ARCH INTERN MED, V161, P421, DOI 10.1001/archinte.161.3.421; Dyar S, 2012, J PALLIAT MED, V15, P890, DOI 10.1089/jpm.2012.0014; Einterz SF, 2014, J AM MED DIR ASSOC, V15, P251, DOI 10.1016/j.jamda.2013.11.020; El-Jawahri A, 2010, J CLIN ONCOL, V28, P305, DOI 10.1200/JCO.2009.24.7502; Engelhardt JB, 2006, AM J MANAG CARE, V12, P93; Engelhardt JB, 2009, AM J MANAG CARE, V15, P817; Epstein AS, 2013, J PALLIAT MED, V16, P623, DOI 10.1089/jpm.2012.0524; Fung AWT, 2010, AGING MENT HEALTH, V14, P994, DOI 10.1080/13607863.2010.501065; GRADE working group, GRADEPRO ONLINE SOFT; Grimaldo DA, 2001, ANESTHESIOLOGY, V95, P43, DOI 10.1097/00000542-200107000-00012; Gutheil IA, 2005, HEALTH SOC WORK, V30, P107, DOI 10.1093/hsw/30.2.107; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Hanson LC, 2005, J PALLIAT MED, V8, P1207, DOI 10.1089/jpm.2005.8.1207; Heiman H, 2004, AM J MED, V117, P318, DOI 10.1016/j.amjmed.2004.03.027; Heyland DK, 2013, JAMA INTERN MED, V173, P778, DOI 10.1001/jamainternmed.2013.180; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; HIGH DM, 1993, GERONTOLOGIST, V33, P342, DOI 10.1093/geront/33.3.342; Hossler C, 2011, AMYOTROPH LATERAL SC, V12, P172, DOI 10.3109/17482968.2010.509865; Jones L, 2011, PALLIAT SUPPORT CARE, V9, P3, DOI 10.1017/S1478951510000490; Kirchhoff KT, 2010, J AM GERIATR SOC, V58, P1233, DOI 10.1111/j.1532-5415.2010.02760.x; Landry FJ, 1997, J GEN INTERN MED, V12, P412, DOI 10.1046/j.1525-1497.1997.00072.x; Barrio-Cantalejo IM, 2009, NURS ETHICS, V16, P93, DOI 10.1177/0969733008097995; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; Morrison RS, 2005, J AM GERIATR SOC, V53, P290, DOI 10.1111/j.1532-5415.2005.53116.x; Murphy CP, 2000, J PROF NURS, V16, P21, DOI 10.1016/S8755-7223(00)80008-3; MURPHY DJ, 1994, NEW ENGL J MED, V330, P545, DOI 10.1056/NEJM199402243300807; Pearlman RA, 2005, ARCH INTERN MED, V165, P667, DOI 10.1001/archinte.165.6.667; Perry E, 2005, AM J KIDNEY DIS, V46, P111, DOI 10.1053/j.ajkd.2005.03.018; REILLY BM, 1995, ARCH INTERN MED, V155, P2202, DOI 10.1001/archinte.155.20.2202; Reinke LF, 2011, AM J HOSP PALLIAT ME, V28, P147, DOI 10.1177/1049909110376807; Rhondali W, 2013, CANCER-AM CANCER SOC, V119, P2067, DOI 10.1002/cncr.27981; Richter K P, 1995, Arch Fam Med, V4, P609, DOI 10.1001/archfami.4.7.609; Rubin SM, 1994, JAMA; SACHS GA, 1992, J AM GERIATR SOC, V40, P269, DOI 10.1111/j.1532-5415.1992.tb02081.x; SCHNEIDERMAN LJ, 1992, ANN INTERN MED, V117, P599, DOI 10.7326/0003-4819-117-7-599; SCHONWETTER RS, 1993, J GEN INTERN MED, V8, P295, DOI 10.1007/BF02600139; SCHONWETTER RS, 1991, J AM GERIATR SOC, V39, P372, DOI 10.1111/j.1532-5415.1991.tb02902.x; Schwartz CE, 2002, ARCH INTERN MED, V162, P1611, DOI 10.1001/archinte.162.14.1611; Siegert EA, 1996, ARCH FAM MED, V5, P207, DOI 10.1001/archfami.5.4.207; SINGER PA, 1995, J AM SOC NEPHROL, V6, P1410; Singer PA, 1997, JOURNAL OF GENERAL; Smucker W D, 1993, J Am Board Fam Pract, V6, P473; Song MK, 2010, APPL NURS RES, V23, P65, DOI 10.1016/j.apnr.2008.05.002; Song MK, 2009, RES NURS HEALTH, V32, P260, DOI 10.1002/nur.20320; Song MK, 2005, MED CARE, V43, P1049, DOI 10.1097/01.mlr.0000178192.10283.b4; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sudore RL, 2007, PATIENT EDUC COUNS, V69, P165, DOI 10.1016/j.pec.2007.08.015; Sudore RL, 2014, J PAIN SYMPTOM MANAG, V47, P674, DOI 10.1016/j.jpainsymman.2013.05.023; Sulmasy DP, 1996, J GEN INTERN MED, V11, P657, DOI 10.1007/BF02600156; Viera AJ, 2005, FAM MED, V37, P360; Volandes AE, 2007, ARCH INTERN MED, V167, P828, DOI 10.1001/archinte.167.8.828; Volandes AE, 2012, CANCER-AM CANCER SOC, V118, P4331, DOI 10.1002/cncr.27423; Volandes AE, 2012, J PALLIAT MED, V15, P805, DOI 10.1089/jpm.2011.0505; Volandes AE, 2011, J PALLIAT MED, V14, P169, DOI 10.1089/jpm.2010.0299; Volandes AE, 2010, MED DECIS MAKING, V30, P29, DOI 10.1177/0272989X09341587; Volandes AE, 2009, J AM MED DIR ASSOC, V10, P575, DOI 10.1016/j.jamda.2009.05.006; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; Wilson KG, 2005, PATIENT EDUC COUNS, V57, P88, DOI 10.1016/j.pec.2004.04.004; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Yamada R, 1999, J GEN INTERN MED, V14, P559, DOI 10.1046/j.1525-1497.1999.11208.x	68	55	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0150671	10.1371/journal.pone.0150671	http://dx.doi.org/10.1371/journal.pone.0150671			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119571	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200003
J	Rossi, R; Zammit, S; Button, KS; Munafo, MR; Lewis, G; David, AS				Rossi, Rodolfo; Zammit, Stanley; Button, Katherine S.; Munafo, Marcus R.; Lewis, Glyn; David, Anthony S.			Psychotic Experiences and Working Memory: A Population-Based Study Using Signal-Detection Analysis	PLOS ONE			English	Article							ULTRA-HIGH RISK; CLINICAL HIGH-RISK; CONTEXT-PROCESSING DEFICITS; AUDITORY HALLUCINATIONS; COGNITIVE DEFICITS; PSYCHIATRIC-DISORDER; DELUSIONAL IDEATION; GENERAL-POPULATION; PREFRONTAL CORTEX; RESPONSE BIAS	Psychotic Experiences (PEs) during adolescence index increased risk for psychotic disorders and schizophrenia in adult life. Working memory (WM) deficits are a core feature of these disorders. Our objective was to examine the relationship between PEs and WM in a general population sample of young people in a case control study. 4744 individuals of age 17-18 from Bristol and surrounding areas (UK) were analyzed in a cross-sectional study nested within the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort study. The dependent variable was PEs, assessed using the semi-structured Psychosis-Like Symptom Interview (PLIKSi). The independent variable was performance on a computerized numerical n-back working memory task. Signal-Detection Theory indices, including standardized hits rate, false alarms rate, discriminability index (d') and response bias (c) from 2-Back and 3-Back tasks were calculated. 3576 and 3527 individuals had complete data for 2-Back and 3-Back respectively. Suspected/definite PEs prevalence was 7.9% (N = 374). Strongest evidence of association was seen between PEs and false alarms on the 2-Back, (odds ratio (OR) = 1.17 [95% confidence intervals (CI) 1.01, 1.35]) and 3-back (OR = 1.35 [1.18, 1.54]) and with c (OR = 1.59 [1.09, 2.34]), and lower d' (OR = 0.76 [0.65, 0.89]), on the 3-Back. Adjustment for several potential confounders, including general IQ, drug exposure and different psycho-social factors, and subsequent multiple imputation of missing data did not materially alter the results. WM is impaired in young people with PEs in the general population. False alarms, rather than poor accuracy, are more closely related to PEs. Such impairment is consistent with different neuropsychological models of psychosis focusing on signal-to-noise discrimination, probabilistic reasoning and impaired reality monitoring as a basis of psychotic symptoms.	[Rossi, Rodolfo] Univ Sch Med Federico II, Sect Psychiat, Naples, Italy; [Rossi, Rodolfo; David, Anthony S.] Kings Coll London, Sect Cognit Neuropsychiat, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Zammit, Stanley] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Zammit, Stanley] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales; [Button, Katherine S.] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Munafo, Marcus R.] Univ Bristol, UK Ctr Tobacco & Alcohol Studies, Sch Expt Psychol, Bristol, Avon, England; [Munafo, Marcus R.] Univ Bristol, MRC, IEU, Bristol, Avon, England; [Lewis, Glyn] UCL, Div Psychiat, London, England	University of Naples Federico II; University of London; King's College London; University of Bristol; Cardiff University; University of Bath; University of Bristol; University of Bristol; University of London; University College London	Rossi, R (corresponding author), Univ Sch Med Federico II, Sect Psychiat, Naples, Italy.; Rossi, R (corresponding author), Kings Coll London, Sect Cognit Neuropsychiat, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England.	rudy86.rossi@gmail.com	David, Anthony/O-1750-2019; Munafo, Marcus/AAE-2306-2020; David, Anthony S/C-1315-2011; Rossi, Rodolfo/P-9228-2019; Lewis, Glyn/E-9944-2012	David, Anthony/0000-0003-0967-774X; Munafo, Marcus/0000-0002-4049-993X; David, Anthony S/0000-0003-0967-774X; Rossi, Rodolfo/0000-0002-6857-898X; Lewis, Glyn/0000-0001-5205-8245; Button, Katherine/0000-0003-4332-8789; Zammit, Stanley/0000-0002-2647-9211	National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at the South London & Maudsley NHS Foundation Trust; Institute of Psychiatry, Psychology and Neuroscience, King's College London; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration; Wellcome Trust [102215/2/13/2]; MRC [G0901885]; MRC [G0801418, G0701503, MC_UU_12013/6] Funding Source: UKRI; Medical Research Council [MC_UU_12013/6, MC_PC_15018, MR/L010305/1, G0801418, G0701503, G0901885] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at the South London & Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); Institute of Psychiatry, Psychology and Neuroscience, King's College London; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ASD receives support from the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at the South London & Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology and Neuroscience, King's College London. MRM is a member of the UK Centre for Tobacco Control Studies, a UKCRC Public Health Research: Centre of Excellence. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The UK Medical Research Council and the Wellcome Trust (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. This research was funded by MRC grant no. G0901885.; We are extremely grateful to all the families who took part in this study and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council and the Wellcome Trust (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. This research was funded by MRC grant no G0901885".	Adams Rick A, 2013, Front Psychiatry, V4, P47, DOI 10.3389/fpsyt.2013.00047; Agnew-Blais J, 2013, COGN NEUROPSYCHIATRY, V18, P44, DOI 10.1080/13546805.2012.676309; Anticevic A, 2015, CLIN PSYCHOL SCI, V3, P433, DOI 10.1177/2167702614562041; Avery MC, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00031; Bang M, 2015, AUST NZ J PSYCHIAT, V49, P462, DOI 10.1177/0004867414561527; Barch DM, 2003, J ABNORM PSYCHOL, V112, P132, DOI 10.1037/0021-843X.112.1.132; Becker HE, 2010, PSYCHOL MED, V40, P1599, DOI 10.1017/S0033291710000048; BENTALL RP, 1985, BRIT J CLIN PSYCHOL, V24, P159, DOI 10.1111/j.2044-8260.1985.tb01331.x; Blanchard MM, 2010, SCHIZOPHR RES, V123, P71, DOI 10.1016/j.schres.2010.05.028; Bora E, 2014, SCHIZOPHRENIA BULL, V40, P744, DOI 10.1093/schbul/sbt085; Bowen E, 2005, BJOG-INT J OBSTET GY, V112, P1083, DOI 10.1111/j.1471-0528.2005.00653.x; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; Brebion G, 2005, NEUROPSYCHOLOGY, V19, P612, DOI 10.1037/0894-4105.19.5.612; Brebion G, 2007, J INT NEUROPSYCH SOC, V13, P832, DOI 10.1017/S135561770707107X; Brebion G, 2013, SCHIZOPHR RES, V151, P70, DOI 10.1016/j.schres.2013.09.009; Brebion G, 2010, J CLIN EXP NEUROPSYC, V32, P847, DOI 10.1080/13803391003596397; Broome MR, 2007, BRIT J PSYCHIAT, V191, pS38, DOI 10.1192/bjp.191.51.s38; Broome MR, 2012, EUR PSYCHIAT, V27, P258, DOI 10.1016/j.eurpsy.2010.07.008; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Carter CS, 1998, AM J PSYCHIAT, V155, P1285, DOI 10.1176/ajp.155.9.1285; Choi JS, 2012, SCHIZOPHRENIA BULL, V38, P1189, DOI 10.1093/schbul/sbr038; Dawkins L, 2007, PSYCHOPHARMACOLOGY, V190, P457, DOI 10.1007/s00213-006-0634-6; De Herdt A, 2013, SCHIZOPHR RES, V149, P48, DOI 10.1016/j.schres.2013.06.017; Dickson H, 2014, J PSYCHIATR RES, V50, P92, DOI 10.1016/j.jpsychires.2013.12.003; Dodgson G, 2009, BEHAV COGN PSYCHOTH, V37, P325, DOI 10.1017/S1352465809005244; Dolgov I, 2005, BEHAV BRAIN SCI, V28, P761, DOI 10.1017/S0140525X05260132; Fatouros-Bergman H, 2014, SCHIZOPHR RES, V158, P156, DOI 10.1016/j.schres.2014.06.034; Fleming SM, 2012, PHILOS T R SOC B, V367, P1280, DOI 10.1098/rstb.2012.0021; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Forbes NF, 2009, PSYCHOL MED, V39, P889, DOI 10.1017/S0033291708004558; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Freeman D, 2014, PSYCHOL MED, V44, P3017, DOI 10.1017/S0033291714000592; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592; Garety P.A., 2011, ADV PSYCHIAT TREATME, V17, P332, DOI [10.1037/0021-843X.114.3.373, 10.1192/apt.bp.109.007104, DOI 10.1192/APT.BP.109.007104]; Garety P, 2013, SCHIZOPHR RES, V150, P570, DOI 10.1016/j.schres.2013.08.035; Garwood L, 2015, BEHAV COGN PSYCHOTH, V43, P52, DOI 10.1017/S1352465813000714; Gerrie MP, 2007, MEMORY, V15, P561, DOI 10.1080/09658210701391634; Giakoumaki SG, 2012, J INT NEUROPSYCH SOC, V18, P643, DOI 10.1017/S135561771200029X; Holmes AJ, 2005, SCHIZOPHR RES, V76, P199, DOI 10.1016/j.schres.2005.01.021; Horwood J, 2008, BRIT J PSYCHIAT, V193, P185, DOI 10.1192/bjp.bp.108.051904; Kaymaz N, 2012, PSYCHOL MED, V42, P2239, DOI 10.1017/S0033291711002911; Keilp JG, 2005, PSYCHIAT RES, V135, P191, DOI 10.1016/j.psychres.2005.03.006; Kelleher I, 2013, SCHIZOPHRENIA BULL, V39, P1018, DOI 10.1093/schbul/sbs086; Kelleher I, 2013, COGN NEUROPSYCHIATRY, V18, P9, DOI 10.1080/13546805.2012.682363; Knowles E E M, 2014, Curr Behav Neurosci Rep, V1, P224; Korponay Cole, 2014, Schizophr Res Cogn, V1, P175; Kounali D, 2014, PSYCHOL MED, V44, P2557, DOI 10.1017/S0033291714000026; Koychev I, 2012, EUR NEUROPSYCHOPHARM, V22, P469, DOI 10.1016/j.euroneuro.2011.10.005; Kumar CTS, 2010, SCHIZOPHR RES, V124, P152, DOI 10.1016/j.schres.2010.07.006; Laurens KR, 2007, SCHIZOPHR RES, V90, P130, DOI 10.1016/j.schres.2006.11.006; Leding JK, 2012, MEMORY, V20, P217, DOI 10.1080/09658211.2011.653373; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; Legleye S., 2007, Journal of Substance Use, V12, P233, DOI 10.1080/14659890701476532; Legleye S, 2013, INT J METH PSYCH RES, V22, P16, DOI 10.1002/mpr.1378; LEWIS G, 1994, J EPIDEMIOL COMMUN H, V48, P207, DOI 10.1136/jech.48.2.207; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; Locke HS, 2008, COGN AFFECT BEHAV NE, V8, P99, DOI 10.3758/CABN.8.1.99; MacDonald AW, 2005, AM J PSYCHIAT, V162, P475, DOI 10.1176/appi.ajp.162.3.475; Macmillan NA, 2005, DETECTION THEORY USE; McGrath JJ, 2015, JAMA PSYCHIAT, V72, P697, DOI 10.1001/jamapsychiatry.2015.0575; Meier MH, 2014, AM J PSYCHIAT, V171, P91, DOI 10.1176/appi.ajp.2013.12111438; Metzler S, 2015, PSYCHOL MED, P1, DOI [10.1017/S0033291715000057, DOI 10.1017/S0033291715000057]; Mollon J, JAMA PSYCHI IN PRESS; Moritz S, 2005, BRIT J CLIN PSYCHOL, V44, P193, DOI 10.1348/014466505X35678; Moutoussis M, 2011, COGN NEUROPSYCHIATRY, V16, P422, DOI 10.1080/13546805.2010.548678; Niarchou M, 2013, AM J PSYCHIAT, V170, P550, DOI 10.1176/appi.ajp.2012.12060792; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Nuechterlein KH, 2015, SCHIZOPHR RES, V163, P38, DOI 10.1016/j.schres.2015.01.017; Ochoa S, 2014, SCHIZOPHR RES, V159, P211, DOI 10.1016/j.schres.2014.07.026; Okimura T, 2015, NEUROSCIENCE, V295, P80, DOI 10.1016/j.neuroscience.2015.03.039; Park Sohee, 2014, Schizophr Res Cogn, V1, P127; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Perlstein WM, 2003, BIOL PSYCHIAT, V53, P25, DOI 10.1016/S0006-3223(02)01675-X; Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14; Radaelli D, 2013, BEHAV SCI-BASEL, V3, P244, DOI 10.3390/bs3020244; RANKIN PM, 1995, BRIT J CLIN PSYCHOL, V34, P517, DOI 10.1111/j.2044-8260.1995.tb01486.x; Reichenberg A, 2010, AM J PSYCHIAT, V167, P160, DOI 10.1176/appi.ajp.2009.09040574; Ross RM, 2015, SCHIZOPHRENIA BULL, V41, P1183, DOI 10.1093/schbul/sbu187; Royston P, 2007, STATA J, V7, P445, DOI 10.1177/1536867X0700700401; Schmidt-Hansen M, 2009, COGN NEUROPSYCHOL, V26, P655, DOI 10.1080/02643291003644501; Shakeel MK, 2012, PSYCHIAT RES, V200, P173, DOI 10.1016/j.psychres.2012.06.014; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stochl J, 2015, PSYCHOL MED, V45, P1483, DOI 10.1017/S003329171400261X; Thapar A, 2012, SCHIZOPHR RES, V140, P104, DOI 10.1016/j.schres.2012.06.024; van der Leer L, 2015, PSYCHOL MED, V45, P1253, DOI 10.1017/S0033291714002359; Vercammen A, 2008, PSYCHOL MED, V38, P1177, DOI 10.1017/S0033291707002437; Wardle MC, 2013, NEUROPSYCHOPHARMACOL, V38, P1253, DOI 10.1038/npp.2013.24; Waters FAV, 2003, SCHIZOPHR RES, V62, P275, DOI 10.1016/S0920-9964(02)00358-4; Waters F, 2012, SCHIZOPHRENIA BULL, V38, P683, DOI 10.1093/schbul/sbs045; Wechsler D., 1992, WISC IIIUK WECHSLER; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Winton-Brown TT, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.09.416; World Health Organization (WHO) Division of Mental Health, 1994, SCHED CLIN ASS NEUR; Zammit S, 2013, AM J PSYCHIAT, V170, P742, DOI 10.1176/appi.ajp.2013.12060768; Ziermans Tim B, 2013, Front Psychiatry, V4, P161, DOI 10.3389/fpsyt.2013.00161	98	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153148	10.1371/journal.pone.0153148	http://dx.doi.org/10.1371/journal.pone.0153148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120349	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000374976200018
J	Bernard, G; Duchene, JC; Romero-Ramirez, A; Lecroart, P; Maire, O; Ciutat, A; Deflandre, B; Gremare, A				Bernard, Guillaume; Duchene, Jean-Claude; Romero-Ramirez, Alicia; Lecroart, Pascal; Maire, Olivier; Ciutat, Aurelie; Deflandre, Bruno; Gremare, Antoine			Experimental Assessment of the Effects of Temperature and Food Availability on Particle Mixing by the Bivalve Abra alba Using New Image Analysis Techniques	PLOS ONE			English	Article							SEDIMENT REWORKING; BIODIFFUSION COEFFICIENT; LUMINOPHORE TRACERS; FEEDING-BEHAVIOR; BIOTURBATION; DEPOSIT; OVATA; QUANTIFICATION; POLYCHAETE; PATTERNS	The effects of temperature and food addition on particle mixing in the deposit-feeding bivalve Abra alba were assessed using an experimental approach allowing for the tracking of individual fluorescent particle (luminophore) displacements. This allowed for the computations of vertical profiles of a set of parameters describing particle mixing. The frequency of luminophore displacements (jumps) was assessed through the measurement of both waiting times (i.e., the time lapses between two consecutive jumps of the same luminophore) and normalized numbers of jumps (i.e., the numbers of jumps detected in a given area divided by the number of luminophores in this area). Jump characteristics included the direction, duration and length of each jump. Particle tracking biodiffusion coefficients (D-b) were also computed. Data originated from 32 experiments carried out under 4 combinations of 2 temperature (Te) and 2 food addition (Fo) levels. For each of these treatments, parameters were computed for 5 experimental durations (Ed). The effects of Se, Fo and Ed were assessed using PERmutational Multivariate ANalyses Of VAriance (PERMANOVAs) carried out on vertical depth profiles of each particle mixing parameter. Inversed waiting times significantly decreased with Ed whereas the normalized number of jumps did not, thereby suggesting that it constitutes a better proxy of jump frequency when assessing particle mixing based on the measure of individual particle displacements. Particle mixing was low during autumn temperature experiments and not affected by Fo, which was attributed to the dominant effect of low temperature. Conversely, particle mixing was high during summer temperature experiments and transitory inhibited by food addition. This last result is coherent with the functional responses (both in terms of activity and particle mixing) already measured for individual of the closely related clam A. ovata originating from temperate populations. It also partly resulted from a transitory switch between deposit-and suspension-feeding caused by the high concentration of suspended particulate organic matter immediately following food addition.	[Bernard, Guillaume; Romero-Ramirez, Alicia; Lecroart, Pascal; Maire, Olivier; Deflandre, Bruno; Gremare, Antoine] Univ Bordeaux, EPOC, UMR 5805, F-33400 Talence, France; [Bernard, Guillaume] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Duchene, Jean-Claude; Romero-Ramirez, Alicia; Ciutat, Aurelie] CNRS, EPOC, UMR 5805, F-33400 Talence, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; University of Helsinki; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU)	Bernard, G (corresponding author), Univ Bordeaux, EPOC, UMR 5805, F-33400 Talence, France.; Bernard, G (corresponding author), Univ Helsinki, Tvarminne Zool Stn, Hango, Finland.	g.bernard.epoc@gmail.com		Lecroart, Pascal/0000-0003-3661-2140; deflandre, Bruno/0000-0002-2405-6223	French "Ministere de l'Enseignement Superieur et de la Recherche"; IZOFLUX (ANR blanche) program; BIOMIN (LEFE-CYBER) program; BIOMIN (EC2CO-PNEC) program; Diagnostic de la Qualite des Milieux Littoraux program; "OSQUAR" (Conseil Regional Aquitaine) program	French "Ministere de l'Enseignement Superieur et de la Recherche"; IZOFLUX (ANR blanche) program(French National Research Agency (ANR)); BIOMIN (LEFE-CYBER) program; BIOMIN (EC2CO-PNEC) program; Diagnostic de la Qualite des Milieux Littoraux program; "OSQUAR" (Conseil Regional Aquitaine) program	Guillaume Bernard was supported by a doctoral grant from the French "Ministere de l'Enseignement Superieur et de la Recherche". This work was funded through the IZOFLUX (ANR blanche), BIOMIN (LEFE-CYBER and EC2CO-PNEC), the "Diagnostic de la Qualite des Milieux Littoraux" and the "OSQUAR" (Conseil Regional Aquitaine) programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller R.C., 1982, Topics in Geobiology, V2, P53; AMOUROUX JM, 1989, MAR ECOL PROG SER, V51, P87, DOI 10.3354/meps051087; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bernard G, 2014, MAR ECOL PROG SER, V514, P71, DOI 10.3354/meps10961; Bernard G, 2012, J MAR RES, V70, P689, DOI 10.1357/002224012806290705; Borja A, 2004, ELSEV OCEANOGR SERIE, V70, P455; BOUDREAU BP, 1986, AM J SCI, V286, P161, DOI 10.2475/ajs.286.3.161; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Caradec S, 2004, J SEA RES, V52, P199, DOI 10.1016/j.seares.2004.02.002; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; De Backer A, 2011, ESTUAR COAST SHELF S, V91, P306, DOI 10.1016/j.ecss.2010.10.031; Dorgan KM, 2006, OCEANOGR MAR BIOL, V44, P85; Gerino M, 1998, ESTUAR COAST SHELF S, V46, P531, DOI 10.1006/ecss.1997.0298; Gilbert F, 2003, J EXP MAR BIOL ECOL, V285, P251, DOI 10.1016/S0022-0981(02)00531-2; Gle C, 2008, ESTUAR COAST SHELF S, V76, P642, DOI 10.1016/j.ecss.2007.07.043; GOLDBERG ED, 1962, GEOCHIM COSMOCHIM AC, V26, P417, DOI 10.1016/0016-7037(62)90112-6; Gray J.S., 1974, Oceanography mar Biol, V12, P223; Gremare A, 2004, MAR ECOL PROG SER, V267, P195, DOI 10.3354/meps267195; GUINASSO NL, 1975, J GEOPHYS RES-OC ATM, V80, P3032, DOI 10.1029/JC080i021p03032; HUGHES TG, 1975, J EXP MAR BIOL ECOL, V20, P137, DOI 10.1016/0022-0981(75)90020-9; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Lazzari P, 2012, BIOGEOSCIENCES, V9, P217, DOI 10.5194/bg-9-217-2012; Lecroart P, 2007, ESTUAR COAST SHELF S, V72, P543, DOI 10.1016/j.ecss.2006.11.020; Lecroart P, 2010, GEOCHIM COSMOCHIM AC, V74, P6049, DOI 10.1016/j.gca.2010.06.010; LEVINTON JS, 1991, MAR BIOL, V110, P375, DOI 10.1007/BF01344356; LEVINTON JS, 2001, MARINE BIOL FUNCTION; Lindahl O, 1998, ICES J MAR SCI, V55, P723, DOI 10.1006/jmsc.1998.0379; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Maire O, 2007, J EXP MAR BIOL ECOL, V343, P21, DOI 10.1016/j.jembe.2006.10.052; Maire O, 2008, AQUAT BIOL, V2, P219, DOI 10.3354/ab00053; Maire O, 2007, MAR ECOL PROG SER, V351, P139, DOI 10.3354/meps07147; Maire O, 2007, MAR BIOL, V151, P737, DOI 10.1007/s00227-006-0519-6; Maire O, 2006, MAR ECOL PROG SER, V319, P135, DOI 10.3354/meps319135; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Meysman FJR, 2008, AQUAT BIOL, V2, P239, DOI 10.3354/ab00054; Meysman FJR, 2008, GEOCHIM COSMOCHIM AC, V72, P3460, DOI 10.1016/j.gca.2008.04.023; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Meysman FJR, 2010, J MAR RES, V68, P881, DOI 10.1357/002224010796673885; Meysman FJR, 2003, J MAR RES, V61, P391, DOI 10.1357/002224003322201241; Michaud E, 2010, ESTUAR COAST SHELF S, V90, P21, DOI 10.1016/j.ecss.2010.08.005; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Rhoads D.C., 1974, Oceanography mar Biol, V12, P263; Rhoads D.C., 1982, TOPICS GEOBIOLOGY, V100, P3; Riisgard HU, 2001, ECOL STU AN, V151, P73; Rosenberg R, 2001, SCI MAR, V65, P107, DOI 10.3989/scimar.2001.65s2107; ROSENBERG R, 1993, SARSIA, V78, P119, DOI 10.1080/00364827.1993.10413528; Rowden AA, 1998, CONT SHELF RES, V18, P1347, DOI 10.1016/S0278-4343(98)00047-8; Schiffers K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028028; Solan M, 2004, MAR ECOL PROG SER, V271, P1, DOI 10.3354/meps271001; Stead RA, 2006, J EXP MAR BIOL ECOL, V332, P37, DOI 10.1016/j.jembe.2005.11.001; TAGHON GL, 1992, LIMNOL OCEANOGR, V37, P1370, DOI 10.4319/lo.1992.37.7.1370; TAGHON GL, 1980, SCIENCE, V210, P562, DOI 10.1126/science.210.4469.562; TENORE KR, 1985, LIMNOL OCEANOGR, V30, P1188, DOI 10.4319/lo.1985.30.6.1188; Van Hoey G, 2005, ESTUAR COAST SHELF S, V64, P751, DOI 10.1016/j.ecss.2005.03.022; Venturini N, 2011, J MARINE SYST, V88, P526, DOI 10.1016/j.jmarsys.2011.07.002; WHEATCROFT RA, 1990, J MAR RES, V48, P177, DOI 10.1357/002224090784984560; WHEATCROFT RA, 1992, LIMNOL OCEANOGR, V37, P90, DOI 10.4319/lo.1992.37.1.0090	60	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154270	10.1371/journal.pone.0154270	http://dx.doi.org/10.1371/journal.pone.0154270			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115148	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600054
J	Kaushal, M; Byrnes, C; Khademian, Z; Duncan, N; Luban, NLC; Miller, JL; Fasano, RM; Meier, ER				Kaushal, Megha; Byrnes, Colleen; Khademian, Zarir; Duncan, Natalie; Luban, Naomi L. C.; Miller, Jeffery L.; Fasano, Ross M.; Meier, Emily Riehm			Examination of Reticulocytosis among Chronically Transfused Children with Sickle Cell Anemia	PLOS ONE			English	Article							SILENT CEREBRAL INFARCTS; RED-CELL; CEREBROVASCULAR ACCIDENTS; HYDROXYUREA SWITCH; MOYAMOYA SYNDROME; CNS INFARCTION; DISEASE; ADHESION; STROKE; BLOOD	Sickle cell anemia (SCA) is an inherited hemolytic anemia with compensatory reticulocytosis. Recent studies have shown that increased levels of reticulocytosis during infancy are associated with increased hospitalizations for SCA sequelae as well as cerebrovascular pathologies. In this study, absolute reticulocyte counts (ARC) measured prior to transfusion were analysed among a cohort of 29 pediatric SCA patients receiving chronic transfusion therapy (CTT) for primary and secondary stroke prevention. A cross-sectional flow cytometric analysis of the reticulocyte phenotype was also performed. Mean duration of CTT was 3.1 +/- 2.6 years. Fifteen subjects with magnetic resonance angiography (MRA) - vasculopathy had significantly higher mean ARC prior to initiating CTT compared to 14 subjects without MRA-vasculopathy (427.6 +/- 109.0 K/mu l vs. 324.8 +/- 109.2 K/mu l, p<0.05). No significant differences in hemoglobin or percentage sickle hemoglobin (HbS) were noted between the two groups at baseline. Reticulocyte phenotyping further demonstrated that the percentages of circulating immature [CD36(+), CD71(+)] reticulocytes positively correlated with ARC in both groups. During the first year of CTT, neither group had significant reductions in ARC. Among this group of children with SCA, cerebrovasculopathy on MRA at initiation of CTT was associated with increased reticulocytosis, which was not reduced after 12 months of transfusions.	[Kaushal, Megha; Byrnes, Colleen; Miller, Jeffery L.; Meier, Emily Riehm] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Kaushal, Megha; Luban, Naomi L. C.; Fasano, Ross M.; Meier, Emily Riehm] Childrens Natl Hlth Syst, Ctr Canc & Blood Disorders, Washington, DC USA; [Khademian, Zarir] Childrens Natl Hlth Syst, Div Diagnost Imaging & Radiol, Washington, DC USA; [Kaushal, Megha; Luban, Naomi L. C.; Fasano, Ross M.; Meier, Emily Riehm] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Duncan, Natalie; Meier, Emily Riehm] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA; [Fasano, Ross M.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Ctr Transfus & Cellular Therapies, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's National Health System; Children's National Health System; George Washington University; Indiana Hemophilia & Thrombosis Center; Emory University	Meier, ER (corresponding author), NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA.; Meier, ER (corresponding author), Childrens Natl Hlth Syst, Ctr Canc & Blood Disorders, Washington, DC USA.; Meier, ER (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.; Meier, ER (corresponding author), Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA.	emeier@ihtc.org			Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; National Heart Lung and Blood Institute [HL110841]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL110841] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases and a T32 from National Heart Lung and Blood Institute [HL110841]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; ANDERSON R, 1963, ARCH INTERN MED, V111, P286, DOI 10.1001/archinte.1963.03620270012003; Borrione P, 2010, INT J LAB HEMATOL, V32, P65, DOI 10.1111/j.1751-553X.2008.01128.x; Browne PV, 1996, J LAB CLIN MED, V127, P340, DOI 10.1016/S0022-2143(96)90181-X; Butthep P, 2015, BLOOD CELL MOL DIS, V54, P170, DOI 10.1016/j.bcmd.2014.11.007; COHEN AR, 1992, BLOOD, V79, P1657; DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731; Detterich JA, 2013, TRANSFUSION, V53, P1059, DOI 10.1111/j.1537-2995.2012.03961.x; Dobson SR, 2002, BLOOD, V99, P3144, DOI 10.1182/blood.V99.9.3144; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Fasano RM, 2015, BLOOD CELL MOL DIS, V54, P17, DOI 10.1016/j.bcmd.2014.08.007; GABUZDA TG, 1967, BLOOD-J HEMATOL, V29, P126, DOI 10.1182/blood.V29.1.126.126; Gladwin MT, 2007, HAEMATOLOGICA, V93, P1, DOI 10.3324/haematol.12318; Hulbert ML, 2011, BLOOD, V117, P772, DOI 10.1182/blood-2010-01-261123; JONECKIS CC, 1993, BLOOD, V82, P3548; Josephson CD, 2007, TRANSFUS MED REV, V21, P118, DOI 10.1016/j.tmrv.2006.11.003; Kennedy BC, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.10.FOCUS13405; Koury MJ, 2005, BLOOD, V105, P2168, DOI 10.1182/blood-2004-02-0616; LUSHER JM, 1976, AM J HEMATOL, V1, P265, DOI 10.1002/ajh.2830010210; Meier ER, 2014, AM J HEMATOL, V89, P904, DOI 10.1002/ajh.23777; Meier ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070794; Meier ER, 2015, J PEDIAT; Odievre MH, 2008, HAEMATOLOGICA, V93, P502, DOI 10.3324/haematol.12070; Ohene-Frempong K, 1998, BLOOD, V91, P288; PEGELOW CH, 1995, J PEDIATR-US, V126, P896, DOI 10.1016/S0022-3476(95)70204-0; POWARS D, 1978, AM J MED, V65, P461, DOI 10.1016/0002-9343(78)90772-6; RUSSELL MO, 1976, J PEDIATR-US, V88, P382, DOI 10.1016/S0022-3476(76)80251-X; Sakamoto TM, 2013, CLIN BIOCHEM, V46, P1798, DOI 10.1016/j.clinbiochem.2013.09.011; SARNAIK S, 1979, AM J DIS CHILD, V133, P1254, DOI 10.1001/archpedi.1979.02130120046009; Setty BNY, 2002, BLOOD, V99, P1564, DOI 10.1182/blood.V99.5.1564; Silva CM, 2011, PEDIATR BLOOD CANCER, V56, P116, DOI 10.1002/pbc.22680; SUGIHARA K, 1992, BLOOD, V80, P2634; Tancabelic J, 1999, AM J HEMATOL, V60, P121, DOI 10.1002/(SICI)1096-8652(199902)60:2<121::AID-AJH6>3.0.CO;2-2; Telen MJ, 2000, SEMIN HEMATOL, V37, P130, DOI 10.1016/S0037-1963(00)90038-6; Trinh-Trang-Tan MM, 2010, HAEMATOL-HEMATOL J, V95, P730, DOI 10.3324/haematol.2009.017392; Ware RE, 2016, LANCET, V387, P661, DOI 10.1016/S0140-6736(15)01041-7; Ware RE, 2012, BLOOD, V119, P3925, DOI 10.1182/blood-2011-11-392340; Ware RE, 2011, PEDIATR BLOOD CANCER, V57, P1011, DOI 10.1002/pbc.23145; Watkins NA, 2003, BLOOD, V102, P718, DOI 10.1182/blood-2002-11-3497; WAYNE AS, 1993, BLOOD, V81, P1109; WILIMAS J, 1980, J PEDIATR-US, V96, P205, DOI 10.1016/S0022-3476(80)80803-1; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517; Zennadi R, 2008, TRANSFUS CLIN BIOL, V15, P23, DOI 10.1016/j.tracli.2008.04.009	43	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153244	10.1371/journal.pone.0153244	http://dx.doi.org/10.1371/journal.pone.0153244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116614	gold, Green Published, Green Submitted			2022-12-27	WOS:000374973600017
J	Park, T; Fitzgerald, EMG; Gallagher, SJ; Tomkins, E; Allan, T				Park, Travis; Fitzgerald, Erich M. G.; Gallagher, Stephen J.; Tomkins, Ellyn; Allan, Tony			New Miocene Fossils and the History of Penguins in Australia	PLOS ONE			English	Article							SOUTHERN-OCEAN; SPHENISCIFORMES; EVOLUTION; AVES; PHYLOGENY; PLIOCENE; BASIN; STRATIGRAPHY; BIOGEOGRAPHY; SUCCESSION	Australia has a fossil record of penguins reaching back to the Eocene, yet today is inhabited by just one breeding species, the little penguin Eudyptula minor. The description of recently collected penguin fossils from the re-dated upper Miocene Port Campbell Limestone of Portland (Victoria), in addition to reanalysis of previously described material, has allowed the Cenozoic history of penguins in Australia to be placed into a global context for the first time. Australian pre-Quaternary fossil penguins represent stem taxa phylogenetically disparate from each other and E. minor, implying multiple dispersals and extinctions. Late Eocene penguins from Australia are closest to contemporaneous taxa in Antarctica, New Zealand and South America. Given current material, the Miocene Australian fossil penguin fauna is apparently unique in harbouring 'giant penguins' after they went extinct elsewhere; and including stem taxa until at least 6 Ma, by which time crown penguins dominated elsewhere in the southern hemisphere. Separation of Australia from Antarctica during the Palaeogene, and its subsequent drift north, appears to have been a major event in Australian penguin biogeography. Increasing isolation through the Cenozoic may have limited penguin dispersal to Australia from outside the Australasian region, until intensification of the eastwards-flowing Antarctic Circumpolar Current in the mid-Miocene established a potential new dispersal vector to Australia.	[Park, Travis] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Park, Travis; Fitzgerald, Erich M. G.; Tomkins, Ellyn] Museum Victoria, Palaeontol, Melbourne, Vic, Australia; [Gallagher, Stephen J.; Tomkins, Ellyn] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Allan, Tony] CSIRO Radiogen Isotope Facil, Sydney, NSW, Australia	Monash University; Museum Victoria; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Park, T (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.; Park, T (corresponding author), Museum Victoria, Palaeontol, Melbourne, Vic, Australia.	travis.park@monash.edu	Park, Travis/B-4294-2016; Park, Travis/N-9176-2019	Park, Travis/0000-0002-9492-8859; Park, Travis/0000-0002-9492-8859; Gallagher, Stephen/0000-0002-5593-2740	Australian Research Council [DP0558150]	Australian Research Council(Australian Research Council)	Grant number: DP0558150, Australian Research Council, funder's website: www.arc.gov.au, author who received funding: SJG and ET. Funding was for fieldwork associated with geologic data collection and subsequent stratigraphic analyses only. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hospitaleche CA, 2013, J S AM EARTH SCI, V43, P101, DOI 10.1016/j.jsames.2013.01.006; Acosta Hospitaleche Carolina, 2008, Oryctos, V7, P109; Baker AJ, 2006, P ROY SOC B-BIOL SCI, V273, P11, DOI 10.1098/rspb.2005.3260; Banks Jonathan C., 2002, Notornis, V49, P29; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Bertelli S, 2005, CLADISTICS, V21, P209, DOI 10.1111/j.1096-0031.2005.00065.x; BOUTAKOFF N, 1963, GEOLOGICAL SURVEY VI, V22, P1; Brand L, 2011, J S AM EARTH SCI, V31, P414, DOI 10.1016/j.jsames.2011.02.015; Hoffmeister MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090043; Chavez-Hoffmeister MF, 2014, AMEGHINIANA, V51, P159, DOI 10.5710/AMGH.14.02.2014.637; Clarke JA, 2007, P NATL ACAD SCI USA, V104, P11545, DOI 10.1073/pnas.0611099104; DARRAGH TA, 1985, ALCHERINGA, V9, P83, DOI 10.1080/03115518508618960; Dickinson JA, 2002, J SEDIMENT RES, V72, P288, DOI 10.1306/082701720288; Eagles G, 2014, TECTONOPHYSICS, V611, P28, DOI 10.1016/j.tecto.2013.11.021; Feldmann RM, 2006, NEW ZEAL J GEOL GEOP, V49, P417, DOI 10.1080/00288306.2006.9515178; Finlayson H. H., 1938, Transactions of the Royal Society of South Australia, V62, P14; Fitzgerald Erich M. G., 2004, Memoirs of Museum Victoria, V61, P183; Fitzgerald Erich M. G., 2005, Memoirs of Museum Victoria, V62, P67; Fordyce R. Ewan, 2003, P154; Gallagher SJ, 2000, PALAEOGEOGR PALAEOCL, V156, P19, DOI 10.1016/S0031-0182(99)00130-3; Gallagher SJ, 2001, PALAEOGEOGR PALAEOCL, V172, P53, DOI 10.1016/S0031-0182(01)00271-1; Giannini NP, 2004, AUK, V121, P422, DOI 10.1642/0004-8038(2004)121[0422:POEPBO]2.0.CO;2; Gohlich UB, 2007, ACTA PALAEONTOL POL, V52, P285; Goloboff P, 2008, CLADISTICS, V24, P91; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hoffmeister MC, 2014, POL POLAR RES, V35, P469, DOI 10.2478/popore-2014-0025; Holdgate G.R., 2003, GEOLOGY VICTORIA, V23, P289; Hospitaleche CA, 2008, J PALEONTOL, V82, P565, DOI 10.1666/07-014.1; Hospitaleche CA, 2007, ACTA PALAEONTOL POL, V52, P299; Hospitaleche CA, 2006, REV GEOL CHILE, V33, P327; Houben AJP, 2013, SCIENCE, V340, P341, DOI 10.1126/science.1223646; Huxley T.H., 1859, Q J GEOL SOC LOND, V15, P670, DOI [10.1144/GSL.JGS.1859.015.01-02.73, DOI 10.1144/GSL.JGS.1859.015.01-02.73]; Jadwiszczak Piotr, 2006, Polish Polar Research, V27, P3; Jadwiszczak P, 2013, ANTARCT SCI, V25, P397, DOI 10.1017/S0954102012000909; Jadwiszczak P, 2012, POL POLAR RES, V33, P259, DOI 10.2478/v10183-012-0017-0; Jenkins R.J.F., 1985, P183; JENKINS R J F, 1974, Palaeontology (Oxford), V17, P291; Ksepka DT, 2006, CLADISTICS, V22, P412, DOI 10.1111/j.1096-0031.2006.00116.x; Ksepka DT, 2012, J VERTEBR PALEONTOL, V32, P235, DOI 10.1080/02724634.2012.652051; Ksepka DT, 2012, P ROY SOC B-BIOL SCI, V279, P1027, DOI 10.1098/rspb.2011.1592; Ksepka DT, 2010, B AM MUS NAT HIST, P1; Ksepka DT., 2011, LIVING DINOSAURS EVO, P155, DOI DOI 10.1002/9781119990475.CH6; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Lee TY, 1995, TECTONOPHYSICS, V251, P85, DOI 10.1016/0040-1951(95)00023-2; Lyle M, 2007, GEOLOGY, V35, P691, DOI 10.1130/G23806A.1; MALLETT CW, 1977, THESIS U MELBOURNE; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; McGowran B, 2004, AUST J EARTH SCI, V51, P459, DOI 10.1111/j.1400-0952.2004.01078.x; McLaren S, 2009, AUST J EARTH SCI, V56, P259, DOI 10.1080/08120090802547074; Morecame M, 2004, FIELD GUIDE AUSTR BI, P384; Nelson CS, 2001, NEW ZEAL J GEOL GEOP, V44, P535, DOI 10.1080/00288306.2001.9514954; NORRIS RD, 1994, MAR MICROPALEONTOL, V23, P121, DOI 10.1016/0377-8398(94)90004-3; Park T, 2014, REDESCRIPTI IN PRESS; Park Travis, 2012, Memoirs of Museum Victoria, V69, P309; Piper KJ, 2006, PALAEONTOLOGY, V49, P1237, DOI 10.1111/j.1475-4983.2006.00595.x; SIMPSON G G, 1972, Records of the Canterbury Museum, V9, P159; Simpson G. G., 1970, Mem. natn. Mus. Vict., VNo. 31, P17; SIMPSON G G, 1979, Annals of the South African Museum, V79, P1; Simpson G. G., 1957, Records of the South Australian Museum, V13, P51; Simpson G. G., 1965, Proceedings of the Royal Society of Victoria, V79, P91; Simpson G. G., 1959, Proceedings of the Royal Society of Victoria N S, V71, P113; Slack KE, 2006, MOL BIOL EVOL, V23, P1144, DOI 10.1093/molbev/msj124; Stucchi M., 2007, Cuadernos del Museo Geominero, V8, P367; Subramanian S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0748; Thomas DB, 2013, ZOOL J LINN SOC-LOND, V168, P207, DOI 10.1111/zoj.12024; Thomas DB, 2012, ANAT REC, V295, P249, DOI 10.1002/ar.21538; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; van Tets G.F., 1983, Records of the Queen Victoria Museum, P1; Walsh S.A., 2006, HIST BIOL, V18, P119, DOI [DOI 10.1080/08912960600640796, 10.1080/08912960600640796]; Worthy TH, 2003, J ROY SOC NEW ZEAL, V33, P427, DOI 10.1080/03014223.2003.9517738; Zinsmeister WJ, 1992, J PALEONTOL, V56, P84	72	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153915	10.1371/journal.pone.0153915	http://dx.doi.org/10.1371/journal.pone.0153915			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115739	Green Published, gold, Green Submitted			2022-12-27	WOS:000374973600034
J	Zhang, LJ; Hu, XW; Miao, XM; Chen, XL; Nan, SZ; Fu, H				Zhang, Lijing; Hu, Xiaowei; Miao, Xiumei; Chen, Xiaolong; Nan, Shuzhen; Fu, Hua			Genome-Scale Transcriptome Analysis of the Desert Shrub Artemisia sphaerocephala	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; FATTY-ACID-COMPOSITION; CONJUGATED LINOLEIC-ACID; OMEGA-3-FATTY-ACID DESATURASE GENES; LINUM-USITATISSIMUM L.; SALT-STRESS-RESPONSE; ARABIDOPSIS-THALIANA; ABIOTIC STRESS; TEMPERATURE STRESS; HEAT-SHOCK	Background Artemisia sphaerocephala, a semi-shrub belonging to the Artemisia genus of the Compositae family, is an important pioneer plant that inhabits moving and semi-stable sand dunes in the deserts and steppes of northwest and north-central China. It is very resilient in extreme environments. Additionally, its seeds have excellent nutritional value, and the abundant lipids and polysaccharides in the seeds make this plant a potential valuable source of bioenergy. However, partly due to the scarcity of genetic information, the genetic mechanisms controlling the traits and environmental adaptation capacity of A. sphaerocephala are unknown. Results Here, we present the first in-depth transcriptomic analysis of A. sphaerocephala. To maximize the representation of conditional transcripts, mRNA was obtained from 17 samples, including living tissues of desert-growing A. sphaerocephala, seeds germinated in the laboratory, and calli subjected to no stress (control) and high and low temperature, high and low osmotic, and salt stresses. De novo transcriptome assembly performed using an Illumina HiSeq 2500 platform resulted in the generation of 68,373 unigenes. We analyzed the key genes involved in the unsaturated fatty acid synthesis pathway and identified 26 A. sphaerocephala fad2 genes, which is the largest fad2 gene family reported to date. Furthermore, a set of genes responsible for resistance to extreme temperatures, salt, drought and a combination of stresses was identified. Conclusion The present work provides abundant genomic information for functional dissection of the important traits of A. sphaerocephala and contributes to the current understanding of molecular adaptive mechanisms of A. sphaerocephala in the desert environment. Identification of the key genes in the unsaturated fatty acid synthesis pathway could increase understanding of the biological regulatory mechanisms of fatty acid composition traits in plants and facilitate genetic manipulation of the fatty acid composition of oil crops.	[Zhang, Lijing; Hu, Xiaowei; Miao, Xiumei; Chen, Xiaolong; Nan, Shuzhen; Fu, Hua] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China	Lanzhou University	Zhang, LJ (corresponding author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China.	lijingzhang501@hotmail.com			National Basic Research Program of China [2014CB138703]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13019]	National Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research was funded by the National Basic Research Program of China ( 2014CB138703) and the Program for Changjiang Scholars and Innovative Research Team in University ( IRT13019).	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Banik M, 2011, GENOME, V54, P471, DOI [10.1139/g11-013, 10.1139/G11-013]; Baux A, 2008, EUR J AGRON, V29, P102, DOI 10.1016/j.eja.2008.04.005; Bilyeu K, 2005, CROP SCI, V45, P1830, DOI 10.2135/cropsci2004.0632; Bilyeu K, 2006, CROP SCI, V46, P1913, DOI 10.2135/cropsci2005.11-0426; Boerma H. R., 2004, SOYBEANS IMPROVEMENT; Cao SJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-5; Chapman MA, 2012, THEOR APPL GENET, V125, P897, DOI 10.1007/s00122-012-1881-z; CHERIAN G, 1991, POULTRY SCI, V70, P917, DOI 10.3382/ps.0700917; Chi XY, 2011, PLANT CELL REP, V30, P1393, DOI 10.1007/s00299-011-1048-4; Chi XY, 2011, PLANT MOL BIOL REP, V29, P769, DOI 10.1007/s11105-010-0284-z; Crumb D. J., 2011, International Journal of Applied Research in Natural Products, V4, P12; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Dilzer Allison, 2012, Crit Rev Food Sci Nutr, V52, P488, DOI 10.1080/10408398.2010.501409; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; EMKEN EA, 1994, BBA-LIPID LIPID MET, V1213, P277, DOI 10.1016/0005-2760(94)00054-9; Evers D, 2012, PLANT MOL BIOL, V78, P503, DOI 10.1007/s11103-012-9879-0; FALCONE DL, 1994, PLANT PHYSIOL, V106, P1453, DOI 10.1104/pp.106.4.1453; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Gaude N, 2004, J BIOL CHEM, V279, P34624, DOI 10.1074/jbc.M404098200; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; Golldack D, 2001, PLANT PHYSIOL, V125, P1643, DOI 10.1104/pp.125.4.1643; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan LL, 2014, GENET MOL RES, V13, P6623, DOI [10.4238/2014.August.28.7, 10.4238/2014]; Gutterman Y, 2002, ISR J PLANT SCI, V50, P165, DOI 10.1560/CD1L-0NCF-G2JC-1MHV; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Horiguchi G, 1996, PHYSIOL PLANTARUM, V96, P275, DOI 10.1111/j.1399-3054.1996.tb00214.x; HOWARTH CJ, 1993, NEW PHYTOL, V125, P1, DOI 10.1111/j.1469-8137.1993.tb03862.x; HUGLY S, 1992, PLANT PHYSIOL, V99, P197, DOI 10.1104/pp.99.1.197; Jia JF, 1995, ACTA BOT BOREALI-OCC, V15, P100; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Jung S, 2000, MOL GEN GENET, V263, P796, DOI 10.1007/s004380000244; Kadota Y, 2012, BBA-MOL CELL RES, V1823, P689, DOI 10.1016/j.bbamcr.2011.09.016; Kanauchi O, 2013, SCAND J GASTROENTERO, V48, P387, DOI 10.3109/00365521.2012.741617; Khadake RM, 2009, MOL BIOTECHNOL, V42, P168, DOI 10.1007/s12033-009-9150-3; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; Kim JY, 2010, J EXP BOT, V61, P2317, DOI 10.1093/jxb/erq058; KODAMA H, 1994, PLANT PHYSIOL, V105, P601, DOI 10.1104/pp.105.2.601; KODAMA H, 1995, PLANT PHYSIOL, V107, P1177, DOI 10.1104/pp.107.4.1177; Krasowska A, 2007, J AM OIL CHEM SOC, V84, P809, DOI 10.1007/s11746-007-1106-9; La Porta N, 2015, MOL BIOTECHNOL, V57, P407, DOI 10.1007/s12033-014-9833-2; Lehnen TE, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0097-4; Li-Beisson Y, 2010, ARABIDOPSIS BOOK, V11, pe0133; Liu DL, 2006, PLANT PHYSIOL BIOCH, V44, P380, DOI 10.1016/j.plaphy.2006.06.011; Liu MQ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-88; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Liu Q, 2001, AM J BOT, V88, P92, DOI 10.2307/2657130; Lu Q, 2012, DESERT PLANTS IN CHI; Lukonge E, 2007, J SCI FOOD AGR, V87, P340, DOI 10.1002/jsfa.2731; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; Matsuda O, 2001, PLANTA, V213, P833, DOI 10.1007/s004250100575; McNeely JA, 2003, J ARID ENVIRON, V54, P61, DOI 10.1006/jare.2001.0890; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Miao XiuMei, 2015, Acta Prataculturae Sinica, V24, P55; Milioni D, 1997, PLANT MOL BIOL, V35, P955, DOI 10.1023/A:1005874521528; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; MIQUEL M, 1993, P NATL ACAD SCI USA, V90, P6208, DOI 10.1073/pnas.90.13.6208; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Nishizawa-Yokoi A, 2010, PLANT CELL PHYSIOL, V51, P486, DOI 10.1093/pcp/pcq015; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Palmquist Donald L, 2005, Adv Food Nutr Res, V50, P179, DOI 10.1016/S1043-4526(05)50006-8; PAREEK A, 1995, PLANT MOL BIOL, V29, P293, DOI 10.1007/BF00043653; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pham AT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-195; Pirtle IL, 2001, BBA-GENE STRUCT EXPR, V1522, P122, DOI 10.1016/S0167-4781(01)00312-8; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Priyanka B, 2010, PLANT BIOTECHNOL J, V8, P76, DOI 10.1111/j.1467-7652.2009.00467.x; Puttick D, 2009, LIPIDS, V44, P753, DOI 10.1007/s11745-009-3315-5; Qin LX, 2013, ACTA PHYSIOL PLANT, V35, P1531, DOI 10.1007/s11738-012-1194-5; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Reddy PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089125; Riserus U, 2001, INT J OBESITY, V25, P1129, DOI 10.1038/sj.ijo.0801659; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Rocco M, 2013, MOL BIOSYST, V9, P1257, DOI 10.1039/c3mb70137a; Rodriguez-Vargas S, 2007, APPL ENVIRON MICROB, V73, P110, DOI 10.1128/AEM.01360-06; Roman O, 2013, LWT-FOOD SCI TECHNOL, V52, P49, DOI 10.1016/j.lwt.2012.12.011; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sabudak T, 2007, CHEM NAT COMPD+, V43, P465, DOI 10.1007/s10600-007-0163-5; Sabzalian MR, 2008, J AM OIL CHEM SOC, V85, P717, DOI 10.1007/s11746-008-1254-6; Saidi Y, 2011, NEW PHYTOL, V190, P556, DOI 10.1111/j.1469-8137.2010.03571.x; Sakamoto H, 2000, GENE, V248, P23, DOI 10.1016/S0378-1119(00)00133-5; Sanchez-Garcia A, 2004, EUR J LIPID SCI TECH, V106, P583, DOI 10.1002/ejlt.200401005; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schlueter JA, 2007, CROP SCI, V47, pS14, DOI 10.2135/cropsci2006.06.0382tpg; Sewelam N, 2014, PLANT CELL ENVIRON, V37, P2024, DOI 10.1111/pce.12274; Shahzad MM, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-683; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; SMART CC, 1993, PLANT J, V4, P279, DOI 10.1046/j.1365-313X.1993.04020279.x; Soetaert SSA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-220; Song HX, 1996, J NW U LIGHT IND, V14, P92; State Forestry Administration, 2011, B STATUS QUO DESERTI; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Tan JL, 2013, PHYSIOL PLANTARUM, V149, P310, DOI 10.1111/ppl.12032; Tao W, 2014, INT SOIL WATER CONSE, V2, P34, DOI 10.1016/S2095-6339(15)30056-3; Thouvenot L, 2015, J PLANT PHYSIOL, V175, P113, DOI 10.1016/j.jplph.2014.11.007; Timpson LM, 2013, APPL MICROBIOL BIOT, V97, P195, DOI 10.1007/s00253-012-4074-4; Valdes AE, 2012, PLANT MOL BIOL, V80, P405, DOI 10.1007/s11103-012-9956-4; Velasco L, 1998, EUPHYTICA, V101, P221, DOI 10.1023/A:1018358707847; Venegas-Caleron M, 2006, PLANT PHYSIOL BIOCH, V44, P517, DOI 10.1016/j.plaphy.2006.09.005; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Vrinten P, 2005, PLANT PHYSIOL, V139, P79, DOI 10.1104/pp.105.064451; Wang YL, 2009, MICROB PATHOGENESIS, V47, P78, DOI 10.1016/j.micpath.2009.04.013; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Williams JP, 1997, PHYSIOLOGY BIOCHEMIS; Xiao H, 2009, PLANT J, V59, P789, DOI 10.1111/j.1365-313X.2009.03913.x; Xing XH, 2009, J ETHNOPHARMACOL, V125, P410, DOI 10.1016/j.jep.2009.07.021; Xu D, 2011, PLANTA, V234, P565, DOI 10.1007/s00425-011-1425-9; YABE N, 1994, PLANT CELL PHYSIOL, V35, P1207, DOI 10.1093/oxfordjournals.pcp.a078715; YADAV NS, 1993, PLANT PHYSIOL, V103, P467, DOI 10.1104/pp.103.2.467; Yamada K, 2007, J BIOL CHEM, V282, P37794, DOI 10.1074/jbc.M707168200; Yang QY, 2012, THEOR APPL GENET, V125, P715, DOI 10.1007/s00122-012-1863-1; [杨廷雪 Yang Tingxue], 2014, [生命科学, Chinese Bulletin of Life Sciences], V26, P440; Yang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034597; Yang XJ, 2010, PLANT PHYSIOL BIOCH, V48, P131, DOI 10.1016/j.plaphy.2009.12.006; Yates SA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-2; You F. M., 2014, Journal of Proteomics and Bioinformatics, V7, P310; Yurchenko OP, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0312-5; Zhang DY, 2009, PLANT PHYSIOL BIOCH, V47, P462, DOI 10.1016/j.plaphy.2008.12.024; Zhang H, 2012, J INTEGR PLANT BIOL, V54, P500, DOI 10.1111/j.1744-7909.2012.01135.x; Zhang J, 2012, J PET EXPLOR PROD TE, V2, P7, DOI 10.1007/s13202-011-0016-4; Zhang JT, 2009, BIOCHEM BIOPH RES CO, V390, P469, DOI 10.1016/j.bbrc.2009.09.095; Zhang XH, 2011, PLANT CELL TISS ORG, V107, P1, DOI 10.1007/s11240-011-9950-6; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhao PS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-872; Zhou R, 2015, ACTA ECOL SIN, V2, P015; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266; Zhou ZJ, 2013, NEW PHYTOL, V198, P699, DOI 10.1111/nph.12211; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	138	12	13	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154300	10.1371/journal.pone.0154300	http://dx.doi.org/10.1371/journal.pone.0154300			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115614	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600057
J	Bundhun, PK; Bhurtu, A; Soogund, MZS; Long, MY				Bundhun, Pravesh Kumar; Bhurtu, Akash; Soogund, Mohammad Zafooruddin Sani; Long, Man-Yun			Comparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials	PLOS ONE			English	Review							PERCUTANEOUS CORONARY INTERVENTION; POOLED ANALYSIS; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; PACLITAXEL; IMPLANTATION; MULTICENTER; EFFICACY; COMPLEX; LESIONS	Background Several studies have shown Drug Eluting Stents (DES) to be better compared to Bare Metal Stents (BMS) in patients with type 2 Diabetes Mellitus (T2DM). Since, the adverse clinical outcomes in patients with Insulin-Treated Type 2 Diabetes Mellitus (ITDM) implanted with DES and BMS have not been previously studied, we aim to compare the clinical outcomes in similar patients with cardiovascular diseases, treated with DES and BMS. Methods Randomized Controlled Trials (RCTs) comparing patients treated with DES and BMS were searched from PubMed and EMBASE databases. Outcome data for the patients with ITDM were carefully extracted. Major Adverse Cardiac Events (MACEs), mortality, Target Vessel Revascularization (TVR), Target Lesion Revascularization (TLR), Myocardial Infarction (MI) and Stent Thrombosis (ST) were considered as the clinical endpoints for this analysis. Odds ratios (OR) with 95% confidence intervals (CIs) were calculated and the pooled analyses were performed with RevMan 5.3 software. Results Ten RCTs consisting of 830 patients with ITDM (477 patients in the DES group and 353 patients in the BMS group) from a total number of 9,141 patients were included in this analysis. During a follow-up period from one month to one year, MACEs were not increased with the use of DES in these patients with ITDM. At 9 months, MACEs were significantly lower in the DES group with OR: 0.40, 95% CI: 0.23-0.72; P = 0.002 with no increase in mortality. TVR and TLR also favored the DES group with OR: 0.44, 95% CI: 0.22-0.88, P = 0.02 and OR: 0.28, 95% CI: 0.14-0.53; P = 0.0001 respectively at 9 months, and OR: 0.46, 95% CI: 0.23-0.94, P = 0.03 and OR: 0.28, 95% CI: 0.14-0.55; P = 0.0003 respectively at one year. Results for MI, and ST were not statistically significant. Conclusion Compared to BMS, DES were associated with a significantly lower rate of repeated revascularization, without any increase in MACEs or mortality in these patients with ITDM during a follow up period of one year. However, due to the very small population size, further studies with a larger number of randomized patients are required to completely solve this issue.	[Bundhun, Pravesh Kumar; Long, Man-Yun] Guangxi Med Univ, Affiliated Hosp 1, Inst Cardiovasc Dis, Nanning 530021, Guangxi, Peoples R China; [Bhurtu, Akash; Soogund, Mohammad Zafooruddin Sani] Guangxi Med Univ, Nanning 530021, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Long, MY (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Inst Cardiovasc Dis, Nanning 530021, Guangxi, Peoples R China.	2015manyun@sina.com	Bundhun, Pravesh Kumar/I-1399-2019		Health self-raising foundation of Guangxi [Z2015528]	Health self-raising foundation of Guangxi	This work was supported by Health self-raising foundation of Guangxi (No. Z2015528).	Akin I, 2010, CLIN RES CARDIOL, V99, P393, DOI 10.1007/s00392-010-0136-8; Bangalore S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5170; Baumgart D, 2007, J AM COLL CARDIOL, V50, P1627, DOI 10.1016/j.jacc.2007.07.035; Bundhun PK, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0300-6; Caixeta A, 2009, J AM COLL CARDIOL, V54, P894, DOI 10.1016/j.jacc.2009.04.077; Dawkins KD, 2005, CIRCULATION, V112, P3306, DOI 10.1161/CIRCULATIONAHA.105.552190; Di Lorenzo E, 2009, JACC-CARDIOVASC INTE, V2, P515, DOI 10.1016/j.jcin.2009.03.012; Hermiller JB, 2005, J AM COLL CARDIOL, V45, P1172, DOI 10.1016/j.jacc.2004.10.075; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Iijima R, 2009, REV ESP CARDIOL, V62, P354, DOI 10.1016/S0300-8932(09)70892-9; JOHNSTONE MT, 1993, CIRCULATION, V88, P2510, DOI 10.1161/01.CIR.88.6.2510; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Kim WJ, 2011, CIRCULATION, V124, P886, DOI 10.1161/CIRCULATIONAHA.110.015453; Kirtane AJ, 2008, J AM COLL CARDIOL, V51, P708, DOI 10.1016/j.jacc.2007.10.035; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Kugelmass Aaron D, 2003, J Invasive Cardiol, V15, P568; Li Y, 2001, AM J PHYSIOL-HEART C, V280, pH1480, DOI 10.1152/ajpheart.2001.280.4.H1480; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mauri L, 2010, JACC-CARDIOVASC INTE, V3, P1240, DOI 10.1016/j.jcin.2010.08.021; Moussa I, 2004, CIRCULATION, V109, P2273, DOI 10.1161/01.CIR.0000129767.45513.71; Otake H, 2010, AM J CARDIOL, V106, P492, DOI 10.1016/j.amjcard.2010.03.059; Palmerini T, 2013, J AM COLL CARDIOL, V62, P496, DOI 10.1016/j.jacc.2013.05.022; Pandya SB, 2010, JACC-CARDIOVASC INTE, V3, P602, DOI 10.1016/j.jcin.2010.03.019; Patti G, 2008, AM J CARDIOL, V102, P1328, DOI 10.1016/j.amjcard.2008.07.012; Rahel BM, 2009, AM HEART J, V157, P149, DOI 10.1016/j.ahj.2008.08.025; Sabate M, 2005, CIRCULATION, V112, P2175, DOI 10.1161/CIRCULATIONAHA.105.562421; Steinberg HO, 1997, J CLIN INVEST, V100, P1230, DOI 10.1172/JCI119636; Stettler C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1331; Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Suttorp MJ, 2006, CIRCULATION, V114, P921, DOI 10.1161/CIRCULATIONAHA.106.613588; Uthamalingam S, 2015, INT J CARDIOL, V179, P385, DOI 10.1016/j.ijcard.2014.11.012; Valgimigli M, 2014, JACC-CARDIOVASC INTE, V7, P20, DOI 10.1016/j.jcin.2013.09.008; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	35	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154064	10.1371/journal.pone.0154064	http://dx.doi.org/10.1371/journal.pone.0154064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111304	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600032
J	Jones, C; Sadarangani, M; Lewis, S; Payne, I; Saleem, M; Derrick, JP; Pollard, AJ				Jones, Claire; Sadarangani, Manish; Lewis, Susan; Payne, Isabelle; Saleem, Muhammad; Derrick, Jeremy P.; Pollard, Andrew J.			Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4(+) T Cells	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; NEISSERIA-MENINGITIDIS; VACCINE; SEROGROUP; RESPONSES; SEQUENCE; DISEASE; CEACAM1; STRAIN; PROLIFERATION	Opa proteins are major surface-expressed proteins located in the Neisseria meningitidis outer membrane, and are potential meningococcal vaccine candidates. Although Opa proteins elicit high levels of bactericidal antibodies following immunisation in mice, progress towards human clinical trials has been delayed due to previous findings that Opa inhibits T cell proliferation in some in vitro assays. However, results from previous studies are conflicting, with different Opa preparations and culture conditions being used. We investigated the effects of various Opa+ and Opa- antigens from N. meningitidis strain H44/76 in a range of in vitro conditions using peripheral blood mononuclear cells (PBMCs) and purified CD4(+) T cells, measuring T cell proliferation by CFSE dilution using flow cytometry. Wild type recombinant and liposomal Opa proteins inhibited CD4(+) T cell proliferation after stimulation with IL-2, anti-CD3 and anti-CD28, and these effects were reduced by mutation of the CEA-CAM1-binding region of Opa. These effects were not observed in culture with ex vivo PBMCs. Opa+ and Opa- OMVs did not consistently exert a stimulatory or inhibitory effect across different culture conditions. These data do not support a hypothesis that Opa proteins would be inhibitory to T cells if given as a vaccine component, and T cell immune responses to OMV vaccines are unlikely to be significantly affected by the presence of Opa proteins.	[Jones, Claire; Sadarangani, Manish; Lewis, Susan; Payne, Isabelle; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Jones, Claire; Sadarangani, Manish; Lewis, Susan; Payne, Isabelle; Pollard, Andrew J.] Oxford Univ Hosp NHS Trust, NIHR Biomed Res Ctr, Oxford, England; [Saleem, Muhammad; Derrick, Jeremy P.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Manchester	Sadarangani, M (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.; Sadarangani, M (corresponding author), Oxford Univ Hosp NHS Trust, NIHR Biomed Res Ctr, Oxford, England.	manish.sadarangani@paediatrics.ox.ac.uk	Sadarangani, Manish/V-5609-2019; Saleem, Muhammad/W-4014-2017	Saleem, Muhammad/0000-0002-0994-9701; Derrick, Jeremy/0000-0002-4350-5354; Sadarangani, Manish/0000-0002-9985-6452	Action Medical Research through a Research Training Fellowship [RTF1263]; Meningitis UK; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's National Institute of Health Research Biomedical Research Centres funding scheme	Action Medical Research through a Research Training Fellowship; Meningitis UK; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's National Institute of Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR))	This study was funded by Action Medical Research through a Research Training Fellowship awarded to MSad (RTF1263) and Meningitis UK through a project grant awarded to AJP and supported by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health's National Institute of Health Research Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Arigita C, 2003, VACCINE, V21, P950, DOI 10.1016/S0264-410X(02)00546-7; Baethgen LF, 2008, TROP MED INT HEALTH, V13, P31, DOI 10.1111/j.1365-3156.2007.01970.x; Baker M G, 2001, J Paediatr Child Health, V37, pS13, DOI 10.1046/j.1440-1754.2001.00722.x; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Borrow R, 2001, METH MOLEC MED, V66, P289, DOI 10.1385/1-59259-148-5:289; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Callaghan MJ, 2011, INFECT IMMUN, V79, P2810, DOI 10.1128/IAI.01338-10; CHILSON OP, 1989, EUR J IMMUNOL, V19, P389, DOI 10.1002/eji.1830190225; de Jonge MI, 2003, MOL MICROBIOL, V50, P1005, DOI 10.1046/j.1365-2958.2003.03749.x; DEMORAES JC, 1992, LANCET, V340, P1074; Dorrell L, 2006, J VIROL, V80, P4705, DOI 10.1128/JVI.80.10.4705-4716.2006; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Gray-Owen SD, 2003, SCAND J INFECT DIS, V35, P614, DOI 10.1080/00365540310016042; Hedges SR, 1999, INFECT IMMUN, V67, P3937, DOI 10.1128/IAI.67.8.3937-3946.1999; KAY JE, 1991, IMMUNOL LETT, V29, P51, DOI 10.1016/0165-2478(91)90198-J; Kennell Amy S M, 2014, BMC Res Notes, V7, P662, DOI 10.1186/1756-0500-7-662; Lee HSW, 2007, INFECT IMMUN, V75, P4449, DOI 10.1128/IAI.00222-07; Lyons AB, 2001, METHOD CELL BIOL, V63, P375; NORONHA CP, 1995, INT J EPIDEMIOL, V24, P1050, DOI 10.1093/ije/24.5.1050; Oster P, 2005, VACCINE, V23, P2191, DOI 10.1016/j.vaccine.2005.01.063; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; PLEBANSKI M, 1994, J IMMUNOL METHODS, V170, P15, DOI 10.1016/0022-1759(94)90241-0; Pollard AJ, 1999, INFECT IMMUN, V67, P2452, DOI 10.1128/IAI.67.5.2452-2463.1999; Ramsay M, 2007, INVASIVE NEISSERIA M; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Sadarangani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051045; Sadarangani M, 2011, FEMS MICROBIOL REV, V35, P498, DOI 10.1111/j.1574-6976.2010.00260.x; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; VIRJI M, 1993, MOL MICROBIOL, V10, P499, DOI 10.1111/j.1365-2958.1993.tb00922.x; WHO, 1998, CONTR EP MEN DIS WHO, V2nd ed.; Wiertz EJHJ, 1996, INFECT IMMUN, V64, P298, DOI 10.1128/IAI.64.1.298-304.1996; WIERTZ EJHJ, 1991, J IMMUNOL, V147, P2012; Youssef AR, 2009, INFECT IMMUN, V77, P5170, DOI 10.1128/IAI.00355-09; Zariri A, 2013, VACCINE, V31, P5585, DOI 10.1016/j.vaccine.2013.07.069	36	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154153	10.1371/journal.pone.0154153	http://dx.doi.org/10.1371/journal.pone.0154153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111850	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600037
J	Kobayashi, T; Ito, S; Kobayashi, D; Shimada, A; Narita, I; Murasawa, A; Nakazono, K; Yoshie, H				Kobayashi, Tetsuo; Ito, Satoshi; Kobayashi, Daisuke; Shimada, Atsushi; Narita, Ichiei; Murasawa, Akira; Nakazono, Kiyoshi; Yoshie, Hiromasa			Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis	PLOS ONE			English	Article							SEDIMENTATION-RATE; ANTI-TNF; PERIODONTITIS; ASSOCIATION; GENES; ALPHA; POLYMORPHISMS; PREDICTORS; RECEPTORS; CYTOKINE	Objectives To determine whether serum immunity to Porphyromonas gingivalis peptidylarginine deiminase (PPAD) affects the clinical response to biological disease-modifying antirheumatic drug (bDMARD) in patients with rheumatoid arthritis (RA). Methods In a retrospective study, rheumatologic and periodontal conditions of 60 patients with RA who had been treated with conventional synthetic DMARD were evaluated before (baseline) and after 3 and 6 months of bDMARD therapy. After serum levels of anti-PPAD immunoglobulin G (IgG) were determined at baseline, the patients were respectively divided into two groups for high and low anti-PPAD IgG titers according to the median measurements. Genotypes at 8 functional single nucleotide polymorphisms (SNPs) related to RA were also determined. Results After 3 and 6 months of therapy, patients with low anti-PPAD IgG titers showed a significantly greater decrease in changes in the Disease Activity Score including 28 joints using C-reactive protein (DAS28-CRP) (P = 0.04 for both) and anti-cyclic citrullinated peptide (CCP) IgG levels (P = 0.03 and P = 0.04) than patients with high anti-PPAD IgG titers, although these parameter values were comparable at baseline. The anti-PPAD IgG titers were significantly positively correlated with changes in the DAS28-CRP (P = 0.01 for both) and the anti-CCP IgG levels (P = 0.02 for both) from baseline to 3 and 6 months later. A multiple regression analysis revealed a significantly positive association between the anti-PPAD IgG titers and changes in the DAS28-CRP after 6 months of bDMARD therapy (P = 0.006), after adjusting for age, gender, smoking, periodontal condition, and RA-related SNPs. Conclusion The serum IgG levels to PPAD affect the clinical response to bDMARD in patients with RA.	[Kobayashi, Tetsuo] Niigata Univ, Gen Dent & Clin Educ Unit, Med & Dent Hosp, Niigata, Japan; [Kobayashi, Tetsuo; Shimada, Atsushi; Yoshie, Hiromasa] Niigata Univ, Grad Sch Med & Dent Sci, Div Periodontol, Dept Oral Biol Sci, Niigata, Japan; [Ito, Satoshi; Kobayashi, Daisuke; Murasawa, Akira; Nakazono, Kiyoshi] Niigata Rheumat Ctr, Dept Rheumatol, Shibata, Japan; [Kobayashi, Daisuke; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Dept Homeostat Regulat Dev, Niigata, Japan	Niigata University; Niigata University; Niigata University	Kobayashi, T (corresponding author), Niigata Univ, Gen Dent & Clin Educ Unit, Med & Dent Hosp, Niigata, Japan.; Kobayashi, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Periodontol, Dept Oral Biol Sci, Niigata, Japan.	kotetsuo@dent.niigata-u.ac.jp	Narita, Ichiei/G-5204-2017; Ito, Satoshi/AAL-9615-2020	Narita, Ichiei/0000-0001-7692-3096; 	Japan Society for the Promotion of Science KAKENHI [24659922, 26463130]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science KAKENHI 24659922 and 26463130. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Bello-Gualtero JM, 2016, J PERIODONTOL, V87, P346, DOI 10.1902/jop.2015.150455; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; de Smit M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4061; Gully N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100838; Gumus P, 2014, J PERIODONTOL, V85, P270, DOI 10.1902/jop.2013.130117; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Han JY, 2012, J PERIODONTAL IMPLAN, V42, P3, DOI 10.5051/jpis.2012.42.1.3; Ikari K, 2005, ARTHRITIS RHEUM, V52, P3054, DOI 10.1002/art.21309; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Kievit W, 2007, ANN RHEUM DIS, V66, P1473, DOI 10.1136/ard.2007.072447; Klaasen R, 2011, RHEUMATOLOGY, V50, P1487, DOI 10.1093/rheumatology/ker010; Kobayashi Tetsuo, 2015, Curr Oral Health Rep, V2, P1; Kobayashi T, 2010, J PERIODONTOL, V81, P650, DOI 10.1902/jop.2010.090688; Konig MF, 2015, ANN RHEUM DIS, V74, P2054, DOI 10.1136/annrheumdis-2014-205385; Konig MF, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2014-206681; Lappin DF, 2013, J CLIN PERIODONTOL, V40, P907, DOI 10.1111/jcpe.12138; Leech MT, 2015, BEST PRACT RES CL RH, V29, P189, DOI 10.1016/j.berh.2015.03.001; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; Maresz KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003627; Matsui T, 2007, ANN RHEUM DIS, V66, P1221, DOI 10.1136/ard.2006.063834; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Mikuls TR, 2014, ARTHRITIS RHEUMATOL, V66, P1090, DOI 10.1002/art.38348; Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577; Narvaez J, 2016, SEMIN ARTHRITIS RHEU, V45, P386, DOI 10.1016/j.semarthrit.2015.07.001; Nomura S, 2007, J BIOCHEM BIOPH METH, V70, P787, DOI 10.1016/j.jbbm.2007.05.012; O'Rielly DD, 2010, PHARMACOGEN PERS MED, V3, P15; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Payne Jeffrey B, 2015, Curr Oral Health Rep, V2, P20; Pers YM, 2014, RHEUMATOLOGY, V53, P76, DOI 10.1093/rheumatology/ket301; Pocock JM, 2008, RHEUMATOLOGY, V47, P1073, DOI 10.1093/rheumatology/ken204; Potter C, 2009, ANN RHEUM DIS, V68, P69, DOI 10.1136/ard.2007.084715; Pussinen PJ, 2011, J CLIN PERIODONTOL, V38, P405, DOI 10.1111/j.1600-051X.2011.01703.x; Quirke AM, 2014, ANN RHEUM DIS, V73, P263, DOI 10.1136/annrheumdis-2012-202726; Rodriguez-Rodriguez L, 2011, ARTHRITIS RHEUM-US, V63, P365, DOI 10.1002/art.30145; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schoels MM, 2013, ANN RHEUM DIS, V72, P583, DOI 10.1136/annrheumdis-2012-202470; Shidara K, 2011, RHEUMATOL INT, V31, P617, DOI 10.1007/s00296-009-1336-2; Shimada A, 2016, J PERIODONTAL RES, V51, P103, DOI 10.1111/jre.12288; Swierkot J, 2015, JOINT BONE SPINE, V82, P94, DOI 10.1016/j.jbspin.2014.08.006; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; van de Stadt LA, 2011, ARTHRITIS RHEUM-US, V63, P3226, DOI 10.1002/art.30537; You CG, 2013, CYTOKINE, V61, P133, DOI 10.1016/j.cyto.2012.09.007	45	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154182	10.1371/journal.pone.0154182	http://dx.doi.org/10.1371/journal.pone.0154182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111223	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600042
J	Lenhard, T; Ott, D; Jakob, NJ; Pham, M; Baumer, P; Martinez-Torres, F; Meyding-Lamade, U				Lenhard, Thorsten; Ott, Daniela; Jakob, Nurith J.; Pham, Mirko; Baeumer, Philipp; Martinez-Torres, Francisco; Meyding-Lamade, Uta			Predictors, Neuroimaging Characteristics and Long-Term Outcome of Severe European Tick-Borne Encephalitis: A Prospective Cohort Study	PLOS ONE			English	Article							VIRUS-INFECTION; CLINICAL-COURSE; EPIDEMIOLOGY; GERMANY; DISEASE; SWEDEN; RISK; MRI	Background and Objectives Tick-borne encephalitis (TBE) still represents a considerable medical and health economic problem in Europe and entails a potential threat to travellers. The aim of this study was to characterise the conditions of severe TBE by precisely recording its clinical variants, the related neuroimaging features, and the variant-specific long-term outcome and by identifying predictors for severe courses. Methods A cohort of 111 TBE patients (median age 51, range 17-75 years; 42% females) was analysed prospectively. Data were acquired from the department of neurology, University Hospital Heidelberg, and the infectious diseases registry of the Robert-Koch institute Berlin. Neurological status was ascertained by protocol at admission and discharge and the degree of disability was scored using the modified RANKIN Scale (mRS; clinical score addressing neurological disability, range from 0, healthy to 6, dead) at admission and at follow-up. Follow-up examination was conducted by means of a telephone interview. To identify independent predictors for severe TBE and functional outcome, modelled logistic regression was performed. MRI changes were correlated with infection variants. To assess alpha-motor neuron injury patterns, we used high-resolution magnetic resonance neurography (hrMRN). Analyses were performed at the Department of Neurology, University Hospital, University of Heidelberg from April 2004 through September 2014 Results Acute course: 3.6% of patients died during the acute infection. All patients with a lethal course suffered from meningoencephaloradiculitis (MER, 14.4% of the cohort), which is associated with a significantly higher risk of requiring intensive care (p = 0.004) and mechanical ventilation (p< 0.001) than menigoencephalitis (ME, 27.9% of the cohort). At admission, both MER and ME groups were severely affected, with the MER group having a statistically higher mRS score (median of 5 in the MER groups versus 4 in the ME group; p< 0.001). Long-term outcome: outcome for MER was considerably worse (median mRS = 4) than for ME (mRS = 1, p< 0.0001) and meningitis (mRS = 0, 57.7% of the cohort). Risk factors: advanced age (p< 0.001) and male gender (p = 0.043) are independent risk factors for a severe infection course. Furthermore, we identified pre-existing diabetes mellitus (p = 0.024) as an independent risk factor for MER. In MER, alpha-motor neuron injury accounts for the poor prognosis confirmed by hrMRN. Conclusion and Relevance These data provide critical information for neurologists and other health professionals to use in evaluating TBEV patients who live in or travel to endemic areas. This information can be used to classify clinical presentation and estimate infection-associated complications and individual prognosis. Furthermore, the risk for severe, disabling infections in older patients should prompt general practitioners to recommend and encourage vaccination to those patients living in or travelling to endemic areas.	[Lenhard, Thorsten; Ott, Daniela; Jakob, Nurith J.; Martinez-Torres, Francisco] Univ Heidelberg Hosp, Dept Neurol, Neuroinfectious Dis Grp, Heidelberg, Germany; [Pham, Mirko; Baeumer, Philipp] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany; [Meyding-Lamade, Uta] Krankenhaus Nordwest Frankfurt, Dept Neurol, Frankfurt, Germany; [Jakob, Nurith J.] Psychiat Klin Sanat Kilchberg, Zurich, Switzerland; [Martinez-Torres, Francisco] Merz Pharmaceut GmbH, Frankfurt, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Krankenhaus Nordwest; Merz Pharmaceuticals GmbH	Lenhard, T (corresponding author), Univ Heidelberg Hosp, Dept Neurol, Neuroinfectious Dis Grp, Heidelberg, Germany.	thorsten.lenhard@med.uni-heidelberg.de	Pham, Mirko/AAI-8713-2020					Alkadhi H, 2000, NEURORADIOLOGY, V42, P753, DOI 10.1007/s002340000396; Antonelli A, 2005, DIABETES CARE, V28, P2548, DOI 10.2337/diacare.28.10.2548; Bender A, 2005, J NEUROL NEUROSUR PS, V76, P135, DOI 10.1136/jnnp.2004.040469; Bruno A, 2010, STROKE, V41, P1048, DOI 10.1161/STROKEAHA.109.571562; Czupryna P, 2011, EUR J NEUROL, V18, P673, DOI 10.1111/j.1468-1331.2010.03278.x; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; Donoso Mantke O, 2011, EURO SURVEILL, V16; Gan YH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003794; Grossman RI, 2010, TECHNIQUES NEUROIMAG, P1; Gunther G, 1997, J NEUROL, V244, P230, DOI 10.1007/s004150050077; Haglund M, 2003, J MED VIROL, V71, P610, DOI 10.1002/jmv.10497; Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3; Hellenbrand W, 2013, EPIDEMIOLOGISCHES B, V18, P151; Jadoon NA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-304; Jellinger K, 1981, TICK BORNE ENCEPHALI, P59; Kaiser R, 1996, INFECTION, V24, P398, DOI 10.1007/BF01716094; Kaiser R, 1999, BRAIN, V122, P2067, DOI 10.1093/brain/122.11.2067; Kaiser R, 2012, WIEN MED WOCHENSCHR, V162, P239, DOI 10.1007/s10354-012-0105-0; Karelis G, 2012, EUR J NEUROL, V19, P62, DOI 10.1111/j.1468-1331.2011.03434.x; Kovalev SY, 2009, J GEN VIROL, V90, P2884, DOI 10.1099/vir.0.012419-0; Kupca AM, 2010, TICKS TICK-BORNE DIS, V1, P44, DOI 10.1016/j.ttbdis.2009.11.002; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Marjelund S, 2004, ACTA RADIOL, V45, P88, DOI 10.1080/02841850410003356; Mickiene A, 2002, CLIN INFECT DIS, V35, P650, DOI 10.1086/342059; Montgomery RR, 2015, EXPERT REV ANTI-INFE, V13, P317, DOI 10.1586/14787210.2015.1007043; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069; Pham M, 2014, NEUROLOGY, V82, P598, DOI 10.1212/WNL.0000000000000128; Pham M, 2011, DIABETES CARE, V34, P721, DOI 10.2337/dc10-1491; Schmutzhard E, 2001, J NEUROL, V248, P469, DOI 10.1007/s004150170155; Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014; Stahl JP, 2011, MED MALADIES INFECT, V41, P453, DOI 10.1016/j.medmal.2011.05.015; Suss J, 2010, TICKS TICK-BORNE DIS, DOI [DOI 10.1016/J.TTBDIS.2010.10.007, 10.1016/j.ttbdis.2010.10.007]; Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013	35	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154143	10.1371/journal.pone.0154143	http://dx.doi.org/10.1371/journal.pone.0154143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111657	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600035
J	Panesar, P; Jones, A; Aldous, A; Kranzer, K; Halpin, E; Fifer, H; Macrae, B; Curtis, C; Pollara, G				Panesar, Preet; Jones, Alisdair; Aldous, Alicia; Kranzer, Katharina; Halpin, Eamus; Fifer, Helen; Macrae, Bruce; Curtis, Carmel; Pollara, Gabriele			Attitudes and Behaviours to Antimicrobial Prescribing following Introduction of a Smartphone App	PLOS ONE			English	Article							HOSPITALS; COHORT; CARE	Objectives Our hospital replaced the format for delivering portable antimicrobial prescribing guidance from a paper-based pocket guide to a smartphone application (app). We used this opportunity to assess the relationship between its use and the attitudes and behaviours of antimicrobial prescribers. Methods We used 2 structured cross-sectional questionnaires issued just prior to and 3 months following the launch of the smartphone app. Ordinal Likert scale responses to both frequencies of use and agreement statements permitted quantitative assessment of the relationship between variables. Results The smartphone app was used more frequently than the pocket guide it replaced (p < 0.01), and its increased use was associated with sentiments that the app was useful, easy to navigate and its content relevant. Users who used the app more frequently were more likely to agree that the app encouraged them to challenge inappropriate prescribing by their colleagues (p = 0.001) and were more aware of the importance of antimicrobial stewardship (p = 0.005). Reduced use of the app was associated with agreement that senior physicians' preferences for antimicrobial prescribing would irrespectively overrule guideline recommendations (p = 0.0002). Conclusions Smartphone apps are an effective and acceptable format to deliver guidance on antimicrobial prescribing. Our findings suggest that they may empower users to challenge incorrect prescribing, breaking well-established behaviours, and thus supporting vital stewardship efforts in an era of increased antimicrobial resistance. Future work will need to focus on the direct impact on drug prescriptions as well as identifying barriers to implementing smartphone apps in other clinical settings.	[Panesar, Preet; Jones, Alisdair; Aldous, Alicia] Univ Coll London Hosp, Dept Pharm, London, England; [Kranzer, Katharina] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Kranzer, Katharina; Fifer, Helen; Macrae, Bruce; Curtis, Carmel; Pollara, Gabriele] Univ Coll London Hosp, Dept Clin Microbiol, London, England; [Halpin, Eamus] Horizon Strateg Partners, Leeds, W Yorkshire, England; [Pollara, Gabriele] UCL, Div Infect & Immun, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Pollara, G (corresponding author), Univ Coll London Hosp, Dept Clin Microbiol, London, England.; Pollara, G (corresponding author), UCL, Div Infect & Immun, London, England.	g.pollara@ucl.ac.uk	Kranzer, Katharina/O-8845-2014	Kranzer, Katharina/0000-0001-5691-7270	Wellcome Trust Postdoctoral Clinical Research Fellowship [WT101766/Z/13/Z]; Horizon Strategic Partners; National Institute for Health Research [ACF-2010-20-001] Funding Source: researchfish	Wellcome Trust Postdoctoral Clinical Research Fellowship; Horizon Strategic Partners; National Institute for Health Research(National Institute for Health Research (NIHR))	GP is recipient of a Wellcome Trust Postdoctoral Clinical Research Fellowship (WT101766/Z/13/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EH is employed by a commercial company (Horizon Strategic Partners). Horizon Strategic Partners provided support in the form of salary for author EH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], JOHNS HOPK ABX GUID; Braykov NP, 2014, LANCET INFECT DIS, V14, P1220, DOI 10.1016/S1473-3099(14)70952-1; Charani E, 2013, CLIN INFECT DIS, V57, P188, DOI 10.1093/cid/cit212; Charani E, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-29; Charani E, 2011, CLIN INFECT DIS, V53, P651, DOI 10.1093/cid/cir445; Charanil E, 2013, J ANTIMICROB CHEMOTH, V68, P960, DOI 10.1093/jac/dks492; Department of Health, 2011, ANT STEW START SMART; Department of Health and Department of Environment Food and Rural Affairs, 2013, UK 5 YEAR ANT RES ST; Horizon Strategic Partners, MICROGUIDE; Koehler N., 2013, J MOBILE TECHNOLOGY, V2, P3, DOI [10.7309/jmtm.76, DOI 10.7309/JMTM.76, 10.7309/jmtm.2.1.2, DOI 10.7309/JMTM.2.1.2]; Payne KFB, 2014, HEALTH INFORM J, V20, P59, DOI 10.1177/1460458213478812; Shaffer VA, 2013, MED DECIS MAKING, V33, P108, DOI 10.1177/0272989X12453501	12	46	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154202	10.1371/journal.pone.0154202	http://dx.doi.org/10.1371/journal.pone.0154202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111775	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000374970600047
J	Aftab, SMA; Rafie, ASM; Razak, NA; Ahmad, KA				Aftab, S. M. A.; Rafie, A. S. Mohd; Razak, N. A.; Ahmad, K. A.			Turbulence Model Selection for Low Reynolds Number Flows	PLOS ONE			English	Article							SEPARATION	One of the major flow phenomena associated with low Reynolds number flow is the formation of separation bubbles on an airfoil's surface. NACA4415 airfoil is commonly used in wind turbines and UAV applications. The stall characteristics are gradual compared to thin airfoils. The primary criterion set for this work is the capture of laminar separation bubble. Flow is simulated for a Reynolds number of 120,000. The numerical analysis carried out shows the advantages and disadvantages of a few turbulence models. The turbulence models tested were: one equation Spallart Allmars (S-A), two equation SST K-omega, three equation Intermittency (gamma) SST, k-kl-omega and finally, the four equation transition gamma-Re-theta SST. However, the variation in flow physics differs between these turbulence models. Procedure to establish the accuracy of the simulation, in accord with previous experimental results, has been discussed in detail.	[Aftab, S. M. A.; Rafie, A. S. Mohd; Ahmad, K. A.] Univ Putra Malaysia, Dept Aerosp Engn, Serdang 43400, Malaysia; [Razak, N. A.] Univ Sains Malaysia, Sch Aerosp Engn, Engn Campus, Nibong Tebal 14300, Pulau Pinang, Malaysia	Universiti Putra Malaysia; Universiti Sains Malaysia	Ahmad, KA (corresponding author), Univ Putra Malaysia, Dept Aerosp Engn, Serdang 43400, Malaysia.	aekamarul@upm.edu.my	Razak, Norizham A Abdul/S-5964-2018; arifin, kamarul/AAL-2920-2020	Razak, Norizham A Abdul/0000-0001-8249-3272; arifin, kamarul/0000-0002-4065-4266; Aftab, Syed/0000-0003-2583-571X	Ministry of Science, Technology and Innovation (MOSTI), Malaysia [04-01-04-SF2206]	Ministry of Science, Technology and Innovation (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	The authors are grateful to the Ministry of Science, Technology and Innovation (MOSTI), Malaysia, for providing funds through the e-science fund, grant no 04-01-04-SF2206 (http://www.mosti.gov.my/).	Aftab S. M. A., 2014, Applied Mechanics and Materials, V629, P30, DOI 10.4028/www.scientific.net/AMM.629.30; Butler RJ, 2001, INT J HEAT FLUID FL, V22, P123, DOI 10.1016/S0142-727X(00)00081-3; Cao N., 2010, THESIS U WINDSOR; Carmichael B., 1981, NASACR165803; Choudhry A, 2015, INT J HEAT FLUID FL, V52, P84, DOI 10.1016/j.ijheatfluidflow.2014.12.001; FLUENT Ansys, 2015, FLUENT ANS US GUID R; FLUENT Ansys, 2015, FLUENT ANS THEOR GUI; Gad-el Hak M., 2007, FLOW CONTROL PASSIVE; Kartikawati N.K., 2014, PRASTYONO BUDIDAYA D, P1; Langtry RB, 2009, AIAA J, V47, P2894, DOI 10.2514/1.42362; LISSAMAN PBS, 1983, ANNU REV FLUID MECH, V15, P223, DOI 10.1146/annurev.fl.15.010183.001255; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; MUELLER TJ, 1982, AIAA J, V20, P457, DOI 10.2514/3.51095; Spalart P. R., 1992, AIAA, V092; Versteeg H. K., 2007, INTRO COMPUTATIONAL; Walters DK, 2008, J FLUID ENG-T ASME, V130, DOI 10.1115/1.2979230	17	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153755	10.1371/journal.pone.0153755	http://dx.doi.org/10.1371/journal.pone.0153755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104354	Green Published, gold			2022-12-27	WOS:000374565100020
J	Afulani, PA; Moyer, C				Afulani, Patience A.; Moyer, Cheryl			Explaining Disparities in Use of Skilled Birth Attendants in Developing Countries: A Conceptual Framework	PLOS ONE			English	Article							MATERNAL HEALTH-CARE; ANTENATAL CARE; DELIVERY; DETERMINANTS; SERVICES; QUALITY; FACILITIES; SATISFACTION; DISTRICT; SITES	Despite World Health Organization recommendations that all women deliver with a skilled birth attendant (SBA), research continues to demonstrate large disparities in use of SBAs by socioeconomic status (SES). Yet few quantitative studies empirically examine the factors underlying these disparities, due in part to the fact that current models do not provide clear pathways-with measurable mediators-for how distal factors like SES may affect maternal health-seeking behaviors like delivering with SBAs. We propose the Disparities in Skilled Birth Attendance (DiSBA) framework for examining the determinants of use of SBAs. We posit that three proximal factors directly affect use of SBAs: perceived need, perceived accessibility of maternal health services, and perceived quality of care. Distal factors like SES affect use of SBAs indirectly through these proximal factors, and the effects can be measured. We test the assumptions of the DiSBA framework using data from the Ghana Maternal Health Survey. The analytic techniques we use include logistic regression with mediation analysis to examine the intervening effects. We find that our proxies for perceived access, perceived need, and perceived quality of care account for approximately 23% of the difference between women with no education and those with primary school education, and about 55% of the difference between women in the lowest wealth quintile and those in the middle wealth quintiles. This study suggests that proximal factors are worthy of increased attention in terms of measurement, data collection, analysis, programmatic efforts, and policy interventions, as these factors are potentially more amenable to change than the distal factors. The effects of proximal factors are also likely context specific, thus sufficient understanding in different contexts is essential to developing appropriate interventions.	[Afulani, Patience A.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Moyer, Cheryl] Univ Michigan, Dept Learning Hlth Sci, Ann Arbor, MI 48109 USA; [Moyer, Cheryl] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Moyer, Cheryl] Univ Michigan, Global REACH, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Afulani, PA (corresponding author), Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.	Patience.Afulani@ucsf.edu		Afulani, Patience/0000-0002-6739-234X; Moyer, Cheryl/0000-0002-5796-157X	University of California Los Angeles (UCLA) Bixby Center on Population and Reproductive Health; University of California San Francisco Preterm Birth Initiative; UCLA Bixby Center on Population and Reproductive Health; UCLA School of Public Health; UCLA Graduate Division; UCSF Preterm Birth Initiative	University of California Los Angeles (UCLA) Bixby Center on Population and Reproductive Health; University of California San Francisco Preterm Birth Initiative; UCLA Bixby Center on Population and Reproductive Health; UCLA School of Public Health; UCLA Graduate Division; UCSF Preterm Birth Initiative	The authors received no specific funding for this manuscript. However, during the period of this work, PA was supported by the following fellowships: the Bixby Doctoral Fellowship in Population from the University of California Los Angeles (UCLA) Bixby Center on Population and Reproductive Health, the Celia and Joseph Blann Fellowship from the UCLA School of Public Health, the Dissertation Year Fellowship from the UCLA Graduate Division; and a post-doctoral fellowship from the University of California San Francisco Preterm Birth Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank MEASURE DHS for granting us access to the data set. We are very grateful to PA's doctoral committee members, especially Anne Pebley and Gail Harrison (her co-chairs), for their suggestions and comments on her dissertation work-from which this paper has emerged. PA is also grateful to the UCLA Bixby Center on Population and Reproductive Health, the UCLA School of Public Health, the UCLA Graduate Division, and the UCSF Preterm Birth Initiative for fellowship support during the period of this work.	Abuya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123606; Afulani PA, 2015, DETERMINANTS MATERNA; Afulani PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117996; Amooti-Kaguna B, 2000, SOC SCI MED, V50, P203, DOI 10.1016/S0277-9536(99)00275-0; Andersen HM, 2004, SOC SCI MED, V59, P2003, DOI 10.1016/j.socscimed.2004.03.005; Aneshensel C. S, 2013, THEORY BASED DATA AN; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Bazzano AN, 2008, INT J GYNECOL OBSTET, V102, P91, DOI 10.1016/j.ijgo.2008.02.004; Bell J, 2003, DHS ANAL STUD; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Boller C, 2003, B WORLD HEALTH ORGAN, V81, P116; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Ghana Health Service, 2013, GHAN HLTH SERV 2012; Ghana Statistical Service, 2012, 2010 CENS REP; Ghana Statistical Service, 2011, MULT IND CLUST SURV; Ghana Statistical Service Ghana Health Service and ICF International, 2015, GHAN DEM HLTH SURV 2; Ghana Statistical Service Ghana Health Service Macro International, 2009, GHAN MAT HLTH SURV 2; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; Glanz K, 1997, NIH PUB; Glei DA, 2003, SOC SCI MED, V57, P2447, DOI 10.1016/S0277-9536(03)00140-0; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; Hamilton L.C., 2012, STAT STATA VERSION 1; Hulton L, 2000, FRAMEWORK EVALUATION; Hutchinson PL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-203; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kohler U, 2011, STATA J, V11, P420, DOI 10.1177/1536867X1101100306; Kyomuhendo GB, 2003, REPROD HEALTH MATTER, V11, P16, DOI 10.1016/S0968-8080(03)02176-1; Magadi M, 2000, SOC BIOL, V47, P164; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; MCCARTHY J, 1992, STUD FAMILY PLANN, V23, P23, DOI 10.2307/1966825; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Mood C, 2010, EUR SOCIOL REV, V26, P67, DOI 10.1093/esr/jcp006; Moyer CA, 2013, THEY TREAT YOU LIKE, DOI [10.1016/j.midw.2013.05.006, DOI 10.1016/J.MIDW.2013.05.006]; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI; Rahmani Z, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-166; Rutstein S.O., 2008, DHS WEALTH INDEX APP; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Srivastava A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0525-0; Stekelenburg J, 2004, TROP MED INT HEALTH, V9, P390, DOI 10.1111/j.1365-3156.2004.01202.x; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tran TK, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-40; Tuncalp O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044536; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization, 2013, MDG 5 IMPR MAT HLTH; World Health Organization, 2013, GLOB HLTH OBS DAT RE; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; Yanagisawa S, 2006, TROP MED INT HEALTH, V11, P238, DOI 10.1111/j.1365-3156.2005.01547.x	54	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154110	10.1371/journal.pone.0154110	http://dx.doi.org/10.1371/journal.pone.0154110			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27105309	Green Submitted, Green Published, gold			2022-12-27	WOS:000374565100045
J	Argyropoulos, AJ; Robichaud, P; Balimunkwe, RM; Fisher, GJ; Hammerberg, C; Yan, Y; Quan, T				Argyropoulos, Angela J.; Robichaud, Patrick; Balimunkwe, Rebecca Mutesi; Fisher, Gary J.; Hammerberg, Craig; Yan, Yan; Quan, Taihao			Alterations of Dermal Connective Tissue Collagen in Diabetes: Molecular Basis of Aged-Appearing Skin	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-1 EXPRESSION; HUMAN ENDOTHELIAL-CELLS; HIGH GLUCOSE; FOOT ULCERS; EXTRACELLULAR-MATRIX; CANCER PROGRESSION; UP-REGULATION; FIBROBLASTS; FRAGMENTATION; HEALTHY	Alterations of the collagen, the major structural protein in skin, contribute significantly to human skin connective tissue aging. As aged-appearing skin is more common in diabetes, here we investigated the molecular basis of aged-appearing skin in diabetes. Among all known human matrix metalloproteinases (MMPs), diabetic skin shows elevated levels of MMP-1 and MMP-2. Laser capture microdissection (LCM) coupled real-time PCR indicated that elevated MMPs in diabetic skin were primarily expressed in the dermis. Furthermore, diabetic skin shows increased lysyl oxidase (LOX) expression and higher cross-linked collagens. Atomic force microscopy (AFM) further indicated that collagen fibrils were fragmented/disorganized, and key mechanical properties of traction force and tensile strength were increased in diabetic skin, compared to intact/well-organized collagen fibrils in nondiabetic skin. In in vitro tissue culture system, multiple MMPs including MMP-1 and MM-2 were induced by high glucose (25 mM) exposure to isolated primary human skin dermal fibroblasts, the major cells responsible for collagen homeostasis in skin. The elevation of MMPs and LOX over the years is thought to result in the accumulation of fragmented and cross-linked collagen, and thus impairs dermal collagen structural integrity and mechanical properties in diabetes. Our data partially explain why old-looking skin is more common in diabetic patients.	[Argyropoulos, Angela J.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Robichaud, Patrick; Balimunkwe, Rebecca Mutesi; Fisher, Gary J.; Hammerberg, Craig; Quan, Taihao] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; [Yan, Yan] Chinese Acad Med Sci, Dept Dermatol, Plast Surg Hosp, Beijing 100730, Peoples R China; [Yan, Yan] Peking Union Med Coll, Beijing 100021, Peoples R China	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Quan, T (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA.	thquan@umich.edu		Quan, Taihao/0000-0002-0954-5109	National Institute of Health [AG019364]; Milstein Medical Asian American Partnership Foundation; NATIONAL INSTITUTE ON AGING [R01AG019364] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milstein Medical Asian American Partnership Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Health (AG019364 to G. J. Fisher and T. Quan). Y. Yan is supported by Milstein Medical Asian American Partnership Foundation (2015 Fellowship Award in Skin Disease). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APELQVIST J, 1993, J INTERN MED, V233, P485, DOI 10.1111/j.1365-2796.1993.tb01003.x; Bank RA, 1997, MATRIX BIOL, V16, P233, DOI 10.1016/S0945-053X(97)90012-3; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Boyko EJ, 1996, DIABETIC MED, V13, P967, DOI 10.1002/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K; Brennan M, 2003, PHOTOCHEM PHOTOBIOL, V78, P43, DOI 10.1562/0031-8655(2003)078<0043:MMITMC>2.0.CO;2; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; Death AK, 2003, ATHEROSCLEROSIS, V168, P263, DOI 10.1016/S0021-9150(03)00140-0; Demirseren DD, 2014, AM J CLIN DERMATOL, V15, P65, DOI 10.1007/s40257-013-0048-2; Du XL, 1999, FREE RADICAL BIO MED, V27, P752, DOI 10.1016/S0891-5849(99)00079-9; Duff Michelle, 2015, Clin Diabetes, V33, P40, DOI 10.2337/diaclin.33.1.40; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fisher GJ, 2008, ARCH DERMATOL, V144, P666, DOI 10.1001/archderm.144.5.666; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; FISHER GJ, 1991, J CELL PHYSIOL, V146, P309, DOI 10.1002/jcp.1041460216; Ho FM, 2007, J CELL BIOCHEM, V101, P442, DOI 10.1002/jcb.21192; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kaminska B, 2000, ACTA NEUROBIOL EXP, V60, P395; Knas M, 2013, PHYSIOL RES, V62, P519, DOI 10.33549/physiolres.932534; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Levy L, 2012, J DIABETES, V4, P68, DOI 10.1111/j.1753-0407.2011.00151.x; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Lopez-Lopez N, 2014, ARCH DERMATOL RES, V306, P809, DOI 10.1007/s00403-014-1494-2; Lu KV, 2004, LAB INVEST, V84, P8, DOI 10.1038/labinvest.3700003; Margolis DJ, 2002, DIABETES CARE, V25, P1835, DOI 10.2337/diacare.25.10.1835; McLennan SV, 2000, KIDNEY INT, V58, pS81, DOI 10.1046/j.1523-1755.2000.07713.x; Muller M, 2008, DIABETIC MED, V25, P419, DOI 10.1111/j.1464-5491.2008.02414.x; Nagai T, 2015, J FOOD SCI TECH MYS, V52, P2344, DOI 10.1007/s13197-014-1266-1; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Pedersen G, 2009, CLIN EXP IMMUNOL, V155, P257, DOI 10.1111/j.1365-2249.2008.03836.x; PEREZ MI, 1994, J AM ACAD DERMATOL, V30, P519, DOI 10.1016/S0190-9622(94)70058-3; Qin ZP, 2014, AGING CELL, V13, P1028, DOI 10.1111/acel.12265; Qin ZP, 2014, AGE, V36, P353, DOI 10.1007/s11357-013-9565-4; Qin ZP, 2013, J BIOL CHEM, V288, P12386, DOI 10.1074/jbc.M112.424358; Quan TH, 2015, GERONTOLOGY, V61, P427, DOI 10.1159/000371708; Quan TH, 2013, J INVEST DERMATOL, V133, P1362, DOI 10.1038/jid.2012.509; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; Quan TH, 2009, J INVEST DERM SYMP P, V14, P20, DOI 10.1038/jidsymp.2009.8; Reiber GE, 1996, DIABETIC MED, V13, pS6, DOI 10.1002/dme.1996.13.s1.6; Spencer VA, 2007, ADV CANCER RES, V97, P275, DOI 10.1016/S0065-230X(06)97012-2; Tsai WC, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-255; UITTO J, 1986, DERMATOL CLIN, V4, P433, DOI 10.1016/S0733-8635(18)30806-4; Varani J, 2004, J INVEST DERMATOL, V122, P1471, DOI 10.1111/j.0022-202X.2004.22614.x; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wilmer WA, 1998, KIDNEY INT, V53, P1172, DOI 10.1046/j.1523-1755.1998.00888.x; Xue SN, 2014, WORLD J EMERG MED, V5, P139, DOI [10.5847/wjem.j.1920-8642.2014.02.011, 10.5847/wjem.j.issn.1920-8642.2014.02.011]; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; Zeng W, 2011, J DIABETES COMPLICAT, V25, P398, DOI 10.1016/j.jdiacomp.2011.10.002	52	49	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153806	10.1371/journal.pone.0153806	http://dx.doi.org/10.1371/journal.pone.0153806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104752	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100022
J	Liu, ZJ; Daftarian, P; Kovalski, L; Wang, B; Tian, RX; Castilla, DM; Dikici, E; Perez, VL; Deo, S; Daunert, S; Velazquez, OC				Liu, Zhao-Jun; Daftarian, Pirouz; Kovalski, Leticia; Wang, Bo; Tian, Runxia; Castilla, Diego M.; Dikici, Emre; Perez, Victor L.; Deo, Sapna; Daunert, Sylvia; Velazquez, Omaida C.			Directing and Potentiating Stem Cell-Mediated Angiogenesis and Tissue Repair by Cell Surface E-Selectin Coating	PLOS ONE			English	Article							PRIMARY MELANOMA PROGRESSION; GLYCOPROTEIN LIGAND-1; IN-VIVO; ISCHEMIC CARDIOMYOPATHY; BIOMEDICAL APPLICATIONS; PAMAM DENDRIMERS; RANDOMIZED-TRIAL; T-CELLS; DELIVERY; RECRUITMENT	Stem cell therapy has emerged as a promising approach for treatment of a number of diseases, including delayed and non-healing wounds. However, targeted systemic delivery of therapeutic cells to the dysfunctional tissues remains one formidable challenge. Herein, we present a targeted nanocarrier-mediated cell delivery method by coating the surface of the cell to be delivered with dendrimer nanocarriers modified with adhesion molecules. Infused nanocarrier-coated cells reach to destination via recognition and association with the counterpart adhesion molecules highly or selectively expressed on the activated endothelium in diseased tissues. Once anchored on the activated endothelium, nanocarriers-coated transporting cells undergo transendothelial migration, extravasation and homing to the targeted tissues to execute their therapeutic role. We now demonstrate feasibility, efficacy and safety of our targeted nanocarrier for delivery of bone marrow cells (BMC) to cutaneous wound tissues and grafted corneas and its advantages over conventional BMC transplantation in mouse models for wound healing and neovascularization. This versatile platform is suited for targeted systemic delivery of virtually any type of therapeutic cell.	[Liu, Zhao-Jun; Wang, Bo; Tian, Runxia; Castilla, Diego M.; Velazquez, Omaida C.] Univ Miami, Sch Med, Dept Surg, Coral Gables, FL 33136 USA; [Daftarian, Pirouz; Kovalski, Leticia; Dikici, Emre; Deo, Sapna; Daunert, Sylvia; Velazquez, Omaida C.] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Coral Gables, FL 33136 USA; [Daftarian, Pirouz; Deo, Sapna; Daunert, Sylvia] Univ Miami, Dr JT Macdonald Biomed Nanotechnol Inst, Coral Gables, FL 33136 USA; [Perez, Victor L.] Univ Miami, Bascom Palmer Eye Inst, Dept Ophthalmol, Coral Gables, FL 33136 USA	University of Miami; University of Miami; University of Miami; Bascom Palmer Eye Institute; University of Miami	Velazquez, OC (corresponding author), Univ Miami, Sch Med, Dept Surg, Coral Gables, FL 33136 USA.; Daunert, S; Velazquez, OC (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, Coral Gables, FL 33136 USA.; Daunert, S (corresponding author), Univ Miami, Dr JT Macdonald Biomed Nanotechnol Inst, Coral Gables, FL 33136 USA.	sdaunert@med.miami.edu; ovelazquez@med.miami.edu			National Institutes of Health [R01DK-071084, R01GM081570, R01GM047915]; David Kimmelman Endowed Chair in Vascular Surgery; Lucille P. Markey Chair in Department of Biochemistry and Molecular Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047915, R01GM081570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David Kimmelman Endowed Chair in Vascular Surgery; Lucille P. Markey Chair in Department of Biochemistry and Molecular Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (R01DK-071084 and R01GM081570 to OV and R01GM047915 to SD). OV is grateful for funding from the David Kimmelman Endowed Chair in Vascular Surgery and SD is also grateful for support by the Lucille P. Markey Chair in Department of Biochemistry and Molecular Biology.	Abdulreda MH, 2011, P NATL ACAD SCI USA, V108, P12863, DOI 10.1073/pnas.1105002108; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Blake DA, 2011, JOVE-J VIS EXP, DOI 10.3791/3289; Borges E, 1997, BLOOD, V90, P1934, DOI 10.1182/blood.V90.5.1934; Campbell NG, 2012, J CARDIOVASC TRANSL, V5, P713, DOI 10.1007/s12265-012-9378-3; Daftarian PM, 2013, J INFECT DIS, V208, P1914, DOI 10.1093/infdis/jit378; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; Gardikis K, 2012, CURR MED CHEM, V19, P4913; Giel-Moloney M, 2007, GENESIS, V45, P83, DOI 10.1002/dvg.20269; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; He X, 2012, J CONTROL RELEASE, V162, P521, DOI 10.1016/j.jconrel.2012.07.023; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Kato N, 2009, J AM SOC NEPHROL, V20, P1565, DOI 10.1681/ASN.2008090957; Kean TJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/732742; Kolhatkar RB, 2007, BIOCONJUGATE CHEM, V18, P2054, DOI 10.1021/bc0603889; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Liu ZJ, 2011, ANN SURG, V254, P450, DOI 10.1097/SLA.0b013e31822a72dc; Liu ZJ, 2010, ANN SURG, V252, P625, DOI 10.1097/SLA.0b013e3181f5a079; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Martins PD, 2007, ARTERIOSCL THROM VAS, V27, P1023, DOI 10.1161/ATVBAHA.107.140442; Nam HY, 2008, INT J PHARMACEUT, V363, P199, DOI 10.1016/j.ijpharm.2008.07.021; Nam HY, 2009, BIOMATERIALS, V30, P665, DOI 10.1016/j.biomaterials.2008.10.013; Oh IY, 2007, BLOOD, V110, P3891, DOI 10.1182/blood-2006-10-048991; Rivera-Nieves J, 2006, J EXP MED, V203, P907, DOI 10.1084/jem.20052530; Sart S, 2014, BIORESEARCH OPEN ACC, V3, P137, DOI 10.1089/biores.2014.0012; Shao H, 2011, ONCOGENE, V30, P4316, DOI 10.1038/onc.2011.142; Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018; Tan YH, 2012, J IMMUNOL, V188, P5962, DOI 10.4049/jimmunol.1103216; Thatte A, 2002, J LEUKOCYTE BIOL, V72, P470; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Zhu DT, 2013, MOL THER, V21, P1621, DOI 10.1038/mt.2013.123	35	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154053	10.1371/journal.pone.0154053	http://dx.doi.org/10.1371/journal.pone.0154053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104647	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100040
J	Shoda, H; Adachi, M; Umeda, T				Shoda, Haruka; Adachi, Mayumi; Umeda, Tomohiro			How Live Performance Moves the Human Heart	PLOS ONE			English	Article							CROSS-MODAL INTERACTIONS; RATE-VARIABILITY; MUSIC; PERCEPTION; MOVEMENT; EXPOSURE	We investigated how the audience member's physiological reactions differ as a function of listening context (i.e., live versus recorded music contexts). Thirty-seven audience members were assigned to one of seven pianists' performances and listened to his/her live performances of six pieces (fast and slow pieces by Bach, Schumann, and Debussy). Approximately 10 weeks after the live performance, each of the audience members returned to the same room and listened to the recorded performances of the same pianists' via speakers. We recorded the audience members' electrocardiograms in listening to the performances in both conditions, and analyzed their heart rates and the spectral features of the heart-rate variability (i.e., HF/TF, LF/HF). Results showed that the audience's heart rate was higher for the faster than the slower piece only in the live condition. As compared with the recorded condition, the audience's sympathovagal balance (LF/HF) was less while their vagal nervous system (HF/TF) was activated more in the live condition, which appears to suggest that sharing the ongoing musical moments with the pianist reduces the audience's physiological stress. The results are discussed in terms of the audience's superior attention and temporal entrainment to live performance.	[Shoda, Haruka; Adachi, Mayumi] Hokkaido Univ, Dept Psychol, Sapporo, Hokkaido, Japan; [Umeda, Tomohiro] Nara Med Univ, Kashihara, Nara 634, Japan; [Shoda, Haruka] Ristumeikan Univ, Ristumeikan Global Innovat Res Org, Nojihigashi 1-1-1, Kusastu, Shiga 5258577, Japan	Hokkaido University; Nara Medical University	Shoda, H (corresponding author), Hokkaido Univ, Dept Psychol, Sapporo, Hokkaido, Japan.; Shoda, H (corresponding author), Ristumeikan Univ, Ristumeikan Global Innovat Res Org, Nojihigashi 1-1-1, Kusastu, Shiga 5258577, Japan.	shoda@frontier.hokudai.ac.jp			Japan Society for the Promotion of Science [10J00985]; Grants-in-Aid for Scientific Research [13J03351] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The experiment was conducted as a part of the first author's doctorate study at Hokkaido University, Japan, supported by Grant-in-Aid for JSPS Fellows (10J00985) by Japan Society for the Promotion of Science (https://kaken.nii.ac.jp/d/p/10J00985.en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 1995, COMPUT CARDIOL, P461, DOI 10.1109/CIC.1995.482685; Adachi, 2012, P 12 INT C MUS PERC, P925; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Camm AJ, 1996, CIRCULATION, V93, P1043; Chapados C, 2008, COGNITION, V108, P639, DOI 10.1016/j.cognition.2008.05.008; Davidson JaneW., 1993, PSYCHOL MUSIC, V21, P103, DOI [DOI 10.1177/030573569302100201, 10.1177/030573569302100201]; Ellis RJ, 2015, PHYSIOL MEAS, V36, P1827, DOI 10.1088/0967-3334/36/9/1827; Garunkstiene R, 2014, NORD J MUSIC THER, V23, P71, DOI 10.1080/08098131.2013.809783; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Hodges DA, 2011, HDB MUSIC EMOTION TH, P279; Ito N, 2012, P FALL M JAP SOC MUS, P15; Iwanaga M, 2005, BIOL PSYCHOL, V70, P61, DOI 10.1016/j.biopsycho.2004.11.015; KESELMAN HJ, 1980, PSYCHOPHYSIOLOGY, V17, P499, DOI 10.1111/j.1469-8986.1980.tb00190.x; Koelsch S, 2015, EUR HEART J, V36, P3043, DOI 10.1093/eurheartj/ehv430; KRISTALBONEH E, 1995, SCAND J WORK ENV HEA, V21, P85, DOI 10.5271/sjweh.15; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Larsen PD, 2006, HEART, V92, P433, DOI 10.1136/hrt.2005.071902; Nakahara H, 2009, ANN NY ACAD SCI, V1169, P359, DOI 10.1111/j.1749-6632.2009.04788.x; Ohgushi K, 1996, P 4 INT C MUS PERC C, P269; Peretz I, 1998, MEM COGNITION, V26, P884, DOI 10.3758/BF03201171; Phillips AC, 2006, PSYCHOPHYSIOLOGY, V43, P633, DOI 10.1111/j.1469-8986.2006.00462.x; PORGES SW, 1992, ATTENTION AND INFORMATION PROCESSING IN INFANTS AND ADULTS, P201; Potter R. F., 2012, PSYCHOPHYSIOLOGICAL; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Shoda H, 2010, P 11 INT C MUS PERC, P843; Shoda H, 2012, MUSIC PERCEPT, V29, P237, DOI 10.1525/MP.2012.29.3.237; Vines BW, 2006, COGNITION, V101, P80, DOI 10.1016/j.cognition.2005.09.003; Watanabe T, 1996, RO-MAN '96 - 5TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN COMMUNICATION, PROCEEDINGS, P141, DOI 10.1109/ROMAN.1996.568786; ZANGEMEISTER WH, 1982, EXP NEUROL, V77, P563, DOI 10.1016/0014-4886(82)90228-X	30	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154322	10.1371/journal.pone.0154322	http://dx.doi.org/10.1371/journal.pone.0154322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27104377	gold, Green Submitted, Green Published			2022-12-27	WOS:000374565100066
J	Villegas, MV; Pallares, CJ; Escandon-Vargas, K; Hernandez-Gomez, C; Correa, A; Alvarez, C; Rosso, F; Matta, L; Luna, C; Zurita, J; Mejia-Villatoro, C; Rodriguez-Noriega, E; Seas, C; Cortesia, M; Guzman-Suarez, A; Guzman-Blanco, M				Virginia Villegas, Maria; Pallares, Christian J.; Escandon-Vargas, Kevin; Hernandez-Gomez, Cristhian; Correa, Adriana; Alvarez, Carlos; Rosso, Fernando; Matta, Lorena; Luna, Carlos; Zurita, Jeannete; Mejia-Villatoro, Carlos; Rodriguez-Noriega, Eduardo; Seas, Carlos; Cortesia, Manuel; Guzman-Suarez, Alfonso; Guzman-Blanco, Manuel			Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries	PLOS ONE			English	Article							RESISTANT KLEBSIELLA-PNEUMONIAE; INTENSIVE-CARE UNITS; K.-PNEUMONIAE; RISK-FACTORS; BACTEREMIA; PREDICTORS; MORTALITY; KPC; EMERGENCE; OUTCOMES	Introduction Infections caused by carbapenem-resistant Enterobacteriaceae are a public health problem associated with higher mortality rates, longer hospitalization and increased healthcare costs. We carried out a study to describe the characteristics of patients with carbapenemase-producing Enterobacteriaceae (CPE) and non-CPE bloodstream infection (BSI) from Latin American hospitals and to determine the clinical impact in terms of mortality and antibiotic therapy. Methods Between July 2013 and November 2014, we conducted a multicenter observational study in 11 hospitals from 7 Latin American countries (Argentina, Colombia, Ecuador, Guatemala, Mexico, Peru, Venezuela). Patients with BSI caused by Enterobacteriaceae were included and classified either as CPE or non-CPE based on detection of bla(KPC), bla(VIM), bla(IMP), bla(NDM) and bla(OXA-48) by polymerase chain reaction. Enrolled subjects were followed until discharge or death. Demographic, microbiological and clinical characteristics were collected from medical records. Both descriptive and inferential statistics were used to analyze the information. Results A total of 255 patients with Enterobacteriaceae BSI were included; CPE were identified in 53 of them. In vitro non-susceptibility to all screened antibiotics was higher in the patients with CPE BSI, remaining colistin, tigecycline and amikacin as the most active drugs. Combination therapy was significantly more frequent in the CPE BSI group (p < 0.001). The most common regimen was carbapenem + colistin or polymyxin B. The overall mortality was 37% (94/255). Overall and attributable mortality were significantly higher in patients with CPE BSI (p < 0.001); however, we found that patients with CPE BSI who received combination therapy and those who received monotherapy had similar mortality. After multivariate adjustment, CPE BSI (adjusted odds ratio [aOR] 4; 95% confidence interval [CI] 1.7-9.5; p = 0.002) and critical illness (aOR 6.5; 95% CI 3.1-13.7; p < 0.001) were independently associated with in-hospital mortality. Conclusions This study provides valuable data on the clinical characteristics and mortality risk factors in patients with CPE BSI. We determined that CPE infection is an independent mortality predictor and thus Latin American hospitals should perform campaigns on prevention and control of CPE BSI.	[Virginia Villegas, Maria; Pallares, Christian J.; Escandon-Vargas, Kevin; Hernandez-Gomez, Cristhian; Correa, Adriana] Int Ctr Med Res & Training CIDEIM, Cali, Colombia; [Pallares, Christian J.] Hosp Univ Valle Evaristo Garcia ESE, Cali, Colombia; [Alvarez, Carlos] Univ Nacl Colombia, Fac Med, Hosp Univ San Ignacio, Bogota, Colombia; [Rosso, Fernando] Clin Fdn Valle del Lili, Cali, Colombia; [Matta, Lorena] Pontificia Univ Javeriana, Cali, Colombia; [Luna, Carlos] Hosp Clin Jose San Martin, Buenos Aires, DF, Argentina; [Zurita, Jeannete] Pontificia Univ Catolica Ecuador, Fac Med, Hosp Vozandes, Quito, Ecuador; [Mejia-Villatoro, Carlos] Hosp Roosevelt, Guatemala City, Guatemala; [Rodriguez-Noriega, Eduardo] Hosp Civil Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico; [Seas, Carlos] Hosp Nacl Cayetano Heredia, Lima, Peru; [Cortesia, Manuel] Hosp Clin Caracas, Caracas, Venezuela; [Guzman-Suarez, Alfonso; Guzman-Blanco, Manuel] Ctr Med Caracas, Caracas, Venezuela	Hospital Universitario San Ignacio; Universidad Nacional de Colombia; Pontificia Universidad Javeriana; University of Buenos Aires; Hospital de Clinicas Jose de San Martin; Pontificia Universidad Catolica del Ecuador	Villegas, MV (corresponding author), Int Ctr Med Res & Training CIDEIM, Cali, Colombia.	mariavirginia.villegas@gmail.com	Luna, Carlos Marcelo/AAN-5089-2021; Escandón, Kevin/P-5168-2015; Matta, Lorena/I-9030-2016; Moreno, carlos Arturo alvarez/P-6678-2016	Escandón, Kevin/0000-0002-7173-7486; Matta, Lorena/0000-0002-5215-3215; Moreno, carlos Arturo alvarez/0000-0001-5419-4494; Seas, Carlos/0000-0001-7067-9141; Rosso, Fernando/0000-0002-2684-9489; Villegas, Maria Virginia/0000-0003-1898-9067; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815	Pfizer [WS2240898]; FOGARTY INTERNATIONAL CENTER [D43TW006589] Funding Source: NIH RePORTER	Pfizer(Pfizer); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a research grant from Pfizer Investigator-Initiated Research (grant number WS2240898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; Ben-David D, 2011, INFECT CONT HOSP EP, V32, P845, DOI 10.1086/661279; Borer A, 2009, INFECT CONT HOSP EP, V30, P972, DOI 10.1086/605922; Carmeli Y, 2010, CLIN MICROBIOL INFEC, V16, P102, DOI 10.1111/j.1469-0691.2009.03115.x; CDC/NHSN, 2014, SURV DEF SPEC TYP IN; CHOW JW, 1991, J ANTIMICROB CHEMOTH, V28, P499, DOI 10.1093/jac/28.4.499; Chow JW, 1999, INT J ANTIMICROB AG, V11, P7, DOI 10.1016/S0924-8579(98)00060-0; Clinical and Laboratory Standards Institute, 2014, CLSI M100 S24; Daikos GL, 2014, ANTIMICROB AGENTS CH, V58, P2322, DOI 10.1128/AAC.02166-13; Daikos GL, 2012, EXPERT REV ANTI-INFE, V10, P1393, DOI [10.1586/eri.12.138, 10.1586/ERI.12.138]; Daikos GL, 2009, ANTIMICROB AGENTS CH, V53, P1868, DOI 10.1128/AAC.00782-08; de Oliveira MS, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.07.010; Doyle D, 2012, J CLIN MICROBIOL, V50, P3877, DOI 10.1128/JCM.02117-12; Falagas ME, 2007, J ANTIMICROB CHEMOTH, V60, P1124, DOI 10.1093/jac/dkm356; Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004; Gasink LB, 2009, INFECT CONT HOSP EP, V30, P1180, DOI 10.1086/648451; Guh AY, 2015, JAMA-J AM MED ASSOC, V314, P1479, DOI 10.1001/jama.2015.12480; Hernandez-Gomez C, 2014, BIOMEDICA, V34, P91, DOI [10.1590/S0120-41572014000500011, 10.7705/biomedica.v34i0.1667]; Hussein K, 2013, J HOSP INFECT, V83, P307, DOI 10.1016/j.jhin.2012.10.012; Jones RN, 2013, BRAZ J INFECT DIS, V17, P672, DOI 10.1016/j.bjid.2013.07.002; Kontopidou F, 2014, CLIN MICROBIOL INFEC, V20, pO117, DOI 10.1111/1469-0691.12341; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; MacKenzie FM, 1997, LANCET, V350, P783, DOI 10.1016/S0140-6736(05)62567-6; Maya JJ, 2013, EXPERT REV ANTI-INFE, V11, P657, DOI 10.1586/14787210.2013.811924; Mouloudi E, 2010, INFECT CONT HOSP EP, V31, P1250, DOI 10.1086/657135; Navarro-San Francisco C, 2013, CLIN MICROBIOL INFEC, V19, pE72, DOI 10.1111/1469-0691.12091; Neuner EA, 2011, DIAGN MICR INFEC DIS, V69, P357, DOI 10.1016/j.diagmicrobio.2010.10.013; Nordmann P, 2014, MED MALADIES INFECT, V44, P51, DOI 10.1016/j.medmal.2013.11.007; Pacheco R, 2014, BIOMEDICA, V34, P81, DOI [10.7705/biomedica.v34i0.1642, 10.1590/S0120-41572014000500010]; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11; Rojas LJ, 2013, ANTIMICROB AGENTS CH, V57, P1101, DOI 10.1128/AAC.01666-12; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Tangden T, 2015, J INTERN MED, V277, P501, DOI 10.1111/joim.12342; Tenover FC, 2006, EMERG INFECT DIS, V12, P1209, DOI 10.3201/eid1708.060291; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Zarkotou O, 2011, CLIN MICROBIOL INFEC, V17, P1798, DOI 10.1111/j.1469-0691.2011.03514.x	38	60	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154092	10.1371/journal.pone.0154092	http://dx.doi.org/10.1371/journal.pone.0154092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104910	Green Published, gold			2022-12-27	WOS:000374565100042
J	Attayek, PJ; Ahmad, AA; Wang, YL; Williamson, I; Sims, CE; Magness, ST; Allbritton, NL				Attayek, Peter J.; Ahmad, Asad A.; Wang, Yuli; Williamson, Ian; Sims, Christopher E.; Magness, Scott T.; Allbritton, Nancy L.			In Vitro Polarization of Colonoids to Create an Intestinal Stem Cell Compartment	PLOS ONE			English	Article							EXPRESSION PATTERN; SELF-RENEWAL; BETA-CATENIN; WNT; EPITHELIUM; CRYPT; MIGRATION; PLATFORM; CULTURE; NICHE	The polarity of proliferative and differentiated cellular compartments of colonic crypts is believed to be specified by gradients of key mitogens and morphogens. Indirect evidence demonstrates a tight correlation between Wnt-pathway activity and the basal-luminal patterning; however, to date there has been no direct experimental manipulation demonstrating that a chemical gradient of signaling factors can produce similar patterning under controlled conditions. In the current work, colonic organoids (colonoids) derived from cultured, multicellular organoid fragments or single stem cells were exposed in culture to steep linear gradients of two Wnt-signaling ligands, Wnt-3a and R-spondin1. The use of a genetically engineered Sox9-Sox9EGFP:.CAGDsRED reporter gene mouse model and EdU-based labeling enabled crypt patterning to be quantified in the developing colonoids. Colonoids derived from multicellular fragments cultured for 5 days under a Wnt-3a or a combined Wnt-3a and R-spondin1 gradient were highly polarized with proliferative cells localizing to the region of the higher morphogen concentration. In a Wnt-3a gradient, Sox9EGFP polarization was 7.3 times greater than that of colonoids cultured in the absence of a gradient; and the extent of EdU polarization was 2.2 times greater than that in the absence of a gradient. Under a Wnt-3a/R-spondin1 gradient, Sox9EGFP polarization was 8.2 times greater than that of colonoids cultured in the absence of a gradient while the extent of EdU polarization was 10 times greater than that in the absence of a gradient. Colonoids derived from single stem cells cultured in Wnt-3a/R-spondin1 gradients were most highly polarized demonstrated by a Sox9EGFP polarization 20 times that of colonoids grown in the absence of a gradient. This data provides direct evidence that a linear gradient of Wnt signaling factors applied to colonic stem cells is sufficient to direct patterning of the colonoid unit in culture.	[Attayek, Peter J.; Ahmad, Asad A.; Williamson, Ian; Allbritton, Nancy L.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Attayek, Peter J.; Ahmad, Asad A.; Williamson, Ian; Allbritton, Nancy L.] N Carolina State Univ, Raleigh, NC 27695 USA; [Wang, Yuli; Sims, Christopher E.; Allbritton, Nancy L.] Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA; [Magness, Scott T.] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Allbritton, NL (corresponding author), Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA.; Allbritton, NL (corresponding author), N Carolina State Univ, Raleigh, NC 27695 USA.; Allbritton, NL (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	nlallbri@unc.edu	Ariel, Pablo/AGJ-4118-2022; Wang, Yuli/C-6297-2011; , Advanced Analytics Core/AAE-5263-2022	Attayek, Peter/0000-0001-7572-6381; Magness, Scott/0000-0002-2746-1224	National Cancer Institute [F31CA183309, CA177993]; National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK34987]; National Institutes Office of the Director [OD0205]; NATIONAL CANCER INSTITUTE [F31CA183309, R01CA177993, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes Office of the Director; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Cancer Institute, Award Numbers: F31CA183309 and CA177993 (http://www.cancer.gov/); National Institute of Diabetes and Digestive and Kidney Diseases, Award Number: P30 DK34987 (http://www.niddk.nih.gov/Pages/default.aspx); and National Institutes Office of the Director, Award Number: OD0205 (http://www.nih.gov/institutes-nih/nih-office-director). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h; Ahmad AA, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-9; Barker N, 1999, AM J PATHOL, V154, P29, DOI 10.1016/S0002-9440(10)65247-9; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Beta C, 2011, EUR J CELL BIOL, V90, P811, DOI 10.1016/j.ejcb.2011.05.006; BRIGHT DS, 1987, J MICROSC-OXFORD, V146, P191, DOI 10.1111/j.1365-2818.1987.tb01340.x; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Clevers H, 2013, NATURE, V495, P53, DOI 10.1038/nature11958; Crank J., 1979, MATH DIFFUSION; Davies PS, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-57; Du HJ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004285; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Glantz S. A., 2005, PRIMER BIOSTATISTICS; Gracz AD, 2015, NAT CELL BIOL, V17, P340, DOI 10.1038/ncb3104; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Leedham SJ, 2013, GUT, V62, P83, DOI 10.1136/gutjnl-2011-301601; LI CH, 1993, PATTERN RECOGN, V26, P617, DOI 10.1016/0031-3203(93)90115-D; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Miyoshi H, 2013, CELL CYCLE, V12, P387, DOI 10.4161/cc.23552; Pfluger CA, 2013, TISSUE ENG PT A, V19, P649, DOI [10.1089/ten.tea.2012.0153, 10.1089/ten.TEA.2012.0153]; Ramalingam S, 2012, AM J PHYSIOL-GASTR L, V302, pG10, DOI 10.1152/ajpgi.00277.2011; Rodriguez LL, 2013, INTEGR BIOL-UK, V5, P1306, DOI 10.1039/c3ib40137e; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007989; Schneider IC, 2006, CELL CYCLE, V5, P1130, DOI 10.4161/cc.5.11.2770; SCOTT M, 1983, J AM STAT ASSOC, V78, P736, DOI 10.2307/2288155; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Shaffiey SA, 2015, REGEN MED; Tehranirokh M, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4826935; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Meer AD, 2012, INTEGR BIOL-UK, V4, P461, DOI 10.1039/c2ib00176d; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; VanDussen KL, 2015, GUT, V64, P911, DOI 10.1136/gutjnl-2013-306651; Wang L, 2010, BIOMATERIALS, V31, P7586, DOI 10.1016/j.biomaterials.2010.06.036; Wang Y, 2013, LAB CHIP, V13, P4625, DOI 10.1039/c3lc50813g; Wrobel MR, 2014, TISSUE ENG PART B-RE, V20, P93, DOI [10.1089/ten.TEB.2013.0233, 10.1089/ten.teb.2013.0233]; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092	55	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153795	10.1371/journal.pone.0153795	http://dx.doi.org/10.1371/journal.pone.0153795			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100890	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500068
J	Chen, GW; Ke, ZC; Liang, TF; Liu, L; Wang, G				Chen, Guowei; Ke, Zhengchen; Liang, Tengfang; Liu, Li; Wang, Gang			Shewanella oneidensis MR-1-Induced Fe(III) Reduction Facilitates Roxarsone Transformation	PLOS ONE			English	Article							MICROBIAL REDUCTION; POULTRY LITTER; CHICKEN MANURE; ARSENIC SPECIATION; PROMOTED REDUCTION; REDUCING BACTERIUM; IRON; MR-1; METABOLITES; IRON(III)	Although microbial activity and associated iron (oxy) hydroxides are known in general to affect the environmental dynamics of 4-hydroxy-3-nitrobenzenearsonic acid (roxarsone), the mechanistic understanding of the underlying biophysico-chemical processes remains unclear due to limited experimental information. We studied how Shewanella oneidensis MR-1 - a widely distributed metal-reducing bacterium, in the presence of dissolved Fe(III), affects roxarsone transformations and biogeochemical cycling in a model aqueous system. The results showed that the MR-1 strain was able to anaerobically use roxarsone as a terminal electron acceptor and to convert it to a single product, 3-amino-4-hydroxybenzene arsonic acid (AHBAA). The presence of Fe(III) stimulated roxarsone transformation via MR-1-induced Fe(III) reduction, whereby the resulting Fe(II) acted as an efficient reductant for roxarsone transformation. In addition, the subsequent secondary Fe(III)/Fe(II) mineralization created conditions for adsorption of organoarsenic compounds to the yielded precipitates and thereby led to arsenic immobilization. The study provided direct evidence of Shewanella oneidensis MR-1-induced direct and Fe(II)-associated roxarsone transformation. Quantitative estimations revealed a candidate mechanism for the early-stage environmental dynamics of roxarsone in nature, which is essential for understanding the environmental dynamics of roxarsone and successful risk assessment.	[Chen, Guowei; Ke, Zhengchen; Liang, Tengfang; Liu, Li] Hefei Univ Technol, Sch Civil & Hydraul Engn, Hefei 230009, Peoples R China; [Wang, Gang] China Agr Univ, Dept Soil & Water Sci, Beijing 100193, Peoples R China	Hefei University of Technology; China Agricultural University	Liu, L (corresponding author), Hefei Univ Technol, Sch Civil & Hydraul Engn, Hefei 230009, Peoples R China.; Wang, G (corresponding author), China Agr Univ, Dept Soil & Water Sci, Beijing 100193, Peoples R China.	lliu@hfut.edu.cn; gangwang@cau.edu.cn	Chen, Guowei/E-4752-2013; Chen, Guowei/AAW-5419-2020; Wang, Gang/GYJ-1308-2022	Chen, Guowei/0000-0002-3093-9866; Chen, Guowei/0000-0002-3093-9866; Wang, Gang/0000-0002-3201-6950	National Natural Science Foundation of China [41401265, 51479046, 51108148]; Chinese Universities Scientific Fund [2016QC056, 2016ZH001]; Program for Changjiang Scholars and Innovative Research Team in University of P.R. China [IRT0412]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund; Program for Changjiang Scholars and Innovative Research Team in University of P.R. China	The authors acknowledge the financial support of the National Natural Science Foundation of China (41401265, 51479046 and 51108148), the Chinese Universities Scientific Fund (2016QC056 and 2016ZH001), and the Program for Changjiang Scholars and Innovative Research Team in University of P.R. China (IRT0412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2003, ENVIRON SCI TECHNOL, V37, P4083, DOI 10.1021/es0340580; Bednar AJ, 2003, SCI TOTAL ENVIRON, V302, P237, DOI 10.1016/S0048-9697(02)00322-4; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Bellows B.C, 2005, ARSENIC POULTRY LITT; Bencheikh-Latmani R, 2005, APPL ENVIRON MICROB, V71, P7453, DOI 10.1128/AEM.71.11.7453-7460.2005; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Campbell KM, 2006, ENVIRON SCI TECHNOL, V40, P5950, DOI 10.1021/es0600476; Chapman HD, 2002, POULTRY SCI, V81, P356, DOI 10.1093/ps/81.3.356; Chen J, 2014, ENVIRON SCI TECHNOL, V48, P1141, DOI 10.1021/es4038319; Chen WR, 2012, J HAZARD MATER, V227, P378, DOI 10.1016/j.jhazmat.2012.05.078; Coker VS, 2006, ENVIRON SCI TECHNOL, V40, P7745, DOI 10.1021/es060990+; Cortinas I, 2006, ENVIRON SCI TECHNOL, V40, P2951, DOI 10.1021/es051981o; Garbarino JR, 2003, ENVIRON SCI TECHNOL, V37, P1509, DOI 10.1021/es026219q; Guo QF, 2013, CHEMOSPHERE, V92, P138, DOI 10.1016/j.chemosphere.2013.02.029; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Hohmann C, 2010, ENVIRON SCI TECHNOL, V44, P94, DOI 10.1021/es900708s; Huang LX, 2013, FOOD ADDIT CONTAM A, V30, P1546, DOI 10.1080/19440049.2013.812809; Huang LX, 2014, CHEMOSPHERE, V100, P57, DOI 10.1016/j.chemosphere.2013.12.074; Icopini GA, 2009, APPL ENVIRON MICROB, V75, P3641, DOI 10.1128/AEM.00022-09; Jiang S, 2013, ENVIRON SCI TECHNOL, V47, P8616, DOI 10.1021/es400534z; Jiang Z, 2013, INT BIODETER BIODEGR, V76, P32, DOI 10.1016/j.ibiod.2012.06.010; Kim DH, 2013, ENVIRON SCI TECHNOL, V47, P8709, DOI 10.1021/es401302w; Kocar BD, 2006, ENVIRON SCI TECHNOL, V40, P6715, DOI 10.1021/es061540k; Kwon JH, 2014, MATERIALS, V7, P1880, DOI 10.3390/ma7031880; Lee JH, 2007, GEOMICROBIOL J, V24, P31, DOI 10.1080/01490450601134291; Liang B, 2014, WATER RES, V54, P137, DOI 10.1016/j.watres.2014.01.052; Liang TF, 2014, CHEMOSPHERE, V112, P128, DOI 10.1016/j.chemosphere.2014.03.103; Liu H, 2014, CHEM ENG J, V255, P500, DOI 10.1016/j.cej.2014.06.030; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; Mestrot A, 2013, APPL GEOCHEM, V33, P294, DOI 10.1016/j.apgeochem.2013.02.023; Muehe EM, 2013, ENVIRON SCI TECHNOL, V47, P8297, DOI 10.1021/es400801z; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; Ouyang BJ, 2014, GEOCHIM COSMOCHIM AC, V124, P54, DOI 10.1016/j.gca.2013.09.020; Ross DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016649; Stolz JF, 2007, ENVIRON SCI TECHNOL, V41, P818, DOI 10.1021/es061802i; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Tufano KJ, 2008, ENVIRON SCI TECHNOL, V42, P4777, DOI 10.1021/es702625e; Wang YH, 2008, GEOCHIM COSMOCHIM AC, V72, P2573, DOI 10.1016/j.gca.2008.03.011; Wielinga B, 2001, ENVIRON SCI TECHNOL, V35, P522, DOI 10.1021/es001457b; Yao LX, 2013, J AGR FOOD CHEM, V61, P320, DOI 10.1021/jf3045022; Yao LX, 2009, PLANT SOIL, V316, P117, DOI 10.1007/s11104-008-9764-4	41	13	13	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154017	10.1371/journal.pone.0154017	http://dx.doi.org/10.1371/journal.pone.0154017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100323	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500124
J	Heers, AM; Baier, DB; Jackson, BE; Dial, KP				Heers, Ashley M.; Baier, David B.; Jackson, Brandon E.; Dial, Kenneth P.			Flapping before Flight: High Resolution, Three-Dimensional Skeletal Kinematics of Wings and Legs during Avian Development	PLOS ONE			English	Article							4-WINGED DINOSAURS; NEST PREDATION; LONG FEATHERS; TAKE-OFF; EVOLUTION; PERFORMANCE; BIRDS; ARCHAEOPTERYX; LOCOMOTION; THEROPOD	Some of the greatest transformations in vertebrate history involve developmental and evolutionary origins of avian flight. Flight is the most power-demanding mode of locomotion, and volant adult birds have many anatomical features that presumably help meet these demands. However, juvenile birds, like the first winged dinosaurs, lack many hallmarks of advanced flight capacity. Instead of large wings they have small "protowings", and instead of robust, interlocking forelimb skeletons their limbs are more gracile and their joints less constrained. Such traits are often thought to preclude extinct theropods from powered flight, yet young birds with similarly rudimentary anatomies flap-run up slopes and even briefly fly, thereby challenging longstanding ideas on skeletal and feather function in the theropodavian lineage. Though skeletons and feathers are the common link between extinct and extant theropods and figure prominently in discussions on flight performance (extant birds) and flight origins (extinct theropods), skeletal inter-workings are hidden from view and their functional relationship with aerodynamically active wings is not known. For the first time, we use X-ray Reconstruction of Moving Morphology to visualize skeletal movement in developing birds, and explore how development of the avian flight apparatus corresponds with ontogenetic trajectories in skeletal kinematics, aerodynamic performance, and the locomotor transition from pre-flight flapping behaviors to full flight capacity. Our findings reveal that developing chukars (Alectoris chukar) with rudimentary flight apparatuses acquire an "avian" flight stroke early in ontogeny, initially by using their wings and legs cooperatively and, as they acquire flight capacity, counteracting ontogenetic increases in aerodynamic output with greater skeletal channelization. In conjunction with previous work, juvenile birds thereby demonstrate that the initial function of developing wings is to enhance leg performance, and that aerodynamically active, flapping wings might better be viewed as adaptations or exaptations for enhancing leg performance.	[Heers, Ashley M.] Amer Museum Nat Hist, Div Paleontol, Cent Pk West & 79th St, New York, NY 10024 USA; [Baier, David B.] Providence Coll, Dept Biol, 1 Cunningham Sq, Providence, RI 02918 USA; [Jackson, Brandon E.] Longwood Univ, Biol & Environm Sci, 201 High St, Farmville, VA 23909 USA; [Dial, Kenneth P.] Univ Montana, Div Biol Sci, 32 Campus Dr, Missoula, MT 59812 USA	American Museum of Natural History (AMNH); Providence College; Longwood University; University of Montana System; University of Montana	Heers, AM (corresponding author), Amer Museum Nat Hist, Div Paleontol, Cent Pk West & 79th St, New York, NY 10024 USA.	ashmheers@gmail.com			National Science Foundation [GRFP-2007057068, 0919799]; W.M. Keck Foundation	National Science Foundation(National Science Foundation (NSF)); W.M. Keck Foundation(W.M. Keck Foundation)	Funding was provided by the National Science Foundation Graduate Research Fellowship, award number GRFP-2007057068 to AMH, by the National Science Foundation grant entitled, "Ontogeny of Avian Locomotion: Aerodynamics, Skeletal Kinematics, and Neuromuscular Control", award number 0919799 to KPD and others, and by the W.M. Keck Foundation grant entitled, "A Proposal to Design and Build a Dynamic 3-D Skeletal Imaging System", to KPD and others.	Alexander DE, 2010, P NATL ACAD SCI USA, V107, P2972, DOI 10.1073/pnas.0911852107; Allen V, 2013, NATURE, V497, P104, DOI 10.1038/nature12059; Altshuler DL, 2010, J EXP BIOL, V213, P725, DOI 10.1242/jeb.037002; Apanius V., 1998, AVIAN GROWTH DEV EVO; Baier DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063982; Benson RBJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1780; Blob RW, 2008, INTEGR COMP BIOL, V48, P734, DOI 10.1093/icb/icn086; Bock W.J., 1986, Memoirs of the California Academy of Sciences, P57; Brainerd EL, 2010, J EXP ZOOL PART A, V313A, P262, DOI 10.1002/jez.589; Carey James R., 2001, Archaeopteryx, V19, P97; Carlson-Kuhta P, 1998, J NEUROPHYSIOL, V79, P1687, DOI 10.1152/jn.1998.79.4.1687; Carrier DR, 1996, PHYSIOL ZOOL, V69, P467, DOI 10.1086/physzool.69.3.30164211; Cartmill M, 2002, ZOOL J LINN SOC-LOND, V136, P401, DOI 10.1046/j.1096-3642.2002.00038.x; Chai P, 1997, J EXP BIOL, V200, P2757; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Cheng YR, 2012, AM NAT, V180, P285, DOI 10.1086/667214; COOMBS WP, 1978, Q REV BIOL, V53, P393, DOI 10.1086/410790; Crisco JJ, 1998, J BIOMECH, V31, P97, DOI 10.1016/S0021-9290(97)00108-5; Dial K, 2011, J VERTEBR PALEONTOL, V31, P99; Dial KP, 2008, NATURE, V451, P985, DOI 10.1038/nature06517; Dial Kenneth P., 2015, P283; Dial KP, 2006, BIOSCIENCE, V56, P437, DOI 10.1641/0006-3568(2006)056[0437:WUIHAW]2.0.CO;2; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Dial TR, 2012, J EXP BIOL, V215, P3693, DOI 10.1242/jeb.062018; Dial TR, 2012, J EXP BIOL, V215, P3703, DOI 10.1242/jeb.057380; Dimond Christopher C., 2011, BIOS, V82, P58; Earls KD, 2000, J EXP BIOL, V203, P725; Feduccia A, 2005, J MORPHOL, V266, P125, DOI 10.1002/jmor.10382; Foth C, 2014, NATURE, V511, P79, DOI 10.1038/nature13467; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028964; Garstang W., 1951, LARVAL FORMS OTHER Z; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; GATESY SM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P219; Gatesy SM, 2010, J EXP ZOOL PART A, V313A, P244, DOI 10.1002/jez.588; George JC, 1966, AVIAN MYOLOGY; Gill FB, 1994, ORNITHOLOGY, V2nd; Godefroit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2389; Gould S. J., 1977, ONTOGENY PHYLOGENY; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Hedrick TL, 2004, J EXP BIOL, V207, P1689, DOI 10.1242/jeb.00933; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Heers AM, 2015, EVOLUTION, V69, P305, DOI 10.1111/evo.12576; Heers AM, 2014, PALEOBIOLOGY, V40, P459, DOI 10.1666/13057; Heers AM, 2012, TRENDS ECOL EVOL, V27, P296, DOI 10.1016/j.tree.2011.12.003; Heers AM, 2011, J EXP BIOL, V214, P717, DOI 10.1242/jeb.051177; Herrel A, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1, DOI 10.1086/498196; HOGG DA, 1980, J ANAT, V130, P725; Hopp TP, 2004, LIFE O PAST, P234; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Jackson BE, 2009, ALLOMETRY BIRD FLIGH; Jackson BE, 2011, J EXP BIOL, V214, P2354, DOI 10.1242/jeb.052829; Jackson BE, 2009, P ROY SOC B-BIOL SCI, V276, P3457, DOI 10.1098/rspb.2009.0794; Kambic RE, 2014, J EXP BIOL, V217, P2770, DOI 10.1242/jeb.101428; Kisia S. M., 2010, VERTEBRATES STRUCTUR; Li QG, 2012, SCIENCE, V335, P1215, DOI 10.1126/science.1213780; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; MARKS JS, 1986, WILSON BULL, V98, P547; Marks JS, 1999, HDB BIRDS WORLD, V5, P76; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; McFarland JC, 2008, J MORPHOL, V269, P967, DOI 10.1002/jmor.10636; McGowen MR, 2014, TRENDS ECOL EVOL, V29, P336, DOI 10.1016/j.tree.2014.04.001; Minelli, 2003, DEV ANIMAL FORM ONTO; Mitchell JS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0608; Mivart St. George, 1871, GENESIS SPECIES; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Muller W, 1998, J EXP BIOL, V201, P2591; Norberg R.A., 1985, P303; Norberg U., 1990, VERTEBRATE FLIGHT ME; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; Nudds RL, 2009, EVOLUTION, V63, P994, DOI 10.1111/j.1558-5646.2009.00613.x; O'Connor JK, 2015, BIOL BULL+, V42, P616, DOI 10.1134/S1062359015070079; O'Connor J, 2013, P NATL ACAD SCI USA, V110, P17404, DOI 10.1073/pnas.1316979110; O'Connor JK, 2012, GEOSCIENCES, V2, P157, DOI 10.3390/geosciences2030157; O'Connor JK, 2012, HIST BIOL, V24, P29, DOI 10.1080/08912963.2011.552720; Ostrom J.H., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P1; Ostrom J.H., 1986, Memoirs of the California Academy of Sciences, P73; OSTROM JH, 1979, AM SCI, V67, P46; OSTROM JH, 1974, Q REV BIOL, V49, P27, DOI 10.1086/407902; Ostrom JH, 1999, SM C PALEOB, P301; PADIAN K, 1985, PALAEONTOLOGY, V28, P413; Padian K, 2013, INTEGR COMP BIOL, V53, pE160; Padian K, 2003, BIOSCIENCE, V53, P450; Poore SO, 1997, NATURE, V387, P799, DOI 10.1038/42930; R Core Team, 2012, R LANG ENV STAT COMP; RAYNER JMV, 1988, BIOL J LINN SOC, V34, P269, DOI 10.1111/j.1095-8312.1988.tb01963.x; Smith KK, 2006, DEV DYNAM, V235, P1181, DOI 10.1002/dvdy.20676; SPRING LOWELL W., 1965, CONDOR, V67, P457, DOI 10.2307/1365612; Tobalske BW, 2007, J EXP BIOL, V210, P1742, DOI 10.1242/jeb.001701; Tobalske BW, 2001, AM ZOOL, V41, P177, DOI 10.1668/0003-1569(2001)041[0177:MVAIFI]2.0.CO;2; Tobalske BW, 2004, J EXP BIOL, V207, P1345, DOI 10.1242/jeb.00889; Townsend Charles W., 1909, Auk Cambridge Mass, V26; VAZQUEZ RJ, 1992, J MORPHOL, V211, P259, DOI 10.1002/jmor.1052110303; VILENSKY JA, 1994, J HUM EVOL, V26, P375, DOI 10.1006/jhev.1994.1024; WALKER AD, 1972, NATURE, V237, P257, DOI 10.1038/237257a0; WALKER WF, 1971, J MORPHOL, V134, P195, DOI 10.1002/jmor.1051340205; WASSERSUG RJ, 1977, ECOLOGY, V58, P830, DOI 10.2307/1936218; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X, 2015, NATURE, V521, P70, DOI 10.1038/nature14423; Yoda K, 2004, P ROY SOC B-BIOL SCI, V271, pS240, DOI 10.1098/rsbl.2003.0157; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753	106	32	32	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153446	10.1371/journal.pone.0153446	http://dx.doi.org/10.1371/journal.pone.0153446			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100994	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500033
J	Morassutto, C; Monasta, L; Ricci, G; Barbone, F; Ronfani, L				Morassutto, Caterina; Monasta, Lorenzo; Ricci, Giuseppe; Barbone, Fabio; Ronfani, Luca			Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy: A Data Linkage Study	PLOS ONE			English	Article							DIAGNOSED ENDOMETRIOSIS; PELVIC ENDOMETRIOSIS; ESHRE GUIDELINE; WOMEN; EPIDEMIOLOGY; ULTRASOUND; SYMPTOMS; DISEASE; COHORT; LIFE	Despite being quite frequent and having serious implications in terms of symptomatology and fertility, data on incidence and prevalence of endometriosis and adenomyosis following gold standard definitions are dramatically lacking. The average time from onset of symptoms to diagnosis in industrialized countries still ranges from five to ten years. Using the regional centralized data linkage system, we calculated incidence and prevalence of endometriosis and adenomyosis in the female population of Friuli Venezia Giulia region, Italy, for the years 2011-2013. Cases were defined as new diagnoses from hospital discharge records, following procedures allowing direct visualization for endometriosis and hysterectomy for adenomyosis, with or without histological confirmation. Diagnoses were considered "new" after verifying women had not been diagnosed in the previous ten years. Incidence of endometriosis and adenomyosis in women aged 15-50 years is 0.14%. Prevalence, estimated from incidence, is 2.00%. Adenomyosis, representing 28% of all diagnoses, becomes increasingly prevalent after the age of 50 years. Our results shows how the study of both endometriosis and adenomyosis should not be limited to women of premenopausal age. Further efforts are needed to sensitize women and health professional, and to find new data linkage possibilities to identify undiagnosed cases.	[Morassutto, Caterina; Monasta, Lorenzo; Ronfani, Luca] IRCCS Burlo Garofolo, Clin Epidemiol & Publ Hlth Res Unit, Inst Maternal & Child Hlth, Trieste, Italy; [Ricci, Giuseppe] IRCCS Burlo Garofolo, Dept Obstet & Gynecol, Inst Maternal & Child Hlth, Trieste, Italy; [Ricci, Giuseppe; Barbone, Fabio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Barbone, Fabio] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; University of Trieste; University of Udine	Monasta, L (corresponding author), IRCCS Burlo Garofolo, Clin Epidemiol & Publ Hlth Res Unit, Inst Maternal & Child Hlth, Trieste, Italy.	lorenzo.monasta@burlo.trieste.it	Ronfani, Luca/B-6668-2013; Barbone, Fabio/K-1755-2014; Ricci, Giuseppe/AAC-3332-2022; Monasta, Lorenzo/B-1388-2012	Ronfani, Luca/0000-0001-5710-3914; Barbone, Fabio/0000-0001-8795-9959; Ricci, Giuseppe/0000-0002-8031-1102; Monasta, Lorenzo/0000-0001-7774-548X; Barbone, Fabio/0000-0003-1337-5111	Regional Health Authority of Friuli Venezia Giulia	Regional Health Authority of Friuli Venezia Giulia	This study was supported by a grant from the Regional Health Authority of Friuli Venezia Giulia (Dec. 979/Pren. 16/10/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2012, EUR J OBSTET GYN R B, V160, P79, DOI 10.1016/j.ejogrb.2011.09.041; Acien Pedro, 2013, ISRN Obstet Gynecol, V2013, P242149, DOI 10.1155/2013/242149; Arruda MS, 2003, HUM REPROD, V18, P756, DOI 10.1093/humrep/deg136; Ballard KD, 2008, BJOG-INT J OBSTET GY, V115, P1382, DOI 10.1111/j.1471-0528.2008.01878.x; Benagiano G, 2015, REPROD BIOMED ONLINE, V30, P220, DOI 10.1016/j.rbmo.2014.11.005; Borghese B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/618964; Champaneria R, 2010, ACTA OBSTET GYN SCAN, V89, P1374, DOI 10.3109/00016349.2010.512061; Cockerham AZ, 2012, J MIDWIFERY WOM HEAL, V57, P212, DOI 10.1111/j.1542-2011.2011.00117.x; Draghici IM, 2015, ROM J MORPHOL EMBRYO, V56, P133; Dunselman GAJ, 2014, HUM REPROD, V29, P400, DOI 10.1093/humrep/det457; Eggert J, 2008, FERTIL STERIL, V90, P1019, DOI 10.1016/j.fertnstert.2007.07.1345; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Ferrero S, 2010, INT J GYNECOL OBSTET, V110, P203, DOI 10.1016/j.ijgo.2010.03.039; Guo SW, 2006, FERTIL STERIL, V86, P1584, DOI 10.1016/j.fertnstert.2006.04.040; Gylfason JT, 2010, AM J EPIDEMIOL, V172, P237, DOI 10.1093/aje/kwq143; Haas D, 2012, ARCH GYNECOL OBSTET, V286, P667, DOI 10.1007/s00404-012-2361-z; HOUSTON DE, 1987, AM J EPIDEMIOL, V125, P959, DOI 10.1093/oxfordjournals.aje.a114634; Hudelist G, 2012, HUM REPROD, V27, P3412, DOI 10.1093/humrep/des316; Jeon Dong-Su, 2013, J Menopausal Med, V19, P151, DOI 10.6118/jmm.2013.19.3.151; Katz VL, 2012, COMPREHENSIVE GYNECO, P383; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Leibson CL, 2004, FERTIL STERIL, V82, P314, DOI 10.1016/j.fertnstert.2004.01.037; Marwan H, 2015, UTERINE ADENOMYOSIS; Migliaretti G, 2012, GYNECOL OBSTET INVES, V73, P135, DOI 10.1159/000332367; Moen MH, 1997, ACTA OBSTET GYN SCAN, V76, P559, DOI 10.3109/00016349709024584; Moore J, 2002, ULTRASOUND OBST GYN, V20, P630, DOI 10.1046/j.1469-0705.2002.00862.x; Nnoaham KE, 2011, FERTIL STERIL, V96, P366, DOI 10.1016/j.fertnstert.2011.05.090; Parente Barbosa C, 2011, Minerva Ginecol, V63, P375; Rosa-e-Silva JC, 2008, CLIMACTERIC, V11, P525, DOI 10.1080/13697130802490256; VESSEY MP, 1993, BRIT MED J, V306, P182, DOI 10.1136/bmj.306.6871.182	30	86	90	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154227	10.1371/journal.pone.0154227	http://dx.doi.org/10.1371/journal.pone.0154227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101396	Green Published, gold			2022-12-27	WOS:000374898500168
J	Weschke, S; Niedeggen, M				Weschke, Sarah; Niedeggen, Michael			Target and Non-Target Processing during Oddball and Cyberball: A Comparative Event-Related Potential Study	PLOS ONE			English	Article							SOCIAL REJECTION; PHYSICAL PAIN; ANTERIOR CINGULATE; NEURAL ACTIVITY; EXCLUSION; PROBABILITY; OSTRACISM; P300; DISTRESS; CYBEROSTRACISM	The phenomenon of social exclusion can be investigated by using a virtual ball-tossing game called Cyberball. In neuroimaging studies, structures have been identified which are activated during social exclusion. But to date the underlying mechanisms are not fully disclosed. In previous electrophysiological studies it was shown that the P3 complex is sensitive to exclusion manipulations in the Cyberball paradigm and that there is a correlation between P3 amplitude and self-reported social pain. Since this posterior event-related potential (ERP) was widely investigated using the oddball paradigm, we directly compared the ERP effects elicited by the target (Cyberball: "ball possession") and non-target (Cyberball: "ball possession of a co-player) events in both paradigms. Analyses mainly focused on the effect of altered stimulus probabilities of the target and non-target events between two consecutive blocks of the tasks. In the first block, the probability of the target and non-target event was 33% (Cyberball: inclusion), in the second block target probability was reduced to 17%, and accordingly, non-target probability was increased to 66% (Cyberball: exclusion). Our results indicate that ERP amplitude differences between inclusion and exclusion are comparable to ERP amplitude effects in a visual oddball task. We therefore suggest that ERP effects-especially in the P3 range-in the Oddball and Cyberball paradigm rely on similar mechanisms, namely the probability of target and non-target events. Since the simulation of social exclusion (Cyberball) did not trigger a unique ERP response, the idea of an exclusion-specific neural alarm system is not supported. The limitations of an ERP-based approach will be discussed.	[Weschke, Sarah; Niedeggen, Michael] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany	Free University of Berlin	Weschke, S (corresponding author), Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany.	sarah.weschke@fu-berlin.de		Weschke, Sarah/0000-0003-2069-9245				Bernstein MJ, 2012, SOC INFLUENCE, V7, P113, DOI 10.1080/15534510.2012.664326; Bocquillon P, 2014, NEUROSCIENCE, V271, P9, DOI 10.1016/j.neuroscience.2014.04.014; Cacioppo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02027; Crowley MJ, 2010, SOC NEUROSCI-UK, V5, P483, DOI 10.1080/17470919.2010.500169; Crowley MJ, 2009, NEUROREPORT, V20, P1518, DOI 10.1097/WNR.0b013e328330377a; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Eisenberger NI, 2006, PAIN, V126, P132, DOI 10.1016/j.pain.2006.06.024; Eisenberger NI, 2012, NAT REV NEUROSCI, V13, P421, DOI 10.1038/nrn3231; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gonzalez-Rosa JJ, 2013, INT J PSYCHOPHYSIOL, V89, P37, DOI 10.1016/j.ijpsycho.2013.04.021; Grzyb KR, 2005, THESIS KONSTANZ U KO; Gutz L, 2015, J ABNORM PSYCHOL, V124, P421, DOI 10.1037/a0038614; Gutz L, 2011, NEUROREPORT, V22, P453, DOI 10.1097/WNR.0b013e3283476b67; Iannetti GD, 2013, TRENDS COGN SCI, V17, P371, DOI 10.1016/j.tics.2013.06.002; Katayama J, 1996, EVOKED POTENTIAL, V100, P555, DOI 10.1016/S0168-5597(96)95171-0; Kawamoto T., 2013, NEUROSCI J, V2013, P11, DOI DOI 10.1155/2013/304674; Kerr NL, 2008, GROUP DYN-THEOR RES, V12, P39, DOI 10.1037/1089-2699.12.1.39; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; Niedeggen M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00935; Polich J, 1997, INT J PSYCHOPHYSIOL, V25, P169, DOI 10.1016/S0167-8760(96)00742-8; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Proulx T, 2012, TRENDS COGN SCI, V16, P285, DOI 10.1016/j.tics.2012.04.002; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rosenfeld JP, 2005, PSYCHOPHYSIOLOGY, V42, P356, DOI 10.1111/j.1469-8986.2005.00283.x; Rotge JY, 2015, SOC COGN AFFECT NEUR, V10, P19, DOI 10.1093/scan/nsu110; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Themanson JR, 2015, SOC NEUROSCI-UK, V10, P55, DOI 10.1080/17470919.2014.956899; Themanson JR, 2013, SOC COGN AFFECT NEUR, V8, P727, DOI 10.1093/scan/nss058; Weschke S, 2015, BRAIN RES; Weschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071928; WIJERS AA, 1987, BIOL PSYCHOL, V25, P33, DOI 10.1016/0301-0511(87)90066-4; Williams K. J., 2001, IEE 29th Annual Weekend Meeting - History of Electrical Engineering (Ref. No.01/162), p2/1; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2002, GROUP DYN-THEOR RES, V6, P65, DOI 10.1037//1089-2699.6.1.65; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Woo CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6380; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006	42	9	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153941	10.1371/journal.pone.0153941	http://dx.doi.org/10.1371/journal.pone.0153941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100787	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500103
J	Gaffin, DD; Brayfield, BP				Gaffin, Douglas D.; Brayfield, Brad P.			Autonomous Visual Navigation of an Indoor Environment Using a Parsimonious, Insect Inspired Familiarity Algorithm	PLOS ONE			English	Article							PATH-INTEGRATION; SLAM; ANTS; BEES	The navigation of bees and ants from hive to food and back has captivated people for more than a century. Recently, the Navigation by Scene Familiarity Hypothesis (NSFH) has been proposed as a parsimonious approach that is congruent with the limited neural elements of these insects' brains. In the NSFH approach, an agent completes an initial training excursion, storing images along the way. To retrace the path, the agent scans the area and compares the current scenes to those previously experienced. By turning and moving to minimize the pixel-by-pixel differences between encountered and stored scenes, the agent is guided along the path without having memorized the sequence. An important premise of the NSFH is that the visual information of the environment is adequate to guide navigation without aliasing. Here we demonstrate that an image landscape of an indoor setting possesses ample navigational information. We produced a visual landscape of our laboratory and part of the adjoining corridor consisting of 2816 panoramic snapshots arranged in a grid at 12.7-cm centers. We show that pixel-by-pixel comparisons of these images yield robust translational and rotational visual information. We also produced a simple algorithm that tracks previously experienced routes within our lab based on an insect-inspired scene familiarity approach and demonstrate that adequate visual information exists for an agent to retrace complex training routes, including those where the path's end is not visible from its origin. We used this landscape to systematically test the interplay of sensor morphology, angles of inspection, and similarity threshold with the recapitulation performance of the agent. Finally, we compared the relative information content and chance of aliasing within our visually rich laboratory landscape to scenes acquired from indoor corridors with more repetitive scenery.	[Gaffin, Douglas D.; Brayfield, Brad P.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Gaffin, DD (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.	ddgaffin@ou.edu		Gaffin, Douglas/0000-0003-3340-9147	Research Council Faculty Investment Grant from the University of Oklahoma	Research Council Faculty Investment Grant from the University of Oklahoma	The authors received funding from a Research Council Faculty Investment Grant from the University of Oklahoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002336; Baddeley B, 2011, ADAPT BEHAV, V19, P3, DOI 10.1177/1059712310395410; Bailey T, 2006, IEEE ROBOT AUTOM MAG, V13, P108, DOI 10.1109/MRA.2006.1678144; BRINES ML, 1982, J EXP BIOL, V96, P69; CARTWRIGHT BA, 1983, J COMP PHYSIOL, V151, P521, DOI 10.1007/BF00605469; Collett M, 2000, BIOL CYBERN, V83, P245, DOI 10.1007/s004220000168; Courbon J, 2010, CONTROL ENG PRACT, V18, P789, DOI 10.1016/j.conengprac.2010.03.004; Courbon J, 2009, IEEE T INTELL TRANSP, V10, P392, DOI 10.1109/TITS.2008.2012375; Denuelle A, 2015, PROCEEDINGS OF THE 2015 6TH INTERNATIONAL CONFERENCE ON AUTOMATION, ROBOTICS AND APPLICATIONS (ICARA), P443, DOI 10.1109/ICARA.2015.7081189; Franz MO, 1998, BIOL CYBERN, V79, P191, DOI 10.1007/s004220050470; Frisch K. v., 1967, DANCE LANGUAGE ORIEN; Gaffin DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122077; Milford M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0484; Milford M, 2013, INT J ROBOT RES, V32, P766, DOI 10.1177/0278364913490323; Milford M, 2010, INT J ROBOT RES, V29, P1131, DOI 10.1177/0278364909340592; Moller R, 2006, BIOL CYBERN, V95, P413, DOI 10.1007/s00422-006-0095-3; Moore D, 2001, J INSECT PHYSIOL, V47, P843, DOI 10.1016/S0022-1910(01)00057-9; MULLER M, 1988, P NATL ACAD SCI USA, V85, P5287, DOI 10.1073/pnas.85.14.5287; Philippides A, 2011, J EXP BIOL, V214, P445, DOI 10.1242/jeb.046755; ROSSEL S, 1982, P NATL ACAD SCI-BIOL, V79, P4451, DOI 10.1073/pnas.79.14.4451; Srinivasan MV, 2011, PHYSIOL REV, V91, P413, DOI 10.1152/physrev.00005.2010; Strydom R, 2014, P AUSTR C ROB AUT 20; Sturzl W, 2007, BIOL CYBERN, V96, P519, DOI 10.1007/s00422-007-0147-3; Thurrowgood S, 2014, J FIELD ROBOT, V31, P699, DOI 10.1002/rob.21527; Vardy A, 2005, CONNECT SCI, V17, P47, DOI 10.1080/09540090500140958; Wagner AE, 2013, J EXP BIOL, V216, P1131, DOI 10.1242/jeb.064881; Wystrach A, 2016, J COMP PHYSIOL A, V202, P87, DOI 10.1007/s00359-015-1052-1; Zeil J, 2003, J OPT SOC AM A, V20, P450, DOI 10.1364/JOSAA.20.000450	28	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153706	10.1371/journal.pone.0153706	http://dx.doi.org/10.1371/journal.pone.0153706			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119720	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200034
J	Gunda, V; Yu, F; Singh, PK				Gunda, Venugopal; Yu, Fang; Singh, Pankaj K.			Validation of Metabolic Alterations in Microscale Cell Culture Lysates Using Hydrophilic Interaction Liquid Chromatography (HILIC)-Tandem Mass Spectrometry-Based Metabolomics	PLOS ONE			English	Article							MS-BASED METABOLOMICS; PANCREATIC-CANCER	By standard convention, in order to increase the efficacy of metabolite detection from cell culture lysates, metabolite extracts from a large quantity of cells are utilized for multiple reaction monitoring-based metabolomic studies. Metabolomics from a small number of cell extracts offers a potential economical alternative to increased cell numbers, in turn increasing the utility of cell culture-based metabolomics. However, the effect of reduced cell numbers on targeted metabolomic profiling is relatively unstudied. Considering the limited knowledge available of the feasibility and accuracy of microscale cell culture metabolomics, the present study analyzes differences in metabolomic profiles of different cell numbers of three pancreatic cancer cell lines. Specifically, it examines the effects of reduced cell numbers on metabolite profiles by obtaining extracts either directly from microscale culture plates or through serial dilution of increased numbers of cellular metabolite extracts. Our results indicate reduced cell numbers only modestly affect the number of metabolites detected (93% ofmetabolites detected in cell numbers as low as 10(4) cells and 97% for 10(5) cells), independent of the method used to obtain the cells. However, metabolite peak intensities were differentially affected by the reduced cell numbers, with some peak intensities inversely proportional to the cell numbers. To help eliminate such potential inverse relationships, peak intensities for increased cell numbers were excluded from the comparative analysis. Overall, metabolite profiles from microscale culture plates were observed to differ from the serial dilution samples, which may be attributable to the medium-to-cell-number ratios. Finally, findings identify perturbations in metabolomic profiling for cellular extracts from reduced cell numbers, which offer future applications in microscale metabolomic evaluations.	[Gunda, Venugopal; Singh, Pankaj K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Yu, Fang] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA; [Singh, Pankaj K.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Singh, Pankaj K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Singh, Pankaj K.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Singh, PK (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.; Singh, PK (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA.; Singh, PK (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA.; Singh, PK (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA.	pankaj.singh@unmc.edu	gunda, venugopal/A-5658-2018	gunda, venugopal/0000-0002-9156-2580; Singh, Pankaj/0000-0001-8903-0131	National Institutes of Health [R01 CA163649]; American Association for Cancer Research (AACR)-Pancreatic Cancer Action Network (PanCAN) Career Development Award [30-20-25-SING]; Specialized Programs for Research Excellence (SPORE) [2P50 CA127297]; Pancreatic Tumor Microenvironment Research Network [U54, CA163120]; Cancer Center support grant [P30 CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727, U54CA163120, P50CA127297, R01CA163649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research (AACR)-Pancreatic Cancer Action Network (PanCAN) Career Development Award; Specialized Programs for Research Excellence (SPORE); Pancreatic Tumor Microenvironment Research Network; Cancer Center support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by funding from the National Institutes of Health grant (R01 CA163649, NCI) to PKS; American Association for Cancer Research (AACR)-Pancreatic Cancer Action Network (PanCAN) Career Development Award (30-20-25-SING) to PKS; the Specialized Programs for Research Excellence (SPORE, 2P50 CA127297, NCI) to PKS; Pancreatic Tumor Microenvironment Research Network (U54, CA163120, NCI) to PKS; and Cancer Center support grant (P30 CA036727, NCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajad S, 2011, METHODS MOL BIOL, V708, P213, DOI 10.1007/978-1-61737-985-7_13; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; Chaika NV, 2012, P NATL ACAD SCI USA, V109, P13787, DOI 10.1073/pnas.1203339109; Cuperlovic-Culf M, 2010, DRUG DISCOV TODAY, V15, P610, DOI 10.1016/j.drudis.2010.06.012; Daemen A, 2015, P NATL ACAD SCI US; Danielsson APH, 2010, ANAL BIOCHEM, V404, P30, DOI 10.1016/j.ab.2010.04.013; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Fernandes TG, 2009, TRENDS BIOTECHNOL, V27, P342, DOI 10.1016/j.tibtech.2009.02.009; Guo B, 2012, CURR DRUG METAB, V13, P1226, DOI 10.2174/138920012803341401; Kraly JR, 2009, ANAL CHIM ACTA, V653, P23, DOI 10.1016/j.aca.2009.08.037; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; McNamara LE, 2012, J R SOC INTERFACE, V9, P1713, DOI 10.1098/rsif.2012.0169; Nordstrom A, 2006, ANAL CHEM, V78, P3289, DOI 10.1021/ac060245f; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pitt James J, 2009, Clin Biochem Rev, V30, P19; Powers R, 2014, J MED CHEM, V57, P5860, DOI 10.1021/jm401803b; Roberts LD, 2012, CURR PROTOC MOL BIOL, V32, P31; Sapcariu SC, 2014, METHODSX, V1, P74, DOI 10.1016/j.mex.2014.07.002; Shukla SK, 2015, ONCOTARGET; Shukla SK, 2015, ONCOTARGET, V6, P19118, DOI 10.18632/oncotarget.4078; Tiziani S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1562; Tsugawa H, 2014, J BIOSCI BIOENG, V117, P122, DOI 10.1016/j.jbiosc.2013.06.009; Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x; Young JD, 2013, CURR OPIN BIOTECH, V24, P1108, DOI 10.1016/j.copbio.2013.04.016; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048	26	22	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154416	10.1371/journal.pone.0154416	http://dx.doi.org/10.1371/journal.pone.0154416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120458	Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200069
J	Hirve, S; Newman, LP; Paget, J; Azziz-Baumgartner, E; Fitzner, J; Bhat, N; Vandemaele, K; Zhang, WQ				Hirve, Siddhivinayak; Newman, Laura P.; Paget, John; Azziz-Baumgartner, Eduardo; Fitzner, Julia; Bhat, Niranjan; Vandemaele, Katelijn; Zhang, Wenqing			Influenza Seasonality in the Tropics and Subtropics - When to Vaccinate?	PLOS ONE			English	Article							COUNTRIES; VIRUS; RECOMMENDATIONS; SELECTION	Background The timing of the biannual WHO influenza vaccine composition selection and production cycle has been historically directed to the influenza seasonality patterns in the temperate regions of the northern and southern hemispheres. Influenza activity, however, is poorly understood in the tropics with multiple peaks and identifiable year-round activity. The evidence-base needed to take informed decisions on vaccination timing and vaccine formulation is often lacking for the tropics and subtropics. This paper aims to assess influenza seasonality in the tropics and subtropics. It explores geographical grouping of countries into vaccination zones based on optimal timing of influenza vaccination. Methods Influenza seasonality was assessed by different analytic approaches (weekly proportion of positive cases, time series analysis, etc.) using FluNet and national surveillance data. In case of discordance in the seasonality assessment, consensus was built through discussions with in-country experts. Countries with similar onset periods of their primary influenza season were grouped into geographical zones. Results The number and period of peak activity was ascertained for 70 of the 138 countries in the tropics and subtropics. Thirty-seven countries had one and seventeen countries had two distinct peaks. Countries near the equator had secondary peaks or even identifiable year-round activity. The main influenza season in most of South America and Asia started between April and June. The start of the main season varied widely in Africa (October and December in northern Africa, April and June in Southern Africa and a mixed pattern in tropical Africa). Eight "influenza vaccination zones" (two each in America and Asia, and four in Africa and Middle East) were defined with recommendations for vaccination timing and vaccine formulation. The main limitation of our study is that FluNet and national surveillance data may lack the granularity to detect sub-national variability in seasonality patterns. Conclusion Distinct influenza seasonality patterns, though complex, could be ascertained for most countries in the tropics and subtropics using national surveillance data. It may be possible to group countries into zones based on similar recommendations for vaccine timing and formulation.	[Hirve, Siddhivinayak; Fitzner, Julia; Vandemaele, Katelijn; Zhang, Wenqing] World Hlth Org, Global Influenza Program, Geneva, Switzerland; [Newman, Laura P.] Univ Washington, Seattle, WA 98195 USA; [Paget, John] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Azziz-Baumgartner, Eduardo] Ctr Dis Control & Prevent, Atlanta, GA USA; [Bhat, Niranjan] Program Appropriate Technol, Seattle, WA USA	World Health Organization; University of Washington; University of Washington Seattle; Netherlands Institute for Health Services Research; Centers for Disease Control & Prevention - USA	Hirve, S (corresponding author), World Hlth Org, Global Influenza Program, Geneva, Switzerland.	hirves@who.int	zhang, wenqing/GYA-0786-2022		Bill and Melinda Gates Foundation, USA [OPP1084574]; WHO grant [2014/430731-0]; Bill and Melinda Gates Foundation, US [OPP1084288]; Sanofi Pasteur grant [GIBS-FLU37-EXT]; WHO grant from the Bill and Melinda Gates Foundation, USA [OPP1084574]; Bill and Melinda Gates Foundation [OPP1084288];  [1U51GH001191-01]	Bill and Melinda Gates Foundation, USA(Bill & Melinda Gates Foundation); WHO grant; Bill and Melinda Gates Foundation, US; Sanofi Pasteur grant; WHO grant from the Bill and Melinda Gates Foundation, USA; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); 	The work was supported by the following: WZ-Grant no. OPP1084574 to the World Health Organization, Geneva from the Bill and Melinda Gates Foundation, USA; JP-Two grants to Netherlands Institute for Health Services Research (WHO grant 2014/430731-0 and an unrestricted Sanofi Pasteur grant GIBS-FLU37-EXT); NB-Grant OPP1084288 to the Program for Appropriate Technology in Health, Seattle, US from the Bill and Melinda Gates Foundation, US; and EAB-grant 1U51GH001191-01 to the Centers for Disease Control and Prevention, Atlanta.; This review was funded through a WHO grant no.OPP1084574 from the Bill and Melinda Gates Foundation, USA. The NIVEL site analysis was supported by two grants (WHO grant 2014/430731-0 and an unrestricted Sanofi Pasteur grant GIBS-FLU37-EXT). The PATH site analysis was financially supported by grant OPP1084288 from the Bill and Melinda Gates Foundation. The CDC site analysis was supported by a grant 1U51GH001191-01 from 2015. The authors would like to acknowledge Lizette Durand (CDC), Francois Seville (NIVEL), Kathy Neuzil, Jessica Fleming (PATH), Loes Soetens, Paulina Sosa and Nesreen Gusbi (WHO) for supporting this work. We acknowledge the expert opinions of country influenza surveillance experts that helped us to resolve discordant seasonality findings. Most of all, we thank the WHO Global Influenza Surveillance and Response System, all the national influenza centres and the national surveillance systems for sharing the surveillance data. Lastly, we thank colleagues in the WHO regional offices and the WHO Global Influenza Program for their support to the collaborative effort. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their institutes.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Ampofo WK, 2015, VACCINE, V33, P4368, DOI 10.1016/j.vaccine.2015.06.090; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Caini S, 2015, INFLUENZA OTHER RESP, V9, P3, DOI 10.1111/irv.12319; Chadha M, 2014, DYNAMICS INFLU UNPUB; Chadha MS, 2012, INFLUENZA OTHER RESP, V6, P196, DOI 10.1111/j.1750-2659.2011.00293.x; Cox N, 2014, B WORLD HEALTH ORGAN, V92, P311, DOI 10.2471/BLT.14.139428; de Mello WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005095; Durand LO, 2015, TIMING INFLUENZA EPI; DWYER D, 2013, W PAC SURVEILL RESPO, V4, P51, DOI DOI 10.5365/WPSAR.2013.4.1.009; Fedson DS, 2005, VACCINE, V23, P5133, DOI 10.1016/j.vaccine.2005.06.010; Flahault A, 1998, JAMA-J AM MED ASSOC, V280, P1330, DOI 10.1001/jama.280.15.1330; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Hirve S, 2015, SEASONAL INFLUENZA V; Johnson LEA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-209; Katz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098615; Khor CS, 2013, J U MALAYA MED CTR, V16, P18; Matheka DM, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.138.2612; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Ropero-Alvarez AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-361; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Saat Z, 2010, SE ASIAN J TROP MED, V41, P1368; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; van Essen GA, 2003, VACCINE, V21, P1780, DOI 10.1016/S0264-410X(03)00072-0; WHO, 2011, INFL TRANSM ZON; World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P474; World Health Organization, 2012, REP 2 WHO CONS GLOB; World Health Organization, 2015, MAN EST DIS BURD ASS; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552	33	109	111	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153003	10.1371/journal.pone.0153003	http://dx.doi.org/10.1371/journal.pone.0153003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119988	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200015
J	Mullins, CS; Huhns, M; Krohn, M; Peters, S; Cheynet, V; Oriol, G; Guillotte, M; Ducrot, S; Mallet, F; Linnebacher, M				Mullins, Christina S.; Huehns, Maja; Krohn, Mathias; Peters, Sven; Cheynet, Valerie; Oriol, Guy; Guillotte, Michele; Ducrot, Sandrine; Mallet, Francois; Linnebacher, Michael			Generation, Characterization and Application of Antibodies Directed against HERV-H Gag Protein in Colorectal Samples	PLOS ONE			English	Article							HUMAN-ENDOGENOUS-RETROVIRUS; BREAST-CANCER; EXPRESSION; CELLS; INFECTION; SEQUENCE; ELEMENTS; IDENTIFICATION; LYMPHOMA; FAMILY	Introduction A substantial part of the human genome originates from transposable elements, remnants of ancient retroviral infections. Roughly 8% of the human genome consists of about 400,000 LTR elements including human endogenous retrovirus (HERV) sequences. Mainly, the interplay between epigenetic and post-transcriptional mechanisms is thought to silence HERV expression in most physiological contexts. Interestingly, aberrant reactivation of several HERV-H loci appears specific to colorectal carcinoma (CRC). Results The expression of HERV-H Gag proteins (Gag-H) was assessed using novel monoclonal mouse anti Gag-H antibodies. In a flow cytometry screen four antibody clones were tested on a panel of primary CRC cell lines and the most well performing ones were subsequently validated in western blot analysis. Finally, Gag-H protein expression was analyzed by immune histology on cell line cytospins and on clinical samples. There, we found a heterogeneous staining pattern with no background staining of endothelial, stromal and infiltrating immune cells but diffuse staining of the cytoplasm for positive tumor and normal crypt cells of the colonic epithelium. Conclusion Taken together, the Gag-H antibody clone(s) present a valuable tool for staining of cells with colonic origin and thus form the basis for future more detailed investigations. The observed Gag-H protein staining in colonic epithelium crypt cells demands profound analyses of a potential role for Gag-H in the normal physiology of the human gut.	[Mullins, Christina S.; Krohn, Mathias; Peters, Sven; Linnebacher, Michael] Univ Med Rostock, Dept Gen Surg Mol Oncol & Immunotherapy, Schillingallee 69, D-18057 Rostock, Germany; [Huehns, Maja] Univ Med Rostock, Inst Pathol, Strempelstr 14, D-18055 Rostock, Germany; [Cheynet, Valerie; Oriol, Guy; Mallet, Francois] Ctr Hosp Lyon Sud, Canc Biomarkers Res Grp, Joint Unit Hosp Civils Lyon, Batiment 3F, F-69495 Lyon, France; [Guillotte, Michele] BioMerieux, Global R&D Immunoassay, Marcy Letoile, France; [Ducrot, Sandrine] BioMerieux, Raw Mat Dept, R&D Immunoassay, Marcy Letoile, France; [Mallet, Francois] Univ Lyon 1, EA Pathophysiol Injury Induced Immunosuppress, Hosp Civils Lyon, BioMerieux,Hop Edouard Herriot, 5 Pl Arsonval, F-69437 Lyon 3, France	University of Rostock; University of Rostock; bioMerieux; CHU Lyon; bioMerieux; bioMerieux; bioMerieux; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Linnebacher, M (corresponding author), Univ Med Rostock, Dept Gen Surg Mol Oncol & Immunotherapy, Schillingallee 69, D-18057 Rostock, Germany.	michael.linnebacher@med.uni-rostock.de	Mallet, Francois/G-4812-2014; Mullins, Christina/ABG-4821-2021; Linnebacher, Michael/AAT-3763-2021	Mullins, Christina/0000-0003-2296-2027; Linnebacher, Michael/0000-0001-8054-1402; MALLET, Francois/0000-0002-1331-096X	Deutsche Krebshilfe; bioMerieux SA; German Cancer Aid (DKH e.V.) [110943]	Deutsche Krebshilfe(Deutsche Krebshilfe); bioMerieux SA; German Cancer Aid (DKH e.V.)	Deutsche Krebshilfe, http://www.krebshilfe.de, funded CSM with a PostDoc scholarship. This work was supported by bioMerieux SA in the form of salaries for authors [VC, GO, MG, SD and FM]. CSM received a "Mildred Scheel PostDoc Stipendium" from the German Cancer Aid (DKH e.V. #110943). The funder provided support, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahn K, 2009, MOL CELLS, V28, P99, DOI 10.1007/s10059-009-0107-y; Alves Pedro M S, 2008, Cancer Immun, V8, P11; Belshaw R, 2005, MOL BIOL EVOL, V22, P814, DOI 10.1093/molbev/msi088; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Bock M, 2000, CURR OPIN GENET DEV, V10, P651, DOI 10.1016/S0959-437X(00)00138-6; Brudek T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-104; Chiang CY, 2005, VIRUS RES, V108, P139, DOI 10.1016/j.virusres.2004.08.022; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; Feng WJN, 2007, INT J CANCER, V120, P81, DOI 10.1002/ijc.22256; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Gimenez J, 2010, NUCLEIC ACIDS RES, V38, P2229, DOI 10.1093/nar/gkp1214; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kraus B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-21; Kudo-Saito C, 2014, CANCER RES, V74, P1361, DOI 10.1158/0008-5472.CAN-13-1349; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liang QY, 2009, BIOCHEM BIOPH RES CO, V382, P468, DOI 10.1016/j.bbrc.2009.03.058; Maldonado JO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00302; Maletzki C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143194; Maletzki C, 2015, WORLD J GASTROENTERO, V21, P164, DOI 10.3748/wjg.v21.i1.164; Maletzki C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052485; Mallet F, 2004, P NATL ACAD SCI USA, V101, P1731, DOI 10.1073/pnas.0305763101; Miyamoto M, 1991, Med J Osaka Univ, V40, P5; Mullins CS, 2012, WORLD J GASTROENTERO, V18, P6027, DOI 10.3748/wjg.v18.i42.6027; Mullins CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071070; Mullins CS, 2014, J CANC SCI THER, V6. 6, P177, DOI [10.4172/1948-5956.1000269, DOI 10.4172/1948-5956.1000269]; Ostwald C, 2009, INT J ONCOL, V35, P321, DOI 10.3892/ijo_00000343; Perot P, ONCOTARGET IN PRESS; Perot P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040194; Sacha JB, 2012, J IMMUNOL, V189, P1467, DOI 10.4049/jimmunol.1200079; Schiavetti F, 2002, CANCER RES, V62, P5510; Stake MS, 2013, VIRUSES-BASEL, V5, P2767, DOI 10.3390/v5112767; Wang DZ, 2013, ANNU REV MED, V64, P131, DOI 10.1146/annurev-med-112211-154330; Wang-Johanning F, 2003, CANCER-AM CANCER SOC, V98, P187, DOI 10.1002/cncr.11451; Wang-Johanning F, 2008, CANCER RES, V68, P5869, DOI 10.1158/0008-5472.CAN-07-6838; Wentzensen N, 2007, INT J CANCER, V121, P1417, DOI 10.1002/ijc.22826	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153349	10.1371/journal.pone.0153349	http://dx.doi.org/10.1371/journal.pone.0153349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119520	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200023
J	Ojima, K; Lin, ZX; de Andrade, IR; Costa, ML; Mermelstein, C				Ojima, Koichi; Lin, Zhong-Xiang; de Andrade, Ivone Rosa; Costa, Manoel Luis; Mermelstein, Claudia			Distinctive Effects of Cytochalasin B in Chick Primary Myoblasts and Fibroblasts	PLOS ONE			English	Article							ACTIN POLYMERIZATION; RHO GTPASES; MYRISTATE ACETATE; FOCAL ADHESIONS; STRIATED-MUSCLE; CELL MOTILITY; IN-VIVO; PROTEINS; FILAMENTS; DYNAMICS	Actin-based structures play fundamental roles in cellular functions. However it remains controversial how cells cope with the absence of F-actin structures. This report focuses on short-and long-term effects of cytochalasin B (CB) on actin-complexes in fibroblasts and myoblasts. Thirty min of CB treatment dispersed subplasma actin cortices, lamellipodia, ruffled membranes, stress fibers and adhesion plaques into actin patches in fibroblasts and muscle cells. In contrast, 72 hrs CB treatment showed distinct morphological effects. Fibroblasts became giant multinucleated-finger shaped with 5 to 10 protrusions, 3-8 mu m in width, and >200 mu m in length. They lacked cortical actin, stress fibers, adhesion plaques and ruffled membranes but contained immense lamelliopodia with abnormal adhesion plaque protein complexes. Muscle cells transformed into multinucleated globular-shaped but contained normal I-Z-I and A-bands, indicating that CB did not interfere with the assembly of myofibrils. Within 30 min after CB removal, finger-shaped fibroblasts returned to their original shape and actin-containing structures rapidly reappeared, whereas muscle cells respond slowly to form elongated myotubes following CB washout. The capacity to grow, complete several nuclear cycles, assemble intermediate filaments and microtubules without a morphologically recognizable actin cytoskeleton raises interesting issues related to the role of the actin compartments in eukaryotic cells.	[Ojima, Koichi] NARO Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki 3050901, Japan; [Lin, Zhong-Xiang] Beijing Med Univ, Beijing Inst Canc Res, Dept Cell Biol, Beijing 100083, Peoples R China; [de Andrade, Ivone Rosa; Costa, Manoel Luis; Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil	National Agriculture & Food Research Organization - Japan; Peking University; Universidade Federal do Rio de Janeiro	Mermelstein, C (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil.	mermelstein@histo.ufrj.br	mermelstein, Claudia S/C-1464-2010; Costa, Manoel/B-5009-2010	mermelstein, Claudia S/0000-0002-8897-8526; Costa, Manoel/0000-0002-9037-0085; Ojima, Koichi/0000-0002-5973-1073	Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ) - Brazil [203.185/2015]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Brazil [300787/2013-8]	Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ) - Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by "Cientista do Nosso Estado" Grant Number 203.185/2015 from Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ) - Brazil, and Grant Number 300787/2013-8 from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT J, 1972, DEV BIOL, V28, P430, DOI 10.1016/0012-1606(72)90024-3; Ballestrem C, 1998, J CELL SCI, V111, P1649; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; BRENNER SL, 1980, J BIOL CHEM, V255, P1670; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; CLARKE M, 1977, ANNU REV BIOCHEM, V46, P797, DOI 10.1146/annurev.bi.46.070177.004053; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; CROOP J, 1975, J CELL BIOL, V65, P271, DOI 10.1083/jcb.65.2.271; ESTENSEN RD, 1972, P NATL ACAD SCI USA, V69, P1430, DOI 10.1073/pnas.69.6.1430; FELDER S, 1990, J CELL BIOL, V111, P2513, DOI 10.1083/jcb.111.6.2513; Fowler VM, 1996, CURR OPIN CELL BIOL, V8, P86, DOI 10.1016/S0955-0674(96)80052-4; FOWLER VM, 1990, J CELL BIOL, V111, P471, DOI 10.1083/jcb.111.2.471; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Lin Z, 1998, DEV BIOL, V199, P291, DOI 10.1006/dbio.1998.8920; LIN ZX, 1987, J CELL BIOL, V105, P1365, DOI 10.1083/jcb.105.3.1365; LIN ZX, 1989, J CELL BIOL, V108, P1079, DOI 10.1083/jcb.108.3.1079; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; Millevoi S, 1998, J MOL BIOL, V282, P111, DOI 10.1006/jmbi.1998.1999; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; OBINATA T, 1984, DEV BIOL, V105, P253, DOI 10.1016/0012-1606(84)90283-5; Ojima K, 1999, J CELL SCI, V112, P4101; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SANGER JW, 1974, P NATL ACAD SCI USA, V71, P3621, DOI 10.1073/pnas.71.9.3621; SANGER JW, 1971, NATURE-NEW BIOL, V229, P121, DOI 10.1038/newbio229121a0; Schachtner H, 2013, CYTOSKELETON, V70, P572, DOI 10.1002/cm.21119; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Verkhovsky AB, 1997, J CELL SCI, V110, P1693; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498	40	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154109	10.1371/journal.pone.0154109	http://dx.doi.org/10.1371/journal.pone.0154109			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119825	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200045
J	Frafjord, K				Frafjord, Karl			Influence of Reproductive Status: Home Range Size in Water Voles (Arvicola amphibius)	PLOS ONE			English	Article							CLETHRIONOMYS-GLAREOLUS; PRAIRIE VOLES; MICROTUS-OCHROGASTER; POPULATION-DYNAMICS; SOCIAL-ORGANIZATION; TERRITORY DEFENSE; ROOT VOLES; BANK VOLES; DISPERSAL; TERRESTRIS	The relationship between home range and reproductive status of water voles (Arvicola amphibius) was studied by radio-tracking on an island off the coast of northern Norway in 2006-2009. The aim was to test assumptions about the species' social structure relative to other microtines. Juveniles used fairly small ranges (about 400 m(2)), with no difference between males and females. Subadults, overwintered voles in April, had ranges similar to juveniles. Reproductively active males (mean 2774.0 m(2)) increased their range seven-fold relative to juvenile males, with ranges on average 3.3 times larger than adult females (mean 848.3 m(2)), which also expanded their range. Most litters were born in May and June, and as reproduction ceased in July adult males reduced their range whilst females did not. Body mass or year did not influence home range size. Overlap of home ranges varied, but could be extensive in both adult males and females. The water vole had a social structure similar to some Microtus species, but females appeared to be non-territorial and males perhaps conditioned territorial and non-territorial.	[Frafjord, Karl] UiT Arctic Univ Norway, Tromso Univ Museum, Dept Nat Sci, Tromso, Norway	UiT The Arctic University of Tromso	Frafjord, K (corresponding author), UiT Arctic Univ Norway, Tromso Univ Museum, Dept Nat Sci, Tromso, Norway.	karl.frafjord@uit.no			Tromso University Museum	Tromso University Museum	This study was funded by Tromso University Museum.	Banks PB, 2004, OIKOS, V106, P176, DOI 10.1111/j.0030-1299.2004.12679.x; BONDRUPNIELSEN S, 1985, ANN ZOOL FENN, V22, P385; Bonesi L, 2002, OIKOS, V99, P220, DOI 10.1034/j.1600-0706.2002.990202.x; BUJALSKA G, 1990, ADV LIF SCI, P155; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; ERLINGE S, 1990, ADV LIF SCI, P45; ERLINGE S, 1990, J MAMMAL, V71, P597, DOI 10.2307/1381799; Forman DW, 2006, AGGRESSIVE BEHAV, V32, P599, DOI 10.1002/ab.20159; Frafjord Karl, 2007, Fauna (Oslo), V59, P144; Frafjord Karl, 2003, Fauna Norvegica, V23, P42; Getz LL, 2005, J MAMMAL, V86, P647, DOI 10.1644/1545-1542(2005)086[0647:FIMDOT]2.0.CO;2; Gliwicz J, 1997, ECOGRAPHY, V20, P383, DOI 10.1111/j.1600-0587.1997.tb00383.x; Gray SJ, 2002, ANIM BEHAV, V63, P531, DOI 10.1006/anbe.2001.1932; Hoffmeyer I, 1985, ANN ZOOL FENN, V22, P269; Hoset KS, 2008, BEHAV ECOL, V19, P139, DOI 10.1093/beheco/arm112; Hoset KS, 2006, THESIS U OSLO OSLO; IMS RA, 1989, ECOLOGY, V70, P607, DOI 10.2307/1940212; JEPPSSON B, 1986, BEHAV ECOL SOCIOBIOL, V19, P293, DOI 10.1007/BF00300644; JEPPSSON B, 1990, ADV LIF SCI, P213; Jeppsson B, 1987, THESIS U LUND LUND; KORN H, 1986, OECOLOGIA, V68, P623, DOI 10.1007/BF00378782; Koskela E, 1997, J ANIM ECOL, V66, P341, DOI 10.2307/5980; Krebs Charles J., 2007, P173; Krebs JR, 1978, BEHAV ECOLOGY EVOLUT; LAMBIN X, 1991, OIKOS, V61, P126, DOI 10.2307/3545414; Le Galliard JF, 2006, BEHAV ECOL, V17, P733, DOI 10.1093/beheco/arl002; Lin YK, 2006, J MAMMAL, V87, P446, DOI 10.1644/05-MAMM-A-201R1.1; Loughran MFE, 2007, ANN ZOOL FENN, V44, P97; MADISON DM, 1990, ADV LIF SCI, P25; MAPPES T, 1995, ECOLOGY, V76, P1276, DOI 10.2307/1940934; McGuire B, 2002, ANIM BEHAV, V64, P645, DOI 10.1006/anbe.2002.3094; MCSHEA WJ, 1990, ANIM BEHAV, V39, P346, DOI 10.1016/S0003-3472(05)80880-2; Moorhouse TP, 2008, J ZOOL, V274, P395, DOI 10.1111/j.1469-7998.2007.00399.x; Moorhouse TP, 2008, J ANIM ECOL, V77, P1288, DOI 10.1111/j.1365-2656.2008.01431.x; Moorhouse TP, 2005, J MAMMAL, V86, P655, DOI 10.1644/1545-1542(2005)086[0655:TPORUI]2.0.CO;2; Pita R, 2010, EUR J WILDLIFE RES, V56, P651, DOI 10.1007/s10344-009-0360-6; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POWELL RA, 1992, BEHAV ECOL, V3, P325, DOI 10.1093/beheco/3.4.325; Remy A, 2011, J ANIM ECOL, V80, P929, DOI 10.1111/j.1365-2656.2011.01849.x; Rosell F, 2008, BEHAV ECOL SOCIOBIOL, V62, P1559, DOI 10.1007/s00265-008-0585-5; SIKORSKI MD, 1990, ADV LIF SCI, P193; Solomon Nancy G., 2007, P42; STODDART DM, 1971, J ANIM ECOL, V40, P487, DOI 10.2307/3257; STODDART DM, 1970, J ANIM ECOL, V39, P403, DOI 10.2307/2979; Tamarin R. H., 1990, SOCIAL SYSTEMS POPUL; Telfer S, 2003, MOL ECOL, V12, P1939, DOI 10.1046/j.1365-294X.2003.01859.x; VIITALA J, 1987, ANN ZOOL FENN, V24, P267; WANG ZX, 1994, ANIM BEHAV, V47, P281, DOI 10.1006/anbe.1994.1040; Waterman Jane, 2007, P27; Wolff J.O., 2007, RODENT SOC ECOLOGICA; WOLFF JO, 1993, OIKOS, V68, P364, DOI 10.2307/3544853; Wolff JO, 1998, ETHOL ECOL EVOL, V10, P227, DOI 10.1080/08927014.1998.9522854; YLONEN H, 1990, ADV LIF SCI, P203; Ylonen H, 1995, ANN ZOOL FENN, V32, P445; YLONEN H, 1990, OECOLOGIA, V83, P333, DOI 10.1007/BF00317556	55	7	9	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154338	10.1371/journal.pone.0154338	http://dx.doi.org/10.1371/journal.pone.0154338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115881	Green Submitted, gold, Green Published			2022-12-27	WOS:000374973600059
J	Maeda, Y; Fang, J; Ikezoe, Y; Pike, DH; Nanda, V; Matsui, H				Maeda, Yoshiaki; Fang, Justin; Ikezoe, Yasuhiro; Pike, Douglas H.; Nanda, Vikas; Matsui, Hiroshi			Molecular Self-Assembly Strategy for Generating Catalytic Hybrid Polypeptides	PLOS ONE			English	Article							AMYLOID PEPTIDE-FRAGMENTS; BINDING POCKET; COMBINATORIAL; DISCOVERY; PROTEINS; DESIGN; PHAGES	Recently, catalytic peptides were introduced that mimicked protease activities and showed promising selectivity of products even in organic solvents where protease cannot perform well. However, their catalytic efficiency was extremely low compared to natural enzyme counterparts presumably due to the lack of stable tertiary fold. We hypothesized that assembling these peptides along with simple hydrophobic pockets, mimicking enzyme active sites, could enhance the catalytic activity. Here we fused the sequence of catalytic peptide CP4, capable of protease and esterase-like activities, into a short amyloidogenic peptide fragment of A beta. When the fused CP4-A beta construct assembled into antiparallel beta-sheets and amyloid fibrils, a 4.0-fold increase in the hydrolysis rate of p-nitrophenyl acetate (p-NPA) compared to neat CP4 peptide was observed. The enhanced catalytic activity of CP4-A beta assembly could be explained both by pre-organization of a catalytically competent Ser-His-acid triad and hydrophobic stabilization of a bound substrate between the triad and p-NPA, indicating that a design strategy for self-assembled peptides is important to accomplish the desired functionality.	[Maeda, Yoshiaki; Fang, Justin; Ikezoe, Yasuhiro; Matsui, Hiroshi] CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA; [Maeda, Yoshiaki; Fang, Justin; Ikezoe, Yasuhiro; Matsui, Hiroshi] CUNY, Grad Ctr, New York, NY USA; [Pike, Douglas H.; Nanda, Vikas] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Biochem, Piscataway, NJ 08854 USA; [Pike, Douglas H.; Nanda, Vikas] Rutgers State Univ, Dept Mol Biol & Biochem, Robert Wood Johnson Med Sch, Piscataway, NJ 08855 USA; [Matsui, Hiroshi] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Cornell University	Matsui, H (corresponding author), CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA.; Matsui, H (corresponding author), CUNY, Grad Ctr, New York, NY USA.; Nanda, V (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Biochem, Piscataway, NJ 08854 USA.; Nanda, V (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Robert Wood Johnson Med Sch, Piscataway, NJ 08855 USA.; Matsui, H (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA.	nanda@cabm.rutgers.edu; hmatsui@hunter.cuny.edu	Maeda, Yoshiaki/H-9910-2013; Ikezoe, Yasuhiro/B-2685-2010	Maeda, Yoshiaki/0000-0001-9206-2601; Pike, Douglas/0000-0001-8880-9485	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG-02-01ER45935]; National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH) [MD007599]; NIH [DP2-OD006478, R01-GM089949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089949] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006478] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All of the work was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Award No. DE-FG-02-01ER45935. Hunter College infrastructure is supported by the National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH) (MD007599). VN and DP were supported by NIH DP2-OD006478 and R01-GM089949. YM thanks Japan Society for the Promotion of Science, and the International Training Program provided through Tokyo University of Agriculture and Technology.	Abbineni G, 2010, MOL PHARMACEUT, V7, P1629, DOI 10.1021/mp100052y; BENDER ML, 1957, J AM CHEM SOC, V79, P1652, DOI 10.1021/ja01564a034; Carey C, 2000, CHEM PHYS, V258, P415, DOI 10.1016/S0301-0104(00)00178-6; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castelletto V, 2010, LANGMUIR, V26, P9986, DOI 10.1021/la100110f; Chen CL, 2010, ANGEW CHEM INT EDIT, V49, P1924, DOI 10.1002/anie.200903572; Cui Y, 2012, ACCOUNTS CHEM RES, V45, P696, DOI 10.1021/ar2002057; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Gao Y, 2010, CHEM SOC REV, V39, P3425, DOI 10.1039/b919450a; Giuliano MW, 2015, ADV SYNTH CATAL, V357, P2301, DOI 10.1002/adsc.201500230; Hamley IW, 2008, LANGMUIR, V24, P8210, DOI 10.1021/la8005426; HARTLEY BS, 1954, BIOCHEM J, V56, P288, DOI 10.1042/bj0560288; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Korendovych IV, 2014, CURR OPIN STRUC BIOL, V27, P113, DOI 10.1016/j.sbi.2014.06.006; Krysmann MJ, 2007, SOFT MATTER, V3, P1401, DOI 10.1039/b709889h; LIBBY P, 1978, SCIENCE, V199, P534, DOI 10.1126/science.622552; Ma K, 2013, ADV FUNCT MATER, V23, P1172, DOI 10.1002/adfm.201102963; Maeda Y, 2014, J AM CHEM SOC, V136, P15893, DOI 10.1021/ja509393p; Maeda Y, 2012, SOFT MATTER, V8, P7533, DOI 10.1039/c2sm25352f; Mayo SL, 2004, P NATL ACAD SCI USA, V101, P11566; Melicher MS, 2015, ORG LETT, V17, P4718, DOI 10.1021/acs.orglett.5b02187; Miller SJ, 2015, TOP CURR CHEM, P1; Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716; Nanda V, 2010, NAT CHEM, V2, P15, DOI [10.1038/NCHEM.473, 10.1038/nchem.473]; Oh JW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4043; Okuyama K, 2012, BIOPOLYMERS, V97, P607, DOI 10.1002/bip.22048; Pearson AD, 2015, SCIENCE, V347, P863, DOI 10.1126/science.aaa2424; Pike DH, 2015, BIOPOLYMERS, V104, P360, DOI 10.1002/bip.22644; Razkin J, 2007, J AM CHEM SOC, V129, P14752, DOI 10.1021/ja075478i; Rufo CM, 2014, NAT CHEM, V6, P303, DOI [10.1038/NCHEM.1894, 10.1038/nchem.1894]; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; SORENSEN SB, 1993, BIOCHEMISTRY-US, V32, P8994, DOI 10.1021/bi00086a003; SUMMA CM, 2002, THESIS; Wang FK, 2012, CHEM SCI, V3, P2639, DOI 10.1039/c2sc00583b; Wang YQ, 2012, J AM CHEM SOC, V134, P16614, DOI 10.1021/ja305300m; Wei ZY, 2011, ANGEW CHEM INT EDIT, V50, P10585, DOI 10.1002/anie.201102582; Xu F, 2013, J AM CHEM SOC, V135, P18762, DOI 10.1021/ja4106545; Zhou XM, 2014, CHEMCATCHEM, V6, P1961, DOI 10.1002/cctc.201402125	39	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153700	10.1371/journal.pone.0153700	http://dx.doi.org/10.1371/journal.pone.0153700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116246	Green Published, gold			2022-12-27	WOS:000374973600026
J	Lyall, DM; Cullen, B; Allerhand, M; Smith, DJ; Mackay, D; Evans, J; Anderson, J; Fawns-Ritchie, C; McIntosh, AM; Deary, IJ; Pell, JP				Lyall, Donald M.; Cullen, Breda; Allerhand, Mike; Smith, Daniel J.; Mackay, Daniel; Evans, Jonathan; Anderson, Jana; Fawns-Ritchie, Chloe; McIntosh, Andrew M.; Deary, Ian J.; Pell, Jill P.			Cognitive Test Scores in UK Biobank: Data Reduction in 480,416 Participants and Longitudinal Stability in 20,346 Participants	PLOS ONE			English	Article							INTELLIGENCE; METAANALYSIS; RELIABILITY; RISK	UK Biobank includes 502,649 middle-and older-aged adults from the general population who have undergone detailed phenotypic assessment. The majority of participants completed tests of cognitive functioning, and on average four years later a sub-group of N = 20,346 participants repeated most of the assessment. These measures will be used in a range of future studies of health outcomes in this cohort. The format and content of the cognitive tasks were partly novel. The aim of the present study was to validate and characterize the cognitive data: to describe the inter-correlational structure of the cognitive variables at baseline assessment, and the degree of stability in scores across longitudinal assessment. Baseline cognitive data were used to examine the inter-correlational/factor-structure, using principal components analysis (PCA). We also assessed the degree of stability in cognitive scores in the subsample of participants with repeat data. The different tests of cognitive ability showed significant raw inter-correlations in the expected directions. PCA suggested a one-factor solution (eigenvalue = 1.60), which accounted for around 40% of the variance. Scores showed varying levels of stability across time-points (intraclass correlation range = 0.16 to 0.65). UK Biobank cognitive data has the potential to be a significant resource for researchers looking to investigate predictors and modifiers of cognitive abilities and associated health outcomes in the general population.	[Lyall, Donald M.; Cullen, Breda; Smith, Daniel J.; Mackay, Daniel; Evans, Jonathan; Anderson, Jana; Fawns-Ritchie, Chloe; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Allerhand, Mike; McIntosh, Andrew M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Edinburgh	Lyall, DM (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	Donald.Lyall@Glasgow.ac.uk	Deary, Ian J/C-6297-2009; McIntosh, Andrew M/B-9379-2008; Cullen, Breda/C-9154-2012; Cullen, Breda/N-3449-2019	Deary, Ian J/0000-0002-1733-263X; McIntosh, Andrew M/0000-0002-0198-4588; Cullen, Breda/0000-0002-7259-9505; Cullen, Breda/0000-0002-7259-9505; Pell, Jill/0000-0002-8898-7035; Smith, Daniel/0000-0002-2267-1951; Fawns-Ritchie, Chloe/0000-0002-7493-2228	Welsh Assembly Government; British Heart Foundation; Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council (EPSRC); Economic and Social Research Council (ESRC); MRC; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [G0700704, MR/K026992/1, MC_qA137853] Funding Source: researchfish; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0700704] Funding Source: UKRI	Welsh Assembly Government; British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has been conducted using the UK Biobank resource. The authors are grateful to UK Biobank participants. UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government, and the Northwest Regional Development Agency. It has also had funding from the Welsh Assembly Government and the British Heart Foundation. The work was undertaken within the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (http://www.ccace.ed.ac.uk), part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Sciences Research Council (EPSRC), Economic and Social Research Council (ESRC), and MRC is gratefully acknowledged. Sponsors and funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Bland JM, 1996, BRIT MED J, V313, P744; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Carroll JB, 1994, ED RES, P35, DOI [10.2307/1177226, DOI 10.2307/1177226]; Cullen B, 2015, EUR PSYCHIAT, V30, P950, DOI 10.1016/j.eurpsy.2015.08.006; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Hagenaars SP, 2016, MOL PSYCHIATR, DOI [10.1038/mp.2015.225, DOI 10.1038/MP.2015.225]; Houlihan LM, 2010, HUM MOL GENET, V19, P2321, DOI 10.1093/hmg/ddq097; Johnson W., 2012, LONGITUDINAL LIFE CO, V3, P3, DOI DOI 10.14301/LLCS.V3I3.198; Lyall DM, 2013, BEHAV GENET, V43, P13, DOI 10.1007/s10519-012-9570-x; Marioni RE, 2016, EUR J HUM GENET, V24, P919, DOI 10.1038/ejhg.2015.210; Martin GM, 2004, NATURE, V431, P247, DOI 10.1038/431247b; Ntuk UE, 2014, DIABETES CARE, V37, P2500, DOI 10.2337/dc13-2966; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Salthouse TA, 2008, NEUROPSYCHOLOGY, V22, P800, DOI 10.1037/a0013091; Salthouse TA, 2014, CURR DIR PSYCHOL SCI, V23, P252, DOI 10.1177/0963721414535212; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075362; Sternberg RJ, 2000, HANDBOOK OF INTELLIG; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Trampush JW, 2015, AM J MED GENET B, V168, P363, DOI 10.1002/ajmg.b.32319; Tyrrell JS, 2013, INT J EPIDEMIOL, V42, P1714, DOI 10.1093/ije/dyt220; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	26	91	92	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154222	10.1371/journal.pone.0154222	http://dx.doi.org/10.1371/journal.pone.0154222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27110937	Green Published, gold, Green Accepted			2022-12-27	WOS:000374970600051
J	Seo, J; Singh, NN; Ottesen, EW; Sivanesan, S; Shishimorova, M; Singh, RN				Seo, Joonbae; Singh, Natalia N.; Ottesen, Eric W.; Sivanesan, Senthilkumar; Shishimorova, Maria; Singh, Ravindra N.			Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene	PLOS ONE			English	Article							MOTOR-NEURON GENE; MESSENGER-RNA; SPLICING REGULATION; PARKINSONS-DISEASE; ANIMAL-MODELS; CELL-DEATH; SMN2; SURVIVAL; MOUSE; NEURODEGENERATION	Humans carry two nearly identical copies of Survival Motor Neuron gene: SMN1 and SMN2. Loss of SMN1 leads to spinal muscular atrophy (SMA), the most frequent genetic cause of infant mortality. While SMN2 cannot compensate for the loss of SMN1 due to predominant skipping of exon 7, correction of SMN2 exon 7 splicing holds the promise of a cure for SMA. Previously, we used cell-based models coupled with a multi-exon-skipping detection assay (MESDA) to demonstrate the vulnerability of SMN2 exons to aberrant splicing under the conditions of oxidative stress (OS). Here we employ a transgenic mouse model and MESDA to examine the OS-induced splicing regulation of SMN2 exons. We induced OS using paraquat that is known to trigger production of reactive oxygen species and cause mitochondrial dysfunction. We show an overwhelming co-skipping of SMN2 exon 5 and exon 7 under OS in all tissues except testis. We also show that OS increases skipping of SMN2 exon 3 in all tissues except testis. We uncover several new SMN2 splice isoforms expressed at elevated levels under the conditions of OS. We analyze cis-elements and transacting factors to demonstrate the diversity of mechanisms for splicing misregulation under OS. Our results of proteome analysis reveal downregulation of hnRNP H as one of the potential consequences of OS in brain. Our findings suggest SMN2 as a sensor of OS with implications to SMA and other diseases impacted by low levels of SMN protein.	[Seo, Joonbae; Singh, Natalia N.; Ottesen, Eric W.; Sivanesan, Senthilkumar; Shishimorova, Maria; Singh, Ravindra N.] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA	Iowa State University	Singh, RN (corresponding author), Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA.	singhr@iastate.edu		Sivanesan, Senthilkumar/0000-0001-5133-7090; Singh, Ravindra/0000-0001-5399-2662	United States National Institutes of Health [R01 NS055925, R21 NS072259, R21 NS080294]; Iowa Center for Advanced Neurotoxicology (ICAN); Salsbury Endowment (Iowa State University, Ames, IA, USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072259, R21NS080294, R01NS055925] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa Center for Advanced Neurotoxicology (ICAN); Salsbury Endowment (Iowa State University, Ames, IA, USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from United States National Institutes of Health (R01 NS055925, R21 NS072259, and R21 NS080294), Iowa Center for Advanced Neurotoxicology (ICAN), and Salsbury Endowment (Iowa State University, Ames, IA, USA) to RNS.	Acsadi G, 2011, J MOL NEUROSCI, V43, P275, DOI 10.1007/s12031-010-9422-1; Ahmad S, 2016, J EXP NEUROSCI, V10, P39, DOI 10.4137/JEN.S33122; Akaike Y, 2014, MOL CELL BIOL, V34, P2857, DOI 10.1128/MCB.00333-14; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bunkar N, 2016, FRONT BIOSCI-LANDMRK, V21, P769, DOI 10.2741/4420; BURGE C, 1999, SPLICING PRECURSORS; Cao WG, 2012, NUCLEIC ACIDS RES, V40, P8059, DOI 10.1093/nar/gks504; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chabot B, 2016, J CELL BIOL, V212, P13, DOI 10.1083/jcb.201510032; Chabot B, 2015, RNA, V21, P582, DOI 10.1261/rna.050617.115; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Chen MT, 2015, MOL CELL BIOL, V35, P3212, DOI 10.1128/MCB.00429-15; Cho SC, 2010, P NATL ACAD SCI USA, V107, P19326, DOI 10.1073/pnas.1005078107; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Decorsiere A, 2011, GENE DEV, V25, P220, DOI 10.1101/gad.607011; Disher K, 2007, GENOME, V50, P946, DOI 10.1139/G07-074; Dujardin G, 2014, MOL CELL, V54, P683, DOI 10.1016/j.molcel.2014.03.044; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Fei Q, 2008, J BIOL CHEM, V283, P3357, DOI 10.1074/jbc.M708451200; Genabai NK, 2015, HUM MOL GENET, V24, P6986, DOI 10.1093/hmg/ddv401; Hashimoto M, 2003, J BIOL CHEM, V278, P5044, DOI 10.1074/jbc.M210129200; Howell MD, 2014, FUTURE MED CHEM, V6, P1081, DOI [10.4155/FMC.14.63, 10.4155/fmc.14.63]; Jodelka FM, 2010, HUM MOL GENET, V19, P4906, DOI 10.1093/hmg/ddq425; Kamel F, 2013, SCIENCE, V341, P722, DOI 10.1126/science.1243619; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Keil JM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.23; Kim J, 2016, NUCLEIC ACIDS RES, V44, P2378, DOI 10.1093/nar/gkw017; Kolb SJ, 2015, NEUROL CLIN, V33, P831, DOI 10.1016/j.ncl.2015.07.004; Kwok CK, 2015, TRENDS BIOCHEM SCI, V40, P221, DOI 10.1016/j.tibs.2015.02.005; Le WD, 2014, NEUROTHERAPEUTICS, V11, P92, DOI 10.1007/s13311-013-0234-1; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lenzken SC, 2011, HUM MUTAT, V32, P168, DOI 10.1002/humu.21394; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Maracchioni A, 2007, J NEUROCHEM, V100, P142, DOI 10.1111/j.1471-4159.2006.04204.x; Margolin G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-39; Matlin AJ, 2007, ADV EXP MED BIOL, V623, P14, DOI 10.1007/978-0-387-77374-2_2; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Millevoi S, 2009, NUCLEIC ACIDS RES, V37, P4672, DOI 10.1093/nar/gkp470; Mitra S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-163; Mitra S, 2013, TOXICOLOGY, V314, P39, DOI 10.1016/j.tox.2013.09.003; Monani UR, 2014, FUTUR NEUROL, V9, P49, DOI 10.2217/FNL.13.58; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nurputra DK, 2013, ANN HUM GENET, V77, P435, DOI 10.1111/ahg.12031; Ottesen EW, 2016, SCI REP-UK, V6, DOI 10.1038/srep20193; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P797, DOI 10.1089/ars.2009.2913; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Papp LV, 2008, NUCLEIC ACIDS RES, V36, P7192, DOI 10.1093/nar/gkn829; Patel S, 2007, NEUROTOXICOL TERATOL, V29, P578, DOI 10.1016/j.ntt.2007.04.002; Rouget RL, 2005, BIOCHEM J, V385, P433, DOI 10.1042/BJ20041024; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Schmid R, 2013, NUCLEIC ACIDS RES, V41, P10170, DOI 10.1093/nar/gkt811; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Seo J, 2013, BBA-MOL BASIS DIS, V1832, P2180, DOI 10.1016/j.bbadis.2013.08.005; Sharma LK, 2011, HUM MOL GENET, V20, P4605, DOI 10.1093/hmg/ddr395; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Singh NN, 2015, FUTURE MED CHEM, V7, P1793, DOI 10.4155/fmc.15.101; Singh NN, 2015, ANN NY ACAD SCI, V1341, P176, DOI 10.1111/nyas.12727; Singh NN, 2013, NUCLEIC ACIDS RES, V41, P8144, DOI 10.1093/nar/gkt609; Singh NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049595; Singh NN, 2011, RNA BIOL, V8, P600, DOI 10.4161/rna.8.4.16224; Singh NN, 2011, MOL CELL BIOL, V31, P935, DOI 10.1128/MCB.00945-10; Singh NN, 2009, RNA BIOL, V6, P341, DOI 10.4161/rna.6.3.8723; Singh NN, 2004, RNA, V10, P1291, DOI 10.1261/rna.7580704; Singh NN, 2004, BIOCHEM BIOPH RES CO, V315, P381, DOI 10.1016/j.bbrc.2004.01.067; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Tisdale S, 2015, J NEUROSCI, V35, P8691, DOI 10.1523/JNEUROSCI.0417-15.2015; Tranell A, 2010, J BIOL CHEM, V285, P31537, DOI 10.1074/jbc.M109.077453; Tsatsakis AM, 1996, VET HUM TOXICOL, V38, P113; Tsuiji H, 2013, EMBO MOL MED, V5, P221, DOI 10.1002/emmm.201202303; Turner BJ, 2014, NEUROBIOL AGING, V35, P906, DOI 10.1016/j.neurobiolaging.2013.09.030; Vitte J, 2007, AM J PATHOL, V171, P1269, DOI 10.2353/ajpath.2007.070399; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wee CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115205; Xing Y, 2007, ADV EXP MED BIOL, V623, P36, DOI 10.1007/978-0-387-77374-2_3; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yarosh CA, 2015, WIRES RNA, V6, P351, DOI 10.1002/wrna.1280	88	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154390	10.1371/journal.pone.0154390	http://dx.doi.org/10.1371/journal.pone.0154390			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111068	gold, Green Published, Green Submitted			2022-12-27	WOS:000374970600063
J	Klein, AN; Ziehm, T; Tusche, M; Buitenhuis, J; Bartnik, D; Boeddrich, A; Wiglenda, T; Wanker, E; Funke, SA; Brener, O; Gremer, L; Kutzsche, J; Willbold, D				Klein, Antonia Nicole; Ziehm, Tamar; Tusche, Markus; Buitenhuis, Johan; Bartnik, Dirk; Boeddrich, Annett; Wiglenda, Thomas; Wanker, Erich; Funke, Susanne Aileen; Brener, Oleksandr; Gremer, Lothar; Kutzsche, Janine; Willbold, Dieter			Optimization of the All-D Peptide D3 for A beta Oligomer Elimination	PLOS ONE			English	Article							THIOFLAVINE-T INTERACTION; ALZHEIMERS-DISEASE; FLUORESCENT; IMPROVES; PROGRESS	The aggregation of amyloid-beta (A beta) is postulated to be the crucial event in Alzheimer's disease (AD). In particular, small neurotoxic A beta oligomers are considered to be responsible for the development and progression of AD. Therefore, elimination of thesis oligomers represents a potential causal therapy of AD. Starting from the well-characterized D-enantiomeric peptide D3, we identified D3 derivatives that bind monomeric A beta. The underlying hypothesis is that ligands bind monomeric A beta and stabilize these species within the various equilibria with A beta assemblies, leading ultimately to the elimination of A beta oligomers. One of the hereby identified D-peptides, DB3, and a head-to-tail tandem of DB3, DB3DB3, were studied in detail. Both peptides were found to: (i) inhibit the formation of Thioflavin T-positive fibrils; (ii) bind to A beta monomers with micromolar affinities; (iii) eliminate A beta oligomers; (iv) reduce A beta-induced cytotoxicity; and (v) disassemble preformed A beta aggregates. The beneficial effects of DB3 were improved by DB3DB3, which showed highly enhanced efficacy. Our approach yielded A beta monomer-stabilizing ligands that can be investigated as a suitable therapeutic strategy against AD.	[Klein, Antonia Nicole; Ziehm, Tamar; Tusche, Markus; Bartnik, Dirk; Funke, Susanne Aileen; Brener, Oleksandr; Gremer, Lothar; Kutzsche, Janine; Willbold, Dieter] Res Ctr Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany; [Buitenhuis, Johan] Res Ctr Julich, Inst Complex Syst, Soft Matter ICS 3, D-52425 Julich, Germany; [Boeddrich, Annett; Wiglenda, Thomas; Wanker, Erich] Max Delbruck Ctr Mol Med, Neuroproteomforsch & Mol Mech Neurodegenerativer, Berlin, Germany; [Funke, Susanne Aileen] Hsch Angew Wissensch Coburg, Fak Angew Nat Wissensch, Bioanalyt, D-96450 Coburg, Germany; [Brener, Oleksandr; Gremer, Lothar; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Heinrich Heine University Dusseldorf	Willbold, D (corresponding author), Res Ctr Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany.; Willbold, D (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany.	d.willbold@fz-juelich.de	Gremer, Lothar/H-9128-2013; Kutzsche, Janine/G-6287-2013; Willbold, Dieter/A-6280-2013; Buitenhuis, Johan/G-5228-2013	Gremer, Lothar/0000-0001-7065-5027; Kutzsche, Janine/0000-0003-0271-7390; Willbold, Dieter/0000-0002-0065-7366; Wiglenda, Thomas/0000-0002-8460-9459; Boddrich, Annett/0000-0001-9118-050X; Brener, Oleksandr/0000-0001-9771-7515; Ziehm, Tamar/0000-0003-0957-2518; Wanker, Erich/0000-0001-8072-1630; Buitenhuis, Johan/0000-0001-8849-2596	Portfolio Technology and Medicine; Portfolio Drug Research; Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; TT-Fonds of the Technology Transfer Department of the Forschungszentrum Julich	Portfolio Technology and Medicine; Portfolio Drug Research; Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; TT-Fonds of the Technology Transfer Department of the Forschungszentrum Julich	D. W. was supported by grants from the "Portfolio Technology and Medicine", the "Portfolio Drug Research" and the Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft. D. W. was also supported by the TT-Fonds of the Technology Transfer Department of the Forschungszentrum Julich.	Bartnik D, 2009, REJUV RES, V13, P202; Brener O, 2015, SCI REP-UK, V5, DOI 10.1038/srep13222; Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Foong YM, 2012, CURR OPIN CHEM BIOL, V16, P234, DOI 10.1016/j.cbpa.2011.12.007; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jiang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128553; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Uttamchandani M, 2008, CURR PHARM DESIGN, V14, P2428, DOI 10.2174/138161208785777450; van Groen T, 2013, J ALZHEIMERS DIS, V34, P609, DOI 10.3233/JAD-121792; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; van Groen T, 2009, CHEMMEDCHEM, V4, P276, DOI 10.1002/cmdc.200800289; Wiesehan K, 2008, PROTEIN ENG DES SEL, V21, P241, DOI 10.1093/protein/gzm054; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631	25	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153035	10.1371/journal.pone.0153035	http://dx.doi.org/10.1371/journal.pone.0153035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105346	gold, Green Published, Green Accepted			2022-12-27	WOS:000374565100009
J	Strawbridge, RJ; Laumen, H; Hamsten, A; Breier, M; Grallert, H; Hauner, H; Arner, P; Dahlman, I				Strawbridge, Rona J.; Laumen, Helmut; Hamsten, Anders; Breier, Michaela; Grallert, Harald; Hauner, Hans; Arner, Peter; Dahlman, Ingrid			Effects of Genetic Loci Associated with Central Obesity on Adipocyte Lipolysis	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; KAPPA-B; ADIPOSE; TURNOVER; RESISTANCE; REVEALS; CELLS; WOMEN	Objectives Numerous genetic loci have been associated with measures of central fat accumulation, such as waist-to-hip ratio adjusted for body mass index (WHRadjBMI). However the mechanisms by which genetic variations influence obesity remain largely elusive. Lipolysis is a key process for regulation of lipid storage in adipocytes, thus is implicated in obesity and its metabolic complications. Here, genetic variants at 36 WHRadjBMI-associated loci were examined for their influence on abdominal subcutaneous adipocyte lipolysis. Subjects and Methods Fasting subcutaneous adipose tissue biopsies were collected from 789 volunteers (587 women and 202 men, body mass index (BMI) range 17.7-62.3 kg/m(2)). We quantified subcutaneous adipocyte lipolysis, both spontaneous and stimulated by the catecholamine isoprenaline or a cyclic AMP analogue. DNA was extracted from peripheral blood mononuclear cells and genotyping of SNPs associated with WHRadjBMI conducted. The effects on adipocyte lipolysis measures were assessed for SNPs individually and combined in a SNP score. Results The WHRadjBMI-associated loci CMIP, PLXND1, VEGFA and ZNRF3-KREMEN1 demonstrated nominal associations with spontaneous and/or stimulated lipolysis. Candidate genes in these loci have been reported to influence NF kappa B-signaling, fat cell size and Wnt signalling, all of which may influence lipolysis. Significance This report provides evidence for specific WHRadjBMI-associated loci as candidates to modulate adipocyte lipolysis. Additionally, our data suggests that genetically increased central fat accumulation is unlikely to be a major cause of altered lipolysis in abdominal adipocytes.	[Strawbridge, Rona J.; Hamsten, Anders] Karolinska Inst, Dept Med Solna, Atherosclerosis Res Unit, Stockholm, Sweden; [Laumen, Helmut; Hauner, Hans] Tech Univ Munich, Chair Nutr Med, Else Kroner Fresenius Ctr Nutr Med, D-80290 Munich, Germany; [Laumen, Helmut; Hauner, Hans] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, D-80290 Munich, Germany; [Laumen, Helmut; Hauner, Hans] Helmholtz Zentrum Muenchen, Clin Cooperat Grp Nutrigen & Type Diabet 2, Munich, Germany; [Laumen, Helmut; Hauner, Hans] Tech Univ Munich, D-80290 Munich, Germany; [Laumen, Helmut; Breier, Michaela; Grallert, Harald; Hauner, Hans] German Ctr Diabet Res DZD, Neuherberg, Germany; [Laumen, Helmut; Breier, Michaela] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Expt Genet, Neuherberg, Germany; [Breier, Michaela; Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Epidemiol 2, Neuherberg, Germany; [Hauner, Hans] Tech Univ Munich, Klinikum Rechts Isar, Else Kroner Fresenius Ctr Nutr Med, D-80290 Munich, Germany; [Arner, Peter; Dahlman, Ingrid] Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Karolinska Institutet	Dahlman, I (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	ingrid.dahlman@ki.se	Grallert, Harald/B-3424-2013; Strawbridge, Rona/H-5422-2012; Laumen, Helmut/M-5140-2013	Strawbridge, Rona/0000-0001-8506-3585; Dahlman, Ingrid/0000-0003-3819-5977; Laumen, Helmut/0000-0002-5885-5242; Arner, Peter/0000-0002-6208-6220	Swedish Research Council; Swedish Diabetes Foundation; Novo-Nordisk Foundation; EASD/lilly program; CIMED; Strategic Research Programme in Diabetes; Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany; Technische Universitat Munchen; SRP Diabetes program at Karolinska Institutet; Novo Nordisk Fonden [NNF15OC0015894] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Foundation; Novo-Nordisk Foundation(Novo Nordisk Foundation); EASD/lilly program; CIMED; Strategic Research Programme in Diabetes; Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany; Technische Universitat Munchen; SRP Diabetes program at Karolinska Institutet; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Swedish Research Council, the Swedish Diabetes Foundation, the Novo-Nordisk Foundation, the EASD/lilly program, CIMED and the Strategic Research Programme in Diabetes. HL, HG and HH acknowledge the grant Clinical Cooperation Group "Nutrigenomics and type 2 diabetes" from the Helmholtz Zentrum Munchen, Munchen-Neuherberg, Germany, and the Technische Universitat Munchen. RJS is supported by the SRP Diabetes program at Karolinska Institutet.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Arner P, 2014, TRENDS ENDOCRIN MET, V25, P255, DOI 10.1016/j.tem.2014.03.002; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Dahlman I, 2016, DIABETES, V65, P433, DOI 10.2337/db15-0828; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Frayn K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003467; Gao H, 2014, CELL METAB, V19, P981, DOI 10.1016/j.cmet.2014.03.032; Girousse A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001485; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hofker M, 2009, NAT GENET, V41, P139, DOI 10.1038/ng0209-139; Kamal M, 2009, MOL IMMUNOL, V46, P991, DOI 10.1016/j.molimm.2008.09.034; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; LANDIN K, 1990, EUR J CLIN INVEST, V20, P530, DOI 10.1111/j.1365-2362.1990.tb01897.x; Langenberg C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001230; Laurencikiene J, 2007, J LIPID RES, V48, P1069, DOI 10.1194/jlr.M600471-JLR200; Minchin JEN, 2015, P NATL ACAD SCI USA, V112, P4363, DOI 10.1073/pnas.1416412112; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; REYNISDOTTIR S, 1994, DIABETOLOGIA, V37, P428, DOI 10.1007/s001250050128; REYNISDOTTIR S, 1995, J CLIN INVEST, V95, P2161, DOI 10.1172/JCI117905; RODBELL M, 1964, J BIOL CHEM, V239, P375; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Ryden M, 2013, J LIPID RES, V54, P2909, DOI 10.1194/jlr.M040345; Schleinitz D, 2014, DIABETOLOGIA, V57, P1276, DOI 10.1007/s00125-014-3214-z; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109	28	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153990	10.1371/journal.pone.0153990	http://dx.doi.org/10.1371/journal.pone.0153990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104953	Green Published, gold, Green Accepted			2022-12-27	WOS:000374565100033
J	Chiu, PY; Tsai, CT; Chen, PK; Chen, WJ; Lai, TJ				Chiu, Pai-Yi; Tsai, Chun-Tang; Chen, Ping-Kun; Chen, Whe-Jen; Lai, Te-Jen			Neuropsychiatric Symptoms in Parkinson's Disease Dementia Are More Similar to Alzheimer's Disease than Dementia with Lewy Bodies: A Case-Control Study	PLOS ONE			English	Article							AUTOPSY-CONFIRMED DEMENTIA; ALPHA-SYNUCLEIN; PSYCHOLOGICAL SYMPTOMS; PSYCHIATRIC-SYMPTOMS; PREVALENCE; DIAGNOSIS; BETA; CAREGIVERS; BURDEN; TAU	Background and purpose Previous studies on the clinical and pathological manifestations of Parkinson's disease dementia (PDD) have reported findings more similar to dementia with Lewy bodies (DLB) than to Alzheimer's disease (AD). The aim of this study was to investigate the neuropsychiatric symptoms of PDD compared to DLB and AD. Methods We conducted a retrospective case-control study on 125 newly diagnosed consecutive PDD patients and age-and dementia stage-matched controls with either DLB (N = 250) or AD (N = 500) who visited the same hospital over the same period. For each case and control, neuropsychiatric symptoms were assessed using the Neuropsychiatric Inventory (NPI). Results Overall, 513 (58.6%) patients were female and 362 (41.4%) were male. Comparisons of clinical data revealed that the PDD group, similar to the AD group, had a lower NPI total score, NPI caregiver burden score, and rate of antipsychotic use (all p < 0.001) than the DLB group. One or more psychiatric symptoms were reported in 95.2% of the PDD, 99.2% of the DLB, and 96.8% of the AD patients. The PDD group had lower subscores in the items of delusions, hallucinations, agitation, anxiety, irritation, aberrant motor behavior compared to the DLB group. Severe neuropsychiatric symptoms among all dementia patients were associated with younger age, more advanced stage, and a diagnosis of DLB. Conclusion Neuropsychiatric symptoms in PDD were more like those in AD than in DLB. Severe neuropsychiatric symptoms in degenerative dementia were associated with younger age, more advanced stage of dementia, and a diagnosis of DLB.	[Chiu, Pai-Yi; Lai, Te-Jen] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chiu, Pai-Yi] Show Chwan Mem Hosp, Dept Neurol, Changhua, Taiwan; [Tsai, Chun-Tang] Natl Changhua Univ Educ, Dept Guidance & Counseling, Changhua 500, Taiwan; [Chen, Ping-Kun; Chen, Whe-Jen] Lin Shin Hosp, Dept Neurol, Taichung, Taiwan; [Lai, Te-Jen] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung 40201, Taiwan	Chung Shan Medical University; Show Chwan Memorial Hospital; National Changhua University of Education; Chung Shan Medical University; Chung Shan Medical University Hospital	Lai, TJ (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Lai, TJ (corresponding author), Chung Shan Med Univ Hosp, Dept Psychiat, Taichung 40201, Taiwan.	tejenlai@hotmail.com						Aarsland D, 2004, J GERIATR PSYCH NEUR, V17, P137, DOI 10.1177/0891988704267470; Aarsland D, 2001, NEUROLOGY, V56, P730, DOI 10.1212/WNL.56.6.730; Aarsland D, 2001, INT J GERIATR PSYCH, V16, P528, DOI 10.1002/gps.389; Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Aarsland D, 2001, INT J GERIATR PSYCH, V16, P184, DOI 10.1002/1099-1166(200102)16:2<184::AID-GPS304>3.0.CO;2-K; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Ballard CG, 2004, AM J PSYCHIAT, V161, P843, DOI 10.1176/appi.ajp.161.5.843; Caputo M, 2008, ACTA PSYCHIAT SCAND, V117, P455, DOI 10.1111/j.1600-0447.2008.01175.x; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Colosimo C, 2003, J NEUROL NEUROSUR PS, V74, P852, DOI 10.1136/jnnp.74.7.852; Cummings J L, 1988, J Geriatr Psychiatry Neurol, V1, P24, DOI 10.1177/089198878800100106; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dugger BN, 2012, MOVEMENT DISORD, V27, P72, DOI 10.1002/mds.24003; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fujishiro H, 2008, J NEUROPATH EXP NEUR, V67, P649, DOI 10.1097/NEN.0b013e31817d7a1d; Hashimoto M, 2015, DEMENT GER COGN D EX, V5, P244, DOI 10.1159/000381800; Huang SS, 2012, ARCH GERONTOL GERIAT, V55, P55, DOI 10.1016/j.archger.2011.04.009; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Johnson DK, 2011, ALZ DIS ASSOC DIS, V25, P326, DOI 10.1097/WAD.0b013e31820d89b6; Kao AW, 2009, ALZ DIS ASSOC DIS, V23, P365, DOI 10.1097/WAD.0b013e3181b5065d; Lee DR, 2013, INT J GERIATR PSYCH, V28, P135, DOI 10.1002/gps.3799; Lin CL, 2016, EXP NEUROL, V275, P84, DOI 10.1016/j.expneurol.2015.10.009; Lopez-Pousa S, 2007, REV NEUROLOGIA, V45, P683, DOI 10.33588/rn.4511.2007535; Martinez-Martin P, 2015, PARKINSONISM RELAT D, V21, P629, DOI 10.1016/j.parkreldis.2015.03.024; McKeith Ian, 2009, Int Psychogeriatr, V21, P220, DOI 10.1017/S1041610208008624; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nambudiri DE, 1997, INT J GERIATR PSYCH, V12, P11, DOI 10.1002/(SICI)1099-1166(199701)12:1<11::AID-GPS435>3.3.CO;2-T; Noe E, 2004, MOVEMENT DISORD, V19, P60, DOI 10.1002/mds.10633; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Sadak TI, 2014, RES GERONTOL NURS, V7, P44, DOI 10.3928/19404921-20130918-01; Savica R, 2013, JAMA NEUROL, V70, P1396, DOI 10.1001/jamaneurol.2013.3579; Starkstein SE, 1996, J NEUROL NEUROSUR PS, V61, P381, DOI 10.1136/jnnp.61.4.381; Suarez-Gonzalez A, 2014, INT PSYCHOGERIATR, V26, P453, DOI 10.1017/S1041610213002068; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602	36	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153989	10.1371/journal.pone.0153989	http://dx.doi.org/10.1371/journal.pone.0153989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27101140	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500118
J	Chua, GL; Tan, SM; Bhattacharjya, S				Chua, Geok-Lin; Tan, Suet-Mien; Bhattacharjya, Surajit			NMR Characterization and Membrane Interactions of the Loop Region of Kindlin-3 F1 Subdomain	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; ADHESION DEFICIENCY-III; UBIQUITIN-LIKE DOMAIN; INTEGRIN ACTIVATION; LEUKOCYTE ADHESION; STRUCTURAL BASIS; TALIN HEAD; BINDING; PROTEIN; EXPRESSION	Kindlins-1,2 and 3 are FERM domain-containing cytosolic proteins involved in the activation and regulation of integrin-mediated cell adhesion. Apart from binding to integrin beta cytosolic tails, kindlins and the well characterized integrin-activator talin bind membrane phospholipids. The ubiquitin-like F1 sub-domain of the FERM domain of talin contains a short loop that binds to the lipid membrane. By contrast, the F1 sub-domain of kindlins contains a long loop demonstrated binding to the membrane. Here, we report structural characterization and lipid interactions of the 83-residue F1 loop of kindlin-3 using NMR and optical spectroscopy methods. NMR studies demonstrated that the F1 loop of kindlin-3 is globally unfolded but stretches of residues assuming transient helical conformations could be detected in aqueous solution. We mapped membrane binding interactions of the F1 loop with small unilamellar vesicles (SUVs) containing either zwitterionic lipids or negatively charged lipids using N-15-H-1 HSQC titrations. These experiments revealed that the F1 loop of kindlin-3 preferentially interacted with the negatively charged SUVs employing almost all of the residues. By contrast, only fewer residues appeared to be interacted with SUVs containing neutral lipids. Further, CD and NMR data suggested stabilization of helical conformations and predominant resonance perturbations of the F1 loop in detergent containing solutions. Conformations of an isolated N-terminal peptide fragment, or EK21, of the F1 loop, containing a poly-Lys sequence motif, important for membrane interactions, were also investigated in detergent solutions. EK21 adopted a rather extended or beta-type conformations in complex with negatively charged SDS micelles. To our knowledge, this is the first report describing the conformations and residue-specific interactions of kindlin F1 loop with lipids. These data therefore provide important insights into the interactions of kindlin FERM domain with membrane lipids that contribute toward the integrin activating property.	[Chua, Geok-Lin; Tan, Suet-Mien; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM; Bhattacharjya, S (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	surajit@ntu.edu.sg; SMTan@ntu.edu.sg	Tan, Suet/A-2224-2011	Tan, Suet-Mien/0000-0003-2371-8739	Ministry of Education (MOE), Singapore [ARC18/13]	Ministry of Education (MOE), Singapore(Ministry of Education, Singapore)	This work was supported by a grant from the Ministry of Education (MOE), Singapore (ARC18/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 2015, P NATL ACAD SCI USA, V112, P9614, DOI 10.1073/pnas.1512799112; Bhunia A, 2009, J BIOL CHEM, V284, P3873, DOI 10.1074/jbc.M807236200; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bouaouina M, 2012, J BIOL CHEM, V287, P6979, DOI 10.1074/jbc.M111.330845; Djaafri I, 2014, ONCOTARGET, V5, P8970, DOI 10.18632/oncotarget.2125; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hart R, 2013, J BIOL CHEM, V288, P14852, DOI 10.1074/jbc.M112.434621; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; JOHANSSON J, 1994, BIOCHEMISTRY-US, V33, P6015, DOI 10.1021/bi00185a042; Kalli AC, 2010, STRUCTURE, V18, P1280, DOI 10.1016/j.str.2010.07.012; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; McDowall A, 2010, BLOOD, V115, P4834, DOI 10.1182/blood-2009-08-238709; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Pluskota E, 2013, BLOOD, V122, P2491, DOI 10.1182/blood-2013-04-497669; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Sossey-Alaoui K, 2014, FASEB J, V28, P2260, DOI 10.1096/fj.13-244004; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8531; Yates LA, 2012, J BIOL CHEM, V287, P43246, DOI 10.1074/jbc.M112.422089; Yu Y, 2013, INT J CANCER, V133, P1368, DOI 10.1002/ijc.28151; YU YW, 2013, PLOS GENET, V9, P71001, DOI DOI 10.1371/JOURNAL.PONE.0063490; Zhan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050313	43	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153501	10.1371/journal.pone.0153501	http://dx.doi.org/10.1371/journal.pone.0153501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101375	Green Published, gold			2022-12-27	WOS:000374898500036
J	Jimenez-Jaimez, J; Doza, JP; Ortega, A; Macias-Ruiz, R; Perin, F; del Rey, MMRV; Ortiz-Genga, M; Monserrat, L; Barriales-Villa, R; Blanca, E; Alvarez, M; Tercedor, L				Jimenez-Jaimez, Juan; Palomino Doza, Julian; Ortega, Angeles; Macias-Ruiz, Rosa; Perin, Francesca; Rodriguez-Vazquez del Rey, M. Mar; Ortiz-Genga, Martin; Monserrat, Lorenzo; Barriales-Villa, Roberto; Blanca, Enrique; Alvarez, Miguel; Tercedor, Luis			Calmodulin 2 Mutation N98S Is Associated with Unexplained Cardiac Arrest in Infants Due to Low Clinical Penetrance Electrical Disorders	PLOS ONE			English	Article							LONG-QT SYNDROME; VENTRICULAR-TACHYCARDIA; DEATH; CHILDREN; INACTIVATION; DYSFUNCTION; DIAGNOSIS; SURVIVORS; BEHAVIOR; HEART	Background Calmodulin 1, 2 and 3 (CALM) mutations have been found to cause cardiac arrest in children at a very early age. The underlying aetiology described is long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT) and idiopathic ventricular fibrillation (IVF). Little phenotypical data about CALM2 mutations is available. Objectives The aim of this paper is to describe the clinical manifestations of the Asn98Ser mutation in CALM2 in two unrelated children in southern Spain with apparently unexplained cardiac arrest/death. Methods Two unrelated children aged 4 and 7, who were born to healthy parents, were studied. Both presented with sudden cardiac arrest. The first was resuscitated after a VF episode, and the second died suddenly. In both cases the baseline QTc interval was within normal limits. Peripheral blood DNA was available to perform targeted gene sequencing. Results The surviving 4-year-old girl had a positive epinephrine test for LQTS, and polymorphic ventricular ectopic beats were seen on a previous 24-hour Holter recording from the deceased 7-year-old boy, suggestive of a possible underlying CPVT phenotype. A p.Asn98Ser mutation in CALM2 was detected in both cases. This affected a highly conserved across species residue, and the location in the protein was adjacent to critical calcium binding loops in the calmodulin carboxyl-terminal domain, predicting a high pathogenic effect. Conclusions Human calmodulin 2 mutation p.Asn98Ser is associated with sudden cardiac death in childhood with a variable clinical penetrance. Our results provide new phenotypical information about clinical behaviour of this mutation.	[Jimenez-Jaimez, Juan; Macias-Ruiz, Rosa; Alvarez, Miguel; Tercedor, Luis] Complejo Hosp Univ Granada, Dept Cardiol, Granada, Spain; [Jimenez-Jaimez, Juan; Macias-Ruiz, Rosa; Alvarez, Miguel; Tercedor, Luis] Inst Invest Biosanitario Granada, Granada, Spain; [Palomino Doza, Julian; Ortiz-Genga, Martin; Monserrat, Lorenzo; Barriales-Villa, Roberto] Hlth Code, Dept Cardiol, La Coruna, Spain; [Ortega, Angeles] Hosp Torrecardenas, Dept Paediat, Almeria, Spain; [Perin, Francesca; Rodriguez-Vazquez del Rey, M. Mar] Complejo Hosp Univ Granada, Dept Paediat, Granada, Spain	University of Granada; Hospital Torrecardenas; University of Granada	Jimenez-Jaimez, J (corresponding author), Complejo Hosp Univ Granada, Dept Cardiol, Granada, Spain.; Jimenez-Jaimez, J (corresponding author), Inst Invest Biosanitario Granada, Granada, Spain.	jimenez.jaimez@gmail.com	Barriales-Villa, Roberto/AAC-6889-2020; Perin, Francesca/G-6536-2019	Barriales-Villa, Roberto/0000-0002-6721-3487; Ortiz-Genga, martin/0000-0001-7453-7896; Monserrat, Lorenzo/0000-0001-5776-0623; Blanca Jover, Enrique/0000-0003-3957-336X; Perin, Francesca/0000-0003-1041-930X; Macias-Ruiz, Rosa/0000-0003-4686-5678				Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Bardai A, 2011, J AM COLL CARDIOL, V57, P1822, DOI 10.1016/j.jacc.2010.11.054; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Ciampa EJ, 2011, J BIOL CHEM, V286, P4141, DOI 10.1074/jbc.M110.158865; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; Halling D Brent, 2006, Sci STKE, V2006, per1; Hwang HS, 2014, CIRC RES, V114, P1114, DOI 10.1161/CIRCRESAHA.114.303391; Jimenez-Jaimez J, 2015, AM J CARDIOL, V116, P894, DOI 10.1016/j.amjcard.2015.06.030; Krahn AD, 2005, CIRCULATION, V112, P2228, DOI 10.1161/CIRCULATIONAHA.105.552166; Krahn AD, 2012, CIRC-ARRHYTHMIA ELEC, V5, P933, DOI 10.1161/CIRCEP.112.973230; Krahn AD, 2009, CIRCULATION, V120, P278, DOI 10.1161/CIRCULATIONAHA.109.853143; Kumar S, 2013, HEART RHYTHM, V10, P1653, DOI 10.1016/j.hrthm.2013.08.022; LEENHARDT A, 1995, CIRCULATION, V91, P1512, DOI 10.1161/01.CIR.91.5.1512; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; Maier LS, 2007, CARDIOVASC RES, V73, P629, DOI 10.1016/j.cardiores.2007.01.005; Makita N, 2014, CIRC-CARDIOVASC GENE, V7, P466, DOI 10.1161/CIRCGENETICS.113.000459; Marsman RF, 2014, J AM COLL CARDIOL, V63, P259, DOI 10.1016/j.jacc.2013.07.091; Medeiros-Domingo A, 2007, REV ESP CARDIOL, V60, P739, DOI 10.1157/13108280; Meyer L, 2012, CIRCULATION, V126, P1363, DOI 10.1161/CIRCULATIONAHA.111.076810; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Schwartz PJ, 2011, CIRCULATION, V124, P2181, DOI 10.1161/CIRCULATIONAHA.111.062182; Schwartz PJ, 2000, NEW ENGL J MED, V343, P262, DOI 10.1056/NEJM200007273430405; Schwartz PJ, 2001, LANCET, V358, P1342, DOI 10.1016/S0140-6736(01)06450-9; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Shimizu W, 2003, J AM COLL CARDIOL, V41, P633, DOI 10.1016/S0735-1097(02)02850-4; Swaminathan PD, 2011, J CLIN INVEST, V121, P3277, DOI 10.1172/JCI57833; Vyas H, 2006, CIRCULATION, V113, P1385, DOI 10.1161/CIRCULATIONAHA.105.600445; Wang DW, 2007, CIRCULATION, V115, P368, DOI 10.1161/CIRCULATIONAHA.106.646513; Yin G, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000996	34	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153851	10.1371/journal.pone.0153851	http://dx.doi.org/10.1371/journal.pone.0153851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100291	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500076
J	Maus, GW; Whitney, D				Maus, Gerrit W.; Whitney, David			Motion-Dependent Filling-In of Spatiotemporal Information at the Blind Spot	PLOS ONE			English	Article							VISUAL-MOTION; POSITION; EXTRAPOLATION; REPRESENTATION; PSYCHOPHYSICS; PREDICTION; RETINOTOPY; SCOTOMAS; OBJECTS; PATTERN	We usually do not notice the blind spot, a receptor-free region on the retina. Stimuli extending through the blind spot appear filled in. However, if an object does not reach through but ends in the blind spot, it is perceived as "cut off" at the boundary. Here we show that even when there is no corresponding stimulation at opposing edges of the blind spot, well known motion-induced position shifts also extend into the blind spot and elicit a dynamic filling-in process that allows spatial structure to be extrapolated into the blind spot. We presented observers with sinusoidal gratings that drifted into or out of the blind spot, or flickered in counterphase. Gratings moving into the blind spot were perceived to be longer than those moving out of the blind spot or flickering, revealing motion-dependent filling-in. Further, observers could perceive more of a grating's spatial structure inside the blind spot than would be predicted from simple filling-in of luminance information from the blind spot edge. This is evidence for a dynamic filling-in process that uses spatiotemporal information from the motion system to extrapolate visual percepts into the scotoma of the blind spot. Our findings also provide further support for the notion that an explicit spatial shift of topographic representations contributes to motion-induced position illusions.	[Maus, Gerrit W.] Nanyang Technol Univ, Sch Humanities & Social Sci, Div Psychol, Singapore 639798, Singapore; [Maus, Gerrit W.; Whitney, David] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Whitney, David] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Whitney, David] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Maus, GW (corresponding author), Nanyang Technol Univ, Sch Humanities & Social Sci, Div Psychol, Singapore 639798, Singapore.; Maus, GW (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	maus@ntu.edu.sg	Maus, Gerrit W/A-7542-2011	Maus, Gerrit W/0000-0003-4843-3748	NIH from National Eye Institute [EY018216]; NATIONAL EYE INSTITUTE [R01EY018216] Funding Source: NIH RePORTER	NIH from National Eye Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grant NIH EY018216 from the National Eye Institute to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstis S, 2010, CURR BIOL, V20, pR664, DOI 10.1016/j.cub.2010.06.029; Araragi Y, 2009, SPATIAL VISION, V22, P339, DOI 10.1163/156856809788746273; Arnold DH, 2007, VISION RES, V47, P2403, DOI 10.1016/j.visres.2007.04.025; Arnold DH, 2014, VISION RES, V98, P99, DOI 10.1016/j.visres.2014.03.003; Awater H, 2005, J NEUROPHYSIOL, V94, P3314, DOI 10.1152/jn.01330.2004; Baek Y, 2012, VISION RES, V58, P33, DOI 10.1016/j.visres.2012.01.020; Berens C, 1923, Trans Am Ophthalmol Soc, V21, P271; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; DURGIN FH, 1995, PERCEPTION, V24, P827, DOI 10.1068/p240827; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Fu YX, 2004, J NEUROSCI, V24, P2165, DOI 10.1523/JNEUROSCI.5145-03.2004; Fu YX, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0003.2001; Kaneko S, 2012, J VISION, V12, DOI 10.1167/12.12.1; KAWABATA N, 1982, PERCEPT MOTOR SKILL, V55, P95, DOI 10.2466/pms.1982.55.1.95; Kleiner M, 2007, PERCEPTION, V36, P14; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Maus GW, 2006, VISION RES, V46, P4375, DOI 10.1016/j.visres.2006.08.028; Maus GW, 2013, NEURON, V78, P554, DOI 10.1016/j.neuron.2013.03.010; Maus GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019796; Maus GW, 2008, PSYCHOL SCI, V19, P1087, DOI 10.1111/j.1467-9280.2008.02205.x; Maus GW, 2009, J EXP PSYCHOL HUMAN, V35, P611, DOI 10.1037/a0012317; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Pessoa L., 2003, FILLING IN PERCEPTUA; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; RAMACHANDRAN VS, 1992, SCI AM, V266, P86, DOI 10.1038/scientificamerican0592-86; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; Roach NW, 2011, CURR BIOL, V21, P740, DOI 10.1016/j.cub.2011.03.031; SAFRAN AB, 1993, NEURO-OPHTHALMOLOGY, V13, P309, DOI 10.3109/01658109309044579; Schlag J, 2002, NAT REV NEUROSCI, V3, P191, DOI 10.1038/nrn750; SPILLMANN L, 1992, VISION RES, V32, P1941, DOI 10.1016/0042-6989(92)90053-L; Spillmann L, 2006, VISION RES, V46, P4252, DOI 10.1016/j.visres.2006.08.033; Sundberg KA, 2006, NEURON, V49, P447, DOI 10.1016/j.neuron.2005.12.023; TRIPATHY SP, 1995, VISUAL NEUROSCI, V12, P385, DOI 10.1017/S0952523800008051; VIRSU V, 1974, PERCEPTION, V3, P323, DOI 10.1068/p030323; Whitney D, 2003, SCIENCE, V302, P878, DOI 10.1126/science.1087839; Whitney D, 2002, TRENDS COGN SCI, V6, P211, DOI 10.1016/S1364-6613(02)01887-9; Zur D, 2003, VISION RES, V43, P971, DOI 10.1016/S0042-6989(03)00038-5	40	7	7	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153896	10.1371/journal.pone.0153896	http://dx.doi.org/10.1371/journal.pone.0153896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100795	Green Published, gold			2022-12-27	WOS:000374898500091
J	Poesen, R; Evenepoel, P; de Loor, H; Delcour, JA; Courtin, CM; Kuypers, D; Augustijns, P; Verbeke, K; Meijers, B				Poesen, Ruben; Evenepoel, Pieter; de Loor, Henriette; Delcour, Jan A.; Courtin, Christophe M.; Kuypers, Dirk; Augustijns, Patrick; Verbeke, Kristin; Meijers, Bjorn			The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial	PLOS ONE			English	Article							P-CRESYL SULFATE; SERUM CONCENTRATIONS; INSULIN-RESISTANCE; MORTALITY; COLON; CRESYLSULPHATE; RISK	The colonic microbial metabolism is a key contributor to uremic retention solutes accumulating in patients with CKD, relating to adverse outcomes and insulin resistance. Whether prebiotics can reduce intestinal generation of these microbial metabolites and improve insulin resistance in CKD patients not yet on dialysis remains unknown. We performed a randomized, placebo-controlled, double-blind, cross-over study in 40 patients with eGFR between 15 and 45 ml/min/1.73 m(2). Patients were randomized to sequential treatment with prebiotic arabinoxylan oligosaccharides (AXOS) (10 g twice daily) and maltodextrin for 4 weeks, or vice versa, with a 4-week wash-out period between both intervention periods. Serum levels and 24h urinary excretion of p-cresyl sulfate, p-cresyl glucuronide, indoxyl sulfate, trimethylamine N-oxide and phenylacetylglutamine were determined at each time point using liquid chromatography-tandem mass spectrometry. In addition, insulin resistance was estimated by the homeostatic model assessment (HOMA-IR). A total of 39 patients completed the study. We observed no significant effect of AXOS on serum p-cresyl sulfate (P 0.42), p-cresyl glucuronide (P 0.59), indoxyl sulfate (P 0.70) and phenylacetylglutamine (P 0.41) and a small, albeit significant decreasing effect on serum trimethylamine N-oxide (P 0.04). There were neither effect of AXOS on 24h urinary excretion of p-cresyl sulfate (P 0.31), p-cresyl glucuronide (P 0.23), indoxyl sulfate (P 0.87) and phenylacetylglutamine (P 0.43), nor on 24h urinary excretion of trimethylamine N-oxide (P 0.97). In addition, we observed no significant change in HOMA-IR (P 0.93). In conclusion, we could not demonstrate an influence of prebiotic AXOS on microbiota derived uremic retention solutes and insulin resistance in patients with CKD not yet on dialysis. Further study is necessary to elucidate whether prebiotic therapy with other characteristics, higher cumulative exposure or in different patient populations may be of benefit.	[Poesen, Ruben; Evenepoel, Pieter; de Loor, Henriette; Kuypers, Dirk; Meijers, Bjorn] Univ Hosp Leuven, Dept Microbiol & Immunol, Div Nephrol, B-3000 Leuven, Belgium; [Delcour, Jan A.; Courtin, Christophe M.] Univ Leuven, Ctr Food & Microbial Technol, Dept Microbial & Mol Syst, B-3000 Leuven, Belgium; [Delcour, Jan A.; Courtin, Christophe M.; Verbeke, Kristin] Univ Leuven, Leuven Food Sci & Nutr Res Ctr LFoRCe, B-3000 Leuven, Belgium; [Augustijns, Patrick] Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Drug Delivery & Disposit, B-3000 Leuven, Belgium; [Verbeke, Kristin] Univ Leuven, Translat Res Gastrointestinal Disorders Targid, B-3000 Leuven, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven	Meijers, B (corresponding author), Univ Hosp Leuven, Dept Microbiol & Immunol, Div Nephrol, B-3000 Leuven, Belgium.	bjorn.meijers@uzleuven.be	P, Evenepoel/D-9597-2018; Augustijns, Patrick F/H-7615-2018; Courtin, Christophe M/Q-1916-2016; Meijers, Bjorn/D-6169-2018; de Loor, Henriette/D-3579-2018; DELCOUR, Jan A/P-4182-2017; Kuypers, Dirk RJ/D-4393-2018	P, Evenepoel/0000-0002-2846-2026; Augustijns, Patrick F/0000-0003-2595-388X; Courtin, Christophe M/0000-0002-1203-9063; Meijers, Bjorn/0000-0002-2846-2026; de Loor, Henriette/0000-0003-4421-6340; DELCOUR, Jan A/0000-0003-2954-1022; Kuypers, Dirk RJ/0000-0001-5546-9680; Verbeke, Kristin/0000-0002-5352-7565	Research Foundation - Flanders (FWO) [11E9813N, G077514N]	Research Foundation - Flanders (FWO)(FWO)	RP is the recipient of a Ph.D. fellowship of the Research Foundation - Flanders (FWO) (grant 11E9813N) (www.fwo.be). Part of the research has been funded by the Research Foundation - Flanders (FWO) (grant G077514N) (www.fwo.be). JAD and KV are jointly chair holders of the W.K. Kellogg Chair in Cereal Science and Nutrition at KU Leuven (www.wkkf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Broekaert WF, 2011, CRIT REV FOOD SCI, V51, P178, DOI 10.1080/10408390903044768; Cloetens L, 2010, BRIT J NUTR, V103, P703, DOI 10.1017/S0007114509992248; Damen B, 2012, J NUTR, V142, P470, DOI 10.3945/jn.111.146464; Francois IE, 2012, B NUTR, P1; Francois IEJA, 2014, J PEDIATR GASTR NUTR, V58, P647, DOI 10.1097/MPG.0000000000000285; Koppe L, 2013, J AM SOC NEPHROL, V24, P88, DOI 10.1681/ASN.2012050503; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meert N, 2012, NEPHROL DIAL TRANSPL, V27, P2388, DOI 10.1093/ndt/gfr672; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers BKI, 2010, NEPHROL DIAL TRANSPL, V25, P219, DOI 10.1093/ndt/gfp414; Meijers B, 2014, SEMIN NEPHROL, V34, P228, DOI 10.1016/j.semnephrol.2014.02.012; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Meyer TW, 2012, KIDNEY INT, V81, P949, DOI 10.1038/ki.2011.504; Poesen R, 2015, J AM SOC NEPHROL; Poesen R, 2013, SEMIN DIALYSIS, V26, P323, DOI 10.1111/sdi.12082; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Salmean YA, 2015, J RENAL NUTR, V25, P316, DOI 10.1053/j.jrn.2014.09.002; Shafi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126048; Sirich TL, 2014, CLIN J AM SOC NEPHRO, V9, P1603, DOI 10.2215/CJN.00490114; Stubbs J. R., 2015, J AM SOC NEPHROL, DOI 10.1681/ASN.201411106:3ASN; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580	28	61	64	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153893	10.1371/journal.pone.0153893	http://dx.doi.org/10.1371/journal.pone.0153893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100399	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000374898500089
J	Santarem, OLD; de Cleva, R; Sasaya, FM; de Assumpcao, MS; Furtado, MS; Barbato, AJG; Herman, P				de Andrade Santarem, Orlando Luis; de Cleva, Roberto; Sasaya, Flavia Megumi; de Assumpcao, Marianna Siqueira; Furtado, Meive Santos; Guedes Barbato, Alfonso Julio; Herman, Paulo			Left Ventricular Dilation and Pulmonary Vasodilatation after Surgical Shunt for Treatment of Pre-Sinusoidal Portal Hypertension	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; HEPATOPULMONARY SYNDROME; LIVER-TRANSPLANTATION; AORTIC REGURGITATION; ESOPHAGEAL DOPPLER; CARDIAC-OUTPUT; CIRRHOSIS; DISEASE; ABNORMALITIES; HEMODYNAMICS	Objective The aim of this study was to prospectively investigate the long-term cardiovascular and pulmonary hemodynamic effects of surgical shunt for treatment of portal hypertension (PH) due to Schistosomiasis mansoni. Location The University of Sao Paulo Medical School, Brazil; Public Practice. Methods Hemodynamic evaluation was performed with transesophageal Doppler and contrast-enhanced echocardiography (ECHO) on twenty-eight participants with schistosomal portal hypertension. Participants were divided into two groups according to the surgical procedure used to treat their schistosomal portal hypertension within the last two years: group 1-distal splenorenal shunt (DSRS, n = 13) and group 2-esophagogastric devascularization and splenectomy (EGDS, n = 15). Results The cardiac output (5.08 +/- 0.91 L/min) and systolic volume (60.1 +/- 5.6 ml) were increased (p = 0.001) in the DSRS group. DSRS participants had a significant increase (p < 0.0001) in their left ventricular end-systolic and end-diastolic diameters as well as in their left ventricular end-diastolic and end-systolic volumes (p < 0.001) compared with the preoperative period. No statistically significant difference was found in the patients who underwent EGDS. ECHO revealed intrapulmonary vasodilatation (IPV) in 18 participants (64%), 9 DSRS and 9 EGDS (p > 0.05). Conclusions The late increase in the cardiac output, stroke volume and left ventricular diameters demonstrated left ventricular dilatation after a distal splenorenal shunt. ECHO revealed a greater prevalence for IPV in patients with schistosomiasis than has previously been described in patients with PH from liver cirrhosis.	[de Andrade Santarem, Orlando Luis; de Cleva, Roberto; Sasaya, Flavia Megumi; de Assumpcao, Marianna Siqueira; Herman, Paulo] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil; [Furtado, Meive Santos; Guedes Barbato, Alfonso Julio] Univ Sao Paulo, Sch Med, Dept Radiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Santarem, OLD (corresponding author), Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil.	orlandoluisantarem@hotmail.com	de cleva, roberto/AAG-6927-2019; Herman, Paulo/J-5457-2013; de cleva, roberto/L-8456-2013	de cleva, roberto/0000-0001-8673-9014; Herman, Paulo/0000-0003-2859-5846; de cleva, roberto/0000-0001-8673-9014	FAPESP (Sao Paulo State Research Foundation)	FAPESP (Sao Paulo State Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by FAPESP (Sao Paulo State Research Foundation).	Abbas SM, 2008, ANAESTHESIA, V63, P44, DOI 10.1111/j.1365-2044.2007.05233.x; Abrams GA, 1998, GASTROENTEROLOGY, V114, P305, DOI 10.1016/S0016-5085(98)70481-0; Abrams GA, 1995, GASTROENTEROLOGY, V114, P305; AGUSTI AG, 1989, AM REV RESPIR DIS, V139, P485, DOI 10.1164/ajrccm/139.2.485; Alizadeh AHM, 2006, WORLD J GASTROENTERO, V12, P1954, DOI 10.3748/wjg.v12.i12.1954; Anand A C, 2001, Indian J Gastroenterol, V20, P24; BABBS C, 1988, GUT, V29, P129, DOI 10.1136/gut.29.1.129; Bina José Carlos, 2003, Rev. Soc. Bras. Med. Trop., V36, P211, DOI 10.1590/S0037-86822003000200003; Brussino L, 2003, LANCET, V362, P43, DOI 10.1016/S0140-6736(03)13807-X; CREMONA G, 1995, EUR RESPIR J, V8, P1883, DOI 10.1183/09031936.95.08111883; Cury AA, 1989, REV COL BRAS CIR, V16, P117; DASILVA LC, 1986, ANN SURG, V204, P148, DOI 10.1097/00000658-198608000-00008; De BK, 2002, GASTROENTEROLOGY, V122, P897, DOI 10.1053/gast.2002.32419; De BK, 2000, GASTROENTEROLOGY, V118, P192, DOI 10.1016/S0016-5085(00)70428-8; de Cleva R, 1999, AM J GASTROENTEROL, V94, P1632, DOI 10.1111/j.1572-0241.1999.01086.x; de Cleva R, 2007, WORLD J GASTROENTERO, V13, P5471, DOI 10.3748/wjg.v13.i41.5471; Eldridge MW, 2004, J APPL PHYSIOL, V97, P797, DOI 10.1152/japplphysiol.00137.2004; EZZAT FA, 1990, ANN SURG, V212, P97, DOI 10.1097/00000658-199007000-00013; Fallon MB, 2005, J CLIN GASTROENTEROL, V39, pS138, DOI 10.1097/01.mcg.0000155570.19340.61; FEINBERG MS, 1995, CHEST, V107, P769, DOI 10.1378/chest.107.3.769; Ferraz AAB, 2001, INT SURG, V86, P1; Ferreira FG, 2009, WORLD J SURG, V33, P2136, DOI 10.1007/s00268-009-0196-y; Fuhrmann V, 2006, GASTROENTEROLOGY, V131, P69, DOI 10.1053/j.gastro.2006.04.014; Gupta D, 2001, AM J GASTROENTEROL, V96, P3395; Helmy A, 2003, GUT, V52, P410, DOI 10.1136/gut.52.3.410; HENRY WL, 1980, CIRCULATION, V61, P484, DOI 10.1161/01.CIR.61.3.484; HIND CRK, 1981, GUT, V22, P1042, DOI 10.1136/gut.22.12.1042; INGRAM CW, 1987, CHEST, V92, P1117, DOI 10.1378/chest.92.6.1117; Kaymakoglu S, 2003, DIGEST DIS SCI, V48, P556, DOI 10.1023/A:1022549018807; KELNER S, 1992, MEM I OSWALDO CRUZ, V87, P357, DOI 10.1590/S0074-02761992000800057; Krowka MJ, 2000, CHEST, V118, P615, DOI 10.1378/chest.118.3.615; Krowka MJ, 2005, CLIN CHEST MED, V26, P587, DOI 10.1016/j.ccm.2005.06.010; KROWKA MJ, 1990, CHEST, V97, P1165, DOI 10.1378/chest.97.5.1165; KROWKA MJ, 1994, CHEST, V105, P1528, DOI 10.1378/chest.105.5.1528; Laupland KB, 2002, CAN J ANAESTH, V49, P393, DOI 10.1007/BF03017329; MacRae JM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2004.01.016; Maganty K, 2011, TRANSPL P, V43, P2814, DOI 10.1016/j.transproceed.2011.07.003; Makdissi FF, 2010, WORLD J SURG, V34, P2682, DOI 10.1007/s00268-010-0717-8; Marciniak A, 2009, EUR J ECHOCARDIOGR, V10, P112, DOI 10.1093/ejechocard/jen185; Martinez G, 1999, J HEPATOL, V30, P882, DOI 10.1016/S0168-8278(99)80143-3; MOORE K, 1992, NEW ENGL J MED, V327, P1774, DOI 10.1056/NEJM199212173272502; Morawietz H, 2000, J PHYSIOL-LONDON, V525, P761, DOI 10.1111/j.1469-7793.2000.00761.x; Ori Y, 1996, NEPHROL DIAL TRANSPL, V11, P94; Poeze M, 1999, CRIT CARE MED, V27, P1288, DOI 10.1097/00003246-199907000-00013; RAIA S, 1984, WORLD J SURG, V8, P738, DOI 10.1007/BF01655771; Rodriguez Roisin R, 2008, NEW ENGL J MED, V358, P2378, DOI DOI 10.1056/NEJMRA0707185; Rodriguez-Roisin R, 2004, EUR RESPIR J, V24, P861, DOI 10.1183/09031936.04.00010904; RODRIGUEZROISIN R, 1994, EUR RESPIR J, V7, P839; RODRIGUEZROISIN R, 1992, THORAX, V47, P897, DOI 10.1136/thx.47.11.897; Rolla G, 1997, HEPATOLOGY, V26, P842, DOI 10.1002/hep.510260406; Rosenhek R, 2010, CIRCULATION, V121, P151, DOI 10.1161/CIRCULATIONAHA.109.894170; Schenk P, 2002, GUT, V51, P853, DOI 10.1136/gut.51.6.853; SINGER M, 1991, CRIT CARE MED, V19, P1132, DOI 10.1097/00003246-199109000-00007; SINGER M, 1989, CRIT CARE MED, V17, P447, DOI 10.1097/00003246-198905000-00014; SINGER M, 1989, CRIT CARE MED, V17, P1060, DOI 10.1097/00003246-198910000-00019; STETZ CW, 1982, AM REV RESPIR DIS, V126, P1001; Stickland MK, 2004, J PHYSIOL-LONDON, V561, P321, DOI 10.1113/jphysiol.2004.069302; Tang LP, 2007, AM J PHYSIOL-LUNG C, V292, pL1467, DOI 10.1152/ajplung.00446.2006; Teuber Gerlinde, 2002, Eur J Intern Med, V13, P311, DOI 10.1016/S0953-6205(02)00066-3; Toledo CF, 2009, DIGEST DIS SCI, V54, P1331, DOI [10.1007/s10620-008-0475-8, DOI 10.1007/S10620-008-0475-8]; Tripathi D, 2006, GUT, V55, P1290, DOI 10.1136/gut.2005.077453; van Duijnhoven ECM, 2001, NEPHROL DIAL TRANSPL, V16, P368, DOI 10.1093/ndt/16.2.368; WEST J, 1990, PULMONARY PATHOPHYSI; WHO, 2007, WHO TECH REP SER, V935, P1; WILLIAMS A, 1979, THORAX, V34, P447, DOI 10.1136/thx.34.4.447	65	1	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154011	10.1371/journal.pone.0154011	http://dx.doi.org/10.1371/journal.pone.0154011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119143	Green Published, gold			2022-12-27	WOS:000374976200040
J	Haines, RJ; Beard, RS; Eitner, RA; Chen, LW; Wu, MH				Haines, Ricci J.; Beard, Richard S., Jr.; Eitner, Rebecca A.; Chen, Liwei; Wu, Mack H.			TNF alpha/IFN gamma Mediated Intestinal Epithelial Barrier Dysfunction Is Attenuated by MicroRNA-93 Downregulation of PTK6 in Mouse Colonic Epithelial Cells	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; TUMOR-NECROSIS-FACTOR; OXIDATIVE STRESS; GENE-EXPRESSION; IFN-GAMMA; ACTIVATION; KINASE; JNK; PERMEABILITY; FAMILY	Since inflammatory bowel diseases (IBD) represent significant morbidity and mortality in the US, the need for defining novel drug targets and inflammatory mechanisms would be of considerable benefit. Although protein tyrosine kinase 6 (PTK6, also known as breast tumor kinase BRK) has been primarily studied in an oncogenic context, it was noted that PTK6 null mice exhibited significantly enhanced colonic epithelial barrier function. Considering that the inflammatory functions of PTK6 have not yet been explored, we hypothesized that cytokines responsible for mediating IBD, such as TNF alpha/IFN gamma, may solicit the action of PTK6 to alter barrier function. After first assessing critical mediators of TNF alpha/IFN gamma driven epithelial barrier dysfunction, we further explored the possibility of PTK6 in this inflammatory context. In this report, we showed that PTK6 siRNA and PTK6 null young adult mouse colonic epithelial cells (YAMC) exhibited significant attenuation of TNF alpha/IFN gamma induced barrier dysfunction as measured by electric cell-substrate impedance sensing (ECIS) assay and permeability assays. In addition, PTK6 null cells transfected with PTK6 cDNA displayed restored barrier dysfunction in response to TNF alpha/IFN gamma, while the cells transfected with vector alone showed similar attenuation of barrier dysfunction. Furthermore, using subcellular fractionation and immunocytochemistry experiments, we found that PTK6 plays a role in FoxO1 nuclear accumulation leading to down-regulation of claudin-3, a tight junction protein. Moreover, we searched for relevant miRNA candidates putative for targeting PTK6 in order to identify and assess the impact of microRNA that target PTK6 with respect to TNF alpha/IFN gamma induced barrier dysfunction. Subsequently, we assayed likely targets and determined their effectiveness in attenuating PTK6 expression as well as cytokine induced barrier dysfunction. Results showed that miR-93 reduced PTK6 expression and attenuated TNF alpha/IFN gamma imposed decrease in transepithelial electrical resistance (TER), as well as excluded FoxO1 from the nucleus. Our results indicate that PTK6 may act as a novel mediator of intestinal epithelial permeability during inflammatory injury, and miR-93 may protect intestinal epithelial barrier function, at least in part, by targeting PTK6.	[Wu, Mack H.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Haines, Ricci J.; Eitner, Rebecca A.; Chen, Liwei; Wu, Mack H.] Univ S Florida, Dept Surg, Morsani Coll Med, Tampa, FL 33620 USA; [Beard, Richard S., Jr.] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Wu, MH (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.; Wu, MH (corresponding author), Univ S Florida, Dept Surg, Morsani Coll Med, Tampa, FL 33620 USA.	mwu1@health.usf.edu	Beard, Richard Scott/I-3695-2019; Beard Jr., Richard/E-2051-2013	Beard, Richard Scott/0000-0001-8545-3014; Beard Jr., Richard/0000-0001-8545-3014	U.S. Department of Veterans' Affairs [BX000799]; National Institutes of Health [R01 HL096640, HL120954]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096640, R01HL120954] Funding Source: NIH RePORTER	U.S. Department of Veterans' Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by U.S. Department of Veterans' Affairs (Merit Review BX000799); National Institutes of Health (R01 HL096640 & HL120954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Amin MR, 2006, AM J PHYSIOL-CELL PH, V291, pC887, DOI 10.1152/ajpcell.00630.2005; Beard RS, 2014, J CELL SCI, V127, P1840, DOI 10.1242/jcs.144550; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Cao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061944; Carrozzino F, 2009, AM J PHYSIOL-CELL PH, V297, pC775, DOI 10.1152/ajpcell.00084.2009; Chang MH, 2004, ZOOLOGY, V107, P121, DOI 10.1016/j.zool.2004.03.001; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Gavard J, 2008, NAT CELL BIOL, V10, P883, DOI 10.1038/ncb0808-883; Ghatak S, 2015, MOL THER, V23, P1201, DOI 10.1038/mt.2015.65; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Haines RJ, 2015, BIOCHEM BIOPH RES CO, V456, P190, DOI 10.1016/j.bbrc.2014.11.057; Hardyman MA, 2013, J ALLERGY CLIN IMMUN, V132, P665, DOI 10.1016/j.jaci.2013.03.005; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jiang LL, 2015, ONCOTARGET, V6, P8286, DOI 10.18632/oncotarget.3221; Lu CM, 2014, GASTROENTEROLOGY, V146, P188, DOI 10.1053/j.gastro.2013.09.006; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; McKay DM, 1997, J IMMUNOL, V159, P2382; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Palka-Hamblin HL, 2010, J CELL SCI, V123, P236, DOI 10.1242/jcs.053264; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Rigor RR, 2013, MED RES REV, V33, P911, DOI 10.1002/med.21270; Seiler F, 2013, J IMMUNOL, V190, P1603, DOI 10.4049/jimmunol.1200596; Shen B, 2010, AM J PHYSIOL-HEART C, V298, pH1048, DOI 10.1152/ajpheart.00826.2009; Sun CX, 2010, CARDIOVASC RES, V87, P348, DOI 10.1093/cvr/cvq060; Terryn C, 2013, CYTOM PART A, V83A, P235, DOI 10.1002/cyto.a.22239; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Wang Y, 2013, ACTA HISTOCHEM, V115, P557, DOI 10.1016/j.acthis.2012.12.005; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Whitehead RH, 2008, J GASTROEN HEPATOL, V23, P1119, DOI 10.1111/j.1440-1746.2008.05308.x; Wicovsky A, 2007, J BIOL CHEM, V282, P2174, DOI 10.1074/jbc.M606167200; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279; Zhang P, 2005, J BIOL CHEM, V280, P1982, DOI 10.1074/jbc.M412038200; Zheng Y, 2013, ONCOGENE, V32, P4304, DOI 10.1038/onc.2012.427; Zhong JL, 2008, MOL CANCER RES, V6, P383, DOI 10.1158/1541-7786.MCR-07-2028	37	30	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154351	10.1371/journal.pone.0154351	http://dx.doi.org/10.1371/journal.pone.0154351			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119373	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200062
J	Hong, YF; Kim, H; Kim, HS; Park, WJ; Kim, JY; Chung, DK				Hong, Yi-Fan; Kim, Hangeun; Kim, Hye Sun; Park, Woo Jung; Kim, Joo-Yun; Chung, Dae Kyun			Lactobacillus acidophilus K301 Inhibits Atherogenesis via Induction of 24 (S), 25-Epoxycholesterol-Mediated ABCA1 and ABCG1 Production and Cholesterol Efflux in Macrophages	PLOS ONE			English	Article							LIVER-X-RECEPTOR; LIPOTEICHOIC ACID; PLANTARUM; ATHEROSCLEROSIS; EXPRESSION; 24(S),25-EPOXYCHOLESTEROL; LIPOPOLYSACCHARIDE; MEMBRANE; LIGAND	Lactobacillus acidophilus species are well-known probiotics with the beneficial activity of regulating cholesterol levels. In this study, we showed that L. acidophilus K301 reduced the level of cholesterol through reverse transport in macrophages. L. acidophilus K301 upregulated the mRNA and protein levels of genes such as ATP-binding cassette A1 (ABCA1) and ATP-binding cassette G1 (ABCG1) under the control of liver X receptor (LXR), resulting in increased apoA-I-dependent cholesterol efflux in phorbol 12-myristate 13-acetate (PMA)-differentiated THP-1 cells. L. acidophilus K301 induced both ABCA1 and ABCG1 through the endogenous LXR agonist 24(S), 25-epoxcycholesterol, which is synthesized by intracellular cholesterol synthetic pathways. In vivo studies using L. acidophilus K301-treated ApoE(-/-) mice showed reduced accumulation of lipoproteins in the arterial lumen. The inhibitory effects of L. acidophilus K301 on accumulation of lipoprotein in atherosclerotic plaques were mediated by the induction of squalene reductase (SQLE) and oxidosqualene cyclase (OSC) and resulted in ABCA1-mediated cholesterol efflux. Taken together, our findings revealed that Lactobacillus acidophilus K301 regulates the expression of genes related to cholesterol reverse transport via the induction of endogenous LXR agonist, suggesting the therapeutic potential of Lactobacillus acidophilus K301 as an anti-atherosclerotic agent.	[Hong, Yi-Fan; Kim, Hangeun; Kim, Hye Sun; Park, Woo Jung; Kim, Joo-Yun; Chung, Dae Kyun] Kyung Hee Univ, Grad Sch Biotechnol, Yongin 446701, South Korea; [Hong, Yi-Fan; Kim, Hangeun; Kim, Hye Sun; Park, Woo Jung; Kim, Joo-Yun; Chung, Dae Kyun] Kyung Hee Univ, Inst Life Sci & Resources, Yongin 446701, South Korea; [Hong, Yi-Fan; Kim, Hangeun; Chung, Dae Kyun] Kyung Hee Univ, Skin Biotechnol Ctr, Yongin 446701, South Korea; [Chung, Dae Kyun] RNA Inc, 308 Life Sceince Bldg, Yongin 446701, South Korea; [Kim, Hye Sun] Ajou Univ, Dept Neurosurg, Sch Med, Suwon 443749, South Korea; [Park, Woo Jung] Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Kangnung 210702, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Ajou University; Kangnung Wonju National University	Kim, JY; Chung, DK (corresponding author), Kyung Hee Univ, Grad Sch Biotechnol, Yongin 446701, South Korea.; Kim, JY; Chung, DK (corresponding author), Kyung Hee Univ, Inst Life Sci & Resources, Yongin 446701, South Korea.; Chung, DK (corresponding author), Kyung Hee Univ, Skin Biotechnol Ctr, Yongin 446701, South Korea.; Chung, DK (corresponding author), RNA Inc, 308 Life Sceince Bldg, Yongin 446701, South Korea.	99djawl@hanmail.net; dkchung@khu.ac.kr	chung, dae kyun/AAG-1058-2021		Kyung Hee University [KHU-20120816]; RNA Inc.	Kyung Hee University; RNA Inc.	This work was supported by a grant from Kyung Hee University in 2012 (KHU-20120816). RNA Inc. provided support in the form of salaries for authors [DKC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Brown AJ, 2009, INT J BIOCHEM CELL B, V41, P744, DOI 10.1016/j.biocel.2008.05.029; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; DESMET I, 1994, MICROB ECOL HEALTH D, V7, P315, DOI 10.3109/08910609409141371; ERKELENS DW, 1988, DRUGS, V36, P87, DOI 10.2165/00003495-198800363-00018; Gill S, 2008, PROG LIPID RES, V47, P391, DOI 10.1016/j.plipres.2008.04.002; GILLILAND SE, 1977, APPL ENVIRON MICROB, V33, P15, DOI 10.1128/AEM.33.1.15-18.1977; GILLILAND SE, 1985, APPL ENVIRON MICROB, V49, P377, DOI 10.1128/AEM.49.2.377-381.1985; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1979, J BIOL CHEM, V254, P5403; Huang Y, 2014, APPL ENVIRON MICROB, V80, P7496, DOI 10.1128/AEM.02926-14; Jeong JH, 2015, IMMUNOBIOLOGY, V220, P460, DOI 10.1016/j.imbio.2014.11.002; Kannel WB, 1984, CIRCULATION, V70, p155A; Kaplan R, 2002, J LIPID RES, V43, P952; Kawashima RL, 2014, BIOCHEM BIOPH RES CO, V450, P1416, DOI 10.1016/j.bbrc.2014.07.015; Kim H, 2014, J MICROBIOL BIOTECHN, V24, P1051, DOI 10.4014/jmb.1403.03012; Kim JS, 2013, MOL CELLS, V35, P17, DOI 10.1007/s10059-013-2154-7; Kumar M, 2012, EXP DIABETES RES, V2012, DOI [10.1155/2012/902917, DOI 10.1155/2012/902917]; LAW MR, 1994, BMJ-BRIT MED J, V308, P363, DOI 10.1136/bmj.308.6925.363; Lehrke M, 2005, CELL METAB, V1, P297, DOI 10.1016/j.cmet.2005.04.005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murthy S, 2002, J LIPID RES, V43, P1054, DOI 10.1194/jlr.M100358-JLR200; Nakaya K, 2007, J ATHEROSCLER THROMB, V14, P133, DOI 10.5551/jat.14.133; Noh DO, 1997, J DAIRY SCI, V80, P3107, DOI 10.3168/jds.S0022-0302(97)76281-7; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Schoonjans K, 2000, J MOL BIOL, V304, P323, DOI 10.1006/jmbi.2000.4218; Slalter J, 1996, NUR FOOD SCI, V96, P29; SUCKLING KE, 1991, ATHEROSCLEROSIS, V89, P183, DOI 10.1016/0021-9150(91)90059-C; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Trasino SE, 2013, J NUTR BIOCHEM, V24, P1931, DOI 10.1016/j.jnutbio.2013.06.001; Usman, 2001, J DAIRY RES, V68, P617, DOI 10.1017/S0022029901005179; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Yoon HS, 2013, J SCI FOOD AGR, V93, P781, DOI 10.1002/jsfa.5797; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1269, DOI 10.1016/j.bbalip.2011.11.009	36	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154302	10.1371/journal.pone.0154302	http://dx.doi.org/10.1371/journal.pone.0154302			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120199	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200057
J	McAuley, K; McAullay, D; Strobel, NA; Marriott, R; Atkinson, DN; Marley, JV; Stanley, FJ; Edmond, KM				McAuley, Kimberley; McAullay, Daniel; Strobel, Natalie A.; Marriott, Rhonda; Atkinson, David N.; Marley, Julia V.; Stanley, Fiona J.; Edmond, Karen M.			Hospital Utilisation in Indigenous and Non-Indigenous Infants under 12 Months of Age in Western Australia, Prospective Population Based Data Linkage Study	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT PRESENTATIONS; STRAIT ISLANDER PEOPLE; HEALTH-SERVICES; RETROSPECTIVE COHORT; IDENTIFICATION; PRACTITIONERS; ACCESSIBILITY; QUALITY; RECORDS	Background Indigenous infants (infants aged under 12 months) have the highest hospital admission and emergency department presentation risks in Australia. However, there have been no recent reports comparing hospital utilisation between Indigenous and non-Indigenous infants. Methods Our primary objective was to use a large prospective population-based linked dataset to assess the risk of all-cause hospital admission and emergency department presentation in Indigenous compared to non-Indigenous infants in Western Australia (WA). Secondary objectives were to assess the effect of socio-economic status (Index of Relative Socio-Economic Disadvantage [IRSD]) on hospital utilisation and to understand the causes of hospital utilisation. Findings There were 3,382 (5.4%) Indigenous and 59,583 (94.6%) non-Indigenous live births in WA from 1 January 2010 to 31 December 2011. Indigenous infants had a greater risk of hospital admission (adjusted odds ratio [aOR] 1.90, 95% confidence interval [95% CI] 1.77-2.04, p = <0.001) and emergency department presentation (aOR 2.15, 95% CI 1.98-2.33, p = <0.001) compared to non-Indigenous infants. Fifty nine percent (59.0%) of admissions in Indigenous children were classified as preventable compared to 31.2% of admissions in non-Indigenous infants (aOR 2.12, 95% CI 1.88-2.39). The risk of hospital admission in the most disadvantaged (IRSD 1) infants in the total cohort (35.7%) was similar to the risk in the least disadvantaged (IRSD 5) infants (30.6%) (aOR 1.04, 95% CI 0.96-1.13, p = 0.356). Interpretation WA Indigenous infants have much higher hospital utilisation than non Indigenous infants. WA health services should prioritise Indigenous infants regardless of their socio economic status or where they live.	[McAuley, Kimberley; McAullay, Daniel; Strobel, Natalie A.; Edmond, Karen M.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [McAullay, Daniel] Edith Cowan Univ, Ctr Indigenous Australian Educ & Res, Kurongkurl Katitjin, Perth, WA, Australia; [Marriott, Rhonda] Murdoch Univ, Sch Psychol & Exercise Sci, Perth, WA, Australia; [Atkinson, David N.; Marley, Julia V.] Univ Western Australia, Rural Clin Sch Western Australia, Broome, WA, Australia; [Stanley, Fiona J.] Telethon Kids Inst, Perth, WA, Australia	University of Western Australia; Edith Cowan University; Murdoch University; University of Western Australia; Telethon Kids Institute	McAuley, K (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	kimberley.mcauley@uwa.edu.au	Marley, Julia V/A-9515-2009; Strobel, Natalie A/O-9174-2014	Marley, Julia V/0000-0003-1014-4860; Strobel, Natalie A/0000-0002-2962-5704; Atkinson, David/0000-0001-7069-5555; McAullay, Daniel/0000-0002-0651-899X				AIHW, 2015, PER STAT SER, V31; AIHW, 2013, HLTH WELF EXP SER, V48; AIHW AIFS, 2013, CLOS GAP CLEAR ANN R; Australan Institute of Health and Welfare, 2012, PICT AUSTR CHILDR 20; Australian Institute of Health and Welfare (AIHW), 2011, HLTH WELF AUSTR AB T; Australian Institute of Health and Welfare (AIHW), 2015, HLTH SERV SER, V60; Bar-Zeev SJ, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-19; COAG, 2009, NAT INT STRAT CLOS G; Commonwealth Department of Health and Aged Care: Measuring remoteness: Accessibility/remoteness index of Australia (ARIA), 2001, INF RES BRANCH OCC P, V14; Costa N, 2008, HEALTH INF MANAG J, V37, P15, DOI 10.1177/183335830803700303; DoH, 2007, EM DEP DAT COLL DAT; Doh, 2013, NAT AB TORR STRAIT I; DoH, 2013, DAT QUAL MIDW NOT SY; DoH, 2010, AB MAT SERV SUPP UN; DoH, 2015, IND AUSTR HLTH PROGR; Downey F., 2007, VALIDATION STUDY W A; Duncan C, 2013, J PAEDIATR CHILD H, V49, pE448, DOI 10.1111/jpc.12225; Freeman T, 2014, AUST NZ J PUBL HEAL, V38, P355, DOI 10.1111/1753-6405.12231; Freeman T, 2011, AUST J PRIM HEALTH, V17, P355, DOI 10.1071/PY11033; Griew R, 2008, LINK PRIMARY HLTH CA; Gruen RL, 2006, LANCET, V368, P130, DOI 10.1016/S0140-6736(06)68812-0; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Joyce A, 2012, W AUSTR MOTHERS BABI; Kearns T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058231; Lawrence D, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-90; Li S. Q., 2011, HOSP ADMISSIONS NO T; Li SQ, 2007, INFANCY YOUNG ADULTH; Mnatzaganian G, 2012, J CLIN EPIDEMIOL, V65, P107, DOI 10.1016/j.jclinepi.2011.03.014; Moore HC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-703; Moorin RE, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-74; NHPA, 2015, HLTH COMM POT PREV H; Pink B, 2008, SOCIOECONOMIC INDEXE; SCRGSP, 2014, OV IND DIS KEY IND 2; Thomas DP, 2008, AUST HEALTH REV, V32, P648, DOI 10.1071/AH080648; Thompson SC, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-133; World Health Organisation, 2019, INT STAT CLASS DIS R, V11th; Zhao YJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-466	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154171	10.1371/journal.pone.0154171	http://dx.doi.org/10.1371/journal.pone.0154171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120331	Green Published, gold			2022-12-27	WOS:000374976200048
J	Wu, MY; He, XY; Hu, CS				Wu, Ming-Yao; He, Xia-Yun; Hu, Chao-Su			Tumor Regression and Patterns of Distant Metastasis of T1-T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							CONCURRENT CHEMORADIOTHERAPY; RADIATION-THERAPY; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; NODE METASTASIS; STAGE-III; PHASE-III; CANCER; SURVIVAL; OUTCOMES	Purpose To study tumor regression and failure patterns in T1-T2 non-metastatic nasopharyngeal carcinoma (NPC) after intensity-modulated radiotherapy (IMRT). Methods A retrospective analysis of 139 nasopharyngeal carcinoma patients treated with IMRT between January 2005 and December 2010 in our center was performed. According to the AJCC staging system, all primary lesions were attributed to T1 and T2. The prescription doses were 66 Gy at 30 fractions to gross tumor volume of the nasopharynx and the positive neck nodes, 60 Gy to high-risk clinical target volume and 54 Gy to low-risk clinical target volume. Patients staged III, IV A/B or II (lymph node measured 4 cm or more in diameter) received platinum-based chemotherapy. Results By the end of radiotherapy, 7.2% (10/139), 23.7% (33/139), and 9.4% (13/139) of patients had residual lesions in the nasopharynx, cervical lymph nodes and retropharyngeal lymph nodes, respectively. The majority of patients had complete remission within 6 months of radiotherapy completion. Five months after IMRT, three patients with residual tumors in the cervical lymph nodes underwent surgery. Among these patients, two patients had positive pathological findings, and one patient had negative findings. With a median follow-up of 59 months, the 5-year overall survival, local control, regional control and distant metastasis-free rates were 87.8%, 96.7%, 94.9% and 89.1%, respectively. Fifteen patients developed distant metastases, representing the primary failure pattern. Conclusions Most residual lesions that persisted after IMRT vanished completely in six months. Considering the potential damage to normal structures, clinicians should be cautious when considering the use of boost irradiation after radiotherapy. Distant metastasis was the primary cause of treatment failure, which was significantly higher in N2-3 patients than in N0-1. Additional studies to better understand distant metastases are needed.	[Wu, Ming-Yao; He, Xia-Yun; Hu, Chao-Su] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Wu, Ming-Yao; He, Xia-Yun; Hu, Chao-Su] Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China	Fudan University	He, XY (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200433, Peoples R China.; He, XY (corresponding author), Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.	donganlu270hao@gmail.com		Hu, Chaosu/0000-0002-6503-0951	Department of Radiation Oncology at the Fudan University Shanghai Cancer Center; Department of Radiation Oncology	Department of Radiation Oncology at the Fudan University Shanghai Cancer Center; Department of Radiation Oncology	This work was supported by the Department of Radiation Oncology at the Fudan University Shanghai Cancer Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of Department of Radiation Oncology. The views expressed in this publication are those of the authors.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Blanchard P, 2015, LANCET ONCOL, V16, P645, DOI 10.1016/S1470-2045(15)70126-9; Chan ATC, 2012, ANN ONCOL, V23, P83, DOI 10.1093/annonc/mds266; Chen J, 2014, INT J CLIN ONCOL, V19, P998, DOI 10.1007/s10147-013-0650-6; Chen Y, 2013, CANCER-AM CANCER SOC, V119, P2230, DOI 10.1002/cncr.28049; Fang FM, 2008, INT J RADIAT ONCOL, V72, P356, DOI 10.1016/j.ijrobp.2007.12.054; Han Lu, 2010, Chin J Cancer, V29, P145; Ho FCH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-98; Kwong DLW, 1999, CANCER, V85, P1446, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1446::AID-CNCR4>3.0.CO;2-3; Lee AWM, 2014, RADIOTHER ONCOL, V110, P377, DOI 10.1016/j.radonc.2014.02.003; Lee AWM, 2012, RADIOTHER ONCOL, V104, P272, DOI 10.1016/j.radonc.2012.08.001; Lee N, 2009, J CLIN ONCOL, V27, P3684, DOI 10.1200/JCO.2008.19.9109; Li AC, 2015, ONCOTARGET, V6, P24511, DOI 10.18632/oncotarget.4312; Li WF, 2013, INT J RADIAT ONCOL, V86, P249, DOI 10.1016/j.ijrobp.2012.09.003; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Lin SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-39; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Su SF, 2012, INT J RADIAT ONCOL, V82, P327, DOI 10.1016/j.ijrobp.2010.09.011; Sun XM, 2014, RADIOTHER ONCOL, V110, P398, DOI 10.1016/j.radonc.2013.10.020; Teo P, 1996, INT J RADIAT ONCOL, V36, P291, DOI 10.1016/S0360-3016(96)00323-9; Wang XS, 2014, ORAL ONCOL, V50, P1109, DOI 10.1016/j.oraloncology.2014.08.007; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Wong FCS, 2010, INT J RADIAT ONCOL, V76, P138, DOI 10.1016/j.ijrobp.2009.01.084; Xu TT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001457; Yeh SA, 2005, INT J RADIAT ONCOL, V62, P672, DOI 10.1016/j.ijrobp.2004.11.002; Zhang N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-136	27	74	77	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154501	10.1371/journal.pone.0154501	http://dx.doi.org/10.1371/journal.pone.0154501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119991	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200085
J	Singla, S; Harjai, K; Katare, OP; Chhibber, S				Singla, Saloni; Harjai, Kusum; Katare, Om Prakash; Chhibber, Sanjay			Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies	PLOS ONE			English	Article							HUMAN EPITHELIAL-CELLS; KLEBSIELLA-PNEUMONIAE; BACTERIAL BIOFILMS; STAPHYLOCOCCUS-AUREUS; BRUCELLA-ABORTUS; PHAGE THERAPY; CIPROFLOXACIN; STREPTOMYCIN; DELIVERY; PENETRATION	Phage therapy has been a centre of attraction for biomedical scientists to treat infections caused by drug resistant strains. However, ability of phage to act only on extracellular bacteria and probability of interference by anti-phage antibodies in vivo is considered as a important limitation of bacteriophage therapy. To overcome these hurdles, liposome were used as delivery vehicle for phage in this study. Anti-phage antibodies were raised in mice and pooled serum was evaluated for its ability to neutralize free and liposome entrapped phage. Further, ability of phage and liposome-entrapped phage to enter mouse peritoneal macrophages and kill intracellular Klebsiella pneumoniae was compared. Also, an attempt to compare the efficacy of free phage and liposome entrapped phage, alone or in conjunction with amikacin in eradicating mature biofilm was made. The entrapment of phage in liposome provided 100% protection to phage from neutralizing antibody. On the contrary unentrapped phage got neutralized within 3 h of its interaction with antibody. Compared to the inability of free phage to enter macrophages, the liposome were able to deliver entrapped phage inside macrophages and cause 94.6% killing of intracellular K. pneumoniae. Liposome entrapped phage showed synergistic activity along with amikacin to eradicate mature biofilm of K. pneumoniae. Our study reinforces the growing interest in using phage therapy as a means of targeting multidrug resistant bacterial infections as liposome entrapment of phage makes them highly effective in vitro as well as in vivo by overcoming the majority of the hurdles related to clinical use of phage.	[Singla, Saloni; Harjai, Kusum; Chhibber, Sanjay] Panjab Univ, Dept Microbiol, Chandigarh 160014, India; [Katare, Om Prakash] Panjab Univ, Univ Inst Pharmaceut Sci, Chandigarh 160014, India	Panjab University; Panjab University	Chhibber, S (corresponding author), Panjab Univ, Dept Microbiol, Chandigarh 160014, India.	sanjaychhibber8@gmail.com						Adams MH, 1959, LYSOGENY BACTERIOPHA, P365; Ahmed K, 2002, J LIPOSOME RES, V12, P285, DOI 10.1081/LPR-120016195; Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; ASHTEKAR D, 1991, J ANTIMICROB CHEMOTH, V28, P615, DOI 10.1093/jac/28.4.615; Beaulac C, 1998, J ANTIMICROB CHEMOTH, V41, P35, DOI 10.1093/jac/41.1.35; Bedi MS, 2009, WORLD J MICROB BIOT, V25, P1145, DOI 10.1007/s11274-009-9991-8; Bhatia A, 2004, J PHARM PHARM SCI, V7, P252; Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; Cairns BJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000253; Cano V, 2015, CELL MICROBIOL, V17, P1537, DOI 10.1111/cmi.12466; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; DEES C, 1990, VET IMMUNOL IMMUNOP, V24, P135, DOI 10.1016/0165-2427(90)90016-L; Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972; Doolittle MM, 1996, J IND MICROBIOL, V16, P331, DOI 10.1007/BF01570111; Fodah RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107394; FOUNTAIN MW, 1985, J INFECT DIS, V152, P529, DOI 10.1093/infdis/152.3.529; Fumagalli O, 1997, INFECT IMMUN, V65, P4445, DOI 10.1128/IAI.65.11.4445-4451.1997; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; Hughes KA, 1998, J APPL MICROBIOL, V85, P583, DOI 10.1046/j.1365-2672.1998.853541.x; Kaszuba M, 1997, COLLOID SURFACE B, V8, P321, DOI 10.1016/S0927-7765(97)00007-6; Kysela DT, 2007, J THEOR BIOL, V249, P411, DOI 10.1016/j.jtbi.2007.08.007; Lasic DD., 1997, LIPOSOMES GENE DELIV, P259; Lederberg J, 1996, P NATL ACAD SCI USA, V93, P3167, DOI 10.1073/pnas.93.8.3167; MACLEOD DL, 1988, CAN J VET RES, V52, P445; MAJUMDAR S, 1992, ANTIMICROB AGENTS CH, V36, P2808, DOI 10.1128/AAC.36.12.2808; Meers P, 2008, J ANTIMICROB CHEMOTH, V61, P859, DOI 10.1093/jac/dkn059; Oelschlaeger TA, 1997, INFECT IMMUN, V65, P2950, DOI 10.1128/IAI.65.7.2950-2958.1997; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; Sihorkar V, 2001, PHARM RES-DORDR, V18, P1247, DOI 10.1023/A:1013073508318; Singla S, 2015, J INFECT DIS, V212, P325, DOI 10.1093/infdis/jiv029; Stent G., 1963, MOL BIOL BACTERIAL V; STEVENSON M, 1983, ANTIMICROB AGENTS CH, V24, P742, DOI 10.1128/AAC.24.5.742; Tullio V, 2000, J ANTIMICROB CHEMOTH, V46, P241, DOI 10.1093/jac/46.2.241; Verma V, 2010, BIOFOULING, V26, P729, DOI 10.1080/08927014.2010.511196; Verma V, 2009, CURR MICROBIOL, V59, P274, DOI 10.1007/s00284-009-9430-y; Vitas AI, 1996, ANTIMICROB AGENTS CH, V40, P146, DOI 10.1128/AAC.40.1.146	39	61	65	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153777	10.1371/journal.pone.0153777	http://dx.doi.org/10.1371/journal.pone.0153777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115154	gold, Green Published, Green Submitted			2022-12-27	WOS:000374973600030
J	Li, MC; Li, H; Ruan, YJ; Wang, T; Liu, JH				Li, Mingchao; Li, Hao; Ruan, Yajun; Wang, Tao; Liu, Jihong			Stem Cell Therapy for Diabetic Erectile Dysfunction in Rats: A Meta-Analysis	PLOS ONE			English	Article							TRANSPLANTATION; IMPOTENCE	Introduction Stem cell therapy is a novel method for the treatment of diabetic erectile dysfunction (ED). Many relative animal studies have been done to evaluate the efficacy of this therapy in rats. Aims This meta-analysis was performed to compare the efficacy of different stem cell therapies, to evaluate the influential factors and to determine the optimal stem cell therapeutic strategy for diabetic ED. Methods We searched the studies analyzing the efficacy of stem cell therapy for diabetic ED in rats published before September 30, 2015 in PubMed, Web of Science and EBSCO. A random effects meta-analysis was conducted to assess the outcomes of stem cell therapy. Subgroup analysis was also performed by separating these studies based on their different characteristics. Changes in the ratio of intracavernous pressure (ICP) to mean arterial pressure (MAP) and in the structure of the cavernous body were compared. Results 10 studies with 302 rats were enrolled in this meta-analysis. Pooled analysis of these studies showed a beneficial effect of stem cell therapy in improving erectile function of diabetic rats (SMD 4.03, 95% CI = 3.22 to 4.84, P< 0.001). In the stem cell therapy group, both the smooth muscle and endothelium content were much more than those in control group. There was also significant increase in the expression of endothelial nitric oxide synthase (eNOS) and neuronal nitric oxide synthase (nNOS), the ratio of smooth muscle to collagen, as well as the secretion of vascular endothelial growth factor (VEGF). Besides, apoptotic cells were reduced by stem cell treatment. The subgroup analysis indicated that modified stem cells were more effective than those without modification. Conclusions Our results confirmed that stem cell therapy could apparently improve the erectile function of diabetic rats. Some specific modification, especially the gene modification with growth factors, could improve the efficacy of stem cell therapy. Stem cell therapy has potential to be an effective therapeutic strategy for diabetic ED.	[Li, Mingchao; Li, Hao; Ruan, Yajun; Wang, Tao; Liu, Jihong] Huazhong Univ Sci & Technol, Dept Urol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Li, H; Liu, JH (corresponding author), Huazhong Univ Sci & Technol, Dept Urol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	ren321zhe@sina.com; jhliu@tjh.tjmu.edu.cn	Liu, Jihong/Q-1364-2015	Liu, Jihong/0000-0001-8685-3036				Alwaal A, 2015, ADV DRUG DELIVER REV, V82-83, P137, DOI 10.1016/j.addr.2014.11.012; Angulo J, 2010, J SEX MED, V7, P758, DOI 10.1111/j.1743-6109.2009.01587.x; Bahk JY, 2010, EXP CLIN TRANSPLANT, V8, P150; Cameron NE, 2007, CURR DIABETES REV, V3, P149, DOI 10.2174/157339907781368977; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; Garcia MM, 2010, J SEX MED, V7, P89, DOI 10.1111/j.1743-6109.2009.01541.x; He Y, 2014, ANDROLOGIA, V46, P479, DOI 10.1111/and.12104; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Li WJ, 2011, J SEX MED, V8, P1072, DOI 10.1111/j.1743-6109.2010.02176.x; Lin CS, 2013, EXPERT OPIN BIOL TH, V13, P1585, DOI 10.1517/14712598.2013.847085; Liu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072790; Liu T, 2015, GROWTH FACTORS, V33, P282, DOI 10.3109/08977194.2015.1077825; Nishimatsu H, 2012, J SEX MED, V9, P482, DOI 10.1111/j.1743-6109.2011.02469.x; Ouyang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092825; Penson DF, 2003, DIABETES CARE, V26, P1093, DOI 10.2337/diacare.26.4.1093; Qiu XF, 2011, J ANDROL, V33, P37, DOI 10.2164/jandrol.110.012666; Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Shan HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121428; Sun C, 2012, INT J ANDROL, V35, P601, DOI 10.1111/j.1365-2605.2012.01250.x; Thorve VS, 2011, J DIABETES COMPLICAT, V25, P129, DOI 10.1016/j.jdiacomp.2010.03.003; Vickers MA, 2002, INT J IMPOT RES, V14, P466, DOI 10.1038/sj.ijir.3900910; Wang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118951; Wu JH, 2011, CHINESE MED J-PEKING, V124, P3810, DOI 10.3760/cma.j.issn.0366-6999.2011.22.037	26	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154341	10.1371/journal.pone.0154341	http://dx.doi.org/10.1371/journal.pone.0154341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111659	Green Published, Green Submitted, gold			2022-12-27	WOS:000374970600057
J	Bano, S; Atia-tul-Wahab; Yousuf, S; Jabeen, A; Mesaik, MA; Atta-ur-Rahman; Choudhary, MI				Bano, Saira; Atia-tul-Wahab; Yousuf, Sammer; Jabeen, Almas; Mesaik, Mohammad Ahmed; Atta-ur-Rahman; Choudhary, M. Iqbal			New Anti-Inflammatory Metabolites by Microbial Transformation of Medrysone	PLOS ONE			English	Article							FUNGAL TRANSFORMATION; CUNNINGHAMELLA-BLAKESLEEANA; INHIBITORY-ACTIVITY; BIOTRANSFORMATION	Microbial transformation of the anti-inflammatory steroid medrysone (1) was carried out for the first time with the filamentous fungi Cunninghamella blakesleeana (ATCC 8688a), Neurospora crassa (ATCC 18419), and Rhizopus stolonifer (TSY 0471). The objective was to evaluate the anti-inflammatory potential of the substrate (1) and its metabolites. This yielded seven new metabolites, 14 alpha-hydroxy-6 alpha-methylpregn-4-ene-3,11,20-trione (2), 6 beta-hydroxy-6 alpha-methylpregn-4-ene-3,11,20-trione (3), 15 beta-hydroxy-6 alpha-methylpregn-4-ene-3,11,20-trione (4), 6 beta, 17 alpha-dihydroxy-6 alpha-methylpregn-4-ene-3,11,20-trione (5), 6 beta,20S-dihydroxy-6 alpha-methylpregn-4-ene-3,11-dione (6), 11 beta,16 beta-dihydroxy-6 alpha-methylpregn-4-ene-3,11-dione (7), and 15 beta,20R-dihydroxy-6 alpha-methylpregn-4-ene-3,11-dione (8). Single-crystal X-ray diffraction technique unambiguously established the structures of the metabolites 2, 4, 6, and 8. Fungal transformation of 1 yielded oxidation at the C-6 beta, -11 beta, -14 alpha, -15 beta, -16 beta positions. Various cellular anti-inflammatory assays, including inhibition of phagocyte oxidative burst, T-cell proliferation, and cytokine were performed. Among all the tested compounds, metabolite 6 (IC50 = 30.3 mu g/mL) moderately inhibited the reactive oxygen species (ROS) produced from zymosan-induced human whole blood cells. Compounds 1, 4, 5, 7, and 8 strongly inhibited the proliferation of T-cells with IC50 values between <0.2-10.4 mu g/mL. Compound 7 was found to be the most potent inhibitor (IC50 < 0.2 mu g/mL), whereas compounds 2, 3, and 6 showed moderate levels of inhibition (IC50 = 14.6-20.0 mu g/mL). Compounds 1, and 7 also inhibited the production of pro-inflammatory cytokine TNF-alpha. All these compounds were found to be non-toxic to 3T3 cells (mouse fibroblast), and also showed no activity when tested against HeLa (human epithelial carcinoma), or against PC3 (prostate cancer) cancer cell lines.	[Bano, Saira; Yousuf, Sammer; Atta-ur-Rahman; Choudhary, M. Iqbal] Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem & Biol Sci, Karachi 75270, Pakistan; [Atia-tul-Wahab; Jabeen, Almas; Choudhary, M. Iqbal] Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi 75270, Pakistan; [Choudhary, M. Iqbal] King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah 21412, Saudi Arabia; [Mesaik, Mohammad Ahmed] Univ Tabuk, Tabuk Med Coll, Tabuk 71491, Saudi Arabia	University of Karachi; University of Karachi; King Abdulaziz University; University of Tabuk	Choudhary, MI (corresponding author), Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem & Biol Sci, Karachi 75270, Pakistan.; Atia-tul-Wahab; Choudhary, MI (corresponding author), Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi 75270, Pakistan.; Choudhary, MI (corresponding author), King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah 21412, Saudi Arabia.	atiatulwahab@gmail.com; iqbal.choudhary@iccs.edu	Wahab, Atia tul/C-5839-2018; Mesaik, Mohammed Ahmed/GRE-9332-2022; Rahman, Atta-ur/M-3329-2013; Choudhary, M. Iqbal iqbal/C-8633-2012	Wahab, Atia tul/0000-0002-2730-5547; Mesaik, Mohammed Ahmed/0000-0003-2010-2568; Choudhary, M. Iqbal iqbal/0000-0001-5356-3585	Higher Education Commission, Islamabad, Pakistan	Higher Education Commission, Islamabad, Pakistan(Higher Education Commission of Pakistan)	One of the authors, SB, acknowledges the enabling role of the Higher Education Commission, Islamabad, Pakistan, through a financial support under, "Indigenous Ph. D. Fellowship Program (5000 Scholarships)."	Ahmad MS, 2014, STEROIDS, V82, P53, DOI 10.1016/j.steroids.2014.01.001; ALTOMARE A, 1993, J APPL CRYSTALLOGR, V26, P343, DOI 10.1107/S0021889892010331; [Anonymous], 2011, J SCI RES, DOI DOI 10.3329/JSR.V3I2.6221; Azizuddin, 2012, J BIOTECHNOL TECHNOL, V3, P336; Baydoun E, 2014, STEROIDS, V88, P95, DOI 10.1016/j.steroids.2014.06.020; Baydoun E, 2014, STEROIDS, V86, P56, DOI 10.1016/j.steroids.2014.04.012; BETTS RE, 1974, J MED CHEM, V17, P599, DOI 10.1021/jm00252a006; Bhatti HN, 2012, STEROIDS, V77, P1267, DOI 10.1016/j.steroids.2012.07.018; Choudhary MI, 2008, CHEM BIODIVERS, V5, P324, DOI 10.1002/cbdv.200890030; Choudhary MI, 2011, STEROIDS, V76, P1288, DOI 10.1016/j.steroids.2011.06.007; Choudhary MI, 2005, NAT PROD RES, V19, P311, DOI 10.1080/14786410410001729168; Choudhary MI, 2005, CHEM BIODIVERS, V2, P392, DOI 10.1002/cbdv.200590019; Choudhary MI, 2004, NAT PROD RES, V18, P529, DOI 10.1080/14786410310001620628; Choudhary MI, 2002, NAT PROD LETT, V16, P101, DOI 10.1080/10575630290019994; Choudhary MI, 2007, Z NATURFORSCH B, V62, P593; Choudhary MI, 2006, CHEM PHARM BULL, V54, P927, DOI 10.1248/cpb.54.927; Dimas K, 1998, PLANTA MED, V64, P208, DOI 10.1055/s-2006-957410; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Gao JM, 2011, STEROIDS, V76, P43, DOI 10.1016/j.steroids.2010.08.006; Habibi Z, 2012, STEROIDS, V77, P1446, DOI 10.1016/j.steroids.2012.08.010; HELFAND SL, 1982, J EXP MED, V156, P492, DOI 10.1084/jem.156.2.492; Johnson C.K, 1976, ORNL5138 ORTEP; Khan NT, 2014, STEROIDS, V85, P65, DOI 10.1016/j.steroids.2014.04.004; Khan NT, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-153; Krieger NR, 1996, J EXP MED, V184, P2013, DOI 10.1084/jem.184.5.2013; Mesaik MA, 2012, CHEM BIOL DRUG DES, V79, P290, DOI 10.1111/j.1747-0285.2011.01310.x; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Nielsen MB, 1998, EXP CLIN IMMUNOGENET, V15, P61, DOI 10.1159/000019055; PETERSON DH, 1952, J AM CHEM SOC, V74, P5933, DOI 10.1021/ja01143a033; Sheldrick G. M., 1997, SHELXTL PC VERSION 5; Siemens A, 1996, SMART SAINT; Smith C, 2015, STEROIDS, V102, P39, DOI 10.1016/j.steroids.2015.06.008; Spooner R, 2011, INT J MOL SCI, V12, P334, DOI 10.3390/ijms12010334; Swizdor A, 2014, STEROIDS, V82, P44, DOI 10.1016/j.steroids.2014.01.006; Yang CR, 2013, CHINESE J CHEM, V31, P127, DOI 10.1002/cjoc.201201080; Zafar S, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-164; Zafar S, 2013, STEROIDS, V78, P418, DOI 10.1016/j.steroids.2013.01.002; Zafar S, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-109	38	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153951	10.1371/journal.pone.0153951	http://dx.doi.org/10.1371/journal.pone.0153951			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104348	gold, Green Published, Green Submitted			2022-12-27	WOS:000374565100029
J	Berlusconi, G; Calderoni, F; Parolini, N; Verani, M; Piccardi, C				Berlusconi, Giulia; Calderoni, Francesco; Parolini, Nicola; Verani, Marco; Piccardi, Carlo			Link Prediction in Criminal Networks: A Tool for Criminal Intelligence Analysis	PLOS ONE			English	Article							LAW-ENFORCEMENT; MISSING LINKS	The problem of link prediction has recently received increasing attention from scholars in network science. In social network analysis, one of its aims is to recover missing links, namely connections among actors which are likely to exist but have not been reported because data are incomplete or subject to various types of uncertainty. In the field of criminal investigations, problems of incomplete information are encountered almost by definition, given the obvious anti-detection strategies set up by criminals and the limited investigative resources. In this paper, we work on a specific dataset obtained from a real investigation, and we propose a strategy to identify missing links in a criminal network on the basis of the topological analysis of the links classified as marginal, i.e. removed during the investigation procedure. The main assumption is that missing links should have opposite features with respect to marginal ones. Measures of node similarity turn out to provide the best characterization in this sense. The inspection of the judicial source documents confirms that the predicted links, in most instances, do relate actors with large likelihood of co-participation in illicit activities.	[Berlusconi, Giulia; Calderoni, Francesco] Univ Cattolica Sacro Cuore, I-20123 Milan, Italy; [Berlusconi, Giulia; Calderoni, Francesco] Transcrime, Milan, Italy; [Parolini, Nicola; Verani, Marco] Politecn Milan, Dept Math, MOX, I-20133 Milan, Italy; [Piccardi, Carlo] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy	Catholic University of the Sacred Heart; Polytechnic University of Milan; Polytechnic University of Milan	Calderoni, F (corresponding author), Univ Cattolica Sacro Cuore, I-20123 Milan, Italy.; Calderoni, F (corresponding author), Transcrime, Milan, Italy.; Piccardi, C (corresponding author), Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy.	francesco.calderoni@unicatt.it; carlo.piccardi@polimi.it	CALDERONI, FRANCESCO/AAF-4440-2020; Verani, Marco/B-7854-2010	CALDERONI, FRANCESCO/0000-0003-2979-4599; VERANI, MARCO/0000-0001-8015-4947; Berlusconi, Giulia/0000-0003-4654-1059; Parolini, Nicola/0000-0002-2497-7276; Piccardi, Carlo/0000-0002-8373-539X	Polisocial Award	Polisocial Award	The Polisocial Award program is the only funding source and it supports the authors NP and MV. No other fund was available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2008, P NATL ACAD SCI USA, V105, P6795, DOI 10.1073/pnas.0802459105; [Anonymous], 2014, CRIME NETWORKS; [Anonymous], [No title captured]; [Anonymous], 1989, METHODS CRIMINOLOGIC; [Anonymous], [No title captured]; Berlusconi G, 2013, GLOB CRIME, V14, P61, DOI 10.1080/17440572.2012.746940; Burt R. S, 1992, STRUCTURAL HOLES; Calderoni F., 2014, CRIME AND NETWORKS, P163; Calderoni F, 2012, CRIME LAW SOCIAL CH, V58, P321, DOI 10.1007/s10611-012-9387-9; Campana P, 2012, TRENDS ORGAN CRIME, V15, P13, DOI 10.1007/s12117-011-9131-3; Chen A, 2011, LECT NOTES SOC NETW, P143, DOI 10.1007/978-3-7091-0388-3_8; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Dorogovtsev SN, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.040601; Duijn PAC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04238; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Gutfraind A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013448; Keegan B., 2010, Proceedings of the 2010 IEEE Second International Conference on Social Computing (SocialCom 2010). the Second IEEE International Conference on Privacy, Security, Risk and Trust (PASSAT 2010), P201, DOI 10.1109/SocialCom.2010.36; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Kossinets G, 2006, SOC NETWORKS, V28, P247, DOI 10.1016/j.socnet.2005.07.002; Laumann E.O., 1992, RES METHODS SOCIAL N, V1st, P61; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Liu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072908; Lu LY, 2015, P NATL ACAD SCI USA, V112, P2325, DOI 10.1073/pnas.1424644112; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Lu LY, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/18001; Malm A, 2011, J RES CRIME DELINQ, V48, P271, DOI 10.1177/0022427810391535; Malm A, 2010, SECUR J, V23, P52, DOI 10.1057/sj.2009.18; MARSDEN PV, 1990, ANNU REV SOCIOL, V16, P435, DOI 10.1146/annurev.so.16.080190.002251; McIllwain JS, 1999, CRIME LAW SOCIAL CH, V32, P301, DOI 10.1023/A:1008354713842; Morselli C, 2009, STUD ORGANIZE CRIME, V8, P1, DOI 10.1007/978-0-387-09526-4; Morselli C., 2010, J CONTEMP CRIM JUST, V26, P382, DOI [10.1177/1043986210377105, DOI 10.1177/1043986210377105]; Morselli C, 2007, SOC NETWORKS, V29, P143, DOI 10.1016/j.socnet.2006.05.001; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Paoli L., 2003, MAFIA BROTHERHOODS O; Rhodes CJ, 2009, J OPER RES SOC, V60, P1373, DOI 10.1057/jors.2008.110; Spapens T, 2011, GLOB CRIME, V12, P19, DOI 10.1080/17440572.2011.548955; SPARROW MK, 1991, SOC NETWORKS, V13, P251, DOI 10.1016/0378-8733(91)90008-H; Strang S.J., 2014, NETWORK ANAL CRIMINA, P1, DOI [10.1007/978-3-319-04147-6_1, DOI 10.1007/978-3-319-04147-6_1]; van der Hulst RC, 2009, TRENDS ORGAN CRIME, V12, P101, DOI 10.1007/s12117-008-9057-6; von Lampe K, 2009, TRENDS ORGAN CRIME, V12, P93, DOI 10.1007/s12117-009-9067-z; Xu J, 2008, COMMUN ACM, V51, P58, DOI 10.1145/1400181.1400198; Zhao J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12261	44	59	61	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154244	10.1371/journal.pone.0154244	http://dx.doi.org/10.1371/journal.pone.0154244			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27104948	Green Published, gold			2022-12-27	WOS:000374565100060
J	Goodwin, L; Ostuzzi, G; Khan, N; Hotopf, MH; Moss-Morris, R				Goodwin, Laura; Ostuzzi, Giovanni; Khan, Nadia; Hotopf, Matthew H.; Moss-Morris, Rona			Can We Identify the Active Ingredients of Behaviour Change Interventions for Coronary Heart Disease Patients? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; CARDIAC REHABILITATION; SECONDARY PREVENTION; MYOCARDIAL-INFARCTION; LIFE-STYLE; FOLLOW-UP; PHYSICAL-ACTIVITY; PRIMARY-CARE; PROGRAM; RISK	Background The main behaviour change intervention available for coronary heart disease (CHD) patients is cardiac rehabilitation. There is little recognition of what the active ingredients of behavioural interventions for CHD might be. Using a behaviour change technique (BCT) framework to code existing interventions may help to identify this. The objectives of this systematic review are to determine the effectiveness of CHD behaviour change interventions and how this may be explained by BCT content and structure. Methods and Findings A systematic search of Medline, EMBASE and PsycInfo electronic databases was conducted over a twelve year period (2003-2015) to identify studies which reported on behaviour change interventions for CHD patients. The content of the behaviour change interventions was coded using the Coventry Aberdeen and London-Refined (CALO-RE) taxonomy. Meta-regression analyses examined the BCT content as a predictor of mortality. Twenty two papers met the criteria for this review, reporting data on 16,766 participants. The most commonly included BCTs were providing information, and goal setting. There was a small but significant effect of the interventions on smoking (risk ratio (RR) = 0.89, 95% CI 0.81-0.97). The interventions did not reduce the risk of CHD events (RR = 0.86, 95% CI 0.68, 1.09), but significantly reduced the risk of mortality (RR = 0.82, 95% CI 0.69, 0.97). Sensitivity analyses did not find that any of the BCT variables predicted mortality and the number of BCTs included in an intervention was not associated with mortality (beta = -0.02, 95% CI -0.06-0.03). Conclusions Behaviour change interventions for CHD patients appear to have a positive impact on a number of outcomes. Using an existing BCT taxonomy to code the interventions helped us to understand which were the most commonly used techniques, providing information and goal setting, but not the active components of these complex interventions.	[Goodwin, Laura; Hotopf, Matthew H.] Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, London, England; [Ostuzzi, Giovanni] Univ Verona, Dept Publ Hlth & Community Med, Sect Psychiat, I-37100 Verona, Italy; [Khan, Nadia] South London & Maudsley NHS Fdn Trust, London, England; [Moss-Morris, Rona] Kings Coll London, Hlth Psychol Sect, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England	University of London; King's College London; University of Verona; South London & Maudsley NHS Trust; University of London; King's College London	Goodwin, L (corresponding author), Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, London, England.	laura.goodwin@kcl.ac.uk	Hotopf, Matthew/E-4971-2010; Ostuzzi, Giovanni/O-3824-2017	Ostuzzi, Giovanni/0000-0003-2248-9524; Hotopf, Matthew/0000-0002-3980-4466; Moss-Morris, Rona/0000-0002-2927-3446; Goodwin, Laura/0000-0002-0354-7787	National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; National Institute for Health Research [NF-SI-0515-10102] Funding Source: researchfish	National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	The author(s) received no specific funding for this work. LG and MHH are part funded by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London.	Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Barth J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006886.pub2; Berndt N, 2014, J BEHAV MED, V37, P709, DOI 10.1007/s10865-013-9522-9; Blasco A, 2012, J CARDIOPULM REHABIL, V32, P25, DOI 10.1097/HCR.0b013e3182343aa7; Chow CK, 2015, JAMA-J AM MED ASSOC, V314, P1255, DOI 10.1001/jama.2015.10945; Dale LP, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4944; de Waure C, 2013, AM J PREV MED, V45, P207, DOI 10.1016/j.amepre.2013.03.020; Doherty P, 2012, HEART, V98, P605, DOI 10.1136/heartjnl-2012-301728; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Giannuzzi P, 2008, ARCH INTERN MED, V168, P2194, DOI 10.1001/archinte.168.20.2194; Hanssen TA, 2007, EUR J CARDIOV PREV R, V14, P429, DOI 10.1097/HJR.0b013e32801da123; Hawkes AL, 2013, INT J BEHAV MED, V20, P413, DOI 10.1007/s12529-012-9250-5; Health & Social Care Information Centre, 2014, QUAL OUTC FRAM PREV; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Jaffray M, 2007, FAM PRACT, V24, P189, DOI 10.1093/fampra/cml075; Jolly K, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11350; Jorstad HT, 2013, HEART, V99, P1421, DOI 10.1136/heartjnl-2013-303989; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Lane D, 2001, J PSYCHOSOM RES, V51, P497, DOI 10.1016/S0022-3999(01)00225-2; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Loucks EB, 2009, AM J EPIDEMIOL, V169, P829, DOI 10.1093/aje/kwn403; MacGregor K, 2006, J AM BOARD FAM MED, V19, P215, DOI 10.3122/jabfm.19.3.215; Melamed RJ, 2014, DTSCH ARZTEBL INT, V111, DOI 10.3238/arztebl.2014.0802; Michie S, 2009, J EPIDEMIOL COMMUN H, V63, P610, DOI 10.1136/jech.2008.078725; Michie S, 2011, PSYCHOL HEALTH, V26, P1479, DOI 10.1080/08870446.2010.540664; Michie S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-40; Moher D., 2010, CONSORT 2010 EXPLANA; Muniz J, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-137; Munoz MA, 2007, INT J CARDIOL, V118, P312, DOI 10.1016/j.ijcard.2006.07.015; Murchie P, 2003, BRIT MED J, V326, P84, DOI 10.1136/bmj.326.7380.84; Murphy AW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4220; Murphy BM, 2013, J CARDIOPULM REHABIL, V33, P220, DOI 10.1097/HCR.0b013e31828c7812; Organization WH, 2016, GLOBAL STATUS REPORT; Roth A, COMPETENCE FRAMEWORK; Schwingshackl L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004487; StataCorp, 2009, STATA STATISTICAL SO; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Townsend N, 2012, CORONARY HEART DIS S; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; Varnfield M, 2014, HEART, V100, P1770, DOI 10.1136/heartjnl-2014-305783; Vestfold Heartcare Study Group, 2003, Eur J Cardiovasc Prev Rehabil, V10, P429; West RR, 2012, HEART, V98, P637, DOI 10.1136/heartjnl-2011-300302; Wister A, 2007, CAN MED ASSOC J, V177, P859, DOI 10.1503/cmaj.061059; Yan J, 2014, INT J NURS STUD, V51, P844, DOI 10.1016/j.ijnurstu.2013.10.011; Zhao Y, 2009, J CLIN NURS, V18, P2444, DOI 10.1111/j.1365-2702.2009.02835.x	48	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153271	10.1371/journal.pone.0153271	http://dx.doi.org/10.1371/journal.pone.0153271			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27105435	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100010
J	Jacoby, J; Galak, J				Jacoby, Jacob; Galak, Jeff			The Influence of Contextual Cues in Judgment Formation: An Ecologically Valid Test	PLOS ONE			English	Article							AWARENESS; BEHAVIOR; EXPOSURE	An ecologically valid experiment investigated the propositions that (a) people's judgments are influenced by contextual cues, (b) that they are often unaware that those cues influenced them, and (c) that even when they know the cues should influence them, they do not readily incorporate those cues into their judgment formation. After participating in a realistic simulation of a shopping experience, 405 consumers made judgments about whether the product they examined contained fresh or preserved grapefruit sections. Our findings show that despite being aware that contextual cues (such as the location within a store where the product is sold, the type of container it is sold in, and whether the container is chilled or not) generally influence the judgment at hand, people generally fail to realize that their specific judgments were influenced at all. These findings replicate prior studies, thereby extending the generalizability and robustness of prior research.	[Jacoby, Jacob] NYU, Stern Sch Business, New York, NY USA; [Galak, Jeff] Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA	New York University; Carnegie Mellon University	Galak, J (corresponding author), Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA.	jgalak@cmu.edu		Galak, Jeff/0000-0003-1166-8842				Berger J, 2008, P NATL ACAD SCI USA, V105, P8846, DOI 10.1073/pnas.0711988105; Berger J, 2008, J MARKETING RES, V45, P1, DOI 10.1509/jmkr.45.1.1; BORNSTEIN RF, 1987, J PERS SOC PSYCHOL, V53, P1070, DOI 10.1037/0022-3514.53.6.1070; CIALDINI RB, 1978, J PERS SOC PSYCHOL, V36, P463, DOI 10.1037/0022-3514.36.5.463; Cialdini RB, 2009, PERSPECT PSYCHOL SCI, V4, P5, DOI 10.1111/j.1745-6924.2009.01091.x; FAZIO RH, 1990, ADV EXP SOC PSYCHOL, V23, P75, DOI 10.1016/S0065-2601(08)60318-4; Hsee CK, 1999, PSYCHOL BULL, V125, P576, DOI 10.1037/0033-2909.125.5.576; JACOBY J, 1975, AM PSYCHOL, V30, P977; JANISZEWSKI C, 1988, J CONSUM RES, V15, P199, DOI 10.1086/209157; KRAUT RE, 1982, J PERS SOC PSYCHOL, V42, P448, DOI 10.1037/0022-3514.42.3.448; MCGUIRE WJ, 1976, J CONSUM RES, V2, P302, DOI 10.1086/208643; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; NISBETT RE, 1977, J PERS SOC PSYCHOL, V35, P250, DOI 10.1037//0022-3514.35.4.250; North A, 1997, NATURE; Shapiro S, 1999, J CONSUM RES, V26, P16, DOI 10.1086/209548; Shapiro S, 1997, J CONSUM RES, V24, P94, DOI 10.1086/209496; SMITH RE, 1983, J MARKETING RES, V20, P257, DOI 10.2307/3151829; WILSON TDC, 1978, US SOC PSYCHOL, V41, P118	18	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154383	10.1371/journal.pone.0154383	http://dx.doi.org/10.1371/journal.pone.0154383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27105148	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100071
J	Moro, A				Moro, Alessandro			Understanding the Dynamics of Violent Political Revolutions in an Agent-Based Framework	PLOS ONE			English	Article								This paper develops an agent-based computational model of violent political revolutions in which a subjugated population of citizens and an armed revolutionary organisation attempt to overthrow a central authority and its loyal forces. The model replicates several patterns of rebellion consistent with major historical revolutions, and provides an explanation for the multiplicity of outcomes that can arise from an uprising. The relevance of the heterogeneity of scenarios predicted by the model can be understood by considering the recent experience of the Arab Spring involving several rebellions that arose in an apparently similar way, but resulted in completely different political outcomes: the successful revolution in Tunisia, the failed protests in Saudi Arabia and Bahrain, and civil war in Syria and Libya.	[Moro, Alessandro] Ca Foscari Univ, Dept Econ, Venice, Italy	Universita Ca Foscari Venezia	Moro, A (corresponding author), Ca Foscari Univ, Dept Econ, Venice, Italy.	alessandro.moro@unive.it		Moro, Alessandro/0000-0002-3610-4691				Acemoglu D, 2001, AM ECON REV, V91, P938, DOI 10.1257/aer.91.4.938; [Anonymous], 1974, PUBLIC CHOICE, DOI [10.1007/BF01718997, DOI 10.1007/BF01718997]; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], PUBLIC CHOICE, V11, P89, DOI 10.1007/BF01726214; Braha D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048596; Collier P, 1998, OXFORD ECON PAP, V50, P563, DOI 10.1093/oep/50.4.563; Collier P, 2004, OXFORD ECON PAP, V56, P563, DOI 10.1093/oep/gpf064; DAVIES JC, 1962, AM SOCIOL REV, V27, P5, DOI 10.2307/2089714; Ellis CJ, 2011, ECON J, V121, P763, DOI 10.1111/j.1468-0297.2010.02401.x; Epstein JM, 2002, P NATL ACAD SCI USA, V99, P7243, DOI 10.1073/pnas.092080199; Fearon JD, 2003, AM POLIT SCI REV, V97, P75, DOI 10.1017/S0003055403000534; Gard-Murray AS, 2015, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-1-4939-1705-1_16; Goldstone JA, 2001, ANNU REV POLIT SCI, V4, P139, DOI 10.1146/annurev.polisci.4.1.139; Goldstone JA, 2011, FOREIGN AFF, V90, P8; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; KIM JW, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI DOI 10.18564/JASSS.1770; KURAN T, 1995, AM J SOCIOL, V100, P1528, DOI 10.1086/230671; KURAN T, 1991, AM ECON REV, V81, P121; KURAN T, 1989, PUBLIC CHOICE, V61, P41, DOI 10.1007/BF00116762; Lagi M., 2011, ARXIV11082455; Leeson PT, 2010, J ECON BEHAV ORGAN, V73, P297, DOI 10.1016/j.jebo.2009.12.003; Lichbach M.I., 1996, COOPERATORS DILEMMA; LICHBACH MI, 1994, RATION SOC, V6, P8, DOI 10.1177/1043463194006001003; Lichbach MI, 1995, REBELS DILEMMA COLLE; Makowsky MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080380; Miguel E, 2004, J POLIT ECON, V112, P725, DOI 10.1086/421174; Rubin J, 2014, J COMP ECON, V42, P340, DOI 10.1016/j.jce.2013.11.002; Skocpol Theda., 1979, STATES SOCIAL REVOLU; Taleb NN, 2015, FOREIGN AFF, V94, P86; WILENSKY U., 2004, NETLOGO REBELLION MO; Wilensky U., 1999, NETLOGO	31	7	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154175	10.1371/journal.pone.0154175	http://dx.doi.org/10.1371/journal.pone.0154175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27104855	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100050
J	Aketi, L; Kashongwe, Z; Kinsiona, C; Fueza, SB; Kokolomami, J; Bolie, G; Lumbala, P; Diayisu, JS				Aketi, Loukia; Kashongwe, Zacharie; Kinsiona, Christian; Fueza, Serge Bisuta; Kokolomami, Jack; Bolie, Grace; Lumbala, Paul; Diayisu, Joseph Shiku			Childhood Tuberculosis in a Sub-Saharan Tertiary Facility: Epidemiology and Factors Associated with Treatment Outcome	PLOS ONE			English	Article							PEDIATRIC TUBERCULOSIS; PULMONARY TUBERCULOSIS; INFECTIOUS-DISEASES; CHILDREN; HIV; DIAGNOSIS; BURDEN; SUSCEPTIBILITY; INTERVENTIONS; CHALLENGES	Childhood tuberculosis (TB) is a diagnostic challenge in developing countries, and patient outcome can be influenced by certain factors. We report the disease course, clinical profile and factors associated with treatment outcome in a tertiary facility of Kinshasa. Documentary and analytical studies were conducted using clinical and exploratory data for children aged up to 15 years who were admitted to the University Clinics of Kinshasa for TB. Data are presented as frequencies and averages, and binary and logistic regression analyses were performed. Of 283 children with TB, 82 (29.0%) had smear-negative TB, 40 (14.1%) had smear-positive TB, 159 (56.1%) had extra-pulmonary TB (EPTB), 2 (0.7%) had multi-drug-resistant TB (MDR-TB), 167 (59.0%) completed treatment, 30 (10.6%) were cured, 7 (2.5%) failed treatment, 4 (1.4%) died, 55 (19.4%) were transferred to health centers nearest their home, and 20 (7.0%) were defaulters. In the binary analysis, reported TB contacts (p = 0.048), type of TB (p = 0.000), HIV status (p = 0.050), Ziehl-Nielsen test result (p = 0.000), Lowenstein culture (p = 0.004) and chest X-ray (p = 0.057) were associated with outcome. In the logistic regression, none of these factors was a significant predictor of outcome. Tertiary level care facilities must improve the diagnosis and care of patients with childhood TB, which justifies the development of alternative diagnostic techniques and the assessment of other factors that potentially affect outcome.	[Aketi, Loukia; Kinsiona, Christian; Bolie, Grace; Lumbala, Paul; Diayisu, Joseph Shiku] Univ Hosp Kinshasa, Dept Pediat, Kinshasa, DEM REP CONGO; [Kashongwe, Zacharie; Fueza, Serge Bisuta] Univ Hosp Kinshasa, Dept Internal Med, Kinshasa, DEM REP CONGO; [Fueza, Serge Bisuta] Natl TB Program, Kinshasa, DEM REP CONGO; [Kokolomami, Jack] Univ Kinshasa, Sch Publ Hlth, Epidemiol & Biostat Dept, Kinshasa, DEM REP CONGO	Universite de Kinshasa	Aketi, L (corresponding author), Univ Hosp Kinshasa, Dept Pediat, Kinshasa, DEM REP CONGO.	akelou@yahoo.fr	Paizanos, Loukia Aketi/AAP-9860-2020					Aagaard C, 2010, NATURE MED, V2285; Adejumo OA, 2015, J TROP PEDIAT; Aketi L, 2008, ARCH PEDIATRIE, V15, P1611, DOI 10.1016/j.arcped.2008.06.020; Alavi SM, 2015, CASP J INTERN MED, V6, P213; Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; [Anonymous], 2008, PROGR NAT LUTT TUB G; Bhutta ZA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-21; Bhutta ZA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-28; Blount RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097267; Brent AJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/865436; Britton Philip, 2013, N S W Public Health Bull, V24, P15, DOI 10.1071/NB12100; Chan PC, 2014, AM J RESP CRIT CARE, V189, P203, DOI 10.1164/rccm.201305-0863OC; Cruz AT, 2013, PEDIATR INFECT DIS J, V32, P937, DOI 10.1097/INF.0b013e3182933214; Dangisso MH, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0461-1; De Onis M, FOOD NUTR B, V25, pS15; Edmonds A, 2009, INT J EPIDEMIOL, P1; Edwards DJ, 2007, INT J TUBERC LUNG D, V11, P263; El Sahly HM, 2004, SCAND J INFECT DIS, V36, P106, DOI 10.1080/00365540310018860; Elhassan MM, 2015, INT J INFECT DIS; Fiebig L, 2014, INT J TUBERC LUNG D, V18, P925, DOI 10.5588/ijtld.13.0578; Hailu D, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-61; Hansen C, 2016, PEDIATR CLIN N AM, V63, P37, DOI 10.1016/j.pcl.2015.08.002; Harries AD, 2002, INT J TUBERC LUNG D, V6, P424; Hatleberg CI, 2014, EUR RESPIR J, V43, P863, DOI 10.1183/09031936.00059913; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Hicks RM, 2014, INT J TUBERC LUNG D, V18, P1074, DOI 10.5588/ijtld.14.0231; Loeffler Ann M, 2003, Semin Respir Infect, V18, P272; Maher D, 2006, INT J TUBERC LUNG D, V10, P1331; Mandalakas AM, 2015, AM J RESP CRIT CARE, V191, P820, DOI 10.1164/rccm.201406-1165OC; Marais BJ, 2006, PEDIATRICS, V118, pE1350, DOI 10.1542/peds.2006-0519; Marais BJ, 2006, CLIN INFECT DIS, V42, pE69, DOI 10.1086/502652; Mbala L, 2013, ARCH PEDIATR, V21, P13; Mombo LE, 2003, GENES IMMUN, V4, P362, DOI 10.1038/sj.gene.6363979; Mtabho CM, 2010, TROP MED INT HEALTH, V15, P496, DOI 10.1111/j.1365-3156.2010.02481.x; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Oeltmann JE, 2008, INT J TUBERC LUNG D, V12, P186; Osman T, 2014, E MEDITERR HEALTH J, V20, P442, DOI 10.26719/2014.20.7.442; Patel MR, 2013, INT J TUBERC LUNG D, V17, P1206, DOI 10.5588/ijtld.12.0833; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Planting NS, 2014, INT J TUBERC LUNG D, V18, P8, DOI 10.5588/ijtld.13.0132; Rabie H, 2015, J INT AIDS SOC, V18, P35, DOI 10.7448/IAS.18.7.20236; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Ritz N, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14000; Seddon JA, 2014, INFECT DRUG RESIST, V7, P153, DOI 10.2147/IDR.S45090; Stop TB, 2006, INT J TUBERC LUNG D, V10, P1091; Swaminathan S, 2015, CLIN PHARMACOL THER, V98, P240, DOI 10.1002/cpt.175; Tiwari S, 2015, INT J MYCOBACT, V4, P48, DOI 10.1016/j.ijmyco.2014.11.063; Weaver MS, 2015, B WORLD HEALTH ORGAN, V93, P700, DOI 10.2471/BLT.14.147231; *WHO, 2011, GLOB PLAN STOP TB 20; Winston CA, 2012, PEDIATRICS, V130, pE1425, DOI 10.1542/peds.2012-1057; World Health Organisation, 2006, GUID NAT TUB PROGR M; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2012, GLOB REP RES INF DIS; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd	54	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153914	10.1371/journal.pone.0153914	http://dx.doi.org/10.1371/journal.pone.0153914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101146	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500094
J	de-Torres, JP; Marin, JM; Pinto-Plata, V; Divo, M; Sanchez-Salcedo, P; Zagaceta, J; Zulueta, JJ; Berto, J; Cabrera, C; Celli, BR; Casanova, C				de-Torres, Juan P.; Marin, Jose M.; Pinto-Plata, Victor; Divo, Miguel; Sanchez-Salcedo, Pablo; Zagaceta, Jorge; Zulueta, Javier J.; Berto, Juan; Cabrera, Carlos; Celli, Bartolome R.; Casanova, Ciro			Is COPD a Progressive Disease? A Long Term Bode Cohort Observation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; LIMITATION	Background The Global Initiative for Obstructive Lung Diseases (GOLD) defines COPD as a disease that is usually progressive. GOLD also provides a spirometric classification of airflow limitation. However, little is known about the long-term changes of patients in different GOLD grades. Objective Explore the proportion and characteristics of COPD patients that change their spirometric GOLD grade over long-term follow-up. Methods Patients alive for at least 8 years since recruitment and those who died with at least 4 years of repeated spirometric measurements were selected from the BODE cohort database. We purposely included the group of non survivors to avoid a "survival selection" bias. The proportion of patients that had a change (improvement or worsening) in their spirometric GOLD grading was calculated and their characteristics compared with those that remained in the same grade. Results A total of 318 patients were included in the survivor and 217 in the non-survivor groups. Nine percent of survivors and 11% of non survivors had an improvement of at least one GOLD grade. Seventy one percent of survivors and non-survivors remained in the same GOLD grade. Those that improved had a greater degree of airway obstruction at baseline. Conclusions In this selected population of COPD patients, a high proportion of patients remained in the same spirometric GOLD grade or improved in a long-term follow-up. These findings suggest that once diagnosed, COPD is usually a non-progressive disease.	[de-Torres, Juan P.; Sanchez-Salcedo, Pablo; Zagaceta, Jorge; Zulueta, Javier J.; Berto, Juan] Univ Navarra Clin, Dept Pulm, Pamplona, Spain; [Marin, Jose M.] Hosp Univ Miguel Servet, Inst Aragones Ciencias Salud, Dept Pulm, Zaragoza, Spain; [Marin, Jose M.] CIBERES, Zaragoza, Spain; [Pinto-Plata, Victor; Divo, Miguel; Celli, Bartolome R.] Harvard Univ, Brigham & Womens Hosp, Dept Pulm, Sch Med, Boston, MA 02115 USA; [Cabrera, Carlos] Hosp Univ Jose Negrin, Dept Pulm, Las Palmas Gran Canaria, Spain; [Casanova, Ciro] Hosp Ntra Sra Candelaria, Dept Pulm, Tenerife, Spain	University of Navarra; Miguel Servet University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Harvard University; Brigham & Women's Hospital; Harvard Medical School	de-Torres, JP (corresponding author), Univ Navarra Clin, Dept Pulm, Pamplona, Spain.	jupa65@hotmail.com	Zulueta, Javier J/H-5127-2011; Zulueta, Javier J/GXZ-5810-2022	Zulueta, Javier J/0000-0003-3182-3555; Berto, Juan/0000-0001-5673-2954; Marin Trigo, Jose Maria/0000-0001-9096-2294; de Torres, Juan Pablo/0000-0003-1231-4894				Agusti A, 2013, EUR RESPIR J, V42, P636, DOI 10.1183/09031936.00195212; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; BURROWS B, 1989, AM REV RESPIR DIS, V140, pS92, DOI 10.1164/ajrccm/140.3_Pt_2.S92; Casanova C, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-3; Casanova C, 2011, AM J RESP CRIT CARE, V184, P1015, DOI 10.1164/rccm.201105-0831OC; Celli BR, 2015, EUR RESPIR J, V45, P879, DOI 10.1183/09031936.00009015; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Nishimura M, 2012, AM J RESP CRIT CARE, V185, P44, DOI 10.1164/rccm.201106-0992OC; Sanchez-Salcedo P, 2014, EUR RESPIR J, V44, P324, DOI 10.1183/09031936.00208613; Tsutsumi Akiko, 2002, Environ Health Prev Med, V6, P240, DOI 10.1007/BF02897976; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482	15	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0151856	10.1371/journal.pone.0151856	http://dx.doi.org/10.1371/journal.pone.0151856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100872	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500008
J	Kormpakis, I; Linderman, SW; Thomopoulos, S; Gelberman, RH				Kormpakis, Ioannis; Linderman, Stephen W.; Thomopoulos, Stavros; Gelberman, Richard H.			Enhanced Zone II Flexor Tendon Repair through a New Half Hitch Loop Suture Configuration	PLOS ONE			English	Article							KNOT LOCATION; STRENGTH; CORE; MOBILIZATION; EXCURSION; LOCKING; STRANDS; SIZE	This study evaluated the impact of a new half hitch loop suture configuration on flexor tendon repair mechanics. Cadaver canine flexor digitorum profundus tendons were repaired with 4-or 8-strands, 4-0 or 3-0 suture, with and without half hitch loops. An additional group underwent repair with half hitch loops but without the terminal knot. Half hitch loops improved the strength of 8-strand repairs by 21% when 4-0, and 33% when 3-0 suture was used, and caused a shift in failure mode from suture pullout to suture breakage. 8-strand repairs with half hitch loops but without a terminal knot produced equivalent mechanical properties to those without half hitch loops but with a terminal knot. 4-strand repairs were limited by the strength of the suture in all groups and, as a result, the presence of half hitch loops did not alter the mechanical properties. Overall, half hitch loops improved repair mechanics, allowing failure strength to reach the full capability of suture strength. Improving the mechanical properties of flexor tendon repair with half hitch loops has the potential to reduce the postoperative risk of gap formation and catastrophic rupture in the early postoperative period.	[Kormpakis, Ioannis; Linderman, Stephen W.; Gelberman, Richard H.] Washington Univ, Dept Orthopaed Surg, St Louis, MO USA; [Linderman, Stephen W.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Thomopoulos, Stavros] Columbia Univ, Dept Orthoped Surg, New York, NY USA; [Thomopoulos, Stavros] Columbia Univ, Dept Biomed Engn, New York, NY USA	Washington University (WUSTL); Washington University (WUSTL); Columbia University; Columbia University	Gelberman, RH (corresponding author), Washington Univ, Dept Orthopaed Surg, St Louis, MO USA.	gelbermanr@wustl.edu	Linderman, Stephen/GQB-4770-2022	Linderman, Stephen/0000-0002-1797-5870	National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01 AR062947, T32 AR060719, T32 GM007200, P30 AR057235]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F30AR069491, T32AR060719, R01AR062947, P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (NIH), specifically the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, http://niams.nih.gov/): R01 AR062947 (to RHG and ST), T32 AR060719 (to SWL), T32 GM007200 (to Medical Scientist Training Program, Washington University in St. Louis), and P30 AR057235 (to Musculoskeletal Research Center, Washington University in St. Louis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINBRIDGE LC, 1994, J HAND SURG-BRIT EUR, V19B, P517, DOI 10.1016/0266-7681(94)90219-4; Barrie KA, 2000, J HAND SURG-AM, V25A, P714, DOI 10.1053/jhsu.2000.9414; Boyer MI, 2001, J BONE JOINT SURG AM, V83A, P891, DOI 10.2106/00004623-200106000-00011; Dong XK, 2016, J HAND SURG-AM, V41, P40, DOI 10.1016/j.jhsa.2015.10.016; Fufa DT, 2012, J HAND SURG-AM, V37A, P2526, DOI 10.1016/j.jhsa.2012.09.012; Gelberman RH, 1999, J BONE JOINT SURG AM, V81A, P975, DOI 10.2106/00004623-199907000-00010; Gelberman RH, 2007, J HAND SURG-AM, V32A, P373, DOI 10.1016/j.jhsa.2006.12.009; Hatanaka H, 2000, CLIN ORTHOP RELAT R, P267; Kelly JD, 2014, CLIN ORTHOP RELAT R, V472, P1930, DOI 10.1007/s11999-014-3478-0; Kim HM, 2010, J HAND SURG-AM, V35A, P1031, DOI 10.1016/j.jhsa.2009.12.044; Lawrence TA, 2005, J HAND SURG-AM, V30A, P836, DOI 10.1016/j.jhsa.2005.03.011; Linderman SW, 2015, ACTA BIOMATER, V23, P229, DOI 10.1016/j.actbio.2015.05.002; Maddox GE, 2015, J HAND SURG-AM, V40, P963, DOI 10.1016/j.jhsa.2015.01.013; McClellan WT, 2011, PLAST RECONSTR SURG, V128, p322E, DOI 10.1097/PRS.0b013e3182268c1f; Miller Timothy, 2010, Orthopedics, V33, P674, DOI 10.3928/01477447-20100722-08; Momose T, 2000, J BIOMED MATER RES, V53, P806, DOI 10.1002/1097-4636(2000)53:6<806::AID-JBM23>3.0.CO;2-P; Nelson GN, 2012, J ORTHOP RES, V30, P1652, DOI 10.1002/jor.22108; Osei DA, 2014, J HAND SURG-AM, V39, P262, DOI 10.1016/j.jhsa.2013.11.001; PENNINGTON DG, 1979, PLAST RECONSTR SURG, V63, P648, DOI 10.1097/00006534-197905000-00007; POTENZA AD, 1962, MIL MED, V127, P34, DOI 10.1093/milmed/127.1.34; Pruitt DL, 1996, J HAND SURG-AM, V21A, P969, DOI 10.1016/S0363-5023(96)80301-7; Tang JB, 2005, J HAND SURG-AM, V30A, P1262, DOI 10.1016/j.jhsa.2005.05.011; Thomopoulos S, 2009, J ORTHOP RES, V27, P1209, DOI 10.1002/jor.20875; Viinikainen A, 2004, J HAND SURG-BRIT EUR, V29B, P536, DOI 10.1016/j.jhsb.2004.05.007; Vizesi F, 2008, J HAND SURG-AM, V33A, P241, DOI 10.1016/j.jhsa.2007.10.011; Winters SC, 1998, J HAND SURG-AM, V23A, P97, DOI 10.1016/S0363-5023(98)80096-8; Wong YR, 2015, J HAND SURG-AM, V40, P1806, DOI 10.1016/j.jhsa.2015.05.007; WOO SLY, 1981, ACTA ORTHOP SCAND, V52, P615, DOI 10.3109/17453678108992156	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153822	10.1371/journal.pone.0153822	http://dx.doi.org/10.1371/journal.pone.0153822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101409	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500072
J	Le, TT; Skak, K; Schroder, K; Schroder, WA; Boyle, GM; Pierce, CJ; Suhrbier, A				Le, Thuy T.; Skak, Kresten; Schroder, Kate; Schroder, Wayne A.; Boyle, Glen M.; Pierce, Carly J.; Suhrbier, Andreas			IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate	PLOS ONE			English	Article							ACTINIC KERATOSIS; TUMOR-GROWTH; RECEPTOR ANTAGONIST; NLRP3 INFLAMMASOME; DOUBLE-BLIND; CELL-DEATH; NEUTROPHILS; GEL; INTERLEUKIN-1-BETA; IL-1-BETA	Ingenol mebutate is approved for the topical treatment of actinic keratoses and may ultimately also find utility in treating skin cancers. Here we show that relapse rates of subcutaneous B16 melanoma tumours treated topically with ingenol mebutate were not significantly different in C57BL/6 and Rag1(-/-) mice, suggesting B and T cells do not play a major role in the anti-cancer efficacy of ingenol mebutate. Relapse rates were, however, significantly increased in MyD88(-/-) mice and in C57BL/6 mice treated with the anti-IL-1 agent, anakinra. Ingenol mebutate treatment induces a pronounced infiltration of neutrophils, which have been shown to have anti-cancer activity in mice. Herein we provide evidence that IL-1 promotes neutrophil recruitment to the tumour, decreases apoptosis of infiltrating neutrophils and increases neutrophil tumour killing activity. These studies suggest IL-1, via its action on neutrophils, promotes the anti-cancer efficacy of ingenol mebutate, with ingenol mebutate treatment causing both IL-1 beta induction and IL-1 alpha released from keratinocytes.	[Le, Thuy T.; Schroder, Wayne A.; Boyle, Glen M.; Pierce, Carly J.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Inflammat Biol, Brisbane, Qld, Australia; [Le, Thuy T.; Schroder, Wayne A.; Boyle, Glen M.; Pierce, Carly J.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Canc Drug Mech Labs, Brisbane, Qld, Australia; [Skak, Kresten] Leo Pharma, Copenhagen, Denmark; [Schroder, Kate] Univ Queensland, Inst Mol Biosci, Inflammasome Lab, Brisbane, Qld, Australia; [Schroder, Kate] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; LEO Pharma; University of Queensland; University of Queensland	Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Inflammat Biol, Brisbane, Qld, Australia.; Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Canc Drug Mech Labs, Brisbane, Qld, Australia.	Andreas.Suhrbier@qimrberghofer.edu.au	Schroder, Kate/C-6132-2008; Boyle, Glen/G-1347-2013	Schroder, Kate/0000-0001-9261-3805; Boyle, Glen/0000-0002-1385-529X; Suhrbier, Andreas/0000-0001-8986-9025	Leo Pharma; Australian National Health & Medical Research Council [APP1043104]; Leo; Australian Research Council Future Fellowship [FT130100361]; Queensland Smart Futures Fund	Leo Pharma(LEO Pharma); Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leo(LEO Pharma); Australian Research Council Future Fellowship(Australian Research Council); Queensland Smart Futures Fund	The research was primarily conducted at QIMR Berghofer Medical Research Institute and was largely funded by Leo Pharma, and in part by a grant from the Australian National Health & Medical Research Council (APP1043104). Leo provided support in the form of salaries for TTL and consumables, was involved in the initial study design, but was not involved in data collection and analysis. Leo was involved in the decision to publish, but provided minimal input into the writing of the manuscript. K. Schroder is supported by an Australian Research Council Future Fellowship (FT130100361), and the Queensland Smart Futures Fund. AS is a Principal Research Fellow with the National Health & Medical Research Council, Australia (APP1058391).	Ackerman AB, 2006, BRIT J DERMATOL, V155, P9, DOI 10.1111/j.1365-2133.2005.07121.x; Albanesi M, 2013, BLOOD, V122, P3160, DOI 10.1182/blood-2013-04-497446; Alchin DR, 2014, DERMATOLOGY THER, V4, P157, DOI 10.1007/s13555-014-0061-2; Anderson L, 2009, J AM ACAD DERMATOL, V60, P934, DOI 10.1016/j.jaad.2009.01.008; Bakele M, 2014, J BIOL CHEM, V289, P5320, DOI 10.1074/jbc.M113.505636; Bjorkdahl O, 1997, CANCER IMMUNOL IMMUN, V44, P273, DOI 10.1007/s002620050383; Bjorkdahl O, 2000, CANCER GENE THER, V7, P1365, DOI 10.1038/sj.cgt.0242; Cantisani C, 2014, DERMATOL THER, V27, P352, DOI 10.1111/dth.12148; Cavanagh LL, 1996, CANCER RES, V56, P2607; Challacombe JM, 2006, J IMMUNOL, V177, P8123, DOI 10.4049/jimmunol.177.11.8123; Chen LC, 2012, EMBO MOL MED, V4, P1276, DOI 10.1002/emmm.201201569; COLOTTA F, 1992, BLOOD, V80, P2012; Cozzi SJ, 2013, ARCH DERMATOL RES, V305, P79, DOI 10.1007/s00403-012-1270-0; Cozzi SJ, 2012, J INVEST DERMATOL, V132, P1263, DOI 10.1038/jid.2011.418; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Feng Y, 2010, AM J PHYSIOL-CELL PH, V299, pC760, DOI 10.1152/ajpcell.00155.2010; Freiberger SN, 2015, MOL CANCER THER, V14, P2132, DOI 10.1158/1535-7163.MCT-15-0023-T; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Glogau RG, 2000, J AM ACAD DERMATOL, V42, pS23, DOI 10.1067/mjd.2000.103339; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Gross O, 2012, METHODS MOL BIOL, V844, P199, DOI 10.1007/978-1-61779-527-5_15; Hampson P, 2008, CANCER IMMUNOL IMMUN, V57, P1241, DOI 10.1007/s00262-008-0458-9; Hayashi T, 2011, MELANOMA RES, V21, P66, DOI 10.1097/CMR.0b013e328340ce6c; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; LALINN M, 1995, J VIROL METHODS, V52, P51; Le TTT, 2009, VACCINE, V27, P3053, DOI 10.1016/j.vaccine.2009.03.025; Lebwohl M, 2013, JAMA DERMATOL, V149, P666, DOI 10.1001/jamadermatol.2013.2766; Lebwohl M, 2012, NEW ENGL J MED, V366, P1010, DOI 10.1056/NEJMoa1111170; Li LW, 2010, CANCER RES, V70, P4509, DOI 10.1158/0008-5472.CAN-09-4303; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Murphy JE, 2003, J IMMUNOL, V170, P5697, DOI 10.4049/jimmunol.170.11.5697; Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631; NEVILLE M E, 1990, Cytokine, V2, P456, DOI 10.1016/1043-4666(90)90055-X; Ogbourne SM, 2004, CANCER RES, V64, P2833, DOI 10.1158/0008-5472.CAN-03-2837; Ogbourne SM, 2014, FITOTERAPIA, V98, P36, DOI 10.1016/j.fitote.2014.07.002; Otten MA, 2012, EUR J IMMUNOL, V42, P1815, DOI 10.1002/eji.201141982; Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13; Prince LR, 2004, AM J PATHOL, V165, P1819, DOI 10.1016/S0002-9440(10)63437-2; Ramsay JR, 2011, BRIT J DERMATOL, V164, P633, DOI 10.1111/j.1365-2133.2010.10184.x; Rauschmayr T, 1997, P NATL ACAD SCI USA, V94, P5814, DOI 10.1073/pnas.94.11.5814; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Siller G, 2009, AUSTRALAS J DERMATOL, V50, P16, DOI 10.1111/j.1440-0960.2008.00497.x; Siller G, 2010, AUSTRALAS J DERMATOL, V51, P99, DOI 10.1111/j.1440-0960.2010.00626.x; SMITH RJ, 1986, INT J IMMUNOPHARMACO, V8, P33, DOI 10.1016/0192-0561(86)90070-6; Sonego F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103734; Stahlhut M, 2012, J DRUGS DERMATOL, V11, P1181; Toda Y, 2002, J IMMUNOL, V168, P1984, DOI 10.4049/jimmunol.168.4.1984; Triozzi PL, 2010, ANTICANCER RES, V30, P345; Tzogani K, 2014, EUR J DERMATOL, V24, P457, DOI 10.1684/ejd.2014.2368; van Egmond M, 2013, SEMIN CANCER BIOL, V23, P190, DOI 10.1016/j.semcancer.2012.12.002; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; William R, 1998, J IMMUNOL, V161, P957; Winkler S, 2015, SEMIN IMMUNOPATHOL, V37, P419, DOI 10.1007/s00281-015-0494-4; Wu T., 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0072404; YAGISAWA M, 1995, EXP HEMATOL, V23, P603; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zarchi K, 2015, CURR PROBL DERMATOL, V46, P136, DOI 10.1159/000366549; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	62	10	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153975	10.1371/journal.pone.0153975	http://dx.doi.org/10.1371/journal.pone.0153975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100888	Green Published, gold			2022-12-27	WOS:000374898500116
J	Li, JH; Yuan, JM; Miao, ZQ; Song, ZG; Yang, Y; Tian, WX; Guo, YM				Li, Jianhui; Yuan, Jianmin; Miao, Zhiqiang; Song, Zhigang; Yang, Yu; Tian, Wenxia; Guo, Yuming			Effect of Dietary Nutrient Density on Small Intestinal Phosphate Transport and Bone Mineralization of Broilers during the Growing Period	PLOS ONE			English	Article							COTRANSPORTER GENE-EXPRESSION; MITOCHONDRIAL-FUNCTION; GROWTH-PERFORMANCE; FEED-EFFICIENCY; VITAMIN-D; NAPI-IIB; CHICKENS; CALCIUM; PHOSPHORUS; QUALITY	A 2 x 4 factorial experiment was conducted to determine the effects of dietary nutrient density on growth performance, small intestinal epithelial phosphate transporter expression, and bone mineralization of broiler chicks fed with diets with different nutrient densities and nonphytate phosphorus (NPP) levels. The broilers were fed with the same starter diets from 0 to 21 days of age. In the grower phase (day 22 to 42), the broilers were randomly divided into eight groups according to body weight. Relatively high dietary nutrient density (HDND) and low dietary nutrient density (LDND) diets were assigned metabolic energy (ME) values of 3,150 and 2,950 kcal/kg, respectively. Crude protein and essential amino acid levels were maintained in the same proportion as ME to prepare the two diet types. NPP levels were 0.25%, 0.30%, 0.35%, and 0.40% of the diets. Results showed that a HDND diet significantly increased the body weight gain (BWG) of broilers and significantly decreased the feed conversion ratio and NPP consumed per BWG. HDND significantly decreased tibial P content of the broilers. Conversely, mRNA expression of NaPi-IIb and protein expression of calbindin were significantly increased in the intestine of broilers fed a HDND diet. HDND also increased vitamin D receptor (VDR) expression, especially at a relatively low dietary NPP level (0.25%). The mRNA expression of NaPi-IIa in the kidneys was significantly increased at a relatively low dietary NPP level (0.25%) to maintain P balance. Tibial P, calcium, and ash content were significantly decreased, as were calbindin and VDR expression levels in the intestine at a low NPP level. Therefore, HDND improved the growth rate of broilers and increased the expression of phosphate and calcium transporter in the small intestine, but adversely affected bone mineralization.	[Li, Jianhui; Miao, Zhiqiang; Yang, Yu; Tian, Wenxia] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Shanxi, Peoples R China; [Li, Jianhui; Yuan, Jianmin; Guo, Yuming] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Song, Zhigang] Shandong Agr Univ, Dept Anim Sci, Tai An 271018, Shandong, Peoples R China	Shanxi Agricultural University; China Agricultural University; Shandong Agricultural University	Guo, YM (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	guoyum@cau.edu.cn		Song, Zhigang/0000-0003-1525-5797	Ear-marked fund for Modern Agro-Industry Technology Research System [CARS-42]; National Youth Science Fund Project [31301992]; Shandong Modern Agricultural Technology and Industry System [SDAIT-13-011-08]; National Science and Technology Support Plan projects [2012BAD39B0402]	Ear-marked fund for Modern Agro-Industry Technology Research System; National Youth Science Fund Project; Shandong Modern Agricultural Technology and Industry System; National Science and Technology Support Plan projects	This study was financially supported by the Ear-marked fund for Modern Agro-Industry Technology Research System (CARS-42), the National Youth Science Fund Project (31301992), the Shandong Modern Agricultural Technology and Industry System (SDAIT-13-011-08) and the National Science and Technology Support Plan projects (2012BAD39B0402).	Bar A, 2003, BRIT J NUTR, V89, P51, DOI 10.1079/BJN2002757; Barreiro FR, 2009, POULTRY SCI, V88, P2644, DOI 10.3382/ps.2008-00079; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brickett KE, 2007, POULTRY SCI, V86, P2117, DOI 10.1093/ps/86.10.2117; Bruno LDG, 2000, BRIT POULTRY SCI, V41, P389, DOI 10.1080/713654955; Casirola DM, 2006, FASEB J, V20, pA1274; Gaffney-Stomberg E, 2014, BONE, V68, P46, DOI 10.1016/j.bone.2014.08.002; Guo JY, 2009, EUR J PHARMACOL, V612, P54, DOI 10.1016/j.ejphar.2009.03.076; Han JC, 2009, POULTRY SCI, V88, P323, DOI 10.3382/ps.2008-00252; Havenstein GB, 2003, POULTRY SCI, V82, P1500, DOI 10.1093/ps/82.10.1500; HURWITZ S, 1995, J NUTR, V125, P2679; Kirchner S, 2008, AM J CLIN NUTR, V87, P1028, DOI 10.1093/ajcn/87.4.1028; Kirchner S, 2007, FASEB J, V21, pA1327; Leterrier C, 1998, BRIT POULTRY SCI, V39, P24, DOI 10.1080/00071669889349; Li JH, 2011, THESIS CHINA AGR U B, P55; Li JH, 2012, ASIAN AUSTRAL J ANIM, V25, P552, DOI 10.5713/ajas.2011.11266; Li JianHui, 2011, Journal of Animal Science and Biotechnology, V2, P102; Moghadam AN, 2006, INT J POULTRY SCI, V5, P666; Ojano-Dirain CP, 2004, POULTRY SCI, V83, P1394, DOI 10.1093/ps/83.8.1394; Onyango EM, 2003, POULTRY SCI, V82, P1787, DOI 10.1093/ps/82.11.1787; Ozeraitiene Violeta, 2006, Medicina (Kaunas), V42, P836; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Stauber A, 2005, AM J PHYSL GASTR L, V288, P351; Wang Jue, 2010, Sarcoma, V2010, P454792, DOI 10.1155/2010/454792; Wang Y, 2015, LIVEST SCI, V176, P135, DOI 10.1016/j.livsci.2015.03.010; Wu W, 2013, CHIN J CLIN ELECT ED, V7, P9200; Xu H, 2003, AM J PHYSIOL-CELL PH, V284, pC1262, DOI 10.1152/ajpcell.00456.2002	29	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153859	10.1371/journal.pone.0153859	http://dx.doi.org/10.1371/journal.pone.0153859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100791	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500079
J	Momose, F; Seo, N; Akahori, Y; Sawada, S; Harada, N; Ogura, T; Akiyoshi, K; Shiku, H				Momose, Fumiyasu; Seo, Naohiro; Akahori, Yasushi; Sawada, Shin-ichi; Harada, Naozumi; Ogura, Toru; Akiyoshi, Kazunari; Shiku, Hiroshi			Guanine-Rich Sequences Are a Dominant Feature of Exosomal microRNAs across the Mammalian Species and Cell Types	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; GASTRIC-CANCER; RNA; GROWTH; PROLIFERATION; BIOGENESIS; BINDING; MEMORY; MIRNA	Exosome is an extracellular vesicle released from multivesicular endosomes and contains micro (mi) RNAs and functional proteins derived from the donor cells. Exosomal miRNAs act as an effector during communication with appropriate recipient cells, this can aid in the utilization of the exosomes in a drug delivery system for various disorders including malignancies. Differences in the miRNA distribution pattern between exosomes and donor cells indicate the active translocation of miRNAs into the exosome cargos in a miRNA sequence-dependent manner, although the molecular mechanism is little known. In this study, we statistically analyzed the miRNA microarray data and revealed that the guanine (G)-rich sequence is a dominant feature of exosome-dominant miRNAs, across the mammalian species-specificity and the cell types. Our results provide important information regarding the potential use of exosome cargos to develop miRNA-based drugs for the treatment of human diseases.	[Momose, Fumiyasu; Seo, Naohiro; Akahori, Yasushi; Harada, Naozumi; Shiku, Hiroshi] Mie Univ, Dept Immunogene Therapy, Grad Sch Med, Tsu, Mie 5148507, Japan; [Sawada, Shin-ichi; Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Momose, Fumiyasu; Seo, Naohiro; Akahori, Yasushi; Sawada, Shin-ichi; Harada, Naozumi; Akiyoshi, Kazunari; Shiku, Hiroshi] Japan Sci & Technol Agcy JST, ERATO Bionanotransporter Project, Tokyo 1020076, Japan; [Ogura, Toru] Mie Univ Hosp, Clin Res Support Ctr, Tsu, Mie 5148507, Japan	Mie University; Kyoto University; Japan Science & Technology Agency (JST); Mie University	Seo, N (corresponding author), Mie Univ, Dept Immunogene Therapy, Grad Sch Med, Tsu, Mie 5148507, Japan.; Seo, N; Shiku, H (corresponding author), Japan Sci & Technol Agcy JST, ERATO Bionanotransporter Project, Tokyo 1020076, Japan.	seo-naohiro@clin.medic.mie-u.ac.jp; shiku@clin.medic.mie-u.ac.jp	Shiku, Hiroshi/U-7321-2019	Shiku, Hiroshi/0000-0002-0362-755X	Ministry of Education, Culture, Sports, Science and Technology of Japan [24800033]; Exploratory Research for Advanced Technology of Japan Science and Technology Agency (ERATO Akiyoshi Bio-nanotransporter Project, JST)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Exploratory Research for Advanced Technology of Japan Science and Technology Agency (ERATO Akiyoshi Bio-nanotransporter Project, JST)	This work was supported by grants from Ministry of Education, Culture, Sports, Science and Technology of Japan (24800033) and Exploratory Research for Advanced Technology of Japan Science and Technology Agency (ERATO Akiyoshi Bio-nanotransporter Project, JST).	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cui ZH, 2014, WORLD J GASTROENTERO, V20, P5493, DOI 10.3748/wjg.v20.i18.5493; D'Andrade Petula N, 2012, Methods Mol Biol, V822, P85, DOI 10.1007/978-1-61779-427-8_6; Denoyelle C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.389; Filosa G, 2013, NEUROMOL MED, V15, P661, DOI 10.1007/s12017-013-8256-8; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Greening DW, 2015, SEMIN CELL DEV BIOL, V40, P72, DOI 10.1016/j.semcdb.2015.02.009; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; He D, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0342-0; Hibio N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00996; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Kooijmans SAA, 2013, J CONTROL RELEASE, V172, P229, DOI 10.1016/j.jconrel.2013.08.014; Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Lee KH, 2014, BBA-MOL CELL RES, V1843, P2055, DOI 10.1016/j.bbamcr.2014.06.001; Leng RB, 2014, FEBS LETT, V588, P2078, DOI 10.1016/j.febslet.2014.04.040; Leung YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098037; Liu JJ, 2014, CANCER LETT, V347, P98, DOI 10.1016/j.canlet.2014.01.024; Lv LL, 2013, INT J BIOL SCI, V9, P1021, DOI 10.7150/ijbs.6100; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Osborne J.W., 2019, PRACT ASSESS RES EVA, V9, P11, DOI [DOI 10.7275/QF69-7K43, 10.7275/ktzq-jq66]; Qin X, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00357; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Shi Y, 2014, CLIN CANCER RES, V20, P1803, DOI 10.1158/1078-0432.CCR-13-2284; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang XW, 2014, BIOINFORMATICS, V30, P1377, DOI 10.1093/bioinformatics/btu045; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zang WQ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0315-3; Zeng H, 2015, FEBS LETT, V589, P812, DOI 10.1016/j.febslet.2015.02.014; Zhao LY, 2014, DIGEST DIS SCI, V59, P1743, DOI 10.1007/s10620-014-3087-5; Zhao Q, 2015, ONCOL REP, V34, P979, DOI 10.3892/or.2015.4013	41	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154134	10.1371/journal.pone.0154134	http://dx.doi.org/10.1371/journal.pone.0154134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101102	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500154
J	Divashuk, MG; Khuat, TML; Kroupin, PY; Kirov, IV; Romanov, DV; Kiseleva, AV; Khrustaleva, LI; Alexeev, DG; Zelenin, AS; Klimushina, MV; Razumova, OV; Karlov, GI				Divashuk, Mikhail G.; Khuat, Thi Mai L.; Kroupin, Pavel Yu.; Kirov, Ilya V.; Romanov, Dmitry V.; Kiseleva, Anna V.; Khrustaleva, Ludmila I.; Alexeev, Dmitry G.; Zelenin, Alexandr S.; Klimushina, Marina V.; Razumova, Olga V.; Karlov, Gennady I.			Variation in Copy Number of Ty3/Gypsy Centromeric Retrotransposons in the Genomes of Thinopyrum intermedium and Its Diploid Progenitors	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CHROMOSOMAL DISTRIBUTION; EVOLUTIONARY DYNAMICS; TRANSPOSABLE ELEMENTS; SATELLITE REPEAT; DNA-SEQUENCES; WHEAT; AEGILOPS; PATTERNS; REVEALS	Speciation and allopolyploidization in cereals may be accompanied by dramatic changes in abundance of centromeric repeated transposable elements. Here we demonstrate that the reverse transcriptase part of Ty3/gypsy centromeric retrotransposon (RT-CR) is highly conservative in the segmental hexaploid Thinopyrum intermedium (J(r)J(vs)St) and its possible diploid progenitors Th. bessarabicum (J(b)), Pseudoroegneria spicata (St) and Dasypyrum villosum (V) but the abundance of the repeats varied to a large extent. Fluorescence in situ hybridization (FISH) showed hybridization signals in centromeric region of all chromosomes in the studied species, although the intensity of the signals drastically differed. In Th. intermedium, the strongest signal of RT-CR probe was detected on the chromosomes of J(v), intermediate on J(r) and faint on J(s) and St subgenome suggesting different abundance of RT-CR on the individual chromosomes rather than the sequence specificity of RT-CRs of the subgenomes. RT-CR quantification using real-time PCR revealed that its content per genome in Th. bessarabicum is similar to 2 times and P. spicata is similar to 1,5 times higher than in genome of D. villosum. The possible burst of Ty3/gypsy centromeric retrotransposon in Th. intermedium during allopolyploidization and its role in proper mitotic and meiotic chromosome behavior in a nascent allopolyploid is discussed.	[Divashuk, Mikhail G.; Khuat, Thi Mai L.; Kroupin, Pavel Yu.; Kirov, Ilya V.; Romanov, Dmitry V.; Kiseleva, Anna V.; Khrustaleva, Ludmila I.; Klimushina, Marina V.; Razumova, Olga V.; Karlov, Gennady I.] Russian State Agr Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Timiryazevskaya St 49, Moscow 127550, Russia; [Alexeev, Dmitry G.; Zelenin, Alexandr S.] FRCC PCM, Moscow, Russia	Russian State Agrarian University - Moscow Timiryazev Agricultural Academy; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency	Divashuk, MG; Karlov, GI (corresponding author), Russian State Agr Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Timiryazevskaya St 49, Moscow 127550, Russia.	divashuk@gmail.com; karlovg@gmail.com	Alexeev, Dmitry/A-6167-2013; Karlov, Gennady/F-7403-2013; Klimushina, Marina V/L-2139-2016; Kroupin, Pavel Yu./D-8515-2014; Khrustaleva, Ludmila/J-9508-2013; Divashuk, Mikhail/T-7621-2019; Киров, Илья/G-2570-2019; Razumova, Olga/N-1037-2016; Kiseleva, Anna/J-8709-2017; Romanov, Dmitry/M-1459-2014	Alexeev, Dmitry/0000-0003-0783-1176; Karlov, Gennady/0000-0002-9016-103X; Klimushina, Marina V/0000-0002-7876-9325; Kroupin, Pavel Yu./0000-0001-6858-3941; Khrustaleva, Ludmila/0000-0002-0614-4641; Divashuk, Mikhail/0000-0001-6221-3659; Киров, Илья/0000-0003-3885-3837; Kiseleva, Anna/0000-0003-4765-8021; Razumova, Olga/0000-0001-5157-0087; Romanov, Dmitry/0000-0002-7495-7572				Bao YG, 2014, J GENET GENOMICS, V41, P663, DOI 10.1016/j.jgg.2014.11.003; Belyayev A, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-6; BERNATZKY R, 1986, GENETICS, V112, P887; Chang ZJ, 2010, HEREDITAS, V147, P304, DOI 10.1111/j.1601-5223.2010.02156.x; Chen GX, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0198-2; Chen Q, 1998, GENOME, V41, P580, DOI 10.1139/gen-41-4-580; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Danilova TV, 2014, THEOR APPL GENET, V127, P715, DOI 10.1007/s00122-013-2253-z; Dawe RK, 2005, P NATL ACAD SCI USA, V102, P11573, DOI 10.1073/pnas.0505100102; Deng CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072564; Dong FG, 1998, P NATL ACAD SCI USA, V95, P8135, DOI 10.1073/pnas.95.14.8135; Dvorak J, 2004, GENETICS, V168, P1665, DOI 10.1534/genetics.103.024927; Eilam T, 2008, GENOME, V51, P616, DOI 10.1139/G08-043; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; Gorinsek B, 2005, CYTOGENET GENOME RES, V110, P543, DOI 10.1159/000084987; Gorinsek B, 2004, MOL BIOL EVOL, V21, P781, DOI 10.1093/molbev/msh057; Guzman C, 2011, MOL BREEDING, V28, P403, DOI 10.1007/s11032-010-9493-2; Helfgott DM, 2004, SYST BOT, V29, P850, DOI 10.1600/0363644042451017; Hu LJ, 2011, EUPHYTICA, V177, P169, DOI 10.1007/s10681-010-0216-x; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Ito H, 2007, MOL GENET GENOMICS, V277, P23, DOI 10.1007/s00438-006-0172-2; Jiang JM, 1996, P NATL ACAD SCI USA, V93, P14210, DOI 10.1073/pnas.93.24.14210; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Karlov GI, 2003, EUPHYTICA, V132, P185, DOI 10.1023/A:1024646818324; Kishii M., 2005, Czech Journal of Genetics and Plant Breeding, V41, P92; Komuro S, 2013, GENOME, V56, P131, DOI 10.1139/gen-2013-0003; Kordis D, 2005, GENE, V347, P161, DOI 10.1016/j.gene.2004.12.017; Kraitshtein Z, 2010, GENETICS, V186, P801, DOI 10.1534/genetics.110.120790; Kroupin PY, 2011, RUSS J GENET+, V47, P432, DOI 10.1134/S1022795411040077; Lee HR, 2005, P NATL ACAD SCI USA, V102, P11793, DOI 10.1073/pnas.0503863102; Levy AA, 2002, PLANT PHYSIOL, V130, P1587, DOI 10.1104/pp.015727; Li BC, 2013, PLANT J, V73, P952, DOI 10.1111/tpj.12086; Li GR, 2012, J GENET, V91, P343, DOI 10.1007/s12041-012-0181-3; Liu C, 2009, CEREAL RES COMMUN, V37, P363, DOI 10.1556/CRC.37.2009.3.5; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Lu Kun, 2009, Yichuan, V31, P1141, DOI 10.3724/SP.J.1005.2009.01141; Mahelka V, 2013, MOL BIOL EVOL, V30, P2065, DOI 10.1093/molbev/mst106; Mahelka V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-127; Mathews S, 1996, MOL BIOL EVOL, V13, P1141, DOI 10.1093/oxfordjournals.molbev.a025677; Melters DP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r10; Miller JT, 1998, GENETICS, V150, P1615; Mujeeb-Kazi A, 2013, ADV AGRON, V122, P179, DOI 10.1016/B978-0-12-417187-9.00004-8; Nagaki K, 2005, MOL BIOL EVOL, V22, P845, DOI 10.1093/molbev/msi069; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nagaki K, 2003, GENETICS, V163, P1221; Nagaki K, 2003, GENETICS, V163, P759; Neumann P, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-4; Parisod C., 2012, PLANT TRANSPOSABLE E, V24, P147, DOI [DOI 10.1007/978-3-642-31842-9_9, 10.1007/978-1-62703-568-2]; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; Qi LL, 2013, CHROMOSOME RES, V21, P507, DOI 10.1007/s10577-013-9378-4; Salina EA, 2015, EUPHYTICA, V204, P91, DOI 10.1007/s10681-014-1344-5; Salina EA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-99; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang S, 2000, THEOR APPL GENET, V100, P344, DOI 10.1007/s001220050045; Wang RRC, 2015, GENOME, V58, P63, DOI 10.1139/gen-2014-0186; Wang RRC, 2014, J SYST EVOL, V52, P697, DOI 10.1111/jse.12084; Wang RRC, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P77, DOI 10.1007/978-3-642-14228-4_2; Yaakov B, 2013, PLANT CELL REP, V32, P1615, DOI 10.1007/s00299-013-1472-8; Zhang XY, 1996, GENOME, V39, P1062, DOI 10.1139/g96-133; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106	60	8	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154241	10.1371/journal.pone.0154241	http://dx.doi.org/10.1371/journal.pone.0154241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119343	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200051
J	Teeranaipong, P; Sirivichayakul, S; Mekprasan, S; Ohata, PJ; Avihingsanon, A; Ruxrungtham, K; Putcharoen, O				Teeranaipong, Phairote; Sirivichayakul, Sunee; Mekprasan, Suwanna; Ohata, Pirapon June; Avihingsanon, Anchalee; Ruxrungtham, Kiat; Putcharoen, Opass			Role of Rilpivirine and Etravirine in Efavirenz and Nevirapine-Based Regimens Failure in a Resource-Limited Country: A Cross-Sectional Study	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITOR; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; RESISTANCE; ADULTS; PHASE-3; DUET-1; THRIVE; TRIAL; ECHO	Introduction Etravirine(ETR) can be used for patients who have failed NNRTI-based regimen. In Thailand, ETR is approximately 45 times more expensive than rilpivirine(RPV). However, there are no data of RPV use in NNRTI failure. Therefore, we assessed the susceptibility and mutation patterns of first line NNRTI failure and the possibility of using RPV compared to ETV in patients who have failed efavirenz(EFV)- and nevirapine(NVP)-based regimens. Methods Clinical samples with confirmed virological failure from EFV- or NVP-based regimens were retrospectively analyzed. Resistance-associated mutations (RAMs) were interpreted by IAS-USA Drug Resistance Mutations. Susceptibility of ETR and RPV were interpreted by DUET, Monogram scoring system, and Stanford University HIV Drug Resistance Database. Results 1,279 and 528 patients failed EFV-and NVP-based regimens, respectively. Y181C was the most common NVP-associated RAM (54.3% vs. 14.7%, p<0.01). K103N was the most common EFV-associated RAM (56.5% vs. 19.1%, P<0.01). The results from all three scoring systems were concordant. 165(11.1%) and 161(10.9%) patients who failed NVP-based regimen were susceptible to ETR and RPV, respectively (p = 0.85). 195 (32.2%) and 191 (31.6%) patients who failed EFV-based regimen, were susceptible to ETR and RPV, respectively (p = 0.79). The susceptibility of ETV and RPV in EFV failure was significantly higher than NVP failure (p<0.01). Conclusion The mutation patterns for ETR and RPV were similar but 32% and 11% of patients who failed EFV and NVP -based regimen, respectivly were susceptible to RPV. This finding suggests that RPV can be used as the alternative antiretroviral agent in patients who have failed EFV-based regimen.	[Teeranaipong, Phairote] Chulalongkorn Univ, Fac Med, Dept Parasitol, Bangkok 10330, Thailand; [Sirivichayakul, Sunee; Mekprasan, Suwanna; Avihingsanon, Anchalee; Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Dept Med, Div Allergy & Clin Immunol, Bangkok 10330, Thailand; [Ohata, Pirapon June; Avihingsanon, Anchalee; Ruxrungtham, Kiat] Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand; [Putcharoen, Opass] Chulalongkorn Univ, Fac Med, Dept Med, Div Infect Dis, Bangkok 10330, Thailand	Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University	Putcharoen, O (corresponding author), Chulalongkorn Univ, Fac Med, Dept Med, Div Infect Dis, Bangkok 10330, Thailand.	opassid@gmail.com	Ohata, June/K-1542-2014	Ohata, June/0000-0001-6067-3707; Ruxrungtham, Kiat/0000-0001-7348-2352	HIV-NAT, The Thai Red Cross AIDS Research Centre; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand	HIV-NAT, The Thai Red Cross AIDS Research Centre; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand	HIV-NAT, The Thai Red Cross AIDS Research Centre and Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, provided money to conduct the study. The funders developed the study protocol, conducted the study, analyzed the data, wrote the paper and made the decision to submit the paper.	Adolescents PoAGfAa, 2015, GUID USE ANT AG HIV; Anta L, 2013, AIDS, V27, P81, DOI 10.1097/QAD.0b013e3283584500; Barcarolo J, 2012, WHO HIV DRUG RES REP; Bunupuradah T, 2011, ANTIVIR THER, V16, P1113, DOI 10.3851/IMP1906; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Imaz A, 2012, AIDS REV, V14, P268; James C, 2012, AM J HEALTH-SYST PH, V69, P857, DOI 10.2146/ajhp110395; Katlama C, 2010, ANTIVIR THER, V15, P1045, DOI 10.3851/IMP1662; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Manosuthi W, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0053-z; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Picchio G, 2011, AIDS RES HUM RETROV, V27, P1272, DOI 10.1089/aid.2011.0049; Porter DP, 2014, JAIDS-J ACQ IMM DEF, V65, P318, DOI 10.1097/QAI.0000000000000017; Rhee SY, 2004, ANTIMICROB AGENTS CH, V48, P3122, DOI 10.1128/AAC.48.8.3122-3126.2004; Rimsky L, 2012, JAIDS-J ACQ IMM DEF, V59, P39, DOI 10.1097/QAI.0b013e31823df4da; Schrijvers R, 2011, LANCET, V378, P201, DOI 10.1016/S0140-6736(11)60992-6; Sharma M, 2013, J ANTIMICROB CHEMOTH, V68, P250, DOI 10.1093/jac/dks404; Sungkanuparph S, 2008, CURR HIV RES, V6, P474, DOI 10.2174/157016208785861230; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Tambuyzer L, 2010, AIDS RES HUM RETROV, V26, P1197, DOI 10.1089/aid.2009.0302; Tang MW, 2012, INTERVIROLOGY, V55, P98, DOI 10.1159/000331998; Vingerhoets J, 2010, AIDS, V24, P503, DOI 10.1097/QAD.0b013e32833677ac; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	24	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154221	10.1371/journal.pone.0154221	http://dx.doi.org/10.1371/journal.pone.0154221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120449	Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200049
J	Bhardwaj, M; Kim, NH; Paul, S; Jakhar, R; Han, J; Kang, SC				Bhardwaj, Monika; Kim, Na-Hyung; Paul, Souren; Jakhar, Rekha; Han, Jaehong; Kang, Sun Chul			5-Hydroxy-7-Methoxyflavone Triggers Mitochondrial-Associated Cell Death via Reactive Oxygen Species Signaling in Human Colon Carcinoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HUMAN COLORECTAL-CANCER; HEPATOMA HEPG2 CELLS; INDUCED APOPTOSIS; CA2+ CONCENTRATION; OXIDATIVE STRESS; ACTIVATION; MEMBRANE; HOMEOSTASIS	Plant-derived compounds are an important source of clinically useful anti-cancer agents. Chrysin, a biologically active flavone found in many plants, has limited usage for cancer chemotherapeutics due to its poor oral bioavailability. 5-Hydroxy-7-methoxyflavone (HMF), an active natural chrysin derivative found in various plant sources, is known to modulate several biological activities. However, the mechanism underlying HMF-induced apoptotic cell death in human colorectal carcinoma cells in vitro is still unknown. Herein, HMF was shown to be capable of inducing cytotoxicity in HCT-116 cells and induced cell death in a dose-dependent manner. Treatment of HCT-116 cells with HMF caused DNA damage and triggered mitochondrial membrane perturbation accompanied by Cyt c release, down-regulation of Bcl-2, activation of BID and Bax, and caspase-3-mediated apoptosis. These results show that ROS generation by HMF was the crucial mediator behind ER stress induction, resulting in intracellular Ca2+ release, JNK phosphorylation, and activation of the mitochondrial apoptosis pathway. Furthermore, time course study also reveals that HMF treatment leads to increase in mitochondrial and cytosolic ROS generation and decrease in antioxidant enzymes expression. Temporal upregulation of IRE1-alpha expression and JNK phosphorylation was noticed after HMF treatment. These results were further confirmed by pretreatment with the ROS scavenger N-acetyl-l-cysteine (NAC), which completely reversed the effects of HMF treatment by preventing lipid peroxidation, followed by abolishment of JNK phosphorylation and attenuation of apoptogenic marker proteins. These results emphasize that ROS generation by HMF treatment regulates the mitochondrial-mediated apoptotic signaling pathway in HCT-116 cells, demonstrating HMF as a promising pro-oxidant therapeutic candidate for targeting colorectal cancer.	[Bhardwaj, Monika; Paul, Souren; Jakhar, Rekha; Kang, Sun Chul] Daegu Univ, Dept Biotechnol, Kyongsan 38453, Kyoungbook, South Korea; [Kim, Na-Hyung] Wonkwang Univ, Dept Oriental Pharm, Iksan 570749, Jeonbuk, South Korea; [Han, Jaehong] Chung Ang Univ, Metalloenzyme Res Grp, Anseong 456756, South Korea; [Han, Jaehong] Chung Ang Univ, Dept Integrat Plant Sci, Anseong 456756, South Korea	Daegu University; Wonkwang University; Chung Ang University; Chung Ang University	Kang, SC (corresponding author), Daegu Univ, Dept Biotechnol, Kyongsan 38453, Kyoungbook, South Korea.	sckang@daegu.ac.kr	Han, Jaehong/C-9230-2011; Shubhakaran, Khichar/AAH-2454-2020; Jakhar, Rekha/O-5722-2017; kim, na-hyung/ABH-1972-2021	Han, Jaehong/0000-0002-5328-3927; Shubhakaran, Khichar/0000-0001-5515-7572; Jakhar, Rekha/0000-0001-6351-2650; kim, na-hyung/0000-0003-1595-5558	Daegu University Research Grant	Daegu University Research Grant	This research was supported by a Daegu University Research Grant, 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASTILHO RF, 1995, FREE RADICAL BIO MED, V18, P479, DOI 10.1016/0891-5849(94)00166-H; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Choi H, 2015, BIOCHIMIE, V115, P108, DOI 10.1016/j.biochi.2015.05.009; Cicek M, 2007, CANCER RES, V67, P10106, DOI 10.1158/0008-5472.CAN-07-1362; Dahan L, 2009, BRIT J PHARMACOL, V158, P610, DOI 10.1111/j.1476-5381.2009.00341.x; Dawson VL, 1996, CELL DEATH DIFFER, V3, P71; Diaz-Ruiz C, 2001, HISTOL HISTOPATHOL, V16, P415, DOI 10.14670/HH-16.415; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Fauzi AN, 2011, FOOD CHEM TOXICOL, V49, P871, DOI 10.1016/j.fct.2010.12.010; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Giorgi C, 2008, CURR MOL MED, V8, P119; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hemachandra LPMP, 2015, CANCER RES, V75, P4973, DOI 10.1158/0008-5472.CAN-14-3799; Hildeman DA, 2003, J CLIN INVEST, V111, P575, DOI 10.1172/JCI200318007; Ji YB, 2011, EXP TOXICOL PATHOL, V63, P69, DOI 10.1016/j.etp.2009.09.010; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Khoo BY, 2010, INT J MOL SCI, V11, P2188, DOI 10.3390/ijms11052188; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kroemer G, 2007, PHYSIOL REV, V87, P519; Papademetrio DL, 2013, REV BRAS FARMACOGN, V23, P455, DOI 10.1590/S0102-695X2013005000025; Lee HH, 2013, INT J ONCOL, V42, P1036, DOI 10.3892/ijo.2013.1762; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Liu M, 2015, J GERIATR CARDIOL, V12, P540, DOI 10.11909/j.issn.1671-5411.2015.05.009; Lu DY, 2012, PHYTOMEDICINE, V19, P1093, DOI 10.1016/j.phymed.2012.06.010; Maddalena F, 2011, CANCER RES, V71, P7659, DOI 10.1158/0008-5472.CAN-11-2172; Mandl J, 2013, MOL ENDOCRINOL, V27, P384, DOI 10.1210/me.2012-1317; Mhaidat N, 2008, APOPTOSIS, V13, P1505, DOI 10.1007/s10495-008-0276-8; Pal HC, 2013, EXP DERMATOL, V22, P470, DOI 10.1111/exd.12181; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Qiu PJ, 2010, MOL NUTR FOOD RES, V54, pS244, DOI 10.1002/mnfr.200900605; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Su CC, 2006, ANTICANCER RES, V26, P4379; SUNDERMAN FW, 1985, ANN CLIN LAB SCI, V15, P229; Ta N, 2007, J STEROID BIOCHEM, V107, P127, DOI 10.1016/j.jsbmb.2007.01.006; Uhl M, 2003, ARCH TOXICOL, V77, P477, DOI 10.1007/s00204-003-0469-4; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Van Cutsem E, 2010, ANN ONCOL, V21, pv93, DOI 10.1093/annonc/mdq222; Walle T, 2001, BRIT J CLIN PHARMACO, V51, P143, DOI 10.1111/j.1365-2125.2001.01317.x; Wang M, 2011, EUR J PHARMACOL, V650, P41, DOI 10.1016/j.ejphar.2010.09.049; Wongsrikaew N, 2011, J KOREAN SOC APPL BI, V54, P1008, DOI 10.3839/jksabc.2011.152; Yang W, 2009, TOXICOL LETT, V191, P203, DOI 10.1016/j.toxlet.2009.08.024; Zhang LB, 2011, EUR J PHARMACOL, V651, P33, DOI 10.1016/j.ejphar.2010.10.067; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089021	53	29	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154525	10.1371/journal.pone.0154525	http://dx.doi.org/10.1371/journal.pone.0154525			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116119	Green Published, gold			2022-12-27	WOS:000374973600073
J	Saverino, A; Waller, D; Rantell, K; Parry, R; Moriarty, A; Playford, ED				Saverino, A.; Waller, D.; Rantell, K.; Parry, R.; Moriarty, A.; Playford, E. D.			The Role of Cognitive Factors in Predicting Balance and Fall Risk in a Neuro-Rehabilitation Setting	PLOS ONE			English	Article							EXECUTIVE FUNCTION; OLDER-ADULTS; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; PROSPECTIVE COHORT; WALKING SPEED; ATTENTION; GAIT; REGRESSION; PEOPLE	Introduction There is a consistent body of evidence supporting the role of cognitive functions, particularly executive function, in the elderly and in neurological conditions which become more frequent with ageing. The aim of our study was to assess the role of different domains of cognitive functions to predict balance and fall risk in a sample of adults with various neurological conditions in a rehabilitation setting. Methods This was a prospective, cohort study conducted in a single centre in the UK. 114 participants consecutively admitted to a Neuro-Rehabilitation Unit were prospectively assessed for fall accidents. Baseline assessment included a measure of balance (Berg Balance Scale) and a battery of standard cognitive tests measuring executive function, speed of information processing, verbal and visual memory, visual perception and intellectual function. The outcomes of interest were the risk of becoming a faller, balance and fall rate. Results Two tests of executive function were significantly associated with fall risk, the Stroop Colour Word Test (IRR 1.01, 95% CI 1.00-1.03) and the number of errors on part B of the Trail Making Test (IRR 1.23, 95% CI 1.03-1.49). Composite scores of executive function, speed of information processing and visual memory domains resulted in 2 to 3 times increased likelihood of having better balance (OR 2.74 95% CI 1.08 to 6.94, OR 2.72 95% CI 1.16 to 6.36 and OR 2.44 95% CI 1.11 to 5.35 respectively). Conclusions Our results show that specific subcomponents of executive functions are able to predict fall risk, while a more global cognitive dysfunction is associated with poorer balance.	[Saverino, A.; Waller, D.; Parry, R.; Moriarty, A.; Playford, E. D.] Natl Hosp Neurol & Neurosurg, Therapy Serv, Queen Sq, London WC1N 3BG, England; [Saverino, A.; Waller, D.; Parry, R.; Moriarty, A.; Playford, E. D.] Natl Hosp Neurol & Neurosurg, Rehabil Serv, Queen Sq, London WC1N 3BG, England; [Saverino, A.] Fdn Salvatore Maugeri, Inst Rehabil, Genoa, Italy; [Saverino, A.] St George Hosp, Wolfson Neurorehabil Ctr, London, England; [Rantell, K.] Joint UCL UCLH Royal Free Hosp, Res Support Ctr, London, England; [Rantell, K.; Playford, E. D.] UCL, Inst Neurol, London, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Istituti Clinici Scientifici Maugeri IRCCS; St Georges University London; University of London; Queen Mary University London; University of London; University College London	Playford, ED (corresponding author), Natl Hosp Neurol & Neurosurg, Therapy Serv, Queen Sq, London WC1N 3BG, England.; Playford, ED (corresponding author), Natl Hosp Neurol & Neurosurg, Rehabil Serv, Queen Sq, London WC1N 3BG, England.; Playford, ED (corresponding author), UCL, Inst Neurol, London, England.	D.Playford@ion.ucl.ac.uk		Playford, E Diane/0000-0001-7314-787X				Alemdaroglu E, 2012, ARCH PHYS MED REHAB, V93, P2244, DOI 10.1016/j.apmr.2012.06.014; Anstey KJ, 2009, NEUROPSYCHOLOGY, V23, P500, DOI 10.1037/a0015389; ARMSTRONG BG, 1989, AM J EPIDEMIOL, V129, P191, DOI 10.1093/oxfordjournals.aje.a115109; Axer H, 2010, CLIN NEUROL NEUROSUR, V112, P265, DOI 10.1016/j.clineuro.2009.12.015; Baddely AD B A, 1994, DOORS PEOPLE TEST VI; BECHTOLDT HP, 1962, PSYCHOL REC, V12, P147, DOI 10.1007/BF03393452; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bergland A, 2004, INJURY PREV, V10, P308, DOI 10.1136/ip.2003.004721; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Campbell GB, 2010, J NURS SCHOLARSHIP, V42, P395, DOI 10.1111/j.1547-5069.2010.01369.x; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; D'Orio VL, 2012, J NEUROL SCI, V316, P42, DOI 10.1016/j.jns.2012.02.003; Coelho FGD, 2012, AGING NEUROPSYCHOL C, V19, P644, DOI 10.1080/13825585.2012.661398; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Gleason CE, 2009, DEMENT GERIATR COGN, V27, P557, DOI 10.1159/000228257; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Grimbergen YAM, 2008, MOVEMENT DISORD, V23, P970, DOI 10.1002/mds.22003; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Hoang PD, 2014, ARCH PHYS MED REHAB, V95, P480, DOI 10.1016/j.apmr.2013.09.017; Holtzer R, 2007, NEUROPSYCHOLOGY, V21, P540, DOI 10.1037/0894-4105.21.5.540; Lee JE, 2008, AM J PHYS MED REHAB, V87, P341, DOI 10.1097/PHM.0b013e31816ddc01; Liu-Ambrose T, 2007, CEREBROVASC DIS, V23, P203, DOI 10.1159/000097642; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627, DOI 10.1093/gerona/56.10.M627; Marshall J., 2012, HDB CLIN NEUROPSYCHO; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Mirelman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040297; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Neumann L, 2013, J NUTR HEALTH AGING, V17, P264, DOI 10.1007/s12603-012-0390-8; NEVITT MC, 1991, J GERONTOL, V46, pM164, DOI 10.1093/geronj/46.5.M164; Pahlman U, 2011, DISABIL REHABIL, V33, P1952, DOI 10.3109/09638288.2011.553703; Reitan R.M., 1992, TRAIL MAKING TEST MA; Saverino A, 2015, DISABIL REHABIL, V37, P355, DOI 10.3109/09638288.2014.923520; Saverino A, 2014, DISABIL REHABIL, V36, P963, DOI 10.3109/09638288.2013.829525; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Sheridan PL, 2003, J AM GERIATR SOC, V51, P1633, DOI 10.1046/j.1532-5415.2003.51516.x; Smith A, 1995, SYMBOL DIGIT MODALIT; Sosnoff JJ, 2013, ARCH PHYS MED REHAB, V94, P1567, DOI 10.1016/j.apmr.2013.02.009; StataCorp, 2011, STAT STAT SOFTW REL, P173; Thurman DJ, 2008, NEUROLOGY, V70, P473, DOI 10.1212/01.wnl.0000299085.18976.20; Warrington E., 1996, CAMDEN MEMORY TESTS; Warrington E.K., 1984, RECOGNITION MEMORY T; Warrington EK., 1991, VISUAL OBJECT SPACE; Wechsler D., 1997, WECHSLER ADULT INTEL; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	51	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153469	10.1371/journal.pone.0153469	http://dx.doi.org/10.1371/journal.pone.0153469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27115880	Green Published, gold			2022-12-27	WOS:000374973600023
J	Schmidt, JFM; Santelli, C; Kozerke, S				Schmidt, Johannes F. M.; Santelli, Claudio; Kozerke, Sebastian			MR Image Reconstruction Using Block Matching and Adaptive Kernel Methods	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; ARBITRARY K-SPACE; DYNAMIC MRI; PARALLEL MRI; COIL ARRAYS; RADIAL MRI; T BLAST; SPARSE; GRAPPA; SENSE	An approach to Magnetic Resonance (MR) image reconstruction from undersampled data is proposed. Undersampling artifacts are removed using an iterative thresholding algorithm applied to nonlinearly transformed image block arrays. Each block array is transformed using kernel principal component analysis where the contribution of each image block to the transform depends in a nonlinear fashion on the distance to other image blocks. Elimination of undersampling artifacts is achieved by conventional principal component analysis in the nonlinear transform domain, projection onto the main components and back-mapping into the image domain. Iterative image reconstruction is performed by interleaving the proposed undersampling artifact removal step and gradient updates enforcing consistency with acquired k-space data. The algorithm is evaluated using retrospectively undersampled MR cardiac cine data and compared to k-t SPARSE-SENSE, block matching with spatial Fourier filtering and k-t l(1)-SPIRiT reconstruction. Evaluation of image quality and root-mean-squared-error (RMSE) reveal improved image reconstruction for up to 8-fold undersampled data with the proposed approach relative to k-t SPARSE-SENSE, block matching with spatial Fourier filtering and k-t l(1)-SPIRiT. In conclusion, block matching and kernel methods can be used for effective removal of undersampling artifacts in MR image reconstruction and outperform methods using standard compressed sensing and l(1)-regularized parallel imaging methods.	[Schmidt, Johannes F. M.; Santelli, Claudio; Kozerke, Sebastian] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Schmidt, Johannes F. M.; Santelli, Claudio; Kozerke, Sebastian] ETH, Zurich, Switzerland; [Kozerke, Sebastian] Kings Coll London, Imaging Sci & Biomed Engn, London WC2R 2LS, England	University of Zurich; ETH Zurich; University of London; King's College London	Kozerke, S (corresponding author), Univ Zurich, Inst Biomed Engn, Zurich, Switzerland.; Kozerke, S (corresponding author), ETH, Zurich, Switzerland.; Kozerke, S (corresponding author), Kings Coll London, Imaging Sci & Biomed Engn, London WC2R 2LS, England.	kozerke@biomed.ee.ethz.ch	Kozerke, Sebastian/J-3209-2015	Kozerke, Sebastian/0000-0003-3725-8884				Adluru G, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/341684; Adluru G, 2007, I S BIOMED IMAGING, P109, DOI 10.1109/ISBI.2007.356800; Akcakaya M, 2011, MAGN RESON MED, V66, P756, DOI 10.1002/mrm.22841; Alzate C, 2008, IEEE T NEURAL NETWOR, V19, P1583, DOI 10.1109/TNN.2008.2000443; Asif MS, 2013, MAGN RESON MED, V70, P800, DOI 10.1002/mrm.24524; Bakir GH, 2004, ADV NEUR IN, V16, P449; Braun ML, 2008, J MACH LEARN RES, V9, P1875; Buehrer M, 2007, MAGN RESON MED, V57, P1131, DOI 10.1002/mrm.21237; Chambolle A, 1998, IEEE T IMAGE PROCESS, V7, P319, DOI 10.1109/83.661182; Chang YC, 2012, MAGN RESON MED, V68, P730, DOI 10.1002/mrm.23279; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Daubechies I, 2004, COMMUN PUR APPL MATH, V57, P1413, DOI 10.1002/cpa.20042; Doneva M, 2010, MAGN RESON MED, V64, P1114, DOI 10.1002/mrm.22483; Donoho DL, 2009, P NATL ACAD SCI USA, V106, P18914, DOI 10.1073/pnas.0909892106; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; ENGL HW, 1987, J APPROX THEORY, V49, P55, DOI 10.1016/0021-9045(87)90113-4; Feng L, 2011, MAGN RESON MED, V65, P1661, DOI 10.1002/mrm.22756; Gamper U, 2008, MAGN RESON MED, V59, P365, DOI 10.1002/mrm.21477; Gleichman S, 2011, IEEE T INFORM THEORY, V57, P6958, DOI 10.1109/TIT.2011.2165821; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Jung H, 2009, MAGN RESON MED, V61, P103, DOI 10.1002/mrm.21757; Kim KI, 2005, IEEE T PATTERN ANAL, V27, P1351, DOI 10.1109/TPAMI.2005.181; Liang ZP, 1997, INT J IMAG SYST TECH, V8, P551, DOI 10.1002/(SICI)1098-1098(1997)8:6<551::AID-IMA7>3.0.CO;2-9; Lingala SG, 2011, I S BIOMED IMAGING, P1280, DOI 10.1109/ISBI.2011.5872635; Lingala SG, 2013, IEEE T MED IMAGING, V32, P1132, DOI 10.1109/TMI.2013.2255133; Lustig M., 2009, P INT SOC MAGN RESON, V17, P379; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Lustig M, 2010, MAGN RESON MED, V64, P457, DOI 10.1002/mrm.22428; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Madore B, 1999, MAGNET RESON MED, V42, P813, DOI 10.1002/(SICI)1522-2594(199911)42:5<813::AID-MRM1>3.0.CO;2-S; Mika S, 1999, ADV NEUR IN, V11, P536; Nakarmi U, 2015, I S BIOMED IMAGING, P331, DOI 10.1109/ISBI.2015.7163880; NOLL DC, 1991, IEEE T MED IMAGING, V10, P154, DOI 10.1109/42.79473; Otazo R, 2010, MAGN RESON MED, V64, P767, DOI 10.1002/mrm.22463; Pauly, 2006, P 13 ANN M ISMRM SEA; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Pruessmann KP, 2001, MAGNET RESON MED, V46, P638, DOI 10.1002/mrm.1241; Rasmussen PM, 2012, NEUROIMAGE, V60, P1807, DOI 10.1016/j.neuroimage.2012.01.096; Scholkopf B., 1997, Artificial Neural Networks - ICANN '97. 7th International Conference Proceedings, P583, DOI 10.1007/BFb0020217; Scholkopf B., 1998, ICANN 98. Proceedings of the 8th International Conference on Artificial Neural Networks, P147; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Tsao J, 2003, MAGNET RESON MED, V50, P1031, DOI 10.1002/mrm.10611; Uecker M, 2014, MAGN RESON MED, V71, P990, DOI 10.1002/mrm.24751; Usman M, 2011, MAGN RESON MED, V66, P1163, DOI 10.1002/mrm.22883; Wang YH, 2014, IEEE ENG MED BIO, P1533, DOI 10.1109/EMBC.2014.6943894; Zhao B, 2010, I S BIOMED IMAGING, P996, DOI 10.1109/ISBI.2010.5490156; Zhou YH, 2013, I S BIOMED IMAGING, P310	49	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153736	10.1371/journal.pone.0153736	http://dx.doi.org/10.1371/journal.pone.0153736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116675	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600029
J	Xu, HT; Yin, WJ; Hsu, PC; Qin, H; An, ZQ; Zhang, CQ; Sheng, JG				Xu, Haitao; Yin, Wenjing; Hsu, Peichun; Qin, Hui; An, Zhiquan; Zhang, Changqing; Sheng, Jiagen			Improve the Efficiency of Surgery for Femoral Shaft Fractures with A Novel Instrument: A Randomized Controlled Trial	PLOS ONE			English	Article							INTRAMEDULLARY NAIL; FIXATION; REDUCTION; FEMUR; ROBOT	Objective To improve the efficacy of closed reduction and wire guiding during intramedullary nail internal fixation in femoral shaft fractures. Methods A novel instrument was designed and manufactured. Sixty-eight patients were enrolled from February 2011 to December 2013. The instrument designed was used during the operation in the experimental group, but not in the control group. Results All patients exhibited fracture union, excluding 1 patient in the experimental group and 2 in the control group who had non-union; all of whom achieved fracture union with reoperation. There were no statistically significant differences in operative blood loss or duration of hospital stay between the groups (P > 0.05). The operative time, frequency of wire drilling, and number of open reduction cases, were significantly smaller in the experimental group than in the control group (P < 0.05). Conclusion Femoral shaft fractures are difficult to reduce using general methods; the novel instrument showed high clinical value and proved effective and safe in assisting with closed reduction and intramedullary nail fixation for femoral shaft fractures.	[Xu, Haitao; Yin, Wenjing; Hsu, Peichun; Qin, Hui; An, Zhiquan; Zhang, Changqing; Sheng, Jiagen] Shanghai Jiao Tong Univ, Dept Orthoped, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Sheng, JG (corresponding author), Shanghai Jiao Tong Univ, Dept Orthoped, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	jiagen_sheng@163.com	An, Zhiquan/CAJ-4467-2022	zhang, changqing/0000-0002-7408-4126; Sheng, Jiagen/0000-0001-7090-0280	Shanghai Municipal Commission of Health and Family Planning [2007040]	Shanghai Municipal Commission of Health and Family Planning	This work was funded by Shanghai Municipal Commission of Health and Family Planning ( Grant No. 2007040, URL: http://www.wsjsw.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrzejewski Krzysztof, 2013, Ortop Traumatol Rehabil, V15, P395, DOI 10.5604/15093492.1084241; BUTLER MS, 1991, J BONE JOINT SURG AM, V73A, P1492, DOI 10.2106/00004623-199173100-00007; Cameron CD, 2014, J ORTHOP TRAUMA, V28, pS11, DOI 10.1097/BOT.0000000000000185; Dennis MG, 2001, J ORTHOP TRAUMA, V15, P177, DOI 10.1097/00005131-200103000-00005; Kesemenli Cumhur Cevdet, 2012, Musculoskelet Surg, V96, P117, DOI 10.1007/s12306-012-0206-3; Konstantinidis L, 2012, P I MECH ENG H, V226, P681, DOI 10.1177/0954411912447011; Latif Abdul, 2013, J Indian Med Assoc, V111, P833; Lin H, 2013, IEEE ENG MED BIO, P4847, DOI 10.1109/EMBC.2013.6610633; Lin SJ, 2014, INJURY, V45, P752, DOI 10.1016/j.injury.2013.10.015; Liu YK, 2010, INJURY, V41, P810, DOI 10.1016/j.injury.2010.03.020; Marsh JL, 2007, J ORTHOP TRAUMA S, V21, pS1, DOI DOI 10.1097/00005131-200711101-00001; Mehlman CT, 2006, J ORTHOP TRAUMA, V20, P608, DOI 10.1097/01.bot.0000249414.59012.d9; MIETTINEN H, 1992, J BIOMAT SCI-POLYM E, V4, P135; Mingo-Robinet J, 2013, Rev Esp Cir Ortop Traumatol, V57, P384, DOI 10.1016/j.recot.2013.07.006; Naraghi F F, 1994, Orthop Rev, V23, P611; Neumann MV, 2015, ACTA CHIR ORTHOP TR, V82, P22; Nishiura T, 2009, INJURY, V40, P1077, DOI 10.1016/j.injury.2009.03.049; Sekimpi P, 2011, J BONE JOINT SURG AM, V93A, P1811, DOI 10.2106/JBJS.J.01322; Wang JQ, 2013, INT J MED ROBOT COMP, V9, P464, DOI 10.1002/rcs.1550; Weber-Spickschen TS, 2010, TECHNOL HEALTH CARE, V18, P207, DOI 10.3233/THC-2010-0583; Xu HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140037; Yun HH, 2013, CLIN ORTHOP SURG, V5, P230, DOI 10.4055/cios.2013.5.3.230	22	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154332	10.1371/journal.pone.0154332	http://dx.doi.org/10.1371/journal.pone.0154332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115752	Green Published, gold, Green Submitted			2022-12-27	WOS:000374973600058
J	Bieghs, L; Brohus, M; Kristensen, IB; Abildgaard, N; Bogsted, M; Johnsen, HE; Conover, CA; De Bruyne, E; Vanderkerken, K; Overgaard, MT; Nyegaard, M				Bieghs, Liesbeth; Brohus, Malene; Kristensen, Ida B.; Abildgaard, Niels; Bogsted, Martin; Johnsen, Hans E.; Conover, Cheryl A.; De Bruyne, Elke; Vanderkerken, Karin; Overgaard, Michael T.; Nyegaard, Mette			Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; MURINE MODEL; FACTOR-I; INSULIN; EXPRESSION; RECEPTOR; IGFBP-2; FIBROBLASTS; BORTEZOMIB; RESISTANT	Insulin-like growth factor (IGF) signalling plays a key role in homing, progression, and treatment resistance in multiple myeloma (MM). In the extracellular environment, the majority of IGF molecules are bound to one of six IGF-binding proteins (IGFBP1-6), leaving a minor fraction of total IGF free and accessible for receptor activation. In MM, high IGF-receptor type 1 expression levels correlate with a poor prognosis, but the status and role of IGF and IGFBPs in the pathobiology of MM is unknown. Here we measured total IGF1, IGF2, and intact IGFBP levels in blood and bone marrow samples from MM (n = 17), monoclonal gammopathy of undetermined significance (MGUS) (n = 37), and control individuals (n = 15), using ELISA (IGFs) and I-125-IGF1 Western Ligand Blotting (IGFBPs). MGUS and MM patients displayed a significant increase in intact IGFBP-2 (2.5-3.8 fold) and decrease in intact IGFBP-3 (0.6-0.5 fold) in the circulation compared to control individuals. Further, IGFBP-2 as well as total IGFBP levels were significantly lower in bone marrow compared to circulation in MM and MGUS only, whereas IGF1, IGF2, and IGFBP-3 were equally distributed between the two compartments. In conclusion, the profound change in IGFBP profile strongly suggests an increased IGF bioavailability in the bone marrow microenvironment in MGUS and MM, despite no change in growth factor concentration.	[Bieghs, Liesbeth; Bogsted, Martin; Johnsen, Hans E.] Aalborg Univ, Dept Hematol, Aalborg Hosp, Aalborg, Denmark; [Bieghs, Liesbeth; De Bruyne, Elke; Vanderkerken, Karin] Vrije Univ Brussel, Dept Hematol & Immunol, Myeloma Ctr Brussel, Brussels, Belgium; [Bieghs, Liesbeth; Nyegaard, Mette] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Brohus, Malene; Overgaard, Michael T.] Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark; [Kristensen, Ida B.; Abildgaard, Niels] Odense Univ Hosp, Dept Haematol, DK-5000 Odense, Denmark; [Conover, Cheryl A.] Mayo Clin, Div Endocrinol Metab & Nutr, Endocrine Res Unit, Rochester, MN USA	Aalborg University; Aalborg University Hospital; Vrije Universiteit Brussel; Aarhus University; Aalborg University; University of Southern Denmark; Odense University Hospital; Mayo Clinic	Overgaard, MT (corresponding author), Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark.	mto@bio.aau.dk	De Bruyne, Elke/Z-3215-2019; Overgaard, Michael Toft/E-1354-2011; De Bruyne, Elke/R-2145-2019; Nyegaard, Mette/M-3379-2019	De Bruyne, Elke/0000-0003-4012-4617; Overgaard, Michael Toft/0000-0002-1423-2481; Nyegaard, Mette/0000-0003-4973-8543; Kristensen, Ida Bruun/0000-0001-8605-9422; Bogsted, Martin/0000-0001-9192-1814; Johnsen, Hans Erik/0000-0001-8253-2913				Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bataille R, 2005, HAEMATOLOGICA, V90, P706; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Bieghs L, 2014, ONCOTARGET, V5, P11193, DOI 10.18632/oncotarget.1933; Birmann BM, 2012, BLOOD, V120, P4929, DOI 10.1182/blood-2012-03-417253; Boldt HB, 2011, ENDOCRINOLOGY, V152, P1470, DOI 10.1210/en.2010-1095; Bolomsky A, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0105-1; Bret C, 2011, EXP HEMATOL; Chng WJ, 2006, LEUKEMIA, V20, P174, DOI 10.1038/sj.leu.2403997; CONOVER CA, 1993, J CLIN INVEST, V91, P1129, DOI 10.1172/JCI116272; Conover CA, 2008, AM J PHYSIOL-ENDOC M, V294, pE10, DOI 10.1152/ajpendo.00648.2007; Fisher MC, 2005, BONE, V37, P741, DOI 10.1016/j.bone.2005.07.024; Fleming JM, 2005, J ENDOCRINOL, V186, P165, DOI 10.1677/joe.1.06164; Grotendorst GR, 2001, J CLIN ENDOCR METAB, V86, P944, DOI 10.1210/jc.86.2.944; Kristensen IB, 2013, EUR J HAEMATOL, V91, P196, DOI 10.1111/ejh.12125; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Lund J, 2014, J MOL ENDOCRINOL, V52, P345, DOI 10.1530/JME-13-0184; Monget P, 2003, BIOL REPROD, V68, P77, DOI 10.1095/biolreprod.102.007609; Moreau P, 2011, LEUKEMIA, V25, P872, DOI 10.1038/leu.2011.4; Moreaux J, 2011, BLOOD, V117, P1280, DOI 10.1182/blood-2010-04-279760; OKAZAKI R, 1994, ENDOCRINOLOGY, V134, P126, DOI 10.1210/en.134.1.126; Ryan AJ, 2009, BRIT J CANCER, V101, P278, DOI 10.1038/sj.bjc.6605141; Soh CL, 2014, BRIT J CANCER, V110, P2855, DOI 10.1038/bjc.2014.232; Sprynski AC, 2009, BLOOD, V113, P4614, DOI 10.1182/blood-2008-07-170464; Standal T, 2002, BLOOD, V100, P3925, DOI 10.1182/blood-2002-05-1406; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258; Yu H, 1999, J CLIN LAB ANAL, V13, P166, DOI 10.1002/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.3.CO;2-O	28	7	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154256	10.1371/journal.pone.0154256	http://dx.doi.org/10.1371/journal.pone.0154256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111220	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600053
J	Wang, XF; Ji, P; Zhang, YH; LaComb, JF; Tian, XY; Li, E; Williams, JL				Wang, Xuefeng; Ji, Ping; Zhang, Yuanhao; LaComb, Joseph F.; Tian, Xinyu; Li, Ellen; Williams, Jennie L.			Aberrant DNA Methylation: Implications in Racial Health Disparity	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RIBOSOMAL-PROTEIN L13A; COLORECTAL-CANCER; COLON-CANCER; DIFFERENTIAL EXPRESSION; MESSENGER-RNAS; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; SIGNALING PATHWAYS; GENE-EXPRESSION	Background Incidence and mortality rates of colorectal carcinoma (CRC) are higher in African Americans (AAs) than in Caucasian Americans (CAs). Deficient micronutrient intake due to dietary restrictions in racial/ethnic populations can alter genetic and molecular profiles leading to dysregulated methylation patterns and the inheritance of somatic to germline mutations. Materials and Methods Total DNA and RNA samples of paired tumor and adjacent normal colon tissues were prepared from AA and CA CRC specimens. Reduced Representation Bisulfite Sequencing (RRBS) and RNA sequencing were employed to evaluate total genome methylation of 5'-regulatory regions and dysregulation of gene expression, respectively. Robust analysis was conducted using a trimming-and-retrieving scheme for RRBS library mapping in conjunction with the BStool toolkit. Results DNA from the tumor of AA CRC patients, compared to adjacent normal tissues, contained 1,588 hypermethylated and 100 hypomethylated differentially methylated regions (DMRs). Whereas, 109 hypermethylated and 4 hypomethylated DMRs were observed in DNA from the tumor of CA CRC patients; representing a 14.6-fold and 25-fold change, respectively. Specifically; CHL1, 4 anti-inflammatory genes (i.e., NELL1, GDF1, ARHGEF4, and ITGA4), and 7 miRNAs (of which miR-9-3p and miR-124-3p have been implicated in CRC) were hypermethylated in DNA samples from AA patients with CRC. From the same sample set, RNAseq analysis revealed 108 downregulated genes (including 14 ribosomal proteins) and 34 upregulated genes (including POLR2B and CYP1B1 [targets of miR-124-3p]) in AA patients with CRC versus CA patients. Conclusion DNA methylation profile and/or products of its downstream targets could serve as biomarker(s) addressing racial health disparity.	[Wang, Xuefeng; Ji, Ping; LaComb, Joseph F.; Williams, Jennie L.] SUNY Stony Brook, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA; [Li, Ellen; Williams, Jennie L.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Wang, Xuefeng] SUNY Stony Brook, Dept Biomed Informat, Stony Brook, NY 11794 USA; [Wang, Xuefeng; Zhang, Yuanhao; Tian, Xinyu] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [LaComb, Joseph F.; Williams, Jennie L.] SUNY Stony Brook, Canc Prevent Div, Stony Brook, NY 11794 USA; [Li, Ellen] SUNY Stony Brook, Div Gastroenterol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Williams, JL (corresponding author), SUNY Stony Brook, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA.; Williams, JL (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.; Williams, JL (corresponding author), SUNY Stony Brook, Canc Prevent Div, Stony Brook, NY 11794 USA.	Jennie.Williams@stonybrookmedicine.edu		LaComb, Joseph/0000-0002-2981-1072	National Institutes of Health-National Cancer Institute;  [R01CA140487];  [P20CA192994]; NATIONAL CANCER INSTITUTE [R01CA140487, P20CA192994, P30CA045508] Funding Source: NIH RePORTER	National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health-National Cancer Institute; http://www.cancer.gov/; grant number R01CA140487 to JLW and award number P20CA192994 to EL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsopoulos VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082487; Antoine M, 2005, BIOCHEM BIOPH RES CO, V338, P1248, DOI 10.1016/j.bbrc.2005.10.079; Artero-Castro A, 2009, EXP CELL RES, V315, P1372, DOI 10.1016/j.yexcr.2009.02.007; Artero-Castro A, 2011, HUM PATHOL, V42, P194, DOI 10.1016/j.humpath.2010.04.020; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bao MW, 2015, J PATHOL, V236, P360, DOI 10.1002/path.4523; BARNARD GF, 1993, CANCER RES, V53, P4048; Basu A, 2014, ARTERIOSCL THROM VAS, V34, P533, DOI 10.1161/ATVBAHA.113.302573; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Bibikova E, 2014, BLOOD, V124, P3791, DOI 10.1182/blood-2014-06-584656; Bjursten M, 2005, EUR J IMMUNOL, V35, P2274, DOI 10.1002/eji.200526022; Brawley OW, 2007, CURR PROB CANCER, V31, P114, DOI 10.1016/j.currproblcancer.2007.02.001; Brim H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082185; Carethers J M, 1999, J Assoc Acad Minor Phys, V10, P59; Cekaite L, 2012, NEOPLASIA, V14, P868, DOI 10.1593/neo.121094; Chan H, 2005, CANCER DETECT PREV, V29, P562, DOI 10.1016/j.cdp.2005.09.007; Chien C, 2005, CANCER, V104, P629, DOI 10.1002/cncr.21204; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Cooper GS, 1997, CANCER EPIDEM BIOMAR, V6, P283; Daftuar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068667; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; FRIGERIO JM, 1995, BBA-GENE STRUCT EXPR, V1262, P64, DOI 10.1016/0167-4781(95)00045-I; Gerecke C, 2015, J CANCER RES CLIN, V141, P2097, DOI 10.1007/s00432-015-1972-8; Gillberg L, 2013, ACTA PHYSIOL, V207, P326, DOI 10.1111/apha.12017; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herrinton LJ, 2012, GASTROENTEROLOGY, V143, P382, DOI 10.1053/j.gastro.2012.04.054; Hodgson DC, 2003, J NATL CANCER I, V95, P708, DOI 10.1093/jnci/95.10.708; Hodgson DC, 2001, JNCI-J NATL CANCER I, V93, P501, DOI 10.1093/jnci/93.7.501; Iorio MV, 2012, CANCER J, V18, P215, DOI 10.1097/PPO.0b013e318250c001; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Kasai H, 2003, J HISTOCHEM CYTOCHEM, V51, P567, DOI 10.1177/002215540305100502; Kitahara O, 2001, CANCER RES, V61, P3544; Kobayashi T, 2006, INT J MOL MED, V18, P161; KONDOH N, 1992, CANCER RES, V52, P791; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Kumar KU, 1999, MOL CELL BIOL, V19, P1116; Kumarakulasingham M, 2005, CLIN CANCER RES, V11, P3758, DOI 10.1158/1078-0432.CCR-04-1848; Lai MD, 2007, CURR GENOMICS, V8, P43; Li E, 2014, INT J ONCOL, V45, P587, DOI 10.3892/ijo.2014.2469; Lieberman DA, 2008, JAMA-J AM MED ASSOC, V300, P1417, DOI 10.1001/jama.300.12.1417; Liu JJ, 2006, J CELL PHYSIOL, V207, P287, DOI 10.1002/jcp.20589; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; Martinez VG, 2008, BRIT J CANCER, V98, P564, DOI 10.1038/sj.bjc.6604195; MAYBERRY RM, 1995, J NATL CANCER I, V87, P1686, DOI 10.1093/jnci/87.22.1686; Meng FY, 2015, AM J PHYSIOL-LUNG C, V308, pL452, DOI 10.1152/ajplung.00170.2014; Michiels S, 2007, CARCINOGENESIS, V28, P1731, DOI 10.1093/carcin/bgm111; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Okugawa Y, 2015, GASTROENTEROLOGY, V149, P1204, DOI 10.1053/j.gastro.2015.07.011; Poddar D, 2013, J IMMUNOL, V190, P3600, DOI 10.4049/jimmunol.1201933; Ponicsan SL, 2013, J MOL BIOL, V425, P3625, DOI 10.1016/j.jmb.2013.01.035; RIES LAG, 1997, SEER CANC STAT REV 1; Rochat B, 2001, J PHARMACOL EXP THER, V296, P537; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107; Salbaum JM, 2012, PROG MOL BIOL TRANSL, V108, P129, DOI 10.1016/B978-0-12-398397-8.00006-X; Samowitz WS, 2008, EXP MOL PATHOL, V85, P64, DOI 10.1016/j.yexmp.2008.03.008; Senchenko VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015612; Shen J, 2013, TISSUE ENG PT A, V19, P2390, DOI [10.1089/ten.tea.2012.0519, 10.1089/ten.TEA.2012.0519]; Slattery M L, 2000, Semin Gastrointest Dis, V11, P142; Slattery ML, 2015, INT J CANCER, V137, P428, DOI 10.1002/ijc.29384; Surovtseva YV, 2011, P NATL ACAD SCI USA, V108, P17921, DOI 10.1073/pnas.1108852108; Taniguchi K, 2015, CANCER LETT, V363, P17, DOI 10.1016/j.canlet.2015.03.026; Teller A, 2015, PATHOL RES PRACT, V211, P62, DOI 10.1016/j.prp.2014.09.005; Tian XQ, 2015, ONCOTARGETS THER, V8, P1691, DOI 10.2147/OTT.S81621; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Wang M, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-6; Wang XF, 2015, BIOINFORMATICS, V31, P2040, DOI 10.1093/bioinformatics/btv089; Zhu HL, 2014, BIOCHEM BIOPH RES CO, V450, P857, DOI 10.1016/j.bbrc.2014.06.073; ZIEMIECKI A, 1990, EMBO J, V9, P191, DOI 10.1002/j.1460-2075.1990.tb08095.x	73	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153125	10.1371/journal.pone.0153125	http://dx.doi.org/10.1371/journal.pone.0153125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111221	Green Published, gold			2022-12-27	WOS:000374970600010
J	Ismail, E; Nofal, OKJ; Sakthiswary, R; Shaharir, SS; Sridharan, R				Ismail, Endom; Nofal, Omimah Khaled Jaber; Sakthiswary, Rajalingham; Shaharir, Syahrul Sazliyana; Sridharan, Radhika			The Clinical Significance of Interleukin-1 Receptor Antagonist+2018 Polymorphism in Rheumatoid Arthritis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GENE POLYMORPHISMS; DISEASE SEVERITY; JOINT DAMAGE; SUSCEPTIBILITY; ASSOCIATION; IL-1RA; AGE; PATHWAYS; REGION	Objective Interleukin-1 receptor antagonist (IL-1Ra) acts as an inhibitor of IL-1; which is one of the culprit cytokines in rheumatoid arthritis (RA). Although +2018 polymorphism of IL-1Ra has been implicated in the pathogenesis of RA, its importance remains poorly understood. Hence, the purpose of this study was to determine the clinical significance of interleukin-1 receptor antagonist (IL-1Ra) +2018 polymorphism in RA. Methods Polymerase chain reaction (PCR) and sequencing were used to determine the genotypes of the IL-1Ra +2018 for 77 RA patients and 18 healthy controls. All RA patients were assessed for the disease activity score that includes 28 joints (DAS28) and radiographic disease damage based on Modified Sharp Score (MSS). Results The frequency of the T/T and C/T genotypes did not differ significantly (p = 0.893) between the RA patients and the controls. The C/T genotype had significantly higher mean disease activity (DAS 28) and disease damage (MSS) scores with p values of 0.017 and 0.004, respectively. Additionally, the ESR (erythrocyte sedimentation rate), CRP (C-reactive protein), the number of swollen and tender joints were higher for the C/T individuals. On multivariate analysis the CRP, swollen joint count and MSS remained significant with the following p values i.e. 0.045, 0.046 and less than 0.05. Conclusions C/T genotype of IL-1Ra +2018 prognosticates more aggressive disease in RA.	[Ismail, Endom; Nofal, Omimah Khaled Jaber] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor, Malaysia; [Sakthiswary, Rajalingham; Shaharir, Syahrul Sazliyana] Univ Kebangsaan Malaysia, Med Ctr, Dept Med, Fac Med, Kuala Lumpur 56000, Malaysia; [Sridharan, Radhika] Univ Kebangsaan Malaysia, Med Ctr, Dept Radiol, Fac Med, Kuala Lumpur 56000, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Sakthiswary, R (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Dept Med, Fac Med, Kuala Lumpur 56000, Malaysia.	sakthis5@hotmail.com	Sakthiswary, Rajalingham/E-8565-2017		Universiti Kebangsaan Malaysia [DLP-2013-039]	Universiti Kebangsaan Malaysia	Funded by DLP-2013-039 by Universiti Kebangsaan Malaysia.	AREND WP, 1995, ARTHRITIS RHEUM, V38, P151, DOI 10.1002/art.1780380202; Arman A, 2006, CLIN EXP RHEUMATOL, V24, P643; Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; BLAKEMORE AIF, 1994, ARTHRITIS RHEUM, V37, P1380, DOI 10.1002/art.1780370917; Buchs N, 2001, GENES IMMUN, V2, P222, DOI 10.1038/sj.gene.6363766; Cantagrel A, 1999, ARTHRITIS RHEUM, V42, P1093, DOI 10.1002/1529-0131(199906)42:6<1093::AID-ANR5>3.0.CO;2-P; Carreira PE, 2005, ARTHRITIS RHEUM-US, V52, P3015, DOI 10.1002/art.21287; Carter MJ, 2004, GENES IMMUN, V5, P8, DOI 10.1038/sj.gene.6364032; Chen Y, 2012, CLIN EXP RHEUMATOL, V30, P894; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Cox A, 1999, HUM MOL GENET, V8, P1707, DOI 10.1093/hmg/8.9.1707; Dalila AS, 2014, KAOHSIUNG J MED SCI, V30, P337, DOI 10.1016/j.kjms.2014.02.010; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Gaafar T, 2013, WORLD APPL SCI J, V27, P574; Harrison P, 2008, RHEUMATOLOGY, V47, P1768, DOI 10.1093/rheumatology/ken374; He YH, 2004, RHEUMATOL INT, V24, P133, DOI 10.1007/s00296-003-0337-9; Huang CM, 2002, CLIN RHEUMATOL, V21, P255, DOI 10.1007/s10067-002-8292-5; Huang CM, 2001, SCAND J RHEUMATOL, V30, P225; John S, 2001, ARTHRITIS RES, V3, P216, DOI 10.1186/ar304; Kapetanovic MC, 2007, J RHEUMATOL, V34, P894; Karlson EW, 2008, ANN RHEUM DIS, V67, P358, DOI 10.1136/ard.2007.071662; Kazkaz L, 2007, ANN RHEUM DIS, V66, P195, DOI 10.1136/ard.2004.033829; Lubbe S, 2008, JOINT BONE SPINE, V75, P422, DOI 10.1016/j.jbspin.2007.09.015; Mino T, 1998, ARTHRITIS RHEUM, V41, P2004, DOI 10.1002/1529-0131(199811)41:11<2004::AID-ART16>3.0.CO;2-Z; Raychaudhuri S, 2010, CURR OPIN RHEUMATOL, V22, P109, DOI 10.1097/BOR.0b013e328336474d; STEINKASSERER A, 1992, GENOMICS, V13, P654, DOI 10.1016/0888-7543(92)90137-H; Swellam M, 2013, IUBMB LIFE, V65, P883, DOI 10.1002/iub.1205; Tan WF, 2010, ARTHRITIS RHEUM-US, V62, P2864, DOI 10.1002/art.27589; Tolusso B, 2006, PHARMACOGENOMICS, V7, P683, DOI 10.2217/14622416.7.5.683; Xue J, 2010, CLIN EXP RHEUMATOL, V28, P654	32	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153752	10.1371/journal.pone.0153752	http://dx.doi.org/10.1371/journal.pone.0153752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105431	gold, Green Published, Green Submitted			2022-12-27	WOS:000374565100019
J	Molloy, SW; Davis, RA; van Etten, EJB				Molloy, Shaun W.; Davis, Robert A.; van Etten, Eddie J. B.			Incorporating Field Studies into Species Distribution and Climate Change Modelling: A Case Study of the Koomal Trichosurus vulpecula hypoleucus (Phalangeridae)	PLOS ONE			English	Article							WESTERN-AUSTRALIA; BRUSHTAIL POSSUM; RANGE; BIODIVERSITY; ADAPTATION; LANDSCAPE; IMPACTS; ABILITY; MAXENT; SPACE	Species distribution models (SDMs) are an effective way of predicting the potential distribution of species and their response to environmental change. Most SDMs apply presence data to a relatively generic set of predictive variables such as climate. However, this weakens the modelling process by overlooking the responses to more cryptic predictive variables. In this paper we demonstrate a means by which data gathered from an intensive animal trapping study can be used to enhance SDMs by combining field data with bioclimatic modelling techniques to determine the future potential distribution for the koomal (Trichosurus vulpecula hypoleucus). The koomal is a geographically isolated subspecies of the common brushtail possum, endemic to south-western Australia. Since European settlement this taxon has undergone a significant reduction in distribution due to its vulnerability to habitat fragmentation, introduced predators and tree/shrub dieback caused by a virulent group of plant pathogens of the genus Phytophthora. An intensive field study found: 1) the home range for the koomal rarely exceeded 1 km in in length at its widest point; 2) areas heavily infested with dieback were not occupied; 3) gap crossing between patches (>400 m) was common behaviour; 4) koomal presence was linked to the extent of suitable vegetation; and 5) where the needs of koomal were met, populations in fragments were demographically similar to those found in contiguous landscapes. We used this information to resolve a more accurate SDM for the koomal than that created from bioclimatic data alone. Specifically, we refined spatial coverages of remnant vegetation and dieback, to develop a set of variables that we combined with selected bioclimatic variables to construct models. We conclude that the utility value of an SDM can be enhanced and given greater resolution by identifying variables that reflect observed, species-specific responses to landscape parameters and incorporating these responses into the model.	[Molloy, Shaun W.; Davis, Robert A.; van Etten, Eddie J. B.] Edith Cowan Univ, Sch Nat Sci, Joondalup, WA, Australia	Edith Cowan University	Molloy, SW (corresponding author), Edith Cowan Univ, Sch Nat Sci, Joondalup, WA, Australia.	shaunecologist@gmail.com	van Etten, Eddie/AAC-2612-2020; Davis, Robert/F-6621-2012	van Etten, Eddie/0000-0002-7311-1794; Davis, Robert/0000-0002-9062-5754; Molloy, Shaun/0000-0002-8659-8992	Holsworth Wildlife Research Endowment; Edith Cowan University	Holsworth Wildlife Research Endowment; Edith Cowan University	Partial funding for this project was provided by the Holsworth Wildlife Research Endowment (http://www.eqt.com.au/not-for-profit-organisations/confirmed-2015-programs/holsworth-grants.aspx). All other funding, in the form of materials and wages, were covered by Edith Cowan University (https://www.ecu.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Hosking C, 2011, WILDLIFE RES, V38, P122, DOI 10.1071/WR10156; Anderson P, 2010, FOREST ECOL MANAG, V259, P1033, DOI 10.1016/j.foreco.2009.12.015; [Anonymous], 2010, MAPPING SPECIES DIST; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Benito BM, 2009, BIODIVERS CONSERV, V18, P2509, DOI 10.1007/s10531-009-9604-8; Bi DH, 2013, AUST METEOROL OCEAN, V63, P41, DOI 10.22499/2.6301.004; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Brotons L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111996; Bystriakova N, 2012, SYST BIODIVERS, V10, P305, DOI 10.1080/14772000.2012.705357; Cruz J, 2012, AUSTRAL ECOL, V37, P893, DOI 10.1111/j.1442-9993.2011.02346.x; DEC, 2007, NATUREMAP MAPP W AUS; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Fordham DA, 2012, GLOBAL CHANGE BIOL, V18, P2743, DOI 10.1111/j.1365-2486.2012.02742.x; Gibson L, 2010, BIOL CONSERV, V143, P2453, DOI 10.1016/j.biocon.2010.06.011; Giovanelli JGR, 2010, ECOL MODEL, V221, P215, DOI 10.1016/j.ecolmodel.2009.10.009; Government of Western Australia, 2013, 2013 STAT VEG STAT I; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hand BK, 2014, BIODIVERS CONSERV, V23, P2761, DOI 10.1007/s10531-014-0747-x; Hearn R, 2003, BIODIVERISTY AUDIT W, P382; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; HOBBS RJ, 1993, BIOL CONSERV, V64, P183, DOI 10.1016/0006-3207(93)90319-V; Hope P., 2015, SO S W FLATLANDS CLU; How RA, 2000, WILDLIFE RES, V27, P81, DOI 10.1071/WR98064; Huntley B, 2010, ECOGRAPHY, V33, P621, DOI 10.1111/j.1600-0587.2009.06023.x; Jakob D, 2012, W AUSTR WEATH CLIM S; Jones Barbara, 2004, P149; KERLE JA, 1991, AUST J ZOOL, V39, P313, DOI 10.1071/ZO9910313; Kim HM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051644; Meineri E, 2015, BIOL REV, V90, P314, DOI 10.1111/brv.12111; Molloy S, 2013, THESIS E COWAN U; Molloy SW, 2014, ENVIRON CONSERV, V41, P176, DOI 10.1017/S0376892913000337; Office of the Auditor General, 2007, MAN NAT VEG CLEAR AU; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Prober SM, 2012, CLIMATIC CHANGE, V110, P227, DOI 10.1007/s10584-011-0092-y; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; SAUNDERS DA, 1990, BIOL CONSERV, V54, P277, DOI 10.1016/0006-3207(90)90057-V; Schroter M, 2014, LESSONS LEARNED SPAT; Shearer B.L., 1989, JARRAH DIEBACK DYNAM; Simova P, 2012, APPL GEOGR, V34, P385, DOI 10.1016/j.apgeog.2012.01.003; Strelein G, 2007, SCRIPT DIEBACK RISK; Urban MC, 2013, ANN NY ACAD SCI, V1297, P44, DOI 10.1111/nyas.12184; Vasconcelos TS, 2012, ECOGRAPHY, V35, P539, DOI 10.1111/j.1600-0587.2011.07050.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Willis SG, 2009, ECOGRAPHY, V32, P5, DOI 10.1111/j.1600-0587.2008.05711.x; WorldClim, 2014, GLOB CLIM DAT BAS 20; Yates CJ, 2010, AUSTRAL ECOL, V35, P374, DOI 10.1111/j.1442-9993.2009.02044.x	53	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154161	10.1371/journal.pone.0154161	http://dx.doi.org/10.1371/journal.pone.0154161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104611	gold, Green Submitted, Green Published			2022-12-27	WOS:000374565100048
J	Rantakokko, M; Portegijs, E; Viljanen, A; Iwarsson, S; Rantanen, T				Rantakokko, Merja; Portegijs, Erja; Viljanen, Anne; Iwarsson, Susanne; Rantanen, Taina			Mobility Modification Alleviates Environmental Influence on Incident Mobility Difficulty among Community-Dwelling Older People: A Two-Year Follow-Up Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; COMPENSATORY STRATEGIES; DISABILITY; WALKING; ADULTS; BARRIERS; WOMEN; GAIT; PERFORMANCE; ADAPTATION	Background Environmental barriers increase risk for mobility difficulties in old age. Mobility difficulty is preceded by a phase where people try to postpone a difficulty through mobility modification. We studied whether perceived environmental mobility barriers outdoors correlate with mobility modification and mobility difficulty, predict development of mobility difficulty over a two-year follow-up, and whether mobility modification alleviates the risk for difficulty. Methods At baseline, 848 people aged 75-90 were interviewed face-to-face. Telephone follow-up interviews were conducted one (n = 816) and two years (n = 761) later. Environmental barriers to mobility were self-reported using a15-item structured questionnaire at baseline, summed and divided into tertiles (0, 1 and 2 or more barriers). Mobility difficulty was assessed as self-reported ability to walk 2 km at all assessment points and categorized into `no difficulty', 'no difficulty but mobility modifications' (reducing frequency, stopping walking, using an aid, slowing down or resting during the performance) and 'difficulty'. Results At baseline, 212 participants reported mobility modifications and 356 mobility difficulties. Those reporting one or multiple environmental barriers had twice the odds for mobility modifications and up to five times the odds for mobility difficulty compared to those reporting no environmental barriers. After multiple adjustments for health and functioning, reporting multiple environmental barriers outdoors continued to predict the development of incident mobility difficulty over the two-year follow-up. Mobility modifications attenuated the association. Conclusion For older people who successfully modify their performance, environmental influence on incident mobility difficulty can be diminished. Older people use mobility modification to alleviate environmental press on mobility.	[Rantakokko, Merja; Portegijs, Erja; Viljanen, Anne; Rantanen, Taina] Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland; [Rantakokko, Merja; Portegijs, Erja; Viljanen, Anne; Rantanen, Taina] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Iwarsson, Susanne] Lund Univ, Dept Hlth Sci, Lund, Sweden	University of Jyvaskyla; University of Jyvaskyla; Lund University	Rantakokko, M (corresponding author), Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland.; Rantakokko, M (corresponding author), Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland.	Merja.rantakokko@jyu.fi	Rantakokko, Merja/I-9779-2019; Rantakokko, Merja/HHC-5689-2022; Rantanen, Taina/O-6579-2016; Iwarsson, Susanne/I-7517-2013	Rantakokko, Merja/0000-0003-3546-1600; Rantanen, Taina/0000-0002-1604-1945; Portegijs, Erja/0000-0002-5205-9616; Viljanen, Anne/0000-0002-8428-3604; Iwarsson, Susanne/0000-0002-6670-7952	Academy of Finland [285747]; Academy of Finland Future of Living and Housing Program (ASU-LIVE) [255403]; Finnish Ministry of Education and Culture; Ribbingska Foundation in Lund, Sweden	Academy of Finland(Academy of Finland); Academy of Finland Future of Living and Housing Program (ASU-LIVE); Finnish Ministry of Education and Culture; Ribbingska Foundation in Lund, Sweden	This work was supported by Academy of Finland (grant number 285747 to [MR]); the Academy of Finland Future of Living and Housing Program (ASU-LIVE) (grant number 255403 to [TR]); the Finnish Ministry of Education and Culture to [TR and EP]; and the Ribbingska Foundation in Lund, Sweden to [SI]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfour JL, 2002, AM J EPIDEMIOL, V155, P507, DOI 10.1093/aje/155.6.507; Baltes PB, 1990, SUCCESSFUL AGING PER; Booth ML, 2000, PREV MED, V31, P15, DOI 10.1006/pmed.2000.0661; Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x; Buchner DM, 2003, AM J PREV MED, V25, P214, DOI 10.1016/S0749-3797(03)00188-0; Clarke P, 2008, AM J EPIDEMIOL, V168, P506, DOI 10.1093/aje/kwn185; Ramos-Pichardo JD, 2014, ARCH GERONTOL GERIAT, V59, P122, DOI 10.1016/j.archger.2014.02.003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedman VA, 2014, AM J PUBLIC HEALTH, V104, pE88, DOI 10.2105/AJPH.2013.301687; Fried LP, 2000, J GERONTOL A-BIOL, V55, pM43; Ganesh SP, 2011, ARCH PHYS MED REHAB, V92, P228, DOI 10.1016/j.apmr.2010.10.012; Gignac MAM, 2002, PSYCHOL AGING, V17, P520, DOI 10.1037//0882-7974.17.3.520; Gill TM, 2003, ARCH INTERN MED, V163, P1317, DOI 10.1001/archinte.163.11.1317; Gregory PC, 2011, J GERONTOL A-BIOL, V66, P577, DOI 10.1093/gerona/glr023; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Higgins TJ, 2014, J GERONTOL B-PSYCHOL, V69, P263, DOI 10.1093/geronb/gbt110; Lawton M., 1973, PSYCHOL ADULT DEV AG, P619, DOI DOI 10.1037/10044-020; LAWTON MP, 1968, GERONTOLOGIST, V8, P108, DOI 10.1093/geront/8.2.108; Lien LL, 2015, INT J ENV RES PUB HE, V12, P11954, DOI 10.3390/ijerph120911954; Manty M, 2007, ARCH PHYS MED REHAB, V88, P1108, DOI 10.1016/j.apmr.2007.06.016; Marigold DS, 2008, GAIT POSTURE, V27, P689, DOI 10.1016/j.gaitpost.2007.09.005; Rantakokko M, 2015, QUAL LIFE RES; Rantakokko M, 2014, J GERONTOL A-BIOL, V69, P1562, DOI 10.1093/gerona/glu069; Rantakokko M, 2012, AGE AGEING, V41, P118, DOI 10.1093/ageing/afr136; Rantakokko M, 2009, J AM GERIATR SOC, V57, P634, DOI 10.1111/j.1532-5415.2009.02180.x; Rantanen T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1018; Richardson JK, 2005, ARCH PHYS MED REHAB, V86, P1539, DOI 10.1016/j.apmr.2004.12.032; Rubin G., 1991, J AGING HEALTH, V3, P285, DOI [10.1177/089826439100300210, DOI 10.1177/089826439100300210]; Rush KL, 2011, CLIN NURS RES, V20, P81, DOI 10.1177/1054773810379401; Thies SB, 2005, GAIT POSTURE, V22, P26, DOI 10.1016/j.gaitpost.2004.06.004; Tsai LT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1054; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Weiss CO, 2012, ARCH GERONTOL GERIAT, V54, pE329, DOI 10.1016/j.archger.2011.08.018; Wellmon R, 2013, GAIT POSTURE, V38, P198, DOI 10.1016/j.gaitpost.2012.11.009	34	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154396	10.1371/journal.pone.0154396	http://dx.doi.org/10.1371/journal.pone.0154396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27104750	gold, Green Published, Green Submitted			2022-12-27	WOS:000374565100076
J	Brossel, R; Yahi, A; David, S; Velasquez, LM; Guinebretiere, JM				Brossel, Remy; Yahi, Alexandre; David, Stephane; Velasquez, Laura Moreno; Guinebretiere, Jean-Marc			Mechanical Signals Inhibit Growth of a Grafted Tumor In Vivo: Proof of Concept	PLOS ONE			English	Article							CANCER-CELLS; FRACTAL ANALYSIS; BREAST-CANCER; NUDE-MICE; MECHANOTRANSDUCTION; MICROENVIRONMENT; PHENOTYPE; ARCHITECTURE; METABOLISM; PLASTICITY	In the past ten years, many studies have shown that malignant tissue has been "normalized" in vitro using mechanical signals. We apply the principles of physical oncology (or mechanobiology) in vivo to show the effect of a "constraint field" on tumor growth. The human breast cancer cell line, MDA MB 231, admixed with ferric nanoparticles was grafted subcutaneously in Nude mice. The magnetizable particles rapidly surrounded the growing tumor. Two permanent magnets located on either side of the tumor created a gradient of magnetic field. Magnetic energy is transformed into mechanical energy by the particles acting as "bioactuators", applying a constraint field and, by consequence, biomechanical stress to the tumor. This biomechanical treatment was applied 2 hours/day during 21 days, from Day 18 to Day 39 following tumor implantation. The study lasted 74 days. Palpable tumor was measured two times a week. There was a significant in vivo difference between the median volume of treated tumors and untreated controls in the mice measured up to D 74 (D 59 + population): (529 [346; 966] mm(3) vs 1334 [256; 2106] mm(3); p = 0.015), treated mice having smaller tumors. The difference was not statistically significant in the group of mice measured at least to D 59 (D 59 population). On ex vivo examination, the surface of the tumor mass, measured on histologic sections, was less in the treated group, G1, than in the control groups: G2 (nanoparticles, no magnetic field), G3 (magnetic field, no nanoparticles), G4 (no nanoparticles, no magnetic field) in the D 59 population (Median left surface was significantly lower in G1 (5.6 [3.0; 42.4] mm(2), p = 0.005) than in G2 (20.8 [4.9; 34.3]), G3 (16.5 [13.2; 23.2]) and G4 (14.8 [1.8; 55.5]); Median right surface was significantly lower in G1 (4.7 [1.9; 29.2] mm(2), p = 0.015) than in G2 (25.0 [5.2; 55.0]), G3 (18.0 [14.6; 35.2]) and G4 (12.5 [1.5; 51.8]). There was no statistically significant difference in the day 59+ population. This is the first demonstration of the effect of stress on tumor growth in vivo suggesting that biomechanical intervention may have a high translational potential as a therapy in locally advanced tumors like pancreatic cancer or primary hepatic carcinoma for which no effective therapy is currently available.	[Brossel, Remy] Cell Constraint & Canc Inc CC&C, Le Mas Lhermite, Raphele Les Arl, France; [Yahi, Alexandre; Velasquez, Laura Moreno] Inst Curie, St Cloud, France; [Yahi, Alexandre] Georgia Inst Technol, Sch Elect & Comp Engn, Coll Engn, Atlanta, GA 30332 USA; [Yahi, Alexandre] Supelec, Gif Sur Yvette, France; [David, Stephane] Altran Res, Velizy Villacoublay, France; [Velasquez, Laura Moreno] Fac Med Alexis Carrel, INSERM, U1028, CNRL,CNRS,UMR5292,Physiol Integree Syst Eveil, F-69372 Lyon, France; [Guinebretiere, Jean-Marc] Hop Rene Huguenin, Dept Pathol, Inst Curie, St Cloud, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University System of Georgia; Georgia Institute of Technology; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Brossel, R (corresponding author), Cell Constraint & Canc Inc CC&C, Le Mas Lhermite, Raphele Les Arl, France.	brossel.remy@gmail.com		Moreno Velasquez, Laura/0000-0001-9735-0039	Cell Constraint & Cancer Inc, France; Cell Constraint and Cancer Inc.	Cell Constraint & Cancer Inc, France; Cell Constraint and Cancer Inc.	Cell Constraint & Cancer Inc, France funded the animal experimentation, the pathological analysis and the statistical analysis. The funder (Cell Constraint and Cancer Inc.) provided support in the form of salaries for authors (Remy Brossel, Alexandre Yahi) but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bainer R, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.COMPSYSBIO-PR09; Baish JW, 2000, CANCER RES, V60, P3683; Bizzarri M, 2011, SEMIN CANCER BIOL, V21, P175, DOI 10.1016/j.semcancer.2011.04.002; Burkel B, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.CHTME14-B02; Canetta E, 2014, ACTA BIOMATER, V10, P2043, DOI 10.1016/j.actbio.2013.12.057; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003; D'Anselmi F, 2011, INT J BIOCHEM CELL B, V43, P1052, DOI 10.1016/j.biocel.2010.05.002; Faurobert E, 2015, CURR OPIN ONCOL, V27, P64, DOI 10.1097/CCO.0000000000000154; Fernandez-Sanchez ME, 2015, NATURE, V523, P92, DOI 10.1038/nature14329; Fleury V, 2015, EUR PHYS J E, V38, DOI 10.1140/epje/i2015-15006-7; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Fuhrmann A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015007; Indra I, 2012, THESIS WAYNE STATE U; Ingber DE., 1985, GENE EXPRESSION NORM, P13; Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jonietz E, 2012, NATURE, V491, pS56, DOI 10.1038/491S56a; Katira P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00145; Lekka M, 2012, MICRON, V43, P1259, DOI 10.1016/j.micron.2012.01.019; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Montel F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188102; Murphy MF, 2013, MICROSC RES TECHNIQ, V76, P36, DOI 10.1002/jemt.22132; Nguyen T. V., 2014, NE BIOENG C NEBEC 20, P1; Olcum M, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0102-z; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Plankar M, 2011, PROG BIOPHYS MOL BIO, V106, P380, DOI 10.1016/j.pbiomolbio.2011.04.001; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Pokorny J, 2012, AIP ADV, V2, DOI 10.1063/1.3699057; Remmerbach TW, 2009, CANCER RES, V69, P1728, DOI 10.1158/0008-5472.CAN-08-4073; Ricca BL, 2013, CURR OPIN CELL BIOL, V25, P558, DOI 10.1016/j.ceb.2013.06.002; SHARKEY FE, 1984, CANCER METAST REV, V3, P341, DOI 10.1007/BF00051459; Simi AK, 2015, CANCER METAST BIOL T, V20, P139; Stein GS, 1999, FASEB J, V13, pS157; Taddei ML, 2013, CANCER LETT, V341, P80, DOI 10.1016/j.canlet.2013.01.042; Tadeo I, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00039; Trepat X, 2011, PHYSICS, V4, P85; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; WATANABE S, 1980, CANCER RES, V40, P2588; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609	42	6	6	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152885	10.1371/journal.pone.0152885	http://dx.doi.org/10.1371/journal.pone.0152885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100674	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500018
J	Cao, SX; Chen, H; Zhang, C; Tang, YF; Liu, JY; Qi, HY				Cao, Songxiao; Chen, Hao; Zhang, Chong; Tang, Yufan; Liu, Jieying; Qi, Hongyan			Heterologous Expression and Biochemical Characterization of Two Lipoxygenases in Oriental Melon, Cucumis melo var. makuwa Makino	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; 9-LIPOXYGENASE GENE; PATHOGEN INFECTION; MOLECULAR-CLONING; FLAVOR COMPOUNDS; INSECT ATTACK; OLIVE FRUIT; DEFENSE; STRESS; L.	Lipoxygenases (LOXs) are a class of non-heme iron-containing dioxygenases that catalyse oxidation of polyunsaturated fatty acids to produce hydroperoxidation that are in turn converted to oxylipins. Although multiple isoforms of LOXs have been detected in several plants, LOXs in oriental melon have not attracted much attention. Two full-length LOX cDNA clones, CmLOX10 and CmLOX13 which have been isolated from oriental melon (Cucumis melo var. makuwa Makino) cultivar "Yumeiren", encode 902 and 906 amino acids, respectively. Bioinformatics analysis showed that CmLOX10 and CmLOX13 included all of the typical LOX domains and shared 58.11% identity at the amino acid level with each other. The phylogenetic analysis revealed that CmLOX10 and CmLOX13 were members of the type 2 13-LOX subgroup which are known to be involved in biotic and abiotic stress. Heterologous expression of the full-length CmLOX10 and truncated CmLOX13 in Escherichia coli revealed that the encoded exogenous proteins were identical to the predicted molecular weights and possessed the lipoxygenase activities. The purified CmLOX10 and CmLOX13 recombinant enzymes exhibited maximum activity at different temperature and pH and both had higher affinity for linoleic acid than linolenic acid. Chromatogram analysis of reaction products from the CmLOX10 and CmLOX13 enzyme reaction revealed that both enzymes produced 13S-hydroperoxides when linoleic acid was used as substrate. Furthermore, the subcellular localization analysis by transient expression of the two LOX fusion proteins in tobacco leaves showed that CmLOX10 and CmLOX13 proteins were located in plasma membrane and chloroplasts respectively. We propose that the two lipoxygenases may play different functions in oriental melon during plant growth and development.	[Cao, Songxiao; Chen, Hao; Zhang, Chong; Tang, Yufan; Liu, Jieying; Qi, Hongyan] Shenyang Agr Univ, Coll Hort, Educ Minist & Liaoning Prov, Key Lab Protected Hort, Shenyang 110161, Liaoning, Peoples R China; [Cao, Songxiao; Qi, Hongyan] Shenyang Agr Univ, Coll Hort, Shenyang 110161, Liaoning, Peoples R China	Shenyang Agricultural University; Shenyang Agricultural University	Qi, HY (corresponding author), Shenyang Agr Univ, Coll Hort, Educ Minist & Liaoning Prov, Key Lab Protected Hort, Shenyang 110161, Liaoning, Peoples R China.; Qi, HY (corresponding author), Shenyang Agr Univ, Coll Hort, Shenyang 110161, Liaoning, Peoples R China.	hyqiaaa@126.com			National Natural Science Foundation of China [31471868]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (31471868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta IF, 2009, SCIENCE, V323, P262, DOI 10.1126/science.1164645; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; Brodhun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064919; Caldelari D, 2011, PLANT MOL BIOL, V75, P25, DOI 10.1007/s11103-010-9701-9; Chen GP, 2004, PLANT PHYSIOL, V136, P2641, DOI 10.1104/pp.104.041608; Chen Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125526; Christensen SA, 2013, PLANT J, V74, P59, DOI 10.1111/tpj.12101; Cipollini D, 2004, MOL ECOL, V13, P1643, DOI 10.1111/j.1365-294X.2004.02161.x; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Farmaki T, 2007, J EXP BOT, V58, P555, DOI 10.1093/jxb/erl230; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Feys BJ, 2000, TRENDS GENET, V16, P449, DOI 10.1016/S0168-9525(00)02107-7; Gao XQ, 2008, PLANTA, V227, P491, DOI 10.1007/s00425-007-0634-8; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gata JL, 1996, J AGR FOOD CHEM, V44, P2573, DOI 10.1021/jf960149n; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Hornung E, 1999, P NATL ACAD SCI USA, V96, P4192, DOI 10.1073/pnas.96.7.4192; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Hwang IS, 2010, PLANT PHYSIOL, V152, P948, DOI 10.1104/pp.109.147827; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kolomiets MV, 2001, PLANT CELL, V13, P613, DOI 10.1105/tpc.13.3.613; Leon J, 2002, J BIOL CHEM, V277, P416, DOI 10.1074/jbc.M107763200; Li ST, 2012, PLANT MOL BIOL REP, V30, P1283, DOI 10.1007/s11105-012-0439-1; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Liu SA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-228; Lohelaid H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089215; Long QZ, 2013, J PLANT BIOL, V56, P232, DOI 10.1007/s12374-013-0085-7; Mariutto M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-29; Padilla MN, 2014, PHYTOCHEMISTRY, V102, P80, DOI 10.1016/j.phytochem.2014.01.024; Padilla MN, 2012, PHYTOCHEMISTRY, V74, P58, DOI 10.1016/j.phytochem.2011.11.006; Padilla MN, 2009, J AGR FOOD CHEM, V57, P9097, DOI 10.1021/jf901777j; Palmieri-Thiers C, 2009, BBA-MOL CELL BIOL L, V1791, P339, DOI 10.1016/j.bbalip.2009.02.012; PENACORTES H, 1993, PLANTA, V191, P123, DOI 10.1007/BF00240903; Podolyan A, 2010, FUNCT PLANT BIOL, V37, P767, DOI 10.1071/FP09271; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Porta H, 2008, PLANTA, V227, P363, DOI 10.1007/s00425-007-0623-y; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x; Seltmann MA, 2010, PLANT PHYSIOL, V152, P1940, DOI 10.1104/pp.110.153114; SIEDOW JN, 1991, ANNU REV PLANT PHYS, V42, P145, DOI 10.1146/annurev.pp.42.060191.001045; Simpson R., 2003, PURIFYING PROTEINS P; Veronico P, 2006, PLANT PHYSIOL, V141, P1045, DOI 10.1104/pp.106.081679; Wang R, 2008, PLANT MOL BIOL, V66, P401, DOI 10.1007/s11103-007-9278-0; Wasternack C, 2002, PROG NUCLEIC ACID RE, V72, P165, DOI 10.1016/S0079-6603(02)72070-9; Zhang C, 2014, SCI HORTIC-AMSTERDAM, V170, P94, DOI 10.1016/j.scienta.2014.03.005; Zhou GX, 2009, PLANT J, V60, P638, DOI 10.1111/j.1365-313X.2009.03988.x; Zhu ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117351	50	9	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153801	10.1371/journal.pone.0153801	http://dx.doi.org/10.1371/journal.pone.0153801			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101009	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500069
J	Zhang, XY; Gamarra, J; Castro, S; Carrasco, E; Hernandez, A; Mock, T; Hadaegh, AR; Read, BA				Zhang, Xiaoyu; Gamarra, Jaime; Castro, Steven; Carrasco, Estela; Hernandez, Aaron; Mock, Thomas; Hadaegh, Ahmad R.; Read, Betsy A.			Characterization of the Small RNA Transcriptome of the Marine Coccolithophorid, Emiliania huxleyi	PLOS ONE			English	Article							PIWI-INTERACTING RNAS; DOUBLE-STRANDED-RNA; EXPERIMENTAL VALIDATION; ANTISENSE TRANSCRIPTS; ARGONAUTE PROTEINS; GENE-EXPRESSION; MICRORNAS; BIOGENESIS; GENOME; SIRNA	Small RNAs (smRNAs) control a variety of cellular processes by silencing target genes at the transcriptional or post-transcription level. While extensively studied in plants, relatively little is known about smRNAs and their targets in marine phytoplankton, such as Emiliania huxleyi (E. huxleyi). Deep sequencing was performed of smRNAs extracted at different time points as E. huxleyi cells transition from logarithmic to stationary phase growth in batch culture. Computational analyses predicted 18 E. huxleyi specific miRNAs. The 18 miRNA candidates and their precursors vary in length (18-24 nt and 71-252 nt, respectively), genome copy number (3-1,459), and the number of genes targeted (2-107). Stem-loop real time reverse transcriptase (RT) PCR was used to validate miRNA expression which varied by nearly three orders of magnitude when growth slows and cells enter stationary phase. Stem-loop RT PCR was also used to examine the expression profiles of miRNA in calcifying and non-calcifying cultures, and a small subset was found to be differentially expressed when nutrients become limiting and calcification is enhanced. In addition to miRNAs, endogenous small RNAs such as ra-siRNAs, ta-siRNAs, nat-siRNAs, and piwiRNAs were predicted along with the machinery for the biogenesis and processing of si-RNAs. This study is the first genome-wide investigation smRNAs pathways in E. huxleyi. Results provide new insights into the importance of smRNAs in regulating aspects of physiological growth and adaptation in marine phytoplankton and further challenge the notion that smRNAs evolved with multicellularity, expanding our perspective of these ancient regulatory pathways.	[Zhang, Xiaoyu; Gamarra, Jaime; Hadaegh, Ahmad R.] Calif State Univ, Dept Comp Sci & Informat Syst, San Marcos, CA 92096 USA; [Castro, Steven; Carrasco, Estela; Hernandez, Aaron; Read, Betsy A.] Calif State Univ, Dept Biol Sci, San Marcos, CA 92096 USA; [Mock, Thomas] Univ E Anglia, Sch Environm Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England	California State University System; California State University San Marcos; California State University System; California State University San Marcos; University of East Anglia	Read, BA (corresponding author), Calif State Univ, Dept Biol Sci, San Marcos, CA 92096 USA.	bread@csusm.edu	Zhang, xiaoyu/GXA-3206-2022; Mock, Thomas/A-3127-2008	Mock, Thomas/0000-0001-9604-0362	National Institutes of Health (NIH) Support of Competitive Research (SCORE) Grant [5SC3GM092765]; NERC [NE/M005755/1] Funding Source: UKRI	National Institutes of Health (NIH) Support of Competitive Research (SCORE) Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Support for the work of XZ and BR was provided by National Institutes of Health (NIH) Support of Competitive Research (SCORE) Grant 5SC3GM092765 "Characterization of Small Silencing RNAs in Emiliania Huxleyi". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Billoud B, 2014, NUCLEIC ACIDS RES, V42, P417, DOI 10.1093/nar/gkt856; Bonnet E, 2006, NEW PHYTOL, V171, P451, DOI 10.1111/j.1469-8137.2006.01806.x; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; De Bodt C, 2008, MINERAL MAG, V72, P251, DOI 10.1180/minmag.2008.072.1.251; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Enright AJ, 2004, GENOME BIOL, V5; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Gao ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109997; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Handler D, 2011, EMBO J, V30, P3977, DOI 10.1038/emboj.2011.308; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HOLLIGAN PM, 1983, NATURE, V304, P339, DOI 10.1038/304339a0; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Jain R, 2011, RNA, V17, P429, DOI 10.1261/rna.2500711; Jin H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-6; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kegel JU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080684; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Kramer Martha F, 2011, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1510s95; Kutter C, 2008, RNA BIOL, V5, P181, DOI 10.4161/rna.7227; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Luhur A, 2014, P NATL ACAD SCI USA, V111, P1421, DOI 10.1073/pnas.1318445111; Mackinder L, 2011, ENVIRON MICROBIOL, V13, P3250, DOI 10.1111/j.1462-2920.2011.02561.x; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200; Marker S, 2010, NUCLEIC ACIDS RES, V38, P4092, DOI 10.1093/nar/gkq131; MARLOWE IT, 1990, CHEM GEOL, V88, P349, DOI 10.1016/0009-2541(90)90098-R; MARLOWE IT, 1984, BRIT PHYCOL J, V19, P203, DOI 10.1080/00071618400650221; Maurin T, 2012, RNA, V18, P2166, DOI 10.1261/rna.036194.112; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Midura RJ, 1996, GLYCOBIOLOGY, V6, P677, DOI 10.1093/glycob/6.7.677; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Norden-Krichmar TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022870; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Firmino AAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085079; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Rokitta SD, 2011, J PHYCOL, V47, P829, DOI 10.1111/j.1529-8817.2011.01014.x; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Shiraiwa Y, 2003, COMP BIOCHEM PHYS B, V136, P775, DOI 10.1016/S1096-4959(03)00221-5; Singh RK, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0364-6; Smit AFA, 2010, REPEATMASKER OPEN 3; Smith S. V., 2013, PARSING OCEANIC CALC; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Strommer J, 1993, ISOLATION CHARACTERI, P49; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; Thomassen GOS, 2006, J BIOMED BIOTECHNOL, V2006, P1; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; von Dassow P, 2015, ISME J, V9, P1365, DOI 10.1038/ismej.2014.221; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; Yan ZG, 2007, BBA-GEN SUBJECTS, V1770, P1338, DOI 10.1016/j.bbagen.2007.06.018; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yi SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-754; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang XM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r20; Zhang Y, 2011, BIOINFORMATICS, V27, P771, DOI 10.1093/bioinformatics/btr016; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	88	10	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154279	10.1371/journal.pone.0154279	http://dx.doi.org/10.1371/journal.pone.0154279			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101007	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500177
J	Mendoza, Y; Mewa, JC; Martinez, AA; Zaldivar, Y; Sosa, N; Arteaga, G; Armien, B; Bautista, CT; Garcia-Morales, C; Tapia-Trejo, D; Avila-Rios, S; Reyes-Teran, G; Bello, G; Pascale, JM				Mendoza, Yaxelis; Mewa, Juan Castillo; Martinez, Alexander A.; Zaldivar, Yamitzel; Sosa, Nestor; Arteaga, Griselda; Armien, Blas; Bautista, Christian T.; Garcia-Morales, Claudia; Tapia-Trejo, Daniela; Avila-Rios, Santiago; Reyes-Teran, Gustavo; Bello, Gonzalo; Pascale, Juan M.			HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naive and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITORS; SUBTYPE B; VIROLOGICAL FAILURE; SURVEILLANCE; EPIDEMIC; INDIVIDUALS; MECHANISM; INFECTION; PATTERNS	The use of antiretroviral therapy in HIV infected subjects prevents AIDS-related illness and delayed occurrence of death. In Panama, rollout of ART started in 1999 and national coverage has reached 62.8% since then. The objective of this study was to determine the level and patterns of acquired drug resistance mutations of clinical relevance (ADR-CRM) and surveillance drug resistance mutations (SDRMs) from 717 HIV-1 pol gene sequences obtained from 467 ARV drug-experienced and 250 ARV drug-naive HIV-1 subtypes B infected subjects during 2007-2013, respectively. The overall prevalence of SDRM and of ADR-CRM during the study period was 9.2% and 87.6%, respectively. The majority of subjects with ADR-CRM had a pattern of mutations that confer resistance to at least two classes of ARV inhibitors. The non-nucleoside reverse transcriptase inhibitor (NNRTI) mutations K103N and P225H were more prevalent in both ARV drug-naive and ARV drug-experienced subjects. The nucleoside reverse transcriptase inhibitor (NRTI) mutation M184V was more frequent in ARV drug-experienced individuals, while T215YFrev and M41L were more frequent in ARV drug-naive subjects. Prevalence of mutations associated to protease inhibitors (PI) was lower than 4.1% in both types of subjects. Therefore, there is a high level of resistance (>73%) to Efavirenz/Nevirapine, Lamivudine and Azidothymidine in ARV drug-experienced subjects, and an intermediate to high level of resistance (5-10%) to Efavirenz/Nevirapine in ARV drug-naive subjects. During the study period, we observed an increasing trend in the prevalence of ADR-CRM in subjects under first-line schemes, but not significant changes in the prevalence of SDRM. These results reinforce the paramount importance of a national surveillance system of ADR-CRM and SDRM for national management policies of subjects living with HIV.	[Mendoza, Yaxelis; Mewa, Juan Castillo; Martinez, Alexander A.; Zaldivar, Yamitzel; Sosa, Nestor; Armien, Blas; Bautista, Christian T.; Pascale, Juan M.] Gorgas Mem Inst Hlth Studies, Direct Res & Technol Dev, Panama City, Panama; [Mendoza, Yaxelis; Martinez, Alexander A.] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur City, India; [Mendoza, Yaxelis] Univ Panama, Sch Biol, Dept Genet & Mol Biol, Panama City, Panama; [Mendoza, Yaxelis; Martinez, Alexander A.] Inst Sci Res & High Technol Serv Panama, Panama City, Panama; [Arteaga, Griselda; Pascale, Juan M.] Univ Panama, Sch Med, Dept Microbiol, Panama City, Panama; [Armien, Blas] Univ Interamer Panama, Fac Ciencias Salud, Panama City, Panama; [Garcia-Morales, Claudia; Tapia-Trejo, Daniela; Avila-Rios, Santiago; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico; [Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil	Instituto Conmemorativo Gorgas de Estudios de la Salud; Acharya Nagarjuna University; Universidad de Panama; Universidad de Panama; Fundacao Oswaldo Cruz	Pascale, JM (corresponding author), Gorgas Mem Inst Hlth Studies, Direct Res & Technol Dev, Panama City, Panama.; Pascale, JM (corresponding author), Univ Panama, Sch Med, Dept Microbiol, Panama City, Panama.	jpascale@gorgas.gob.pa	Bentancor, Gonzalo Jose Bello/N-7377-2019; Martínez, Alexander/HHC-2101-2022; Avila-Rios, Santiago/AAB-4383-2020; Bello, Gonzalo/E-6842-2013	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Bautista, Christian/0000-0002-1228-0754; Reyes-Teran, Gustavo/0000-0002-4115-4888	Department of Genomics and Proteomics (ICGES, Panama); Ministry of Health (Panama); International Atomic Energy Agency (IAEA, Austria) [PAN-6011]; Secretaria de Ciencia y Tecnologia (SENACYT, Panama) [ECS11-012]; SENACYT; Instituto para la Formacion de Recursos Humanos (IFARHU)	Department of Genomics and Proteomics (ICGES, Panama); Ministry of Health (Panama); International Atomic Energy Agency (IAEA, Austria)(International Atomic Energy Agency); Secretaria de Ciencia y Tecnologia (SENACYT, Panama); SENACYT; Instituto para la Formacion de Recursos Humanos (IFARHU)	This work was supported by the Department of Genomics and Proteomics (ICGES, Panama), the Ministry of Health (Panama), grants PAN-6011 from the International Atomic Energy Agency (IAEA, Austria) and grants ECS11-012 from Secretaria de Ciencia y Tecnologia (SENACYT, Panama). YM was funded by a fellowship from SENACYT and Instituto para la Formacion de Recursos Humanos (IFARHU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada-Ruiz S, 2008, AIDS RES HUM RETROV, V24, P1461, DOI 10.1089/aid.2008.0153; Ahumada-Ruiz S, 2009, INFECT GENET EVOL, V9, P933, DOI 10.1016/j.meegid.2009.06.013; Altfeld M, 2012, HIV 2012 2013; [Anonymous], 2011, B EST, P113; [Anonymous], 1999, AIDS TREATMENT NEWS; [Anonymous], 2011, NORM MAN TER PERS CO; [Anonymous], 2006, NIV FLUJ REC COST EN; [Anonymous], 2007, NORM MAN TER PERS CO; [Anonymous], 2006, NORM AT INT PERS CON; Avila-Rios S, 2015, AIDS RES HUM RETROV, V31, P401, DOI 10.1089/aid.2014.0057; Avila-Rios S, 2011, REV PANAM SALUD PUBL, V30, P641, DOI 10.1590/S1020-49892011001200024; Avila-Rios S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027812; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Cabello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106045; Castillo J, 2011, REV PANAM SALUD PUBL, V30, P649, DOI 10.1590/S1020-49892011001200025; Comision Nacional para la Prevencion y Control del VIH SIDA C, 2009, PLAN ESTR NAC MULT I, P1; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072448; DiazGranados CA, 2010, INT J INFECT DIS, V14, pE298, DOI 10.1016/j.ijid.2009.05.006; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; Holguin A, 2013, CLIN MICROBIOL INFEC, V17, P1469; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; Ivetac A, 2009, J MOL BIOL, V388, P644, DOI 10.1016/j.jmb.2009.03.037; Iyidogan P, 2014, VIRUSES-BASEL, V6, P4095, DOI 10.3390/v6104095; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; LARDER BA, 1991, J VIROL, V65, P5232, DOI 10.1128/JVI.65.10.5232-5236.1991; Lessells RJ, 2012, CURR OPIN VIROL, V2, P636, DOI 10.1016/j.coviro.2012.08.006; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Li Z, 2012, AIDS, V26, P877, DOI 10.1097/QAD.0b013e328351430d; Li ZF, 2013, ANTIMICROB AGENTS CH, V57, P5500, DOI 10.1128/AAC.01195-13; Marcelin AG, 2004, J MED VIROL, V72, P162, DOI 10.1002/jmv.10550; Mendoza Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095360; Mendoza Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085153; Meresse M, 2014, HIV MED, V15, P478, DOI 10.1111/hiv.12140; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Murillo W, 2010, J CLIN VIROL, V49, P239, DOI 10.1016/j.jcv.2010.03.013; Nadai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004814; Nunez A, 2014, INFROM NACL PROGR RE; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ren J, 2000, STRUCTURE, V8, P1089, DOI 10.1016/S0969-2126(00)00513-X; Santoro MM, 2013, ISRN MICROBIOL, V2013, DOI DOI 10.1155/2013/481314; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Sui HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091803; UNAIDS, 2015, FACT SHEET GLOB HIV; Vingerhoets J, 2009, ANTIVIR THER, V14, pA35; Wheeler DA, 2001, JAMA-J AM MED ASSOC, V286, P853, DOI 10.1001/jama.286.7.853; WHO, 2012, WHO GLOB STRAT SURV	53	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154317	10.1371/journal.pone.0154317	http://dx.doi.org/10.1371/journal.pone.0154317			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119150	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200060
J	Fumian, TM; de Andrade, JDR; Leite, JPG; Miagostovich, MP				Fumian, Tulio Machado; Ribeiro de Andrade, Juliana da Silva; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira			Norovirus Recombinant Strains Isolated from Gastroenteritis Outbreaks in Southern Brazil, 2004-2011	PLOS ONE			English	Article							GENETIC DIVERSITY; UNITED-STATES; MOLECULAR EPIDEMIOLOGY; ASYMPTOMATIC CHILDREN; PREVALENCE; EMERGENCE; VARIANT; RNA	Noroviruses are recognized as one of the leading causes of viral acute gastroenteritis, responsible for almost 50% of acute gastroenteritis outbreaks worldwide. The positive single-strand RNA genome of noroviruses presents a high mutation rate and these viruses are constantly evolving by nucleotide mutation and genome recombination. Norovirus recombinant strains have been detected as causing acute gastroenteritis outbreaks in several countries. However, in Brazil, only one report of a norovirus recombinant strain (GII.P7/GII.20) has been described in the northern region so far. For this study, 38 norovirus strains representative of outbreaks, 11 GII.4 and 27 non-GII.4, were randomly selected and amplified at the ORF1/ORF2 junction. Genetic recombination was identified by constructing phylogenetic trees of the polymerase and capsid genes, and further SimPlot and Bootscan analysis of the ORF1/ORF2 overlap. Sequence analysis revealed that 23 out of 27 (85%) non-GII.4 noroviruses were recombinant strains, characterized as: GII.P7/GII. 6 (n = 9); GIIP.g/GII.12 (n = 4); GII.P16/GII.3 (n = 4); GII.Pe/GII.17 (n = 2); GII.P7/GII. 14 (n = 1); GII.P13/GII. 17 (n = 1); GII.P21/GII. 3 (n = 1); and GII.P21/GII. 13 (n = 1). On the other hand, among the GII.4 variants analyzed (Den Haag_2006b and New Orleans_2009) no recombination was observed. These data revealed the great diversity of norovirus recombinant strains associated with outbreaks, and describe for the first time these recombinant types circulating in Brazil. Our results obtained in southern Brazil corroborate the previous report for the northern region, demonstrating that norovirus recombinant strains are circulating more frequently than we expected. In addition, these results emphasize the relevance of including ORF1/ORF2-based analysis in surveillance studies as well as the importance of characterizing strains from other Brazilian regions to obtain epidemiological data for norovirus recombinant strains circulating in the country.	[Fumian, Tulio Machado; Ribeiro de Andrade, Juliana da Silva; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Fumian, TM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, Brazil.	tuliomf@ioc.fiocruz.br	LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020; Fumian, Tulio/AAC-4724-2021		Excellence Program of Research (PROEP-CNPq/IOC); General Coordination of Laboratories/Secretary of Health Surveillance, Ministry of Health	Excellence Program of Research (PROEP-CNPq/IOC); General Coordination of Laboratories/Secretary of Health Surveillance, Ministry of Health	This work was funded by Excellence Program of Research (PROEP-CNPq/IOC) and General Coordination of Laboratories/Secretary of Health Surveillance, Ministry of Health. MP Miagostovich and JPG Leite are CNPq fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragao GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056608; Arana A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098875; Atmar RL, 2006, GASTROENTEROL CLIN N, V35, P275, DOI 10.1016/j.gtc.2006.03.001; Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P41; Chan MCW, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00140-12; Chhabra P, 2010, VIRUS RES, V147, P242, DOI 10.1016/j.virusres.2009.11.007; de Graaf M, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.26.21178; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Fajardo A, 2014, INFECT GENET EVOL, V28, P328, DOI 10.1016/j.meegid.2014.10.026; Fioretti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092988; Fioretti JM, 2011, MEM I OSWALDO CRUZ, V106, P942, DOI 10.1590/S0074-02762011000800008; Fumian TM, 2012, ARCH VIROL, V157, P2389, DOI 10.1007/s00705-012-1428-2; Fumian TM, 2013, J CLIN VIROL, V58, P31, DOI 10.1016/j.jcv.2013.06.043; Giammanco GM, 2012, INFECT GENET EVOL, V12, P169, DOI 10.1016/j.meegid.2011.10.021; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Barreira DMPG, 2010, J CLIN VIROL, V47, P60, DOI 10.1016/j.jcv.2009.11.012; Green K, FIELDS VIROLOGY, P949; Hall AJ, 2013, EMERG INFECT DIS, V19, P1305, DOI 10.3201/eid1908.130482; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han TH, 2011, ARCH VIROL, V156, P323, DOI 10.1007/s00705-010-0844-4; Huynen P, 2013, J CLIN VIROL, V58, P515, DOI 10.1016/j.jcv.2013.08.013; JIANG X, 1990, Science (Washington D C), V250, P1580; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Lim KL, 2013, J MED VIROL, V85, P1842, DOI 10.1002/jmv.23669; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mahar JE, 2011, J MED VIROL, V83, P2213, DOI 10.1002/jmv.22215; Mans J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-168; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Mathijs E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-310; Medici MC, 2014, VIRUS RES, V188, P142, DOI 10.1016/j.virusres.2014.04.005; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Nahar S, 2013, INFECT GENET EVOL, V20, P325, DOI 10.1016/j.meegid.2013.09.021; Lemes LGN, 2014, J CLIN VIROL, V61, P329, DOI 10.1016/j.jcv.2014.08.004; Puustinen L, 2011, SCAND J INFECT DIS, V43, P804, DOI 10.3109/00365548.2011.588610; de Andrade JDR, 2014, J CLIN VIROL, V61, P345, DOI 10.1016/j.jcv.2014.08.024; Ferreira MSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033754; Sang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088210; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Takanashi S, 2011, J CLIN MICROBIOL, V49, P3234, DOI 10.1128/JCM.00305-11; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Vega E, 2011, EMERG INFECT DIS, V17, P1516, DOI 10.3201/eid1708.110025; White PA, 2014, CLIN MICROBIOL INFEC, V20, P741, DOI 10.1111/1469-0691.12746; Wu XF, 2015, ARCH VIROL, V160, P1705, DOI 10.1007/s00705-015-2440-0; Yu YX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/196169; Zeng M, 2011, JPN J INFECT DIS, V64, P417; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	54	29	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0145391	10.1371/journal.pone.0145391	http://dx.doi.org/10.1371/journal.pone.0145391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116353	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600003
J	Kruse, N; Schlossmacher, MG; Schulz-Schaeffer, WJ; Vanmechelen, E; Vanderstichele, H; El-Agnaf, OM; Mollenhauer, B				Kruse, Niels; Schlossmacher, Michael G.; Schulz-Schaeffer, Walter J.; Vanmechelen, Eugeen; Vanderstichele, Hugo; El-Agnaf, Omar M.; Mollenhauer, Brit			A First Tetraplex Assay for the Simultaneous Quantification of Total alpha-Synuclein, Tau, beta-Amyloid(42) and DJ-1 in Human Cerebrospinal Fluid	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; LEWY BODIES; PARKINSONS-DISEASE; COGNITIVE IMPAIRMENT; BIOMARKERS; DEMENTIA; VALIDATION; PROTEIN; BETA; IMMUNOASSAY	The quantification of four distinct proteins (alpha-synuclein, beta-amyloid(1-42), DJ-1, and total tau) in cerebrospinal fluid (CSF) has been proposed as a laboratory-based platform for the diagnosis of Parkinson's disease (PD) and Alzheimer's disease (AD). While there is some clinical utility in measuring these markers individually, their usage in routine clinical testing remains challenging, in part due to substantial overlap of concentrations between healthy controls and diseased subjects. In contrast, measurement of different analytes in a single sample from individual patients in parallel appears to considerably improve the accuracy of AD or PD diagnosis. Here, we report the development and initial characterization of a first, electrochemiluminescence-based multiplex immunoassay for the simultaneous quantification of all four proteins ('tetraplex') in as little as 50 mu l of CSF. In analytical performance experiments, we assessed its sensitivity, spike-recovery rate, parallelism and dilution linearity as well as the intra-and inter-assay variability. Using our in-house calibrators, we recorded a lower limit of detection for alpha-synuclein, beta-amyloid(42), DJ-1, and t-tau of 1.95, 1.24, 5.63, and 4.05 pg/ml, respectively. The corresponding, linear concentration range covered > 3 orders of magnitude. In diluted CSF samples (up to 1: 4), spike-recovery rates ranged from a low of 55% for beta-amyloid(42) to a high of 98% for DJ-1. Hillslopes ranged from 1.03 to 1.30, and inter-assay variability demonstrated very high reproducibility. Our newly established tetraplex assay represents a significant technical advance for fluid-based biomarker studies in neurodegenerative disorders allowing the simultaneous measurement of four pivotal makers in single CSF specimens. It provides exceptional sensitivity, accuracy and speed.	[Kruse, Niels; Schulz-Schaeffer, Walter J.] Univ Med Ctr, Dept Neuropathol, Gottingen, Germany; [Schlossmacher, Michael G.] Univ Ottawa, Ottawa Hosp, Program Neurosci, Brain & Mind Res Inst, Ottawa, ON, Canada; [Schlossmacher, Michael G.] Univ Ottawa, Ottawa Hosp, Div Neurol, Brain & Mind Res Inst, Ottawa, ON, Canada; [Vanmechelen, Eugeen; Vanderstichele, Hugo] ADx NeuroSci, R&D, Ghent, Belgium; [El-Agnaf, Omar M.] HBKU, Qatar Fdn, Neurol Disorders Ctr, Qatar Biomed Res Inst, Doha, Qatar; [El-Agnaf, Omar M.] HBKU, Coll Sci & Engn, Qatar Fdn, Doha, Qatar; [Mollenhauer, Brit] Paracelsus Elena Klin, Kassel, Germany; [Mollenhauer, Brit] Univ Med Ctr, Gottingen, Germany	University of Gottingen; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI); Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; University of Gottingen	Kruse, N (corresponding author), Univ Med Ctr, Dept Neuropathol, Gottingen, Germany.	n.kruse@med.uni-goettingen.de	Vanderstichele, Hugo/AAD-2601-2019; Kruse, Niels/AAN-7037-2020; Vanmechelen, Eugeen/AAA-8005-2019	Schlossmacher, Michael/0000-0002-0394-0300; Vanmechelen, Eugeen/0000-0002-9466-5366	Michael J. Fox Foundation for Parkinson's Research (MJFF); ADx NeuroSciences	Michael J. Fox Foundation for Parkinson's Research (MJFF); ADx NeuroSciences	This work was funded by the Michael J. Fox Foundation for Parkinson's Research (MJFF). Eugeen Vanmechelen and Hugo Vanderstichele are affiliated to ADx NeuroSciences. ADx NeuroSciences provided support in the form of salaries for authors EV and HV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Aerts MB, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.001; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; Bastarache JA, 2014, J IMMUNOL METHODS, V408, P13, DOI 10.1016/j.jim.2014.04.006; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; Clark CM, 2003, ARCH NEUROL-CHICAGO, V60, P1696, DOI 10.1001/archneur.60.12.1696; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Ellington AA, 2009, CLIN CHEM, V55, P1092, DOI 10.1373/clinchem.2008.120717; European Medicine Agency, 2011, GUID BIOM METH VAL; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Kanemaru K, 2000, NEUROLOGY, V54, P1875, DOI 10.1212/WNL.54.9.1875; Kruse N, 2015, NEUROBIOL AGING, V36, P2587, DOI 10.1016/j.neurobiolaging.2015.05.003; Kruse N, 2012, METHODS, V56, P514, DOI 10.1016/j.ymeth.2012.03.016; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Leviton A, 2013, J CHILD NEUROL, V28, P1637, DOI 10.1177/0883073812463068; Marchese RD, 2009, CLIN VACCINE IMMUNOL, V16, P387, DOI 10.1128/CVI.00415-08; Mattsson N, 2011, ALZHEIMERS DEMENT, V7, P386, DOI 10.1016/j.jalz.2011.05.2243; Mollenhauer B, 2005, DEMENT GERIATR COGN, V19, P164, DOI 10.1159/000083178; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2012, J NEURAL TRANSM, V119, P739, DOI 10.1007/s00702-012-0784-0; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Mollenhauer B, 2010, BIOMARK MED, V4, P683, DOI 10.2217/BMM.10.90; Montine TJ, 2010, MOVEMENT DISORD, V25, P2682, DOI 10.1002/mds.23287; Ostendorff HP, 2013, J IMMUNOL METHODS, V400, P58, DOI 10.1016/j.jim.2013.09.013; Pan C, 2015, J ALZHEIMERS DIS, V45, P709, DOI 10.3233/JAD-143099; Schade S, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0072-3; Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0; Sharma J, 2014, PROSTATE, V74, P820, DOI 10.1002/pros.22788; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Thway T, 2010, J PHARMACEUT BIOMED, V51, P626, DOI 10.1016/j.jpba.2009.09.035; U.S. FDA, 1998, GUIDANCE IND BIOANAL	36	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153564	10.1371/journal.pone.0153564	http://dx.doi.org/10.1371/journal.pone.0153564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116005	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600024
J	Ren, XX; Chen, ZA; Zheng, S; Han, TT; Li, YX; Liu, W; Hu, YM				Ren, Xingxing; Chen, Zeng. ai; Zheng, Shuang; Han, Tingting; Li, Yangxue; Liu, Wei; Hu, Yaomin			Association between Triglyceride to HDL-C Ratio (TG/HDL-C) and Insulin Resistance in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; BETA-CELL FUNCTION; HOMEOSTASIS MODEL ASSESSMENT; GLUCOSE CLAMP TECHNIQUE; CORONARY-HEART-DISEASE; AFRICAN-AMERICANS; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; KOREAN POPULATION; PLASMA-GLUCOSE	Objectives To explore the association between the triglyceride to HDL-C ratio (TG/HDL-C) and insulin resistance in Chinese patients with newly diagnosed type 2 diabetes mellitus. Methods Patients with newly diagnosed type 2 diabetes mellitus (272 men and 288 women) were enrolled and divided into three groups according to TG/HDL-C tertiles. Insulin resistance was defined by homeostatic model assessment of insulin resistance (HOMA-IR). Demographic information and clinical characteristics were obtained. Spearman's correlation was used to estimate the association between TG/HDL-C and other variables. Multiple logistic regression analyses were adopted to obtain probabilities of insulin resistance. A receiver operating characteristic analysis was conducted to evaluate the ability of TG/HDL-C to discriminate insulin resistance. Results TG/HDL-C was associated with insulin resistance in Chinese patients with newly diagnosed T2DM (Spearman's correlation coefficient = 0.21, P < 0.01). Patients in the higher tertiles of TG/HDL-C had significantly higher HOMA-IR values than patients in the lower tertiles [T1: 2.68(1.74-3.70); T2: 2.96(2.29-4.56); T3: 3.09(2.30-4.99)]. Multiple logistic regression analysis showed that TG/HDL-C was significantly associated with HOMA-IR, and patients in the higher TG/HDL-C tertile had a higher OR than those in the lower TG/HDL-C tertile, after adjusting for multiple covariates including indices for central obesity [T1: 1; T2: 4.02 (1.86-8.71); T3: 4.30(1.99-9.29)]. Following stratification of waist circumference into quartiles, the effect of TG/HDL-C on insulin resistance remained significant irrespective of waist circumference. Conclusions TG/HDL-C was associated with insulin resistance independent of waist circumference. Whether it could be a surrogate marker for insulin resistance in Chinese patients with newly diagnosed type 2 diabetes mellitus still needs to be confirmed by more researches.	[Ren, Xingxing; Zheng, Shuang; Han, Tingting; Li, Yangxue; Liu, Wei; Hu, Yaomin] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Endocrinol, Shanghai 200030, Peoples R China; [Chen, Zeng. ai] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Radiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hu, YM (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Endocrinol, Shanghai 200030, Peoples R China.	amin1031@hotmail.com	HAN, TINGTING/GQZ-8692-2022		National Scientific Foundation of China [81270946, 81170758, 30670988]; Foundation from Renji Hospital; Shanghai Jiaotong University [RJZZ14-003]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation from Renji Hospital; Shanghai Jiaotong University	This work was supported by National Scientific Foundation of China ( No. 81270946, 81170758, 30670988), http://www.nsfc.gov.cn/; Foundation from Renji Hospital, Shanghai Jiaotong University (RJZZ14-003), http://www.renji.com/index.aspx, receiver: Yaomi Hu. All sponsors or funders played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aoyama-Sasabe S, 2014, J DIABETES INVEST, V5, P663, DOI 10.1111/jdi.12239; Armato J., 2015, ENDOCR PRACT, V21, P495, DOI [DOI 10.4158/EP14479.OR, 10.4158/EP14479.OR]; Bacopoulou F, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0366-z; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Bittner V, 2009, AM HEART J, V157, P548, DOI 10.1016/j.ahj.2008.11.014; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Bovet P, 2006, ARCH INTERN MED, V166, P1236, DOI 10.1001/archinte.166.11.1236-b; Chen SY, 2014, ENDOCRINE, V46, P496, DOI 10.1007/s12020-013-0079-8; Chen SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074058; Chiang JK, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-93; Colman PG, 1999, NEW ZEAL MED J, V112, P139; Cordero A, 2009, AM J CARDIOL, V104, P1393, DOI 10.1016/j.amjcard.2009.07.008; Coresh J, 1996, JAMA-J AM MED ASSOC, V276, P914, DOI 10.1001/jama.276.11.914; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dobiasova M, 2000, Vnitr Lek, V46, P152; Festa A, 2006, DIABETES, V55, P1114, DOI 10.2337/diabetes.55.04.06.db05-1100; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; Gasevic D, 2012, METABOLISM, V61, P583, DOI 10.1016/j.metabol.2011.09.009; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Hadaegh F, 2009, NUTR METAB CARDIOVAS, V19, P401, DOI 10.1016/j.numecd.2008.09.003; Haffner SM, 1999, DIABETES CARE, V22, P562, DOI 10.2337/diacare.22.4.562; He JY, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/105168; He S, 2012, METABOLISM, V61, P30, DOI 10.1016/j.metabol.2011.05.007; Hermans MP, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-88; Hirschler V, 2015, PEDIATR DIABETES, V16, P606, DOI 10.1111/pedi.12228; Hu Y, 2007, J LIPID RES, V48, P1681, DOI 10.1194/jlr.M600382-JLR200; Hu YM, 2006, J LIPID RES, V47, P1908, DOI 10.1194/jlr.M600108-JLR200; Kang HT, 2012, NUTR METAB CARDIOVAS, V22, P1054, DOI 10.1016/j.numecd.2011.01.013; Kim JS, 2012, DIABETES RES CLIN PR, V97, P132, DOI 10.1016/j.diabres.2012.04.022; Kim-Dorner SJ, 2010, METABOLISM, V59, P299, DOI 10.1016/j.metabol.2009.07.027; Kimm H, 2010, CIRC J, V74, P931, DOI 10.1253/circj.CJ-09-0571; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Li CY, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-4; Maruyama Chizuko, 2003, J Atheroscler Thromb, V10, P186; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Molarius A, 1999, INT J OBESITY, V23, P116, DOI 10.1038/sj.ijo.0800772; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Rajappa Medha, 2014, ISRN Endocrinol, V2014, P981524, DOI 10.1155/2014/981524; Ray Sayantan, 2012, Indian J Endocrinol Metab, V16, pS460, DOI 10.4103/2230-8210.104132; Reaven G, 2006, ARCH INTERN MED, V166, P249, DOI 10.1001/archinte.166.2.249-a; Simental-Mendia LE, 2015, EUR J PEDIATR, V174, P597, DOI 10.1007/s00431-014-2426-z; Sumner AE, 2005, ARCH INTERN MED, V165, P1395, DOI 10.1001/archinte.165.12.1395; Sun GZ, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-189; Tanaka S, 2003, ACTA DIABETOL, V40, pS302, DOI 10.1007/s00592-003-0093-z; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang H, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/725731; [邢小燕 Xing Xiaoyan], 2004, [中华糖尿病杂志, Chinese Journal of Diabetes], V12, P182; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171; Zhang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116110; Zheng S, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0018-1	53	56	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154345	10.1371/journal.pone.0154345	http://dx.doi.org/10.1371/journal.pone.0154345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115999	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600060
J	Begum, M; Lewison, G; Wright, JSF; Pallari, E; Sullivan, R				Begum, Mursheda; Lewison, Grant; Wright, John S. F.; Pallari, Elena; Sullivan, Richard			European Non-Communicable Respiratory Disease Research, 2002-13: Bibliometric Study of Outputs and Funding	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CLIMATE-CHANGE; CYSTIC-FIBROSIS; CHILDHOOD ASTHMA; COMMON RAGWEED; PUBLIC-HEALTH; SMOKING; BURDEN; COPD; INDICATORS	This study was conducted in order to map European research in chronic respiratory diseases (CRDs). It was intended to assist the European Commission and other research funders to identify gaps and overlaps in their portfolios, and to suggest ways in which they could improve the effectiveness of their support and increase the impact of the research on patient care and on the reduction of the incidence of the CRDs. Articles and reviews were identified in the Web of Science on research in six non-communicable respiratory diseases that were published in 2002-13 from 31 European countries. They represented only 0.8% of biomedical research output but these diseases accounted for 4.7% of the European disease burden, as measured by Disability-Adjusted Life Years (DALYs), so the sub-field is seriously under-researched. Europe is prominent in the sub-field and published 56% of the world total, with the UK the most productive and publishing more than France and Italy, the next two countries, combined. Asthma and Chronic Obstructive Pulmonary Disease (COPD) were the diseases with the most publications and the highest citation rates. They also received the most funding, with around two acknowledgments per paper (in 2009-13), whereas cystic fibrosis and emphysema averaged only one. Just over 37% of papers had no specific funding and depended on institutional support from universities and hospitals.	[Begum, Mursheda; Lewison, Grant; Pallari, Elena; Sullivan, Richard] Kings Coll London, Dept Canc Studies, Div Canc Epidemiol & Populat Hlth, Guys Hosp, London WC2R 2LS, England; [Wright, John S. F.] Univ London London Sch Econ & Polit Sci, LSE Hlth, Dept Social Policy, Houghton St, London WC2A 2AE, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; London School Economics & Political Science	Lewison, G (corresponding author), Kings Coll London, Dept Canc Studies, Div Canc Epidemiol & Populat Hlth, Guys Hosp, London WC2R 2LS, England.	grant.lewison@kcl.ac.uk	Pallari, Elena/AAC-8223-2020	Pallari, Elena/0000-0003-1967-6345; Sullivan, Richard/0000-0002-6435-1825	European Union [EC/FP7/602536]	European Union(European Commission)	European Union funded this project under grant no. EC/FP7/602536. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript	Agusti Alvar G N, 2005, Proc Am Thorac Soc, V2, P367, DOI 10.1513/pats.200504-026SR; Ait-Khaled N, 2001, B WORLD HEALTH ORGAN, V79, P971; Beggs PJ, 2005, ENVIRON HEALTH PERSP, V113, P915, DOI 10.1289/ehp.7724; Bousquet J, 2007, EUR RESPIR J, V29, P233, DOI 10.1183/09031936.00138606; Cheng K, 1998, PEDIATR PULM, V26, P101, DOI 10.1002/(SICI)1099-0496(199808)26:2<101::AID-PPUL5>3.3.CO;2-C; Coogan PF, 2015, AM J RESP CRIT CARE, V191, P168, DOI 10.1164/rccm.201406-1108OC; de Granda-Orive JI, 2002, ARCH BRONCONEUMOL, V38, P523, DOI 10.1016/S0300-2896(02)75281-2; Decramer M, 2008, COPD, V5, P235, DOI 10.1080/15412550802237531; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; FRAME JD, 1977, FED PROC, V36, P1790; Heneberg P, 2013, J AM SOC INF SCI TEC, V64, P334, DOI 10.1002/asi.22753; Jehn M, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-99; Kellner P, SMOKING KILLS PROTEC; Klinke ME, 2014, CHRON RESP DIS, V11, P229, DOI 10.1177/1479972314546764; Lewison G, 2002, RES EVALUAT, V11, P155, DOI 10.3152/147154402781776826; Lewison G, 2015, SCIENTOMETRICS, V102, P2151, DOI 10.1007/s11192-014-1507-0; Lewison G, 2010, RES EVALUAT, V19, P129, DOI 10.3152/095820210X510098; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; LUCOTTE G, 1995, HUM BIOL, V67, P797; Mannino David M, 2006, Int J Chron Obstruct Pulmon Dis, V1, P219; Myers DG, 2009, AM J CARDIOL, V54, P1249, DOI DOI 10.1016/J.JACC.2009.07.022; Neidell MJ, 2004, J HEALTH ECON, V23, P1209, DOI 10.1016/j.jhealeco.2004.05.002; Pallasaho P, 2014, COPD, V11, P88, DOI 10.3109/15412555.2013.830095; Public Health England, RESP PROF N E ENGL; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rippon I, 2005, THORAX, V60, P63, DOI 10.1136/thx.2004.031229; Sheffield PE, 2011, AM J PREV MED, V41, P251, DOI 10.1016/j.amepre.2011.04.017; SIAFAKAS NM, 1995, EUR RESPIR J, V8, P1398, DOI 10.1183/09031936.95.08081398; Soyseth V, 2011, AM J RESP CRIT CARE, V183; Sullivan R, 2008, MONITORING FINANCIAL, P65; The Organisation for Economic Co-operation and Development (OECD), HLTH GLANC EUR 2012; Trupin L, 2003, EUR RESPIR J, V22, P462, DOI 10.1183/09031936.03.00094203; Vitzthum K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011254; World Bank, HUM DEV PUBL SERV PR; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Ye B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004201; Ziska LH, 2000, AUST J PLANT PHYSIOL, V27, P893; Ziska LH, 2003, J ALLERGY CLIN IMMUN, V111, P290, DOI 10.1067/mai.2003.53	39	18	18	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154197	10.1371/journal.pone.0154197	http://dx.doi.org/10.1371/journal.pone.0154197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111670	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000374970600046
J	Ann, HW; Jun, S; Shin, NY; Han, S; Ahn, JY; Ahn, MY; Jeon, YD; Jung, IY; Kim, MH; Jeong, WY; Ku, NS; Kim, JM; Smith, DM; Choi, JY				Ann, Hea Won; Jun, Suhnyoung; Shin, Na-Young; Han, Sanghoon; Ahn, Jin Young; Ahn, Mi Young; Jeon, Yong Duk; Jung, In Young; Kim, Moo Hyun; Jeong, Woo Yong; Ku, Nam Su; Kim, June Myung; Smith, Davey M.; Choi, Jun Yong			Characteristics of Resting-State Functional Connectivity in HIV-Associated Neurocognitive Disorder	PLOS ONE			English	Article							ABNORMALITIES; IMPAIRMENT; NETWORK; MEMORY	Background HIV-associated neurocognitive disorder (HAND) can occur in patients without prior AIDS defining illness and can be debilitating. This study aimed to evaluate the difference in the patterns of intrinsic brain activity between patients with or without HAND for deepening our understanding of HAND. Methods We evaluated 24 HIV-infected individuals, 12 with previously diagnosed HAND and 12 previously diagnosed without HAND, and 11 seronegative individuals. These individuals then underwent repeat NP testing and a functional brain MRI scan. For functional MRI analysis, seed-based analysis with bilateral precuneus cortex seed was applied. Results Among the 12 individuals with previously diagnosed HAND, 3 showed improvement of their neurocognitive function and 1 was excluded for worsening liver disease. Among the 12 patients who previously had normal neurocognitive function, 2 showed neurocognitive impairment. Overall, the HAND group, who had impaired cognitive function at the time of MRI scan, showed significant decrease of resting status functional connectivity between bilateral precuneus and prefrontal cortex (PFC) compared with nonHAND group, those who had normal neurocognitive function (Corrected P<0.05). The functional connectivity with the right inferior frontal operculum and right superior frontal gyrus was positively correlated with memory and learning ability. Conclusions This cross-sectional study found a significant difference in fMRI patterns between patients with and without HAND. Decreased functional connectivity between precuneus and PFC could be possible functional substrate for cognitive dysfunction in HIV patients, which should be characterized in a longitudinal study.	[Ann, Hea Won; Ahn, Jin Young; Ahn, Mi Young; Jeon, Yong Duk; Jung, In Young; Kim, Moo Hyun; Jeong, Woo Yong; Ku, Nam Su; Kim, June Myung; Choi, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Ann, Hea Won; Ahn, Jin Young; Ahn, Mi Young; Jeon, Yong Duk; Ku, Nam Su; Kim, June Myung; Choi, Jun Yong] Yonsei Univ, Coll Med, Dept AIDS, Res Inst, Seoul, South Korea; [Jun, Suhnyoung; Han, Sanghoon] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea; [Shin, Na-Young] Ewha Womans Univ, Sch Med, Dept Radiol, Seoul, South Korea; [Smith, Davey M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Ewha Womans University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Choi, JY (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Choi, JY (corresponding author), Yonsei Univ, Coll Med, Dept AIDS, Res Inst, Seoul, South Korea.	seran@yuhs.ac	Smith, David/GQQ-8257-2022; Jeon, Yong Duk/AAC-7563-2022	Jeon, Yong Duk/0000-0002-4588-4781; Ku, Nam Su/0000-0002-9717-4327; Ahn, Jin Young/0000-0002-3740-2826; Choi, Jun Yong/0000-0002-2775-3315; Jun, Suhnyoung/0000-0001-7849-0837; Smith, Davey/0000-0003-3603-1733	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2005412]; Chronic Infectious Disease Cohort grant from Korea Centers for Disease Control and Prevention [4800-4859-304-260]; BioNano Health-Guard Research Center - Ministry of Science, ICT, and Future Planning of Korea as a Global Frontier Project [H-GUARD_2013M3A6B2078953]; Ministry of Health & Welfare, Republic of Korea [HI14C1324]; San Diego Veterans Affairs Healthcare system; National Institutes of Health [AI100665, MH062512, AI036214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI100665, P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Chronic Infectious Disease Cohort grant from Korea Centers for Disease Control and Prevention; BioNano Health-Guard Research Center - Ministry of Science, ICT, and Future Planning of Korea as a Global Frontier Project; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); San Diego Veterans Affairs Healthcare system; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2005412), a Chronic Infectious Disease Cohort grant (4800-4859-304-260) from the Korea Centers for Disease Control and Prevention, and BioNano Health-Guard Research Center funded by the Ministry of Science, ICT, and Future Planning of Korea as a Global Frontier Project (Grant H-GUARD_2013M3A6B2078953) and a grant from the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1324). DMS was supported by the San Diego Veterans Affairs Healthcare system and National Institutes of Health grants AI100665, MH062512 and AI036214.	Ances B, 2011, NEUROIMAGE, V54, P2156, DOI 10.1016/j.neuroimage.2010.09.081; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Becker JT, 2012, BRAIN IMAGING BEHAV, V6, P366, DOI 10.1007/s11682-012-9149-4; Chan LG, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000662; Chang YL, 2010, CEREB CORTEX, V20, P1305, DOI 10.1093/cercor/bhp192; Chernoff RA, 2010, J INT NEUROPSYCH SOC, V16, P38, DOI 10.1017/S1355617709990828; Du Plessis S, 2014, AIDS, V28, P803, DOI 10.1097/QAD.0000000000000151; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Hanning U, 2011, ACAD RADIOL, V18, P1144, DOI 10.1016/j.acra.2011.04.013; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Heaton RK, 2014, CLIN INFECT DIS; Ku NS, 2014, HIV MED, V15, P470, DOI 10.1111/hiv.12137; Kuper M, 2011, J NEUROL, V258, P1066, DOI 10.1007/s00415-010-5883-y; Letendre Scott L, 2010, Top HIV Med, V18, P45; Li CX, 2011, NEUROIMAGE, V58, P286, DOI 10.1016/j.neuroimage.2011.05.068; MOR V, 1984, CANCER-AM CANCER SOC, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Towgood KJ, 2012, CORTEX, V48, P230, DOI 10.1016/j.cortex.2011.03.006; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang Z, 2014, NEUROIMAGE, V89, P45, DOI 10.1016/j.neuroimage.2013.10.039	21	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153493	10.1371/journal.pone.0153493	http://dx.doi.org/10.1371/journal.pone.0153493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104345	Green Submitted, Green Published, gold			2022-12-27	WOS:000374565100011
J	Ericsson, M; Henriksen, R; Belteky, J; Sundman, AS; Shionoya, K; Jensen, P				Ericsson, Maria; Henriksen, Rie; Belteky, Johan; Sundman, Ann-Sofie; Shionoya, Kiseko; Jensen, Per			Long-Term and Transgenerational Effects of Stress Experienced during Different Life Phases in Chickens (Gallus gallus)	PLOS ONE			English	Article							SOCIAL-ISOLATION; GENE-EXPRESSION; FEATHER PECKING; ADRENOCORTICAL-RESPONSE; DEVELOPMENTAL STRESS; SINGLE EXPOSURE; RED JUNGLEFOWL; DOMESTIC-FOWL; BEHAVIOR; RATS	Stress in animals causes not only immediate reactions, but may affect their biology for long periods, even across generations. Particular interest has been paid to perinatal stress, but also adolescence has been shown to be a sensitive period in mammals. So far, no systematic study has been performed of the relative importance of stress encountered during different life phases. In this study, groups of chickens were exposed to a six-day period of repeated stress during three different life phases: early (two weeks), early puberty (eight weeks) and late puberty (17 weeks), and the effects were compared to an unstressed control group. The short-term effects were assessed by behaviour, and the long-term and transgenerational effects were determined by effects on behavior and corticosterone secretion, as well as on hypothalamic gene expression. Short-term effects were strongest in the two week group and the eight week group, whereas long-term and transgenerational effects were detected in all three stress groups. However, stress at different ages affected different aspects of the biology of the chickens, and it was not possible to determine a particularly sensitive life phase. The results show that stress during puberty appears to be at least equally critical as the previously studied early life phase. These findings may have important implications for animal welfare in egg production, since laying hens are often exposed to stress during the three periods pinpointed here.	[Ericsson, Maria; Henriksen, Rie; Belteky, Johan; Sundman, Ann-Sofie; Jensen, Per] Linkoping Univ, AVIAN Behav Physiol & Genom Grp, IFM Biol, Linkoping, Sweden; [Shionoya, Kiseko] Linkoping Univ, Dept Clin & Expt Med, IKE, Div Cell Biol, Linkoping, Sweden	Linkoping University; Linkoping University	Jensen, P (corresponding author), Linkoping Univ, AVIAN Behav Physiol & Genom Grp, IFM Biol, Linkoping, Sweden.	perje@ifm.liu.se			Swedish Research Council [621-2011-4731]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [221-2011-1088]; European Research Council [322206]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); European Research Council(European Research Council (ERC)European Commission)	Funding provided by Swedish Research Council, http://www.vr.se/, Grant no: 621-2011-4731 (PJ), Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, http://www.formas.se/, Grant no: 221-2011-1088 (PJ) and European Research Council, https://erc.europa.eu/, Grant no: 322206 (PJ).	Agnvall B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035162; Appleby M.C., 2004, POULTRY BEHAV WELFAR; Ball GF, 2013, HORM BEHAV, V64, P211, DOI 10.1016/j.yhbeh.2013.05.002; Barbazanges A, 1996, J NEUROSCI, V16, P7783; Biagini G, 1998, INT J DEV NEUROSCI, V16, P187, DOI 10.1016/S0736-5748(98)00019-7; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Brown GR, 2013, NEUROSCIENCE, V249, P115, DOI 10.1016/j.neuroscience.2012.12.016; Calandreau L, 2011, BEHAV BRAIN RES, V217, P104, DOI 10.1016/j.bbr.2010.10.004; Chaby LE, 2015, BEHAV BRAIN RES, V278, P492, DOI 10.1016/j.bbr.2014.09.003; Chow A, 2005, APPL ANIM BEHAV SCI, V93, P283, DOI 10.1016/j.applanim.2005.01.004; de Haas EN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090577; Ericsson M, 2014, PHYSIOL BEHAV, V133, P161, DOI 10.1016/j.physbeh.2014.05.024; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Goerlich VC, 2012, HORM BEHAV, V61, P711, DOI 10.1016/j.yhbeh.2012.03.006; HAGEN P, 1961, BRIT J PHARM CHEMOTH, V17, P267, DOI 10.1111/j.1476-5381.1961.tb01287.x; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Jensen AB, 2006, APPL ANIM BEHAV SCI, V99, P287, DOI 10.1016/j.applanim.2005.10.017; Johnsen PF, 1998, APPL ANIM BEHAV SCI, V60, P25, DOI 10.1016/S0168-1591(98)00149-X; Kanitz E, 2004, BRAIN BEHAV IMMUN, V18, P35, DOI 10.1016/S0889-1591(03)00085-0; Kanitz E, 2009, PHYSIOL BEHAV, V98, P176, DOI 10.1016/j.physbeh.2009.05.007; LEVINE S, 1967, PHYSIOL BEHAV, V2, P55, DOI 10.1016/0031-9384(67)90011-X; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; McCormick CM, 2007, PHARMACOL BIOCHEM BE, V86, P220, DOI 10.1016/j.pbb.2006.07.012; McCormick CM, 2013, HORM BEHAV, V63, P5, DOI 10.1016/j.yhbeh.2012.11.009; McCormick CM, 2010, PROG NEURO-PSYCHOPH, V34, P756, DOI 10.1016/j.pnpbp.2009.09.019; MCNAUGHTON FJ, 1992, J ENDOCRINOL, V132, P411, DOI 10.1677/joe.0.1320411; Morrissey MD, 2011, NEUROBIOL LEARN MEM, V95, P46, DOI 10.1016/j.nlm.2010.10.007; Natt D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006405; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Poletto R, 2006, BRAIN RES, V1067, P36, DOI 10.1016/j.brainres.2005.10.001; Pravosudov VV, 2006, GEN COMP ENDOCR, V145, P25, DOI 10.1016/j.ygcen.2005.06.011; Pryce CR, 2002, NEWS PHYSIOL SCI, V17, P150, DOI 10.1152/nips.01367.2001; ROSTAS JAP, 1991, MOL NEUROBIOL, V5, P203, DOI 10.1007/BF02935546; Salvatierra NA, 2009, STRESS, V12, P328, DOI 10.1080/10253890802455433; Satterlee DG, 2006, POULTRY SCI, V85, P1087, DOI 10.1093/ps/85.6.1087; Schutz K, 2002, BEHAV GENET, V32, P423, DOI 10.1023/A:1020880211144; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Spencer KA, 2005, BEHAV ECOL SOCIOBIOL, V58, P423, DOI 10.1007/s00265-005-0927-5; Spencer KA, 2004, P ROY SOC B-BIOL SCI, V271, pS121, DOI 10.1098/rsbl.2003.0122; Spencer KA, 2009, ENDOCRINOLOGY, V150, P1931, DOI 10.1210/en.2008-1471; STANSFIELD SC, 1988, ENDOCRINOLOGY, V123, P787, DOI 10.1210/endo-123-2-787; Suchecki D, 2000, BEHAV BRAIN RES, V111, P99, DOI 10.1016/S0166-4328(00)00148-0; Toth E, 2008, BEHAV BRAIN RES, V190, P135, DOI 10.1016/j.bbr.2008.02.012; Valles A, 2000, AM J PHYSIOL-REG I, V279, pR1138, DOI 10.1152/ajpregu.2000.279.3.R1138; van Oers HJJ, 1998, DEV BRAIN RES, V111, P245, DOI 10.1016/S0165-3806(98)00143-6; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WINGFIELD JC, 1992, J EXP ZOOL, V264, P419, DOI 10.1002/jez.1402640407; Zimmerberg B, 1998, INT J DEV NEUROSCI, V16, P217, DOI 10.1016/S0736-5748(98)00024-0	49	42	42	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153879	10.1371/journal.pone.0153879	http://dx.doi.org/10.1371/journal.pone.0153879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105229	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100026
J	Paradowska, E; Jablonska, A; Studzinska, M; Skowronska, K; Suski, P; Wisniewska-Ligier, M; Wozniakowska-Gesicka, T; Nowakowska, D; Gaj, Z; Wilczynski, J; Lesnikowski, ZJ				Paradowska, Edyta; Jablonska, Agnieszka; Studzinska, Miroslawa; Skowronska, Katarzyna; Suski, Patrycja; Wisniewska-Ligier, Malgorzata; Wozniakowska-Gesicka, Teresa; Nowakowska, Dorota; Gaj, Zuzanna; Wilczynski, Jan; Lesnikowski, Zbigniew J.			TLR9-1486T/C and 2848C/T SNPs Are Associated with Human Cytomegalovirus Infection in Infants	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; SINGLE-NUCLEOTIDE POLYMORPHISM; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TLR9 GENE; ADAPTER PROTEIN; GLYCOPROTEIN-B; VIRAL LOAD; DISEASE; TOLL-LIKE-RECEPTOR-9; MYD88	Toll-like receptor 9 (TLR9) recognizes non-methylated viral CpG-containing DNA and serves as a pattern recognition receptor that signals the presence of human cytomegalovirus (HCMV). Here, we present the genotype distribution of single-nucleotide polymorphisms (SNPs) of the TLR9 gene in infants and the relationship between TLR9 polymorphisms and HCMV infection. Four polymorphisms (-1237T/C, rs5743836; -1486T/C, rs187084; 1174G/A, rs352139; and 2848C/T, rs352140) in the TLR9 gene were genotyped in 72 infants with symptomatic HCMV infection and 70 healthy individuals. SNP genotyping was performed by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Digested fragments were separated and identified by capillary electrophoresis. The HCMV DNA copy number was measured by a quantitative real-time PCR assay. We found an increased frequency of heterozygous genotypes TLR9 -1486T/C and 2848C/T in infants with HCMV infection compared with uninfected cases. Heterozygous variants of these two SNPs increased the risk of HCMV disease in children (P = 0.044 and P = 0.029, respectively). In infants with a mutation present in at least one allele of -1486T/C and 2848C/T SNPs, a trend towards increased risk of cytomegaly was confirmed after Bonferroni's correction for multiple testing (Pc = 0.063). The rs352139 GG genotype showed a significantly reduced relative risk for HCMV infection (Pc = 0.006). In contrast, the -1237T/C SNP was not related to viral infection. We found no evidence for linkage disequilibrium with the four examined TLR9 SNPs. The findings suggest that the TLR9 -1486T/C and 2848C/T polymorphisms could be a genetic risk factor for the development of HCMV disease.	[Paradowska, Edyta; Jablonska, Agnieszka; Studzinska, Miroslawa; Skowronska, Katarzyna; Suski, Patrycja; Lesnikowski, Zbigniew J.] Polish Acad Sci, Inst Med Biol, Lab Mol Virol & Biol Chem, Lodz, Poland; [Wisniewska-Ligier, Malgorzata] Polish Mothers Mem Hosp Res Inst, Dept Pediat Immunol & Nephrol, Lodz, Poland; [Wozniakowska-Gesicka, Teresa] Polish Mothers Mem Hosp Res Inst, Dept Pediat 3, Lodz, Poland; [Nowakowska, Dorota; Gaj, Zuzanna] Polish Mothers Mem Hosp Res Inst, Dept Perinatol & Gynecol, Lodz, Poland; [Gaj, Zuzanna] Polish Mothers Mem Hosp Res Inst, Sci Lab, Ctr Med Lab Diagnost, Lodz, Poland; [Wilczynski, Jan] Med Univ Warsaw, Dept Obstet & Gynecol 2, Warsaw, Poland; [Skowronska, Katarzyna] Polish Acad Sci, Dept Neurotoxicol, Mossakowski Med Res Ctr, Warsaw, Poland	Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Medical University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Paradowska, E (corresponding author), Polish Acad Sci, Inst Med Biol, Lab Mol Virol & Biol Chem, Lodz, Poland.	eparadowska@cbm.pan.pl	Skowrońska, Katarzyna/K-8832-2019; Jabłońska, Agnieszka/AAG-8207-2021; Lesnikowski, Zbigniew/AAG-7006-2020; Jabłońska, Agnieszka/AAF-8078-2019; Gaj, Zuzanna/O-3749-2014	Skowrońska, Katarzyna/0000-0002-2612-3186; Lesnikowski, Zbigniew/0000-0003-3158-5796; Jabłońska, Agnieszka/0000-0002-6688-043X; Gaj, Zuzanna/0000-0002-1803-1935; Paradowska, Edyta/0000-0001-9446-0136; Studzinska, Miroslawa/0000-0002-4851-2190	National Science Centre of Poland [2014/13/B/NZ7/02317]; European Regional Development Fund under Operational Programme Innovative Economy [POIG.01.01.02-10-107/09]	National Science Centre of Poland(National Science Centre, Poland); European Regional Development Fund under Operational Programme Innovative Economy	This work was supported by the National Science Centre of Poland (No. 2014/13/B/NZ7/02317) (http://www.ncn.gov.pl/) and by the European Regional Development Fund under Operational Programme Innovative Economy (No. POIG.01.01.02-10-107/09) (http://www.poig.gov.pl/english). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arav-Boger Ravit, 2012, BMC Res Notes, V5, P140, DOI 10.1186/1756-0500-5-140; Bochud PY, 2007, AIDS, V21, P441, DOI 10.1097/QAD.0b013e328012b8ac; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Brown RA, 2009, CLIN INFECT DIS, V49, pE96, DOI 10.1086/644501; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Carvalho A, 2012, GENES IMMUN, V13, P197, DOI 10.1038/gene.2011.59; Carvalho A, 2009, EXP HEMATOL, V37, P1022, DOI 10.1016/j.exphem.2009.06.004; Cervera C, 2007, TRANSPLANTATION, V83, P1493, DOI 10.1097/01.tp.0000264999.71318.2b; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fang J, 2013, INVEST OPHTH VIS SCI, V54, P8384, DOI 10.1167/iovs.13-12878; Fiola S, 2010, J IMMUNOL, V185, P3620, DOI 10.4049/jimmunol.0903736; Freguja R, 2012, AIDS, V26, P765, DOI 10.1097/QAD.0b013e3283514350; Hamann L, 2004, J IMMUNOL METHODS, V285, P281, DOI 10.1016/j.jim.2003.12.005; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Iversen AC, 2009, J IMMUNOL, V182, P5672, DOI 10.4049/jimmunol.0801268; Jablonska A, 2014, INT J INFECT DIS, V25, P11, DOI 10.1016/j.ijid.2014.04.001; Kang SH, 2012, J INFECT DIS, V205, P639, DOI 10.1093/infdis/jir819; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Kijpittayarit S, 2007, CLIN INFECT DIS, V44, P1315, DOI 10.1086/514339; Kikuchi K, 2005, J AUTOIMMUN, V24, P347, DOI 10.1016/j.jaut.2005.03.002; Kruger B, 2010, CLIN SCI, V119, P535, DOI 10.1042/CS20100190; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Lai ZZ, 2013, J INT MED RES, V41, P1027, DOI 10.1177/0300060513483398; Latz E, 2004, J IMMUNOL, V172, P2431, DOI 10.4049/jimmunol.172.4.2431; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Lore K, 2003, J IMMUNOL, V171, P4320, DOI 10.4049/jimmunol.171.8.4320; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Mollaki V, 2009, J HUM GENET, V54, P655, DOI 10.1038/jhg.2009.90; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Ng MW, 2005, RHEUMATOLOGY, V44, P1456, DOI 10.1093/rheumatology/kei120; Novak N, 2007, ALLERGY, V62, P766, DOI 10.1111/j.1398-9995.2007.01358.x; Paradowska E, 2006, APMIS, V114, P764, DOI 10.1111/j.1600-0463.2006.apm_31.x; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pine SO, 2009, AIDS, V23, P2387, DOI 10.1097/QAD.0b013e328330b489; Piotrowski P, 2013, RHEUMATOL INT, V33, P1121, DOI 10.1007/s00296-012-2509-y; Ricci E, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-49; Roszak A, 2012, MOL BIOL REP, V39, P8425, DOI 10.1007/s11033-012-1695-8; Sanders MS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-112; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Soriano-Sarabia N, 2008, JAIDS-J ACQ IMM DEF, V49, P128, DOI 10.1097/QAI.0b013e318184fb41; Stagno S., 1995, INFECT DIS FETUS NEW, P312; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Taniguchi R, 2013, INT J INFECT DIS, V17, pE1092, DOI 10.1016/j.ijid.2013.06.004; Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961; Vaidya SA, 2003, CURR OPIN IMMUNOL, V15, P402, DOI 10.1016/S0952-7915(03)00070-0; Varani S, 2007, J IMMUNOL, V179, P7767, DOI 10.4049/jimmunol.179.11.7767; Velez DR, 2010, HUM GENET, V127, P65, DOI 10.1007/s00439-009-0741-7; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Wang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065731; Wu JF, 2012, J INFECT DIS, V206, P662, DOI 10.1093/infdis/jis420; Wujcicka W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122831; Xiao HW, 2014, BONE MARROW TRANSPL, V49, P241, DOI 10.1038/bmt.2013.160; Yang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058444; Yew KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044500	59	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154100	10.1371/journal.pone.0154100	http://dx.doi.org/10.1371/journal.pone.0154100			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105145	Green Submitted, gold, Green Published			2022-12-27	WOS:000374565100044
J	Borzova, VA; Markossian, KA; Chebotareva, NA; Kleymenov, SY; Poliansky, NB; Muranov, KO; Stein-Margolina, VA; Shubin, VV; Markov, DI; Kurganov, BI				Borzova, Vera A.; Markossian, Kira A.; Chebotareva, Natalia A.; Kleymenov, Sergey Yu.; Poliansky, Nikolay B.; Muranov, Konstantin O.; Stein-Margolina, Vita A.; Shubin, Vladimir V.; Markov, Denis I.; Kurganov, Boris I.			Kinetics of Thermal Denaturation and Aggregation of Bovine Serum Albumin	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; DYNAMIC LIGHT-SCATTERING; CIRCULAR-DICHROISM; STRUCTURAL-CHANGES; INCLUSION-BODIES; ANALYTICAL ULTRACENTRIFUGATION; HETEROGENEOUS NUCLEATION; CONFORMATIONAL-CHANGES; FTIR SPECTROSCOPY; DISULFIDE BRIDGES	Thermal aggregation of bovine serum albumin (BSA) has been studied using dynamic light scattering, asymmetric flow field-flow fractionation and analytical ultracentrifugation. The studies were carried out at fixed temperatures (60 degrees C, 65 degrees C, 70 degrees C and 80 degrees C) in 0.1 M phosphate buffer, pH 7.0, at BSA concentration of 1 mg/ml. Thermal denaturation of the protein was studied by differential scanning calorimetry. Analysis of the experimental data shows that at 65 degrees C the stage of protein unfolding and individual stages of protein aggregation are markedly separated in time. This circumstance allowed us to propose the following mechanism of thermal aggregation of BSA. Protein unfolding results in the formation of two forms of the non-native protein with different propensity to aggregation. One of the forms (highly reactive unfolded form, U-hr) is characterized by a high rate of aggregation. Aggregation of U-hr leads to the formation of primary aggregates with the hydrodynamic radius (R-h,R- 1) of 10.3 nm. The second form (low reactive unfolded form, U-lr) participates in the aggregation process by its attachment to the primary aggregates produced by the U-hr form and possesses ability for self-aggregation with formation of stable small-sized aggregates (A(st)). At complete exhaustion of U-lr, secondary aggregates with the hydrodynamic radius (R-h,R- 2) of 12.8 nm are formed. At 60 degrees C the rates of unfolding and aggregation are commensurate, at 70 degrees C the rates of formation of the primary and secondary aggregates are commensurate, at 80 degrees C the registration of the initial stages of aggregation is complicated by formation of large-sized aggregates.	[Borzova, Vera A.; Markossian, Kira A.; Chebotareva, Natalia A.; Kleymenov, Sergey Yu.; Stein-Margolina, Vita A.; Markov, Denis I.; Kurganov, Boris I.] Russian Acad Sci, Dept Struct Biochem Prot, Bach Inst Biochem, Biotechnol Res Ctr, Moscow, Russia; [Kleymenov, Sergey Yu.] Russian Acad Sci, Dept Biophys, Koltsov Inst Dev Biol, Moscow, Russia; [Poliansky, Nikolay B.; Muranov, Konstantin O.] Russian Acad Sci, Dept Chem & Biol Proc Kinet, Emanuel Inst Biochem Phys, Moscow, Russia; [Shubin, Vladimir V.] Russian Acad Sci, Dept Biochem Chloroplast, Bach Inst Biochem, Biotechnol Res Ctr, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Russian Academy of Sciences; Emanuel Institute of Biochemical Physics; Research Center of Biotechnology RAS; Russian Academy of Sciences	Kurganov, BI (corresponding author), Russian Acad Sci, Dept Struct Biochem Prot, Bach Inst Biochem, Biotechnol Res Ctr, Moscow, Russia.	kurganov@inbi.ras.ru	Муранов, Константин/AAF-7887-2019; Kurganov, Boris/M-1286-2019; Borzova, Vera/F-4021-2017; Kleymenov, Sergey/R-1195-2018	Borzova, Vera/0000-0003-1544-8804; Kleymenov, Sergey/0000-0001-5085-0327; Kurganov, Boris/0000-0002-2930-2286	Russian Foundation for Basic Research [14-04-01530-a, 16-04-00997-mol_a, 16-04-00560-a]; Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences)	The work was supported by the following: Russian Foundation for Basic Research, http://www.rfbr.ru, 14-04-01530-a, VAB KAM NAC SYK BIK; Russian Foundation for Basic Research, http://www.rfbr.ru, 16-04-00997-mol_a, VAB; Russian Foundation for Basic Research, http://www.rfbr.ru, 16-04-00560-a, NAC; and Russian Academy of Sciences, http://www.ras.ru, Program "Molecular and Cell Biology", VAB KAM NAC SYK VAS-M DIM BIK. The funders had no role in study design, data collection and analysis decision to publich, or preparation of the manuscript.	Ahmad E, 2011, CELL BIOCHEM BIOPHYS, V61, P313, DOI 10.1007/s12013-011-9214-4; BARONE G, 1992, THERMOCHIM ACTA, V199, P197, DOI 10.1016/0040-6031(92)80263-V; Barone G, 1995, J THERM ANAL, V45, P1255, DOI 10.1007/BF02547420; Borzova VA, 2015, INT J BIOL MACROMOL, V80, P130, DOI 10.1016/j.ijbiomac.2015.06.040; Borzova VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074367; Brown PH, 2007, BIOMACROMOLECULES, V8, P2011, DOI 10.1021/bm070193j; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Bulone D, 2001, BIOPHYS CHEM, V91, P61, DOI 10.1016/S0301-4622(01)00155-7; Dobson CM, 2013, AMYLOID FIBRILS PREF, P1; Donato L, 2005, BIOMACROMOLECULES, V6, P2157, DOI 10.1021/bm050132q; Duy C, 2006, BIOPHYS J, V90, P3704, DOI 10.1529/biophysj.105.078980; Eronina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022154; Ferrone FA, 2002, BIOPHYS J, V82, P399, DOI 10.1016/S0006-3495(02)75404-0; GALLIER J, 1987, BIOCHIM BIOPHYS ACTA, V915, P1, DOI 10.1016/0167-4838(87)90119-1; Gayen A, 2008, BIOMACROMOLECULES, V9, P974, DOI 10.1021/bm701144k; Gelamo EL, 2002, BBA-PROTEIN STRUCT M, V1594, P84, DOI 10.1016/S0167-4838(01)00287-4; Giancola C, 1997, INT J BIOL MACROMOL, V20, P193, DOI 10.1016/S0141-8130(97)01159-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gobbo J, 2011, METHODS MOL BIOL, V787, P137, DOI 10.1007/978-1-61779-295-3_11; Golub N, 2007, FEBS LETT, V581, P4223, DOI 10.1016/j.febslet.2007.07.066; Golub NV, 2009, EUR BIOPHYS J BIOPHY, V38, P547, DOI 10.1007/s00249-009-0403-7; Harris J Robin, 2012, Subcell Biochem, V65, P3, DOI 10.1007/978-94-007-5416-4_1; HIRAYAMA K, 1990, BIOCHEM BIOPH RES CO, V173, P639, DOI 10.1016/S0006-291X(05)80083-X; HO JX, 1993, EUR J BIOCHEM, V215, P205, DOI 10.1111/j.1432-1033.1993.tb18024.x; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; Honda C, 2000, CHEM PHARM BULL, V48, P464; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; Jun-tao Guo CKH, 2007, COMPUTATIONAL METHOD, P279; KATCHALSKI E, 1957, J AM CHEM SOC, V79, P4096, DOI 10.1021/ja01572a034; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Khanova HA, 2005, BIOCHEMISTRY-US, V44, P15480, DOI 10.1021/bi051175u; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LIN MY, 1989, P ROY SOC LOND A MAT, V423, P71, DOI 10.1098/rspa.1989.0042; Maloletkina OI, 2010, BIOPHYS CHEM, V148, P121, DOI 10.1016/j.bpc.2010.03.005; Markossian K. A., 2006, P89; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P971, DOI 10.1023/B:BIRY.0000043539.07961.4c; Markossian KA, 2008, BBA-PROTEINS PROTEOM, V1784, P1286, DOI 10.1016/j.bbapap.2008.04.030; Markossian KA, 2006, BIOCHEMISTRY-US, V45, P13375, DOI 10.1021/bi0610707; Markov DI, 2010, INT J MOL SCI, V11, P4194, DOI 10.3390/ijms11114194; Meremyanin AV, 2008, BIOPOLYMERS, V89, P124, DOI 10.1002/bip.20872; Michnik A, 2003, J THERM ANAL CALORIM, V71, P509, DOI 10.1023/A:1022851809481; Militello V, 2004, BIOPHYS CHEM, V107, P175, DOI 10.1016/j.bpc.2003.09.004; Militello V, 2003, BIOPHYS CHEM, V105, P133, DOI 10.1016/S0301-4622(03)00153-4; Moriyama Y, 2008, J PHYS CHEM B, V112, P16585, DOI 10.1021/jp8067624; Nakamura K, 1997, FEBS LETT, V417, P375, DOI 10.1016/S0014-5793(97)01326-4; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; Panyukov Y, 2007, BIOPHYS CHEM, V127, P9, DOI 10.1016/j.bpc.2006.11.006; Paris G, 2012, BIOPOLYMERS, V97, P889, DOI 10.1002/bip.22096; Pearce FG, 2007, J AGR FOOD CHEM, V55, P318, DOI 10.1021/jf062154p; Perutz MF, 1997, NATURE, V385, P773, DOI 10.1038/385773a0; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rombouts I, 2015, SCI REP-UK, V5, DOI 10.1038/srep12210; Rondeau P, 2007, ARCH BIOCHEM BIOPHYS, V460, P141, DOI 10.1016/j.abb.2007.01.014; Rotter MA, 2005, BIOPHYS J, V89, P2677, DOI 10.1529/biophysj.105.067785; SADLER PJ, 1993, EUR J BIOCHEM, V212, P811, DOI 10.1111/j.1432-1033.1993.tb17722.x; Sahin Z, 2016, EUR J PHARM SCI, V86, P115, DOI 10.1016/j.ejps.2016.03.007; Scientist for Experimental Data Fitting, 1995, SCI EXP DAT FITT MIC; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shah D, 2012, BIOTECHNOL PROGR, V28, P223, DOI 10.1002/btpr.710; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; STEINHARDT J, 1971, BIOCHEMISTRY-US, V10, P4005, DOI 10.1021/bi00798a001; Su RX, 2008, FOOD HYDROCOLLOID, V22, P995, DOI 10.1016/j.foodhyd.2007.05.021; VANSTOKKUM IHM, 1995, BIOCHEMISTRY-US, V34, P10508, DOI 10.1021/bi00033a024; Vetri V, 2007, EUR BIOPHYS J BIOPHY, V36, P717, DOI 10.1007/s00249-007-0196-5; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; Wen LL, 2015, INT J PHARMACEUT, V478, P753, DOI 10.1016/j.ijpharm.2014.12.038; Yohannes G, 2010, ANAL CHIM ACTA, V675, P191, DOI 10.1016/j.aca.2010.07.016; Zhang HM, 2014, LANGMUIR, V30, P5536, DOI 10.1021/la501129y	71	120	122	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153495	10.1371/journal.pone.0153495	http://dx.doi.org/10.1371/journal.pone.0153495			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101281	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500035
J	Mou, WS; Li, DD; Bu, JW; Jiang, YY; Khan, ZU; Luo, ZS; Mao, LC; Ying, TJ				Mou, Wangshu; Li, Dongdong; Bu, Jianwen; Jiang, Yuanyuan; Khan, Zia Ullah; Luo, Zisheng; Mao, Linchun; Ying, Tiejin			Comprehensive Analysis of ABA Effects on Ethylene Biosynthesis and Signaling during Tomato Fruit Ripening	PLOS ONE			English	Article							ABSCISIC-ACID	ABA has been widely acknowledged to regulate ethylene biosynthesis and signaling during fruit ripening, but the molecular mechanism underlying the interaction between these two hormones are largely unexplored. In the present study, exogenous ABA treatment obviously promoted fruit ripening as well as ethylene emission, whereas NDGA (Nordihydroguaiaretic acid, an inhibitor of ABA biosynthesis) application showed the opposite biological effects. Combined RNA-seq with time-course RT-PCR analysis, our study not only helped to illustrate how ABA regulated itself at the transcription level, but also revealed that ABA can facilitate ethylene production and response probably by regulating some crucial genes such as LeACS4, LeACO1, GR and LeETR6. In addition, investigation on the fruits treated with 1-MCP immediately after ABA exposure revealed that ethylene might be essential for the induction of ABA biosynthesis and signaling at the onset of fruit ripening. Furthermore, some specific transcription factors (TFs) known as regulators of ethylene synthesis and sensibility (e.g. MADS-RIN, TAGL1, CNR and NOR) were also observed to be ABA responsive, which implied that ABA influenced ethylene action possibly through the regulation of these TFs expression. Our comprehensive physiological and molecular-level analysis shed light on the mechanism of cross-talk between ABA and ethylene during the process of tomato fruit ripening.	[Mou, Wangshu; Li, Dongdong; Jiang, Yuanyuan; Luo, Zisheng; Mao, Linchun; Ying, Tiejin] Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Zhejiang R&D Ctr Food Technol & Equipment, Coll Biosyst Engn & Food Sci,Fuli Inst Food Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Bu, Jianwen] Shandong Agr & Engn Univ, Dept Food Sci & Engn, Jinan 250100, Peoples R China; [Khan, Zia Ullah] Abdul Wali Khan Univ, Dept Agr, Mardan 23200, KPK, Pakistan	Zhejiang University; Shandong Agriculture & Engineering University; Abdul Wali Khan University	Ying, TJ (corresponding author), Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Zhejiang R&D Ctr Food Technol & Equipment, Coll Biosyst Engn & Food Sci,Fuli Inst Food Sci, Hangzhou 310058, Zhejiang, Peoples R China.	tjying@zju.edu.cn	jiang, anyi/GPT-0379-2022		National Basic Research Program of China [2013CB127101]	National Basic Research Program of China(National Basic Research Program of China)	The research was financially supported by the National Basic Research Program of China (2013CB127101).	Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Babak B, 2013, DNA RES, V20, P315, DOI 10.1093/dnares/dst012; Barickman TC, 2014, J AM SOC HORTIC SCI, V139, P261, DOI 10.21273/JASHS.139.3.261; Barry CS, 2007, J PLANT GROWTH REGUL, V26, P143, DOI 10.1007/s00344-007-9002-y; Barry CS, 1996, PLANT J, V9, P525, DOI 10.1046/j.1365-313X.1996.09040525.x; Barry CS, 2000, PLANT PHYSIOL, V123, P979, DOI 10.1104/pp.123.3.979; Bemer M, 2012, PLANT CELL, V24, P4437, DOI 10.1105/tpc.112.103283; Binder BM, 2010, J BIOL CHEM, V285, P37263, DOI 10.1074/jbc.M110.170027; Bisson MMA, 2010, MOL PLANT, V3, P882, DOI 10.1093/mp/ssq036; Blume B, 1997, PLANT J, V12, P731, DOI 10.1046/j.1365-313X.1997.12040731.x; Bouvier F, 2000, EUR J BIOCHEM, V267, P6346, DOI 10.1046/j.1432-1327.2000.01722.x; Bu JW, 2013, POSTHARVEST BIOL TEC, V86, P337, DOI 10.1016/j.postharvbio.2013.07.026; Burbidge A, 1999, PLANT J, V17, P427, DOI 10.1046/j.1365-313X.1999.00386.x; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cutler AJ, 1999, TRENDS PLANT SCI, V4, P472, DOI 10.1016/S1360-1385(99)01497-1; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; Diretto G, 2010, PLANT PHYSIOL, V154, P899, DOI 10.1104/pp.110.159368; Dong TT, 2013, PLANT PHYSIOL, V163, P1026, DOI 10.1104/pp.113.224436; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Fujisawa M, 2013, PLANT CELL, V25, P371, DOI 10.1105/tpc.112.108118; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Galpaz N, 2008, PLANT J, V53, P717, DOI 10.1111/j.1365-313X.2007.03362.x; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Itkin M, 2009, PLANT J, V60, P1081, DOI 10.1111/j.1365-313X.2009.04064.x; Ji K, 2014, J EXP BOT, V65, P5243, DOI 10.1093/jxb/eru288; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jiang YM, 2000, J PLANT GROWTH REGUL, V19, P106, DOI 10.1007/s003440000011; Joo S, 2008, PLANT J, V54, P129, DOI 10.1111/j.1365-313X.2008.03404.x; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Kang CY, 2013, PLANT CELL, V25, P1960, DOI 10.1105/tpc.113.111732; Karlova R, 2014, J EXP BOT, V65, P4527, DOI 10.1093/jxb/eru316; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; KONDO S, 1991, J JPN SOC HORTIC SCI, V60, P505, DOI 10.2503/jjshs.60.505; Kondo S, 1997, J HORTIC SCI BIOTECH, V72, P221, DOI 10.1080/14620316.1997.11515509; Krochko JE, 1998, PLANT PHYSIOL, V118, P849, DOI 10.1104/pp.118.3.849; Kumar R, 2014, J EXP BOT, V65, P4561, DOI 10.1093/jxb/eru277; Kumar R, 2012, MOL GENET GENOMICS, V287, P189, DOI 10.1007/s00438-011-0671-7; Lara I, 2000, J AM SOC HORTIC SCI, V2, P183; Leng P, 2009, CHINESE SCI BULL, V54, P2830, DOI 10.1007/s11434-009-0486-7; Li XW, 2011, J SCI FOOD AGR, V91, P2684, DOI 10.1002/jsfa.4514; Lim EK, 2005, TETRAHEDRON-ASYMMETR, V16, P143, DOI 10.1016/j.tetasy.2004.11.062; Lin ZF, 2008, PLANT J, V55, P301, DOI 10.1111/j.1365-313X.2008.03505.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIZADA MCC, 1979, ANAL BIOCHEM, V100, P140, DOI 10.1016/0003-2697(79)90123-4; Lohani S, 2004, POSTHARVEST BIOL TEC, V31, P119, DOI 10.1016/j.postharvbio.2003.08.001; Ma NN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0351-y; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Marin E, 1996, EMBO J, V15, P2331, DOI 10.1002/j.1460-2075.1996.tb00589.x; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; MartinezMadrid MC, 1996, PHYTOCHEMISTRY, V43, P323, DOI 10.1016/0031-9422(96)00192-6; McAtee P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00079; MIYAZAKI JH, 1987, PHYSIOL PLANTARUM, V69, P366, DOI 10.1111/j.1399-3054.1987.tb04302.x; MIZRAHI Y, 1975, PLANT PHYSIOL, V56, P544, DOI 10.1104/pp.56.4.544; Mou WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129598; Nakatsuka A, 1998, PLANT PHYSIOL, V118, P1295, DOI 10.1104/pp.118.4.1295; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Osorio S, 2011, PLANT PHYSIOL, V157, P405, DOI 10.1104/pp.111.175463; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Qiu LP, 2012, PLANT PHYSIOL, V159, P1263, DOI 10.1104/pp.112.193979; Resnick JS, 2008, PLANT J, V56, P423, DOI 10.1111/j.1365-313X.2008.03615.x; Rohrmann J, 2011, PLANT J, V68, P999, DOI 10.1111/j.1365-313X.2011.04750.x; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schwartz SH, 1997, PLANT PHYSIOL, V114, P161, DOI 10.1104/pp.114.1.161; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Shima Y, 2013, PLANT MOL BIOL, V82, P427, DOI 10.1007/s11103-013-0071-y; Srivastava A, 2005, J PLANT GROWTH REGUL, V24, P67, DOI 10.1007/s00344-005-0015-0; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Sun L, 2012, J EXP BOT, V63, P3097, DOI 10.1093/jxb/ers026; Sun L, 2012, PLANT PHYSIOL, V158, P283, DOI 10.1104/pp.111.186866; Sun LA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-257; Sun Y, 2013, J PLANT GROWTH REGUL, V32, P233, DOI 10.1007/s00344-012-9293-5; Thompson AJ, 2004, PLANT CELL ENVIRON, V27, P459, DOI 10.1111/j.1365-3040.2003.01164.x; Thompson AJ, 1999, PLANT PHYSIOL, V120, P383, DOI 10.1104/pp.120.2.383; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang HC, 2007, PLANT GROWTH REGUL, V52, P189, DOI 10.1007/s10725-007-9189-8; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-841; Wang YP, 2013, PLANT PHYSIOL BIOCH, V64, P70, DOI 10.1016/j.plaphy.2012.12.015; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Yoo SD, 2009, TRENDS PLANT SCI, V14, P270, DOI 10.1016/j.tplants.2009.02.007; Yu LJ, 2012, NEW PHYTOL, V195, P97, DOI 10.1111/j.1469-8137.2012.04154.x; Zaharah SS, 2013, POSTHARVEST BIOL TEC, V75, P37, DOI 10.1016/j.postharvbio.2012.07.009; ZEEVAART JAD, 1983, PLANT PHYSIOL, V71, P477, DOI 10.1104/pp.71.3.477; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang M, 2009, MATER TODAY, V12, P12, DOI 10.1016/S1369-7021(09)70176-2; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zouari I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-221; Zouine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084203	99	73	80	10	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154072	10.1371/journal.pone.0154072	http://dx.doi.org/10.1371/journal.pone.0154072			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100326	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500136
J	Nguyen, A; Mamarbachi, M; Turcot, V; Lessard, S; Yu, C; Luo, XY; Lalonge, J; Hayami, D; Gayda, M; Juneau, M; Thorin-Trescases, N; Lettre, G; Nigam, A; Thorin, E				Nguyen, Albert; Mamarbachi, Maya; Turcot, Valerie; Lessard, Samuel; Yu, Carol; Luo, Xiaoyan; Lalonge, Julie; Hayami, Doug; Gayda, Mathieu; Juneau, Martin; Thorin-Trescases, Nathalie; Lettre, Guillaume; Nigam, Anil; Thorin, Eric			Lower Methylation of the ANGPTL2 Gene in Leukocytes from Post-Acute Coronary Syndrome Patients	PLOS ONE			English	Article							ANGIOPOIETIN-LIKE PROTEIN-2; DNA METHYLATION; TOBACCO SMOKING; BLOOD-PRESSURE; INFLAMMATION; EPIGENETICS; ASSOCIATION; RISK; DIAGNOSIS; HEALTH	DNA methylation is believed to regulate gene expression during adulthood in response to the constant changes in environment. The methylome is therefore proposed to be a biomarker of health through age. ANGPTL2 is a circulating pro-inflammatory protein that increases with age and prematurely in patients with coronary artery diseases; integrating the methylation pattern of the promoter may help differentiate age-vs. disease-related change in its expression. We believe that in a pro-inflammatory environment, ANGPTL2 is differentially methylated, regulating ANGPTL2 expression. To test this hypothesis we investigated the changes in promoter methylation of ANGPTL2 gene in leukocytes from patients suffering from post-acute coronary syndrome (ACS). DNA was extracted from circulating leukocytes of post-ACS patients with cardiovascular risk factors and from healthy young and age-matched controls. Methylation sites (CpGs) found in the ANGPTL2 gene were targeted for specific DNA methylation quantification. The functionality of ANGPTL2 methylation was assessed by an in vitro luciferase assay. In post-ACS patients, C-reactive protein and ANGPTL2 circulating levels increased significantly when compared to healthy controls. Decreased methylation of specific CpGs were found in the promoter of ANGPTL2 and allowed to discriminate age vs. disease associated methylation. In vitro DNA methylation of specific CpG lead to inhibition of ANGPTL2 promoter activity. Reduced leukocyte DNA methylation in the promoter region of ANGPTL2 is associated with the pro-inflammatory environment that characterizes patients with post-ACS differently from age-matched healthy controls. Methylation of different CpGs in ANGPTL2 gene may prove to be a reliable biomarker of coronary disease.	[Nguyen, Albert; Mamarbachi, Maya; Turcot, Valerie; Lessard, Samuel; Yu, Carol; Luo, Xiaoyan; Lalonge, Julie; Hayami, Doug; Gayda, Mathieu; Juneau, Martin; Thorin-Trescases, Nathalie; Lettre, Guillaume; Nigam, Anil; Thorin, Eric] Univ Montreal, Res Ctr, Montreal Heart Inst, Montreal, PQ, Canada; [Nguyen, Albert; Yu, Carol] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Lalonge, Julie; Hayami, Doug; Gayda, Mathieu; Juneau, Martin; Nigam, Anil] Univ Montreal, Montreal Heart Inst, Cardiac Rehabil & Prevent Ctr EPIC, Montreal, PQ, Canada; [Hayami, Doug; Gayda, Mathieu; Juneau, Martin; Lettre, Guillaume; Nigam, Anil] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada; [Thorin, Eric] Univ Montreal, Fac Med, Dept Surg, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Nigam, A; Thorin, E (corresponding author), Univ Montreal, Res Ctr, Montreal Heart Inst, Montreal, PQ, Canada.; Nigam, A (corresponding author), Univ Montreal, Montreal Heart Inst, Cardiac Rehabil & Prevent Ctr EPIC, Montreal, PQ, Canada.; Nigam, A (corresponding author), Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada.; Thorin, E (corresponding author), Univ Montreal, Fac Med, Dept Surg, Montreal, PQ H3C 3J7, Canada.	anil.nigam@icm-mhi.org; eric.thorin@umontreal.ca	Thorin, Eric/K-3978-2013; Gayda, Mathieu/U-8520-2019	Thorin, Eric/0000-0001-5827-8935; Gayda, Mathieu/0000-0003-1721-2299	Canadian Institute for Health Research; Montreal Heart Institute; EPIC Foundation; prevention center of the Montreal Heart Institute	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Montreal Heart Institute; EPIC Foundation; prevention center of the Montreal Heart Institute	The work was funded by the Canadian Institute for Health Research (ET). Students were supported through fellowship (VT) and scholarship (SL) of the Canadian Institute for Health Research. GL holds a Canada Research Chair. Clinical research (JL, MG, DH, MJ, A Nigam) and basic research (ET, NTT) teams are supported by an annual grant of the Foundation of the Montreal Heart Institute. Clinical research in prevention is supported by the EPIC Foundation, the prevention center of the Montreal Heart Institute.	Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bauer M, 2016, CLIN EPIGENETICS, V8, DOI [10.1186/s13148-015-0113-1, 10.1186/s13148-016-0249-7]; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Bouwland-Both MI, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0115-z; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Burris HH, 2015, EPIGENETICS-US, V10, P913, DOI 10.1080/15592294.2015.1078963; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Daskalopoulou SS, 2015, CAN J CARDIOL, V31, P549, DOI 10.1016/j.cjca.2015.02.016; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Doi Y, 2013, DIABETES CARE, V36, P98, DOI 10.2337/dc12-0166; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Farhat N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000201; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Horsburgh S, 2015, EXERC IMMUNOL REV, V21, P26; Huang CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138678; Ide S, 2015, ANN SURG ONCOL, V22, P2585, DOI 10.1245/s10434-014-4315-0; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Kikuchi R, 2008, CANCER RES, V68, P5067, DOI 10.1158/0008-5472.CAN-08-0062; Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523; Kim YR, 2012, AM J PHYSIOL-HEART C, V303, pH189, DOI 10.1152/ajpheart.01218.2011; Larouche JF, 2015, CAN J CARDIOL, V31, P1232, DOI 10.1016/j.cjca.2015.01.038; Lee HJ, 2013, BIOCHEM BIOPH RES CO, V430, P981, DOI 10.1016/j.bbrc.2012.11.127; Lee Suee, 2012, Korean J Hematol, V47, P186, DOI 10.5045/kjh.2012.47.3.186; Li Q, 2013, DIABETES RES CLIN PR, V100, P385, DOI 10.1016/j.diabres.2013.03.028; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu X, 2014, ENVIRON MOL MUTAGEN, V55, P223, DOI 10.1002/em.21827; Mansego ML, 2015, INT J MOL SCI, V16, P16816, DOI 10.3390/ijms160816816; Lund G, 2011, CURR ATHEROSCLER REP, V13, P208, DOI 10.1007/s11883-011-0174-3; Malhotra P, 2014, J BIOL CHEM, V289, P23132, DOI 10.1074/jbc.M113.546283; Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6; Meng QX, 2013, EXP THER MED, V5, P1631, DOI 10.3892/etm.2013.1045; Mitra S, 2011, AM J PHYSIOL-HEART C, V301, pH506, DOI 10.1152/ajpheart.00252.2011; Muramoto A, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.16; Nestor CE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004059; Nguyen A, 2016, PLOS ONE IN PRESS; Nguyen A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8627384; Obata Y, 2015, IMMUNOL CELL BIOL, V93, P226, DOI 10.1038/icb.2014.114; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Oike Y, 2009, CIRC J, V73, P2192, DOI 10.1253/circj.CJ-09-0710; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Sasaki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131176; Shimura T, 2015, ANTICANCER RES, V35, P4633; Swain L, 2014, J LEUKOCYTE BIOL, V96, P365, DOI 10.1189/jlb.2HI1013-533R; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Thorin-Trescases N, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.19; Toiyama Y, 2015, CARCINOGENESIS, V36, P1474, DOI 10.1093/carcin/bgv139; Toiyama Y, 2015, ANTICANCER RES, V35, P2849; Toiyama Y, 2014, CLIN CANCER RES, V20, P6175, DOI 10.1158/1078-0432.CCR-14-0007; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; Udali S, 2013, MOL ASPECTS MED, V34, P883, DOI 10.1016/j.mam.2012.08.001; van Dijk SJ, 2015, INT J OBESITY, V39, P85, DOI 10.1038/ijo.2014.34; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wang J, 2015, J HUM HYPERTENS, V29, P575, DOI 10.1038/jhh.2014.132; Wang JY, 2015, WORLD J MICROB BIOT, V31, P1235, DOI 10.1007/s11274-015-1873-7; Wang ZQ, 2015, ARCH MED RES, V46, P257, DOI 10.1016/j.arcmed.2015.05.003; Webster ALH, 2013, CAN J CARDIOL, V29, P46, DOI 10.1016/j.cjca.2012.10.023; Wierda RJ, 2010, J CELL MOL MED, V14, P1225, DOI 10.1111/j.1582-4934.2010.01022.x; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Yara S, 2015, EPIGENOMICS-UK, V7, P283, DOI [10.2217/EPI.14.84, 10.2217/epi.14.84]	67	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153920	10.1371/journal.pone.0153920	http://dx.doi.org/10.1371/journal.pone.0153920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101308	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500095
J	Faber, TW; van Elk, M; Jonas, KJ				Faber, Tim W.; van Elk, Michiel; Jonas, Kai J.			Complementary Hand Responses Occur in Both Peri- and Extrapersonal Space	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; AUTOMATIC IMITATION; MOTOR IMAGERY; JOINT ACTION; COMPATIBILITY; OBJECTS; SIMULATION; ERP	Human beings have a strong tendency to imitate. Evidence from motor priming paradigms suggests that people automatically tend to imitate observed actions such as hand gestures by performing mirror-congruent movements (e.g., lifting one's right finger upon observing a left finger movement; from a mirror perspective). Many observed actions however, do not require mirror-congruent responses but afford complementary (fitting) responses instead (e.g., handing over a cup; shaking hands). Crucially, whereas mirror-congruent responses don't require physical interaction with another person, complementary actions often do. Given that most experiments studying motor priming have used stimuli devoid of contextual information, this space or interaction-dependency of complementary responses has not yet been assessed. To address this issue, we let participants perform a task in which they had to mirror or complement a hand gesture (fist or open hand) performed by an actor depicted either within or outside of reach. In three studies, we observed faster reaction times and less response errors for complementary relative to mirrored hand movements in response to open hand gestures (i.e., 'hand-shaking') irrespective of the perceived interpersonal distance of the actor. This complementary effect could not be accounted for by a low-level spatial cueing effect. These results demonstrate that humans have a strong and automatic tendency to respond by performing complementary actions. In addition, our findings underline the limitations of manipulations of space in modulating effects of motor priming and the perception of affordances.	[Faber, Tim W.; van Elk, Michiel; Jonas, Kai J.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	University of Amsterdam	Faber, TW (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	T.W.Faber@uva.nl	Jonas, Kai/AAB-3120-2021	Jonas, Kai/0000-0001-6607-1993; Faber, Tim/0000-0002-7910-6566	Netherlands Organisation for Scientific Research [016.135.135]; Kurt Lewin Institute Graduate School through the Netherlands Organisation for Scientific Research	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Kurt Lewin Institute Graduate School through the Netherlands Organisation for Scientific Research	This work was supported by Netherlands Organisation for Scientific Research (grant recipient MvE; grant number: 016.135.135). TF is supported by the Kurt Lewin Institute Graduate School through the Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini E, 2013, EXP BRAIN RES, V229, P197, DOI 10.1007/s00221-013-3607-0; Bertenthal BI, 2006, J EXP PSYCHOL HUMAN, V32, P210, DOI 10.1037/0096-1523.32.2.210; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Cavallo A, 2014, SOC COGN AFFECT NEUR, V9, P1082, DOI 10.1093/scan/nst085; Cesario J, 2006, J PERS SOC PSYCHOL, V90, P893, DOI 10.1037/0022-3514.90.6.893; Cook R, 2010, J EXP PSYCHOL HUMAN, V36, P840, DOI 10.1037/a0019256; Costantini M, 2011, PSYCHON B REV, V18, P302, DOI 10.3758/s13423-011-0054-4; Costantini M, 2010, EXP BRAIN RES, V207, P95, DOI 10.1007/s00221-010-2435-8; Crostella F, 2009, EXP BRAIN RES, V197, P143, DOI 10.1007/s00221-009-1900-8; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Flach R, 2010, BRIT J PSYCHOL, V101, P739, DOI 10.1348/000712609X484595; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GREENWALD AG, 1970, PSYCHOL REV, V77, P73, DOI 10.1037/h0028689; Heed T, 2010, CURR BIOL, V20, P1345, DOI 10.1016/j.cub.2010.05.068; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; Jeannerod M, 1999, CURR OPIN NEUROBIOL, V9, P735, DOI 10.1016/S0959-4388(99)00038-0; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jonas KJ, 2006, J PERS SOC PSYCHOL, V90, P709, DOI 10.1037/0022-3514.90.5.709; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Kourtis D, 2010, BIOL LETTERS, V6, P758, DOI 10.1098/rsbl.2010.0478; LAMBERTS K, 1992, ACTA PSYCHOL, V79, P115, DOI 10.1016/0001-6918(92)90028-C; Liepelt R, 2010, COGNITION, V115, P426, DOI 10.1016/j.cognition.2010.03.003; Love J., 2015, JASP VERSION 0 7; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Obhi SS, 2011, EXP BRAIN RES, V211, P329, DOI 10.1007/s00221-011-2721-0; Ocampo B, 2010, EXP BRAIN RES, V201, P743, DOI 10.1007/s00221-009-2089-6; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; Richardson D. C., 2008, P 30 ANN C COGN SCI, P309; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Sartori L, 2015, CORTEX, V70, P169, DOI 10.1016/j.cortex.2015.01.019; Sartori L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00557; Sartori L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00702; Sartori L, 2013, SOC COGN AFFECT NEUR, V8, P662, DOI 10.1093/scan/nss044; Sartori L, 2012, SOC NEUROSCI-UK, V7, P146, DOI 10.1080/17470919.2011.586579; Sartori L, 2011, EXP BRAIN RES, V211, P557, DOI 10.1007/s00221-011-2650-y; Schilbach L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00278; Sebanz N, 2006, J COGNITIVE NEUROSCI, V18, P859, DOI 10.1162/jocn.2006.18.5.859; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Shibata T, 2011, J VISION, V11, DOI 10.1167/11.8.11; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Turvey M. T., 1992, ECOL PSYCHOL, V4, P173, DOI [10.1207/s15326969eco0403_3, DOI 10.1207/S15326969EC00403_]; Tversky B., 2005, CAMBRIDGE HDB VISUOS, P1, DOI DOI 10.1017/CBO9780511610448.002; Valdes-Conroy B, 2014, NEUROPSYCHOLOGIA, V59, P27, DOI 10.1016/j.neuropsychologia.2014.04.009; van Dam WO, 2012, HUM BRAIN MAPP, V33, P2322, DOI 10.1002/hbm.21365; van Elk M, 2009, J EXP PSYCHOL HUMAN, V35, P1118, DOI 10.1037/a0015024; van Schie HT, 2008, J EXP PSYCHOL HUMAN, V34, P1493, DOI 10.1037/a0011750; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson A, 2014, NOTES FROM TWO SCIEN, V10, P8; Wilson AD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00058; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Yu AB, 2014, J EXP PSYCHOL HUMAN, V40, P1861, DOI 10.1037/a0037397	63	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154457	10.1371/journal.pone.0154457	http://dx.doi.org/10.1371/journal.pone.0154457			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120470	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200079
J	Martins, CS; Leitao, RFC; Costa, DVS; Melo, IM; Santos, GS; Lima, V; Baldim, V; Wong, DVT; Bonfim, LE; Melo, CB; de Oliveira, MG; Brito, GAC				Martins, Conceiao S.; Leitao, Renata F. C.; Costa, Deiziane V. S.; Melo, Iracema M.; Santos, Glaylton S.; Lima, Vilma; Baldim, Victor; Wong, Deysi V. T.; Bonfim, Luana E.; Melo, Cintia B.; de Oliveira, Marcelo G.; Brito, Gerly A. C.			Topical HPMC/S-Nitrosoglutathione Solution Decreases Inflammation and Bone Resorption in Experimental Periodontal Disease in Rats	PLOS ONE			English	Article							NITRIC-OXIDE; S-NITROSOGLUTATHIONE; EXPRESSION; PREVENTION; HYDROGEL; SYNTHASE	S-nitrosoglutathione (GSNO) is a nitric oxide (NO) donor, which exerts antioxidant, anti-inflammatory, and microbicidal actions. Intragingival application of GSNO was already shown to decrease alveolar bone loss, inflammation and oxidative stress in an experimental periodontal disease (EPD) model. In the present study, we evaluated the potential therapeutic effect of topical applications of hydroxypropylmethylcellulose (HPMC)/GSNO solutions on EPD in Wistar rats. EPD was induced by placing a sterilized nylon (3.0) thread ligature around the cervix of the second left upper molar of the animals, which received topical applications of a HPMC solutions containing GSNO 2 or 10 mM or vehicle (HPMC solution), 1 h prior to the placement of the ligature and then twice daily until sacrifice on day 11. Treatment with HPMC/ GSNO 10 mM solution significantly reduced alveolar bone loss, oxidative stress and TNF-alpha e IL-1 beta levels in the surrounding gingival tissue, and led to a decreased transcription of RANK and TNF-alpha genes and elevated bone alkaline phosphatase, compared to the HPMC group. In conclusion, topical application of HPMC/GSNO solution is a potential treatment to reduce inflammation and bone loss in periodontal disease.	[Martins, Conceiao S.; Leitao, Renata F. C.; Costa, Deiziane V. S.; Santos, Glaylton S.; Bonfim, Luana E.; Melo, Cintia B.; Brito, Gerly A. C.] Univ Fed Ceara, Postgrad Program Morphofunct Sci, Dept Morphol, Sch Med, Fortaleza, Ceara, Brazil; [Melo, Iracema M.] Univ Fed Ceara, Dept Clin Dent, Fac Pharm Dent & Nursing, Sch Dent, Fortaleza, Ceara, Brazil; [Lima, Vilma; Wong, Deysi V. T.] Univ Fed Ceara, Dept Physiol & Pharmacol, Sch Med, Fortaleza, Ceara, Brazil; [Baldim, Victor; de Oliveira, Marcelo G.] Univ Estadual Campinas, UNICAMP, Inst Chem, Sao Paulo, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Estadual de Campinas	Brito, GAC (corresponding author), Univ Fed Ceara, Postgrad Program Morphofunct Sci, Dept Morphol, Sch Med, Fortaleza, Ceara, Brazil.; de Oliveira, MG (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Chem, Sao Paulo, Brazil.	mgo@iqm.unicamp; gerlybrito@hotmail.com	Lima, Vilma/ABE-8964-2020; de Castro Brito, Gerly Anne/C-8597-2013; Leitao, Renata/ABG-7682-2020; Costa, Deiziane VS/C-4727-2017; Brito, Gerly/AHB-3965-2022; Wong, Deysi Viviana Tenazoa/AAH-3575-2020; Leitao, Renata/ABF-9158-2020; de Oliveira, Marcelo/B-4709-2013; Leitão, Renata FC/GQI-3555-2022	Lima, Vilma/0000-0002-8652-4133; de Castro Brito, Gerly Anne/0000-0002-8214-4379; Costa, Deiziane VS/0000-0001-6402-8908; Brito, Gerly/0000-0002-8214-4379; Wong, Deysi Viviana Tenazoa/0000-0002-9741-7560; de Oliveira, Marcelo/0000-0002-9371-9975; Leitão, Renata FC/0000-0003-0202-771X; Martins, Conceicao/0000-0001-8710-1856; Baldim, Victor/0000-0002-3003-7328	National Council for Scientific and Technological Development - CNPq [478380/2011-9, 309390/2011-7]	National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Leitao RFC and de Oliveira MG would like to acknowledge grants from The National Council for Scientific and Technological Development - CNPq (http://www.cnpq.br/) (projects #478380/2011-9 and 309390/2011-7, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P6876, DOI 10.1021/bi010066m; de Menezes AMA, 2012, J PERIODONTOL, V83, P514, DOI 10.1902/jop.2011.110332; Assuma R, 1998, J IMMUNOL, V160, P403; Bayer E A, 1980, Methods Biochem Anal, V26, P1; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Cariello AJ, 2010, J ANTIMICROB CHEMOTH, V65, P588, DOI 10.1093/jac/dkp485; Chae HJ, 1997, J PHARM PHARMACOL, V49, P897, DOI 10.1111/j.2042-7158.1997.tb06132.x; Chiueh CC, 1999, FREE RADICAL RES, V31, P641, DOI 10.1080/10715769900301211; COLASANTI M, 1995, J BIOL CHEM, V270, P26731, DOI 10.1074/jbc.270.45.26731; Dahiya Parveen, 2013, J Indian Soc Periodontol, V17, P411, DOI 10.4103/0972-124X.118306; de Lima V, 2000, EUR J ORAL SCI, V108, P123, DOI 10.1034/j.1600-0722.2000.00766.x; Simoes MMDG, 2010, J BIOMED MATER RES B, V93B, P416, DOI 10.1002/jbm.b.31598; DING AH, 1988, J IMMUNOL, V141, P2407; Fini M, 2001, BIOMED PHARMACOTHER, V55, P213, DOI 10.1016/S0753-3322(01)00054-3; de Souza GFP, 2006, NITRIC OXIDE-BIOL CH, V15, P209, DOI 10.1016/j.niox.2006.01.011; Fyfe CA, 1997, MACROMOLECULES, V30, P6230, DOI 10.1021/ma970076o; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P1349, DOI 10.1177/29.11.6172466; Joshi MS, 1999, FREE RADICAL BIO MED, V27, P1357, DOI 10.1016/S0891-5849(99)00179-3; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kinney JS, 2007, ANN NY ACAD SCI, V1098, P230, DOI 10.1196/annals.1384.028; Kuhr A, 2004, J PERIODONTAL RES, V39, P101, DOI 10.1111/j.1600-0765.2004.00710.x; Leitao RFC, 2005, J PERIODONTOL, V76, P956, DOI 10.1902/jop.2005.76.6.956; Leitao RFC, 2004, J PERIODONTOL, V75, P1227, DOI 10.1902/jop.2004.75.9.1227; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Raitapuro-Murray T, 2014, BRIT DENT J, V217, P459, DOI 10.1038/sj.bdj.2014.908; SALLAY K, 1982, J PERIODONTAL RES, V17, P263, DOI 10.1111/j.1600-0765.1982.tb01153.x; Schanuel FS, 2015, COLLOID SURFACE B, V130, P182, DOI 10.1016/j.colsurfb.2015.04.007; Silva SMC, 2008, J COLLOID INTERF SCI, V327, P333, DOI 10.1016/j.jcis.2008.08.056; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Skeff MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113378; Tay JYY, 2004, J DENT RES, V83, P349, DOI 10.1177/154405910408300415; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; WHITBY LG, 1975, CLIN CHIM ACTA, V59, P361, DOI 10.1016/0009-8981(75)90012-1; Wimalawansa SJ, 1997, BONE, V21, P275, DOI 10.1016/S8756-3282(97)00125-7; Wimalawansa SM, 2001, J MUSCULOSKEL NEURON, V1, P141; Wimalawansa SJ, 2008, EXPERT OPIN PHARMACO, V9, P1935, DOI 10.1517/14656566.9.11.1935 ; Wimalawansa SJ, 2007, ANN NY ACAD SCI, V1117, P283, DOI 10.1196/annals.1402.066; Wimalawansa SJ, 2010, ANN NY ACAD SCI, V1192, P391, DOI 10.1111/j.1749-6632.2009.05230.x; Zhang M, 2010, SCI CHINA LIFE SCI, V53, P112, DOI 10.1007/s11427-010-0013-8	45	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153716	10.1371/journal.pone.0153716	http://dx.doi.org/10.1371/journal.pone.0153716			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116554	Green Published, gold			2022-12-27	WOS:000374973600028
J	Prasai, TP; Walsh, KB; Bhattarai, SP; Midmore, DJ; Van, TTH; Moore, RJ; Stanley, D				Prasai, Tanka P.; Walsh, Kerry B.; Bhattarai, Surya P.; Midmore, David J.; Van, Thi T. H.; Moore, Robert J.; Stanley, Dragana			Biochar, Bentonite and Zeolite Supplemented Feeding of Layer Chickens Alters Intestinal Microbiota and Reduces Campylobacter Load	PLOS ONE			English	Article							ENTEROCOCCUS-CECORUM; HELICOBACTER PULLORUM; DIETARY INCLUSION; SODIUM BENTONITE; GROWTH PROMOTERS; LIVER-DISEASE; LAYING HENS; BROILER; PERFORMANCE; SEPIOLITE	A range of feed supplements, including antibiotics, have been commonly used in poultry production to improve health and productivity. Alternative methods are needed to suppress pathogen loads and maintain productivity. As an alternative to antibiotics use, we investigated the ability of biochar, bentonite and zeolite as separate 4% feed additives, to selectively remove pathogens without reducing microbial richness and diversity in the gut. Neither biochar, bentonite nor zeolite made any significant alterations to the overall richness and diversity of intestinal bacterial community. However, reduction of some bacterial species, including some potential pathogens was detected. The microbiota of bentonite fed animals were lacking all members of the order Campylobacterales. Specifically, the following operational taxonomic units (OTUs) were absent: an OTU 100% identical to Campylobacter jejuni; an OTU 99% identical to Helicobacter pullorum; multiple Gallibacterium anatis (> 97%) related OTUs; Bacteroides dorei (99%) and Clostridium aldenense (95%) related OTUs. Biochar and zeolite treatments had similar but milder effects compared to bentonite. Zeolite amended feed was also associated with significant reduction in the phylum Proteobacteria. All three additives showed potential for the control of major poultry zoonotic pathogens.	[Prasai, Tanka P.; Walsh, Kerry B.; Bhattarai, Surya P.; Midmore, David J.; Stanley, Dragana] Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld 4702, Australia; [Van, Thi T. H.; Moore, Robert J.] RMIT Univ, Sch Appl Sci, Bundoora, Vic, Australia; [Van, Thi T. H.; Moore, Robert J.] Hlth Innovat Res Inst, Bundoora, Vic, Australia; [Moore, Robert J.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Central Queensland University; Royal Melbourne Institute of Technology (RMIT); Monash University	Stanley, D (corresponding author), Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld 4702, Australia.	D.Stanley@cqu.edu.au	Midmore, David/I-7657-2019; Stanley, Dragana/AAC-2596-2020; Moore, Robert J/D-8352-2011	Midmore, David/0000-0001-9946-5008; Stanley, Dragana/0000-0001-7019-4726; Moore, Robert J/0000-0002-0776-5861; walsh, kerry/0000-0002-3033-8622; Van, Thi Thu Hao/0000-0002-1559-568X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alzueta C, 2002, ANIM FEED SCI TECH, V97, P169, DOI 10.1016/S0377-8401(02)00030-5; ANGULO E, 1995, ANIM FEED SCI TECH, V53, P233, DOI 10.1016/0377-8401(94)00749-Y; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Belmares J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-4; Boerlin P, 2012, VET MICROBIOL, V157, P405, DOI 10.1016/j.vetmic.2012.01.001; CABEZAS MJ, 1991, J CHEM TECHNOL BIOT, V52, P265; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Crawshaw TR, 2015, VET MICROBIOL, V179, P315, DOI 10.1016/j.vetmic.2015.06.008; Daimon Yasushi, 2008, Kansenshogaku Zasshi, V82, P205; Dakovic A, 2005, COLLOID SURFACE B, V46, P20, DOI 10.1016/j.colsurfb.2005.08.013; Damiri H, 2010, J ANIM VET ADV, V9, P2668; Davis-Richardson AG, 2015, DIABETOLOGIA, V58, P1386, DOI 10.1007/s00125-015-3614-8; Davis-Richardson AG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00678; De Baere T, 2000, J CLIN MICROBIOL, V38, P3511, DOI 10.1128/JCM.38.9.3511-3512.2000; Delaunay E., 2015, New Microbes and New Infections, V7, P50, DOI 10.1016/j.nmni.2015.06.004; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eleroglu H, 2011, S AFR J ANIM SCI, V41, P319, DOI 10.4314/sajas.v41i4.1; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; FETHIERE R, 1990, POULTRY SCI, V69, P2195, DOI 10.3382/ps.0692195; FETHIERE R, 1994, POULTRY SCI, V73, P118, DOI 10.3382/ps.0730118; Gerlach H., 2012, ITHAKA J, V2012, P262; Greub G, 1997, EUR J CLIN MICROBIOL, V16, P594, DOI 10.1007/BF02447923; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Hansen R, 2011, FEMS IMMUNOL MED MIC, V61, P1, DOI 10.1111/j.1574-695X.2010.00744.x; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Kana JR, 2010, ADV ANIMAL BIOSCIENC, V1, P462, DOI [10.1017/S2040470010000841, DOI 10.1017/S2040470010000841]; Kutlu HR, 2001, ANIM FEED SCI TECH, V90, P213, DOI 10.1016/S0377-8401(01)00205-X; Laharie D, 2009, ALIMENT PHARM THER, V30, P283, DOI 10.1111/j.1365-2036.2009.04034.x; Lin J, 2013, FOODBORNE PATHOG DIS, V10, P331, DOI 10.1089/fpd.2012.1348; Lone AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075325; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Moghaddam H. N., 2008, Journal of Biological Sciences, V8, P328; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Neubauer C, 2009, AVIAN PATHOL, V38, P1, DOI 10.1080/03079450802577848; Olver M, 1983, S AFRICAN J ANIMAL S; Olver MD, 1997, BRIT POULTRY SCI, V38, P220, DOI 10.1080/00071669708417973; Ouhida I, 2000, ANIM FEED SCI TECH, V85, P183, DOI 10.1016/S0377-8401(00)00148-6; Papaioannou D, 2005, MICROPOR MESOPOR MAT, V84, P161, DOI 10.1016/j.micromeso.2005.05.030; Papaioannou DS, 2002, RES VET SCI, V72, P61, DOI 10.1053/rvsc.2001.0524; Parisini P, 1999, ANIM FEED SCI TECH, V79, P155, DOI 10.1016/S0377-8401(99)00008-5; Pasha TN, 2007, ANIM FEED SCI TECH, V132, P103, DOI 10.1016/j.anifeedsci.2006.03.014; Paudel S, 2014, AVIAN PATHOL, V43, P443, DOI 10.1080/03079457.2014.955782; Prvulovic D, 2008, TURK J VET ANIM SCI, V32, P183; Ruttanavut J., 2009, International Journal of Poultry Science, V8, P229; Safaeikatouli M, 2010, INT J AGRIC BIOL, V12, P877; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Stalker MJ, 2010, J VET DIAGN INVEST, V22, P643, DOI 10.1177/104063871002200426; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; STANLEY J, 1994, MICROBIOL-UK, V140, P3441, DOI 10.1099/13500872-140-12-3441; Steinbrueckner B, 1997, SCAND J INFECT DIS, V29, P315, DOI 10.3109/00365549709019053; Uchida T, 1992, Hinyokika Kiyo, V38, P973; Veijola L, 2007, ANN MED, V39, P554, DOI 10.1080/07853890701545714; Williams OM, 2010, ANAEROBE, V16, P475, DOI 10.1016/j.anaerobe.2010.08.004; Xia MS, 2004, POULTRY SCI, V83, P1868, DOI 10.1093/ps/83.11.1868	57	47	51	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154061	10.1371/journal.pone.0154061	http://dx.doi.org/10.1371/journal.pone.0154061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116607	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600041
J	Chen, Y; Fang, F; Hu, Y; Liu, Q; Bu, DF; Tan, M; Wu, LS; Zhu, P				Chen, Yan; Fang, Fang; Hu, Yang; Liu, Qian; Bu, Dingfang; Tan, Mei; Wu, Liusong; Zhu, Ping			The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; JAK2 EXON-12 MUTATIONS; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; IDIOPATHIC ERYTHROCYTOSIS; ACTIVATING MUTATION; MYELOID METAPLASIA; BLOOD-PRESSURE; MPL MUTATIONS	Objective LNK is an adapter protein negatively regulating the JAK/STAT cell signaling pathway. In this study, we observed the correlation between variation in LNK gene and the clinical type of myeloproliferative neoplasms (MPN). Methods A total of 285 MPN cases were recruited, including essential thrombocythemia (ET) 154 cases, polycythemia vera (PV) 76 cases, primary myelofibrosis (PMF) 19 cases, and chronic myeloid leukemia (CML) 36 cases. Ninety-three healthy individuals were used as normal controls. V617F mutation in JAK2 was identified by allele-specific PCR method, RTPCR was used for the detection of BCR/ABL1 fusion gene, and mutations and variations in coding exons and their flanking sequences of LNK gene were examined by PCR-sequencing. Results Missense mutations of A300V, V402M, and R415H in LNK were found in 8 patients including ET (4 cases, all combined with JAK2-V617F mutation), PV (2 cases, one combined with JAK2-V617F mutation), PMF (one case, combined with JAK2-V617F mutation) and CML (one case, combined with BCR/ABL1 fusion gene). The genotype and allele frequencies of the three SNPs (rs3184504, rs111340708 and rs78894077) in LNK were significantly different between MPN patients and controls. For rs3184504 (T/C, in exon2), the T allele (p.262W) and TT genotype were frequently seen in ET, PV and PMF (P< 0.01), and C allele (p.262R) and CC genotype were frequently seen in CML (P< 0.01). For rs78894077 (T/C, in exon1), the T allele (p.242S) was frequently found in ET (P< 0.05). For rs111340708 (TGGGGx5/TGGGGx4, in intron 5), the TGGGG x4 allele was infrequently found in ET, PMF and CML(P< 0.01). Conclusion Mutations in LNK could be found in some of MPN patients in the presence or absence of JAK2-V617F mutation. Several polymorphisms in LNK gene may affect the clinical type or the genetic predisposition of MPN.	[Chen, Yan; Fang, Fang; Hu, Yang; Liu, Qian; Bu, Dingfang; Zhu, Ping] Peking Univ, Dept Hematol, Hosp 1, Beijing 100871, Peoples R China; [Chen, Yan; Tan, Mei; Wu, Liusong] Zunyi Med Coll, Affiliated Hosp, Zunyi, Guizhou, Peoples R China	Peking University; Zunyi Medical University	Zhu, P (corresponding author), Peking Univ, Dept Hematol, Hosp 1, Beijing 100871, Peoples R China.	zhuping@bjmu.edu.cn		Fang, Fang/0000-0002-0338-5466	National Natural Science Foundation of China [81370612]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the National Natural Science Foundation of China (Grant No. 81370612).	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bellosillo B, 2007, LEUKEMIA, V21, P1331, DOI 10.1038/sj.leu.2404649; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Bersenev A, 2010, J CLIN INVEST, V120, P2058, DOI 10.1172/JCI42032; Cario H, 2005, BRIT J HAEMATOL, V130, P800, DOI 10.1111/j.1365-2141.2005.05683.x; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Landgren O, 2008, BLOOD, V112, P2199, DOI 10.1182/blood-2008-03-143602; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; LEVINE RL, 2006, HEMATOL-AM SOC HEMAT, V510, P233, DOI DOI 10.1182/ASHEDUCATI0N-2006.1.233; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liu Hong-xing, 2009, Zhonghua Yi Xue Za Zhi, V89, P220; Martinez-Aviles L, 2007, HAEMATOLOGICA, V92, P1717, DOI 10.3324/haematol.12011; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Olcaydu D, 2011, HAEMATOL-HEMATOL J, V96, P367, DOI 10.3324/haematol.2010.034488; Pardanani A, 2010, LEUKEMIA, V24, P1713, DOI 10.1038/leu.2010.163; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pare G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001374; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Ranjan A, 2013, CLIN GENET, V83, P99, DOI 10.1111/cge.12044; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Saint-Martin C, 2009, BLOOD, V114, P1628, DOI 10.1182/blood-2009-01-197525; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Tefferi A, 2008, LEUKEMIA LYMPHOMA, V49, P388, DOI 10.1080/10428190801895360; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; Tong W, 2004, J EXP MED, V200, P569, DOI 10.1084/jem.20040762; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883	36	15	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154183	10.1371/journal.pone.0154183	http://dx.doi.org/10.1371/journal.pone.0154183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111338	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600043
J	Vogt, LJ; Steveling, A; Meffert, PJ; Kromrey, ML; Kessler, R; Hosten, N; Kruger, J; Gartner, S; Aghdassi, AA; Mayerle, J; Lerch, MM; Kehn, JP				Vogt, Lena J.; Steveling, Antje; Meffert, Peter J.; Kromrey, Marie-Luise; Kessler, Rebecca; Hosten, Norbert; Krueger, Janine; Gaertner, Simone; Aghdassi, Ali A.; Mayerle, Julia; Lerch, Markus M.; Kuehn, Jens-Peter			Magnetic Resonance Imaging of Changes in Abdominal Compartments in Obese Diabetics during a Low-Calorie Weight-Loss Program	PLOS ONE			English	Article							FATTY LIVER-DISEASE; BETA-CELL FUNCTION; BONE-MARROW FAT; INSULIN SENSITIVITY; METABOLIC SYNDROME; QUANTIFICATION; DIET; SARCOPENIA; ADIPOSITY; PANCREAS	Objectives To investigate changes in the fat content of abdominal compartments and muscle area during weight loss using confounder-adjusted chemical-shift-encoded magnetic resonance imaging (MRI) in overweight diabetics. Methods Twenty-nine obese diabetics (10/19 men/women, median age: 59.0 years, median body mass index (BMI): 34.0 kg/m(2)) prospectively joined a standardized 15-week weight-loss program (six weeks of formula diet exclusively, followed by reintroduction of regular food with gradually increasing energy content over nine weeks) over 15 weeks. All subjects underwent a standardized MRI protocol including a confounder-adjusted chemical-shift-encoded MR sequence with water/fat separation before the program as well at the end of the six weeks of formula diet and at the end of the program at 15 weeks. Fat fractions of abdominal organs and vertebral bone marrow as well as volumes of visceral and subcutaneous fat were determined. Furthermore, muscle area was evaluated using the L4/L5 method. Data were compared using the Wilcoxon signed-rank test for paired samples. Results Median BMI decreased significantly from 34.0 kg/m(2) to 29.9 kg/m(2) (p < 0.001) at 15 weeks. Liver fat content was normalized (14.2% to 4.1%, p < 0.001) and vertebral bone marrow fat (57.5% to 53.6%, p = 0.018) decreased significantly throughout the program, while fat content of pancreas (9.0%), spleen (0.0%), and psoas muscle (0.0%) did not (p > 0.15). Visceral fat volume (3.2 L to 1.6 L, p < 0.001) and subcutaneous fat diameter (3.0 cm to 2.2 cm, p < 0.001) also decreased significantly. Muscle area declined by 6.8% from 243.9 cm(2) to 226.8 cm(2). Conclusion MRI allows noninvasive monitoring of changes in abdominal compartments during weight loss. In overweight diabetics, weight loss leads to fat reduction in abdominal compartments, such as visceral fat, as well as liver fat and vertebral bone marrow fat while pancreas fat remains unchanged.	[Vogt, Lena J.; Steveling, Antje; Krueger, Janine; Gaertner, Simone; Aghdassi, Ali A.; Mayerle, Julia; Lerch, Markus M.] Univ Med Greifswald, Dept Med A, Greifswald, Germany; [Meffert, Peter J.] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Kromrey, Marie-Luise; Kessler, Rebecca; Hosten, Norbert; Kuehn, Jens-Peter] Univ Med Greifswald, Dept Radiol & Neuroradiol, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Kehn, JP (corresponding author), Univ Med Greifswald, Dept Radiol & Neuroradiol, Greifswald, Germany.	kuehn@uni-greifswald.de	Lerch, Markus M./E-2206-2016; Aghdassi, Ali/X-5836-2019; Mayerle, Julia/W-7907-2019	Lerch, Markus M./0000-0002-9643-8263; Aghdassi, Ali/0000-0002-0569-7316; Mayerle, Julia/0000-0002-3666-6459	University Medicine Greifswald through an unrestricted educational grant from Baxter Deutschland GmbH (Unterschleissheim, Germany); Medinal GmbH (Greven, Germany); Nutricia GmbH (Erlangen, Germany); Nestle HealthCare Science GmbH	University Medicine Greifswald through an unrestricted educational grant from Baxter Deutschland GmbH (Unterschleissheim, Germany); Medinal GmbH (Greven, Germany); Nutricia GmbH (Erlangen, Germany)(Danone Nutricia); Nestle HealthCare Science GmbH(Nestle SA)	Two authors of this manuscript declare relationships with the following companies: LJV and JK received a Gerhard Domagk scholarship from University Medicine Greifswald made possible through an unrestricted educational grant from Baxter Deutschland GmbH (Unterschleissheim, Germany), Medinal GmbH (Greven, Germany) and Nutricia GmbH (Erlangen, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors have no conflict of interests. In addition, this study has received funding by Nestle HealthCare Science GmbH. The standardized weight-loss program OPTIFAST (R) was used with the consent of Nestle HealthCare Science GmbH. Nestle HealthCare Science GmbH supported the study by granting study participants a 15% discount for the formula diet.	Artz NS, 2015, J MAGN RESON IMAGING, V42, P811, DOI 10.1002/jmri.24842; Asrih M, 2013, J ENDOCRINOL, V218, pR25, DOI 10.1530/JOE-13-0201; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; Bischoff SC, 2012, INT J OBESITY, V36, P614, DOI 10.1038/ijo.2011.107; Chang Jerry S, 2006, AJR Am J Roentgenol, V187, pW103, DOI 10.2214/AJR.05.0695; Colles SL, 2006, AM J CLIN NUTR, V84, P304; Demerath EW, 2008, AM J CLIN NUTR, V88, P1263, DOI 10.3945/ajcn.2008.26546; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Dixon JB, 2004, HEPATOLOGY, V39, P1647, DOI 10.1002/hep.20251; Durand F, 2014, J HEPATOL, V60, P1151, DOI 10.1016/j.jhep.2014.02.026; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fazeli PK, 2010, J CLIN ENDOCR METAB, V95, P407, DOI 10.1210/jc.2009-1152; Fock KM, 2013, J GASTROEN HEPATOL, V28, P59, DOI 10.1111/jgh.12407; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Gastaldelli A, 2002, J CLIN ENDOCR METAB, V87, P5098, DOI 10.1210/jc.2002-020696; Guiu B, 2009, RADIOLOGY, V250, P95, DOI 10.1148/radiol.2493080217; Idoate F, 2015, EUR RADIOL, V25, P2163, DOI 10.1007/s00330-014-3555-5; Iozzo P, 2003, J CLIN ENDOCR METAB, V88, P2055, DOI 10.1210/jc.2002-021446; Kang GH, 2011, J MAGN RESON IMAGING, V34, P928, DOI 10.1002/jmri.22701; Kim HK, 2009, AM J MED SCI, V337, P98, DOI 10.1097/MAJ.0b013e3181812879; Kuhn JP, 2015, RADIOLOGY, V276, P129, DOI 10.1148/radiol.15140446; Kuhn JP, 2014, J MAGN RESON IMAGING, V40, P875, DOI 10.1002/jmri.24457; Kuhn JP, 2014, J MAGN RESON IMAGING, V39, P1494, DOI 10.1002/jmri.24289; Kuhn JP, 2012, RADIOLOGY, V265, P133, DOI 10.1148/radiol.12112520; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Lewis MC, 2006, OBES SURG, V16, P697, DOI 10.1381/096089206777346682; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Lingvay I, 2009, J CLIN ENDOCR METAB, V94, P4070, DOI 10.1210/jc.2009-0584; Liu CY, 2007, MAGN RESON MED, V58, P354, DOI 10.1002/mrm.21301; Marceau P, 1999, J CLIN ENDOCR METAB, V84, P1513, DOI 10.1210/jc.84.5.1513; Masuda T, 2014, LIVER TRANSPLANT, V20, P401, DOI 10.1002/lt.23811; Meisamy S, 2011, RADIOLOGY, V258, P767, DOI 10.1148/radiol.10100708; Oza N, 2009, J GASTROENTEROL, V44, P1203, DOI 10.1007/s00535-009-0115-x; Patsch JM, 2013, J BONE MINER RES, V28, P1721, DOI 10.1002/jbmr.1950; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Poonawalla AH, 2013, J MAGN RESON IMAGING, V37, P707, DOI 10.1002/jmri.23846; Reeder SB, 2012, J MAGN RESON IMAGING, V36, P1011, DOI 10.1002/jmri.23741; Reeder SB, 2010, MAGN RESON IMAGING C, V18, P337, DOI 10.1016/j.mric.2010.08.013; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rossi AP, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.5; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; Schafer AL, 2015, BONE, V74, P140, DOI 10.1016/j.bone.2015.01.010; Shah K, 2009, OBESITY, V17, P2162, DOI 10.1038/oby.2009.126; Snel M, 2012, OBESITY, V20, P1572, DOI 10.1038/oby.2011.390; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; Tsien C, 2013, EUR J GASTROEN HEPAT, V25, P85, DOI 10.1097/MEG.0b013e328359a759; Tushuizen ME, 2007, DIABETES CARE, V30, P2916, DOI 10.2337/dc07-0326; van Geenen EJM, 2010, PANCREAS, V39, P1185, DOI 10.1097/MPA.0b013e3181f6fce2; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Viljanen APM, 2009, J CLIN ENDOCR METAB, V94, P50, DOI 10.1210/jc.2008-1689; Wechsler JG, 2011, ADIPOSITAS, V5, P89; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WHO, 2000, OB PREV MAN GLOB EP; Yip C, 2014, EUR RADIOL, V24, P998, DOI 10.1007/s00330-014-3110-4; Yokoo T, 2011, RADIOLOGY, V258, P749, DOI 10.1148/radiol.10100659; Yu HZ, 2007, J MAGN RESON IMAGING, V26, P1153, DOI 10.1002/jmri.21090	58	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153595	10.1371/journal.pone.0153595	http://dx.doi.org/10.1371/journal.pone.0153595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110719	Green Published, Green Submitted, gold			2022-12-27	WOS:000374970600018
J	Cunha, LP; Lopes, LC; Costa-Cunha, LVF; Costa, CF; Pires, LA; Almeida, ALM; Monteiro, MLR				Cunha, Leonardo Provetti; Lopes, Luciana Cheker; Ferreira Costa-Cunha, Luciana Virgnia; Costa, Carolina Ferreira; Pires, Leopoldo Antonio; Maciel Almeida, Ana Laura; Ribeiro Monteiro, Myrio Luiz			Macular Thickness Measurements with Frequency Domain-OCT for Quantification of Retinal Neural Loss and its Correlation with Cognitive Impairment in Alzheimer's Disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; PSEUDOTUMOR CEREBRI SYNDROME; PATTERN ELECTRORETINOGRAM; NEUROMYELITIS-OPTICA; CHIASMAL COMPRESSION; AUTOMATED PERIMETRY; CHRONIC PAPILLEDEMA; MULTIPLE-SCLEROSIS; ABNORMALITIES	Purpose To evaluate the ability of frequency domain optical coherence tomography (fd-OCT) to estimate retinal neural loss in eyes with Alzheimer's disease (AD). We also verified the existence of a correlation between AD-related cognitive impairment and macular and peripapillary retinal nerve fiber layer (RNFL) thickness measurements. Methods fd-OCT scans were obtained from 45 eyes of 24 patients with AD and 48 control eyes. Peripapillary RNFL, macular full-thickness and segmented inner macular thickness parameters were calculated. The inner macular parameters included macular retinal nerve fiber layer (mRNFL) thickness, ganglion cell layer (GCL) plus inner plexiform layer thickness (GCL+), and RNFL plus GCL+ thickness (GCL++). The Mini-Mental State Examination (MMSE) was used to assess cognition in all subjects. The two groups were compared and the relationship between MMSE scores and fd-OCT measurements was verified. Results Average, superior and inferior quadrant RNFL thickness parameters and all but one of the nine full-thickness macular measurements were significantly reduced in AD patients compared to controls. The segmented layers, GCL+ and GCL++ were significantly reduced in AD eyes. A significant correlation was found between most fd-OCT parameters (especially macular thickness measurements) and MMSE scores. Conclusions Most fd-OCT peripapillary RNFL and macular full-thickness and segmented inner retinal layers parameters were reduced in AD eyes compared to controls. Moreover, neuronal loss, especially as reflected in macular parameters, correlated well with cognitive impairment in AD. Our results suggest that fd-OCT could be a potentially useful diagnostic tool in the evaluation and follow-up of AD patients.	[Cunha, Leonardo Provetti; Lopes, Luciana Cheker] Univ Fed Juiz de Fora, Sch Med, Dept Ophtalmol, Juiz De Fora, MG, Brazil; [Cunha, Leonardo Provetti; Ferreira Costa-Cunha, Luciana Virgnia; Costa, Carolina Ferreira] Juiz de Fora Eye Hosp, Juiz De Fora, MG, Brazil; [Pires, Leopoldo Antonio; Maciel Almeida, Ana Laura] Univ Fed Juiz de Fora, Dept Neurol, Sch Med, Juiz De Fora, MG, Brazil; [Ribeiro Monteiro, Myrio Luiz] Univ Sao Paulo, Sch Med, Div Ophtalmol, Sao Paulo, Brazil	Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Universidade de Sao Paulo	Cunha, LP (corresponding author), Univ Fed Juiz de Fora, Sch Med, Dept Ophtalmol, Juiz De Fora, MG, Brazil.; Cunha, LP (corresponding author), Juiz de Fora Eye Hosp, Juiz De Fora, MG, Brazil.	leonardo_provetti@yahoo.com.br	Lopes-Júnior, Luís Carlos/B-8540-2015; MONTEIRO, MARIO L R/C-8891-2012; Cunha, Leonardo/AAD-3573-2019	Lopes-Júnior, Luís Carlos/0000-0002-2424-6510; MONTEIRO, MARIO L R/0000-0002-7281-2791; Cunha, Leonardo/0000-0001-7984-1790	LPC Programas Institucionais de Bolsas de Iniciacao Cientifica : XXVII BIC/UFJF, Universidade Federal de Juiz de Fora, Minas Gerais, Brazil [30997]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brasilia, Brazil [307393/2014-3]	LPC Programas Institucionais de Bolsas de Iniciacao Cientifica : XXVII BIC/UFJF, Universidade Federal de Juiz de Fora, Minas Gerais, Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	LPC Programas Institucionais de Bolsas de Iniciacao Cientifica : XXVII BIC/UFJF - 2014/2015 (number 30997), Universidade Federal de Juiz de Fora, Minas Gerais, Brazil. (http://www.ufjf.br/propesq) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MLRM Grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq (number 307393/2014-3), Brasilia, Brazil (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2015, INVEST OPHTH VIS SCI, V56, P3656, DOI 10.1167/iovs.15-16768; Alexandrov PN, 2011, NEUROREPORT, V22, P623, DOI 10.1097/WNR.0b013e3283497334; Armstrong RA, 1996, OPTOMETRY VISION SCI, V73, P677, DOI 10.1097/00006324-199611000-00001; Ascaso FJ, 2014, J NEUROL, V261, P1522, DOI 10.1007/s00415-014-7374-z; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; Blanks JC, 1996, NEUROBIOL AGING, V17, P377, DOI 10.1016/0197-4580(96)00010-3; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; Coppola G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134750; CRONINGOLOMB A, 1995, GERONTOLOGIST, V35, P370, DOI 10.1093/geront/35.3.370; CRONINGOLOMB A, 1991, ANN NEUROL, V29, P41, DOI 10.1002/ana.410290110; CURCIO CA, 1993, ANN NEUROL, V33, P248, DOI 10.1002/ana.410330305; DAVIES DC, 1995, BRIT J OPHTHALMOL, V79, P596, DOI 10.1136/bjo.79.6.596; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dutescu RM, 2009, GRAEF ARCH CLIN EXP, V247, P1213, DOI 10.1007/s00417-009-1060-3; Fernandes DB, 2013, OPHTHALMOLOGY, V120, P387, DOI 10.1016/j.ophtha.2012.07.066; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gao LY, 2015, ARCH GERONTOL GERIAT, V60, P162, DOI 10.1016/j.archger.2014.10.011; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Hood DC, 2014, INVEST OPHTH VIS SCI, V55, P632, DOI 10.1167/iovs.13-13130; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; Kirbas S, 2013, J NEURO-OPHTHALMOL, V33, P58, DOI 10.1097/WNO.0b013e318267fd5f; Kromer Robert, 2014, Front Psychiatry, V5, P22, DOI 10.3389/fpsyt.2014.00022; Liu DC, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0268-6; Lu Y, 2010, NEUROSCI LETT, V480, P69, DOI 10.1016/j.neulet.2010.06.006; Marziani E, 2013, INVEST OPHTH VIS SCI, V54, P5953, DOI 10.1167/iovs.13-12046; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Monteiro MLR, 2014, EYE, V28, P390, DOI 10.1038/eye.2013.301; Monteiro MLR, 2014, INVEST OPHTH VIS SCI, V55, P3328, DOI 10.1167/iovs.14-14118; Monteiro MLR, 2012, INVEST OPHTH VIS SCI, V53, P3959, DOI 10.1167/iovs.11-9324; Monteiro MLR, 2009, INVEST OPHTH VIS SCI, V50, P3535, DOI 10.1167/iovs.08-3093; MORRISON JH, 1991, ANN NY ACAD SCI, V640, P36; Moschos MM, 2012, CURR ALZHEIMER RES, V9, P782; Oktem EO, 2015, NEUROL SCI, V36, P1141, DOI 10.1007/s10072-014-2055-3; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; SADUN AA, 1990, OPHTHALMOLOGY, V97, P9; Shi ZY, 2014, J ALZHEIMERS DIS, V40, P277, DOI 10.3233/JAD-131898; Tatrai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030922; Warner CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022947	40	55	55	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153830	10.1371/journal.pone.0153830	http://dx.doi.org/10.1371/journal.pone.0153830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104962	gold, Green Published, Green Submitted			2022-12-27	WOS:000374565100024
J	Talbot, SL; Sage, GK; Rearick, JR; Fowler, MC; Muniz-Salazar, R; Baibak, B; Wyllie-Echeverria, S; Cabello-Pasini, A; Ward, DH				Talbot, Sandra L.; Sage, George K.; Rearick, Jolene R.; Fowler, Meg C.; Muniz-Salazar, Raquel; Baibak, Bethany; Wyllie-Echeverria, Sandy; Cabello-Pasini, Alejandro; Ward, David H.			The Structure of Genetic Diversity in Eelgrass (Zostera marina L.) along the North Pacific and Bering Sea Coasts of Alaska	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; POPULATION-STRUCTURE; MICROSATELLITE LOCI; GLACIAL REFUGIA; HETEROZOSTERA ZOSTERACEAE; HYDROPHILOUS ANGIOSPERMS; REPRODUCTIVE STRATEGIES; GEOGRAPHIC DISTANCE; COALESCENT APPROACH; COMPUTER-PROGRAM	Eelgrass (Zostera marina) populations occupying coastal waters of Alaska are separated by a peninsula and island archipelago into two Large Marine Ecosystems (LMEs). From populations in both LMEs, we characterize genetic diversity, population structure, and polarity in gene flow using nuclear microsatellite fragment and chloroplast and nuclear sequence data. An inverse relationship between genetic diversity and latitude was observed (heterozygosity: R-2 = 0.738, P < 0.001; allelic richness: R-2 = 0.327, P = 0.047), as was significant genetic partitioning across most sampling sites (theta = 0.302, P < 0.0001). Variance in allele frequency was significantly partitioned by region only in cases when a population geographically in the Gulf of Alaska LME (Kinzarof Lagoon) was instead included with populations in the Eastern Bering Sea LME (theta(p) = 0.128-0.172; P < 0.003), suggesting gene flow between the two LMEs in this region. Gene flow among locales was rarely symmetrical, with notable exceptions generally following net coastal ocean current direction. Genetic data failed to support recent proposals that multiple Zostera species (i.e. Z. japonica and Z. angustifolia) are codistributed with Z. marina in Alaska. Comparative analyses also failed to support the hypothesis that eelgrass populations in the North Atlantic derived from eelgrass retained in northeastern Pacific Last Glacial Maximum refugia. These data suggest northeastern Pacific populations are derived from populations expanding northward from temperate populations following climate amelioration at the terminus of the last Pleistocene glaciation.	[Talbot, Sandra L.; Sage, George K.; Rearick, Jolene R.; Fowler, Meg C.; Ward, David H.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Rearick, Jolene R.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Muniz-Salazar, Raquel] Univ Autonoma Baja California, Escuela Ciencias Salud, Ensenada, Baja California, Mexico; [Baibak, Bethany] Humboldt State Univ, Biol Sci, Arcata, CA 95521 USA; [Wyllie-Echeverria, Sandy] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA; [Wyllie-Echeverria, Sandy] Univ Virgin Islands, Ctr Marine & Environm Studies, St Thomas, VI USA; [Cabello-Pasini, Alejandro] Univ Autonoma Baja California, Inst Invest Oceanol, Tijuana, CA, Mexico	United States Department of the Interior; United States Geological Survey; University of New Mexico; California State University System; California State Polytechnic University, Humboldt; University of Washington; University of the Virgin Islands; Universidad Autonoma de Baja California	Talbot, SL (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA.	stalbot@usgs.gov	MUNIZ-SALAZAR, RAQUEL/F-5309-2019	MUNIZ-SALAZAR, RAQUEL/0000-0001-5528-7772	Alaska Science Center, U.S. Geological Survey; Universidad Autonoma de Baja California [4033, 4023]; Ramsar Convention on Wetlands [WFF/00-2/MEX/3]	Alaska Science Center, U.S. Geological Survey(United States Geological Survey); Universidad Autonoma de Baja California; Ramsar Convention on Wetlands	Funding for this research was provided by the Alaska Science Center, U.S. Geological Survey to SLT, the Universidad Autonoma de Baja California (#4033, #4023) to RMS and ACP and Ramsar Convention on Wetlands (WFF/00-2/MEX/3) to DHW.	Arasaki S., 1950, NIPPON SUISAN GAKK, V16, P70, DOI [10.2331/suisan.16.70, DOI 10.2331/SUISAN.16.70]; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Avise J, 2004, MOL MARKERS NATURAL; BACKMAN TWH, 1991, CAN J BOT, V69, P1361, DOI 10.1139/b91-176; BAKKER FT, 1995, J MOL EVOL, V40, P640, DOI 10.1007/BF00160512; BANDELT HJ, 1995, GENETICS, V141, P743; Barilani M, 2007, CONSERV GENET, V8, P343, DOI 10.1007/s10592-006-9174-1; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Becheler R, 2010, MOL ECOL, V19, P2394, DOI 10.1111/j.1365-294X.2010.04649.x; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bennett, 1997, EVOLUTION ECOLOGY PA; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Brower W. A. Jr., 1988, CLIMATIC ATLAS OUTER, V1; Brower WA, 1988, CLIMATIC ATLAS OUTER, V2; Brower WA, 1977, CLIMATIC ATLAS OF TH, VII; Cabello-Pasini A, 1984, TRANSPLANTES ZOSTERA; Campanella JJ, 2010, J HERED, V101, P61, DOI 10.1093/jhered/esp103; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; COACHMAN LK, 1966, LIMNOL OCEANOGR, V11, P44, DOI 10.4319/lo.1966.11.1.0044; Comps B, 2001, GENETICS, V157, P389; Cope JM, 2004, CAN J FISH AQUAT SCI, V61, P332, DOI 10.1139/F04-008; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Coyer JA, 2008, ANN BOT-LONDON, V101, P73, DOI 10.1093/aob/mcm288; Coyer JA, 2001, J PHYCOL, V37, P574, DOI 10.1046/j.1529-8817.2001.037001574.x; Coyer JA, 2011, J BIOGEOGR, V38, P756, DOI 10.1111/j.1365-2699.2010.02437.x; Coyle KO, 2005, FISH OCEANOGR, V14, P77, DOI 10.1111/j.1365-2419.2005.00367.x; CROOM M, 1995, GLOBAL REPRESENTATIV, V4, P55; Cullis-Suzuki S, 2015, AQUAT BOT, V127, P26, DOI 10.1016/j.aquabot.2015.07.001; DEHEIJ H, 1992, J EXP MAR BIOL ECOL, V161, P1, DOI 10.1016/0022-0981(92)90185-D; den Hartog C., 1970, SEAGRASSES WORLD, V59; den Hartog C., 1975, AQUAT BOT, V1, P141, DOI DOI 10.1016/0304-3770(75)90019-4; DENNISON WC, 1986, J EXP MAR BIOL ECOL, V98, P265, DOI 10.1016/0022-0981(86)90217-0; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Ebbesmeyer C., 2003, FARE FLUNG BATHTUB T; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Elven R, 2005, LIDS NORSK FLORA; Elven R., 2007, 230101 02 ZOSTERA MA; ESRI, ARCGIS DESKT; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eyerdam W, 1971, GREAT ALASKA EARTHQU, P69; Farmer M.W., 1989, Proceedings of the Gulf and Caribbean Fisheries Institute, V39, P318; Goudet J, 1996, GENETICS, V144, P1933; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Green E. P., 2003, WORLD ATLAS OF SEAGR; Haynes RR, 2000, MAGNOLIOPHYTA ALISMA, V22, P90; HEDGECOCK D, 1986, B MAR SCI, V39, P550; HELLBERG ME, 1994, EVOLUTION, V48, P1829, DOI 10.1111/j.1558-5646.1994.tb02218.x; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hickerson MJ, 2005, EVOLUTION, V59, P344; Hogrefe KR, 2014, REMOTE SENS-BASEL, V6, P12447, DOI 10.3390/rs61212447; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Ingraham WJ, 1976, FINAL REPORT 357; Jacobs DK, 2004, ANNU REV EARTH PL SC, V32, P601, DOI 10.1146/annurev.earth.32.092203.122436; Johnson MR, 2003, ESTUARIES, V26, P106, DOI 10.1007/BF02691698; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T., 2014, TUTORIAL DISCRIMINAN, P1; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kallstrom B, 2008, AQUAT BOT, V88, P148, DOI 10.1016/j.aquabot.2007.09.005; Kato Y, 2003, GENES GENET SYST, V78, P329, DOI 10.1266/ggs.78.329; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Ladd C, 2005, FISH OCEANOGR, V14, P22, DOI 10.1111/j.1365-2419.2005.00373.x; Langella O., 2010, POPULATIONS 1 2 30 P; Larned ST, 2003, MAR ECOL PROG SER, V254, P69, DOI 10.3354/meps254069; LAUSHMAN RH, 1993, AQUAT BOT, V44, P147, DOI 10.1016/0304-3770(93)90069-9; Lee KM, 2012, MAR BIOL, V159, P1021, DOI 10.1007/s00227-012-1882-0; LES DH, 1988, ANN MO BOT GARD, V75, P819, DOI 10.2307/2399370; Les DH, 2002, SYST BOT, V27, P468; Lewis PO, 2001, GENETIC DATA ANAL GD; Li WT, 2010, ESTUAR COAST SHELF S, V88, P377, DOI 10.1016/j.ecss.2010.04.017; Lucas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029987; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Malaney JL, 2013, MOL ECOL, V22, P6000, DOI 10.1111/mec.12476; Markgraf F., 1972, TAXON, V21, P715; Markgraf F, 1981, NEW FLORA BRIT ISLES; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; MCMILLAN C, 1982, AQUAT BOT, V14, P231, DOI 10.1016/0304-3770(82)90101-2; MCROY CP, 1968, PAC SCI, V22, P507; McRoy CP., 1966, THE STANDING STOCK A; McRoy CP, 1998, EELGRASS SURVEY E PR; Michalakis Y, 1996, GENETICS, V142, P1061; MUEHLSTEIN LK, 1992, CAN J BOT, V70, P2081, DOI 10.1139/b92-258; Muniz-Salazar R, 2006, MAR ECOL PROG SER, V309, P107, DOI 10.3354/meps309107; Muniz-Salazar R, 2005, MOL ECOL, V14, P711, DOI 10.1111/j.1365-294X.2005.02454.x; Murie OJ, 1959, N AM FAUNA, V61, P1; Nacken N, 2000, HELGOLAND MAR RES, V54, P87, DOI 10.1007/s101520050006; Nei M., 1975, N HOLLAND RES MONOGR, DOI [10.1086/408797, DOI 10.1086/408797]; O'Reilly PT, 2004, MOL ECOL, V13, P1799, DOI 10.1111/j.1365-294X.2004.02214.x; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; Ort BS, 2012, J HERED, V103, P533, DOI 10.1093/jhered/ess022; ORTH RJ, 1994, ECOLOGY, V75, P1927, DOI 10.2307/1941597; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park S, 2000, MICROSATELLITE TOOLK; Parsons KM, 2013, J HERED, V104, P737, DOI 10.1093/jhered/est037; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; Percival SM, 1996, J APPL ECOL, V33, P979, DOI 10.2307/2404679; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; PHILLIPS R. C., 1988, SMITHSONIAN CONTRIBU, V34, P1, DOI DOI 10.1086/277620; PHILLIPS RC, 1983, AQUAT BOT, V16, P1, DOI 10.1016/0304-3770(83)90047-5; Plus M, 2003, AQUAT BOT, V77, P121, DOI 10.1016/S0304-3770(03)00089-5; Poumian-Tapia M, 1999, ESTUARIES, V22, P837, DOI 10.2307/1353065; Procaccini G, 2001, MOL ECOL, V10, P1413, DOI 10.1046/j.1365-294X.2001.01290.x; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Provan J, 2008, CONSERV GENET, V9, P271, DOI 10.1007/s10592-007-9338-7; Rader RB, 2005, ANIM CONSERV, V8, P239, DOI 10.1017/S1367943005002271; REED A, 1989, J WILDLIFE MANAGE, V53, P720, DOI 10.2307/3809203; Reusch TBH, 1999, MOL ECOL, V8, P317, DOI 10.1046/j.1365-294X.1999.00531.x; Reusch TBH, 2000, MOL ECOL, V9, P127, DOI 10.1046/j.1365-294x.2000.00839.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 1996, GENETICS, V142, P1357; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; ROYER TC, 1975, DEEP-SEA RES, V22, P403, DOI 10.1016/0011-7471(75)90062-5; Ruckelshaus MH, 1996, EVOLUTION, V50, P856, DOI 10.1111/j.1558-5646.1996.tb03894.x; Ruckelshaus MH, 1998, EVOLUTION, V52, P330, DOI 10.1111/j.1558-5646.1998.tb01635.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez MI, 2006, J AVIAN BIOL, V37, P201, DOI 10.1111/j.2006.0908-8857.03719.x; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; SHERMAN K, 1994, MAR ECOL PROG SER, V112, P277, DOI 10.3354/meps112277; Short FT, 1996, ESTUARIES, V19, P730, DOI 10.2307/1352532; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P5, DOI 10.1016/B978-044450891-1/50002-5; SHORT FT, 1987, BIOL BULL, V173, P557, DOI 10.2307/1541701; SLATKIN M, 1995, GENETICS, V139, P457; SOROSPOTTRUFF CL, 1995, INT J PLANT SCI, V156, P143, DOI 10.1086/297236; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Stabeno PJ, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2007JC004705; Stabeno P.J., 2006, SEA, V14, P1177; STABENO PJ, 1991, DEEP-SEA RES, V38, P289, DOI 10.1016/0198-0149(91)90069-R; STABENO PJ, 1992, GEOPHYS RES LETT, V19, P1671, DOI 10.1029/92GL01688; Stace C., 1997, NEW FLORA BRIT ISLES; Sumoski SE, 2012, MAR ECOL PROG SER, V471, P1, DOI 10.3354/meps10145; Talbot SL, 2006, AQUAT BOT, V85, P169, DOI 10.1016/j.aquabot.2006.03.011; Talbot SS, 2006, RHODORA, V108, P249, DOI 10.3119/0035-4902(2006)108[249:VFOINW]2.0.CO;2; Tanaka N, 2003, J PLANT RES, V116, P273, DOI 10.1007/s10265-003-0090-x; Tanaka Norio, 2011, Bulletin of the National Museum of Nature and Science Series B-Botany, V37, P23; Tanaka N, 2011, MAR BIOL, V158, P871, DOI 10.1007/s00227-010-1614-2; Toussaint RK, 2012, CONSERV GENET, V13, P1483, DOI 10.1007/s10592-012-0392-4; Valentine James W., 1993, P341; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Vandergast AG, 2007, MOL ECOL, V16, P977, DOI 10.1111/j.1365-294X.2006.03216.x; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; Ward DH, 2003, ESTUARIES, V26, P1529, DOI 10.1007/BF02803661; Ward DH, 1997, J WILDLIFE MANAGE, V61, P773, DOI 10.2307/3802184; Ward DH, 1997, AQUAT BOT, V58, P229, DOI 10.1016/S0304-3770(97)00037-5; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams MAJ, 1998, QUATERNARY ENV; Wyllie-Echeverria S., 1999, SEAGRASS BIOME PROTE; Wyllie-Echeverria S, 2010, ESTUAR COAST, V33, P811, DOI 10.1007/s12237-009-9243-z; WYLLIEECHEVERRI.S, 2003, WORLD ATLAS SEAGRASS, P199; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	161	13	13	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0152701	10.1371/journal.pone.0152701	http://dx.doi.org/10.1371/journal.pone.0152701			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104836	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100005
J	Li, JJ; Li, YH; Gong, HQ; Liang, PJ; Zhang, PM; Lu, QC				Li, Jia-Jia; Li, Yong-Hua; Gong, Hai-Qing; Liang, Pei-Ji; Zhang, Pu-Ming; Lu, Qin-Chi			The Spatiotemporal Dynamics of Phase Synchronization during Epileptogenesis in Amygdala-Kindling Mice	PLOS ONE			English	Article							MIDLINE THALAMUS; LIMBIC SYSTEM; EPILEPSY; SEIZURE; NETWORK; BRAIN; CONNECTIVITY; OSCILLATIONS; STIMULATION; DISCHARGES	The synchronization among the activities of neural populations in functional regions is one of the most important electrophysiological phenomena in epileptic brains. The spatiotemporal dynamics of phase synchronization was investigated to reveal the reciprocal interaction between different functional regions during epileptogenesis. Local field potentials (LFPs) were recorded simultaneously from the basolateral amygdala (BLA), the cornu ammonis 1 of hippocampus (CA1) and the mediodorsal nucleus of thalamus (MDT) in the mouse amygdala-kindling models during the development of epileptic seizures. The synchronization of LFPs was quantified between BLA, CA1 and MDT using phase-locking value (PLV). During amygdala kindling, behavioral changes (from stage 0 to stage 5) of mice were accompanied by after-discharges (ADs) of similar waveforms appearing almost simultaneously in CA1, MDT, as well as BLA. AD durations were positively related to the intensity of seizures. During seizures at stages 1 similar to 2, PLVs remained relatively low and increased dramatically shortly after the termination of the seizures; by contrast, for stages 3 similar to 5, PLVs remained a relatively low level during the initial period but increased dramatically before the seizure termination. And in the theta band, the degree of PLV enhancement was positively associated with seizure intensity. The results suggested that during epileptogenesis, the functional regions were kept desynchronized rather than hyper-synchronized during either the initial or the entire period of the seizures; so different dynamic patterns of phase synchronization may be involved in different periods of the epileptogenesis, and this might also reflect that during seizures at different stages, the mechanisms underlying the dynamics of phase synchronization were different.	[Li, Jia-Jia; Lu, Qin-Chi] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurol, 160 Pujian Rd, Shanghai 200127, Peoples R China; [Li, Yong-Hua; Gong, Hai-Qing; Liang, Pei-Ji; Zhang, Pu-Ming] Shanghai Jiao Tong Univ, Sch Biomed Engn, 800 Dongchuan Rd, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, QC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurol, 160 Pujian Rd, Shanghai 200127, Peoples R China.; Zhang, PM (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	pmzhang@sjtu.edu.cn; qinchilu@yahoo.com			Key Basic Research Project of Science and Technology Commission of Shanghai [13DJ1400303]; Shanghai Jiao Tong University Fund for Interdisciplinary Research for Medical Applications [YG2012ZD08]; Ren Ji Hospital [RJ ZZ13-005]	Key Basic Research Project of Science and Technology Commission of Shanghai; Shanghai Jiao Tong University Fund for Interdisciplinary Research for Medical Applications; Ren Ji Hospital	This work was supported by the Key Basic Research Project of Science and Technology Commission of Shanghai (13DJ1400303), Shanghai Jiao Tong University Fund for Interdisciplinary Research for Medical Applications (YG2012ZD08), and the Seed Fund of Ren Ji Hospital (RJ ZZ13-005).	Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Benedek K, 2004, EPILEPSIA, V45, P1100, DOI 10.1111/j.0013-9580.2004.43303.x; Bertram E, 2007, EPILEPSIA, V48, P65, DOI 10.1111/j.1528-1167.2007.01068.x; Bertram EH, 2008, EPILEPSIA, V49, P256, DOI 10.1111/j.1528-1167.2007.01408.x; Bertram EH, 2001, EPILEPSIA, V42, P967, DOI 10.1046/j.1528-1157.2001.042008967.x; Blumenfeld H, 2007, EPILEPSIA, V48, P254, DOI 10.1111/j.1528-1167.2006.00934.x; BURCHFIEL JL, 1989, NEUROSCI BIOBEHAV R, V13, P289, DOI 10.1016/S0149-7634(89)80065-X; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; Coulter DA, 2002, BRAIN PATHOL, V12, P240; Cymerblit-Sabba A, 2010, J NEUROSCI, V30, P1619, DOI 10.1523/JNEUROSCI.5078-09.2010; D'Antuono M, 2010, EPILEPSIA, V51, P423, DOI 10.1111/j.1528-1167.2009.02273.x; Dominguez LG, 2005, J NEUROSCI, V25, P8077, DOI 10.1523/JNEUROSCI.1046-05.2005; Dominguez LG, 2008, INT J BIFURCAT CHAOS, V18, P429; Douw L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-103; Fraklin KBJ., 2007, MOUSE BRAIN STEREOTA; Gong XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092961; Guye M, 2006, BRAIN, V129, P1917, DOI 10.1093/brain/awl151; Jiruska P, 2013, J PHYSIOL-LONDON, V591, P787, DOI 10.1113/jphysiol.2012.239590; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Li YH, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/675128; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Majumdar K, 2014, BRAIN TOPOGR, V27, P112, DOI 10.1007/s10548-013-0284-z; Margineanu DG, 2000, PHARMACOL RES, V42, P281; McIntyre DC, 2002, EPILEPSY RES, V50, P79, DOI 10.1016/S0920-1211(02)00071-2; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; PARMEGGIANI PL, 1971, BRAIN RES, V30, P357, DOI 10.1016/0006-8993(71)90086-2; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rey HG, 2015, BRAIN RES BULL, V119, P106, DOI 10.1016/j.brainresbull.2015.04.007; SATO M, 1990, ELECTROEN CLIN NEURO, V76, P459, DOI 10.1016/0013-4694(90)90099-6; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Schindler K, 2007, CLIN NEUROPHYSIOL, V118, P1955, DOI 10.1016/j.clinph.2007.06.006; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Sloan DM, 2011, NEUROBIOL DIS, V43, P435, DOI 10.1016/j.nbd.2011.04.017; Sobayo T, 2013, IEEE T BIO-MED ENG, V60, P821, DOI 10.1109/TBME.2012.2189113; Stratton P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038482; SU HS, 1990, J COMP NEUROL, V297, P582, DOI 10.1002/cne.902970410; Takekawa T, 2010, EUR J NEUROSCI, V31, P263, DOI 10.1111/j.1460-9568.2009.07068.x; Tan GH, 2012, NAT NEUROSCI, V15, P258, DOI 10.1038/nn.3005; Tassi L, 2009, EPILEPTIC DISORD, V11, P281, DOI 10.1684/epd.2009.0279; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang Y, 2014, BRAIN STRUCT FUNCT, V219, P1685, DOI 10.1007/s00429-013-0594-7; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Zhang DX, 2002, J NEUROSCI, V22, P3277, DOI 10.1523/JNEUROSCI.22-08-03277.2002	51	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153897	10.1371/journal.pone.0153897	http://dx.doi.org/10.1371/journal.pone.0153897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100891	Green Submitted, gold, Green Published			2022-12-27	WOS:000374898500092
J	Liu, ZD; Qin, AZ; Zhao, B; Ata-Ul-Karim, ST; Xiao, JF; Sun, JS; Ning, DF; Liu, ZG; Nan, JQ; Duan, AW				Liu, Zhandong; Qin, Anzhen; Zhao, Ben; Ata-Ul-Karim, Syed Tahir; Xiao, Junfu; Sun, Jingsheng; Ning, Dongfeng; Liu, Zugui; Nan, Jiqin; Duan, Aiwang			Yield Response of Spring Maize to Inter-Row Subsoiling and Soil Water Deficit in Northern China	PLOS ONE			English	Article							USE EFFICIENCY; CONSERVATION TILLAGE; GRAIN-YIELD; ROOT-GROWTH; WHEAT; COMPACTION; VERTISOL; CLIMATE; CARBON	Background Long-term tillage has been shown to induce water stress episode during crop growth period due to low water retention capacity. It is unclear whether integrated water conservation tillage systems, such asspringdeepinter-row subsoiling with annual or biennial repetitions, can be developed to alleviate this issue while improve crop productivity. Methods Experimentswere carried out in a spring maize cropping system on Calcaric-fluvicCambisol-satJiaozuoexperimentstation, northern China, in 2009 to 2014. Effects of threesubsoiling depths (i.e., 30 cm, 40 cm, and 50 cm) in combination with annual and biennial repetitions-wasdetermined in two single-years (i.e., 2012 and 2014) againstthe conventional tillage. The objectives were to investigateyield response to subsoiling depths and soil water deficit (SWD), and to identify the most effective subsoiling treatment using a systematic assessment. Results Annualsubsoiling to 50 cm (AS-50) increased soil water storage (SWS, mm) by an average of8% in 0-20 cm soil depth, 19% in 20-80 cm depth, and 10% in 80-120 cm depth, followed by AS-40 and BS-50, whereas AS-30 and BS-30 showed much less effects in increasing SWS across the 0-120 cm soil profile, compared to the CK. AS-50 significantly reduced soil water deficit (SWD, mm) by an average of123% during sowing to jointing, 318% during jointing to filling, and 221% during filling to maturity, compared to the CK, followed by AS-40 and BS-50. An integrated effect on increasing SWS and reducing SWD helped AS-50 boost grain yield by an average of 31% and biomass yield by 30%, compared to the CK. A power function for subsoiling depth and a negative linear function for SWD were used to fit the measured yields, showing the deepest subsoiling depth (50 cm) with the lowest SWD contributed to the highest yield. Systematic assessment showed that AS-50 received the highest evaluation index (0.69 out of 1.0) among all treatments. Conclusion Deepinter-row subsoilingwith annual repetition significantly boosts yield by alleviating SWD in critical growth period and increasing SWS in 20-80 cm soil depth. The results allow us to conclude that AS-50 can be adopted as an effective approach to increase crop productivity, alleviate water stress, and improve soil water availability for spring maize in northern China.	[Liu, Zhandong; Qin, Anzhen; Zhao, Ben; Xiao, Junfu; Sun, Jingsheng; Ning, Dongfeng; Liu, Zugui; Nan, Jiqin; Duan, Aiwang] Chinese Acad Agr Sci, Key Lab Crop Water Use & Regulat, Minist Agr, Farmland Irrigat Res Inst, Xinxiang, Peoples R China; [Ata-Ul-Karim, Syed Tahir] Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Farmland Irrigation Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Duan, AW (corresponding author), Chinese Acad Agr Sci, Key Lab Crop Water Use & Regulat, Minist Agr, Farmland Irrigat Res Inst, Xinxiang, Peoples R China.	duanaiwang@aliyun.com	Ata-Ul-Karim, Syed Tahir/F-7468-2017; Ata-Ul-Karim, Syed Tahir/AAB-6257-2020; Qin, Anzhen/AAY-2027-2020	Ata-Ul-Karim, Syed Tahir/0000-0001-5233-4502; Ata-Ul-Karim, Syed Tahir/0000-0001-5233-4502; 	China Agriculture Research System [CARS-02]; National Natural Science Fund [51309226]; Agricultural Science and Technology Innovation Program (ASTIP); Special Fund for Agro-scientific Research in the Public Interest [201203077, 201503117]; Natural Science Foundation of Henan Province [162300410154]	China Agriculture Research System; National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program (ASTIP); Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of Henan Province	This research was jointly supported by the China Agriculture Research System (CARS-02), the National Natural Science Fund (51309226), the Agricultural Science and Technology Innovation Program (ASTIP), the Special Fund for Agro-scientific Research in the Public Interest (201203077 and 201503117), and the Natural Science Foundation of Henan Province (162300410154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci I, 2004, SOIL TILL RES, V77, P203, DOI 10.1016/j.still.2003.12.006; Allen R. G., 1998, FAO Irrigation and Drainage Paper; BUSSCHER WJ, 1988, SOIL SCI SOC AM J, V52, P804, DOI 10.2136/sssaj1988.03615995005200030037x; Cai HG, 2014, CROP J, V2, P297, DOI 10.1016/j.cj.2014.04.006; Castrignano A, 1997, SOIL TILL RES, V40, P227, DOI 10.1016/S0167-1987(96)01054-9; Chen HW, 2014, AGR RES, V3, P321, DOI 10.1007/s40003-014-0134-6; DeJonge KC, 2015, AGR WATER MANAGE, V156, P51, DOI 10.1016/j.agwat.2015.03.023; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; Gan YT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6012; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Guan DH, 2014, FIELD CROP RES, V157, P89, DOI 10.1016/j.fcr.2013.12.015; GUPTA RK, 2001, INDIGENOUS NUTR MANA; He J, 2007, SOIL TILL RES, V94, P493, DOI 10.1016/j.still.2006.10.005; He YB, 2015, GEODERMA, V245, P83, DOI 10.1016/j.geoderma.2015.01.020; Heatherly LG, 2001, AGRON J, V93, P511, DOI 10.2134/agronj2001.933511x; Hemmat A, 2004, FIELD CROP RES, V89, P123, DOI 10.1016/j.fcr.2004.01.019; IUSS Working Group WRB, 2006, WORLD REFERENCE BASE, V103; Kong LA, 2014, AGRON SUSTAIN DEV, V34, P405, DOI 10.1007/s13593-013-0182-5; Li N, 2015, NUTR CYCL AGROECOSYS, V102, P397, DOI 10.1007/s10705-015-9713-6; Liu XJ, 2013, NAT HAZARDS, V65, P1393, DOI 10.1007/s11069-012-0416-x; Lopez-Fando C, 2009, SOIL TILL RES, V104, P278, DOI 10.1016/j.still.2009.03.005; Meng QF, 2013, FIELD CROP RES, V143, P91, DOI 10.1016/j.fcr.2012.09.023; Mohanty M, 2007, SOIL TILL RES, V93, P420, DOI 10.1016/j.still.2006.06.002; Mosaddeghi MR, 2009, SOIL TILL RES, V104, P173, DOI 10.1016/j.still.2008.10.011; Munkholm LJ, 2005, SOIL TILL RES, V80, P149, DOI 10.1016/j.still.2004.03.015; Patil SL, 2006, SOIL TILL RES, V89, P246, DOI 10.1016/j.still.2005.07.013; Qin AZ., 2013, THESIS GANSU AGR U L; Raper RL, 2007, SOIL TILL RES, V96, P174, DOI 10.1016/j.still.2007.05.004; Raper RL, 2005, T ASAE, V48, P2047, DOI 10.13031/2013.20081; Raper RL, 2005, APPL ENG AGRIC, V21, P337; TAYLOR HM, 1991, SOIL TILL RES, V19, P111, DOI 10.1016/0167-1987(91)90080-H; Verhulst N, 2011, PLANT SOIL, V344, P73, DOI 10.1007/s11104-011-0728-8; Wang QJ, 2014, SOIL TILL RES, V137, P43, DOI 10.1016/j.still.2013.11.006; Wang XB, 2006, CATENA, V66, P221, DOI 10.1016/j.catena.2006.02.006; Wang XB, 2012, FIELD CROP RES, V132, P106, DOI 10.1016/j.fcr.2011.09.012; Zhang YQ, 2004, AGR WATER MANAGE, V64, P107, DOI 10.1016/S0378-3774(03)00201-4; Zhao JF, 2015, AGR ECOSYST ENVIRON, V207, P79, DOI 10.1016/j.agee.2015.04.006; Zheng CY, 2014, J INTEGR AGR, V13, P2378, DOI 10.1016/S2095-3119(13)60733-9	38	9	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153809	10.1371/journal.pone.0153809	http://dx.doi.org/10.1371/journal.pone.0153809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101145	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500070
J	Schausberger, P; Patino-Ruiz, JD; Osakabe, M; Murata, Y; Sugimoto, N; Uesugi, R; Walzer, A				Schausberger, Peter; Patino-Ruiz, J. David; Osakabe, Masahiro; Murata, Yasumasa; Sugimoto, Naoya; Uesugi, Ryuji; Walzer, Andreas			Ultimate Drivers and Proximate Correlates of Polyandry in Predatory Mites	PLOS ONE			English	Article							GENETIC BENEFITS; MATING FREQUENCY; SEXUAL SELECTION; EVOLUTION; ACARI; LONGEVITY; FECUNDITY; BEHAVIOR; FEMALES; PLASTICITY	Polyandry is more widespread than anticipated from Bateman's principle but its ultimate (evolutionary) causes and proximate (mechanistic) correlates are more difficult to pinpoint than those of polygyny. Here, we combined mating experiments, quantification of reproductive traits and microsatellite genotyping to determine the fitness implications of polyandry in two predatory mite species, where males are highly polygynous (up to 45 fertilized females during life), whereas females range from monandry to various polyandry levels. The medium-level polyandrous (up to eight male mates possible) Neoseiulus californicus received clear direct and indirect benefits: multiply mated females produced more offspring with higher survival chances over longer times than singly mated females. In contrast, singly and multiply mated females of the low-level polyandrous (commonly two male mates at maximum) Phytoseiulus persimilis produced similar numbers of offspring having similar survival chances. In both species, multiple mating resulted in mixed offspring paternities, opening the chance for indirect fitness benefits such as enhanced genetic compatibility, complementarity and/or variability. However, the female re-mating likelihood and the paternity chance of non-first male mates were lower in P. persimilis than in N. californicus. Regarding proximate factors, in both species first mating duration and female re-mating likelihood were negatively correlated. Based on occasional fertilization failure of first male mates in P. persimilis, and mixed offspring paternities in both species, we argue that fertilization assurance and the chance to gain indirect fitness benefits are the ultimate drivers of polyandry in P. persimilis, whereas those of N. californicus are higher offspring numbers coupled with enhanced offspring viability and possibly other indirect fitness benefits. Overall, the adaptive significance and proximate events well reflected the polyandry levels. Our study provides a key example for linking behavioral experiments, quantification of reproductive traits and paternity analysis via offspring genotyping to explain the evolution of differing levels of polyandry.	[Schausberger, Peter; Patino-Ruiz, J. David; Walzer, Andreas] Univ Nat Resources & Life Sci, Dept Crop Sci, Grp Arthropod Ecol & Behav, Vienna, Austria; [Schausberger, Peter] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Osakabe, Masahiro; Murata, Yasumasa; Sugimoto, Naoya; Uesugi, Ryuji] Kyoto Univ, Lab Ecol Informat, Grad Sch Agr, Sakyo Ku, Oiwake Cho, Kyoto, Japan	University of Natural Resources & Life Sciences, Vienna; University of Vienna; Kyoto University	Schausberger, P (corresponding author), Univ Nat Resources & Life Sci, Dept Crop Sci, Grp Arthropod Ecol & Behav, Vienna, Austria.; Schausberger, P (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	peter.schausberger@univie.ac.at	Osakabe, Masahiro/H-8587-2019; Uesugi, Ryuji/HGC-2486-2022	Osakabe, Masahiro/0000-0002-2246-3431; Uesugi, Ryuji/0000-0003-4688-4975; Schausberger, Peter/0000-0002-1529-3198	Austrian Science Fund (FWF) [P 23504-B17]; Austrian Science Fund (FWF) [P 23504, P 25876] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financed by a grant from the Austrian Science Fund (FWF; P 23504-B17) to PS.	AMANO H, 1979, ACAROLOGIA, V20, P196; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Crean AJ, 2014, ECOL LETT, V17, P1545, DOI 10.1111/ele.12373; Crean AJ, 2013, ECOLOGY, V94, P2575, DOI 10.1890/13-0184.1; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Enigl M, 2004, ENTOMOL EXP APPL, V112, P21, DOI 10.1111/j.0013-8703.2004.00175.x; Firman RC, 2012, ECOL LETT, V15, P42, DOI 10.1111/j.1461-0248.2011.01706.x; Fisher DN, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-157; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; FOX CW, 1993, FUNCT ECOL, V7, P203, DOI 10.2307/2389888; Gotoh T, 2008, EXP APPL ACAROL, V44, P185, DOI 10.1007/s10493-008-9143-0; Gowaty PA, 2013, ANIM BEHAV, V86, P877, DOI 10.1016/j.anbehav.2013.08.015; Gowaty PA, 2012, FLY, V6, P3, DOI 10.4161/fly.18330; Gowaty PA, 2010, P NATL ACAD SCI USA, V107, P13771, DOI 10.1073/pnas.1006174107; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Ivy TM, 2005, EVOLUTION, V59, P152, DOI 10.1111/j.0014-3820.2005.tb00902.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Ji J, 2007, EXP APPL ACAROL, V43, P171, DOI 10.1007/s10493-007-9114-x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karlsson B, 1998, ECOLOGY, V79, P2931, DOI 10.1890/0012-9658(1998)079[2931:NGRBAR]2.0.CO;2; Kvarnemo C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0042; Pappas ML, 2007, EXP APPL ACAROL, V43, P161, DOI 10.1007/s10493-007-9112-z; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Perry JC, 2013, TRENDS ECOL EVOL, V28, P414, DOI 10.1016/j.tree.2013.03.005; POE SL, 1970, CAN ENTOMOL, V102, P1222, DOI 10.4039/Ent1021222-10; RIDLEY M, 1989, ANIM BEHAV, V37, P535, DOI 10.1016/0003-3472(89)90033-X; RIDLEY M, 1988, BIOL REV, V63, P509, DOI 10.1111/j.1469-185X.1988.tb00669.x; Sabelis M.W., 1985, P141; SABELIS MW, 1988, EXP APPL ACAROL, V4, P301, DOI 10.1007/BF01196192; Schausberger P, 2007, BEHAV ECOL SOCIOBIOL, V62, P119, DOI 10.1007/s00265-007-0444-9; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Slatyer RA, 2012, BIOL REV, V87, P1, DOI 10.1111/j.1469-185X.2011.00182.x; Strodl MA, 2012, NATURWISSENSCHAFTEN, V99, P303, DOI 10.1007/s00114-012-0903-7; Thornhill N.W., 1993, NATURAL HIST INBREED; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tsunoda T, 2001, APPL ENTOMOL ZOOL, V36, P393, DOI 10.1303/aez.2001.393; Walzer A, 2015, ANIM BEHAV, V100, P96, DOI 10.1016/j.anbehav.2014.11.017; Walzer A, 2014, BIOL J LINN SOC, V111, P889, DOI 10.1111/bij.12235; Walzer A, 2011, BIOL J LINN SOC, V102, P650, DOI 10.1111/j.1095-8312.2010.01593.x; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4	45	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154355	10.1371/journal.pone.0154355	http://dx.doi.org/10.1371/journal.pone.0154355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100395	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500185
J	Soyka, RPW; Helgason, B; Marangalou, JH; van den Bergh, JP; van Rietbergen, B; Ferguson, SJ				Soyka, Rene P. Widmer; Helgason, Benedikt; Marangalou, Javad Hazrati; van den Bergh, Joop P.; van Rietbergen, Bert; Ferguson, Stephen J.			The Effectiveness of Percutaneous Vertebroplasty Is Determined by the Patient-Specific Bone Condition and the Treatment Strategy	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; VERTEBRAL BODY; CEMENT VOLUME; INTERVERTEBRAL DISC; RANDOMIZED-TRIAL; PROXIMAL FEMUR; FOLLOW-UP; FRACTURES; BIOMECHANICS; STIFFNESS	Purpose Vertebral fragility fractures are often treated by injecting bone cement into the collapsed vertebral bodies (vertebroplasty). The mechanisms by which vertebroplasty induces pain relief are not completely understood yet and recent debates cast doubt over the outcome of the procedure. The controversy is intensified by inconsistent results of randomized clinical trials and biomechanical studies that have investigated the effectiveness or the change in biomechanical response due to the reinforcement. The purpose of this study was to evaluate the effectiveness of vertebroplasty, by varying the relevant treatment parameters and (a) computationally predicting the improvement of the fracture risk depending on the chosen treatment strategy, and (b) identifying the determinants of a successful treatment. Methods A Finite Element model with a patient-specific failure criterion and direct simulation of PMMA infiltration in four lumbar vertebrae was used to assess the condition of the bone under compressive load before and after the virtual treatment, simulating in a total of 12000 virtual treatments. Results The results showed that vertebroplasty is capable of reducing the fracture risk by magnitudes, but can also have a detrimental effect. Effectiveness was strongly influenced by interactions between local bone quality, cement volume and injection location. However, only a moderate number of the investigated treatment strategies were able to achieve the necessary improvement for preventing a fracture. Conclusions We conclude that the effectiveness of vertebroplasty is sensitive to the patient's condition and the treatment strategy.	[Soyka, Rene P. Widmer; Helgason, Benedikt; Ferguson, Stephen J.] ETH, Inst Biomech, Zurich, Switzerland; [Marangalou, Javad Hazrati; van Rietbergen, Bert] Eindhoven Univ Technol, Orthopaed Biomech, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands; [van den Bergh, Joop P.] Maastricht Univ, Med Ctr, Dept Internal Med, NL-6200 MD Maastricht, Netherlands; [van den Bergh, Joop P.] Viecuri Med Ctr, Dept Internal Med, Venlo, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Eindhoven University of Technology; Maastricht University; VieCuri Medical Center	Soyka, RPW (corresponding author), ETH, Inst Biomech, Zurich, Switzerland.	bhelgason@ethz.ch	Ferguson, Stephen J./A-4118-2012; Helgason, Benedikt/A-4386-2012	Ferguson, Stephen J./0000-0003-0650-5889; van den Bergh, Joop/0000-0003-3984-2232; Hazrati, Javad/0000-0002-1119-3587; Helgason, Benedikt/0000-0001-8324-2651	European Research Council [FP7-ICT-223865-VPHOP]	European Research Council(European Research Council (ERC)European Commission)	This work was funded by the European Research Council project FP7-ICT-223865-VPHOP.	Al-Ali F, 2009, AM J NEURORADIOL, V30, P1835, DOI 10.3174/ajnr.A1732; Andersson GBJ, 2009, NAT REV RHEUMATOL, V5, P662, DOI 10.1038/nrrheum.2009.233; Baerlocher MO, 2010, RADIOLOGY, V255, P669, DOI 10.1148/radiol.10092107; Baroud G, 2006, JOINT BONE SPINE, V73, P144, DOI 10.1016/j.jbspin.2005.02.004; Baroud G, 2003, RADIOLOGY, V229, P606, DOI 10.1148/radiol.2292030378; Baroud G, 2003, EUR SPINE J, V12, P421, DOI 10.1007/s00586-002-0512-9; Baroud G, 2003, MED ENG PHYS, V25, P283, DOI 10.1016/S1350-4533(02)00223-0; Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4; Belkoff SM, 2001, SPINE, V26, P1537, DOI 10.1097/00007632-200107150-00007; Berlemann U, 2002, J BONE JOINT SURG BR, V84B, P748, DOI 10.1302/0301-620X.84B5.11841; Blasco J, 2012, J BONE MINER RES, V27, P1159, DOI 10.1002/jbmr.1564; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Chevalier Y, 2008, SPINE, V33, P1722, DOI 10.1097/BRS.0b013e31817c750b; Clark W, 2009, NEW ENGL J MED, V361, P2097, DOI 10.1056/NEJMc096289; Dall'Ara E, 2012, OSTEOPOROSIS INT, V23, P563, DOI 10.1007/s00198-011-1568-3; Dickey BT, 2012, J MECH BEHAV BIOMED, V5, P283, DOI 10.1016/j.jmbbm.2011.08.007; Dragomir-Daescu D, 2011, ANN BIOMED ENG, V39, P742, DOI 10.1007/s10439-010-0196-y; Edidin AA, 2013, OSTEOPOROSIS INT, V24, P451, DOI 10.1007/s00198-012-1965-2; Edidin AA, 2012, APPL HEALTH ECON HEA, V10, P273, DOI 10.2165/11633220-000000000-00000; Garcia D, 2009, BIOMECH MODEL MECHAN, V8, P149, DOI 10.1007/s10237-008-0125-2; Graham J, 2007, SPINE, V32, pE505, DOI 10.1097/BRS.0b013e318133fc73; Grassi L, 2011, MED ENG PHYS, V33, P112, DOI 10.1016/j.medengphy.2010.09.014; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; Heini PF, 2004, ORTHOPADE, P22; Helgason B, 2013, J BIOMED MATER RES B, V101B, P364, DOI 10.1002/jbm.b.32847; Helgason B, 2008, J BIOMECH, V41, P1675, DOI 10.1016/j.jbiomech.2008.03.007; Higgins KB, 2003, SPINE, V28, P1540, DOI 10.1097/00007632-200307150-00012; Hulme PA, 2006, SPINE, V31, P1983, DOI 10.1097/01.brs.0000229254.89952.6b; Jones AC, 2008, MED ENG PHYS, V30, P1287, DOI 10.1016/j.medengphy.2008.09.006; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P229, DOI 10.1007/s00198-004-1811-2; Kaufmann TJ, 2006, AM J NEURORADIOL, V27, P1933; Klazen CAH, 2010, AM J NEURORADIOL, V31, P1447, DOI 10.3174/ajnr.A2148; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Kopperdahl DL, 2014, J BONE MINER RES, V29, P570, DOI 10.1002/jbmr.2069; Lau E, 2008, J BONE JOINT SURG AM, V90A, P1479, DOI 10.2106/JBJS.G.00675; Liebschner MAK, 2001, SPINE, V26, P1547, DOI 10.1097/00007632-200107150-00009; Luo J, 2009, SPINE, V34, P2865, DOI 10.1097/BRS.0b013e3181b4ea1e; Marangalou JH, 2013, J BIOMECH, V46, P2356, DOI 10.1016/j.jbiomech.2013.07.042; Masala S, 2009, SKELETAL RADIOL, V38, P863, DOI 10.1007/s00256-009-0712-z; Masala S, 2009, EUR RADIOL, V19, P165, DOI 10.1007/s00330-008-1133-4; Mazzantini M, 2011, OSTEOPOROSIS INT, V22, P1599, DOI 10.1007/s00198-010-1341-z; Meijer GJM, 2010, J BIOMECH, V43, P1590, DOI 10.1016/j.jbiomech.2010.01.028; Molloy S, 2003, SPINE, V28, P1549, DOI 10.1097/00007632-200307150-00014; Polikeit A, 2003, SPINE, V28, P991, DOI 10.1097/00007632-200305150-00006; Race A, 2007, J BIOMECH, V40, P1002, DOI 10.1016/j.jbiomech.2006.04.003; Robinson Y, 2012, MATURITAS, V72, P42, DOI 10.1016/j.maturitas.2012.02.010; Rohlmann A, 2010, EUR SPINE J, V19, P1585, DOI 10.1007/s00586-010-1386-x; Sambrook P, 2009, IBMS BONEKEY, V5, P385; Soyka RPW, 2013, J MECH BEHAV BIOMED, V27, P43, DOI 10.1016/j.jmbbm.2013.06.007; Sun K, 2004, SPINE, V29, P1428, DOI 10.1097/01.BRS.0000128760.94173.90; Sun K, 2004, ANN BIOMED ENG, V32, P77, DOI 10.1023/B:ABME.0000007793.49771.6d; Svedbom A, 2013, OSTEOPOROSIS INT, V24, P355, DOI 10.1007/s00198-012-2102-y; Tohmeh AG, 1999, SPINE, V24, P1772, DOI 10.1097/00007632-199909010-00004; Truumees Eeric, 2004, Spine J, V4, P218, DOI 10.1016/j.spinee.2003.08.029; Tschirhart CE, 2005, J BIOMECH, V38, P1582, DOI 10.1016/j.jbiomech.2004.07.023; Wasnich RD, 1996, BONE, V18, pS179, DOI 10.1016/8756-3282(95)00499-8; Widmer RP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003735; Widmer RP, 2012, COMPUT METHODS BIOME; Wilcox RK, 2006, P I MECH ENG H, V220, P565, DOI 10.1243/09544119H00305; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Zysset PK, 1998, J BIOMECH ENG-T ASME, V120, P640, DOI 10.1115/1.2834756	63	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0151680	10.1371/journal.pone.0151680	http://dx.doi.org/10.1371/journal.pone.0151680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100630	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500006
J	Zhou, R; Kuang, Y; Zhou, J; Du, XW; Li, J; Shi, JF; Haburcak, R; Xu, B				Zhou, Rong; Kuang, Yi; Zhou, Jie; Du, Xuewen; Li, Jie; Shi, Junfeng; Haburcak, Richard; Xu, Bing			Nanonets Collect Cancer Secretome from Pericellular Space	PLOS ONE			English	Article							PROTEIN IDENTIFICATION DATA; CELL-LINES; TUMOR MICROENVIRONMENT; INTERSTITIAL FLUID; SMALL MOLECULES; HYDROGELATION; MECHANISMS; PROTEOMICS; PEPTIDES; EXOSOMES	Identifying novel cancer biomarkers is important for early cancer detection as it can reduce mortality rates. The cancer secretome, the collection of all macromolecules secreted by a tumor cell, alters its composition compared to normal tissue, and this change plays an important role in the observation of cancer progression. The collection and accurate analysis of cancer secretomes could lead to the discovery of novel biomarkers, thus improving outcomes of cancer treatment. We unexpectedly discovered that enzyme-instructed self-assembly (EISA) of a D-peptide hydrogelator results in nanonets/hydrogel around cancer cells that overexpress ectophosphatases. Here we show that these nanonets are able to rapidly collect proteins in the pericellular space (i.e., near the surface) of cancer cells. Because the secretory substances are at their highest concentration near the cell surface, the use of pericellular nanonets to collect the cancer secretome maximizes the yield and quality of samples, reduces pre-analytical variations, and allows the dynamic profiling of secretome samples. Thus, this new approach has great potential in identifying the heterotypic signaling in tumor microenvironments thereby improving the understanding of tumor microenvironments and accelerating the discovery of potential biomarkers in cancer biology. Data are available via ProteomeXchange with identifier PXD003924.	[Zhou, Rong; Kuang, Yi; Zhou, Jie; Du, Xuewen; Li, Jie; Shi, Junfeng; Haburcak, Richard; Xu, Bing] Brandeis Univ, Dept Chem, Waltham, MA 02254 USA	Brandeis University	Xu, B (corresponding author), Brandeis Univ, Dept Chem, Waltham, MA 02254 USA.	bxu@brandeis.edu	Li, Jie/ABD-8476-2021; XU, Bing/A-7828-2008	XU, Bing/0000-0002-4639-387X; Kuang, Yi/0000-0003-3643-2684; Haburcak, Richard/0000-0002-6591-8918	National Institutes of Health [R01CA142746]; Kenneth Rainin Foundation; National Science Foundation [DMR-1420382]; NATIONAL CANCER INSTITUTE [R01CA142746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kenneth Rainin Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is partially supported by National Institutes of Health (R01CA142746), Kenneth Rainin Foundation, and a National Science Foundation grant (DMR-1420382). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; BERNHARD A, 1953, SCIENCE, V118, P114, DOI 10.1126/science.118.3056.114; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Bradshaw RA, 2006, MOL CELL PROTEOMICS, V5, P787, DOI 10.1074/mcp.E600005-MCP200; Brown KJ, 2013, BBA-PROTEINS PROTEOM, V1834, P2454, DOI 10.1016/j.bbapap.2013.04.007; Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; ESTEBAN C, 1991, INT J CANCER, V49, P425, DOI 10.1002/ijc.2910490320; Gao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2040; Gromov P, 2013, BBA-PROTEINS PROTEOM, V1834, P2259, DOI 10.1016/j.bbapap.2013.01.013; Haslene-Hox H, 2013, BBA-PROTEINS PROTEOM, V1834, P2336, DOI 10.1016/j.bbapap.2013.01.028; Iguchi Haruhisa, 2010, Commun Integr Biol, V3, P478, DOI 10.4161/cib.3.5.12693; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iwata M, 2014, STEM CELLS DEV, V23, P729, DOI 10.1089/scd.2013.0300; Jeffries GDM, 2007, NANO LETT, V7, P415, DOI 10.1021/nl0626784; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Kuang Y, 2014, ANGEW CHEM IN PRESS, V53; Lei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107746; Li JY, 2013, J AM CHEM SOC, V135, P542, DOI 10.1021/ja310019x; Lin QF, 2013, BBA-PROTEINS PROTEOM, V1834, P2360, DOI 10.1016/j.bbapap.2013.01.030; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; Mbeunkui F, 2006, J PROTEOME RES, V5, P899, DOI 10.1021/pr050375p; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Polacek M, 2010, J ORTHOP RES, V28, P1040, DOI 10.1002/jor.21067; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Richards RI, 1997, TRENDS BIOCHEM SCI, V22, P432, DOI 10.1016/S0968-0004(97)01108-0; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Shin SJ, 2013, P NATL ACAD SCI USA, V110, P19414, DOI 10.1073/pnas.1309720110; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Tan HY, 2008, OPT COMMUN, V281, P3013, DOI 10.1016/j.optcom.2008.01.012; TANAKA T, 1967, J BIOCHEM-TOKYO, V62, P71, DOI 10.1093/oxfordjournals.jbchem.a128639; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang XW, 1998, LIFE SCI, V64, P17, DOI 10.1016/S0024-3205(98)00529-3; Whitaker RD, 2011, J BIOL CHEM, V286, P21623, DOI 10.1074/jbc.M111.239897; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52; Yang Z, 2008, ACCOUNTS CHEM RES, V41, P315, DOI 10.1021/ar7001914; Yang Z, 2007, ANGEW CHEM INT EDIT, V46, P8216, DOI 10.1002/anie.200701697; Yang ZM, 2007, ADV MATER, V19, P3152, DOI 10.1002/adma.200701971; Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y; Yang ZM, 2004, ADV MATER, V16, P1440, DOI 10.1002/adma.200400340; Zhou J, 2014, J AM CHEM S IN PRESS	49	4	4	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154126	10.1371/journal.pone.0154126	http://dx.doi.org/10.1371/journal.pone.0154126			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100780	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500151
J	Alos, J; Palmer, M; Balle, S; Arlinghaus, R				Alos, Josep; Palmer, Miquel; Balle, Salvador; Arlinghaus, Robert			Bayesian State-Space Modelling of Conventional Acoustic Tracking Provides Accurate Descriptors of Home Range Behavior in a Small-Bodied Coastal Fish Species	PLOS ONE			English	Article							PEARLY RAZORFISH; TELEMETRY DATA; DIEL BEHAVIOR; MOVEMENT DATA; DESIGN; PERFORMANCE; NOVACULA; ATLANTIC; SYSTEM; SCALES	State-space models (SSM) are increasingly applied in studies involving biotelemetry-generated positional data because they are able to estimate movement parameters from positions that are unobserved or have been observed with non-negligible observational error. Popular telemetry systems in marine coastal fish consist of arrays of omnidirectional acoustic receivers, which generate a multivariate time-series of detection events across the tracking period. Here we report a novel Bayesian fitting of a SSM application that couples mechanistic movement properties within a home range (a specific case of random walk weighted by an Ornstein-Uhlenbeck process) with a model of observational error typical for data obtained from acoustic receiver arrays. We explored the performance and accuracy of the approach through simulation modelling and extensive sensitivity analyses of the effects of various configurations of movement properties and time-steps among positions. Model results show an accurate and unbiased estimation of the movement parameters, and in most cases the simulated movement parameters were properly retrieved. Only in extreme situations (when fast swimming speeds are combined with pooling the number of detections over long time-steps) the model produced some bias that needs to be accounted for in field applications. Our method was subsequently applied to real acoustic tracking data collected from a small marine coastal fish species, the pearly razorfish, Xyrichtys novacula. The Bayesian SSM we present here constitutes an alternative for those used to the Bayesian way of reasoning. Our Bayesian SSM can be easily adapted and generalized to any species, thereby allowing studies in freely roaming animals on the ecological and evolutionary consequences of home ranges and territory establishment, both in fishes and in other taxa.	[Alos, Josep; Arlinghaus, Robert] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Muggelseedamm 310, D-12587 Berlin, Germany; [Alos, Josep; Palmer, Miquel; Balle, Salvador] IMEDEA CSIC UIB, Inst Mediterraneo Estudios Avanzados, C Miquel Marques 21, Esporles 07190, Illes Balears, Spain; [Arlinghaus, Robert] Humboldt Univ, Div Integrat Fisheries Management, Fac Life Sci, Invalidenstr 42, D-10155 Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Humboldt University of Berlin	Alos, J (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Muggelseedamm 310, D-12587 Berlin, Germany.; Alos, J (corresponding author), IMEDEA CSIC UIB, Inst Mediterraneo Estudios Avanzados, C Miquel Marques 21, Esporles 07190, Illes Balears, Spain.	alos@imedea.uib-csic.es	Arlinghaus, Robert/J-6171-2019; Balle, Salvador/F-8575-2013; Arlinghaus, Robert/E-3340-2010; Palmer, Miquel/E-3561-2013	Balle, Salvador/0000-0002-7026-1391; Arlinghaus, Robert/0000-0003-2861-527X; Miquel, Palmer/0000-0002-7875-3673	Marie Curie Post-Doc grant (FP7-PEOPLE-IEF) [327160]; research project REC2 - Spanish Ministry of Economy and Competiveness [CTM2011-23835]; research project CONFLICT - Spanish Ministry of Economy and Competiveness [CGL2008-00958]; Juan de la Cierva Post-doc grant - Spanish Ministry of Economy and Competiveness [FJCI-2014-21239]; B-Types project through Leibniz Competition [SAW-2013-IGB-2]	Marie Curie Post-Doc grant (FP7-PEOPLE-IEF); research project REC2 - Spanish Ministry of Economy and Competiveness; research project CONFLICT - Spanish Ministry of Economy and Competiveness; Juan de la Cierva Post-doc grant - Spanish Ministry of Economy and Competiveness; B-Types project through Leibniz Competition	This study was funded through a Marie Curie Post-Doc grant (FP7-PEOPLE-2012-IEF, grant no. 327160). MP received additional funding from the research project REC2 (grant no. CTM2011-23835) and the research project CONFLICT (grant no. CGL2008-00958) and JA from a Juan de la Cierva Post-doc grant (grant no. FJCI-2014-21239), all of them funded by the Spanish Ministry of Economy and Competiveness. The project also received additional funding from the B-Types project funded through Leibniz Competition (grant no. SAW-2013-IGB-2) to RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2015, MAR ECOL PROG SER, V518, P255, DOI 10.3354/meps11054; Albertsen CM, 2015, ECOLOGY, V96, P2598, DOI 10.1890/14-2101.1.sm; Alos J, 2012, MAR ECOL PROG SER, V460, P207, DOI 10.3354/meps09755; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Alos J, 2011, MAR ECOL PROG SER, V427, P173, DOI 10.3354/meps09042; Andrews KS, 2011, MAR BIOL, V158, P2377, DOI 10.1007/s00227-011-1724-5; Arlinghaus R, 2016, TRENDS ECOL EVOL, V31, P92, DOI 10.1016/j.tree.2015.11.008; Baktoft H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126534; Benhamou S, 2014, ECOL LETT, V17, P261, DOI 10.1111/ele.12225; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Botsford LW, 2003, ECOL APPL, V13, pS25; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Candi G, 2004, J FISH BIOL, V64, P1498, DOI 10.1111/j.0022-1112.2004.0404.x; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; D'Anna G, 2010, ITALIAN J ZOOLOGY, V78, P255; Donaldson MR, 2014, FRONT ECOL ENVIRON, V12, P565, DOI 10.1890/130283; DUNN JE, 1977, BIOMETRICS, V33, P85, DOI 10.2307/2529305; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Fagan W.F., 2014, B ECOL SOC AM, V95, P204, DOI DOI 10.1890/0012-9623-95.3.204; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Farmer NA, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-7; Gardiner C. W., 1990, HDB STOCHASTIC METHO; Gelman A., 2021, BAYESIAN DATA ANAL; Grothues TM, 2009, REV-METHODS TECHNOL, V9, P77, DOI 10.1007/978-1-4020-9640-2_5; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hedger RD, 2008, ICES J MAR SCI, V65, P1248, DOI 10.1093/icesjms/fsn109; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heupel MR, 2008, LIMNOL OCEANOGR-METH, V6, P327, DOI 10.4319/lom.2008.6.327; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; How J, 2012, MARINE FRESHWATER RE, V63, P321; How JR, 2012, MAR FRESHWATER RES, V63, P312, DOI 10.1071/MF11194; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Katsanevakis S, 2005, SCI MAR, V69, P223, DOI 10.3989/scimar.2005.69n2223; Kessel ST, 2014, REV FISH BIOL FISHER, V24, P199, DOI 10.1007/s11160-013-9328-4; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Klimley AP, 1998, MAR TECHNOL SOC J, V32, P94; Koeck B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069303; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Krause J, 2013, TRENDS ECOL EVOL, V28, P541, DOI 10.1016/j.tree.2013.06.002; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; March D, 2010, MAR ECOL PROG SER, V400, P195, DOI 10.3354/meps08410; MARCONATO A, 1995, J FISH BIOL, V47, P292, DOI 10.1006/jfbi.1995.0134; MARTINS EG, 2014, ANIMAL BIOTELEMETRY, V0002, P00013, DOI DOI 10.1186/2050-3385-2-13; Mathies NH, 2014, MAR ECOL PROG SER, V495, P27, DOI 10.3354/meps10582; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Moffitt EA, 2009, ECOL APPL, V19, P1835, DOI 10.1890/08-1101.1; Moorcroft PR, 2006, P ROY SOC B-BIOL SCI, V273, P1651, DOI 10.1098/rspb.2005.3439; Morales-Nin B, 2005, ICES J MAR SCI, V62, P727, DOI 10.1016/j.icesjms.2005.01.022; Musyl M, 2001, ELECT TAGGING TRACKI, P343, DOI [10.1007/978-94-017-1402-0_19, DOI 10.3354/MEPS09899]; Palmer M, 2011, MAR ECOL PROG SER, V430, P87, DOI 10.3354/meps09109; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Payne NL, 2011, MARINE ECOLOGY PROGR, V419, P295; Pedersen MW, 2014, METHODS ECOL EVOL, V5, P1043, DOI 10.1111/2041-210X.12255; Pedersen MW, 2013, METHODS ECOL EVOL, V4, P920, DOI 10.1111/2041-210X.12086; Plummer M, 2006, R NEWS, V6, P5; Roy R., 2014, ANIM BIOTELEM, V2, P1, DOI DOI 10.1186/2050-3385-2-1; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Singh L, 2009, AFR J MAR SCI, V31, P355, DOI 10.2989/AJMS.2009.31.3.8.996; Smith GW, 1998, HYDROBIOLOGIA, V372, P9, DOI 10.1023/A:1017039325661; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Tolon V, 2009, CAN J ZOOL, V87, P1129, DOI 10.1139/Z09-101; Turchin Peter, 1998; Tuya F, 2005, MAR BIOL, V147, P1229, DOI 10.1007/s00227-005-0018-1; Van Moorter B, 2016, J ANIM ECOL, V85, P21, DOI 10.1111/1365-2656.12394; Villegas-Rios D, 2013, J SEA RES, V80, P61, DOI 10.1016/j.seares.2013.02.009; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1	78	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154089	10.1371/journal.pone.0154089	http://dx.doi.org/10.1371/journal.pone.0154089			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119718	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200044
J	Wong, DWC; Niu, WX; Wang, Y; Zhang, M				Wong, Duo Wai-Chi; Niu, Wenxin; Wang, Yan; Zhang, Ming			Finite Element Analysis of Foot and Ankle Impact Injury: Risk Evaluation of Calcaneus and Talus Fracture	PLOS ONE			English	Article							TRABECULAR BONE; BIOMECHANICS; MODEL; JOINT; TOLERANCE; LIGAMENTS; COMPLEX; WALKING; TRAUMA; SHEAR	Introduction Foot and ankle impact injury is common in geriatric trauma and often leads to fracture of rearfoot, including calcaneus and talus. The objective of this study was to assess the influence of foot impact on the risk of calcaneus and talus fracture via finite element analysis. Methods A three-dimensional finite element model of foot and ankle was constructed based on magnetic resonance images of a female aged 28. The foot sustained a 7-kg passive impact through a foot plate. The simulated impact velocities were from 2.0 to 7.0 m/s with 1.0 m/s interval. Results At 5.0 m/s impact velocity, the maximum von Mises stress of the trabecular calcaneus and talus were 3.21MPa and 2.41MPa respectively, while that of the Tresca stress were 3.46MPa and 2.55MPa. About 94% and 84% of the trabecular calcaneus and talus exceeded the shear yielding stress, while 21.7% and 18.3% yielded the compressive stress. The peak stresses were distributed around the talocalcaneal articulation and the calcaneal tuberosity inferiorly, which corresponded to the common fracture sites. Conclusions The prediction in this study showed that axial compressive impact at 5.0 m/s could produce considerable yielding of trabecular bone in both calcaneus and talus, dominantly by shear and compounded with compression that predispose the rearfoot in the risk of fracture. This study suggested the injury pattern and fracture mode of high energy trauma that provides insights in injury prevention and fracture management.	[Wong, Duo Wai-Chi; Niu, Wenxin; Wang, Yan; Zhang, Ming] Hong Kong Polytech Univ, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Niu, Wenxin] Tongji Univ, Sch Med, Shanghai Yang Zhi Rehabil Hosp, Shanghai 200092, Peoples R China	Hong Kong Polytechnic University; Tongji University	Zhang, M (corresponding author), Hong Kong Polytech Univ, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China.	ming.zhang@polyu.edu.hk	Zhang, Ming/F-8331-2011; Wong, Duo Wai-Chi/B-4127-2015; Wang, Yan/AAU-3194-2021	Zhang, Ming/0000-0002-6027-4594; Wong, Duo Wai-Chi/0000-0002-8805-1157; Wang, Yan/0000-0002-5404-4098; Niu, Wenxin/0000-0003-1349-4524	Research Grants Council of Hong Kong [PolyU5326/11E, PolyU152216/14E, PolyU15200215]; National Natural Science Foundation of China [11272273, 11120101001, 11302154]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Research Grants Council of Hong Kong (PolyU5326/11E, PolyU152216/14E, PolyU15200215), http://www.ugc.edu.hk/, and National Natural Science Foundation of China (11272273, 11120101001, 11302154), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou KA, 1998, CLIN ORTHOP RELAT R, P269; Bailey AM, 2015, TRAFFIC INJ PREV, V16, pS96, DOI 10.1080/15389588.2015.1061185; Banerjee R, 2014, MANNS SURG FOOT ANKL, V9th, P2101; Chang CY, 2008, STAPP CAR C, V52, P475; Chen WM, 2015, COMPUT METHOD BIOMEC, V18, P1582, DOI 10.1080/10255842.2014.930447; Cheung JTM, 2009, FOOTWEAR SCI, V1, P31, DOI 10.1080/19424280903002323; Cheung JTM, 2005, J BIOMECH, V38, P1045, DOI 10.1016/j.jbiomech.2004.05.035; Chi KJ, 2005, J BIOMECH, V38, P1387, DOI 10.1016/j.jbiomech.2004.06.020; Cho JR, 2009, J MECH SCI TECHNOL, V23, P2583, DOI 10.1007/s12206-009-0801-x; Crandall JR, BIOMECHANICAL RESPON; Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003; Farhang B, 2015, P I MECH ENG P-J SPO; Federal Aviation Administration, 1985, INJ CRIT HUM EXP IMP; Forman JL, 2015, ACCIDENT ANAL PREV, V80, P7, DOI 10.1016/j.aap.2015.03.004; Funk JR, 2002, J BIOMECH ENG-T ASME, V124, P750, DOI 10.1115/1.1514675; Gallenberger Kathryn, 2013, Ann Adv Automot Med, V57, P123; Garnier KB, 1999, MED ENG PHYS, V21, P641, DOI 10.1016/S1350-4533(99)00096-X; Gowing R, 2007, CAN J SURG, V50, P437; Gu YD, 2010, SKIN RES TECHNOL, V16, P291, DOI 10.1111/j.1600-0846.2010.00425.x; Herscovici D, 2012, GERIATR ORTHOP SURG, V3, P33, DOI 10.1177/2151458511436112; Hubbard M, 2009, SAFER SKI JUMP LANDI, P17; Kelly N, 2012, J MECH BEHAV BIOMED, V9, P184, DOI 10.1016/j.jmbbm.2011.11.013; Klopp G, 1997, P 1997 INT IRC C BIO; Lemmon D, 1997, J BIOMECH, V30, P615, DOI 10.1016/S0021-9290(97)00006-7; MCGEE A, 2004, TRAUMA, V6, P29, DOI DOI 10.1191/1460408604TA295OA; McKay BJ, 2009, STAPP CAR CRASH JO, V53, P229; Milz P, 1998, ACTA ORTHOP SCAND, V69, P51, DOI 10.3109/17453679809002357; Mittra E, 2008, J BIOMECH, V41, P368, DOI 10.1016/j.jbiomech.2007.09.003; Morales-Orcajo E., 2015, ARCH COMPUT METHODS, P1; Nakamura S, 1981, Bull Prosthet Res, V10-35, P27; Niu WX, 2011, HUM MOVEMENT SCI, V30, P614, DOI 10.1016/j.humov.2010.10.010; Parenteau CS, 1998, J BIOMECH ENG-T ASME, V120, P105, DOI 10.1115/1.2834289; Qian Z, 2013, DYNAMIC FINITE ELEME; Rammelt S, 2004, INJURY, V35, P443, DOI 10.1016/j.injury.2003.10.006; Sabry FF, 2000, FOOT ANKLE INT, V21, P114, DOI 10.1177/107110070002100204; Sanders RW, 2014, MANNS SURG FOOT ANKL, P2041; Sanyal A, 2012, J BIOMECH, V45, P2513, DOI 10.1016/j.jbiomech.2012.07.023; Schuenke M., 2007, THIEME ATLAS ANATOMY; SCHWAB CW, 1992, ARCH SURG-CHICAGO, V127, P701; Shin J, 2012, ANN BIOMED ENG, V40, P2519, DOI 10.1007/s10439-012-0607-3; SIEGLER S, 1988, FOOT ANKLE, V8, P234, DOI 10.1177/107110078800800502; Smith B R, 2005, Traffic Inj Prev, V6, P156, DOI 10.1080/15389580590931635; Telfer S, 2014, WHAT HAS FINITE ELEM; Wang Y, 2016, ANN BIOMED ENG, V44, P213, DOI 10.1007/s10439-015-1359-7; Wang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134340; Wong DWC, 2015, J BIOMECH, V48, P3142, DOI 10.1016/j.jbiomech.2015.07.013; Wong DWC, 2014, MED ENG PHYS, V36, P1388, DOI 10.1016/j.medengphy.2014.03.004; Yoganandan N, 1997, J BIOMECH ENG-T ASME, V119, P433, DOI 10.1115/1.2798290; Zhang M, 1999, PROSTHET ORTHOT INT, V23, P135	49	46	47	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154435	10.1371/journal.pone.0154435	http://dx.doi.org/10.1371/journal.pone.0154435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119740	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200074
J	Javanbakht, T; Laurent, S; Stanicki, D; Wilkinson, KJ				Javanbakht, Taraneh; Laurent, Sophie; Stanicki, Dimitri; Wilkinson, Kevin J.			Relating the Surface Properties of Superparamagnetic Iron Oxide Nanoparticles (SPIONs) to Their Bactericidal Effect towards a Biofilm of Streptococcus mutans	PLOS ONE			English	Article							DIFFUSION; CHARGE	This study was designed to determine the effects of superparamagnetic iron oxide nanoparticles (SPIONs) on the biological activity of a bacterial biofilm (Streptococcus mutans). Our hypothesis was that the diffusion of the SPIONs into biofilms would depend on their surface properties, which in turn would largely be determined by their surface functionality. Bare, positively charged and negatively charged SPIONs, with hydrodynamic diameters of 14.6 +/- 1.4 nm, 20.4 +/- 1.3 nm and 21.2 +/- 1.6 nm were evaluated. Time-of-flight secondary ion mass spectrometry (TOF-SIMS) and electrophoretic mobility (EPM) measurements were used to confirm that carboxylic functional groups predominated on the negatively charged SPIONS, whereas amine functional groups predominated on the positively charged particles. Transmission electron microscopy (TEM) showed the morphology and sizes of SPIONs. Scanning electron microscopy (SEM) and EPM measurements indicated that the surfaces of the SPIONs were covered with biomolecules following their incubation with the biofilm. Bare SPIONs killed bacteria less than the positively charged SPIONs at the highest exposure concentrations, but the toxicity of the bare and positively charged SPIONs was the same for lower SPION concentrations. The positively charged SPIONs were more effective in killing bacteria than the negatively charged ones. Nonetheless, electrophoretic mobilities of all three SPIONs (negative, bare and positively charged) became more negative following incubation with the (negatively-charged) biofilm. Therefore, while the surface charge of SPIONS was important in determining their biological activity, the initial surface charge was not constant in the presence of the biofilm, leading eventually to SPIONS with fairly similar surface charges in situ. The study nonetheless suggests that the surface characteristics of the SPIONS is an important parameter controlling the efficiency of antimicrobial agents. The analysis of the CFU/mL values shows that the SPIONs have the same toxicity on bacteria in solution in comparison with that on the biofilm.	[Javanbakht, Taraneh; Wilkinson, Kevin J.] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Laurent, Sophie; Stanicki, Dimitri] Univ Mons, Lab NMR & Mol Imaging, B-7000 Mons, Belgium; [Laurent, Sophie] CMMI, Gosselies, Belgium	Universite de Montreal	Javanbakht, T (corresponding author), Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada.	taraneh.javanbakht@umontreal.ca	Javanbakht, Taraneh/B-7775-2015; Wilkinson, Kevin J/I-4193-2012	Javanbakht, Taraneh/0000-0002-2658-330X; Wilkinson, Kevin J/0000-0002-7182-3624				Attila C, 2008, MICROB BIOTECHNOL, V1, P17, DOI 10.1111/j.1751-7915.2007.00002.x; Bridot JL, 2013, CONTRAST MEDIA MOL I, V8, P466, DOI 10.1002/cmmi.1552; Chen B, 2011, CURR CANCER DRUG TAR, V11, P184, DOI 10.2174/156800911794328475; Chen Yue, 2010, Chin J Cancer, V29, P125; Chew SC, 2014, MBIO, V5, DOI 10.1128/mBio.01536-14; Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P7277, DOI 10.1021/es900249m; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Golmohamadi M, 2013, ENVIRON CHEM, V10, P34, DOI 10.1071/EN12106; Hong B, 2008, ADV EXP MED BIOL, V614, P265, DOI 10.1007/978-0-387-74911-2_30; Hu Y., 2012, THESIS TU DENMARK, P19; Issa B, 2013, INT J MOL SCI, V14, P21266, DOI 10.3390/ijms141121266; Javanbakht T, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-3276-y; Jia F, 2013, J CONTROL RELEASE, V172, P1020, DOI 10.1016/j.jconrel.2013.10.012; Kazemzadeh Hamid, 2012, International Journal of Modern Physics: Conference Series, V5, P160, DOI 10.1142/S2010194512001973; Laurent S, 2012, PLOS ONE, V7, P306, DOI 10.1371/journal.pone.0029997; Leuba KD, 2013, INT J NANOMED, V8, P731, DOI 10.2147/IJN.S38256; Li XN, 2015, CHEM COMMUN, V51, P282, DOI 10.1039/c4cc07737g; Maurer-Jones MA, 2013, ANAL CHEM, V85, P3036, DOI 10.1021/ac303636s; Namanga J, 2013, J NANOMATER, V2013, DOI 10.1155/2013/137275; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; Park H, 2011, J MICROBIOL METH, V84, P41, DOI 10.1016/j.mimet.2010.10.010; Peulen TO, 2011, ENVIRON SCI TECHNOL, V45, P3367, DOI 10.1021/es103450g; Sakulkhu U, 2014, SCI REP-UK, V4, DOI 10.1038/srep05020; Subbiandoss G, 2012, ACTA BIOMATER, V8, P2047, DOI 10.1016/j.actbio.2012.03.002; Taylor EN, 2012, SMALL, V8, P3016, DOI 10.1002/smll.201200575; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhang XF, 2011, J PHYS CHEM C, V115, P1436, DOI 10.1021/jp1075498; Zhang ZS, 2011, ANTIMICROB AGENTS CH, V55, P1075, DOI 10.1128/AAC.01329-10	28	29	29	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154445	10.1371/journal.pone.0154445	http://dx.doi.org/10.1371/journal.pone.0154445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115356	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600067
J	Yabe, S; Yamasaki, M; Ebana, K; Hayashi, T; Iwata, H				Yabe, Shiori; Yamasaki, Masanori; Ebana, Kaworu; Hayashi, Takeshi; Iwata, Hiroyoshi			Island-Model Genomic Selection for Long-Term Genetic Improvement of Autogamous Crops	PLOS ONE			English	Article								Acceleration of genetic improvement of autogamous crops such as wheat and rice is necessary to increase cereal production in response to the global food crisis. Population and pedigree methods of breeding, which are based on inbred line selection, are used commonly in the genetic improvement of autogamous crops. These methods, however, produce a few novel combinations of genes in a breeding population. Recurrent selection promotes recombination among genes and produces novel combinations of genes in a breeding population, but it requires inaccurate single-plant evaluation for selection. Genomic selection (GS), which can predict genetic potential of individuals based on their marker genotype, might have high reliability of single-plant evaluation and might be effective in recurrent selection. To evaluate the efficiency of recurrent selection with GS, we conducted simulations using real marker genotype data of rice cultivars. Additionally, we introduced the concept of an "island model" inspired by evolutionary algorithms that might be useful to maintain genetic variation through the breeding process. We conducted GS simulations using real marker genotype data of rice cultivars to evaluate the efficiency of recurrent selection and the island model in an autogamous species. Results demonstrated the importance of producing novel combinations of genes through recurrent selection. An initial population derived from admixture of multiple bi-parental crosses showed larger genetic gains than a population derived from a single bi-parental cross in whole cycles, suggesting the importance of genetic variation in an initial population. The island-model GS better maintained genetic improvement in later generations than the other GS methods, suggesting that the island-model GS can utilize genetic variation in breeding and can retain alleles with small effects in the breeding population. The island-model GS will become a new breeding method that enhances the potential of genomic selection in autogamous crops, especially bringing long-term improvement.	[Yabe, Shiori; Iwata, Hiroyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo, Japan; [Yamasaki, Masanori] Kobe Univ, Food Resources Educ & Res Ctr, Grad Sch Agr Sci, Kasai, Hyogo, Japan; [Ebana, Kaworu] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan; [Yabe, Shiori; Hayashi, Takeshi] Natl Agr & Food Res Org, Agr Res Ctr, Tsukuba, Ibaraki, Japan	University of Tokyo; Kobe University; National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan	Iwata, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo, Japan.	aiwata@mail.ecc.u-tokyo.ac.jp	Yamasaki, Masanori/C-5193-2018	Yamasaki, Masanori/0000-0001-7759-3965	JSPS KAKENHI Grant [25_6921]; MEXT [25252002]; Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [NVR-0002]; JST/CREST; Grants-in-Aid for Scientific Research [25252002] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); JST/CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI Grant Number 25_6921, by a Grant-in-Aid for Scientific Research (A), MEXT, No. 25252002, by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, NVR-0002) and by JST/CREST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, 1203 ESA FAO UN AGR, DOI [10.22004/ag.econ.288998, DOI 10.22004/AG.ECON.288998]; Brown J., 2008, INTRO PLANT BREEDING; Cheng ZK, 2001, GENETICS, V157, P1749; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Falconer D. S., 1996, Introduction to quantitative genetics.; FUJIMAKI H, 1979, JARQ-JPN AGR RES Q, V13, P153; HANSON WD, 1959, GENETICS, V44, P857; Hartl DL, 2007, PRINCIPLES POPULATIO; Harushima Y, 1998, GENETICS, V148, P479; Iwata H, 2011, TREE GENET GENOMES, V7, P747, DOI 10.1007/s11295-011-0371-9; Iwata H, 2010, CROP SCI, V50, P1269, DOI 10.2135/cropsci2009.08.0434; Jannink JL, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-35; Kurata N, 1997, PLANT MOL BIOL, V35, P101, DOI 10.1023/A:1005760717474; LANDE R, 1990, GENETICS, V124, P743; McClosky B, 2013, THEOR APPL GENET, V126, P2907, DOI 10.1007/s00122-013-2182-x; Meuwissen THE, 2001, GENETICS, V157, P1819; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagasaki H, 2010, BREEDING SCI, V60, P648, DOI 10.1270/jsbbs.60.648; O'Hagan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048862; R Core Team, 2021, R LANGUAGE ENV STAT; Rutkoski JE, 2011, EUPHYTICA, V179, P161, DOI 10.1007/s10681-010-0301-1; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thompson SR, 2008, 004408 AEDEWP OH STA; Ukai Y, 2003, PLANT BREEDING; Verhoeven KJF, 2006, HEREDITY, V96, P139, DOI 10.1038/sj.hdy.6800763; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Whitley D., 1999, Journal of Computing and Information Technology - CIT, V7, P33; Wright S, 1943, GENETICS, V28, P114; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Yabe S, 2014, CROP SCI, V54, P1448, DOI 10.2135/cropsci2013.05.0319; Yabe S, 2013, CROP SCI, V53, P95, DOI 10.2135/cropsci2012.03.0167; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yamasaki M, 2013, BREEDING SCI, V63, P49, DOI 10.1270/jsbbs.63.49	35	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153945	10.1371/journal.pone.0153945	http://dx.doi.org/10.1371/journal.pone.0153945			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115872	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600035
J	Tolstykh, EI; Degteva, MO; Bougrov, NG; Napier, BA				Tolstykh, Evgenia I.; Degteva, Marina O.; Bougrov, Nikolay G.; Napier, Bruce A.			Body Potassium Content and Radiation Dose from K-40 for the Urals Population (Russia)	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; AGE; SARCOPENIA; ETHNICITY; CHILDREN; SPAN; LIFE	Long-term whole-body monitoring of radionuclides in residents of the Urals Region has been performed at the Urals Research Center for Radiation Medicine (URCRM, Chelyabinsk). Quantification of K-40 was achieved by measuring the K-40 photopeak with four phoswich detectors in whole body counter SICH-9.1M. The current study presents the results of K-40 measurements in 3,651 women and 1,961 t-test; U-test men aged 11-90; measurements were performed in 2006-2014. The residents belonged to two ethnic groups, Turkic (Tatar, Bashkir) and Slavs (mainly Russian). The levels of K-40-body contents depend upon gender, age, and body mass. Significant ethnic-differences were not found in K-40-body contents and K-40 concentrations in terms of Bq per kg of body weight (in groups homogenous by age and gender). Both K-40-body contents and concentrations were significantly higher in men than in women in all age-groups; the difference was about 25%. The measured K-40-body content in men of 20-50 years was about 4200 Bq (134 g of K) and about 3000 Bq (95 g of K) in women. By the age of 80 these values decreased to 3200 Bq (102 g of K) in men and 2500 Bq (80 g of K) in women. Annual dose rates were maximal in the age group of 20-30 years-0.16 mGy/y for men and 0.13 mGy/y for women. Further, the dose-rates decreased with age and in the groups of 60-80 years were 0.13 mGy/y for men and 0.10 mGy/y for women. Within groups homogeneous by age and gender, individual dose rates are described by a normal statistical distribution. The coefficient of variation ranges from 9 to 14%, and on the average is 12.5%. Doses from naturally occurring K-40 accumulated over 70 years were found to be 9.9 mGy for men and 8.3 mGy for women; over 90 years - 12.5 and 10.4 mGy.	[Tolstykh, Evgenia I.; Degteva, Marina O.; Bougrov, Nikolay G.] Urals Res Ctr Radiat Med, Biophys Lab, Chelyabinsk, Russia; [Napier, Bruce A.] Pacific NW Natl Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Tolstykh, EI (corresponding author), Urals Res Ctr Radiat Med, Biophys Lab, Chelyabinsk, Russia.	evgnia@urcrm.ru	Degteva, Marina/AAV-9175-2020; Bugrov, Nikolay/G-8322-2016; Толстых, Евгения/A-7747-2016	Bugrov, Nikolay/0000-0002-3693-9218; Degteva, Marina/0000-0002-0248-9829	U.S. Department of Energy's, Office of International Health Programs; Federal Medical-Biological Agency [27.504.14.9]	U.S. Department of Energy's, Office of International Health Programs; Federal Medical-Biological Agency	The research was funded by the U.S. Department of Energy's, Office of International Health Programs (http://www.energy.gov/ehss/russian-health-studies-program-active-projects, Barret N. Fountos, Program Manager, to BN, MO); and by Federal Medical-Biological Agency (contract 27.504.14.9 http://fcp.economy.gov.ru/cgi-bin/cis/fcp.cgi/Fcp/ViewFcp/View/2012/368/, to ET, NB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, REP GEN ASS SCI ANN, V1; Batsis JA, 2014, EUR J CLIN NUTR, V68, P1001, DOI 10.1038/ejcn.2014.117; Bougrov NG, 2008, MED EXTREME SITUATIO, V4, P78; Butte NF, 2000, PEDIATR RES, V47, P578, DOI 10.1203/00006450-200005000-00004; Degteva M., 2013, RAD HYG, V6, P5; Demontis F, 2013, DIS MODEL MECH, V6, P1339, DOI 10.1242/dmm.012559; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; FLYNN MA, 1989, AM J CLIN NUTR, V50, P713, DOI 10.1093/ajcn/50.4.713; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Gohary M. I., 2010, IRPS B, V24, P6; ICRP-23, 1975, ICRP23; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Khokhryakov VV, 2002, CONSEQUENCES ANTHROP, P8; Kovtun AN, 2000, RADIAT PROT DOSIM, V89, P239, DOI 10.1093/oxfordjournals.rpd.a033071; KOZHEUROV VP, 1994, SCI TOTAL ENVIRON, V142, P37, DOI 10.1016/0048-9697(94)90072-8; Lynch TP, 2004, RADIAT PROT DOSIM, V111, P319, DOI 10.1093/rpd/nch345; Murphy AJ, 2008, BRIT J NUTR, V100, P666, DOI 10.1017/S0007114507901269; Nikolic M, 2005, COLLEGIUM ANTROPOL, V29, P67; Siegel JA, 2007, J NUCL MED, V48, P253; Silva AM, 2010, AM J HUM BIOL, V22, P76, DOI 10.1002/ajhb.20956; Solomon AM, 2006, J ENDOCRINOL, V191, P349, DOI 10.1677/joe.1.06837; SPADY DW, 1986, J PEDIATR GASTR NUTR, V5, P750, DOI 10.1097/00005176-198609000-00015; Strom D. J., 2009, PNNL18240; Tolstykh EI, 2012, 4 UR RES CTR RAD MED; Wang ZM, 2007, J NUTR, V137, P1988, DOI 10.1093/jn/137.8.1988; Welle S, 2002, CAN J APPL PHYSIOL, V27, P19, DOI 10.1139/h02-002	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154266	10.1371/journal.pone.0154266	http://dx.doi.org/10.1371/journal.pone.0154266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111330	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600054
J	Apetri, MM; Harkes, R; Subramaniam, V; Canters, GW; Schmidt, T; Aartsma, TJ				Apetri, Mihaela M.; Harkes, Rolf; Subramaniam, Vinod; Canters, Gerard W.; Schmidt, Thomas; Aartsma, Thijs J.			Direct Observation of alpha-Synuclein Amyloid Aggregates in Endocytic Vesicles of Neuroblastoma Cells	PLOS ONE			English	Article							ENDOSOMAL-LYSOSOMAL SYSTEM; PARKINSONS-DISEASE; LEWY BODY; FIBRILS; INCLUSIONS; CLEARANCE; NEURONS; SEED	Aggregation of alpha-synuclein has been linked to both familial and sporadic Parkinson's disease. Recent studies suggest that alpha-synuclein aggregates may spread from cell to cell and raise questions about the propagation of neurodegeneration. While continuous progress has been made characterizing alpha-synuclein aggregates in vitro, there is a lack of information regarding the structure of these species inside the cells. Here, we use confocal fluorescence microscopy in combination with direct stochastic optical reconstruction microscopy, dSTORM, to investigate alpha-synuclein uptake when added exogenously to SH-SY5Y neuroblastoma cells, and to probe in situ morphological features of alpha-synuclein aggregates with near nanometer resolution. We demonstrate that using dSTORM, it is possible to follow noninvasively the uptake of extracellularly added alpha-synuclein aggregates by the cells. Once the aggregates are internalized, they move through the endosomal pathway and accumulate in lysosomes to be degraded. Our dSTORM data show that alpha-synuclein aggregates remain assembled after internalization and they are shortened as they move through the endosomal pathway. No further aggregation was observed inside the lysosomes as speculated in the literature, nor in the cytoplasm of the cells. Our study thus highlights the super-resolution capability of dSTORM to follow directly the endocytotic uptake of extracellularly added amyloid aggregates and to probe the morphology of in situ protein aggregates even when they accumulate in small vesicular compartments.	[Apetri, Mihaela M.; Harkes, Rolf; Canters, Gerard W.; Schmidt, Thomas; Aartsma, Thijs J.] Leiden Univ, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands; [Subramaniam, Vinod] FOM Inst AMOLF, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; AMOLF	Schmidt, T; Aartsma, TJ (corresponding author), Leiden Univ, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands.	schmidt@physics.leidenuniv.nl; aartsma@physics.leidenuniv.nl	Subramaniam, Vinod/B-4197-2010; Schmidt, Thomas/B-6296-2009	Subramaniam, Vinod/0000-0001-6712-7266; Schmidt, Thomas/0000-0002-0045-1851; Harkes, Rolf/0000-0001-6592-654X				Bahr BA, 2002, J NEUROCHEM, V83, P481, DOI 10.1046/j.1471-4159.2002.01192.x; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Devic I, 2011, BRAIN, V134, DOI 10.1093/brain/awr015; Duim WC, 2011, CHEMPHYSCHEM, V12, P2386, DOI 10.1002/cphc.201100392; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Esbjorner EK, 2014, CHEM BIOL, V21, P732, DOI 10.1016/j.chembiol.2014.03.014; Freeman D, 2012, PLOS ONE, V8; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; Roberti MJ, 2012, BIOPHYS J, V102, P1598, DOI 10.1016/j.bpj.2012.03.010; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; NIXON RA, 1995, TRENDS NEUROSCI, V18, P489, DOI 10.1016/0166-2236(95)92772-I; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Pinotsi D, 2014, NANO LETT, V14, P339, DOI 10.1021/nl4041093; Ries J, 2013, ACS CHEM NEUROSCI, V4, P1057, DOI 10.1021/cn400091m; Sahl SJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00895; Schierle GSK, 2011, J AM CHEM SOC, V133, P12902, DOI 10.1021/ja201651w; Schmidt T, 1996, P NATL ACAD SCI USA, V93, P2926, DOI 10.1073/pnas.93.7.2926; Sidhu A, 2014, BBA-PROTEINS PROTEOM, V1844, P2127, DOI 10.1016/j.bbapap.2014.09.007; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung JY, 2001, J BIOL CHEM, P276; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Waxman EA, 2010, J NEUROCHEM, V113, P374, DOI 10.1111/j.1471-4159.2010.06592.x	31	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153020	10.1371/journal.pone.0153020	http://dx.doi.org/10.1371/journal.pone.0153020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105068	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100007
J	Lauks, J; Mramor, B; Baumgartl, K; Maier, H; Nickel, CH; Bingisser, R				Lauks, Juliane; Mramor, Blaz; Baumgartl, Klaus; Maier, Heinrich; Nickel, Christian H.; Bingisser, Roland			Medical Team Evaluation: Effect on Emergency Department Waiting Time and Length of Stay	PLOS ONE			English	Article							PATIENT SATISFACTION; HOSPITAL ADMISSION; SEVERITY INDEX; TRIAGE; IMPACT; PHYSICIAN; THROUGHPUT; CARE; REGISTRATION; ASSOCIATION	Emergency Departments (ED) are trying to alleviate crowding using various interventions. We assessed the effect of an alternative model of care, the Medical Team Evaluation (MTE) concept, encompassing team triage, quick registration, redesign of triage rooms and electronic medical records (EMR) on door-to-doctor (waiting) time and ED length of stay (LOS). We conducted an observational, before-and-after study at an urban academic tertiary care centre. On July 17th 2014, MTE was initiated from 9: 00 a.m. to 10 p.m., 7 days a week. A registered triage nurse was teamed with an additional senior ED physician. Data of the 5-month pre-MTE and the 5-month MTE period were analysed. A matched comparison of waiting times and ED LOS of discharged and admitted patients pertaining to various Emergency Severity Index (ESI) triage categories was performed based on propensity scores. With MTE, the median waiting times improved from 41.2 (24.8-66.6) to 10.2 (5.7-18.1) minutes (min; P < 0.01). Though being beneficial for all strata, the improvement was somewhat greater for discharged, than for admitted patients. With a reduction from 54.3 (34.2-84.7) to 10.5 (5.9-18.4) min (P < 0.01), in terms of waiting times, MTE was most advantageous for ESI4 patients. The overall median ED LOS increased for about 15 min (P < 0.01), increasing from 3.4 (2.1-5.3) to 3.7 (2.3-5.6) hours. A significant increase was observed for all the strata, except for ESI5 patients. Their median ED LOS dropped by 73% from 1.2 (0.8-1.8) to 0.3 (0.2-0.5) hours (P < 0.01). In the same period the total orders for diagnostic radiology increased by 1,178 (11%) from 10,924 to 12,102 orders, with more imaging tests being ordered for ESI 2, 3 and 4 patients. Despite improved waiting times a decrease of ED LOS was only seen in ESI level 5 patients, whereas in all the other strata ED LOS increased. We speculate that this was brought about by the tendency of triage physicians to order more diagnostic radiology, anticipating that it may be better for the downstream physician to have more information rather than less.	[Lauks, Juliane; Baumgartl, Klaus; Maier, Heinrich] Univ Basel Hosp, Dept Informat & Commun Technol, CH-4031 Basel, Switzerland; [Mramor, Blaz] Univ Freiburg, Freiburg Inst Adv Studies, Hugstetter Str 55, D-79106 Freiburg, Germany; [Nickel, Christian H.; Bingisser, Roland] Univ Basel Hosp, Emergency Dept, CH-4031 Basel, Switzerland	University of Basel; University of Freiburg; University of Basel	Bingisser, R (corresponding author), Univ Basel Hosp, Emergency Dept, CH-4031 Basel, Switzerland.	roland.bingisser@usb.ch			University of Basel Hospital	University of Basel Hospital	The research was funded by scientific funds of the University of Basel Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulwahid MA, 2016, EMERG MED J, V33, P504, DOI 10.1136/emermed-2014-204388; Asaro PV, 2007, ACAD EMERG MED, V14, P235, DOI 10.1197/j.aem.2006.10.104; Asha SE, 2013, EMERG MED AUSTRALAS, V25, P445, DOI 10.1111/1742-6723.12128; Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Beglinger B, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000374; Boudreaux ED, 2004, ACAD EMERG MED, V11, P51, DOI 10.1197/S1069-6563(03)00584-0; Boyle A, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/838610; Chan TC, 2005, ANN EMERG MED, V46, P491, DOI 10.1016/j.annemergmed.2005.06.013; Cheng I, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-17; Choi YF, 2006, EMERG MED J, V23, P262, DOI 10.1136/emj.2005.025254; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Davis RA, 2014, EMERG MED AUSTRALAS, V26, P343, DOI 10.1111/1742-6723.12256; Di Somma S, 2015, INTERN EMERG MED, V10, P171, DOI 10.1007/s11739-014-1154-8; Diercks DB, 2007, ANN EMERG MED, V50, P489, DOI 10.1016/j.annemergmed.2007.03.033; Foley M, 2011, WEST J EMERG MED, V12, P192; Gordon BD, 2008, ANN EMERG MED, V52, P504, DOI 10.1016/j.annemergmed.2007.11.036; Gorelick MH, 2005, ANN EMERG MED, V45, P128, DOI 10.1016/j.annemergmed.2004.08.041; Gorlicki J, 2015, EUR J EMERG MED, V22, P366, DOI 10.1097/MEJ.0000000000000232; Grant S, 1999, EMERGEN MED, V11, p72?7, DOI DOI 10.1046/J.1442-2026.1999.00017.X; Green NA, 2012, PEDIATR EMERG CARE, V28, P753, DOI 10.1097/PEC.0b013e3182621813; Grossmann FF, 2011, ANN EMERG MED, V57, P257, DOI 10.1016/j.annemergmed.2010.07.021; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; Han JH, 2010, J EMERG MED, V39, P227, DOI 10.1016/j.jemermed.2008.10.006; Henderson K, 2014, BRIT J HOSP MED, V75, P623, DOI 10.12968/hmed.2014.75.11.623; Holden D., 1999, EMERGEN MED, V11, P3, DOI [10.1046/j.1442-2026.1999.03114.x, DOI 10.1046/J.1442-2026.1999.03114.X]; Holroyd BR, 2007, ACAD EMERG MED, V14, P702, DOI 10.1197/j.aem.2007.04.018; Hwang U, 2011, ACAD EMERG MED, V18, P526, DOI 10.1111/j.1553-2712.2011.01054.x; KROCHMAL P, 1994, AM J EMERG MED, V12, P265, DOI 10.1016/0735-6757(94)90135-X; Levsky ME, 2008, MIL MED, V173, P999, DOI 10.7205/MILMED.173.10.999; Mackway-Jones K, 1997, MANCHESTER TRIAGE GR; Murrell KL, 2011, WEST J EMERG MED, V12, P184; Nestler DM, 2014, ACAD EMERG MED, V21, P794, DOI 10.1111/acem.12416; Nestler DM, 2012, ACAD EMERG MED, V19, P1235, DOI 10.1111/acem.12010; Partovi SN, 2001, ACAD EMERG MED, V8, P990, DOI 10.1111/j.1553-2712.2001.tb01099.x; Pines JM, 2008, ACAD EMERG MED, V15, P825, DOI 10.1111/j.1553-2712.2008.00200.x; Pines JM, 2011, ACAD EMERG MED, V18, P1358, DOI 10.1111/j.1553-2712.2011.01235.x; Quitt J, 2009, EUR J EMERG MED, V16, P172, DOI 10.1097/MEJ.0b013e32830c2193; Richardson DB, 2006, MED J AUSTRALIA, V184, P213, DOI 10.5694/j.1326-5377.2006.tb00204.x; Richardson DB, 2002, MED J AUSTRALIA, V177, P492, DOI 10.5694/j.1326-5377.2002.tb04917.x; Richardson Joanna R, 2004, Emerg Med Australas, V16, P41, DOI 10.1111/j.1742-6723.2004.00541.x; Rogers Tessa, 2004, Accid Emerg Nurs, V12, P24, DOI 10.1016/j.aaen.2003.08.005; Rohacek M, 2015, INT J CLIN PRACT, V69, P710, DOI 10.1111/ijcp.12606; Rowe BH, 2011, ACAD EMERG MED, V18, P111, DOI 10.1111/j.1553-2712.2010.00984.x; Russ S, 2010, ANN EMERG MED, V56, P27, DOI 10.1016/j.annemergmed.2010.02.006; Sinreich David, 2005, J Health Organ Manag, V19, P88, DOI 10.1108/14777260510600022; Subash F, 2004, EMERG MED J, V21, P542, DOI 10.1136/emj.2002.003665; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026; Takakuwa KM, 2007, J EMERG MED, V32, P337, DOI 10.1016/j.jemermed.2006.07.031; Terris J, 2004, EMERG MED J, V21, P537, DOI 10.1136/emj.2002.003913; Traub SJ, 2015, J EMERG MED, V48, P620, DOI 10.1016/j.jemermed.2014.12.025; Travers JP, 2006, EUR J EMERG MED, V13, P342; Wiler JL, 2010, ANN EMERG MED, V55, P142, DOI 10.1016/j.annemergmed.2009.05.021; Wiswell J, 2013, AM J EMERG MED, V31, P1448, DOI 10.1016/j.ajem.2013.07.018; Wuerz RC, 2000, ACAD EMERG MED, V7, P236, DOI 10.1111/j.1553-2712.2000.tb01066.x	54	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154372	10.1371/journal.pone.0154372	http://dx.doi.org/10.1371/journal.pone.0154372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104911	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100069
J	Lindsay, T; Valdes, A				Lindsay, Tabitha; Valdes, Angel			The Model Organism Hermissenda crassicornis (Gastropoda: Heterobranchia) Is a Species Complex	PLOS ONE			English	Article							MOLLUSK; NUDIBRANCHIA; NETWORK; OPISTHOBRANCHIA; GLAUCIDAE; BEHAVIOR; GROWTH	Hermissenda crassicornis is a model organism used in various fields of research including neurology, ecology, pharmacology, and toxicology. In order to investigate the systematics of this species and the presence of cryptic species in H. crassicornis, we conducted a comprehensive molecular and morphological analysis of this species covering its entire range across the North Pacific Ocean. We determined that H. crassicornis constitutes a species complex of three distinct species. The name Hermissensa crassicornis is retained for the northeast Pacific species, occurring from Alaska to Northern California. The name H. opalescens is reinstated for a species occurring from the Sea of Cortez to Northern California. Finally, the name H. emurai is maintained for the northwestern species, found in Japan and in the Russian Far East. These three species have consistent morphological and color pattern differences that can be used for identification in the field.	[Lindsay, Tabitha; Valdes, Angel] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona	Valdes, A (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	aavaldes@cpp.edu	Valdes, Angel/Q-1729-2018	Valdes, Angel/0000-0002-2347-4896	California State University Program for Education and Research in Biotechnology; Prete Foundation; Conchologists of America; California State Polytechnic University	California State University Program for Education and Research in Biotechnology; Prete Foundation; Conchologists of America; California State Polytechnic University	Funded by California State University Program for Education and Research in Biotechnology (http://www.calstate.edu/csuperb/) to AV, Prete Foundation to TL, Conchologists of America (http://www.conchologistsofamerica.org/home/) to TL, and the California State Polytechnic University (http://www.cpp.edu/) to TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Avila C, 1998, MAR FRESHW BEHAV PHY, V31, P1, DOI 10.1080/10236249809387059; Avila C, 1997, J EXP MAR BIOL ECOL, V218, P243, DOI 10.1016/S0022-0981(97)00077-4; AVILA C, 1994, BIOL BULL, V187, P252, DOI 10.1086/BBLv187n2p252; Baba K., 1937, J DEP AGR KYUSHU IMP, V5, P289; Behrens D.W., 2005, E PACIFIC NUDIBRANCH; Bergh R., 1878, VERH ZOOL BOT GES WI, V28, P553; Bergh R., 1879, P ACAD NAT SCI PHILA, V2, P71; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blackwell Kim T., 2006, Anatomical Record Part B:The New Anatomist, V289, P25, DOI 10.1002/ar.b.20090; Blackwell KT, 2000, J COMPUT NEUROSCI, V9, P149, DOI 10.1023/A:1008919924579; BUCHANAN J, 1986, J ULTRA MOL STRUCT R, V94, P52, DOI 10.1016/0889-1605(86)90051-0; Carmona L, 2014, ZOOL J LINN SOC-LOND, V170, P132, DOI 10.1111/zoj12098; Carmona L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063000; Churchill CKC, 2014, INVERTEBR SYST, V28, P174, DOI 10.1071/IS13038; Churchill CKC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1224; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cockerell T. D. A., 1905, Journal of Malacology, Vxii, P31; Cockerell TDA, 1901, J MALACOLOGY, V8, P121; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Cooper, 1863, P CALIFORNIA ACAD NA, V2, P202; Cooper J. G., 1863, P CALIFORNIA ACAD SC, V3, P56; Cooper JG, 1862, P CAL ACAD NAT SCI, V2, P207; Crow T, 2013, J NEUROPHYSIOL, V109, P640, DOI 10.1152/jn.00803.2012; CROW TJ, 1980, SCIENCE, V209, P412, DOI 10.1126/science.209.4454.412; CROW TJ, 1978, SCIENCE, V201, P1239, DOI 10.1126/science.694512; de Carvalho MR, 2005, SCIENCE, V307, P353; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; EAKIN RM, 1967, J CELL SCI, V2, P349; Epstein DA, 2000, BIOL BULL, V199, P182, DOI 10.2307/1542887; Eschscholtz JF, 1831, ZOOLOGISCHER ATLAS B; ETCHEBERRIGARAY R, 1992, P NATL ACAD SCI USA, V89, P7184, DOI 10.1073/pnas.89.15.7184; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; HODGE AJ, 1980, J ULTRA MOL STRUCT R, V70, P220, DOI 10.1016/S0022-5320(80)80007-4; Kasheverov IE, 2015, MAR DRUGS, V13, P1255, DOI 10.3390/md13031255; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; LEDERHENDLER II, 1986, J NEUROSCI, V6, P1325; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; MCDONALD GR, 1983, MALACOLOGIA, V24, P114; MILLER MC, 1974, ZOOL J LINN SOC-LOND, V54, P31, DOI 10.1111/j.1096-3642.1974.tb00792.x; O'Donoghue C. H., 1921, Transactions of the Canadian Institute, V13, P147; O'Donoghue C. H., 1922, Transactions of the Canadian Institute, V14, P123; O'Donoghue C. H., 1922, Nautilus Boston Mass, V35, P74; ODonoghue C. H., 1922, Transactions of the Canadian Institute, V14, P131; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Pola M, 2012, ZOOL J LINN SOC-LOND, V165, P311, DOI 10.1111/j.1096-3642.2012.00816.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; RAM JL, 1988, BEHAV NEURAL BIOL, V49, P97, DOI 10.1016/S0163-1047(88)91282-4; RICHARDS WG, 1987, BRAIN RES BULL, V19, P175, DOI 10.1016/0361-9230(87)90083-9; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Scotland Robert, 2003, Systematics and Biodiversity, V1, P139, DOI 10.1017/S1477200003001178; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TAKEDA T, 1982, VISION RES, V22, P303, DOI 10.1016/0042-6989(82)90130-4; TAMSE CT, 1994, BIOL BULL, V187, P251, DOI 10.1086/BBLv187n2p251; WERNESS SA, 1992, BIOL CYBERN, V68, P125, DOI 10.1007/BF00201434; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452; Wollscheid E, 1999, MOL PHYLOGENET EVOL, V13, P215, DOI 10.1006/mpev.1999.0664; YAMOAH EN, 1994, J NEUROPHYSIOL, V72, P2196, DOI 10.1152/jn.1994.72.5.2196; ZACK S, 1975, BEHAVIOUR, V53, P238, DOI 10.1163/156853975X00218	64	38	43	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154265	10.1371/journal.pone.0154265	http://dx.doi.org/10.1371/journal.pone.0154265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105319	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100063
J	Dou, HL; Yang, HT; Feng, LM; Mou, P; Wang, TM; Ge, JP				Dou, Hailong; Yang, Haitao; Feng, Limin; Mou, Pu; Wang, Tianming; Ge, Jianping			Estimating the Population Size and Genetic Diversity of Amur Tigers in Northeast China	PLOS ONE			English	Article							PANTHERA-TIGRIS-ALTAICA; NATIONAL NATURE-RESERVE; SIBERIAN TIGER; CONSERVATION; LANDSCAPE; HUNCHUN; DENSITY; LEOPARD; PREY; IDENTIFICATION	Over the past century, the endangered Amur tiger (Panthera tigris altaica) has experienced a severe contraction in demography and geographic range because of habitat loss, poaching, and prey depletion. In its historical home in Northeast China, there appears to be a single tiger population that includes tigers in Southwest Primorye and Northeast China; however, the current demographic status of this population is uncertain. Information on the abundance, distribution and genetic diversity of this population for assessing the efficacy of conservation interventions are scarce. We used noninvasive genetic detection data from scats, capture-recapture models and an accumulation curve method to estimate the abundance of Amur tigers in Northeast China. We identified 11 individual tigers (6 females and 5 males) using 10 microsatellite loci in three nature reserves between April 2013 and May 2015. These tigers are confined primarily to a Hunchun Nature Reserve along the border with Russia, with an estimated population abundance of 9-11 tigers during the winter of 2014-2015. They showed a low level of genetic diversity. The mean number of alleles per locus was 2.60 and expected and observed heterozygosity were 0.42 and 0.49, respectively. We also documented long-distance dispersal (similar to 270 km) of a male Amur tiger to Huangnihe Nature Reserve from the border, suggesting that the expansion of neighboring Russian populations may eventually help sustain Chinese populations. However, the small and isolated population recorded by this study demonstrate that there is an urgent need for more intensive regional management to create a tiger-permeable landscape and increased genetic connectivity with other populations.	[Wang, Tianming] Beijing Normal Univ, Key Lab Biodivers Sci & Engn, Minist Educ, Beijing 100875, Peoples R China; Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Wang, TM (corresponding author), Beijing Normal Univ, Key Lab Biodivers Sci & Engn, Minist Educ, Beijing 100875, Peoples R China.	wangtianming@bnu.edu.cn	Feng, Limin/G-9539-2014	Feng, Limin/0000-0001-9526-1681	National Natural Science Foundation of China [31470566, 31270567, 31210103911, 31421063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31470566, 31270567, 31210103911and 31421063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasaad S, 2011, MAMM BIOL, V76, P722, DOI 10.1016/j.mambio.2011.01.011; Anuradha Reddy P, 2012, CONSERV GENET, V13, P779, DOI 10.1007/s10592-012-0326-1; Banks SC, 2003, ANIM CONSERV, V6, P101, DOI 10.1017/S1367943003003135; Caragiulo A, 2015, ORYX, V49, P632, DOI 10.1017/S0030605314000817; Chen Jiu-Yi, 2011, Chinese Journal of Zoology, V46, P46; Dunishenko, 2006, SURVEY AMUR SIBERIAN; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Gopalaswamy AM, 2012, ECOLOGY, V93, P1741, DOI 10.1890/11-2110.1; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hebblewhite M, 2012, ANIM CONSERV, V15, P579, DOI 10.1111/j.1469-1795.2012.00552.x; Henry P, 2009, MOL ECOL, V18, P3173, DOI 10.1111/j.1365-294X.2009.04266.x; Hernandez-Blanco JA, 2015, INTEGR ZOOL, V10, P365, DOI 10.1111/1749-4877.12140; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Joshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077980; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Kohn MH, 1999, P ROY SOC B-BIOL SCI, V266, P657, DOI 10.1098/rspb.1999.0686; Linkie M, 2008, BIOL CONSERV, V141, P2410, DOI 10.1016/j.biocon.2008.07.002; Liu D, 2013, CHINESE SCI BULL, V58, P2230, DOI 10.1007/s11434-013-5722-5; Luo SJ, 2010, INTEGR ZOOL, V5, P351, DOI 10.1111/j.1749-4877.2010.00222.x; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; McDonald T., 2015, MRA ANAL MARK RECAPT; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Miquelle DG, 2015, INTEGR ZOOL, V10, P389, DOI 10.1111/1749-4877.12146; Miquelle DG, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P403, DOI 10.1016/B978-0-8155-1570-8.00032-3; Miquelle Dale G., 2010, P325; Mondol S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000585; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029827; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Russello MA, 2004, CONSERV GENET, V5, P707, DOI 10.1007/s10592-004-1860-2; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; Singh SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118846; Soh YH, 2014, BIOL CONSERV, V169, P117, DOI 10.1016/j.biocon.2013.10.011; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Sollmann R, 2013, BIOL CONSERV, V167, P242, DOI 10.1016/j.biocon.2013.08.003; Sorokin PA, 2016, INTEGR ZOOL, V11, P25, DOI 10.1111/1749-4877.12175; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Stephens PA, 2015, J APPL ECOL, V52, P1, DOI 10.1111/1365-2664.12383; Sugimoto T, 2006, CONSERV GENET, V7, P799, DOI 10.1007/s10592-005-9071-z; Sugimoto T, 2014, CONSERV GENET, V15, P521, DOI 10.1007/s10592-013-0558-8; Sugimoto T, 2012, J MAMMAL, V93, P93, DOI 10.1644/10-MAMM-A-368.1; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tian Y, 2011, ECOL MODEL, V222, P3166, DOI 10.1016/j.ecolmodel.2011.06.003; Tian Yu, 2009, Shengwu Duoyangxing, V17, P211; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Wang TM, 2016, LANDSCAPE ECOL, V31, P491, DOI 10.1007/s10980-015-0278-1; Wang TM, 2015, ORYX, V49, P578, DOI 10.1017/S0030605315000794; Wang Tianming, 2014, Cat News, V61, P18; Wu Z., 2013, REPORT SPECIFIC SURV; Xiao Wenhong, 2014, Biodiversity Science, V22, P717, DOI 10.3724/SP.J.1003.2014.14184; Xiao WH, 2014, THESIS BEIJING NORMA; Zhou Shaochun, 2008, Acta Theriologica Sinica, V28, P165	53	19	27	2	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154254	10.1371/journal.pone.0154254	http://dx.doi.org/10.1371/journal.pone.0154254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100387	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500173
J	Lee-Miller, T; Marneweck, M; Santello, M; Gordon, AM				Lee-Miller, Trevor; Marneweck, Michelle; Santello, Marco; Gordon, Andrew M.			Visual Cues of Object Properties Differentially Affect Anticipatory Planning of Digit Forces and Placement	PLOS ONE			English	Article							CENTER-OF-MASS; MEMORY REPRESENTATIONS; SENSORIMOTOR MEMORY; PRECISION GRIP; MANIPULATION; WEIGHT; INFORMATION; ADAPTATION; POSITIONS; REVEALS	Studies on anticipatory planning of object manipulation showed initial task failure (i.e., object roll) when visual object shape cues are incongruent with other visual cues, such as weight distribution/density (e.g., symmetrically shaped object with an asymmetrical density). This suggests that shape cues override density cues. However, these studies typically only measured forces, with digit placement constrained. Recent evidence suggests that when digit placement is unconstrained, subjects modulate digit forces and placement. Thus, unconstrained digit placement might be modulated on initial trials (since it is an explicit process), but not forces (since it is an implicit process). We tested whether shape and density cues would differentially influence anticipatory planning of digit placement and forces during initial trials of a two-digit object manipulation task. Furthermore, we tested whether shape cues would override density cues when cues are incongruent. Subjects grasped and lifted an object with the aim of preventing roll. In Experiment 1, the object was symmetrically shaped, but with asymmetrical density (incongruent cues). In Experiment 2, the object was asymmetrical in shape and density (congruent cues). In Experiment 3, the object was asymmetrically shaped, but with symmetrical density (incongruent cues). Results showed differential modulation of digit placement and forces (modulation of load force but not placement), but only when shape and density cues were congruent. When shape and density cues were incongruent, we found collinear digit placement and symmetrical force sharing. This suggests that congruent and incongruent shape and density cues differentially influence anticipatory planning of digit forces and placement. Furthermore, shape cues do not always override density cues. A continuum of visual cues, such as those alluding to shape and density, need to be integrated.	[Lee-Miller, Trevor; Marneweck, Michelle; Gordon, Andrew M.] Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA; [Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA	Columbia University; Columbia University Teachers College; Arizona State University; Arizona State University-Tempe	Gordon, AM (corresponding author), Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA.	ag275@columbia.edu		Marneweck, Michelle/0000-0002-3953-5956; Gordon, Andrew/0000-0003-1041-0479	National Science Foundation (NSF) [BCS-1153034, BCS 1152916]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research was supported by a Collaborative Research Grant BCS-1153034 (MS) and BCS 1152916 (AG) from the National Science Foundation (NSF; http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINGHAM GP, 1993, PERCEPT PSYCHOPHYS, V54, P617, DOI 10.3758/BF03211785; Buckingham G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054709; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Bursztyn LLCD, 2008, EXP BRAIN RES, V184, P127, DOI 10.1007/s00221-007-1173-z; Chouinard PA, 2009, NEUROIMAGE, V48, P696, DOI 10.1016/j.neuroimage.2009.07.020; Craje C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076855; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Davare M, 2007, J NEUROSCI, V27, P3974, DOI 10.1523/JNEUROSCI.0426-07.2007; Fu QS, 2012, J NEUROSCI, V32, P15086, DOI 10.1523/JNEUROSCI.2468-12.2012; Fu QS, 2011, J NEUROSCI, V31, P13576, DOI 10.1523/JNEUROSCI.1143-11.2011; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; Gordon AM, 2004, IEMBS04, V2, P4641; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Ingram JN, 2010, CURR BIOL, V20, P618, DOI 10.1016/j.cub.2010.01.054; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Kroliczak G, 2008, J NEUROPHYSIOL, V100, P2627, DOI 10.1152/jn.01376.2007; Loh MN, 2010, J NEUROSCI, V30, P6984, DOI 10.1523/JNEUROSCI.6207-09.2010; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; Marneweck M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138258; Monaco S, 2014, CEREB CORTEX, V24, P1540, DOI 10.1093/cercor/bht006; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Salimi I, 2003, EXP BRAIN RES, V150, P9, DOI 10.1007/s00221-003-1394-8; Salimi I, 2000, J NEUROPHYSIOL, V84, P2390, DOI 10.1152/jn.2000.84.5.2390; Zhang W, 2010, J NEUROPHYSIOL, V103, P2953, DOI 10.1152/jn.00140.2010	28	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154033	10.1371/journal.pone.0154033	http://dx.doi.org/10.1371/journal.pone.0154033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100830	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500127
J	Shi, JJ; Chang, LW; Wang, J; Zhang, S; Yao, YH; Zhang, SX; Jiang, RF; Guo, LY; Guan, HX; Zhu, WZ				Shi, Jingjing; Chang, Liwen; Wang, Jian; Zhang, Shun; Yao, Yihao; Zhang, Shuixia; Jiang, Rifeng; Guo, Linying; Guan, Hanxiong; Zhu, Wenzhen			Initial Application of Diffusional Kurtosis Imaging in Evaluating Brain Development of Healthy Preterm Infants	PLOS ONE			English	Article							WHITE-MATTER DEVELOPMENT; LOW-BIRTH-WEIGHT; HUMAN FETAL; NERVOUS-SYSTEM; MATURATION; TRACTOGRAPHY; NEWBORNS; ABNORMALITIES; QUANTITATION; PARAMETERS	Objective To explore the parametric characteristics of diffusional kurtosis imaging (DKI) in the brain development of healthy preterm infants. Materials and Methods Conventional magnetic resonance imaging (MRI) and DKI were performed in 35 preterm (29 to 36 weeks gestational age [GA]; scanned at 33 to 44 weeks postmenstrual age [PMA]) and 10 term infants (37.4 to 40.7 weeks GA; scanned at 38.3 to 42.9 weeks PMA). Fractional anisotropy (FA), mean diffusivity (MD) and mean kurtosis (MK) values from 8 regions of interest, including both white matter (WM) and gray matter (GM), were obtained. Results MK and FA values were positively correlated with PMA in most selected WM regions, such as the posterior limbs of the internal capsule (PLIC) and the splenium of the corpus callosum (SCC). The positive correlation between MK value and PMA in the deep GM region was higher than that between FA and PMA. The MK value gradually decreased from the PLIC to the cerebral lobe. In addition, DKI parameters exhibited subtle differences in the parietal WM between the preterm and term control groups. Conclusions MK may serve as a more reliable imaging marker of the normal myelination process and provide a more robust characterization of deep GM maturation.	[Shi, Jingjing; Wang, Jian; Zhang, Shun; Yao, Yihao; Zhang, Shuixia; Jiang, Rifeng; Guo, Linying; Guan, Hanxiong; Zhu, Wenzhen] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Radiol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Chang, Liwen] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Ofneonatol, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Guan, HX; Zhu, WZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Radiol, Tongji Med Coll, Wuhan 430074, Peoples R China.	hxguan@tjh.tjmu.edu.cn; zhuwenzhen@hotmail.com		Zhang, Shun/0000-0002-0001-1880	National Program of the Ministry of Science and Technology of China [2011BAI08B10]; National Natural Science Foundation of China [81171308]	National Program of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Program of the Ministry of Science and Technology of China during the "12th Five-Year Plan" (2011BAI08B10) (http://www.most.gov.cn/index.htm), and The National Natural Science Foundation of China (81171308) (http://www.nsfc.gov.cn/).	Ball G, 2013, P NATL ACAD SCI USA, V110, P9541, DOI 10.1073/pnas.1301652110; Benitez A, 2014, NEUROIMAGE-CLIN, V4, P64, DOI 10.1016/j.nicl.2013.11.001; Broekman BFP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115229; Chau V, 2009, PEDIATRICS, V123, P319, DOI 10.1542/peds.2008-0283; Chen YY, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/820847; de Vries LS, 2013, NEURORADIOLOGY, V55, P13, DOI 10.1007/s00234-013-1233-y; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Gao Y, 2012, NMR BIOMED, V25, P1369, DOI 10.1002/nbm.2809; Geng XJ, 2012, NEUROIMAGE, V61, P542, DOI 10.1016/j.neuroimage.2012.03.057; Gimenez M, 2008, NEUROIMAGE, V41, P728, DOI 10.1016/j.neuroimage.2008.02.029; Glenn GR, 2015, NMR BIOMED, V28, P1245, DOI 10.1002/nbm.3374; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Hui ES, 2015, NEUROIMAGE, V106, P391, DOI 10.1016/j.neuroimage.2014.11.015; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Hui ES, 2008, IEEE ENG MED BIO, P3941, DOI 10.1109/IEMBS.2008.4650072; Huppi PS, 1998, PEDIATR RES, V44, P584; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Kolasinski J, 2013, NEUROIMAGE, V79, P412, DOI 10.1016/j.neuroimage.2013.04.125; Ling XY, 2013, EUR J RADIOL, V82, pE476, DOI 10.1016/j.ejrad.2013.04.003; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; O'Rahilly R, 1999, TERATOLOGY, V60, P39, DOI 10.1002/(SICI)1096-9926(199907)60:1<39::AID-TERA11>3.0.CO;2-I; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Paydar A, 2014, AM J NEURORADIOL, V35, P808, DOI 10.3174/ajnr.A3764; Rodrigues K, 2011, NEUROIMAG CLIN N AM, V21, P127, DOI 10.1016/j.nic.2011.01.012; Rose SE, 2008, MAGN RESON MED, V60, P761, DOI 10.1002/mrm.21689; Shimony JS, 1999, RADIOLOGY, V212, P770, DOI 10.1148/radiology.212.3.r99au51770; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Veraart J, 2011, MAGN RESON MED, V65, P138, DOI 10.1002/mrm.22603; Weber RA, 2015, STROKE, V46, P545, DOI 10.1161/STROKEAHA.114.006782; Xu G, 2014, CEREB CORTEX, V24, P579, DOI 10.1093/cercor/bhs330; Yoshida S, 2013, PEDIATR RADIOL, V43, P15, DOI 10.1007/s00247-012-2496-x	39	7	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154146	10.1371/journal.pone.0154146	http://dx.doi.org/10.1371/journal.pone.0154146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101246	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500155
J	Esposito, F; Angileri, FF; Kruse, P; Cavallo, LM; Solari, D; Esposito, V; Tomasello, F; Cappabianca, P				Esposito, Felice; Angileri, Filippo Flavio; Kruse, Peter; Cavallo, Luigi Maria; Solari, Domenico; Esposito, Vincenzo; Tomasello, Francesco; Cappabianca, Paolo			Fibrin Sealants in Dura Sealing: A Systematic Literature Review	PLOS ONE			English	Review							CEREBROSPINAL-FLUID LEAK; COLLAGEN-ONLY BIOMATRIX; TRANSSPHENOIDAL SURGERY; ALLERGIC REACTION; MATER SUBSTITUTE; TISSUE ADHESIVE; SELLAR REPAIR; GLUE; PREVENTION; MANAGEMENT	Background Fibrin sealants are widely used in neurosurgery to seal the suture line, provide watertight closure, and prevent cerebrospinal fluid leaks. The aim of this systematic review is to summarize the current efficacy and safety literature of fibrin sealants in dura sealing and the prevention/treatment of cerebrospinal fluid leaks. Methods A comprehensive electronic literature search was run in the following databases: Cochrane Database of Systematic Reviews, Cochrane Central Resister of Controlled Trials, clinical-trials.gov, MEDLINE/PubMed, and EMBASE. Titles and abstracts of potential articles of interest were reviewed independently by 3 of the authors. Results A total of 1006 database records and additional records were identified. After screening for duplicates and relevance, a total of 78 articles were assessed by the investigators for eligibility. Thirty-eight were excluded and the full-text of 40 articles were included in the qualitative synthesis. Seven of these included only safety data and were included in the safety assessment. The remaining 33 articles included findings from 32 studies that enrolled a total of 2935 patients who were exposed to fibrin sealant. Among these 33 studies there were only 3 randomized controlled trials, with the remaining being prospective cohort analysis, case controlled studies, prospective or retrospective case series. One randomized controlled trial, with 89 patients exposed to fibrin sealant, found a greater rate of intraoperative watertight dura closure in the fibrin sealant group than the control group (92.1% versus 38.0%, p<0.001); however, post-operative cerebrospinal fluid leakage occurred in more fibrin sealant than control patients (6.7% versus 2.0%, p>0.05). Other clinical trials evaluated the effect of fibrin sealant in the postoperative prevention of cerebrospinal fluid leaks. These were generally lower level evidence studies (ie, not prospective, randomized, controlled trials) that were not designed or powered to demonstrate a significant advantage to fibrin sealant use. Two small case series studies evaluated the effect of fibrin sealants in persistent cerebrospinal fluid leak treatment, but did not establish firm efficacy conclusions. Specific adverse reports where fibrin sealants were used for dura sealing were limited, with only 8 cases reported in neurosurgical procedures since 1987 and most reporting only a speculative relationship/association with fibrin sealant exposure. Conclusions A major finding of this systematic literature review is that there is a paucity of randomized studies that have evaluated the effectiveness and safety of fibrin sealants in providing intraoperative watertight dura closure and post-operative cerebrospinal fluid leakage. Among the limited studies available, evidence from a single randomized, controlled trial indicates that fibrin sealants provide a higher rate of intraoperative watertight closure of the dura suture line than control, albeit with a higher rate of postoperative cerebrospinal fluid leakage. Evidence from non-randomized, controlled trials suggests that fibrin sealants may be effective in preventing cerebrospinal fluid leaks with an acceptable safety profile. There is a substantial need for randomized, controlled clinical trials or well-designed prospective observational trials where the conduct of a randomized trial is not feasible to fully assess the impact of fibrin sealant utilization on the rates of intraoperative dura closure, postoperative cerebrospinal leakage, and safety.	[Esposito, Felice; Angileri, Filippo Flavio; Tomasello, Francesco] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Div Neurosurg, Messina, Italy; [Cavallo, Luigi Maria; Solari, Domenico; Cappabianca, Paolo] Univ Naples Federico II, Dept Neurosci & Odontostomatol & Reprod Sci, Div Neurosurg, Naples, Italy; [Esposito, Vincenzo] Univ Roma La Sapienza, Div Neurosurg, Piazzale Aldo Moro 5, I-00185 Rome, Italy	University of Messina; University of Naples Federico II; Sapienza University Rome	Esposito, F (corresponding author), Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Div Neurosurg, Messina, Italy.	fesposito@unime.it	Angileri, Filippo/AAL-4851-2021; Esposito, Felice/F-4238-2012; Esposito, Felice/AAC-4646-2019; Angileri, Filippo Flavio/J-3533-2012; Esposito, Vincenzo/E-9994-2011; Angileri, Filippo/N-8556-2019	Esposito, Felice/0000-0003-1051-5924; Esposito, Felice/0000-0003-1051-5924; Angileri, Filippo Flavio/0000-0002-1107-4115; Esposito, Vincenzo/0000-0001-7316-5461; Angileri, Filippo/0000-0002-1107-4115; Esposito, Vincenzo/0000-0002-0647-5619	Baxter Italy	Baxter Italy	Dr. Felice Esposito received an unrestricted research grant from Baxter Italy and has given some didactic presentations on Dural Sealing methods. Dr. Paolo Cappabianca received an unrestricted research grant from Baxter Italy and has given some didactic presentations on Dural Sealing methods. Dr. Peter Kruse was paid for this structured literature review as an independent clinical consultant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Felice Esposito has given some didactic presentations on Dural Sealing methods. Paolo Cappabianca received an unrestricted research grant from Baxter Italy and has given some didactic presentations on Dural Sealing methods. Peter Kruse was paid for this structured literature review as an independent clinical consultant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KP, 2012, J NEUROL SURG PART B, V73, P401, DOI 10.1055/s-0032-1329618; Altomare DF, 2011, COLORECTAL DIS, V13, P82, DOI 10.1111/j.1463-1318.2009.02056.x; [Anonymous], 2013, TISSEEL PACKAGE INSE; [Anonymous], 2009, OXFORD CTR EVIDENCE; Becker SS, 2003, OTOL NEUROTOL, V24, P107, DOI 10.1097/00129492-200301000-00021; Beierlein W, 2000, TRANSFUSION, V40, P302, DOI 10.1046/j.1537-2995.2000.40030302.x; Biroli Francesco, 2008, Neurosurgery, V62, P273, DOI 10.1227/01.neu.0000317404.31336.69; Black P, 2002, J NEUROSURG, V96, P250, DOI 10.3171/spi.2002.96.2.0250; Cappabianca P, 2006, SURG NEUROL, V65, P144, DOI 10.1016/j.surneu.2005.08.023; Cappabianca P, 2004, SURG NEUROL, V62, P227, DOI 10.1016/j.surneu.2004.01.016; Cappabianca P, 2002, NEUROSURGERY, V51, P1365, DOI 10.1227/01.NEU.0000035904.77559.9F; Cappabianca P, 2010, ACTA NEUROCHIR, V152, P897, DOI 10.1007/s00701-009-0580-2; Carless PA, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004171; Cassano M, 2009, RHINOLOGY, V47, P362, DOI 10.4193/Rhin08.175; Cavallo LM, 2013, TRANSL MED UNISA, V7, P23; Cavallo LM, 2007, J NEUROSURG, V107, P713, DOI 10.3171/JNS-07/10/0713; Cho JM, 2011, NEUROSURGERY, V68, DOI 10.1227/NEU.0b013e318207b4ea; Czepko Ryszard, 2006, Polim Med, V36, P3; DANDREA AA, 1994, ITAL J GASTROENTEROL, V26, P283; Esposito F, 2008, CLIN NEUROL NEUROSUR, V110, P343, DOI 10.1016/j.clineuro.2007.12.016; Esposito F, 2013, CLIN NEUROL NEUROSUR, V115, P1735, DOI 10.1016/j.clineuro.2013.03.013; Felema GG, 2013, PEDIATR ANESTH, V23, P754, DOI 10.1111/pan.12180; Gazzeri R, 2011, WORLD NEUROSURG, V76, P173, DOI 10.1016/j.wneu.2010.09.029; Gazzeri R, 2009, ACTA NEUROCHIR, V151, P537, DOI 10.1007/s00701-009-0290-9; GILLMAN GS, 1995, J OTOLARYNGOL, V24, P191; Gonfiotti A, 2011, ANN THORAC SURG, V92, P1217, DOI 10.1016/j.athoracsur.2011.05.104; Gopal SC, 2008, J PEDIATR SURG, V43, P1869, DOI 10.1016/j.jpedsurg.2008.04.022; Green Alexander L, 2015, Br J Neurosurg, V29, P11, DOI 10.3109/02688697.2014.948808; Grimaud JC, 2010, GASTROENTEROLOGY, V138, P2275, DOI 10.1053/j.gastro.2010.02.013; Handa J, 1989, Nihon Geka Hokan, V58, P231; Hida K, 2006, SURG NEUROL, V65, P136, DOI 10.1016/j.surneu.2005.07.059; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hobbs CGL, 2011, J LARYNGOL OTOL, V125, P311, DOI 10.1017/S0022215110002483; Jankowitz BT, 2009, EUR SPINE J, V18, P1169, DOI 10.1007/s00586-009-0928-6; Kanazawa R, 2010, NEUROL MED-CHIR, V50, P608, DOI 10.2176/nmc.50.608; Kassam A, 2003, NEUROSURGERY, V52, P1102, DOI 10.1227/01.NEU.0000057699.37541.76; Kurschel S, 2007, CHILD NERV SYST, V23, P521, DOI 10.1007/s00381-006-0278-1; Lago Oliver J, 2010, CIR ESPAN, V90, P647; Lindsey I, 2002, DIS COLON RECTUM, V45, P1608, DOI 10.1007/s10350-004-7247-0; Mansouri A, 2016, J NEUROSURG, V124, P558, DOI 10.3171/2014.12.JNS142465; Merkus P, 2010, OTOL NEUROTOL, V31, P276, DOI 10.1097/MAO.0b013e3181cc06ad; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Murai Y, 2014, WORLD NEUROSURG, V81, P344, DOI 10.1016/j.wneu.2013.01.032; Nakamura H, 2005, SPINE, V30, pE347, DOI 10.1097/01.brs.0000167820.54413.8e; Nistor RF, 1997, SKULL BASE SURG, V7, P23, DOI 10.1055/s-2008-1058620; Parker SR, 2011, J NEUROSURG-PEDIATR, V8, P177, DOI 10.3171/2011.5.PEDS10362; Parlato C, 2011, ACTA NEUROCHIR, V153, P142, DOI 10.1007/s00701-010-0718-2; Reddy M, 2002, ACTA NEUROCHIR, V144, P265, DOI 10.1007/s007010200034; Reddy M, 2003, EUR SURG, V35, P278; Safan A, 2009, NEUROUROL URODYNAM, V28, P438, DOI 10.1002/nau.20754; SCHLENKER M, 1987, J NEUROL NEUROSUR PS, V50, P1715, DOI 10.1136/jnnp.50.12.1715; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Seda L, 2006, SURG NEUROL, V66, P46, DOI 10.1016/j.surneu.2005.10.021; Silecchia G, 2006, OBES SURG, V16, P125, DOI 10.1381/096089206775565249; Spotnitz WD, 2012, TRANSFUSION, V52, P2243, DOI 10.1111/j.1537-2995.2012.03707.x; SUZUKI Y, 1995, ARCH SURG-CHICAGO, V130, P952; Tamasauskas A, 2008, MEDICINA-LITHUANIA, V44, P302, DOI 10.3390/medicina44040039; Than KD, 2008, NEUROSURGERY, V63, P182, DOI 10.1227/01.NEU.0000313116.28200.67; Upadhyaya VD, 2007, WORLD J SURG, V31, P2412, DOI 10.1007/s00268-007-9244-7; VANVELTHOVEN V, 1991, ACTA NEUROCHIR, V109, P26, DOI 10.1007/BF01405692; Wakamoto H, 2002, NEUROL SURG TOKYO, V30, P1331; Weber R, 1996, ARCH OTOLARYNGOL, V122, P732; Yin Jian, 2005, Chinese Medical Sciences Journal, V20, P198; Yoshimoto Tetsuyuki, 1997, Neurologia Medico-Chirurgica, V37, P886, DOI 10.2176/nmc.37.886; Yu FB, 2015, J SPINAL DISORD TECH, V28, P389, DOI 10.1097/BSD.0000000000000031	65	49	52	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0151533	10.1371/journal.pone.0151533	http://dx.doi.org/10.1371/journal.pone.0151533			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119993	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200005
J	Guntinas-Lichius, O; Geissler, K; Komann, M; Schlattmann, P; Meissner, W				Guntinas-Lichius, Orlando; Geissler, Katharina; Komann, Marcus; Schlattmann, Peter; Meissner, Winfried			Inter-Hospital Variability of Postoperative Pain after Tonsillectomy: Prospective Registry-Based Multicentre Cohort Study	PLOS ONE			English	Article							OTO-RHINO-LARYNGOLOGY; QUALITY IMPROVEMENT; SURGERY; PREDICTORS; PERCEPTION; MANAGEMENT; GUIDELINES; WOMEN; HEAD	Objectives Although tonsillectomy is one of the most frequent and painful surgeries, the association between baseline and process parameters and postoperative pain are not fully understood. Methods A multicentre prospective cohort study using a web-based registry enrolled 1,527 women and 1,008 men aged 4 to 85 years from 52 German hospitals between 2006 and 2015. Maximal pain (MP) score the first day after surgery on a numeric rating scale (NRS) from 0 (no pain) to 10 (MP) was the main outcome parameter. Results The mean maximal pain score was 5.8 +/- 2.2 (median 6). Multivariable analysis revealed that female gender (Odds ratio [OR] = 1.33; 95% confidence interval [CI] = 1.12 to 1.56; p = 0.001), age <20 years (OR = 1.56; CI = 1.27 to 1.91; p<0.0001), no pain counselling (OR = 1.78; CI = 1.370 to 2.316; p<0.001), chronic pain (OR = 1.34; CI = 1.107 to 1.64; p = 0.004), and receiving opioids in recovery room(OR = 1.89; CI = 1.55 to 2.325; p<0.001) or on ward (OR = 1.79; CI = 1.42 to 2.27; p<0.001) were independently associated with higher experienced maximal postoperative pain (greater the median of 6). The effect of age on pain was not linear. Maximal pain increased in underage patients to a peak at the age of 18 to 20 years. From the age of >= 20 years on, maximal pain after tonsillectomy continuously decreased. Even after adjustment to all statistically important baseline and process parameters, there was substantial variability of maximal pain between hospitals with a heterogeneity variance of 0.31. Conclusion Many patients seem to receive insufficient or ineffective analgesia after tonsillectomy. Further research should address if populations at risk of higher postoperative pain such as females, younger patients or those with preexisting pain might profit from a special pain management protocol. Beyond classical demographical and process parameters the large variability between different hospitals is striking and indicates the existence of other unknown factors influencing postoperative pain after tonsillectomy.	[Guntinas-Lichius, Orlando; Geissler, Katharina] Jena Univ Hosp, Dept Otorhinolaryngol, Jena, Germany; [Komann, Marcus; Meissner, Winfried] Jena Univ Hosp, Dept Anaesthesiol & Intens Care Med, Jena, Germany; [Schlattmann, Peter] Jena Univ Hosp, Dept Med Stat Comp Sci & Documentat, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Guntinas-Lichius, O (corresponding author), Jena Univ Hosp, Dept Otorhinolaryngol, Jena, Germany.	orlando.guntinas@med.uni-jena.de	Guntinas-Lichius, Orlando/L-1871-2016	Guntinas-Lichius, Orlando/0000-0001-9671-0784	German Ministry of Health	German Ministry of Health	The QUIPS project is under the patronage of the German Societies of Surgeons and German Societies of Anaesthesiologists (Deutsche Gesellschaft fur Chirurgie, Berufsverband der Deutschen Chirurgen, Deutsche Gesellschaft fur Anasthesiologie und Intensivmedizin, and Berufsverband Deutscher Anasthesisten). Development of QUIPS was funded by the German Ministry of Health from 2003-2006.	Al-Hashimi M, 2015, BRIT J PAIN, V9, P167, DOI 10.1177/2049463714559254; Alspach G, 2010, CRIT CARE NURSE, V30, P11, DOI 10.4037/ccn2010383; Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; Brown H, 2015, APPL MIXED MODELS ME; Cano A, 2010, PAIN, V149, P9, DOI 10.1016/j.pain.2009.10.010; Caumo W, 2002, ACTA ANAESTH SCAND, V46, P1265, DOI 10.1034/j.1399-6576.2002.461015.x; Cepeda MS, 2003, ANESTH ANALG, V97, P1464, DOI 10.1213/01.ANE.0000080153.36643.83; Colloca L, 2013, PAIN, V154, P511, DOI 10.1016/j.pain.2013.02.002; Constant I, 2014, EUR ANN OTORHINOLARY, V131, P233, DOI 10.1016/j.anorl.2014.06.001; Cullen Karen A, 2009, Natl Health Stat Report, P1; Edmond SN, 2015, PAIN, V156, P215, DOI 10.1097/01.j.pain.0000460301.18207.c2; Ericsson E, 2015, INT J PEDIATR OTORHI, V79, P443, DOI 10.1016/j.ijporl.2015.01.016; Finkensieper M, 2013, EUR ARCH OTO-RHINO-L, V270, P157, DOI 10.1007/s00405-012-2015-6; Gerbershagen HJ, 2014, ANESTHESIOLOGY, V120, P1237, DOI 10.1097/ALN.0000000000000108; Gerbershagen HJ, 2013, ANESTHESIOLOGY, V118, P934, DOI 10.1097/ALN.0b013e31828866b3; Grainger J, 2008, CLIN OTOLARYNGOL, V33, P411, DOI 10.1111/j.1749-4486.2008.01815.x; Guntinas-Lichius O, 2014, CLIN J PAIN, V30, P978, DOI 10.1097/AJP.0000000000000050; Guntinas-Lichius O, 2014, EUR ARCH OTO-RHINO-L, V271, P2049, DOI 10.1007/s00405-014-2914-9; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Hospital Episode Statistics, 2015, ADM PAT CAR ENGL 201; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Lavin R, 2014, J APPL GERONTOL, V33, P258, DOI 10.1177/0733464812459372; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Meissner W, 2008, DTSCH ARZTEBL INT, V105, P865, DOI 10.3238/arztebl.2008.0865; Paganelli A, 2014, EUR ANN OTORHINOLARY, V131, P227, DOI 10.1016/j.anorl.2014.05.003; Pinder DK, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002211.pub2; Poller K, 2011, LARYNGO RHINO OTOL, V90, P82, DOI 10.1055/s-0030-1269848; Racine M, 2012, PAIN, V153, P619, DOI 10.1016/j.pain.2011.11.026; Rahim-Williams B, 2012, PAIN MED, V13, P522, DOI 10.1111/j.1526-4637.2012.01336.x; Rothaug J, 2013, J PAIN, V14, P1361, DOI 10.1016/j.jpain.2013.05.016; Royston P, 2008, MULTIVARIABLE MODEL; Schnelle A, 2013, PAIN MED, V14, P1786, DOI 10.1111/pme.12209; Sommer M, 2009, ARCH OTOLARYNGOL, V135, P124, DOI 10.1001/archoto.2009.3; Statistisches Bundesamt. Gesundheit, 2014, FALLP KRANK DRG STAT; Tighe PJ, 2014, PAIN MED, V15, P1390, DOI 10.1111/pme.12498; Zaslansky R, 2014, J EVAL CLIN PRACT, V20, P1090, DOI 10.1111/jep.12205	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154155	10.1371/journal.pone.0154155	http://dx.doi.org/10.1371/journal.pone.0154155			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120174	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200047
J	Howard, MG; McDonald, WJF; Forster, PI; Kress, WJ; Erickson, D; Faith, DP; Shapcott, A				Howard, Marion G.; McDonald, William J. F.; Forster, Paul I.; Kress, W. John; Erickson, David; Faith, Daniel P.; Shapcott, Alison			Patterns of Phylogenetic Diversity of Subtropical Rainforest of the Great Sandy Region, Australia Indicate Long Term Climatic Refugia	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; FRASER ISLAND; DIVERSIFICATION; BIODIVERSITY; ENDEMISM; FRAGMENTATION; BIOGEOGRAPHY; COMMUNITIES; QUEENSLAND; EVOLUTION	Australia's Great Sandy Region is of international significance containing two World Heritage areas and patches of rainforest growing on white sand. Previous broad-scale analysis found the Great Sandy biogeographic subregion contained a significantly more phylogenetically even subset of species than expected by chance contrasting with rainforest on white sand in Peru. This study aimed to test the patterns of rainforest diversity and relatedness at a finer scale and to investigate why we may find different patterns of phylogenetic evenness compared with rainforests on white sands in other parts of the world. This study focussed on rainforest sites within the Great Sandy and surrounding areas in South East Queensland (SEQ), Australia. We undertook field collections, expanded our three-marker DNA barcode library of SEQ rainforest plants and updated the phylogeny to 95% of the SEQ rainforest flora. We sampled species composition of rainforest in fixed area plots from 100 sites. We calculated phylogenetic diversity (PD) measures as well as species richness (SR) for each rainforest community. These combined with site variables such as geology, were used to evaluate patterns and relatedness. We found that many rainforest communities in the Great Sandy area were significantly phylogenetically even at the individual site level consistent with a broader subregion analysis. Sites from adjacent areas were either not significant or were significantly phylogenetically clustered. Some results in the neighbouring areas were consistent with historic range expansions. In contrast with expectations, sites located on the oldest substrates had significantly lower phylogenetic diversity (PD). Fraser Island was once connected to mainland Australia, our results are consistent with a region geologically old enough to have continuously supported rainforest in refugia. The interface of tropical and temperate floras in part also explains the significant phylogenetic evenness and higher than expected phylogenetic diversity.	[Howard, Marion G.; Shapcott, Alison] Univ Sunshine Coast, Fac Sci Hlth Educ, Genecol Res Ctr, Maroochydore, Qld, Australia; [McDonald, William J. F.; Forster, Paul I.] Queensland Herbarium, Queensland Dept Sci Informat Technol & Innovat, Brisbane Bot Gardens, Toowong, Qld, Australia; [Kress, W. John; Erickson, David] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Faith, Daniel P.] Australian Museum, 6-8 Coll St, Sydney, NSW 2000, Australia	University of the Sunshine Coast; Smithsonian Institution; Smithsonian National Museum of Natural History; Australian Museum	Shapcott, A (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ, Genecol Res Ctr, Maroochydore, Qld, Australia.	ashapcot@usc.edu.au			Queensland Smithsonian Fellowship; Honours student Marion Howard	Queensland Smithsonian Fellowship; Honours student Marion Howard	This study was funded by student grant to Honours student Marion Howard; However it built on a previous larger project funded by Queensland Smithsonian Fellowship awarded to AS.	Accad A., 2013, REMNANT VEGETATION Q; Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; BURBRIDGE NANCY T., 1960, AUSTRALIAN JOUR BOT, V8, P75, DOI 10.1071/BT9600075; Butler DW, 2007, J BIOGEOGR, V34, P1736, DOI 10.1111/j.1365-2699.2007.01734.x; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Clarke K.R., 2006, PRIMER V6 USER MANUA; Costion CM, 2014, DIVERS DISTRIB, V21, P1; Costion CM, 2015, DIVERS DISTRIB, V21, P279, DOI 10.1111/ddi.12266; Donders TH, 2006, PALAEOGEOGR PALAEOCL, V241, P417, DOI 10.1016/j.palaeo.2006.04.008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erickson DL, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00358; ESRI, 2013, ARCGIS DESKT REL 10; Faith Daniel P., 2001, Pacific Conservation Biology, V6, P304; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fayolle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042381; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; Fine PVA, 2005, EVOLUTION, V59, P1464; Geological Survey of Queensland, 2011, DIG GEOSC VECT DAT Q; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Harrold AG., 1987, STUDIES LANDSCAPE DY; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heads M, 2009, BIOL J LINN SOC, V96, P222, DOI 10.1111/j.1095-8312.2008.01118.x; IBM, 2013, SPSS STAT WIND VERS; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kooyman R, 2011, GLOBAL ECOL BIOGEOGR, V20, P707, DOI 10.1111/j.1466-8238.2010.00641.x; Kooyman RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080685; KRUCKEBERG AR, 1986, SYST BOT, V11, P455, DOI 10.2307/2419082; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawson Ben E., 2006, Pacific Conservation Biology, V12, P288; Lees BG, 2006, J COASTAL RES, V22, P78, DOI 10.2112/05A-0007.1; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Longmore ME, 1997, AUST J BOT, V45, P507, DOI 10.1071/BT96109; Maddison, 2018, MESQUITE MODULAR SYS; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Mayfield MM, 2009, AM NAT, V174, pE1, DOI 10.1086/599293; Mellick R, 2011, AUST J BOT, V59, P351, DOI 10.1071/BT10291; Miller M.A., 2010, P GAT COMP ENV WORKS; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Mwavu EN, 2015, BIOTROPICA, V47, P424, DOI 10.1111/btp.12223; NELDNER VJ, 2005, METHODOLOGY SURVEY M; Nichols WF, 1998, CONSERV BIOL, V12, P371, DOI 10.1046/j.1523-1739.1998.96237.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Queensland Herbarium, 2013, SURV MAPP 2011 VEG C; Saner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029642; Sattler P., 1999, CONSERVATION STATUS; Schnitzler J, 2011, SYST BIOL, V60, P343, DOI 10.1093/sysbio/syr006; Shapcott A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122164; Smith-Ramirez C, 2004, BIODIVERS CONSERV, V13, P373, DOI 10.1023/B:BIOC.0000006505.67560.9f; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Swenson Nathan G, 2012, Methods Mol Biol, V858, P409, DOI 10.1007/978-1-61779-591-6_20; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Waters JM, 2015, QUATERNARY SCI REV, V120, P47, DOI 10.1016/j.quascirev.2015.04.023; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEBB LJ, 1984, AUST J ECOL, V9, P169, DOI 10.1111/j.1442-9993.1984.tb01356.x; Weber LC, 2014, J BIOGEOGR, V41, P222, DOI 10.1111/jbi.12219; WHITEHEAD DR, 1969, EVOLUTION, V23, P171, DOI 10.1111/j.1558-5646.1969.tb03503.x; Yokoyama Y, 2001, QUATERN INT, V83-5, P9, DOI 10.1016/S1040-6182(01)00028-3	61	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153565	10.1371/journal.pone.0153565	http://dx.doi.org/10.1371/journal.pone.0153565			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119149	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200030
J	Kumar, N; Bera, BC; Greenbaum, BD; Bhatia, S; Sood, R; Selvaraj, P; Anand, T; Tripathi, BN; Virmani, N				Kumar, Naveen; Bera, Bidhan Chandra; Greenbaum, Benjamin D.; Bhatia, Sandeep; Sood, Richa; Selvaraj, Pavulraj; Anand, Taruna; Tripathi, Bhupendra Nath; Virmani, Nitin			Revelation of Influencing Factors in Overall Codon Usage Bias of Equine Influenza Viruses	PLOS ONE			English	Article							A VIRUS; RNASE-L; SYNONYMOUS MUTATIONS; ESCHERICHIA-COLI; EVOLUTION; SELECTION; GENOME; GENES; NUCLEOTIDE; ADAPTATION	Equine influenza viruses (EIVs) of H3N8 subtype are culprits of severe acute respiratory infections in horses, and are still responsible for significant outbreaks worldwide. Adaptability of influenza viruses to a particular host is significantly influenced by their codon usage preference, due to an absolute dependence on the host cellular machinery for their replication. In the present study, we analyzed genome-wide codon usage patterns in 92 EIV strains, including both H3N8 and H7N7 subtypes by computing several codon usage indices and applying multivariate statistical methods. Relative synonymous codon usage (RSCU) analysis disclosed bias of preferred synonymous codons towards A/U-ended codons. The overall codon usage bias in EIVs was slightly lower, and mainly affected by the nucleotide compositional constraints as inferred from the RSCU and effective number of codon (ENc) analysis. Our data suggested that codon usage pattern in EIVs is governed by the interplay of mutation pressure, natural selection from its hosts and undefined factors. The H7N7 subtype was found less fit to its host (horse) in comparison to H3N8, by possessing higher codon bias, lower mutation pressure and much less adaptation to tRNA pool of equine cells. To the best of our knowledge, this is the first report describing the codon usage analysis of the complete genomes of EIVs. The outcome of our study is likely to enhance our understanding of factors involved in viral adaptation, evolution, and fitness towards their hosts.	[Kumar, Naveen; Bhatia, Sandeep; Sood, Richa] NIHSAD, Immunol Lab, Bhopal, Madhya Pradesh, India; [Bera, Bidhan Chandra; Anand, Taruna] NRCE, Vet Type Culture Collect, Biotechnol Lab, Hisar, Haryana, India; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, New York, NY 10029 USA; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Hematol & Med Pathol, New York, NY 10029 USA; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Pathol, New York, NY 10029 USA; [Selvaraj, Pavulraj; Tripathi, Bhupendra Nath; Virmani, Nitin] NRCE, Equine Pathol Lab, Hisar, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute of High Security Animal Diseases; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines	Virmani, N (corresponding author), NRCE, Equine Pathol Lab, Hisar, Haryana, India.	nvirmani@gmail.com	Kumar, Naveen/L-1588-2019; Kumar, Naveen/GZK-9881-2022; Kumar, Naveen/V-1009-2019; Selvaraj, Pavulraj/AAV-8266-2021	Kumar, Naveen/0000-0002-3326-5465; Kumar, Naveen/0000-0003-2529-8344; 	Indian Council of Agricultural Research, India	Indian Council of Agricultural Research, India(Indian Council of Agricultural Research (ICAR))	The Indian Council of Agricultural Research, India provided the necessary funding for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2004, ARCH VIROL, V149, P113, DOI 10.1007/s00705-003-0186-6; Agashe D, 2013, MOL BIOL EVOL, V30, P549, DOI 10.1093/molbev/mss273; Anhlan D, 2011, RNA, V17, P64, DOI 10.1261/rna.2395211; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Biro JC, 2008, THEOR BIOL MED MODEL, V5, P1; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; BULMER M, 1991, GENETICS, V129, P897; Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905; Carroll TD, 2014, J INFECT DIS, V209, P24, DOI 10.1093/infdis/jit540; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chen Y., 2014, JVIRUSES, V2014, DOI [DOI 10.1155/2014/329049, 10.1155/2014/329049]; Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Cooper DA, 2015, J VIROL, V89, P2764, DOI 10.1128/JVI.02953-14; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; DESCHAVANNE P, 1995, NUCLEIC ACIDS RES, V23, P1350, DOI 10.1093/nar/23.8.1350; Dorn A, 2008, CURR OPIN MOL THER, V10, P10; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M., 2013, STRANGE SIMPLICITY C; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Feng KH, 2015, J VIROL, V89, P6860, DOI 10.1128/JVI.00521-15; Fu MH, 2010, ARCH VIROL, V155, P391, DOI 10.1007/s00705-010-0597-0; Gomez MM, 2011, INFECT GENET EVOL, V11, P580, DOI 10.1016/j.meegid.2011.01.006; Goni N, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-263; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Greenacre Michael, 1984, THEORY APPL CORRES A; Greenbaum BD, 2014, P NATL ACAD SCI USA, V111, P5054, DOI 10.1073/pnas.1402285111; Greenbaum BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005969; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; GUO YJ, 1992, VIROLOGY, V188, P245, DOI 10.1016/0042-6822(92)90754-D; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; Jimenez-Baranda S, 2011, J VIROL, V85, P3893, DOI 10.1128/JVI.01908-10; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Karlsson EA, 2012, EMERG INFECT DIS, V18, P1672, DOI 10.3201/eid1810.120214; Kitano M, 2010, VIROLOGY, V407, P178, DOI 10.1016/j.virol.2010.08.006; KURLAND CG, 1993, BIOCHEM SOC T, V21, P841, DOI 10.1042/bst0210841; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lu G, 2013, VIRUS GENES, V47, P250, DOI 10.1007/s11262-013-0935-x; Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001; Murcia PR, 2011, J VIROL, V85, P5312, DOI 10.1128/JVI.02619-10; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; Peden JF, 1999, THESIS NOTTINGHAM U; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Rabadan R, 2006, J VIROL, V80, P11887, DOI 10.1128/JVI.01414-06; Romero H, 2003, GENE, V317, P141, DOI 10.1016/S0378-1119(03)00701-7; ROTHBERG PG, 1981, NUCLEIC ACIDS RES, V9, P6221, DOI 10.1093/nar/9.23.6221; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; SHARP PM, 1995, PHILOS T R SOC B, V349, P241, DOI 10.1098/rstb.1995.0108; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Skinner JA, 2014, CLIN VACCINE IMMUNOL, V21, P1668, DOI 10.1128/CVI.00547-14; Smith JM, 1996, GENETICS, V142, P1037; Solovyov A, 2010, PLOS CURRENTS, V2; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Supek F, 2004, BIOINFORMATICS, V20, P2329, DOI 10.1093/bioinformatics/bth238; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z; van Weringh A, 2011, MOL BIOL EVOL, V28, P1827, DOI 10.1093/molbev/msr005; Vetsigian K, 2009, P NATL ACAD SCI USA, V106, P215, DOI 10.1073/pnas.0810122106; Vider-Shalit T, 2007, J VIROL, V81, P9536, DOI 10.1128/JVI.02636-06; Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0; WEBSTER RG, 1993, EQUINE VET J, V25, P537, DOI 10.1111/j.2042-3306.1993.tb03009.x; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Yin X, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-356; Zhang YQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-174; Zhao KN, 2003, VIRUS RES, V98, P95, DOI 10.1016/j.virusres.2003.08.019; Zhong J, 2007, VIRUS GENES, V35, P767, DOI 10.1007/s11262-007-0159-z; Zhou T, 2005, BIOSYSTEMS, V81, P77, DOI 10.1016/j.biosystems.2005.03.002	83	62	70	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154376	10.1371/journal.pone.0154376	http://dx.doi.org/10.1371/journal.pone.0154376			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119730	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200064
J	Palik, DJ; Snow, AA; Stottlemyer, AL; Miriti, MN; Heaton, EA				Palik, D. J.; Snow, A. A.; Stottlemyer, A. L.; Miriti, M. N.; Heaton, E. A.			Relative Performance of Non-Local Cultivars and Local, Wild Populations of Switchgrass (Panicum virgatum) in Competition Experiments	PLOS ONE			English	Article							GENOTYPIC VARIATION; PROPAGULE PRESSURE; GENETIC DIVERSITY; SEED; ADAPTATION; BIOENERGY; DYNAMICS; INVASION; ECOTYPES; PATTERNS	The possibility of increased invasiveness in cultivated varieties of native perennial species is a question of interest in biofuel risk assessment. Competitive success is a key factor in the fitness and invasive potential of perennial plants, and thus the large-scale release of high-yielding biomass cultivars warrants empirical comparisons with local conspecifics in the presence of competitors. We evaluated the performance of non-local cultivars and local wild biotypes of the tallgrass species Panicum virgatum L. (switchgrass) in competition experiments during two growing seasons in Ohio and Iowa. At each location, we measured growth and reproductive traits (plant height, tiller number, flowering time, aboveground biomass, and seed production) of four non-locally sourced cultivars and two locally collected wild biotypes. Plants were grown in common garden experiments under three types of competition, referred to as none, moderate (with Schizachyrium scoparium), and high (with Bromus inermis). In both states, the two "lowland" cultivars grew taller, flowered later, and produced between 2x and 7.5x more biomass and between 3x and 34x more seeds per plant than local wild biotypes, while the other two cultivars were comparable to wild biotypes in these traits. Competition did not affect relative differences among biotypes, with the exception of shoot number, which was more similar among biotypes under high competition. Insights into functional differences between cultivars and wild biotypes are crucial for developing biomass crops while mitigating the potential for invasiveness. Here, two of the four cultivars generally performed better than wild biotypes, indicating that these biotypes may pose more of a risk in terms of their ability to establish vigorous feral populations in new regions outside of their area of origin. Our results support an ongoing assessment of switchgrass cultivars developed for large-scale planting for biofuels.	[Palik, D. J.; Snow, A. A.; Stottlemyer, A. L.; Miriti, M. N.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Heaton, E. A.] Iowa State Univ, Dept Agron, Ames, IA USA	University System of Ohio; Ohio State University; Iowa State University	Palik, DJ (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA.	palik.2@osu.edu			Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture [2010-33522-21703]	Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture	This project was supported by Biotechnology Risk Assessment Grant Program, grant no. 2010-33522-21703, from the USDA National Institute of Food and Agriculture (recipient: Ohio State University, AA Snow) (http://www.reeis.usda.gov/web/crisprojectpages/0223354-gene-flow-and-fitness-studies-of-switchgrass-implications-for-new-biofuel-crops.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 2002, OIKOS, V96, P531, DOI 10.1034/j.1600-0706.2002.960314.x; Aspinwall MJ, 2013, NEW PHYTOL, V199, P966, DOI 10.1111/nph.12341; Baer SG, 2014, EVOL APPL, V7, P323, DOI 10.1111/eva.12124; Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Barney JN, 2012, BIOMASS BIOENERG, V40, P143, DOI 10.1016/j.biombioe.2012.02.013; Barney JN, 2009, PLANT SCI, V177, P724, DOI 10.1016/j.plantsci.2009.09.003; BENGTSSON J, 1994, TRENDS ECOL EVOL, V9, P246, DOI 10.1016/0169-5347(94)90289-5; Benson EJ, 2006, PLANT ECOL, V187, P163, DOI 10.1007/s11258-005-0975-y; Bock J. H., 1998, GREAT PLAINS RES, V8, P213; Boe A, 1998, CROP SCI, V38, P540, DOI 10.2135/cropsci1998.0011183X003800020058x; Casler MD, 2007, CROP SCI, V47, P2249, DOI 10.2135/cropsci2006.12.0780; Casler MD, 2004, CROP SCI, V44, P293, DOI 10.2135/cropsci2004.2930; Casler MD, 2007, CROP SCI, V47, P2261, DOI 10.2135/cropsci2006.12.0797; Casler MD, 2014, CROP SCI, V54, P626, DOI 10.2135/cropsci2013.04.0239; Casler MD, 2011, PLANT GENOME-US, V4, P273, DOI 10.3835/plantgenome2011.10.0026; Cortese LM, 2010, BIOENERG RES, V3, P262, DOI 10.1007/s12155-010-9078-2; Dillemuth FP, 2009, BIOL INVASIONS, V11, P1381, DOI 10.1007/s10530-008-9346-7; DiTomaso JM, 2013, CALIF AGR, V67, P96, DOI 10.3733/ca.v067n02p96; Ecker G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130414; Gibson DJ, 2013, J VEG SCI, V24, P429, DOI 10.1111/j.1654-1103.2012.01475.x; Gibson DJ, 2012, OIKOS, V121, P496, DOI 10.1111/j.1600-0706.2011.19447.x; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; GROSS KL, 1991, OECOLOGIA, V87, P270, DOI 10.1007/BF00325266; Gustafson DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091511; Gustafson DJ, 2004, FUNCT ECOL, V18, P451, DOI 10.1111/j.0269-8463.2004.00850.x; Gustafson DJ., 2001, P 17 N AM PRAIRIE C, P118; HARTNETT DC, 1993, AM J BOT, V80, P1114, DOI 10.2307/2445538; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Heaton EA, 2008, CURR OPIN BIOTECH, V19, P202, DOI 10.1016/j.copbio.2008.05.001; Herget ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119889; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Klopf RP, 2011, RESTOR ECOL, V19, P112, DOI 10.1111/j.1526-100X.2009.00539.x; Lambert AM, 2011, RESTOR ECOL, V19, P43, DOI 10.1111/j.1526-100X.2010.00673.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lowry DB, 2014, AM NAT, V183, P682, DOI 10.1086/675760; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; Mutegi E., 2013, RESTORATION ECOLOGY, V22, P223; Nageswara-Rao M, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-77; Nageswara-Rao M, 2013, GENET RESOUR CROP EV, V60, P1057, DOI 10.1007/s10722-012-9903-x; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Polley HW, 2005, RESTOR ECOL, V13, P480, DOI 10.1111/j.1526-100X.2005.00060.x; R Core Team, 2021, R LANGUAGE ENV STAT; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schroder R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071066; Simberloff D, 2008, WEED SCI, V56, P867, DOI 10.1614/WS-08-046.1; Sripathi R, 2013, EUPHYTICA, V191, P437, DOI 10.1007/s10681-013-0911-5; Stottlemyer AL, 2012, THESIS OHIO STATE U; USDA FSA, 2013, CONS RES PROGR; USDA/NRCS (U.S. Department of Agriculture/National Resources Conservation Service, 2013, THE PLANTS DAT; USDA-NRCS, 2011, REL BROCH BLACKW SWI; USDA-NRCS, 2011, REL BROCH KANL SWITC; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Wittmann MJ, 2014, OIKOS, V123, P441, DOI 10.1111/j.1600-0706.2013.01025.x; Wright L, 2010, BIOMASS BIOENERG, V34, P851, DOI 10.1016/j.biombioe.2010.01.030; WULFF RD, 1986, J ECOL, V74, P99, DOI 10.2307/2260351; Wullschleger SD, 2010, AGRON J, V102, P1158, DOI 10.2134/agronj2010.0087; Zalapa JE, 2011, THEOR APPL GENET, V122, P805, DOI 10.1007/s00122-010-1488-1; Zhang YW, 2011, GENETICA, V139, P933, DOI 10.1007/s10709-011-9597-6	61	11	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154444	10.1371/journal.pone.0154444	http://dx.doi.org/10.1371/journal.pone.0154444			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120201	Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200077
J	Costa, A; Ianez, E; Ubeda, A; Hortal, E; Del-Ama, AJ; Gil-Agudo, A; Azorin, JM				Costa, Alvaro; Ianez, Eduardo; Ubeda, Andres; Hortal, Enrique; Del-Ama, Antonio J.; Gil-Agudo, Angel; Azorin, Jose M.			Decoding the Attentional Demands of Gait through EEG Gamma Band Features	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; MAXIMUM-ENTROPY METHOD; SPINAL-CORD-INJURY; MOTOR IMAGERY; BHATTACHARYYA DISTANCE; NEUROLOGICAL REHABILITATION; SELECTIVE ATTENTION; FREQUENCY-ANALYSIS; EXECUTIVE FUNCTION; TASK DEMANDS	Rehabilitation techniques are evolving focused on improving their performance in terms of duration and level of recovery. Current studies encourage the patient's involvement in their rehabilitation. Brain-Computer Interfaces are capable of decoding the cognitive state of users to provide feedback to an external device. On this paper, cortical information obtained from the scalp is acquired with the goal of studying the cognitive mechanisms related to the users' attention to the gait. Data from 10 healthy users and 3 incomplete Spinal Cord Injury patients are acquired during treadmill walking. During gait, users are asked to perform 4 attentional tasks. Data obtained are treated to reduce movement artifacts. Features from delta(1 - 4Hz), theta(4 -8Hz), alpha(8 - 12Hz), beta(12 -30Hz), gamma(low)(30 -50Hz), gamma(high)(50 - 90Hz) frequency bands are extracted and analyzed to find which ones provide more information related to attention. The selected bands are tested with 5 classifiers to distinguish between tasks. Classification results are also compared with chance levels to evaluate performance. Results show success rates of similar to 67% for healthy users and similar to 59% for patients. These values are obtained using features from. band suggesting that the attention mechanisms are related to selective attention mechanisms, meaning that, while the attention on gait decreases the level of attention on the environment and external visual information increases. Linear Discriminant Analysis, K-Nearest Neighbors and Support Vector Machine classifiers provide the best results for all users. Results from patients are slightly lower, but significantly different, than those obtained from healthy users supporting the idea that the patients pay more attention to gait during non-attentional tasks due to the inherent difficulties they have during normal gait. This study provides evidence of the existence of classifiable cortical information related to the attention level on the gait. This fact could allow the development of a real-time system that obtains the attention level during lower limb rehabilitation. This information could be used as feedback to adapt the rehabilitation strategy.	[Costa, Alvaro; Ianez, Eduardo; Ubeda, Andres; Hortal, Enrique; Azorin, Jose M.] Miguel Hernandez Univ, Brain Machine Interface Syst Lab, Ave Univ S-N, Elche 03202, Spain; [Del-Ama, Antonio J.; Gil-Agudo, Angel] Natl Hosp Spinal Cord Injury, Phys Med & Rehabil Dept, Biomech Unit, SESCAM, Finca Peraleda S-N, Toledo 45071, Spain; [Del-Ama, Antonio J.; Gil-Agudo, Angel] Natl Hosp Spinal Cord Injury, Phys Med & Rehabil Dept, Tech Aids Unit, SESCAM, Finca Peraleda S-N, Toledo 45071, Spain	Universidad Miguel Hernandez de Elche	Costa, A (corresponding author), Miguel Hernandez Univ, Brain Machine Interface Syst Lab, Ave Univ S-N, Elche 03202, Spain.	acosta@umh.es	del-Ama, Antonio J./G-3141-2016; Ubeda, Andres/E-9811-2018; Hortal, Enrique/R-9176-2018; Azorin, Jose M./M-8956-2019; Iáñez, Eduardo/J-9765-2014; Azorin, Jose M/G-2157-2011; Gil-Agudo, Ángel/ABD-3065-2021; Ubeda, Andres/K-4883-2015	del-Ama, Antonio J./0000-0001-6215-2593; Hortal, Enrique/0000-0003-2119-4169; Azorin, Jose M./0000-0001-5548-9657; Iáñez, Eduardo/0000-0001-8057-5952; Azorin, Jose M/0000-0001-5548-9657; Gil-Agudo, Ángel/0000-0001-5082-4225; Ubeda, Andres/0000-0003-3223-025X	Commission of the European Union under the BioMot project - Smart Wearable Robots with Bioinspired Sensory-Motor Skills [IFP7-ICT-2013-10-611695]	Commission of the European Union under the BioMot project - Smart Wearable Robots with Bioinspired Sensory-Motor Skills	This research has been funded by the Commission of the European Union under the BioMot project - Smart Wearable Robots with Bioinspired Sensory-Motor Skills ( Grant Agreement number IFP7-ICT-2013-10-611695). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2009, IEEE ENG MED BIO, P5981, DOI 10.1109/IEMBS.2009.5335381; [Anonymous], IEEE REG 10 ANN INT; Antos A, 1999, IEEE T PATTERN ANAL, V21, P643, DOI 10.1109/34.777375; Bhattacharyya A, 1946, SANKHYA, V7, P401; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Brunner Clemens, 2008, INT J BIOELEKTROMAGN, V10, P52, DOI DOI 10.1.1.330.3349; CHAUDHURI G, 1991, COMMUN STAT THEORY, V20, P2195, DOI 10.1080/03610929108830627; Choi E, 2003, PATTERN RECOGN, V36, P1703, DOI 10.1016/S0031-3203(03)00035-9; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cunningham P., 2007, UCDCSI20074, DOI [10.1145/3459665, DOI 10.1145/3459665]; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Dobkin BH, 2007, J PHYSIOL-LONDON, V579, P637, DOI 10.1113/jphysiol.2006.123067; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Fell J, 2003, BRAIN RES REV, V42, P265, DOI 10.1016/S0165-0173(03)00178-4; Florez F, 2011, NCTA 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON NEURAL COMPUTATION THEORY AND APPLICATIONS, P415; Garipelli G, 2011, I IEEE EMBS C NEUR E, P408, DOI 10.1109/NER.2011.5910573; GASSER T, 1985, ELECTROEN CLIN NEURO, V61, P181, DOI 10.1016/0013-4694(85)91058-2; Genz A, 2000, J STAT COMPUT SIM, V68, P1, DOI 10.1080/00949650008812053; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Grosse P, 2002, CLIN NEUROPHYSIOL, V113, P1523, DOI 10.1016/S1388-2457(02)00223-7; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Heruti RJ, 2002, ARCH PHYS MED REHAB, V83, P742, DOI 10.1053/apmr.2002.32739; HOLSHEIMER J, 1977, ELECTROEN CLIN NEURO, V43, P52, DOI 10.1016/0013-4694(77)90194-8; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; KALRA L, 1993, STROKE, V24, P1462, DOI 10.1161/01.STR.24.10.1462; Kay E., 1994, PHYSIOTHERAPY, V80, P77, DOI [DOI 10.1016/S0031-9406(10)61012-7, https://doi.org/10.1016/S0031-9406(10)61012-7]; Killane I, 2013, IEEE ENG MED BIO, P6397, DOI 10.1109/EMBC.2013.6611018; Klimesch W, 1998, NEUROSCI LETT, V244, P73, DOI 10.1016/S0304-3940(98)00122-0; Kline JE, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046022; Koenig A, 2008, VIRTUAL ENV INCREASE; Lachaux JP, 1997, HUM BRAIN MAPP, V5, P26, DOI 10.1002/(SICI)1097-0193(1997)5:1<26::AID-HBM4>3.0.CO;2-P; Lansbergen MM, 2011, PROG NEURO-PSYCHOPH, V35, P47, DOI 10.1016/j.pnpbp.2010.08.004; Lotte Fabien, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3712, DOI 10.1109/ICPR.2010.904; Martin KL, 2013, J GERONTOL A-BIOL, V68, P726, DOI 10.1093/gerona/gls224; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Muller MM, 2000, INT J PSYCHOPHYSIOL, V38, P283, DOI 10.1016/s0167-8760(00)00171-9; Murphy Kevin P., 2006, NAIVE BAYES CLASSIFI; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; POLICH J, 1986, ELECTROEN CLIN NEURO, V63, P251, DOI 10.1016/0013-4694(86)90093-3; Porro CA, 1996, J NEUROSCI, V16, P7688; RAINFORD BD, 1994, HYPERFINE INTERACT, V87, P1129, DOI 10.1007/BF02068515; RAY WJ, 1985, INT J PSYCHOPHYSIOL, V3, P43, DOI 10.1016/0167-8760(85)90018-2; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; Ryu K, 2005, INT J IND ERGONOM, V35, P991, DOI 10.1016/j.ergon.2005.04.005; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; Samek W, 2013, IEEE T BIO-MED ENG, V60, P2289, DOI 10.1109/TBME.2013.2253608; Sanei S., 2013, EEG SIGNAL PROCESSIN; SCHELS HF, 1991, IEEE T BIO-MED ENG, V38, P821, DOI 10.1109/10.83601; Scholkopft B., 1999, NEURAL NETW SIGNAL P, V1, P1; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Stephenson R., 1993, PHYSIOTHERAPY, V79, P699, DOI [10.1016/s0031-9406(10)60008-9, DOI 10.1016/S0031-9406(10)60008-9]; Stevens JA, 2003, ARCH PHYS MED REHAB, V84, P1090, DOI 10.1016/S0003-9993(03)00042-X; Thome Antonio Carlos Gay, 2012, SVM CLASSIFIERS CONC; Ting-Yang Lin, 2013, Proceedings of the 2013 7th Asia Modelling Symposium (AMS 2013), P149, DOI 10.1109/AMS.2013.29; van Twillert S, 2009, CLIN REHABIL, V23, P938, DOI 10.1177/0269215509338125; Westgren N, 1998, ARCH PHYS MED REHAB, V79, P1433, DOI 10.1016/S0003-9993(98)90240-4; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Xuan Guorong, 1996, Proceedings of the 13th International Conference on Pattern Recognition, P195, DOI 10.1109/ICPR.1996.546751; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zimmerli L, 2009, 2009 VIRTUAL REHABILITATION INTERNATIONAL CONFERENCE, P150, DOI 10.1109/ICVR.2009.5174223	64	26	27	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154136	10.1371/journal.pone.0154136	http://dx.doi.org/10.1371/journal.pone.0154136			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115740	gold, Green Published, Green Submitted			2022-12-27	WOS:000374973600046
J	Faraji, A; Unlu, I; Crepeau, T; Healy, S; Crans, S; Lizarraga, G; Fonseca, D; Gaugler, R				Faraji, Ary; Unlu, Isik; Crepeau, Taryn; Healy, Sean; Crans, Scott; Lizarraga, Griffith; Fonseca, Dina; Gaugler, Randy			Droplet Characterization and Penetration of an Ultra-Low Volume Mosquito Adulticide Spray Targeting the Asian Tiger Mosquito, Aedes albopictus, within Urban and Suburban Environments of Northeastern USA	PLOS ONE			English	Article							COLD AEROSOL SPRAYER; DIPTERA-CULICIDAE; SPACE SPRAYS; INVASIVE MOSQUITOS; AEGYPTI L; MALATHION; EFFICACY; SIZE; INSECTICIDE; POPULATIONS	Adult control of Aedes albopictus via ultra-low volume is difficult because this species occurs primarily in peridomestic habitats where obstacles such as buildings and vegetation can disrupt spray plumes and droplet dispersion. We determined droplet penetration and characterization of a pyrethroid adulticide applied from the ground at mid (46.77 ml/ha) and maximum (93.53 ml/ha) label rates within cryptic habitats of urban and suburban environments. Droplets were collected from all habitats, with no significant differences detected between locations within the same application rate or collection method. No differences were detected in droplet densities (drops per mm(2)) between rates within urban environments, but more droplets were collected in urban (149.93 +/- 11.07 SE) than suburban sites (114.37 +/- 11.32) at the maximum label rate (P = 0.003). The excellent penetration of aerosols into cryptic habitats of an urban site was likely due to the shorter spray paths afforded by our network of roads and alleys. Mid label rates displayed similar droplet density values as maximum label rates in urban areas, indicating that lower rates may be used effectively to reduce costs, lessen non-target effects, and increase environmental stewardship. Advances in formulations and technology are driving changes in adulticide applications, leading to use of the minimum effective dose for maximum efficacy, precision, and accountability.	[Faraji, Ary; Unlu, Isik; Crans, Scott; Fonseca, Dina; Gaugler, Randy] Rutgers State Univ, Dept Entomol, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Faraji, Ary; Unlu, Isik] Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT USA; [Crepeau, Taryn; Healy, Sean] Monmouth Cty Mosquito Exterminat Commiss, Eatontown, NJ USA; [Healy, Sean] Louisiana State Univ, Dept Entomol, Baton Rouge, LA 70803 USA; [Lizarraga, Griffith] Clarke Mosquito Control, Dept Environm Sci, Roselle, IL USA	Rutgers State University New Brunswick; Louisiana State University System; Louisiana State University	Faraji, A (corresponding author), Rutgers State Univ, Dept Entomol, Ctr Vector Biol, New Brunswick, NJ 08903 USA.; Faraji, A (corresponding author), Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT USA.	ary@slcmad.org	Fonseca, Dina/HHS-1320-2022; Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100	USDA [USDA-ARS-58-6615-8-105]; Rutgers University [USDA-ARS-58-6615-8-105]; Clarke Mosquito Control	USDA(United States Department of Agriculture (USDA)); Rutgers University; Clarke Mosquito Control	This work was funded by a cooperative Agreement between USDA and Rutgers University (USDA-ARS-58-6615-8-105) entitled "Area-wide Pest Management Program for the Asian Tiger Mosquito in New Jersey." Partial funding was provided by Clarke Mosquito Control through equipment and product support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache D.H., 1992, MICROCLIMATE SPRAY D; Barber JAS, 2007, J AM MOSQUITO CONTR, V23, P55, DOI 10.2987/8756-971X(2007)23[55:FTOMAP]2.0.CO;2; Bonds JAS, 2009, J AM MOSQUITO CONTR, V25, P474, DOI 10.2987/09-5882.1; Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x; Centers for Disease Control and Prevention, 2013, W NIL VIR US GUID SU; Clark GG, 2013, J MED ENTOMOL, V50, P1059, DOI 10.1603/ME12210; Clayson PJ, 2010, J AM MOSQUITO CONTR, V26, P229, DOI 10.2987/10-5999.1; Cooperband MF, 2010, J MED ENTOMOL, V47, P1099, DOI 10.1603/ME10021; CURTIS GA, 1988, J AM MOSQUITO CONTR, V4, P345; Enserink M, 2014, SCIENCE, V344, P678, DOI 10.1126/science.344.6185.678; Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P304, DOI 10.2987/13-6334R.1; Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181; Farajollahi A, 2009, J MED ENTOMOL, V46, P1220, DOI 10.1603/033.046.0533; Farooq M, 2009, J AM MOSQUITO CONTR, V25, P521, DOI 10.2987/09-0009R.1; FOCKS DA, 1987, AM J TROP MED HYG, V36, P639, DOI 10.4269/ajtmh.1987.36.639; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Fritz BK, 2011, T ASABE, V54, P57; Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227; HAILE DG, 1982, MOSQ NEWS, V42, P576; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; LOFGREN CS, 1973, J ECON ENTOMOL, V66, P1085, DOI 10.1093/jee/66.5.1085; Matsunaga T., 1987, Japanese Journal of Sanitary Zoology, V38, P219; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; MOUNT GA, 1970, MOSQ NEWS, V30, P70; Mount GA, 1998, J AM MOSQUITO CONTR, V14, P305; PANT CP, 1971, B WORLD HEALTH ORGAN, V45, P805; PERICH MJ, 1990, J AM MOSQUITO CONTR, V6, P1; PERICH MJ, 1992, J AM MOSQUITO CONTR, V8, P137; Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541; RATHBURN CB, 1989, J AM MOSQUITO CONTR, V5, P173; Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630; Reiter Paul, 1997, P425; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; [Rutgers University Center for Vector Biology], 2014, AR WID MAN AS TIG MO; Schleier JJ, 2010, J ENVIRON SCI HEAL B, V45, P621, DOI 10.1080/03601234.2010.502410; Suman DS, 2012, J AM MOSQUITO CONTR, V28, P338, DOI 10.2987/12-6289R.1; Unlu I, 2014, ACTA TROP, V137, P201, DOI 10.1016/j.actatropica.2014.05.009; Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999; Unlu I, 2012, J AM MOSQUITO CONTR, V28, P334, DOI 10.2987/12-6262R.1; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; WHO, 2006, PEST THEIR APPL	42	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0152069	10.1371/journal.pone.0152069	http://dx.doi.org/10.1371/journal.pone.0152069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116103	Green Published, gold, Green Submitted			2022-12-27	WOS:000374973600013
J	Tomasi, D; Shokri-Kojori, E; Volkow, ND				Tomasi, D.; Shokri-Kojori, E.; Volkow, N. D.			Temporal Changes in Local Functional Connectivity Density Reflect the Temporal Variability of the Amplitude of Low Frequency Fluctuations in Gray Matter	PLOS ONE			English	Article							GLOBAL SIGNAL REGRESSION; ANTI-CORRELATED NETWORKS; RESTING-STATE FMRI; HUMAN CONNECTOME; CORTICAL NETWORKS; BRAIN; PATTERNS; HUBS; ORGANIZATION; DYNAMICS	Data-driven functional connectivity density (FCD) mapping is being increasingly utilized to assess brain connectomics at rest in the healthy brain and its disruption in neuropsychiatric diseases with the underlying assumption that the spatiotemporal hub distribution is stationary. However, recent studies show that functional connectivity is highly dynamic. Here we study the temporal variability of the local FCD (lFCD) at high spatiotemporal resolution (2-mm isotropic; 0.72s) using a sliding-window approach and 'resting-state' datasets from 40 healthy subjects collected under the Human Connectome Project. Prominent functional connectivity hubs in visual and posterior parietal cortices had pronounced temporal changes in local FCD. These dynamic patterns in the strength of the lFCD hubs occurred in cortical gray matter with high sensitivity (up to 85%) and specificity (> 85%) and showed high reproducibility (up to 72%) across sessions and high test-retest reliability (ICC(3,1) > 0.5). The temporal changes in lFCD predominantly occurred in medial occipitoparietal regions and were proportional to the strength of the connectivity hubs. The temporal variability of the lFCD was associated with the amplitude of the low frequency fluctuations (ALFF). Pure randomness did not account for the probability distribution of lFCD. Shannon entropy increased in proportion to the strength of the lFCD hubs suggesting high average flow of information per unit of time in the lFCD hubs, particularly in medial occipitoparietal regions. Thus, the higher dynamic range of the lFCD hubs is consistent with their role in the complex orchestration of interacting brain networks.	[Tomasi, D.; Shokri-Kojori, E.; Volkow, N. D.] NIAAA, Bethesda, MD USA; [Volkow, N. D.] NIDA, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Tomasi, D (corresponding author), NIAAA, Bethesda, MD USA.	dardo.tomasi@nih.gov			NIH [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; National Institutes of Alcohol Abuse and Alcoholism [Y1AA-3009]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Center for Systems Neuroscience at Washington University; National Institutes of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Data were provided by the Human Connectome Project, WU-Minn Consortium ( Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research and by the McDonnell Center for Systems Neuroscience at Washington University. This work was accomplished with support from the National Institutes of Alcohol Abuse and Alcoholism (Y1AA-3009).	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Anteraper SA, 2013, BRAIN CONNECT, V3, P302, DOI 10.1089/brain.2012.0113; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blanken LME, 2015, AM J PSYCHIAT, V172, P479, DOI 10.1176/appi.ajp.2014.14040482; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Caeyenberghs K, 2014, BRAIN CONNECT; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chang C, 2013, NEUROIMAGE, V72, P227, DOI 10.1016/j.neuroimage.2013.01.049; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Ding JR, 2014, EPILEPSY RES, V108, P1184, DOI 10.1016/j.eplepsyres.2014.05.006; Doucet G, 2012, NEUROIMAGE, V59, P3194, DOI 10.1016/j.neuroimage.2011.11.059; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Handwerker DA, 2012, NEUROIMAGE, V63, P1712, DOI 10.1016/j.neuroimage.2012.06.078; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Kiviniemi V, 2011, BRAIN CONNECT, V1, P339, DOI 10.1089/brain.2011.0036; Konova A. B., 2015, BRAIN RES; Lang X, 2015, NEUROREPORT, V26, P17, DOI 10.1097/WNR.0000000000000294; Langbaum JBS, 2009, NEUROIMAGE, V45, P1107, DOI 10.1016/j.neuroimage.2008.12.072; Leonardi N, 2015, NEUROIMAGE, V104, P430, DOI 10.1016/j.neuroimage.2014.09.007; Liu B, 2015, BRAIN STRUCT FUNCT, V220, P91, DOI 10.1007/s00429-013-0640-5; Liu X, 2013, P NATL ACAD SCI USA, V110, P4392, DOI 10.1073/pnas.1216856110; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Magri C, 2012, J NEUROSCI, V32, P1395, DOI 10.1523/JNEUROSCI.3985-11.2012; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Press W. H., 1992, ART SCI COMPUTING; Qin W, 2014, CEREB CORTEX; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tagliazucchi E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00339; Tian T, 2013, J NEUROSCI, V33, P17519, DOI 10.1523/JNEUROSCI.2163-13.2013; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Tomasi D., 2015, CEREB CORTEX; Tomasi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096176; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Tomasi D, 2012, HUM BRAIN MAPP, V33, P849, DOI 10.1002/hbm.21252; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Wong CW, 2012, NEUROIMAGE, V63, P356, DOI 10.1016/j.neuroimage.2012.06.035; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yang Z, 2014, NEUROIMAGE, V93, P124, DOI 10.1016/j.neuroimage.2014.02.014; Yu QB, 2015, NEUROIMAGE, V107, P345, DOI 10.1016/j.neuroimage.2014.12.020; Zalesky A, 2015, NEUROIMAGE, V114, P466, DOI 10.1016/j.neuroimage.2015.03.047; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zhuo CJ, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00404	62	30	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154407	10.1371/journal.pone.0154407	http://dx.doi.org/10.1371/journal.pone.0154407			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116610	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600065
J	Aissani, B; Wiener, HW; Zhang, K				Aissani, Brahim; Wiener, Howard W.; Zhang, Kui			Fine Mapping of the Body Fat QTL on Human Chromosome 1q43	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEVERE OBESITY; MICE LACKING; LINKAGE; ASSOCIATION; RECEPTOR; DOMAIN; RISK	Introduction Evidence for linkage and association of obesity-related quantitative traits to chromosome 1q43 has been reported in the Quebec Family Study (QFS) and in populations of Caribbean Hispanic ancestries yet no specific candidate locus has been replicated to date. Methods Using a set of 1,902 single nucleotide polymorphisms (SNPs) genotyped in 525 African American (AA) and 391 European American (EA) women enrolled in the NIEHS uterine fibroid study (NIEHS-UFS), we generated a fine association map for the body mass index (BMI) across a 2.3 megabase-long interval delimited by RGS7 (regulator of G-protein signaling 7) and PLD5 (Phospholipase D, member 5). Multivariable-adjusted linear regression models were fitted to the data to evaluate the association in race-stratified analyses and meta-analysis. Results The strongest associations were observed in a recessive genetic model and peaked in the 3' end of RGS7 at intronic rs261802 variant in the AA group (p = 1.0 x 10(-4)) and in meta-analysis of AA and EA samples (p = 9.0 x 10(-5)). In the EA group, moderate associations peaked at rs6429264 (p = 2.0 x 10(-3)) in the 2 Kb upstream sequence of RGS7. In the reference populations for the European ancestry in the 1,000 genomes project, rs6429264 occurs in strong linkage disequilibrium(D' = 0.94) with rs1341467, the strongest candidate SNP for total body fat in QFS that failed genotyping in the present study. Additionally we report moderate associations at the 3' end of PLD5 in meta-analysis (3.2 x 10(-4) <= p <= 5.8 x 10(-4)). Conclusion We report replication data suggesting that RGS7, a gene abundantly expressed in the brain, might be a putative body fat QTL on human chromosome 1q43. Future genetic and functional studies are required to substantiate our observations and to potentially link them to the neurobehavioral phenotypes associated with the RGS7 region.	[Aissani, Brahim; Wiener, Howard W.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Zhang, Kui] Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA	University of Alabama System; University of Alabama Birmingham; Michigan Technological University	Aissani, B (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	baissani@uab.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD064398]; National Institute for Environmental Health Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064398] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant R01-HD064398 to BA from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (https://www.nichd.nih.gov/Pages/index.aspx) and the National Institute for Environmental Health Science (http://www.niehs.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Aissani B., 2015, ENDOCR RELAT CANC; Aissani B, 2006, OBESITY, V14, P1605, DOI 10.1038/oby.2006.185; Aissani B, 2014, J HUM GENET, V59, P110, DOI 10.1038/jhg.2013.130; Aissani B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058399; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Baird DD, 2007, AM J EPIDEMIOL, V165, P157, DOI 10.1093/aje/kwj363; Benzing T, 2000, J BIOL CHEM, V275, P28167; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong CH, 2011, HUM GENET, V129, P209, DOI 10.1007/s00439-010-0916-2; Dong CH, 2010, STROKE, V41, P2750, DOI 10.1161/STROKEAHA.110.596981; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Gross KL, 2004, GENE CHROMOSOME CANC, V41, P183, DOI 10.1002/gcc.20079; Guo HY, 2014, ONCOTARGET, V5, P8625, DOI 10.18632/oncotarget.2349; He CC, 2013, CELL, V154, P1085, DOI 10.1016/j.cell.2013.07.035; Holder JL, 2000, HUM MOL GENET, V9, P101; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lim GE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8671; Mustelin L, 2009, INT J OBESITY, V33, P29, DOI 10.1038/ijo.2008.258; Nelson RK, 2015, J LIPID RES, V56, P2229, DOI 10.1194/jlr.R059220; Paternoster L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003247; Pinhas-Hamiel O, 2006, ARCH PEDIAT ADOL MED, V160, P933, DOI 10.1001/archpedi.160.9.933; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Ukkola O, 2002, J CLIN ENDOCR METAB, V87, P3708, DOI 10.1210/jc.87.8.3708; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vogel H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053025; Wang Q, 2011, FASEB J, V25, P3949, DOI 10.1096/fj.11-190157; Waugh JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027984; Wise LA, 2005, EPIDEMIOLOGY, V16, P346, DOI 10.1097/01.ede.0000158742.11877.99; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336	40	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153794	10.1371/journal.pone.0153794	http://dx.doi.org/10.1371/journal.pone.0153794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111224	Green Published, Green Submitted, gold			2022-12-27	WOS:000374970600021
J	Fitzpatrick, KE; Gray, R; Quigley, MA				Fitzpatrick, Kate E.; Gray, Ron; Quigley, Maria A.			Women's Longitudinal Patterns of Smoking during the Pre-Conception, Pregnancy and Postnatal Period: Evidence from the UK Infant Feeding Survey	PLOS ONE			English	Article							MODEL-SELECTION; CESSATION; RELAPSE; COHORT; EPIDEMIOLOGY; PREVALENCE; CRITERION; OUTCOMES	Background An understanding of women's longitudinal patterns of smoking during the pre-conception, pregnancy and postnatal period and the factors associated with these patterns could help better inform smoking cessation services and interventions. Methods Latent class analysis (LCA) was used to empirically identify women's smoking patterns in a sample of 10,768 mothers from the 2010 UK Infant Feeding Survey. Multinomial logistic regression was used to identify characteristics associated with these patterns. Results LCA identified five distinct smoking patterns during the pre-conception, pregnancy and postnatal period: "non-smokers" (74.1% of women); "pregnancy-inspired quitters" (10.2%); "persistent smokers" (10.1%); "temporary quitters" (4.4%); and postnatal quitters (1.1%). Smoking patterns varied markedly according to socio-demographic variables and parity. After adjusting for these variables, mothers who lived during pregnancy with a partner who smoked were more likely to be temporary quitters (aOR 2.64, 95% CI 1.74-3.99) or persistent smokers (aOR 3.32, 95% CI 2.34-4.72) than pregnancy-inspired quitters. Mothers who lived during pregnancy with someone else other than a partner who smoked were more likely to be persistent smokers (aOR 2.34, 95% CI 1.38-3.97) or postnatal quitters (aOR 2.97, 95% CI 1.078.24) than pregnancy-inspired quitters. Mothers given information on how their partner could stop smoking if they lived during pregnancy with a smoking partner were less likely to be persistent smokers (aOR 0.42, 95% CI 0.27-0.65) than pregnancy-inspired quitters. Conclusion Health professionals should ask about smoking at every opportunity, and refer women who self-report as current smokers to an evidence based smoking cessation service.	[Fitzpatrick, Kate E.; Gray, Ron; Quigley, Maria A.] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Policy Res Unit Maternal Hlth & Care, Oxford, England	University of Oxford	Quigley, MA (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Policy Res Unit Maternal Hlth & Care, Oxford, England.	maria.quigley@npeu.ox.ac.uk		Quigley, Maria/0000-0002-8058-6181	Policy Research Programme in the Department of Health	Policy Research Programme in the Department of Health	This paper reports on an independent study which is funded by the Policy Research Programme in the Department of Health. The views expressed are not necessarily those of the Department.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Chamberlain C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub4; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Colman GJ, 2003, AM J PREV MED, V24, P29, DOI 10.1016/S0749-3797(02)00574-3; Flemming K, 2015, J ADV NURS, V71, P1210, DOI 10.1111/jan.12580; Gray R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3754; Harmer C, 2013, NICOTINE TOB RES, V15, P904, DOI 10.1093/ntr/nts221; Hauge LJ, 2013, NICOTINE TOB RES, V15, P428, DOI 10.1093/ntr/nts147; Health and Social Care Information Centre, 2014, STAT WOM SMOK STAT T, V4; Health and Social Care Information Centre, 2012, STAT WOM SMOK STAT T; Hemsing N, 2009, NICE RAPID REV; Kahn RS, 2002, AM J PUBLIC HEALTH, V92, P1801, DOI 10.2105/AJPH.92.11.1801; Lanza ST, 2014, CA STATA PLUGIN USER; Lu Y, 2001, HEALTH PROMOT INT, V16, P355, DOI 10.1093/heapro/16.4.355; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; McAndrew F, 2012, INFANT FEEDING SURVE; Mumford EA, 2014, MATERN CHILD HLTH J, V18, P810, DOI 10.1007/s10995-013-1305-y; Munafo M, 2008, NICOTINE TOB RES, V10, P1609, DOI 10.1080/14622200802412895; Murphy DJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h297; Myers K., 2009, RAPID REV INTERVENTI; National Institute for Health & Clinical Excellence, 2010, NICE PUBL HLTH GUID; Prady SL, 2012, MATERN CHILD HLTH J, V16, P1364, DOI 10.1007/s10995-011-0899-1; Raisanen S, 2014, J EPIDEMIOL COMMUN H, V68, P159, DOI 10.1136/jech-2013-202991; *ROYAL COLL PHYS, 1992, SMOK YOUNG REP WORK; Royal College of Physicians, 2010, PASS SMOK CHILDR; Salihu HM, 2007, EARLY HUM DEV, V83, P713, DOI 10.1016/j.earlhumdev.2007.08.002; Schneider S, 2008, EUR J CONTRACEP REPR, V13, P138, DOI 10.1080/13625180802027993; Schneider S, 2010, DRUG ALCOHOL REV, V29, P81, DOI 10.1111/j.1465-3362.2009.00098.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; Shipton D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4347; Solomon LJ, 2007, DRUG ALCOHOL DEPEN, V90, P224, DOI 10.1016/j.drugalcdep.2007.03.012	35	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153447	10.1371/journal.pone.0153447	http://dx.doi.org/10.1371/journal.pone.0153447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27111661	gold, Green Published, Green Submitted			2022-12-27	WOS:000374970600014
J	Ye, H; Yan, ST; Jin, ZJ				Ye, Hao; Yan, Sunting; Jin, Zhijiang			Collapse of Corroded Pipelines under Combined Tension and External Pressure	PLOS ONE			English	Article							THICK-WALLED TUBES; HYDROSTATIC-PRESSURE; ASYMMETRIC COLLAPSE; CYLINDRICAL-SHELLS; OFFSHORE PIPELINES; NONUNIFORM; PIPES; LONG	In this work, collapse of corroded pipeline under combined external pressure and tension is investigated through numerical method. Axially uniform corrosion with symmetric imperfections is firstly considered. After verifying with existing experimental results, the finite element model is used to study the effect of tension on collapse pressure. An extensive parametric study is carried out using Python script and FORTRAN subroutine to investigate the influence of geometric parameters on the collapse behavior under combined loads. The results are used to develop an empirical equation for estimating the collapse pressure under tension. In addition, the effects of loading path, initial imperfection length, yielding anisotropy and corrosion defect length on the collapse behavior are also investigated. It is found that tension has a significant influence on collapse pressure of corroded pipelines. Loading path and anisotropic yielding are also important factors affecting the collapse behavior. For pipelines with relatively long corrosion defect, axially uniform corrosion models could be used to estimate the collapse pressure.	[Ye, Hao; Yan, Sunting; Jin, Zhijiang] Zhejiang Univ, Inst Proc Equipment, Coll Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Jin, ZJ (corresponding author), Zhejiang Univ, Inst Proc Equipment, Coll Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China.	jzj@zju.edu.cn		JIN, Zhi-jiang/0000-0002-8063-709X	National Natural Science Foundation of China [51175454]; Key Science-Technology Team of Zhejiang Province [2011R50005]; Zhejiang Science and Technology Plan Project [2012C11002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science-Technology Team of Zhejiang Province; Zhejiang Science and Technology Plan Project	This research was supported by the National Natural Science Foundation of China (51175454), Key Science-Technology Team of Zhejiang Province (2011R50005) and Zhejiang Science and Technology Plan Project (2012C11002). It is ZJ who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ABAQUS US MAN VERS 6; API Specification 5L, 2000, SPEC LIN PIP; BAI Y, 1995, J CONSTR STEEL RES, V32, P233, DOI 10.1016/0143-974X(95)93897-D; Corona E, 2000, J ENG MECH-ASCE, V126, P1232, DOI 10.1061/(ASCE)0733-9399(2000)126:12(1232); CORONA E, 1988, INT J SOLIDS STRUCT, V24, P505, DOI 10.1016/0020-7683(88)90005-4; CORONA E, 1987, J PRESS VESS-T ASME, V109, P302, DOI 10.1115/1.3264868; DYAU JY, 1993, INT J SOLIDS STRUCT, V30, P463, DOI 10.1016/0020-7683(93)90181-6; Fatt MSH, 1999, THIN WALL STRUCT, V35, P117, DOI 10.1016/S0263-8231(99)00021-X; Gere JM., 1961, THEORY ELASTIC STABI; Gong SF, 2013, SHIPS OFFSHORE STRUC, V8, P176, DOI 10.1080/17445302.2012.691273; Gong SF, 2011, J ZHEJIANG UNIV-SC A, V12, P627, DOI 10.1631/jzus.A1000489; He T, 2014, APPL OCEAN RES, V47, P199, DOI 10.1016/j.apor.2014.05.006; HILL R, 1948, PROC R SOC LON SER-A, V193, P281, DOI 10.1098/rspa.1948.0045; Kyriakides S., 2007, MECH OFFSHORE PIPELI; MADHAVAN R, 1993, J PRESS VESS-T ASME, V115, P15, DOI 10.1115/1.2929488; Netto TA, 2007, INT J SOLIDS STRUCT, V44, P7597, DOI 10.1016/j.ijsolstr.2007.04.028; Netto TA, 2010, APPL OCEAN RES, V32, P132, DOI 10.1016/j.apor.2009.12.007; Netto TA, 2009, APPL OCEAN RES, V31, P75, DOI 10.1016/j.apor.2009.07.004; Pinna R, 2000, J CONSTR STEEL RES, V56, P1, DOI 10.1016/S0143-974X(99)00104-2; Sakakibara N, 2008, INT J MECH SCI, V50, P1586, DOI 10.1016/j.ijmecsci.2008.10.006; Xue J, 2002, ENG STRUCT, V24, P1027, DOI 10.1016/S0141-0296(02)00029-9; Xue JH, 2008, J PRESS VESS-T ASME, V130, DOI 10.1115/1.2894293; Yan ST, 2015, ENG FAIL ANAL, V55, P39, DOI 10.1016/j.engfailanal.2015.05.005; Yan Sunting, 2014, Advanced Materials Research, V1008-1009, P1134, DOI 10.4028/www.scientific.net/AMR.1008-1009.1134; YEH MK, 1986, J ENERG RESOUR-ASME, V108, P35, DOI 10.1115/1.3231239	25	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154314	10.1371/journal.pone.0154314	http://dx.doi.org/10.1371/journal.pone.0154314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111544	Green Published, Green Submitted, gold			2022-12-27	WOS:000374970600056
J	Zhang, FP; Yang, QY; Zhang, SB				Zhang, Feng-Ping; Yang, Qiu-Yun; Zhang, Shi-Bao			Dual Effect of Phenolic Nectar on Three Floral Visitors of Elsholtzia rugulosa (Lamiaceae) in SW China	PLOS ONE			English	Article							4-HYDROXYBENZOIC ACID; TOXIC NECTAR; SALICYLIC-ACID; PLANT; HONEYS; COMPONENTS; MODULATE; FLOWERS; FILTER; BIRD	Some plants secrete toxic nectar to appeal to most effective pollinators and deter non-pollinators or nectar thieves; however available information about ecological function of toxic nectar remains scarce. Elsholtzia rugulosa stands out as a plant with toxic nectar recorded in SW China. We focused on the functional significance of the phenolic compound that imparts toxic to the nectar of E. rugulosa. The effects of phenolic nectar were studied in three visitors of the flowers of the winter-blooming E. rugulosa Hemsl. (Lamiaceae) in SW China. The pollinating species Apis cerana Fabricius (Apidae; Asian honey bee) and two occasional visitors, Vespa velutina Lepeletier (Vespidae; yellow-legged Asian hornet) and Bombus eximius Smith (Apidae; a bumble bee) were tested for their preferences for low and high concentrations of 4-hydroxybenzoic acid in hexose and sucrose solutions. The pollinator is important for the plant, which is dependent on pollinator visits to attain a higher seed production and it is most likely that the combination of phenolic toxic nectar and the adaptation to phenolic nectar by A. cerana delivers an evolutionary advantage to both actors. The low and high concentrations of the phenolic acid were nearly totally refused by both occasional visitors V. velutina and B. eximius and were preferred by the pollinator A. cerana. E. rugulosa gains by having a much higher seed production and the pollinating honey bee by having an exclusive and reliable food source during the winter season at high altitudes in SW China. We found that the function of the toxic phenolic compound has dual roles by appealing to legitimate pollinators and deterring non-pollinators of E. rugulosa.	[Zhang, Feng-Ping; Yang, Qiu-Yun; Zhang, Shi-Bao] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming 650201, Yunnan, Peoples R China; [Zhang, Feng-Ping; Yang, Qiu-Yun; Zhang, Shi-Bao] Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Res & Dev Wild Plant Resources, Kunming 650201, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Zhang, SB (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming 650201, Yunnan, Peoples R China.; Zhang, SB (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Res & Dev Wild Plant Resources, Kunming 650201, Yunnan, Peoples R China.	sbzhang@mail.kib.ac.cn			National Natural Science Foundation of China [31300200, 31170315, 31370362]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Natural Science Foundation of China (31300200, 31170315, 31370362).	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; BACH M, 1993, PLANT PHYSIOL, V103, P407, DOI 10.1104/pp.103.2.407; Baker H. G., 1975, Coevolution of animals and plants. Symposium 5 of the 1st International Congress of Systematic and Evolutionary Biology, Boulder, Colorado, USA. (Editors L. E. Gilbert and P. H. Raven)., P100; BAKER HG, 1977, APIDOLOGIE, V8, P349, DOI 10.1051/apido:19770405; BERNARDELLO LM, 1994, BIOTROPICA, V26, P113, DOI 10.2307/2389115; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; Frankel S, 1998, J APICULT RES, V37, P27, DOI 10.1080/00218839.1998.11100951; Gheldof N, 2002, J AGR FOOD CHEM, V50, P5870, DOI 10.1021/jf0256135; Gronquist M, 2001, P NATL ACAD SCI USA, V98, P13745, DOI 10.1073/pnas.231471698; HAGLER JR, 1993, J KANSAS ENTOMOL SOC, V66, P223; HASLAM E, 1988, J CHEM ECOL, V14, P1789, DOI 10.1007/BF01013477; Horvath E, 2007, BIOL PLANTARUM, V51, P480, DOI 10.1007/s10535-007-0101-1; Ish-Am G, 1998, J HORTIC SCI BIOTECH, V73, P195, DOI 10.1080/14620316.1998.11510965; Janzen DH, 1977, BIOTROPICA, V9, P1252, DOI 10.2307/2388142; Johnson SD, 2006, ECOLOGY, V87, P2709, DOI 10.1890/0012-9658(2006)87[2709:DBNFAA]2.0.CO;2; Kevan P.G., 1995, P113; Liu F, 2007, FUNCT ECOL, V21, P96, DOI 10.1111/j.1365-2435.2006.01200.x; Liu FL, 2004, J APICULT RES, V43, P155; Liu FL, 2004, AM BEE J, V144, P707; Nagai T, 2001, FOOD CHEM, V75, P237, DOI 10.1016/S0308-8146(01)00193-5; Nicolson SW, 2015, EVOL ECOL, V29, P405, DOI 10.1007/s10682-014-9718-7; RHOADES DF, 1981, AM NAT, V117, P798, DOI 10.1086/283765; Rosenthal G.A., 1991, HERBIVORES THEIR INT, V1; Shi B, 2000, PLANT POLYPHENOLS, V280; Smith-Becker J, 1998, PLANT PHYSIOL, V116, P231, DOI 10.1104/pp.116.1.231; Tan K, 2012, ANIM BEHAV, V84, P1589, DOI 10.1016/j.anbehav.2012.09.037; Winston M.L., 1987, BIOL HONEY BEE, p[169, 46]	27	12	13	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154381	10.1371/journal.pone.0154381	http://dx.doi.org/10.1371/journal.pone.0154381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105024	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100070
J	Zoladz, JA; Majerczak, J; Grassi, B; Szkutnik, Z; Korostynski, M; Golda, S; Grandys, M; Jarmuszkiewicz, W; Kilarski, W; Karasinski, J; Korzeniewski, B				Zoladz, Jerzy A.; Majerczak, Joanna; Grassi, Bruno; Szkutnik, Zbigniew; Korostynski, Michal; Golda, Slawomir; Grandys, Marcin; Jarmuszkiewicz, Wieslawa; Kilarski, Wincenty; Karasinski, Janusz; Korzeniewski, Bernard			Mechanisms of Attenuation of Pulmonary V'O-2 Slow Component in Humans after Prolonged Endurance Training	PLOS ONE			English	Article							OXYGEN-UPTAKE KINETICS; SKELETAL-MUSCLE FATIGUE; OXIDATIVE-PHOSPHORYLATION; O-2 UPTAKE; SUBMAXIMAL EXERCISE; POWER-OUTPUT; ON-KINETICS; PROGRESSIVE RECRUITMENT; INDUCED ACCELERATION; INTENSITY EXERCISE	In this study we have examined the effect of prolonged endurance training program on the pulmonary oxygen uptake (V'O-2) kinetics during heavy-intensity cycling-exercise and its impact on maximal cycling and running performance. Twelve healthy, physically active men (mean +/- SD: age 22.33 +/- 1.44 years, V'O-2peak 3198 +/- 458 mL.min(-1)) performed an endurance training composed mainly of moderate-intensity cycling, lasting 20 weeks. Training resulted in a decrease (by similar to 5%, P = 0.027) in V'O-2 during prior low-intensity exercise (20 W) and in shortening of tau(p) of the V'O-2 on-kinetics (30.1 +/- 5.9 s vs. 25.4 +/- 1.5 s, P = 0.007) during subsequent heavy-intensity cycling. This was accompanied by a decrease of the slow component of V'O-2 on-kinetics by 49% (P = 0.001) and a decrease in the end-exercise V'O-2 by similar to 5% (P = 0.005). An increase (P = 0.02) in the vascular endothelial growth factor receptor 2 mRNA level and a tendency (P = 0.06) to higher capillary-to-fiber ratio in the vastus lateralis muscle were found after training (n = 11). No significant effect of training on the V'O-2peak was found (P = 0.12). However, the power output reached at the lactate threshold increased by 19% (P = 0.01). The power output obtained at the V'O-2peak increased by 14% (P = 0.003) and the time of 1,500-m performance decreased by 5% (P = 0.001). Computer modeling of the skeletal muscle bioenergetic system suggests that the training-induced decrease in the slow component of V'O-2 on-kinetics found in the present study is mainly caused by two factors: an intensification of the each-step activation (ESA) of oxidative phosphorylation (OXPHOS) complexes after training and decrease in the "additional" ATP usage rising gradually during heavy-intensity exercise.	[Zoladz, Jerzy A.; Majerczak, Joanna; Grandys, Marcin] Univ Sch Phys Educ, Fac Rehabil, Dept Muscle Physiol, Chair Physiol & Biochem, Krakow, Poland; [Grassi, Bruno] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy; [Szkutnik, Zbigniew] AGH Univ Sci & Technol, Fac Appl Math, PL-30059 Krakow, Poland; [Korostynski, Michal; Golda, Slawomir] Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, Krakow, Poland; [Jarmuszkiewicz, Wieslawa] Adam Mickiewicz Univ, Inst Mol Biol & Biotechnol, Dept Bioenerget, Poznan, Poland; [Kilarski, Wincenty; Karasinski, Janusz] Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, PL-30060 Krakow, Poland; [Korzeniewski, Bernard] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland	University of Udine; AGH University of Science & Technology; Polish Academy of Sciences; Adam Mickiewicz University; Jagiellonian University; Jagiellonian University	Zoladz, JA (corresponding author), Univ Sch Phys Educ, Fac Rehabil, Dept Muscle Physiol, Chair Physiol & Biochem, Krakow, Poland.	jerzy.zoladz@awf.krakow.pl	Szkutnik, Zbigniew/B-2214-2014; Grassi, Bruno/AAC-7262-2022; Korostynski, Michal/AAS-2626-2021; Grandys, Marcin/B-1839-2017; Karasiński, Janusz/U-4476-2018; Majerczak, Joanna/V-7492-2019	Szkutnik, Zbigniew/0000-0002-4607-6268; Korostynski, Michal/0000-0002-4273-7401; Grandys, Marcin/0000-0001-6438-8540; Karasiński, Janusz/0000-0001-8869-3216; Majerczak, Joanna/0000-0003-0898-1707; Golda, Slawomir/0000-0002-5834-8590; Golda, Slawomir/0000-0003-1663-0587; Zoladz, Jerzy A./0000-0002-1143-5590; Jarmuszkiewicz, Wieslawa/0000-0001-8550-8337	European Union [POIG.01.01.02-00-069/09]	European Union(European Commission)	This work was supported by the European Union from the resources of the European Regional Development Fund under the Innovative Economy Program (grant coordinated by JCET-UJ, No. POIG.01.01.02-00-069/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay CJ, 1996, J PHYSIOL-LONDON, V497, P781, DOI 10.1113/jphysiol.1996.sp021809; BARSTOW TJ, 1994, J APPL PHYSIOL, V77, P1742, DOI 10.1152/jappl.1994.77.4.1742; Barstow TJ, 1996, J APPL PHYSIOL, V81, P1642, DOI 10.1152/jappl.1996.81.4.1642; Borrani F, 2001, J APPL PHYSIOL, V90, P2212, DOI 10.1152/jappl.2001.90.6.2212; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; Cannon DT, 2014, J PHYSIOL-LONDON, V592, P5287, DOI 10.1113/jphysiol.2014.279174; Cannon DT, 2011, J PHYSIOL-LONDON, V589, P727, DOI 10.1113/jphysiol.2010.197723; Carter H, 2000, J APPL PHYSIOL, V89, P1744, DOI 10.1152/jappl.2000.89.5.1744; CASABURI R, 1987, J APPL PHYSIOL, V62, P199, DOI 10.1152/jappl.1987.62.1.199; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; Grassi B, 1996, J APPL PHYSIOL, V80, P988, DOI 10.1152/jappl.1996.80.3.988; Grassi B, 2005, MED SCI SPORT EXER, V37, P1567, DOI 10.1249/01.mss.0000177472.67419.0a; Grassi B, 2015, EXERC SPORT SCI REV, V43, P75, DOI 10.1249/JES.0000000000000043; Grassi B, 2011, EUR J APPL PHYSIOL, V111, P345, DOI 10.1007/s00421-010-1609-1; Haseler LJ, 1998, J APPL PHYSIOL, V85, P1457, DOI 10.1152/jappl.1998.85.4.1457; Hepple RT, 2010, AM J PHYSIOL-REG I, V298, pR983, DOI 10.1152/ajpregu.00715.2009; Hochachka PW, 1997, J EXP BIOL, V200, P381; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Jarmuszkiewicz W, 2015, FREE RADICAL BIO MED, V83, P12, DOI 10.1016/j.freeradbiomed.2015.02.012; Jones A. M., 2005, OXYGEN UPTAKE KINETI, P373; Jones AM, 2011, MED SCI SPORT EXER, V43, P2046, DOI 10.1249/MSS.0b013e31821fcfc1; Jones AM, 2010, MED SCI SPORT EXER, V42, P1876, DOI 10.1249/MSS.0b013e3181d9cf7f; Koga S, 2014, MED SCI SPORT EXER, V46, P860, DOI 10.1249/MSS.0000000000000178; Korzeniewski B, 2003, BIOCHEM J, V375, P799, DOI 10.1042/BJ20030882; Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189; Korzeniewski B, 2003, BIOCHEM J, V374, P37, DOI 10.1042/BJ20030526; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Korzeniewski B, 2004, BIOPHYS CHEM, V110, P147, DOI 10.1016/j.bpc.2004.01.011; Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013; Korzeniewski B, 2015, J PHYSIOL-LONDON, V593, P5255, DOI 10.1113/JP271299; Korzeniewski B, 2015, J APPL PHYSIOL, V118, P1240, DOI 10.1152/japplphysiol.00027.2015; Korzeniewski B, 2014, J APPL PHYSIOL, V116, P83, DOI 10.1152/japplphysiol.00759.2013; LAMARRA N, 1987, J APPL PHYSIOL, V62, P2003, DOI 10.1152/jappl.1987.62.5.2003; Liguzinski P, 2007, AM J PHYSIOL-HEART C, V293, pH343, DOI 10.1152/ajpheart.01371.2006; Liguzinski P, 2006, AM J PHYSIOL-CELL PH, V291, pC1213, DOI 10.1152/ajpcell.00078.2006; Majerczak J, 2014, J PHYSIOL PHARMACOL, V65, P217; Majerczak J, 2012, EXP PHYSIOL, V97, P386, DOI 10.1113/expphysiol.2011.062992; Murias JM, 2014, EXERC SPORT SCI REV, V42, P4, DOI 10.1249/JES.0000000000000005; Phillips SM, 1995, J APPL PHYSIOL, V79, P1914, DOI 10.1152/jappl.1995.79.6.1914; Poole D.C., 2005, OXYGEN UPTAKE KINETI, P294; POOLE DC, 1994, J APPL PHYSIOL, V76, P787, DOI 10.1152/jappl.1994.76.2.787; POOLE DC, 1991, J APPL PHYSIOL, V71, P1245, DOI 10.1152/jappl.1991.71.4.1245; POOLE DC, 1992, J APPL PHYSIOL, V72, P805, DOI 10.1152/jappl.1992.72.2.805; POOLE DC, 1988, ERGONOMICS, V31, P1265, DOI 10.1080/00140138808966766; Pringle JSM, 2003, EUR J APPL PHYSIOL, V89, P289, DOI 10.1007/s00421-003-0799-1; Rossiter HB, 2011, COMPR PHYSIOL, V1, P203, DOI 10.1002/cphy.c090010; Rossiter HB, 2002, J PHYSIOL-LONDON, V541, P991, DOI 10.1113/jphysiol.2001.012910; ROSTON WL, 1987, AM REV RESPIR DIS, V135, P1080; Vanhatalo A, 2011, AM J PHYSIOL-REG I, V300, pR700, DOI 10.1152/ajpregu.00761.2010; WHIPP BJ, 1986, FED PROC, V45, P2942; Whipp BJ., 2005, OXYGEN UPTAKE KINETI, V62, P94; WILLIS WT, 1994, MED SCI SPORT EXER, V26, P1347; WILSON DF, 1979, ARCH BIOCHEM BIOPHYS, V195, P485, DOI 10.1016/0003-9861(79)90375-8; Woledge RC, 1998, ACTA PHYSIOL SCAND, V162, P267, DOI 10.1046/j.1365-201X.1998.0294e.x; WOMACK CJ, 1995, J APPL PHYSIOL, V79, P838, DOI 10.1152/jappl.1995.79.3.838; Wust RCI, 2011, J PHYSIOL-LONDON, V589, P3995, DOI 10.1113/jphysiol.2010.203422; Zoladz J, 1998, J PHYSIOL PHARMACOL, V49, P443; Zoladz JA, 2006, J PHYSIOL PHARMACOL, V57, P67; Zoladz JA, 2005, J APPL PHYSIOL, V98, P895, DOI 10.1152/japplphysiol.01194.2003; ZOLADZ JA, 1995, J PHYSIOL-LONDON, V488, P211, DOI 10.1113/jphysiol.1995.sp020959; ZOLADZ JA, 1993, EUR J APPL PHYSIOL O, V67, P71, DOI 10.1007/BF00377708; Zoladz JA, 2001, J PHYSIOL PHARMACOL, V52, P167; Zoladz JA, 2008, J APPL PHYSIOL, V105, P575, DOI 10.1152/japplphysiol.01129.2007; Zoladz JA, 2014, AM J PHYSIOL-REG I, V307, pR1101, DOI 10.1152/ajpregu.00046.2014; Zoladz JA, 2013, EXP PHYSIOL, V98, P883, DOI 10.1113/expphysiol.2012.069443	68	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154135	10.1371/journal.pone.0154135	http://dx.doi.org/10.1371/journal.pone.0154135			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104346	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100047
J	Gasca-Salas, C; Masellis, M; Khoo, E; Shah, BB; Fisman, D; Lang, AE; Kleiner-Fisman, G				Gasca-Salas, Carmen; Masellis, Mario; Khoo, Edwin; Shah, Binit B.; Fisman, David; Lang, Anthony E.; Kleiner-Fisman, Galit			Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; AMYOTROPHIC-LATERAL-SCLEROSIS; C9ORF72 REPEAT EXPANSIONS; TAU-GENE; PHENOTYPIC VARIABILITY; CORTICOBASAL SYNDROME; HEXANUCLEOTIDE REPEAT; P301L MUTATION; SITE MUTATION; PPND FAMILY	Background Mutations in granulin (PGRN) and tau (MAPT), and hexanucleotide repeat expansions near the C9orf72 genes are the most prevalent genetic causes of frontotemporal lobar degeneration. Although behavior, language and movement presentations are common, the relationship between genetic subgroup and movement disorder phenomenology is unclear. Objective We conducted a systematic review and meta-analysis of the literature characterizing the spectrum and prevalence of movement disorders in genetic frontotemporal lobar degeneration. Methods Electronic databases were searched using terms related to frontotemporal lobar degeneration and movement disorders. Articles were included when cases had a proven genetic cause. Study-specific prevalence estimates for clinical features were transformed using Freeman-Tukey arcsine transformation, allowing for pooled estimates of prevalence to be generated using random-effects models. Results The mean age at onset was earlier in those with MAPT mutations compared to PGRN (p<0.001) and C9orf72 (p = 0.024). 66.5% of subjects had an initial non-movement presentation that was most likely a behavioral syndrome (35.7%). At any point during the disease, parkinsonism was the most common movement syndrome reported in 79.8% followed by progressive supranuclear palsy (PSPS) and corticobasal (CBS) syndromes in 12.2% and 10.7%, respectively. The prevalence of movement disorder as initial presentation was higher in MAPT subjects (35.8%) compared to PGRN subjects (10.1). In those with a non-movement presentation, language disorder was more common in PGRN subjects (18.7%) compared to MAPT subjects (5.4%). Summary This represents the first systematic review and meta-analysis of the occurrence of movement disorder phenomenology in genetic frontotemporal lobar degeneration. Standardized prospective collection of clinical information in conjunction with genetic characterization will be crucial for accurate clinico-genetic correlation.	[Gasca-Salas, Carmen; Lang, Anthony E.] TWH, Morton & Gloria Shulman Movement Disorders Clin, Toronto, ON, Canada; [Gasca-Salas, Carmen; Lang, Anthony E.] TWH, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada; [Gasca-Salas, Carmen; Kleiner-Fisman, Galit] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Gasca-Salas, Carmen; Masellis, Mario] CEU San Pablo Univ, HM Hosp Puerta Sur, CINAC, Madrid, Spain; [Masellis, Mario] Sunnybrook Hlth Sci Ctr, Cognit & Movement Disorders Clin, Toronto, ON M4N 3M5, Canada; [Khoo, Edwin; Fisman, David] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Shah, Binit B.] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Kleiner-Fisman, Galit] Baycrest Ctr Geriatr Hlth, Jeff & Diane Ross Movement Disorders Clin, Toronto, ON, Canada	University of Toronto; San Pablo CEU University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Virginia; University of Toronto; University Toronto Affiliates; Baycrest	Gasca-Salas, C (corresponding author), TWH, Morton & Gloria Shulman Movement Disorders Clin, Toronto, ON, Canada.; Gasca-Salas, C (corresponding author), TWH, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada.; Gasca-Salas, C (corresponding author), Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada.; Gasca-Salas, C (corresponding author), CEU San Pablo Univ, HM Hosp Puerta Sur, CINAC, Madrid, Spain.	menchgasca@gmail.com	Lang, Anthony/ABF-8114-2021; Gasca-Salas, Carmen/J-6992-2019	Gasca-Salas, Carmen/0000-0001-7411-8106; Lang, Anthony/0000-0003-1229-3667				Annan Mariam, 2013, BMC Res Notes, V6, P343, DOI 10.1186/1756-0500-6-343; Antonell A, 2012, J ALZHEIMERS DIS, V31, P581, DOI 10.3233/JAD-2012-112120; Arosio B, 2013, J ALZHEIMERS DIS, V35, P669, DOI 10.3233/JAD-130053; Arvanitakis Z, 2007, PARKINSONISM RELAT D, V13, P230, DOI 10.1016/j.parkreldis.2006.10.007; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bermingham N, 2008, NEUROPATH APPL NEURO, V34, P366, DOI 10.1111/j.1365-2990.2007.00918.x; Boeve BF, 2005, BRAIN, V128, P752, DOI 10.1093/brain/awh356; Boeve BF, 2003, ANN NEUROL, V54, pS15, DOI 10.1002/ana.10570; Boeve BF, 2006, BRAIN, V129, P3103, DOI 10.1093/brain/awl268; Boeve BF, 2012, BRAIN, V135, P765, DOI 10.1093/brain/aws004; Boxer AL, 2011, J NEUROL NEUROSUR PS, V82, P196, DOI 10.1136/jnnp.2009.204081; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Cannon A, 2013, NEUROLOGY, V80, P1771, DOI 10.1212/WNL.0b013e3182919059; Carney RM, 2014, ALZHEIMERS DEMENT, V10, P360, DOI 10.1016/j.jalz.2013.02.011; Chaunu MP, 2013, J ALZHEIMERS DIS, V37, P769, DOI 10.3233/JAD-130413; Chen-Plotkin AS, 2011, ARCH NEUROL-CHICAGO, V68, P488, DOI 10.1001/archneurol.2011.53; Choumert A, 2012, MOVEMENT DISORD, V27, P581, DOI 10.1002/mds.24060; Chow TW, 1999, ARCH NEUROL-CHICAGO, V56, P817, DOI 10.1001/archneur.56.7.817; Coppola C, 2012, NEUROL SCI, V33, P93, DOI 10.1007/s10072-011-0655-8; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Fabio R, 2010, PARKINSONISM RELAT D, V16, P484, DOI 10.1016/j.parkreldis.2010.05.001; Dols-Icardo O, 2014, HUM MOL GENET, V23, P749, DOI 10.1093/hmg/ddt460; Dopper EGP, 2011, J MOL NEUROSCI, V45, P354, DOI 10.1007/s12031-011-9626-z; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Espay AJ, 2011, J MOL NEUROSCI, V45, P343, DOI 10.1007/s12031-011-9632-1; Ferman TJ, 2003, PARKINSONISM RELAT D, V9, P265, DOI 10.1016/S1353-8020(02)00098-6; Floris G, 2012, J NEUROL, V259, P1749, DOI 10.1007/s00415-012-6444-3; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Fu YJ, 2010, ACTA NEUROPATHOL, V120, P21, DOI 10.1007/s00401-010-0649-2; Fujioka S, 2011, J MOL NEUROSCI, V45, P359, DOI 10.1007/s12031-011-9568-5; Galimberti D, 2013, BIOL PSYCHIAT, V74, P384, DOI 10.1016/j.biopsych.2013.01.031; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Ghetti B, 2008, NEURODEGENER DIS, V5, P215, DOI 10.1159/000113706; Grasbeck A, 2003, INT J GERIATR PSYCH, V18, P594, DOI 10.1002/gps.885; Hardy J, 2014, EXP NEUROL, V262, P75, DOI 10.1016/j.expneurol.2013.11.006; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirano S, 2006, NEUROLOGY, V66, P1276, DOI 10.1212/01.wnl.0000208515.50924.94; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis P, 2012, J NEUROL SCI, V318, P171, DOI 10.1016/j.jns.2012.04.002; Iseki E, 2001, ACTA NEUROPATHOL, V102, P285; Kelley BJ, 2009, NEUROBIOL AGING, V30, P739, DOI 10.1016/j.neurobiolaging.2007.08.022; Kertesz A, 2011, J MOL NEUROSCI, V45, P336, DOI 10.1007/s12031-011-9616-1; Knezevic A., 2008, STATNEWS, V73; Kobayashi T, 2002, J NEUROL, V249, P669, DOI 10.1007/s00415-002-0687-3; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kowalska Anna, 2002, Journal of Applied Genetics, V43, P535; Le Ber I, 2008, BRAIN, V131, P732, DOI 10.1093/brain/awn012; Le Ber I, 2007, HUM MUTAT, V28, P846, DOI 10.1002/humu.20520; Le Ber I, 2013, J ALZHEIMERS DIS, V34, P485, DOI 10.3233/JAD-121456; Lee SE, 2013, ALZ DIS ASSOC DIS, V27, P302, DOI 10.1097/WAD.0b013e31828cc357; Lesage S, 2013, BRAIN, V136, P385, DOI 10.1093/brain/aws357; Leverenz JB, 2007, BRAIN, V130, P1360, DOI 10.1093/brain/awm069; Lindquist SG, 2013, CLIN GENET, V83, P279, DOI 10.1111/j.1399-0004.2012.01903.x; Lippa CF, 2000, ANN NEUROL, V48, P850, DOI 10.1002/1531-8249(200012)48:6<850::AID-ANA5>3.3.CO;2-M; Lossos A, 2003, J NEUROL, V250, P733, DOI 10.1007/s00415-003-1074-4; Luigetti M, 2013, AMYOTROPH LAT SCL FR, V14, P66, DOI 10.3109/17482968.2012.692383; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Masellis M, 2006, BRAIN, V129, P3115, DOI 10.1093/brain/awl276; Mirra SS, 1999, J NEUROPATH EXP NEUR, V58, P335, DOI 10.1097/00005072-199904000-00004; Momeni P, 2010, CLIN NEUROL NEUROSUR, V112, P917, DOI 10.1016/j.clineuro.2010.07.015; Narozanska E, 2011, EUR J NEUROL, V18, P535, DOI 10.1111/j.1468-1331.2010.03107.x; Nasreddine ZS, 1999, ANN NEUROL, V45, P704, DOI 10.1002/1531-8249(199906)45:6<704::AID-ANA4>3.0.CO;2-X; Neumann M, 2005, NEUROPATH APPL NEURO, V31, P362, DOI 10.1111/j.1365-2990.2005.00629.x; Nuytemans K, 2014, MOVEMENT DISORD, V29, P827, DOI 10.1002/mds.25838; O'Dowd S, 2012, MOVEMENT DISORD, V27, P1072, DOI 10.1002/mds.25022; O'Dowd S, 2012, MOVEMENT DISORD, V27, P817, DOI 10.1002/mds.24052; Ogaki K, 2013, PARKINSONISM RELAT D, V19, P15, DOI 10.1016/j.parkreldis.2012.06.019; Origone P, 2013, AMYOTROPH LAT SCL FR, V14, P479, DOI 10.3109/21678421.2013.774020; Padovani A, 2007, NEUROSCI LETT, V422, P39, DOI 10.1016/j.neulet.2007.05.049; Pan XD, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-8; Parka HK, 2013, J MOV DISORD, V6, P1, DOI 10.14802/jmd.13001; Passov V, 2011, ARCH NEUROL-CHICAGO, V68, P376, DOI 10.1001/archneurol.2011.26; Pearson JP, 2011, J NEUROL, V258, P647, DOI 10.1007/s00415-010-5815-x; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pires C, 2013, J ALZHEIMERS DIS, V37, P335, DOI 10.3233/JAD-130146; Rademakers R, 2007, LANCET NEUROL, V6, P857, DOI 10.1016/S1474-4422(07)70221-1; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Rodriguez-Rodriguez E, 2013, PARKINSONISM RELAT D, V19, P768, DOI 10.1016/j.parkreldis.2013.04.008; Rohrer JD, 2010, NEUROLOGY, V75, P2204, DOI 10.1212/WNL.0b013e318202038c; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Rohrer JD, 2011, BRAIN, V134, P2565, DOI 10.1093/brain/awr198; Rohrer JD, 2011, NEURODEGENER DIS, V8, P149, DOI 10.1159/000319454; Rohrer JD, 2010, MOVEMENT DISORD, V25, P179, DOI 10.1002/mds.22946; Rossi G, 2008, MOVEMENT DISORD, V23, P893, DOI 10.1002/mds.21970; Rothman KJGS., 2008, MEASURES EFFECT MEAS; Rusina R, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-50; Savica R, 2012, ARCH NEUROL-CHICAGO, V69, P1164, DOI 10.1001/archneurol.2012.772; Sieben A, 2012, ACTA NEUROPATHOL, V124, P353, DOI 10.1007/s00401-012-1029-x; Sitek EJ, 2009, ACTA NEUROPSYCHIATR, V21, P209, DOI 10.1111/j.1601-5215.2009.00367.x; Siuda J, 2014, PARKINSONISM RELAT D, V20, P957, DOI 10.1016/j.parkreldis.2014.06.004; Skoglund L, 2008, EUR J NEUROL, V15, P156, DOI 10.1111/j.1468-1331.2007.02017.x; Snowden JS, 2012, J NEUROL NEUROSUR PS, V83, P1031, DOI 10.1136/jnnp-2012-303032; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Soliveri P, 2003, ARCH NEUROL-CHICAGO, V60, P1454, DOI 10.1001/archneur.60.10.1454; Spagnolo F, 2011, MOVEMENT DISORD, V26, P2131, DOI 10.1002/mds.23768; Spector AR, 2011, ANN NEUROL, V69, P1014, DOI 10.1002/ana.22340; Sperfeld AD, 1999, ANN NEUROL, V46, P708, DOI 10.1002/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K; Spina S, 2007, J NEUROPATH EXP NEUR, V66, P892, DOI 10.1097/nen.0b013e3181567873; Spina S, 2007, ACTA NEUROPATHOL, V113, P461, DOI 10.1007/s00401-006-0182-5; Taipa R, 2012, J ALZHEIMERS DIS, V30, P83, DOI 10.3233/JAD-2012-112084; Takada LT, 2012, ARCH NEUROL-CHICAGO, V69, P1149, DOI 10.1001/archneurol.2012.650; Theuns J, 2014, NEUROLOGY, V83, P1906, DOI 10.1212/WNL.0000000000001012; Tolnay M, 2000, NEUROPATH APPL NEURO, V26, P368, DOI 10.1046/j.1365-2990.2000.00109.x; Tremolizzo L, 2011, MOVEMENT DISORD, V26, P1964, DOI 10.1002/mds.23749; Tsai RM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0319-0; TUKEY JW, 1977, SCIENCE, V198, P679, DOI 10.1126/science.333584; Warren JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4827; Werber E, 2003, MOVEMENT DISORD, V18, P595, DOI 10.1002/mds.10401; Wider C, 2008, MOVEMENT DISORD, V23, P1168, DOI 10.1002/mds.22065; Wszolek ZK, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-30; Xi ZR, 2012, ARCH NEUROL-CHICAGO, V69, P1583, DOI 10.1001/archneurol.2012.2016; Yasuda M, 2000, NEUROLOGY, V55, P1224, DOI 10.1212/WNL.55.8.1224; Zarranz JJ, 2005, NEUROLOGY, V64, P1578, DOI 10.1212/01.WNL.0000160116.65034.12	116	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153852	10.1371/journal.pone.0153852	http://dx.doi.org/10.1371/journal.pone.0153852			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100392	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500077
J	Pickles, K; Carter, SM; Rychetnik, L; McCaffery, K; Entwistle, VA				Pickles, Kristen; Carter, Stacy M.; Rychetnik, Lucie; McCaffery, Kirsten; Entwistle, Vikki A.			General Practitioners' Experiences of, and Responses to, Uncertainty in Prostate Cancer Screening: Insights from a Qualitative Study	PLOS ONE			English	Article							EXPRESSIONS; MEN	Background Prostate-specific antigen (PSA) testing for prostate cancer is controversial. There are unresolved tensions and disagreements amongst experts, and clinical guidelines conflict. This both reflects and generates significant uncertainty about the appropriateness of screening. Little is known about general practitioners' (GPs') perspectives and experiences in relation to PSA testing of asymptomatic men. In this paper we asked the following questions: (1) What are the primary sources of uncertainty as described by GPs in the context of PSA testing? (2) How do GPs experience and respond to different sources of uncertainty? Methods This was a qualitative study that explored general practitioners' current approaches to, and reasoning about, PSA testing of asymptomatic men. We draw on accounts generated from interviews with 69 general practitioners located in Australia (n = 40) and the United Kingdom (n = 29). The interviews were conducted in 2013-2014. Data were analysed using grounded theory methods. Uncertainty in PSA testing was identified as a core issue. Findings Australian GPs reported experiencing substantially more uncertainty than UK GPs. This seemed partly explainable by notable differences in conditions of practice between the two countries. Using Han et al's taxonomy of uncertainty as an initial framework, we first outline the different sources of uncertainty GPs (mostly Australian) described encountering in relation to prostate cancer screening and what the uncertainty was about. We then suggest an extension to Han et al's taxonomy based on our analysis of data relating to the varied ways that GPs manage uncertainties in the context of PSA testing. We outline three broad strategies: (1) taking charge of uncertainty; (2) engaging others in managing uncertainty; and (3) transferring the responsibility for reducing or managing some uncertainties to other parties. Conclusion Our analysis suggests some GPs experienced uncertainties associated with ambiguous guidance and the complexities of their situation as professionals with responsibilities to patients as considerably burdensome. This raises important questions about responsibility for uncertainty. In Australia in particular they feel insufficiently supported by the health care system to practice in ways that are recognisably consistent with 'evidence based' professional standards and appropriate for patients. More work is needed to clarify under what circumstances and how uncertainty should be communicated. Closer attention to different types and aspects of the uncertainty construct could be useful.	[Pickles, Kristen; Carter, Stacy M.] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia; [Rychetnik, Lucie] Univ Notre Dame, Sch Med, Sydney, NSW, Australia; [McCaffery, Kirsten] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Entwistle, Vikki A.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB9 1FX, Scotland	University of Sydney; University of Notre Dame Australia; University of Sydney; University of Aberdeen	Pickles, K (corresponding author), Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia.	kristen.pickles@sydney.edu.au	Entwistle, Vikki Ann/I-9266-2019; McCaffery, Kirsten/K-7945-2019; Pickles, Kristen/AAE-8668-2021; Carter, Stacy/A-6544-2011	Entwistle, Vikki Ann/0000-0002-0856-4025; McCaffery, Kirsten/0000-0003-2696-5006; Pickles, Kristen/0000-0002-1621-3217; Carter, Stacy/0000-0003-2617-8694; Rychetnik, Lucie/0000-0001-6855-2897	National Health and Medical Research Council [1023197, 1032963]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The project was funded by a National Health and Medical Research Council grant 1023197 (https://www.nhmrc.gov.au/). SMC and LR obtained funding and are CIs on the NHMRC funded project grant. SMC is supported by NHMRC Career Development Fellowship 1032963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON P, 1984, SOC SCI MED, V19, P949, DOI 10.1016/0277-9536(84)90324-1; Burt RS, 2005, BROKERAGE CLOSURE IN; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Chapple A, 2008, QUAL HEALTH RES, V18, P56, DOI 10.1177/1049732307309000; Charmaz K, 2007, SAGE HDB GROUNDED TH, DOI DOI 10.4135/9781848607941; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Frosch DL, 2003, J GEN INTERN MED, V18, P781, DOI 10.1046/j.1525-1497.2003.20911.x; Germino BB, 1998, CANCER PRACT, V6, P107, DOI 10.1046/j.1523-5394.1998.1998006107.x; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gordon GH, 2000, PATIENT EDUC COUNS, V40, P59, DOI 10.1016/S0738-3991(99)00069-5; Griffiths F, 2006, SOC SCI MED, V62, P1078, DOI 10.1016/j.socscimed.2005.07.027; Hall KH, 2002, MED EDUC, V36, P216, DOI 10.1046/j.1365-2923.2002.01140.x; Han PKJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003226; Han PKJ, 2013, MED CARE RES REV, V70, p14S, DOI 10.1177/1077558712459361; Han PKJ, 2011, MED DECIS MAKING, V31, P828, DOI 10.1177/0272989X11393976; Hewson MG, 1996, J GEN INTERN MED, V11, P481, DOI 10.1007/BF02599044; Hoffman JR, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5702; JOHNSON BB, 1995, RISK ANAL, V15, P485, DOI 10.1111/j.1539-6924.1995.tb00341.x; KATZ J, 1984, HASTINGS CENT REP, V14, P35, DOI 10.2307/3560848; MANSON Neil, 2007, RETHINKING INFORM CO; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Ogden J, 2002, PATIENT EDUC COUNS, V48, P171, DOI 10.1016/S0738-3991(02)00020-4; Parascandola M, 2002, KENNEDY INST ETHIC J, V12, P245, DOI 10.1353/ken.2002.0018; Pickles K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006367; Politi MC, 2007, MED DECIS MAKING, V27, P681, DOI 10.1177/0272989x07307270; QUILL TE, 1993, HUM MED, V9, P109; RACGP, 2012, GUID PREV ACT GEN PR; RIZZO JA, 1993, SOC SCI MED, V37, P1451, DOI 10.1016/0277-9536(93)90179-8; Volk Robert J, 2003, Ann Fam Med, V1, P22, DOI 10.1370/afm.7	30	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153299	10.1371/journal.pone.0153299	http://dx.doi.org/10.1371/journal.pone.0153299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100402	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500029
J	Zeyer, F; Mothes, B; Will, C; Carevic, M; Rottenberger, J; Nurnberg, B; Hartl, D; Handgretinger, R; Beer-Hammer, S; Kormann, MSD				Zeyer, Franziska; Mothes, Benedikt; Will, Clara; Carevic, Melanie; Rottenberger, Jennifer; Nuernberg, Bernd; Hartl, Dominik; Handgretinger, Rupert; Beer-Hammer, Sandra; Kormann, Michael S. D.			mRNA-Mediated Gene Supplementation of Toll-Like Receptors as Treatment Strategy for Asthma In Vivo	PLOS ONE			English	Article							AIRWAY HYPERRESPONSIVENESS; ALLERGIC-ASTHMA; POLYMORPHISM; EXPRESSION; DIAGNOSIS; EXPOSURE; HYGIENE; PSEUDOURIDINE; ASSOCIATION; POPULATION	Asthma is the most common chronic disease in childhood. Although several therapeutic options are currently available to control the symptoms, many drugs have significant side effects and asthma remains an incurable disease. Microbial exposure in early life reduces the risk of asthma and several studies have suggested protective effects of Toll-like receptor (TLR) activation. We showed previously that modified mRNA provides a safe and efficient therapeutic tool for in vivo gene supplementation. Since current asthma drugs do not take patient specific immune and TLR backgrounds into consideration, treatment with tailored mRNA could be an attractive approach to account for the patient's individual asthma phenotype. Therefore, we investigated the effect of a preventative treatment with combinations of Tlr1, Tlr2 and Tlr6 mRNA in a House Dust Mite-induced mouse model of asthma. We used chemically modified mRNA which is-in contrast to conventional viral vectors-non-integrating and highly efficient in gene transfer. In our study, we found that treatment with either Tlr1/2 mRNA or Tlr2/6 mRNA, but not Tlr2 mRNA alone, resulted in better lung function as well as reduced airway inflammation in vivo. The present results point to a potentially protective effect of TLR heterodimers in asthma pathogenesis.	[Zeyer, Franziska; Will, Clara; Carevic, Melanie; Rottenberger, Jennifer; Hartl, Dominik; Handgretinger, Rupert; Kormann, Michael S. D.] Univ Tubingen, Dept Pediat 1, Pediat Infectiol & Immunol, Translat Genom & Gene Therapy, Tubingen, Germany; [Mothes, Benedikt; Nuernberg, Bernd; Beer-Hammer, Sandra] Univ Tubingen, Dept Pharmacol & Expt Therapy, Tubingen, Germany; [Mothes, Benedikt; Nuernberg, Bernd; Beer-Hammer, Sandra] Univ Tubingen, ICePhA, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Kormann, MSD (corresponding author), Univ Tubingen, Dept Pediat 1, Pediat Infectiol & Immunol, Translat Genom & Gene Therapy, Tubingen, Germany.	michael.kormann@med.uni-tuebingen.de	Beer-Hammer, Sandra/AAK-4516-2020	Beer-Hammer, Sandra/0000-0001-6049-0257; Nurnberg, Bernd/0000-0002-5995-6555; Duckworth-Mothes, Benedikt/0000-0002-2352-2325	Deutsche Forschungsgemeinschaft (DFG) [DFG KO 4258/2-1]; University of Tubingen [2201-0-0]; European Respiratory Society (Maurizio Vignola Award); Gesellschaft fur Pulmonale Pneumologie (Klosterfrau grant); Interfaculty Center for Pharmacogenomics and Drug Research (ICEPHA Twinning Grant) [22-0-0]; DFG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Tubingen; European Respiratory Society (Maurizio Vignola Award); Gesellschaft fur Pulmonale Pneumologie (Klosterfrau grant); Interfaculty Center for Pharmacogenomics and Drug Research (ICEPHA Twinning Grant); DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de, DFG KO 4258/2-1, to MSDK), by the University of Tubingen with a fortune grant (no. 2201-0-0) and an IZKF graduate program grant (to FZ), by the European Respiratory Society (Maurizio Vignola Award, to MSDK), by the Gesellschaft fur Pulmonale Pneumologie (Klosterfrau grant, to MSDK), in part the Interfaculty Center for Pharmacogenomics and Drug Research (ICEPHA Twinning Grant 22-0-0, to SBH), and in part by the DFG (to BN and SBH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Aryan Z, 2015, CURR OPIN ALLERGY CL, V15, P568, DOI 10.1097/ACI.0000000000000212; Bezemer GFG, 2012, PHARMACOL REV, V64, P337, DOI 10.1124/pr.111.004622; Bottcher MF, 2004, J ALLERGY CLIN IMMUN, V114, P561, DOI 10.1016/j.jaci.2004.04.050; BOUSQUET J, 1992, ALLERGY, V47, P129, DOI 10.1111/j.1398-9995.1992.tb00952.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Brown EM, 2013, SEMIN IMMUNOL, V25, P378, DOI 10.1016/j.smim.2013.09.003; Chen SZ, 2012, J ASTHMA, V49, P999, DOI 10.3109/02770903.2012.738270; Cohn L, 1998, J IMMUNOL, V161, P3813; Cui XY, 2015, OTOLARYNG HEAD NECK, V152, P233, DOI 10.1177/0194599814562173; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Ferreira DS, 2012, CLIN EXP ALLERGY, V42, P1459, DOI 10.1111/j.1365-2222.2012.04047.x; Fleming L, 2015, EUR RESPIR J, V46, P1322, DOI 10.1183/13993003.00780-2015; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; Guilbert TW, 2014, J ALLER CL IMM-PRACT, V2, P489, DOI 10.1016/j.jaip.2014.06.022; Hoffjan S, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-34; Holgate ST, 2006, LANCET, V368, P780, DOI 10.1016/S0140-6736(06)69288-X; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2012, MOL THER, V20, P948, DOI 10.1038/mt.2012.7; Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695; Kim DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125983; Koponen P, 2014, PEDIATR INFECT DIS J, V33, P463, DOI 10.1097/INF.0000000000000253; Kormann MSD, 2008, J ALLERGY CLIN IMMUN, V122, P86, DOI 10.1016/j.jaci.2008.04.039; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Kvarnhammar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068701; Li XD, 2014, ALLERGY ASTHMA PROC, V35, pE15, DOI 10.2500/aap.2014.35.3735; Liu CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075983; Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241; Martinez FD, 1999, LANCET, V354, pS12, DOI 10.1016/S0140-6736(99)90437-3; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Mays LE, 2013, J CLIN INVEST, V123, P1216, DOI 10.1172/JCI65351; Moreira AP, 2011, J CLIN INVEST, V121, P4420, DOI 10.1172/JCI44999; Renkonen J, 2010, J ASTHMA ALLERGY, V3, P177, DOI 10.2147/JAA.S14459; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sahin F, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-20; SEARS MR, 1993, ALLERGY, V48, P12, DOI 10.1111/j.1398-9995.1993.tb04692.x; Sherriff A, 2002, ARCH DIS CHILD, V87, P26, DOI 10.1136/adc.87.1.26; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259	39	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154001	10.1371/journal.pone.0154001	http://dx.doi.org/10.1371/journal.pone.0154001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101288	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500119
J	Bak, TH; Long, MR; Vega-Mendoza, M; Sorace, A				Bak, Thomas H.; Long, Madeleine R.; Vega-Mendoza, Mariana; Sorace, Antonella			Novelty, Challenge, and Practice: The Impact of Intensive Language Learning on Attentional Functions	PLOS ONE			English	Article							BILINGUAL ADVANTAGE; EXECUTIVE-CONTROL; ENGAGEMENT; DEMENTIA; ONSET	We investigated the impact of a short intensive language course on attentional functions. We examined 33 participants of a one-week Scottish Gaelic course and compared them to 34 controls: 16 active controls who participated in courses of comparable duration and intensity but not involving foreign language learning and 18 passive controls who followed their usual routines. Participants completed auditory tests of attentional inhibition and switching. There was no difference between the groups in any measures at the beginning of the course. At the end of the course, a significant improvement in attention switching was observed in the language group (p<.001) but not the control group (p=.127), independent of the age of participants (18-78 years). Half of the language participants (n = 17) were retested nine months after their course. All those who practiced Gaelic 5 hours or more per week improved from their baseline performance. In contrast, those who practiced 4 hours or fewer showed an inconsistent pattern: some improved while others stayed the same or deteriorated. Our results suggest that even a short period of intensive language learning can modulate attentional functions and that all age groups can benefit from this effect. Moreover, these short-term effects can be maintained through continuous practice.	[Bak, Thomas H.; Long, Madeleine R.; Vega-Mendoza, Mariana] Univ Edinburgh, Dept Psychol, Sch Philosophy Psychol & Language Sci, Edinburgh, Midlothian, Scotland; [Bak, Thomas H.; Long, Madeleine R.] Ctr Cognit Ageing & Cognit Epidemiol CCACE, Edinburgh, Midlothian, Scotland; [Long, Madeleine R.; Sorace, Antonella] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Dept Linguist, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Bak, TH (corresponding author), Univ Edinburgh, Dept Psychol, Sch Philosophy Psychol & Language Sci, Edinburgh, Midlothian, Scotland.; Bak, TH (corresponding author), Ctr Cognit Ageing & Cognit Epidemiol CCACE, Edinburgh, Midlothian, Scotland.	thomas.bak@ed.ac.uk		Vega-Mendoza, Mariana/0000-0003-2511-1631	School of Philosophy, Psychology and Language Studies of the University of Edinburgh; Medical Research Council [MR/K026992/1] Funding Source: researchfish	School of Philosophy, Psychology and Language Studies of the University of Edinburgh; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the postgraduate Research Support Grant of the School of Philosophy, Psychology and Language Studies of the University of Edinburgh.; We thank our participants for their patience and kindness, Sabhal Mor Ostaig for all their help in conducting this study, all other involved institutions for allowing us to recruit from their courses and Margot Overman for her contribution to data collection. We would also like to thank Hannah Rohde for her advice, the PLOS reviewers for their thoughtful comments and Richard Morris and Ian Robertson for inspiring discussions about fundamental questions of memory and attention. The study was supported by the postgraduate Research Support Grant from the School of Philosophy, Psychology and Language Studies of the University of Edinburgh, granted to Madeleine R. Long.	Abutalebi J, 2013, CORTEX, V49, P905, DOI 10.1016/j.cortex.2012.08.018; Alladi S, 2016, STROKE, V47, P258, DOI 10.1161/STROKEAHA.115.010418; Alladi S, 2013, NEUROLOGY, V81, P1938, DOI 10.1212/01.wnl.0000436620.33155.a4; Bak T. H., 2014, ANN NEUROLOGY; Bak T. H., 2014, FRONT PSYCHOL, V5; Bak T. H., 2016, LINGUISTIC APPROACHE; Bialystok Ellen, 2009, Psychol Sci Public Interest, V10, P89, DOI 10.1177/1529100610387084; Bialystok E, 2009, COGNITION, V112, P494, DOI 10.1016/j.cognition.2009.06.014; Bjork RA, 2015, AM J PSYCHOL, V128, P241; Burke DM, 2004, CURR DIR PSYCHOL SCI, V13, P21, DOI 10.1111/j.0963-7214.2004.01301006.x; Costa A, 2009, COGNITION, V113, P135, DOI 10.1016/j.cognition.2009.08.001; de Bruin A., 2014, PSYCHOL SCI; Gillies W., 2008, THE CELTIC LANGUAGES, P230; Janus M, 2016, J EXP CHILD PSYCHOL, V144, P84, DOI 10.1016/j.jecp.2015.11.009; Karbach J, 2014, PSYCHOL SCI, V25, P2027, DOI 10.1177/0956797614548725; Kave G, 2008, PSYCHOL AGING, V23, P70, DOI 10.1037/0882-7974.23.1.70; Lampit A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001756; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Park DC, 2014, PSYCHOL SCI, V25, P103, DOI 10.1177/0956797613499592; Robertson I. H., 1994, TEST EVERYDAY ATTENT; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Sullivan M., 2014, BRAIN LANG, P13984; Tao L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00123; Valenzuela M, 2009, AM J GERIAT PSYCHIAT, V17, P179, DOI 10.1097/JGP.0b013e3181953b57; Vega-Mendoza M, 2015, COGNITION, V137, P40, DOI 10.1016/j.cognition.2014.12.008; Veyrac A, 2009, NEUROPSYCHOPHARMACOL, V34, P786, DOI 10.1038/npp.2008.191; Wang SH, 2010, P NATL ACAD SCI USA, V107, P19537, DOI 10.1073/pnas.1008638107	27	62	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153485	10.1371/journal.pone.0153485	http://dx.doi.org/10.1371/journal.pone.0153485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120179	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200027
J	Bolt, CC; Negi, S; Guimaraes-Camboa, N; Zhang, HM; Troy, JM; Lu, XC; Kispert, A; Evans, SM; Stubbs, L				Bolt, C. Chase; Negi, Soumya; Guimaraes-Camboa, Nuno; Zhang, Huimin; Troy, Joseph M.; Lu, Xiaochen; Kispert, Andreas; Evans, Sylvia M.; Stubbs, Lisa			Tbx18 Regulates the Differentiation of Periductal Smooth Muscle Stroma and the Maintenance of Epithelial Integrity in the Prostate	PLOS ONE			English	Article							UROGENITAL SINUS EPITHELIUM; ANDROGEN RECEPTOR; GENE-EXPRESSION; REACTIVE STROMA; MOUSE PROSTATE; MYOFIBROBLAST DIFFERENTIATION; BRANCHING MORPHOGENESIS; URETERAL MESENCHYME; REGIONAL-VARIATION; SEMINAL-VESICLE	The T-box transcription factor TBX18 is essential to mesenchymal cell differentiation in several tissues and Tbx18 loss-of-function results in dramatic organ malformations and perinatal lethality. Here we demonstrate for the first time that Tbx18 is required for the normal development of periductal smooth muscle stromal cells in prostate, particularly in the anterior lobe, with a clear impact on prostate health in adult mice. Prostate abnormalities are only subtly apparent in Tbx18 mutants at birth; to examine postnatal prostate development we utilized a relatively long-lived hypomorphic mutant and a novel conditional Tbx18 allele. Similar to the ureter, cells that fail to express Tbx18 do not condense normally into smooth muscle cells of the periductal prostatic stroma. However, in contrast to ureter, the periductal stromal cells in mutant prostate assume a hypertrophic, myofibroblastic state and the adjacent epithelium becomes grossly disorganized. To identify molecular events preceding the onset of this pathology, we compared gene expression in the urogenital sinus (UGS), from which the prostate develops, in Tbx18-null and wild type littermates at two embryonic stages. Genes that regulate cell proliferation, smooth muscle differentiation, prostate epithelium development, and inflammatory response were significantly dysregulated in the mutant urogenital sinus around the time that Tbx18 is first expressed in the wild type UGS, suggesting a direct role in regulating those genes. Together, these results argue that Tbx18 is essential to the differentiation and maintenance of the prostate periurethral mesenchyme and that it indirectly regulates epithelial differentiation through control of stromal-epithelial signaling.	[Bolt, C. Chase; Negi, Soumya; Zhang, Huimin; Lu, Xiaochen; Stubbs, Lisa] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Bolt, C. Chase; Negi, Soumya; Zhang, Huimin; Troy, Joseph M.; Lu, Xiaochen; Stubbs, Lisa] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Guimaraes-Camboa, Nuno; Evans, Sylvia M.] Univ Calif San Diego, Dept Med, Skaggs Sch Pharm, La Jolla, CA 92037 USA; [Guimaraes-Camboa, Nuno; Evans, Sylvia M.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92037 USA; [Troy, Joseph M.; Stubbs, Lisa] Univ Illinois, Illinois Informat Inst, Urbana, IL 61801 USA; [Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, OE5250,Carl Neuberg Str 1, D-30625 Hannover, Germany	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Illinois System; University of Illinois Urbana-Champaign; Hannover Medical School	Stubbs, L (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA.; Stubbs, L (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.; Stubbs, L (corresponding author), Univ Illinois, Illinois Informat Inst, Urbana, IL 61801 USA.	ljstubbs@illinois.edu	Guimarães-Camboa, Nuno/K-5519-2016	Guimarães-Camboa, Nuno/0000-0001-5349-4604; Stubbs, Lisa/0000-0002-9556-1972; Bolt, Christopher Chase/0000-0002-3544-3552	U.S. National Institute of Diabetes and Digestive and Kidney Disorders [DK095685]; U.S. NIH National Heart, Lung, and Blood Institute R01 grants [HL123747, HL117649, HL074066]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074066, DP1HL117649, R01HL123747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095685] Funding Source: NIH RePORTER	U.S. National Institute of Diabetes and Digestive and Kidney Disorders; U.S. NIH National Heart, Lung, and Blood Institute R01 grants; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant number DK095685 from the U.S. National Institute of Diabetes and Digestive and Kidney Disorders (awarded to L.S.). The production of the Tbx18flox, Tbx18Cre, and Tbx18GFP alleles was supported by U.S. NIH National Heart, Lung, and Blood Institute R01 grants HL123747, HL117649, and HL074066 (awarded to S.M.E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Airik R, 2010, HUM MOL GENET, V19, P4918, DOI 10.1093/hmg/ddq426; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Bauman TM, 2014, AM J CLIN EXP UROL, V2, P313; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bierhoff E, 1997, PROSTATE, V31, P234, DOI 10.1002/(SICI)1097-0045(19970601)31:4<234::AID-PROS4>3.0.CO;2-K; Blum R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013024; Bohnenpoll T, 2013, DEV BIOL, V380, P25, DOI 10.1016/j.ydbio.2013.04.036; Bolt CC, 2014, DEV BIOL, V392, P483, DOI 10.1016/j.ydbio.2014.05.010; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai Y, 2013, JOVE-J VIS EXP, DOI 10.3791/50327; Doles J, 2006, DEV BIOL, V295, P13, DOI 10.1016/j.ydbio.2005.12.002; DONJACOUR AA, 1995, DEVELOPMENT, V121, P2199; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; Grabowska MM, 2014, CANCER METAST REV, V33, P377, DOI 10.1007/s10555-013-9487-8; Grishina IB, 2005, DEV BIOL, V288, P334, DOI 10.1016/j.ydbio.2005.08.018; Haraguchi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042245; Hayward SW, 1996, ACTA ANAT, V155, P94; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZH, 2012, ONCOTARGET, V3, P651, DOI 10.18632/oncotarget.531; Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468; Kim W, 2014, P NATL ACAD SCI USA, V111, P16389, DOI 10.1073/pnas.1407097111; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lai KP, 2012, MOL ENDOCRINOL, V26, P52, DOI 10.1210/me.2011-1189; LEE C, 1990, BIOL REPROD, V43, P1079, DOI 10.1095/biolreprod43.6.1079; Mehta V, 2013, DEV BIOL, V376, P125, DOI 10.1016/j.ydbio.2013.01.034; Mehta V, 2011, DEV DYNAM, V240, P2548, DOI 10.1002/dvdy.22741; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Negmadjanov U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123046; Nemeth JA, 1996, PROSTATE, V28, P124; Nie XG, 2010, DEVELOPMENT, V137, P755, DOI 10.1242/dev.045757; Niu YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020202; Peng YC, 2013, P NATL ACADAY SCI; Peng YC, 2015, DEV BIOL, V400, P94, DOI 10.1016/j.ydbio.2015.01.019; Podlasek CA, 1997, DEV DYNAM, V208, P454; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; Schauer IG, 2011, DIFFERENTIATION, V82, P200, DOI 10.1016/j.diff.2011.05.007; Schweizer L, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-4; Shaw A, 2008, DIFFERENTIATION, V76, P599, DOI 10.1111/j.1432-0436.2008.00275.x; Simons BW, 2012, DEV BIOL, V371, P246, DOI 10.1016/j.ydbio.2012.08.016; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Thomsen MK, 2008, DEV BIOL, V316, P302, DOI 10.1016/j.ydbio.2008.01.030; Trowe MO, 2012, DEVELOPMENT, V139, P3099, DOI 10.1242/dev.077388; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wang YQ, 2009, GENESIS, V47, P409, DOI 10.1002/dvg.20515; Wu XY, 2011, DEV BIOL, V356, P337, DOI 10.1016/j.ydbio.2011.05.659; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yang XH, 2014, EUR J PHARMACOL, V734, P83, DOI 10.1016/j.ejphar.2014.04.007; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698; Zhang YY, 2008, DEVELOPMENT, V135, P775, DOI 10.1242/dev.009910; Zhu GD, 2007, PROSTATE, V67, P674, DOI 10.1002/pros.20563	61	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154413	10.1371/journal.pone.0154413	http://dx.doi.org/10.1371/journal.pone.0154413			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120339	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200068
J	Krull, AC; Cooper, VL; Coatney, JW; Shearer, JK; Gorden, PJ; Plummer, PJ				Krull, Adam C.; Cooper, Vickie L.; Coatney, John W.; Shearer, Jan K.; Gorden, Patrick J.; Plummer, Paul J.			A Highly Effective Protocol for the Rapid and Consistent Induction of Digital Dermatitis in Holstein Calves	PLOS ONE			English	Article							DAIRY-CATTLE; DICHELOBACTER-NODOSUS; INTERDIGITAL PAPILLOMATOSIS; CROSS-INFECTION; 1ST LACTATION; UK CATTLE; LESIONS; COWS; PREVALENCE; TREPONEMES	Bovine Digital Dermatitis (DD) is a leading cause of lameness in dairy cattle. DD is reportedly increasing in prevalence in beef cattle feedlots of the US. The exact etiologic agent(s) responsible for the disease have yet to be determined. Multiple studies have demonstrated the presence of a variety of Treponema spp. within lesions. Attempts to reproduce clinically relevant disease using pure cultures of these organisms has failed to result in lesions that mirror the morphology and severity of naturally occurring lesions. This manuscript details the systematic development of an experimental protocol that reliably induces digital dermatitis lesions on a large enough scale to allow experimental evaluation of treatment and prevention measures. In total, 21 protocols from five experiments were evaluated on their effectiveness in inducing DD lesions in 126 Holstein calves (504 feet). The protocols varied in the type and concentration of inoculum, frequency of inoculation, duration the feet were wrapped, and type of experimental controls need to validate a successful induction. Knowledge gained in the first four experiments resulted in a final protocol capable of inducing DD lesions in 42 of 44 (95%) feet over a 28 day period. All induced lesions were macroscopically and microscopically identified as clinical DD lesions by individuals blinded to protocols. Lesions were also located at the site of inoculation in the palmer aspect of the interdigital space, and induced clinically measurable lameness in a significant portion of the calves. Collectively these results validate the model and provide a rapid and reliable means of inducing DD in large groups of calves.	[Krull, Adam C.; Cooper, Vickie L.; Coatney, John W.; Shearer, Jan K.; Gorden, Patrick J.; Plummer, Paul J.] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Plummer, Paul J.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Preventat Med, Ames, IA USA	Iowa State University; Iowa State University	Plummer, PJ (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA.; Plummer, PJ (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Preventat Med, Ames, IA USA.	pplummer@iastate.edu	Gorden, Patrick/AAT-4403-2021	Gorden, Patrick/0000-0002-6096-0965	Boehringer Ingelheim Vetmedica Inc.; Iowa State University Faculty Startup-Funds	Boehringer Ingelheim Vetmedica Inc.(Boehringer Ingelheim); Iowa State University Faculty Startup-Funds	Boehringer Ingelheim Vetmedica Inc. provided funds for a portion of the research. Additional funds were provided by Iowa State University Faculty Startup-Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2009, J VET MED SCI, V71, P391, DOI 10.1292/jvms.71.391; Berry SL, 2004, 13 INT S RUM LAM 200; Berry SL, 2010, JAVMA-J AM VET MED A, V237, P555, DOI 10.2460/javma.237.5.555; BLOWEY RW, 1994, VET REC, V135, P577; BLOWEY RW, 1994, VET REC, V135, P115, DOI 10.1136/vr.135.5.115; BLOWEY RW, 1988, VET REC, V122, P505, DOI 10.1136/vr.122.21.505; Brandt S, 2011, VET MICROBIOL, V148, P161, DOI 10.1016/j.vetmic.2010.08.031; Brown CC, 2000, AM J VET RES, V61, P928, DOI 10.2460/ajvr.2000.61.928; Capion N, 2012, J DAIRY SCI, V95, P6457, DOI 10.3168/jds.2012-5335; Capion N, 2009, VET J, V182, P50, DOI 10.1016/j.tvjl.2008.05.026; Cheli R, 1974, 8 INT M DIS CATTL PI; Choi BK, 1997, INT J SYST BACTERIOL, V47, P175, DOI 10.1099/00207713-47-1-175; Clifford JR, 2014, 800200 USDA APHIS VE; Collighan RJ, 1997, FEMS MICROBIOL LETT, V156, P37, DOI 10.1016/S0378-1097(97)00399-6; Cornelisse JL, 1982, 4 INT S DIS RUM DIG; Cruz CEF, 2005, VET REC, V157, P834, DOI 10.1136/vr.157.26.834; Demirkan I, 2006, J APPL MICROBIOL, V101, P948, DOI 10.1111/j.1365-2672.2006.02976.x; Demirkan I, 1998, VET MICROBIOL, V60, P285, DOI 10.1016/S0378-1135(98)00146-1; Dopfer D, 1997, VET REC, V140, P620, DOI 10.1136/vr.140.24.620; Elliott MK, 2007, INFECT IMMUN, V75, P4400, DOI 10.1128/IAI.00019-07; Evans NJ, 2008, VET MICROBIOL, V130, P141, DOI 10.1016/j.vetmic.2007.12.019; Evans NJ, 2009, J CLIN MICROBIOL, V47, P689, DOI 10.1128/JCM.01914-08; Frankena K, 2009, PREV VET MED, V88, P150, DOI 10.1016/j.prevetmed.2008.08.004; Gilhuus M, 2013, VET MICROBIOL, V163, P142, DOI 10.1016/j.vetmic.2012.12.020; Gomez A, 2015, J DAIRY SCI, V98, P4487, DOI 10.3168/jds.2014-9041; Gomez A, 2012, J DAIRY SCI, V95, P1821, DOI 10.3168/jds.2011-4754; GRUND S, 1995, J VET MED B, V42, P533, DOI 10.1111/j.1439-0450.1995.tb00745.x; Klitgaard K, 2008, J CLIN MICROBIOL, V46, P3012, DOI 10.1128/JCM.00670-08; Knappe-Poindecker M, 2013, J DAIRY SCI, V96, P7617, DOI 10.3168/jds.2013-6717; Knappe-Poindecker M, 2014, VET MICROBIOL, V170, P375, DOI 10.1016/j.vetmic.2014.02.044; KONIAROVA I, 1993, VET MED-CZECH, V38, P589; Krull AC, 2014, INFECT IMMUN, V82, P3359, DOI 10.1128/IAI.02077-14; Laven RA, 2007, VET J, V174, P310, DOI 10.1016/j.tvjl.2006.07.008; Laven RA, 2006, VET REC, V159, P19, DOI 10.1136/vr.159.1.19; Laven RA, 2006, VET J, V171, P79, DOI 10.1016/j.tvjl.2004.08.009; Logue DN, 2005, VET J, V170, P12, DOI 10.1016/j.tvjl.2005.04.030; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Nishikawa A, 2008, VET REC, V163, P574, DOI 10.1136/vr.163.19.574; Nordhoff M, 2008, VET MICROBIOL, V131, P293, DOI 10.1016/j.vetmic.2008.04.019; Ohya T, 1999, VET REC, V145, P316, DOI 10.1136/vr.145.11.316; Rasmussen M, 2012, VET MICROBIOL, V160, P151, DOI 10.1016/j.vetmic.2012.05.018; Read D. H., 1996, VET PATHOL, V33, P607; Read DH, 1998, J VET DIAGN INVEST, V10, P67, DOI 10.1177/104063879801000112; READ DH, 1992, VET REC, V130, P59, DOI 10.1136/vr.130.3.59; REBHUN WC, 1980, J AM VET MED ASSOC, V177, P437; Rogdo T, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-19; Santos TMA, 2012, FEMS MICROBIOL ECOL, V79, P518, DOI 10.1111/j.1574-6941.2011.01234.x; Schlafer S, 2008, VET MICROBIOL, V128, P118, DOI 10.1016/j.vetmic.2007.09.024; Schrank K, 1999, INT J SYST BACTERIOL, V49, P43, DOI 10.1099/00207713-49-1-43; Schroeder CM, 2003, ANAEROBE, V9, P151, DOI 10.1016/S1075-9964(03)00084-2; Silva LAF, 2005, CAN VET J, V46, P345; SKERMAN TM, 1975, J GEN MICROBIOL, V87, P107, DOI 10.1099/00221287-87-1-107; Sprecher DJ, 1997, THERIOGENOLOGY, V47, P1179, DOI 10.1016/S0093-691X(97)00098-8; Sullivan LE, 2013, VET REC, V173, P582, DOI 10.1136/vr.101802; Trott DJ, 2003, J CLIN MICROBIOL, V41, P2522, DOI 10.1128/JCM.41.6.2522-2529.2003; USDA, 2009, DAIR 2007 4; VANAMSTEL SR, 1995, J S AFR VET ASSOC, V66, P177; Walker RL, 1995, VET MICROBIOL, V47, P343, DOI 10.1016/0378-1135(95)00114-X; Yano T, 2010, VET MICROBIOL, V143, P352, DOI 10.1016/j.vetmic.2009.12.009	59	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154481	10.1371/journal.pone.0154481	http://dx.doi.org/10.1371/journal.pone.0154481			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119564	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200083
J	Merlo, J; Wagner, P; Ghith, N; Leckie, G				Merlo, Juan; Wagner, Philippe; Ghith, Nermin; Leckie, George			An Original Stepwise Multilevel Logistic Regression Analysis of Discriminatory Accuracy: The Case of Neighbourhoods and Health	PLOS ONE			English	Article							BRIEF CONCEPTUAL TUTORIAL; SMALL-AREA VARIATION; SOCIAL EPIDEMIOLOGY; ADMINISTRATIVE BOUNDARIES; CONTEXTUAL PHENOMENA; PREDICTION MODELS; INDIVIDUAL HEALTH; BLOOD-PRESSURE; LIFE-COURSE; RISK	Background and Aim Many multilevel logistic regression analyses of "neighbourhood and health" focus on interpreting measures of associations (e.g., odds ratio, OR). In contrast, multilevel analysis of variance is rarely considered. We propose an original stepwise analytical approach that distinguishes between "specific" (measures of association) and "general" (measures of variance) contextual effects. Performing two empirical examples we illustrate the methodology, interpret the results and discuss the implications of this kind of analysis in public health. Methods We analyse 43,291 individuals residing in 218 neighbourhoods in the city of Malm, Sweden in 2006. We study two individual outcomes (psychotropic drug use and choice of private vs. public general practitioner, GP) for which the relative importance of neighbourhood as a source of individual variation differs substantially. In Step 1 of the analysis, we evaluate the OR and the area under the receiver operating characteristic (AUC) curve for individual-level covariates (i.e., age, sex and individual low income). In Step 2, we assess general contextual effects using the AUC. Finally, in Step 3 the OR for a specific neighbourhood characteristic (i.e., neighbourhood income) is interpreted jointly with the proportional change in variance (i.e., PCV) and the proportion of ORs in the opposite direction (POOR) statistics. Results For both outcomes, information on individual characteristics (Step 1) provide a low discriminatory accuracy (AUC = 0.616 for psychotropic drugs; = 0.600 for choosing a private GP). Accounting for neighbourhood of residence (Step 2) only improved the AUC for choosing a private GP (+0.295 units). High neighbourhood income (Step 3) was strongly associated to choosing a private GP (OR = 3.50) but the PCV was only 11% and the POOR 33%. Conclusion Applying an innovative stepwise multilevel analysis, we observed that, in Malmo, the neighbourhood context per se had a negligible influence on individual use of psychotropic drugs, but appears to strongly condition individual choice of a private GP. However, the latter was only modestly explained by the socioeconomic circumstances of the neighbourhoods. Our analyses are based on real data and provide useful information for understanding neighbourhood level influences in general and on individual use of psychotropic drugs and choice of GP in particular. However, our primary aim is to illustrate how to perform and interpret a multilevel analysis of individual heterogeneity in social epidemiology and public health. Our study shows that neighbourhood "effects" are not properly quantified by reporting differences between neighbourhood averages but rather by measuring the share of the individual heterogeneity that exists at the neighbourhood level.	[Merlo, Juan; Wagner, Philippe; Ghith, Nermin] Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden; [Wagner, Philippe] Uppsala Univ, Ctr Clin Res Vastmanland, Uppsala, Sweden; [Ghith, Nermin] Bispebjerg Hosp, Res Unit Chron Condit, Copenhagen, Denmark; [Leckie, George] Univ Bristol, Ctr Multilevel Modelling, Bristol, Avon, England	Lund University; Uppsala University; University of Copenhagen; Bispebjerg Hospital; University of Bristol	Merlo, J (corresponding author), Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden.	juan.merlo@med.lu.se	Merlo, Juan/E-2136-2011; Leckie, George/F-4599-2010; Ghith, Nermin/B-3163-2013	Merlo, Juan/0000-0001-8379-9708; Leckie, George/0000-0003-1486-745X; Ghith, Nermin/0000-0002-5863-5442	Swedish Research Council [2013-2484]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (JM, 2013-2484) http://www.vr.se/inenglish.4 12fff4451215cbd83e4800015152.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, HALSO SJUKVARDSLAG, P763; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Beckman A, 2005, THESIS MALMO LUNDS U; Bennett BM., 1980, BIOMETR J, V22, P335; Boyle MH, 1999, AM J EPIDEMIOL, V149, P577; Browne W., 2009, MCMC ESTIMATION MLWI; Browne WJ, 2001, STAT MODEL, V1, P103, DOI 10.1177/1471082X0100100202; Browne WJ, 2005, J ROY STAT SOC A STA, V168, P599, DOI 10.1111/j.1467-985X.2004.00365.x; Browne WJ, 2014, MCMC ESTIMATION MLWI; Clarke P, 2007, SOCIOL METHOD RES, V35, P311, DOI 10.1177/0049124106292362; Collaboration, 2006, FARMAKOTERAPI ANGEST, V4, P2006; Cummins S, 2007, SOC SCI MED, V65, P1825, DOI 10.1016/j.socscimed.2007.05.036; DUNCAN C, 1993, SOC SCI MED, V37, P725, DOI 10.1016/0277-9536(93)90366-C; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Dundas R, 2014, AM J EPIDEMIOLOGY; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Goldstein H, 2003, OXFORD REV EDUC, V29, P225, DOI 10.1080/0305498032000080693; Hidden J, 2012, 1208 U COP DEP BIOST; Ibanez B, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-60; Johnell K, 2004, J EPIDEMIOL COMMUN H, V58, P59, DOI 10.1136/jech.58.1.59; Jones K, 2015, DEV MULTILEVEL MODEL; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; LECKIE G, 2013, LEMMA VLE MODULE, V13, P1; Leckie G, 2011, FISCAL STUDIES; Leckie G., 2013, LEMMA VLE MODULE, V12, P1; Leckie G, 2015, J R STAT SOC A STAT, V178, P405, DOI 10.1111/rssa.12066; Leckie G, 2012, J EDUC BEHAV STAT, V37, P3, DOI 10.3102/1076998610394367; Leckie G, 2011, J R STAT SOC A STAT, V174, P833, DOI 10.1111/j.1467-985X.2010.00688.x; Leckie G, 2009, J R STAT SOC A STAT, V172, P835, DOI 10.1111/j.1467-985X.2009.00597.x; Leckie G, 2009, J ROY STAT SOC A STA, V172, P537, DOI 10.1111/j.1467-985X.2008.00577.x; Leyland AH, 2009, J R STAT SOC A STAT, V172, P555, DOI 10.1111/j.1467-985X.2008.00581.x; Li JL, 2008, COMMUN STAT-SIMUL C, V37, P2010, DOI 10.1080/03610910802361366; Lorenzo-Seva U, 2012, BEHAV RES METHODS, V44, P1191, DOI 10.3758/s13428-012-0200-6; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Lunn D., 2012, CRC TEXTS STAT SCI; Maas CJM, 2004, COMPUT STAT DATA AN, V46, P427, DOI 10.1016/j.csda.2003.08.006; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160; Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310; Merlo J, 2001, J EPIDEMIOL COMMUN H, V55, P791, DOI 10.1136/jech.55.11.791; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Merlo J, 2013, EUR J EPIDEMIOL, V28, P135; Merlo J, 2013, EUR J EPIDEMIOL S, V28, P148; Merlo J, 2014, AM J EPIDEMIOL, V180, P208, DOI 10.1093/aje/kwu108; Merlo J, 2013, SOC SCI MED, V76, P39, DOI 10.1016/j.socscimed.2012.08.034; Merlo J, 2012, SOC SCI MED, V75, P1477, DOI 10.1016/j.socscimed.2012.06.004; Mitchell R, 2001, ENVIRON PLANN A, V33, P1357; Morenoff JD, 2003, AM J SOCIOL, V108, P976, DOI 10.1086/374405; Mulinari S, 2015, PLOS 1 IN PRESS; Neyman J, 1948, ECONOMETRICA, V16, P1, DOI 10.2307/1914288; Oakes JM, 2004, SOC SCI MED, V58, P1929, DOI 10.1016/j.socscimed.2003.08.004; Ohlsson H, 2011, SOC SCI MED, V73, P1145, DOI 10.1016/j.socscimed.2011.08.005; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pepe MS, 2015, STAT BIOSCI, V7, P282, DOI 10.1007/s12561-014-9118-0; Pepe MS, 2011, AM J EPIDEMIOL, V173, P1327, DOI 10.1093/aje/kwr013; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Petronis KR, 2003, J EPIDEMIOL COMMUN H, V57, P893, DOI 10.1136/jech.57.11.893; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Rasbash J, 2010, J R STAT SOC A STAT, V173, P657, DOI 10.1111/j.1467-985X.2010.00642.x; Riva M, 2007, J EPIDEMIOL COMMUN H, V61, P853, DOI 10.1136/jech.2006.050740; Rose G, 2001, B WORLD HEALTH ORGAN, V79, P990; Roux AVD, 2008, J EPIDEMIOL COMMUN H, V62, P957, DOI 10.1136/jech.2007.064311; Roux AVD, 2003, J URBAN HEALTH, V80, P569, DOI 10.1093/jurban/jtg065; Sariaslan A, 2013, INT J EPIDEMIOL, V42, P1057, DOI 10.1093/ije/dyt066; Skrondal A, 2009, J R STAT SOC A STAT, V172, P659, DOI 10.1111/j.1467-985X.2009.00587.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Subramanian S. V., 2003, Neighborhoods and health, P65; Sweden S, 2014, PRODUCT CATALOGUE ST; Van Oirbeek R, 2012, COMPUT STAT DATA AN, V56, P1966, DOI 10.1016/j.csda.2011.11.023; Veblen T, 1899, THEORY LEISURE CLASS; Wagner P, 2014, IEA WORLD C EP WCE20; Wemrell M, 2016, SOCIOL COMPASS, V10, P153, DOI 10.1111/soc4.12345; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; WHO Collaborating Centre for Drug Statistics Methodology, 2013, ATC DDD IND; Yang M, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-31	83	115	116	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153778	10.1371/journal.pone.0153778	http://dx.doi.org/10.1371/journal.pone.0153778			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120054	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200036
J	Bu, JD; Zhao, J; Liu, MJ				Bu, Jiaodi; Zhao, Jin; Liu, Mengjun			Expression Stabilities of Candidate Reference Genes for RT-qPCR in Chinese Jujube (Ziziphus jujuba Mill.) under a Variety of Conditions	PLOS ONE			English	Article							REAL-TIME PCR; INTERNAL CONTROL; SELECTION; NORMALIZATION; VALIDATION	Reverse transcription-quantitative real-time polymerase chain reaction (RT-qPCR) is a powerful method for evaluating patterns of gene expression. Jujube whole-genome sequencing has been completed, and analysis of gene function, an important part of any follow-up study, requires the appropriate selection of reference genes. Indeed, suitable reference gene selection for RT-qPCR is critical for accurate normalization of target gene expression. In this study, the software packages geNorm and NormFinder were employed to examine the expression stabilities of nine candidate reference genes under a variety of conditions. Actin-depolymerizing factor 1 (ACT1), Histone-H3 (His3), and Polyadenylate-binding protein-interacting protein (PAIP) were determined to be the most stably expressed genes during five stages of fruit development and ACT1, SiR-Fd, BTF3, and Tubulin alpha chain (TUA) across different tissues/organs. Whereas ACT1, Basic Transcription factor 3 (BTF3), Glyceraldehyde-3-phosphate dehydrogenase (GADPH), and PAIP were the most stable under dark conditions. ACT1, PAIP, BTF3, and Elongation factor 1-gamma (EF1 gamma) were the most stably expressed genes under phytoplasma infection. Among these genes, SiR-Fd and PAIP are here first reported as stable reference genes. When normalized using these most stable reference genes, the expression patterns of four target genes were found to be in accordance with physiological data, indicating that the reference genes selected in our study are suitable for use in such analyses. This study provides appropriate reference genes and corresponding primers for further RT-qPCR studies in Chinese jujube and emphasizes the importance of validating reference genes for gene expression analysis under variable experimental conditions.	[Bu, Jiaodi; Zhao, Jin] Agr Univ Hebei, Coll Life Sci, Baoding, Hebei, Peoples R China; [Liu, Mengjun] Agr Univ Hebei, Res Ctr Chinese Jujube, Baoding, Hebei, Peoples R China	Hebei Agricultural University; Hebei Agricultural University	Zhao, J (corresponding author), Agr Univ Hebei, Coll Life Sci, Baoding, Hebei, Peoples R China.; Liu, MJ (corresponding author), Agr Univ Hebei, Res Ctr Chinese Jujube, Baoding, Hebei, Peoples R China.	zhaojinbd@126.com; lmj1234567@aliyun.com			Funds for Hebei Distinguished Young Scholar [2016204145]; National Science and Technology Support Plan of China [2013BAD14B03]; Agricultural University of Hebei Foundation for Leaders of Disciplines in Science Technology	Funds for Hebei Distinguished Young Scholar; National Science and Technology Support Plan of China; Agricultural University of Hebei Foundation for Leaders of Disciplines in Science Technology	This study was supported by grants from Funds for Hebei Distinguished Young Scholar ( 2016204145), the National Science and Technology Support Plan of China ( 2013BAD14B03), and Agricultural University of Hebei Foundation for Leaders of Disciplines in Science Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Banda M, 2008, MUTAT RES-GEN TOX EN, V649, P126, DOI 10.1016/j.mrgentox.2007.08.005; Borges AF, 2014, PLOS ONE, V9, P1; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Feng H, 2012, PLANT PHYSIOL BIOCH, V51, P116, DOI 10.1016/j.plaphy.2011.10.010; Han X, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0050868; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Liu M., 2010, JUJUBE WITCHES BROOM; Liu M, 2009, CHINESE JUJUBE GERMS; Liu MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6315; Ma S, 2013, OXID MED CELL LONGEV, V2013, P1; Meng YL, 2013, SCI HORTIC-AMSTERDAM, V158, P16, DOI 10.1016/j.scienta.2013.04.019; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pinto F, 2012, PLOS ONE, V7, P1; Pinto F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034983; Sun HF, 2009, MOL BIOL REP, V36, P2183, DOI 10.1007/s11033-008-9433-y; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu JX, 2014, SCI HORTIC-AMSTERDAM, V176, P180, DOI 10.1016/j.scienta.2014.06.040; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Ye X, 2015, SCI HORTIC-AMSTERDAM, V181, P182, DOI 10.1016/j.scienta.2014.10.027; Zhang CM, 2015, SCI HORTIC-AMSTERDAM, V197, P166, DOI 10.1016/j.scienta.2015.09.026; [赵锦 ZHAO Jin], 2009, [植物遗传资源学报, Journal of Plant Genetic Resources], V10, P111; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8; Zhuang HH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00475	31	29	34	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154212	10.1371/journal.pone.0154212	http://dx.doi.org/10.1371/journal.pone.0154212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116123	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600049
J	Hammond, KR; O'Keefe, JM; Aldrich, SP; Loeb, SC				Hammond, Kristina R.; O'Keefe, Joy M.; Aldrich, Stephen P.; Loeb, Susan C.			A Presence-Only Model of Suitable Roosting Habitat for the Endangered Indiana Bat in the Southern Appalachians	PLOS ONE			English	Article							BLACK-HILLS; SELECTION; PERFORMANCE; CHIROPTERA; ECOLOGY; FORESTS; PINE; SPP.	We know little about how forest bats, which are cryptic and mobile, use roosts on a landscape scale. For widely distributed species like the endangered Indiana bat Myotis sodalis, identifying landscape-scale roost habitat associations will be important for managing the species in different regions where it occurs. For example, in the southern Appalachian Mountains, USA, M. sodalis roosts are scattered across a heavily forested landscape, which makes protecting individual roosts impractical during large-scale management activities. We created a predictive spatial model of summer roosting habitat to identify important predictors using the presence-only modeling program MaxEnt and an information theoretic approach for model comparison. Two of 26 candidate models together accounted for > 0.93 of AICc weights. Elevation and forest type were top predictors of presence; aspect north/south and distance-to-ridge were also important. The final average best model indicated that 5% of the study area was suitable habitat and 0.5% was optimal. This model matched our field observations that, in the southern Appalachian Mountains, optimal roosting habitat for M. sodalis is near the ridge top in south-facing mixed pine-hardwood forests at elevations from 260-575 m. Our findings, coupled with data from other studies, suggest M. sodalis is flexible in roost habitat selection across different ecoregions with varying topography and land use patterns. We caution that, while mature pine-hardwood forests are important now, specific areas of suitable and optimal habitat will change over time. Combining the information theoretic approach with presence-only models makes it possible to develop landscape-scale habitat suitability maps for forest bats.	[Hammond, Kristina R.; O'Keefe, Joy M.] Indiana State Univ, Ctr Bat Res Outreach & Conservat, Terre Haute, IN 47809 USA; [Aldrich, Stephen P.] Indiana State Univ, Dept Earth & Environm Syst, Terre Haute, IN 47809 USA; [Loeb, Susan C.] US Forest Serv, USDA, Southern Res Stn, Clemson, SC USA	Indiana State University; Indiana State University; United States Department of Agriculture (USDA); United States Forest Service	O'Keefe, JM (corresponding author), Indiana State Univ, Ctr Bat Res Outreach & Conservat, Terre Haute, IN 47809 USA.	joyokeefe@gmail.com	Aldrich, Stephen/AAD-6928-2019	Aldrich, Stephen/0000-0002-0492-2841	Joint Fire Science Program [09-1-08-2]; USDA Forest Service; Indiana Space Grant Consortium; Tallassee Fund; National Park Service; North Carolina Wildlife Resources Commission; Tennessee Wildlife Resources Agency; Eastern Band of Cherokee Indians	Joint Fire Science Program; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Indiana Space Grant Consortium; Tallassee Fund; National Park Service; North Carolina Wildlife Resources Commission; Tennessee Wildlife Resources Agency; Eastern Band of Cherokee Indians	Funding for this project was provided by the Joint Fire Science Program (09-1-08-2), USDA Forest Service, Indiana Space Grant Consortium, the Tallassee Fund, the National Park Service, the North Carolina Wildlife Resources Commission, Tennessee Wildlife Resources Agency, and the Eastern Band of Cherokee Indians. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RA, 2008, J WILDLIFE MANAGE, V72, P1717, DOI 10.2193/2007-393; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Barclay Robert M.R., 2007, P17; Bellamy C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128440; Bellamy C, 2013, J APPL ECOL, V50, P892, DOI 10.1111/1365-2664.12117; Britzke ER, 2003, SOUTHEAST NAT, V2, P235, DOI 10.1656/1528-7092(2003)002[0235:IBMSMR]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burns R.M., 1990, AGR HDB, V654; Carter TC, 2006, J WILDLIFE MANAGE, V70, P1185, DOI 10.2193/0022-541X(2006)70[1185:IBITMT]2.0.CO;2; Carter Timothy C., 2002, P160; Cryan PM, 2000, J MAMMAL, V81, P719, DOI 10.1644/1545-1542(2000)081<0719:EOEODO>2.3.CO;2; Cryan PM, 2001, ACTA CHIROPTEROL, V3, P43; DuChamp JE, 2007, BATS FORESTS CONSERV, P239; Dyer JM, 2006, BIOSCIENCE, V56, P341, DOI 10.1641/0006-3568(2006)56[341:RTDFOE]2.0.CO;2; Franzreb KE, 2005, PSWGTR1912005 USDA F; Gumbert Mark W., 2002, P143; Gumbert MW, 2001, THESIS E KENTUCKY U; Harvey Michael J., 2002, P29; Hein CD, 2008, J MAMMAL, V89, P964, DOI 10.1644/07-MAMM-A-335.1; HUMPHREY SR, 1977, J MAMMAL, V58, P334, DOI 10.2307/1379332; Iverson LR, 2002, FOREST ECOL MANAG, V155, P205, DOI 10.1016/S0378-1127(01)00559-X; Jaberg C, 2001, J APPL ECOL, V38, P1169, DOI 10.1046/j.0021-8901.2001.00668.x; Kalcounis-Ruppell MC, 2005, WILDLIFE SOC B, V33, P1123, DOI 10.2193/0091-7648(2005)33[1123:TRSBBA]2.0.CO;2; Krusac Dennis L., 2002, P55; Kurta Allen, 2002, P118; Lafon CW, 2007, RESTOR ECOL, V15, P400, DOI 10.1111/j.1526-100X.2007.00236.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loeb SC, 2013, ECOL EVOL, V3, P103, DOI 10.1002/ece3.440; Martinuzzi S, 2009, REMOTE SENS ENVIRON, V113, P2533, DOI 10.1016/j.rse.2009.07.002; Merckx B, 2011, ECOL MODEL, V222, P588, DOI 10.1016/j.ecolmodel.2010.11.016; Meyer ALS, 2014, AM J PRIMATOL, V76, P551, DOI 10.1002/ajp.22247; Miller DA, 2003, WILDLIFE SOC B, V31, P30; Miller Nancy E., 2002, P165; Moratelli R, 2011, MAMMALIA, V75, P227, DOI 10.1515/MAMM.2011.028; Neubaum DJ, 2006, J MAMMAL, V87, P470, DOI 10.1644/05-MAMM-A-252R1.1; Nowak J, 2008, J FOREST, V106, P261; Nuckolls AE, 2009, ECOSYSTEMS, V12, P179, DOI 10.1007/s10021-008-9215-3; O'Farrell MJ, 1999, J MAMMAL, V80, P24, DOI 10.2307/1383204; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Phillips A., 2010, ON BALANCE; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pie MR, 2013, ECOL MODEL, V250, P165, DOI 10.1016/j.ecolmodel.2012.10.019; Rebelo H, 2010, J APPL ECOL, V47, P410, DOI 10.1111/j.1365-2664.2009.01765.x; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Russo D, 2015, J ZOOL, V297, P165, DOI 10.1111/jzo.12271; Schafale M.P., 2012, GUIDE NATURAL COMMUN; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Tessarolo G, 2014, DIVERS DISTRIB, V20, P1258, DOI 10.1111/ddi.12236; U. S. Fish & Wildlife Service (USFWS), 2011, SUPP DEC DOC RES WNS; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weller Theodore J., 2007, P263	55	16	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154464	10.1371/journal.pone.0154464	http://dx.doi.org/10.1371/journal.pone.0154464			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115605	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600069
J	Kirby, AE; Streby, A; Moe, CL				Kirby, Amy E.; Streby, Ashleigh; Moe, Christine L.			Vomiting as a Symptom and Transmission Risk in Norovirus Illness: Evidence from Human Challenge Studies	PLOS ONE			English	Article							NORWALK-LIKE VIRUS; AIRBORNE TRANSMISSION; UNITED-STATES; OUTBREAK; GASTROENTERITIS; PERSISTENCE; INFECTION; DISEASE	Background In the US, noroviruses are estimated to cause 21 million cases annually with economic losses reaching $2 billion. Outbreak investigations frequently implicate vomiting as a major transmission risk. However, little is known about the characteristics of vomiting as a symptom or the amount of virus present in emesis. Methodology and Principal Findings Emesis samples and symptomology data were obtained from previous norovirus human challenge studies with GI.1 Norwalk virus, GII.2 Snow Mountain virus, and a pilot study with GII.1 Hawaii virus. Viral titers in emesis were determined using strain-specific quantitative RT-PCR. In all four studies, vomiting was common with 40-100% of infected subjects vomiting at least once. However, only 45% of subjects with vomiting also had diarrhea. Most of the emesis samples had detectable virus and the mean viral titers were 8.0 x 10(5) and 3.9 x 10(4) genomic equivalent copies (GEC)/ml for GI and GII viruses, respectively (p = 0.02). Sample pH was correlated with GII.2 Snow Mountain virus detection. Conclusions and Significance Half of all subjects with symptomatic infection experienced vomiting and the average subject shed 1.7 x 10(8) GEC in emesis. Unlike shedding through stool, vomiting is more likely to result in significant environmental contamination, leading to transmission through fomites and airborne droplets. This quantitative data will be critical for risk assessment studies to further understand norovirus transmission and develop effective control measures. The correlation between sample pH and virus detection is consistent with a single site of virus replication in the small intestine and stomach contents becoming contaminated by intestinal reflux. Additionally, the frequency of vomiting without concurrent diarrhea suggests that epidemiology studies that enroll subjects based on the presence of diarrhea may be significantly underestimating the true burden of norovirus disease.	[Kirby, Amy E.; Streby, Ashleigh; Moe, Christine L.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Kirby, AE (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	aekirby@emory.edu		Kirby, Amy/0000-0002-6928-668X	Agriculture and Food Research Initiative Competitive grant from the US Department of Agriculture, National Institute of Food and Agriculture through the NoroCORE project [2011-68003-30395]	Agriculture and Food Research Initiative Competitive grant from the US Department of Agriculture, National Institute of Food and Agriculture through the NoroCORE project	This work was supported by the Agriculture and Food Research Initiative Competitive grant no. 2011-68003-30395 from the US Department of Agriculture, National Institute of Food and Agriculture through the NoroCORE project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong D, 2004, ALIMENT PHARM THERAP, V20, P19, DOI 10.1111/j.1365-2036.2004.02140.x; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Bernard H, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.8.20719; Bernstein DI, 2015, J INFECT DIS, V211, P870, DOI 10.1093/infdis/jiu497; Chan MCW, 2011, J VIROL, V85, P8427, DOI 10.1128/JVI.05016-11; Evans MR, 2002, EPIDEMIOL INFECT, V129, P355, DOI 10.1017/S0950268802007446; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hoefnagel J, 2012, EUROSURVEILLANCE, V17, P17; Karst SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004626; Kirby AE, 2014, J MED VIROL, V86, P2055, DOI 10.1002/jmv.23905; Leon JS, 2011, APPL ENVIRON MICROB, V77, P5476, DOI 10.1128/AEM.02801-10; Lindesmith L, 2005, J VIROL, V79, P2900, DOI 10.1128/JVI.79.5.2900-2909.2005; Liu PB, 2010, J MED VIROL, V82, P1612, DOI 10.1002/jmv.21851; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; Magill-Collins A, 2015, WILD ENVIRON MED, V26, P312, DOI 10.1016/j.wem.2015.02.007; Makison Booth Catherine, 2014, J Infect Prev, V15, P176, DOI 10.1177/1757177414545390; Marks PJ, 2000, EPIDEMIOL INFECT, V124, P481, DOI 10.1017/S0950268899003805; Marks PJ, 2003, EPIDEMIOL INFECT, V131, P727, DOI 10.1017/S0950268803008689; Morawska L, 2006, INDOOR AIR, V16, P335, DOI 10.1111/j.1600-0668.2006.00432.x; Muller L, 2015, EPIDEMIOL INFECT, V143, P2299, DOI 10.1017/S0950268814003409; Patterson W, 1997, Commun Dis Rep CDR Rev, V7, pR101; Petrignani M, 2015, J HOSP INFECT, V89, P163, DOI 10.1016/j.jhin.2014.11.015; Polkowska A, 2014, EPIDEMIOL INFECT, V142, P1877, DOI 10.1017/S0950268813002847; Ramani S, 2014, CURR OPIN GASTROEN, V30, P25, DOI 10.1097/MOG.0000000000000022; Repp KK, 2012, J INFECT DIS, V205, P1639, DOI 10.1093/infdis/jis250; Sartorius B, 2007, SCAND J INFECT DIS, V39, P323, DOI 10.1080/00365540601053006; Seitz SR, 2011, APPL ENVIRON MICROB, V77, P6884, DOI 10.1128/AEM.05806-11; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Thornley CN, 2011, CLIN INFECT DIS, V53, P515, DOI 10.1093/cid/cir465; Tung-Thompson G, 2015, FOOD ENVIRON VIROL, V7, P32, DOI 10.1007/s12560-014-9170-4; Wikswo M, 2014, AM J PUBLIC HEALTH, V104, pE13, DOI 10.2105/AJPH.2014.10411e13; Wikswo ME, 2011, CLIN INFECT DIS, V52, P1116, DOI 10.1093/cid/cir144; Zlot A, 2015, MMWR-MORBID MORTAL W, V64, P621	33	55	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0143759	10.1371/journal.pone.0143759	http://dx.doi.org/10.1371/journal.pone.0143759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116105	Green Published, gold, Green Submitted			2022-12-27	WOS:000374973600001
J	Sewe, MO; Ahlm, C; Rocklov, J				Sewe, Maquins Odhiambo; Ahlm, Clas; Rocklov, Joacim			Remotely Sensed Environmental Conditions and Malaria Mortality in Three Malaria Endemic Regions in Western Kenya	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; DEMOGRAPHIC SURVEILLANCE; LAND-COVER; ANOPHELES-GAMBIAE; HUMAN HEALTH; EAST-AFRICA; MODELS; RISK; ASSOCIATION; VARIABILITY	Background Malaria is an important cause of morbidity and mortality in malaria endemic countries. The malaria mosquito vectors depend on environmental conditions, such as temperature and rainfall, for reproduction and survival. To investigate the potential for weather driven early warning systems to prevent disease occurrence, the disease relationship to weather conditions need to be carefully investigated. Where meteorological observations are scarce, satellite derived products provide new opportunities to study the disease patterns depending on remotely sensed variables. In this study, we explored the lagged association of Normalized Difference Vegetation Index (NVDI), day Land Surface Temperature (LST) and precipitation on malaria mortality in three areas in Western Kenya. Methodology and Findings The lagged effect of each environmental variable on weekly malaria mortality was modeled using a Distributed Lag Non Linear Modeling approach. For each variable we constructed a natural spline basis with 3 degrees of freedom for both the lag dimension and the variable. Lag periods up to 12 weeks were considered. The effect of day LST varied between the areas with longer lags. In all the three areas, malaria mortality was associated with precipitation. The risk increased with increasing weekly total precipitation above 20 mm and peaking at 80 mm. The NDVI threshold for increased mortality risk was between 0.3 and 0.4 at shorter lags. Conclusion This study identified lag patterns and association of remote-sensing environmental factors and malaria mortality in three malaria endemic regions in Western Kenya. Our results show that rainfall has the most consistent predictive pattern to malaria transmission in the endemic study area. Results highlight a potential for development of locally based early warning forecasts that could potentially reduce the disease burden by enabling timely control actions.	[Sewe, Maquins Odhiambo] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Sewe, Maquins Odhiambo; Rocklov, Joacim] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden; [Ahlm, Clas] Umea Univ, Infect Dis, Dept Clin Microbiol, Umea, Sweden	Kenya Medical Research Institute; Umea University; Umea University	Sewe, MO (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.; Sewe, MO (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden.	sewemaquins@gmail.com		Rocklov, Joacim/0000-0003-4030-0449; sewe, maquins/0000-0003-1267-649X	President's Emergency Plan for AIDS Relief (PEPFAR) from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA) and Division of Parasitic Diseases and Malaria (DPDM) [GH10-1001]; President's Malaria Initiative (PMI) from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA) [GH10-1001]; HDSS; INDEPTH network; FAS, the Swedish Council for Working Life and Social Research [2006-1512]; President's Malaria Initiative (PMI) from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Parasitic Diseases and Malaria (DPDM) [GH10-1001]	President's Emergency Plan for AIDS Relief (PEPFAR) from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA) and Division of Parasitic Diseases and Malaria (DPDM); President's Malaria Initiative (PMI) from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA); HDSS; INDEPTH network; FAS, the Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); President's Malaria Initiative (PMI) from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Parasitic Diseases and Malaria (DPDM)	The KEMRI/CDC HDSS is funded by the President's Emergency Plan for AIDS Relief (PEPFAR) and the President's Malaria Initiative (PMI) through cooperative agreement No. GH10-1001 from the U.S. HHS/Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global HIV/AIDS (DGHA) and Division of Parasitic Diseases and Malaria (DPDM). Funding has also been received through the studies nested in the HDSS and the INDEPTH network. This research was partly undertaken within the Umea Centre for Global Health Research at Umea University, with support from FAS, the Swedish Council for Working Life and Social Research ( grant no. 2006-1512). The funders had no role in design, analysis and writing of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Amek N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-86; Amek N, 2011, SPAT SPATIO-TEMPORAL, V2, P283, DOI 10.1016/j.sste.2011.08.001; Amek NO, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25581; [Anonymous], 2014, R LANG ENV STAT COMP; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Becking LE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075996, 10.1371/journal.pone.0079276]; Bi Y, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-357; Brown ME, 2014, POPUL ENVIRON, V36, P48, DOI 10.1007/s11111-013-0201-0; Byass P, 2015, J GLOB HEALTH, V5, P65, DOI 10.7189/jogh.05.010402; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Ceccato P., 2005, Parassitologia (Rome), V47, P81; Christiansen-Jucht C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0489-3; Clennon JA, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-58; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-328; Connor SJ, 2006, GEOSPATIAL HEALTH, V1, P17, DOI 10.4081/gh.2006.278; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Juri MJD, 2015, J VECTOR ECOL, V40, P36, DOI 10.1111/jvec.12130; Desai M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106197; Ehlkes L, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-35; Gasparrini A, 2014, STAT MED, V33, P881, DOI 10.1002/sim.5963; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Hallman J, TIS TIME INDEXES TIM; Haque U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014341; Hashemi S. A., 2011, World Applied Sciences Journal, V14, P1678; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Krefis AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017905; McCann RS, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-17; Midekisa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-165; Mutuku FM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-19; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Omumbo JA, 2005, TROP MED INT HEALTH, V10, P557, DOI 10.1111/j.1365-3156.2005.01424.x; Omumbo JA, 2002, PHOTOGRAMM ENG REM S, V68, P161; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Sewe M, 2015, INT J ENV RES PUB HE, V12, P1983, DOI 10.3390/ijerph120201983; Snow RW, 1998, T ROY SOC TROP MED H, V92, P601, DOI 10.1016/S0035-9203(98)90781-7; Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25369; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-41; Thomson MC, 1997, PARASITOL TODAY, V13, P313, DOI 10.1016/S0169-4758(97)01097-1; Walker M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-311; WHO, WORLD MAL REP 2013; Zhao X, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-57	45	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154204	10.1371/journal.pone.0154204	http://dx.doi.org/10.1371/journal.pone.0154204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115874	gold, Green Published			2022-12-27	WOS:000374973600047
J	Pridmore, RW				Pridmore, Ralph W.			When Do Short-Wave Cones Signal Blue or Red? A Solution Introducing the Concept of Primary and Secondary Cone Outputs	PLOS ONE			English	Article							OPPONENT-COLORS THEORY; SPECTRAL SENSITIVITIES; COMPLEMENTARY COLORS; QUANTITATIVE ASPECTS; HUE; SATURATION	A recent paper by Oh and Sakata investigates the "incompletely solved mystery" of how the three cone responses map onto perceived hue, and particularly the S cone's well-known problematic contribution to blueness and redness. Citing previous workers, they argue the twentieth century traditional multistage model does not satisfactorily account for color appearance. In their experiment, increasing S cone excitation with shortening wavelength from about 480-460 nm increased perceived blueness up to the unique Blue point at 470 nm, when (a) it began decreasing and (b) redness perception began increasing. The authors asked, What mechanism can be responsible for such functions? I demonstrate a solution. First, it is shown the problem does not lie in the traditional opponent color chromatic responses yellow-blue, red-green (y-b, r-g, which accurately predict the above functions), but in the traditional multistage model of mapping cone responses to chromatic response functions. Arguably, this is due to the S cone's hypothetically signaling both blueness and redness by the same mechanism rather than by different, independent, mechanisms. Hence a new distinction or mechanism is proposed for a more accurate model, that introduces the new terms primary and secondary cone outputs. However, this distinction requires that the cones S, M, L each directly produce one of the three spectral chromatic responses b, g, y. Such a model was recently published, based on extremely high correlation of SML cone responsivities with the three spectral (bgy) chromatic responses. This model encodes the former directly onto the latter one-to-one as cone primary outputs, whilst S and L cones have a further or secondary function where each produces one of the two spectral lobes of r chromatic response. The proposed distinction between primary and secondary cone outputs is a new concept and useful tool in detailing cone outputs to chromatic channels, and provides a solution to the above "incompletely solved mystery." Thus the S cone has a primary output producing the total b chromatic response and a secondary output that shares with the L cone the production of r chromatic response, thus aligning with Oh and Sokata's results. The model similarly maps L cone to yellowness as primary output and to redness as secondary output.	[Pridmore, Ralph W.] Cent Houses Pty Ltd, 8c Rothwell Rd, Sydney, NSW 2074, Australia		Pridmore, RW (corresponding author), Cent Houses Pty Ltd, 8c Rothwell Rd, Sydney, NSW 2074, Australia.	rpridmo@bigpond.net.au		pridmore, ralph/0000-0001-7166-7249	Central Houses Pty Ltd	Central Houses Pty Ltd	The author is a director of Central Houses Pty Ltd, a private, small, family company, which only provided financial support in the form of research materials, and had no role in the study design or the preparation of the MS.	Abramov I, ANN REV PSYCHOL, V45, P451; BURNS SA, 1984, VISION RES, V24, P479, DOI 10.1016/0042-6989(84)90045-2; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P512, DOI 10.1073/pnas.97.1.512; Dowling J. E., 1987, RETINA APPROACHABLE; DRUM B, 1989, COLOR RES APPL, V14, P293, DOI 10.1002/col.5080140607; Estevez O., 1979, THESIS; Fairchild M. D., 2005, COLOR APPEARANCE MOD; FULD K, 1991, VISION RES, V31, P237, DOI 10.1016/0042-6989(91)90114-K; Hoyland H, 2009, SYSTEM RELIABILITY T; HURVICH LM, 1955, J OPT SOC AM, V45, P602, DOI 10.1364/JOSA.45.000602; Hurvich LM., 1981, COLOR VISION; INGLING CR, 1982, COLOR RES APPL, V7, P191, DOI 10.1002/col.5080070229; INGLING CR, 1977, VISION RES, V17, P1083, DOI 10.1016/0042-6989(77)90014-1; JAMESON D, 1955, J OPT SOC AM, V45, P546, DOI 10.1364/JOSA.45.000546; JAMESON D, 1968, J OPT SOC AM, V58, P429; Judd D. B., 1975, COLOR BUSINESS SCI I; Knoblauch K, 2001, VISUAL NEUROSCI, V18, P901, DOI 10.1017/S0952523801186062; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; KULP TD, 1995, VISION RES, V35, P2967, DOI 10.1016/0042-6989(95)00049-6; Mollon JD, 1987, COLOUR VISION DEFICI, P473; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Oh S, 2015, COLOR RES APPL, V40, P323, DOI 10.1002/col.21900; Pridmore RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077134; Pridmore RW, 2010, COLOR RES APPL, V35, P122, DOI 10.1002/col.20534; PRIDMORE RW, 1978, J OPT SOC AM, V68, P1490, DOI 10.1364/JOSA.68.001490; PRIDMORE RW, 1980, J OPT SOC AM, V70, P248, DOI 10.1364/JOSA.70.000248; Pridmore RW, 2007, EFFECT PURITY HUE AB; Romeskie MI., 1976, THESIS BROWN U; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; TAKAHASHI S, 1985, J OPT SOC AM A, V2, P705, DOI 10.1364/JOSAA.2.000705; VOS JJ, 1990, VISION RES, V30, P937, DOI 10.1016/0042-6989(90)90059-T; WERNER JS, 1979, J OPT SOC AM, V69, P422, DOI 10.1364/JOSA.69.000422; Wyszecki G, 1982, COLOR SCI, Vsecond	35	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154048	10.1371/journal.pone.0154048	http://dx.doi.org/10.1371/journal.pone.0154048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27110938	gold, Green Published			2022-12-27	WOS:000374565100038
J	Zeb, A; Zaman, G; Erturk, VS; Alzalg, B; Yousafzai, F; Khan, M				Zeb, Anwar; Zaman, Gul; Erturk, Vedat Suat; Alzalg, Baha; Yousafzai, Faisal; Khan, Madad			Approximating a Giving Up Smoking Dynamic on Adolescent Nicotine Dependence in Fractional Order	PLOS ONE			English	Article							DIFFERENTIAL TRANSFORM METHOD; EQUATIONS	In this work, we consider giving up smoking dynamic on adolescent nicotine dependence. First, we use the Caputo derivative to develop the model in fractional order. Then we apply two different numerical methods to compute accurate approximate solutions of this new model in fractional order and compare their results. In order to do this, we consider the generalized Euler method (GEM) and multi-step generalized differential transform method (MSGDTM). We also show the unique positive solution for this model and present numerical results graphically.	[Zeb, Anwar; Khan, Madad] COMSATS Inst Informat Technol, Dept Math, Abbottabad, Kpk, Pakistan; [Zaman, Gul] Univ Malakand, Dept Math, Chakdara Dir Lower, Khyber Pakhtunk, Pakistan; [Erturk, Vedat Suat] Ondokuz Mayis Univ, Fac Arts & Sci, Dept Math, Samsun, Turkey; [Alzalg, Baha] Buraimi Univ Coll, Dept Business Adm & Accounting, Al Buraimi, Oman; [Yousafzai, Faisal] COMSATS Inst Informat Technol Attack, Dept Math, Lahore, Pakistan	COMSATS University Islamabad (CUI); Ondokuz Mayis University; COMSATS University Islamabad (CUI)	Khan, M (corresponding author), COMSATS Inst Informat Technol, Dept Math, Abbottabad, Kpk, Pakistan.	madadmath@yahoo.com	Alzalg, Baha/Q-7575-2019; Alzalg, Baha/G-5775-2016; ERTURK, Vedat Suat/ABD-4512-2021	Alzalg, Baha/0000-0002-1839-8083; ERTURK, Vedat Suat/0000-0002-1322-8843; Khan, Madad/0000-0003-0044-961X				Alomari AK, 2011, COMPUT MATH APPL, V61, P2528, DOI 10.1016/j.camwa.2011.02.043; Brauer F., 2012, MATH MODELS POPULATI, V2; CAPUTO M, 1967, GEOPHYS J ROY ASTR S, V13, P529, DOI 10.1111/j.1365-246X.1967.tb02303.x; Choi H., 2011, KSIAM 2011 SPRING C; Das S., 2011, FUNCT FRACT CALC 2; Erturk VS, 2008, COMMUN NONLINEAR SCI, V13, P1642, DOI 10.1016/j.cnsns.2007.02.006; Gokdogan A, 2011, MATH COMPUT MODEL, V54, P2132, DOI 10.1016/j.mcm.2011.05.022; Jafari H, 2006, J COMPUT APPL MATH, V196, P644, DOI 10.1016/j.cam.2005.10.017; Kurulay M, 2010, COMMUN NONLINEAR SCI, V15, P1777, DOI 10.1016/j.cnsns.2009.07.014; Magin R.-L., 2006, FRACTIONAL CALCULUS; Momani S, 2008, J COMPUT APPL MATH, V220, P85, DOI 10.1016/j.cam.2007.07.033; Odibat Z, 2008, APPL MATH COMPUT, V197, P467, DOI 10.1016/j.amc.2007.07.068; Odibat Z, 2008, APPL MATH LETT, V21, P194, DOI 10.1016/j.aml.2007.02.022; Odibat ZM, 2007, APPL MATH COMPUT, V186, P286, DOI 10.1016/j.amc.2006.07.102; Odibat Zaid M., 2008, Journal of Applied Mathematics and Informatics, V26, P15; Podlubny I., 1999, FRACTIONAL DIFFERENT; SWARTZ JB, 1992, J EPIDEMIOL COMMUN H, V46, P311, DOI 10.1136/jech.46.3.311; Zeb A, 2013, APPL MATH MODEL, V37, P5326, DOI 10.1016/j.apm.2012.10.005	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0103617	10.1371/journal.pone.0103617	http://dx.doi.org/10.1371/journal.pone.0103617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105426	Green Published, gold			2022-12-27	WOS:000374565100001
J	Ali, AAA; Lee, YR; Chen, TC; Chen, CL; Lee, CC; Shiau, CY; Chiang, CH; Huang, HS				Ali, Ahmed Atef Ahmed; Lee, Yu-Ru; Chen, Tsung-Chih; Chen, Chun-Liang; Lee, Chia-Chung; Shiau, Chia-Yang; Chiang, Chiao-Hsi; Huang, Hsu-Shan			Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets Determination	PLOS ONE			English	Article							NF-KAPPA-B; CACO-2 CELL-PERMEABILITY; DRUG-DELIVERY REVIEWS; IN-VITRO; MYCOBACTERIUM-TUBERCULOSIS; INFLAMMATORY RESPONSES; CANCER; ACTIVATION; RESISTANCE; TOXICITY	The novel compounds NSC745885 and NSC757963 developed at our laboratory were tested against a panel of 60 cancer cell lines at the National Cancer Institute, USA, and a panel of 39 cancer cell lines at the Japanese Foundation of Cancer Research. Both compounds demonstrated selective unique multi-log differential patterns of activity, with GI(50) values in the sub-micro molar range against cancer cells rather than normal cardiac cells. NSC757963 showed high selectivity towards the leukemia subpanel. Activities of both compounds strongly correlated to expression of NFKB1 and CSNK2B genes, implying that they may inhibit the NF-kappa B pathway. Immunocytochemical microscopy of OVCAR-3 cells showed clear cytosolic accumulation of the NF-kappa B p65 subunit following treatment. Western blotting showed dose dependent inhibition of the nuclear expression of the NF-kappa B p65 subunit with subsequent accumulation in the cytosol following treatment. Docking experiments showed binding of both compounds to the NF-kappa B activator IKK beta subunit preventing its translocation to the nucleus. Collectively, these results confirm the ability of our compounds to inhibit the constitutively active NF-kappa B pathway of OVCAR-3 cells. Furthermore, COMPARE analysis indicated that the activity of NSC757963 is similar to the antituberculosis agent rifamycin SV, this was confirmed by testing the antimycobacterial activity of NSC757963 against Mycobacterium tuberculosis, results revealed potent activity suitable for use in clinical practice. Molecular properties and Lipinski's parameters predicted acceptable bioavailability properties with no indication of mutagenicity, tumorigenicity, irritability and reproductive effects. Oral absorption experiments using the human Caco-2 model showed high intestinal absorption of NSC745885 by passive transport mechanism with no intestinal efflux or active transport mechanisms. The unique molecular characterization as well as the illustrated anticancer spectra of activity and bioavailability properties warrant further development of our compounds and present a foundation brick in the pre-clinical investigations to implement such compounds in clinical practice.	[Ali, Ahmed Atef Ahmed; Huang, Hsu-Shan] Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Mol & Cell Biol, Taipei, Taiwan; [Ali, Ahmed Atef Ahmed; Lee, Yu-Ru; Chiang, Chiao-Hsi; Huang, Hsu-Shan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Ali, Ahmed Atef Ahmed; Chen, Tsung-Chih; Chen, Chun-Liang; Lee, Chia-Chung; Huang, Hsu-Shan] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan; [Shiau, Chia-Yang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Taipei Medical University; National Defense Medical Center	Huang, HS (corresponding author), Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Mol & Cell Biol, Taipei, Taiwan.; Huang, HS (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Huang, HS (corresponding author), Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan.	huanghs99@tmu.edu.tw	Chiang, Chiao-Hsi/AAS-9777-2021	Ali, Ahmed/0000-0002-0375-6511; CHEN, Tsung-Chih/0000-0001-8256-6240; Huang, Hsu-Shan/0000-0001-8162-5608	Taipei Medical University [TMU-NDMC-104-02]	Taipei Medical University	This work was supported by Taipei Medical University, TMU-NDMC-104-02, http://www.tmu.edu.tw/english/main.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AR, 2014, EUR J MED CHEM, V75, P492, DOI 10.1016/j.ejmech.2013.12.010; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Ataie-Kachoie P, 2013, MOL CANCER RES, V11, P1279, DOI 10.1158/1541-7786.MCR-13-0239; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Bhat-Nakshatri P, 2002, ONCOGENE, V21, P2066, DOI 10.1038/sj.onc.1205243; Blanchfield JT, 2003, J MED CHEM, V46, P1266, DOI 10.1021/jm020426j; Broeders JJW, 2012, CHEM RES TOXICOL, V25, P1442, DOI 10.1021/tx300221k; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Chang YL, 2011, INT J BIOCHEM CELL B, V43, P1720, DOI 10.1016/j.biocel.2011.08.006; Chen JE, 2015, BIOINFORMATICS, V31, P1484, DOI 10.1093/bioinformatics/btu841; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; Fang XL, 2004, J CHEM INF COMP SCI, V44, P249, DOI 10.1021/ci034209i; Gills JJ, 2006, MOL CANCER THER, V5, P713, DOI 10.1158/1535-7163.MCT-05-0484; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hall L, 2011, JOVE-J VIS EXP, DOI 10.3791/3094; Hu CS, 2012, INT J NANOMED, V7, P4861, DOI 10.2147/IJN.S34770; Hu SQ, 2012, INT J MOL SCI, V13, P15653, DOI 10.3390/ijms131215653; Huang HS, 2009, BIOORGAN MED CHEM, V17, P7418, DOI 10.1016/j.bmc.2009.09.033; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Hwang JK, 2013, RHEUMATOLOGY, V52, P1583, DOI 10.1093/rheumatology/ket178; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Jhamb SS, 2014, BRAZ J INFECT DIS, V18, P336, DOI 10.1016/j.bjid.2013.12.004; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kratz JM, 2011, BRAZ J MED BIOL RES, V44, P531, DOI 10.1590/S0100-879X2011007500060; Lavon I, 2007, CANCER RES, V67, P8952, DOI 10.1158/0008-5472.CAN-06-3820; Lee YR, 2015, EUR J MED CHEM, V102, P661, DOI 10.1016/j.ejmech.2015.07.052; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu SP, 2013, J BIOL CHEM, V288, P22758, DOI 10.1074/jbc.M113.482596; Luzina EL, 2013, J FLUORINE CHEM, V148, P41, DOI 10.1016/j.jfluchem.2013.01.033; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Meng GQ, 2010, BRIT J PHARMACOL, V161, P1628, DOI 10.1111/j.1476-5381.2010.00993.x; Moreira AC, 2014, BBA-MOL BASIS DIS, V1842, P2468, DOI 10.1016/j.bbadis.2014.09.015; Naasani Imad, 2002, Methods Mol Biol, V191, P197; Narva S, 2016, EUR J MED CHEM, V114, P220, DOI 10.1016/j.ejmech.2016.02.059; Passagne I, 2006, TOXICOL APPL PHARM, V211, P97, DOI 10.1016/j.taap.2005.06.009; Rashidipour S, 2016, J BIOMOL STRUCT DYN, V34, P57, DOI 10.1080/07391102.2015.1009946; Ravi R, 2004, DRUG RESIST UPDATE, V7, P53, DOI 10.1016/j.drup.2004.01.003; Rostom SAF, 2006, BIOORGAN MED CHEM, V14, P6475, DOI 10.1016/j.bmc.2006.06.020; Sattar Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084045; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Tang SH, 2014, ONCOTARGET, V5, P10342, DOI 10.18632/oncotarget.1867; Torrea G, 2015, J ANTIMICROB CHEMOTH, V70, P2300, DOI 10.1093/jac/dkv117; Toungoussova OS, 2005, EUR J CLIN MICROBIOL, V24, P202, DOI 10.1007/s10096-005-1284-z; van Breemen Richard B, 2005, Expert Opin Drug Metab Toxicol, V1, P175, DOI 10.1517/17425255.1.2.175; Vavricka SR, 2002, HEPATOLOGY, V36, P164, DOI 10.1053/jhep.2002.34133; von Korff M, 2006, J CHEM INF MODEL, V46, P536, DOI 10.1021/ci050358k; Weaver KD, 2003, J NEURO-ONCOL, V61, P187, DOI 10.1023/A:1022554824129; Werngren J, 2014, ANTIMICROB AGENTS CH, V58, P4222, DOI 10.1128/AAC.02718-14; Wessling ST, 2007, BIOORGAN MED CHEM, V15, P4946, DOI 10.1016/j.bmc.2007.04.042; Xing MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133569; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977	55	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154278	10.1371/journal.pone.0154278	http://dx.doi.org/10.1371/journal.pone.0154278			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100886	Green Submitted, gold, Green Published			2022-12-27	WOS:000374898500176
J	Cunningham, AL; Guentzel, MN; Yu, JJ; Hung, CY; Forsthuber, TG; Navara, CS; Yagita, H; Williams, IR; Klose, KE; Eaves-Pyles, TD; Arulanandam, BP				Cunningham, Aimee L.; Guentzel, M. Neal; Yu, Jieh-Juen; Hung, Chiung-Yu; Forsthuber, Thomas G.; Navara, Christopher S.; Yagita, Hideo; Williams, Ifor R.; Klose, Karl E.; Eaves-Pyles, Tonyia D.; Arulanandam, Bernard P.			M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensis	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; TRANSEPITHELIAL TRANSPORT; ANTIGEN; STRAIN; CHALLENGE; INFECTION; BACTERIA; MICE; DIFFERENTIATION; RESPONSES	M-cells (microfold cells) are thought to be a primary conduit of intestinal antigen trafficking. Using an established neutralizing anti-RANKL (Receptor Activator of NF-kappa B Ligand) antibody treatment to transiently deplete M-cells in vivo, we sought to determine whether intestinal M-cells were required for the effective induction of protective immunity following oral vaccination with Delta iglB (a defined live attenuated Francisella novicida mutant). M-cell depleted, Delta iglB-vaccinated mice exhibited increased (but not significant) morbidity and mortality following a subsequent homotypic or heterotypic pulmonary F. tularensis challenge. No significant differences in splenic IFN-gamma, IL-2, or IL-17 or serum antibody (IgG1, IgG2a, IgA) production were observed compared to non-depleted, Delta iglB-vaccinated animals suggesting complementary mechanisms for Delta iglB entry. Thus, we examined other possible routes of gastrointestinal antigen sampling following oral vaccination and found that Delta iglB co-localized to villus goblet cells and enterocytes. These results provide insight into the role of M-cells and complementary pathways in intestinal antigen trafficking that may be involved in the generation of optimal immunity following oral vaccination.	[Cunningham, Aimee L.; Guentzel, M. Neal; Yu, Jieh-Juen; Hung, Chiung-Yu; Forsthuber, Thomas G.; Navara, Christopher S.; Klose, Karl E.; Arulanandam, Bernard P.] Univ Texas San Antonio, Dept Biol, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Cunningham, Aimee L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Yagita, Hideo] Juntendo Univ, Dept Immunol, Tokyo, Japan; [Williams, Ifor R.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Eaves-Pyles, Tonyia D.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio; Juntendo University; Emory University; University of Texas System; University of Texas Medical Branch Galveston	Arulanandam, BP (corresponding author), Univ Texas San Antonio, Dept Biol, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA.	bernard.arulanandam@utsa.edu	Navara, Christopher/C-2813-2011; Forsthuber, Thomas/AID-8080-2022; Williams, Ifor R/D-3648-2011	Williams, Ifor R/0000-0002-8810-2911; /0000-0003-0692-7125; Hung, Chiung Yu/0000-0003-1091-3420	UTHSCSA Department of Microbiology and Immunology Microbial Pathogenesis training grant (NIH) [T32AI007271]; UTSA Center for Excellence in Infection Genomics training grant (DOD) [W911NF-11-1-0136]; UTSA RCMI (Regional Centers in Minority Institutions) from the National Institute on Minority Health and Health Disparities [G12MD007591]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114762, T32AI007271] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	UTHSCSA Department of Microbiology and Immunology Microbial Pathogenesis training grant (NIH); UTSA Center for Excellence in Infection Genomics training grant (DOD); UTSA RCMI (Regional Centers in Minority Institutions) from the National Institute on Minority Health and Health Disparities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the UTHSCSA Department of Microbiology and Immunology Microbial Pathogenesis training grant (NIH #T32AI007271), the UTSA Center for Excellence in Infection Genomics training grant (DOD #W911NF-11-1-0136 for BPA), and a UTSA RCMI (Regional Centers in Minority Institutions) grant (#G12MD007591) from the National Institute on Minority Health and Health Disparities. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; AMERONGEN HM, 1991, J ACQ IMMUN DEF SYND, V4, P760; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brandtzaeg P, 2001, NAT IMMUNOL, V2, P1093, DOI 10.1038/ni1201-1093; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Cong Y, 2009, VACCINE, V27, P5554, DOI 10.1016/j.vaccine.2009.07.034; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Dietrich G, 2003, VACCINE, V21, P678, DOI 10.1016/S0264-410X(02)00579-0; Donaldson DS, 2012, MUCOSAL IMMUNOL, V5, P216, DOI 10.1038/mi.2011.68; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fotopoulos G, 2002, P NATL ACAD SCI USA, V99, P9410, DOI 10.1073/pnas.142586899; Frey A, 1997, Behring Inst Mitt, P376; Geem D, 2012, JOVE-J VIS EXP, DOI 10.3791/4040; GODEFROY O, 1988, BIOL CELL, V63, P41, DOI 10.1016/0248-4900(88)90107-4; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; HUET C, 1987, J CELL BIOL, V105, P345, DOI 10.1083/jcb.105.1.345; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Kim SH, 2010, J IMMUNOL, V185, P5787, DOI 10.4049/jimmunol.0903184; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; KRAEHENBUHL JP, 1992, PHYSIOL REV, V72, P853, DOI 10.1152/physrev.1992.72.4.853; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; KuoLee R, 2007, VACCINE, V25, P3781, DOI 10.1016/j.vaccine.2007.02.014; Levine MM, 2003, NAT MED, V9, P99, DOI 10.1038/nm0103-99; Li WD, 2013, VACCINE, V31, P5722, DOI 10.1016/j.vaccine.2013.09.036; Liu JR, 2007, BIOTECHNIQUES, V43, P487, DOI 10.2144/000112574; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Misumi S, 2009, J IMMUNOL, V182, P6061, DOI 10.4049/jimmunol.0802928; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; Nikitas G, 2011, J EXP MED, V208, P2263, DOI 10.1084/jem.20110560; Ray HJ, 2009, CLIN VACCINE IMMUNOL, V16, P444, DOI 10.1128/CVI.00405-08; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Roth-Walter F, 2005, IMMUNOL LETT, V100, P182, DOI 10.1016/j.imlet.2005.03.020; Signarovitz AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047639; Skyberg JA, 2013, INFECT IMMUN, V81, P3099, DOI 10.1128/IAI.00203-13; SURCEL HM, 1991, INFECT IMMUN, V59, P1948, DOI 10.1128/IAI.59.6.1948-1953.1991; Tsai YH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003381; Westphal S, 2008, AM J PATHOL, V172, P671, DOI 10.2353/ajpath.2008.070393	44	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153402	10.1371/journal.pone.0153402	http://dx.doi.org/10.1371/journal.pone.0153402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100824	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500031
J	Davis, JC; Hsiung, GY; Bryan, S; Jacova, C; Jacova, P; Munkacsy, M; Cheung, W; Lee, P; Liu-Ambrose, T				Davis, Jennifer C.; Hsiung, Ging-Yuek; Bryan, Stirling; Jacova, Claudia; Jacova, Patrizio; Munkacsy, Michelle; Cheung, Winnie; Lee, Philip; Liu-Ambrose, Teresa			Agreement between Patient and Proxy Assessments of Quality of Life among Older Adults with Vascular Cognitive Impairment Using the EQ-5D-3L and ICECAP-O	PLOS ONE			English	Article							CONTROLLED-TRIAL; DEMENTIA; CAPABILITY; PERSPECTIVES; DONEPEZIL; EFFICACY; UTILITY; LESIONS; FALLS; SCALE	Background The assessment of quality of life is critical in ascertaining the benefit of interventions aimed to reduce morbidity among individuals with cognitive impairment. However, the assessment of quality of life is challenging in this population due to the uncertain validity of patient responses as cognitive function declines. Hence, we examined the level of agreement between patient and proxy assessments of health related quality of life (HRQoL) and wellbeing based on the domains that comprise each of these constructs. Methods Analysis of baseline data from 71 community-dwelling older adults with mild Vascular Cognitive Impairment (VCI) who participated in a six-month proof-of-concept single-blinded randomized trial. Level of agreement between patient and caregiver ratings of HRQoL (EQ-5D-3L) and wellbeing (ICECAP-O) were compared using raw agreement (%), intraclass correlation coefficient (ICC) and weighted Cohen's kappa statistic. Results Self-care (assessed via the EQ-5D-3L) demonstrated almost perfect raw agreement between the patient and caregiver ratings. Three domains (mobility, pain and anxiety) of the EQ-5D-3L demonstrated fair agreement between the patient and caregiver ratings. Two (attachment and control) of the five ICECAP-O domains demonstrated slight agreement. The ICC indicated good agreement for the EQ-5D-3L and poor agreement for the ICECAP-O. Conclusion There is better patient-proxy agreement for the EQ-5D-3L compared with the ICECAP-O among individuals with mild VCI. These findings imply that the ICECAP-O may have limited clinical, research and policy related utility among individuals with mild VCI.	[Davis, Jennifer C.; Bryan, Stirling] Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver, BC V5Z 1M9, Canada; [Davis, Jennifer C.; Bryan, Stirling] VCHRI, Vancouver, BC, Canada; [Hsiung, Ging-Yuek; Jacova, Claudia] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V5Z 1M9, Canada; [Davis, Jennifer C.; Jacova, Patrizio; Munkacsy, Michelle; Cheung, Winnie; Liu-Ambrose, Teresa] Univ British Columbia, Aging Mobil & Cognit Neurosci Lab, Vancouver, BC V5Z 1M9, Canada; [Liu-Ambrose, Teresa] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Davis, Jennifer C.; Liu-Ambrose, Teresa] Univ British Columbia, Ctr Hip Hlth & Mobil, Vancouver, BC V5Z 1M9, Canada; [Lee, Philip] St Pauls Hosp, Providence Hlth Care Dept Med, Vancouver, BC V6Z 1Y6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan	Davis, JC (corresponding author), Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver, BC V5Z 1M9, Canada.; Davis, JC (corresponding author), VCHRI, Vancouver, BC, Canada.; Davis, JC (corresponding author), Univ British Columbia, Aging Mobil & Cognit Neurosci Lab, Vancouver, BC V5Z 1M9, Canada.; Davis, JC (corresponding author), Univ British Columbia, Ctr Hip Hlth & Mobil, Vancouver, BC V5Z 1M9, Canada.	Jennifer.davis@ubc.ca	Liu-Ambrose, Teresa/W-2332-2019; Hsiung, Robin/AAT-1661-2021; Jacova, Claudia/AAJ-4890-2021	Liu-Ambrose, Teresa/0000-0002-8297-5308; Hsiung, Robin/0000-0002-8017-0856; Jacova, Claudia/0000-0001-8227-8564	Canadian Stroke Network; Heart and Stroke Foundation of Canada	Canadian Stroke Network; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	The authors thank the study participants. This study is jointly funded by the Canadian Stroke Network and the Heart and Stroke Foundation of Canada. TLA is a Canada Research Chair in Physical Activity, Mobility, and Cognitive Neuroscience, a Michael Smith Foundation for Health Research (MSFHR) Scholar, a Canadian Institutes of Health Research (CIHR) New Investigator, and a Heart and Stroke Foundation of Canada's Henry JM Barnett's Scholarship recipient. These funding agencies did not play a role in study design.	Bansback N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031115; Brazier J, 2007, MEASURING VALUING HL; Bryan S, 2005, QUAL LIFE RES, V14, P107, DOI 10.1007/s11136-004-1920-6; Coast J, 2008, QUAL LIFE RES, V17, P967, DOI 10.1007/s11136-008-9372-z; Coast J, 2008, SOC SCI MED, V67, P874, DOI 10.1016/j.socscimed.2008.05.015; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Davis JC, 2012, QUAL LIFE RES; Delbaere K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4165; Desmond DW, 1999, ALZ DIS ASSOC DIS, V13, pS21, DOI 10.1097/00002093-199912001-00005; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Erkinjuntti T, 1999, ALZ DIS ASSOC DIS, V13, pS81, DOI 10.1097/00002093-199912001-00013; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; Farlow M, 2004, PHARMACOGENOMICS J, V4, P332, DOI 10.1038/sj.tpj.6500267; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Flynn TN, 2011, APPL HEALTH ECON HEA, V9, P317, DOI 10.2165/11594150-000000000-00000; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Jia JJ., ALZHEIMERS DEMENTIA; Jonsson L, 2006, ALZ DIS ASSOC DIS, V20, P49; Kemp PM, 2003, J NEUROL NEUROSUR PS, V74, P1567, DOI 10.1136/jnnp.74.11.1567; Liu-Ambrose T, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-14; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; LORD S, 2001, PHYSL PROFILE APPROA; LORD S, 2001, PHYSL PROFILE APPROA, P221; LORD SR, 1994, J AM GERIATR SOC, V42, P1110, DOI 10.1111/j.1532-5415.1994.tb06218.x; LORD SR, 1991, J AM GERIATR SOC, V39, P1194, DOI 10.1111/j.1532-5415.1991.tb03574.x; Makai P, 2014, EUR J HLTH EC; Makai P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092016; Makai P, 2012, QUAL LIFE RES, V21, P801, DOI 10.1007/s11136-011-9997-1; Marra CA, 2004, MED CARE, V42, P1125, DOI 10.1097/00005650-200411000-00012; McPhail S, 2008, MED CARE, V46, P1140, DOI 10.1097/MLR.0b013e31817d69a6; Mitchell PM, 2015, SOC SCI MED, V139, P71, DOI 10.1016/j.socscimed.2015.06.037; Moniz-Cook E, 2008, AGING MENT HEALTH, V12, P14, DOI 10.1080/13607860801919850; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Orgogozo JM, 2002, STROKE, V33, P1834, DOI 10.1161/01.STR.0000020094.08790.49; Pantoni L, 1999, ALZ DIS ASSOC DIS, V13, pS49, DOI 10.1097/00002093-199912001-00008; Pusswald G, 2015, J ALZHEIMERS DIS, V47, P479, DOI 10.3233/JAD-150284; Rabins PV, 2007, INT PSYCHOGERIATR, V19, P401, DOI 10.1017/S1041610207004863; Ready RE, 2004, INT J GERIATR PSYCH, V19, P256, DOI 10.1002/gps.1075; Rockwood K, 2000, NEUROLOGY, V54, P447, DOI 10.1212/WNL.54.2.447; Roman GC, 2002, J NEUROL SCI, V203, P7, DOI 10.1016/S0022-510X(02)00252-6; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Rowen D, 2011, HLTH EC; Salloway S, 2004, NEUROLOGY, V63, P651, DOI 10.1212/01.WNL.0000134664.80320.92; Sen A, 1993, CAPABILITY WELL BEIN, DOI 10.1093/0198287976.001.0001; Vogel A, 2006, INT J GERIATR PSYCH, V21, P1132, DOI 10.1002/gps.1619; Wilkinson D, 2003, NEUROLOGY, V61, P479, DOI 10.1212/01.WNL.0000078943.50032.FC; Ylikoski R, 2007, DEMENT GERIATR COGN, V24, P73, DOI 10.1159/000103865	47	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153878	10.1371/journal.pone.0153878	http://dx.doi.org/10.1371/journal.pone.0153878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27101402	Green Submitted, gold, Green Published			2022-12-27	WOS:000374898500084
J	Ostrowski, MF; Prosperi, JM; David, J				Ostrowski, Marie-France; Prosperi, Jean-Marie; David, Jacques			Potential Implications of Climate Change on Aegilops Species Distribution: Sympatry of These Crop Wild Relatives with the Major European Crop Triticum aestivum and Conservation Issues	PLOS ONE			English	Article							GENE FLOW; MALE-STERILITY; HEAT-STRESS; BREAD WHEAT; D-GENOME; LAND-USE; CYLINDRICA; DIVERSITY; L.; GENICULATA	Gene flow from crop to wild relatives is a common phenomenon which can lead to reduced adaptation of the wild relatives to natural ecosystems and/or increased adaptation to agro-systems (weediness). With global warming, wild relative distributions will likely change, thus modifying the width and/ or location of co-occurrence zones where crop-wild hybridization events could occur (sympatry). This study investigates current and 2050 projected changes in sympatry levels between cultivated wheat and six of the most common Aegilops species in Europe. Projections were generated using MaxEnt on presence-only data, bioclimatic variables, and considering two migration hypotheses and two 2050 climate scenarios (RCP4.5 and RCP8.5). Overall, a general decline in suitable climatic conditions for Aegilops species outside the European zone and a parallel increase in Europe were predicted. If no migration could occur, the decline was predicted to be more acute outside than within the European zone. The potential sympatry level in Europe by 2050 was predicted to increase at a higher rate than species richness, and most expansions were predicted to occur in three countries, which are currently among the top four wheat producers in Europe: Russia, France and Ukraine. The results are also discussed with regard to conservation issues of these crop wild relatives.	[Ostrowski, Marie-France; Prosperi, Jean-Marie] Montpellier Supagro, Inst Natl Rech Agron, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France; [Ostrowski, Marie-France; David, Jacques] Montpellier Supagro, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France	INRAE; Institut Agro; Montpellier SupAgro; Institut Agro; Montpellier SupAgro	Ostrowski, MF; Prosperi, JM (corresponding author), Montpellier Supagro, Inst Natl Rech Agron, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France.; Ostrowski, MF; David, J (corresponding author), Montpellier Supagro, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France.	marie-france.ostrowski@orange.fr; jean-marie.prosperi@supagro.inra.fr; jacques.david@supagro.inra.fr	PROSPERI, Jean-Marie/B-9036-2008		Institut National de la Recherche Agronomique (INRA); Ministere de l'Enseignement et de la Recherche; Ministere de l'Agriculture, France	Institut National de la Recherche Agronomique (INRA); Ministere de l'Enseignement et de la Recherche; Ministere de l'Agriculture, France	This work was a part of a project supported by the Institut National de la Recherche Agronomique (INRA:http://www.montpellier.inra.fr/), Ministere de l'Enseignement et de la Recherche (http://www.enseignementsup-recherche.gouv.fr/) and Ministere de l'Agriculture (http://agriculture.gouv.fr/), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; Arrigo N, 2011, EVOL APPL, V4, P685, DOI 10.1111/j.1752-4571.2011.00191.x; Arrigo N, 2010, NEW PHYTOL, V187, P1170, DOI 10.1111/j.1469-8137.2010.03328.x; Audsley E, 2015, CLIMATIC CHANGE, V128, P215, DOI 10.1007/s10584-014-1164-6; Badaeva ED, 2002, PLANT SYST EVOL, V231, P163, DOI 10.1007/s006060200018; Beauregard F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092642; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Cicero C, 2004, EVOLUTION, V58, P1573; Cifuentes M, 2010, CYTOGENET GENOME RES, V129, P124, DOI 10.1159/000313593; DATTA SC, 1972, PLANTA, V105, P155, DOI 10.1007/BF00385574; David JL, 2004, BIOL J LINN SOC, V82, P503, DOI 10.1111/j.1095-8312.2004.00336.x; DAVID JL, 1993, J EVOLUTION BIOL, V6, P659, DOI 10.1046/j.1420-9101.1993.6050659.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Davy JS, 2008, U CALIFORNIA PUBLICA; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; DiTomaso J.M., 2007, WEEDS CALIFORNIA OTH, V3488; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; DONALD WW, 1991, WEED TECHNOL, V5, P3, DOI 10.1017/S0890037X00033170; DONALD WW, 1984, WEED SCI, V32, P631, DOI 10.1017/S0043174500059701; Dyer AR, 2010, EVOL APPL, V3, P179, DOI 10.1111/j.1752-4571.2010.00118.x; Econopouly BF, 2013, AGR ECOSYST ENVIRON, V164, P244, DOI 10.1016/j.agee.2012.10.005; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Ellstrand N. C., 2003, DANGEROUS LIAISONS C; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; Fandrich L, 2006, WEED SCI, V54, P443, DOI 10.1614/WS-05-103R.1; Farooq M, 2011, CRIT REV PLANT SCI, V30, P491, DOI 10.1080/07352689.2011.615687; Gandhi HT, 2009, THEOR APPL GENET, V119, P1013, DOI 10.1007/s00122-009-1105-3; Guadagnuolo R, 2001, THEOR APPL GENET, V103, P1, DOI 10.1007/s001220100636; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HAMMER K, 1980, Kulturpflanze, V28, P33; Harfoot M, 2014, GLOBAL ECOL BIOGEOGR, V23, P124, DOI 10.1111/geb.12100; Haygood R, 2003, P ROY SOC B-BIOL SCI, V270, P1879, DOI 10.1098/rspb.2003.2426; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hufbauer RA, 2013, J EVOLUTION BIOL, V26, P1691, DOI 10.1111/jeb.12167; Hufford MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047659; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; International Union for Conservation of Nature Natural Resources. Species Survival Commission IUCN Species Survival Commission, 2001, IUCN RED LIST CAT CR; Jarvis A, 2008, AGR ECOSYST ENVIRON, V126, P13, DOI 10.1016/j.agee.2008.01.013; Jenczewski Eric, 2003, Environmental Biosafety Research, V2, P9, DOI 10.1051/ebr:2003001; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kilian B, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P1, DOI 10.1007/978-3-642-14228-4_1; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loureiro I, 2008, WEED RES, V48, P561, DOI 10.1111/j.1365-3180.2008.00659.x; Loureiro I, 2009, SPAN J AGRIC RES, V7, P614; Lukac M, 2012, ANN BOT-LONDON, V109, P843, DOI 10.1093/aob/mcr308; LYON DJ, 1992, J PROD AGRIC, V5, P282, DOI 10.2134/jpa1992.0282; Lyons KG, 2010, INVAS PLANT SCI MANA, V3, P376, DOI 10.1614/IPSM-09-036.1; Mahjoub A., 2008, World Journal of Agricultural Sciences, V4, P737; Maillet J, 2000, WEED RES, V40, P11, DOI 10.1046/j.1365-3180.2000.00171.x; MARANON T, 1989, SEED SCI TECHNOL, V17, P583; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Maxted N., 2008, Plant Genetic Resources Characterization and Utilization, V6, P126, DOI 10.1017/S147926210899314X; Maxted N, 2009, ESTABLISHMENT GLOBAL, V266; Meesean A, 2012, SIGMEA SUSTAINABLE I; Meimberg H, 2010, MOL ECOL, V19, P5308, DOI 10.1111/j.1365-294X.2010.04875.x; Meimberg H, 2009, AM J BOT, V96, P1262, DOI 10.3732/ajb.0800345; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Morrison LA, 2002, CROP SCI, V42, P1863, DOI 10.2135/cropsci2002.1863; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Pajkovic M, 2014, MOL ECOL, V23, P5089, DOI 10.1111/mec.12918; Parisod C, 2013, J EVOLUTION BIOL, V26, P223, DOI 10.1111/jeb.12040; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perrino EV, 2014, SYST BIODIVERS, V12, P331, DOI 10.1080/14772000.2014.909543; Peters A., 1996, Rangelands, V18, P8; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Phillips S., 2011, BRIEF TUTORIAL MAXEN; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Qin D, 2014, CLIMATE CHANGE 2013; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Rice KJ, 2013, BIOL INVASIONS, V15, P2531, DOI 10.1007/s10530-013-0471-6; Rounsevell MDA, 2005, AGR ECOSYST ENVIRON, V107, P117, DOI 10.1016/j.agee.2004.12.002; SAINI HS, 1984, AUST J PLANT PHYSIOL, V11, P243, DOI 10.1071/PP9840243; Sakata T, 2000, J PLANT RES, V113, P395, DOI 10.1007/PL00013947; Sakata T., 2008, INT J PLANT DEV BIOL, V2, P42; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; Schoenenberger N, 2005, THEOR APPL GENET, V111, P1338, DOI 10.1007/s00122-005-0063-7; Snyder JR, 2000, WEED SCI, V48, P588, DOI 10.1614/0043-1745(2000)048[0588:SPOTAB]2.0.CO;2; Swenson NG, 2006, J EVOLUTION BIOL, V19, P717, DOI 10.1111/j.1420-9101.2005.01066.x; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomson DM, 2007, ECOLOGY, V88, P3126, DOI 10.1890/06-1463.1; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; Van Slageren M.W., 1994, ICARDA WAGENINGEN AG; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Waines JG, 2003, CROP SCI, V43, P451, DOI 10.2135/cropsci2003.0451; Wang AB, 2010, ANN BOT-LONDON, V106, P95, DOI 10.1093/aob/mcq089; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Weissmann S, 2005, MOL BIOL EVOL, V22, P2055, DOI 10.1093/molbev/msi196; Westbrooks R, 1998, 490 FED INT COMM MAN; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475; Zaharieva M, 2006, CROP SCI, V46, P512, DOI 10.2135/cropsci2005.0023; Zaharieva M, 2004, BIODIVERS CONSERV, V13, P2319, DOI 10.1023/B:BIOC.0000047917.11509.a2; Zaharieva M, 2003, GENET RESOUR CROP EV, V50, P507, DOI 10.1023/A:1023938621936; Zaharieva M, 2001, CROP SCI, V41, P1321, DOI 10.2135/cropsci2001.4141321x; ZOHARY D, 1969, EUPHYTICA, V18, P58; ZOHARY D, 1962, EVOLUTION, V16, P44, DOI 10.2307/2406265; ZOHARY D., 1965, The genetics of colonizing species: Proc. 1st Internat. Union. biol. Sci., Asilomar, California., P403	110	10	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153974	10.1371/journal.pone.0153974	http://dx.doi.org/10.1371/journal.pone.0153974			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100790	gold, Green Submitted, Green Published			2022-12-27	WOS:000374898500115
J	Rebolleda, N; Losada-Fernandez, I; Perez-Chacon, G; Castejon, R; Rosado, S; Morado, M; Vallejo-Cremades, MT; Martinez, A; Vargas-Nunez, JA; Perez-Aciego, P				Rebolleda, Nerea; Losada-Fernandez, Ignacio; Perez-Chacon, Gema; Castejon, Raquel; Rosado, Silvia; Morado, Marta; Teresa Vallejo-Cremades, Maria; Martinez, Andrea; Vargas-Nunez, Juan A.; Perez-Aciego, Paloma			Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model	PLOS ONE			English	Article							INDUCED LUNG TUMORIGENESIS; HSP90 INHIBITOR SNX-7081; COLON-CANCER CELLS; PRIMARY CLL CELLS; HEAT-SHOCK-PROTEIN-90 HSP90; AKT INHIBITOR; IN-VIVO; B-CELLS; APOPTOSIS; MICE	B-cell chronic lymphocytic leukemia (CLL) remains an incurable disease, and despite the improvement achieved by therapeutic regimes developed over the last years still a subset of patients face a rather poor prognosis and will eventually relapse and become refractory to therapy. The natural rotenoid deguelin has been shown to induce apoptosis in several cancer cells and cell lines, including primary human CLL cells, and to act as a chemo-preventive agent in animal models of induced carcinogenesis. In this work, we show that deguelin induces apoptosis in vitro in primary human CLL cells and in CLL-like cells from the New Zealand Black (NZB) mouse strain. In both of them, deguelin dowregulates AKT, NF kappa B and several downstream antiapoptotic proteins (XIAP, cIAP, BCL2, BCL-XL and survivin), activating the mitochondrial pathway of apoptosis. Moreover, deguelin inhibits stromal cell-mediated c-Myc upregulation and resistance to fludarabine, increasing fludarabine induced DNA damage. We further show that deguelin has activity in vivo against NZB CLL-like cells in an experimental model of CLL in young NZB mice transplanted with spleen cells from aged NZB mice with lymphoproliferation. Moreover, the combination of deguelin and fludarabine in this model prolonged the survival of transplanted mice at doses of both compounds that were ineffective when administered individually. These results suggest deguelin could have potential for the treatment of human CLL.	[Rebolleda, Nerea; Losada-Fernandez, Ignacio; Martinez, Andrea; Perez-Aciego, Paloma] Fdn LAIR, Madrid, Spain; [Perez-Chacon, Gema] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Castejon, Raquel; Rosado, Silvia; Vargas-Nunez, Juan A.] Univ Autonoma Madrid, Med Interna Serv, Hosp Univ Puerta Hierro Majadahonda, IDIPHIM, Madrid, Spain; [Morado, Marta] Hosp Univ La Paz, Serv Hematol & Hemoterapia, Madrid, Spain; [Teresa Vallejo-Cremades, Maria] Hosp Univ La Paz, IdiPaz, Lab Imagen Plataforma Apoyo & Invest, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Hospital Puerta de Hierro-Majadahonda; Hospital Universitario La Paz; Hospital Universitario La Paz	Perez-Aciego, P (corresponding author), Fdn LAIR, Madrid, Spain.	paloma_perez@cilsp.com	Vargas, Juan Antonion/H-8933-2017; García, Silvia Rosado/H-7461-2017; Perez-Chacon, Gema/H-5954-2015	Vargas, Juan Antonion/0000-0002-2221-4304; García, Silvia Rosado/0000-0001-8131-819X; Perez-Chacon, Gema/0000-0002-2081-0882; Perez-Aciego, Paloma/0000-0003-4819-5890	Fondo de Investigaciones Sanitarias, Ministerio de Sanidad [PI08/1099, PI13/01607]; La Caixa [P22664]; Fundacion LAIR [P160105]	Fondo de Investigaciones Sanitarias, Ministerio de Sanidad(Spanish GovernmentInstituto de Salud Carlos III); La Caixa(La Caixa Foundation); Fundacion LAIR	This work was supported by Fondo de Investigaciones Sanitarias, Ministerio de Sanidad, (http://www.isciii.es/ISCIII/es/general/index.shtml): PI08/1099, JAV-N; Fondo de Investigaciones Sanitarias, Ministerio de Sanidad (http://www.isciii.es/ISCIII/es/general/index.shtml): PI13/01607, JAV-N; La Caixa (http://obrasocial.lacaixa.es/): P22664, PP-A; and Fundacion LAIR (http://www.fundacionlair.org): P160105, NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banz VM, 2009, BBA-MOL CELL RES, V1793, P1597, DOI 10.1016/j.bbamcr.2009.08.002; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Best OG, 2010, BRIT J HAEMATOL, V151, P185, DOI 10.1111/j.1365-2141.2010.08348.x; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Burger JA, 2014, SEMIN CANCER BIOL, V24, P71, DOI 10.1016/j.semcancer.2013.08.011; Castro JE, 2005, BLOOD, V106, P2506, DOI 10.1182/blood-2005-03-1099; Chang DJ, 2012, J MED CHEM, V55, P10863, DOI 10.1021/jm301488q; Che YP, 2013, J PROTEOME RES, V12, P1710, DOI 10.1021/pr301055y; Chen Y, 2009, INT J HEMATOL, V89, P618, DOI 10.1007/s12185-009-0307-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chun KH, 2003, JNCI-J NATL CANCER I, V95, P291, DOI 10.1093/jnci/95.4.291; Cuni S, 2004, LEUKEMIA, V18, P1391, DOI 10.1038/sj.leu.2403398; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Duerfeldt AS, 2010, BIOORG MED CHEM LETT, V20, P4983, DOI 10.1016/j.bmcl.2010.06.108; EAST J, 1969, CLIN EXP IMMUNOL, V4, P621; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FESTING M F W, 1971, Laboratory Animals (London), V5, P179, DOI 10.1258/002367771781006564; Fiorcari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083830; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; Geeraerts B, 2007, LEUKEMIA, V21, P1610, DOI 10.1038/sj.leu.2404788; Granziero L, 2001, BLOOD, V97, P2777, DOI 10.1182/blood.V97.9.2777; Hail N, 2004, APOPTOSIS, V9, P437; Hallek M, 2015, AM J HEMATOL, V90, P446, DOI 10.1002/ajh.23979; Hallek M, 2010, ANN ONCOL, V21, P154, DOI 10.1093/annonc/mdq373; Herishanu Y, 2013, HEMATOL ONCOL CLIN N, V27, P173, DOI 10.1016/j.hoc.2013.01.002; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Horie R, 2006, LEUKEMIA, V20, P800, DOI 10.1038/sj.leu.2404167; HUANG P, 1990, J BIOL CHEM, V265, P16617; Jitschin R, 2015, BLOOD, V125, P3432, DOI 10.1182/blood-2014-10-607036; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kaufman KL, 2015, ONCOTARGET, V6, P40981, DOI 10.18632/oncotarget.5715; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Lee HY, 2005, J NATL CANCER I, V97, P1695, DOI 10.1093/jnci/dji377; Lefranc Marie-Paule, 2004, In Silico Biology, V4, P17; Li R, 2009, INT J HEMATOL, V89, P628, DOI 10.1007/s12185-009-0311-8; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Matthews C, 2004, LEUKEMIA LYMPHOMA, V45, P1899, DOI 10.1080/10428190410001710812; Mehta R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065113; Moreno C, 2010, BLOOD, V116, P4771, DOI 10.1182/blood-2010-05-286500; Moussay E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-115; Munzert G, 2002, BLOOD, V100, P3749, DOI 10.1182/blood.V100.10.3749; Murillo G, 2003, INT J CANCER, V104, P7, DOI 10.1002/ijc.10901; Murillo G, 2002, EUR J CANCER, V38, P2446, DOI 10.1016/S0959-8049(02)00192-2; Nair AS, 2006, J IMMUNOL, V177, P5612, DOI 10.4049/jimmunol.177.8.5612; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Neffendorf JE, 2013, NEW ENGL J MED, V369, P1277, DOI 10.1056/NEJMc1309710; Oh SH, 2007, J NATL CANCER I, V99, P949, DOI 10.1093/jnci/djm007; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Peng XH, 2007, MOL PHARMACOL, V71, P101, DOI 10.1124/mol.106.027367; Perez-Chacon G, 2009, INT J LAB HEMATOL, V31, P327, DOI 10.1111/j.1751-553X.2008.01030.x; Perez-Chacon G, 2007, LEUKEMIA RES, V31, P183, DOI 10.1016/j.leukres.2006.03.021; Perez-Chacon G, 2012, J IMMUNOL, V189, P1053, DOI 10.4049/jimmunol.1200814; Purroy N, 2014, LEUKEMIA, V28, P1993, DOI 10.1038/leu.2014.96; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; RAVECHE ES, 1988, J IMMUNOL, V141, P4133; Regan PL, 2011, INT J ONCOL, V38, P105, DOI 10.3892/ijo_00000829; Salerno E, 2010, CYTOM PART B-CLIN CY, V78B, pS98, DOI 10.1002/cyto.b.20544; Scaglione BJ, 2007, BRIT J HAEMATOL, V139, P645, DOI 10.1111/j.1365-2141.2007.06851.x; SHIRAI T, 1992, ANN NY ACAD SCI, V651, P509; STALL AM, 1988, P NATL ACAD SCI USA, V85, P7312, DOI 10.1073/pnas.85.19.7312; Tillotson B, 2010, J BIOL CHEM, V285, P39835, DOI 10.1074/jbc.M110.141580; Tsimberidou AM, 2009, CANCER-AM CANCER SOC, V115, P2824, DOI 10.1002/cncr.24329; URASHIMA M, 1995, BLOOD, V85, P1903, DOI 10.1182/blood.V85.7.1903.bloodjournal8571903; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Walsby E, 2012, ONCOTARGET, V3, P525; Woo JK, 2009, CANCER PREV RES, V2, P361, DOI 10.1158/1940-6207.CAPR-08-0237; Zhou YF, 2012, CANCER RES, V72, P304, DOI 10.1158/0008-5472.CAN-11-1674	69	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154159	10.1371/journal.pone.0154159	http://dx.doi.org/10.1371/journal.pone.0154159			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101369	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500156
J	Tsurugizawa, T; Tokuda, S; Harada, T; Takahashi, T; Sadato, N				Tsurugizawa, Tomokazu; Tokuda, Shinsuke; Harada, Tokiko; Takahashi, Taiki; Sadato, Norihiro			Pharmacological and Expectancy Effects of a Low Amount of Alcohol Drinking on Outcome Valuation and Risk Perception in Males and Females	PLOS ONE			English	Article							GENDER-DIFFERENCES; DECISION-MAKING; TIME PERCEPTION; PSYCHOPHYSICS; REWARD	The high-dose, alcohol-induced influences on risk perception and loss aversion depend on sex. On the other hand, low-dose alcohol has less effect on risky behavior. However, the effect of low-dose alcohol on subjective valuation of gain or loss and also the effect of placebo (expectancy of alcohol) on risk perception have not been fully investigated. We investigated the effects of low-dose alcohol (0.02 g/100 ml blood alcohol concentration) and placebo effects on subjective risk perception and subjective valuation of uncertain gain and loss in females and males. Participants in the control group and the placebo group were served alcohol-free, wine-flavored beverage and participants of alcohol group were served wine (14% alcohol). The placebo group was not informed that the drink was not alcohol but the control group was informed. Then paper-pencil tasks for subjective risk perception and valuation of gain or loss were performed 45 min after drinking the beverage. The participants were asked to draw the line on a 180 mm scale for each question. The placebo effects as well as the low-dose alcohol effects were observed in subjective valuations of gain or loss. Except for effect of beverages, a gender difference was also observed for subjective likelihood. The females estimated a low-probability loss as more likely and estimated a high-probability gain as less likely than did the males. From the Stevens' law fitting analysis, the placebo, not alcohol, significantly induced the psychophysical effect of the subjective valuation of gain or loss. These results indicate that the psychological effects of expectancy of alcohol (placebo) could be a major factor in changing the subjective valuation of gain or loss over the pharmacological effects of a small amount of alcohol (like a glass of wine). Furthermore, these results also indicate that gender differences should be taken into account when investigating pharmacological or psychological effect on decision-making.	[Tsurugizawa, Tomokazu] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan; [Tsurugizawa, Tomokazu] CEA Saclay, NeuroSpin, Commissariat Energie Atom & Energies Alternat, F-91191 Gif Sur Yvette, France; [Tokuda, Shinsuke; Takahashi, Taiki] Hokkaido Univ, Grad Sch Letters, Dept Behav Sci, Sapporo, Hokkaido, Japan; [Harada, Tokiko; Sadato, Norihiro] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan; [Harada, Tokiko; Sadato, Norihiro] Grad Univ Adv Studies, SOKENDAI, Dept Physiol Sci, Okazaki, Aichi, Japan	Ajinomoto Co Inc; CEA; UDICE-French Research Universities; Universite Paris Saclay; Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Tsurugizawa, T (corresponding author), Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan.; Tsurugizawa, T (corresponding author), CEA Saclay, NeuroSpin, Commissariat Energie Atom & Energies Alternat, F-91191 Gif Sur Yvette, France.	tsurugizawa@gmail.com	Tsurugizawa, Tomokazu/AAQ-4810-2020	Tsurugizawa, Tomokazu/0000-0003-3194-578X; Sadato, Norihiro/0000-0002-9786-3907	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23118001, 25610109]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The research reported in this paper was also financially supported by grants from the Grant-in-Aid for Scientific Research on Innovative Areas (23118001; Adolescent Mind and Self-Regulation) and Challenging Exploratory Research (25610109) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BM, 2011, ALCOHOL CLIN EXP RES, V35, P156, DOI 10.1111/j.1530-0277.2010.01332.x; Andersson A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-229; Corazzini L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121530; Dawes John., 2014, J SERV MARK, V18, P35, DOI [10.1108/08876040410520690, DOI 10.1108/08876040410520690]; Evans KL, 2015, BRAIN COGNITION, V93, P42, DOI 10.1016/j.bandc.2014.11.006; Grevenstein D, 2015, SUBST USE MISUSE, V50, P376, DOI 10.3109/10826084.2014.984847; Gundersen Hilde, 2008, Open Neuroimag J, V2, P65, DOI 10.2174/1874440000802010065; Han RK, 2012, PHYSICA A, V391, P6568, DOI 10.1016/j.physa.2012.07.012; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Lane SD, 2004, PSYCHOPHARMACOLOGY, V172, P68, DOI 10.1007/s00213-003-1628-2; Lundborg P, 2002, ADDICTION, V97, P1573, DOI 10.1046/j.1360-0443.2002.00231.x; Mather M, 2012, CURR DIR PSYCHOL SCI, V21, P36, DOI 10.1177/0963721411429452; McGraw AP, 2010, PSYCHOL SCI, V21, P1438, DOI 10.1177/0956797610381504; McKerchar TL, 2009, BEHAV PROCESS, V81, P256, DOI 10.1016/j.beproc.2008.12.017; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Rau HA, 2014, ECON LETT, V123, P33, DOI 10.1016/j.econlet.2014.01.020; Rick S, 2011, J CONSUM PSYCHOL, V21, P453, DOI 10.1016/j.jcps.2010.04.004; Singh V, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00107; Sjoberg L, 1998, ALCOHOL CLIN EXP RES, V22, p277S, DOI 10.1111/j.1530-0277.1998.tb04380.x; SPIGNER C, 1993, WOMEN HEALTH, V20, P87, DOI 10.1300/J013v20n01_06; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; Stigler GJ, 1950, I J POLIT EC; Takahashi T., 2013, APPL MATH, V4, P1520; Takahashi T, 2008, PHYSICA A, V387, P2066, DOI 10.1016/j.physa.2007.11.047; Takahashi T, 2011, PHYSICA A, V390, P902, DOI 10.1016/j.physa.2010.10.004; Testa M, 2006, ALCOHOL CLIN EXP RES, V30, P339, DOI 10.1111/j.1530-0277.2006.00039.x; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Van Horn JD, 2006, NEUROIMAGE, V31, P1209, DOI 10.1016/j.neuroimage.2006.01.020; Viegas RG, 2012, PSICOLOGICA, V33, P711	30	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154083	10.1371/journal.pone.0154083	http://dx.doi.org/10.1371/journal.pone.0154083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100898	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500140
J	Davern, SM; McKnight, TE; Standaert, RF; Morrell-Falvey, JL; Shpak, ED; Kalluri, UC; Jelenska, J; Greenberg, JT; Mirzadeh, S				Davern, Sandra M.; McKnight, Timothy E.; Standaert, Robert F.; Morrell-Falvey, Jennifer L.; Shpak, Elena D.; Kalluri, Udaya C.; Jelenska, Joanna; Greenberg, Jean T.; Mirzadeh, Saed			Carbon Nanofiber Arrays: A Novel Tool for Microdelivery of Biomolecules to Plants	PLOS ONE			English	Article							POST-PHLOEM TRANSPORT; FLUORESCENT TRACERS; MOVEMENT PROTEIN; LUCIFER YELLOW; MOSAIC-VIRUS; MINOR VEINS; SIEVE TUBE; TRANSIENT TRANSFORMATION; SYMPLASTIC TRANSPORT; HYDRODYNAMIC RADII	Effective methods for delivering bioprobes into the cells of intact plants are essential for investigating diverse biological processes. Increasing research on trees, such as Populus spp., for bioenergy applications is driving the need for techniques that work well with tree species. This report introduces vertically aligned carbon nanofiber (VACNF) arrays as a new tool for microdelivery of labeled molecules to Populus leaf tissue and whole plants. We demonstrated that VACNFs penetrate the leaf surface to deliver sub-microliter quantities of solution containing fluorescent or radiolabeled molecules into Populus leaf cells. Importantly, VACNFs proved to be gentler than abrasion with carborundum, a common way to introduce material into leaves. Unlike carborundum, VACNFs did not disrupt cell or tissue integrity, nor did they induce production of hydrogen peroxide, a typical wound response. We show that femtomole to picomole quantities of labeled molecules (fluorescent dyes, small proteins and dextran), ranging from 0.5-500 kDa, can be introduced by VACNFs, and we demonstrate the use of the approach to track delivered probes from their site of introduction on the leaf to distal plant regions. VACNF arrays thus offer an attractive microdelivery method for the introduction of biomolecules and other probes into trees and potentially other types of plants.	[Davern, Sandra M.; Standaert, Robert F.; Morrell-Falvey, Jennifer L.; Kalluri, Udaya C.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [McKnight, Timothy E.] Oak Ridge Natl Lab, Elect & Elect Syst Res Div, Oak Ridge, TN USA; [Standaert, Robert F.] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN USA; [Mirzadeh, Saed] Oak Ridge Natl Lab, Nucl Secur & Isotope Technol Div, Oak Ridge, TN USA; [Standaert, Robert F.; Morrell-Falvey, Jennifer L.; Shpak, Elena D.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA; [Jelenska, Joanna; Greenberg, Jean T.] Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Chicago	Standaert, RF (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA.; Standaert, RF (corresponding author), Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN USA.; Standaert, RF (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA.	standaertrf@ornl.gov	Standaert, Robert F/D-9467-2013; Standaert, Robert F./AAI-1532-2021; Morrell-Falvey, Jennifer L/A-6615-2011	Standaert, Robert F/0000-0002-5684-1322; Morrell-Falvey, Jennifer L/0000-0002-9362-7528; Greenberg, Jean/0000-0002-7213-7618; KALLURI, UDAYA/0000-0002-5963-8370	U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research [ERKP-417]; U.S. Department of Energy [DE-AC05-00OR22725]	U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research, ERKP-417, http://science.energy.gov/ber/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. David Weston and Dr. Abhijit Karve for the CmPP16-1 DNA. We acknowledge Dr. Tim Tschaplinski and Dr. Mitch Doktycz for critical review of the manuscript. We thank Trish Lankford for technical assistance, and Zackary Moore for assistance with plant growth and maintenance. Nanofiber arrays were produced at the Center for Nanophase Materials Sciences (CNMS), which is a DOE Office of Science User Facility. We thank Dale Hensley and the CNMS for assistance with the production of nanofiber arrays. This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a non-exclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).	Aciksoz SB, 2011, PLANT SOIL, V349, P215, DOI 10.1007/s11104-011-0863-2; Aoki K, 2005, PLANT CELL, V17, P1801, DOI 10.1105/tpc.105.031419; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Ascencio-Ibanez JT, 2007, J VIROL METHODS, V142, P198, DOI 10.1016/j.jviromet.2007.01.031; Balachandran S, 1997, P NATL ACAD SCI USA, V94, P14150, DOI 10.1073/pnas.94.25.14150; Bishopp A, 2011, CURR BIOL, V21, P927, DOI 10.1016/j.cub.2011.04.049; Brown PH, 1999, PLANT PHYSIOL, V119, P17, DOI 10.1104/pp.119.1.17; Buhtz A, 2008, PLANT J, V53, P739, DOI 10.1111/j.1365-313X.2007.03368.x; Cheng YH, 1996, PLANT CELL REP, V16, P127, DOI 10.1007/BF01890852; Coleman JS, 1986, TREE PHYSIOL, V2, P289, DOI 10.1093/treephys/2.1-2-3.289; Curuk S, 2005, ENG LIFE SCI, V5, P169, DOI 10.1002/elsc.200520069; DERRICK PM, 1990, PLANTA, V181, P555, DOI 10.1007/BF00193010; ERWEE MG, 1983, PLANTA, V158, P320, DOI 10.1007/BF00397334; Etxeberria E, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1500106; Fisher DB, 2000, PLANT PHYSIOL, V123, P125, DOI 10.1104/pp.123.1.125; FISHER DG, 1988, PLANT CELL ENVIRON, V11, P639, DOI 10.1111/j.1365-3040.1988.tb01806.x; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Fujimaki S, 2000, PLANT CELL PHYSIOL, V41, P124, DOI 10.1093/pcp/41.1.124; GEIGER DR, 1974, PLANT PHYSIOL, V54, P892, DOI 10.1104/pp.54.6.892; GOODWIN PB, 1983, PLANTA, V157, P124, DOI 10.1007/BF00393645; IFletcher BL, 2006, ADV MATER, V18, P1689, DOI [10.1002/adma.200502688, DOI 10.1002/ADMA.200502688]; Jones Huw D., 2009, V513, P131, DOI 10.1007/978-1-59745-427-8_8; Jones Huw D., 2009, V513, P111, DOI 10.1007/978-1-59745-427-8_7; Kaplan M, 2010, J FOOD AGRIC ENVIRON, V8, P728; Kempers R, 1999, PLANT BIOLOGY, V1, P61, DOI 10.1055/s-2007-978489; Kim I, 2005, P NATL ACAD SCI USA, V102, P11945, DOI 10.1073/pnas.0505622102; Kim I, 2005, P NATL ACAD SCI USA, V102, P2227, DOI 10.1073/pnas.0409193102; Knoblauch M, 1998, PLANT CELL, V10, P35, DOI 10.1105/tpc.10.1.35; Lin YH, 2011, NAT PROTOC, V6, P36, DOI 10.1038/nprot.2010.171; MADORE MA, 1986, PLANT PHYSIOL, V82, P432, DOI 10.1104/pp.82.2.432; Mandal B, 2001, PLANT DIS, V85, P1259, DOI 10.1094/PDIS.2001.85.12.1259; Mann DGJ, 2008, ACS NANO, V2, P69, DOI 10.1021/nn700198y; MCCONAHEY PJ, 1966, INT ARCH ALLER A IMM, V29, P185, DOI 10.1159/000229699; McKnight TE, 2005, METH MOL B, V303, P191; McKnight TE, 2004, NANO LETT, V4, P1213, DOI 10.1021/nl049504b; Melechko AV, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/19/193001; Melechko AV, 2005, J APPL PHYS, V97, DOI 10.1063/1.1857591; Melechko AV, 2002, J VAC SCI TECHNOL B, V20, P2730, DOI 10.1116/1.1515306; Neumann PM, 2010, J EXP BOT, V61, P1711, DOI 10.1093/jxb/erq037; NEUMANN PM, 1987, PLANT PHYSIOL, V83, P941, DOI 10.1104/pp.83.4.941; OPARKA KJ, 1988, PLANTA, V176, P533, DOI 10.1007/BF00397661; OPARKA KJ, 1991, J EXP BOT, V42, P565, DOI 10.1093/jxb/42.5.565; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; PALEVITZ BA, 1985, PLANTA, V164, P473, DOI 10.1007/BF00395962; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Picard K, 2013, METHODS MOL BIOL, V1069, P215, DOI 10.1007/978-1-62703-613-9_15; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Rasmussen J, 2015, J PLANT BIOL, V58, P1, DOI 10.1007/s12374-014-0258-z; RUSSIN WA, 1985, AM J BOT, V72, P1232, DOI 10.2307/2443404; SEEAR J, 1968, PHYSIOL PLANTARUM, V21, P979, DOI 10.1111/j.1399-3054.1968.tb07325.x; Siuti P, 2011, LAB CHIP, V11, P3523, DOI 10.1039/c1lc20462a; SRISINK S, 1994, AUST J AGR RES, V45, P625, DOI 10.1071/AR9940625; Takata N, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-30; TERRY BR, 1987, PLANTA, V171, P145, DOI 10.1007/BF00391090; Tsuda K, 2012, PLANT J, V69, P713, DOI 10.1111/j.1365-313X.2011.04819.x; TUCKER EB, 1982, PROTOPLASMA, V113, P193, DOI 10.1007/BF01280907; TURGEON R, 1989, PLANTA, V179, P24, DOI 10.1007/BF00395767; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; ULRICH JM, 1965, AM J BOT, V52, P120, DOI 10.2307/2440226; VANALFEN NK, 1979, PLANT PHYSIOL, V63, P1072, DOI 10.1104/pp.63.6.1072; VANKESTEREN WJP, 1988, PLANT PHYSIOL, V88, P667, DOI 10.1104/pp.88.3.667; WAIGMANN E, 1994, P NATL ACAD SCI USA, V91, P1433, DOI 10.1073/pnas.91.4.1433; WANG N, 1994, PLANT PHYSIOL, V104, P17, DOI 10.1104/pp.104.1.17; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; WOLF S, 1989, SCIENCE, V246, P377, DOI 10.1126/science.246.4928.377; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94; Yang XH, 2011, GENOME RES, V21, P634, DOI 10.1101/gr.109280.110; Zhang CK, 2014, PLANT PHYSIOL, V166, P306, DOI 10.1104/pp.114.245845	70	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153621	10.1371/journal.pone.0153621	http://dx.doi.org/10.1371/journal.pone.0153621			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119338	gold, Green Submitted, Green Published			2022-12-27	WOS:000374976200031
J	Delroisse, J; Mallefet, J; Flammang, P				Delroisse, Jerome; Mallefet, Jerome; Flammang, Patrick			De Novo Adult Transcriptomes of Two European Brittle Stars: Spotlight on Opsin-Based Photoreception	PLOS ONE			English	Article							CUCUMBER APOSTICHOPUS-JAPONICUS; RNA-SEQ; AMPHIURA-FILIFORMIS; SEQUENCE ALIGNMENT; GENE-EXPRESSION; EVOLUTION; PHOTOTRANSDUCTION; RHODOPSIN; PROTEIN; SYSTEM	Next generation sequencing (NGS) technology allows to obtain a deeper and more complete view of transcriptomes. For non-model or emerging model marine organisms, NGS technologies offer a great opportunity for rapid access to genetic information. In this study, paired-end Illumina HiSeq (TM) technology has been employed to analyse transcriptomes from the arm tissues of two European brittle star species, Amphiura filiformis and Ophiopsila aranea. About 48 million Illumina reads were generated and 136,387 total unigenes were predicted from A. filiformis arm tissues. For O. aranea arm tissues, about 47 million reads were generated and 123,324 total unigenes were obtained. Twenty-four percent of the total unigenes from A. filiformis show significant matches with sequences present in reference online databases, whereas, for O. aranea, this percentage amounts to 23%. In both species, around 50% of the predicted annotated unigenes were significantly similar to transcripts from the purple sea urchin, the closest species to date that has undergone complete genome sequencing and annotation. GO, COG and KEGG analyses were performed on predicted brittle star unigenes. We focused our analyses on the phototransduction actors involved in light perception. Firstly, two new echinoderm opsins were identified in O. aranea: one rhabdomeric opsin (homologous to vertebrate melanopsin) and one RGR opsin. The RGR-opsin is supposed to be involved in retinal regeneration while the r-opsin is suspected to play a role in visual-like behaviour. Secondly, potential phototransduction actors were identified in both transcriptomes using the fly (rhabdomeric) and mammal (ciliary) classical phototransduction pathways as references. Finally, the sensitivity of O. aranea to monochromatic light was investigated to complement data available for A. filiformis. The presence of microlens-like structures at the surface of dorsal arm plate of O. aranea could potentially explain phototactic behaviour differences between the two species. The results confirm (i) the ability of these brittle stars to perceive light using opsin-based photoreception, (ii) suggest the co-occurrence of both rhabdomeric and ciliary photoreceptors, and (iii) emphasise the complexity of light perception in this echinoderm class.	[Delroisse, Jerome; Flammang, Patrick] Univ Mons UMONS, Res Inst Biosci Biol Marine Organisms & Biomimet, Mons, Belgium; [Delroisse, Jerome] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Mallefet, Jerome] Catholic Univ Louvain La Neuve, Marine Biol Lab, Louvain, Belgium	University of Mons; University of London; Queen Mary University London; Universite Catholique Louvain	Delroisse, J (corresponding author), Univ Mons UMONS, Res Inst Biosci Biol Marine Organisms & Biomimet, Mons, Belgium.	jerome.delroisse@umons.ac.be	Flammang, Patrick/H-9465-2019; Delroisse, Jérôme/G-1274-2014; Delroisse, Jerome/H-3658-2019	Flammang, Patrick/0000-0001-9938-1154; Delroisse, Jérôme/0000-0002-9233-6470; Delroisse, Jerome/0000-0002-9233-6470; mallefet, jerome/0000-0003-0918-3491	FRFC [2.4590.11]	FRFC(Fonds de la Recherche Scientifique - FNRS)	JD, JM and PF are respectively Research Fellow, Research Associate, and Research Director of the Fund for Scientific Research of Belgium (F.R. S.-FNRS). Work supported in part by a FRFC Grant no 2.4590.11. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Alice Jones for O. aranea collections. We thank BGI for cDNA library preparation, sequencing and preliminary data analysis. J.D., J.M. and P.F. are respectively Research Fellow, Research Associate, and Research Director of the Fund for Scientific Research of Belgium (F.R. S.-FNRS). Work supported in part by a FRFC Grant no 2.4590.11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study is a contribution from the "Centre Interuniversitaire de Biologie Marine" (CIBIM).	Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, FASTQC QUALITY CONTR; Arendt D, 2003, INT J DEV BIOL, V47, P563; Astley HC, 2012, J EXP BIOL, V215, P1923, DOI 10.1242/jeb.068460; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Burns G, 2013, MAR GENOM, V9, P9, DOI 10.1016/j.margen.2012.05.003; Byrne Maria, 1994, P247; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; Cao PX, 2012, FASEB J, V26, P480, DOI 10.1096/fj.11-197798; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cronin TW, 2014, EVOLUTION VISUAL NON, P105, DOI DOI 10.1007/978-1-4614-4355-1_4; D'Aniello S, 2015, MAR GENOM, V24, P177, DOI 10.1016/j.margen.2015.10.001; Delroisse J, 2015, MAR GENOM, V23, P109, DOI 10.1016/j.margen.2015.05.014; Delroisse J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1035; Delroisse J, 2013, CAH BIOL MAR, V54, P721; Dilly GF, 2015, MOL ECOL RESOUR, V15, P425, DOI 10.1111/1755-0998.12316; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elphick MR, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00002; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Falkner I, 2006, J MAR BIOL ASSOC UK, V86, P1199, DOI 10.1017/S0025315406014196; Feuda R, 2014, GENOME BIOL EVOL, V6, P1964, DOI 10.1093/gbe/evu154; Feuda R, 2012, P NATL ACAD SCI USA, V109, P18868, DOI 10.1073/pnas.1204609109; Franchini Paolo, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-59; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gehring WJ, 2014, WIRES DEV BIOL, V3, P1, DOI 10.1002/wdev.96; Gillard GB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-45; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; Heinzeller T, 2005, MUNCH P 11 INT ECH C; Hemandezl V, 2006, CHALL OPP HEALTHGR P; HENDLER G, 1988, BIOL BULL, V174, P20, DOI 10.2307/1541755; HENDLER G, 1984, PSZNI MAR ECOL, V5, P379, DOI 10.1111/j.1439-0485.1984.tb00131.x; HENDLER G, 1987, ZOOMORPHOLOGY, V107, P261, DOI 10.1007/BF00312172; Hennebert E, 2014, P NATL ACAD SCI USA, V111, P6317, DOI 10.1073/pnas.1400089111; Hodkinson BP, 2015, ADV WOUND CARE, V4, P50, DOI 10.1089/wound.2014.0542; Iseli C, 1999, ESTSCAN PROGRAM DETE; Johnsen S, 1997, BIOL BULL, V193, P97, DOI 10.2307/1542739; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lawrence J. M., 1987, FUNCTIONAL BIOL ECHI, DOI 10.1002/iroh.19890740316; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Ma DY, 2014, J OCEAN U CHINA, V13, P1033, DOI 10.1007/s11802-014-2297-y; Ma DY, 2014, ACTA OCEANOL SIN, V33, P55, DOI 10.1007/s13131-014-0464-z; Ma DY, 2014, CHIN J OCEANOL LIMN, V32, P34, DOI 10.1007/s00343-014-3041-6; MARKEL K, 1985, ZOOMORPHOLOGY, V105, P197, DOI 10.1007/BF00312157; Mashanov VS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-357; Matsumoto Y, 2006, GENE, V371, P268, DOI 10.1016/j.gene.2005.12.005; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oppenheim SJ, 2015, INSECT MOL BIOL, V24, P139, DOI 10.1111/imb.12154; Pairett AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069852; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Plachetzki DC, 2010, P ROY SOC B-BIOL SCI, V277, P1963, DOI 10.1098/rspb.2009.1797; Purushothaman S, 2015, J PROTEOMICS, V112, P113, DOI 10.1016/j.jprot.2014.08.011; Raible F, 2006, DEV BIOL, V300, P461, DOI 10.1016/j.ydbio.2006.08.070; Reich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119627; Rosenberg R, 2004, MAR BIOL, V145, P651, DOI 10.1007/s00227-004-1365-z; Schnitzler CE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-107; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Tamura K., 2013, MOL BIOL EVOL; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Telford MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0479; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Terakita A, 2012, WIRES MEMBR TRANSP S, V1, P104, DOI [10.1002/wmts.6, DOI 10.1002/WMTS.6]; Tong D, 2009, P NATL ACAD SCI USA, V106, P9836, DOI 10.1073/pnas.0904571106; Tu Q, 2014, DEV BIOL, V385, P160, DOI 10.1016/j.ydbio.2013.11.019; Ullrich-Luter EM, 2013, INTEGR COMP BIOL, V53, P27, DOI 10.1093/icb/ict050; Ullrich-Luter EM, 2011, P NATL ACAD SCI USA, V108, P8367, DOI 10.1073/pnas.1018495108; Vaughn R, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-19; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wygoda JA, 2014, GENOME BIOL EVOL, V6, P964, DOI 10.1093/gbe/evu070; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yewers MS, 2015, J EXP BIOL, V218, P1556, DOI 10.1242/jeb.119404; Zhao Y, 2014, COMP BIOCHEM PHYS D, V10, P30, DOI 10.1016/j.cbd.2014.02.002; Zhao Yunde, 2014, Arabidopsis Book, V12, pe0173, DOI 10.1199/tab.0173; Zhou ZC, 2014, MOL ECOL RESOUR, V14, P127, DOI 10.1111/1755-0998.12147	96	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152988	10.1371/journal.pone.0152988	http://dx.doi.org/10.1371/journal.pone.0152988			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119739	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200014
J	Ojeda, B; Salazar, A; Duenas, M; Torres, LM; Mico, JA; Failde, I				Ojeda, B.; Salazar, A.; Duenas, M.; Torres, L. M.; Mico, J. A.; Failde, I.			Assessing the Construct Validity and Internal Reliability of the Screening Tool Test Your Memory in Patients with Chronic Pain	PLOS ONE			English	Article							MINI-MENTAL-STATE; LOW-BACK-PAIN; COGNITIVE FUNCTION; PSYCHOMETRIC PROPERTIES; FIBROMYALGIA SYNDROME; MEDICAL OUTCOMES; SPANISH VERSION; IMPAIRMENT; ATTENTION; SLEEP	Patients with chronic pain often complain about cognitive difficulties, and since these symptoms represent an additional source of suffering and distress, evaluating the cognitive status of these patients with valid and reliable tests should be an important part of their overall assessment. Although cognitive impairment is a critical characteristic of pain, there is no specific measure designed to detect these effects in this population. The objective was to analyze the psychometric properties of the "Test Your Memory" (TYM) test in patients with chronic pain of three different origins. A cross-sectional study was carried out on 72 subjects free of pain and 254 patients suffering from different types of chronic pain: neuropathic pain (104), musculoskeletal pain (99) and fibromyalgia (51). The construct validity of the TYM was assessed using the Mini-Mental State Examination (MMSE), Hospital Anxiety and Depression Scale (HADs), Index-9 from MOS-sleep, SF-12, and through the intensity (Visual Analogical Scale) and duration of pain. An exploratory factor analysis was also performed and internal reliability was assessed using Cronbach's alpha. After adjusting for potential confounders the TYM could distinguish between pain and pain-free patients, and it was correlated with the: MMSE (0.89, p<0.001); HAD-anxiety (-0.50, p<0.001) and HAD-depression scales (-0.52, p<0.001); MOS-sleep Index-9 (-0.49, p<0.001); and the physical (0.49, p<.001) and mental components (0.55, p<.001) of SF-12. The exploratory structure of the TYM showed an 8-factor solution that explained 53% of the variance, and Cronbach's alpha was 0.66. The TYM is a valid and reliable screening instrument to assess cognitive function in chronic pain patients that will be of particular value in clinical situations.	[Ojeda, B.; Salazar, A.; Failde, I.] Univ Cadiz, Prevent Med & Publ Hlth Area, Observ Pain External Chair Pain, Cadiz, Spain; [Duenas, M.] Univ Cadiz, Salus Infirmorum Fac Nursing, Cadiz, Spain; [Torres, L. M.] Univ Hosp Puerta del Mar, Dept Anesthesiol Crit Care & Pain Management, Cadiz, Spain; [Mico, J. A.] Univ Cadiz, Inst Salud Carlos III, Dept Neurosci Pharmacol & Psychiat, CIBER Mental Hlth,CIBERSAM, Cadiz, Spain	Universidad de Cadiz; Universidad de Cadiz; Universidad de Cadiz; Hospital Universitario Puerta del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Universidad de Cadiz	Ojeda, B (corresponding author), Univ Cadiz, Prevent Med & Publ Hlth Area, Observ Pain External Chair Pain, Cadiz, Spain.	begona.ojeda@uca.es	MICO, JUAN ANTONIO/E-1527-2013; Failde, Immaculada/AAL-8563-2020; Salazar, Alejandro/K-9183-2014; Torres, Luis M/Q-6983-2019; Dueñas, María/AAT-1354-2020; Torres, Luis Miguel/O-1720-2015	MICO, JUAN ANTONIO/0000-0001-8905-8484; Failde, Immaculada/0000-0002-6603-3054; Salazar, Alejandro/0000-0001-9567-462X; Duenas, Maria/0000-0003-4822-7258; Ojeda, Begona/0000-0002-7844-8986; Torres, Luis Miguel/0000-0002-0194-7875	Grunenthal Foundation; External Chair of Pain	Grunenthal Foundation; External Chair of Pain	This study was funded by the Grunenthal Foundation with an unrestricted grant for data collection and analysis. The authors are also grateful to the External Chair of Pain for the funding that allowed them to carry out this research, collaboration between the University of Cadiz and the Grunenthal Foundation. No member of Grunenthal Foundation staff had any role in the interpretation of data, in the writing of the report or in the decision to submit the paper for publication to the journal.	ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Beblo T, 2011, NEUROPSYCHOL REV, V21, P337, DOI 10.1007/s11065-011-9171-0; Brown J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2030; Brown SC, 2002, PAIN, V96, P279, DOI 10.1016/S0304-3959(01)00457-2; Castel A., 2008, Rev. Soc. Esp. Dolor, V15, P358; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Dick BD, 2007, ANESTH ANALG, V104, P1223, DOI 10.1213/01.ane.0000263280.49786.f5; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Eccleston C, 1997, PAIN, V72, P209, DOI 10.1016/S0304-3959(97)00030-4; Fernandez E, 2012, PAIN COMORBIDITIES U, P279; Ferrero-Arias J, 2016, NEUROLOGIA, V31, P33, DOI 10.1016/j.nrl.2013.12.009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Gustin SM, 2015, PAIN PRACT; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Hays RD, 2005, SLEEP MED, V6, P41, DOI 10.1016/j.sleep.2004.07.006; Herrero MJ, 2003, GEN HOSP PSYCHIAT, V25, P277, DOI 10.1016/S0163-8343(03)00043-4; Huh J, 2006, J CONSUM AFF, V40, P90; Iezzi T, 1999, J BEHAV MED, V22, P205, DOI 10.1023/A:1018791622441; Joliffe IT., 1996, PRINCIPAL COMPONENTS; Jorge LL, 2009, EUR J PHYS REHAB MED, V45, P469; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kendall M. G, 1979, ADV THEORY STAT, V4th; Koekkoek PS, 2013, J NEUROL SCI, V328, P92, DOI 10.1016/j.jns.2013.02.028; Kurita GP, 2012, ACTA ANAESTH SCAND, V56, P1257, DOI 10.1111/j.1399-6576.2012.02760.x; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Lezak MD, 2012, VERBAL FUNCTIONS LEN, P542; Lobo A, 1999, MED CLIN-BARCELONA, V112, P767; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; Melkumova KA, 2011, NEUROSCIENCE BEHAV P, V41, P20, DOI DOI 10.1007/S11055-010-9376-3; Meyer JS, 2000, HEADACHE, V40, P638, DOI 10.1046/j.1526-4610.2000.040008638.x; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Munoz M, 2005, CLIN J PAIN, V21, P287; Ojeda B, 2012, MED CLIN-BARCELONA, V138, P429, DOI 10.1016/j.medcli.2011.08.007; Oosterman JM, 2011, CLIN J PAIN, V27, P70, DOI 10.1097/AJP.0b013e3181f15cf5; Pincus T, 1998, BRIT J CLIN PSYCHOL, V37, P49, DOI 10.1111/j.2044-8260.1998.tb01278.x; PITMAN E., 1949, LECT NOTES NONPARAME; Povedano M, 2007, J PAIN SYMPTOM MANAG, V33, P78, DOI 10.1016/j.jpainsymman.2006.07.012; Rami L, 2010, ARCH GERONTOL GERIAT, V50, P171, DOI 10.1016/j.archger.2009.03.005; Rejas J, 2007, EUR J PAIN, V11, P329, DOI 10.1016/j.ejpain.2006.05.002; del Paso GAR, 2012, EUR J PAIN, V16, P421, DOI 10.1002/j.1532-2149.2011.00032.x; Rodriguez-Andreu J, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-162; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Sjogren P, 2005, EUR J PAIN, V9, P453, DOI 10.1016/j.ejpain.2004.10.005; Soderfjell S, 2006, SCAND J PSYCHOL, V47, P349, DOI 10.1111/j.1467-9450.2006.00540.x; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Tejero A., 1986, REV DEP PSIQUIATRIA, V13, P233; van Schalkwyk G, 2012, J GERIATR PSYCH NEUR, V25, P85, DOI 10.1177/0891988712447895; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Weiner DK, 2006, PAIN MED, V7, P60, DOI 10.1111/j.1526-4637.2006.00091.x; Williams DA, 2011, J MUSCULOSKELET PAIN, V19, P66, DOI 10.3109/10582452.2011.558989; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154240	10.1371/journal.pone.0154240	http://dx.doi.org/10.1371/journal.pone.0154240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119165	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200050
J	Thibodeau, PH				Thibodeau, Paul H.			A Moist Crevice for Word Aversion: In Semantics Not Sounds	PLOS ONE			English	Article							FACIAL EFFERENCE; EMOTIONAL WORDS; DISGUST; DOMAINS; CONSEQUENCES; ORGANIZATION; ASSOCIATION; SENSITIVITY; HYPOTHESIS; RESPONSES	Why do people self-report an aversion to words like "moist"? The present studies represent an initial scientific exploration into the phenomenon of word aversion by investigating its prevalence and cause. Results of five experiments indicate that about 10-20% of the population is averse to the word "moist." This population often speculates that phonological properties of the word are the cause of their displeasure. However, data from the current studies point to semantic features of the word-namely, associations with disgusting bodily functions-as a more prominent source of peoples' unpleasant experience. "Moist," for averse participants, was notable for its valence and personal use, rather than imagery or arousal-a finding that was confirmed by an experiment designed to induce an aversion to the word. Analyses of individual difference measures suggest that word aversion is more prevalent among younger, more educated, and more neurotic people, and is more commonly reported by females than males.	[Thibodeau, Paul H.] Oberlin Coll, Dept Psychol, Oberlin, OH 44074 USA	Oberlin College	Thibodeau, PH (corresponding author), Oberlin Coll, Dept Psychol, Oberlin, OH 44074 USA.	paul.thibodeau@oberlin.edu	Thibodeau, Paul/AAY-7259-2021					Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; [Anonymous], 2013, PEOPLE MAGAZINE 0211; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barsalou L.W., 2012, CAMBRIDGE HDB PSYCHO, P239, DOI [10.1017/CBO9781139029377.017, DOI 10.1017/CBO9781139029377.017]; Bates D., 2015, LINEAR MIXED EFFECTS; BUCK R, 1980, J PERS SOC PSYCHOL, V38, P811, DOI 10.1037/0022-3514.38.5.811; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Corkin S., 2003, PNAS, V101, P310; Cox TJ, 2008, APPL ACOUST, V69, P1195, DOI 10.1016/j.apacoust.2007.11.004; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; Dingemanse M, 2015, TRENDS COGN SCI, V19, P603, DOI 10.1016/j.tics.2015.07.013; Druschel BA, 1999, PERS INDIV DIFFER, V26, P739, DOI 10.1016/S0191-8869(98)00196-2; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; ELY DJ, 1975, B PSYCHONOMIC SOC, V6, P295, DOI 10.3758/BF03336667; Friedrich Paul, 1979, LANGUAGE CONTEXT IMA, P1; GAZZANIGA MS, 1995, NEURON, V14, P217, DOI 10.1016/0896-6273(95)90280-5; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Greenman B., 2012, NEW YORKER; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2000, MORAL DUMBFOUN UNPUB; HALPERN DL, 1986, PERCEPT PSYCHOPHYS, V39, P77, DOI 10.3758/BF03211488; HERR PM, 1983, J EXP SOC PSYCHOL, V19, P323, DOI 10.1016/0022-1031(83)90026-4; HOCKETT CF, 1960, SCI AM, V203, P88, DOI 10.1038/scientificamerican0960-88; Hutchison KA, 2008, Q J EXP PSYCHOL, V61, P1036, DOI 10.1080/17470210701438111; Janschewitz K, 2008, BEHAV RES METHODS, V40, P1065, DOI 10.3758/BRM.40.4.1065; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lockwood G., 2015, FRONT PSYCHOL, V6, P1, DOI DOI 10.3389/fpsyg.2015.01246; Malady J. X. M., 2013, SLATE; McCabe G.., 1999, PRACTICE STAT; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Nelson DL, 2000, MEM COGNITION, V28, P887, DOI 10.3758/BF03209337; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Nisita L, 2013, REFINERY 29     1121; Nuckolls JB, 1999, ANNU REV ANTHROPOL, V28, P225, DOI 10.1146/annurev.anthro.28.1.225; Oehler M., 2011, THE J, V130, DOI [10.1121/1.3655174, DOI 10.1121/1.3655174]; Perniss P, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00227; Pinker S., 2007, STUFF THOUGHT LANGUA; Preston JL, 2012, J EXP SOC PSYCHOL, V48, P1365, DOI 10.1016/j.jesp.2012.05.015; Ripley B, 2014, SUPPORT FUNCTIONS DA; ROZIN P, 1986, J PERS SOC PSYCHOL, V50, P703, DOI 10.1037/0022-3514.50.4.703; Rozin P, 2013, TRENDS COGN SCI, V17, P367, DOI 10.1016/j.tics.2013.06.001; Shah Y., 2015, HUFFINGTON POST; Strack F., 1988, J PERS SOC PSYCHOL, V54, P768; Strawbridge WJ, 1998, J GERONTOL B-PSYCHOL, V53, pS118, DOI 10.1093/geronb/53B.3.S118; Swann WB, 2001, J PERS SOC PSYCHOL, V81, P1160, DOI 10.1037/0022-3514.81.6.1160; Talmi D, 2004, MEM COGNITION, V32, P742, DOI 10.3758/BF03195864; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; UNDERWOOD BJ, 1965, J EXP PSYCHOL, V70, P122, DOI 10.1037/h0022014; Venables WN., 2002, MODERN APPL STAT S 4; Ward R., 2009, MISSISSIPPI STA 0409; ZAJONC RB, 1985, SCIENCE, V228, P15, DOI 10.1126/science.3883492; ZAJONC RB, 1989, PSYCHOL REV, V96, P395, DOI 10.1037/0033-295X.96.3.395	57	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153686	10.1371/journal.pone.0153686	http://dx.doi.org/10.1371/journal.pone.0153686			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27119522	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200033
J	Yan, J; Liu, J; Su, B; Pan, XH; Wang, Z; Wu, JJ; Zhang, JF; Ruan, YH; Hsi, J; Liao, LJ; Shao, YM; Xing, H				Yan, Jing; Liu, Jia; Su, Bin; Pan, Xiaohong; Wang, Zhe; Wu, Jianjun; Zhang, Jiafeng; Ruan, Yuhua; Hsi, Jenny; Liao, Lingjie; Shao, Yiming; Xing, Hui			Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; ANTIRETROVIRAL THERAPY; SELF-REPORT; INFECTED PATIENTS; CLINICAL-TRIALS; ADHERENCE; OUTCOMES; PLASMA; HAART; PHARMACOKINETICS	Background The assessment of adherence to antiretroviral therapy (ART) is important in order to predict treatment outcomes. Lamivudine (3TC) is one of the most widely used NRTIs in China, but its concentrations in hair and association with virologic failure and drug resistance have not been studied. Methods We conducted a cross-sectional survey to investigate 3TC concentrations in hair as a predictor of virologic failure and drug resistance among HIV patients receiving free ART. We also compared the capacity of hair 3TC concentrations with self-reported adherence in predicting virologic responses. Hair 3TC concentrations were detected through the LC-MS/MS system. Results In patients without HIV drug resistance (HIVDR), with a threshold hair 3TC concentration of 260 ng/g, the sensitivity and specificity in predicting virologic suppression were 76.9% and 89.9%, respectively. Some factors, including CD4(+) cell counts, initial treatment regimens with 3TC, and current regimens with second-line drugs, influenced the association between hair 3TC concentrations and virologic suppression. In patients who experienced virologic failure with HIVDR, with a threshold of 180 ng/g, the sensitivity and specificity were 70.0% and 74.4%, respectively. Hair 3TC concentrations had higher sensitivity and specificity in predicting virologic failure and drug resistance than self-reported adherence. Conclusions The hair 3TC concentration was a stronger indicator than self-reported adherence in predicting virologic failure and drug resistance in HIV patients receiving free ART.	[Yan, Jing; Ruan, Yuhua; Hsi, Jenny; Liao, Lingjie; Shao, Yiming; Xing, Hui] Collaborat Innovat Ctr Diag & Treatment Infect Di, Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control NCAIDS & Prevent, State Key Lab Infect Dis Prevent & Control SKLID, Beijing, Peoples R China; [Liu, Jia; Wang, Zhe] Henan Ctr Dis Control & Prevent, Zhenzhou, Henan Province, Peoples R China; [Su, Bin; Wu, Jianjun] Anhui Ctr Dis Control & Prevent, Hefei, Anhui, Peoples R China; [Pan, Xiaohong; Zhang, Jiafeng] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Xing, H (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control NCAIDS & Prevent, State Key Lab Infect Dis Prevent & Control SKLID, Beijing, Peoples R China.	xingh@chinaaids.cn	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	Ministry of Science and Technology of China [2012ZX10001-002, 2009DFB30420]; Chinese State Key Laboratory of Infectious Disease Develop Grant; International Development Research Center of Canada [104519-010]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese State Key Laboratory of Infectious Disease Develop Grant; International Development Research Center of Canada	This study was supported by grants from the Ministry of Science and Technology of China (2012ZX10001-002 and 2009DFB30420), the Chinese State Key Laboratory of Infectious Disease Develop Grant, and the International Development Research Center of Canada (grant #104519-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico KR, 2006, JAIDS-J ACQ IMM DEF, V42, P455, DOI 10.1097/01.qai.0000225020.73760.c2; [Anonymous], 2005, CHINA FREE ART MANUA; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Back D, 2002, AIDS, V16, pS5, DOI 10.1097/00002030-200203001-00002; Baxi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129100; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; Bernard L, 2002, ANN INTERN MED, V137, P656, DOI 10.7326/0003-4819-137-8-200210150-00009; Condra JH, 1998, ANN INTERN MED, V128, P951, DOI 10.7326/0003-4819-128-11-199806010-00017; Duong M, 2001, CLIN INFECT DIS, V33, P386, DOI 10.1086/321876; Fletcher CV, 1999, ANN PHARMACOTHER, V33, P989, DOI 10.1345/aph.19075; Friedland GH, 1999, AIDS, V13, pS61; Gandhi M, 2002, ANN INTERN MED, V137, P696, DOI 10.7326/0003-4819-137-8-200210150-00016; Gandhi M, 2014, AIDS RES HUM RETROV, V30, P25, DOI [10.1089/aid.2013.0239, 10.1089/AID.2013.0239]; Gandhi M, 2011, CLIN INFECT DIS, V52, P1267, DOI 10.1093/cid/cir131; Gandhi M, 2009, AIDS, V23, P471, DOI 10.1097/QAD.0b013e328325a4a9; GRAHAM K, 1989, JAMA-J AM MED ASSOC, V262, P3328, DOI 10.1001/jama.262.23.3328; Huang Y, 2008, RAPID COMMUN MASS SP, V22, P3401, DOI 10.1002/rcm.3750; Huang Y, 2011, ANAL BIOANAL CHEM, V401, P1923, DOI 10.1007/s00216-011-5278-7; KINTZ P, 1993, INT J LEGAL MED, V105, P283, DOI 10.1007/BF01370386; Kumar AKH, 2009, INDIAN J MED RES, V130, P451; Kumar Agibothu K Hemanth, 2006, MedGenMed, V8, P53; LeBeau MA, 2011, FORENSIC SCI INT, V210, P110, DOI 10.1016/j.forsciint.2011.02.015; Leng XB, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005886; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Marcellin F, 2013, EXPERT REV ANTI-INFE, V11, P239, DOI [10.1586/ERI.13.8, 10.1586/eri.13.8]; Minzi OM, 2011, THER CLIN RISK MANAG, V7, P441, DOI 10.2147/TCRM.S23625; Nakahara Y, 1999, J CHROMATOGR B, V733, P161, DOI 10.1016/S0378-4347(99)00059-6; Panhard X, 2007, EUR J CLIN PHARMACOL, V63, P1019, DOI 10.1007/s00228-007-0337-x; Ruan YH, 2010, TROP MED INT HEALTH, V15, P1357, DOI 10.1111/j.1365-3156.2010.02621.x; van Zyl GU, 2011, JAIDS-J ACQ IMM DEF, V56, P333, DOI 10.1097/QAI.0b013e31820dc0cc; Wang X, 2011, CURR HIV RES, V9, P103, DOI 10.2174/157016211795569122; Xing H, 2015, J ANTIMICROB CHEMOTH, V70, P2097, DOI 10.1093/jac/dkv078; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054917; Yuen GJ, 2004, ANTIMICROB AGENTS CH, V48, P176, DOI 10.1128/AAC.48.1.176-182.2004; Zhang F, 2008, CHINA FREE ART MANUA	36	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154421	10.1371/journal.pone.0154421	http://dx.doi.org/10.1371/journal.pone.0154421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119346	gold, Green Submitted, Green Published			2022-12-27	WOS:000374976200071
J	Gillen, JB; Martin, BJ; MacInnis, MJ; Skelly, LE; Tarnopolsky, MA; Gibala, MJ				Gillen, Jenna B.; Martin, Brian J.; MacInnis, Martin J.; Skelly, Lauren E.; Tarnopolsky, Mark A.; Gibala, Martin J.			Twelve Weeks of Sprint Interval Training Improves Indices of Cardiometabolic Health Similar to Traditional Endurance Training despite a Five-Fold Lower Exercise Volume and Time Commitment	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; SKELETAL-MUSCLE; CARDIORESPIRATORY FITNESS; GLUCOSE-TOLERANCE; PHYSICAL-ACTIVITY; INSULIN SENSITIVITY; INTENSITY; ADAPTATIONS; CAPACITY; ADULTS	Aims We investigated whether sprint interval training (SIT) was a time-efficient exercise strategy to improve insulin sensitivity and other indices of cardiometabolic health to the same extent as traditional moderate-intensity continuous training (MICT). SIT involved 1 minute of intense exercise within a 10-minute time commitment, whereas MICT involved 50 minutes of continuous exercise per session. Methods Sedentary men (27 +/- 8y; BMI = 26 +/- 6kg/m(2)) performed three weekly sessions of SIT (n = 9) or MICT (n = 10) for 12 weeks or served as non-training controls (n = 6). SIT involved 3x20second 'all-out' cycle sprints (similar to 500W) interspersed with 2 minutes of cycling at 50W, whereas MICT involved 45 minutes of continuous cycling at similar to 70% maximal heart rate (similar to 110W). Both protocols involved a 2-minute warm-up and 3-minute cool-down at 50W. Results Peak oxygen uptake increased after training by 19% in both groups (SIT: 32 +/- 7 to 38 +/- 8; MICT: 34 +/- 6 to 40 +/- 8ml/kg/min; p< 0.001 for both). Insulin sensitivity index (CSI), determined by intravenous glucose tolerance tests performed before and 72 hours after training, increased similarly after SIT (4.9 +/- 2.5 to 7.5 +/- 4.7, p = 0.002) and MICT (5.0 +/- 3.3 to 6.7 +/- 5.0 x 10(-4) min(-1) [mu/mL](-1), p = 0.013) (p< 0.05). Skeletal muscle mitochondrial content also increased similarly after SIT and MICT, as primarily reflected by the maximal activity of citrate synthase (CS; P< 0.001). The corresponding changes in the control group were small for VO(2)peak (p = 0.99), CSI (p = 0.63) and CS (p = 0.97). Conclusions Twelve weeks of brief intense interval exercise improved indices of cardiometabolic health to the same extent as traditional endurance training in sedentary men, despite a five-fold lower exercise volume and time commitment.	[Gillen, Jenna B.; Martin, Brian J.; MacInnis, Martin J.; Skelly, Lauren E.; Tarnopolsky, Mark A.; Gibala, Martin J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat & Med, Hamilton, ON, Canada	McMaster University; McMaster University	Gibala, MJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	gibalam@mcmaster.ca		MacInnis, Martin/0000-0002-0377-5800	Natural Sciences and Engineering Research Council (NSERC) [RGPIN/227858-2010]; McMaster University	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); McMaster University	This project was supported by an operating grant from the Natural Sciences and Engineering Research Council (NSERC; grant number RGPIN/227858-2010) and an internally-sponsored research grant from McMaster University to MJG. JBG held a NSERC Vanier Canada Graduate Scholarship. MJM held an NSERC Postdoctoral Fellowship. LES held an NSERC Canada Graduate Scholarship (Masters).	Akerstrom T, 2014, AM J PHYSIOL-ENDOC M, V307, pE1105, DOI 10.1152/ajpendo.00020.2014; [Anonymous], 2013, OPEN J MOL INTEGR PH, V03, P202, DOI [10.4236/ojmip.2013.34027, DOI 10.4236/OJMIP.2013.34027]; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Barry VW, 2014, PROG CARDIOVASC DIS, V56, P382, DOI 10.1016/j.pcad.2013.09.002; Biddle SJH, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0254-9; Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012; BLOMQVIST CG, 1983, ANNU REV PHYSIOL, V45, P169, DOI 10.1146/annurev.ph.45.030183.001125; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Carter SL, 2001, CAN J PHYSIOL PHARM, V79, P386, DOI 10.1139/cjpp-79-5-386; Cocks M, 2016, J PHYSIOL-LONDON, V594, P2307, DOI 10.1113/jphysiol.2014.285254; Cocks M, 2013, J PHYSIOL-LONDON, V591, P641, DOI 10.1113/jphysiol.2012.239566; Colley RC, 2011, HLTH REP, V22, P7; Egan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074098; Ekkekakis P, 2009, SPORTS MED, V39, P857, DOI 10.2165/11315210-000000000-00000; Ortega JF, 2014, APPL PHYSIOL NUTR ME, V39, P787, DOI 10.1139/apnm-2013-0507; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gillen JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111489; Gillen JB, 2014, APPL PHYSIOL NUTR ME, V39, P409, DOI 10.1139/apnm-2013-0187; Gormley SE, 2008, MED SCI SPORT EXER, V40, P1336, DOI 10.1249/MSS.0b013e31816c4839; Hawley JA, 2004, DIABETES-METAB RES, V20, P383, DOI 10.1002/dmrr.505; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Houmard JA, 2004, J APPL PHYSIOL, V96, P101, DOI 10.1152/japplphysiol.00707.2003; Jung ME, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/191595; Jung ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114541; Karstoft K, 2013, DIABETES CARE, V36, P228, DOI 10.2337/dc12-0658; KNUTTGEN HG, 1973, MED SCI SPORT EXER, V5, P220; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Macpherson REK, 2011, MED SCI SPORT EXER, V43, P115, DOI 10.1249/MSS.0b013e3181e5eacd; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matsuo T, 2014, MED SCI SPORT EXER, V46, P42, DOI 10.1249/MSS.0b013e3182a38da8; Metcalfe RS, 2012, EUR J APPL PHYSIOL, V112, P2767, DOI 10.1007/s00421-011-2254-z; Murias JM, 2010, J APPL PHYSIOL, V108, P621, DOI 10.1152/japplphysiol.01152.2009; Ortega JF, 2015, INT J SPORTS MED, V36, P209, DOI 10.1055/s-0034-1389942; Parfitt G, 2009, J EXERC SCI FIT, V7, pS34, DOI 10.1016/S1728-869X(09)60021-6; Richards JC, 2010, J PHYSIOL-LONDON, V588, P2961, DOI 10.1113/jphysiol.2010.189886; Ross R, 2015, MAYO CLIN PROC, V90, P1506, DOI 10.1016/j.mayocp.2015.07.024; Ross R, 2015, ANN INTERN MED, V162, P325, DOI 10.7326/M14-1189; Samjoo IA, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.30; Shepherd SO, 2013, J PHYSIOL-LONDON, V591, P657, DOI 10.1113/jphysiol.2012.240952; Sloth M, 2013, SCAND J MED SCI SPOR, V23, pE341, DOI 10.1111/sms.12092; Stephenson EJ, 2014, BBA-GEN SUBJECTS, V1840, P1285, DOI 10.1016/j.bbagen.2013.12.004; Tabata I, 1996, MED SCI SPORT EXER, V28, P1327, DOI 10.1097/00005768-199610000-00018; Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; Trilk JL, 2011, EUR J APPL PHYSIOL, V111, P1591, DOI 10.1007/s00421-010-1777-z; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Tura A, 2010, DIABETOLOGIA, V53, P144, DOI 10.1007/s00125-009-1547-9; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	57	178	181	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154075	10.1371/journal.pone.0154075	http://dx.doi.org/10.1371/journal.pone.0154075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115137	Green Published, gold, Green Submitted			2022-12-27	WOS:000374973600042
J	Grytdal, SP; DeBess, E; Lee, LE; Blythe, D; Ryan, P; Biggs, C; Cameron, M; Schmidt, M; Parashar, UD; Hall, AJ				Grytdal, Scott P.; DeBess, Emilio; Lee, Lore E.; Blythe, David; Ryan, Patricia; Biggs, Christianne; Cameron, Miriam; Schmidt, Mark; Parashar, Umesh D.; Hall, Aron J.			Incidence of Norovirus and Other Viral Pathogens That Cause Acute Gastroenteritis (AGE) among Kaiser Permanente Member Populations in the United States, 2012-2013	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; FOODBORNE ILLNESS; UNSPECIFIED AGENTS; ROTAVIRUS VACCINE; BURDEN; COMMUNITY; OUTBREAKS; CHILDREN	Noroviruses and other viral pathogens are increasingly recognized as frequent causes of acute gastroenteritis (AGE). However, few laboratory-based data are available on the incidence of AGE caused by viral pathogens in the U.S. This study examined stool specimens submitted for routine clinical diagnostics from patients enrolled in Kaiser Permanente (KP) health plans in metro Portland, OR, and the Maryland, District of Columbia, and northern Virginia geographic areas to estimate the incidence of viral enteropathogens in these populations. Over a one-year study period, participating laboratories randomly selected stools submitted for routine clinical diagnostics for inclusion in the study along with accompanying demographic and clinical data. Selected stools were tested for norovirus, rotavirus, sapovirus, and astrovirus using standardized real-time RT-PCR protocols. Each KP site provided administrative data which were used in conjunction with previously published data on healthcare utilization to extrapolate pathogen detection rates into population-based incidence rates. A total of 1,099 specimens collected during August 2012 to September 2013 were included. Mean age of patients providing stool specimens was 46 years (range: 0-98 years). Noroviruses were the most common viral pathogen identified among patients with AGE (n = 63 specimens, 6% of specimens tested). In addition, 22 (2%) of specimens were positive for rotavirus; 19 (2%) were positive for sapovirus; and 7 (1%) were positive for astrovirus. Incidence of norovirus-associated outpatient visits was 5.6 per 1,000 person-years; incidence of norovirus disease in the community was estimated to be 69.5 per 1,000 person-years. Norovirus incidence was highest among children < 5 years of age (outpatient incidence = 25.6 per 1,000 person-years; community incidence = 152.2 per 1,000 personyears), followed by older adults aged > 65 years (outpatient incidence = 7.8 per 1,000 person-years; community incidence = 75.8 per 1,000 person-years). Outpatient incidence rates of rotavirus, sapovirus, and astrovirus were 2.0, 1.6, 0.6 per 1,000 person-years, respectively; community incidence rates for these viruses were 23.4, 22.5, and 8.5 per 1,000 person-years, respectively. This study provides the first age-group specific laboratory-based community and outpatient incidence rates for norovirus AGE in the U.S. Norovirus was the most frequently detected viral enteropathogen across the age spectrum with the highest rates of norovirus disease observed among young children and, to a lesser extent, the elderly. These data provide a better understanding of the norovirus disease burden in the United States, including variations within different age groups, which can help inform the development, targeting, and future impacts of interventions, including vaccines.	[Grytdal, Scott P.; Parashar, Umesh D.; Hall, Aron J.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [DeBess, Emilio; Lee, Lore E.] Oregon Hlth Author, Publ Hlth Div, Dept Human Serv, Portland, OR USA; [Blythe, David; Ryan, Patricia; Biggs, Christianne] Maryland Dept Hlth & Mental Hyg, Off Infect Dis & Epidemiol, Baltimore, MD USA; [Cameron, Miriam] Kaiser Permanente Mid Atlantic States, Rockville, MD USA; [Schmidt, Mark] Kaiser Permanente Ctr Hlth Res, Portland, OR USA	Centers for Disease Control & Prevention - USA; Maryland Department of Health & Mental Hygiene; Kaiser Permanente; Kaiser Permanente	Grytdal, SP (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.	spgrytdal@cdc.gov			National Institute of Food and Agriculture, U.S. Department of Agriculture, [2011-68003-30395]	National Institute of Food and Agriculture, U.S. Department of Agriculture,(United States Department of Agriculture (USDA))	This study was supported in part by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2011-68003-30395.	Ahmed SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075922; Belliot G, 1997, ARCH VIROL, V142, P1323, DOI 10.1007/s007050050163; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Freeman MM, 2008, J MED VIROL, V80, P1489, DOI 10.1002/jmv.21228; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Grytdal SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126733; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Jones TF, 2007, EPIDEMIOL INFECT, V135, P293, DOI 10.1017/S0950268806006765; Karsten C, 2009, EUR J CLIN MICROBIOL, V28, P935, DOI 10.1007/s10096-009-0729-1; Leshem E, 2015, JAMA-J AM MED ASSOC, V313, P2282, DOI 10.1001/jama.2015.5571; Leshem E, 2014, PEDIATRICS, V134, P15, DOI 10.1542/peds.2013-3849; Leshem E, 2013, EMERG INFECT DIS, V19, P1231, DOI 10.3201/eid1908.130458; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Okada M, 2006, ARCH VIROL, V151, P2503, DOI 10.1007/s00705-006-0820-1; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021; Pringle K, 2015, FUTURE MICROBIOL, V10, P53, DOI 10.2217/fmb.14.102; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS30, DOI 10.1097/INF.0b013e3181ffe3eb; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Verhoef L., 2012, EPIDEMIOLOGY INFECT, P1, DOI DOI 10.1017/S0950268812000799.[EPUB	27	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0148395	10.1371/journal.pone.0148395	http://dx.doi.org/10.1371/journal.pone.0148395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115485	gold, Green Submitted, Green Published			2022-12-27	WOS:000374973600008
J	Rha, B; Lopman, BA; Alcala, AN; Riddle, MS; Porter, CK				Rha, Brian; Lopman, Benjamin A.; Alcala, Ashley N.; Riddle, Mark S.; Porter, Chad K.			Incidence of Norovirus-Associated Medical Encounters among Active Duty United States Military Personnel and Their Dependents	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; ACUTE GASTROENTERITIS; ENGLAND; BURDEN; ADULTS; WALES; SURVEILLANCE; COMMUNITY; OUTBREAKS; ILLNESS	Background Norovirus is a leading cause of gastroenteritis episodes and outbreaks in US military deployments, but estimates of endemic disease burden among military personnel in garrison are lacking. Methods Diagnostic codes from gastroenteritis-associated medical encounters of active duty military personnel and their beneficiaries from July 1998-June 2011 were obtained from the Armed Forces Health Surveillance Center. Using time-series regression models, cause-unspecified encounters were modeled as a function of encounters for specific enteropathogens. Model residuals (representing unexplained encounters) were used to estimate norovirus-attributable medical encounters. Incidence rates were calculated using population data for both active duty and beneficiary populations. Results The estimated annual mean rate of norovirus-associated medically-attended visits among active duty personnel and their beneficiaries was 292 (95% CI: 258 to 326) and 93 (95% CI: 80 to 105) encounters per 10,000 persons, respectively. Rates were highest among beneficiaries < 5 years of age with a median annual rate of 435 (range: 318 to 646) encounters per 10,000 children. Norovirus was estimated to cause 31% and 27% of all-cause gastroenteritis encounters in the active duty and beneficiary populations, respectively, with over 60% occurring between November and April. There was no evidence of any lag effect where norovirus disease occurred in one population before the other, or in one beneficiary age group before the others. Conclusions Norovirus is a major cause of medically-attended gastroenteritis among non-deployed US military active duty members as well as in their beneficiaries.	[Rha, Brian; Lopman, Benjamin A.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Rha, Brian] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Alcala, Ashley N.; Riddle, Mark S.; Porter, Chad K.] Naval Med Res Ctr, Silver Spring, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Naval Medical Research Center (NMRC)	Rha, B; Lopman, BA (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.; Rha, B (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.	wif8@cdc.gov; blopman@cdc.gov	Riddle, Mark/R-8788-2019	Riddle, Mark/0000-0002-0607-7880	Military Infectious Disease Research Program	Military Infectious Disease Research Program	This work was supported/funded by the Military Infectious Disease Research Program, but without specific funding for this project.	[Anonymous], 2011, MSMR, V18, P7; Armed Forces Health Surveillance C, 2013, MSMR, V20, P7; Armed Forces Health Surveillance C, 2013, MSMR, V20; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Bartsch SM, 2012, VACCINE, V30, P7097, DOI 10.1016/j.vaccine.2012.09.040; Bentham G, 2001, INT J BIOMETEOROL, V45, P22, DOI 10.1007/s004840000083; Blankson KL, 2014, PEDIATRICS, V133, P627, DOI 10.1542/peds.2013-1630; Bresee JS, 2012, J INFECT DIS, V205, P1374, DOI 10.1093/infdis/jis206; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Hashizume M, 2007, INT J EPIDEMIOL, V36, P1030, DOI 10.1093/ije/dym148; Haustein T, 2009, CLIN INFECT DIS, V49, P1890, DOI 10.1086/648440; Karsten C, 2009, EUR J CLIN MICROBIOL, V28, P935, DOI 10.1007/s10096-009-0729-1; Lopman BA, 2003, EMERG INFECT DIS, V9, P71; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Markov PV, 2007, EPIDEMIOL INFECT, V135, P17, DOI 10.1017/S0950268806006625; Moore M., 2010, HARNESSING FULL VALU; Mounts AW, 2000, J INFECT DIS, V181, pS284, DOI 10.1086/315586; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021; Porter CK, 2012, CLIN INFECT DIS, V55, P915, DOI 10.1093/cid/cis576; Reaves Erik J, 2012, MSMR, V19, P17; Richardson C, 2013, EXPERT REV VACCINES, V12, P155, DOI [10.1586/erv.12.145, 10.1586/ERV.12.145]; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Verhoef L, 2013, EPIDEMIOL INFECT, V141, P496, DOI 10.1017/S0950268812000799; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Zanini B, 2012, AM J GASTROENTEROL, V107, P891, DOI 10.1038/ajg.2012.102	35	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0148505	10.1371/journal.pone.0148505	http://dx.doi.org/10.1371/journal.pone.0148505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115602	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600009
J	Arts, RAGJ; George, ELJ; Janssen, M; Griessner, A; Zierhofer, C; Stokroos, RJ				Arts, Remo A. G. J.; George, Erwin L. J.; Janssen, Miranda; Griessner, Andreas; Zierhofer, Clemens; Stokroos, Robert J.			Tinnitus Suppression by Intracochlear Electrical Stimulation in Single Sided Deafness - A Prospective Clinical Trial: Follow-Up	PLOS ONE			English	Article							QUALITY-OF-LIFE; COCHLEAR IMPLANTATION; HEARING-LOSS; INVENTORY; METAANALYSIS; DEPRESSION; HEALTH	Introduction Earlier studies show that a Cochlear Implant (CI), capable of providing intracochlear electrical stimulation independent of environmental sounds, appears to suppress tinnitus at least for minutes. The current main objective is to compare the long-term suppressive effects of looped (i.e. repeated) electrical stimulation (without environmental sound perception) with the standard stimulation pattern of a CI (with environmental sound perception). This could open new possibilities for the development of a "Tinnitus Implant" (TI), an intracochlear pulse generator for the suppression of tinnitus. Materials and Methods Ten patients with single sided deafness suffering from unilateral tinnitus in the deaf ear are fitted with a CI (MED-EL Corporation, Innsbruck, Austria). Stimulation patterns are optimized for each individual patient, after which they are compared using a randomized crossover design, with a follow-up of six months, followed by a 3 month period using the modality of patient's choice. Results Results show that tinnitus can be suppressed with intracochlear electrical stimulation independent of environmental sounds, even long term. No significant difference in tinnitus suppression was found between the standard clinical CI and the TI. Conclusion It can be concluded that coding of environmental sounds is no requirement for tinnitus suppression with intracochlear electrical stimulation. It is therefore plausible that tinnitus suppression by CI is not solely caused by an attention shift from the tinnitus to environmental sounds. Both the standard clinical CI and the experimental TI are potential treatment options for tinnitus. These findings offer perspectives for a successful clinical application of the TI, possibly even in patients with significant residual hearing.	[Arts, Remo A. G. J.; George, Erwin L. J.; Janssen, Miranda; Stokroos, Robert J.] Maastricht Univ, MHeNS Sch Mental Hlth & Neurosci, Med Ctr, Dept ENT Head & Neck Surg, NL-6200 MD Maastricht, Netherlands; [Janssen, Miranda] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Methodol & Stat, NL-6200 MD Maastricht, Netherlands; [Griessner, Andreas; Zierhofer, Clemens] Univ Innsbruck, Inst Mechatron, A-6020 Innsbruck, Austria	Maastricht University; Maastricht University; University of Innsbruck	Arts, RAGJ (corresponding author), Maastricht Univ, MHeNS Sch Mental Hlth & Neurosci, Med Ctr, Dept ENT Head & Neck Surg, NL-6200 MD Maastricht, Netherlands.	remo.arts1987@gmail.com	stokroos, robert/AAC-9814-2021	Zierhofer, Clemens M./0000-0003-0899-8023	MED-EL (MED-EL Corporation, Innsbruck, Austria); Dutch Heinsius Houbolt Foundation	MED-EL (MED-EL Corporation, Innsbruck, Austria); Dutch Heinsius Houbolt Foundation	This study was financially supported by MED-EL (MED-EL Corporation, Innsbruck, Austria) and the Dutch Heinsius Houbolt Foundation. The funding sources had no involvement in the study design; in the collection, analyses and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The authors declare that they have no conflict of interest.	Arndt S, 2010, OTOL NEUROTOL, V31, P67, DOI 10.1097/MAO.0b013e3181c0e972; Arts RAGJ, ENT J IN PRESS; Arts RAGJ, 2015, AUDIOL NEURO-OTOL, V20, P294, DOI 10.1159/000381936; Arts RAGJ, 2015, EAR HEARING, V36, P125, DOI 10.1097/AUD.0000000000000090; Arts RAGJ, 2012, CURR OPIN OTOLARYNGO, V20, P398, DOI 10.1097/MOO.0b013e3283577b66; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Blasco MA, 2014, OTOL NEUROTOL, V35, P1426, DOI 10.1097/MAO.0000000000000431; BOUMAN TK, 1985, GEDRAG GEZOND, V13, P13; Bovo R, 2011, AURIS NASUS LARYNX, V38, P14, DOI 10.1016/j.anl.2010.05.003; Buechner A, 2010, OTOL NEUROTOL, V31, P1381, DOI 10.1097/MAO.0b013e3181e3d353; Cederroth CR, 2013, NAT BIOTECHNOL, V31, P972, DOI 10.1038/nbt.2736; de Heyning PV, 2008, ANN OTO RHINOL LARYN, V117, P645, DOI 10.1177/000348940811700903; Di Nardo W, 2007, EUR ARCH OTO-RHINO-L, V264, P1145, DOI 10.1007/s00405-007-0352-7; Dobie RA, 1999, LARYNGOSCOPE, V109, P1202, DOI 10.1097/00005537-199908000-00004; Feeny D, 2004, QUAL LIFE RES, V13, P1659, DOI 10.1007/s11136-004-6189-2; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; HELLER MF, 1953, ANN OTO RHINOL LARYN, V62, P73, DOI 10.1177/000348945306200107; Landsberger DM, 2015, EAR HEAR; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Maes IHL, 2013, EAR HEARING, V34, P508, DOI 10.1097/AUD.0b013e31827d113a; Maes IHL, 2011, EAR HEARING, V32, P428, DOI 10.1097/AUD.0b013e3181fdf09f; Meeus O, 2007, B-ENT, P11; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Olze H, 2011, LARYNGOSCOPE, V121, P2220, DOI 10.1002/lary.22145; Olze H, 2012, AUDIOL NEURO-OTOL, V17, P2, DOI 10.1159/000323847; Osaki Y, 2005, NEUROREPORT, V16, P1625, DOI 10.1097/01.wnr.0000183899.85277.08; Schaette R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035238; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schwartz C, 2006, QUAL LIFE RES, V15, P1503, DOI 10.1007/s11136-006-0008-x; Stakhovskaya O, 2007, JARO-J ASSOC RES OTO, V8, P220, DOI 10.1007/s10162-007-0076-9; Tyler RS, 2015, AM J AUDIOL; Valles-Varela H, 2013, ACTA OTORRINOLAR ESP, V64, P253, DOI 10.1016/j.otorri.2012.11.008; van Zon A, 2015, OTOL NEUROTOL, V36, P209, DOI 10.1097/MAO.0000000000000681; Vernon JA, 2003, OTOLARYNG CLIN N AM, V36, P307, DOI 10.1016/S0030-6665(02)00163-9; Vlastarakos PV, 2014, EUR ARCH OTO-RHINO-L, V271, P2119, DOI 10.1007/s00405-013-2746-z; Zeman F, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-128; Zeng F-G, FRONT SYST NEUROSCI	39	24	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153131	10.1371/journal.pone.0153131	http://dx.doi.org/10.1371/journal.pone.0153131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111333	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600011
J	Center, KE; Gunn, JKL; Asaolu, IO; Gibson, SJ; Ehiri, JE				Center, Katherine E.; Gunn, Jayleen K. L.; Asaolu, Ibitola O.; Gibson, Steven J.; Ehiri, John E.			Contraceptive Use and Uptake of HIV-Testing among Sub-Saharan African Women	PLOS ONE			English	Article							PREVENTION; INFECTION; ABC	Despite improved availability of simple, relatively inexpensive, and highly effective antiretroviral treatment for HIV/AIDS, the disease remains a major public health challenge for women in sub-Saharan Africa (SSA). Given the numerous barriers in access to care for women in this region, every health issue that brings them into contact with the health system should be optimized as an opportunity to integrate HIV/AIDS prevention. Because most non-condom forms of modern contraception require a clinical appointment for use, contraception appointments could provide a confidential opportunity for access to HIV counseling, testing, and referral to care. This study sought to investigate the relationship between contraceptive methods and HIV testing among women in SSA. Data from the Demographic and Health Survey from four African countries-Congo, Mozambique, Nigeria, and Uganda-was used to examine whether modern (e.g., pills, condom) or traditional (e.g., periodic abstinence, withdrawal) forms of contraception were associated with uptake of HIV testing. Data for the current analyses were restricted to 35,748 women with complete information on the variables of interest. Chi-square tests and logistic regression models were used to assess the relationship between uptake of HIV testing and respondents' baseline characteristics and contraceptive methods. In the total sample and in Mozambique, women who used modern forms of contraception were more likely to be tested for HIV compared to those who did not use contraception. This positive association was not demonstrated in Congo, Nigeria, or Uganda. That many women who access modern contraception are not tested for HIV in high HIV burden areas highlights a missed opportunity to deliver an important intervention to promote maternal and child health. Given the increasing popularity of hormonal contraception methods in low-income countries, there is an urgent need to integrate HIV counseling, testing, and treatment into family planning programs. Women on hormonal contraceptives should be encouraged to continue to use condoms for HIV-prevention.	[Center, Katherine E.] Univ Arizona, Dept Obstet & Gynecol, Tucson, AZ USA; [Center, Katherine E.] Biomed Res & Educ Fdn Southern Arizona, Tucson, AZ USA; [Gunn, Jayleen K. L.] Univ Arizona, Dept Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Asaolu, Ibitola O.; Ehiri, John E.] Univ Arizona, Dept Hlth Promot Sci, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Gibson, Steven J.] Univ Arizona, Ctr Canc, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Ehiri, JE (corresponding author), Univ Arizona, Dept Hlth Promot Sci, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA.	jehiri@email.arizona.edu						[Anonymous], 2007, COCHRANE LIB, DOI DOI 10.1002/14651858; [Anonymous], 2013, WORLD CONTR PATT 201; [Anonymous], 2015, PREV MOTH TO CHILD T; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Chiao C, 2009, HEALTH PLACE, V15, P742, DOI 10.1016/j.healthplace.2008.12.001; Cleland J, 2006, LANCET, V368, P1788, DOI 10.1016/S0140-6736(06)69738-9; Collins L., 2013, SEXUAL HLTH EXCHANGE, P4; Dworkin SL, 2007, AM J PUBLIC HEALTH, V97, P13, DOI 10.2105/AJPH.2005.074591; Emina JBO, 2014, CONTRACEPTION, V90, P154, DOI 10.1016/j.contraception.2014.02.001; Gage AJ, 1998, STUD FAMILY PLANN, V29, P154, DOI 10.2307/172156; Heikinheimo O, 2009, HUM REPROD UPDATE, V15, P165, DOI 10.1093/humupd/dmn049; Korra A., 2002, ATTITUDES FAMILY PLA; Madsen EL, 2015, J BIOSOC SCI, V47, P329, DOI 10.1017/S0021932014000108; Morrison CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001778; Pacque-Margolis S, 2013, EXPLORING CONTRACEPT; Reid-Hresko J, 2014, CULT HEALTH SEX, V16, P765, DOI 10.1080/13691058.2014.911959; Sambisa W, 2010, AIDS CARE, V22, P170, DOI 10.1080/09540120903038374; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Staveteig S, 2013, DHS COMPARATIVE REPO; Survey TDaH, 2015, SURVEY TDAH DATA COL; The Demographic and Health Surveys, 2015, US DAT AN; UNAIDS, 2014, GAP REP; UNICEF, HIV AIDS DEF IND; USAID website, TECHN BRIEF HORM CON; Wang CC, 1999, J ACQ IMMUN DEF SYND, V21, P51, DOI 10.1097/00126334-199905010-00007; WELLER SC, 1993, SOC SCI MED, V36, P1635, DOI 10.1016/0277-9536(93)90352-5; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3; World Health Organization, 2012, PROGR RES CONS HORM; World Health Organization, 2015, FAM PLANN CONTR	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154213	10.1371/journal.pone.0154213	http://dx.doi.org/10.1371/journal.pone.0154213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27111915	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600049
J	Hornig, NC; de Beaufort, C; Denzer, F; Cools, M; Wabitsch, M; Ukat, M; Kulle, AE; Schweikert, HU; Werner, R; Hiort, O; Audi, L; Siebert, R; Ammerpohl, O; Holterhus, PM				Hornig, Nadine C.; de Beaufort, Carine; Denzer, Friederike; Cools, Martine; Wabitsch, Martin; Ukat, Martin; Kulle, Alexandra E.; Schweikert, Hans-Udo; Werner, Ralf; Hiort, Olaf; Audi, Laura; Siebert, Reiner; Ammerpohl, Ole; Holterhus, Paul-Martin			A Recurrent Germline Mutation in the 5'UTR of the Androgen Receptor Causes Complete Androgen Insensitivity by Activating Aberrant uORF Translation	PLOS ONE			English	Article							GENITAL SKIN FIBROBLASTS; OPEN READING FRAMES; SEX DEVELOPMENT; GENE-MUTATIONS; MESSENGER-RNA; IDENTIFICATION; TRANSCRIPTION; INITIATION; PHENOTYPE; CANCER	A subset of patients with monogenic disorders lacks disease causing mutations in the protein coding region of the corresponding gene. Here we describe a recurrent germline mutation found in two unrelated patients with complete androgen insensitivity syndrome (CAIS) generating an upstream open reading frame (uORF) in the 5' untranslated region (5'-UTR) of the androgen receptor (AR) gene. We show in patient derived primary genital skin fibroblasts as well as in cell-based reporter assays that this mutation severely impacts AR function by reducing AR protein levels without affecting AR mRNA levels. Importantly, the newly generated uORF translates into a polypeptide and the expression level of this polypeptide inversely correlates with protein translation from the primary ORF of the AR thereby providing a model for AR-5'UTR mediated translational repression. Our findings not only add a hitherto unrecognized genetic cause to complete androgen insensitivity but also underline the importance of 5'UTR mutations affecting uORFs for the pathogenesis of monogenic disorders in general.	[Hornig, Nadine C.; Ukat, Martin; Kulle, Alexandra E.; Holterhus, Paul-Martin] Univ Kiel, Dept Pediat, Div Pediat Endocrinol & Diabet, Campus Kiel, Kiel, Germany; [Hornig, Nadine C.; Ukat, Martin; Kulle, Alexandra E.; Siebert, Reiner; Ammerpohl, Ole; Holterhus, Paul-Martin] Univ Hosp Schleswig Holstein, Campus Kiel, Kiel, Germany; [de Beaufort, Carine] CH Luxembourg, Pediat Clin, Luxembourg, Luxembourg; [Denzer, Friederike; Wabitsch, Martin] Univ Ulm, Dept Pediat, Div Pediat Endocrinol & Diabetol, D-89069 Ulm, Germany; [Cools, Martine] Ghent Univ Hosp, Dept Pediat, Div Pediat Endocrinol, Ghent, Belgium; [Cools, Martine] Univ Ghent, B-9000 Ghent, Belgium; [Schweikert, Hans-Udo] Univ Bonn, Dept Med 3, Bonn, Germany; [Werner, Ralf; Hiort, Olaf] Med Univ Lubeck, Dept Pediat, Div Expt Pediat Endocrinol, D-23538 Lubeck, Germany; [Audi, Laura] Hosp Valle De Hebron, Vall dHebron Res Inst VHIR, Barcelona, Spain; [Audi, Laura] Ctr Biomed Res Network Rare Dis CIBERER, Barcelona, Spain; [Hornig, Nadine C.; Siebert, Reiner; Ammerpohl, Ole] Univ Kiel, Inst Human Genet, Campus Kiel, Kiel, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Ulm University; Ghent University; Ghent University Hospital; Ghent University; University of Bonn; University of Lubeck; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Kiel	Hornig, NC; Holterhus, PM (corresponding author), Univ Kiel, Dept Pediat, Div Pediat Endocrinol & Diabet, Campus Kiel, Kiel, Germany.; Hornig, NC; Holterhus, PM (corresponding author), Univ Hosp Schleswig Holstein, Campus Kiel, Kiel, Germany.; Hornig, NC (corresponding author), Univ Kiel, Inst Human Genet, Campus Kiel, Kiel, Germany.	nhornig@medgen.uni-kiel.de; holterhus@pediatrics.uni-kiel.de	Siebert, Reiner/A-8049-2010; de Beaufort, Carine/AAJ-8063-2021; Cools, Martine/J-4580-2012; Ammerpohl, Ole/G-2691-2010; Hornig, Nadine/AAO-2648-2021	de Beaufort, Carine/0000-0003-4310-6799; Cools, Martine/0000-0002-9552-4899; Werner, Ralf/0000-0003-3718-3595	Medical Faculty of the Christian-Albrechts-University, CAU, Kiel, Germany (Forschungsforderung - Anschub); German Research Council (Deutsche Forschungsgemeinschaft, DFG) [Ho2073/7-1/7-3, AM 343/2-1/2-3]	Medical Faculty of the Christian-Albrechts-University, CAU, Kiel, Germany (Forschungsforderung - Anschub); German Research Council (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	The study has been funded by the Medical Faculty of the Christian-Albrechts-University, CAU, Kiel, Germany (Forschungsforderung 2015 - Anschub to NH) and the German Research Council (Deutsche Forschungsgemeinschaft, DFG) (Ho2073/7-1/7-3 to PMH and AM 343/2-1/2-3 to OA). The authors thank the KinderKrebsInitiative Buchholz/Holm-Seppensen for providing infrastructure.	Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Appari M, 2009, J MOL MED, V87, P623, DOI 10.1007/s00109-009-0462-3; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Audi L, 2010, J CLIN ENDOCR METAB, V95, P1876, DOI 10.1210/jc.2009-2146; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Crocitto LE, 1997, J UROLOGY, V158, P1599, DOI 10.1016/S0022-5347(01)64287-3; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Deeb A, 2005, CLIN ENDOCRINOL, V63, P56, DOI 10.1111/j.1365-2265.2005.02298.x; Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046; Hiort O, 2014, NAT REV ENDOCRINOL, V10, P520, DOI 10.1038/nrendo.2014.108; Holterhus PM, 1997, J CLIN ENDOCR METAB, V82, P3584, DOI 10.1210/jc.82.11.3584; Jaaskelainen J, 2012, MOL CELL ENDOCRINOL, V352, P4, DOI 10.1016/j.mce.2011.08.006; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Liegibel UM, 2003, STEROIDS, V68, P1179, DOI 10.1016/j.steroids.2003.08.016; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; MIZOKAMI A, 1994, J BIOL CHEM, V269, P25655; Mongan NP, 2015, BEST PRACT RES CL EN, V29, P569, DOI 10.1016/j.beem.2015.04.005; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; Peters KM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-132; Ramalingam P, 2014, RNA, V20, P76, DOI 10.1261/rna.041814.113; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005; Werner R, 2014, ENDOCR DEV, V27, P28, DOI 10.1159/000363610; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; WILSON CM, 1994, P NATL ACAD SCI USA, V91, P1234, DOI 10.1073/pnas.91.4.1234; ZOPPI S, 1993, J CLIN INVEST, V91, P1105, DOI 10.1172/JCI116269	29	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154158	10.1371/journal.pone.0154158	http://dx.doi.org/10.1371/journal.pone.0154158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110943	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600040
J	Zhang, XM; Zhou, YF; Xu, MM; Chen, G				Zhang, Xiaoming; Zhou, Youfa; Xu, Mingmin; Chen, Gang			Autophagy Is Involved in the Sevoflurane Anesthesia-Induced Cognitive Dysfunction of Aged Rats	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES	Autophagy is associated with regulation of both the survival and death of neurons, and has been linked to many neurodegenerative diseases. Postoperative cognitive dysfunction is commonly observed in elderly patients following anesthesia, but the pathophysiological mechanisms are largely unexplored. Similar effects have been found in aged rats under sevoflurane anesthesia; however, the role of autophagy in sevoflurane anesthesia-induced hippocampal neuron apoptosis of older rats remains elusive. The present study was designed to investigate the effects of autophagy on the sevoflurane-induced cognitive dysfunction in aged rats, and to identify the role of autophagy in sevoflurane-induced neuron apoptosis. We used 20-month-old rats under sevoflurane anesthesia to study memory performance, neuron apoptosis, and autophagy. The results demonstrated that sevoflurane anesthesia significantly impaired memory performance and induced hippocampal neuron apoptosis. Interestingly, treatment of rapamycin, an autophagy inducer, improved the cognitive deficit observed in the aged rats under sevoflurane anesthesia by improving autophagic flux. Rapamycin treatment led to the rapid accumulation of autophagic bodies and autophagy lysosomes, decreased p62 protein levels, and increased the ratio of microtubule-associated protein light chain 3 II (LC3-II) to LC3-I in hippocampal neurons through the mTOR signaling pathway. However, administration of an autophagy inhibitor (chloroquine) attenuated the autophagic flux and increased the severity of sevoflurane anesthesia-induced neuronal apoptosis and memory impairment. These findings suggest that impaired autophagy in the hippocampal neurons of aged rats after sevoflurane anesthesia may contribute to cognitive impairment. Therefore, our findings represent a potential novel target for proautophagy treatments in patients with sevoflurane anesthesia-induced neurodegeneration.	[Zhang, Xiaoming; Xu, Mingmin] Zhejiang Univ, Sch Med, Dept Anat & Cell Biol, Hangzhou, Peoples R China; [Zhou, Youfa; Chen, Gang] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Mingmin] First Hosp Jiaxing City, Dept Anesthesiol, Jiaxing, Peoples R China	Zhejiang University; Zhejiang University	Chen, G (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China.	dctor_gangchen@163.com			National Natural Science Foundation of China [81371214]; Zhejiang Provincial Natural Science Foundation of China [LY12H09005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The paper was supported by grants from the National Natural Science Foundation of China (No. 81371214) and Zhejiang Provincial Natural Science Foundation of China (No. LY12H09005).	Booth LA, 2014, CELL SIGNAL, V26, P549, DOI 10.1016/j.cellsig.2013.11.028; Cai N, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-28; Carroll B, 2015, AMINO ACIDS, V47, P2065, DOI 10.1007/s00726-014-1775-2; Castets P, 2013, AUTOPHAGY, V9, P1435, DOI 10.4161/auto.25722; Chang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081095; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057870; Coburn M, 2010, ANAESTHESIST, V59, P177, DOI 10.1007/s00101-009-1657-2; Fernandez AF, 2015, J CLIN INVEST, V125, P33, DOI 10.1172/JCI73940; Hu FL, 2014, APOPTOSIS, V19, P210, DOI 10.1007/s10495-013-0914-7; Kiriyama Y, 2015, INT J MOL SCI, V16, P26797, DOI 10.3390/ijms161125990; Liu YZ, 2013, AM J MED SCI, V345, P355, DOI 10.1097/MAJ.0b013e31825a674d; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mufson EJ, 2015, NEUROSCIENCE, V309, P51, DOI 10.1016/j.neuroscience.2015.03.006; Nah J, 2015, MOL CELLS, V38, P381, DOI 10.14348/molcells.2015.0034; Newton PT, 2015, AUTOPHAGY, V11, P1594, DOI 10.1080/15548627.2015.1068489; Nijholt DAT, 2011, CELL DEATH DIFFER, V18, P1071, DOI 10.1038/cdd.2010.176; Papackova Z, 2014, PHYSIOL RES, V63, P409, DOI 10.33549/physiolres.932684; Passot JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032560; Qiao Y, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0130-9; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Shoair Osama A, 2015, J Anaesthesiol Clin Pharmacol, V31, P30, DOI 10.4103/0970-9185.150530; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tao H, 2014, MED SCI MONITOR, V20, P1902, DOI [10.12659/MSM.892271, 10.12659/MSM.892485]; Viiri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069563; Xiong WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079408; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	26	32	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153505	10.1371/journal.pone.0153505	http://dx.doi.org/10.1371/journal.pone.0153505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111854	gold, Green Published, Green Submitted			2022-12-27	WOS:000374970600016
J	Liang, CT; Huang, HB; Wang, CC; Chen, YR; Chang, CF; Shiao, MS; Chen, YC; Lin, TH				Liang, Chu-Ting; Huang, Hsien-Bin; Wang, Chih-Ching; Chen, Yi-Ru; Chang, Chi-Fon; Shiao, Ming-Shi; Chen, Yi-Cheng; Lin, Ta-Hsien			L17A/F19A Substitutions Augment the alpha-Helicity of beta-Amyloid Peptide Discordant Segment	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; FIBRIL-FORMING PROTEINS; SOLID-STATE NMR; ALZHEIMERS-DISEASE; CHEMICAL-SHIFTS; AGGREGATION; NEUROTOXICITY; DOMAIN	beta-amyloid peptide (A beta) aggregation has been thought to be associated with the pathogenesis of Alzheimer's disease. Recently, we showed that L17A/F19A substitutions may increase the structural stability of wild-type and Arctic-type A beta(40) and decrease the rates of structural conversion and fibril formation. However, the underlying mechanism for the increase of structural stability as a result of the alanine substitutions remained elusive. In this study, we apply nuclear magnetic resonance and circular dichroism spectroscopies to characterize the A beta(40) structure, demonstrating that L17A/F19A substitutions can augment the alpha-helicity of the residues located in the alpha/beta-discordant segment (resides 15 to 23) of both wild-type and Arctic-type A beta(40). These results provide a structural basis to link the alpha-helicity of the alpha/beta-discordant/beta-discordant segment with the conformational conversion propensity of A beta.	[Liang, Chu-Ting; Lin, Ta-Hsien] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Liang, Chu-Ting; Lin, Ta-Hsien] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Liang, Chu-Ting; Lin, Ta-Hsien] Taipei Vet Gen Hosp, Basic Res Div, Dept Med Res, Taipei, Taiwan; [Huang, Hsien-Bin] Natl Chung Cheng Univ, Dept Life Sci, Chiayi 621, Taiwan; [Huang, Hsien-Bin] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi 621, Taiwan; [Wang, Chih-Ching; Chen, Yi-Ru; Lin, Ta-Hsien] Natl Yang Ming Univ, Struct Biol Program, Taipei 112, Taiwan; [Wang, Chih-Ching; Lin, Ta-Hsien] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Chen, Yi-Ru] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Chang, Chi-Fon] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Shiao, Ming-Shi] Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan; [Chen, Yi-Cheng] Mackay Med Coll, Dept Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Chung Cheng University; National Chung Cheng University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Chang Gung University; Mackay Medical College	Lin, TH (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.; Lin, TH (corresponding author), Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan.; Lin, TH (corresponding author), Taipei Vet Gen Hosp, Basic Res Div, Dept Med Res, Taipei, Taiwan.; Lin, TH (corresponding author), Natl Yang Ming Univ, Struct Biol Program, Taipei 112, Taiwan.; Lin, TH (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.; Chen, YC (corresponding author), Mackay Med Coll, Dept Med, Taipei, Taiwan.	chen15@mmc.edu.tw; thlin@vghtpe.gov.tw		Chang, Chi-Fon/0000-0002-2961-0748	National Science Council of the Republic of China [NSC99-2320-B-194-003-MY3, NSC101-2113-M-010-003-MY2, MOST103-2113-M-010-002]; Taipei Veterans General Hospital, Taiwan, ROC [V100C-180, V101C-003, V102C-037]; Ministry of Education, Aiming for the Top University Plan	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taiwan, ROC(Taipei Veterans General Hospital); Ministry of Education, Aiming for the Top University Plan	This work was supported by grants from the National Science Council of the Republic of China (NSC99-2320-B-194-003-MY3, NSC101-2113-M-010-003-MY2 and MOST103-2113-M-010-002), Taipei Veterans General Hospital, Taiwan, ROC (V100C-180, V101C-003 and V102C-037) and a grant from Ministry of Education, Aiming for the Top University Plan.	Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Carter MD, 2010, CLIN PHARMACOL THER, V88, P475, DOI 10.1038/clpt.2010.165; Chen YR, 2011, BIOCHEM BIOPH RES CO, V405, P91, DOI 10.1016/j.bbrc.2010.12.133; [陈颖 Chen Ying], 2013, [广东农业科学, Guangdong Agricultural Sciences], V40, P8; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Dyson HJ, 1998, NAT STRUCT BIOL, V5, P499, DOI 10.1038/739; Esler WP, 1996, BIOCHEMISTRY-US, V35, P13914, DOI 10.1021/bi961302+; Findeis MA, 2000, BBA-MOL BASIS DIS, V1502, P76, DOI 10.1016/S0925-4439(00)00034-X; Funke SA, 2012, CURR PHARM DESIGN, V18, P755; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Jana AK, 2013, PHYS CHEM CHEM PHYS, V15, P837, DOI 10.1039/c2cp42933k; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kumar J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129087; Kumar J, 2014, PRION, V8, P118, DOI 10.4161/pri.28220; Lee EK, 2005, PROTEIN EXPRES PURIF, V40, P183, DOI 10.1016/j.pep.2004.12.014; Lo CJ, 2015, AMYLOID, V22, P8, DOI 10.3109/13506129.2014.980943; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Morimoto A, 2002, BIOCHEM BIOPH RES CO, V295, P306, DOI 10.1016/S0006-291X(02)00670-8; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; Parthasarathy S, 2015, J AM CHEM SOC, V137, P6480, DOI 10.1021/jacs.5b03373; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Song YL, 2014, J AM CHEM SOC, V136, P4093, DOI 10.1021/ja4114374; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Wang CC, 2012, J BIOMOL STRUCT DYN, V30, P160, DOI 10.1080/07391102.2012.677767; Weinstock DS, 2008, PROTEIN SCI, V17, P950, DOI 10.1110/ps.073365408; WISHART DS, 1994, J BIOMOL NMR, V4, P171	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154327	10.1371/journal.pone.0154327	http://dx.doi.org/10.1371/journal.pone.0154327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104649	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100067
J	Cao, B; Christophersen, L; Kolpen, M; Jensen, PO; Sneppen, K; Hoiby, N; Moser, C; Sams, T				Cao, Bao; Christophersen, Lars; Kolpen, Mette; Jensen, Peter Ostrup; Sneppen, Kim; Hoiby, Niels; Moser, Claus; Sams, Thomas			Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm Model	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; INFLAMMATORY RESPONSE; LUNG INFECTION; BACTERIAL; GELS; EXOPOLYSACCHARIDE; PHARMACOKINETICS; PENETRATION; STRATEGIES	Microbial cells embedded in a self-produced extracellular biofilm matrix cause chronic infections, e. g. by Pseudomonas aeruginosa in the lungs of cystic fibrosis patients. The antibiotic killing of bacteria in biofilms is generally known to be reduced by 100-1000 times relative to planktonic bacteria. This makes such infections difficult to treat. We have therefore proposed that biofilms can be regarded as an independent compartment with distinct pharmacokinetics. To elucidate this pharmacokinetics we have measured the penetration of the tobramycin into seaweed alginate beads which serve as a model of the extracellular polysaccharide matrix in P. aeruginosa biofilm. We find that, rather than a normal first order saturation curve, the concentration of tobramycin in the alginate beads follows a power-law as a function of the external concentration. Further, the tobramycin is observed to be uniformly distributed throughout the volume of the alginate bead. The power-law appears to be a consequence of binding to a multitude of different binding sites. In a diffusion model these results are shown to produce pronounced retardation of the penetration of tobramycin into the biofilm. This filtering of the free tobramycin concentration inside biofilm beads is expected to aid in augmenting the survival probability of bacteria residing in the biofilm.	[Cao, Bao; Christophersen, Lars; Kolpen, Mette; Jensen, Peter Ostrup; Hoiby, Niels; Moser, Claus] Rigshosp, Copenhagen Univ Hosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Kolpen, Mette; Hoiby, Niels] Univ Copenhagen, Dept Immunol & Microbiol, UC CARE, Fac Hlth Sci, DK-2200 Copenhagen, Denmark; [Sneppen, Kim] Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark; [Sams, Thomas] Tech Univ Denmark, Dept Elect Engn, Biomed Engn, DK-2800 Lyngby, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Niels Bohr Institute; Technical University of Denmark	Sams, T (corresponding author), Tech Univ Denmark, Dept Elect Engn, Biomed Engn, DK-2800 Lyngby, Denmark.	tsams@dtu.dk	Jensen, Peter Ostrup/HGD-7725-2022; Sams, Thomas/A-9781-2014; Moser, Claus Ernst/GPK-5546-2022; Moser, Claus Ernst/N-5951-2017	Sams, Thomas/0000-0002-6316-2539; Moser, Claus Ernst/0000-0002-7664-8570; Moser, Claus Ernst/0000-0002-7664-8570; Jensen, Peter Ostrup/0000-0003-1648-7186; Sneppen, Kim/0000-0001-9820-3567; Hoiby, Niels/0000-0002-1347-725X; Kolpen, Mette/0000-0001-5575-0384				[Anonymous], 2015, MATLAB VERSION 8 6 0; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; BROWN W, 1981, POLYMER, V22, P185, DOI 10.1016/0032-3861(81)90196-8; Cao B, 2015, J ANTIMICROB CHEMOTH, V70, P2057, DOI 10.1093/jac/dkv058; Christophersen LJ, 2012, CLIN EXP IMMUNOL, V170, P222, DOI 10.1111/j.1365-2249.2012.04652.x; Demczar DJ, 1997, ANTIMICROB AGENTS CH, V41, P1115, DOI 10.1128/AAC.41.5.1115; Ferkinghoff-Borg J, 2014, MOL BIOSYST, V10, P103, DOI 10.1039/c3mb70230h; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; GORDON CA, 1988, J ANTIMICROB CHEMOTH, V22, P667, DOI 10.1093/jac/22.5.667; Hennig S, 2013, CLIN PHARMACOKINET, V52, P289, DOI 10.1007/s40262-013-0036-y; Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1128/AAC.49.6.2467-2473.2005; Lorain Victor, 2005, ANTIBIOTICS LAB MED; MACKIE JS, 1955, PROC R SOC LON SER-A, V232, P498, DOI 10.1098/rspa.1955.0234; MUHR AH, 1982, POLYMER, V23, P1012, DOI 10.1016/0032-3861(82)90402-5; NICHOLS WW, 1988, ANTIMICROB AGENTS CH, V32, P518, DOI 10.1128/AAC.32.4.518; PEDERSEN SS, 1990, INFECT IMMUN, V58, P3363, DOI 10.1128/IAI.58.10.3363-3368.1990; PEDERSEN SS, 1990, APMIS, V98, P203, DOI 10.1111/j.1699-0463.1990.tb01023.x; SKEEL RD, 1990, SIAM J SCI STAT COMP, V11, P1, DOI 10.1137/0911001; Sneppen K., 2014, MODELS OF LIFE; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; STEWART PS, 1993, APPL ENVIRON MICROB, V59, P327, DOI 10.1128/AEM.59.1.327-329.1993; Stoodley P, 1999, BIOTECHNOL BIOENG, V65, P83, DOI 10.1002/(SICI)1097-0290(19991005)65:1<83::AID-BIT10>3.0.CO;2-B; Sun FJ, 2013, FUTURE MICROBIOL, V8, P877, DOI 10.2217/fmb.13.58; Szomolay B, 2005, ENVIRON MICROBIOL, V7, P1186, DOI 10.1111/j.1462-2920.2005.00797.x; TANNENBAUM CS, 1984, ANTIMICROB AGENTS CH, V25, P673, DOI 10.1128/AAC.25.6.673; Tseng BS, 2013, ENVIRON MICROBIOL, V15, P2865, DOI 10.1111/1462-2920.12155; Van Acker H, 2014, TRENDS MICROBIOL, V22, P326, DOI 10.1016/j.tim.2014.02.001; WESTRIN BA, 1991, BIOTECHNOL BIOENG, V38, P439, DOI 10.1002/bit.260380502	28	33	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153616	10.1371/journal.pone.0153616	http://dx.doi.org/10.1371/journal.pone.0153616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100887	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500044
J	Eriksson, J; Langel, U				Eriksson, Jonas; Langel, Ulo			Quantitative Microplate Assay for Real-Time Nuclease Kinetics	PLOS ONE			English	Article							INORGANIC-PHOSPHATE; EXONUCLEASE-III; RNA; ENZYME	Utilizing the phenomenon of nucleases exposing oligonucleotide phosphate backbones to phosphatases we present a novel quantitative method for kinetics of nuclease catalysis. Inorganic phosphate released from nuclease products by phosphatases could be quantified in real-time by a fluorescent sensor of inorganic phosphate. Two different nucleases were employed, showing the versatility of this assay for multiple turnover label-free nuclease studies.	[Eriksson, Jonas; Langel, Ulo] Stockholm Univ, Dept Neurochem, S-10691 Stockholm, Sweden	Stockholm University	Eriksson, J (corresponding author), Stockholm Univ, Dept Neurochem, S-10691 Stockholm, Sweden.	jonas.eriksson@neurochem.su.se	Langel, Ulo/K-9773-2018	Eriksson, Jonas/0000-0001-8813-1096; Langel, Ulo/0000-0001-6107-0844	Swedish Research Council for Natural Sciences [621-2011-5902]; Swedish Research Council for Medical Research [K2012-66X-21148-04-5]; Swedish Cancer Society [CAN 2012/251]	Swedish Research Council for Natural Sciences; Swedish Research Council for Medical Research; Swedish Cancer Society(Swedish Cancer Society)	This work was supported by grants to UL from the Swedish Research Council for Natural Sciences (621-2011-5902), the Swedish Research Council for Medical Research (K2012-66X-21148-04-5) and the Swedish Cancer Society (CAN 2012/251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CHOU KC, 1994, ANAL BIOCHEM, V221, P217, DOI 10.1006/abio.1994.1405; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; CUATRECA.P, 1967, J BIOL CHEM, V242, P1541; Das U, 2013, NUCLEIC ACIDS RES, V41, P355, DOI 10.1093/nar/gks977; DUSSOIX D, 1962, J MOL BIOL, V5, P37, DOI 10.1016/S0022-2836(62)80059-X; Eriksson J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135984; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kay HD, 1929, BRIT J EXP PATHOL, V10, P253; Lee J, 2012, ANALYST, V137, P2024, DOI 10.1039/c2an16214h; Li J J, 2000, Nucleic Acids Res, V28, pE52, DOI 10.1093/nar/28.11.e52; LINXWEILER W, 1982, NUCLEIC ACIDS RES, V10, P4845, DOI 10.1093/nar/10.16.4845; Liu L, 2013, TALANTA, V115, P819, DOI 10.1016/j.talanta.2013.06.062; LOWRY OH, 1946, J BIOL CHEM, V162, P421; Mei SHJ, 2003, J AM CHEM SOC, V125, P412, DOI 10.1021/ja0281232; Michaelis L, 1913, BIOCHEM Z, V49, P333; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Morse DP, 1997, BIOCHEMISTRY-US, V36, P8429, DOI 10.1021/bi9709607; Mouratou B, 2002, ANAL BIOCHEM, V309, P40, DOI 10.1016/S0003-2697(02)00272-5; Nixon AE, 1998, ANAL BIOCHEM, V265, P299, DOI 10.1006/abio.1998.2916; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; SHAK S, 1990, P NATL ACAD SCI USA, V87, P9188, DOI 10.1073/pnas.87.23.9188; THOMAS KR, 1978, J BIOL CHEM, V253, P424; Wang LH, 2015, ANAL BIOCHEM, V468, P34, DOI 10.1016/j.ab.2014.09.011; Xu QF, 2012, ANAL CHEM, V84, P10845, DOI 10.1021/ac303095z	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154099	10.1371/journal.pone.0154099	http://dx.doi.org/10.1371/journal.pone.0154099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101307	Green Published, gold			2022-12-27	WOS:000374898500143
J	Nonnemacher, MR; Pirrone, V; Feng, R; Moldover, B; Passic, S; Aiamkitsumrit, B; Dampier, W; Wojno, A; Kilareski, E; Blakey, B; Ku, TSJ; Shah, S; Sullivan, NT; Jacobson, JM; Wigdahl, B				Nonnemacher, Michael R.; Pirrone, Vanessa; Feng, Rui; Moldover, Brian; Passic, Shendra; Aiamkitsumrit, Benjamas; Dampier, Will; Wojno, Adam; Kilareski, Evelyn; Blakey, Brandon; Ku, Tse-Sheun Jade; Shah, Sonia; Sullivan, Neil T.; Jacobson, Jeffrey M.; Wigdahl, Brian			HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; NEGATIVE REGULATORY ELEMENT; CENTRAL-NERVOUS-SYSTEM; SEQUENCE CONFIGURATIONS; BIOLOGICAL PHENOTYPE; MICROGLIAL CELLS; WIDE-RANGE; TYPE-1; INFECTION	The large majority of human immunodeficiency virus type 1 (HIV-1) markers of disease progression/severity previously identified have been associated with alterations in host genetic and immune responses, with few studies focused on viral genetic markers correlate with changes in disease severity. This study presents a cross-sectional/longitudinal study of HIV-1 single nucleotide polymorphisms (SNPs) contained within the viral promoter or long terminal repeat (LTR)in patients within the Drexel Medicine CNS AIDS Research and Eradication Study (CARES) Cohort. HIV-1 LTR SNPs were found to associate with the classical clinical disease parameters CD4(+) T-cell count and log viral load. They were found in both defined and undefined transcription factor binding sites of the LTR. A novel SNP identified at position 108 in a known COUP (chicken ovalbumin upstream promoter)/AP1 transcription factor binding site was significantly correlated with binding phenotypes that are potentially the underlying cause of the associated clinical outcome (increase in viral load and decrease in CD4(+) T-cell count).	[Nonnemacher, Michael R.; Pirrone, Vanessa; Passic, Shendra; Aiamkitsumrit, Benjamas; Dampier, Will; Wojno, Adam; Kilareski, Evelyn; Blakey, Brandon; Ku, Tse-Sheun Jade; Shah, Sonia; Sullivan, Neil T.; Jacobson, Jeffrey M.; Wigdahl, Brian] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Nonnemacher, Michael R.; Pirrone, Vanessa; Passic, Shendra; Aiamkitsumrit, Benjamas; Dampier, Will; Wojno, Adam; Kilareski, Evelyn; Blakey, Brandon; Ku, Tse-Sheun Jade; Shah, Sonia; Sullivan, Neil T.; Jacobson, Jeffrey M.; Wigdahl, Brian] Drexel Univ, Coll Med, Ctr Mol Virol & Translat Neurosci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA; [Feng, Rui] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Moldover, Brian] B Tech Consulting Ltd, Philadelphia, PA USA; [Jacobson, Jeffrey M.; Wigdahl, Brian] Drexel Univ, Ctr Clin & Translat Med, Inst Mol Med & Infect Dis, Coll Med, Philadelphia, PA 19104 USA; [Jacobson, Jeffrey M.] Drexel Univ, Div Infect Dis & HIV Med, Dept Med, Coll Med, Philadelphia, PA 19104 USA	Drexel University; Drexel University; University of Pennsylvania; Pennsylvania Medicine; Drexel University; Drexel University	Wigdahl, B (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.; Wigdahl, B (corresponding author), Drexel Univ, Coll Med, Ctr Mol Virol & Translat Neurosci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA.; Wigdahl, B (corresponding author), Drexel Univ, Ctr Clin & Translat Med, Inst Mol Med & Infect Dis, Coll Med, Philadelphia, PA 19104 USA.	bwigdahl@drexelmed.edu		Sullivan, Neil/0000-0002-4589-9182	Public Health Service; National Institutes of Health through the National Institute of Neurological Disorders and Stroke [NS32092, NS46263]; National Institute of Drug Abuse [DA19807]; National Institute for Mental Health under the Ruth L. Kirschstein National Research Service [5T32MH079785]; B-Tech Consulting; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH079785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046263, R01NS032092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019807] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health through the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute for Mental Health under the Ruth L. Kirschstein National Research Service; B-Tech Consulting; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were funded in part by the Public Health Service, National Institutes of Health through grants from the National Institute of Neurological Disorders and Stroke, NS32092 and NS46263, the National Institute of Drug Abuse, DA19807 (Dr. Brian Wigdahl, Principal Investigator), and from the National Institute for Mental Health under the Ruth L. Kirschstein National Research Service Award 5T32MH079785. Brian Moldover receives a salary from B-Tech Consulting; the specific role of this author is articulated in the Author Contributions section. These contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKHALED M, 1995, AIDS, V9, P675, DOI 10.1097/00002030-199507000-00002; AITKHALED M, 1994, J GEN VIROL, V75, P1615, DOI 10.1099/0022-1317-75-7-1615; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bartlett JG, 2005, CHARGE TRANSFER DNA, P1; Bhatia R, 2005, GUIDELINES HIV DIAGN; BOZZETTE SA, 1993, J INFECT DIS, V168, P1374, DOI 10.1093/infdis/168.6.1374; Bracho MA, 1998, J GEN VIROL, V79, P2921, DOI 10.1099/0022-1317-79-12-2921; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Burdo TH, 2004, J NEUROVIROL, V10, P7, DOI [10.1080/753312746, 10.1080/13550280490270789]; Burdo TH, 2004, DNA CELL BIOL, V23, P261, DOI 10.1089/104454904773819842; CANONNEHERGAUX F, 1995, J VIROL, V69, P6634, DOI 10.1128/JVI.69.11.6634-6642.1995; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; CONNOR RI, 1993, J VIROL, V67, P1772, DOI 10.1128/JVI.67.4.1772-1777.1993; COONEY AJ, 1991, J VIROL, V65, P2853, DOI 10.1128/JVI.65.6.2853-2860.1991; CORBOY JR, 1992, SCIENCE, V258, P1804, DOI 10.1126/science.1465618; CULLEN BR, 1991, ANNU REV MICROBIOL, V45, P219; Dahiya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088116; DELASSUS S, 1991, J VIROL, V65, P225, DOI 10.1128/JVI.65.1.225-231.1991; Dunfee RL, 2006, P NATL ACAD SCI USA, V103, P15160, DOI 10.1073/pnas.0605513103; Estable MC, 1996, J VIROL, V70, P4053, DOI 10.1128/JVI.70.6.4053-4062.1996; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2011, J INFECT DIS, V203, P773, DOI 10.1093/infdis/jiq125; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Hogan TH, 2003, J NEUROVIROL, V9, P55, DOI 10.1080/13550280390173292; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Kingsman SM, 1996, EUR J BIOCHEM, V240, P491, DOI 10.1111/j.1432-1033.1996.0491h.x; Kirchhoff F, 1997, VIROLOGY, V232, P319, DOI 10.1006/viro.1997.8586; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; KOOT M, 1992, AIDS, V6, P49, DOI 10.1097/00002030-199201000-00006; LADIAS JAA, 1994, J BIOL CHEM, V269, P5944; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li LN, 2011, J NEUROVIROL, V17, P92, DOI 10.1007/s13365-010-0014-1; Lingappa JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028632; LU YC, 1990, J VIROL, V64, P5226, DOI 10.1128/JVI.64.10.5226-5229.1990; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; MICHAEL NL, 1994, J VIROL, V68, P3163, DOI 10.1128/JVI.68.5.3163-3174.1994; Naggie S, 2012, J INFECT DIS, V205, P376, DOI 10.1093/infdis/jir754; NIELSEN C, 1993, AIDS, V7, P1035, DOI 10.1097/00002030-199308000-00002; Nonnemacher MR, 2004, J NEUROIMMUNOL, V157, P39, DOI 10.1016/j.jneuroim.2004.08.021; ORCHARD K, 1992, NUCLEIC ACIDS RES, V20, P5429, DOI 10.1093/nar/20.20.5429; ORCHARD K, 1990, J VIROL, V64, P3234, DOI 10.1128/JVI.64.7.3234-3239.1990; PANG S, 1992, AIDS, V6, P453, DOI 10.1097/00002030-199205000-00003; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pelak K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001208; Petrovski S, 2011, AIDS, V25, P513, DOI 10.1097/QAD.0b013e328343817b; Pirrone V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/548749; Poon AFY, 2010, MOL BIOL EVOL, V27, P819, DOI 10.1093/molbev/msp289; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rallon NI, 2011, AIDS, V25, P269, DOI 10.1097/QAD.0b013e328341b84e; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Rohr O, 1997, J BIOL CHEM, V272, P31149, DOI 10.1074/jbc.272.49.31149; Ross HL, 2001, J NEUROVIROL, V7, P235; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schwartz GW, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/3/035005; Shah S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/320642; Shea PR, 2013, ANNU REV MED, V64, P203, DOI 10.1146/annurev-med-052511-135400; Shi J, 2015, J VIROL, V89, P208, DOI 10.1128/JVI.01411-14; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; van Manen D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-70; Verbeke G, 2000, LINEAR MIXED MODELS; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	65	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0150835	10.1371/journal.pone.0150835	http://dx.doi.org/10.1371/journal.pone.0150835			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100290	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500004
J	Rizk, HH; Hamdy, NM; Al-Ansari, NL; El-Mesallamy, HO				Rizk, Hanan H.; Hamdy, Nadia M.; Al-Ansari, Nadia L.; El-Mesallamy, Hala O.			Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; RIBAVIRIN TREATMENT; INSULIN-RESISTANCE; EXPRESSION LEVELS; PLUS RIBAVIRIN; VIRUS; IL28B; PD-1; INFECTION; CTLA-4	Background Egypt has the highest prevalence of a difficult to treat chronic hepatitis C virus (HCV), genotype 4. Pretreatment factors could guide individualization of therapy which aids in treatment optimization and interleukin IL28B gene polymorphism has been shown to closely relate to HCV treatment response. Polymorphisms in genes encoding inhibitors of T-cell response, which have role in disease progression as Programmed Cell Death 1 (PD-1), and Cytotoxic T-Lymphocytes Antigen-4 (CTLA-4), could be candidate markers predicting treatment response. Methods This cohort study consisted of 200 chronic HCV genotype 4 infected patients treated with PegIFN alpha-2a and RBV in 2 hepatology centers. Genotyping of the polymorphisms in the IL28B gene region (rs12979860), PD1.3 (rs11568821) and CTLA-4 (rs231775) was performed on DNA collected from each patient using TaqMan (R) genotyping assay. Groups were classified according to response into sustained virological responders (SVR), or non-responders (NR). A multivariate logistic regression analysis was used to identify potential markers, host pretreatment clinical and viral predictive factors including viral load, insulin resistance, and alpha fetoprotein (AFP) related to treatment response. Results Our results showed that in a multivariate analyses IL28B C/C genotype was the most significant predictor for SVR (OR = 10.86; p<0.0001) followed by AFP (OR = 0.915; p = 0.001) then CTLA-4/G genotypes (OR = 1.948; p = 0.022). However, PD-1.3/A genotypes and platelets count were significantly related to response in univariate analysis only (OR = 1.973; p = 0.023; OR = 1.007; p = 0.009 respectively). Conclusion IL28B SNP, AFP level, and CTLA-4 SNP could be used in conjunction to predict treatment response in HCV genotype 4 infected Egyptian patients.	[Rizk, Hanan H.; Hamdy, Nadia M.; El-Mesallamy, Hala O.] Ain Shams Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Al-Ansari, Nadia L.] Ain Shams Univ, Fac Med, Endem Med Dept & Hepatol Unit, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University	El-Mesallamy, HO (corresponding author), Ain Shams Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.	hala.elmesallamy@hotmail.com	Hamdy, Nadia/AAB-6087-2021	Hamdy, Nadia/0000-0003-2105-107X				Abdoul H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002391; Aggour S., 2015, DAILY NEWS EGYPT; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Barth H, 2015, WORLD J HEPATOL, V7, P725, DOI 10.4254/wjh.v7.i5.725; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Danilovic DLS, 2012, LIVER INT, V32, P803, DOI 10.1111/j.1478-3231.2011.02694.x; De Nicola S, 2012, HEPATOLOGY, V55, P336, DOI 10.1002/hep.24683; Sabaawy D, 2015, APMIS, V123, P482, DOI 10.1111/apm.12377; El Sayed Nasr, 2012, Morbidity and Mortality Weekly Report, V61, P545; Estrabaud E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121395; Feeney ER, 2014, BMJ-BRIT MED J, V348, P3308; Ford N, 2012, B WORLD HEALTH ORGAN, V90, P540, DOI 10.2471/BLT.11.097147; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hayes CN, 2012, NAT REV GASTRO HEPAT, V9, P406, DOI 10.1038/nrgastro.2012.101; Intlekofer AM, 2013, J LEUKOCYTE BIOL, V94, P25, DOI 10.1189/jlb.1212621; Kamal-Yanni M, 2015, LANCET GLOB HEALTH, V3, pE73, DOI 10.1016/S2214-109X(14)70365-1; Kanda T, 2013, WORLD J HEPATOL, V5, P182, DOI 10.4254/wjh.v5.i4.182; Khairy M, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10509; Khudayberganova D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093011; Kristjansdottir H, 2010, ARTHRITIS RHEUM-US, V62, P1702, DOI 10.1002/art.27417; Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514; LEE YH, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1039/C4CC06435F); Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; Matas M, 2014, INT MICROBIOL, V17, P11, DOI 10.2436/20.1501.01.203; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107; Newby PR, 2007, CLIN ENDOCRINOL, V67, P125, DOI 10.1111/j.1365-2265.2007.02848.x; O'Brien TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020904; Ogawa E, 2012, J HEPATOL, V56, pS474, DOI 10.1016/S0168-8278(12)61209-4; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pawlotsky JM, 2014, J HEPATOL, V61, P373, DOI 10.1016/j.jhep.2014.05.001; Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015; Vidal-Castineira JR, 2012, J HEPATOL, V56, P1230, DOI 10.1016/j.jhep.2012.01.011; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Saleh HM, 2009, IRAN J PUBLIC HEALTH, V38, P56; Shehab H, 2014, J INTERF CYTOK RES, V34, P727, DOI 10.1089/jir.2013.0127; Smith KR, 2011, GENOME MED, P3; Strahotin CS, 2012, ADV VIROL, V2012, DOI 10.1155/2012/267483; Tachi Y, 2016, J GASTROEN HEPATOL, V31, P1001, DOI 10.1111/jgh.13245; Tipu I, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.15076; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Wang L, 2014, BIOMED REP, V2, P270, DOI 10.3892/br.2014.217; Wang XB, 2008, J INTERN MED, V263, P61, DOI 10.1111/j.1365-2796.2007.01879.x; World Health Organization, 2015, HEP C; Yee LJ, 2003, J INFECT DIS, V187, P1264, DOI 10.1086/374561; Younossi ZM, 2012, J TRANSL MED, V7, P10; Youssef SS, 2014, J INTERF CYTOK RES, V34, P505, DOI 10.1089/jir.2013.0115	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153895	10.1371/journal.pone.0153895	http://dx.doi.org/10.1371/journal.pone.0153895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100663	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500090
J	Rutkis, R; Strazdina, I; Balodite, E; Lasa, Z; Galinina, N; Kalnenieks, U				Rutkis, Reinis; Strazdina, Inese; Balodite, Elina; Lasa, Zane; Galinina, Nina; Kalnenieks, Uldis			The Low Energy-Coupling Respiration in Zymomonas mobilis Accelerates Flux in the Entner-Doudoroff Pathway	PLOS ONE			English	Article							ALCOHOL-DEHYDROGENASE-II; ETHANOL-PRODUCTION; GENOME SEQUENCE; ELECTRON-TRANSPORT; AEROBIC GROWTH; CHAIN; METABOLISM; OXIDASE; CYANIDE; OXYGEN	Performing oxidative phosphorylation is the primary role of respiratory chain both in bacteria and eukaryotes. Yet, the branched respiratory chains of prokaryotes contain alternative, low energy-coupling electron pathways, which serve for functions other than oxidative ATP generation (like those of respiratory protection, adaptation to low-oxygen media, redox balancing, etc.), some of which are still poorly understood. We here demonstrate that withdrawal of reducing equivalents by the energetically uncoupled respiratory chain of the bacterium Zymomonas mobilis accelerates its fermentative catabolism, increasing the glucose consumption rate. This is in contrast to what has been observed in other respiring bacteria and yeast. This effect takes place after air is introduced to glucose-consuming anaerobic cell suspension, and can be simulated using a kinetic model of the Entner-Doudoroff pathway in combination with a simple net reaction of NADH oxidation that does not involve oxidative phosphorylation. Although aeration hampers batch growth of respiring Z. mobilis culture due to accumulation of toxic byproducts, nevertheless under non-growing conditions respiration is shown to confer an adaptive advantage for the wild type over the non-respiring Ndh knock-out mutant. If cells get occasional access to limited amount of glucose for short periods of time, the elevated glucose uptake rate selectively improves survival of the respiring Z. mobilis phenotype.	[Rutkis, Reinis; Strazdina, Inese; Balodite, Elina; Lasa, Zane; Galinina, Nina; Kalnenieks, Uldis] Univ Latvia, Inst Microbiol & Biotechnol, Jelgavas St 1, LV-1004 Riga, Latvia	Riga Stradins University; University of Latvia	Kalnenieks, U (corresponding author), Univ Latvia, Inst Microbiol & Biotechnol, Jelgavas St 1, LV-1004 Riga, Latvia.	kalnen@lanet.lv			Latvian Council of Science [536/2012]	Latvian Council of Science(Latvian Ministry of Education and Science)	All authors received funding from grant No. 536/2012 of the Latvian Council of Science (http://www.lzp.lv/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN HJ, 1991, J BACTERIOL, V173, P5975, DOI 10.1128/jb.173.19.5975-5982.1991; Balodite E, 2014, MICROBIOL-SGM, V160, P2045, DOI 10.1099/mic.0.081612-0; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN, V1; BRINGER S, 1984, ARCH MICROBIOL, V139, P376, DOI 10.1007/BF00408383; BRINGERMEYER S, 1989, APPL MICROBIOL BIOT, V31, P529, DOI 10.1007/BF00270789; CHANCE B, 1959, NATURE, V184, P931, DOI 10.1038/184931a0; DAWES EA, 1970, J GEN MICROBIOL, V60, P31, DOI 10.1099/00221287-60-1-31; Desiniotis A, 2012, J BACTERIOL, V194, P5966, DOI 10.1128/JB.01398-12; DIMARCO AA, 1985, APPL ENVIRON MICROB, V49, P151, DOI 10.1128/AEM.49.1.151-157.1985; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Hayashi T, 2015, MICROBIOL-SGM, V161, P2384, DOI 10.1099/mic.0.000195; Hayashi T, 2012, APPL ENVIRON MICROB, V78, P5622, DOI 10.1128/AEM.00733-12; Hayashi T, 2011, J BIOSCI BIOENG, V111, P414, DOI 10.1016/j.jbiosc.2010.12.009; KALNENIEKS U, 1993, ARCH MICROBIOL, V160, P74, DOI 10.1007/BF00258148; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; Kalnenieks U, 2000, MICROBIOL-UK, V146, P1259, DOI 10.1099/00221287-146-6-1259; Kalnenieks U, 2005, ARCH MICROBIOL, V183, P450, DOI 10.1007/s00203-005-0023-2; Kalnenieks U, 2008, MICROBIOL-SGM, V154, P989, DOI 10.1099/mic.0.2007/012682-0; Kalnenieks U, 2006, ADV MICROB PHYSIOL, V51, P73, DOI 10.1016/S0065-2911(06)51002-1; KIM YJ, 1995, J BACTERIOL, V177, P5176, DOI 10.1128/jb.177.17.5176-5178.1995; Kouvelis VN, 2011, J BACTERIOL, V193, P5049, DOI 10.1128/JB.05273-11; Kouvelis VN, 2009, J BACTERIOL, V191, P7140, DOI 10.1128/JB.01084-09; KREBS EG, 1955, METHOD ENZYMOL, V1, P407, DOI 10.1016/0076-6879(55)01066-5; Kremer TA, 2015, P NATL ACAD SCI USA, V112, P2222, DOI 10.1073/pnas.1420663112; OHTA K, 1991, APPL ENVIRON MICROB, V57, P893, DOI 10.1128/AEM.57.4.893-900.1991; PANKOVA LM, 1988, APPL MICROBIOL BIOT, V28, P583; Pentjuss A, 2013, J BIOTECHNOL, V165, P1, DOI 10.1016/j.jbiotec.2013.02.014; Poole RK, 1997, BIOSCIENCE REP, V17, P303, DOI 10.1023/A:1027336712748; Rogers PL, 2007, ADV BIOCHEM ENG BIOT, V108, P263, DOI 10.1007/10_2007_060; Rogers P. L., 1982, MICROB REACT, V23, P37; Rutkis R., 2014, J BASIC MICROB, V54, P1; Rutkis R, 2013, MICROBIOL-SGM, V159, P2674, DOI 10.1099/mic.0.071340-0; SAHM H, 1987, ACTA BIOTECHNOL, V7, P307, DOI 10.1002/abio.370070405; Scopes RK, 1997, BIOCHEM J, V326, P731, DOI 10.1042/bj3260731; Seo JS, 2005, NAT BIOTECHNOL, V23, P63, DOI 10.1038/nbt1045; Sootsuwan K, 2008, J MOL MICROB BIOTECH, V14, P163, DOI 10.1159/000112598; Sootsuwan K, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-180; STANLEY GA, 1993, BIOTECHNOL BIOENG, V42, P24, DOI 10.1002/bit.260420104; Strazdina I, 2012, ARCH MICROBIOL, V194, P461, DOI 10.1007/s00203-011-0785-7; STROHDEICHER M, 1990, ARCH MICROBIOL, V154, P536; Toh H, 1997, ARCH MICROBIOL, V168, P46, DOI 10.1007/s002030050468; Widiastuti H, 2011, BIOTECHNOL BIOENG, V108, P655, DOI 10.1002/bit.22965; Yang SH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00246; ZHANG M, 1995, SCIENCE, V267, P240, DOI 10.1126/science.267.5195.240; [No title captured]	45	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153866	10.1371/journal.pone.0153866	http://dx.doi.org/10.1371/journal.pone.0153866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100889	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500080
J	Samotus, O; Rahimi, F; Lee, J; Jog, M				Samotus, Olivia; Rahimi, Fariborz; Lee, Jack; Jog, Mandar			Functional Ability Improved in Essential Tremor by IncobotulinumtoxinA Injections Using Kinematically Determined Biomechanical Patterns - A New Future	PLOS ONE			English	Article							BOTULINUM TOXIN TREATMENT; UPPER-LIMB TREMOR; HAND TREMOR	Objective Effective treatment for functional disability caused by essential tremor is a significant unmet need faced by many clinicians today. Current literature regarding focal therapy by botulinum toxin type A (BoNT-A) injections uses fixed dosing regimens, which cannot be individualized, provides only limited functional benefit and unacceptable muscle weakness commonly occurs. This 38-week open label study, the longest to-date, demonstrates how kinematic technology addressed all these issues by guiding muscle selection. Method Participants (n = 24) were assessed at weeks 0, 6, 16, 22, 32, and 38 and injected with incobo-tulinumtoxinA at weeks 0, 16, and 32. Clinical assessments including UPDRS tremor items, Fahn-Tolosa-Marin (FTM) tremor rating scale assessing tremor severity, writing and functional ability, quality of life questionnaire (QUEST) and objective kinematic assessments were completed at every visit. Participants performed two postural and two weight-bearing scripted tasks with motion sensors placed over the wrist, elbow and shoulder joints. These sensors captured angular tremor amplitude (RMS units) and acceleration joint motion that was segmented into directional components: flexion-extension (F/E), pronation-supination and radial-ulnar at the wrist, F/E at the elbow, and F/E and adduction-abduction at the shoulder. Injection parameters were determined using kinematics, followed by the clinician's determination of which muscles would contribute to the specific upper limb tremor biomechanics and dosing per participant. Results Multi-joint biomechanical recordings allowed individualized muscle selection and showed significant improvement in whole-arm function, FTM parts A-C scores, at week 6 which continued throughout the study. By week 38, the total FTM score statistically significantly reduced from 16.2 +/- 4.6 at week 0 to 9.5 +/- 6.3 (p< 0.0005). UPDRS item 21 score rating action tremor was significantly reduced from 2.6 +/- 0.5 at week 0 to 1.6 +/- 1.1 (p = 0.01) at week 32. Quality of life (QUEST) significantly improved from 40.3 +/- 15.8 at week 0 to 31.1 +/- 15.3 (p = 0.035) at week 32 and to 27.8 +/- 15.3 (p = 0.028) at week 38. Kinematics provided an objective, secondary outcome measure, which showed a significant decrease in tremor amplitude in the wrist and shoulder joints (p< 0.05). Eight participants (40%) self-reported mild weakness in injected muscles but had no interference in arm function. Conclusion Kinematic tremor assessments provide the injector unique insight to objectively individualize and personalize injection parameters demonstrating BoNT-A effectively alleviates functional disability caused by essential tremor. Kinematic technology is a promising method for standardizing assessments and for focal upper limb tremor treatment.	[Samotus, Olivia; Rahimi, Fariborz; Lee, Jack; Jog, Mandar] London Hlth Sci Ctr, Lawson Hlth Res Inst, Dept Clin Neurol Sci, London, ON, Canada; [Samotus, Olivia; Jog, Mandar] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Rahimi, Fariborz] Univ Bonab, Dept Elect & Comp Engn, Bonab, East Azerbaijan, Iran	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Bonab	Jog, M (corresponding author), London Hlth Sci Ctr, Lawson Hlth Res Inst, Dept Clin Neurol Sci, London, ON, Canada.; Jog, M (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada.	mandar.jog@lhsc.on.ca			Merz Pharma [R.14.022]	Merz Pharma	Merz Pharma (www.merzcanada.com), grant #R.14.022, provided funding for this investigator-initiated trial. Dr. Mandar Jog's role included study design and supervision, treatment administration, preparation and decision to publish the manuscript. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baizabal-Carvallo JF, 2014, J NEUROL NEUROSUR PS, V85, P567, DOI 10.1136/jnnp-2013-304943; Brin MF, 2001, NEUROLOGY, V56, P1523, DOI 10.1212/WNL.56.11.1523; Deuschl G, 2011, LANCET NEUROL, V10, P148, DOI 10.1016/S1474-4422(10)70322-7; Henderson JM, 1996, EUR NEUROL, V36, P29, DOI 10.1159/000117196; JANKOVIC J, 1991, NEUROLOGY, V41, P1185, DOI 10.1212/WNL.41.8.1185; Jankovic J, 1996, MOVEMENT DISORD, V11, P250, DOI 10.1002/mds.870110306; JANKOVIC J, 1990, J NEUROL NEUROSUR PS, V53, P633, DOI 10.1136/jnnp.53.8.633; Kim SD, 2014, MOVEMENT DISORD, V29, P835, DOI 10.1002/mds.25739; KOLLER WC, 1989, NEUROLOGY, V39, P1587, DOI 10.1212/WNL.39.12.1587; Pacchetti C, 2000, NEUROL SCI, V21, P349, DOI 10.1007/s100720070049; Pullman SL, 1996, ARCH NEUROL-CHICAGO, V53, P617, DOI 10.1001/archneur.1996.00550070055012; Rahimi F, 2015, TREMOR OTHER HYPERK, V5, DOI 10.7916/D8BP0270; Rahimi F, 2011, IEEE ENG MED BIO, P470, DOI 10.1109/IEMBS.2011.6090067; Rahimi F, 2015, CAN J NEUROL SCI, V42, P116, DOI 10.1017/cjn.2015.12; Rahimi F, 2013, CAN J NEUROL SCI, V40, P663, DOI 10.1017/S031716710001489X; Rajput AH, 2014, J CENT NERV SYST DIS, V6, P29, DOI 10.4137/JCNSD.S13570; Rozman J., 2007, Journal of Medical Engineering & Technology, V31, P305, DOI 10.1080/03091900600992064; TROSCH RM, 1994, MOVEMENT DISORD, V9, P601, DOI 10.1002/mds.870090604; Zesiewicz TA, 2005, NEUROLOGY, V64, P2008, DOI 10.1212/01.WNL.0000163769.28552.CD; Zesiewicz TA, 2013, CURR TREAT OPTION NE, V15, P410, DOI 10.1007/s11940-013-0239-4	20	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153739	10.1371/journal.pone.0153739	http://dx.doi.org/10.1371/journal.pone.0153739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101283	Green Published, gold			2022-12-27	WOS:000374898500059
J	Sato, K; Suda, K; Shimizu, S; Sakai, K; Mizuuchi, H; Tomizawa, K; Takemoto, T; Nishio, K; Mitsudomi, T				Sato, Katsuaki; Suda, Kenichi; Shimizu, Shigeki; Sakai, Kazuko; Mizuuchi, Hiroshi; Tomizawa, Kenji; Takemoto, Toshiki; Nishio, Kazuto; Mitsudomi, Tetsuya			Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; TYROSINE KINASE AXL; ACQUIRED-RESISTANCE; CELL CARCINOMA; OVARIAN-CANCER; SURVIVAL; CLASSIFICATION; AMPLIFICATION; ACTIVATION; INHIBITORS	The receptor tyrosine kinase AXL is a member of the Tyro3-Axl-Mer receptor tyrosine kinase subfamily. AXL affects several cellular functions, including growth and migration. AXL aberration is reportedly a marker for poor prognosis and treatment resistance in various cancers. In this study, we analyzed clinical, pathological, and molecular features of AXL expression in lung adenocarcinomas (LADs). We examined 161 LAD specimens from patients who underwent pulmonary resections. When AXL protein expression was quantified (0, 1+, 2+, 3+) according to immunohistochemical staining intensity, results were 0: 35%; 1+: 20%; 2+: 37%; and 3+: 7% for the 161 samples. AXL expression status did not correlate with clinical features, including smoking status and pathological stage. However, patients whose specimens showed strong AXL expression (3+) had markedly poorer prognoses than other groups (P = 0.0033). Strong AXL expression was also significantly associated with downregulation of E-cadherin (P = 0.025) and CD44 (P = 0.0010). In addition, 9 of 12 specimens with strong AXL expression had driver gene mutations (6 with EGFR, 2 with KRAS, 1 with ALK). In conclusion, we found that strong AXL expression in surgically resected LADs was a predictor of poor prognosis. LADs with strong AXL expression were characterized by mesenchymal status, higher expression of stem-cell-like markers, and frequent driver gene mutations.	[Sato, Katsuaki; Suda, Kenichi; Mizuuchi, Hiroshi; Tomizawa, Kenji; Takemoto, Toshiki; Mitsudomi, Tetsuya] Kinki Univ, Div Thorac Surg, Dept Surg, Fac Med, Osaka, Japan; [Shimizu, Shigeki] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo, Japan; [Sakai, Kazuko; Nishio, Kazuto] Kinki Univ, Dept Genome Biol, Fac Med, Osaka, Japan	Kindai University (Kinki University); Hyogo College of Medicine; Kindai University (Kinki University)	Mitsudomi, T (corresponding author), Kinki Univ, Div Thorac Surg, Dept Surg, Fac Med, Osaka, Japan.	mitsudom@surg.med.kindai.ac.jp		Mitsudomi, Tetsuya/0000-0001-9860-8505; Suda, Kenichi/0000-0002-0842-8832; Sato, Katsuaki/0000-0003-4045-7796	Ministry of Education, Science, Sports, and Culture of Japan [15K18450]; Uehara Memorial Foundation; Takeda Science Foundation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	The present study is partly supported by Grants-in-Aid of Cancer Research from the Ministry of Education, Science, Sports, and Culture of Japan (K. Suda, 15K18450); the Uehara Memorial Foundation (T. Mitsudomi); and the Takeda Science Foundation (T. Mitsudomi).; The authors are grateful to Ms. Tomoko Hashimoto for her technical assistance. The present study is partly supported by Grants-in-Aid of Cancer Research from the Ministry of Education, Science, Sports, and Culture of Japan (K. Suda, 15K18450), the Uehara Memorial Foundation (T. Mitsudomi), and the Takeda Science Foundation (T. Mitsudomi).	Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Bae SY, 2015, ONCOTARGET; Brand TM, 2014, AXL MEDIATES RESISTA, DOI [10.1158/0008-5472.CAN-14-0294, DOI 10.1158/0008-5472.CAN-14-0294]; Cheng P, 2015, STEM CELL REP, V4, P899, DOI 10.1016/j.stemcr.2015.03.005; Cichon MA, 2014, ONCOGENE, V33, P4185, DOI 10.1038/onc.2013.388; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gustafsson A, 2009, CLIN CANCER RES, V15, P4742, DOI 10.1158/1078-0432.CCR-08-2514; Hong J, 2013, CANCER RES, V73, P331, DOI 10.1158/0008-5472.CAN-12-3151; Ishikawa M, 2013, ANN SURG ONCOL, V20, pS467, DOI 10.1245/s10434-012-2795-3; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Macleod K, 2005, CANCER RES, V65, P6789, DOI 10.1158/0008-5472.CAN-04-2684; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Narahara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100924; Paccez JD, 2014, INT J CANCER, V134, P1024, DOI 10.1002/ijc.28246; Postel-Vinay S, 2012, NAT GENET, V44, P835, DOI 10.1038/ng.2362; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Rho JK, 2014, CANCER RES, V74, P253, DOI 10.1158/0008-5472.CAN-13-1103; Sakai K, 2014, ONCOTARGET, V5, P9641, DOI 10.18632/oncotarget.2438; Sica G, 2010, AM J SURG PATHOL, V34, P1155, DOI 10.1097/PAS.0b013e3181e4ee32; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Suda K, 2011, INT J CLIN ONCOL, V16, P294, DOI 10.1007/s10147-011-0262-y; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Sung WJ, 2015, INT J CLIN EXP PATHO, V8, P8997; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wu F, 2014, INT J CLIN EXP PATHO, V7, P6653; Yang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099763; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	32	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154186	10.1371/journal.pone.0154186	http://dx.doi.org/10.1371/journal.pone.0154186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100677	Green Published, gold			2022-12-27	WOS:000374898500162
J	Weikl, F; Tischer, C; Probst, AJ; Heinrich, J; Markevych, I; Jochner, S; Pritsch, K				Weikl, Fabian; Tischer, Christina; Probst, Alexander J.; Heinrich, Joachim; Markevych, Iana; Jochner, Susanne; Pritsch, Karin			Fungal and Bacterial Communities in Indoor Dust Follow Different Environmental Determinants	PLOS ONE			English	Article							AIRBORNE BACTERIAL; TEMPORAL VARIABILITY; ATOPIC SENSITIZATION; SEASONAL VARIABILITY; MICROBIAL DIVERSITY; PARTICULATE MATTER; OUTDOOR AIR; ENDOTOXIN; ALLERGENS; PRIMERS	People spend most of their time inside buildings and the indoor microbiome is a major part of our everyday environment. It affects humans' wellbeing and therefore its composition is important for use in inferring human health impacts. It is still not well understood how environmental conditions affect indoor microbial communities. Existing studies have mostly focussed on the local (e.g., building units) or continental scale and rarely on the regional scale, e.g. a specific metropolitan area. Therefore, we wanted to identify key environmental determinants for the house dust microbiome from an existing collection of spatially (area of Munich, Germany) and temporally (301 days) distributed samples and to determine changes in the community as a function of time. To that end, dust samples that had been collected once from the living room floors of 286 individual households, were profiled for fungal and bacterial community variation and diversity using microbial fingerprinting techniques. The profiles were tested for their association with occupant behaviour, building characteristics, outdoor pollution, vegetation, and urbanization. Our results showed that more environmental and particularly outdoor factors (vegetation, urbanization, airborne particulate matter) affected the community composition of indoor fungi than of bacteria. The passage of time affected fungi and, surprisingly, also strongly affected bacteria. We inferred that fungal communities in indoor dust changed semi-annually, whereas bacterial communities paralleled outdoor plant phenological periods. These differences in temporal dynamics cannot be fully explained and should be further investigated in future studies on indoor microbiomes.	[Weikl, Fabian; Pritsch, Karin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Neuherberg, Germany; [Tischer, Christina; Heinrich, Joachim; Markevych, Iana] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Tischer, Christina] Ctr Res Environm Epidemiol, Barcelona, Spain; [Probst, Alexander J.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Heinrich, Joachim] Univ Munich, Univ Hosp Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Markevych, Iana] Univ Munich, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Munich, Germany; [Jochner, Susanne] Catholic Univ Eichstatt Ingolstadt, Phys Geog Landscape Ecol & Sustainable Ecosyst De, Eichstatt, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California Berkeley; University of Munich; University of Munich	Weikl, F (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Neuherberg, Germany.	fabian.weikl@helmholtz-muenchen.de	Heinrich, Joachim/N-1720-2013; Probst, Alexander J/K-2813-2016; Jochner-Oette, Susanne/D-4201-2017; Markevych, Iana/AAQ-3332-2020	Heinrich, Joachim/0000-0002-9620-1629; Markevych, Iana/0000-0002-5214-0748; Weikl, Fabian Christopher/0000-0003-3973-6341; Probst, Alexander/0000-0002-9392-6544; Jochner-Oette, Susanne/0000-0002-5371-9516				Adams RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091283; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Adhikari A, 2006, ENVIRON POLLUT, V140, P16, DOI 10.1016/j.envpol.2005.07.004; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Barberan A, 2015, P ROY SOC B-BIOL SCI, V282, P212, DOI 10.1098/rspb.2015.1139; Barberan A, 2015, P NATL ACAD SCI USA, V112, P5756, DOI 10.1073/pnas.1420815112; Bertolini V, 2013, APPL MICROBIOL BIOT, V97, P6561, DOI 10.1007/s00253-012-4450-0; Bowers RM, 2013, ENVIRON SCI TECHNOL, V47, P12097, DOI 10.1021/es402970s; Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Burge HA, 2002, J ALLERGY CLIN IMMUN, V110, P544, DOI 10.1067/mai.2002.128674; Casas L, 2013, INDOOR AIR, V23, P208, DOI 10.1111/ina.12017; Chen J, GUNIFRAC GENERALIZED; Collins RE, 2007, NUCLEIC ACIDS RES, V35, pW58, DOI 10.1093/nar/gkm384; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Fernandez-Rodriguez S, 2014, FUNGAL ECOL, V7, P16, DOI 10.1016/j.funeco.2013.11.004; Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07; Franzetti A, 2011, APPL MICROBIOL BIOT, V90, P745, DOI 10.1007/s00253-010-3048-7; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Heald CL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037493; Heinrich J, 2003, J EXPO ANAL ENV EPID, V13, P152, DOI 10.1038/sj.jea.7500267; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; Heseltine E, 2009, WHO GUIDELINES FOR I; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Jiang HC, 2006, APPL ENVIRON MICROB, V72, P3832, DOI 10.1128/AEM.02869-05; Kelley ST, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-202; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Kettleson EM, 2015, ENVIRON RES, V138, P130, DOI 10.1016/j.envres.2015.02.003; Koch A, 2000, ALLERGY, V55, P176, DOI 10.1034/j.1398-9995.2000.00233.x; Kopperud RJ, 2004, J AIR WASTE MANAGE, V54, P1188, DOI 10.1080/10473289.2004.10470983; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Li KJ, 2010, AEROBIOLOGIA, V26, P233, DOI 10.1007/s10453-010-9159-x; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Maron PA, 2005, ATMOS ENVIRON, V39, P3687, DOI 10.1016/j.atmosenv.2005.03.002; Martin LJ, 2015, TRENDS ECOL EVOL, V30, P223, DOI 10.1016/j.tree.2015.02.001; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Mitakakis T., 1997, AEROBIOLOGIA, V13, P83, DOI [10.1007/BF02694423, DOI 10.1007/BF02694423]; Moschandreas DJ, 2003, AEROSOL SCI TECH, V37, P899, DOI 10.1080/02786820300935; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Nevalainen A, 2005, INDOOR AIR, V15, P58, DOI 10.1111/j.1600-0668.2005.00344.x; Nevalainen A, 2015, INDOOR AIR, V25, P125, DOI 10.1111/ina.12182; Oksanen J., **DATA OBJECT**; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; Polymenakou PN, 2013, AEROBIOLOGIA, V29, P429, DOI 10.1007/s10453-013-9295-1; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Ruokolainen L, 2015, ALLERGY, V70, P195, DOI 10.1111/all.12545; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045; Team RC., 2013, R A LANGUAGE AND ENV; Valkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131594; Vesper S, 2007, J OCCUP ENVIRON MED, V49, P829, DOI 10.1097/JOM.0b013e3181255e98; White T.J., 1990, INFECT GENET EVOL, V3, P315; Yamamoto N, 2012, ISME J, V6, P1801, DOI 10.1038/ismej.2012.30; Zhang T, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024010; Zutavern A, 2006, PEDIATRICS, V117, P401, DOI 10.1542/peds.2004-2521	60	54	55	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154131	10.1371/journal.pone.0154131	http://dx.doi.org/10.1371/journal.pone.0154131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100967	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500153
J	Bieri, T; Onishi, M; Xiang, TT; Grossman, AR; Pringle, JR				Bieri, Tamaki; Onishi, Masayuki; Xiang, Tingting; Grossman, Arthur R.; Pringle, John R.			Relative Contributions of Various Cellular Mechanisms to Loss of Algae during Cnidarian Bleaching	PLOS ONE			English	Article							SYMBIOTIC SEA-ANEMONE; DINOFLAGELLATE SYMBIOSIS; SCLERACTINIAN CORALS; AIPTASIA-PALLIDA; MODEL SYSTEM; ENDOSYMBIOTIC ALGAE; OXIDATIVE STRESS; LIGHT-INTENSITY; THERMAL-STRESS; HEAT-STRESS	When exposed to stress such as high seawater temperature, corals and other cnidarians can bleach due to loss of symbiotic algae from the host tissue and/or loss of pigments from the algae. Although the environmental conditions that trigger bleaching are reasonably well known, its cellular and molecular mechanisms are not well understood. Previous studies have reported the occurrence of at least four different cellular mechanisms for the loss of symbiotic algae from the host tissue: in situ degradation of algae, exocytic release of algae from the host, detachment of host cells containing algae, and death of host cells containing algae. The relative contributions of these several mechanisms to bleaching remain unclear, and it is also not known whether these relative contributions change in animals subjected to different types and/or durations of stresses. In this study, we used a clonal population of the small sea anemone Aiptasia, exposed individuals to various precisely controlled stress conditions, and quantitatively assessed the several possible bleaching mechanisms in parallel. Under all stress conditions tested, except for acute cold shock at 4 degrees C, expulsion of intact algae from the host cells appeared to be by far the predominant mechanism of bleaching. During acute cold shock, in situ degradation of algae and host-cell detachment also became quantitatively significant, and the algae released under these conditions appeared to be severely damaged.	[Bieri, Tamaki; Onishi, Masayuki; Pringle, John R.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Bieri, Tamaki; Grossman, Arthur R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA	Stanford University; Stanford University; Carnegie Institution for Science	Pringle, JR (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	jpringle@stanford.edu	Xiang, Tingting/H-9352-2019	Xiang, Tingting/0000-0001-9062-2273; Onishi, Masayuki/0000-0002-9799-4501	Gordon and Betty Moore Foundation [2629]; International Fulbright Science and Technology Program; National Institutes of Health Instrumentation Grant; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026780] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); International Fulbright Science and Technology Program; National Institutes of Health Instrumentation Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Gordon and Betty Moore Foundation (www.moore.org) Grant 2629 to JRP and ARG, International Fulbright Science and Technology Program to TB, and National Institutes of Health Instrumentation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, CORAL REEFS, V27, P593, DOI 10.1007/s00338-008-0355-x; Baumgarten S, 2015, P NATL ACAD SCI USA, V112, P11893, DOI 10.1073/pnas.1513318112; BROWN BE, 1995, MAR BIOL, V122, P655, DOI 10.1007/BF00350687; Burriesci MS, 2012, J EXP BIOL, V215, P3467, DOI 10.1242/jeb.070946; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Downs CA, 2009, AUTOPHAGY, V5, P211, DOI 10.4161/auto.5.2.7405; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2006, J MOL EVOL, V63, P95, DOI 10.1007/s00239-005-0236-7; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039024; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; Dunn SR, 2002, J EXP MAR BIOL ECOL, V272, P29, DOI 10.1016/S0022-0981(02)00036-9; DYKENS JA, 1992, J EXP BIOL, V168, P219; Franklin DJ, 2004, MAR ECOL PROG SER, V272, P117, DOI 10.3354/meps272117; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Fujise Lisa, 2013, Galaxea - Tokyo, V15, P29; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; GLYNN PW, 1985, DIS AQUAT ORGAN, V1, P29, DOI 10.3354/dao001029; Hambleton EA, 2014, J EXP BIOL, V217, P1613, DOI 10.1242/jeb.095679; Hanes SD, 2013, INVERTEBR BIOL, V132, P95, DOI 10.1111/ivb.12018; Hawkins TD, 2013, FASEB J, V27, P4790, DOI 10.1096/fj.13-235051; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOEGHGULDBERG O, 1987, CORAL REEFS, V5, P201, DOI 10.1007/BF00300964; Krediet CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135725; Kvitt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028665; Lajeunesse TC, 2012, J PHYCOL, V48, P1380, DOI 10.1111/j.1529-8817.2012.01217.x; Leal MC, 2015, J EXP BIOL, V218, P858, DOI 10.1242/jeb.115519; Lehnert EM, 2014, G3-GENES GENOM GENET, V4, P277, DOI 10.1534/g3.113.009084; Lehnert EM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-271; LeTissier MDA, 1996, MAR ECOL PROG SER, V136, P235, DOI 10.3354/meps136235; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; National Oceanic and Athmospheric Administration, 2011, VAL COR EC; Nii CM, 1997, BIOL BULL, V192, P444, DOI 10.2307/1542753; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Paxton CW, 2013, J EXP BIOL, V216, P2813, DOI 10.1242/jeb.087858; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; Pochon X, 2014, PEERJ, V2, DOI 10.7717/peerj.394; Poreba M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008680; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Sawyer SJ, 2001, J EXP BIOL, V204, P3443; SCHOENBERG DA, 1980, PROC R SOC SER B-BIO, V207, P445, DOI 10.1098/rspb.1980.0033; STEELE RD, 1976, J ZOOL, V179, P387; STEEN RG, 1987, BIOL BULL, V172, P246, DOI 10.2307/1541797; Strychar KB, 2004, PHYCOLOGIA, V43, P768, DOI 10.2216/i0031-8884-43-6-768.1; Strychar KB, 2004, MAR FRESHWATER RES, V55, P135, DOI 10.1071/MF03080; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; Tchernov D, 2011, P NATL ACAD SCI USA, V108, P9905, DOI 10.1073/pnas.1106924108; Titlyanov EA, 1996, MAR ECOL PROG SER, V139, P167, DOI 10.3354/meps139167; Tolleter D, 2013, CURR BIOL, V23, P1782, DOI 10.1016/j.cub.2013.07.041; Voolstra CR, 2013, MOL ECOL, V22, P4366, DOI 10.1111/mec.12464; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; Xiang TT, 2015, PLANT J, V82, P67, DOI 10.1111/tpj.12789; Xiang TT, 2013, J PHYCOL, V49, P447, DOI 10.1111/jpy.12055; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	59	54	56	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152693	10.1371/journal.pone.0152693	http://dx.doi.org/10.1371/journal.pone.0152693			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119147	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200010
J	Daujeard, C; Geraads, D; Gallotti, R; Lefevre, D; Mohib, A; Raynal, JP; Hublin, JJ				Daujeard, Camille; Geraads, Denis; Gallotti, Rosalia; Lefevre, David; Mohib, Abderrahim; Raynal, Jean-Paul; Hublin, Jean-Jacques			Pleistocene Hominins as a Resource for Carnivores: A c. 500,000-Year-Old Human Femur Bearing Tooth-Marks in North Africa (Thomas Quarry I, Morocco)	PLOS ONE			English	Article							GRAN DOLINA SIERRA; MIDDLE PLEISTOCENE; HUMAN REMAINS; LONG BONES; LOS HUESOS; EARLIEST OCCUPATION; NEANDERTHAL REMAINS; HOMO; CAVE; CONSUMPTION	In many Middle Pleistocene sites, the co-occurrence of hominins with carnivores, who both contributed to faunal accumulations, suggests competition for resources as well as for living spaces. Despite this, there is very little evidence of direct interaction between them to-date. Recently, a human femoral diaphysis has been recognized in South-West of Casablanca (Morocco), in the locality called Thomas Quarry I. This site is famous for its Middle Pleistocene fossil hominins considered representatives of Homo rhodesiensis. The bone was discovered in Unit 4 of the Grotte a Hominides (GH), dated to c.500 ky and was associated with Acheulean artefacts and a rich mammalian fauna. Anatomically, it fits well within the group of known early Middle Pleistocene Homo, but its chief point of interest is that the diaphyseal ends display numerous tooth marks showing that it had been consumed shortly after death by a large carnivore, probably a hyena. This bone represents the first evidence of consumption of human remains by carnivores in the cave. Whether predated or scavenged, this chewed femur indicates that humans were a resource for carnivores, underlining their close relationships during the Middle Pleistocene in Atlantic Morocco.	[Daujeard, Camille] UPVD, UPMC, Univ Paris 04, CNRS,HNHP,MNHN,UMR 7194, Paris, France; [Geraads, Denis] UPMC, Univ Paris 04, CNRS, CR2P,MNHN,UMR 7207, Paris, France; [Geraads, Denis; Raynal, Jean-Paul; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Gallotti, Rosalia] Univ Roma La Sapienza, Dipartimento Sci Antichita, Via Volsci 122, I-00185 Rome, Italy; [Gallotti, Rosalia; Raynal, Jean-Paul] Univ Bordeaux, PACEA, CNRS, UMR 5199, Pessac, France; [Lefevre, David] Univ Montpellier 3, CNRS, UMR 5140, Archeol Soc Mediterraneennes, F-34032 Montpellier, France; [Mohib, Abderrahim] Inst Natl Sci Archeol Patrimoine, Rabat, Morocco	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Montpellier; Universite Paul-Valery	Hublin, JJ (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	hublin@eva.mpg.de	Daujeard, Camille/AAQ-4952-2020; Gallotti, Rosalia/AAP-4599-2020; Geraads, Denis/AAY-6051-2020; GERAADS, Denis/AAC-7241-2021	Daujeard, Camille/0000-0001-7489-8691; Gallotti, Rosalia/0000-0001-7308-7715; GERAADS, Denis/0000-0003-2475-8011; LEFEVRE, David/0000-0002-9086-4093	Ministere de la Culture of the Kingdom of Morocco (Institut National des Sciences de l'Archeologie et du Patrimoine - INSAP); Ministere des Affaires etrangeres et du Developpement International of France; Region Aquitaine for project Origines III [20101401006]; Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany	Ministere de la Culture of the Kingdom of Morocco (Institut National des Sciences de l'Archeologie et du Patrimoine - INSAP); Ministere des Affaires etrangeres et du Developpement International of France; Region Aquitaine for project Origines III; Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany	The Morocco-France Casablanca Project was jointly funded by the Ministere de la Culture of the Kingdom of Morocco (Institut National des Sciences de l'Archeologie et du Patrimoine - INSAP), the Ministere des Affaires etrangeres et du Developpement International of France, the Funding Region Aquitaine for project Origines III (contract 20101401006) and the Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany.	Andres M, 2003, ARCHAEOL ANTHROP SCI, V4, P209; Andrews P, 1997, J HUM EVOL, V33, P191, DOI 10.1006/jhev.1997.0137; Arilla M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102457; Arribas A, 1999, J ARCHAEOL SCI, V26, P571, DOI 10.1006/jasc.1998.0346; Arribas A., 1997, CUATERNARIO GEOMORFO, V11, P55; Arsuaga JL, 2007, J HUM EVOL, V52, P31, DOI 10.1016/j.jhevol.2006.07.011; Auguste P., 1995, B SOC PREHISTORIQUE, V92, P155; Barba R, 2007, VERTEBR PALEOBIOL PA, P217; Baynes-Rock M, 2008, THESIS J COOK U; Beauval C, 2005, P NATL ACAD SCI USA, V102, P7085, DOI 10.1073/pnas.0502656102; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Bernoussi R, 1997, THESIS U BORDEAUX 1; Biberson P, 1956, B ARCHEOLOGIE MAROCA, V1, P39; Biberson P., 1961, PUBLICATIONS SERVICE, V17; Binford L.R., 1981, BONES ANCIENT MEN MO; Blasco R, 2011, J ARCHAEOL SCI, V38, P3373, DOI 10.1016/j.jas.2011.07.023; Blasco R, 2010, J ARCHAEOL SCI, V37, P2051, DOI 10.1016/j.jas.2010.03.010; Blasco R, 2009, CR PALEVOL, V8, P579, DOI 10.1016/j.crpv.2009.06.003; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; Blumenschine RJ, 1986, OXFORD BAR INT SERIE, V283; Boaz NT, 2004, J HUM EVOL, V46, P519, DOI 10.1016/j.jhevol.2004.01.007; Boaz NT., 2000, ACTA ANTHR SINICA, V19, P224; Brain CK, 1981, HUNTERS HUNTED; Brantingham PJ, 1998, J ANTHROPOL ARCHAEOL, V17, P327, DOI 10.1006/jaar.1998.0326; Brugal Jean-Philip, 2004, Revue de Paleobiologie, V23, P575; Camaros E, 2015, ARCHAEOL AN IN PRESS; Campmas E, 2008, ANN PALEONTOL, V94, P167, DOI 10.1016/j.annpal.2008.06.001; Carretero JM, 2012, J HUM EVOL, V62, P242, DOI 10.1016/j.jhevol.2011.11.004; Coard R, 2007, J ARCHAEOL SCI, V34, P1677, DOI 10.1016/j.jas.2006.12.006; Daujeard Camille, 2012, Journal of Taphonomy, V10, P349; David F, 2009, J HUM EVOL, V57, P805, DOI 10.1016/j.jhevol.2009.03.006; Delaney-Rivera C, 2009, J ARCHAEOL SCI, V36, P2597, DOI 10.1016/j.jas.2009.08.001; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P1385, DOI 10.1016/S0305-4403(03)00027-X; Dominguez-Rodrigo M, 1999, PALAEOGEOGR PALAEOCL, V149, P373, DOI 10.1016/S0031-0182(98)00213-2; Dominguez-Rodrigo M, 2015, QUATERNARY SCI REV, V126, P67, DOI 10.1016/j.quascirev.2015.08.020; Dominguez-Rodrigo Manuel, 2012, Journal of Taphonomy, V10, P147; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Eng CM, 2013, AM J PHYS ANTHROPOL, V151, P544, DOI 10.1002/ajpa.22296; ENNOUCHI E, 1969, CR ACAD SCI D NAT, V269, P763; Fosse P., 1997, PALEO, V9, P15, DOI [10.3406/pal.1997.1227, DOI 10.3406/PAL.1997.1227]; Fourvel Jean-Baptiste, 2012, Journal of Taphonomy, V10, P239; GERAADS D, 1980, CR ACAD SCI D NAT, V291, P195; Geraads D., 1980, Quaternaria, V22, P65; GERAADS D, 1983, ANTHROPOLOGIE, V87, P138; GERAADS D, 1986, QUATERNARY RES, V25, P380, DOI 10.1016/0033-5894(86)90008-6; Geraads D., 2010, ANTHROPOLOGIE, V114, P324; Geraads Denis, 2002, Quaternaire, V13, P43; Geraads D, 2011, PALAEONTOLOGY, V54, P429, DOI 10.1111/j.1475-4983.2011.01039.x; Geraads D, 2008, CR PALEVOL, V7, P591, DOI 10.1016/j.crpv.2008.09.008; Giacobini G, 1991, QUATERN NOVA, V1, P593; Gidna A, 2013, J ARCHAEOL SCI, V40, P1903, DOI 10.1016/j.jas.2012.11.023; Gidna AO, 2014, QUATERN INT, V322, P167, DOI 10.1016/j.quaint.2013.08.059; Gilbert WH, 2008, HOMOERECTUS PLEISTOC, P376; Grayson DK, 2003, J ARCHAEOL SCI, V30, P585, DOI 10.1016/S0305-4403(02)00205-4; GRIMAUDHERVE D, 1994, CR ACAD SCI II, V318, P1139; GRINE FE, 1995, AM J PHYS ANTHROPOL, V97, P151, DOI 10.1002/ajpa.1330970207; HAYNES G, 1983, PALEOBIOLOGY, V9, P164, DOI 10.1017/S0094837300007545; HAYNES G, 1980, PALEOBIOLOGY, V6, P341, DOI 10.1017/S0094837300006849; Hossini S, 2002, THESIS U MOULAY ISMA; Hublin J.J., 2001, HUMAN ROOTS AFRICA A, P99; Hublin JJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0062; HUBLIN JJ, 1992, CR ACAD SCI II, V314, P975; Janssens L, 2015, LATE GLACIAL BURIAL, P253; KENNEDY GE, 1983, J HUM EVOL, V12, P587, DOI 10.1016/S0047-2484(83)80001-3; Kitagawa Keiko, 2012, Journal of Taphonomy, V10, P439; Lefevre D., 2002, PALEORIVAGES CASABLA, V13, P9, DOI DOI 10.3406/quate.2002.1700; Lefevre D, 2000, THESIS U P VALERY MO; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Arsuaga JL, 2015, P NATL ACAD SCI USA, V112, P11524, DOI 10.1073/pnas.1514828112; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Mann AE, 2005, PALEOANTHROPOLOGY A, V28; Martinez-Moreno J., 2010, ZONA ARQUEOLOGICA, V13, P230; McCown TD., 1939, FOSSIL HUMAN REMAINS; Moncel MH, 2012, J HUM EVOL, V63, P653, DOI 10.1016/j.jhevol.2012.08.001; Moncel MH, 2008, MEMOIRE SOC PREHISTO, V46; Moncel MH, 2015, QUATERN INT IN PRESS; Munzel SC, 2004, INT J OSTEOARCHAEOL, V14, P225, DOI 10.1002/oa.758; Njau JK, 2012, J HUM EVOL, V63, P408, DOI 10.1016/j.jhevol.2011.05.008; Oakley K.P., 1977, P PREHIST SOC, V43, P13, DOI [10.1017/S0079497X00010343, DOI 10.1017/S0079497X00010343]; Palombo MR, 2008, QUATERN INT, V179, P176, DOI 10.1016/j.quaint.2007.08.029; Palombo MR, 2006, QUATERN INT, V149, P94, DOI 10.1016/j.quaint.2005.11.022; Palombo MR, 2010, QUATERN INT, V223, P179, DOI 10.1016/j.quaint.2009.11.016; Parkinson JA, 2015, J HUM EVOL, V80, P114, DOI 10.1016/j.jhevol.2014.10.011; Pickering TR, 2004, J HUM EVOL, V46, P595, DOI 10.1016/j.jhevol.2004.03.002; Pickering TR, 2002, INT J OSTEOARCHAEOL, V12, P127, DOI 10.1002/oa.594; Puymerail L., 2011, THESIS MUSEUM NATL H; Puymerail L, 2012, CR PALEVOL, V11, P581, DOI 10.1016/j.crpv.2012.07.001; Quam RM, 2001, J HUM EVOL, V41, P385, DOI 10.1006/jhev.2001.0486; Raynal J.-P., 2002, QUATERNAIRE, V13, P65, DOI DOI 10.3406/QUATE.2002.1704]; Raynal JP, 2010, QUATERN INT, V223, P369, DOI 10.1016/j.quaint.2010.03.011; Raynal JP, 2001, QUATERN INT, V75, P65, DOI 10.1016/S1040-6182(00)00078-1; Raynal JP, 1995, EARLIEST OCCUPATION, P255; Raynal JP, 2011, B SOC PREHISTORIQUE, V108, P1; Rhodes EJ, 2006, QUATERNARY SCI REV, V25, P2569, DOI 10.1016/j.quascirev.2005.09.010; Roebroeks W, 2001, J HUM EVOL, V41, P437, DOI 10.1006/jhev.2001.0499; Rolland N, 2010, QUATERN INT, V223, P54, DOI 10.1016/j.quaint.2010.02.011; Rosell Jordi, 2012, Journal of Taphonomy, V10, P125; Rosell Jordi, 2009, Journal of Taphonomy, V7, P305; Ruff CB, 1983, AM J PHYS ANTHROPOL, V60, P259; Sahnouni M, 2013, J HUM EVOL, V64, P137, DOI 10.1016/j.jhevol.2012.10.007; Saladie P, 2013, INT J OSTEOARCHAEOL, V23, P13, DOI 10.1002/oa.1237; Saladie P, 2014, QUATERNARY SCI REV, V93, P47, DOI 10.1016/j.quascirev.2014.04.001; Sam Y, 2011, ACT 30 RENC INT ARCH, P65; Schulting RJ, 2005, J HUM EVOL, V48, P493, DOI 10.1016/j.jhevol.2005.02.001; Selvaggio MM, 2001, J ARCHAEOL SCI, V28, P465, DOI 10.1006/jasc.2000.0557; Serangeli J, 2015, J HUM EVOL, V89, P172, DOI 10.1016/j.jhevol.2015.08.005; SHIPMAN P, 1984, CURR ANTHROPOL, V25, P116, DOI 10.1086/203091; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Stiner Mary C., 2012, Journal of Taphonomy, V10, P129; Stiner MC, 2002, J ARCHAEOL RES, V10, P1, DOI 10.1023/A:1014588307174; Texier JP, 2002, PALEORIVAGES CASABLA, V13, P23; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Tournepiche J.-F., 1994, PALEO, V6, P319; Tournepiche JF, 1996, CR ACAD SCI II A, V322, P429; Trinkaus E, 2008, AM J PHYS ANTHROPOL, V135, P371, DOI 10.1002/ajpa.20753; Trinkaus E, 2007, AM J PHYS ANTHROPOL, V134, P263, DOI 10.1002/ajpa.20669; Trinkaus Erik, 2012, Paleoanthropology, V2012, P13; TURNER A, 1992, J HUM EVOL, V22, P109, DOI 10.1016/0047-2484(92)90033-6; Valensi P, 2004, INT J OSTEOARCHAEOL, V14, P256, DOI 10.1002/oa.760; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Werdelin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057944; WHITE TD, 1991, CURR ANTHROPOL, V32, P118, DOI 10.1086/203931	122	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0152284	10.1371/journal.pone.0152284	http://dx.doi.org/10.1371/journal.pone.0152284			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120202	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200007
J	Fujiwara, M; Kawasaki, Y; Yamada, H				Fujiwara, Masakazu; Kawasaki, Yohei; Yamada, Hiroshi			A Pharmacovigilance Approach for Post-Marketing in Japan Using the Japanese Adverse Drug Event Report (JADER) Database and Association Analysis	PLOS ONE			English	Article							RISK	Background Rapid dissemination of information regarding adverse drug reactions is a key aspect for improving pharmacovigilance. There is a possibility that unknown adverse drug reactions will become apparent through post-marketing administration. Currently, although there have been studies evaluating the relationships between a drug and adverse drug reactions using the JADER database which collects reported spontaneous adverse drug reactions, an efficient approach to assess the association between adverse drug reactions of drugs with the same indications as well as the influence of demographics (e.g. gender) has not been proposed. Methods and Findings We utilized the REAC and DEMO tables from the May 2015 version of JADER for patients taking antidepressant drugs (SSRI, SNRI, and NaSSA). We evaluated the associations using association analyses with an apriori algorithm. Support, confidence, lift, and conviction were used as indicators for associations. The highest score in adverse drug reactions for SSRI was obtained for "aspartate aminotransferase increased", "alanine aminotransferase increased", with values of 0.0059, 0.93, 135.5, and 13.9 for support, confidence, lift and conviction, respectively. For SNRI, "international normalized ratio increased", "drug interaction" were observed with 0.0064, 1.00, 71.9, and NA. For NaSSA, "anxiety", "irritability" were observed with 0.0058, 0.80, 49.9, and 4.9. For female taking SSRI, the highest support scores were observed in "twenties", "suicide attempt", whereas "thirties", "neuroleptic malignant syndrome" were observed for male. Second, for SNRI, "eighties", "inappropriate antidiuretic hormone secretion" were observed for female, whereas "interstitial lung disease" and "hepatitis fulminant" were for male. Finally, for NaSSA, "suicidal ideation" was for female, and "rhabdomyolysis" was for male. Conclusions Different combinations of adverse drug reactions were noted between the antidepressants. In addition, the reported adverse drug reactions differed by gender. This approach using a large database for examining the associations can improve safety monitoring during the post-marketing phase.	[Fujiwara, Masakazu; Kawasaki, Yohei; Yamada, Hiroshi] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka 4228526, Japan; [Fujiwara, Masakazu] Shionogi Pharmaceut Co, Dept Biostat, Osaka, Japan	University of Shizuoka; Shionogi & Company Limited	Fujiwara, M (corresponding author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka 4228526, Japan.; Fujiwara, M (corresponding author), Shionogi Pharmaceut Co, Dept Biostat, Osaka, Japan.	masakazu.fujiwara@shionogi.co.jp		Kawasaki, Yohei/0000-0002-7474-7647	Japanese Ministry of Health, Labor and Welfare [24220501]; Shionogi Pharmaceutical Company	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Shionogi Pharmaceutical Company	This work was supported in part by a grant from the Japanese Ministry of Health, Labor and Welfare (No. 24220501) to HY. No additional external funding was received for this study. Shionogi Pharmaceutical Company provided support in the form of salaries for author MF but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Agrawal R., 1994, P 20 INT C VER LARG, P487; [Anonymous], 2005, GUID IND GOOD PHARM; [Anonymous], 2004, PHARM PLANN; Dodd S, 2011, AUST NZ J PSYCHIAT, V45, P712, DOI 10.3109/00048674.2011.595686; Food and Drug Administration, 2005, GUID IND PREM RISK A; Grigoriadis Sophie, 2007, Ann Clin Psychiatry, V19, P247, DOI 10.1080/10401230701653294; Hahsler M., 2005, J STAT SOFTW, V14, P1, DOI DOI 10.18637/JSS.V014.I15; Hahsler M., 2014, PACKAGE ARULES; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Lenca P, 2008, EUR J OPER RES, V184, P610, DOI 10.1016/j.ejor.2006.10.059; Mizutani S, 2014, COMPUT BIOL CHEM, V50, P50, DOI 10.1016/j.compbiolchem.2014.01.006; Nomura K, 2015, DRUG DES DEV THER, V9, P3031, DOI 10.2147/DDDT.S81998; Pharmaceutical and Medical Devices Agency, 2012, RISK MAN PLAN GUID; Takarabe M, 2012, BIOINFORMATICS, V28, pI611, DOI 10.1093/bioinformatics/bts413; Takarabe M, 2011, J CHEM INF MODEL, V51, P2977, DOI 10.1021/ci200367w; Takarabe Masataka, 2010, V22, P167; Tatonetti NP, 2012, J AM MED INFORM ASSN, V19, P79, DOI 10.1136/amiajnl-2011-000214; Umetsu R, 2014, YAKUGAKU ZASSHI, V134, P299, DOI 10.1248/yakushi.13-00225; Voican CS, 2014, AM J PSYCHIAT, V171, P404, DOI 10.1176/appi.ajp.2013.13050709; Weeke P, 2012, CLIN PHARMACOL THER, V92, P72, DOI 10.1038/clpt.2011.368; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; Yukio T., 2014, JPN J PHARMACOEPIDEM, V19, P14	23	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154425	10.1371/journal.pone.0154425	http://dx.doi.org/10.1371/journal.pone.0154425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119382	Green Submitted, gold, Green Published			2022-12-27	WOS:000374976200072
J	Lin, GL; Chai, J; Yuan, S; Mai, C; Cai, L; Murphy, RW; Zhou, W; Luo, J				Lin, Guoliang; Chai, Jing; Yuan, Shuo; Mai, Chao; Cai, Li; Murphy, Robert W.; Zhou, Wei; Luo, Jing			VennPainter: A Tool for the Comparison and Identification of Candidate Genes Based on Venn Diagrams	PLOS ONE			English	Article							COMPARATIVE GENOMICS; PROVIDES INSIGHTS; HOST ADAPTATION; EULER DIAGRAMS; VISUALIZATION; EVOLUTIONARY; REVEAL	VennPainter is a program for depicting unique and shared sets of genes lists and generating Venn diagrams, by using the Qt C++ framework. The software produces Classic Venn, Edwards' Venn and Nested Venn diagrams and allows for eight sets in a graph mode and 31 sets in data processing mode only. In comparison, previous programs produce Classic Venn and Edwards' Venn diagrams and allow for a maximum of six sets. The software incorporates user-friendly features and works in Windows, Linux and Mac OS. Its graphical interface does not require a user to have programing skills. Users can modify diagram content for up to eight datasets because of the Scalable Vector Graphics output. VennPainter can provide output results in vertical, horizontal and matrix formats, which facilitates sharing datasets as required for further identification of candidate genes. Users can obtain gene lists from shared sets by clicking the numbers on the diagram. Thus, VennPainter is an easy-to-use, highly efficient, cross-platform and powerful program that provides a more comprehensive tool for identifying candidate genes and visualizing the relationships among genes or gene families in comparative analysis.	[Lin, Guoliang; Chai, Jing; Luo, Jing] Yunnan Univ, Sch Life Sci, Key Lab Anim Genet Divers & Evolut High Educ Yunn, Kunming 650091, Peoples R China; [Yuan, Shuo; Mai, Chao; Cai, Li; Zhou, Wei] Yunnan Univ, Sch Software, Kunming 650091, Yunnan, Peoples R China; [Lin, Guoliang; Chai, Jing; Luo, Jing] Yunnan Univ, State Key Lab Conservat & Utilizat Bioresource, Kunming 650091, Yunnan, Peoples R China; [Chai, Jing; Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China; [Chai, Jing] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming 650000, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada; [Cai, Li] Fudan Univ, Sch Comp & Sci, Shanghai 200433, Peoples R China	Yunnan University; Yunnan University; Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Royal Ontario Museum; Fudan University	Luo, J (corresponding author), Yunnan Univ, Sch Life Sci, Key Lab Anim Genet Divers & Evolut High Educ Yunn, Kunming 650091, Peoples R China.; Zhou, W (corresponding author), Yunnan Univ, Sch Software, Kunming 650091, Yunnan, Peoples R China.; Luo, J (corresponding author), Yunnan Univ, State Key Lab Conservat & Utilizat Bioresource, Kunming 650091, Yunnan, Peoples R China.	zwei@ynu.edu.cn; jingluo@ynu.edu.cn	Chai, Jing/AFE-1480-2022; Chai, Jing/AAE-9518-2022	Lin, Guoliang/0000-0001-7326-5286	National Natural Science Foundation of China [91331105, 31360514, 61363021]; Program for Innovative Research Team (in Science and Technology) in University of Yunnan Province; State Key laboratory of Genetics, Resources and Evolution, Kunming Institute of Zoology, CAS; National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team (in Science and Technology) in University of Yunnan Province; State Key laboratory of Genetics, Resources and Evolution, Kunming Institute of Zoology, CAS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (91331105, 31360514 and 61363021), Program for Innovative Research Team (in Science and Technology) in University of Yunnan Province, and the State Key laboratory of Genetics, Resources and Evolution, Kunming Institute of Zoology, CAS. The funders JL and WZ (three projects of the National Natural Science Foundation of China) conceived and designed the study. The other funders (the last two projects in the above list) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-72; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Bare JC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-382; Bauer J, 2010, AGING-US, V2, P298, DOI 10.18632/aging.100146; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Bultena B, 2013, FACE BALANCED VENN P; Cai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053388; Cain AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046401; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen YS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-294; Chen ZY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1313-y; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Demchak Barry, 2014, F1000Res, V3, P151, DOI 10.12688/f1000research.4492.2; Edwards A.W.F., 2004, COGWHEELS MIND STORY; Ferraiolo J., 2000, SCALABLE VECTOR GRAP; Forman JJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-260; Goecks J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-397; HENDERSON DW, 1963, AM MATH MON, V70, P424, DOI 10.2307/2311865; Hu Y, 2014, CANCER INFORM, V13, P13, DOI 10.4137/CIN.S13495; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kestler HA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-67; Liu SJ, 2016, P NATL ACAD SCI USA, V113, P1327, DOI 10.1073/pnas.1512955113; Martin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036911; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Phanstiel DH, 2014, BIOINFORMATICS, V30, P2808, DOI 10.1093/bioinformatics/btu379; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Quint A, 2003, IEEE MULTIMEDIA, V10, P99, DOI 10.1109/MMUL.2003.1218261; Radcliffe NJ, 2010, NESTED VENN DIAGRAMS; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; RUSKEY F, 1997, ELECT J COMBINATORIC, V4; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Thorvaldsen S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-573; Tobias CM, 2008, PLANT GENOME-US, V1, P111, DOI 10.3835/plantgenome2008.08.0003; Wilkinson P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-302; Zhang QJ, 2014, P NATL ACAD SCI USA, V111, pE4954, DOI 10.1073/pnas.1418307111; Zhang YR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-164; Zhou XM, 2014, NAT GENET, V46, P1303, DOI 10.1038/ng.3137	39	57	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154315	10.1371/journal.pone.0154315	http://dx.doi.org/10.1371/journal.pone.0154315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120465	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200059
J	Tawada, M; Ito, Y; Hamada, C; Honda, K; Mizuno, M; Suzuki, Y; Sakata, F; Terabayashi, T; Matsukawa, Y; Maruyama, S; Imai, E; Matsuo, S; Takei, Y				Tawada, Mitsuhiro; Ito, Yasuhiko; Hamada, Chieko; Honda, Kazuho; Mizuno, Masashi; Suzuki, Yasuhiro; Sakata, Fumiko; Terabayashi, Takeshi; Matsukawa, Yoshihisa; Maruyama, Shoichi; Imai, Enyu; Matsuo, Seiichi; Takei, Yoshifumi			Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients	PLOS ONE			English	Article							RISK-FACTORS; MEMBRANE; FIBROSIS; MODEL; DIAGNOSIS; TRANSPORT; EPS; LYMPHANGIOGENESIS; RECOMMENDATIONS; PERMEABILITY	Background and Objectives Encapsulating peritoneal sclerosis (EPS) is a rare but serious and life-threatening complication of peritoneal dialysis (PD). However, the precise pathogenesis remains unclear; in addition, predictors and early diagnostic biomarkers for EPS have not yet to be established. Methods Eighty-three peritoneal membrane samples taken at catheter removal were examined to identify pathological characteristics of chronic peritoneal deterioration, which promotes EPS in patients undergoing long-term PD treatment with low occurrence of peritonitis. Results According to univariable logistic regression analysis of the pathological findings, thickness of the peritoneal membrane (P = 0.045), new membrane formation score (P = 0.006), ratio of luminal diameter to vessel diameter (L/V ratio, P<0.001), presence of CD31-negative vessels (P = 0.021), fibrin deposition (P<0.001), and collagen volume fraction (P = 0.018) were associated with EPS development. In analyses of samples with and without EPS matched for PD treatment period, non-diabetes, and PD solution, univariable analysis identified L/V ratio (per 0.1 increase: odds ratio (OR) 0.44, P = 0.003) and fibrin deposition (OR 6.35, P = 0.027) as the factors associated with EPS. L/V ratio was lower in patients with fibrin exudation than in patients without fibrin exudation. Conclusions These findings suggest that damage to vascular endothelial cells, as represented by low L/V ratio, could be a predictive finding for the development of EPS, particularly in long-term PD patients unaffected by peritonitis.	[Tawada, Mitsuhiro; Ito, Yasuhiko; Mizuno, Masashi; Suzuki, Yasuhiro; Sakata, Fumiko; Terabayashi, Takeshi; Maruyama, Shoichi; Imai, Enyu; Matsuo, Seiichi] Nagoya Univ, Grad Sch Med, Dept Nephrol & Renal Replacement Therapy, Nagoya, Aichi 4648601, Japan; [Hamada, Chieko] Juntendo Univ, Dept Nephrol, Tokyo, Japan; [Honda, Kazuho] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan; [Matsukawa, Yoshihisa] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4648601, Japan; [Takei, Yoshifumi] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4648601, Japan	Nagoya University; Juntendo University; Tokyo Women's Medical University; Nagoya University; Nagoya University	Ito, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol & Renal Replacement Therapy, Nagoya, Aichi 4648601, Japan.	yasuito@med.nagoya-u.ac.jp	Mizuno, Masashi/I-7347-2014		Ministry of Education, Science, and Culture, Japan [20590972]; Aichi Kidney Foundation; Grants-in-Aid for Scientific Research [15K15063] Funding Source: KAKEN	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Aichi Kidney Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture, Japan (YI, #20590972), and a 2014 research grant from the Aichi Kidney Foundation (MT and YI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramaniam G, 2009, NEPHROL DIAL TRANSPL, V24, P3209, DOI 10.1093/ndt/gfp008; Braun N, 2011, NEPHROL DIAL TRANSPL, V26, P1033, DOI 10.1093/ndt/gfq488; Brown EA, 2009, PERITON DIALYSIS INT, V29, P595; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Devuyst O, 2010, J AM SOC NEPHROL, V21, P1077, DOI 10.1681/ASN.2009070694; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Flessner MF, 2008, PERITON DIALYSIS INT, V28, P6; Goodlad C, 2011, NEPHROL DIAL TRANSPL, V26, P1374, DOI 10.1093/ndt/gfq533; Gupta S, 2007, CLIN NEPHROL, V68, P125; Habib AM, 2010, NEPHROL DIAL TRANSPL, V25, P1633, DOI 10.1093/ndt/gfp677; Habib SM, 2013, AM J NEPHROL, V37, P223, DOI 10.1159/000348267; Hamada C, 2015, J ARTIF ORGANS, V18, P243, DOI 10.1007/s10047-015-0822-4; Honda K, 2005, PERITON DIALYSIS INT, V25, pS19; Honda K, 2008, CLIN J AM SOC NEPHRO, V3, P720, DOI 10.2215/CJN.03630807; Johnson DW, 2010, KIDNEY INT, V77, P904, DOI 10.1038/ki.2010.16; Kato H, 2012, NEPHROL DIAL TRANSPL, V27, P526, DOI 10.1093/ndt/gfr302; Kawaguchi Y, 2005, PERITON DIALYSIS INT, V25, pS83; Kawanishi K, 2013, PERITON DIALYSIS INT, V33, P242, DOI 10.3747/pdi.2011.00270; Kim YL, 1999, PERITON DIALYSIS INT, V19, pS384; Kinashi H, 2013, J AM SOC NEPHROL, V24, P1627, DOI 10.1681/ASN.2012030226; Kojima H, 2013, AM J PATHOL, V182, P410, DOI 10.1016/j.ajpath.2012.10.016; Korte MR, 2007, NEPHROL DIAL TRANSPL, V22, P2412, DOI 10.1093/ndt/gfm171; Korte MR, 2011, NAT REV NEPHROL, V7, P528, DOI 10.1038/nrneph.2011.93; Korte MR, 2011, PERITON DIALYSIS INT, V31, P269, DOI 10.3747/pdi.2010.00167; Lambie ML, 2010, KIDNEY INT, V78, P611, DOI 10.1038/ki.2010.186; Lee HY, 2003, NEPHROLOGY, V8, pS33, DOI 10.1046/j.1440-1797.8.s.11.x; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Mizuno M, 2012, AM J PHYSIOL-RENAL, V302, pF1245, DOI 10.1152/ajprenal.00652.2011; Mizuno M, 2009, J IMMUNOL, V183, P1403, DOI 10.4049/jimmunol.0804245; Moberly JB, 2002, KIDNEY INT, V62, pS23, DOI 10.1046/j.1523-1755.62.s81.5.x; Morelle J, 2015, J AM SOC NEPHROL, V26, P2521, DOI 10.1681/ASN.2014090939; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Nakayama M, 2005, PERITON DIALYSIS INT, V25, pS71; Nishimura H, 2008, AM J PHYSIOL-RENAL, V294, pF1084, DOI 10.1152/ajprenal.00565.2007; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Rigby RJ, 1998, NEPHROL DIAL TRANSPL, V13, P154, DOI 10.1093/ndt/13.1.154; Sakamoto I, 2009, KIDNEY INT, V75, P828, DOI 10.1038/ki.2008.661; Sampimon DE, 2010, PERITON DIALYSIS INT, V30, P163, DOI 10.3747/pdi.2009.00022; Sawai A, 2011, NEPHROL DIAL TRANSPL, V26, P2322, DOI 10.1093/ndt/gfq702; Sherif AM, 2008, THER APHER DIAL, V12, P33, DOI 10.1111/j.1744-9987.2007.00538.x; Summers AM, 2010, PERITON DIALYSIS INT, V30, P158, DOI 10.3747/pdi.2009.00267; Suzuki Y, 2012, KIDNEY INT, V81, P865, DOI 10.1038/ki.2011.464; Tarzi RM, 2008, CLIN J AM SOC NEPHRO, V3, P1702, DOI 10.2215/CJN.01820408; Terabayashi T, 2015, LAB INVEST, V95, P1029, DOI 10.1038/labinvest.2015.87; Trigka K, 2011, INT UROL NEPHROL, V43, P519, DOI 10.1007/s11255-010-9848-y; Troidle Laura, 2005, Adv Perit Dial, V21, P98; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Yamamoto Ryo, 2005, Clin Exp Nephrol, V9, P148, DOI 10.1007/s10157-005-0349-8; Yamamoto T, 2010, PERITON DIALYSIS INT, V30, P343, DOI 10.3747/pdi.2008.00273	49	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154644	10.1371/journal.pone.0154644	http://dx.doi.org/10.1371/journal.pone.0154644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119341	Green Submitted, gold, Green Published			2022-12-27	WOS:000374976200091
J	Zhang, YD; Zheng, T; Tu, XA; Chen, X; Wang, Z; Chen, SF; Yang, QY; Wan, Z; Han, DY; Xiao, HP; Sun, XZ; Deng, CH				Zhang, Yadong; Zheng, Tao; Tu, Xiang'an; Chen, Xin; Wang, Zhu; Chen, Shengfu; Yang, Qiyun; Wan, Zi; Han, Dayu; Xiao, Haipeng; Sun, Xiangzhou; Deng, Chunhua			Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; SEXUAL DYSFUNCTION; MEN; UPOINT; ASSOCIATION; PREVALENCE; CLASSIFICATION; POPULATION; MANAGEMENT	The aim of this study was to investigate the prevalence of erectile dysfunction (ED) in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and explore the influence of UPOINT domains, National Institutes of Health-CP symptom index (NIH-CPSI) and other factors on ED prevalence. This was a prospective study of consecutive patients with CP/CPPS seen at 11 tertiary hospitals during January-July 2014. ED was diagnosed as a score of <21 on the International Index of Erectile Function (IIEF-5). Patients from one center were evaluated by the UPOINT system and NIH-CPSI. Each patient was assessed using clinical examination, asocio-demographic questionnaire, the Patient Health Questionnaire (PHQ), the Pain Catastrophizing Scale (PCS), NIH-CPSI and IIEF-5.1406 patients from 11 centers (mean age, 32.18 years; range 18-60 years) were enrolled. ED was found in 638/1406 patients (45.4%), and was categorized as mild in 291(45.6%), moderate in 297 (46.6%) and severe in50(7.7%). 192 patients from one center(mean age, 31.3 years; range 18-57 years) were further studied. IIEF-5 score correlated negatively with NIH-CPSI(r = 0.251), PHQ (r = 0.355) and PCS (r = 0.322) scores (P<0.001). PHQ score correlated positively with NIH-CPSI (r = 0.586) and PCS(r = 0.662) scores (P<0.001). NIH-CPSI, PHQ, PCS and IIEF-5 scores did not differ significantly between class IIIA and IIIB CP/CPPS. Multivariate logistic regression showed that UPOINT psychological (P) domain and NIH-CPSI symptom severity were independent risk factors for ED in CP/CPPS. It is concluded that psychological factors and symptom severity are independent risk factors for ED in CP/CPPS.	[Zhang, Yadong; Zheng, Tao; Tu, Xiang'an; Chen, Xin; Chen, Shengfu; Yang, Qiyun; Wan, Zi; Han, Dayu; Sun, Xiangzhou; Deng, Chunhua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Zhu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Ultrasound Med, Guangzhou 510080, Guangdong, Peoples R China; [Xiao, Haipeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhang, YD (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510080, Guangdong, Peoples R China.	zydyd@163.com; dch0313@163.com			National Natural Science Foundation of China [81270696]; Natural Science Foundation of Guangdong Province [S2013040012294]; Guangdong Provincial Medical Research Foundation [C2013022]; Science and Technology Planning Project of Guangdong Province [2012B031800361]; Science and Technology Planning Project of Guangzhou [2013J4500010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Medical Research Foundation; Science and Technology Planning Project of Guangdong Province; Science and Technology Planning Project of Guangzhou	This project was supported by the National Natural Science Foundation of China (grant no. 81270696), the Natural Science Foundation of Guangdong Province (grant no. S2013040012294), Guangdong Provincial Medical Research Foundation (grant no. C2013022), Science and Technology Planning Project of Guangdong Province (grant no. 2012B031800361) and Science and Technology Planning Project of Guangzhou (grant no. 2013J4500010).	Araujo AB, 1998, PSYCHOSOM MED, V60, P458, DOI 10.1097/00006842-199807000-00011; Aubin S, 2008, J SEX MED, V5, P657, DOI 10.1111/j.1743-6109.2007.00736.x; Bartoletti R, 2007, J UROLOGY, V178, P2411, DOI 10.1016/j.juro.2007.08.046; Calhoun EA, 2004, ARCH INTERN MED, V164, P1231; Chung SD, 2012, BJU INT, V110, P726, DOI 10.1111/j.1464-410X.2011.10807.x; Collins MM, 2001, J GEN INTERN MED, V16, P656; Davis SNP, 2013, J UROLOGY, V189, P146, DOI 10.1016/j.juro.2012.08.083; Hao ZY, 2011, J ANDROL, V32, P496, DOI 10.2164/jandrol.110.012138; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Ku JH, 2005, UROLOGY, V66, P693, DOI 10.1016/j.urology.2005.04.050; Ku JH, 2002, SCAND J UROL NEPHROL, V36, P296, DOI 10.1080/003655902320248272; Lee SWH, 2008, UROLOGY, V71, P79, DOI 10.1016/j.urology.2007.08.043; Lewis RW, 2010, J SEX MED, V7, P1598, DOI 10.1111/j.1743-6109.2010.01778.x; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Marszalek M, 2007, J UROLOGY, V177, P1815, DOI 10.1016/j.juro.2007.01.008; McVary K, 2006, BJU INT, V97, P23, DOI 10.1111/j.1464-410X.2006.06102.x; Mehik A, 2001, BJU INT, V88, P35, DOI 10.1046/j.1464-410x.2001.02259.x; Mondul AM, 2008, J UROLOGY, V179, P2321, DOI 10.1016/j.juro.2008.01.150; Osman A, 1997, J BEHAV MED, V20, P589, DOI 10.1023/A:1025570508954; Ponholzer A, 2007, INT J IMPOT RES, V19, P544, DOI 10.1038/sj.ijir.3901578; Ponholzer A, 2004, UROLOGY, V64, P772, DOI 10.1016/j.urology.2004.05.025; Samplaski MK, 2011, UROLOGY, V78, P653, DOI 10.1016/j.urology.2011.04.016; Shoskes DA, 2009, PROSTATE CANCER P D, V12, P177, DOI 10.1038/pcan.2008.42; Shoskes DA, 2013, WORLD J UROL, V31, P755, DOI 10.1007/s00345-013-1075-6; Shoskes DA, 2012, CURR UROL REP, V13, P263, DOI 10.1007/s11934-012-0254-0; Shoskes DA, 2010, UROLOGY, V75, P1249, DOI 10.1016/j.urology.2010.01.021; Staab JP, 2001, MED CLIN N AM, V85, P579, DOI 10.1016/S0025-7125(05)70330-8; Tran CN, 2013, WORLD J UROL, V31, P741, DOI 10.1007/s00345-013-1076-5; Tripp DA, 2006, J PAIN, V7, P697, DOI 10.1016/j.jpain.2006.03.006; Zhao Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052044, 10.1371/journal.pone.0061814, 10.1371/journal.pone.0080574]	30	48	56	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153054	10.1371/journal.pone.0153054	http://dx.doi.org/10.1371/journal.pone.0153054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120096	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200016
J	Prays, N; Kaupenjohann, M				Prays, Nadia; Kaupenjohann, Martin			Initial Effects of Differently Treated Biogas Residues from Municipal and Industrial Wastes on Spring Barley Yield Formation	PLOS ONE			English	Article							SEPARATED HOUSEHOLD WASTE; ANAEROBIC-DIGESTION; NITROGEN-FERTILIZER; CURRENT STATE; CROP GROWTH; SOIL; MANURE; QUALITY; AVAILABILITY; AMENDMENT	Soil application of biogas residues (BGRs) is important for closing nutrient cycles. This study examined the efficiency and impact on yields and yield formation of solid-liquid separated residues from biodegradable municipal and industrial wastes (bio-waste) in comparison to complete BGRs, nitrification inhibitor, agricultural BGRs, mineral fertilizer and unfertilized plots as control. The experiment was set up as a randomized block design on silt loam Cambisol. Biogas residues from four biogas plants were evaluated. Plants per m(2), ears per plant, grains per ear and thousand grain weight (TGW) were measured at harvest. Fertilization with BGRs resulted in similar biomass yields compared with mineral fertilizer. Mineral fertilizer (71 dt/ha) and plots fertilized with liquid fraction (59-62 dt/ha) indicated a trend to higher yields than solid fraction or complete BGR due to its high ammonia content. Liquid fractions and fraction with nitrification inhibitor induced fewer plants per m(2) than corresponding solid and complete variants due to a potential phytotoxicity of high NH4-N concentration during germination. However, barley on plots fertilized with liquid fraction compensated the disadvantages at the beginning during the vegetation period and induced higher grain yields than solid fraction. This was attributable to a higher number of ears per plant and grains per ear. In conclusion, BGRs from biodegradable municipal and industrial wastes can be used for soil fertilization and replace considerable amounts of mineral fertilizer. Our study showed that direct application of the liquid fraction of BGR is the most suitable strategy to achieve highest grain yields. Nevertheless potential phytotoxicity of the high NH4-N concentration in the liquid fraction should be considered.	[Prays, Nadia] UFZ Helmholtz Ctr Environm Res, Dept Bioenergy, Halle, Germany; [Kaupenjohann, Martin] Tech Univ Berlin, Dept Soil Sci, Berlin, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Berlin	Prays, N (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Bioenergy, Halle, Germany.	nadia.prays@ufz.de		Prays, Nadia/0000-0003-3134-7704	Helmholtz Association of German Research Centres within the Initiative and Networking Fund for the Department of Bioenergy (UFZ)	Helmholtz Association of German Research Centres within the Initiative and Networking Fund for the Department of Bioenergy (UFZ)	The present study was supported by the Helmholtz Association of German Research Centres within the Initiative and Networking Fund for the Department of Bioenergy (UFZ).	Abdullahi YA, 2008, BIORESOURCE TECHNOL, V99, P8631, DOI 10.1016/j.biortech.2008.04.027; Abubaker J, 2012, APPL ENERG, V99, P126, DOI 10.1016/j.apenergy.2012.04.050; Al-Juhaimi FY, 2014, PAK J BOT, V46, P471; [Anonymous], 2001, 12879 DIN EN; [Anonymous], 2014, AGRON SUSTAIN DEV, V34, P473, DOI [10.1007/s13593-013-0196-z, DOI 10.1007/S13593-013-0196-Z]; [Anonymous], 2014, WORLD SOIL RESOURCES; [Anonymous], 2001, 12880 DIN EN; [Anonymous], 1993, 25663 DIN EN; Alburquerque JA, 2012, AGR ECOSYST ENVIRON, V160, P15, DOI 10.1016/j.agee.2011.03.007; Alburquerque JA, 2012, BIOMASS BIOENERG, V40, P181, DOI 10.1016/j.biombioe.2012.02.018; Bachmann S, 2014, BIOMASS BIOENERG, V70, P429, DOI 10.1016/j.biombioe.2014.08.004; BAETHGEN WE, 1995, FIELD CROP RES, V43, P87, DOI 10.1016/0378-4290(95)00034-N; Bath B, 1999, ACTA AGR SCAND B-S P, V49, P201, DOI 10.1080/713782027; Chen RR, 2012, BIOMASS BIOENERG, V45, P221, DOI 10.1016/j.biombioe.2012.06.014; de la Fuente C, 2013, BIOL FERT SOILS, V49, P313, DOI 10.1007/s00374-012-0719-9; Diepenbrock W., 1999, SPEZIELLER PFLANZENB; DIN, 2002, 11277 DIN ISO; DIN (Deutsches Institut fur Normung e. V.) 38406-5, 1983, 384065 DIN; Fachagentur fur nachwachsende Rohstoffe e. V, 2014, BAS BIOEN DEUTSCHL 2; Federal Ministry for Economic Affairs and Energy, 2014, 2 FED MIN EC AFF EN; German National Academy of Sciences Leopoldina, 2012, BIOEN CHANC LIM; Haraldsen TK, 2011, WASTE MANAGE RES, V29, P1271, DOI 10.1177/0734242X11411975; Herrmann A, 2013, J AGR SCI-CAMBRIDGE, V151, P449, DOI 10.1017/S0021859612000548; Herrmann A, 2013, BIOENERG RES, V6, P372, DOI 10.1007/s12155-012-9227-x; Holm-Nielsen JB, 2009, BIORESOURCE TECHNOL, V100, P5478, DOI 10.1016/j.biortech.2008.12.046; Insam H, 2015, SOIL BIOL BIOCHEM, V84, P1, DOI 10.1016/j.soilbio.2015.02.006; Jorgensen K, 2009, BIORESOURCE TECHNOL, V100, P3088, DOI 10.1016/j.biortech.2009.01.065; Koutna K, 2003, PLANT SOIL ENVIRON, V49, P457, DOI 10.17221/4157-PSE; Loria ER, 2007, AGRON J, V99, P1119, DOI 10.2134/agronj2006.0251; MA BL, 1992, J AGRON CROP SCI, V169, P151, DOI 10.1111/j.1439-037X.1992.tb01021.x; Moller K, 2008, NUTR CYCL AGROECOSYS, V82, P209, DOI 10.1007/s10705-008-9196-9; Moller K, 2015, AGRON SUSTAIN DEV, V35, P1021, DOI 10.1007/s13593-015-0284-3; Moller K, 2012, ENG LIFE SCI, V12, P242, DOI 10.1002/elsc.201100085; Moeller K, 2009, EUR J AGRON, V30, P1, DOI 10.1016/j.eja.2008.06.003; Moller HB, 2007, T ASABE, V50, P193, DOI 10.13031/2013.22400; Moller HB, 2002, BIORESOURCE TECHNOL, V85, P189, DOI 10.1016/S0960-8524(02)00047-0; Nicoletto C, 2014, SCI HORTIC-AMSTERDAM, V180, P207, DOI 10.1016/j.scienta.2014.10.028; Odlare M, 2008, WASTE MANAGE, V28, P1246, DOI 10.1016/j.wasman.2007.06.005; Odlare M, 2014, J AGR SCI, V152, P134, DOI 10.1017/S0021859612001050; Odlare M, 2011, APPL ENERG, V88, P2210, DOI 10.1016/j.apenergy.2010.12.043; Petr J, 1988, YIELD FORMATION MAIN, P1; Sanger A, 2010, J PLANT NUTR SOIL SC, V173, P692, DOI 10.1002/jpln.200900254; Schittenhelm S, 2006, J AGRON CROP SCI, V192, P434, DOI 10.1111/j.1439-037X.2006.00226.x; Statistisches Landesamt, 2012, STATISTISCHER BERICH; Svensson K, 2004, J AGR SCI-CAMBRIDGE, V142, P461, DOI 10.1017/S0021859604004514; Tambone F, 2010, CHEMOSPHERE, V81, P577, DOI 10.1016/j.chemosphere.2010.08.034; Teglia C, 2011, WASTE BIOMASS VALORI, V2, P113, DOI 10.1007/s12649-010-9059-x; Thran D, 2015, SCHRIFTENREIHE BMWI; Thran D., 2015, IEA BIOENERGY TASK 4; Weiland P, 2003, APPL BIOCHEM BIOTECH, V109, P263, DOI 10.1385/ABAB:109:1-3:263; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Zirkler D, 2014, BIOMASS BIOENERG, V67, P89, DOI 10.1016/j.biombioe.2014.04.021	52	4	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154232	10.1371/journal.pone.0154232	http://dx.doi.org/10.1371/journal.pone.0154232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116355	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600051
J	Amouzou, C; Breuker, C; Fabre, O; Bourret, A; Lambert, K; Birot, O; Fedou, C; Dupuy, AM; Cristol, JP; Sutra, T; Molinari, N; Maimoun, L; Mariano-Goulart, D; Galtier, F; Avignon, A; Stanke-Labesque, F; Mercier, J; Sultan, A; Bisbal, C				Amouzou, Cacylde; Breuker, Cyril; Fabre, Odile; Bourret, Annick; Lambert, Karen; Birot, Olivier; Fedou, Christine; Dupuy, Anne-Marie; Cristol, Jean-Paul; Sutra, Thibault; Molinari, Nicolas; Maimoun, Laurent; Mariano-Goulart, Denis; Galtier, Florence; Avignon, Antoine; Stanke-Labesque, Francoise; Mercier, Jacques; Sultan, Ariane; Bisbal, Catherine			Skeletal Muscle Insulin Resistance and Absence of Inflammation Characterize Insulin-Resistant Grade I Obese Women	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ADIPOSE-TISSUE DYSFUNCTION; METABOLICALLY HEALTHY; GLUCOSE-UPTAKE; FATTY-ACIDS; EXTRACELLULAR-MATRIX; WAIST CIRCUMFERENCE; FETUIN-A; MACROPHAGES; SENSITIVITY	Context Obesity is associated with insulin-resistance (IR), the key feature of type 2 diabetes. Although chronic low-grade inflammation has been identified as a central effector of IR development, it has never been investigated simultaneously at systemic level and locally in skeletal muscle and adipose tissue in obese humans characterized for their insulin sensitivity. Objectives We compared metabolic parameters and inflammation at systemic and tissue levels in normal-weight and obese subjects with different insulin sensitivity to better understand the mechanisms involved in IR development. Methods 30 post-menopausal women were classified as normal-weight insulin-sensitive (controls, CT) and obese (grade I) insulin-sensitive (OIS) or insulin-resistant (OIR) according to their body mass index and homeostasis model assessment of IR index. They underwent a hyperinsulinemic-euglycemic clamp, blood sampling, skeletal muscle and subcutaneous adipose tissue biopsies, an activity questionnaire and a self-administrated dietary recall. We analyzed insulin sensitivity, inflammation and IR-related parameters at the systemic level. In tissues, insulin response was assessed by P-Akt/Akt expression and inflammation by macrophage infiltration as well as cytokines and I kappa B alpha expression. Results Systemic levels of lipids, adipokines, inflammatory cytokines, and lipopolysaccharides were equivalent between OIS and OIR subjects. In subcutaneous adipose tissue, the number of anti-inflammatory macrophages was higher in OIR than in CT and OIS and was associated with higher IL-6 level. Insulin induced Akt phosphorylation to the same extent in CT, OIS and OIR. In skeletal muscle, we could not detect any inflammation even though I kappa B alpha expression was lower in OIR compared to CT. However, while P-Akt/Akt level increased following insulin stimulation in CT and OIS, it remained unchanged in OIR. Conclusion Our results show that systemic IR occurs without any change in systemic and tissues inflammation. We identified a muscle defect in insulin response as an early mechanism of IR development in grade I obese post-menopausal women.	[Amouzou, Cacylde; Breuker, Cyril; Fabre, Odile; Bourret, Annick; Lambert, Karen; Fedou, Christine; Cristol, Jean-Paul; Sutra, Thibault; Molinari, Nicolas; Maimoun, Laurent; Mariano-Goulart, Denis; Avignon, Antoine; Mercier, Jacques; Sultan, Ariane; Bisbal, Catherine] Univ Montpellier, PhyMedExp, INSERM U1046, CNRS UMR 9214, F-34059 Montpellier, France; [Breuker, Cyril; Fedou, Christine; Dupuy, Anne-Marie; Cristol, Jean-Paul; Sutra, Thibault; Molinari, Nicolas; Maimoun, Laurent; Mariano-Goulart, Denis; Galtier, Florence; Avignon, Antoine; Mercier, Jacques; Sultan, Ariane] CHRU Montpellier, Montpellier, France; [Birot, Olivier] York Univ, Fac Hlth, York, ON, Canada; [Stanke-Labesque, Francoise] Univ Grenoble Alpes, CHU Albert Michalon, INSERM U1042, HP2, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; York University - Canada; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Sultan, A; Bisbal, C (corresponding author), Univ Montpellier, PhyMedExp, INSERM U1046, CNRS UMR 9214, F-34059 Montpellier, France.; Sultan, A (corresponding author), CHRU Montpellier, Montpellier, France.	a-sultan@chu-montpellier.fr; catherine.bisbal@inserm.fr	Avignon, Antoine/AAD-5441-2020; Stanke, Francoise/M-7142-2014; Bisbal, Catherine/I-6984-2016; molinari, nicolas/Y-9681-2019; Fabre, Odile MJ/N-8371-2015	Stanke, Francoise/0000-0002-4643-6323; Bisbal, Catherine/0000-0003-1086-020X; Fabre, Odile MJ/0000-0003-0892-8412; Galtier, Florence/0000-0002-0720-6277; dupuy, anne marie/0000-0001-6538-3944; Mariano-Goulart, Denis/0000-0001-7044-2961; Lambert, Karen/0000-0002-6389-2451; Breuker, Cyril/0000-0002-9023-2686	CHRU Montpellier [PROM8685]; French Society of Diabetes; Ministere de l'Enseignement Superieur et de la Recherche	CHRU Montpellier; French Society of Diabetes; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council)	This study was funded by the CHRU Montpellier PROM8685 and the French Society of Diabetes (http://www.sfdiabete.org/). OF and CA were recipient of a Ministere de l'Enseignement Superieur et de la Recherche (www.enseignementsuprecherche.gouv.fr/) fellowship.	Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Andersson DP, 2014, DIABETES CARE, V37, P1831, DOI 10.2337/dc13-2395; Antuna-Puente B, 2011, DIABETES METAB, V37, P179, DOI 10.1016/j.diabet.2011.01.002; Arner P, 2010, BIOCHEM BIOPH RES CO, V396, P101, DOI 10.1016/j.bbrc.2010.02.165; Aronson D, 2004, INT J OBESITY, V28, P674, DOI 10.1038/sj.ijo.0802609; Barbarroja N, 2010, BIOCHEM J, V430, P141, DOI 10.1042/BJ20100285; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bluher M, 2012, CURR OPIN ENDOCRINOL, V19, P341, DOI 10.1097/MED.0b013e328357f0a3; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Bosma M, 2012, PROG LIPID RES, V51, P36, DOI 10.1016/j.plipres.2011.11.003; Bremer AA, 2013, J OBES, V2013, DOI 10.1155/2013/393192; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Calle MC, 2012, DIABETES METAB, V38, P183, DOI 10.1016/j.diabet.2011.11.006; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Roriz AKC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103499; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; Defronzo R A, 1981, Bull Schweiz Akad Med Wiss, P223; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Dupuy AM, 2003, CLIN CHEM LAB MED, V41, P948, DOI 10.1515/CCLM.2003.144; Fabre O, 2012, CELL DEATH DIFFER, V19, P1470, DOI 10.1038/cdd.2012.23; Fink LN, 2013, DIABETOLOGIA, V56, P1623, DOI 10.1007/s00125-013-2897-x; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Fjeldborg K, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/309548; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Goustin AS, 2011, CELL SIGNAL, V23, P980, DOI 10.1016/j.cellsig.2010.11.003; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Hak AE, 1999, ARTERIOSCL THROM VAS, V19, P1986, DOI 10.1161/01.ATV.19.8.1986; Hankinson AL, 2013, OBESITY, V21, P637, DOI 10.1002/oby.20257; Harford KA, 2011, P NUTR SOC, V70, P408, DOI 10.1017/S0029665111000565; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hoffman RP, 2004, PEDIATR DIABETES, V5, P122, DOI 10.1111/j.1399-543X.2004.00050.x; Hokayem M, 2013, DIABETES CARE, V36, P1454, DOI 10.2337/dc12-1652; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Ishibashi A, 2010, J ATHEROSCLER THROMB, V17, P925, DOI 10.5551/jat.3830; Jialal I, 2014, J CLIN ENDOCR METAB, V99, P39, DOI 10.1210/jc.2013-3092; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Karlsson HKR, 2009, DIABETES, V58, P847, DOI 10.2337/db08-1539; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kimokoti RW, 2014, J NUTR, V144, P2018, DOI 10.3945/jn.114.198341; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Klein S, 2007, AM J CLIN NUTR, V85, P1197, DOI 10.1093/ajcn/85.5.1197; Knights AJ, 2014, ADIPOCYTE, V3, P88, DOI 10.4161/adip.27552; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Lionetti L, 2009, NUTR METAB CARDIOVAS, V19, P146, DOI 10.1016/j.numecd.2008.10.010; Liu YJ, 2016, J CLIN ENDOCR METAB, V101, P292, DOI 10.1210/jc.2015-3348; Ma YJ, 2015, BBA-MOL BASIS DIS, V1852, P1001, DOI 10.1016/j.bbadis.2015.01.017; Martinez-Santibanez G, 2014, ANNU REV NUTR, V34, P57, DOI 10.1146/annurev-nutr-071812-161113; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; McLaughlin T, 2014, OBESITY, V22, P673, DOI 10.1002/oby.20209; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Moro C, 2015, HORM MOL BIOL CLIN I; Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Patsouris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110653; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Poulos SP, 2010, MOL CELL ENDOCRINOL, V323, P20, DOI 10.1016/j.mce.2009.12.011; Rhee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098369; Ringseis R, 2015, EXERC IMMUNOL REV, V21, P58; Salehzada T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007563; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Spencer M, 2011, J CLIN ENDOCR METAB, V96, pE1990, DOI 10.1210/jc.2011-1567; Steinberg GR, 2007, CELL CYCLE, V6, P888, DOI 10.4161/cc.6.8.4135; Travers RL, 2015, INT J OBESITY, V39, P762, DOI 10.1038/ijo.2014.195; Tripathy D, 2004, DIABETES CARE, V27, P2204, DOI 10.2337/diacare.27.9.2204; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Velloso LA, 2015, ENDOCR REV; VIGUSHIN DM, 1993, J CLIN INVEST, V91, P1351, DOI 10.1172/JCI116336; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; VOORRIPS LE, 1991, MED SCI SPORT EXER, V23, P974, DOI 10.1249/00005768-199108000-00015; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Williams AS, 2015, TRENDS ENDOCRIN MET, V26, P357, DOI 10.1016/j.tem.2015.05.006; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; ZIERATH JR, 1994, DIABETOLOGIA, V37, P270, DOI 10.1007/BF00398054	89	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154119	10.1371/journal.pone.0154119	http://dx.doi.org/10.1371/journal.pone.0154119			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111539	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600034
J	Ferreira, HR; Ferreira, PG; Loures, JP; Fernandes, J; Fernandes, LC; Buck, HS; Montor, WR				Ferreira, Heros Ribeiro; Ferreira, Pamela Gill; Loures, Joao Paulo; Fernandes Filho, Jose; Fernandes, Luiz Claudio; Buck, Hudson Sousa; Montor, Wagner Ricardo			Acute Oxidative Effect and Muscle Damage after a Maximum 4 Min Test in High Performance Athletes	PLOS ONE			English	Article							KAYAK ERGOMETER PERFORMANCE; ANTIOXIDANT STATUS; ALPHA-TOCOPHEROL; EXERCISE; STRESS; RESPONSES; PADDLERS; INTENSITY; STRENGTH; SWIMMERS	The purpose of this investigation was to determine lipid peroxidation markers, physiological stress and muscle damage in elite kayakers in response to a maximum 4-min kayak ergometer test (KE test), and possible correlations with individual 1000m kayaking performances. The sample consisted of twenty-three adult male and nine adult female elite kayakers, with more than three years' experience in international events, who voluntarily took part in this study. The subjects performed a 10-min warm-up, followed by a 2-min passive interval, before starting the test itself, which consisted of a maximum 4-min work paddling on an ergometer; right after the end of the test, an 8 ml blood sample was collected for analysis. 72 hours after the test, all athletes took part in an official race, when then it was possible to check their performance in the on site K1 1000m test (P1000m). The results showed that all lipoproteins and hematological parameters tested presented a significant difference (p less than or similar to 0.05) after exercise for both genders. In addition, parameters related to muscle damage such as lactate dehydrogenase (LDH) and creatine kinase (CK) presented significant differences after stress. Uric acid presented an inverse correlation with the performance (r = -0.76), while CK presented a positive correlation (r = 0.46) with it. Based on these results, it was possible to verify muscle damage and the level of oxidative stress caused by indoor training with specific ergometers for speed kayaking, highlighting the importance of analyzing and getting to know the physiological responses to this type of training, in order to provide information to coaches and optimize athletic performance.	[Ferreira, Heros Ribeiro; Buck, Hudson Sousa; Montor, Wagner Ricardo] Santa Casa Sao Paulo Sch Med Sci, Sao Paulo, SP, Brazil; [Ferreira, Pamela Gill; Fernandes, Luiz Claudio] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil; [Loures, Joao Paulo] Univ Sao Paulo, Sao Paulo, SP, Brazil; [Fernandes Filho, Jose] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Ferreira, Heros Ribeiro] Santa Casa Sao Paulo Sch Med Sci, Dept Physiol Sci, Sao Paulo, SP, Brazil	Universidade Federal do Parana; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Ferreira, HR (corresponding author), Santa Casa Sao Paulo Sch Med Sci, Sao Paulo, SP, Brazil.; Ferreira, HR (corresponding author), Santa Casa Sao Paulo Sch Med Sci, Dept Physiol Sci, Sao Paulo, SP, Brazil.	heros.esporte@gmail.com	Fernandes, Luiz C/I-4907-2014; Loures, Joao Paulo/N-1997-2019; Buck, Hudson/E-7664-2013; Montor, Wagner/J-2568-2012; Montor, Wagner/AAF-2538-2021	Loures, Joao Paulo/0000-0002-6778-3877; Buck, Hudson/0000-0002-1867-2441; Montor, Wagner/0000-0003-3746-9366; 	CAPES (Coordination of Improvement of Higher Education Personnel-Improvement Coordination of Higher Education Personnel); FAP (Research Support Fund-FCMSCSP-Santa Casa de Sao Paulo School of Medical Sciences-Research support fund-Santa Casa de Sao Paulo School of Medical Sciences)	CAPES (Coordination of Improvement of Higher Education Personnel-Improvement Coordination of Higher Education Personnel); FAP (Research Support Fund-FCMSCSP-Santa Casa de Sao Paulo School of Medical Sciences-Research support fund-Santa Casa de Sao Paulo School of Medical Sciences)	This work was supported by CAPES (Coordination of Improvement of Higher Education Personnel-Improvement Coordination of Higher Education Personnel) and FAP (Research Support Fund-FCMSCSP-Santa Casa de Sao Paulo School of Medical Sciences-Research support fund-Santa Casa de Sao Paulo School of Medical Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland TR, 2003, J SCI MED SPORT, V6, P285, DOI 10.1016/S1440-2440(03)80022-1; Aguilo A, 2005, PHYSIOL BEHAV, V84, P1, DOI 10.1016/j.physbeh.2004.07.034; ARMSTRONG RB, 1984, MED SCI SPORT EXER, V16, P529; Billat V, 1996, ERGONOMICS, V39, P267, DOI 10.1080/00140139608964457; Bishop D, 2000, EUR J APPL PHYSIOL, V82, P91, DOI 10.1007/s004210050656; Bishop D, 2004, INT J SPORTS MED, V25, P68; Bishop D, 2003, J SPORT SCI, V21, P13, DOI 10.1080/0264041031000070912; Bishop D, 2002, MED SCI SPORT EXER, V34, P1041, DOI 10.1097/00005768-200206000-00022; Bjerkefors A, 2006, EUR J APPL PHYSIOL, V97, P613, DOI 10.1007/s00421-006-0231-8; Bouzid MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090420; Crewther BT, 2011, SPORTS MED, V41, P103, DOI 10.2165/11539170-000000000-00000; Davranche K, 2009, J SPORT EXERCISE PSY, V31, P554, DOI 10.1123/jsep.31.4.554; Ferreira HF, 2015, J ANDALUZA SPORT MED, V12, P120; Ferreira HF, 2014, J EXERCISE PHYSL, V17, P34; Ferreira HF, 2012, FIEP B, V1, P12; Ferreira HF, 2015, J ANDALUZA SPORT MED, V2, P1; Ferreira HF, 2008, EF DEPORTES J, V13, P1; FERREIRA HF, 2015, J EXERCISE PHYSL, V18, P84; FLYNN MG, 1994, INT J SPORTS MED, V15, P21, DOI 10.1055/s-2007-1021014; Janssen I, 2010, SPORT BIOMECH, V9, P47, DOI 10.1080/14763141003690229; Meyer T, 2001, MED SCI SPORT EXER, V33, P549; Minematsu T, 2013, WOUND REPAIR REGEN, V21, P329, DOI 10.1111/wrr.12017; Mujika I, 1996, MED SCI SPORT EXER, V28, P251, DOI 10.1097/00005768-199602000-00015; Paschalis V, 2005, INT J SPORTS MED, V26, P827, DOI 10.1055/s-2005-837461; RIDGE BR, 1976, MED SCI SPORT EXER, V8, P18; Santhiago V, 2011, J STRENGTH COND RES, V25, P825, DOI 10.1519/JSC.0b013e3181c69996; Schroder H, 2001, EUR J NUTR, V40, P178, DOI 10.1007/s003940170006; SHEPHARD RJ, 1987, SPORTS MED, V4, P19, DOI 10.2165/00007256-198704010-00003; Sondergaard E, 2014, METABOLISM, V63, P61, DOI 10.1016/j.metabol.2013.08.011; Subudhi AW, 2001, INT J SPORT NUTR EXE, V11, P32, DOI 10.1123/ijsnem.11.1.32; Tanhoffer R., 2013, J EXER PHYS ONLINE, V16, P53; Teixeira VH, 2013, J SPORT MED PHYS FIT, V53, P71; Teixeira V, 2009, INT J SPORT NUTR EXE, V19, P443, DOI 10.1123/ijsnem.19.5.443; TESCH PA, 1984, EUR J APPL PHYSIOL O, V52, P441, DOI 10.1007/BF00943377; van Someren KA, 2000, INT J SPORTS MED, V21, P200; van Someren KA, 2002, INT J SPORTS MED, V23, P28, DOI 10.1055/s-2002-19268; van Someren KA, 2008, INTJ SPORT PHYSIOL, V3, P207, DOI 10.1123/ijspp.3.2.207; Vollaard NBJ, 2006, MED SCI SPORT EXER, V38, P1335, DOI 10.1249/01.mss.0000227320.23847.80; Wozniak A, 2007, EUR J APPL PHYSIOL, V100, P137, DOI 10.1007/s00421-007-0404-0; You ZS, 2002, GENE DEV, V16, P1182, DOI 10.1101/gad.985302; Zeni AI, 1996, JAMA-J AM MED ASSOC, V275, P1424, DOI 10.1001/jama.275.18.1424; Ziolkowski W, 2015, FREE RADICAL RES, V49, P7, DOI 10.3109/10715762.2014.968147; Ziouzenkova O, 1996, J LIPID RES, V37, P1936	43	4	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153709	10.1371/journal.pone.0153709	http://dx.doi.org/10.1371/journal.pone.0153709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111088	gold, Green Published			2022-12-27	WOS:000374970600020
J	Meyers, DJ; Ozonoff, A; Baruwal, A; Pande, S; Harsha, A; Sharma, R; Schwarz, D; Schwarz, RK; Bista, D; Halliday, S; Maru, DSR				Meyers, David J.; Ozonoff, Al; Baruwal, Ashma; Pande, Sami; Harsha, Alex; Sharma, Ranju; Schwarz, Dan; Schwarz, Ryan K.; Bista, Deepak; Halliday, Scott; Maru, Duncan S. R.			Combining Healthcare-Based and Participatory Approaches to Surveillance: Trends in Diarrheal and Respiratory Conditions Collected by a Mobile Phone System by Community Health Workers in Rural Nepal	PLOS ONE			English	Article							INFLUENZA-LIKE ILLNESS; GENERAL-POPULATION; DISEASE; BANGLADESH; COVERAGE; WEB	Background Surveillance systems are increasingly relying upon community-based or crowd-sourced data to complement traditional facilities-based data sources. Data collected by community health workers during the routine course of care could combine the early warning power of community-based data collection with the predictability and diagnostic regularity of facility data. These data could inform public health responses to epidemics and spatially-clustered endemic diseases. Here, we analyze data collected on a daily basis by community health workers during the routine course of clinical care in rural Nepal. We evaluate if such community-based surveillance systems can capture temporal trends in diarrheal diseases and acute respiratory infections. Methods During the course of their clinical activities from January to December 2013, community health workers recorded healthcare encounters using mobile phones. In parallel, we accessed condition-specific admissions from 2011-2013 in the hospital from which the community health program was based. We compared diarrhea and acute respiratory infection rates from both the hospital and the community, and assigned three categories of local disease activity (low, medium, and high) to each week in each village cluster with categories determined by tertiles. We compared condition-specific mean hospital rates across categories using ANOVA to assess concordance between hospital and community-collected data. Results There were 2,710 cases of diarrhea and 373 cases of acute respiratory infection reported by community health workers during the one-year study period. At the hospital, the average weekly incidence of diarrhea and acute respiratory infections over the three-year period was 1.8 and 3.9 cases respectively per 1,000 people in each village cluster. In the community, the average weekly rate of diarrhea and acute respiratory infections was 2.7 and 0.5 cases respectively per 1,000 people. Both diarrhea and acute respiratory infections exhibited significant differences between the three categories of disease rate burden (diarrhea p = 0.009, acute respiratory infection p = 0.001) when comparing community health worker-collected rates to hospital rates. Conclusion Community-level data on diarrhea and acute respiratory infections modestly correlated with hospital data for the same condition in each village each week. Our experience suggests that community health worker-collected data on mobile phones may be a feasible adjunct to other community-and healthcare-related data sources for surveillance of such conditions. Such systems are vitally needed in resource-limited settings like rural Nepal.	[Meyers, David J.; Baruwal, Ashma; Harsha, Alex; Schwarz, Dan; Schwarz, Ryan K.; Bista, Deepak; Halliday, Scott; Maru, Duncan S. R.] Bayalpata Hosp, Possible, Sanfebagar 10, Achham, Nepal; [Meyers, David J.] Harvard Univ, Dept Hlth Policy & Management, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Ozonoff, Al] Boston Childrens Hosp, Ctr Patient Safety & Qual Res, Boston, MA USA; [Ozonoff, Al; Harsha, Alex] Harvard Univ, Sch Med, Boston, MA USA; [Pande, Sami] United Nations Populat Fund, Kathmandu, Nepal; [Sharma, Ranju] Medic Mobile, San Francisco, CA USA; [Schwarz, Dan; Schwarz, Ryan K.; Halliday, Scott; Maru, Duncan S. R.] Brigham & Womens Hosp, Dept Med, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Schwarz, Dan; Schwarz, Ryan K.; Maru, Duncan S. R.] Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA; [Halliday, Scott] Univ Washington, Henry M Jackson Sch Int Studies, Seattle, WA 98195 USA; [Maru, Duncan S. R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; United Nations Population Fund; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School	Maru, DSR (corresponding author), Bayalpata Hosp, Possible, Sanfebagar 10, Achham, Nepal.; Maru, DSR (corresponding author), Brigham & Womens Hosp, Dept Med, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.; Maru, DSR (corresponding author), Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA.; Maru, DSR (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA USA.	duncan@possiblehealth.org	Meyers, David J/AFI-1703-2022; Urzua, Andrea Silva/AAS-7284-2020	Meyers, David J/0000-0002-4081-1751; Halliday, Scott/0000-0003-1178-6937; Maru, Duncan/0000-0002-5923-6910	Grand Challenges Canada; Government of Canada; Thrasher Research Fund	Grand Challenges Canada(CGIAR); Government of Canada(CGIAR); Thrasher Research Fund	This work was supported by a "Stars in Global Health" grant from Grand Challenges Canada. Grand Challenges Canada is funded by the Government of Canada and is dedicated to supporting Bold Ideas with Big Impact in global health. This work was also supported by an "Early Career Award" from the Thrasher Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouzou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088939; Aryal Umesh Raj, 2012, BMC Res Notes, V5, P489, DOI 10.1186/1756-0500-5-489; Bodnar T, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P651, DOI 10.1145/2567948.2579272; Bodnar T, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P699; Breiman RF, 2004, LANCET, V364, P2204, DOI 10.1016/S0140-6736(04)17593-4; Brinkel J, 2014, INT J ENV RES PUB HE, V11, P11559, DOI 10.3390/ijerph111111559; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Central Bureau of Statistics, 2012, NAT POP HOUS CENS 20; Chang AY, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-49; Chretien JP, 2008, PLOS MED, V5, P367, DOI 10.1371/journal.pmed.0050072; Darmstadt GL, 2010, HEALTH POLICY PLANN, V25, P112, DOI 10.1093/heapol/czp048; Friesema IHM, 2009, VACCINE, V27, P6353, DOI 10.1016/j.vaccine.2009.05.042; Goutard FL, 2015, PREV VET MED, V120, P12, DOI 10.1016/j.prevetmed.2015.02.014; Government of Nepal National Planning Commission, 2014, NEP HUM DEV REP 2014; Huaman MA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-16; Huang CY, 2011, TECHNOL FORECAST SOC, V78, P703, DOI 10.1016/j.techfore.2010.10.009; Johansson M, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P695; Kasolo F, 2013, BIOSECUR BIOTERROR, V11, P163, DOI 10.1089/bsp.2013.0032; Kostkova P., 2013, P 22 INT C WORLD WID, P687; Kostkova P, 2013, J MED INTERNET RES, V15, P167, DOI 10.2196/jmir.2146; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Lazarus R, 2002, EMERG INFECT DIS, V8, P753, DOI 10.3201/eid0808.020239; Lewis MD, 2002, AM J PREV MED, V23, P180, DOI 10.1016/S0749-3797(02)00490-7; Mallat SG, 2014, BMC PUBLIC HEALTH, V14, P1; Marquet RL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-242; McNeill A, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P673, DOI 10.1145/2567948.2579280; Ministry of Health and Population (MOHP), 2012, NEP DEM HLTH SURV 20; Otieno CF, 2012, J COMMUN HEALTH, V37, P48, DOI 10.1007/s10900-011-9414-2; Paolotti D, 2014, CLIN MICROBIOL INFEC, V20, P17, DOI 10.1111/1469-0691.12477; Rajput ZA, 2012, J AM MED INFORM ASSN, V19, P655, DOI 10.1136/amiajnl-2011-000476; Rosenthal EL, 2011, J AMBUL CARE MANAG, V34, P247, DOI 10.1097/JAC.0b013e31821c64d7; Seddon D, 2002, CRIT ASIAN STUD, V34, P19, DOI 10.1080/146727102760166581; Shears P, 2000, ACTA TROP, V76, P3, DOI 10.1016/S0001-706X(00)00081-4; Susumpow P, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P663, DOI 10.1145/2567948.2579273; THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; van der Goot E, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P703; World Health Organization, 2014, TOP 10 CAUS DEATH; Yom-Tov E., 2015, P 5 INT C DIG HLTH 2, P115, DOI DOI 10.1145/2750511.2750512; Zaidi SMA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002574	41	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0152738	10.1371/journal.pone.0152738	http://dx.doi.org/10.1371/journal.pone.0152738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27111734	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600004
J	Gallay, PA; Chatterji, U; Bobardt, MD; Long, ZY; Zhang, SL; Su, Z				Gallay, Philippe A.; Chatterji, Udayan; Bobardt, Michael D.; Long, Zhengyu; Zhang, Shengli; Su, Zhuang			Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; GENOTYPE 1 INFECTION; NS5A DOMAIN-II; CYCLOSPORINE-A; ISOMERASE ACTIVITY; ALISPORIVIR PLUS; BINDING-SITE; REPLICATION; RESISTANCE; INTERFERON	Shortened current direct-acting antiviral (DAA) therapies while less expensive, have not provided satisfactory efficacy in naive cirrhotics, treatment experienced non-cirrhotics or even genotype-3 (GT3)-infected patients. Since DAA regimens consist of the same classes of inhibitors-NS5A (NS5Ai) and NS5B (NS5Bi) +/- NS3 (NS3i) inhibitors-it is likely that their costs will be high and will provide similar degrees of protection. Integrating drugs with distinct mechanisms of action (MoA) into DAA regimens could provide the solution for shortening the period of treatment. One such class of agents is the cyclophilin inhibitors (CypI), which has shown efficacy in patients. Resistance-associated variants persist for years post-treatment in patients exposed to NS5Ai or NS5Bi who fail to achieve a sustained virologic response, impairing their chance for cure on retreatment with existing DAA combinations. Because of their high barrier to resistance, CypI may be particularly useful as a rescue therapy for patients who have relapsed with DAA resistance-associated variants. In this study, we analyzed the anti-HCV properties of the novel cyclosporine A (CsA) derivate-STG-175. The non-immunosuppressive STG-175 possesses a high (EC50 11.5-38.9 nM) multi-genotypic (GT1a to 4a) anti-HCV activity. STG-175 clears cells from HCV since no viral replication rebound was observed after cessation of drug treatment. It presents a higher barrier to resistance than other CypI or selected DAAs. HCV variants, which emerged under STG-175 pressure, are only similar to 2-fold resistant to the drug. No cross-resistance was observed with DAAs STG-175 was efficacious against DAA-resistant HCV variants. Drug combination studies revealed that STG-175 provides additive and synergistic effects against GT1a to 4a. STG-175 inhibits the infection of HCV, HIV-1 and HBV in mono-, dual-and triple-infection settings. Altogether these results suggest that the new CypI STG-175 represents an attractive drug partner for IFN-free DAA regimens for the treatment of HCV and co-infections.	[Gallay, Philippe A.; Chatterji, Udayan; Bobardt, Michael D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Long, Zhengyu; Zhang, Shengli; Su, Zhuang] S&T Global Inc, 470 Wildwood Ave,Unit 3, Woburn, MA 01801 USA	Scripps Research Institute	Gallay, PA (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Su, Z (corresponding author), S&T Global Inc, 470 Wildwood Ave,Unit 3, Woburn, MA 01801 USA.	gallay@scripps.edu; zhuang.su@stglobalinc.com			U.S. Public Health Service grant from the National Institute of Allergy and Infectious Diseases (NIAID) [AI087746]; ST Global [2179]; S T Global, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087746, R01AI105007] Funding Source: NIH RePORTER	U.S. Public Health Service grant from the National Institute of Allergy and Infectious Diseases (NIAID); ST Global; S T Global, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. Public Health Service grant no. Grant no. AI087746 (P.A.G.) from the National Institute of Allergy and Infectious Diseases (NIAID) (https://www.niaid.nih.gov) and a Special Funding Project 2179 from S&T Global (http://www.stglobalinc.com). S & T Global, Inc. provided support in the form of salaries for authors ZL, SZ and ZS, and also play additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Ansari IUH, 2013, VIROLOGY, V436, P268, DOI 10.1016/j.virol.2012.11.018; Ansari IUH, 2012, VIRUSES-BASEL, V4, P3303, DOI 10.3390/v4123303; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; BAUMANN G, 1992, TRANSPLANT P, V24, P43; Berger C, 2014, GASTROENTEROLOGY, V147, P1094, DOI 10.1053/j.gastro.2014.07.019; Bobardt MD, 2008, P NATL ACAD SCI USA, V105, P5525, DOI 10.1073/pnas.0801388105; Buti M, 2015, J VIRAL HEPATITIS, V22, P596, DOI 10.1111/jvh.12360; Chatterji U, 2015, ANTIMICROB AGENTS CH; Chatterji U, 2014, ANTIMICROB AGENTS CH, V58, P3327, DOI 10.1128/AAC.00016-14; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; Cross TJS, 2008, POSTGRAD MED J, V84, DOI 10.1136/pgmj.2008.068205; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P231, DOI 10.1053/j.gastro.2005.11.010; Dorner M, 2013, NATURE, V501, P237, DOI 10.1038/nature12427; Dvory-Sobol H, 2015, J HEPATOL, V62, pS221, DOI 10.1016/S0168-8278(15)30073-8; Eyre Nicholas S, 2014, Gastroenterology, V147, P959, DOI 10.1053/j.gastro.2014.09.024; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; FISCHER G, 1984, BIOCHIM BIOPHYS ACTA, V791, P87, DOI 10.1016/0167-4838(84)90285-1; Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; Gaither LA, 2010, VIROLOGY, V397, P43, DOI 10.1016/j.virol.2009.10.043; Gallay PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134707; Garcia-Rivera JA, 2012, ANTIMICROB AGENTS CH, V56, P5113, DOI 10.1128/AAC.00919-12; Gawlik K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088866; Grise H, 2012, J VIROL, V86, P4811, DOI 10.1128/JVI.06641-11; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hansson MJ, 2015, CHEM BIOL, V22, P285, DOI 10.1016/j.chembiol.2014.10.023; Hopkins S, 2012, ANTIMICROB AGENTS CH, V56, P3888, DOI 10.1128/AAC.00693-12; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krishnan P, 2015, J HEPATOL, V62, pS220, DOI 10.1016/S0168-8278(15)30071-4; Liu SK, 2004, NUCLEIC ACIDS RES, V32, P3752, DOI 10.1093/nar/gkh715; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Madan V, 2014, GASTROENTEROLOGY, V146, P1361, DOI 10.1053/j.gastro.2014.01.055; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Pawlotsky JM, 2015, NAT REV GASTRO HEPAT, V12, P673, DOI 10.1038/nrgastro.2015.184; Pawlotsky JM, 2015, HEPATOLOGY, V62, P1013, DOI 10.1002/hep.27960; Pawlotsky JM, 2014, SEMIN LIVER DIS, V34, P22, DOI 10.1055/s-0034-1371007; Phillips S, 2015, GASTROENTEROLOGY, V148, P403, DOI 10.1053/j.gastro.2014.10.004; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; Robinson M, 2010, ANTIMICROB AGENTS CH, V54, P3099, DOI 10.1128/AAC.00289-10; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Rosnoblet C, 2012, J BIOL CHEM, V287, P44249, DOI 10.1074/jbc.M112.392209; Saeed M, 2012, ANTIMICROB AGENTS CH, V56, P5365, DOI 10.1128/AAC.01256-12; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; Soriano V, 2008, EXPERT OPIN EMERG DR, V13, P1, DOI 10.1517/14728214.13.1.1 ; Sy Theodore, 2006, Int J Med Sci, V3, P41; Tiongyip C, 2011, 6 INT WORKSH HEP C R; Tong MJ, 1997, HEPATOLOGY, V26, P747, DOI 10.1002/hep.510260330; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; U.S. Food and Drug Administration, 2014, SOVALDITM SOFOSBUVIR; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118; Zeuzem S, 2015, ALIMENT PHARM THER, V42, P829, DOI 10.1111/apt.13342; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	68	5	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0152036	10.1371/journal.pone.0152036	http://dx.doi.org/10.1371/journal.pone.0152036			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104614	Green Published, gold			2022-12-27	WOS:000374565100003
J	Hou, X; Xiao, M; Chen, SCA; Wang, H; Zhang, L; Fan, X; Xu, ZP; Cheng, JW; Kong, FR; Zhao, YP; Xu, YC				Hou, Xin; Xiao, Meng; Chen, Sharon C-A; Wang, He; Zhang, Li; Fan, Xin; Xu, Zhi-Peng; Cheng, Jing-Wei; Kong, Fanrong; Zhao, Yu-Pei; Xu, Ying-Chun			Sequencer-Based Capillary Gel Electrophoresis (SCGE) Targeting the rDNA Internal Transcribed Spacer (ITS) Regions for Accurate Identification of Clinically Important Yeast Species	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; ROLLING-CIRCLE AMPLIFICATION; MULTIPLEX PCR ASSAY; MEDICALLY IMPORTANT; CANDIDA-GLABRATA; PATHOGENIC YEASTS; GROUP-II; CHINA; SURVEILLANCE; FUNGAL	Accurate species identification of Candida, Cryptococcus, Trichosporon and other yeast pathogens is important for clinical management. In the present study, we developed and evaluated a yeast species identification scheme by determining the rDNA internal transcribed spacer (ITS) region length types (LTs) using a sequencer-based capillary gel electrophoresis (SCGE) approach. A total of 156 yeast isolates encompassing 32 species were first used to establish a reference SCGE ITS LT database. Evaluation of the ITS LT database was then performed on (i) a separate set of (n = 97) clinical isolates by SCGE, and (ii) 41 isolates of 41 additional yeast species from GenBank by in silico analysis. Of 156 isolates used to build the reference database, 41 ITS LTs were identified, which correctly identified 29 of the 32 (90.6%) species, with the exception of Trichosporon asahii, Trichosporon japonicum and Trichosporon asteroides. In addition, eight of the 32 species revealed different electropherograms and were subtyped into 2-3 different ITS LTs each. Of the 97 test isolates used to evaluate the ITS LT scheme, 96 (99.0%) were correctly identified to species level, with the remaining isolate having a novel ITS LT. Of the additional 41 isolates for in silico analysis, none was misidentified by the ITS LT database except for Trichosporon mucoides whose ITS LT profile was identical to that of Trichosporon dermatis. In conclusion, yeast identification by the present SCGE ITS LT assay is a fast, reproducible and accurate alternative for the identification of clinically important yeasts with the exception of Trichosporon species.	[Hou, Xin; Xiao, Meng; Wang, He; Zhang, Li; Fan, Xin; Xu, Zhi-Peng; Cheng, Jing-Wei; Xu, Ying-Chun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China; [Hou, Xin; Xiao, Meng; Wang, He; Zhang, Li; Fan, Xin; Xu, Zhi-Peng; Cheng, Jing-Wei] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing 100730, Peoples R China; [Chen, Sharon C-A; Kong, Fanrong] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Lab Serv,ICPMR Pathol West, Darcy Rd, Westmead, NSW 2145, Australia; [Zhao, Yu-Pei] Chinese Acad Med Sci, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Sydney; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Xu, YC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008	National Research Special Fund for Public Welfare Industry of Health of China [201402001]	National Research Special Fund for Public Welfare Industry of Health of China	This work was funded by the National Research Special Fund for Public Welfare Industry of Health of China (grant number 201402001), http://www.nhfpc.gov.cn/zwgkzt/pkjjy1/201302/9cb220c8a5704c0a9ebf5ef65a337544.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; Borman AM, 2010, J CLIN MICROBIOL, V48, P3648, DOI 10.1128/JCM.01071-10; Bougnoux ME, 2004, INFECT GENET EVOL, V4, P243, DOI 10.1016/j.meegid.2004.06.002; Capoor MR, 2014, INDIAN J MED MICROBI, V32, P304, DOI 10.4103/0255-0857.136576; Cendejas-Bueno E, 2012, J CLIN MICROBIOL, V50, P3641, DOI 10.1128/JCM.02248-12; Chagas-Neto TC, 2009, J CLIN MICROBIOL, V47, P1074, DOI 10.1128/JCM.01614-08; Chitasombat MN, 2012, J INFECTION, V64, P68, DOI 10.1016/j.jinf.2011.11.002; Roman ADE, 2014, INT J STD AIDS, V25, P70, DOI 10.1177/0956462413487716; Dignani Maria Cecilia, 2014, F1000Prime Rep, V6, P81, DOI 10.12703/P6-81; Fan X, 2014, CHINESE MED J-PEKING, V127, P4226, DOI 10.3760/cma.j.issn.0366-6999.20142048; Fan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106949; Gil-Alonso S, 2015, ANTIMICROB AGENTS CH, V59, P3615, DOI 10.1128/AAC.04474-14; Gray TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102290; Guo LN, 2011, J CLIN MICROBIOL, V49, P3805, DOI 10.1128/JCM.00937-11; Katsu M, 2004, FEMS YEAST RES, V4, P377, DOI 10.1016/S1567-1356(03)00176-4; Kwon-Chung KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019760; Mallus F, 2013, J MICROBIOL METH, V92, P150, DOI 10.1016/j.mimet.2012.11.022; Merseguel KB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0793-3; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Monstein HJ, 2014, J MICROBIOL METH, V96, P81, DOI 10.1016/j.mimet.2013.11.004; Nilsson RH, 2015, MICROBES ENVIRON, V30, P145, DOI 10.1264/jsme2.ME14121; Pannanusorn S, 2012, MYCOSES, V55, P172, DOI 10.1111/j.1439-0507.2011.02064.x; Playford EG, 2006, J CLIN MICROBIOL, V44, P876, DOI 10.1128/JCM.44.3.876-880.2006; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sugita T, 2004, J CLIN MICROBIOL, V42, P5467, DOI 10.1128/JCM.42.12.5467-5471.2004; Swoboda-Kopec E, 2014, MYCOSES, V57, P747, DOI 10.1111/myc.12264; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5593, DOI 10.1128/JCM.43.11.5593-5600.2005; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Wang H, 2012, J CLIN MICROBIOL, V50, P3952, DOI 10.1128/JCM.01130-12; Wehrhahn MC, 2012, J CLIN MICROBIOL, V50, P3478, DOI 10.1128/JCM.01311-12; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xiao M, 2016, J CLIN MICROBIOL, V54, P226, DOI 10.1128/JCM.02830-15; Xiao M, 2014, J CLIN MICROBIOL, V52, P3044, DOI 10.1128/JCM.00246-14; Xiao M, 2013, MED MYCOL, V51, P300, DOI 10.3109/13693786.2012.723223; Xiao M, 2012, J CLIN MICROBIOL, V50, P2755, DOI 10.1128/JCM.00777-12; Zhang L, 2014, J CLIN MICROBIOL, V52, P572, DOI 10.1128/JCM.02543-13; Zhao Y, 2015, INT J MOL SCI, V16, P25067, DOI 10.3390/ijms161025067; Zhou XY, 2008, J CLIN MICROBIOL, V46, P2423, DOI 10.1128/JCM.00420-08	38	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154385	10.1371/journal.pone.0154385	http://dx.doi.org/10.1371/journal.pone.0154385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105313	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100072
J	Mahmood, L; Hopthrow, T; de Moura, GR				Mahmood, Lynsey; Hopthrow, Tim; de Moura, Georgina Randsley			A Moment of Mindfulness: Computer-Mediated Mindfulness Practice Increases State Mindfulness	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; STRESS REDUCTION; METAANALYSIS; MIND; INTERVENTION; ANXIETY; MECHANISMS; DEPRESSION; SYMPTOMS	Three studies investigated the use of a 5-minute, computer-mediated mindfulness practice in increasing levels of state mindfulness. In Study 1, 54 high school students completed the computer-mediated mindfulness practice in a lab setting and Toronto Mindfulness Scale (TMS) scores were measured before and after the practice. In Study 2 (N = 90) and Study 3 (N = 61), the mindfulness practice was tested with an entirely online sample to test the delivery of the 5-minute mindfulness practice via the internet. In Study 2 and 3, we found a significant increase in TMS scores in the mindful condition, but not in the control condition. These findings highlight the impact of a brief, mindfulness practice for single-session, computermediated use to increase mindfulness as a state.	[Mahmood, Lynsey; Hopthrow, Tim; de Moura, Georgina Randsley] Univ Kent, Sch Psychol, Ctr Study Grp Proc, Canterbury, Kent, England	University of Kent	Mahmood, L (corresponding author), Univ Kent, Sch Psychol, Ctr Study Grp Proc, Canterbury, Kent, England.	lm455@kent.ac.uk	Mahmood, Lynsey/H-8857-2019	Mahmood, Lynsey/0000-0002-8433-1637; Hopthrow, Tim/0000-0003-2331-7150				Aikens KA, 2014, J OCCUP ENVIRON MED, V56, P721, DOI 10.1097/JOM.0000000000000209; Allexandre D, 2012, INT RES C INT MED HL; Beattie A, 2008, HLTH EXPECTATIONS, V12, P45, DOI [10.1111/j.1369-7625.2008.00531.x, DOI 10.1111/J.1369.7625.2008.00531.X]; Behrend TS, 2011, BEHAV RES METHODS, V43, P800, DOI 10.3758/s13428-011-0081-0; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Boettcher J, 2014, BEHAV THER, V45, P241, DOI 10.1016/j.beth.2013.11.003; Bohlmeijer E, 2010, J PSYCHOSOM RES, V68, P539, DOI 10.1016/j.jpsychores.2009.10.005; Brown KW, 2007, PSYCHOL INQ, V18, P211, DOI 10.1080/10478400701598298; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Carmody J, 2009, J CLIN PSYCHOL, V65, P613, DOI 10.1002/jclp.20579; Cavanagh K, 2013, BEHAV RES THER, V51, P573, DOI 10.1016/j.brat.2013.06.003; Christensen H, 2006, PSYCHOL MED, V36, P1737, DOI 10.1017/S0033291706008695; Cleirigh DO, 2015, MINDFULNESS, V6, P601, DOI 10.1007/s12671-014-0295-1; Cropley M, 2007, ADDICTION, V102, P989, DOI 10.1111/j.1360-0443.2007.01832.x; Erisman SM, 2010, EMOTION, V10, P72, DOI 10.1037/a0017162; Frewen P., 2011, MINDFULNESS, V2, P254, DOI [10.1007/s12671-011-0069-y, DOI 10.1007/S12671-011-0069-Y]; Friese M, 2012, CONSCIOUS COGN, V21, P1016, DOI 10.1016/j.concog.2012.01.008; Gluck TM, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-175; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Greenberg J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036206; Hanley A, 2015, MINDFULNESS, V6, P202, DOI 10.1007/s12671-013-0245-3; Heppner WL, 2008, AGGRESSIVE BEHAV, V34, P486, DOI 10.1002/ab.20258; Hopthrow T, 2017, Q J EXP PSYCHOL, V70, P351, DOI 10.1080/17470218.2016.1149498; Johnson S, 2015, MINDFULNESS, V6, P88, DOI 10.1007/s12671-013-0234-6; Jordan CH, 2014, PERS INDIV DIFFER, V68, P107, DOI 10.1016/j.paid.2014.04.013; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Keng SL, 2011, CLIN PSYCHOL REV, V31, P1041, DOI 10.1016/j.cpr.2011.04.006; Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005; Kiken LG, 2015, PERS INDIV DIFFER, V81, P41, DOI 10.1016/j.paid.2014.12.044; Krusche A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003498; Krusche A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000803; Lau MA, 2006, J CLIN PSYCHOL, V62, P1445, DOI 10.1002/jclp.20326; Mindful, 2012, BOD SCAN PRACT; Mohan A, 2011, J ALTERN COMPLEM MED, V17, P207, DOI 10.1089/acm.2010.0142; Morledge TJ, 2013, ANN BEHAV MED, V46, P137, DOI 10.1007/s12160-013-9490-x; Mrazek MD, 2013, PSYCHOL SCI, V24, P776, DOI 10.1177/0956797612459659; Mrazek MD, 2012, EMOTION, V12, P442, DOI 10.1037/a0026678; Ostafin BD, 2012, CONSCIOUS COGN, V21, P1031, DOI 10.1016/j.concog.2012.02.014; Piet J, 2012, J CONSULT CLIN PSYCH, V80, P1007, DOI 10.1037/a0028329; Piet J, 2011, CLIN PSYCHOL REV, V31, P1032, DOI 10.1016/j.cpr.2011.05.002; Shapiro SL, 2006, J CLIN PSYCHOL, V62, P373, DOI 10.1002/jclp.20237; Singh NN, 2008, BEHAV COGN PSYCHOTH, V36, P659, DOI 10.1017/S1352465808004827; Singh NN, 2003, RES DEV DISABIL, V24, P158, DOI 10.1016/S0891-4222(03)00026-X; Spielberger CD, 1994, STATE TRAIT ANXIETY; Tacon AM, 2004, FAMILIES SYSTEMS HLT, V22, P193, DOI DOI 10.1037/1091-7527.22.2.193; Tanay G, 2012, BEHAV THER, V43, P492, DOI 10.1016/j.beth.2011.06.003; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Weger UW, 2012, CONSCIOUS COGN, V21, P471, DOI 10.1016/j.concog.2011.10.011; Wilson TD, 2014, SCIENCE, V345, P75, DOI 10.1126/science.1250830; Wolever RQ, 2012, J OCCUP HEALTH PSYCH, V17, P246, DOI 10.1037/a0027278; Zeidan F, 2010, J PAIN, V11, P199, DOI 10.1016/j.jpain.2009.07.015	52	30	32	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153923	10.1371/journal.pone.0153923	http://dx.doi.org/10.1371/journal.pone.0153923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27105428	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000374565100028
J	Maranda, L; Gupta, OT				Maranda, Louise; Gupta, Olga T.			Association between Responsible Pet Ownership and Glycemic Control in Youths with Type 1 Diabetes	PLOS ONE			English	Article							HUMAN HEALTH; METABOLIC-CONTROL; SELF-MANAGEMENT; ADOLESCENTS; ADHERENCE; CHILDREN; ANIMALS; CARE	Type 1 diabetes mellitus (T1DM) a chronic characterized by an absolute insulin deficiency requires conscientious patient self-management to maintain glucose control within a normal range. Family cohesion and adaptability, positive coping strategies, social support and adequate self-regulatory behavior are found to favorably influence glycemic control. Our hypothesis was that the responsible care of a companion animal is associated with these positive attributes and correlated with the successful management of a chronic illness such as type 1 diabetes. We recruited 223 youths between 9 and 19 years of age from the Pediatric Diabetes clinic at the University of Massachusetts Medical School, reviewed the status of their glycemic control (using three consecutive A1c values) and asked them questions about the presence of a pet at home, and their level of involvement with its care. Multivariate analyses show that children who care actively for one or more pets at home are 2.5 times more likely to have control over their glycemic levels than children who do not care for a pet, adjusting for duration of disease, socio-economic status, age and self-management [1.1 to 5.8], p(Wald) = 0.032. A separate model involving the care of a petdog only yielded comparable results (ORa = 2.6 [1.1 to 5.9], p(Wald) = 0.023).	[Maranda, Louise] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Gupta, Olga T.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Endocrinol, Dallas, TX 75390 USA; [Maranda, Louise] UMass Med Sch, Dept Quantitat Hlth Sci, Albert Sherman Ctr, AS6-1063,55 Lave Ave North, Worcester, MA 01655 USA; [Gupta, Olga T.] Univ Texas SW Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Massachusetts System; University of Massachusetts Worcester; University of Texas System; University of Texas Southwestern Medical Center Dallas	Maranda, L (corresponding author), Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA.; Maranda, L (corresponding author), UMass Med Sch, Dept Quantitat Hlth Sci, Albert Sherman Ctr, AS6-1063,55 Lave Ave North, Worcester, MA 01655 USA.	louise.maranda@umassmed.edu	Maranda, Louise/C-7304-2017	Maranda, Louise/0000-0003-2913-2552	Eunice Kennedy Shriver National Institute of Child Health & Human Development; WALTHAM Centre for Pet Nutrition, a division of Mars, Incorporated;  [R03-HD071263-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD071263] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); WALTHAM Centre for Pet Nutrition, a division of Mars, Incorporated; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project described was supported by Grant Number R03-HD071263-01, co-funded by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (www.nichd.nih.gov) and WALTHAM Centre for Pet Nutrition (www.mars.com), a division of Mars, Incorporated. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institutes of Health, or Mars-Waltham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, DIABETES CARE, V28, pS4; Barker SB, 2003, AM BEHAV SCI, V47, P94, DOI 10.1177/0002764203255215; Downs TJ, ENV HLTH PERSPEC, V118, P1318; Greening L, 2007, J PEDIATR PSYCHOL, V32, P437, DOI 10.1093/jpepsy/jsl029; Hanna KM, 2005, J PEDIATR PSYCHOL, V30, P257, DOI 10.1093/jpepsy/jsi036; Hermanns N, 2007, DIABETOLOGIA, V50, P930, DOI 10.1007/s00125-007-0643-y; Iannotti RJ, 2006, J DEV BEHAV PEDIATR, V27, P98, DOI 10.1097/00004703-200604000-00003; King PS, 2012, J ADOLESCENT HEALTH, V50, P491, DOI 10.1016/j.jadohealth.2011.09.007; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; Mortensen HB, 1998, DIABETIC MED, V15, P752, DOI 10.1002/(SICI)1096-9136(199809)15:9<752::AID-DIA678>3.0.CO;2-W; O'Haire M, 2010, J VET BEHAV, V5, P226, DOI 10.1016/j.jveb.2010.02.002; Ohmann S, 2010, PSYCHOL MED, V40, P95, DOI 10.1017/S0033291709005777; Peel E, 2010, BRIT J GEN PRACT, V60, P570, DOI 10.3399/bjgp10X515061; Rausch JR, 2012, DIABETES CARE, V35, P1219, DOI 10.2337/dc11-2163; Schilling LS, 2009, NURS RES, V58, P228, DOI 10.1097/NNR.0b013e3181ac142a; Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186; Wells DL, 2007, BRIT J HEALTH PSYCH, V12, P145, DOI 10.1348/135910706X103284; Wells DL, 2009, J SOC ISSUES, V65, P523, DOI 10.1111/j.1540-4560.2009.01612.x; Wells DL, 2008, J ALTERN COMPLEM MED, V14, P1235, DOI 10.1089/acm.2008.0288; Yi-Frazier JP, 2012, PSYCHOLOGY, V03, P1116	20	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0152332	10.1371/journal.pone.0152332	http://dx.doi.org/10.1371/journal.pone.0152332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27104736	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100004
J	Ayiasi, RM; Kolsteren, P; Batwala, V; Criel, B; Orach, CG				Ayiasi, Richard Mangwi; Kolsteren, Patrick; Batwala, Vincent; Criel, Bart; Orach, Christopher Garimoi			Effect of Village Health Team Home Visits and Mobile Phone Consultations on Maternal and Newborn Care Practices in Masindi and Kiryandongo, Uganda: A Community-Intervention Trial	PLOS ONE			English	Article							NEONATAL-MORTALITY; BANGLADESH; PREVENT; WORKERS; PACKAGE; DEATHS; IMPACT	Introduction The World Health Organisation recommends home visits conducted by Community Health Workers (in Uganda known as Village Health Teams-VHTs) in order to improve maternal and newborn health. This study measured the effect of home visits combined with mobile phone consultations on maternal and newborn care practices. Method In a community intervention trial design 16 health centres in Masindi and Kiryandongo districts, Uganda were randomly and equally allocated to one of two arms: control and intervention arms. Eight control health centres received the usual maternal and newborn educational messages offered by professional health workers and eight intervention health centres that received an intervention package for maternal care and essential newborn care practices. In the intervention arm VHTs made two prenatal and one postnatal home visit to households. VHTs were provided with mobile phones to enable them make regular telephone consultations with health workers at the health centre serving the catchment area. The primary outcome was health facility delivery. Other outcomes included antenatal attendances, birth preparedness, cord and thermal care and breastfeeding practices. Analysis was by intention-to-treat. Results A total of 1385 pregnant women were analysed: 758 and 627 in the control and intervention arms respectively. Significant post-intervention differences were: delivery place [adjusted Odds Ratio aOR: 17.94(95% CI: 6.26-51.37); p< 0.001], cord care [aOR: 3.05(95% CI: 1.81-5.12); p< 0.001] thermal care [aOR: 7.58(95% CI: 2.52-22.82); p< 0.001], and timely care-seeking for newborn illness [aOR: 4.93(95% CI: 1.59-15.31); p = 0.006]. Conclusion VHTs can have an effect in promoting proper cord and thermal care for the newborn and improve timely care-seeking for health facility delivery and newborn illness, because they could answer questions and refer patients correctly. However, VHTs should be supported by professional health workers through the use of mobile phones.	[Ayiasi, Richard Mangwi; Orach, Christopher Garimoi] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, POB 7072, Kampala, Uganda; [Batwala, Vincent] Mbarara Univ Sci & Technol, POB 1410, Mbarara, Uganda; [Kolsteren, Patrick; Criel, Bart] Inst Trop Med, Natl Str 150, B-2000 Antwerp, Belgium	Makerere University; Mbarara University of Science & Technology; Institute of Tropical Medicine (ITM)	Ayiasi, RM (corresponding author), Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, POB 7072, Kampala, Uganda.	mangwirichard@gmail.com	Urzua, Andrea Silva/AAS-7284-2020		Directorate General for Development Cooperation (DGDC) of Belgium	Directorate General for Development Cooperation (DGDC) of Belgium	Directorate General for Development Cooperation (DGDC) of Belgium. The funders had no role in the study design, data management and manuscript writing.	Alshurafa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049163; Ayiasi MR, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-176; Ayiasi RM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1939-3; Ayiasi RM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-114; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065772; De Amici D, 2000, CONTROL CLIN TRIALS, V21, P103, DOI 10.1016/S0197-2456(99)00054-9; DHO, 2010, MAS DISTR ANN PLAN B; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Government of Uganda, 2010, VHT VILL HLTH TEAM H; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kirkwood BR, 2013, LANCET, V381, P2184, DOI 10.1016/S0140-6736(13)60095-1; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Kumar V, 2010, SEMIN PERINATOL, V34, P446, DOI 10.1053/j.semperi.2010.09.006; Lawn J, 2006, AFRICAS NEWBORNS COU; Lawn JE, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.27363; Ministry of Health, 2010, VHT VILL HLTH TEAM S; Nalwadda CK, 2013, TROP MED INT HEALTH, V18, P898, DOI 10.1111/tmi.12106; Owais A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-239; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Thorpe KE, 2009, CAN MED ASSOC J, V180, pE47, DOI 10.1503/cmaj.090523; Tomlinson M, 2014, TROP MED INT HEALTH, V19, P256, DOI 10.1111/tmi.12257; Treweek S, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-37; UDHS and ICF, 2012, UG DEM HLTH SURV 201; Uganda Bureau of Statistics, 2014, 2014 STAT ABSTR; UGANDA BUREAU OF STATISTICS AND BANK OF UGANDA, 2008, UGANDA WORKERSREMITT; UNICEF, 2014, COMM CHILD SURV PROM; UNICEF, 2009, STATE WORLDS CHILDRE; Waiswa P, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.24584; Waiswa P, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-9; WHO ICM, 2014, TRENDS MAT MORT 1990; WHO/UNICEF, 2009, HOM VIS NEWB CHILD S; World Health Organization, 2015, GLOB STRAT WOM CHILD; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	36	25	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153051	10.1371/journal.pone.0153051	http://dx.doi.org/10.1371/journal.pone.0153051			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101379	Green Published, gold			2022-12-27	WOS:000374898500024
J	Di Mattei, VE; Carnelli, L; Mazzetti, M; Bernardi, M; Di Pierro, R; Bergamini, A; Mangili, G; Candiani, M; Sarno, L				Di Mattei, Valentina E.; Carnelli, Letizia; Mazzetti, Martina; Bernardi, Martina; Di Pierro, Rossella; Bergamini, Alice; Mangili, Giorgia; Candiani, Massimo; Sarno, Lucio			Mental Representations of Illness in Patients with Gestational Trophoblastic Disease: How Do Patients Perceive Their Condition?	PLOS ONE			English	Article							COMMON-SENSE MODEL; CANCER-PATIENTS; PERCEPTION QUESTIONNAIRE; PSYCHOLOGICAL DISTRESS; MOLAR PREGNANCY; DIAGNOSIS; SURVIVORS; ADJUSTMENT; OUTCOMES; HEALTH	Background Gestational Trophoblastic Disease comprises a group of benign and malignant disorders that derive from the placenta. Using Leventhal's Common-Sense Model as a theoretical framework, this paper examines illness perception in women who have been diagnosed with this disease. Methods Thirty-one women diagnosed with Gestational Trophoblastic Disease in a hospital in Italy were asked to complete the Illness Perception Questionnaire-Revised to measure the following: illness Identity, illness opinions and causes of Gestational Trophoblastic Disease. Results High mean scores were observed in the Emotional representations and Treatment control subscales. A significant difference emerged between hydatidiform mole patients and those with gestational trophoblastic neoplasia on the Identity subscale. A significant correlation emerged between "time since diagnosis" and the Treatment control subscale. Discussion This study is the first to investigate illness perception in Gestational Trophoblastic Disease. From a clinical perspective the results highlight the need for multidisciplinary support programs to promote a more realistic illness perception.	[Di Mattei, Valentina E.; Carnelli, Letizia; Mazzetti, Martina; Bernardi, Martina; Candiani, Massimo; Sarno, Lucio] Univ Vita Salute San Raffaele, Milan, Italy; [Di Mattei, Valentina E.; Carnelli, Letizia; Sarno, Lucio] IRCCS San Raffaele Hosp, Clin & Hlth Psychol Unit, Milan, Italy; [Di Pierro, Rossella] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Bergamini, Alice; Mangili, Giorgia; Candiani, Massimo] IRCCS San Raffaele Hosp, Obstet & Gynecol Unit, Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milano-Bicocca; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Carnelli, L (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.; Carnelli, L (corresponding author), IRCCS San Raffaele Hosp, Clin & Hlth Psychol Unit, Milan, Italy.	carnelli.letizia@hsr.it	BERGAMINI, ALICE/AAN-2060-2020; mangili, giorgia/Y-9673-2019; Di Mattei, Valentina/AAC-4634-2022; Candiani, Massimo/ABG-9811-2020	BERGAMINI, ALICE/0000-0002-1915-8313; mangili, giorgia/0000-0002-8451-429X; DI PIERRO, ROSSELLA/0000-0001-7930-1559; CANDIANI, Massimo/0000-0002-2129-2626				Allen JE, 2003, AM J OBSTET GYNECOL, V188, P1151, DOI 10.1067/mob.2003.297; Bess Karen A, 2006, AWHONN Lifelines, V10, P320; Dempster M, 2012, DIS ESOPHAGUS, V25, P222, DOI 10.1111/j.1442-2050.2011.01233.x; Di Mattei VE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128354; Di Mattei VE, 2014, J REPROD MED, V59, P488; Fischer MJ, 2013, BRIT J HEALTH PSYCH, V18, P526, DOI 10.1111/j.2044-8287.2012.02100.x; FLAM F, 1993, J PSYCHOSOM OBST GYN, V14, P241, DOI 10.3109/01674829309084447; Foster NE, 2008, PAIN, V136, P177, DOI 10.1016/j.pain.2007.12.007; Garner E, 2003, BEST PRACT RES CL OB, V17, P959, DOI 10.1016/S1521-6934(03)00093-2; Giardini A, 2007, G Ital Med Lav Ergon, V29, pA64; Gould RV, 2010, PSYCHOL HEALTH, V25, P633, DOI 10.1080/08870440902811163; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Hale ED, 2007, RHEUMATOLOGY, V46, P904, DOI 10.1093/rheumatology/kem060; Hopman P, 2015, PSYCHO-ONCOLOGY, V24, P11, DOI 10.1002/pon.3591; Horowitz NS, 2009, GESTATIONAL TROPHOBL, Vthird, P460; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Ireson J, 2014, J REPROD MED, V59, P195; Jorgensen IL, 2009, ACTA ONCOL, V48, P1119, DOI 10.3109/02841860903033922; Keeling M, 2013, PSYCHO-ONCOLOGY, V22, P1421, DOI 10.1002/pon.3158; Lau R. R., 1983, HEALTH PSYCHOL, V2, P167, DOI [10.1037/0278-6133.2.2.167, DOI 10.1037/0278-6133.2.2.167]; Leventhal H., 1984, HDB PSYCHOL HLTH, V4, P219; Leventhal H., 1982, 20 INT C APPL PSYCH; Leventhal H, 1980, CONTRIBUTIONS MED PS, P17; Llewellyn CD, 2007, J PSYCHOSOM RES, V63, P17, DOI 10.1016/j.jpsychores.2007.01.013; Lurain JR, 2010, AM J OBSTET GYNECOL, V203, P531, DOI 10.1016/j.ajog.2010.06.073; Mangili G, 2014, INT J GYNECOL CANCER, V24, pS109, DOI 10.1097/IGC.0000000000000294; Mangili G, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.036; McCorry NK, 2013, PSYCHO-ONCOLOGY, V22, P692, DOI 10.1002/pon.3054; MEYER D, 1985, HEALTH PSYCHOL, V4, P115, DOI 10.1037/0278-6133.4.2.115; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; NGAN HYS, 1986, J REPROD MED, V31, P173; Parazzini F, 2012, INT J GYNECOL CANCER, V22, P318, DOI 10.1097/IGC.0b013e31823b3504; Paschali AA, 2015, PSYCHO-ONCOLOGY, V24, P901, DOI 10.1002/pon.3741; Petersen RW, 2005, GYNECOL ONCOL, V97, P535, DOI 10.1016/j.ygyno.2005.01.015; Razavi D, 2002, BRIT J CANCER, V87, P1, DOI 10.1038/sj.bjc.6600412; Rozema H, 2009, PSYCHO-ONCOLOGY, V18, P849, DOI 10.1002/pon.1488; Savage PM, 2013, J OBSTET GYNAECOL, V33, P406, DOI 10.3109/01443615.2013.771159; Seckl MJ, 2013, ANN ONCOL, V24, P39, DOI 10.1093/annonc/mdt345; Soper JT, 2006, OBSTET GYNECOL, V108, P176, DOI 10.1097/01.AOG.0000224697.31138.a1; Stafford L, 2011, INT J GYNECOL CANCER, V21, P1256, DOI 10.1097/IGC.0b013e3182259c04; Stafford L, 2011, INT J GYNECOL CANCER, V21, P161, DOI 10.1097/IGC.0b013e31820156d8; Tse KY, 2012, BEST PRACT RES CL OB, V26, P357, DOI 10.1016/j.bpobgyn.2011.11.009; Vaughan R, 2003, BRIT J HEALTH PSYCH, V8, P287, DOI 10.1348/135910703322370860; Ferreira EGV, 2009, J REPROD MED, V54, P239; Walsh JC, 2004, J PSYCHOSOM RES, V56, P67, DOI 10.1016/S0022-3999(03)00082-5; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; WENZEL L, 1992, GYNECOL ONCOL, V46, P74, DOI 10.1016/0090-8258(92)90200-3; Wenzel L, 2004, J REPROD MED, V49, P589; Wenzel L, 2002, J REPROD MED, V47, P387; WENZEL LB, 1994, J REPROD MED, V39, P163	50	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153869	10.1371/journal.pone.0153869	http://dx.doi.org/10.1371/journal.pone.0153869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27101144	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500082
J	Lu, YR; Li, LX; Zhang, H; Yang, YX				Lu, Yanrong; Li, Lixiang; Zhang, Hao; Yang, Yixian			An Extended Chaotic Maps-Based Three-Party Password-Authenticated Key Agreement with User Anonymity	PLOS ONE			English	Article							EXCHANGE PROTOCOL; NETWORKS; SECURITY; EFFICIENT; SCHEMES; MOBILE	User anonymity is one of the key security features of an authenticated key agreement especially for communicating messages via an insecure network. Owing to the better properties and higher performance of chaotic theory, the chaotic maps have been introduced into the security schemes, and hence numerous key agreement schemes have been put forward under chaotic-maps. Recently, Xie et al. released an enhanced scheme under Farash et al.'s scheme and claimed their improvements could withstand the security loopholes pointed out in the scheme of Farash et al., i.e., resistance to the off-line password guessing and user impersonation attacks. Nevertheless, through our careful analysis, the improvements were released by Xie et al. still could not solve the problems troubled in Farash et al. Besides, Xie et al.'s improvements failed to achieve the user anonymity and the session key security. With the purpose of eliminating the security risks of the scheme of Xie et al., we design an anonymous password-based three-party authenticated key agreement under chaotic maps. Both the formal analysis and the formal security verification using AVISPA are presented. Also, BAN logic is used to show the correctness of the enhancements. Furthermore, we also demonstrate that the design thwarts most of the common attacks. We also make a comparison between the recent chaotic-maps based schemes and our enhancements in terms of performance.	[Lu, Yanrong; Li, Lixiang; Zhang, Hao; Yang, Yixian] Beijing Univ Posts & Telecommun, Informat Secur Ctr, State Key Lab Networking & Switching Technol, Beijing 100876, Peoples R China; [Lu, Yanrong; Li, Lixiang; Zhang, Hao; Yang, Yixian] Beijing Univ Posts & Telecommun, Natl Engn Lab Disaster Backup & Recovery, Beijing 100876, Peoples R China	Beijing University of Posts & Telecommunications; Beijing University of Posts & Telecommunications	Li, LX (corresponding author), Beijing Univ Posts & Telecommun, Informat Secur Ctr, State Key Lab Networking & Switching Technol, Beijing 100876, Peoples R China.; Li, LX (corresponding author), Beijing Univ Posts & Telecommun, Natl Engn Lab Disaster Backup & Recovery, Beijing 100876, Peoples R China.	lixiang@bupt.edu.cn	Li, lixiang/G-6222-2011	Li, lixiang/0000-0001-9949-8731; Li, Lixiang/0000-0001-8541-308X	National Natural Science Foundation of China [61472045, 61573067]; Beijing Natural Science Foundation [4142016]; BUPT Excellent Ph.D. Students Foundation [CX2015310]; Asia Foresight Program under NSFC [61411146001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); BUPT Excellent Ph.D. Students Foundation; Asia Foresight Program under NSFC	This paper is supported by the National Natural Science Foundation of China (Grant Nos. 61472045, 61573067), the Beijing Natural Science Foundation (Grant No. 4142016), the BUPT Excellent Ph.D. Students Foundation (Grant No. CX2015310), and the Asia Foresight Program under NSFC Grant (Grant No. 61411146001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alomair B, 2014, IEEE T MOBILE COMPUT, V13, P469, DOI 10.1109/TMC.2012.252; AVISPA, AUT VAL INT SEC PROT; Bergamo P, 2005, IEEE T CIRCUITS-I, V52, P1382, DOI 10.1109/TCSI.2005.851701; BURROWS M, 1990, ACM T COMPUT SYST, V8, P18, DOI [10.1145/77648.77649, 10.1145/74851.74852]; Chain K, 2013, NONLINEAR DYNAM, V74, P1003, DOI 10.1007/s11071-013-1018-1; Chou CH, 2013, J SUPERCOMPUT, V66, P973, DOI 10.1007/s11227-013-0962-3; Deng SJ, 2010, COMMUN NONLINEAR SCI, V15, P1338, DOI 10.1016/j.cnsns.2009.05.065; Farash MS, 2014, NONLINEAR DYNAM, V77, P399, DOI 10.1007/s11071-014-1304-6; Guo LK, 2014, IEEE T MOBILE COMPUT, V13, P1927, DOI 10.1109/TMC.2013.84; He D., IEEE SYSTEMS J; Hu XX, 2014, NONLINEAR DYNAM, V78, P1293, DOI 10.1007/s11071-014-1515-x; Islam SKH, 2016, INT J COMMUN SYST, V29, P2442, DOI 10.1002/dac.2847; Khan M, 2013, NONLINEAR DYNAM, V71, P489, DOI 10.1007/s11071-012-0675-9; Kilinc HH, 2014, IEEE COMMUN SURV TUT, V16, P1005, DOI 10.1109/SURV.2013.091513.00050; Lee CC, 2013, NONLINEAR DYNAM, V73, P125, DOI 10.1007/s11071-013-0772-4; Lee TF, 2015, INFORM SCIENCES, V290, P63, DOI 10.1016/j.ins.2014.08.041; Li X, NONLINEAR DYNAMICS; Lian SG, 2005, CHAOS SOLITON FRACT, V26, P117, DOI 10.1016/j.chaos.2004.11.096; Lin HY, 2015, COMMUN NONLINEAR SCI, V20, P482, DOI 10.1016/j.cnsns.2014.05.027; Liu JW, 2014, IEEE T PARALL DISTR, V25, P332, DOI 10.1109/TPDS.2013.145; Lu RX, 2012, IEEE T PARALL DISTR, V23, P32, DOI 10.1109/TPDS.2011.95; Mason J. C., 2003, CHEBYSHEV POLYNOMIAL; Nam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116709; Ozkaynak F, 2013, NONLINEAR DYNAM, V74, P551, DOI 10.1007/s11071-013-0987-4; Turkanovic M, 2014, AD HOC NETW, V20, P96, DOI 10.1016/j.adhoc.2014.03.009; Wang D, 2014, IEEE T DEPEND SECURE, P99; Wang XY, 2010, COMMUN NONLINEAR SCI, V15, P99, DOI 10.1016/j.cnsns.2008.05.002; Wang XY, 2010, COMMUN NONLINEAR SCI, V15, P4052, DOI 10.1016/j.cnsns.2010.02.014; Xiao D, 2007, INFORM SCIENCES, V177, P1136, DOI 10.1016/j.ins.2006.07.026; Xie Q, 2015, NONLINEAR DYNAM, V79, P2345, DOI 10.1007/s11071-014-1816-0; Xu J, 2009, COMPUT STAND INTER, V31, P723, DOI 10.1016/j.csi.2008.09.006; Xue KP, 2012, COMMUN NONLINEAR SCI, V17, P2969, DOI 10.1016/j.cnsns.2011.11.025; Yoon EJ, 2011, COMMUN NONLINEAR SCI, V16, P2383, DOI 10.1016/j.cnsns.2010.09.021; Zhang LH, 2008, CHAOS SOLITON FRACT, V37, P669, DOI 10.1016/j.chaos.2006.09.047; Zhu F, 2012, PERVASIVE MOB COMPUT, V8, P777, DOI 10.1016/j.pmcj.2011.06.007	35	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153870	10.1371/journal.pone.0153870	http://dx.doi.org/10.1371/journal.pone.0153870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101305	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500083
J	Chiu, TCR; Ngo, HC; Lau, LW; Leung, KW; Lo, MH; Yu, HF; Ying, M				Chiu, Tsz-chun Roxy; Ngo, Hiu-ching; Lau, Lai-wa; Leung, King-wah; Lo, Man-him; Yu, Ho-fai; Ying, Michael			An Investigation of the Immediate Effect of Static Stretching on the Morphology and Stiffness of Achilles Tendon in Dominant and Non-Dominant Legs	PLOS ONE			English	Article							IN-VIVO; BIOMECHANICAL PROPERTIES; GASTROCNEMIUS-MUSCLE; CALCANEAL TENDON; ANKLE; TENDINOPATHY; ELASTOGRAPHY; ASYMMETRY; RESPONSES; EXERCISE	Aims This study was undertaken to investigate the immediate effect of static stretching on normal Achilles tendon morphology and stiffness, and the different effect on dominant and non-dominant legs; and to evaluate inter-operator and intra-operator reliability of using shear-wave elastography in measuring Achilles tendon stiffness. Methods 20 healthy subjects (13 males, 7 females) were included in the study. Thickness, cross-sectional area and stiffness of Achilles tendons in both legs were measured before and after 5-min static stretching using grey-scale ultrasound and shear-wave elastography. Inter-operator and intra-operator reliability of tendon stiffness measurements of six operators were evaluated. Results Result showed that there was no significant change in the thickness and cross-sectional area of Achilles tendon after static stretching in both dominant and non-dominant legs (p > 0.05). Tendon stiffness showed a significant increase in non-dominant leg (p < 0.05) but not in dominant leg (p > 0.05). The inter-operator reliability of shear-wave elastography measurements was 0.749 and the intra-operator reliability ranged from 0.751 to 0.941. Conclusion Shear-wave elastography is a useful and non-invasive imaging tool to assess the immediate stiffness change of Achilles tendon in response to static stretching with high intra-operator and inter-operator reliability.	[Chiu, Tsz-chun Roxy; Ngo, Hiu-ching; Lau, Lai-wa; Leung, King-wah; Lo, Man-him; Yu, Ho-fai; Ying, Michael] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Ying, M (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.	htmying@polyu.edu.hk		Ying, Michael/0000-0001-5979-6072				Arampatzis A, 2007, J EXP BIOL, V210, P2743, DOI 10.1242/jeb.003814; Aubry S, 2013, SKELETAL RADIOL, V42, P1143, DOI 10.1007/s00256-013-1649-9; Avela J, 2004, J APPL PHYSIOL, V96, P2325, DOI 10.1152/japplphysiol.01010.2003; Bohm S, 2015, SCAND J MED SCI SPOR, V25, pE124, DOI 10.1111/sms.12242; Brum J, 2014, PHYS MED BIOL, V59, P505, DOI 10.1088/0031-9155/59/3/505; Burgess KE, 2009, J ORTHOP RES, V27, P510, DOI 10.1002/jor.20768; Chen XM, 2013, J ULTRAS MED, V32, P449, DOI 10.7863/jum.2013.32.3.449; de Almeida FM, 2009, CONNECT TISSUE RES, V50, P279, DOI 10.3109/03008200802697435; Kato E, 2010, EUR J SPORT SCI, V10, P111, DOI 10.1080/17461390903307834; Kubo K, 2002, ACTA PHYSIOL SCAND, V175, P157, DOI 10.1046/j.1365-201X.2002.00976.x; Nakamura M, 2011, J ORTHOP RES, V29, P1759, DOI 10.1002/jor.21445; Obst SJ, 2013, MED SCI SPORT EXER, V45, P1534, DOI 10.1249/MSS.0b013e318289d821; Pang BSF, 2006, J ULTRAS MED, V25, P1291, DOI 10.7863/jum.2006.25.10.1291; Park DY, 2006, FOOT ANKLE INT, V27, P1086, DOI 10.1177/107110070602701215; Peltz CD, 2013, SKELETAL RADIOL, V42, P1151, DOI 10.1007/s00256-013-1629-0; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Simmons JG, 2002, AM J PHYSIOL-GASTR L, V283, pG809, DOI 10.1152/ajpgi.00057.2002; Valderrabano V, 2007, FOOT ANKLE INT, V28, P242, DOI 10.3113/FAI.2007.0242; Velotta J, 2011, PORTUGESE J SPORT SC, V11, P1035; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Wang JHC, 2006, CLIN ORTHOP RELAT R, P320, DOI 10.1097/01.blo.0000195927.81845.46; Wang Y, 2012, J APPL BIOMECH, V28, P473, DOI 10.1123/jab.28.4.473; Ying M, 2003, ULTRASOUND MED BIOL, V29, P637, DOI 10.1016/S0301-5629(03)00008-5	23	18	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154443	10.1371/journal.pone.0154443	http://dx.doi.org/10.1371/journal.pone.0154443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120097	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200076
J	Colombara, DV; Hernandez, B; Schaefer, A; Zyznieuski, N; Bryant, MF; Desai, SS; Gagnier, MC; Johanns, CK; McNellan, CR; Palmisano, EB; Rios-Zertuche, D; Zuniga-Brenes, P; Iriarte, E; Mokdad, AH				Colombara, Danny V.; Hernandez, Bernardo; Schaefer, Alexandra; Zyznieuski, Nicholas; Bryant, Miranda F.; Desai, Sima S.; Gagnier, Marielle C.; Johanns, Casey K.; McNellan, Claire R.; Palmisano, Erin B.; Rios-Zertuche, Diego; Zuniga-Brenes, Paola; Iriarte, Emma; Mokdad, Ali H.			Institutional Delivery and Satisfaction among Indigenous and Poor Women in Guatemala, Mexico, and Panama	PLOS ONE			English	Article							PREGNANCY-RELATED CARE; MATERNAL HEALTH; ETHNIC-GROUPS; CHIAPAS; DIVERSITY; PROGRAMS; MIDWIVES; DEATHS; FAMILY	Indigenous women in Mesoamerica experience disproportionately high maternal mortality rates and are less likely to have institutional deliveries. Identifying correlates of institutional delivery, and satisfaction with institutional deliveries, may help improve facility utilization and health outcomes in this population. We used baseline surveys from the Salud Meso-america Initiative to analyze data from 10,895 indigenous and non-indigenous women in Guatemala and Mexico (Chiapas State) and indigenous women in Panama. We created multivariable Poisson regression models for indigenous (Guatemala, Mexico, Panama) and non-indigenous (Guatemala, Mexico) women to identify correlates of institutional delivery and satisfaction. Compared to their non-indigenous peers, indigenous women were substantially less likely to have an institutional delivery (15.2% vs. 41.5% in Guatemala (P<0.001), 29.1% vs. 73.9% in Mexico (P<0.001), and 70.3% among indigenous Panamanian women). Indigenous women who had at least one antenatal care visit were more than 90% more likely to have an institutional delivery (adjusted risk ratio (aRR) = 1.94, 95% confidence interval (CI): 1.44-2.61), compared to those who had no visits. Indigenous women who were advised to give birth in a health facility (aRR = 1.46, 95% CI: 1.18-1.81), primiparous (aRR = 1.44, 95% CI: 1.24-1.68), informed that she should have a Caesarean section (aRR = 1.41, 95% CI: 1.21-1.63), and had a secondary or higher level of education (aRR = 1.36, 95% CI: 1.04-1.79) also had substantially higher likelihoods of institutional delivery. Satisfaction among indigenous women was associated with being able to be accompanied by a community health worker (aRR = 1.15, 95% CI: 1.05-1.26) and facility staff speaking an indigenous language (aRR = 1.10, 95% CI: 1.02-1.19). Additional effort should be exerted to increase utilization of birthing facilities by indigenous and poor women in the region. Improving access to antenatal care and opportunities for higher-level education may increase institutional delivery rates, and providing culturally adapted services may improve satisfaction.	[Colombara, Danny V.; Hernandez, Bernardo; Schaefer, Alexandra; Zyznieuski, Nicholas; Bryant, Miranda F.; Desai, Sima S.; Gagnier, Marielle C.; Johanns, Casey K.; McNellan, Claire R.; Palmisano, Erin B.; Mokdad, Ali H.] Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA USA; [Rios-Zertuche, Diego; Zuniga-Brenes, Paola; Iriarte, Emma] Interamer Dev Bank, Salud Mesoamer Initiat, Calle 50 Con Calle Elvira Mendez, Panama City, Panama	Institute for Health Metrics & Evaluation	Colombara, DV (corresponding author), Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA USA.	dvc2@uw.edu	Prado, Bernardo Hernandez/AAG-9292-2019; Mokdad, Ali H./AAD-1232-2022; McNellan, Claire/GMW-6098-2022; Rios-Zertuche, Diego/AAG-2710-2020; Colombara, Danny/H-7202-2015	Prado, Bernardo Hernandez/0000-0002-5960-8841; Mokdad, Ali H./0000-0002-4994-3339; Rios-Zertuche, Diego/0000-0003-1853-728X; Colombara, Danny/0000-0002-5237-1300	Bill & Melinda Gates Foundation; Spanish Agency for International Development Cooperation; Carlos Slim Health Institute through the Inter-American Development Bank	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Spanish Agency for International Development Cooperation(Spanish Government); Carlos Slim Health Institute through the Inter-American Development Bank	All phases of this study were supported by the Bill & Melinda Gates Foundation (www.gatesfoundation.org), the Spanish Agency for International Development Cooperation (www.aecid.es), and the Carlos Slim Health Institute (www.salud.carlosslim.org) through the Inter-American Development Bank (www.iadb.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the Inter American Development Bank, its Board of Directors, or the countries they represent.	Becker S, 2006, SOC SCI MED, V62, P2313, DOI 10.1016/j.socscimed.2005.10.006; Berry NS, 2008, MED ANTHROPOL, V27, P164, DOI 10.1080/01459740802017413; Berry NS, 2006, SOC SCI MED, V62, P1958, DOI 10.1016/j.socscimed.2005.09.005; Betran AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148343; Brentlinger PE, 2005, SOC SCI MED, V61, P1001, DOI 10.1016/j.socscimed.2004.12.022; Camacho AV, 2006, INT J GYNECOL OBSTET, V94, P357, DOI 10.1016/j.ijgo.2006.04.028; Castaneda-Camey X, 1992, Salud Publica Mex, V34, P528; Chomat AM, 2014, REV PANAM SALUD PUBL, V35, P113; COSMINSKY S, 1977, SOC SCI MED, V11, P325, DOI 10.1016/0037-7856(77)90190-1; De Broe S, 2005, J FAM PLAN REPROD H, V31, P199, DOI 10.1783/1471189054483889; De Broe S, 2005, J BIOSOC SCI, V37, P301, DOI 10.1017/S0021932004006650; Dixon LZ, 2015, MED ANTHROPOL Q, V29, P437, DOI 10.1111/maq.12174; Freyermuth-Enciso G, 2009, SALUD PUBLICA MEXICO, V51, P450, DOI 10.1590/S0036-36342009000600002; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Garces A, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S14; Glei DA, 2003, SOC SCI MED, V57, P2447, DOI 10.1016/S0277-9536(03)00140-0; Glei DA, 2000, ETHNIC HEALTH, V5, P5, DOI 10.1080/13557850050007301; Hunt Linda M, 2002, Health Care Women Int, V23, P98, DOI 10.1080/073993302753428465; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Ministerio de Salud Publica y Asistencia Social, NORM AT SAL INT PRIM; Mokdad AH, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0034-4; Pebley AR, 1996, DEMOGRAPHY, V33, P231, DOI 10.2307/2061874; Pelcastre Blanca, 2005, Rev. esc. enferm. USP, V39, P375, DOI 10.1590/S0080-62342005000400002; Saleem S, 2014, B WORLD HEALTH ORGAN, V92, P605, DOI 10.2471/BLT.13.127464; Smith-Oka V, 2009, SOC SCI MED, V68, P2069, DOI 10.1016/j.socscimed.2009.03.026; Torres MDH, 2006, REV PANAM SALUD PUBL, V19, P69, DOI 10.1590/S1020-49892006000200001; Tucker K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-94; van Dijk M, 2013, CULT HEALTH SEX, V15, pS365, DOI 10.1080/13691058.2013.779026; Walsh LV, 2006, J TRANSCULT NURS, V17, P148, DOI 10.1177/1043659605285412; Waters WF, 2010, DEV PRACT, V20, P678, DOI 10.1080/09614524.2010.491526; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154388	10.1371/journal.pone.0154388	http://dx.doi.org/10.1371/journal.pone.0154388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QZ	27120070	Green Submitted, gold, Green Published			2022-12-27	WOS:000374976200066
J	dos Reis, VM; Karez, CS; Mariath, R; de Moraes, FC; de Carvalho, RT; Brasileiro, PS; Bahia, RD; Lotufo, TMD; Ramalho, LV; de Moura, RL; Francini, RB; Pereira, GH; Thompson, FL; Bastos, AC; Salgado, LT; Amado, GM				dos Reis, Vanessa Moura; Karez, Claudia Santiago; Mariath, Rodrigo; de Moraes, Fernando Coreixas; de Carvalho, Rodrigo Tomazetto; Brasileiro, Poliana Silva; Bahia, Ricardo da Gama; da Cruz Lotufo, Tito Monteiro; Ramalho, Lais Vieira; de Moura, Rodrigo Leao; Francini-Filho, Ronaldo Bastos; Pereira-Filho, Guilherme Henrique; Thompson, Fabiano Lopes; Bastos, Alex Cardoso; Salgado, Leonardo Tavares; Amado-Filho, Gilberto Menezes			Carbonate Production by Benthic Communities on Shallow Coralgal Reefs of Abrolhos Bank, Brazil	PLOS ONE			English	Article							CRUSTOSE CORALLINE ALGAE; CLIMATE-CHANGE; ENCRUSTER COMMUNITIES; ARTIFICIAL REEF; SOUTH ATLANTIC; SEDIMENTATION; RHODOPHYTA; DECLINE; GROWTH; RATES	The abundance of reef builders, non-builders and the calcium carbonate produced by communities established in Calcification Accretion Units (CAUs) were determined in three Abrolhos Bank shallow reefs during the period from 2012 to 2014. In addition, the seawater temperature, the irradiance, and the amount and composition of the sediments were determined. The inner and outer reef arcs were compared. CAUs located on the inner reef shelf were under the influence of terrigenous sediments. On the outer reefs, the sediments were composed primarily of marine biogenic carbonates. The mean carbonate production in shallow reefs of Abrolhos was 579 +/- 98 g m(-2) y(-1). The builder community was dominated by crustose coralline algae, while the non-builder community was dominated by turf. A marine heat wave was detected during the summer of 2013-2014, and the number of consecutive days with a temperature above or below the summer mean was positively correlated with the turf cover increase. The mean carbonate production of the shallow reefs of Abrolhos Bank was greater than the estimated carbonate production measured for artificial structures on several other shallow reefs of the world. The calcimass was higher than the non-calcareous mass, suggesting that the Abrolhos reefs are still in a positive carbonate production balance. Given that marine heat waves produce an increase of turf cover on the shallow reefs of the Abrolhos, a decrease in the cover represented by reef builders and shifting carbonate production are expected in the near future.	[dos Reis, Vanessa Moura; Karez, Claudia Santiago; Mariath, Rodrigo; de Moraes, Fernando Coreixas; de Carvalho, Rodrigo Tomazetto; Brasileiro, Poliana Silva; Bahia, Ricardo da Gama; Salgado, Leonardo Tavares; Amado-Filho, Gilberto Menezes] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Rio De Janeiro, Brazil; [da Cruz Lotufo, Tito Monteiro] Univ Sao Paulo, Inst Oceanog, Sao Paulo, SP, Brazil; [Ramalho, Lais Vieira] Museu Nacl Rio de Janeiro, Dept Invertebrados, Rio De Janeiro, Rio De Janeiro, Brazil; [de Moura, Rodrigo Leao; Thompson, Fabiano Lopes] Univ Fed Rio de Janeiro, Dept Biol Marinha, Rio De Janeiro, Rio De Janeiro, Brazil; [Francini-Filho, Ronaldo Bastos] Univ Fed Paraiba, Dept Engn & Meio Ambiente, Rio Tinto, Paraiba, Brazil; [Pereira-Filho, Guilherme Henrique] Univ Fed Sao Paulo, Inst Mar, Sao Paulo, Brazil; [Bastos, Alex Cardoso] Univ Fed Espirito Santo, Dept Oceanog, Vitoria, ES, Brazil	Jardim Botanico do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade Federal da Paraiba; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Espirito Santo	Amado, GM (corresponding author), Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Rio De Janeiro, Brazil.	gfilho@jbrj.gov.br	Salgado, Leonardo T/F-1123-2013; Francini-Filho, Ronaldo/I-5708-2012; Ramalho, Lais Vieira/AAH-1596-2019; Karez, Claudia S/N-6656-2015; Pereira-Filho, Guilherme-Henrique/I-2946-2013; Carvalho, Rodrigo/GLU-1952-2022; de Moura, Rodrigo Leao/AAL-5781-2020; Lotufo, Tito M. C./E-7836-2011	Francini-Filho, Ronaldo/0000-0002-7678-6797; Ramalho, Lais Vieira/0000-0003-1459-3954; Karez, Claudia S/0000-0003-0820-4166; Pereira-Filho, Guilherme-Henrique/0000-0001-6078-2241; Carvalho, Rodrigo/0000-0002-2613-0001; de Moura, Rodrigo Leao/0000-0002-5597-6196; Lotufo, Tito M. C./0000-0003-3630-1342; Thompson, Fabiano/0000-0002-7562-1683	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Pesquisa Ecologica de Longa Duracao-PELD [34/2012]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao de Amparo a Pesquisa do Estado do Espirito Santo; Rede Abrolhos/SISBIOTA (MCT/CNPq/CAPES/FAPES); Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis/BRASOIL-Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Pesquisa Ecologica de Longa Duracao-PELD; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo; Rede Abrolhos/SISBIOTA (MCT/CNPq/CAPES/FAPES); Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis/BRASOIL-Brazil	Financial support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Pesquisa Ecologica de Longa Duracao-PELD (#34/2012), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Fundacao de Amparo a Pesquisa do Estado do Espirito Santo, Rede Abrolhos/SISBIOTA (MCT/CNPq/CAPES/FAPES) and Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis/BRASOIL-Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEY W H, 1975, Phycologia, V14, P55, DOI 10.2216/i0031-8884-14-2-55.1; AIROLDI L, 1995, BOT MAR, V38, P227, DOI 10.1515/botm.1995.38.1-6.227; Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Airoldi L, 1997, J EXP MAR BIOL ECOL, V215, P269, DOI 10.1016/S0022-0981(96)02770-0; Almeida VES, 2011, THESIS U FEDERAL BAH; Alves N, 2010, ENV MICROBIOL REP, V2, P90, DOI 10.1111/j.1758-2229.2009.00101.x; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Antunes P, 1999, ECOL ECON, V31, P215, DOI 10.1016/S0921-8009(99)00080-4; Azevedo FBB, 2006, BRAZ ARCH BIOL TECHN, V49, P263, DOI 10.1590/S1516-89132006000300012; BAILEYBROCK JH, 1989, B MAR SCI, V44, P580; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Basso D, 2012, GEODIVERSITAS, V34, P13, DOI 10.5252/g2012n1a2; BENAYAHU Y, 1981, B MAR SCI, V31, P514; Benzoni F, 2011, MAR BIOL, V158, P2419, DOI 10.1007/s00227-011-1743-2; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Castro Clovis B., 1999, Revista Brasileira de Oceanografia, V47, P87; Cetz-Navarro NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054810; Connell SD, 2014, MAR ECOL PROG SER, V495, P299, DOI 10.3354/meps10513; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; Costa OS, 2002, P 9 INT COR REEF S, P507; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Field SN, 2007, CORAL REEFS, V26, P279, DOI 10.1007/s00338-006-0191-9; Figueiredo MAO, 2002, P 9 INT COR REEF S, P498; Figueiredo MAO, 2006, RAP B BIOL ASSESS, V38, P67; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Francini-Filho RB, 2008, FISH RES, V93, P346, DOI 10.1016/j.fishres.2008.06.011; Francini RB, 2008, MAR POLLUT BULL, V56, P1008, DOI 10.1016/j.marpolbul.2008.02.013; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Francini RB, 2010, J MAR BIOL ASSOC UK, V90, P481, DOI 10.1017/S0025315409991147; Gherardi DFM, 2001, CORAL REEFS, V19, P205, DOI 10.1007/s003380000100; Ginsburg RN, 1994, PROCEEDINGS OF THE C; Glasby TM, 2000, J EXP MAR BIOL ECOL, V248, P177, DOI 10.1016/S0022-0981(00)00169-6; GROSBERG RK, 1981, NATURE, V290, P700, DOI 10.1038/290700a0; Haas A, 2010, CORAL REEFS, V29, P93, DOI 10.1007/s00338-009-0556-y; HAY ME, 1981, ECOLOGY, V62, P739, DOI 10.2307/1937742; Hepburn LJ, 2015, CORAL REEFS, V34, P189, DOI 10.1007/s00338-014-1227-1; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Instituto Nacional de Pesquisas Espaciais, 2015, TEMP VER VAO SUP 201; Jameson S. C, 1995, STATE REEFS REGIONAL; Kamenos NA, 2010, J PHYCOL, V46, P331, DOI 10.1111/j.1529-8817.2009.00780.x; Kuffner IB, 2013, CORAL REEFS, V32, P987, DOI 10.1007/s00338-013-1047-8; Leao Z, 1997, P 8 INT COR REEF S, V2, P1767; Leao Z. M. A. N., 2002, DNPM CPRM COMISSAO B, V1, P345; Leão Zelinda Margarida Andrade Nery, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000300006; LITTLER MM, 1980, AM NAT, V116, P25, DOI 10.1086/283610; Mallela J, 2007, CORAL REEFS, V26, P775, DOI 10.1007/s00338-007-0260-8; Mallela J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060010; Mariath R, 2013, HELGOLAND MAR RES, V67, P687, DOI 10.1007/s10152-013-0354-3; MATSUDA S, 1989, CORAL REEFS, V7, P185, DOI 10.1007/BF00301597; Maughan BC, 2001, J EXP MAR BIOL ECOL, V256, P59, DOI 10.1016/S0022-0981(00)00304-X; Monniot C, 1991, CORAL REEF ASCIDIANS; Morgan KM, 2014, MAR FRESHWATER RES, V65, P720, DOI 10.1071/MF13155; Moura R. L., 2007, AQUATIC PROTECTED AR, P175; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; Newman SP, 2015, J ANIM ECOL, V84, P1678, DOI 10.1111/1365-2656.12429; Pari N, 1998, MAR ECOL PROG SER, V166, P119, DOI 10.3354/meps166119; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; QUINN JF, 1982, OECOLOGIA, V54, P129, DOI 10.1007/BF00541119; Schroeder PA, 2014, ELEMENTS, V10, P177, DOI 10.2113/gselements.10.3.177; SCHUHMACHER H, 1977, HELGOLAND WISS MEER, V30, P400, DOI 10.1007/BF02207850; Segal B, 2011, BRAZ J OCEANOGR, V59, P119, DOI 10.1590/S1679-87592011000200001; Shenkar N, 2012, MAR BIODIVERS, V42, P459, DOI 10.1007/s12526-012-0124-5; Short J, 2015, CONT SHELF RES, V106, P38, DOI 10.1016/j.csr.2015.07.003; Silva AS, 2013, CONT SHELF RES, V70, P159, DOI 10.1016/j.csr.2013.06.002; SOUSA WP, 1981, OECOLOGIA, V48, P297, DOI 10.1007/BF00346486; SOUSA WP, 1980, OECOLOGIA, V45, P72, DOI 10.1007/BF00346709; Spieler RE, 2001, B MAR SCI, V69, P1013; Steneck R.S., 1997, P 8 INT CORAL REEF S, P6; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; STEWART JG, 1989, J PHYCOL, V25, P436, DOI 10.1111/j.1529-8817.1989.tb00248.x; Stocker T.F., 2013, CLIMATE CHANGE 2013; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Tâmega Frederico Tapajós de Souza, 2007, Rodriguésia, V58, P941, DOI 10.1590/2175-7860200758413; Taylor Paul D., 2000, P195, DOI 10.1017/CBO9780511535505.015; Titschack J, 2011, AM MINERAL, V96, P1028, DOI 10.2138/am.2011.3665; Vargas-Angel B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142196; Villaca Roberto, 1997, Revista Brasileira de Oceanografia, V45, P35; Villas Bôas Alexandre Bigio, 2005, Braz. j. oceanogr., V53, P147, DOI 10.1590/S1679-87592005000200005; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361	86	16	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154417	10.1371/journal.pone.0154417	http://dx.doi.org/10.1371/journal.pone.0154417			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119151	Green Published, gold, Green Submitted			2022-12-27	WOS:000374976200070
J	Penso-Dolfin, L; Swofford, R; Johnson, J; Alfoldi, J; Lindblad-Toh, K; Swarbreck, D; Moxon, S; Di Palma, F				Penso-Dolfin, Luca; Swofford, Ross; Johnson, Jeremy; Alfoldi, Jessica; Lindblad-Toh, Kerstin; Swarbreck, David; Moxon, Simon; Di Palma, Federica			An Improved microRNA Annotation of the Canine Genome	PLOS ONE			English	Article							SMALL RNAS; HEART-FAILURE; EXPRESSION; EVOLUTION; BIOGENESIS; GROWTH; GENES; IDENTIFICATION; ACCUMULATION; MECHANISMS	The domestic dog, Canis familiaris, is a valuable model for studying human diseases. The publication of the latest Canine genome build and annotation, CanFam3.1 provides an opportunity to enhance our understanding of gene regulation across tissues in the dog model system. In this study, we used the latest dog genome assembly and small RNA sequencing data from 9 different dog tissues to predict novel miRNAs in the dog genome, as well as to annotate conserved miRNAs from the miRBase database that were missing from the current dog annotation. We used both miRCat and miRDeep2 algorithms to computationally predict miRNA loci. The resulting, putative hairpin sequences were analysed in order to discard false positives, based on predicted secondary structures and patterns of small RNA read alignments. Results were further divided into high and low confidence miRNAs, using the same criteria. We generated tissue specific expression profiles for the resulting set of 811 loci: 720 conserved miRNAs, (207 of which had not been previously annotated in the dog genome) and 91 novel miRNA loci. Comparative analyses revealed 8 putative homologues of some novel miRNA in ferret, and one in microbat. All miRNAs were also classified into the genic and intergenic categories, based on the Ensembl RefSeq gene annotation for CanFam3.1. This additionally allowed us to identify four previously undescribed MiRtrons among our total set of miRNAs. We additionally annotated piRNAs, using proTRAC on the same input data. We thus identified 263 putative clusters, most of which (211 clusters) were found to be expressed in testis. Our results represent an important improvement of the dog genome annotation, paving the way to further research on the evolution of gene regulation, as well as on the contribution of post-transcriptional regulation to pathological conditions.	[Penso-Dolfin, Luca; Di Palma, Federica] Genome Anal Ctr, Vertebrate & Hlth Genom, Norwich, Norfolk, England; [Swarbreck, David; Moxon, Simon] Genome Anal Ctr, Regulatory Genom, Norwich, Norfolk, England; [Swofford, Ross; Johnson, Jeremy; Alfoldi, Jessica; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Vertebrate Genome Biol, Cambridge, MA USA; [Lindblad-Toh, Kerstin] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Uppsala, Sweden	The Genome Analysis Centre (TGAC); The Genome Analysis Centre (TGAC); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Uppsala University	Di Palma, F (corresponding author), Genome Anal Ctr, Vertebrate & Hlth Genom, Norwich, Norfolk, England.; Moxon, S (corresponding author), Genome Anal Ctr, Regulatory Genom, Norwich, Norfolk, England.	Simon.Moxon@tgac.ac.uk; Federica.Di-Palma@tgac.ac.uk		Di-Palma, Federica/0000-0002-4394-0102; Swofford, Ross/0000-0003-3676-8479; Swarbreck, David/0000-0002-5453-1013; Penso Dolfin, Luca/0000-0002-4893-2400; Moxon, Simon/0000-0003-4644-1816	BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Bannasch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009632; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Brown Miguel, 2013, Frontiers in Genetics, V4, P145, DOI 10.3389/fgene.2013.00145; Buza Teresia, 2014, BMC Res Notes, V7, P403, DOI 10.1186/1756-0500-7-403; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen YH, 2000, RNA, V6, P1277, DOI 10.1017/S1355838200000285; Chen Y, 2014, J MOL CELL CARDIOL, V77, P113, DOI 10.1016/j.yjmcc.2014.10.001; Dai Zhong-Hua, 2010, Yichuan, V32, P105, DOI 10.3724/SP.J.1005.2010.00105; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; Dreger DL, 2013, J HERED, V104, P399, DOI 10.1093/jhered/est012; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Genini S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-172; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Guo JW, 2012, J BONE MINER RES, V27, P1607, DOI 10.1002/jbmr.1597; Ha H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-545; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hoeppner MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091172; HOFACKER IL, 2009, CURR PROTOC BIOINFOR, pCH12, DOI DOI 10.1002/0471250953.BI1202S26; Hoopes BC, 2012, MAMM GENOME, V23, P780, DOI 10.1007/s00335-012-9417-z; Jain M, 2014, J EXP BOT, V65, P5945, DOI 10.1093/jxb/eru333; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Ladewig E, 2012, GENOME RES, V22, P1634, DOI 10.1101/gr.133553.111; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lulli V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060436; Maxwell EK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-714; Melman YF, 2015, CIRCULATION, V131, P2202, DOI 10.1161/CIRCULATIONAHA.114.013220; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mraz M, 2012, EXPERT REV HEMATOL, V5, P579, DOI [10.1586/ehm.12.54, 10.1586/EHM.12.54]; Noguchi S, 2016, VET COMP ONCOL, V14, P384, DOI 10.1111/vco.12118; Noguchi S, 2013, VET COMP ONCOL, V11, P113, DOI 10.1002/vco.306; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Pazzaglia L, 2015, RES VET SCI, V99, P112, DOI 10.1016/j.rvsc.2014.12.017; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Rosenkranz D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-5; Seppala EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002194; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Stroynowska-Czerwinska A, 2014, CELL MOL LIFE SCI, V71, P2253, DOI 10.1007/s00018-013-1551-6; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Uhl E, 2011, GENE CHROMOSOME CANC, V50, P950, DOI 10.1002/gcc.20917; Wang LS, 2015, BLOOD, V125, P1302, DOI 10.1182/blood-2014-06-581926; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Zhao FR, 2014, INFECT GENET EVOL, V21, P367, DOI 10.1016/j.meegid.2013.11.019	68	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153453	10.1371/journal.pone.0153453	http://dx.doi.org/10.1371/journal.pone.0153453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119849	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200025
J	Furukawa, H; Oka, S; Kawasaki, A; Shimada, K; Sugii, S; Matsushita, T; Hashimoto, A; Komiya, A; Fukui, N; Kobayashi, K; Osada, A; Ihata, A; Kondo, Y; Nagai, T; Setoguchi, K; Okamoto, A; Okamoto, A; Chiba, N; Suematsu, E; Kono, H; Katayama, M; Hirohata, S; Sumida, T; Migita, K; Hasegawa, M; Fujimoto, M; Sato, S; Nagaoka, S; Takehara, K; Tohma, S; Tsuchiya, N				Furukawa, Hiroshi; Oka, Shomi; Kawasaki, Aya; Shimada, Kota; Sugii, Shoji; Matsushita, Takashi; Hashimoto, Atsushi; Komiya, Akiko; Fukui, Naoshi; Kobayashi, Kouji; Osada, Atsumu; Ihata, Atsushi; Kondo, Yuya; Nagai, Tatsuo; Setoguchi, Keigo; Okamoto, Akiko; Okamoto, Akira; Chiba, Noriyuki; Suematsu, Eiichi; Kono, Hajime; Katayama, Masao; Hirohata, Shunsei; Sumida, Takayuki; Migita, Kiyoshi; Hasegawa, Minoru; Fujimoto, Manabu; Sato, Shinichi; Nagaoka, Shouhei; Takehara, Kazuhiko; Tohma, Shigeto; Tsuchiya, Naoyuki			Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01	PLOS ONE			English	Article							CLASS-II GENES; SCLERODERMA; SUSCEPTIBILITY; ASSOCIATION; AUTOANTIBODY; GENETICS; DISEASE	Objective Several studies on associations between human leukocyte antigen (HLA) allele frequencies and susceptibility to systemic sclerosis (SSc) have been reported. Anti-centromere antibodies (ACA) and anti-topoisomerase I antibodies (ATA) are found in SSc patients. Here, we sought to identify HLA alleles associated with SSc in Japanese, and explored their associations with SSc phenotypes including the presence of autoantibodies. Methods Associations of HLA-DRB1, DQB1, and DPB1 were analyzed in 463 Japanese SSc patients and 413 controls. Results We found that DRB1* 13: 02 (P = 0.0011, Pc = 0.0319, odds ratio [OR] 0.46, 95% confidence interval [CI] 0.29-0.73), DRB1* 14: 06 (P = 6.60X10(-5), Pc = 0.0020, OR 0.05, 95% CI 0.01-0.41), DQB1* 03: 01 (P = 0.0009, Pc = 0.0150, OR 0.56, 95% CI 0.40-0.79), and DPB1* 02: 01 (P = 5.16X10(-6), Pc = 8.77X10(-5), OR 0.52, 95% CI 0.39-0.69) were protectively associated with SSc. In addition, these four alleles seemed to be independently associated with the protection against the susceptibility of SSc. On the other hand, we could not find predisposing alleles for overall SSc. With respect to SSc subsets, a tendency for these four alleles to be protectively associated was observed. However, there was a significant association between DRB1* 01: 01, DRB1* 10: 01, DQB1* 05: 01, and DPB1* 04: 02 and the susceptibility to SSc with ACA. On the other hand, the presence of DRB1* 15: 02, DQB1* 06: 01, DPB1* 03: 01, and DPB1* 09: 01 was associated with SSc with ATA. Conclusion Thus, the present study has identified protective associations of the four HLA class II alleles with overall Japanese SSc and predisposing associations of HLA class II alleles with Japanese SSc subsets.	[Furukawa, Hiroshi; Oka, Shomi; Kawasaki, Aya; Tsuchiya, Naoyuki] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Furukawa, Hiroshi; Oka, Shomi; Komiya, Akiko; Fukui, Naoshi; Tohma, Shigeto] Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa, Japan; [Shimada, Kota; Hashimoto, Atsushi] Natl Hosp Org, Sagamihara Hosp, Dept Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa, Japan; [Shimada, Kota; Sugii, Shoji] Tokyo Metropolitan Tama Med Ctr, Dept Rheumat Dis, 2-8-29 Musashi Dai, Fuchu, Tokyo, Japan; [Matsushita, Takashi; Takehara, Kazuhiko] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Dept Dermatol, Fac Med, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan; [Kobayashi, Kouji; Osada, Atsumu; Ihata, Atsushi; Nagaoka, Shouhei] Yokohama Minami Kyosai Hosp, Dept Rheumatol, Kanazawa Ku, 1-21-1 Rokuura Higashi, Yokohama, Kanagawa, Japan; [Kondo, Yuya; Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Nagai, Tatsuo; Hirohata, Shunsei] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 228, Japan; [Setoguchi, Keigo] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Allergy & Immunol Dis, Bunkyo Ku, 3-18-22 Hon Komagome, Tokyo, Japan; [Okamoto, Akiko; Kono, Hajime] Teikyo Univ, Dept Internal Med, Itabashi Ku, 2-11-1 Kaga, Tokyo, Japan; [Okamoto, Akira] Natl Hosp Org, Himeji Med Ctr, Dept Rheumatol, 68 Hon Machi, Himeji, Hyogo, Japan; [Chiba, Noriyuki] Natl Hosp Org, Morioka Hosp, Dept Rheumatol, 1-25-1 Aoyama, Morioka, Iwate, Japan; [Suematsu, Eiichi] Natl Hosp Org, Dept Internal Med & Rheumatol, Kyushu Med Ctr, Clin Res Inst,Chuo Ku, 1-8-1 Jigyohama, Fukuoka, Japan; [Katayama, Masao] Natl Hosp Org, Nagoya Med Ctr, Dept Internal Med, Naka Ku, 4-1-1 Sannomaru, Nagoya, Aichi, Japan; [Migita, Kiyoshi] Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, 2-1001-1 Kubara, Omura, Japan; [Hasegawa, Minoru] Univ Fukui, Sch Med, Dept Dermatol, Fac Med Sci, 23-3 Matsuokashimoaizuki, Eiheiji, Japan; [Fujimoto, Manabu] Univ Tsukuba, Dept Dermatol, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Sato, Shinichi] Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan	University of Tsukuba; Kanazawa University; University of Tsukuba; Kitasato University; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Teikyo University; Nagoya Medical Center; University of Fukui; University of Tsukuba; University of Tokyo	Furukawa, H (corresponding author), Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.; Furukawa, H (corresponding author), Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa, Japan.	furukawa-tky@umin.org	Matsushita, Takashi/C-4750-2015; Tsuchiya, Naoyuki/CAA-4545-2022	Matsushita, Takashi/0000-0002-1617-086X; Tsuchiya, Naoyuki/0000-0002-6776-5580; Fujimoto, Manabu/0000-0002-3062-4872; Kono, Hajime/0000-0002-4578-8677; Hasegawa, Minoru/0000-0003-3738-2682	Japan Society for the Promotion of Science [26293123, 22591090, 24791018]; Ministry of Health, Labour, and Welfare of Japan; National Hospital Organization; Daiwa Securities Health Foundation; Japan Research Foundation for Clinical Pharmacology; Nakatomi Foundation; Takeda Science Foundation; Mitsui Sumitomo Insurance Welfare Foundation; Kato Memorial Trust for Nambyo Research; Abbott Japan Co., Ltd.; Astellas Pharma Inc.; Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.; Mitsuibishi Tanabe Pharma Corporation; Merck Sharp and Dohme Inc.; Pfizer Japan Inc.; Takeda Pharmaceutical Company Limited; Teijin Pharma Limited	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Hospital Organization; Daiwa Securities Health Foundation; Japan Research Foundation for Clinical Pharmacology; Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Kato Memorial Trust for Nambyo Research(Kato Memorial Trust for Nambyo Research); Abbott Japan Co., Ltd.(Abbott Laboratories); Astellas Pharma Inc.(Astellas Pharmaceuticals); Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.(Eisai Co Ltd); Mitsuibishi Tanabe Pharma Corporation; Merck Sharp and Dohme Inc.(Merck & Company); Pfizer Japan Inc.(Pfizer); Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd); Teijin Pharma Limited(Teijin Pharma Limited)	The study was supported by Grants-in-Aid for Scientific Research ( B, C) ( 26293123, 22591090) and for Young Scientists ( B) ( 24791018) from the Japan Society for the Promotion of Science, Health and Labour Science Research Grants from the Ministry of Health, Labour, and Welfare of Japan, Grants-in-Aid for Clinical Research from National Hospital Organization, Research Grants from Daiwa Securities Health Foundation, Research Grants from Japan Research Foundation for Clinical Pharmacology, Research Grants from The Nakatomi Foundation, Research Grants from Takeda Science Foundation, Research Grants from Mitsui Sumitomo Insurance Welfare Foundation, Research Grants from Kato Memorial Trust for Nambyo Research, and research grants from the following pharmaceutical companies: Abbott Japan Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsuibishi Tanabe Pharma Corporation, Merck Sharp and Dohme Inc., Pfizer Japan Inc., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparing the manuscript.	Agarwal SK, 2010, DISCOV MED, V10, P134; Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; Assassi S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-9; Beretta L, 2012, RHEUMATOLOGY, V51, P52, DOI 10.1093/rheumatology/ker335; DOUVAS AS, 1979, J BIOL CHEM, V254, P10514; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Furukawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087792; Furukawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033133; He DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106939; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kamatani N, 2004, TISSUE CULTURE RES C, V23, P71; Kuwana M, 1999, INTERNAL MED, V38, P336, DOI 10.2169/internalmedicine.38.336; KUWANA M, 1995, ANN RHEUM DIS, V54, P983, DOI 10.1136/ard.54.12.983; LEROY EC, 1988, J RHEUMATOL, V15, P202; Louthrenoo W, 2013, RHEUMATOL INT, V33, P2069, DOI 10.1007/s00296-013-2686-3; Mayes MD, 2014, AM J HUM GENET, V94, P47, DOI 10.1016/j.ajhg.2013.12.002; Migita K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078699; MOROI Y, 1980, P NATL ACAD SCI-BIOL, V77, P1627, DOI 10.1073/pnas.77.3.1627; Nakajima F, 2001, MHC, V8, P1; Oka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099453; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ueki A, 2001, IMMUNOBIOLOGY, V204, P458, DOI 10.1078/0171-2985-00055; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Zhou XD, 2013, INT J IMMUNOPATH PH, V26, P747, DOI 10.1177/039463201302600318	28	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154255	10.1371/journal.pone.0154255	http://dx.doi.org/10.1371/journal.pone.0154255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116456	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600052
J	Martinez, RDF; Lamanna, MC; Novas, FE; Ridgely, RC; Casal, GA; Martinez, JE; Vita, JR; Witmer, LM				Martinez, Ruben D. F.; Lamanna, Matthew C.; Novas, Fernando E.; Ridgely, Ryan C.; Casal, Gabriel A.; Martinez, Javier E.; Vita, Javier R.; Witmer, Lawrence M.			A Basal Lithostrotian Titanosaur (Dinosauria: Sauropoda) with a Complete Skull: Implications for the Evolution and Paleobiology of Titanosauria	PLOS ONE			English	Article							BAJO BARREAL FORMATION; SAN-JORGE BASIN; RIO NEGRO PROVINCE; RAPETOSAURUS-KRAUSEI SAUROPODA; SP-NOV.; CENTRAL PATAGONIA; KATEPENSAURUS-GOICOECHEAI; REBBACHISAURID SAUROPODA; FEEDING STRATEGIES; DENTAL MICROWEAR	We describe Sarmientosaurus musacchioi gen. et sp. nov., a titanosaurian sauropod dinosaur from the Upper Cretaceous (Cenomanian-Turonian) Lower Member of the Bajo Barreal Formation of southern Chubut Province in central Patagonia, Argentina. The holotypic and only known specimen consists of an articulated, virtually complete skull and part of the cranial and middle cervical series. Sarmientosaurus exhibits the following distinctive features that we interpret as autapomorphies: (1) maximum diameter of orbit nearly 40% rostrocaudal length of cranium; (2) complex maxilla-lacrimal articulation, in which the lacrimal clasps the ascending ramus of the maxilla; (3) medial edge of caudal sector of maxillary ascending ramus bordering bony nasal aperture with low but distinct ridge; (4) 'tongue-like' ventral process of quadratojugal that overlaps quadrate caudally; (5) separate foramina for all three branches of the trigeminal nerve; (6) absence of median venous canal connecting infundibular region to ventral part of brainstem; (7) subvertical premaxillary, procumbent maxillary, and recumbent dentary teeth; (8) cervical vertebrae with 'strut-like' centroprezy-gapophyseal laminae; (9) extremely elongate and slender ossified tendon positioned ventrolateral to cervical vertebrae and ribs. The cranial endocast of Sarmientosaurus preserves some of the most complete information obtained to date regarding the brain and sensory systems of sauropods. Phylogenetic analysis recovers the new taxon as a basal member of Lithostrotia, as the most plesiomorphic titanosaurian to be preserved with a complete skull. Sarmientosaurus provides a wealth of new cranial evidence that reaffirms the close relationship of titanosaurs to Brachiosauridae. Moreover, the presence of the relatively derived lithostrotian Tapuiasaurus in Aptian deposits indicates that the new Patagonian genus represents a 'ghost lineage' with a comparatively plesiomorphic craniodental form, the evolutionary history of which is missing for at least 13 million years of the Cretaceous. The skull anatomy of Sarmientosaurus suggests that multiple titanosaurian species with dissimilar cranial structures coexisted in the early Late Cretaceous of southern South America. Furthermore, the new taxon possesses a number of distinctive morphologies-such as the ossified cervical tendon, extremely pneumatized cervical vertebrae, and a habitually downward-facing snout-that have rarely, if ever, been documented in other titanosaurs, thus broadening our understanding of the anatomical diversity of this remarkable sauropod clade. The latter two features were convergently acquired by at least one penecontemporaneous diplodocoid, and may represent mutual specializations for consuming low-growing vegetation.	[Martinez, Ruben D. F.; Casal, Gabriel A.] Univ Nacl Patagonia San Juan Bosco, Lab Paleovertebrados, Rivadavia, Chubut, Argentina; [Lamanna, Matthew C.] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA USA; [Novas, Fernando E.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Lab Anat Comparada & Evoluc Vertebrados, Buenos Aires, DF, Argentina; [Ridgely, Ryan C.; Witmer, Lawrence M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Martinez, Javier E.] Hosp Reg Comodoro Rivadavia, Comodoro Rivadavia, Chubut, Argentina; [Vita, Javier R.] Resonancia Magnet Borelli, Comodoro Rivadavia, Chubut, Argentina	Universidad Nacional de la Patagonia San Juan Bosco; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); University System of Ohio; Ohio University	Martinez, RDF (corresponding author), Univ Nacl Patagonia San Juan Bosco, Lab Paleovertebrados, Rivadavia, Chubut, Argentina.	rudaframartinez@gmail.com		Witmer, Lawrence/0000-0002-7610-0118	Facultad de Ciencias Naturales of the Universidad Nacional de la Patagonia San Juan Bosco; National Geographic Society [6646-99]; Ohio University Heritage College of Osteopathic Medicine; National Science Foundation [IBN-0343744, IOB-0517257, IOS-1050154]; Ohio Supercomputing Center; Division Of Integrative Organismal Systems [1456503, 1050154] Funding Source: National Science Foundation	Facultad de Ciencias Naturales of the Universidad Nacional de la Patagonia San Juan Bosco; National Geographic Society(National Geographic Society); Ohio University Heritage College of Osteopathic Medicine; National Science Foundation(National Science Foundation (NSF)); Ohio Supercomputing Center; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	R.D. F.M. and G.A.C. were supported by the Facultad de Ciencias Naturales of the Universidad Nacional de la Patagonia San Juan Bosco (http://www.fcn.unp.edu.ar/). M.C.L.'s participation in the research was supported by Carnegie Museum of Natural History (http://www.carnegiemnh.org/), the University of Pennsylvania (http://www.upenn.edu/), the National Geographic Society (Grant 6646-99) (http://www.nationalgeographic.com/), the Jurassic Foundation (http://jurassicfoundation.org/), the Evolving Earth Foundation (http://www.evolvingearth.org/), the Delaware Valley Paleontological Society (http://dvps.essentrix.net/), and the Paleontological Society (http://www.paleosoc.org/). L.M.W. and R.C.R. acknowledge funding support from the Ohio University Heritage College of Osteopathic Medicine (http://www.oucom.ohiou.edu/) and the National Science Foundation (IBN-0343744, IOB-0517257, IOS-1050154) (http://www.nsf.gov/). The Ohio Supercomputing Center (https://www.osc.edu/) provided additional support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerda IA, 2009, AMEGHINIANA, V46, P193; Allain R, 1998, DESCRIPTION SYSTEMAT, P79; Apesteguia S, 2004, NATURWISSENSCHAFTEN, V91, P493, DOI 10.1007/s00114-004-0560-6; Apesteguia S., 2006, REV MUSEO ARGENTINO, V7, P153; ARCHANGELSKY S, 1994, CRETACEOUS RES, V15, P127, DOI 10.1006/cres.1994.1006; ARCHANGELSKY S, 2001, PUBLICACION ESPECIAL, V7, P15; Archangelsky S, 2009, CRETACEOUS RES, V30, P1073, DOI 10.1016/j.cretres.2009.03.001; BAKKER RT, 1978, NATURE, V274, P661, DOI 10.1038/274661a0; Barrett Paul M., 1994, Gaia, V10, P195; Barrett PM, 2002, PALAEONTOLOGY, V45, P1197, DOI 10.1111/1475-4983.00282; BERMAN D S, 1982, Annals of Carnegie Museum, V51, P405; Bonaparte J. F., 1979, ACTAS, V2, P393; Bonaparte JF., 1993, AMEGHINIANA, V30, P217; Bonaparte JF, 2006, CRETACEOUS RES, V27, P364, DOI 10.1016/j.cretres.2005.07.004; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Bremer K, 2002, EVOLUTION, V56, P1374, DOI 10.1111/j.0014-3820.2002.tb01451.x; Bridge JS, 2000, J SEDIMENT RES, V70, P341, DOI 10.1306/2DC40915-0E47-11D7-8643000102C1865D; Britt BB, 1993, THESIS; Bruner HL, 1907, AM J ANAT, V7, P1, DOI 10.1002/aja.1000070102; Button DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2114; Calvo JO, 2006, AN ACAD BRAS CIENC, V78, P175, DOI 10.1590/S0001-37652006000100015; Calvo JO, 2003, REV GEOL CHILE, V30, P333; Calvo JO, 1996, AMEGHINIANA, V33, P461; Calvo Jorge O., 1994, Gaia, V10, P183; Calvo Jorge O., 1995, Gaia, V11, P13; Calvo Jorge O., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P485; CANUDO JI., 2002, ASOCIACION PALEONTOL, V32, P12; Carabajal AP, 2008, CRETACEOUS RES, V29, P643, DOI 10.1016/j.cretres.2008.01.011; Carabajal AP, 2014, J VERTEBR PALEONTOL, V34, P870, DOI 10.1080/02724634.2014.838174; Carabajal AP, 2012, ANAT REC, V295, P2141, DOI 10.1002/ar.22572; Carballido JL, 2014, J SYST PALAEONTOL, V12, P335, DOI 10.1080/14772019.2013.764935; Carpenter K, 2005, LIFE O PAST, P78; Carpenter Kenneth, 1998, Modern Geology, V23, P69; Casal G, 2010, REV BRAS PALEONTOLOG, V13, P247, DOI 10.4072/rbp.2010.3.08; Casal G, 2009, GEOBIOS-LYON, V42, P553, DOI 10.1016/j.geobios.2009.03.002; Casal Gabriel A, 2015, Rev. Asoc. Geol. Argent., V72, P77; Casal GA, 2013, AMEGHINIANA, V50, P571, DOI 10.5710/AMGH.23.08.2013.617; Cerda IA, 2012, PALAEONTOL Z, V86, P441, DOI 10.1007/s12542-012-0140-6; Cerda IA, 2012, NATURWISSENSCHAFTEN, V99, P83, DOI 10.1007/s00114-011-0869-x; Chatterjee S, 2002, ZOOL J LINN SOC-LOND, V136, P145, DOI 10.1046/j.1096-3642.2002.00037.x; Chatterjee Sankar, 1996, Memoirs of the Queensland Museum, V39, P489; Chiappe LM, 2001, SCIENCE, V293, P2444, DOI 10.1126/science.1063723; Christiansen Per, 2000, Historical Biology, V14, P137; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Clyde WC, 2014, GEOL SOC AM BULL, V126, P289, DOI 10.1130/B30915.1; COLBERT EH, 1993, AM J SCI, V293A, P1, DOI 10.2475/ajs.293.A.1; COOMBS WP, 1975, PALAEOGEOGR PALAEOCL, V17, P1, DOI 10.1016/0031-0182(75)90027-9; Coria RA, 2001, AMEGHINIANA, V38, P463; Coria RA, 2005, LIFE O PAST, P153; Coria RA, 1999, AMEGHINIANA, V36, P98; Curry KA, 2001, THESIS; D'Emic MD, 2013, J SYST PALAEONTOL, V11, P707, DOI 10.1080/14772019.2012.667446; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; D'Emic MD, 2012, J VERTEBR PALEONTOL, V32, P883, DOI 10.1080/02724634.2012.671204; Dalla Vecchia Fabio M., 1999, Natura Nascosta, V18, P6; De Almeida Campos Diogenes, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P565; de Broin FD, 2001, CR ACAD SCI II A, V333, P463; Diaz VD, 2012, P GEOLOGIST ASSOC, V123, P626, DOI 10.1016/j.pgeola.2012.04.002; Diaz VD, 2011, ACTA PALAEONTOL POL, V56, P521, DOI 10.4202/app.2010.0043; FARLOW JO, 1987, PALEOBIOLOGY, V13, P60; Figari E., 1990, 3 REUN ARGENTINA SED, V1, P130; Filippi LS, 2011, GEOL ACTA, V9, P1, DOI 10.1344/105.000001648; Filippi LS, 2008, AMEGHINIANA, V45, P575; Filippi LS, 2011, ACTA PALAEONTOL POL, V56, P505, DOI 10.4202/app.2010.0019; Franzosa J.W., 2004, THESIS; Gallina PA, 2011, ACTA PALAEONTOL POL, V56, P45, DOI 10.4202/app.2010.0011; Galton P.M., 1985, Geologica et Palaeontologica, V19, P119; Garcia G, 2010, B SOC GEOL FR, V181, P269, DOI 10.2113/gssgfbull.181.3.269; Garcia RA, 2008, GEOBIOS-LYON, V41, P625, DOI 10.1016/j.geobios.2007.11.005; Garcia RA, 2015, AMEGHINIANA, V52, P29, DOI 10.5710/AMGH.16.07.2014.829; Garcia RA, 2010, AMEGHINIANA, V47, P409, DOI 10.5710/AMGH.v47i4.4; Garcia RA, 2010, AMEGHINIANA, V47, P45, DOI 10.5710/AMGH.v47i1.6; Garrido Alberto C., 2010, Rev. Mus. Argent. Cienc. Nat., V12, P121; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gee Carole T., 2011, P34; Gilmore C. W., 1933, American Museum Novitates, V679, P1; Gimenez O., 2008, NATURALIA PATAGONICA, V4, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gomani Elizabeth M., 2005, Palaeontologia Electronica, V8, P1; Gomani EM, 1999, THESIS; Riga BJG, 2014, AMEGHINIANA, V51, P3, DOI 10.5710/AMEGH.26.12.1013.1889; Riga BJG, 2009, CRETACEOUS RES, V30, P135, DOI 10.1016/j.cretres.2008.06.006; Gonzalez Riga BJ., 2011, PALEONTOLOG A DINOSA, P125; Goswami A, 2005, J VERTEBR PALEONTOL, V25, P320, DOI 10.1671/0272-4634(2005)025[0320:DMITAI]2.0.CO;2; Harris JD, 2006, J VERTEBR PALEONTOL, V26, P88, DOI 10.1671/0272-4634(2006)26[88:COOSES]2.0.CO;2; Harris JD, 2006, J SYST PALAEONTOL, V4, P185, DOI 10.1017/S1477201906001805; Holland W. J., 1924, Memoirs of the Carnegie Museum, V9, P379; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Hopson J.A., 1979, P39; Huene F.V., 1933, MEMOIRS GEOLOGICAL S, V21, P1; Huene F. von, 1929, Anales del Museo de La Plata, V3, P1; Huene F. von, 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; Hutchinson JR, 2002, COMP BIOCHEM PHYS A, V133, P1051, DOI 10.1016/S1095-6433(02)00158-7; Ibiricu L.M., 2011, BRAZILIAN GEOGR J GE, V2, P337; Ibiricu LM, 2015, AMEGHINIANA, V52, P430, DOI 10.5710/AMGH.24.04.2015.2830; Ibiricu LM, 2014, ZOOTAXA, V3786, P401, DOI 10.11646/zootaxa.3786.4.1; Ibiricu LM, 2013, J VERTEBR PALEONTOL, V33, P1351, DOI 10.1080/02724634.2013.776562; Ibiricu LM, 2012, AMEGHINIANA, V49, P657, DOI 10.5710/AMGH.28.4.2011.520; Ibiricu LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064253; Ibiricu LM, 2012, CRETACEOUS RES, V34, P220, DOI 10.1016/j.cretres.2011.11.003; Iglesias A, 2007, PALAEONTOLOGY, V50, P445, DOI 10.1111/j.1475-4983.2007.00639.x; JACOBS LL, 1993, PALAEONTOLOGY, V36, P523; Jain SL, 1997, J VERTEBR PALEONTOL, V17, P114, DOI 10.1080/02724634.1997.10010958; JANENSCH W., 1950, PALAEONTOGRAPHICA SUPPL, V7, P31; Janensch W., 1936, Palaeontologische Zeitschrift, V18, P181; Janensch W, 1935, PALAEONTOGRAPHICA S, V7, P145; Kellner A. W. A, 2006, GEOLOGIA, V74, P1; Kellner Alexander W.A., 1999, National Science Museum Monographs, V15, P111; Klein N., 2011, BIOL SAUROPOD DINOSA; Klein N, 2012, BIOL LETT, V2012; Knoll F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054991; Knoll F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030060; Knoll F, 2009, ANN PALEONTOL, V95, P165, DOI 10.1016/j.annpal.2009.06.001; Ksepka DT, 2010, AM MUS NOVIT, P1, DOI 10.1206/3700.2; Ksepka DT, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3508[1:EEALSF]2.0.CO;2; KURZANOV SM, 1983, PALEONTOL ZH, P90; Lacovara KJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06196; Lamanna M. C., 2004, THESIS; Lamanna MC, 2012, J VERTEBR PALEONTOL, V32, P124; Lamanna MC, 2002, J VERTEBR PALEONTOL, V22, P58, DOI 10.1671/0272-4634(2002)022[0058:ADATDF]2.0.CO;2; Le Loeuff J, 2005, LIFE O PAST, P115; LELOEUFF J, 1989, CR ACAD SCI II, V309, P851; LELOEUFF J, 1995, CR ACAD SCI II A, V321, P693; Carballido JL, 2012, HIST BIOL, V24, P631, DOI 10.1080/08912963.2012.672416; Machado EB, 2013, ZOOTAXA, V3701, P301, DOI 10.11646/zootaxa.3701.3.1; Madsen James H. Jr, 1995, Bulletin of Carnegie Museum of Natural History, V31, P1; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Mannion PD, 2012, J VERTEBR PALEONTOL, V32, P614, DOI 10.1080/02724634.2012.660898; Mannion PD, 2011, J SYST PALAEONTOL, V9, P355, DOI 10.1080/14772019.2010.527379; Marpmann JS, 2015, J SYST PALAEONTOL, V13, P221, DOI 10.1080/14772019.2013.875074; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; Martin Valerie, 1999, Oryctos, V2, P39; Martin Valerie, 1994, Gaia, V10, P147; Martinelli AG, 2015, J S AM EARTH SCI, V61, P164, DOI 10.1016/j.jsames.2015.02.009; Martinelli Agustin G., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P257; Martinez R, 2004, AMEGHINIANA, V41, P577; Martinez R., 1986, 4 C ARG PAL BIOESTR, V2, P23; Martinez R, 1998, 3 ANN C SAMC PROJ, V381, P20; Martinez R, 2009, AMEGHINIANA, V46, p36R; Martinez RD, 2004, J VERTEBR PALEONTOL, V24, P107, DOI 10.1671/9.1; Martinez RD, 1998, ACTA GEOLOGICA LEOPO, VXXI, P119; Martinez Ruben, 1998, Journal of Vertebrate Paleontology, V18, p61A; Martinez Ruben D., 2006, Revista del Museo Argentino de Ciencias Naturales, V8, P243; Mateer N.J., 1985, Bulletin of the Geological Institutions of the University of Uppsala, P125; McIntosh J.S., 1990, P345; MCINTOSH JS, 1975, J PALEONTOL, V49, P187; Miyashita T, 2011, J ANAT, V219, P661, DOI 10.1111/j.1469-7580.2011.01427.x; Mohabey DM, 2005, GONDWANA GEOLOGICAL, P101; Navarrete C, 2011, REV BRAS PALEONTOLOG, V14, P1, DOI 10.4072/rbp.2011.1.01; Novas F. E., 2009, AGE DINOSAURS S AM; Nowinski A., 1971, Palaeontologia Polonica, VNo. 25, P57; O'Donoghue CH, 1921, PHILOS T R SOC LON B, V210, P175, DOI 10.1098/rstb.1921.0006; OELRICH THOMAS M., 1956, MISC PUBL MUS ZOOL U MICHIGAN, V94, P9; Organ CL, 2005, J VERTEBR PALEONTOL, V25, P602, DOI 10.1671/0272-4634(2005)025[0602:THOOTI]2.0.CO;2; Osborn H. F., 1924, American Museum Novitates, VNo. 128, P1; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Otero A, 2011, AMEGHINIANA, V48, P655, DOI 10.5710/AMGH.v48i4(482); Parrish JM, 2003, J VERTEBR PALEONTOL, V23, p85A; Paulina Carabajal A, 2007, AMEGHINIANA, V44, P109; Poropat SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079932; Porter WR., 2015, THESIS; Powell J., 1989, AN 11 C BRAS PAL, V89, P165, DOI [10.35537/10915/4308, DOI 10.35537/10915/4308]; POWELL J E, 1979, Ameghiniana, V16, P191; Powell J.E., 1992, DINOSAURIOS ENTORNO, P165; Powell J.E., 1987, ANAIS X C BRAS PAL C, V1, P155; Powell J.E., 1990, ACT 5 C ARG PAL BIOE, V1, P123, DOI DOI 10.1016/J.GEOBIOS.2005.06.001; Powell JE., 2003, RECORDS QUEEN VICTOR, V111, P1; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Pujana Roberto R., 2007, Revista del Museo Argentino de Ciencias Naturales, V9, P161; Riga BJG, 2003, AMEGHINIANA, V40, P155; Rodriguez J.F.R., 1993, 2 C GEOL ARG 12 C EX, V1, P194; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Rogers KC, 2014, J VERTEBR PALEONTOL, V34, P606, DOI 10.1080/02724634.2013.822874; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Rose Peter J., 2007, Palaeontologia Electronica, V10, P1; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2082, DOI 10.1139/e93-180; Ryan M.J., 1997, ENCY DINOSAURS, P169; Saegusa H, 2014, ZOOTAXA, V3848, P1, DOI 10.11646/zootaxa.3848.1.1; Salgado L, 2005, ACTA PALAEONTOL POL, V50, P79; Salgado L, 2015, HIST BIOL, V27, P525, DOI 10.1080/08912963.2014.894038; Salgado L, 1999, AMEGHINIANA, V36, P203; Salgado Leonardo, 1997, Ameghiniana, V34, P33; Salgado Leonardo, 2007, P188; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Sampson S.D., 2007, SOC VERTEBRATE PALEO, V8, P32, DOI DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO; SANDER P.M., 2010, PLANTS MESOZOIC TIME, P330; Sander PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078573; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2013, PLOS ONE COLLECTIONS; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Schwarz D, 2006, ECLOGAE GEOL HELV, V99, P65, DOI 10.1007/s00015-006-1177-x; Sciutto JC., 1994, NATURALIA PATAG NICA, V2, P27; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Snively E, 2007, ANAT REC, V290, P934, DOI 10.1002/ar.20563; Stevens KA, 2005, LIFE O PAST, P212; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; STOKES WL, 1987, J PALEONTOL, V61, P1242, DOI 10.1017/S0022336000029619; Suarez M, 2014, J S AM EARTH SCI, V50, P67, DOI 10.1016/j.jsames.2013.10.008; Sues HD, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.889145; Suteethorn S, 2009, GEOL SOC SPEC PUBL, V315, P189, DOI 10.1144/SP315.14; Taggart Ralph E., 1997, P403; Tidwell V, 2003, J VERTEBR PALEONTOL, V23, P176, DOI 10.1671/0272-4634(2003)23[176:BOAECT]2.0.CO;2; Tsuihiji T, 2007, J MORPHOL, V268, P986, DOI 10.1002/jmor.10565; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Vakhrameev V.A., 1988, JURASSIC CRETACEOUS; Walker JD, 2013, GEOL SOC AM BULL, V125, P259, DOI 10.1130/B30712.1; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; Wedel MJ, 2000, J VERTEBR PALEONTOL, V20, P109, DOI 10.1671/0272-4634(2000)020[0109:SPANSF]2.0.CO;2; Wedel MJ, 2007, THESIS; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; WEISHAMPEL DB, 1991, RES EXPLOR, V7, P196; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Williams VS, 2009, P NATL ACAD SCI USA, V106, P11194, DOI 10.1073/pnas.0812631106; WILSON J., 2006, ACT 3 JORN DIN ENT B, P169; Wilson J. A., 2009, Contributions from the Museum of Paleontology University of Michigan, V32, P17; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P471, DOI 10.1671/0272-4634(2006)26[471:ATDSAF]2.0.CO;2; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Wiman C, 1929, PALAEONTOLOGIA SINIC, V6, P1; Wings O, 2007, P ROY SOC B-BIOL SCI, V274, P635, DOI 10.1098/rspb.2006.3763; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Witmer Lawrence M., 2008, P117; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Witmer LM, 2001, SCIENCE, V293, P850, DOI 10.1126/science.1062681; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Young C.C., 1972, I VERTEBRATE PALEO A, V8, P1; Young MT, 2012, NATURWISSENSCHAFTEN, V99, P637, DOI 10.1007/s00114-012-0944-y; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663; Zheng Z., 1996, THESIS	243	57	58	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0151661	10.1371/journal.pone.0151661	http://dx.doi.org/10.1371/journal.pone.0151661			82	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115989	Green Published, gold			2022-12-27	WOS:000374973600012
J	Wang, PQ; Cao, JB; Liu, N; Ma, L; Zhou, XY; Zhang, H; Wang, YG				Wang, Peiqi; Cao, Jiangbei; Liu, Na; Ma, Li; Zhou, Xueyue; Zhang, Hong; Wang, Yongan			Protective Effects of Edaravone in Adult Rats with Surgery and Lipopolysaccharide Administration-Induced Cognitive Function Impairment	PLOS ONE			English	Article							MORRIS WATER MAZE; BLOOD-BRAIN-BARRIER; OXIDATIVE STRESS; PARKINSONS-DISEASE; RADICAL SCAVENGER; AGED MICE; MEMORY; DYSFUNCTION; NEUROINFLAMMATION; ACTIVATION	Postoperative cognitive dysfunction (POCD) is a clinical syndrome characterized by cognitive declines in patients after surgery. Previous studies have suggested that surgery contributed to such impairment. It has been proven that neuroinflammation may exacerbate surgery-induced cognitive impairment in aged rats. The free radical scavenger edaravone has high blood brain barrier permeability, and was demonstrated to effectively remove free radicals from the brain and alleviate the development of POCD in patients undergoing carotid endarterectomy, suggesting its potential role in preventing POCD. For this reason, this study was designed to determine whether edaravone is protective against POCD through its inhibitory effects on inflammatory cytokines and oxidative stress. First, Sprague Dawley adult male rats were administered 3 mg/ kg edaravone intraperitoneally after undergoing a unilateral nephrectomy combined with lipopolysaccharide injection. Second, behavioral parameters related to cognitive function were recorded by fear conditioning and Morris Water Maze tests. Last, superoxide dismutase activities and malondialdehyde levels were measured in the hippocampi and prefrontal cortex on postoperative days 3 and 7, and microglial (Iba1) activation, p-Akt and p-mTOR protein expression, and synaptic function (synapsin 1) were also examined 3 and 7 days after surgery. Rats that underwent surgery plus lipopolysaccharide administration showed significant impairments in spatial and working memory, accompanied by significant reductions in hippocampal-dependent and independent fear responses. All impairments were attenuated by treatment with edaravone. Moreover, an abnormal decrease in superoxide dismutase activation, abnormal increase in malondialdehyde levels, significant increase in microglial reactivity, downregulation of p-Akt and p-mTOR protein expression, and a statistically significant decrease in synapsin-1 were observed in the hippocampi and prefrontal cortices of rats at different time points after surgery. All mentioned abnormal changes were totally or partially reversed by edaravone. To our knowledge, few reports have shown greater protective effects of edaravone on POCD induced by surgery plus lipopolysaccharide administration from its anti-oxidative stress and anti-inflammatory effects, as well as maintenance of Akt/mTOR signal pathway activation; these might be closely related to the therapeutic effects of edaravone. Our research demonstrates the potential use of edaravone in the treatment of POCD.	[Wang, Peiqi; Cao, Jiangbei; Liu, Na; Ma, Li; Zhou, Xueyue; Zhang, Hong] Chinese PLA, Gen Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Wang, Peiqi; Cao, Jiangbei; Liu, Na; Ma, Li; Zhou, Xueyue; Zhang, Hong] Chinese PLA, Gen Hosp, Operat Ctr, Beijing, Peoples R China; [Liu, Na] Chengde Med Univ, Affiliated Hosp, Dept Anesthesiol, Chengde, Peoples R China; [Ma, Li] Chinese Peoples Liberat Army, Dept Anesthesiol, Beijing Mil Gen Hosp, Beijing, Peoples R China; [Wang, Yongan] Acad Mil Med Sci, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China	Chengde Medical University; Academy of Military Medical Sciences - China	Zhang, H (corresponding author), Chinese PLA, Gen Hosp, Dept Anesthesiol, Beijing, Peoples R China.; Zhang, H (corresponding author), Chinese PLA, Gen Hosp, Operat Ctr, Beijing, Peoples R China.; Wang, YG (corresponding author), Acad Mil Med Sci, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China.	mazuima301@163.com; yonganw@sina.com	Cao, Jiangbei/ADE-0079-2022; Cao, jiangbei/AFS-3772-2022	Cao, Jiangbei/0000-0003-1218-4639; 	General Logistics Department [13BJZ38]; Military Medical Scientific and Technological Project for the "Twelfth Five-year Plan" [AWS15J007, BWS12J042]	General Logistics Department; Military Medical Scientific and Technological Project for the "Twelfth Five-year Plan"	This study was supported by a grant in the special subject of health care from the General Logistics Department (13BJZ38) and a Military Medical Scientific and Technological Project for the "Twelfth Five-year Plan" (AWS15J007, BWS12J042).	Al Banchaabouchi M, 2001, NEPHRON, V89, P90, DOI 10.1159/000046049; Banoub JH, 2010, MASS SPECTROM REV, V29, P606, DOI 10.1002/mas.20258; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Cain DP, 1996, REV NEUROSCIENCE, V7, P215; Calvino E, 2011, BIOCHEM PHARMACOL, V82, P1619, DOI 10.1016/j.bcp.2011.08.017; Chen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134307; Choopankareh S, 2015, TURK J MED SCI, V45, P842, DOI 10.3906/sag-1406-35; Chung E, 2015, CARDIOVASC PSYCHIAT, V2015, P1, DOI 10.1155/2015/370612; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Di Vita G, 2006, WOUND REPAIR REGEN, V14, P259, DOI 10.1111/j.1743-6109.2006.00120.x; Diana G, 2007, P NATL ACAD SCI USA, V104, P636, DOI 10.1073/pnas.0610059104; Dohare P, 2014, FREE RADICAL BIO MED, V77, P168, DOI 10.1016/j.freeradbiomed.2014.08.029; Dong HQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0140-4; Dong ZF, 2013, NEUROPHARMACOLOGY, V64, P65, DOI 10.1016/j.neuropharm.2012.06.027; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fidalgo AR, 2011, NEUROSCI LETT, V498, P63, DOI 10.1016/j.neulet.2011.04.063; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Hara N, 2015, SHOCK, V44, P578, DOI 10.1097/SHK.0000000000000465; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hovens IB, 2012, BRAIN BEHAV IMMUN, V26, P1169, DOI 10.1016/j.bbi.2012.06.004; Huang CS, 2015, BIOCHEM PHARMACOL, V93, P352, DOI 10.1016/j.bcp.2014.12.005; INOUE T, 1994, PHARMACOL BIOCHEM BE, V49, P911, DOI 10.1016/0091-3057(94)90243-7; Jiao SS, 2015, P NATL ACAD SCI USA, V112, P5225, DOI 10.1073/pnas.1422998112; Kalb A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062679; Kempermann G., 2015, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPE; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kobbe P, 2008, SHOCK, V30, P43, DOI [10.1097/SHK.0b013e318d190b, 10.1097/SHK.0b013e31815d190b]; Krenk L, 2010, ACTA ANAESTH SCAND, V54, P951, DOI 10.1111/j.1399-6576.2010.02268.x; Lee J, 2016, REPRODUCTION, V151, P187, DOI 10.1530/REP-15-0302; Li L, 2015, EXP NEUROL, V272, P135, DOI 10.1016/j.expneurol.2014.12.020; Lin DW, 2011, NEUROPHARMACOLOGY, V61, P1354, DOI 10.1016/j.neuropharm.2011.08.011; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; O' Neill C, 2013, EXP GERONTOL, V48, P647, DOI 10.1016/j.exger.2013.02.025; Oddo Salvatore, 2012, Front Biosci (Schol Ed), V4, P941; Ogasawara K, 2005, SURG NEUROL, V64, P309, DOI 10.1016/j.surneu.2005.01.008; Pasechnik I. N., 2009, Anesteziologiya i Reanimatologiya, P50; Peng SY, 2015, J NEUROSCI, V35, P1250, DOI 10.1523/JNEUROSCI.2444-14.2015; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Qiao Y, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0130-9; Ramirez-Sanchez J, 2015, NEUROCHEM INT, V90, P215, DOI 10.1016/j.neuint.2015.09.003; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Sun J, 2016, NEUROSCI LETT, V613, P30, DOI 10.1016/j.neulet.2015.12.047; Sun YY, 2015, STROKE, V46, P1947, DOI 10.1161/STROKEAHA.115.009162; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tarassishin L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-187; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wang YR, 2015, INT IMMUNOPHARMACOL, V28, P136, DOI 10.1016/j.intimp.2015.05.044; Xia SF, 2015, PHYSIOL BEHAV, V138, P325, DOI 10.1016/j.physbeh.2014.09.008; Yang R, 2015, NEUROL SCI; Zhang XQ, 2013, J NEUROSCI, V33, P17737, DOI 10.1523/JNEUROSCI.2049-13.2013	60	22	23	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153708	10.1371/journal.pone.0153708	http://dx.doi.org/10.1371/journal.pone.0153708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116382	gold, Green Published, Green Submitted			2022-12-27	WOS:000374973600027
J	Ting, WH; Chien, MN; Lo, FS; Wang, CH; Huang, CY; Lin, CL; Lin, WS; Chang, TY; Yang, HW; Chen, WF; Lien, YP; Cheng, BW; Lin, CH; Chen, CC; Wu, YL; Hung, CM; Li, HJ; Chan, CI; Lee, YJ				Ting, Wei-Hsin; Chien, Ming-Nan; Lo, Fu-Sung; Wang, Chao-Hung; Huang, Chi-Yu; Lin, Chiung-Ling; Lin, Wen-Shan; Chang, Tzu-Yang; Yang, Horng-Woei; Chen, Wei-Fang; Lien, Ya-Ping; Cheng, Bi-Wen; Lin, Chao-Hsu; Chen, Chia-Ching; Wu, Yi-Lei; Hung, Chen-Mei; Li, Hsin-Jung; Chan, Chon-In; Lee, Yann-Jinn			Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study	PLOS ONE			English	Article							GRAVES-DISEASE; HASHIMOTOS-THYROIDITIS; CHROMOSOME 2Q33; SOLUBLE CTLA-4; STOP-SIGNAL; SUSCEPTIBILITY; POPULATION; METAANALYSIS; PROMOTER; JAPANESE	Autoimmune thyroid disease (AITD), including Graves disease (GD) and Hashimoto disease (HD), is an organ-specific autoimmune disease with a strong genetic component. Although the cytotoxic T-lymphocyte-associated protein 4 (CTLA4) polymorphism has been reported to be associated with AITD in adults, few studies have focused on children. The aim of our study was to investigate whether the CTLA4 polymorphisms, including -318C/T (rs5742909), + 49A/G (rs231775), and CT60 (rs3087243), were associated with GD and HD in Han Chinese adults and children. We studied 289 adult GD, 265 pediatric GD, 229 pediatric HD patients, and 1058 healthy controls and then compared genotype, allele, carrier, and haplotype frequencies between patients and controls. We found that CTLA4 SNPs + 49A/G and CT60 were associated with GD in adults and children. Allele G of + 49A/G was significantly associated with GD in adults (odds ratio [OR], 1.50; 95% confidence interval [CI], 1.21-1.84; corrected P value [Pc] < 0.001) and children (OR, 1.42; 95% CI, 1.15-1.77; Pc = 0.002). Allele G of CT60 also significantly increased risk of GD in adults (OR, 1.63; 95% CI, 1.27-2.09; Pc < 0.001) and GD in children (OR, 1.58; 95% CI, 1.22-2.04; Pc < 0.001). Significant linkage disequilibrium was found between +49A/G and CT60 in GD and control subjects (D' = 0.92). Our results showed that CTLA4 was associated with both GD and HD and played an equivalent role in both adult and pediatric GD in Han Chinese population.	[Ting, Wei-Hsin; Huang, Chi-Yu; Chan, Chon-In; Lee, Yann-Jinn] MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan; [Chien, Ming-Nan; Wang, Chao-Hung] MacKay Mem Hosp, Dept Endocrinol & Metab, Taipei, Taiwan; [Ting, Wei-Hsin; Chien, Ming-Nan; Huang, Chi-Yu; Lee, Yann-Jinn] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Chien, Ming-Nan] Natl Taipei Univ Technol, Inst Mechatron Engn, Taipei 106, Taiwan; [Ting, Wei-Hsin; Chien, Ming-Nan] MacKay Jr Coll Med Nursing & Management, New Taipei, Taiwan; [Lo, Fu-Sung] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Lo, Fu-Sung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lin, Chiung-Ling; Lin, Wen-Shan; Chang, Tzu-Yang; Yang, Horng-Woei; Chen, Wei-Fang; Lien, Ya-Ping; Lee, Yann-Jinn] MacKay Mem Hosp Tamsui, Dept Med Res, New Taipei, Taiwan; [Cheng, Bi-Wen; Lin, Chao-Hsu] MacKay Mem Hosp HsinChu, Dept Pediat, Hsinchu, Taiwan; [Chen, Chia-Ching] Chiayi Christian Hosp, Dept Pediat, Chiayi, Taiwan; [Wu, Yi-Lei] Changhua Christian Hosp, Dept Pediat, Changhua, Taiwan; [Hung, Chen-Mei] Hsinchu Cathay Gen Hosp, Dept Pediat, Hsinchu, Taiwan; [Li, Hsin-Jung] St Martin De Porres Hosp, Dept Pediat, Chiayi, Taiwan; [Lee, Yann-Jinn] Taipei Med Univ, Sch Med, Dept Pediat, Coll Med, Taipei, Taiwan; [Lee, Yann-Jinn] MacKay Med Coll, Inst Biomed Sci, New Taipei, Taiwan	Mackay Memorial Hospital; Mackay Medical College; National Taipei University of Technology; Mackay Junior College of Medicine, Nursing & Management; Chang Gung Memorial Hospital; Chang Gung University; Mackay Memorial Hospital; Chia-Yi Christian Hospital; Changhua Christian Hospital; Cathay General Hospital; Taipei Medical University; Mackay Medical College	Lee, YJ (corresponding author), MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan.; Lee, YJ (corresponding author), MacKay Med Coll, Dept Med, New Taipei, Taiwan.; Lee, YJ (corresponding author), MacKay Mem Hosp Tamsui, Dept Med Res, New Taipei, Taiwan.; Lee, YJ (corresponding author), Taipei Med Univ, Sch Med, Dept Pediat, Coll Med, Taipei, Taiwan.; Lee, YJ (corresponding author), MacKay Med Coll, Inst Biomed Sci, New Taipei, Taiwan.	yannlee@mmh.org.tw	Wang, Chao/GXF-8353-2022		Ministry of Science and Technology, Executive Yuan [NSC 101-2314-B-715-002-MY3]; MacKay Memorial Hospital, Taipei [MMH E-102-07]; MacKay Medical College, New Taipei City, Taiwan [MMC RD1010045]	Ministry of Science and Technology, Executive Yuan; MacKay Memorial Hospital, Taipei; MacKay Medical College, New Taipei City, Taiwan	This study was supported by grants NSC 101-2314-B-715-002-MY3 from the Ministry of Science and Technology, Executive Yuan; MMH E-102-07 from MacKay Memorial Hospital, Taipei; and MMC RD1010045 from MacKay Medical College, New Taipei City, Taiwan.	Anjos S, 2002, J BIOL CHEM, V277, P46478, DOI 10.1074/jbc.M206894200; Antonelli A, 2015, AUTOIMMUN REV, V14, P174, DOI 10.1016/j.autrev.2014.10.016; Ban Y, 2004, J CLIN ENDOCR METAB, V89, P4562, DOI 10.1210/jc.2003-031693; Ban Y, 2003, GENES IMMUN, V4, P586, DOI 10.1038/sj.gene.6364018; Barlow ABT, 1996, CLIN ENDOCRINOL, V44, P73, DOI 10.1046/j.1365-2265.1996.634454.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bicek A, 2009, HUM IMMUNOL, V70, P820, DOI 10.1016/j.humimm.2009.06.016; Brandstaetter A, 2010, PLOS ONE, V5, pe9821, DOI [10.1371/journal.pone.0009821, DOI 10.1371/JOURNAL.PONE.0009821]; Braun J, 1998, TISSUE ANTIGENS, V51, P563, DOI 10.1111/j.1399-0039.1998.tb02993.x; Brix TH, 2011, ANN ENDOCRINOL-PARIS, V72, P103, DOI 10.1016/j.ando.2011.03.013; Brix TH, 2001, J CLIN ENDOCR METAB, V86, P930, DOI 10.1210/jc.86.2.930; Brown RS, 2009, BROOKS CLIN PEDIAT E, P250; Butty V, 2007, P NATL ACAD SCI USA, V104, P570, DOI 10.1073/pnas.0610124104; Chong KKL, 2008, INVEST OPHTH VIS SCI, V49, P2409, DOI 10.1167/iovs.07-1433; Cury AN, 2008, HORM RES, V70, P36, DOI 10.1159/000129676; DARIAVACH P, 1988, EUR J IMMUNOL, V18, P1901, DOI 10.1002/eji.1830181206; Daroszewski J, 2009, EUR J ENDOCRINOL, V161, P787, DOI 10.1530/EJE-09-0600; Deichmann K, 1996, BIOCHEM BIOPH RES CO, V225, P817, DOI 10.1006/bbrc.1996.1256; Donner H, 1997, J CLIN ENDOCR METAB, V82, P4130, DOI 10.1210/jc.82.12.4130; Du L, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-46; Feng M, 2013, ENDOCRINE, V44, P350, DOI 10.1007/s12020-013-0014-z; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Furugaki K, 2004, J HUM GENET, V49, P166, DOI 10.1007/s10038-003-0120-5; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Han SZ, 2006, HUM IMMUNOL, V67, P618, DOI 10.1016/j.humimm.2006.05.003; HARPER K, 1991, J IMMUNOL, V147, P1037; Heward JM, 1999, J CLIN ENDOCR METAB, V84, P2398, DOI 10.1210/jc.84.7.2398; Huang CY, 2013, HUM IMMUNOL, V74, P120, DOI 10.1016/j.humimm.2012.10.005; Iwama S, 2005, HORM RES, V63, P55, DOI 10.1159/000083137; JAKSIC J, 1994, ARCH DIS CHILD, V70, P103, DOI 10.1136/adc.70.2.103; Kavvoura FK, 2007, J CLIN ENDOCR METAB, V92, P3162, DOI 10.1210/jc.2007-0147; Kliegman RM, 2011, NELSON TXB PEDIAT, P1895; Kolar P, 2009, ARTHRITIS RHEUM-US, V60, P123, DOI 10.1002/art.24181; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Kucharska AM, 2012, HORM RES PAEDIAT, V78, P67, DOI 10.1159/000338997; Lee HJ, 2015, J AUTOIMMUN, V64, P82, DOI 10.1016/j.jaut.2015.07.009; Lee YJ, 1998, M D COMPUT, V15, P327; Ligers A, 2001, GENES IMMUN, V2, P145, DOI 10.1038/sj.gene.6363752; Mandel SJ, 2011, WILLIAMS TXB ENDOCRI, P362; McGrogan A, 2008, CLIN ENDOCRINOL, V69, P687, DOI 10.1111/j.1365-2265.2008.03338.x; Ni J, 2014, ENDOCR RES, V39, P180, DOI 10.3109/07435800.2013.879167; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Nyholt DR, 2001, HUM GENET, V109, P564, DOI 10.1007/s00439-001-0611-4; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Ohashi J, 2001, ANN HUM GENET, V65, P197, DOI 10.1017/S000348000100851X; Orozco G, 2004, TISSUE ANTIGENS, V64, P667, DOI 10.1111/j.1399-0039.2004.00318.x; Pastuszak-Lewandoska D, 2012, ARCH MED SCI, V8, P415, DOI 10.5114/aoms.2012.28593; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purohit Sharad, 2005, J Autoimmune Dis, V2, P8, DOI 10.1186/1740-2557-2-8; Qiu H, 2014, ENDOCRINE, V45, P198, DOI 10.1007/s12020-013-9985-z; Rudd CE, 2008, NAT REV IMMUNOL, V8, P153, DOI 10.1038/nri2253; Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Si XY, 2012, EXP THER MED, V4, P538, DOI 10.3892/etm.2012.618; STENSZKY V, 1985, J CLIN ENDOCR METAB, V61, P735, DOI 10.1210/jcem-61-4-735; Su TH, 2007, CARCINOGENESIS, V28, P1237, DOI 10.1093/carcin/bgm043; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; Tanda ML, 2009, HORM METAB RES, V41, P436, DOI 10.1055/s-0029-1215568; Terauchi M, 2003, J ENDOCRINOL INVEST, V26, P1208, DOI 10.1007/BF03349159; Tomer Y, 2001, J CLIN ENDOCR METAB, V86, P1687, DOI 10.1210/jc.86.4.1687; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Tomer Y, 2009, J AUTOIMMUN, V32, P231, DOI 10.1016/j.jaut.2009.02.007; Tomoyose T, 2002, THYROID, V12, P673, DOI 10.1089/105072502760258640; Torres B, 2004, ARTHRITIS RHEUM-US, V50, P2211, DOI 10.1002/art.20347; Tsai ST, 2008, J PEDIATR ENDOCR MET, V21, P665; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vaidya B, 2004, EUR J ENDOCRINOL, V150, P619, DOI 10.1530/eje.0.1500619; Vaidya B, 2003, CLIN ENDOCRINOL, V58, P732, DOI 10.1046/j.1365-2265.2003.01778.x; Wang PW, 2004, J CLIN ENDOCR METAB, V89, P169, DOI 10.1210/jc.2003-030854; Wang XB, 2002, GENES IMMUN, V3, P233, DOI 10.1038/sj.gene.6363869; Weng YC, 2005, ANN CLIN LAB SCI, V35, P259; Yesilkaya E, 2008, GENET TEST, V12, P461, DOI 10.1089/gte.2008.0053; Yung E, 2002, CLIN ENDOCRINOL, V56, P649, DOI 10.1046/j.1365-2265.2002.01234.x; Zhang Qin, 2006, J Zhejiang Univ Sci B, V7, P887, DOI 10.1631/jzus.2006.B0887	74	45	53	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154394	10.1371/journal.pone.0154394	http://dx.doi.org/10.1371/journal.pone.0154394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111218	Green Published, Green Submitted, gold			2022-12-27	WOS:000374970600064
J	Belote, RT; Dietz, MS; McRae, BH; Theobald, DM; McClure, ML; Irwin, GH; McKinley, PS; Gage, JA; Aplet, GH				Belote, R. Travis; Dietz, Matthew S.; McRae, Brad H.; Theobald, David M.; McClure, Meredith L.; Irwin, G. Hugh; McKinley, Peter S.; Gage, Josh A.; Aplet, Gregory H.			Identifying Corridors among Large Protected Areas in the United States	PLOS ONE			English	Article							CONSERVING BIODIVERSITY; CLIMATE-CHANGE; CONSERVATION; CONNECTIVITY; MANAGEMENT; NETWORK; MODEL; WILDERNESS; MAMMALS	Conservation scientists emphasize the importance of maintaining a connected network of protected areas to prevent ecosystems and populations from becoming isolated, reduce the risk of extinction, and ultimately sustain biodiversity. Keeping protected areas connected in a network is increasingly recognized as a conservation priority in the current era of rapid climate change. Models that identify suitable linkages between core areas have been used to prioritize potentially important corridors for maintaining functional connectivity. Here, we identify the most "natural" (i.e., least human-modified) corridors between large protected areas in the contiguous Unites States. We aggregated results from multiple connectivity models to develop a composite map of corridors reflecting agreement of models run under different assumptions about how human modification of land may influence connectivity. To identify which land units are most important for sustaining structural connectivity, we used the composite map of corridors to evaluate connectivity priorities in two ways: (1) among land units outside of our pool of large core protected areas and (2) among units administratively protected as Inventoried Roadless (IRAs) or Wilderness Study Areas (WSAs). Corridor values varied substantially among classes of "unprotected" non-core land units, and land units of high connectivity value and priority represent diverse ownerships and existing levels of protections. We provide a ranking of IRAs and WSAs that should be prioritized for additional protection to maintain minimal human modification. Our results provide a coarsescale assessment of connectivity priorities for maintaining a connected network of protected areas.	[Belote, R. Travis] Wilderness Soc, Bozeman, MT USA; [Dietz, Matthew S.] Wilderness Soc, San Francisco, CA USA; [McRae, Brad H.] Nature Conservancy, Seattle, WA USA; [Theobald, David M.] Conservat Sci Partners Inc, Ft Collins, CO USA; [McClure, Meredith L.] Ctr Large Landscape Conservat, Bozeman, MT USA; [Irwin, G. Hugh] Wilderness Soc, Black Mt, NC USA; [McKinley, Peter S.] Wilderness Soc, Hallowell, ME USA; [Gage, Josh A.] Gage Cartograph, Bozeman, MT USA; [Aplet, Gregory H.] Wilderness Soc, Denver, CO USA	Nature Conservancy	Belote, RT (corresponding author), Wilderness Soc, Bozeman, MT USA.	travis_belote@tws.org			Wilderness Society	Wilderness Society	The Wilderness Society funded this work. The funder provided support in the form of salaries for author JAG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Ament R, 2014, WILDLIFE CONNECTIVIT; Aplet G, 2000, US FOR SERV RMRS-P, V2, P89; Aplet GH, 1999, DENVER U LAW REV, V76, P347; Aycrigg JL, 2015, J-FOR, V114, P1, DOI DOI 10.5849/JOF.15-050; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beier Paul, 2012, Ecological Restoration, V30, P312, DOI 10.3368/er.30.4.312; Beier P, 2011, CONSERV BIOL, V25, P879, DOI 10.1111/j.1523-1739.2011.01716.x; Bowman J, 2002, ECOLOGY, V83, P2049, DOI 10.2307/3071786; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Dickson BG, 2014, BIOL CONSERV, V178, P117, DOI 10.1016/j.biocon.2014.08.001; Dietz MS, 2015, BIOL CONSERV, V184, P431, DOI 10.1016/j.biocon.2015.02.024; Fremier AK, 2015, BIOL CONSERV, V191, P29, DOI 10.1016/j.biocon.2015.06.029; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gergely KJ, 2013, PAD US NATL INVENTOR; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hagerman SM, 2014, ECOL APPL, V24, P548, DOI 10.1890/13-0400.1; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Hoctor T, 2008, J CONSERVATION PLANN, V4, P90; Keeley ATK, 2015, COMP ESTIMATES LANDS; Keeley ATK, LANDSC ECOL IN PRESS; Krosby M, 2015, LANDSCAPE ECOL, V30, P2121, DOI 10.1007/s10980-015-0235-z; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; McRae, 2014, RIPARIAN CLIMATE COR; McRae B, 2012, LINKAGE MAPPER USER, P1; McRae B., 2009, CIRCUITSCAPE USER GU; Minor ES, 2010, CONSERV BIOL, V24, P1549, DOI 10.1111/j.1523-1739.2010.01558.x; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Ordonez A, 2014, NAT CLIM CHANGE, V4, P811, DOI [10.1038/nclimate2337, 10.1038/NCLIMATE2337]; Pachauri R.K., 2014, CONTRIBUTION WORKING; QUAMMEN D, 1996, SONG DODO ISLAND BIO; Rayfield B, 2011, ECOLOGY, V92, P847, DOI 10.1890/09-2190.1; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Rudnick D.A., 2012, ISSUES ECOLOGY, V11, P28; Schmitz OJ, 2015, NAT AREA J, V35, P190, DOI 10.3375/043.035.0120; Shah VB, 2007, ECOLOGY, V89, P2712; SIMBERLOFF D, 1992, CONSERV BIOL, V6, P493, DOI 10.1046/j.1523-1739.1992.06040493.x; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Tewksbury JJ, 2002, P NATL ACAD SCI USA, V99, P12923, DOI 10.1073/pnas.202242699; Theobald DM, 2013, LANDSCAPE ECOL, V28, P1859, DOI 10.1007/s10980-013-9941-6; Theobald DM, 2012, CONSERV LETT, V5, P123, DOI 10.1111/j.1755-263X.2011.00218.x; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	48	76	79	17	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154223	10.1371/journal.pone.0154223	http://dx.doi.org/10.1371/journal.pone.0154223			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104683	Green Submitted, Green Published, gold			2022-12-27	WOS:000374565100058
J	Ackema, KB; Prescianotto-Baschong, C; Hench, J; Wang, SC; Chia, ZH; Mergentaler, H; Bard, F; Frank, S; Spang, A				Ackema, Karin B.; Prescianotto-Baschong, Cristina; Hench, Jurgen; Wang, Shyi Chyi; Chia, Zhi Hui; Mergentaler, Heidi; Bard, Frederic; Frank, Stephan; Spang, Anne			Sar1, a Novel Regulator of ER-Mitochondrial Contact Sites	PLOS ONE			English	Article							EARLY SECRETORY PATHWAY; OUTER-MEMBRANE PROTEIN; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; C-ELEGANS; CAENORHABDITIS-ELEGANS; COPII VESICLE; YEAST; COMPLEX; GTPASE	Endoplasmic reticulum (ER)-mitochondrial contact sites play a pivotal role in exchange of lipids and ions between the two organelles. How size and function of these contact sites are regulated remains elusive. Here we report a previously unanticipated, but conserved role of the small GTPase Sar1 in the regulation of ER-mitochondrial contact site size. Activated Sar1 introduces membrane curvature through its N-terminal amphiphatic helix at the ER-mitochondria interphase and thereby reducing contact size. Conversely, the S. cerevisiae N3-Sar1 mutant, in which curvature induction is decreased, caused an increase in ER-mitochondrial contacts. As a consequence, ER tubules are no longer able to mark the prospective scission site on mitochondria, thereby impairing mitochondrial dynamics. Consistently, blocking mitochondrial fusion partially rescued, whereas deletion of the dynamin-like protein enhanced the phenotype in the sar1D32G mutant. We conclude that Sar1 regulates the size of ER-mitochondria contact sites through its effects on membrane curvature.	[Ackema, Karin B.; Prescianotto-Baschong, Cristina; Mergentaler, Heidi; Spang, Anne] Univ Basel, Growth & Dev, Biozentrum, CH-4056 Basel, Switzerland; [Hench, Jurgen; Frank, Stephan] Univ Basel Hosp, Inst Pathol, Div Neuropathol, CH-4031 Basel, Switzerland; [Wang, Shyi Chyi; Chia, Zhi Hui; Bard, Frederic] Inst Mol & Cell Biol, Singapore 138673, Singapore	University of Basel; University of Basel; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Spang, A (corresponding author), Univ Basel, Growth & Dev, Biozentrum, CH-4056 Basel, Switzerland.	anne.spang@unibas.ch	Spang, Anne/M-7223-2019	Spang, Anne/0000-0002-2387-6203	University of Basel: unibas.ch; Swiss National Science Foundation [31003A_141207]; University of Basel	University of Basel: unibas.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel	This work was supported by the University of Basel: unibas.ch, and Swiss National Science Foundation: 31003A_141207, snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank M. Lee, E. Miller, R. Schekman, B. Westermann, K. Sato, A. van der Bliek, J. Shaw and the Caenorhabditis Genetics Center for reagents, S. Ipsen for technical support, and I. G. Macara for critical comments on the manuscript. We thank B. Westermann for helpful discussions on mitochondrial phenotypes. The Biozentrum Imaging Core Facility is acknowledged for technical support. This research was supported by the Swiss National Science Foundation (31003A_141207) and the University of Basel.	Ackema KB, 2014, EMBO J, DOI 10.15252/embj.201489039; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; BRENNER S, 1974, GENETICS, V77, P71; Elbaz-Alon Y, 2015, CELL REP, V12, P7, DOI 10.1016/j.celrep.2015.06.022; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Fernandez-Busnadiego R, 2015, P NATL ACAD SCI USA, V112, pE2004, DOI 10.1073/pnas.1503191112; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Hariri H, 2014, J MOL BIOL, V426, P3811, DOI 10.1016/j.jmb.2014.08.023; Hench J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028417; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Itoh K, 2013, MOL BIOL CELL, V24, P1842, DOI 10.1091/mbc.E13-03-0125; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kodera C, 2014, J BIOL CHEM, V289, P21423, DOI 10.1074/jbc.M114.553917; Kondo-Okamoto N, 2008, EMBO REP, V9, P63, DOI 10.1038/sj.embor.7401113; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murley A, 2013, ELIFE, V2, DOI 10.7554/eLife.00422; Nguyen TT, 2012, TRAFFIC, V13, P880, DOI 10.1111/j.1600-0854.2012.01352.x; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prescianotto-Baschong C, 2002, TRAFFIC, V3, P37, DOI 10.1034/j.1600-0854.2002.30106.x; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Saito K, 2014, J CELL BIOL, V206, P751, DOI 10.1083/jcb.201312062; Saito Y, 1999, J BIOCHEM-TOKYO, V125, P130, DOI 10.1093/oxfordjournals.jbchem.a022249; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Settles EI, 2010, BIOPHYS J, V99, P1539, DOI 10.1016/j.bpj.2010.06.059; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Voss C, 2012, J CELL SCI, V125, P4791, DOI 10.1242/jcs.105635; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L	46	15	15	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154280	10.1371/journal.pone.0154280	http://dx.doi.org/10.1371/journal.pone.0154280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101143	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000374898500178
J	Janmaat, VT; Bruno, MJ; Polinder, S; Lorenzen, S; Lordick, F; Peppelenbosch, MP; Spaander, MCW				Janmaat, Vincent T.; Bruno, Marco J.; Polinder, Suzanne; Lorenzen, Sylvie; Lordick, Florian; Peppelenbosch, Maikel P.; Spaander, Manon C. W.			Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; GROWTH-FACTOR-RECEPTOR; CLINICAL-TRIAL; PHASE-II; SURVIVAL; POLYMORPHISMS; OVEREXPRESSION; AMPLIFICATION; SURVEILLANCE; PANITUMUMAB	Background Costly biologicals in palliative oncology are emerging at a rapid pace. For example, in patients with advanced esophageal squamous cell carcinoma addition of cetuximab to a palliative chemotherapy regimen appears to improve survival. However, it simultaneously results in higher costs. We aimed to determine the incremental cost-effectiveness ratio of adding cetuximab to first-line chemotherapeutic treatment of patients with advanced esophageal squamous cell carcinoma, based on data from a randomized controlled phase II trial. Methods A cost effectiveness analysis model was applied based on individual patient data. It included only direct medical costs from the health-care perspective. Quality-adjusted life-years and incremental cost-effectiveness ratios were calculated. Sensitivity analysis was performed by a Monte Carlo analysis. Results Adding cetuximab to a cisplatin-5-fluorouracil first-line regimen for advanced esophageal squamous cell carcinoma resulted in an the incremental cost-effectiveness ratio of (sic)252,203 per quality-adjusted life-year. Sensitivity analysis shows that there is a chance of less than 0.001 that the incremental cost-effectiveness ratio will be less than a maximum willingness to pay threshold of (sic)40,000 per quality-adjusted life-year, which is representative for the threshold used in The Netherlands and other developed countries. Conclusions Addition of cetuximab to a cisplatin-5-fluorouracil first-line regimen for advanced esophageal squamous cell carcinoma is not cost-effective when appraised according to currently accepted criteria. Cost-effectiveness analyses using outcome data from early clinical trials (i.c. a phase II trial) enable pharmaceutical companies and policy makers to gain early insight into whether a new drug meets the current eligibility standards for reimbursement and thereby potential admittance for use in regular clinical practice.	[Janmaat, Vincent T.; Bruno, Marco J.; Peppelenbosch, Maikel P.; Spaander, Manon C. W.] Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Polinder, Suzanne] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Lorenzen, Sylvie] Tech Univ Munich, Dept Internal Med Hematol Med Oncol 3, D-80290 Munich, Germany; [Lordick, Florian] Univ Leipzig, UCCL, D-04109 Leipzig, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Technical University of Munich; Leipzig University	Spaander, MCW (corresponding author), Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	v.spaander@erasmusmc.nl	Peppelenbosch, Maikel P./U-5304-2019	Janmaat, Vincent/0000-0002-8279-1816; Peppelenbosch, Maikel/0000-0001-9112-6028	Merck Serono	Merck Serono(Merck & Company)	One of the authors F. Lordick received research support, travel support and lecture honoraria from Merck Serono. This did not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Appleby J, 2009, HEALTH POLICY, V91, P239, DOI 10.1016/j.healthpol.2008.12.010; Council for Public Health and Health Care to the Minister of Health, 2006, WELF SPORT SENS SUST; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Garside R, 2006, HEALTH TECHNOL ASSES, V10, P1; Gibault L, 2005, BRIT J CANCER, V93, P107, DOI 10.1038/sj.bjc.6602625; Graziano F, 2008, J CLIN ONCOL, V26, P1427, DOI 10.1200/JCO.2007.12.4602; Greenhalgh J, 2009, HEALTH TECHNOL ASSES, V13, P49, DOI 10.3310/hta13suppl3/08; Hakkaart-van Roijen L, 2010, HANDLEIDING KOSTENON; Hanawa M, 2006, INT J CANCER, V118, P1173, DOI 10.1002/ijc.21454; Higginson IJ, 2009, J PAIN SYMPTOM MANAG, V38, P816, DOI 10.1016/j.jpainsymman.2009.07.002; Hill S, 2003, PHARMACOECONOMICS, V21, P761, DOI 10.2165/00019053-200321110-00001; Hoyle M, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17140; Hughes DA, 2001, PHARMACOECONOMICS, V19, P1069, DOI 10.2165/00019053-200119110-00001; Hulp CF, 2007, FARMACOTHERAPEUTISCH; Hurt CN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-466; ITAKURA Y, 1994, CANCER, V74, P795, DOI 10.1002/1097-0142(19940801)74:3<795::AID-CNCR2820740303>3.0.CO;2-I; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lorenzen S, 2009, ANN ONCOL, V20, P1667, DOI 10.1093/annonc/mdp069; Lurje G, 2008, CLIN CANCER RES, V14, P7884, DOI 10.1158/1078-0432.CCR-07-5165; Martin S, 2012, HEALTH ECON, V21, P316, DOI 10.1002/hec.1716; Mittmann N, 2009, J NATL CANCER I, V101, P1182, DOI 10.1093/jnci/djp232; National Institute for Care and health Excellence (NICE), 2009, CET TREATM REC MET S; National Institute for Health and Clinical Excellence, 2010, BARR OES ABL THER TR; Pander J, 2010, EUR J CANCER, V46, P1829, DOI 10.1016/j.ejca.2010.03.017; Polednak AP, 2003, INT J CANCER, V105, P98, DOI 10.1002/ijc.11029; Rickwood S, 2017, GLOBAL USE MED OUTLO; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Simoens S, 2011, CLINICOECONOMIC OUTC, V3, P29, DOI 10.2147/CEOR.S12494; Smulders Y M, 2006, Ned Tijdschr Geneeskd, V150, P2467; Thijssen J, 2014, PACE, V37, P25, DOI 10.1111/pace.12238; Zhang W, 2006, PHARMACOGENET GENOM, V16, P475, DOI 10.1097/01.fpc.0000220562.67595.a5	35	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153943	10.1371/journal.pone.0153943	http://dx.doi.org/10.1371/journal.pone.0153943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100871	gold, Green Submitted, Green Published			2022-12-27	WOS:000374898500104
J	Nicotra, A; Newman, C; Johnson, M; Eremin, O; Friede, T; Malik, O; Nicholas, R				Nicotra, Alessia; Newman, Claus; Johnson, Martin; Eremin, Oleg; Friede, Tim; Malik, Omar; Nicholas, Richard			Peripheral Nerve Dysfunction in Middle-Aged Subjects Born with Thalidomide Embryopathy	PLOS ONE			English	Article							NEUROPATHY	Background Phocomelia is an extremely rare congenital malformation that emerged as one extreme of a range of defects resulting from in utero exposure to thalidomide. Individuals with thalidomide embryopathy (TE) have reported developing symptoms suggestive of peripheral nervous system dysfunction in the mal-developed limbs in later life. Methods Case control study comparing TE subjects with upper limb anomalies and neuropathic symptoms with healthy controls using standard neurophysiological testing. Other causes of a peripheral neuropathy were excluded prior to assessment. Results Clinical examination of 17 subjects with TE (aged 50.4 +/- 1.3 [mean +/- standard deviation] years, 10 females) and 17 controls (37.9 +/- 9.0 years; 8 females) demonstrated features of upper limb compressive neuropathy in three-quarters of subjects. Additionally there were examination findings suggestive of mild sensory neuropathy in the lower limbs (n = 1), L5 radiculopathic sensory impairment (n = 1) and cervical myelopathy (n = 1). In TE there were electrophysiological changes consistent with a median large fibre neuropathic abnormality (mean compound muscle action potential difference -6.3 mV ([-9.3, -3.3], p = 0.0002) ([95% CI], p-value)) and reduced sympathetic skin response amplitudes (-0.8 mV ([-1.5, -0.2], p = 0.0089)) in the affected upper limbs. In the lower limbs there was evidence of sural nerve dysfunction (sensory nerve action potential -5.8 mu V ([-10.7, -0.8], p = 0.0232)) and impaired warm perception thresholds (+3.0 degrees C ([0.6, 5.4], p = 0.0169)). Conclusions We found a range of clinical features relevant to individuals with TE beyond upper limb compressive neuropathies supporting the need for a detailed neurological examination to exclude other treatable pathologies. The electrophysiological evidence of large and small fibre axonal nerve dysfunction in symptomatic and asymptomatic limbs may be a result of the original insult and merits further investigation.	[Nicotra, Alessia; Malik, Omar; Nicholas, Richard] Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, Dept Neurosci, Fulham Palace Rd, London W6 8RF, England; [Newman, Claus; Johnson, Martin] Thalidomide Trust, 1 Eaton Court Rd,Colmworth Business Pk, St Neots PE19 8ER, Cambs, England; [Eremin, Oleg] Lincoln Cty Hosp, United Lincolnshire Hosp NHS Trust, Greetwell Rd, Lincoln LN2 5QY, England; [Friede, Tim] Univ Med Ctr Gottingen, Dept Med Stat, D-37073 Gottingen, Germany; [Nicholas, Richard] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Expt Med, Ctr Neurosci,Wolfson Neurosci Labs, London, England	Imperial College London; University of Gottingen; Imperial College London	Nicholas, R (corresponding author), Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, Dept Neurosci, Fulham Palace Rd, London W6 8RF, England.; Nicholas, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Expt Med, Ctr Neurosci,Wolfson Neurosci Labs, London, England.	r.nicholas@imperial.ac.uk	Friede, Tim/ABF-1132-2021	Friede, Tim/0000-0001-5347-7441	Thalidomide Trust	Thalidomide Trust	Grant from the Thalidomide Trust, who had no role in the design and analysis of the study.	[Anonymous], 1964, MINISTRY HLTH REPORT, V112; Bastuji-Garin S, 2002, J INVEST DERMATOL, V119, P1020, DOI 10.1046/j.1523-1747.2002.19502.x; Cohen S, 1962, NEW ENGL J MED, V266, P1208; Cortes-Hernandez J, 2012, BRIT J DERMATOL, V166, P616, DOI 10.1111/j.1365-2133.2011.10693.x; FULLERTON P, 1961, BMJ-BRIT MED J, V2, P855, DOI 10.1136/bmj.2.5256.855; Jankelowitz SK, 2013, EUR J NEUROL, V20, P509, DOI 10.1111/ene.12005; KIDA M, 1987, THALIDOMIDE EMBRYOPA; LAGUENY A, 1986, MUSCLE NERVE, V9, P837, DOI 10.1002/mus.880090907; LENZ W, 1962, LANCET, V1, P45; McCredie J., 2007, THALIDOMIDE BIRTH DE; MELLIN GW, 1962, NEW ENGL J MED, V267, P1238, DOI 10.1056/NEJM196212132672407; NEWMAN CGH, 1986, CLIN PERINATOL, V13, P555, DOI 10.1016/S0095-5108(18)30810-8; OCHONISKY S, 1994, ARCH DERMATOL, V130, P66, DOI 10.1001/archderm.130.1.66; Spiers AL, 1962, LANCET, V279, P303; WULFF CH, 1985, BRIT J DERMATOL, V112, P475, DOI 10.1111/j.1365-2133.1985.tb02323.x	15	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152902	10.1371/journal.pone.0152902	http://dx.doi.org/10.1371/journal.pone.0152902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100829	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500019
J	Nie, XQ; Yang, YH; Yang, LC; Zhou, GY				Nie, Xiuqing; Yang, Yuanhe; Yang, Lucun; Zhou, Guoying			Above- and Belowground Biomass Allocation in Shrub Biomes across the Northeast Tibetan Plateau	PLOS ONE			English	Article							GLOBAL PATTERNS; GROWTH; PLANTS; LAND	Biomass partitioning has been explored across various biomes. However, the strategies of allocation in plants still remain contentious. This study investigated allocation patterns of above-and belowground biomass at the community level, using biomass survey from the Tibetan Plateau. We explored above-and belowground biomass by conducting three consecutive sampling campaigns across shrub biomes on the northeast Tibetan Plateau during 2011-2013. We then documented the above-ground biomass (AGB), below-ground biomass (BGB) and root: shoot ratio (R/S) and the relationships between R/S and environment factors using data from 201 plots surveyed from 67 sites. We further examined relationships between above-ground and below-ground biomass across various shrub types. Our results indicated that the median values of AGB, BGB, and R/S in Tibetan shrub were 1102.55, 874.91 g m(-2), and 0.85, respectively. R/S showed significant trend with mean annual precipitation (MAP), while decreased with mean annual temperature (MAT). Reduced major axis analysis indicated that the slope of the log-log relationship between above-and belowground biomass revealed a significant difference from 1.0 over space, supporting the optimal hypothesis. Interestingly, the slopes of the allometric relationship between log AGB and log BGB differed significantly between alpine and desert shrub. Our findings supported the optimal theory of above-and belowground biomass partitioning in Tibetan shrub, while the isometric hypothesis for alpine shrub at the community level.	[Nie, Xiuqing; Yang, Lucun; Zhou, Guoying] Chinese Acad Sci, Northwest Inst Plateau Biol, Xining 810008, Peoples R China; [Nie, Xiuqing; Yang, Lucun; Zhou, Guoying] Chinese Acad Sci, Key Lab Tibetan Med Res, Xining 810008, Peoples R China; [Yang, Yuanhe] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China; [Nie, Xiuqing] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, GY (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Xining 810008, Peoples R China.; Zhou, GY (corresponding author), Chinese Acad Sci, Key Lab Tibetan Med Res, Xining 810008, Peoples R China.	zhougy@nwipb.cas.cn	Zhou, Guoying/AAE-5590-2020; Yang, Yuanhe/D-1448-2011		National Program on Key Basic Research Project [2012CB026105]; National Science and Technology Support Project [2014BAC05B01]; "Strategic Priority Research Program" of CAS [XDA05050303]; National Natural Science Foundation of China [40801076]	National Program on Key Basic Research Project(National Basic Research Program of China); National Science and Technology Support Project; "Strategic Priority Research Program" of CAS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the "National Program on Key Basic Research Project" (grant number 2012CB026105), "National Science and Technology Support Project" (grant number 2014BAC05B01; http://168.160.10.98/sbksdy/#), "Strategic Priority Research Program" of CAS (grant number XDA05050303) and "National Natural Science Foundation of China" (grant number 40801076; http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). All funding was received by Guoying Zhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Cheng DL, 2007, ANN BOT-LONDON, V99, P95, DOI 10.1093/aob/mcl206; DAVIDSON RL, 1969, ANN BOT-LONDON, V33, P561, DOI 10.1093/oxfordjournals.aob.a084308; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Fan JW, 2009, J ARID ENVIRON, V73, P521, DOI 10.1016/j.jaridenv.2008.12.004; Fang JingYun, 2009, Biodiversity Science, V17, P533, DOI 10.3724/SP.J.1003.2009.09253; GALE J, 1972, ECOLOGY, V53, P494, DOI 10.2307/1934239; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Gilmanov TG, 1997, ECOL MODEL, V96, P191, DOI 10.1016/S0304-3800(96)00067-1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hui D., 2005, NEW PHYTOL, V169, P85; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; [马文红 Ma Wenhong], 2006, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V42, P774; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; Ma WH, 2010, GLOBAL ECOL BIOGEOGR, V19, P233, DOI 10.1111/j.1466-8238.2009.00508.x; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; Niklas KJ, 2005, ANN BOT-LONDON, V95, P315, DOI 10.1093/aob/mci028; Niu Cun-yang, 2013, Shengtaixue Zazhi, V32, P1980; Paruelo JM, 1999, ECOSYSTEMS, V2, P64, DOI 10.1007/s100219900058; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Titlyanova AA, 1999, J VEG SCI, V10, P307, DOI 10.2307/3237060; Vogt K., 1991, TECHNIQUES APPROACHE, P477; WOODWARD FI, 1986, OECOLOGIA, V70, P580, DOI 10.1007/BF00379908; WOODWARD FI, 1975, NEW PHYTOL, V74, P335, DOI 10.1111/j.1469-8137.1975.tb02621.x; Wright I.J., 2003, S MATR STANDARDIZED; Wu, 1980, VEGETATION CHINA, P430; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; [杨昊天 Yang Haotian], 2013, [中国沙漠, Journal of Desert Research], V33, P1340; Yang X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05448; Yang YH, 2011, J ECOL, V99, P431, DOI 10.1111/j.1365-2745.2010.01774.x; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; ZHANG Z, 2009, GEOGRAPHY QINGHAI PL, P25; Zhao Can, 2014, Journal of Beijing Forestry University, V36, P62; ZHOU X, 1987, VEGETATION QINGHAI P, P53; 王亮, 2010, [中国科学：生命科学, Scientia Sinica Vitae], V40, P642	42	24	29	5	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154251	10.1371/journal.pone.0154251	http://dx.doi.org/10.1371/journal.pone.0154251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119379	Green Submitted, Green Published, gold			2022-12-27	WOS:000374976200052
J	Zhao, L; Mahony, D; Cavallro, AS; Zhang, B; Zhang, J; Deringer, JR; Zhao, CX; Brown, WC; Yu, CZ; Mitter, N; Middelberg, APJ				Zhao, Liang; Mahony, Donna; Cavallro, Antonino S.; Zhang, Bing; Zhang, Jun; Deringer, James R.; Zhao, Chun-Xia; Brown, Wendy C.; Yu, Chengzhong; Mitter, Neena; Middelberg, Anton P. J.			Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale	PLOS ONE			English	Article							IV SECRETION SYSTEM; MESOPOROUS SILICA NANOPARTICLES; VIRUS E2 PROTEIN; VACCINE; ADJUVANTS; PURIFICATION; INFECTION; RESPONSES; DELIVERY; COMPLEX	Anaplasma marginale is the most prevalent tick-borne livestock pathogen and poses a significant threat to cattle industry. In contrast to currently available live blood-derived vaccines against A. marginale, alternative safer and better-defined subunit vaccines will be of great significance. Two proteins (VirB9-1 and VirB9-2) from the Type IV secretion system of A. marginale have been shown to induce humoral and cellular immunity. In this study, Escherichia coli were used to express VirB9-1 and VirB9-2 proteins. Silica vesicles having a thin wall of 6 nm and pore size of 5.8 nm were used as the carrier and adjuvant to deliver these two antigens both as individual or mixed nano-formulations. High loading capacity was achieved for both proteins, and the mouse immunisation trial with individual as well as mixed nano-formulations showed high levels of antibody titres over 107 and strong T-cell responses. The mixed nano-formulation also stimulated high-level recall responses in bovine T-cell proliferation assays. These results open a promising path towards the development of efficient A. marginale vaccines and provide better understanding on the role of silica vesicles to deliver multivalent vaccines as mixed nano-formulations able to activate both B-cell and T-cell immunity, for improved animal health.	[Zhao, Liang; Zhang, Jun; Zhao, Chun-Xia; Yu, Chengzhong; Middelberg, Anton P. J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia; [Mahony, Donna; Cavallro, Antonino S.; Mitter, Neena] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld 4072, Australia; [Zhang, Bing] Queensland Dept Agr Fisheries & Forestry, Anim Sci, St Lucia, Qld 4072, Australia; [Deringer, James R.; Brown, Wendy C.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, POB 647040, Pullman, WA 99164 USA	University of Queensland; University of Queensland; Queensland Department of Agriculture & Fisheries; Washington State University	Middelberg, APJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia.; Mitter, N (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld 4072, Australia.	n.mitter@uq.edu.au; a.middelberg@uq.edu.au	Zhao, Chun-Xia Rosie/I-4224-2012; Yu, Chengzhong/I-8663-2012; Zhao, Chun-Xia/AAT-2168-2020; mitter, neena/D-1862-2013	Zhao, Chun-Xia Rosie/0000-0002-3365-3759; Yu, Chengzhong/0000-0003-3707-0785; Zhao, Chun-Xia/0000-0002-3365-3759; mitter, neena/0000-0001-6146-6179; Cavallaro, Tony/0000-0002-3601-3386; Middelberg, Anton/0000-0001-5922-5704; Zhang, Jun/0000-0001-7030-2686	Queensland Government Research Partnerships grant [013936_471]	Queensland Government Research Partnerships grant	This work was supported by the Queensland Government Research Partnerships grant ( Project 013936_471), https://www.business.qld.gov.au/industry/science/grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brown WC, 1998, INFECT IMMUN, V66, P5406, DOI 10.1128/IAI.66.11.5406-5413.1998; Cavallaro AS, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-57; Chuan YP, 2008, J BIOTECHNOL, V134, P64, DOI 10.1016/j.jbiotec.2007.12.004; Cohen S, 1994, Int J Technol Assess Health Care, V10, P121; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Heath DD, 2012, VACCINE, V30, P3076, DOI 10.1016/j.vaccine.2012.02.073; KENSIL CR, 1991, J IMMUNOL, V146, P431; Kocan KM, 2003, CLIN MICROBIOL REV, V16, P698, DOI 10.1128/CMR.16.4.698-712.2003; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; Lopez JE, 2007, INFECT IMMUN, V75, P2333, DOI 10.1128/IAI.00061-07; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; Mahony D, 2014, NANOSCALE, V6, P6617, DOI 10.1039/c4nr01202j; Mahony D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141870; Mahony D, 2013, SMALL, V9, P3138, DOI 10.1002/smll.201300012; Marcelino I, 2012, J PROTEOMICS, V75, P4232, DOI 10.1016/j.jprot.2012.03.026; Mody KT, 2014, BIOMATERIALS, V35, P9972, DOI 10.1016/j.biomaterials.2014.08.044; Morse K, 2012, IMMUNOGENETICS, V64, P507, DOI 10.1007/s00251-012-0606-4; Morse K, 2012, INFECT IMMUN, V80, P215, DOI 10.1128/IAI.05798-11; Palmer GH, 1999, PARASITOL TODAY, V15, P281, DOI 10.1016/S0169-4758(99)01469-6; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Rice-Ficht AC, 2010, CURR OPIN MICROBIOL, V13, P106, DOI 10.1016/j.mib.2009.12.001; Schadlicha L, 2009, VACCINE, V27, P1511, DOI 10.1016/j.vaccine.2009.01.014; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; Spickler AR, 2003, J VET INTERN MED, V17, P273, DOI 10.1892/0891-6640(2003)017&lt;0273:AIVVMO&gt;2.3.CO;2; Sutten EL, 2010, INFECT IMMUN, V78, P1314, DOI 10.1128/IAI.01207-09; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; [Tick Fever Centre Queensland Australia Department of Agriculture Fisheries and Forestry], 2007, COMB 3 1 LIV TICK FE; Yuan H, 2001, J VIROL, V75, P7848, DOI 10.1128/JVI.75.17.7848-7853.2001; Zhang J, 2014, SMALL, V10, P5068, DOI 10.1002/smll.201401538; Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069	32	16	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154295	10.1371/journal.pone.0154295	http://dx.doi.org/10.1371/journal.pone.0154295			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115492	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600056
J	Marini, G; Poletti, P; Giacobini, M; Pugliese, A; Merler, S; Rosa, R				Marini, Giovanni; Poletti, Piero; Giacobini, Mario; Pugliese, Andrea; Merler, Stefano; Rosa, Roberto			The Role of Climatic and Density Dependent Factors in Shaping Mosquito Population Dynamics: The Case of Culex pipiens in Northwestern Italy	PLOS ONE			English	Article							WEST-NILE-VIRUS; DRIVEN ABUNDANCE MODEL; AEDES-ALBOPICTUS; HUMAN-DISEASE; TEMPERATURE; TRANSMISSION; SURVIVAL; COMPLEX; EUROPE; REGION	Culex pipiens mosquito is a species widely spread across Europe and represents a competent vector for many arboviruses such as West Nile virus (WNV), which has been recently circulating in many European countries, causing hundreds of human cases. In order to identify the main determinants of the high heterogeneity in Cx. pipiens abundance observed in Piedmont region (Northwestern Italy) among different seasons, we developed a density-dependent stochastic model that takes explicitly into account the role played by temperature, which affects both developmental and mortality rates of different life stages. The model was calibrated with a Markov chain Monte Carlo approach exploring the likelihood of recorded capture data gathered in the study area from 2000 to 2011; in this way, we disentangled the role played by different seasonal eco-climatic factors in shaping the vector abundance. Illustrative simulations have been performed to forecast likely changes if temperature or density-dependent inputs would change. Our analysis suggests that inter-seasonal differences in the mosquito dynamics are largely driven by different temporal patterns of temperature and seasonal-specific larval carrying capacities. Specifically, high temperatures during early spring hasten the onset of the breeding season and increase population abundance in that period, while, high temperatures during the summer can decrease population size by increasing adult mortality. Higher densities of adult mosquitoes are associated with higher larval carrying capacities, which are positively correlated with spring precipitations. Finally, an increase in larval carrying capacity is expected to proportionally increase adult mosquito abundance.	[Marini, Giovanni; Pugliese, Andrea] Univ Trento, Dept Math, Trento, Italy; [Marini, Giovanni; Rosa, Roberto] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, TN, Italy; [Poletti, Piero; Merler, Stefano] Bruno Kessler Fdn, Trento, Italy; [Poletti, Piero] Univ Commerciale L Bocconi, Dondena Ctr Res Social Dynam & Publ Policy, Dept Policy Anal & Publ Management, Milan, Italy; [Giacobini, Mario] Univ Turin, Dept Vet Sci, Turin, Italy	University of Trento; Fondazione Edmund Mach; Fondazione Bruno Kessler; Bocconi University; University of Turin	Marini, G (corresponding author), Univ Trento, Dept Math, Trento, Italy.; Marini, G (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, TN, Italy.	giovanni.marini@fmach.it	merler, stefano/I-3557-2017; Marini, Giovanni/C-3808-2018; Rosa, Roberto/B-8562-2011; Pugliese, Andrea/E-1905-2011; Rosà, Roberto/AAB-4479-2021	merler, stefano/0000-0002-5117-0611; Marini, Giovanni/0000-0001-9721-7211; Rosa, Roberto/0000-0002-8655-2230; Pugliese, Andrea/0000-0002-3512-8560; Rosà, Roberto/0000-0002-8655-2230; Poletti, Piero/0000-0001-5453-5199	Regione Piemonte; Autonomous Province of Trento (Italy) [319292-S116-2013]; Project LExEM (Laboratory of excellence for epidemiology and modelling)	Regione Piemonte(Regione Piemonte); Autonomous Province of Trento (Italy)(Autonomous Province of Trento); Project LExEM (Laboratory of excellence for epidemiology and modelling)	The field work was supported by Regione Piemonte, according the regional law 75/95. This work was funded by the Autonomous Province of Trento (Italy), Research funds for Grandi Progetti (Prot. n. 319292-S116-2013), Project LExEM (Laboratory of excellence for epidemiology and modelling, http://www.lexem.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arifin SMN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-424; Arpa Piemonte, 2015, DAT AMB; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Becking LE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075996, 10.1371/journal.pone.0079276]; Bisanzio D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-230; Bolker B, 2008, ECOLOGICAL MODELS DA; Cailly P, 2012, ECOL MODEL, V227, P7, DOI 10.1016/j.ecolmodel.2011.10.027; Calistri P, 2010, ZOONOSES PUBLIC HLTH, V57, P211, DOI 10.1111/j.1863-2378.2009.01303.x; Centers for Disease Control and Prevention, 2015, FIN MAPS DAT 1999 20; Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011; Ciota AT, 2014, J MED ENTOMOL, V51, P55, DOI 10.1603/ME13003; Colborn JM, 2013, J AM MOSQUITO CONTR, V29, P123, DOI 10.2987/13-6326r.1; Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023; EIRAYAH E, 1983, ENTOMOL EXP APPL, V33, P349, DOI 10.1111/j.1570-7458.1983.tb03281.x; Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 EM V; Faraj C., 2006, Bulletin de la Societe de Pathologie Exotique, V99, P119; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Gaibani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064761; Gilks W.R., 1996, MARKOV CHAIN MONTE C; Gong HF, 2011, INT J BIOMETEOROL, V55, P435, DOI 10.1007/s00484-010-0354-9; Kilpatrick AM, 2013, AM J EPIDEMIOL, V178, P829, DOI 10.1093/aje/kwt046; Loetti V., 2011, Journal of Natural History, V45, P2203, DOI 10.1080/00222933.2011.590946; Loncaric Z, 2013, THEOR POPUL BIOL, V83, P82, DOI 10.1016/j.tpb.2012.08.002; Lundstrom JO, 2001, J MED ENTOMOL, V38, P289, DOI 10.1603/0022-2585-38.2.289; Monaco F, 2010, ZOONOSES PUBLIC HLTH, V57, P476, DOI 10.1111/j.1863-2378.2009.01245.x; Morin CW, 2010, INT J BIOMETEOROL, V54, P517, DOI 10.1007/s00484-010-0349-6; Mulatti P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-26; NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339; Pawelek KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108452; Pecorari M, 2009, EUROSURVEILLANCE, V14, P15; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; Reisen WK, 2008, J MED ENTOMOL, V45, P494, DOI 10.1603/0022-2585(2008)45[494:PWNVTA]2.0.CO;2; Rizzoli A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0831-4; Rosa R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-269; Simpson JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007861; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SPIELMAN A, 1973, ANN ENTOMOL SOC AM, V66, P905, DOI 10.1093/aesa/66.4.905; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Turell MJ, 2014, J AM MOSQUITO CONTR, V30, P253, DOI 10.2987/14-6441R.1; United States Naval Meteorology and Oceanography Command, 2015, NAV OC PORT DAT SERV; Vinogradova EB, 2011, ENTMOL REV, V91, P729; Yamana TK, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-235; Zeller HG, 2004, EUR J CLIN MICROBIOL, V23, P147, DOI 10.1007/s10096-003-1085-1	46	26	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154018	10.1371/journal.pone.0154018	http://dx.doi.org/10.1371/journal.pone.0154018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105065	Green Published, gold, Green Submitted			2022-12-27	WOS:000374565100034
J	Wang, JR; Carrillo, JJ; Lin, HV				Wang, Jingru; Carrillo, Juan J.; Lin, Hua V.			GPR142 Agonists Stimulate Glucose-Dependent Insulin Secretion via Gq-Dependent Signaling	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CELLS; SYSTEM	GPR142 is an islet-enriched G protein-coupled receptor that has been investigated as a novel therapeutic target for the treatment of type 2 diabetes by virtue of its insulin secretagogue activity. However, the signaling pathways downstream of GPR142 and whether its stimulation of insulin release is glucose-dependent remain poorly characterized. In this study, we show that both native and synthetic GPR142 agonists can activate Gq as well as Gi signaling when GPR142 is recombinantly expressed in HEK293 cells. However, in primary pancreatic islets, a native cellular system, the insulin secretagogue activity of GPR142 agonists only requires Gq activation. In addition, our results show that stimulation of insulin secretion by GPR142 in pancreatic islets is strictly glucose-dependent.	[Wang, Jingru; Lin, Hua V.] Eli Lilly & Co, LCRDC, Shanghai, Peoples R China; [Carrillo, Juan J.] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly	Lin, HV (corresponding author), Eli Lilly & Co, LCRDC, Shanghai, Peoples R China.	lin_hua@lilly.com		Lin, Hua/0000-0001-5001-5567	Eli Lilly Co.	Eli Lilly Co.(Eli Lilly)	All authors are employees of Eli Lilly & Co. Eli Lilly & Co. provided support in the form of salaries for authors (JW, JJC, HVL) and funding for research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of each author are articulated in the 'author contributions' section.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Amisten S, 2013, PHARMACOL THERAPEUT, V139, P359, DOI 10.1016/j.pharmthera.2013.05.004; Bandholtz S, 2015, DIABETES S1, V64, pA341; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Campbell JE, 2016, NAT MED, V22, P84, DOI 10.1038/nm.3997; Cryer PE, 2014, DIABETES, V63, P2188, DOI 10.2337/db14-0059; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Eastwood BJ, 2006, J BIOMOL SCREEN, V11, P253, DOI 10.1177/1087057105285611; Eishingdrelo Haifeng, 2013, Curr Chem Genom Transl Med, V7, P9, DOI 10.2174/2213988501307010009; Engelstoft MS, 2013, MOL METAB, V2, P376, DOI 10.1016/j.molmet.2013.08.006; Farrell SR, 2014, CHANNELS, V8, P519, DOI 10.4161/19336950.2014.967623; Inamdar V, 2015, PLATELETS, V26, P771, DOI 10.3109/09537104.2014.998993; Jacobson KA, 2015, MOL PHARMACOL, V88, P220, DOI 10.1124/mol.114.095711; Kenakin T, 1997, TRENDS PHARMACOL SCI, V18, P456, DOI 10.1016/S0165-6147(97)90683-0; Koyama H, 2016, ENDOCRINOLOGY, V157, P692, DOI 10.1210/en.2015-1784; Lizarzaburu M, 2012, BIOORG MED CHEM LETT, V22, P5942, DOI 10.1016/j.bmcl.2012.07.063; Matsuo A, 2005, BIOCHEM BIOPH RES CO, V331, P363, DOI 10.1016/j.bbrc.2005.03.174; Ogawa Y., 2008, International patent, Patent No. [WO 2008/045484 A1, 2008045484]; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Toda N, 2013, ACS MED CHEM LETT, V4, P790, DOI 10.1021/ml400186z; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yang SK, 2007, AM J PHYSIOL-ENDOC M, V292, pE1863, DOI 10.1152/ajpendo.00047.2007; Zhang XY, 2015, P NATL ACAD SCI USA, V112, P13651, DOI 10.1073/pnas.1518540112	25	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154452	10.1371/journal.pone.0154452	http://dx.doi.org/10.1371/journal.pone.0154452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104960	Green Submitted, Green Published, gold			2022-12-27	WOS:000374565100078
J	Yokota, RTD; Nusselder, WJ; Robine, JM; Tafforeau, J; Deboosere, P; Van Oyen, H				Yokota, Renata Tiene de Carvalho; Nusselder, Wilma Johanna; Robine, Jean-Marie; Tafforeau, Jean; Deboosere, Patrick; Van Oyen, Herman			Contribution of Chronic Conditions to the Disability Burden across Smoking Categories in Middle-Aged Adults, Belgium	PLOS ONE			English	Article							STYLE RISK-FACTORS; CIGARETTE-SMOKING; LIFE-STYLE; EDUCATIONAL DISPARITIES; NATIONAL-HEALTH; DEPRESSION; OLDER; POPULATION; ASSOCIATION; PREVALENCE	Introduction Smoking is considered the single most important preventable cause of morbidity and mortality worldwide, contributing to increased incidence and severity of disabling conditions. The aim of this study was to assess the contribution of chronic conditions to the disability burden across smoking categories in middle-aged adults in Belgium. Methods Data from 10,224 individuals aged 40 to 60 years who participated in the 1997, 2001, 2004, or 2008 Health Interview Surveys in Belgium were used. Smoking status was defined as never, former (cessation >= 2 years), former (cessation <2 years), occasional light (<20 cigarettes/day), daily light, and daily heavy (>= 20 cigarettes/day). To attribute disability to chronic conditions, binomial additive hazards models were fitted separately for each smoking category adjusted for gender, except for former (cessation <2 years) and occasional light smokers due to the small sample size. Results An increasing trend in the disability prevalence was observed across smoking categories in men (never = 4.8%, former (cessation >= 2 years) = 5.8%, daily light = 7.8%, daily heavy = 10.7%) and women (never = 7.6%, former (cessation >= 2 years) = 8.0%, daily light = 10.2%, daily heavy = 12.0%). Musculoskeletal conditions showed a substantial contribution to the disability burden in men and women across all smoking categories. Other important contributors were depression and cardiovascular diseases in never smokers; depression, chronic respiratory diseases, and diabetes in former smokers (cessation >= 2 years); chronic respiratory diseases, cancer, and cardiovascular diseases in daily light smokers; cardiovascular diseases and chronic respiratory diseases in men and depression and diabetes in women daily heavy smokers. Conclusions Beyond the well-known effect of smoking on mortality, our findings showed an increasing trend of the disability prevalence and different contributors to the disability burden across smoking categories. This information can be useful from a public health perspective to define strategies to reduce disability in Belgium.	[Yokota, Renata Tiene de Carvalho; Tafforeau, Jean; Van Oyen, Herman] Sci Inst Publ Hlth, Dept Publ Hlth & Surveillance, Rue Juliette Wytsmanstr 14, B-1050 Brussels, Belgium; [Yokota, Renata Tiene de Carvalho; Deboosere, Patrick] Vrije Univ Brussel, Dept Sociol, Interface Demog, Brussels, Belgium; [Nusselder, Wilma Johanna] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Robine, Jean-Marie] French Inst Hlth & Med Res INSERM, Montpellier, France; [Robine, Jean-Marie] Ecole Prat Hautes Etud, Paris, France; [Van Oyen, Herman] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	Vrije Universiteit Brussel; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Ghent University	Yokota, RTD (corresponding author), Sci Inst Publ Hlth, Dept Publ Hlth & Surveillance, Rue Juliette Wytsmanstr 14, B-1050 Brussels, Belgium.; Yokota, RTD (corresponding author), Vrije Univ Brussel, Dept Sociol, Interface Demog, Brussels, Belgium.	renata.yokota@wiv-isp.be	Robine, Jean-Marie/F-5439-2011; Deboosere, Patrick/C-1113-2014	Robine, Jean-Marie/0000-0002-4111-6195; Deboosere, Patrick/0000-0002-8148-3694; Van Oyen, Herman/0000-0003-2119-4433	Scientific Institute of Public Health (WIV-ISP) in Belgium [W3033.0601.1]	Scientific Institute of Public Health (WIV-ISP) in Belgium	This study is part of the HYSMOKHIA project - "Healthy Life Years and Smoking: a Health Impact Assessment of Tobacco Control Scenarios on Smoking-related Mortality, Morbidity and Disability in Belgium" - funded by the Scientific Institute of Public Health (WIV-ISP) in Belgium (Grant Number: W3033.0601.1). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Artaud F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4240; Bakhshaie J, 2015, COMPR PSYCHIAT, V60, P142, DOI 10.1016/j.comppsych.2014.10.012; Benson BW, 2005, NICOTINE TOB RES, V7, P719, DOI 10.1080/14622200500259119; Boden JM, 2010, BRIT J PSYCHIAT, V196, P440, DOI 10.1192/bjp.bp.109.065912; Caraballo RS, 2001, AM J EPIDEMIOL, V153, P807, DOI 10.1093/aje/153.8.807; Center for Disease Control and Prevention,, 2010, TOB SMOK CAUS DIS BI; Chakravarty EF, 2012, AM J MED, V125, P190, DOI 10.1016/j.amjmed.2011.08.006; Chen H, 2014, J AGING HEALTH, V26, P261, DOI 10.1177/0898264313514442; CHIANG CL, 1991, ANNU REV PUBL HEALTH, V12, P281, DOI 10.1146/annurev.pu.12.050191.001433; Courtney-Long E, 2014, PUBLIC HEALTH REP, V129, P252, DOI 10.1177/003335491412900307; Demarest S, 2013, EUR J PUBLIC HEALTH, V23, P981, DOI 10.1093/eurpub/cks158; Demarest S, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/0778-7367-71-24; Ebrahim S, 2000, INT J EPIDEMIOL, V29, P478, DOI 10.1093/ije/29.3.478; Efron B., 1994, INTRO BOOTSTRAP; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Flensborg-Madsen T, 2011, J PSYCHIATR RES, V45, P143, DOI 10.1016/j.jpsychires.2010.06.006; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Gisle L, 2013, 2 SCI I PUBL HLTH; GURALNIK JM, 1989, AM J PUBLIC HEALTH, V79, P703, DOI 10.2105/AJPH.79.6.703; Hansen H, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-39; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Klijs B, 2014, AM J PUBLIC HEALTH, V104, pE141, DOI 10.2105/AJPH.2014.301924; Klijs B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025325; Klijs B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-378; Koskenvuo K, 2011, EUR RESPIR J, V37, P26, DOI 10.1183/09031936.00008910; Laaksonen M, 2006, PREV MED, V42, P206, DOI 10.1016/j.ypmed.2005.12.003; Lahiri M, 2012, RHEUMATOLOGY, V51, P499, DOI 10.1093/rheumatology/ker299; Lincoln AE, 2003, AM J IND MED, V43, P337, DOI 10.1002/ajim.10195; Luger TM, 2014, ADDICT BEHAV, V39, P1418, DOI 10.1016/j.addbeh.2014.05.011; Mykletun A, 2008, EUR PSYCHIAT, V23, P77, DOI 10.1016/j.eurpsy.2007.10.005; Nusselder WJ, 2005, AM J PUBLIC HEALTH, V95, P2035, DOI 10.2105/AJPH.2004.054700; Nusselder WJ, 2004, DEMOGRAPHY, V41, P315, DOI 10.1353/dem.2004.0017; Nusselder WJ, 2010, 72 EHEMU; Organization WH, 2016, GLOBAL STATUS REPORT; Ostbye T, 2002, J AM GERIATR SOC, V50, P691, DOI 10.1046/j.1532-5415.2002.50164.x; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Reuser M, 2009, SMOKING KILLS OBESIT, P1; Reuser M, 2009, OBESITY, V17, P783, DOI 10.1038/oby.2008.640; Ropponen A, 2013, PREV MED, V57, P889, DOI 10.1016/j.ypmed.2013.10.001; Schane RE, 2010, CIRCULATION, V121, P1518, DOI 10.1161/CIRCULATIONAHA.109.904235; Schmitz N, 2007, NICOTINE TOB RES, V9, P959, DOI 10.1080/14622200701540846; Sitas F, 2014, J CLIN ONCOL, V32, P3593, DOI 10.1200/JCO.2014.55.9666; Stovring N, 2004, SCAND J PUBLIC HEALT, V32, P296, DOI 10.1080/14034940410024176; Strobl R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-137; Takashima N, 2010, NICOTINE TOB RES, V12, P944, DOI 10.1093/ntr/ntq121; Van Oyen H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-723; VERBRUGGE LM, 1989, MILBANK Q, V67, P450, DOI 10.2307/3350223; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Wong E, 2015, J EPIDEMIOL COMMUN H, V69, P70, DOI 10.1136/jech-2014-204456; Yokota RTC, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0083-y; Yokota RTC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1574-z; Yokota RTD, 2016, J GERONTOL A-BIOL, V71, P903, DOI 10.1093/gerona/glv234	56	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153726	10.1371/journal.pone.0153726	http://dx.doi.org/10.1371/journal.pone.0153726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9WX	27105185	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100017
J	Liu, BJ; Zhang, BD; Xue, DX; Gao, TX; Liu, JX				Liu, Bing-Jian; Zhang, Bai-Dong; Xue, Dong-Xiu; Gao, Tian-Xiang; Liu, Jin-Xian			Population Structure and Adaptive Divergence in a High Gene Flow Marine Fish: The Small Yellow Croaker (Larimichthys polyactis)	PLOS ONE			English	Article							DEMOGRAPHIC HISTORY; LOCAL SELECTION; DIVERSITY; SOFTWARE; SEA; DIFFERENTIATION; ADAPTATION; MICROSATELLITES; CONSERVATION; CONNECTIVITY	The spatial distribution of genetic diversity has been long considered as a key component of policy development for management and conservation of marine fishes. However, unraveling the population genetic structure of migratory fish species is challenging due to high potential for gene flow. Despite the shallow population differentiation revealed by putatively neutral loci, the higher genetic differentiation with panels of putatively adaptive loci could provide greater resolution for stock identification. Here, patterns of population differentiation of small yellow croaker (Larimichthys polyactis) were investigated by genotyping 15 highly polymorphic microsatellites in 337 individuals of 15 geographic populations collected from both spawning and overwintering grounds. Outlier analyses indicated that the locus Lpol03 might be under directional selection, which showed a strong homology with Grid2 gene encoding the glutamate receptor delta 2 protein (GluR delta 2). Based on Lpol03, two distinct clusters were identified by both STRUCTURE and PCoA analyses, suggesting that there were two overwintering aggregations of L. polyactis. A novel migration pattern was suggested for L. polyactis, which was inconsistent with results of previous studies based on historical fishing yield statistics. These results provided new perspectives on the population genetic structure and migratory routes of L. polyactis, which could have significant implications for sustainable management and utilization of this important fishery resource.	[Liu, Bing-Jian; Zhang, Bai-Dong; Xue, Dong-Xiu; Liu, Jin-Xian] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Shandong, Peoples R China; [Liu, Bing-Jian; Zhang, Bai-Dong; Xue, Dong-Xiu; Liu, Jin-Xian] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Liu, Bing-Jian; Zhang, Bai-Dong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Tian-Xiang] Zhejiang Ocean Univ, Sch Fisheries, Zhoushan, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang Ocean University	Liu, JX (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Shandong, Peoples R China.; Liu, JX (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	jinxianliu@gmail.com	Zhang, Baidong/AAA-9633-2022		Joint Project of the National Natural Science Foundation of China and Shandong Province: Marine Ecology and Environmental Sciences [U1406403]; National Natural Science Foundation of China [30471329]; 100 Talents Program of the Chinese Academy of Sciences; Strategic Priority Research Program of Chinese Academy of Sciences [XDA11020704]	Joint Project of the National Natural Science Foundation of China and Shandong Province: Marine Ecology and Environmental Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by the Joint Project of the National Natural Science Foundation of China and Shandong Province: Marine Ecology and Environmental Sciences (U1406403) to JXL, the National Natural Science Foundation of China (No. 30471329) to TXG, and 100 Talents Program of the Chinese Academy of Sciences to JXL; and the Strategic Priority Research Program of Chinese Academy of Sciences (No. XDA11020704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HS, 2013, MOL BIOL REP, V40, P3445, DOI 10.1007/s11033-012-2044-7; Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Banks MA, 1999, J HERED, V90, P281, DOI 10.1093/jhered/90.2.281; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bekkevold D, 2005, EVOLUTION, V59, P2656; Chu YT, 1963, MONOGRAPHS FISHES CH, p[i, 1]; Cunningham KM, 2009, CAN J FISH AQUAT SCI, V66, P153, DOI 10.1139/F08-199; DeFaveri J, 2013, EVOLUTION, V67, P2530, DOI 10.1111/evo.12097; [丁峰元 DING Fengyuan], 2007, [自然资源学报, Journal of Natural Resources], V22, P1013; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Florin AB, 2010, FISH RES, V102, P207, DOI 10.1016/j.fishres.2009.12.002; Fourcade Y, 2013, MOL ECOL, V22, P2065, DOI 10.1111/mec.12158; Froese R, 2003, GLOBAL CAPTURE PRODU; Gagnaire PA, 2012, GENETICS, V190, P725, DOI 10.1534/genetics.111.134825; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Galindo HM, 2010, MOL ECOL, V19, P3692, DOI 10.1111/j.1365-294X.2010.04694.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Han ZQ, 2009, AFR J AGR RES, V4, P605; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jin XS, 2004, ESTUAR COAST SHELF S, V59, P163, DOI 10.1016/j.ecss.2003.08.005; Karlsson S, 2005, ICES J MAR SCI, V62, P1588, DOI 10.1016/j.icesjms.2005.05.009; Kim JK, 2010, ANIM CELLS SYST, V14, P45, DOI 10.1080/19768351003764973; Kim MJ, 2010, FISHERIES SCI, V76, P595, DOI 10.1007/s12562-010-0249-z; KIMURA M, 1964, GENETICS, V49, P725; Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamichhaney S, 2012, P NATL ACAD SCI USA, V109, P19345, DOI 10.1073/pnas.1216128109; Larmuseau MHD, 2009, MOL ECOL, V18, P4227, DOI 10.1111/j.1365-294X.2009.04331.x; [李建生 LI Jian-sheng], 2009, [中国水产科学, Journal of Fishery Sciences of China], V16, P348; [李峣 LI Yao], 2007, [海洋水产研究, Marine Fisheries Research], V28, P104; Li Y, 2013, BIOCHEM SYST ECOL, V50, P331, DOI 10.1016/j.bse.2013.05.003; Lie HJ, 2001, J GEOPHYS RES-OCEANS, V106, P22199, DOI 10.1029/2000JC000629; Lin LS, 2009, AFR J BIOTECHNOL, V8, P2700; Lin Long-shan, 2008, Marine Fisheries, V30, P126; [林龙山 Lin Longshan], 2004, [中国海洋大学学报. 自然科学版, Journal of Ocean University of China], V34, P565; Liu BJ, 2014, CONSERV GENET RESOUR, V6, P397, DOI 10.1007/s12686-013-0102-7; Liu JX, 2006, MOL PHYLOGENET EVOL, V39, P799, DOI 10.1016/j.ympev.2006.01.009; Liu JX, 2011, MAR BIOL, V158, P893, DOI 10.1007/s00227-010-1616-0; Liu QA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000097; Liu X., 1962, RES SMALL YELLOW CRO, P35; Marchant S, 2009, AQUAC RES, V40, P298, DOI 10.1111/j.1365-2109.2008.02089.x; Meng Zi-Ning, 2003, Shengwu Duoyangxing, V11, P197; Mikami Y, 2004, BIOCHEM BIOPH RES CO, V322, P168, DOI 10.1016/j.bbrc.2004.07.095; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nielsen EE, 2004, MOL ECOL, V13, P585, DOI 10.1046/j.1365-294X.2004.02097.x; Park SDE, 2001, THESIS; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard J. K., 2009, DOCUMENTATION STRUCT, P1; Pujolar JM, 2014, MOL ECOL, V23, P2514, DOI 10.1111/mec.12753; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Russello MA, 2012, EVOL APPL, V5, P39, DOI 10.1111/j.1752-4571.2011.00206.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Shepherd TD, 2004, FISH FISH, V5, P141, DOI 10.1111/j.1467-2979.2004.00143.x; Shikano T, 2010, MOL ECOL, V19, P1147, DOI 10.1111/j.1365-294X.2010.04553.x; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Strasburg JL, 2009, MOL BIOL EVOL, V26, P1341, DOI 10.1093/molbev/msp043; Tang Yan-Cheng, 2000, Acta Botanica Yunnanica, V22, P1; Teacher AGF, 2013, EVOL APPL, V6, P549, DOI 10.1111/eva.12042; Turner TL, 2010, MOL ECOL, V19, P848, DOI 10.1111/j.1365-294X.2010.04532.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandamme SG, 2014, MOL ECOL, V23, P618, DOI 10.1111/mec.12628; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Wang L, 2015, FISH RES, V161, P86, DOI 10.1016/j.fishres.2014.06.006; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083493; Was A, 2008, ICES J MAR SCI, V65, P216, DOI 10.1093/icesjms/fsm187; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Xiao YS, 2015, MITOCHONDR DNA, V26, P409, DOI 10.3109/19401736.2013.843076; Xiao YS, 2009, ENVIRON BIOL FISH, V85, P303, DOI 10.1007/s10641-009-9497-0; Xu Zhao-li, 2010, Yingyong Shengtai Xuebao, V21, P2856; [徐兆礼 XU Zhao-li], 2009, [中国水产科学, Journal of Fishery Sciences of China], V16, P931; [于非 YU Fei], 2006, [海洋学报, Acta Oceanologica Sinica], V28, P26	79	16	17	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154020	10.1371/journal.pone.0154020	http://dx.doi.org/10.1371/journal.pone.0154020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100462	Green Submitted, gold, Green Published			2022-12-27	WOS:000374898500125
J	Liu, LL; Cheng, JH; Liu, YH; Sheng, JD				Liu, Lili; Cheng, Junhui; Liu, Yunhua; Sheng, Jiandong			Relationship of Productivity to Species Richness in the Xinjiang Temperate Grassland	PLOS ONE			English	Article							BETA DIVERSITY; ECOSYSTEM STABILITY; BIODIVERSITY; PRECIPITATION; VARIABILITY; COEXISTENCE; RESOURCE	The relationship between species richness (SR) and above ground net primary productivity (ANPP) is still a central and debated issue in community ecology. Previous studies have often emphasized the relationship of alpha diversity (number of species identity) to the mean ANPP with respect to the SR-ANPP relationship while neglecting the contribution of beta diversity (dissimilarity in species composition) to the mean ANPP and to the stability of ANPP (coefficient of ANPP: CV of ANPP). In this study, we used alpha and beta diversity, mean ANPP and the CV of ANPP collected from 159 sites and belonging to three vegetation types in the Xinjiang temperate grassland to first examine their trends along climatic factors and among different vegetation types and then test the relationship among alpha (beta) diversity and mean ANPP and the CV of ANPP. Our results showed that in the Xinjiang temperate grasslands, alpha diversity was positively and linearly correlated with MAP but unimodally correlated with MAT. Meanwhile, beta diversity was unimodally correlated with MAP but linearly correlated with MAT. Relative to desert steppe, meadow steppe and typical steppe had the highest alpha and beta diversity, respectively. Except for ANPP exhibiting a quadratic relationship with MAP, no significant relationship was found among ANPP, the CV of ANPP and climatic factors. ANPP and the CV of ANPP also exhibited no apparent patterns in variation among different vegetation types. Our results further showed that mean ANPP was closely associated with alpha diversity. Both linear and unimodal relationships were detected between alpha diversity and mean ANPP, but their particular form was texture-dependent. Meanwhile, the CV of ANPP was positively correlated with beta diversity. Our results indicated that in addition to incorporating alpha diversity and mean ANPP, incorporating beta diversity and the CV of ANPP could expand our understanding of the SR-ANPP relationship.	[Liu, Lili; Cheng, Junhui; Liu, Yunhua; Sheng, Jiandong] Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Soil & Plant Ecol Proc, Urumqi, Peoples R China	Xinjiang Agricultural University	Sheng, JD (corresponding author), Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Soil & Plant Ecol Proc, Urumqi, Peoples R China.	sjd_2004@126.com			Strategic Priority Research Program of Chinese Academy of Sciences [XDA05050405]	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was financially supported by Strategic Priority Research Program of Chinese Academy of Sciences (XDA05050405). JD S received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson TM, 2004, OECOLOGIA, V139, P277, DOI 10.1007/s00442-004-1499-1; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Department of Animal Husbandry of Xinjiang Uygur Autonomous Region, 1993, RES ULT XINJ GRASSL; Fan Lian-Lian, 2012, Chinese Journal of Plant Ecology, V36, P126, DOI 10.3724/SP.J.1258.2012.00126; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Grime J. P., 2001, PLANT STRATEGIES VEG; Gross KL, 2000, OIKOS, V89, P417, DOI 10.1034/j.1600-0706.2000.890301.x; Guo QF, 1998, ECOLOGY, V79, P2555, DOI 10.1890/0012-9658(1998)079[2555:SRABDO]2.0.CO;2; Harrison S, 2006, J ECOL, V94, P110, DOI 10.1111/j.1365-2745.2005.01078.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; [胡列群 Hu Liequn], 2013, [冰川冻土, Journal of Glaciology and Geocryology], V35, P793; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; Johnson KH, 1996, TRENDS ECOL EVOL, V11, P372, DOI 10.1016/0169-5347(96)10040-9; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Li JF, 1991, CLIMATE IN XINJIANG; Li LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066450; Ma WH, 2010, GLOBAL ECOL BIOGEOGR, V19, P233, DOI 10.1111/j.1466-8238.2009.00508.x; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Ninyerola M, 2000, INT J CLIMATOL, V20, P1823, DOI 10.1002/1097-0088(20001130)20:14<1823::AID-JOC566>3.0.CO;2-B; R Development Core Team, 2012, R LANG ENV STAT COMP; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Trumbore S, 2009, ANNU REV EARTH PL SC, V37, P47, DOI 10.1146/annurev.earth.36.031207.124300; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5799; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; Yang HJ, 2012, ECOL LETT, V15, P619, DOI 10.1111/j.1461-0248.2012.01778.x; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x	36	5	6	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154026	10.1371/journal.pone.0154026	http://dx.doi.org/10.1371/journal.pone.0154026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100676	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500126
J	Marrazzo, P; Maccari, S; Taddei, A; Bevan, L; Telford, J; Soriani, M; Pezzicoli, A				Marrazzo, Pasquale; Maccari, Silvia; Taddei, Annarita; Bevan, Luke; Telford, John; Soriani, Marco; Pezzicoli, Alfredo			3D Reconstruction of the Human Airway Mucosa In Vitro as an Experimental Model to Study NTHi Infections	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; MESENCHYMAL STEM-CELLS; RESPIRATORY-TRACT; EPITHELIAL-CELLS; REGENERATION; TISSUE; MECHANISMS; COCULTURE; EXPLANTS; DISEASE	We have established an in vitro 3D system which recapitulates the human tracheo-bronchial mucosa comprehensive of the pseudostratified epithelium and the underlying stromal tissue. In particular, we reported that the mature model, entirely constituted of primary cells of human origin, develops key markers proper of the native tissue such as the mucociliary differentiation of the epithelial sheet and the formation of the basement membrane. The infection of the pseudo-tissue with a strain of NonTypeable Haemophilus influenzae results in bacteria association and crossing of the mucus layer leading to an apparent targeting of the stromal space where they release large amounts of vesicles and form macro-structures. In summary, we propose our in vitro model as a reliable and potentially customizable system to study mid/long term host-pathogen processes.	[Marrazzo, Pasquale; Maccari, Silvia; Telford, John; Soriani, Marco; Pezzicoli, Alfredo] GSK Vaccines Srl, Via Fiorentina 1, I-53100 Siena, Italy; [Taddei, Annarita] Univ Tuscia, Interdept Ctr Electron Microscopy, Viterbo, Italy; [Bevan, Luke] Novartis Inst BioMed Res, Resp Dis Area, Horsham RH12 5AB, W Sussex, England	GlaxoSmithKline; Tuscia University; Novartis	Soriani, M; Pezzicoli, A (corresponding author), GSK Vaccines Srl, Via Fiorentina 1, I-53100 Siena, Italy.	marco.x.soriani@gsk.com; alfredo.x.pezzicoli@gsk.com	Marrazzo, Pasquale/G-9857-2016; Telford, John Laird/ABG-8144-2020	Marrazzo, Pasquale/0000-0001-6644-5828; SORIANI, Marco/0000-0002-9752-5844	GSK Vaccines	GSK Vaccines	This work was supported by internal funding from GSK Vaccines. The funder provided support in the form of salaries for authors PM, SM, JT, MS and AP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Akram KM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-9; Anh TNH, 2012, AM J PHYSIOL-LUNG C, V302, pL226, DOI 10.1152/ajplung.00059.2011; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Bandi V, 2001, AM J RESP CRIT CARE, V164, P2114, DOI 10.1164/ajrccm.164.11.2104093; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Bouhout S., 2014, PRODUCTION TISSUE EN; Brand-Saberi BEM, 2014, THORAC SURG CLIN, V24, P1, DOI 10.1016/j.thorsurg.2013.09.004; Choe MM, 2006, NAT PROTOC, V1, P357, DOI 10.1038/nprot.2006.54; Clementi CF, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00001; De Chiara M, 2014, P NATL ACAD SCI USA, V111, P5439, DOI 10.1073/pnas.1403353111; Dromann D, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-67; Duell BL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/852419; ECAY TW, 1992, EXP CELL RES, V203, P32, DOI 10.1016/0014-4827(92)90036-8; FORSGREN J, 1994, INFECT IMMUN, V62, P673, DOI 10.1128/IAI.62.2.673-679.1994; Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245; Harrington H, 2014, MOL PHARMACEUT, V11, P2082, DOI 10.1021/mp5000295; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Hong WZ, 2007, J BACTERIOL, V189, P8300, DOI 10.1128/JB.00532-07; Kobayashi K, 2006, TISSUE ENG, V12, P2619, DOI 10.1089/ten.2006.12.2619; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Le Visage C, 2004, TISSUE ENG, V10, P1426, DOI 10.1089/ten.2004.10.1426; Liu YY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00342; Mazzoleni G, 2009, GENES NUTR, V4, P13, DOI 10.1007/s12263-008-0107-0; Moller LVM, 1998, AM J RESP CRIT CARE, V157, P950; Nistico L, 2011, J CLIN MICROBIOL, V49, P1411, DOI 10.1128/JCM.00756-10; Pageau SC, 2011, BIOMATERIALS, V32, P7169, DOI 10.1016/j.biomaterials.2011.06.017; Paquette JS, 2003, IN VITRO CELL DEV-AN, V39, P213; Pohl C, 2009, EUR J PHARM BIOPHARM, V72, P339, DOI 10.1016/j.ejpb.2008.07.012; Power PM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-273; Ren DB, 2012, EXP BIOL MED, V237, P540, DOI 10.1258/ebm.2012.011377; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rothen-Rutishauser BM, 2005, AM J RESP CELL MOL, V32, P281, DOI 10.1165/rcmb.2004-0187OC; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Sharpe SW, 2011, INFECT IMMUN, V79, P4361, DOI 10.1128/IAI.05332-11; Steinke M, 2014, BIOMATERIALS, V35, P7355, DOI 10.1016/j.biomaterials.2014.05.031; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; Van Eldere J, 2014, LANCET INFECT DIS, V14, P1281, DOI 10.1016/S1473-3099(14)70734-0; van Schilfgaarde M, 1999, MICROB PATHOGENESIS, V26, P249, DOI 10.1006/mpat.1998.0269; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045	40	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153985	10.1371/journal.pone.0153985	http://dx.doi.org/10.1371/journal.pone.0153985			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101006	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500117
J	Munoz, R; Borobia, AM; Quintana, M; Martinez, A; Ramirez, E; Munoz, M; Frias, J; Carcas, AJ				Munoz, Ral; Borobia, Alberto M.; Quintana, Manuel; Martinez, Ana; Ramirez, Elena; Munoz, Mario; Frias, Jesus; Carcas, Antonio J.			Outcomes and Costs of Poisoned Patients Admitted to an Adult Emergency Department of a Spanish Tertiary Hospital: Evaluation through a Toxicovigilance Program	PLOS ONE			English	Article							TRENDS; REPETITION; MORTALITY; STAY	The Abstract Toxicovigilance is the active process of identifying and evaluating the toxic risks existing in a community, and evaluating the measures taken to reduce or eliminate them. Objective Through a validated toxicovigilance program (SAT-HULP) we examined the characteristics of acute poisoning cases (APC) attended in the Emergency Department (ED) of La Paz Hospital (Madrid, Spain) and assessed their economic impact on the health system. Material and Methods The active poisoning surveillance system performs a daily search for cases in the hospital's computerized case records. Found cases are entered into a database for recording of type of poisoning episode, reasons for exposure, causative agent, signs and symptoms and treatment. We carried out a cross-sectional epidemiological study with analytical projection, based on an impact study on cost per survivor. The data for the costs attributable to cases of APC observed at HULP (outpatients and inpatients) was obtained from the based on the information provided by the diagnosis-related groups (DRG) through the corresponding hospital discharge reports (available through SAT-HULP). Results During the first 30 month of SAT-HULP operation we found a total of 3,195 APC, a cumulative incidence rate of 1.75% of patients attended in the ED. The mean (SD) patient age was 40.9 (17.8) years and 51.2% were men. Drug abuse accounted for 47.5% of the cases. Suicide attempt was the second most frequent category (38.1%) and other causes accounted for 14.5% of APC. The total cost of hospital care for our hospital rose to (sic)1,825,263.24 (approximately (sic)730,105.30/year) resulting in a permanent occupation of 4 beds/year. Conclusions SAT-HULP constitutes a validated toxicovigilance tool, which continuously integrates available data in real-time and helps health services manage APC data flexibly, including the consumption of resources from the health system.	[Munoz, Ral; Borobia, Alberto M.; Ramirez, Elena; Munoz, Mario; Frias, Jesus; Carcas, Antonio J.] Univ Autonoma Madrid, Clin Pharmacol Deparment, Hosp Univ La Paz, IdiPaz,Sch Med, Madrid, Spain; [Borobia, Alberto M.; Quintana, Manuel; Martinez, Ana] Univ Autonoma Madrid, Dept Accid & Emergency, Hosp Univ La Paz, Crit Care Dept,Sch Med,IdiPaz, Madrid, Spain; [Munoz, Ral; Borobia, Alberto M.; Quintana, Manuel; Martinez, Ana; Munoz, Mario; Frias, Jesus; Carcas, Antonio J.] Hosp Univ La Paz, Clin Toxicol Unit, Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitario La Paz	Munoz, R; Carcas, AJ (corresponding author), Univ Autonoma Madrid, Clin Pharmacol Deparment, Hosp Univ La Paz, IdiPaz,Sch Med, Madrid, Spain.; Munoz, R; Carcas, AJ (corresponding author), Hosp Univ La Paz, Clin Toxicol Unit, Madrid, Spain.	rmunozromo@gmail.com; antonio.carcas@uam.es	Ramírez, Elena/S-5600-2018; Quintana-Díaz, Manuel/M-2313-2017; Quintana-Diaz, Manuel/AAE-2265-2022; Ramírez, Elena/AGX-8858-2022; Carcas, Antonio J/E-1149-2012; Borobia, Alberto M./H-6887-2013	Ramírez, Elena/0000-0002-4052-8876; Quintana-Díaz, Manuel/0000-0003-4852-4148; Quintana-Diaz, Manuel/0000-0003-4852-4148; Ramírez, Elena/0000-0002-4052-8876; Carcas, Antonio J/0000-0003-1823-4174; Borobia, Alberto M./0000-0002-8584-3263				Abad-Santos F, 2000, THER DRUG MONIT, V22, P163, DOI 10.1097/00007691-200004000-00004; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 2009, INF AN 2009; [Anonymous], 2009, B OFICIAL COMUNIDAD, V215, P15; Barrientos R, 1996, REV CALIDAD ASISTENC, V11, P37; Barrientos R, 2003, MED INTENSIVA, V27, P391; Buehler W, 2004, MMWR-MORBID MORTAL W, V53, P1; Putze GB, 2008, EMERGENCIAS, V20, P15; Camidge DR, 2003, BRIT J CLIN PHARMACO, V56, P613, DOI 10.1046/j.1365-2125.2003.01910.x; Carlsten A, 1996, ACTA PSYCHIAT SCAND, V94, P94, DOI 10.1111/j.1600-0447.1996.tb09831.x; Ferrer A, 2000, MED CLIN-BARCELONA, V115, P238, DOI 10.1016/S0025-7753(00)71518-1; Friedman LS, 2014, CLIN TOXICOL, V52, P198, DOI 10.3109/15563650.2014.892125; Andres MCG, 2011, EMERGENCIAS, V23, P193; Hawton K, 1997, DRUG ALCOHOL REV, V16, P123, DOI 10.1080/09595239700186411; Heyerdahl F, 2009, BRIT J PSYCHIAT, V194, P73, DOI 10.1192/bjp.bp.107.048322; Hoyt BT, 1999, ACAD EMERG MED, V6, P851, DOI 10.1111/j.1553-2712.1999.tb01220.x; Hu YH, 2010, J CHIN MED ASSOC, V73, P78, DOI 10.1016/S1726-4901(10)70006-X; Johnsson E, 1997, ACTA PSYCHIAT SCAND, V96, P362, DOI 10.1111/j.1600-0447.1997.tb09930.x; Kapur N, 1999, BRIT J GEN PRACT, V49, P733; Kapur N, 1998, BRIT MED J, V316, P831, DOI 10.1136/bmj.316.7134.831; Krajewski AK, 2015, CLIN TOXICOL, V53, P433, DOI 10.3109/15563650.2015.1030677; Librero J, 1999, J CLIN EPIDEMIOL, V52, P171, DOI 10.1016/S0895-4356(98)00160-7; Liisanantti JH, 2011, J CRIT CARE, V26, P160, DOI 10.1016/j.jcrc.2010.08.009; Litovitz T, 1998, DRUG SAFETY, V18, P9, DOI 10.2165/00002018-199818010-00002; McKenzie MS, 2007, PHARMACOEPIDEM DR S, V16, P513, DOI 10.1002/pds.1355; Moran JL, 2008, CRIT CARE MED, V36, P46, DOI 10.1097/01.CCM.0000295313.08084.58; Munoz R, 2013, EMERGENCIAS, V25, P423; Okumura Y, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001857; Okumura Y, 2012, GEN HOSP PSYCHIAT, V34, P681, DOI 10.1016/j.genhosppsych.2012.07.009; Prescott K, 2009, BRIT J CLIN PHARMACO, V68, P260, DOI 10.1111/j.1365-2125.2009.03458.x; Rafnsson SB, 2007, HUM EXP TOXICOL, V26, P49, DOI 10.1177/0960327107071855; Ruse M, 2000, ANN EMERG MED, V35, P512, DOI 10.1016/S0196-0644(00)70016-3; Satar S, 2005, ADV THER, V22, P137, DOI 10.1007/BF02849884; Strassels SA, 2009, J MANAGE CARE PHARM, V15, P556, DOI 10.18553/jmcp.2009.15.7.556; Townsend E, 2001, SOC PSYCH PSYCH EPID, V36, P228, DOI 10.1007/s001270170053; Watson AW, 2005, TOXICOL APPL PHARM, V207, pS604; Watson WA, 2005, AM J EMERG MED, V23, P589, DOI 10.1016/j.ajem.2005.05.001; White AM, 2011, J STUD ALCOHOL DRUGS, V72, P774, DOI 10.15288/jsad.2011.72.774; World Health Organisation, 2011, POIS PREV MAN 2011; Wu AHB, 2010, CLIN PHARMACOL THER, V88, P295, DOI 10.1038/clpt.2010.45; Yang ChM, 2006, HEALTH SERV RES, V125, P1	41	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152876	10.1371/journal.pone.0152876	http://dx.doi.org/10.1371/journal.pone.0152876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100460	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500017
J	Suwarnalata, G; Tan, AH; Isa, H; Gudimella, R; Anwar, A; Loke, MF; Mahadeva, S; Lim, SY; Vadivelu, J				Suwarnalata, Gunasekaran; Tan, Ai Huey; Isa, Hidayah; Gudimella, Ranganath; Anwar, Arif; Loke, Mun Fai; Mahadeva, Sanjiv; Lim, Shen-Yang; Vadivelu, Jamuna			Augmentation of Autoantibodies by Helicobacter pylori in Parkinson's Disease Patients May Be Linked to Greater Severity	PLOS ONE			English	Article							IDIOPATHIC PARKINSONISM; GROWTH-FACTOR; DOPAMINERGIC-NEURONS; GASTROINTESTINAL-TRACT; INFECTION; GASTRITIS; RAT; ERADICATION; PROTEIN; BRAIN	Parkinson's disease (PD) is the second most common chronic and progressive neuro-degenerative disorder. Its etiology remains elusive and at present only symptomatic treatments exists. Helicobacter pylori chronically colonizes the gastric mucosa of more than half of the global human population. Interestingly, H. pylori positivity has been found to be associated with greater of PD motor severity. In order to investigate the underlying cause of this association, the Sengenics Immunome protein array, which enables simultaneous screening for autoantibodies against 1636 human proteins, was used to screen the serum of 30 H. pylori-seropositive PD patients (case) and 30 age-and gender-matched H. pylori-seronegative PD patients (control) in this study. In total, 13 significant autoantibodies were identified and ranked, with 8 up-regulated and 5 down-regulated in the case group. Among autoantibodies found to be elevated in H. pylori-seropositive PD were included antibodies that recognize Nuclear factor I subtype A (NFIA), Platelet-derived growth factor B (PDGFB) and Eukaryotic translation initiation factor 4A3 (eIFA3). The presence of elevated autoantibodies against proteins essential for normal neurological functions suggest that immunomodulatory properties of H. pylori may explain the association between H. pylori positivity and greater PD motor severity.	[Suwarnalata, Gunasekaran; Isa, Hidayah; Loke, Mun Fai; Vadivelu, Jamuna] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Tan, Ai Huey; Lim, Shen-Yang] Univ Malaya, Div Neurol, Kuala Lumpur, Malaysia; [Tan, Ai Huey; Lim, Shen-Yang] Univ Malaya, Mah Pooi Soo & Tan Chin Nam Ctr Parkinsons & Rela, Kuala Lumpur, Malaysia; [Gudimella, Ranganath; Anwar, Arif] Univ Malaya, Sengen Sdn Bhd, Kuala Lumpur, Malaysia; [Mahadeva, Sanjiv] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.	jamuna@ummc.edu.my	Loke, Mun Fai/B-1060-2011; Lim, Shen-Yang/E-5099-2010; Tan, Ai Huey/G-5264-2016; Mahadeva, Sanjiv/E-1711-2011; VADIVELU, JAMUNARANI S/B-8696-2010	Loke, Mun Fai/0000-0002-3554-5313; Mahadeva, Sanjiv/0000-0001-5824-0590; VADIVELU, JAMUNARANI S/0000-0001-7322-3676	University of Malaya-Ministry of Education (UM-MoE) High Impact Research (HIR) Grant [UM.C/625/1/HIR/MOE/CHAN/13/4, H-50001-00-A000029]	University of Malaya-Ministry of Education (UM-MoE) High Impact Research (HIR) Grant	This study was supported by the University of Malaya-Ministry of Education (UM-MoE) High Impact Research (HIR) Grant UM.C/625/1/HIR/MOE/CHAN/13/4 (Account No. H-50001-00-A000029). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arai H, 2006, HISTOL HISTOPATHOL, V21, P673, DOI 10.14670/HH-21.673; Ayada K, 2009, LUPUS, V18, P1154, DOI 10.1177/0961203309106600; Barker-Haliski ML, 2012, NEUROSCIENCE, V226, P51, DOI 10.1016/j.neuroscience.2012.09.003; Baudron CR, 2013, HELICOBACTER, V18, P44, DOI 10.1111/hel.12077; Bauer B., 2011, ULCERS, V2011, DOI [DOI 10.1155/2011/340157, 10.1155/2011/340157]; Boutell JM, 2004, PROTEOMICS, V4, P1950, DOI 10.1002/pmic.200300722; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Cersosimo MG, 2008, MOVEMENT DISORD, V23, P1065, DOI 10.1002/mds.22051; Contreras M, 2008, AM J TROP MED HYG, V78, P574, DOI 10.4269/ajtmh.2008.78.574; Deretzi G, 2011, CURR MOL MED, V11, P696, DOI 10.2174/156652411797536660; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Dobbs RJ, 2008, HELICOBACTER, V13, P309, DOI 10.1111/j.1523-5378.2008.00622.x; Dobbs RJ, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-12; Dobbs RJ, 2012, NEURODEGENER DIS, V10, P183, DOI 10.1159/000332807; Dobbs SM, 2000, MED HYPOTHESES, V55, P93, DOI 10.1054/mehy.2000.1110; Dobbs SM, 2016, J NEUROVIROL, V22, P22, DOI 10.1007/s13365-015-0357-8; Dobbs SM, 2013, HELICOBACTER, V18, P187, DOI 10.1111/hel.12035; Dobbs SM, 2010, HELICOBACTER, V15, P279, DOI 10.1111/j.1523-5378.2010.00768.x; Everhart JE, 2002, CLIN DIAGN LAB IMMUN, V9, P412, DOI 10.1128/CDLI.9.2.412-416.2002; Funa K, 1996, NEUROSCIENCE, V74, P825, DOI 10.1016/0306-4522(96)00152-2; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Liu B, 2003, ENVIRON HEALTH PERSP, V111, P1065, DOI 10.1289/ehp.6361; NEGRINI R, 1993, EUR J GASTROEN HEPAT, V5, pS27; NEGRINI R, 1992, SCAND J GASTROENTERO, V27, P599, DOI 10.3109/00365529209000125; NEGRINI R, 1991, GASTROENTEROLOGY, V101, P437, DOI 10.1016/0016-5085(91)90023-E; Nielsen HH, 2012, EUR J NEUROL, V19, P864, DOI 10.1111/j.1468-1331.2011.03643.x; NIKKHAH G, 1993, EXP BRAIN RES, V92, P516; OTHBERG A, 1995, EXP BRAIN RES, V105, P111; Paul G, 2015, J CLIN INVEST, V125, P1339, DOI 10.1172/JCI79635; Peleteiro B, 2014, DIGEST DIS SCI, V59, P1698, DOI 10.1007/s10620-014-3063-0; Pierantozzi M, 2006, NEUROLOGY, V66, P1824, DOI 10.1212/01.wnl.0000221672.01272.ba; Pietz K, 1996, NEUROSCI LETT, V204, P101, DOI 10.1016/0304-3940(96)12326-0; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Ram M, 2013, CLIN CHEM LAB MED, V51, P1075, DOI 10.1515/cclm-2012-0477; Rees K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008535.pub2; Robinson WH, 2003, PROTEOMICS, V3, P2077, DOI 10.1002/pmic.200300583; Romero-Gallo J, 2002, CLIN DIAGN LAB IMMUN, V9, P1313, DOI 10.1128/CDLI.9.6.1313-1317.2002; Sakagami T, 1996, GUT, V39, P639, DOI 10.1136/gut.39.5.639; Solari N, 2013, LEARN MEMORY, V20, P592, DOI 10.1101/lm.032029.113; STRANG R R, 1965, Med J Aust, V1, P842; STRANG RR, 1966, ACTA NEUROL SCAND, V42, P124, DOI 10.1111/j.1600-0404.1966.tb05991.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Supajatura V, 2002, J IMMUNOL, V168, P2603, DOI 10.4049/jimmunol.168.6.2603; Takahashi T, 2004, BRIT J HAEMATOL, V124, P91, DOI 10.1046/j.1365-2141.2003.04735.x; Tan AH, 2015, PARKINSONISM RELAT D, V21, P221, DOI 10.1016/j.parkreldis.2014.12.009; Toh BH, 2014, AUTOIMMUN REV, V13, P459, DOI 10.1016/j.autrev.2014.01.048; Weller C, 2005, HELICOBACTER, V10, P288, DOI 10.1111/j.1523-5378.2005.00329.x; Zachrisson O, 2011, J PARKINSON DIS, V1, P49, DOI 10.3233/JPD-2011-0003; Zheng S, 2010, J CLIN INVEST, V120, P2446, DOI 10.1172/JCI33144	49	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153725	10.1371/journal.pone.0153725	http://dx.doi.org/10.1371/journal.pone.0153725			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100827	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500055
J	Zhang, YP; Li, J; Song, S; Tardif, T; Burmeister, M; Villafuerte, SM; Su, MM; McBride, C; Shu, H				Zhang, Yuping; Li, Jun; Song, Shuang; Tardif, Twila; Burmeister, Margit; Villafuerte, Sandra M.; Su, Mengmeng; McBride, Catherine; Shu, Hua			Association of DCDC2 Polymorphisms with Normal Variations in Reading Abilities in a Chinese Population	PLOS ONE			English	Article							DYSLEXIA SUSCEPTIBILITY GENE; DEVELOPMENTAL DYSLEXIA; ENVIRONMENTAL-INFLUENCES; PHONOLOGICAL SKILLS; KIAA0319; CHILDREN; LINKAGE; DISABILITIES; AWARENESS; LANGUAGE	The doublecortin domain-containing 2 (DCDC2) gene, which is located on chromosome 6p22.1, has been widely suggested to be a candidate gene for dyslexia, but its role in typical reading development over time remains to be clarified. In the present study, we explored the role of DCDC2 in contributing to the individual differences in reading development from ages 6 to 11 years by analysing data from 284 unrelated children who were participating in the Chinese Longitudinal Study of Reading Development (CLSRD). The associations of eight single nucleotide polymorphisms (SNPs) in DCDC2 with the latent intercept and slope of children's reading scores were examined in the first step. There was significant support for an association of rs807724 with the intercept for the reading comprehension measure of reading fluency, and the minor "G" allele was associated with poor reading performance. Next, we further tested the rs807724 SNP in association with the reading ability at each tested time and revealed that, in addition to significant associations with the two main reading measures (reading fluency and Chinese character reading) over multiple testing occasions, this SNP also showed associations with reading-related cognitive skills, including morphological production, orthographic judgment and phonological processing skills (rapid number naming, phoneme deletion, and tone detection). This study provides support for DCDC2 as a risk gene for reading disability and suggests that this gene is also operative for typical reading development in the Han population.	[Zhang, Yuping] Chengdu Med Coll, Dept Psychol, Chengdu, Peoples R China; [Zhang, Yuping] Chengdu Med Coll, ResearchCtr Appl Psychol Sichuan, Chengdu, Peoples R China; [Zhang, Yuping; Li, Jun; Song, Shuang; Su, Mengmeng; Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Tardif, Twila] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Burmeister, Margit; Villafuerte, Sandra M.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Burmeister, Margit; Villafuerte, Sandra M.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Burmeister, Margit] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [McBride, Catherine] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Shu, Hua] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China	Chengdu Medical College; Chengdu Medical College; Beijing Normal University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese University of Hong Kong; Beijing Normal University; Beijing Normal University	Zhang, YP (corresponding author), Chengdu Med Coll, Dept Psychol, Chengdu, Peoples R China.; Zhang, YP (corresponding author), Chengdu Med Coll, ResearchCtr Appl Psychol Sichuan, Chengdu, Peoples R China.; Zhang, YP; Shu, H (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.; Shu, H (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.; Shu, H (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China.	michelle1368@126.com; shuh@bnu.edu.cn		Tardif, Twila Z/0000-0001-8739-9090	National Key Basic Research Program of China [2014CB846103]; Major Project of Philosophy and Social Science Foundation by Ministry of Education [11JZD041]; National Natural Science Foundation of China [31271082, 31500910, 81461130018]; National Institute of Child Health and Human Development [P01 HD001994]; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning [CNLZD1202]; Humanities and Social Science Project of Sichuan Educational Committee [CSXL-131001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD001994] Funding Source: NIH RePORTER	National Key Basic Research Program of China(National Basic Research Program of China); Major Project of Philosophy and Social Science Foundation by Ministry of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning; Humanities and Social Science Project of Sichuan Educational Committee; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by National Key Basic Research Program of China (2014CB846103), by Major Project of Philosophy and Social Science Foundation by Ministry of Education (11JZD041), by the National Natural Science Foundation of China (31271082, 31500910, 81461130018), by the National Institute of Child Health and Human Development (P01 HD001994) to Haskins Laboratories, and by a grant from the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (CNLZD1202), as well as CSXL-131001 from the Humanities and Social Science Project of Sichuan Educational Committee.	Anthoni H, 2007, HUM MOL GENET, V16, P667, DOI 10.1093/hmg/ddm009; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Chow BW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047872, DOI 10.1371/JOURNAL.PONE.0047872]; Christopher ME, 2013, SCI STUD READ, V17, P350, DOI 10.1080/10888438.2012.729119; Christopher ME, 2013, J EXP CHILD PSYCHOL, V115, P453, DOI 10.1016/j.jecp.2013.03.008; Chun D., 2015, J 2 LANG PRONUNCIATI, V1, P86, DOI [10.1075/jslp.1.1.04chu, DOI 10.1075/JSLP.1.1.04CHU]; Couto JM, 2010, AM J MED GENET B, V153B, P447, DOI 10.1002/ajmg.b.30999; Deffenbacher KE, 2004, HUM GENET, V115, P128, DOI 10.1007/s00439-004-1126-6; Duncan T, 2006, INTRO LATENT VARIABL; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gayan J, 2001, DEV NEUROPSYCHOL, V20, P483, DOI 10.1207/S15326942DN2002_3; Harold D, 2006, MOL PSYCHIATR, V11, P1085, DOI 10.1038/sj.mp.4001904; Ho CSH, 1997, DEV PSYCHOL, V33, P946, DOI 10.1037/0012-1649.33.6.946; Ho CSH, 2004, COGNITION, V91, P43, DOI 10.1016/S0010-0277(03)00163-X; Kere J, 2011, WIRES COGN SCI, V2, P441, DOI 10.1002/wcs.138; Lei L, 2011, J CHILD PSYCHOL PSYC, V52, P212, DOI 10.1111/j.1469-7610.2010.02311.x; Leong CK, 2008, READ WRIT, V21, P559, DOI 10.1007/s11145-007-9113-7; Li H, 2012, J RES READ, V35, P287, DOI 10.1111/j.1467-9817.2010.01460.x; Lind PA, 2010, EUR J HUM GENET, V18, P668, DOI 10.1038/ejhg.2009.237; Logan JAR, 2013, CHILD DEV, V84, P2131, DOI 10.1111/cdev.12104; Ludwig KU, 2008, J NEURAL TRANSM, V115, P1587, DOI 10.1007/s00702-008-0124-6; Marino C, 2011, BEHAV GENET, V41, P67, DOI 10.1007/s10519-010-9412-7; McBride-Chang Catherine., 2005, READ WRIT, V18, P99, DOI [10.1007/s11145-004-7343-5, DOI 10.1007/S11145-004-7343-5]; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Moll K, 2009, SCI STUD READ, V13, P1, DOI 10.1080/10888430802631684; Muthen L.K., MPLUS USERS GUIDE, V8th; Newbury DF, 2011, BEHAV GENET, V41, P90, DOI 10.1007/s10519-010-9424-3; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Paracchini S, 2008, AM J PSYCHIAT, V165, P1576, DOI 10.1176/appi.ajp.2008.07121872; Petrill SA, 2007, READ WRIT, V20, P127, DOI 10.1007/s11145-006-9021-2; Petrill SA, 2010, J CHILD PSYCHOL PSYC, V51, P660, DOI 10.1111/j.1469-7610.2009.02204.x; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scerri TS, 2011, BIOL PSYCHIAT, V70, P237, DOI 10.1016/j.biopsych.2011.02.005; Schumacher J, 2006, AM J HUM GENET, V78, P52, DOI 10.1086/498992; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Shu H, 2006, J EDUC PSYCHOL, V98, P122, DOI 10.1037/0022-0663.98.1.122; Shu H, 2003, CHILD DEV, V74, P27, DOI 10.1111/1467-8624.00519; Shu H, 2008, DEVELOPMENTAL SCI, V11, P171, DOI 10.1111/j.1467-7687.2007.00654.x; Sun YM, 2014, AM J MED GENET B, V165, P627, DOI 10.1002/ajmg.b.32267; Wilcke A, 2009, ANN DYSLEXIA, V59, P1, DOI 10.1007/s11881-008-0020-7; Wolf M., 2002, READING WRITING INTE, V15, P43, DOI [10.1023/A:1013816320290, DOI 10.1023/A:1013816320290]; Ziegler JC, 2010, PSYCHOL SCI, V21, P551, DOI 10.1177/0956797610363406	44	11	12	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153603	10.1371/journal.pone.0153603	http://dx.doi.org/10.1371/journal.pone.0153603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100778	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500043
J	Cheng, J; Su, XO; Yao, Y; Han, CQ; Wang, S; Zhao, YP				Cheng, Jie; Su, Xiao-Ou; Yao, Yue; Han, Caiqin; Wang, Shi; Zhao, Yiping			Highly Sensitive Detection of Melamine Using a One-Step Sample Treatment Combined with a Portable Ag Nanostructure Array SERS Sensor	PLOS ONE			English	Article							ENHANCED RAMAN-SPECTROSCOPY; NANOPARTICLES; TOXICITY; FORMULA; POWDER; CATS; MILK	There is an urgent need for rapid and reliable methods able to detect melamine in animal feed. In this study, a quick, simple, and sensitive method for the determination of melamine content in animal feed was developed using surface-enhanced Raman spectroscopy on fabricated Ag nanorod (AgNR) array substrates with a one-step sample extraction procedure. The AgNR array substrates washed by HNO3 solvent (10(-7) M) and methanol and showed the good stability within 6 months. The Raman shift at Delta v = 682 cm(-1) was used as the characteristic melamine peak in the calculations. Sufficient linearity was obtained in the 2-200 mu g.g(-1) range (R-2 = 0.926). The limits of detection and quantification were 0.9 and 2 mu g.g(-1), respectively. The recovery rates were 89.7-93.3%, with coefficients of variation below 2.02%. The method showed good accuracy compared with the tradition GC-MS analysis. This new protocol only need 2 min to fininsh the detection which could be developed for rapid onsite screening of melamine contamination in quality control and market surveillance applications.	[Cheng, Jie; Su, Xiao-Ou; Wang, Shi] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China; [Yao, Yue; Han, Caiqin] Jiangsu Normal Univ, Sch Phys & Elect Engn, Nanjing, Jiangsu, Peoples R China; [Zhao, Yiping] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; Jiangsu Normal University; University System of Georgia; University of Georgia	Su, XO (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China.	suxiaoou@caas.cn	Cheng, Jie/ABG-3067-2021; Li, Xiaomin/ABI-2638-2020; Zhao, Yiping/A-4968-2008	Zhao, Yiping/0000-0002-3710-4159	innovation project for the Chinese Academy of Agricultural Sciences; Div Of Chem, Bioeng, Env, & Transp Sys [1064228] Funding Source: National Science Foundation	innovation project for the Chinese Academy of Agricultural Sciences; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the innovation project for the Chinese Academy of Agricultural Sciences (http://www.caas.cn/kjcxgczl/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, BULLET 1372 2007 CHI, P6; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Brown CA, 2007, J VET DIAGN INVEST, V19, P525, DOI 10.1177/104063870701900510; Chen J, 2015, J RAMAN SPECTROSC, V46, P64, DOI 10.1002/jrs.4612; Cheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107770; Dobson RLM, 2008, TOXICOL SCI, V106, P251, DOI 10.1093/toxsci/kfn160; Driskell JD, 2008, J PHYS CHEM C, V112, P895, DOI 10.1021/jp075288u; Du XB, 2010, APPL SPECTROSC, V64, P781, DOI 10.1366/000370210791666426; Eric LR, 2009, PRINCIPLES SURFACE E; Fu JX, 2008, J PHYS CHEM C, V112, P16784, DOI 10.1021/jp802909g; Garber EAE, 2008, J FOOD PROTECT, V71, P590, DOI 10.4315/0362-028X-71.3.590; Han CQ, 2014, TALANTA, V128, P293, DOI 10.1016/j.talanta.2014.04.083; Hau AKC, 2009, J AM SOC NEPHROL, V20, P245, DOI 10.1681/ASN.2008101065; Haughey SA, 2013, FOOD CHEM, V136, P1557, DOI 10.1016/j.foodchem.2012.01.068; Haynes CL, 2005, ANAL CHEM, V77, p338A, DOI 10.1021/ac053456d; Kneipp K, 2002, APPL SPECTROSC, V56, P150, DOI 10.1366/0003702021954557; Lam CW, 2009, CLIN CHIM ACTA, V402, P150, DOI 10.1016/j.cca.2008.12.035; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lin M, 2008, J FOOD SCI, V73, pT129, DOI 10.1111/j.1750-3841.2008.00901.x; Liu YJ, 2010, J PHYS CHEM C, V114, P8176, DOI 10.1021/jp1001644; Mauer LJ, 2009, J AGR FOOD CHEM, V57, P3974, DOI 10.1021/jf900587m; Mecker LC, 2012, ANAL CHIM ACTA, V733, P48, DOI 10.1016/j.aca.2012.05.001; Moskovits M, 2005, J RAMAN SPECTROSC, V36, P485, DOI 10.1002/jrs.1362; Muniz-Valencia R, 2008, ANAL BIOANAL CHEM, V392, P523, DOI 10.1007/s00216-008-2294-3; Negri P, 2011, APPL SPECTROSC, V65, P66, DOI 10.1366/10-06037; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Vivo-Truyols G, 2006, ANAL CHEM, V78, P4598, DOI 10.1021/ac0600196; Wu XM, 2013, ANALYST, V138, P3005, DOI 10.1039/c3an00186e; Wu XM, 2012, ANALYST, V137, P4226, DOI 10.1039/c2an35378d; Xu WG, 2012, P NATL ACAD SCI USA, V109, P9281, DOI 10.1073/pnas.1205478109; Xu XM, 2009, ANAL CHIM ACTA, V650, P39, DOI 10.1016/j.aca.2009.04.026; Xu XW, 2009, BIOSENS BIOELECTRON, V24, P3153, DOI 10.1016/j.bios.2009.03.025; Yazgan NN, 2012, ANAL BIOANAL CHEM, V403, P2009, DOI 10.1007/s00216-012-5971-1; Yin WW, 2010, J AGR FOOD CHEM, V58, P8152, DOI 10.1021/jf1006209	34	18	18	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154402	10.1371/journal.pone.0154402	http://dx.doi.org/10.1371/journal.pone.0154402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27120183	Green Published, gold			2022-12-27	WOS:000374976200067
J	Edwards, PM				Edwards, Patrick M.			The Value of Long-Term Stream Invertebrate Data Collected by Citizen Scientists	PLOS ONE			English	Article							MACROINVERTEBRATES; VARIABILITY	The purpose of this investigation was to systematically examine the variability associated with temporally-oriented invertebrate data collected by citizen scientists and consider the value of such data for use in stream management. Variability in invertebrate data was estimated for three sources of variation: sampling, within-reach spatial and long-term temporal. Long-term temporal data were also evaluated using ordinations and an Index of Biotic Integrity (IBI). Through two separate investigations over an 11-year study period, participants collected more than 400 within-reach samples during 44 sampling events at three streams in the western United States. Within-reach invertebrate abundance coefficient of variation (CV) ranged from 0.44-0.50 with approximately 62% of the observed variation strictly due to sampling. Long-term temporal CV ranged from 0.31-0.36 with 27-30% of the observed variation in invertebrate abundance related to climate conditions (El Nino strength) and sampling year. Ordinations showed that citizen-generated assemblage data could reliably detect differences between study streams and seasons. IBI scores were significantly different between streams but not seasons. The findings of this study suggest that citizen data would likely detect a change in mean invertebrate density greater than 50% and would also be useful for monitoring changes in assemblage. The information presented here will help stream managers interpret and evaluate changes to the stream invertebrate community detected by citizen-based programs.	[Edwards, Patrick M.] Portland State Univ, Environm Sci & Management, Portland, OR 97207 USA	Portland State University	Edwards, PM (corresponding author), Portland State Univ, Environm Sci & Management, Portland, OR 97207 USA.	patrick.edwards@pdx.edu						Barbour MT, 1996, J N AM BENTHOL SOC, V15, P386, DOI 10.2307/1467285; Beche LA, 2007, FRESHWATER BIOL, V52, P2317, DOI 10.1111/j.1365-2427.2007.01859.x; Bradley DC, 2001, J ANIM ECOL, V70, P987, DOI 10.1046/j.0021-8790.2001.00551.x; Carter JL, 2006, METHODS STREAM ECOLO; Caton L.W., 1991, J N AMER BENTHOL SOC, V8, P317; Cooper CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106508; Ely E., 2005, NATL NEWSLETTER VOLU, V17, P1; Engel Sarah R., 2002, American Entomologist, V48, P164; Fleming B, 2001, J AM PLANN ASSOC, V67, P456, DOI 10.1080/01944360108976252; Fore LS, 2001, FRESHWATER BIOL, V46, P109, DOI 10.1046/j.1365-2427.2001.00640.x; Gromping U, 2007, AM STAT, V61, P139, DOI 10.1198/000313007X188252; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Growns I, 2006, ENVIRON MONIT ASSESS, V117, P173, DOI 10.1007/s10661-006-0231-5; Henderson S, 2012, FRONT ECOL ENVIRON, V10, P283, DOI 10.1890/1540-9295-10.6.283; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Jackson JK, 2006, FRESHWATER BIOL, V51, P591, DOI 10.1111/j.1365-2427.2006.01503.x; Karasek T, 2015, HYDROBIOLOGIA, V751, P215, DOI 10.1007/s10750-015-2188-2; KARR JR, 1991, ECOL APPL, V1, P66, DOI 10.2307/1941848; Kerr Meg, 1994, Lake and Reservoir Management, V9, P1; Legendre P., 2012, NUMERICAL ECOLOGY; LENAT D R, 1988, Journal of the North American Benthological Society, V7, P222, DOI 10.2307/1467422; Li JL, 2011, J N AM BENTHOL SOC, V30, P474, DOI 10.1899/10-024.1; Likens GE, 1987, LONG TERM STUDIES EC; Mazor RD, 2009, ENVIRON MANAGE, V43, P1269, DOI 10.1007/s00267-009-9294-8; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Nerbonne JF, 2003, J N AM BENTHOL SOC, V22, P152, DOI 10.2307/1467984; Nerbonne JF, 2008, ENVIRON MANAGE, V42, P470, DOI 10.1007/s00267-008-9103-9; Nichols SJ, 2006, HYDROBIOLOGIA, V572, P195, DOI 10.1007/s10750-006-0253-6; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Oregon Watershed Assessment Manual, 1999, OR WAT ASS MAN; PENROSE D, 1995, J N AM BENTHOL SOC, V14, P203, DOI 10.2307/1467735; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; R Development Core Team, 2007, R LANG ENV STAT COMP; Relyea CD, 2012, ENVIRON MANAGE, V49, P242, DOI 10.1007/s00267-011-9784-3; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; U.S. EPA, 1997, PB94178670 US EPA OF; U.S. EPA, 841B97003 US EPA; USGS (United States Geologic Survey), 1995, 95742 USGS; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336	39	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0153713	10.1371/journal.pone.0153713	http://dx.doi.org/10.1371/journal.pone.0153713			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119850	Green Published, gold			2022-12-27	WOS:000374976200035
J	Hinder, M; Perdomo, A; Tracy, M				Hinder, Murray; Perdomo, Aldo; Tracy, Mark			Dangerous Pressurization and Inappropriate Alarms during Water Occlusion of the Expiratory Circuit of Commonly Used Infant Ventilators	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; MECHANICAL VENTILATION; PRETERM INFANTS; NASAL CPAP; PERFORMANCE; HUMIDIFIERS; LIMB	Background Non-invasive continuous positive airways pressure is commonly a primary respiratory therapy delivered via multi-purpose ventilators in premature newborns. Expiratory limb occlusion due to water accumulation or 'rainout' from gas humidification is a frequent issue. A case of expiratory limb occlusion due to rainout causing unexpected and excessive repetitive airway pressurisation in a Draeger VN500 prompted a systematic bench test examination of currently available ventilators. Objective To assess neonatal ventilator response to partial or complete expiratory limb occlusion when set to non-invasive continuous positive airway pressure mode. Design Seven commercially available neonatal ventilators connected to a test lung using a standard infant humidifier circuit with partial and/or complete expiratory limb occlusion were examined in a bench test study. Each ventilator was set to deliver 6 cmH(2)O in non-invasive mode and respiratory mechanics data for 75%, 80% and 100% occlusion were collected. Results Several ventilators responded inappropriately with complete occlusion by cyclical pressurisation/depressurisation to peak pressures of between 19.4 and 64.6 cmH(2)O at rates varying between 2 to 77 inflations per minute. Tidal volumes varied between 10.1 and 24.3mL. Alarm responses varied from 'specific' (tube occluded) to 'ambiguous' (Safety valve open). Carefusion Avea responded by continuing to provide the set distending pressure and displaying an appropriate alarm message. Draeger Babylog 8000 did not alarm with partial occlusions and incorrectly displayed airways pressure at 6.1cmH(2)O compared to the measured values of 13cmH(2)O. Conclusions This study found a potential for significant adverse ventilator response due to complete or near complete expiratory limb occlusion in CPAP mode.	[Hinder, Murray; Perdomo, Aldo; Tracy, Mark] Westmead Hosp, Neonatal Intens Care Unit, Sydney, NSW, Australia; [Hinder, Murray] Univ Sydney, Sydney, NSW 2006, Australia; [Tracy, Mark] Univ Sydney, Dept Paediat & Child Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Tracy, M (corresponding author), Westmead Hosp, Neonatal Intens Care Unit, Sydney, NSW, Australia.; Tracy, M (corresponding author), Univ Sydney, Dept Paediat & Child Hlth, Sydney, NSW 2006, Australia.	mark.tracy@health.nsw.gov.au		Hinder, Murray/0000-0002-9179-316X; Perdomo, Aldo/0000-0002-4103-5109; Tracy, Mark/0000-0001-5648-468X				Chatburn RL, 2014, RESP CARE, V59, P1747, DOI 10.4187/respcare.03057; Chatburn RL, 2011, RESP CARE, V56, P85, DOI 10.4187/respcare.00967; CHILTON HW, 1979, J PEDIATR-US, V94, P808, DOI 10.1016/S0022-3476(79)80163-8; Claure N, 2007, ARCH DIS CHILD-FETAL, V92, P508, DOI 10.1136/adc.2006.108852; De Paoli AG, 2005, ARCH DIS CHILD-FETAL, V90, pF79, DOI 10.1136/adc.2004.052274; Fisher & Paykel Healthcare, 2012, RT265 INF CIRC KIT P; Fisher & Paykel Healthcare, 2003, WHAT IS OPT CIRC CON; Fisher & Paykel Healthcare, 2005, NEON CIRC SETU 18504; HALL MW, 1983, CRIT CARE MED, V11, P26, DOI 10.1097/00003246-198301000-00008; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; International Organization for Standardization, 2004, 1065112004 ISO; Lellouche F, 2004, AM J RESP CRIT CARE, V170, P1073, DOI 10.1164/rccm.200309-1245OC; Makhoul IR, 2002, ASAIO J, V48, P476, DOI 10.1097/00002480-200209000-00006; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Pillow JJ, 2012, CLIN PERINATOL, V39, P483, DOI 10.1016/j.clp.2012.06.007; Schena E, 2013, PHYSIOL MEAS, V34, P813, DOI 10.1088/0967-3334/34/7/813; Todd DA, 2001, J PAEDIATR CHILD H, V37, P489, DOI 10.1046/j.1440-1754.2001.00750.x; Youngquist TM, 2013, RESP CARE, V58, P1840, DOI 10.4187/respcare.02322	18	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154034	10.1371/journal.pone.0154034	http://dx.doi.org/10.1371/journal.pone.0154034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116224	gold, Green Published, Green Submitted			2022-12-27	WOS:000374973600038
J	Matsuba, R; Imamura, M; Tanaka, Y; Iwata, M; Hirose, H; Kaku, K; Maegawa, H; Watada, H; Tobe, K; Kashiwagi, A; Kawamori, R; Maeda, S				Matsuba, Ren; Imamura, Minako; Tanaka, Yasushi; Iwata, Minoru; Hirose, Hiroshi; Kaku, Kohei; Maegawa, Hiroshi; Watada, Hirotaka; Tobe, Kazuyuki; Kashiwagi, Atsunori; Kawamori, Ryuzo; Maeda, Shiro			Replication Study in a Japanese Population of Six Susceptibility Loci for Type 2 Diabetes Originally Identified by a Transethnic Meta-Analysis of Genome-Wide Association Studies	PLOS ONE			English	Article							GENETIC ARCHITECTURE; RISK LOCI; VARIANTS; HOMEOSTASIS; GLUCOSE; TCF7L2; KCNQ1	Aim We performed a replication study in a Japanese population to evaluate the association between type 2 diabetes and six susceptibility loci (TMEM154, SSR1, FAF1, POU5F1, ARL15, and MPHOSPH9) originally identified by a transethnic meta-analysis of genome-wide association studies (GWAS) in 2014. Methods We genotyped 7,620 Japanese participants (5,817 type 2 diabetes patients and 1,803 controls) for each of the single nucleotide polymorphisms (SNPs) using a multiplex polymerase chain reaction invader assay. The association of each SNP locus with the disease was evaluated using logistic regression analysis. Results Of the six SNPs examined in this study, four (rs6813195 near TMEM154, rs17106184 in FAF1, rs3130501 in POU5F1 and rs4275659 near MPHOSPH9) had the same direction of effect as in the original reports, but two (rs9505118 in SSR1 and rs702634 in ARL15) had the opposite direction of effect. Among these loci, rs3130501 and rs4275659 were nominally associated with type 2 diabetes (rs3130501; p = 0.017, odds ratio [OR] = 1.113, 95% confidence interval [CI] 1.019-1.215, rs4275659; p = 0.012, OR = 1.127, 95% CI 1.026-1.238, adjusted for sex, age and body mass index), but we did not observe a significant association with type 2 diabetes for any of the six evaluated SNP loci in our Japanese population. Conclusions Our results indicate that effects of the six SNP loci identified in the transethnic GWAS meta-analysis are not major among the Japanese, although SNPs in POU5F1 and MPHOSPH9 loci may have some effect on susceptibility to type 2 diabetes in this population.	[Matsuba, Ren; Imamura, Minako; Maeda, Shiro] RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan; [Matsuba, Ren; Tanaka, Yasushi] St Marianna Univ, Sch Med, Div Endocrinol & Metab, Dept Internal Med, Kawasaki, Kanagawa, Japan; [Iwata, Minoru; Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Toyama 930, Japan; [Iwata, Minoru] Toyama Univ, Hlth Adm Ctr, Toyama 930, Japan; [Hirose, Hiroshi] Keio Univ, Sch Med, Ctr Hlth, Tokyo, Japan; [Kaku, Kohei] Kawasaki Med Sch, Dept Internal Med, Kurashiki, Okayama, Japan; [Maegawa, Hiroshi; Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Tokyo, Japan; [Watada, Hirotaka; Kawamori, Ryuzo] Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, Japan; [Maeda, Shiro] Univ Ryukyus, Grad Sch Med, Dept Adv Genom & Lab Med, Nishihara, Okinawa 90301, Japan; [Maeda, Shiro] Univ Ryukyus Hosp, Div Clin Lab & Blood Transfus, Nishihara, Okinawa, Japan	RIKEN; Saint Marianna University; University of Toyama; University of Toyama; Keio University; Kawasaki Medical School; Shiga University of Medical Science; Juntendo University; Juntendo University; University of the Ryukyus; University of the Ryukyus	Imamura, M (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan.	minako.imamura@riken.jp	Kashiwagi, Atsunori/H-8712-2019; Hirose, Hiroshi/F-8556-2014	Maegawa, Hiroshi/0000-0002-4611-8149; Watada, Hirotaka/0000-0001-5961-1816; Matsuba, Ren/0000-0001-5041-6344	Novo Nordisk Pharma; Eli Lilly Japan; Sanofi; Dainippon Sumitomo Pharma; Fujifilm; Bayer; Kissei Phamaceutical Co.; Mochida Pharmaceutical Co; MSD; Takeda Pharmaceutical Co; Boehringer Ingelheim; Daiichi Sankyo, Inc; Ono Pharmaceutical Co.; Novartis Pharmaceuticals; Mitsubishi-Tanabe Pharma; AstraZeneca; Kyowa Hokko Kirin Co; Sanwa Kagaku Kenkyusho Co; Kowa Co.; Astellas Pharma Inc.; Pfizer Inc.; Johnson Johnson; Kyowa Hokko Kirin Co.; Bristol-Myers Squibb; Dainippon Sumitomo Pharma.; Teijin Pharma; Mochida Pharmaceutical Co.; Sanwa Kagaku Kenkyusho Co.; Takeda Pharmaceutical Co.; Taisho Toyama Pharmaceutical Co	Novo Nordisk Pharma(Novo Nordisk); Eli Lilly Japan(Eli Lilly); Sanofi; Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Fujifilm; Bayer(Bayer AG); Kissei Phamaceutical Co.(Kissei Pharmaceutical Co LtdInoue Research Award for Young ScientistsMukai Science and Technology Foundation); Mochida Pharmaceutical Co; MSD; Takeda Pharmaceutical Co(Takeda Pharmaceutical Company Ltd); Boehringer Ingelheim(Boehringer Ingelheim); Daiichi Sankyo, Inc(Daiichi Sankyo Company Limited); Ono Pharmaceutical Co.; Novartis Pharmaceuticals(Novartis); Mitsubishi-Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); AstraZeneca(AstraZeneca); Kyowa Hokko Kirin Co; Sanwa Kagaku Kenkyusho Co; Kowa Co.; Astellas Pharma Inc.(Astellas Pharmaceuticals); Pfizer Inc.(Pfizer); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Kyowa Hokko Kirin Co.; Bristol-Myers Squibb(Bristol-Myers Squibb); Dainippon Sumitomo Pharma.(Dainippon Sumitomo Pharma Co., Ltd.); Teijin Pharma; Mochida Pharmaceutical Co.; Sanwa Kagaku Kenkyusho Co.; Takeda Pharmaceutical Co.(Takeda Pharmaceutical Company Ltd); Taisho Toyama Pharmaceutical Co	The authors have read the journal's policy and the authors of this manuscript have the following competing interests. HW is a member of advisory panel of Novo Nordisk Pharma, Sanofi, Dainippon Sumitomo Pharma, Mochida Pharmaceutical Co, MSD, Takeda Pharmaceutical Co, Boehringer Ingelheim, Ono Pharmaceutical Co., Novartis Pharmaceuticals, Mitsubishi-Tanabe Pharma, AstraZeneca, Kowa Co. Astellas Pharma Inc., Pfizer Inc., has received lecture fees from Novo Nordisk Pharma, Eli Lilly Japan, Sanofi, Dainippon Sumitomo Pharma, Fujifilm, Bayer, Kissei Phamaceutical Co., Mochida Pharmaceutical Co, MSD, Takeda Pharmaceutical Co, Boehringer Ingelheim, Daiichi Sankyo, Inc, Ono Pharmaceutical Co. Novartis Pharmaceuticals, Boehringer Ingelheim, Mitsubishi-Tanabe Pharma, AstraZeneca, Kyowa Hokko Kirin Co, Sanwa Kagaku Kenkyusho Co, Kowa Co. Astellas Pharma Inc., Pfizer Inc., and received research funds from Johnson & Johnson, Kyowa Hokko Kirin Co., Kissei Phamaceutical Co., Bristol-Myers Squibb, Novo Nordisk Pharma, Astellas Pharma Inc., MSD, Dainippon Sumitomo Pharma., AstraZeneca, Teijin Pharma, Mochida Pharmaceutical Co., Sanofi, Sanwa Kagaku Kenkyusho Co., Boehringer Ingelheim, Pfizer Inc., Novartis Pharmaceuticals, Ono Pharmaceutical Co., Mitsubishi-Tanabe Pharma, Daiichi Sankyo, Inc, Takeda Pharmaceutical Co., Eli Lilly Japan, Taisho Toyama Pharmaceutical Co. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 2013, DIABETES ATLAS; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fukuda H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046263; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Imamura M, 2011, DIABETOLOGIA, V54, P3071, DOI 10.1007/s00125-011-2293-3; Imamura M, 2013, J DIABETES INVEST, V4, P168, DOI 10.1111/jdi.12017; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Omori S, 2009, DIABETOLOGIA, V52, P1554, DOI 10.1007/s00125-009-1397-5; Sakai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076317; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154093	10.1371/journal.pone.0154093	http://dx.doi.org/10.1371/journal.pone.0154093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115357	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600043
J	Ramanathan, A; Gusarova, V; Stahl, N; Gurnett-Bander, A; Kyratsous, CA				Ramanathan, Aarti; Gusarova, Viktoria; Stahl, Neil; Gurnett-Bander, Anne; Kyratsous, Christos A.			Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; CARDIOVASCULAR RISK PATIENTS; MONOCLONAL-ANTIBODY; LDL CHOLESTEROL; CELL ENTRY; INHIBITOR ALIROCUMAB; HYPERCHOLESTEROLEMIA; EFFICACY; BINDING; SAFETY	Background Proprotein convertase subtilisin/kexin type 9 (PSCK9) is secreted mainly from the liver and binds to the low-density lipoprotein receptor (LDLR), reducing LDLR availability and thus resulting in an increase in LDL-cholesterol. While the LDLR has been implicated in the cell entry process of the hepatitis C virus (HCV), overexpression of an artificial non-secreted, cell membrane-bound form of PCSK9 has also been shown to reduce surface expression of CD81, a major component of the HCV entry complex, leading to concerns that pharmacological inhibition of PCSK9 may increase susceptibility to HCV infection by increasing either CD81 or LDLR availability. Here, we evaluated effects of PCSK9 and PCSK9 blockade on CD81 levels and HCV entry with a physiologically relevant model using native secreted PCSK9 and a monoclonal antibody to PCSK9, alirocumab. Methods and Results Flow cytometry and Western blotting of human hepatocyte Huh-7 cells showed that, although LDLR levels were reduced when cells were exposed to increasing PCSK9 concentrations, there was no correlation between total or surface CD81 levels and the presence and amount of soluble PCSK9. Moreover, inhibiting PCSK9 with the monoclonal antibody alirocumab did not affect expression levels of CD81. In an in vitro model of HCV entry, addition of soluble PCSK9 or treatment with alirocumab had no effect on the ability of either lentiviral particles bearing the HCV glycoproteins or JFH-1 based cell culture virus to enter hepatocytes. Consistent with these in vitro findings, no differences were observed in hepatic CD81 levels using in vivo mouse models, including Pcsk9(-/-) mice compared with wild-type controls and hyperlipidemic mice homozygous for human Pcsk9 and heterozygous for Ldlr deletion, treated with either alirocumab or isotype control antibody. Conclusion These results suggest that inhibition of PCSK9 with alirocumab has no effect on CD81 and does not result in increased susceptibility to HCV entry.	[Ramanathan, Aarti; Gusarova, Viktoria; Stahl, Neil; Gurnett-Bander, Anne; Kyratsous, Christos A.] Regeneron Pharmaceut Inc, Tarrytown, NY USA; [Ramanathan, Aarti] Drexel Coll Med, Dept Microbiol & Immunol, Philadelphia, PA USA	Regeneron; Drexel University	Kyratsous, CA (corresponding author), Regeneron Pharmaceut Inc, Tarrytown, NY USA.	christos.kyratsous@regeneron.com			Sanofi; Regeneron Pharmaceuticals, Inc.; Regeneron Pharmaceuticals Inc.	Sanofi(Sanofi-Aventis); Regeneron Pharmaceuticals, Inc.(Regeneron); Regeneron Pharmaceuticals Inc.(Regeneron)	This study was funded by Sanofi and Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals Inc. provided support in the form of salaries, stock option and/or stock for authors [ AR, VG, NS, AGB, CAK]. The specific roles of these authors are articulated in the "author contributions" section. Sanofi and Regeneron Pharmaceuticals, Inc. funded materials for conduct of the study, and were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch Birke, 2009, V510, P279, DOI 10.1007/978-1-59745-394-3_21; Bays H, 2015, J CLIN ENDOCR METAB, V100, P3140, DOI 10.1210/jc.2015-1520; Cannon CP, 2015, EUR HEART J, V36, P1186, DOI 10.1093/eurheartj/ehv028; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Gusarova V, 2012, CLIN LIPIDOL, V7, P737, DOI 10.2217/CLP.12.70; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Kastelein JJP, 2015, EUR HEART J, V36, P2996, DOI 10.1093/eurheartj/ehv370; Kereiakes DJ, 2015, AM HEART J, V169, P906, DOI 10.1016/j.ahj.2015.03.004; Labonte P, 2009, HEPATOLOGY, V50, P17, DOI 10.1002/hep.22911; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Le QT, 2015, J BIOL CHEM, V290, P23385, DOI 10.1074/jbc.M115.642991; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Milazzo L, 2012, NEW ENGL J MED, V366, P2425, DOI 10.1056/NEJMc1204929; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2012, CURR OPIN VIROL, V2, P14, DOI 10.1016/j.coviro.2011.12.007; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Roth EM, 2014, INT J CARDIOL, V176, P55, DOI 10.1016/j.ijcard.2014.06.049; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Swergold GD, 2012, NEW ENGL J MED, V366, P2426; Vieyres G, 2013, METHODS, V59, P233, DOI 10.1016/j.ymeth.2012.09.005; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	31	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154498	10.1371/journal.pone.0154498	http://dx.doi.org/10.1371/journal.pone.0154498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115873	gold, Green Published			2022-12-27	WOS:000374973600071
J	Shah, B; Lutter, D; Bochenek, ML; Kato, K; Tsytsyura, Y; Glyvuk, N; Sakakibara, A; Klingauf, J; Adams, RH; Puschel, AW				Shah, Bhavin; Lutter, Daniela; Bochenek, Magdalena L.; Kato, Katsuhiro; Tsytsyura, Yaroslav; Glyvuk, Natalia; Sakakibara, Akira; Klingauf, Juergen; Adams, Ralf H.; Pueschel, Andreas W.			C3G/Rapgef1 Is Required in Multipolar Neurons for the Transition to a Bipolar Morphology during Cortical Development	PLOS ONE			English	Article							DEVELOPING CEREBRAL-CORTEX; NUCLEOTIDE EXCHANGE FACTOR; PYRAMIDAL NEURONS; RADIAL GLIA; MIGRATION; REELIN; POLARITY; ACTIVATION; RAP1; NEOCORTEX	The establishment of a polarized morphology is essential for the development and function of neurons. During the development of the mammalian neocortex, neurons arise in the ventricular zone (VZ) from radial glia cells (RGCs) and leave the VZ to generate the cortical plate (CP). During their migration, newborn neurons first assume a multipolar morphology in the subventricular zone (SVZ) and lower intermediate zone (IZ). Subsequently, they undergo a multi-to-bipolar (MTB) transition to become bipolar in the upper IZ by developing a leading process and a trailing axon. The small GTPases Rap1A and Rap1B act as master regulators of neural cell polarity in the developing mouse neocortex. They are required for maintaining the polarity of RGCs and directing the MTB transition of multipolar neurons. Here we show that the Rap1 guanine nucleotide exchange factor (GEF) C3G (encoded by the Rapgef1 gene) is a crucial regulator of the MTB transition in vivo by conditionally inactivating the Rapgef1 gene in the developing mouse cortex at different time points during neuronal development. Inactivation of C3G results in defects in neuronal migration, axon formation and cortical lamination. Live cell imaging shows that C3G is required in cortical neurons for both the specification of an axon and the initiation of radial migration by forming a leading process.	[Shah, Bhavin; Lutter, Daniela; Pueschel, Andreas W.] Univ Munster, Inst Mol Zellbiol, Schlosspl 5, D-48149 Munster, Germany; [Bochenek, Magdalena L.; Kato, Katsuhiro; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Bochenek, Magdalena L.; Kato, Katsuhiro; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Tsytsyura, Yaroslav; Glyvuk, Natalia; Klingauf, Juergen] Inst Med Phys & Biophys, Robert Koch Str 31, D-48149 Munster, Germany; [Shah, Bhavin; Pueschel, Andreas W.] Univ Munster, Cells In Mot Cluster Excellence, D-48149 Munster, Germany; [Sakakibara, Akira] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan; [Bochenek, Magdalena L.] Univ Med Ctr Mainz, Div Cardiol, Ctr Thrombosis & Hemostasis, Mainz, Germany	University of Munster; Max Planck Society; University of Munster; University of Munster; Chubu University; Johannes Gutenberg University of Mainz	Puschel, AW (corresponding author), Univ Munster, Inst Mol Zellbiol, Schlosspl 5, D-48149 Munster, Germany.; Puschel, AW (corresponding author), Univ Munster, Cells In Mot Cluster Excellence, D-48149 Munster, Germany.	apuschel@uni-muenster.de	Kato, Katsuhiro/AAV-8356-2020; Adams, Ralf H/AAE-9274-2019		Deutsche Forschungsgemeinschaft (AWP) [SFB 629 TP A15, EXC 1003-CiM]	Deutsche Forschungsgemeinschaft (AWP)	Support from the Deutsche Forschungsgemeinschaft (AWP: SFB 629 TP A15 and EXC 1003-CiM) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Bilasy SE, 2009, EUR J NEUROSCI, V29, P1994, DOI 10.1111/j.1460-9568.2009.06754.x; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Cooper JA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00386; Del Rio JA, 2000, CEREB CORTEX, V10, P784, DOI 10.1093/cercor/10.8.784; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Gloerich M, 2011, TRENDS CELL BIOL, V21, P615, DOI 10.1016/j.tcb.2011.07.001; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Guo HL, 2000, BIOCHEM BIOPH RES CO, V273, P661, DOI 10.1006/bbrc.2000.2870; Hatanaka Y, 2013, CEREB CORTEX, V23, P105, DOI 10.1093/cercor/bhr383; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Kitazawa A, 2014, J NEUROSCI, V34, P1115, DOI 10.1523/JNEUROSCI.2254-13.2014; Kuo G, 2005, J NEUROSCI, V25, P8578, DOI 10.1523/JNEUROSCI.1656-05.2005; Lakoma J, 2011, DEVELOPMENT, V138, P5223, DOI 10.1242/dev.063776; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Namba T, 2014, NEURON, V81, P814, DOI 10.1016/j.neuron.2013.12.015; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Okamoto M, 2013, NAT NEUROSCI, V16, P1556, DOI 10.1038/nn.3525; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009; Sakakibara A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00116; Sakakibara A, 2014, CEREB CORTEX, V24, P1301, DOI 10.1093/cercor/bhs411; Schmid MT, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00215; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Sekine K, 2012, NEURON, V76, P353, DOI 10.1016/j.neuron.2012.07.020; Shah B, 2017, CEREB CORTEX, V27, P1253, DOI 10.1093/cercor/bhv341; Tabata H, 2003, J NEUROSCI, V23, P9996; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Voss AK, 2003, DEVELOPMENT, V130, P355, DOI 10.1242/dev.00217; Voss AK, 2008, DEVELOPMENT, V135, P2139, DOI 10.1242/dev.016725; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Ye T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5826	46	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154174	10.1371/journal.pone.0154174	http://dx.doi.org/10.1371/journal.pone.0154174			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111087	Green Published, gold			2022-12-27	WOS:000374970600041
J	Annarapu, GK; Singhal, R; Peng, YD; Guchhait, P				Annarapu, Gowtham K.; Singhal, Rashi; Peng, Yuandong; Guchhait, Prasenjit			Inhibition of Hb Binding to GP1b alpha Abrogates Hb-Mediated Thrombus Formation on Immobilized VWF and Collagen under Physiological Shear Stress	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; VON-WILLEBRAND-FACTOR; INTRAVASCULAR HEMOLYSIS; PLATELET ACTIVATION; MECHANISM; ADHESION; DISEASE	Background Reports including our own describe that intravascular hemolysis increases the risk of thrombosis in hemolytic disorders. Our recent study shows that plasma Hb concentrations correlate directly with platelet activation in patients with paroxysmal nocturnal hemoglobinuria (PNH). The binding of Hb to glycoprotein1ba (GP1b alpha) increases platelet activation. A peptide AA1-50, designed from N-terminal amino acid sequence of GP1b alpha significantly inhibits the Hb binding to GP1b alpha as well as Hb-induced platelet activation. This study further examined if the Hb-mediated platelet activation plays any significant role in thrombus formation on subendothelium matrix under physiological flow shear stresses and the inhibition of Hbplatelet interaction can abrogate the above effects of Hb. Methods and Results Study performed thrombus formation assay in vitro by perfusing whole blood over immobilized VWF or collagen type I in presence of Hb under shear stresses simulating arterial or venous flow. The Hb concentrations ranging from 5 to 10 mu M, commonly observed level in plasma of the hemolytic patients including PNH, dose-dependently increased thrombus formation on immobilized VWF under higher shear stress of 25 dyne/cm(2), but not at 5 dyne/cm(2). The above Hb concentrations also increased thrombus formation on immobilized collagen under both shear stresses of 5 and 25 dyne/cm(2). The peptide AA1-50 abrogated invariably the above effects of Hb on thrombus formation. Conclusions and Significance This study therefore indicates that the Hb-induced platelet activation plays a crucial role in thrombus formation on immobilized VWF or collagen under physiological flow shear stresses. Thus suggesting a probable role of this mechanism in facilitating thrombosis under hemolytic conditions.	[Annarapu, Gowtham K.; Singhal, Rashi; Guchhait, Prasenjit] Natl Capital Reg Biotech Sci Cluster, Reg Ctr Biotechnol, Dis Biol Lab, Faridabad, India; [Annarapu, Gowtham K.; Singhal, Rashi] Manipal Univ, Dept Biotechnol, Manipal, Karnataka, India; [Peng, Yuandong] Baylor Coll Med, Dept Med, Cardiovasc Res Sect, Houston, TX 77030 USA	Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Manipal Academy of Higher Education (MAHE); Baylor College of Medicine	Guchhait, P (corresponding author), Natl Capital Reg Biotech Sci Cluster, Reg Ctr Biotechnol, Dis Biol Lab, Faridabad, India.	prasenjit@rcb.res.in	Annarapu, Gowtham K/N-5829-2017	Annarapu, Gowtham K/0000-0002-6761-0976	Department of Biotechnology, Govt. of India [BTPR8501, BTPR9389]; American Heart Association [SDG 0635155N]; National Institute of Health USA [HL095676]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095676] Funding Source: NIH RePORTER	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); American Heart Association(American Heart Association); National Institute of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was financially supported by grants (BTPR8501 and BTPR9389) from the Department of Biotechnology, Govt. of India to PG, and grants from the American Heart Association (SDG 0635155N) and the National Institute of Health USA (HL095676) to YP.	ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Audebert HJ, 2005, J NEUROL, V252, P1379, DOI 10.1007/s00415-005-0871-3; Cappellini Maria Domenica, 2007, Hematology Am Soc Hematol Educ Program, P74; DIXON RH, 1977, J CLIN INVEST, V59, P360, DOI 10.1172/JCI108648; Fu XY, 2011, BLOOD, V118, P5283, DOI 10.1182/blood-2011-01-331074; GRALNICK HR, 1995, BRIT J HAEMATOL, V91, P697, DOI 10.1111/j.1365-2141.1995.tb05371.x; Helms CC, 2013, J THROMB HAEMOST, V11, P2148, DOI 10.1111/jth.12422; Hill A, 2013, BLOOD, V121, P4985, DOI 10.1182/blood-2012-09-311381; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Poulou LS, 2008, THROMB HAEMOSTASIS, V99, P642, DOI 10.1160/TH07-11-0664; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Singhal R, 2015, HAEMATOLOGICA, V100, P1526, DOI 10.3324/haematol.2015.132183; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhou Z, 2009, THROMB HAEMOSTASIS, V101, P1070, DOI 10.1160/TH08-10-0677; Ziakas PD, 2007, J THROMB HAEMOST, V5, P642, DOI 10.1111/j.1538-7836.2007.02379.x	17	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154276	10.1371/journal.pone.0154276	http://dx.doi.org/10.1371/journal.pone.0154276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27105433	Green Submitted, Green Published, gold			2022-12-27	WOS:000374565100064
J	Xu, Y; Ding, J; Wu, LY				Xu, Yan; Ding, Jun; Wu, Ling-Yun			iSulf-Cys: Prediction of S-sulfenylation Sites in Proteins with Physicochemical Properties of Amino Acids	PLOS ONE			English	Article							IDENTIFICATION; LOGO; TOOL	Cysteine S-sulfenylation is an important post-translational modification (PTM) in proteins, and provides redox regulation of protein functions. Bioinformatics and structural analyses indicated that S-sulfenylation could impact many biological and functional categories and had distinct structural features. However, major limitations for identifying cysteine S-sulfenylation were expensive and low-throughout. In view of this situation, the establishment of a useful computational method and the development of an efficient predictor are highly desired. In this study, a predictor iSulf-Cys which incorporated 14 kinds of physicochemical properties of amino acids was proposed. With the 10-fold cross-validation, the value of area under the curve (AUC) was 0.7155 +/- 0.0085, MCC 0.3122 +/- 0.0144 on the training dataset for 20 times. iSulf-Cys also showed satisfying performance in the independent testing dataset with AUC 0.7343 and MCC 0.3315. Features which were constructed from physicochemical properties and position were carefully analyzed. Meanwhile, a user-friendly webserver for iSulf-Cys is accessible at http://app.aporc.org/iSulf-Cys/.	[Xu, Yan; Ding, Jun] Univ Sci & Technol Beijing, Dept Informat & Comp Sci, Beijing 100083, Peoples R China; [Wu, Ling-Yun] Chinese Acad Sci, Inst Appl Math, Acad Math & Syst Sci, Beijing 100190, Peoples R China	University of Science & Technology Beijing; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Xu, Y (corresponding author), Univ Sci & Technol Beijing, Dept Informat & Comp Sci, Beijing 100083, Peoples R China.	xuyan@ustb.edu.cn		Xu, Yan/0000-0001-9462-580X	Natural Science Foundation of China [11301024, 31171263, 81272578, J1103514]; Fundamental Research Funds for the Central Universities [FRF-BR-15-075A]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the Natural Science Foundation of China (11301024, 31171263, 81272578, and J1103514) and the Fundamental Research Funds for the Central Universities (No. FRF-BR-15-075A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Hayat M, 2012, J THEOR BIOL, V292, P93, DOI 10.1016/j.jtbi.2011.09.026; Jahandideh S, 2012, J THEOR BIOL, V312, P65, DOI 10.1016/j.jtbi.2012.07.013; Japkowicz N, 2000, IC-AI'2000: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOL 1-III, P111; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Li FY, 2015, BIOINFORMATICS, V31, P1411, DOI 10.1093/bioinformatics/btu852; Li SL, 2009, PROTEIN PEPTIDE LETT, V16, P977, DOI 10.2174/092986609788923338; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Liu XY, 2006, IEEE DATA MINING, P970; Nanni L, 2012, AMINO ACIDS, V43, P657, DOI 10.1007/s00726-011-1114-9; Pan ZC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07331; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Simon GM, 2013, NAT CHEM BIOL, V9, P200, DOI 10.1038/nchembio.1211; Szychowski J, 2010, J AM CHEM SOC, V132, P18351, DOI 10.1021/ja1083909; Tang YR, 2007, PROTEIN ENG DES SEL, V20, P405, DOI 10.1093/protein/gzm035; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Bui VM, 2016, BIOINFORMATICS, V32, P165, DOI 10.1093/bioinformatics/btv558; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Xu HD, 2015, BIOINFORMATICS, V31, P3748, DOI 10.1093/bioinformatics/btv439; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5776; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383; Zhao XW, 2015, J THEOR BIOL, V374, P60, DOI 10.1016/j.jtbi.2015.03.029; Zhao XW, 2015, MOL BIOSYST, V11, P923, DOI 10.1039/c4mb00680a; Zhao XW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/109549; Zheng LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028221	30	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154237	10.1371/journal.pone.0154237	http://dx.doi.org/10.1371/journal.pone.0154237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104833	gold, Green Published, Green Submitted			2022-12-27	WOS:000374565100059
J	Froyen, G; Broekmans, A; Hillen, F; Pat, K; Achten, R; Mebis, J; Rummens, JL; Willemse, J; Maes, B				Froyen, Guy; Broekmans, An; Hillen, Femke; Pat, Karin; Achten, Ruth; Mebis, Jeroen; Rummens, Jean-Luc; Willemse, Johan; Maes, Brigitte			Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors	PLOS ONE			English	Article							CELL LUNG-CARCINOMA; LABORATORY STANDARDS; CANCER GENOMICS; CLINICAL-TRIALS; ONCOLOGY; VARIANTS; MEDICINE; PCR	The inevitable switch from standard molecular methods to next-generation sequencing for the molecular profiling of tumors is challenging for most diagnostic laboratories. However, fixed validation criteria for diagnostic accreditation are not in place because of the great variability in methods and aims. Here, we describe the validation of a custom panel of hotspots in 24 genes for the detection of somatic mutations in non-small cell lung carcinoma, colorectal carcinoma and malignant melanoma starting from FFPE sections, using 14, 36 and 5 cases, respectively. The targeted hotspots were selected for their present or future clinical relevance in solid tumor types. The target regions were enriched with the TruSeq approach starting from limited amounts of DNA. Cost effective sequencing of 12 pooled libraries was done using a micro flow cell on the MiSeq and subsequent data analysis with MiSeqReporter and VariantStudio. The entire workflow was diagnostically validated showing a robust performance with maximal sensitivity and specificity using as thresholds a variant allele frequency >5% and a minimal amplicon coverage of 300. We implemented this method through the analysis of 150 routine diagnostic samples and identified clinically relevant mutations in 16 genes including KRAS (32%), TP53 (32%), BRAF (12%), APC (11%), EGFR (8%) and NRAS (5%). Importantly, the highest success rate was obtained when using also the low quality DNA samples. In conclusion, we provide a workflow for the validation of targeted NGS by a custom-designed pan-solid tumor panel in a molecular diagnostic lab and demonstrate its robustness in a clinical setting.	[Froyen, Guy; Broekmans, An; Hillen, Femke; Rummens, Jean-Luc; Willemse, Johan; Maes, Brigitte] Jessa Hosp, Dept Biol Clin, Hasselt, Belgium; [Pat, Karin] Jessa Hosp, Dept Pneumol, Hasselt, Belgium; [Achten, Ruth] Jessa Hosp, Dept Pathol, Hasselt, Belgium; [Mebis, Jeroen] Jessa Hosp, Dept Med Oncol, Hasselt, Belgium; [Willemse, Johan] AZ Turnhout, Dept Biol Clin, Turnhout, Belgium		Froyen, G (corresponding author), Jessa Hosp, Dept Biol Clin, Hasselt, Belgium.	guy.froyen@jessazh.be	Maes, Brigitte/AFP-8088-2022					Ananda G, 2015, EXP MOL PATHOL, V98, P106, DOI 10.1016/j.yexmp.2014.12.009; Aziz N, 2015, ARCH PATHOL LAB MED, V139, P481, DOI 10.5858/arpa.2014-0250-CP; Bai J, 2015, J HUM GENET, V60, P589, DOI 10.1038/jhg.2015.71; Bennett NC, 2014, CANCERS, V6, P2296, DOI 10.3390/cancers6042296; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; Cuomo AM, 2015, NEW YORK STATE DEP H; Damodaran S., 2015, AM SOC CLIN ONCOL ED, V35, pe175; Damodaran S, 2015, J MOL DIAGN, V17, P554, DOI 10.1016/j.jmoldx.2015.05.002; Dienstmann R, 2014, MOL ONCOL, V8, P859, DOI 10.1016/j.molonc.2014.03.021; Erdmann J, 2015, NAT MED, V21, P655, DOI 10.1038/nm0715-655; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gagan J, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0203-x; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Hagemann IS, 2015, CANCER-AM CANCER SOC, V121, P631, DOI 10.1002/cncr.29089; Han SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064271; Johnson DB, 2014, ONCOLOGIST, V19, P616, DOI 10.1634/theoncologist.2014-0011; Lee LA, 2015, J MOL DIAGN, V17, P339, DOI 10.1016/j.jmoldx.2015.03.003; Luthra R, 2015, CANCERS, V7, P2023, DOI 10.3390/cancers7040874; Mendelsohn J, 2013, J CLIN ONCOL, V31, P1904, DOI 10.1200/JCO.2012.45.3605; Pant S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00078; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Ross JS, 2015, JAMA ONCOL, V1, P40, DOI 10.1001/jamaoncol.2014.216; Scarpa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080478; Sie D, 2014, CELL ONCOL, V37, P353, DOI 10.1007/s13402-014-0196-2; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Siroy AE, 2015, J INVEST DERMATOL, V135, P508, DOI 10.1038/jid.2014.366; Thomas A, 2013, ANN ONCOL, V24, P577, DOI 10.1093/annonc/mds478; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Tuononen K, 2013, GENE CHROMOSOME CANC, V52, P503, DOI 10.1002/gcc.22047; Wang M, 2015, J MOL DIAGN, V17, P521, DOI 10.1016/j.jmoldx.2015.04.008; Wong SQ, 2015, BRIT J CANCER, V112, P1411, DOI 10.1038/bjc.2015.80; Zhang LX, 2014, ONCOLOGIST, V19, P336, DOI 10.1634/theoncologist.2013-0180; Zutter MM, 2015, ARCH PATHOL LAB MED, V139, P989, DOI 10.5858/arpa.2014-0330-CP	35	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154038	10.1371/journal.pone.0154038	http://dx.doi.org/10.1371/journal.pone.0154038			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101000	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500129
J	Kumwenda, M; Desmond, N; Hart, G; Choko, A; Chipungu, GA; Nyirenda, D; Shand, T; Corbett, EL; Chikovore, J				Kumwenda, Moses; Desmond, Nicola; Hart, Graham; Choko, Augustine; Chipungu, Geoffrey A.; Nyirenda, Deborah; Shand, Tim; Corbett, Elizabeth L.; Chikovore, Jeremiah			Treatment-Seeking for Tuberculosis-Suggestive Symptoms: A Reflection on the Role of Human Agency in the Context of Universal Health Coverage in Malawi	PLOS ONE			English	Article							CARE-SEEKING; CHRONIC COUGH; PULMONARY TUBERCULOSIS; URBAN ZAMBIA; DIAGNOSIS; SERVICES; GENDER; HIV; BARRIERS; BEHAVIOR	Tuberculosis (TB) is highly infectious and one of the leading killers globally. Several studies from sub-Saharan Africa highlight health systems challenges that affect ability to cope with existing disease burden, including TB, although most of these employ survey-type approaches. Consequently, few address community or patient perspectives and experiences. At the same time, understanding of the mechanisms by which the health systems challenges translate into seeking or avoidance of formal health care remains limited. This paper applies the notion of human agency to examine the ways people who have symptoms suggestive of TB respond to and deal with the symptoms vis-a-vis major challenges inherent within health delivery systems. Empirical data were drawn from a qualitative study exploring the ways in which notions of masculinity affect engagement with care, including men's well-documented tendency to delay in seeking care for TB symptoms. The study was carried out in three high-density locales of urban Blantyre, Malawi. Data were collected in March 2011 -March 2012 using focus group discussions, of which eight (mixed sex = two; female only = three; male only = three) were with 74 ordinary community members, and two (both mixed sex) were with 20 health workers; and in-depth interviews with 20 TB patients (female = 14) and 20 un-investigated chronic coughers (female = eight). The research process employed a modified version of grounded theory. Data were coded using a coding scheme that was initially generated from the study aims and subsequently progressively amended to incorporate concepts emerging during the analysis. Coded data were retrieved, re-read, and broken down and reconnected iteratively to generate themes. A myriad of problems were described for health systems at the primary health care level, centring largely on shortages of resources (human, equipment, and drugs) and unprofessional conduct by health care providers. Participants consistently pointed out how the problems could drive patients from promptly reporting symptoms at primary healthcare centres. The accounts suggest that in responding to illness symptoms including those suggestive of TB, patients navigate their options taking into cognisance past and current experiences with formal health systems. Understanding and factoring in the mediating role of such 'agency' is critical when implementing efforts to promote timely response to TB-suggestive symptoms.	[Kumwenda, Moses; Desmond, Nicola; Choko, Augustine; Corbett, Elizabeth L.] Malawi Liverpool Wellcome Res Programme, Blantyre, Malawi; [Kumwenda, Moses; Chipungu, Geoffrey A.] Coll Med, Helse Nord TB Initiat, Blantyre, Malawi; [Desmond, Nicola; Nyirenda, Deborah] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Hart, Graham] UCL, Sch Life & Med Sci, London, England; [Choko, Augustine; Corbett, Elizabeth L.] London Sch Hyg & Trop Med, London WC1, England; [Nyirenda, Deborah] Coll Med, Sch Publ Hlth & Family Med, Blantyre, Malawi; [Shand, Tim] UCL, Inst Global Hlth, London, England; [Shand, Tim] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Chikovore, Jeremiah] Human Sci Res Council, HIV AIDS Sexually Transmitted Infect & TB, Durban, South Africa	University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Malawi; University of London; University College London; University of Cape Town; Human Sciences Research Council-South Africa	Chikovore, J (corresponding author), Human Sci Res Council, HIV AIDS Sexually Transmitted Infect & TB, Durban, South Africa.	jchikovore@hsrc.ac.za	Desmond, Nicola/ABA-6504-2020; Desmond, Nicola/GYQ-8574-2022	Desmond, Nicola/0000-0002-2874-8569; Kumwenda, Moses Kelly/0000-0003-3091-7330; Nyirenda, Deborah/0000-0002-5867-4687; Corbett, Elizabeth/0000-0002-3552-3181; Chikovore, Jeremiah/0000-0002-4910-6952	Wellcome Trust; Helse-Noord Initiative grant; National Institute for Health Research [NF-SI-0611-10255] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Helse-Noord Initiative grant; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was mainly supported via a Wellcome Trust Training Fellowship award to Jeremiah Chikovore, with additional support coming from a Wellcome Trust Senior Research Fellowship award to Professor Liz Corbett, and a Helse-Noord Initiative grant to Moses Kumwenda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayisi JG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-515; Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Baltussen RMPM, 2002, HEALTH POLICY PLANN, V17, P42, DOI 10.1093/heapol/17.1.42; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Bedell RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039347; Beyers N, 2003, PREVALENCE TUBERCULO; Boon H, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-15; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Cambanis A, 2005, TROP MED INT HEALTH, V10, P330, DOI 10.1111/j.1365-3156.2005.01393.x; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Chikovore J, 2015, GLOBAL HLTH ACTION, V8; Chikovore J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1053; Corbett E, 2012, INTENSIFIED HIV TB P, V10; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Crampin AC, 2009, INT J TUBERC LUNG D, V13, P153; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Dimitrova B, 2006, HEALTH POLICY PLANN, V21, P265, DOI 10.1093/heapol/czl014; Eastwood SV, 2004, INT J TUBERC LUNG D, V8, P70; Emirbayer M, 1998, AM J SOCIOL, V103, P962, DOI 10.1086/231294; Emslie C, 2006, SOC SCI MED, V62, P2246, DOI 10.1016/j.socscimed.2005.10.017; Godfrey-Faussett R, 2002, INT J TUBERC LUNG D, V6, P796; Houben RMGJ, 2009, T ROY SOC TROP MED H, V103, P1187, DOI 10.1016/j.trstmh.2009.03.013; Hu A, 2012, HEALTH CARE WOMEN IN, V33, P29, DOI 10.1080/07399332.2011.630495; Jonsen K, 2009, QUAL RES ORGAN MANAG, V4, P123, DOI 10.1108/17465640910978391; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Kumwenda M, 2011, INT J TUBERC LUNG D, V15, P1663, DOI 10.5588/ijtld.10.0741; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Long Q, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-202; MacPherson P, 2013, AM J EPIDEMIOL, V177, P1143, DOI 10.1093/aje/kws376; Malcher G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7054; Mavhu W, 2010, TROP MED INT HEALTH, V15, P574, DOI 10.1111/j.1365-3156.2010.02493.x; Moynihan C, 1998, BRIT MED J, V317, P1072; Needham DM, 1998, INT J TUBERC LUNG D, V2, P811; Needham DM, 2001, TROP MED INT HEALTH, V6, P256, DOI 10.1046/j.1365-3156.2001.00709.x; Nliwasa M, 2016, INT J TUBERC LUNG D, V20, P202, DOI 10.5588/ijtld.15.0388; Phetlhu DR., 2011, J SOC SCI, V29, P23; Priest Helena, 2002, Nurse Res, V10, P30; Ridde V, 2011, HEALTH POLICY PLANN, V26, P1, DOI 10.1093/heapol/czq021; Salaniponi FML, 2000, INT J TUBERC LUNG D, V4, P327; Sandelowski M, 2000, RES NURS HEALTH, V23, P246, DOI 10.1002/1098-240X(200006)23:3<246::AID-NUR9>3.0.CO;2-H; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Simwaka Bertha Nhlema, 2007, Int J Equity Health, V6, P24, DOI 10.1186/1475-9276-6-24; Siu GE, 2013, SOC SCI MED, V89, P45, DOI 10.1016/j.socscimed.2013.04.025; Steen TW, 1998, INT J TUBERC LUNG D, V2, P627; Thorson A, 2001, Curr Opin Pulm Med, V7, P165, DOI 10.1097/00063198-200105000-00009; White A., 2003, REPORT STATE MENS HL; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2015, GLOB TUB REP 2015; Yamasaki-Nakagawa M, 2001, INT J TUBERC LUNG D, V5, P24; Zhang TH, 2007, HEALTH POLICY, V81, P155, DOI 10.1016/j.healthpol.2005.12.009	53	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154103	10.1371/journal.pone.0154103	http://dx.doi.org/10.1371/journal.pone.0154103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27101407	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500144
J	McFadden-Hiller, JE; Beyer, DE; Belant, JL				McFadden-Hiller, Jamie E.; Beyer, Dean E., Jr.; Belant, Jerrold L.			Spatial Distribution of Black Bear Incident Reports in Michigan	PLOS ONE			English	Article							CARNIVORE CONSERVATION; CONFLICTS; SELECTION; BEHAVIOR; ROADS; MANAGEMENT; PATTERNS; PROGRAMS; SPACE	Interactions between humans and carnivores have existed for centuries due to competition for food and space. American black bears are increasing in abundance and populations are expanding geographically in many portions of its range, including areas that are also increasing in human density, often resulting in associated increases in human-bear conflict (hereafter, bear incidents). We used public reports of bear incidents in Michigan, USA, from 2003-2011 to assess the relative contributions of ecological and anthropogenic variables in explaining the spatial distribution of bear incidents and estimated the potential risk of bear incidents. We used weighted Normalized Difference Vegetation Index mean as an index of primary productivity, region (i.e., Upper Peninsula or Lower Peninsula), primary and secondary road densities, and percentage land cover type within 6.5-km(2) circular buffers around bear incidents and random points. We developed 22 a priori models and used generalized linear models and Akaike's Information Criterion (AIC) to rank models. The global model was the best compromise between model complexity and model fit (w = 0.99), with a Delta AIC 8.99 units from the second best performing model. We found that as deciduous forest cover increased, the probability of bear incident occurrence increased. Among the measured anthropogenic variables, cultivated crops and primary roads were the most important in our AIC-best model and were both positively related to the probability of bear incident occurrence. The spatial distribution of relative bear incident risk varied markedly throughout Michigan. Forest cover fragmented with agriculture and other anthropogenic activities presents an environment that likely facilitates bear incidents. Our map can help wildlife managers identify areas of bear incident occurrence, which in turn can be used to help develop strategies aimed at reducing incidents. Researchers and wildlife managers can use similar mapping techniques to assess locations of specific conflict types or to address human impacts on endangered species.	[McFadden-Hiller, Jamie E.; Belant, Jerrold L.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Starkville, MS USA; [Beyer, Dean E., Jr.] Michigan Dept Nat Resources, Wildlife Div, Marquette, MI USA	Mississippi State University	McFadden-Hiller, JE; Belant, JL (corresponding author), Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Starkville, MS USA.	jem739@msstate.edu; j.belant@msstate.edu	Belant, Jerrold/HDM-7749-2022		Mississippi State University; Michigan Department of Natural Resources	Mississippi State University; Michigan Department of Natural Resources	This study was supported by Mississippi State University and Michigan Department of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DA, 1995, 178 GTRNC US FOR SER; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baruch-Mordo S, 2008, J WILDLIFE MANAGE, V72, P1853, DOI 10.2193/2007-442; Baruch-Mordo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085122; Beckmann Jon P., 2008, Human-Wildlife Conflicts, V2, P168; Beckmann JP, 2004, WILDLIFE SOC B, V32, P1141, DOI 10.2193/0091-7648(2004)032[1141:EODTAD]2.0.CO;2; Belant JL, 2011, URSUS, V22, P9, DOI 10.2192/URSUS-D-10-00011.1; BELANT JL, 2011, HUM WILDLIFE CONFLIC, V0001, P00001; Beyer H. L, 2012, GEOSPATIAL MODELLING; Boitani L, 2000, 113 COUNC EUR; Bojarska K, 2012, MAMMAL REV, V42, P120, DOI 10.1111/j.1365-2907.2011.00192.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carter N., 2007, THESIS U MICHIGAN; Carter NH, 2010, URSUS, V21, P57, DOI 10.2192/09GR011.1; City and County of Denver Technology Service/G.I.S. Data, 2011, CENS BLOCKS 2010 VEC; Conover M., 2002, RESOLVING HUMAN WILD; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Ditmer MA, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00199.1; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Dreher BP, 2007, J WILDLIFE MANAGE, V71, P2684, DOI 10.2193/2006-398; Elfstrom M, 2014, MAMMAL REV, V44, P5, DOI 10.1111/j.1365-2907.2012.00223.x; Ellis RD, 2012, LANDSCAPE ECOL, V27, P1, DOI 10.1007/s10980-011-9671-6; Environmental Systems Research Institute Inc., 2014, ARCGIS VERS 10 2; Etter DR, 2003, 17 E BLACK BEAR WORK, P41; Etter DR, 2002, W127R20 MICH DEP NAT; Evans MJ, 2014, J WILDLIFE MANAGE, V78, P1477, DOI 10.1002/jwmg.796; Fecske DM, 2002, SOUTHEAST NAT, V1, P77, DOI 10.1656/1528-7092(2002)001[0077:HUBFBB]2.0.CO;2; FHWA, 2013, HIGHW FUNCT CLASS CO; Gompper ME, 2015, SCIENCE, V347, P381, DOI 10.1126/science.347.6220.382-b; Gore ML, 2006, WILDLIFE SOC B, V34, P36, DOI 10.2193/0091-7648(2006)34[36:SPORAW]2.0.CO;2; Gore ML, 2006, URSUS, V17, P75, DOI 10.2192/1537-6176(2006)17[75:EPFRAB]2.0.CO;2; Gray RM, 2004, URSUS, V15, P188, DOI 10.2192/1537-6176(2004)015<0188:FWABBI>2.0.CO;2; HELLGREN E.C., 1992, E WORKSH P BLACK BEA, V11, P154; Herrero S, 1972, ASPECTS EVOLUTION AD, P221; Hexagon Geospatial, 2012, ERDAS IM 2013; Hijmans RJ., 2015, PACKAGE RASTER R PAC; Hiller TL, 2015, J ZOOL, V296, P200, DOI 10.1111/jzo.12234; Hiller TL, 2015, URSUS, V26, P116, DOI 10.2192/URSUS-D-15-00023.1; Hopkins JB, 2010, URSUS, V21, P154, DOI 10.2192/URSUS-D-10-00005.1; Hostetler JA, 2009, BIOL CONSERV, V142, P2456, DOI 10.1016/j.biocon.2009.05.029; Jones Mark D., 2003, Ursus (Knoxville), V14, P188; Kellert SR, 1996, CONSERV BIOL, V10, P977, DOI 10.1046/j.1523-1739.1996.10040977.x; Kerley LL, 2002, CONSERV BIOL, V16, P97, DOI 10.1046/j.1523-1739.2002.99290.x; Kretser HE, 2008, LANDSCAPE URBAN PLAN, V84, P282, DOI 10.1016/j.landurbplan.2007.08.007; Leigh Jennifer, 2008, Human-Wildlife Conflicts, V2, P175; Lemelin RH, 2008, MARINE WILDLIFE AND TOURISM MANAGEMENT: INSIGHTS FROM THE NATURAL AND SOCIAL SCIENCES, P91, DOI 10.1079/9781845933456.0091; Manly BFJ., 2002, RESOURCE SELECTION A, P83; Manville A.M, 1983, INT C BEAR RES MANAG, V5, P20; McKinley BK, 2014, HUM-WILDL INTERACT, V8, P228; Merkle JA, 2013, J MAMMAL, V94, P378, DOI 10.1644/12-MAMM-A-002.1; Merkle JA, 2011, J WILDLIFE MANAGE, V75, P1121, DOI 10.1002/jwmg.153; Michigan Department of Natural Resources, 2001, MICH UPP PEN GAP AN; Michigan Department of Natural Resources, 2001, MICH LOW PEN GAP LAN; Michigan Department of Natural Resources, 1992, MIRIS BAS DAT LAND M; Michigan Department of Technology Management and Budget, 2002, MICH GEOGR FRAM STAT; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Pelton M. R., 2003, BLACK BEAR URSUS AM, P547; Peyton RB, 2001, ASSESSMENT SOCIAL CA; Public Sector Consultants, 2001, MICH LAND RES PROJ; Reynolds-Hogland MJ, 2007, J MAMMAL, V88, P1050, DOI 10.1644/06-MAMM-A-072R1.1; Riitters KH, 2003, FRONT ECOL ENVIRON, V1, P125, DOI 10.1890/1540-9295(2003)001[0125:HFTTNR]2.0.CO;2; Shepherd B, 2006, ECOL SOC, V11; Sheskin D. J., 2007, HDB PARAMETRIC NONPA; Stillfried M, 2015, BEHAV PROCESS, V120, P30, DOI 10.1016/j.beproc.2015.08.003; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Tyre AJ, 2000, AUSTRAL ECOL, V25, P327, DOI 10.1111/j.1442-9993.2000.tb00037.x; U.S. Geological Survey, 2011, NAT LAND COV DAT 200; U.S. Geological Survey Earth Resources Observation and Science Center, 2016, EARTHEXPLORER VEG MO; Vaughan MR, 1990, T INT UNION GAME BIO, V19, P581; Wagner KK, 1997, WILDLIFE SOC B, V25, P312; Waller BW, 2014, MAMM STUDY, V39, P115, DOI 10.3106/041.039.0207; Waller JS, 2005, J WILDLIFE MANAGE, V69, P985, DOI 10.2193/0022-541X(2005)069[0985:EOTIOG]2.0.CO;2; Wildlife Division, 2009, 3497 WILDL DIV MICH; Wilton CM, 2014, URSUS, V25, P53, DOI 10.2192/URSUS-D-13-00017.1; Wolgast L. J., 2005, COMPREHENSIVE BLACK; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Woodroffe R., 2005, CONSERV BIOL; [No title captured]	81	8	8	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154474	10.1371/journal.pone.0154474	http://dx.doi.org/10.1371/journal.pone.0154474			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119344	Green Published, Green Submitted, gold			2022-12-27	WOS:000374976200081
J	Allen, DJ; Trainor, E; Callaghan, A; O'Brien, SJ; Cunliffe, NA; Iturriza-Gomara, M				Allen, David J.; Trainor, Eamonn; Callaghan, Anna; O'Brien, Sarah J.; Cunliffe, Nigel A.; Iturriza-Gomara, Miren			Early Detection of Epidemic GII-4 Norovirus Strains in UK and Malawi: Role of Surveillance of Sporadic Acute Gastroenteritis in Anticipating Global Epidemics	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; NATIONAL SURVEILLANCE; GENERAL-PRACTICE; UNITED-KINGDOM; COMMUNITY; CHILDREN; OUTBREAKS; ENGLAND; TRANSMISSION; NOMENCLATURE	Noroviruses are endemic in the human population, and are recognised as a leading cause of acute gastroenteritis worldwide. Although they are a highly diverse group of viruses, genogroup-II genotype-4 (GII-4) noroviruses are the most frequently identified strains worldwide. The predominance of GII-4 norovirus strains is driven by the periodic emergence of antigenic variants capable of evading herd protection. The global molecular epidemiology of emerging GII-4 strains is largely based on data from outbreak surveillance programmes, but the epidemiology of GII-4 strains among sporadic or community cases is far less well studied. To understand the distribution of GII-4 norovirus strains associated with gastroenteritis in the wider population, we characterised the GII-4 norovirus strains detected during studies of sporadic cases of infectious gastroenteritis collected in the UK and Malawi between 1993 and 2009. Our data shows that GII-4 norovirus strains that have emerged as strains of global epidemic importance have circulated in the community up to 18 years before their recognition as pandemic strains associated with increases in outbreaks. These data may suggest that more comprehensive surveillance programmes that incorporate strains associated with sporadic cases may provide a way for early detection of emerging strains with pandemic potential. This may be of particular relevance as vaccines become available.	[Allen, David J.; Callaghan, Anna] Publ Hlth England, Virus Reference Dept, London, England; [Trainor, Eamonn; Cunliffe, Nigel A.; Iturriza-Gomara, Miren] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Callaghan, Anna] London Sch Hyg & Trop Med, Pathogen Mol Biol Unit, London WC1, England; [O'Brien, Sarah J.] Univ Liverpool, Dept Epidemiol & Publ Hlth, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Allen, David J.; O'Brien, Sarah J.; Iturriza-Gomara, Miren] Univ Liverpool, NIHR Hlth Protect Res Unit Gastrointestinal Infec, Liverpool L69 3BX, Merseyside, England; [Trainor, Eamonn] St Helens & Knowsley Teaching Hosp NHS Trust, Liverpool, Merseyside, England	Public Health England; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; University of Liverpool; University of Liverpool	Iturriza-Gomara, M (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England.; Iturriza-Gomara, M (corresponding author), Univ Liverpool, NIHR Hlth Protect Res Unit Gastrointestinal Infec, Liverpool L69 3BX, Merseyside, England.	M.Iturriza-Gomara@liverpool.ac.uk	Gomara, Miren Iturriza/B-4351-2013	Gomara, Miren Iturriza/0000-0001-5816-6423; O'Brien, Sarah Jane/0000-0003-2896-8999; Callaghan, Anna/0000-0003-1160-2376; Allen, David/0000-0002-1194-0415	Wellcome Trust; National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections at the University of Liverpool	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections at the University of Liverpool	MIG receives support from The Wellcome Trust and the National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections at the University of Liverpool. DJA receives support from the National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections at the University of Liverpool.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Alfano-Sobsey E, 2012, EPIDEMIOL INFECT, V140, P276, DOI 10.1017/S0950268811000665; Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Allen DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088978; Amar CFL, 2007, EUR J CLIN MICROBIOL, V26, P311, DOI 10.1007/s10096-007-0290-8; Cunliffe NA, 2010, J INFECT DIS, V202, pS168, DOI 10.1086/653577; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Iturriza-Gomara M, 2009, EPIDEMIOL INFECT, V137, P922, DOI 10.1017/S0950268808001556; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001807; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Lopman BA, 2003, EMERG INFECT DIS, V9, P71; Malek Mark, 2009, Clin Infect Dis, V48, P31, DOI 10.1086/594118; Morter S, 2011, J HOSP INFECT, V77, P106, DOI 10.1016/j.jhin.2010.09.035; O'Brien SJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-39; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Shioda K, 2015, VACCINE, V33, P4065, DOI 10.1016/j.vaccine.2015.05.051; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Trainor E, 2013, J MED VIROL, V85, P1299, DOI 10.1002/jmv.23589; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; Xerry J, 2008, J CLIN MICROBIOL, V46, P947, DOI 10.1128/JCM.02240-07; Zakikhany K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041625; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	31	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0146972	10.1371/journal.pone.0146972	http://dx.doi.org/10.1371/journal.pone.0146972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115152	Green Published, gold, Green Accepted			2022-12-27	WOS:000374973600006
J	Brown, KW; Goodman, RJ; Ryan, RM; Analayo, B				Brown, Kirk Warren; Goodman, Robert J.; Ryan, Richard M.; Analayo, Bhikkhu			Mindfulness Enhances Episodic Memory Performance: Evidence from a Multimethod Investigation	PLOS ONE			English	Article							ATTENTIONAL CONTROL; RECOLLECTIVE EXPERIENCE; RECOGNITION MEMORY; ANTERIOR CINGULATE; DECISION-PROCESSES; MEDITATION; RESPONSES; BENEFITS; HIPPOCAMPUS; DISTRACTION	Training in mindfulness, classically described as a receptive attentiveness to present events and experiences, has been shown to improve attention and working memory. Both are key to long-term memory formation, and the present three-study series used multiple methods to examine whether mindfulness would enhance episodic memory, a key form of long-term memory. In Study 1 (N = 143), a self-reported state of mindful attention predicted better recognition performance in the Remember-Know (R-K) paradigm. In Study 2 (N = 93), very brief training in a focused attention form of mindfulness also produced better recognition memory performance on the R-K task relative to a randomized, well-matched active control condition. Study 3 (N = 57) extended these findings by showing that relative to randomized active and inactive control conditions the effect of very brief mindfulness training generalized to free-recall memory performance. This study also found evidence for mediation of the mindfulness training-episodic memory relation by intrinsic motivation. These findings indicate that mindful attention can beneficially impact motivation and episodic memory, with potential implications for educational and occupational performance.	[Brown, Kirk Warren; Goodman, Robert J.] Virginia Commonwealth Univ, Dept Psychol, 806 W Franklin St, Richmond, VA 23284 USA; [Ryan, Richard M.] Australian Catholic Univ, Inst Posit Psychol & Educ, Locked Bag 2002, Strathfield, NSW 2135, Australia; [Ryan, Richard M.] Univ Rochester, Clin & Social Sci Psychol, Meliora Hall,POB 270266, Rochester, NY 14627 USA; [Analayo, Bhikkhu] Univ Hamburg, Numata Ctr Buddhist Studies, Alsterterrasse 1, D-20354 Hamburg, Germany; [Analayo, Bhikkhu] Univ Hamburg, Kultur Indiens & Tibets, Alsterterrasse 1, D-20354 Hamburg, Germany; [Goodman, Robert J.] No Arizona Univ, Dept Psychol Sci, Flagstaff, AZ 86011 USA	Virginia Commonwealth University; Australian Catholic University; University of Rochester; University of Hamburg; University of Hamburg; Northern Arizona University	Brown, KW (corresponding author), Virginia Commonwealth Univ, Dept Psychol, 806 W Franklin St, Richmond, VA 23284 USA.	kwbrown@vcu.edu	Brown, Kirk Warren/AAI-5032-2021; Ryan, Richard M./H-1459-2019; Brown, Kirk Warren/AAI-5033-2021	Brown, Kirk Warren/0000-0001-8350-5888; Ryan, Richard M./0000-0002-2355-6154; Brown, Kirk Warren/0000-0001-8350-5888				Analayo B., 2003, SATIPATTHANA DIRECT; Analayo Bh, 2013, MINDFULNESS EA UNPUB; Arch JJ, 2006, BEHAV RES THER, V44, P1849, DOI 10.1016/j.brat.2005.12.007; Arch JJ, 2014, PSYCHONEUROENDOCRINO, V42, P49, DOI 10.1016/j.psyneuen.2013.12.018; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Bissig D, 2007, PSYCHOL SCI, V18, P720, DOI 10.1111/j.1467-9280.2007.01966.x; Bodhi B., 2000, CONNECTED DISCOURSE; Boot WR, 2013, PERSPECT PSYCHOL SCI, V8, P445, DOI 10.1177/1745691613491271; Broderick P, 2005, COGNITIVE THER RES, V29, P501, DOI 10.1007/s10608-005-3888-0; Brown K. W., 2015, HDB MINDFULNESS THEO, P311; Brown KW, 2011, PSYCHOL ASSESSMENT, V23, P1041, DOI 10.1037/a0025781; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chambers R, 2008, COGNITIVE THER RES, V32, P303, DOI 10.1007/s10608-007-9119-0; Chambon C, 2014, PSYCHOL AGING, V29, P731, DOI 10.1037/a0037477; Chiesa A, 2011, CLIN PSYCHOL REV, V31, P449, DOI 10.1016/j.cpr.2010.11.003; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Covey S.R., 1989, 7 HABITS HIGHLY EFFE; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Csikszentmihalyi M., 1997, FINDING FLOW PSYCHOL; Deci E. L., 2015, HDB MINDFULNESS THEO, P112; Dehn MJ, 2008, WORKING MEMORY ACAD; Derryberry D, 2002, J ABNORM PSYCHOL, V111, P225, DOI 10.1037//0021-843X.111.2.225; Donaldson W, 1996, MEM COGNITION, V24, P523, DOI 10.3758/BF03200940; Dreyfus G, 2011, CONTEMP BUDDHISM, V12, P41, DOI 10.1080/14639947.2011.564815; Dudukovic NM, 2009, MEM COGNITION, V37, P953, DOI 10.3758/MC.37.7.953; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Dunne J, 2011, CONTEMP BUDDHISM, V12, P71, DOI 10.1080/14639947.2011.564820; Eisenberg Daniel, 2015, J MENT HEALTH, V20, P222, DOI [10.3109/10673229.2012.712839, DOI 10.3109/09638237.2014.954693, 10.3109/08039481003777484]; Gardiner JM, 2002, MEMORY, V10, P83, DOI 10.1080/09658210143000281; GARDINER JM, 1988, MEM COGNITION, V16, P309, DOI 10.3758/BF03197041; GARDINER JM, 1991, MEM COGNITION, V19, P617, DOI 10.3758/BF03197157; Grossman P, 2008, J PSYCHOSOM RES, V64, P405, DOI 10.1016/j.jpsychores.2008.02.001; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Jensen CG, 2012, J EXP PSYCHOL GEN, V141, P106, DOI 10.1037/a0024931; Jha AP, 2007, COGN AFFECT BEHAV NE, V7, P109, DOI 10.3758/CABN.7.2.109; Jones D, 1999, BRIT J PSYCHOL, V90, P167, DOI 10.1348/000712699161314; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Keng SL, 2013, BEHAV RES THER, V51, P899, DOI 10.1016/j.brat.2013.10.006; Kintsch W, 1998, COMPREHENSION PARADI; Kintsch W., 1974, REPRESENTATION MEANI; Kujala T, 2009, BIOL PSYCHOL, V81, P135, DOI 10.1016/j.biopsycho.2009.03.010; Levesque C, 2007, MOTIV EMOTION, V31, P284, DOI 10.1007/s11031-007-9075-8; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; Lykins ELB, 2012, COGNITIVE THER RES, V36, P103, DOI 10.1007/s10608-010-9318-y; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; McNair D., 1971, MANUAL PROFILE MOOD; Meade AW, 2012, PSYCHOL METHODS, V17, P437, DOI 10.1037/a0028085; Pagnoni G, 2012, J NEUROSCI, V32, P5242, DOI 10.1523/JNEUROSCI.4135-11.2012; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Posner MI, 2009, PHYS LIFE REV, V6, P103, DOI 10.1016/j.plrev.2009.02.001; Raaijmakers J.G.W., 1980, PSYCHOL LEARNING MOT, V14, P207, DOI DOI 10.1016/S0079-7421(08)60162-0; RAJARAM S, 1993, MEM COGNITION, V21, P89, DOI 10.3758/BF03211168; Ranganath C, 2011, NEURON, V72, P688, DOI 10.1016/j.neuron.2011.10.022; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Ryan R., 1990, LEARN INDIVID DIFFER, V2, P1, DOI [DOI 10.1016/1041-6080(90)90014-8, 10.1016/1041-6080(90)90014-8]; Ryan RM, 2010, J SOC CLIN PSYCHOL, V29, P95, DOI 10.1521/jscp.2010.29.1.95; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Ryan RM, 2000, PSYCHOL INQ, V11, P319, DOI 10.1207/S15327965PLI1104_03; Segal Z. V., 2002, MINDFULNESS BASED CO; Soderlund GBW, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-55; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107; Tang YY, 2009, TRENDS COGN SCI, V13, P222, DOI 10.1016/j.tics.2009.01.009; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; van Vugt Marieke K., 2015, HDB MINDFULNESS THEO, P190; Wass SV, 2012, DEV REV, V32, P360, DOI 10.1016/j.dr.2012.07.001; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D, 1999, PANAS X MANUAL POSIT, DOI DOI 10.17077/48VT-M4T2; Williams JMG, 2010, EMOTION, V10, P1, DOI 10.1037/a0018360; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Zeidan F, 2010, CONSCIOUS COGN, V19, P597, DOI 10.1016/j.concog.2010.03.014	80	39	39	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153309	10.1371/journal.pone.0153309	http://dx.doi.org/10.1371/journal.pone.0153309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27115491	Green Published, gold, Green Submitted			2022-12-27	WOS:000374973600020
J	Sato, S; Murakami, A; Kuwajima, A; Takehara, K; Mimori, T; Kawakami, A; Mishima, M; Suda, T; Seishima, M; Fujimoto, M; Kuwana, M				Sato, Shinji; Murakami, Akihiro; Kuwajima, Akiko; Takehara, Kazuhiko; Mimori, Tsuneyo; Kawakami, Atsushi; Mishima, Michiaki; Suda, Takafumi; Seishima, Mariko; Fujimoto, Manabu; Kuwana, Masataka			Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; JAPANESE PATIENTS; DERMATOMYOSITIS PATIENTS; CLASSIFICATION CRITERIA; ANTI-MDA5 ANTIBODIES; AUTOANTIGEN; CADM-140; MYOSITIS	Objective Autoantibodies to melanoma differentiation-associated gene 5 (MDA5) are specifically expressed in patients with dermatomyositis (DM) and are associated with a subset of DM patients with rapidly progressive interstitial lung disease (RP-ILD). Here, we examined the clinical utility of a newly developed enzyme-linked immunosorbent assay (ELISA) system for detecting these antibodies. Methods Here we developed an improved ELISA for detecting anti-MDA5 antibodies. We then performed a multicenter clinical study involving 8 medical centers and enrolled 242 adult patients with polymyositis (PM)/DM, 190 with non-PM/DM connective tissue disease (CTD), 154 with idiopathic interstitial pneumonia (IIP), and 123 healthy controls. Anti-MDA5 antibodies in the patients' serum samples were quantified using our newly developed ELISA, and the results were compared to those obtained using the gold-standard immunoprecipitation (IP) assay. In addition, correlations between the ELISA-quantified anti-MDA5 antibodies and clinical characteristics were evaluated. Results In patients with PM/DM, the anti-MDA5 antibody measurements obtained from the ELISA and IP assay were highly concordant; the ELISA exhibited an analytical sensitivity of 98.2%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 99.5% (compared to the IP assay). Anti-MDA5 antibodies were detected in 22.7% of the DM patients, but not in any of the patients with PM, non-PM/DM CTD, or IIP. Clinically amyopathic DM, RP-ILD, arthritis, and fever were more prevalent in DM patients who were anti-MDA5 antibody-positive than in those who were antibody-negative (P <= 0.0002 for all comparisons). In addition, anti-MDA5 antibody-positive patients with RP-ILD exhibited higher antibody levels than those without RP-ILD (P = 0.006). Conclusion Our newly developed ELISA can detect anti-MDA5 antibodies as efficiently as the gold standard IP assay and has the potential to facilitate the routine clinical measurement of anti-MDA5 antibodies in patients who suspected to have DM.	[Sato, Shinji] Tokai Univ, Sch Med, Div Rheumatol, Dept Internal Med, Isehara, Kanagawa 2591193, Japan; [Murakami, Akihiro; Kuwajima, Akiko] Med & Biol Labs, Nagoya, Aichi 4600008, Japan; [Takehara, Kazuhiko] Kanazawa Univ, Dept Dermatol Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9208641, Japan; [Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto 6068507, Japan; [Kawakami, Atsushi] Nagasaki Univ, Dept Immunol & Rheumatol, Unit Translat Med, Grad Sch Biomed Sci, Nagasaki 8528501, Japan; [Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto 6068507, Japan; [Suda, Takafumi] Hamamatsu Univ Sch Med, Div 2, Dept Internal Med, Hamamatsu, Shizuoka 4313192, Japan; [Seishima, Mariko] Gifu Univ, Grad Sch Med, Dept Dermatol, Gifu 5011194, Japan; [Fujimoto, Manabu] Univ Tsukuba, Dept Dermatol, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Kuwana, Masataka] Nippon Med Sch, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 1138603, Japan	Tokai University; Kanazawa University; Kyoto University; Nagasaki University; Kyoto University; Hamamatsu University School of Medicine; Gifu University; University of Tsukuba; Nippon Medical School	Kuwana, M (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 1138603, Japan.	kuwanam@nms.ac.jp	Sato, Shinji/AAN-8803-2020; Sato, Shinji/V-7271-2019	Mimori, Tsuneyo/0000-0003-0016-2053; Fujimoto, Manabu/0000-0002-3062-4872	Japanese Ministry of Health, Labor, and Welfare	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a research grant on intractable diseases from the Japanese Ministry of Health, Labor, and Welfare. The funder had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Cao H, 2012, ARTHRIT CARE RES, V64, P1602, DOI 10.1002/acr.21728; Ceribelli A, 2014, CLIN EXP RHEUMATOL, V32, P891; Chaisson NF, 2012, MEDICINE, V91, P220, DOI 10.1097/MD.0b013e3182606f0b; Chen ZY, 2013, ARTHRIT CARE RES, V65, P1316, DOI 10.1002/acr.21985; Fiorentino D, 2011, J AM ACAD DERMATOL, V65, P25, DOI 10.1016/j.jaad.2010.09.016; Fujikawa K, 2009, SCAND J RHEUMATOL, V38, P263, DOI 10.1080/03009740802687455; Hall JC, 2013, ARTHRIT CARE RES, V65, P1307, DOI 10.1002/acr.21992; Hamaguchi Y, 2011, ARCH DERMATOL, V147, P391, DOI 10.1001/archdermatol.2011.52; Hoshino K, 2010, RHEUMATOLOGY, V49, P1726, DOI 10.1093/rheumatology/keq153; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Koga T, 2012, RHEUMATOLOGY, V51, P1278, DOI 10.1093/rheumatology/ker518; Kuwana M, 2015, INT J CLIN RHEUMATOL, V10, P257; Labrador-Horrillo M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/290797; Mimori T, 2007, CURR OPIN RHEUMATOL, V19, P523, DOI 10.1097/BOR.0b013e3282f01a8c; Nakashima R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085062; Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; PORTER JF, 1988, ARTHRITIS RHEUM, V31, P219, DOI 10.1002/art.1780310210; Sato S, 2005, ARTHRITIS RHEUM-US, V52, P1571, DOI 10.1002/art.21023; Sato S, 2013, MOD RHEUMATOL, V23, P496, DOI 10.1007/s10165-012-0663-4; Sato S, 2012, MOD RHEUMATOL, V22, P625, DOI 10.1007/s10165-011-0558-9; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tanizawa K, 2011, RESP MED, V105, P1380, DOI 10.1016/j.rmed.2011.05.006; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Watanabe K, 2011, RESP MED, V105, P1238, DOI 10.1016/j.rmed.2011.03.022	29	80	84	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154285	10.1371/journal.pone.0154285	http://dx.doi.org/10.1371/journal.pone.0154285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115353	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600055
J	Shen, HC; Tang, SY; Mahapatra, T; Tucker, JD; Huang, SJ; Yang, B; Zhao, JK; Detels, R; Tang, WM				Shen, Hongcheng; Tang, Songyuan; Mahapatra, Tanmay; Tucker, Joseph D.; Huang, Shujie; Yang, Bin; Zhao, Jinkou; Detels, Roger; Tang, Weiming			Condomless Vaginal Intercourse and Its Associates among Men Who Have Sex with Men in China	PLOS ONE			English	Article							BISEXUAL MEN; HIV; METAANALYSIS; PREVALENCE; SYPHILIS	Background HIV prevalence has increased rapidly among men who have sex with men (MSM) in China reaching alarmingly high levels in some cities. Bisexual MSM have potential to transmit HIV and syphilis to their female partners through condomless vaginal intercourse (CVI). Thus, estimation of the burden of CVI and identification of its associates seemed necessary to control this cross-gender transmission. Method In a cross-sectional study, using respondent-driven-sampling and snowball sampling, 2958 MSM were recruited from seven Chinese cities, interviewed and tested for HIV and syphilis. Descriptive analysis of the socio-demographic and behaviors followed by simple and multiple logistic regressions [adjusted for income, city, race and social network size to determine adjusted odds ratio (aOR)] were performed using SAS-9.1. Results Among participating MSM, 19.03% were engaged in CVI. Prevalence of HIV and syphilis among participants involved in CVI were 5.86% and 14.74% respectively. MSM who were older [aOR for aged 40-49 = 2.60 (95% CI: 1.54-4.37)], married [aOR = 6.13 (4.95-7.58)], attended primary school or below [aOR = 3.86 (2.26-6.69)], met male partners at spa/bath-house/sauna/massage parlor [aOR = 3.52 (2.62-4.72)] and had heterosexual orientation [aOR = 13.81 (7.14-26.70)] were more likely to have CVI. Furthermore, correct knowledge regarding HIV [aOR = 0.70 (0.55, 0.88)] and exposure to HIV prevention interventions [aOR = 0.67 (0.54, 0.82)] were negatively associated with CVI. Conclusions CVI was found to be common among MSM in China. To minimize the transmission of HIV and syphilis from bisexual MSM to their relatively female partners, targeted interventions should specifically focus on bisexual MSM especially the older and married subgroups.	[Shen, Hongcheng; Tang, Songyuan; Huang, Shujie; Yang, Bin; Tang, Weiming] Guangdong Prov Ctr Skin Dis & STI Control, Guangzhou, Guangdong, Peoples R China; [Tang, Songyuan; Tucker, Joseph D.; Tang, Weiming] Univ N Carolina, Project China, Guangzhou, Guangdong, Peoples R China; [Mahapatra, Tanmay; Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Monitoring & Evaluat Unit, Geneva, Switzerland	University of California System; University of California Los Angeles	Tang, WM (corresponding author), Guangdong Prov Ctr Skin Dis & STI Control, Guangzhou, Guangdong, Peoples R China.; Tang, WM (corresponding author), Univ N Carolina, Project China, Guangzhou, Guangdong, Peoples R China.	weimingtangscience@gmail.com		Zhao, Jinkou/0000-0001-9184-3385; Tucker, Joseph/0000-0003-2804-1181	National Institutes of Health [National Institute of Allergy and Infectious Diseases] [1R01AI114310]; UNC-South China STD Research Training Centre [Fogarty International Centre] [1D43TW009532]; UNC Center for AIDS Research [National Institute of Allergy and Infectious Diseases] [5P30AI050410]; UNC Chapel Hill, Johns Hopkins University, Morehead School of Medicine and Tulane University (UJMT) Fogarty Fellowship [FIC R25TW0093]; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114310, P30AI050410] Funding Source: NIH RePORTER	National Institutes of Health [National Institute of Allergy and Infectious Diseases](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UNC-South China STD Research Training Centre [Fogarty International Centre]; UNC Center for AIDS Research [National Institute of Allergy and Infectious Diseases]; UNC Chapel Hill, Johns Hopkins University, Morehead School of Medicine and Tulane University (UJMT) Fogarty Fellowship; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health [National Institute of Allergy and Infectious Diseases 1R01AI114310]; UNC-South China STD Research Training Centre [Fogarty International Centre 1D43TW009532]; UNC Center for AIDS Research [National Institute of Allergy and Infectious Diseases 5P30AI050410]; and the UNC Chapel Hill, Johns Hopkins University, Morehead School of Medicine and Tulane University (UJMT) Fogarty Fellowship [FIC R25TW0093].	[Anonymous], 2014, UNAIDS REPORT GLOBAL; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Cai YuMao, 2007, China Tropical Medicine, V7, P2131; Chow EPF, 2012, INT J INFECT DIS, V16, pE312, DOI 10.1016/j.ijid.2012.01.012; Chow EPF, 2012, AIDS BEHAV, V16, P653, DOI 10.1007/s10461-011-9935-9; Chow EPF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-242; Das A, 2015, INT J STD AIDS, V26, P145, DOI 10.1177/0956462414531560; Fan S, 2012, AIDS PATIENT CARE ST, V26, P148, DOI 10.1089/apc.2011.0277; Godbole S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107439; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Liao MZ, 2011, AIDS PATIENT CARE ST, V25, P683, DOI 10.1089/apc.2010.0371; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Liu HJ, 2009, AIDS PATIENT CARE ST, V23, P885, DOI 10.1089/apc.2009.0043; Neilands TB, 2008, ARCH SEX BEHAV, V37, P838, DOI 10.1007/s10508-007-9305-x; Qi Jinlei, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P399; Quan SC, 2005, CELL RES, V15, P58; Rutledge SE, 2005, AIDS PATIENT CARE ST, V19, P186, DOI 10.1089/apc.2005.19.186; Tang WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077645; Tang WM, 2013, AIDS BEHAV, V17, P1415, DOI 10.1007/s10461-013-0413-4; Tao J, 2013, AIDS PATIENT CARE ST, V27, P524, DOI 10.1089/apc.2013.0161; Wang C, 2007, CHINESE J HLTH LAB T, V17, P2291; Wang L, 2012, CHINESE MED J-PEKING, V125, P1857, DOI 10.3760/cma.j.issn.0366-6999.2012.11.003; Zhang B., 2000, CHIN J STD AIDS PREV, V3, P155; Zhang B, 2008, CHINJ HUM SEX, V17, P6; Zule WA, 2009, J URBAN HEALTH, V86, pS48, DOI 10.1007/s11524-009-9366-3	26	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154132	10.1371/journal.pone.0154132	http://dx.doi.org/10.1371/journal.pone.0154132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27115604	Green Published, Green Accepted, gold			2022-12-27	WOS:000374973600045
J	Zhang, QH; Huang, FF; Liu, ZL; Zhang, N; Mahapatra, T; Tang, WM; Lei, Y; Dai, YL; Tang, SY; Zhang, JP				Zhang, Qinghua; Huang, Feifei; Liu, Zaoling; Zhang, Na; Mahapatra, Tanmay; Tang, Weiming; Lei, Yang; Dai, Yali; Tang, Songyuan; Zhang, Jingping			Cross-Cultural Validation of the High Blood Pressure Health Literacy Scale in a Chinese Community	PLOS ONE			English	Article							HYPERTENSION; PREVALENCE; OUTCOMES; ADULTS; CARE; RECOMMENDATIONS; INTERVENTION; AWARENESS; VALIDITY; DISEASE	Background Considering the importance of health literacy (HL) for the maximum yield from the hypertension control programs, development of a reliable and valid instrument of hypertension-related HL is critical. This study aimed to translate and validate the High Blood Pressure-Health Literacy Scale (HBP-HLS) into Chinese (C-HBP-HLS) and evaluate its psychometric properties in Chinese context. Method Between June 2013 and January 2014, a cross-sectional study was conducted among recruited hypertensive patients belonging to the Han and Kazakh-Chinese communities in Urumqi, Xinjiang, China. Results A pilot sample (n = 242) was selected for the exploratory factor analysis of the translated and modified instrument. Another sample (n = 308) was recruited for the confirmatory factor analysis. C-HBP-HLS consisted of five dimensions (Print Health Literacy, Medication Label, Understanding Ability, Newest Vital Sign Test, and Avoiding Food Allergy) containing 15 items, accounting for 77.7% of the total variance. The 5-factor model demonstrated a good overall fit. The scale-level content validity index was 0.85. Cronbach's alpha of the overall scale was 0.78 and test-retest reliability was 0.96. Education level had a strong positive correlation with the scores for items Q1, Q2, and Q3(r = 0.481, 0.492, 0.475, respectively). Health Literacy scores among Kazakh patients were significantly lower than Han (7.13 +/- 7.90 vs. 30.10 +/- 13.42, Z = -14.573, P<0.001). Conclusion C-HBP-HLS demonstrated suitable factor structure and robust psychometric properties for measuring health literacy level among hypertensive patients in China.	[Zhang, Qinghua; Lei, Yang; Zhang, Jingping] Cent S Univ, Xiang Ya Nursing Sch, Changsha, Hunan, Peoples R China; [Zhang, Qinghua; Dai, Yali] XinJiang Med Univ, Sch Nursing, Urumqi, Xinjiang, Peoples R China; [Huang, Feifei] FuJian Med Univ, Sch Nursing, Fuzhou, Fu Jian, Peoples R China; [Liu, Zaoling] XinJiang Med Univ, Sch Publ Hlth, Urumqi, Xinjiang, Peoples R China; [Zhang, Na] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Mahapatra, Tanmay] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Tang, Weiming; Tang, Songyuan] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China	Central South University; Xinjiang Medical University; Fujian Medical University; Xinjiang Medical University; University of Hong Kong; University of California System; University of California Los Angeles	Zhang, JP (corresponding author), Cent S Univ, Xiang Ya Nursing Sch, Changsha, Hunan, Peoples R China.	jpzhang1965@163.com	Zhang, Jingping/ABA-4179-2020	Zhang, Jingping/0000-0002-7800-9617	Fundamental Research Funds for the Central South University [2013zzts079]; Research Funds of Humanities & Social Science from the Ministry of Education of the People's Republic of China [15YJCZH223]	Fundamental Research Funds for the Central South University; Research Funds of Humanities & Social Science from the Ministry of Education of the People's Republic of China	This study was supported by the Fundamental Research Funds for the Central South University (number 2013zzts079) and the Research Funds of Humanities & Social Science from the Ministry of Education of the People's Republic of China(number 15YJCZH223).	Bryant FB, 1999, ACAD EMERG MED, V6, P54, DOI 10.1111/j.1553-2712.1999.tb00096.x; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Davis T C, 1991, Fam Med, V23, P433; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Fransen Mirjam P, 2013, Ned Tijdschr Geneeskd, V157, pA5581; Gaskin CJ, 2014, INT J NURS STUD, V51, P511, DOI 10.1016/j.ijnurstu.2013.10.005; Hancock G.R., 2001, STRUCTURAL EQUATION, P195; Heinrich C, 2012, J AM ACAD NURSE PRAC, V24, P218, DOI 10.1111/j.1745-7599.2012.00698.x; Howard DH, 2005, AM J MED, V118, P371, DOI 10.1016/j.amjmed.2005.01.010; Jones K, 2014, COMMUNITY DENT HLTH, V31, P37, DOI 10.1922/CDH_3269Jones07; Kim KB, 2014, AM J HYPERTENS, V27, P1199, DOI 10.1093/ajh/hpu041; Kim MT, 2012, PATIENT EDUC COUNS, V87, P165, DOI 10.1016/j.pec.2011.09.005; Leung AYM, 2013, J HEALTH COMMUN, V18, P205, DOI 10.1080/10810730.2013.829138; Markus KA, 2012, STRUCT EQU MODELING, V19, P509, DOI 10.1080/10705511.2012.687667; McNaughton CD, 2014, PATIENT EDUC COUNS, V96, P165, DOI 10.1016/j.pec.2014.05.007; Nguyen TH, 2014, PATIENT, V7, P23, DOI 10.1007/s40271-013-0041-0; Oke AE, 2012, CONSTR ECON BUILD, V12, P89, DOI 10.5130/AJCEB.v12i3.2658; Omachi TA, 2013, J GEN INTERN MED, V28, P74, DOI 10.1007/s11606-012-2177-3; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Parker R, 2010, J HEALTH COMMUN, V15, P20, DOI 10.1080/10810730.2010.501094; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Shi Jingcheng, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P152, DOI 10.3969/j.issn.1672-7347.2012.02.007; Sperber NR, 2013, HEALTH EDUC RES, V28, P502, DOI 10.1093/her/cyt043; Suka M, 2013, ENVIRON HEALTH PREV, V18, P407, DOI 10.1007/s12199-013-0340-z; Tadakamadla SK, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-120; Tao J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-185; Wang JW, 2014, AM J HYPERTENS, V27, P1355, DOI 10.1093/ajh/hpu053; Xi B, 2012, INT J CARDIOL, V158, P326, DOI 10.1016/j.ijcard.2012.04.140; Zhai Yi, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P744; Zhao QL, 2014, APPL DEV NURSING ASS	30	12	15	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0152182	10.1371/journal.pone.0152182	http://dx.doi.org/10.1371/journal.pone.0152182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5QB	27116336	Green Published, gold			2022-12-27	WOS:000374973600015
J	Ziemba, AM; Forman, SA				Ziemba, Alexis M.; Forman, Stuart A.			Correction for Inhibition Leads to an Allosteric Co-Agonist Model for Pentobarbital Modulation and Activation of alpha 1 beta 3 gamma 2L GABA(A) Receptors	PLOS ONE			English	Article							TRANSMEMBRANE DOMAIN; ETOMIDATE SITES; SUBUNIT; BARBITURATE; CHANNEL; BINDING; IDENTIFICATION; ANESTHETICS; MUTATIONS; BLOCK	Background Pentobarbital, like propofol and etomidate, produces important general anesthetic effects through GABA(A) receptors. Photolabeling also indicates that pentobarbital binds to some of the same sites where propofol and etomidate act. Quantitative allosteric co-agonist models for propofol and etomidate account for modulatory and agonist effects in GABA(A) receptors and have proven valuable in establishing drug site characteristics and for functional analysis of mutants. We therefore sought to establish an allosteric co-agonist model for pentobarbital activation and modulation of alpha 1 beta 3 gamma 2L receptors, using a novel approach to first correct pentobarbital activation data for inhibitory effects in the same concentration range. Methods Using oocyte-expressed alpha 1 beta 3 gamma 2L GABA(A) receptors and two-microelectrode voltage-clamp, we quantified modulation of GABA responses by a low pentobarbital concentration and direct effects of high pentobarbital concentrations, the latter displaying mixed agonist and inhibitory effects. We then isolated and quantified pentobarbital inhibition in activated receptors using a novel single-sweep "notch" approach, and used these results to correct steady-state direct activation for inhibition. Results Combining results for GABA modulation and corrected direct activation, we estimated receptor open probability and optimized parameters for a Monod-Wyman-Changeux allosteric co-agonist model. Inhibition by pentobarbital was consistent with two sites with IC(50)s near 1 mM, while co-agonist model parameters suggest two allosteric pentobarbital agonist sites characterized by K-PB approximate to 5 mM and high efficacy. The results also indicate that pentobarbital may be a more efficacious agonist than GABA. Conclusions Our novel approach to quantifying both inhibitory and co-agonist effects of pentobarbital provides a basis for future structure-function analyses of GABA(A) receptor mutations in putative pentobarbital binding sites.	[Ziemba, Alexis M.; Forman, Stuart A.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Ziemba, Alexis M.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA	Harvard University; Massachusetts General Hospital; Rensselaer Polytechnic Institute	Forman, SA (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	saforman@partners.org	Forman, Stuart/Q-6590-2019; Ziemba, Alexis/GRJ-4381-2022	Forman, Stuart/0000-0001-6340-2478; Ziemba, Alexis M/0000-0001-8947-9617	NIH [P01 GM058448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant to SAF from NIH (P01 GM058448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G, 2000, BRIT J PHARMACOL, V130, P249, DOI 10.1038/sj.bjp.0703335; Akk G, 2004, J PHYSIOL-LONDON, V556, P387, DOI 10.1113/jphysiol.2003.058230; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Bevington P. R., 2002, DATA REDUCTION ERROR; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; CHRISTENSEN HD, 1973, TOXICOL APPL PHARM, V26, P495, DOI 10.1016/0041-008X(73)90287-1; Desai R, 2015, J PHYSIOL-LONDON, V593, P4943, DOI 10.1113/JP270971; Desai R, 2009, ANESTHESIOLOGY, V111, P774, DOI 10.1097/ALN.0b013e3181b55fae; Feng HJ, 2004, MOL PHARMACOL, V66, P988, DOI 10.1124/mol.104.002543; Forman SA, 2012, METHODS MOL BIOL, V796, P317, DOI 10.1007/978-1-61779-334-9_17; Gingrich KJ, 2009, J GEN PHYSIOL, V133, P171, DOI 10.1085/jgp.200810081; Guitchounts G, 2012, ANESTHESIOLOGY, V116, P1235, DOI 10.1097/ALN.0b013e3182567df3; Husain SS, 2010, J MED CHEM, V53, P6432, DOI 10.1021/jm100498u; Jayakar SS, 2015, J BIOL CHEM, V290, P23432, DOI 10.1074/jbc.M115.672006; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Krampfl K, 2002, EUR J PHARMACOL, V435, P1, DOI 10.1016/S0014-2999(01)01558-8; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Maldifassi MC, 2016, NEUROPHARMACOLOGY, V105, P207, DOI 10.1016/j.neuropharm.2016.01.003; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Raines DE, 2003, ANESTH ANALG, V96, P112, DOI 10.1097/00000539-200301000-00024; Ruesch D, 2012, ANESTHESIOLOGY, V116, P47, DOI 10.1097/ALN.0b013e31823d0c36; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; Serafini R, 2000, J PHYSIOL-LONDON, V524, P649, DOI 10.1111/j.1469-7793.2000.00649.x; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Thompson SA, 1996, BRIT J PHARMACOL, V117, P521, DOI 10.1111/j.1476-5381.1996.tb15221.x; Tomlin SL, 1999, ANESTHESIOLOGY, V90, P1714, DOI 10.1097/00000542-199906000-00029; Zeller A, 2007, MOL PHARMACOL, V71, P852, DOI 10.1124/mol.106.030049	28	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154031	10.1371/journal.pone.0154031	http://dx.doi.org/10.1371/journal.pone.0154031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27110714	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600029
J	Hayat, T; Nawaz, S; Alsaedi, A; Rafiq, M				Hayat, Tasawar; Nawaz, Sadaf; Alsaedi, Ahmed; Rafiq, Maimona			Mixed Convective Peristaltic Flow of Water Based Nanofluids with Joule Heating and Convective Boundary Conditions	PLOS ONE			English	Article							TRANSPORT; FLUID; MHD; CHANNEL; MODEL; MOTION; SLIP; HALL	Main objective of present study is to analyze the mixed convective peristaltic transport of water based nanofluids using five different nanoparticles i.e. (Al2O3, CuO, Cu, Ag and TiO2). Two thermal conductivity models namely the Maxwell's and Hamilton-Crosser's are used in this study. Hall and Joule heating effects are also given consideration. Convection boundary conditions are employed. Furthermore, viscous dissipation and heat generation/absorption are used to model the energy equation. Problem is simplified by employing lubrication approach. System of equations are solved numerically. Influence of pertinent parameters on the velocity and temperature are discussed. Also the heat transfer rate at the wall is observed for considered five nanofluids using the two phase models via graphs.	[Hayat, Tasawar; Nawaz, Sadaf; Rafiq, Maimona] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Nawaz, S (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan.	sadafnawaz26@gmail.com	Rafiq, Maimona/AAM-7714-2020; Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasi FM, 2015, J MOL LIQ, V207, P248, DOI 10.1016/j.molliq.2015.03.042; Abbasi FM, 2015, J MAGN MAGN MATER, V382, P104, DOI 10.1016/j.jmmm.2015.01.040; Abbasi FM, 2015, PHYSICA E, V68, P123, DOI 10.1016/j.physe.2014.12.026; Abbasi FM, 2015, PHYSICA E, V67, P47, DOI 10.1016/j.physe.2014.11.002; Abbasi FM, 2015, Z NATURFORSCH A, V70, P125, DOI 10.1515/zna-2014-0213; Abbasi FM, 2014, Z NATURFORSCH A, V69, P451, DOI 10.5560/ZNA.2014-0041; Abbasi FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105440; Akram S, 2014, J MAGN MAGN MATER, V358, P183, DOI 10.1016/j.jmmm.2014.01.052; Ali N, 2013, Z NATURFORSCH A, V68, P515, DOI 10.5560/ZNA.2013-0033; [Anonymous], 1967, P WORKSH URET REFL C; Asghar S., 2013, Mathematical and Computational Applications, V18, P198; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Choi SUS., 1995, ASME PUBLICATIONS FE, P99; Ebaid A, 2014, COMPUT MATH APPL, V68, P77, DOI 10.1016/j.camwa.2014.05.008; Ellahi R, 2015, J MAGN MAGN MATER, V393, P284, DOI 10.1016/j.jmmm.2015.05.071; HAMILTON RL, 1962, IND ENG CHEM FUND, V1, P187, DOI 10.1021/i160003a005; Hayat T, 2015, INT J BIOMATH, V8, DOI 10.1142/S1793524515500734; Hayat T, 2014, SAINS MALAYS, V43, P1583; Hayat T, 2014, J MOL LIQ, V194, P93, DOI 10.1016/j.molliq.2014.01.021; Hayat T, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14063-9; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4923396; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095070; Hina S, 2014, APPL MATH MECH-ENGL, V35, P73, DOI 10.1007/s10483-014-1773-7; Khan JA, 2015, INT J HEAT MASS TRAN, V86, P158, DOI 10.1016/j.ijheatmasstransfer.2015.02.078; Lin YH, 2015, INT J HEAT MASS TRAN, V84, P903, DOI 10.1016/j.ijheatmasstransfer.2015.01.099; Maxwell JC., 1904, TREATISE ELECT MAGNE, P435; Mekheimer KS, 2013, INT J BIOMATH, V6, DOI 10.1142/S1793524513500265; Munir AF, 2014, J CENT SOUTH UNIV, V21, P1411, DOI 10.1007/s11771-014-2079-0; Shehzad SA, 2015, J MOL LIQ, V209, P723, DOI 10.1016/j.molliq.2015.05.058; Shehzad SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111417; Sheikholeslami M, 2015, J MAGN MAGN MATER, V374, P36, DOI 10.1016/j.jmmm.2014.08.021; SrinivaS S, 2008, INT COMMUN HEAT MASS, V35, P514, DOI 10.1016/j.icheatmasstransfer.2007.08.011; Turkyilmazoglu M, 2013, INT J MECH SCI, V77, P263, DOI 10.1016/j.ijmecsci.2013.10.011; Turkyilmazoglu M, 2014, COMPUT FLUIDS, V94, P139, DOI 10.1016/j.compfluid.2014.02.009; Weinberg Steven Louis, 1970, PHD DISS	35	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153537	10.1371/journal.pone.0153537	http://dx.doi.org/10.1371/journal.pone.0153537			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104596	gold, Green Published, Green Submitted			2022-12-27	WOS:000374565100012
J	Vigna, BBZ; Santos, JCS; Jungmann, L; do Valle, CB; Mollinari, M; Pastina, MM; Pagliarini, MS; Garcia, AAF; Souza, AP				Vigna, Bianca B. Z.; Santos, Jean C. S.; Jungmann, Leticia; do Valle, Cacilda B.; Mollinari, Marcelo; Pastina, Maria M.; Pagliarini, Maria Suely; Garcia, Antonio A. F.; Souza, Anete P.			Evidence of Allopolyploidy in Urochloa humidicola Based on Cytological Analysis and Genetic Linkage Mapping	PLOS ONE			English	Article							POACEAE PANICOIDEAE PANICEAE; DOSE RESTRICTION FRAGMENTS; SPP. COMMERCIAL CROSS; GENOMIC REGION; PENNISETUM-SQUAMULATUM; BRACHIARIA-BRIZANTHA; CENCHRUS-CILIARIS; MEIOTIC BEHAVIOR; SACCHARUM SPP.; AFLP MARKERS	The African species Urochloa humidicola (Rendle) Morrone & Zuloaga (syn. Brachiaria humidicola (Rendle) Schweick.) is an important perennial forage grass found throughout the tropics. This species is polyploid, ranging from tetra to nonaploid, and apomictic, which makes genetic studies challenging; therefore, the number of currently available genetic resources is limited. The genomic architecture and evolution of U. humidicola and the molecular markers linked to apomixis were investigated in a full-sib F-1 population obtained by crossing the sexual accession H031 and the apomictic cultivar U. humidicola cv. BRS Tupi, both of which are hexaploid. A simple sequence repeat (SSR)-based linkage map was constructed for the species from 102 polymorphic and specific SSR markers based on simplex and double-simplex markers. The map consisted of 49 linkage groups (LGs) and had a total length of 1702.82 cM, with 89 microsatellite loci and an average map density of 10.6 cM. Eight homology groups (HGs) were formed, comprising 22 LGs, and the other LGs remained ungrouped. The locus that controls apospory (apo-locus) was mapped in LG02 and was located 19.4 cM from the locus Bh027.c.D2. In the cytological analyses of some hybrids, bi-to hexavalents at diakinesis were observed, as well as two nucleoli in some meiocytes, smaller chromosomes with preferential allocation within the first metaphase plate and asynchronous chromosome migration to the poles during anaphase. The linkage map and the meiocyte analyses confirm previous reports of hybridization and suggest an allopolyploid origin of the hexaploid U. humidicola. This is the first linkage map of an Urochloa species, and it will be useful for future quantitative trait locus (QTL) analysis after saturation of the map and for genome assembly and evolutionary studies in Urochloa spp. Moreover, the results of the apomixis mapping are consistent with previous reports and confirm the need for additional studies to search for a co-segregating marker.	[Vigna, Bianca B. Z.; Santos, Jean C. S.; Souza, Anete P.] Univ Campinas UNICAMP, CBMEG, CP 6010, BR-13083970 Campinas, SP, Brazil; [Vigna, Bianca B. Z.] Embrapa Pecuaria Sudeste, CP 399, BR-13560970 Sao Carlos, SP, Brazil; [Jungmann, Leticia; do Valle, Cacilda B.] Embrapa Gado Corte, Av Radio Maia 830, BR-79106550 Campo Grande, MS, Brazil; [Mollinari, Marcelo; Garcia, Antonio A. F.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Genet, CP 83, BR-13400970 Piracicaba, SP, Brazil; [Pastina, Maria M.] Embrapa Milho & Sorgo, Rod MG 424,Km 65, BR-35701970 Sete Lagoas, MG, Brazil; [Pagliarini, Maria Suely] Univ Maringa UEM, Dept Genet & Cell Biol, Av Colombo,5790,Zona 7, BR-87020900 Maringa, Parana, Brazil; [Souza, Anete P.] Univ Campinas UNICAMP, Inst Biol, Dept Plant Biol, CP6109, BR-13083970 Campinas, SP, Brazil; [Jungmann, Leticia] Embrapa Agroenergia, CP 40-315, BR-70770901 Brasilia, DF, Brazil	Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Souza, AP (corresponding author), Univ Campinas UNICAMP, CBMEG, CP 6010, BR-13083970 Campinas, SP, Brazil.; Souza, AP (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Plant Biol, CP6109, BR-13083970 Campinas, SP, Brazil.	anete@unicamp.br	Garcia, Antonio A F/A-4538-2010; Vigna, Bianca BZ/H-8853-2013; DE SOUZA, ANETE PEREIRA/B-8663-2012; Vigna, Bianca BZ/B-7640-2012; Mollinari, Marcelo/E-7678-2012; Pastina, Maria Marta/F-9216-2011	Garcia, Antonio A F/0000-0003-0634-3277; Vigna, Bianca BZ/0000-0003-0192-9877; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Vigna, Bianca BZ/0000-0003-0192-9877; Mollinari, Marcelo/0000-0002-7001-8498; Pastina, Maria Marta/0000-0002-9112-3457	Brazilian Agricultural Research Corporation (Embrapa); Brazilian National Council for Scientific and Technological Development (CNPq) [478262/2004-3, 502336/2005-6, 482458/2007-0]; State of Sao Paulo Research Foundation (FAPESP) [2005/51010-0, 2008/52197-4]; Foundation for Science and Technological Development of the State of Mato Grosso do Sul (Fundect); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPESP [2007/57022-5, 2010/50032-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - EMBRAPA Program); CNPq [304914/2010-0]; CNPq	Brazilian Agricultural Research Corporation (Embrapa)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Foundation for Science and Technological Development of the State of Mato Grosso do Sul (Fundect); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - EMBRAPA Program); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to acknowledge the financial support of the Brazilian Agricultural Research Corporation (Embrapa), the Brazilian National Council for Scientific and Technological Development (CNPq, http://www.cnpq.br/, grant numbers 478262/2004-3, 502336/2005-6 and 482458/2007-0), the State of Sao Paulo Research Foundation (FAPESP, http://www.fapesp.br/, grant numbers 2005/51010-0 and 2008/52197-4), and the Foundation for Science and Technological Development of the State of Mato Grosso do Sul (Fundect, http://fundect.ledes.net/) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br/, Computacional Biology Program). BBZV was the recipient of graduate fellowships (2007/57022-5; 2010/50032-8) from FAPESP; JCS is the recipient of a graduate fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - EMBRAPA Program); APS is the recipient of a research fellowship from CNPq (304914/2010-0); AAFG is the recipient of a research fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adantowski EV, 2007, GENET MOL RES, V6, P616; Aitken KS, 2007, GENOME, V50, P742, DOI 10.1139/G07-056; Akiyama Y, 2005, THEOR APPL GENET, V111, P1042, DOI 10.1007/s00122-005-0020-5; ALJANABI SM, 1993, GENETICS, V134, P1249; Barcaccia G., 2014, Diversity, V6, P633, DOI 10.3390/d6040633; Mendes-Bonato A, 2006, J GENET, V85, P83, DOI 10.1007/BF02728976; Bernini C, 2001, CYTOBIOS, V104, P157; Bethel CM, 2006, THEOR APPL GENET, V112, P727, DOI 10.1007/s00122-005-0177-y; Bitencourt GA, 2007, AN 54 C BRAS GEN 200; Bitencourt GA, 2008, B PESQUISA, V23; Boldrini KR, 2009, GENET MOL RES, V8, P888, DOI [10.4238/vol8-3gmr617, 10.4238/vol8-4gmr679]; Boldrini KR, 2006, J GENET, V85, P225, DOI 10.1007/BF02935337; Boldrini KR, 2010, J GENET, V89, P91, DOI 10.1007/s12041-010-0016-z; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; Castiglioni P, 1999, THEOR APPL GENET, V99, P425, DOI 10.1007/s001220051253; Cervantes-Flores JC, 2008, MOL BREEDING, V21, P511, DOI 10.1007/s11032-007-9150-6; Chiappe LM, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3594[1:JBFTEC]2.0.CO;2; Clevenger J, 2015, MOL PLANT, V8, P831, DOI 10.1016/j.molp.2015.02.002; Conner JA, 2008, PLANT PHYSIOL, V147, P1396, DOI 10.1104/pp.108.119081; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; DASILVA JAG, 1993, GENOME, V36, P782, DOI 10.1139/g93-103; de Penteado MIO, 2000, DETERMINACAO PLOIDIA; do Valle CB, 2008, INT C SEX PLANT REPR, V20, P197; Do Valle CD., 1996, BRACHIARIA BIOL AGRO, P147; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; Ebina Masumi, 2005, Grassland Science, V51, P71, DOI 10.1111/j.1744-697X.2005.00011.x; Gallo PH, 2007, EUPHYTICA, V154, P255, DOI 10.1007/s10681-006-9294-1; Garcia AAF, 2006, THEOR APPL GENET, V112, P298, DOI 10.1007/s00122-005-0129-6; Garcia AAF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03399; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Goel S, 2006, GENETICS, V173, P389, DOI 10.1534/genetics.105.054429; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Gualtieri G, 2006, PLANT PHYSIOL, V140, P963, DOI 10.1104/pp.105.073809; Hackett CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063939; Hoarau JY, 2001, THEOR APPL GENET, V103, P84, DOI 10.1007/s001220000390; Hojsgaard D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00082; Huo HQ, 2009, THEOR APPL GENET, V119, P199, DOI 10.1007/s00122-009-1029-y; Ishigaki G, 2010, GRASSL SCI, V56, P240, DOI 10.1111/j.1744-697X.2010.00200.x; Jessup RW, 2003, GENOME, V46, P304, DOI [10.1139/g03-005, 10.1139/G03-005]; Jungmann L, 2009, CONSERV GENET RESOUR, V1, P475, DOI 10.1007/s12686-009-9111-y; Jungmann L, 2010, GENOME, V53, P698, DOI [10.1139/G10-055, 10.1139/g10-055]; Keller-Grein G., 1996, BRACHIARIA BIOL AGRO, P16; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Leach LJ, 2010, P NATL ACAD SCI USA, V107, P4270, DOI 10.1073/pnas.0908477107; Lewis MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000815; Lewis MS, 2004, GENETICS, V167, P931, DOI 10.1534/genetics.103.026203; Maliepaard C, 1997, GENET RES, V70, P237, DOI 10.1017/S0016672397003005; Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x; Mendes DV, 2006, BOT J LINN SOC, V150, P441, DOI 10.1111/j.1095-8339.2006.00493.x; Mendes-Bonato AB, 2006, GENET MOL BIOL, V29, P122, DOI 10.1590/S1415-47572006000100023; Mendes-Bonato AB, 2002, CELL BIOL INT, V26, P641, DOI 10.1006/cbir.2002.0929; Miles JW, 1997, CAN J PLANT SCI, V77, P105, DOI 10.4141/P95-187; Miller JM, 2014, HEREDITY, V112, P240, DOI 10.1038/hdy.2013.99; Ming R, 1998, GENETICS, V150, P1663; Mollinari M, 2009, RES 55 C BRAS GEN AG; Nielen S, 2010, SEX PLANT REPROD, V23, P45, DOI 10.1007/s00497-009-0124-1; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Oliveira KM, 2007, MOL BREEDING, V20, P189, DOI 10.1007/s11032-007-9082-1; Ozias-Akins P, 1998, P NATL ACAD SCI USA, V95, P5127, DOI 10.1073/pnas.95.9.5127; Ozias-Akins Peggy, 2003, Functional & Integrative Genomics, V3, P94, DOI 10.1007/s10142-003-0084-8; Pagliarini MS, 2008, EUPHYTICA, V164, P181, DOI 10.1007/s10681-008-9697-2; Pastina MM, 2012, THEOR APPL GENET, V124, P835, DOI 10.1007/s00122-011-1748-8; Pessino SC, 1997, THEOR APPL GENET, V94, P439, DOI 10.1007/s001220050434; Pessino SC, 1998, HEREDITAS, V128, P153, DOI 10.1111/j.1601-5223.1998.00153.x; Pikaard CS, 2000, PLANT MOL BIOL, V43, P163, DOI 10.1023/A:1006471009225; Porceddu A, 2002, THEOR APPL GENET, V104, P273, DOI 10.1007/s001220100659; Ricci GL, 2011, EUPHYTICA, V182, P355, DOI 10.1007/s10681-011-0486-y; Rife TW, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1404-9; Ripol MI, 1999, GENE, V235, P31, DOI 10.1016/S0378-1119(99)00218-8; Risso-Pascotto C, 2006, GENET MOL RES, V5, P797; Risso-Pascotto C, 2006, GENET RESOUR CROP EV, V53, P7, DOI 10.1007/s10722-005-7762-4; Saha MC, 2005, THEOR APPL GENET, V110, P323, DOI 10.1007/s00122-004-1843-1; Santos Jean C S, 2015, BMC Res Notes, V8, P83, DOI 10.1186/s13104-015-1044-9; Serang O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030906; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Stein J, 2007, MOL BREEDING, V20, P153, DOI 10.1007/s11032-007-9083-0; TANKSLEY SD, 1992, GENETICS, V132, P1141; Tate Jennifer A., 2005, P371, DOI 10.1016/B978-012301463-4/50009-7; Tuna M, 2001, CROP SCI, V41, P831, DOI 10.2135/cropsci2001.413831x; Uitdewilligen JGAML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062355; Utsunomiya KS, 2005, BIOCELL, V29, P295; Vigna BBZ, 2011, BMC RES NOTES, V4, P5; WU KK, 1992, THEOR APPL GENET, V83, P294, DOI 10.1007/BF00224274; Wu RL, 2002, GENET RES, V79, P85, DOI 10.1017/S0016672301005389; Wu RL, 2002, THEOR POPUL BIOL, V61, P349, DOI 10.1006/tpbi.2002.1577; YOUNG BA, 1979, CAN J BOT, V57, P1668, DOI 10.1139/b79-204; Zorzatto C, 2010, PLANT BREEDING, V129, P734, DOI 10.1111/j.1439-0523.2010.01763.x	88	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0153764	10.1371/journal.pone.0153764	http://dx.doi.org/10.1371/journal.pone.0153764			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104622	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100021
J	Wu, JX; Fu, LL; Yi, HL				Wu, Juxun; Fu, Lili; Yi, Hualin			Genome-Wide Identification of the Transcription Factors Involved in Citrus Fruit Ripening from the Transcriptomes of a Late-Ripening Sweet Orange Mutant and Its Wild Type	PLOS ONE			English	Article							ABSCISIC-ACID RESPONSE; FINGER PROTEIN ZAT12; SINENSIS L. OSBECK; PRUNUS-AVIUM L.; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; ABIOTIC STRESS; ANTHOCYANIN ACCUMULATION; DOMAIN PROTEINS; WEB SERVER	Fruit ripening is a genetically programmed process. Transcription factors (TFs) play key roles in plant development and ripening by temporarily and spatially regulating the transcription of their target genes. In this study, a total of 159 TFs were identified from a spontaneous late-ripening mutant 'Fengwan' (C. sinensis L. Osbeck) sweet orange (MT) and its wild-type counterpart (' Fengjie 72-1', WT) along the ripening period via the Transcription Factor Prediction of PlantTFDB 3.0. Fifty-two differentially expressed TFs were identified between MT and WT; 92 and 120 differentially expressed TFs were identified in WT and MT, respectively. The Venn diagram analysis showed that 16 differentially expressed TFs were identified between MT and WT and during the ripening of WT and MT. These TFs were primarily assigned to the families of C2H2, Dof, bHLH, ERF, MYB, NAC and LBD. Particularly, the number of TFs of the ERF family was the greatest between MT and WT. According to the results of the WGCNA analysis, a weighted correlation network analysis tool, several important TFs correlated to abscisic acid (ABA), citric acid, fructose, glucose and sucrose were identified, such as RD26, NTT, GATA7 and MYB21/62/77. Hierarchical cluster analysis and the expression analysis conducted at five fruit ripening stages further validated the pivotal TFs that potentially function during orange fruit development and ripening.	[Wu, Juxun; Fu, Lili; Yi, Hualin] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Coll Hort & Forestry Sci, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Yi, HL (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Coll Hort & Forestry Sci, Wuhan 430070, Peoples R China.	yihualin@mail.hzau.edu.cn		Wu, Juxun/0000-0003-0785-1927	National Modern Citrus Industry System [CARS-27]; Ministry of Education Innovation Team [IRT13065]; National Science and Technology Support Project [2013BAD021302]; China Postdoctoral Science Foundation [2015M582242]; Special Project on the Integration of Industry, Education and Research of Guangdong Province [2012B091100169]	National Modern Citrus Industry System; Ministry of Education Innovation Team; National Science and Technology Support Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Special Project on the Integration of Industry, Education and Research of Guangdong Province	This research was supported by the National Modern Citrus Industry System (CARS-27), the Ministry of Education Innovation Team (IRT13065), the National Science and Technology Support Project (2013BAD021302), the China Postdoctoral Science Foundation (2015M582242) and the Special Project on the Integration of Industry, Education and Research of Guangdong Province (2012B091100169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Ballester AR, 2010, PLANT PHYSIOL, V152, P71, DOI 10.1104/pp.109.147322; Benjamini Y, 2001, ANN STAT, V29, P1165; Bi YM, 2005, PLANT J, V44, P680, DOI 10.1111/j.1365-313X.2005.02568.x; Borsani J, 2009, J EXP BOT, V60, P1823, DOI 10.1093/jxb/erp055; Cercos M, 2006, PLANT MOL BIOL, V62, P513, DOI 10.1007/s11103-006-9037-7; Chen XY, 2012, PLANT GROWTH REGUL, V66, P271, DOI 10.1007/s10725-011-9651-5; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Chiang YH, 2012, PLANT PHYSIOL, V160, P332, DOI 10.1104/pp.112.198705; Chung MY, 2010, PLANT J, V64, P936, DOI 10.1111/j.1365-313X.2010.04384.x; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Barajas-Lopez JD, 2012, J EXP BOT, V63, P4887, DOI 10.1093/jxb/ers163; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gaur VS, 2011, MOL BIOL REP, V38, P2827, DOI 10.1007/s11033-010-0429-z; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Iancu OD, 2012, BIOINFORMATICS, V28, P1592, DOI 10.1093/bioinformatics/bts245; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kielbowicz-Matuk A, 2012, PLANT SCI, V185, P78, DOI 10.1016/j.plantsci.2011.11.015; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Kuang JF, 2012, J EXP BOT, V63, P441, DOI 10.1093/jxb/err290; Kumar R, 2009, MOL BIOL REP, V36, P2209, DOI 10.1007/s11033-008-9436-8; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee JM, 2012, PLANT J, V70, P191, DOI 10.1111/j.1365-313X.2011.04863.x; Leng P, 2014, J EXP BOT, V65, P4577, DOI 10.1093/jxb/eru204; Li JH, 2012, J EXP BOT, V63, P6407, DOI 10.1093/jxb/ers295; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Liu Q, 2007, J EXP BOT, V58, P4161, DOI 10.1093/jxb/erm273; Liu Q, 2009, J EXP BOT, V60, P801, DOI 10.1093/jxb/ern329; [LIU Yongzhong 刘永忠], 2006, [华中农业大学学报, Journal of Huazhong Agricultural University], V25, P300; Ma NN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0351-y; Manfield IW, 2007, PLANT PHYSIOL, V143, P941, DOI 10.1104/pp.106.090761; Medina-Puche L, 2014, J EXP BOT, V65, P401, DOI 10.1093/jxb/ert377; Nicolas P, 2014, PLANT PHYSIOL, V164, P365, DOI 10.1104/pp.113.231977; Paul V, 2012, J FOOD SCI TECH MYS, V49, P1, DOI 10.1007/s13197-011-0293-4; Prasanna V, 2007, CRIT REV FOOD SCI, V47, P1, DOI 10.1080/10408390600976841; Qi TC, 2011, PLANT CELL, V23, P1795, DOI 10.1105/tpc.111.083261; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Rios G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-276; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Shan W, 2012, J EXP BOT, V63, P5171, DOI 10.1093/jxb/ers178; Shen XJ, 2014, PLANT CELL PHYSIOL, V55, P862, DOI 10.1093/pcp/pcu013; Shlizerman L, 2007, PHYSIOL PLANTARUM, V131, P72, DOI 10.1111/j.1399-3054.2007.00935.x; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Tanaka M, 2009, PLANTA, V230, P737, DOI 10.1007/s00425-009-0979-2; Walker RP, 2011, J EXP BOT, V62, P5357, DOI 10.1093/jxb/err189; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Wu J, 2014, J EXPT BOT; Wu JX, 2014, SCI HORTIC-AMSTERDAM, V176, P180, DOI 10.1016/j.scienta.2014.06.040; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie XB, 2012, PLANT CELL ENVIRON, V35, P1884, DOI 10.1111/j.1365-3040.2012.02523.x; Xie XL, 2014, MOL BIOL REP, V41, P4261, DOI 10.1007/s11033-014-3297-0; Xu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-540; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yang LT, 2011, PLANT SCI, V180, P521, DOI 10.1016/j.plantsci.2010.11.011; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Zhang H, 2014, J EXP BOT, V65, P5795, DOI 10.1093/jxb/eru313; Zhang Y, 2015, NEW MEDIA SOC, V17, P1007, DOI 10.1177/1461444813520477; Zhang ZJ, 2009, PLANT PHYSIOL, V150, P365, DOI 10.1104/pp.109.135830; Zhao CS, 2011, PLANT J, V66, P502, DOI 10.1111/j.1365-313X.2011.04508.x; Zhao Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005051; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P12822, DOI 10.1073/pnas.1202630109	73	18	19	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2016	11	4							e0154330	10.1371/journal.pone.0154330	http://dx.doi.org/10.1371/journal.pone.0154330			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9WX	27104786	Green Published, Green Submitted, gold			2022-12-27	WOS:000374565100068
J	Carrer, F; Colonese, AC; Lucquin, A; Guedes, EP; Thompson, A; Walsh, K; Reitmaier, T; Craig, OE				Carrer, Francesco; Colonese, Andre Carlo; Lucquin, Alexandre; Guedes, Eduardo Petersen; Thompson, Anu; Walsh, Kevin; Reitmaier, Thomas; Craig, Oliver E.			Chemical Analysis of Pottery Demonstrates Prehistoric Origin for High-Altitude Alpine Dairying	PLOS ONE			English	Article							ARCHAEOLOGICAL POTTERY; BRONZE-AGE; ALPS; MILK; EXPLOITATION; SWITZERLAND; PASTORALISM; PRODUCTS; RESIDUES; IMPACT	The European high Alps are internationally renowned for their dairy produce, which are of huge cultural and economic significance to the region. Although the recent history of alpine dairying has been well studied, virtually nothing is known regarding the origins of this practice. This is due to poor preservation of high altitude archaeological sites and the ephemeral nature of transhumance economic practices. Archaeologists have suggested that stone structures that appear around 3,000 years ago are associated with more intense seasonal occupation of the high Alps and perhaps the establishment of new economic strategies. Here, we report on organic residue analysis of small fragments of pottery sherds that are occasionally preserved both at these sites and earlier prehistoric rock-shelters. Based mainly on isotopic criteria, dairy lipids could only be identified on ceramics from the stone structures, which date to the Iron Age (ca. 3,000-2,500 BP), providing the earliest evidence of this practice in the high Alps. Dairy production in such a marginal environment implies a high degree of risk even by today's standards. We postulate that this practice was driven by population increase and climate deterioration that put pressure on lowland agropastoral systems and the establishment of more extensive trade networks, leading to greater demand for highly nutritious and transportable dairy products.	[Carrer, Francesco; Walsh, Kevin] Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England; [Colonese, Andre Carlo; Lucquin, Alexandre; Craig, Oliver E.] Univ York, Dept Archaeol, BioArCh, York YO10 5DD, N Yorkshire, England; [Guedes, Eduardo Petersen] Univ Fed Rio Grande do Sul, Inst Biociencias, Porto Alegre, RS, Brazil; [Thompson, Anu] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Reitmaier, Thomas] Archaeol Serv Canton Grisons, Chur, Switzerland; [Carrer, Francesco] Newcastle Univ, Sch Hist Class & Archaeol, McCord Ctr Landscape, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of York - UK; University of York - UK; Universidade Federal do Rio Grande do Sul; University of Liverpool; Newcastle University - UK	Carrer, F (corresponding author), Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England.; Carrer, F (corresponding author), Newcastle Univ, Sch Hist Class & Archaeol, McCord Ctr Landscape, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	francesco.carrer@newcastle.ac.uk	Colonese, Andre Carlo/AAA-9266-2020; Lucquin, Alexandre/K-9045-2017	Colonese, Andre Carlo/0000-0002-0279-6634; Walsh, Kevin/0000-0003-1621-2625; Lucquin, Alexandre/0000-0003-4892-6323	Archaeological Service of the Canton of Grisons; EU; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil	Archaeological Service of the Canton of Grisons; EU(European Commission); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by The Archaeological Service of the Canton of Grisons, 7th EU framework Marie Curie Intra-European Fellowship (FP7-PEOPLE-2012-IEF), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil.	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Alther Y., 2014, ARCHAOLOGIE GRABUNDE; Arbos Ph., 1922, VIE PASTORALE ALPES; Carrer F, 2015, J MEDITERR ARCHAEOL, V28, P3, DOI 10.1558/jmea.v28i1.27499; Collis J., 2003, EUROPEAN IRON AGE; Copley MS, 2002, P NATL ACAD SCI US; Correa-Ascencio M, 2014, ANAL METHODS-UK, V6, P1330, DOI 10.1039/c3ay41678j; Craig OE, 2005, ANTIQUITY, V79, P882, DOI 10.1017/S0003598X00115017; Craig OE, 2012, RAPID COMMUN MASS SP, V26, P2359, DOI 10.1002/rcm.6349; Curdy P., 2007, PREISTORIA ALP, V42, P99, DOI DOI 10.1111/J.1472-4642.2012.00930.X; Della Casa P, 2013, PREISTORIA ALPINA, V47, P39; Dietre B, 2014, QUATERN INT, V353, P3, DOI 10.1016/j.quaint.2014.05.001; Dudd SN, 1999, J ARCHAEOL SCI, V26, P1473, DOI 10.1006/jasc.1998.0434; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Festi D, 2014, QUATERN INT, V353, P17, DOI 10.1016/j.quaint.2013.07.052; Frodin JOH, 1940, I SAMMENLIGNENDE K B; Giguet-Covex C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4211; Gleirscher P, 2010, ARCHAOLOGIE ALPEN AL, P43; Grasseni C, 2011, ANTHR FOOD, V8; Greenfield HJ, 2010, WORLD ARCHAEOL, V42, P29, DOI 10.1080/00438240903429722; Grillo KM, 2014, AFR ARCHAEOL REV, V31, P105, DOI 10.1007/s10437-014-9147-6; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Horvat J, 2010, ARCHAOLOGIE ALPEN AL, P89; Kern A, 2013, HALLSTATT 7000; Kindstedt PS., 2012, CHEESE CULTURE HIST; Kothieringer K, 2015, Z GEOMORPHOL, V59, P177, DOI 10.1127/zfg_suppl/2015/S-59210; Krause R., 2009, MONTAFON, P10; Laland KN, 2010, J ARCHAEOL METHOD TH, V17, P303, DOI 10.1007/s10816-010-9096-6; Leiber F, 2004, ANIM SCI, V78, P451, DOI 10.1017/S1357729800058859; Leuzinger U, 2014, JB ARCHAOLOGIE SCHWE, V97, P153; Marini L, 2011, ENVIRON SCI POLICY, V14, P258, DOI 10.1016/j.envsci.2010.12.003; Marzatico F., 2009, GLOBE, V149, P117, DOI DOI 10.3406/GLOBE.2009.1558; Moe D, 2007, VEG HIST ARCHAEOBOT, V16, P431, DOI 10.1007/s00334-006-0088-0; Orland B., 2004, Environment and History, V10, P327, DOI 10.3197/0967340041794286; Papakosta V, 2015, MICROCHEM J, V123, P196, DOI 10.1016/j.microc.2015.06.013; Putzer A, 2009, ARCHAEOL AUSTRIACA, P33, DOI 10.1553/archaeologia93s33; Putzer A, 2014, PRAEHIST Z, V89, P55, DOI 10.1515/pz-2014-0005; Raven AM, 1997, J ANAL APPL PYROL, V40-1, P267, DOI 10.1016/S0165-2370(97)00036-3; Regert M, 2011, MASS SPECTROM REV, V30, P177, DOI 10.1002/mas.20271; Reitmaier T., 2012, LETZTE JAGER ERSTE H; Riedel A., 2001, PREISTORIA ALPINA, V35, P105; Ropke A, 2011, HOLOCENE, V21, P485, DOI 10.1177/0959683610385727; Salque M, 2013, NATURE, V493, P522, DOI 10.1038/nature11698; SHERRATT A, 1983, WORLD ARCHAEOL, V15, P90, DOI 10.1080/00438243.1983.9979887; Spangenberg JE, 2006, J ARCHAEOL SCI, V33, P1, DOI 10.1016/j.jas.2005.05.013; Spangenberg JE, 2008, ISOT ENVIRON HEALT S, V44, P189, DOI 10.1080/10256010802066349; Steiner H, 2010, ALPINE BRANDOPFERPLA; Stopp B., 2015, END LAKE DWELLINGS C; Vigne Jean-Denis, 2007, Anthropozoologica, V42, P9; Walsh K, 2014, QUATERN INT, V353, P52, DOI 10.1016/j.quaint.2013.08.060; Walsh K, 2011, EUR J ARCHAEOL, V14, P88, DOI 10.1179/146195711798369427; Weishaupl B, 2014, CONSERVATUM EST FEST, P457	52	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0151442	10.1371/journal.pone.0151442	http://dx.doi.org/10.1371/journal.pone.0151442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DK4OR	27100391	Green Published, Green Accepted, gold			2022-12-27	WOS:000374898500005
J	Grassme, KS; Garza-Garcia, A; Delgado, JP; Godwin, JW; Kumar, A; Gates, PB; Driscoll, PC; Brockes, JP				Grassme, Kathrin S.; Garza-Garcia, Acely; Delgado, Jean-Paul; Godwin, James W.; Kumar, Anoop; Gates, Phillip B.; Driscoll, Paul C.; Brockes, Jeremy P.			Mechanism of Action of Secreted Newt Anterior Gradient Protein	PLOS ONE			English	Article							LIMB REGENERATION; XENOPUS-LAEVIS; AGR2; METASTASIS; GENE; CONVERGENCE; THIOREDOXIN; EXPRESSION; REQUIRES; GROWTH	Anterior gradient (AG) proteins have a thioredoxin fold and are targeted to the secretory pathway where they may act in the ER, as well as after secretion into the extracellular space. A newt member of the family (nAG) was previously identified as interacting with the GPI-anchored salamander-specific three-finger protein called Prod1. Expression of nAG has been implicated in the nerve dependence of limb regeneration in salamanders, and nAG acted as a growth factor for cultured newt limb blastemal (progenitor) cells, but the mechanism of action was not understood. Here we show that addition of a peptide antibody to Prod1 specifically inhibit the proliferation of blastema cells, suggesting that Prod1 acts as a cell surface receptor for secreted nAG, leading to S phase entry. Mutation of the single cysteine residue in the canonical active site of nAG to alanine or serine leads to protein degradation, but addition of residues at the C terminus stabilises the secreted protein. The mutation of the cysteine residue led to no detectable activity on S phase entry in cultured newt limb blastemal cells. In addition, our phylogenetic analyses have identified a new Caudata AG protein called AG4. A comparison of the AG proteins in a cell culture assay indicates that nAG secretion is significantly higher than AGR2 or AG4, suggesting that this property may vary in different members of the family.	[Grassme, Kathrin S.; Delgado, Jean-Paul; Godwin, James W.; Kumar, Anoop; Gates, Phillip B.; Brockes, Jeremy P.] UCL, Inst Struct & Mol Biol, Div Biosci, London, England; [Garza-Garcia, Acely; Driscoll, Paul C.] Francis Crick Inst, Mill Hill Lab, London, England; [Grassme, Kathrin S.] Boston Healthcare Associates Int Gmbh, Berlin, Germany; [Delgado, Jean-Paul] Univ Antioquia, Inst Biol, Grp Genet Regenerac & Canc, Medellin, Colombia; [Godwin, James W.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia	University of London; Birkbeck University London; University College London; Francis Crick Institute; Universidad de Antioquia; Australian Regenerative Medicine Institute; Monash University	Driscoll, PC (corresponding author), Francis Crick Inst, Mill Hill Lab, London, England.	paul.driscoll@crick.ac.uk	delgado, jean paul/AAH-4374-2021	Godwin, James/0000-0002-9234-7807; Garza-Garcia, Acely/0000-0003-0307-0138; Driscoll, Paul/0000-0002-4124-6950	Medical Research Council (MRC grant) [G1000870]; MRC [U117574559]; Medical Research Council [G1000870, G0701297] Funding Source: researchfish; MRC [G0701297, G1000870] Funding Source: UKRI	Medical Research Council (MRC grant)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The JB group is supported by the Medical Research Council, http://www.mrc.ac.uk (MRC grant code G1000870), and a Non-clinical Research Professorship to JPB. PD and AG were funded by the MRC (file reference U117574559). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullayev I, 2013, EXP CELL RES, V319, P1187, DOI 10.1016/j.yexcr.2013.02.013; Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Arumugam T, 2015, MOL CANCER THER, V14, P941, DOI 10.1158/1535-7163.MCT-14-0470; Baddar NWA, 2015, METHODS MOL BIOL, V1290, P321, DOI 10.1007/978-1-4939-2495-0_25; Bergstrom JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104186; Blassberg RA, 2011, J CELL SCI, V124, P47, DOI 10.1242/jcs.076331; Brychtova V, 2011, CANCER LETT, V304, P1, DOI 10.1016/j.canlet.2010.12.023; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034408; Chevet E, 2013, ONCOGENE, V32, P2499, DOI 10.1038/onc.2012.346; Clarke C, 2015, MOL CELL BIOCHEM, V408, P245, DOI 10.1007/s11010-015-2502-3; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; Dong AW, 2015, J BIOL CHEM, V290, P8016, DOI 10.1074/jbc.M114.623207; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta A, 2013, J BIOL CHEM, V288, P4321, DOI 10.1074/jbc.M112.433086; Gupta A, 2012, J BIOL CHEM, V287, P4773, DOI 10.1074/jbc.M111.301531; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ivanova AS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08123; Ivanova AS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01279; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Keane T.M., 2004, MODELGENERATOR AMINO; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Kumar Anoop, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5367; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Looso M, 2015, METHODS MOL BIOL, V1290, P337, DOI 10.1007/978-1-4939-2495-0_26; Nguyen VD, 2011, CRYSTAL STRUCTURE HU, V3; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Patel P, 2013, J MOL BIOL, V425, P929, DOI 10.1016/j.jmb.2012.12.009; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ryu J, 2013, BIOCHEM BIOPH RES CO, V430, P610, DOI 10.1016/j.bbrc.2012.11.105; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Tereshina MB, 2014, BIOL OPEN, V3, P192, DOI 10.1242/bio.20147401; Thompson DA, 1997, J STEROID BIOCHEM, V62, P143, DOI 10.1016/S0960-0760(97)00029-0; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008	38	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154176	10.1371/journal.pone.0154176	http://dx.doi.org/10.1371/journal.pone.0154176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100463	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500161
J	Hou, JJ; Jiang, PP; Qi, SM; Zhang, K; He, QX; Xu, CZ; Ding, ZH; Zhang, KW; Li, KP				Hou, Jiajia; Jiang, Pingping; Qi, Shoumei; Zhang, Ke; He, Qiuxia; Xu, Changzheng; Ding, Zhaohua; Zhang, Kewei; Li, Kunpeng			Isolation and Functional Validation of Salinity and Osmotic Stress Inducible Promoter from the Maize Type-II H+-Pyrophosphatase Gene by Deletion Analysis in Transgenic Tobacco Plants	PLOS ONE			English	Article							ENHANCES SALT TOLERANCE; ROOT-SPECIFIC GENE; HETEROLOGOUS EXPRESSION; MOLECULAR-CLONING; THELLUNGIELLA-HALOPHILA; REGULATORY ELEMENTS; DROUGHT TOLERANCE; DNA ELEMENTS; PPASE GENE; ARABIDOPSIS	Salinity and drought severely affect both plant growth and productivity, making the isolation and characterization of salinity-or drought-inducible promoters suitable for genetic improvement of crop resistance highly desirable. In this study, a 1468-bp sequence upstream of the translation initiation codon ATG of the promoter for ZmGAPP (maize Type-II H+-pyrophosphatase gene) was cloned. Nine 5' deletion fragments (D1-D9) of different lengths of the ZmGAPP promoter were fused with the GUS reporter and translocated into tobacco. The deletion analysis showed that fragments D1-D8 responded well to NaCl and PEG stresses, whereas fragment D9 and CaMV 35S did not. The D8 segment (219 bp; -219 to -1 bp) exhibited the highest promoter activity of all tissues, with the exception of petals among the D1-D9 transgenic tobacco, which corresponds to about 10% and 25% of CaMV 35S under normal and NaCl or PEG stress conditions, respectively. As such, the D8 segment may confer strong gene expression in a salinity and osmotic stress inducible manner. A 71-bp segment (-219 to -148 bp) was considered as the key region regulating ZmGAPP response to NaCl or PEG stress, as transient transformation assays demonstrated that the 71-bp sequence was sufficient for the salinity or osmotic stress response. These results enhance our understanding of the molecular mechanisms regulating ZmGAPP expression, and that the D8 promoter would be an ideal candidate for moderating expression of drought and salinity response genes in transgenic plants.	[Hou, Jiajia; Jiang, Pingping; Qi, Shoumei; Zhang, Ke; Zhang, Kewei; Li, Kunpeng] Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Innovat, Shanda South Rd 27, Jinan 250100, Shandong, Peoples R China; [He, Qiuxia] Shandong Acad Sci, Inst Biol, Jinan, Shandong, Peoples R China; [Xu, Changzheng] Southwest Univ, Coll Resources & Environm, RCBB, Tiansheng Rd 2, Chongqing 400716, Peoples R China; [Ding, Zhaohua] Shandong Acad Agr Sci, Maize Inst, Jinan, Shandong, Peoples R China	Shandong University; Qilu University of Technology; Southwest University - China; Shandong Academy of Agricultural Sciences	Li, KP (corresponding author), Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Innovat, Shanda South Rd 27, Jinan 250100, Shandong, Peoples R China.	likp@sdu.edu.cn	zhang, ke/AAH-8217-2019; Xu, Changzheng/AAD-4043-2021	Xu, Changzheng/0000-0002-4048-3620; Li, Kunpeng/0000-0003-1807-4545	National Program of Transgenic Variety Development of China [2014ZX0800922B]; State Key Laboratory of Crop Biology [2015KF03]; Shandong Province Agricultural Seed Project of China [SDLZGC2014960302]	National Program of Transgenic Variety Development of China; State Key Laboratory of Crop Biology; Shandong Province Agricultural Seed Project of China	This work was supported by grants from the National Program of Transgenic Variety Development of China (2014ZX0800922B), State Key Laboratory of Crop Biology (2015KF03) and Shandong Province Agricultural Seed Project of China (SDLZGC2014960302)	Agarwal PK, 2013, MOL BIOTECHNOL, V54, P102, DOI 10.1007/s12033-012-9538-3; BALLAS N, 1995, P NATL ACAD SCI USA, V92, P3483, DOI 10.1073/pnas.92.8.3483; Bang SW, 2013, PLANTA, V237, P211, DOI 10.1007/s00425-012-1764-1; Bao AK, 2009, PLANT SCI, V176, P232, DOI 10.1016/j.plantsci.2008.10.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carre IA, 1995, PLANT CELL, V7, P2039, DOI 10.2307/3870149; CASTRESANA C, 1988, EMBO J, V7, P1929, DOI 10.1002/j.1460-2075.1988.tb03030.x; Chen AP, 2007, J PLANT RES, V120, P337, DOI 10.1007/s10265-006-0058-8; Chen L, 2015, PLANT CELL TISS ORG, V121, P259, DOI 10.1007/s11240-014-0682-2; Cheon BY, 2004, TRANSGENIC RES, V13, P541, DOI 10.1007/s11248-004-2737-3; CORNEJO MJ, 1993, PLANT MOL BIOL, V23, P567, DOI 10.1007/BF00019304; De Wilde C, 2000, PLANT MOL BIOL, V43, P347, DOI 10.1023/A:1006464304199; Delaney SK, 2007, PLANT CELL PHYSIOL, V48, P1426, DOI 10.1093/pcp/pcm111; Dong Q, 2015, APPL BIOCHEM BIOTECH, V175, P1344, DOI 10.1007/s12010-014-1277-4; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Drozdowicz YM, 2000, PLANT PHYSIOL, V123, P353, DOI 10.1104/pp.123.1.353; Furtado A, 2005, PLANT BIOTECHNOL J, V3, P421, DOI 10.1111/j.1467-7652.2005.00135.x; Gao F, 2006, J EXP BOT, V57, P3259, DOI 10.1093/jxb/erl090; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Guo SL, 2006, PLANT MOL BIOL, V60, P41, DOI 10.1007/s11103-005-2417-6; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P283, DOI 10.1016/j.tibtech.2005.04.009; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Han YJ, 2015, PLANT CELL REP, V34, P265, DOI 10.1007/s00299-014-1705-5; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hsieh TH, 2002, PLANT PHYSIOL, V130, P618, DOI 10.1104/pp.006783; Huda KMK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057803; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeon JS, 1999, PLANT MOL BIOL, V39, P35, DOI 10.1023/A:1006157603096; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kaur C, 2015, MOL BIOL REP, V42, P1139, DOI 10.1007/s11033-015-3851-4; KOLTUNOW AM, 1990, PLANT CELL, V2, P1201, DOI 10.1105/tpc.2.12.1201; Kumpatla SP, 1998, TRENDS PLANT SCI, V3, P97, DOI 10.1016/S1360-1385(97)01194-1; Lai CX, 2009, PLANT CELL REP, V28, P851, DOI 10.1007/s00299-009-0689-z; LAURSEN NB, 1994, PLANT CELL, V6, P659, DOI 10.1105/tpc.6.5.659; Lee JT, 2003, PLANT CELL ENVIRON, V26, P1181, DOI 10.1046/j.1365-3040.2003.01048.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li B, 2008, PLANT BIOTECHNOL J, V6, P146, DOI 10.1111/j.1467-7652.2007.00301.x; Li XJ, 2014, J EXP BOT, V65, P683, DOI 10.1093/jxb/ert442; Li ZG, 2010, PLANT CELL ENVIRON, V33, P272, DOI 10.1111/j.1365-3040.2009.02080.x; Liu L, 2011, J INTEGR PLANT BIOL, V53, P731, DOI 10.1111/j.1744-7909.2011.01066.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv SL, 2009, PLANTA, V229, P899, DOI 10.1007/s00425-008-0880-4; Lv S, 2008, PLANT CELL PHYSIOL, V49, P1150, DOI 10.1093/pcp/pcn090; Lv SL, 2015, PLANT CELL ENVIRON, V38, P2433, DOI 10.1111/pce.12557; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Marraccini P, 2003, PLANT PHYSIOL BIOCH, V41, P17, DOI 10.1016/S0981-9428(02)00004-9; MATZKE MA, 1995, TRENDS GENET, V11, P1, DOI 10.1016/S0168-9525(00)88973-8; Mitsuda N, 2001, FEBS LETT, V488, P29, DOI 10.1016/S0014-5793(00)02400-5; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Opsahl-Sorteberg HG, 2004, GENE, V341, P49, DOI 10.1016/j.gene.2004.06.059; Pan YL, 2015, PLANTA, V241, P57, DOI 10.1007/s00425-014-2164-5; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Pasapula V, 2011, PLANT BIOTECHNOL J, V9, P88, DOI 10.1111/j.1467-7652.2010.00535.x; PAUL W, 1992, PLANT MOL BIOL, V19, P611, DOI 10.1007/BF00026787; Peremarti A, 2010, PLANT MOL BIOL, V73, P363, DOI 10.1007/s11103-010-9628-1; Potenza C, 2004, IN VITRO CELL DEV-PL, V40, P1, DOI 10.1079/IVP2003477; Qu LQ, 2004, PLANT BIOTECHNOL J, V2, P113, DOI 10.1111/j.1467-7652.2004.00055.x; Rai M, 2009, TRANSGENIC RES, V18, P787, DOI 10.1007/s11248-009-9263-2; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; SCHLEDZEWSKI K, 1994, TRANSGENIC RES, V3, P249, DOI 10.1007/BF02336778; Sun QH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-90; Tao YB, 2015, PLANTA, V241, P823, DOI 10.1007/s00425-014-2222-z; Tavakol E, 2014, GENE, V549, P24, DOI 10.1016/j.gene.2014.07.020; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thilmony R, 2009, PLANT BIOTECHNOL J, V7, P867, DOI 10.1111/j.1467-7652.2009.00449.x; Verdaguer B, 1996, PLANT MOL BIOL, V31, P1129, DOI 10.1007/BF00040830; Vijayan J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00371; VOELKER T, 1987, EMBO J, V6, P3571, DOI 10.1002/j.1460-2075.1987.tb02687.x; Wu G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00198; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V236, P331, DOI 10.1007/BF00277130; YAMAMOTO YT, 1991, PLANT CELL, V3, P371, DOI 10.1105/tpc.3.4.371; Yang YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087283; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Yue GD, 2008, DNA SEQUENCE, V19, P79, DOI 10.1080/10425170701445519; Zavallo D, 2010, PLANT CELL REP, V29, P239, DOI 10.1007/s00299-010-0816-x; Zhang Y, 2008, PLANT CELL REP, V27, P585, DOI 10.1007/s00299-007-0459-8; Zhao JS, 2007, PLANT CELL REP, V26, P1521, DOI 10.1007/s00299-007-0362-3; Zhou J, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-29	81	29	30	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154041	10.1371/journal.pone.0154041	http://dx.doi.org/10.1371/journal.pone.0154041			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101137	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500130
J	Matsudaira, I; Yokota, S; Hashimoto, T; Takeuchi, H; Asano, K; Asano, M; Sassa, Y; Taki, Y; Kawashima, R				Matsudaira, Izumi; Yokota, Susumu; Hashimoto, Teruo; Takeuchi, Hikaru; Asano, Kohei; Asano, Michiko; Sassa, Yuko; Taki, Yasuyuki; Kawashima, Ryuta			Parental Praise Correlates with Posterior Insular Cortex Gray Matter Volume in Children and Adolescents	PLOS ONE			English	Article							ANTERIOR INSULA; PREDICTS; PERSONALITY; LINKS	A positive parenting style affects psychological and cognitive development in children. Neuroimaging studies revealed that a positive parenting style influenced brain structure in children. Parental praise is a concrete behavior observed in positive parenting. Although previous psychological studies revealed a positive effect of parental praise on children, little is known about the relationship between parental praise and brain structure in children. Thus, the purpose of the present study was to determine whether there was a correlation between the parental attitude towards praising their child and gray matter volume in the children (116 boys and 109 girls; mean age, 10.6 years old). We examined the correlation between regional gray matter volume and parental praise using voxel-based morphometry (VBM) following magnetic resonance imaging (MRI). In addition, to confirm the positive effects of parental praise, we analyzed the correlation between the frequency of parental praise and personality traits in children. We showed that the parental attitude towards praising their child was significantly and positively correlated with the gray matter volume of the left posterior insular cortex in children. Moreover, we found a significant positive correlation between parental attitude towards praising their child and the personality traits of conscientiousness and openness to experience in the children. Prior studies said that gray matter volume in the posterior insula was correlated with empathy, and the functional connectivity between this area and the amygdala was associated with emotional regulation. Furthermore, the posterior insula relates to auditory function, and therefore, was likely involved in the processing of parental praise. Considering the possibility of experience-dependent plasticity, frequent parental praise would lead to increased posterior insular gray matter volume in children. Our study is the first to elucidate the relationship between a specific positive parenting behavior and brain structure in children.	[Matsudaira, Izumi; Taki, Yasuyuki] Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Yokota, Susumu; Hashimoto, Teruo; Takeuchi, Hikaru; Asano, Kohei; Asano, Michiko; Sassa, Yuko; Taki, Yasuyuki; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki] Tohoku Univ, Div Med Neuroimaging Anal, Dept Community Med Supports, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Smart Aging Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Yokota, S (corresponding author), Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	yokota.e1@tohoku.ac.jp	Takeuchi, Hikaru/D-1057-2011; Hashimoto, Teruo/C-4196-2013	Hashimoto, Teruo/0000-0002-5327-0667; Takeuchi, Hikaru/0000-0002-8022-9694	Ministry of Education, Culture, Sports, Science and Technology [20790875]; Kumon Institute of Education Co., Ltd.	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kumon Institute of Education Co., Ltd.	This study was funded by a Grant-in-Aid for Young Scientists (B), 20790875, from the Ministry of Education, Culture, Sports, Science and Technology. This study was also funded by Kumon Institute of Education Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2010, AM J NEURORADIOL, V31, P131, DOI 10.3174/ajnr.A1789; Azuma H, 2002, FAMILY DIAGNOSTIC TE; Bamiou DE, 2003, BRAIN RES REV, V42, P143, DOI 10.1016/S0165-0173(03)00172-3; BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x; Baumrind D, 1989, REARING COMPETENT CH, P349; Brummelman E, 2014, J EXP PSYCHOL GEN, V143, P9, DOI 10.1037/a0031917; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Denny BT, 2014, SOC COGN AFFECT NEUR, V9, P1660, DOI 10.1093/scan/nst160; Ebisch SJH, 2011, HUM BRAIN MAPP, V32, P1013, DOI 10.1002/hbm.21085; FELSON RB, 1989, J MARRIAGE FAM, V51, P727, DOI 10.2307/352171; Giuliani NR, 2011, NEUROIMAGE, V58, P10, DOI 10.1016/j.neuroimage.2011.06.028; Goerlich-Dobre KS, 2015, HUM BRAIN MAPP, V36, P3805, DOI 10.1002/hbm.22879; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Gunderson EA, 2013, CHILD DEV, V84, P1526, DOI 10.1111/cdev.12064; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Kamins ML, 1999, DEV PSYCHOL, V35, P835, DOI 10.1037/0012-1649.35.3.835; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Luby JL, 2012, P NATL ACAD SCI USA, V109, P2854, DOI 10.1073/pnas.1118003109; Malhi P, 2014, INDIAN J PEDIATR, V81, P333, DOI 10.1007/s12098-013-1154-0; Mesulam EJM M.M., 1985, CEREB CORTEX, V4, P179; Mesurado B, 2013, CHILDRENS PERCEPTION, P1; Michiaki Nagai, 2002, ADV RES NERV SYST IG, V46, P157; Murakami Y., 1997, JPN J PERSONAL, V6, P29, DOI DOI 10.2132/JJPJSPP.6.1_29; Murakami Y., 2010, JAPANESE J BEHAV, V37, P93; Nakagawa S, 2015, NEUROIMAGE, V105, P248, DOI 10.1016/j.neuroimage.2014.11.004; Nieuwenhuys R, 2012, PROG BRAIN RES, V195, P123, DOI 10.1016/B978-0-444-53860-4.00007-6; O'Connor BP, 2002, J PERS SOC PSYCHOL, V83, P962, DOI 10.1037//0022-3514.83.4.962; Ohira Hideki, 2014, Brain Nerve, V66, P417; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen DJ, 2012, CLIN CHILD FAM PSYCH, V15, P364, DOI 10.1007/s10567-012-0120-0; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; Polcari A, 2014, CHILD ABUSE NEGLECT, V38, P91, DOI 10.1016/j.chiabu.2013.10.003; Raboteg-Saric Z, 2014, APPL RES QUAL LIFE, V9, P749, DOI 10.1007/s11482-013-9268-0; Reti IM, 2002, PSYCHIAT RES, V111, P55, DOI 10.1016/S0165-1781(02)00128-2; Roopnarine JL, 2006, EARLY CHILD RES Q, V21, P238, DOI 10.1016/j.ecresq.2006.04.007; Seay A, 2014, NURS FORUM, V49, P200, DOI 10.1111/nuf.12093; Sheikh HI, 2014, NEUROIMAGE-CLIN, V6, P77, DOI 10.1016/j.nicl.2014.08.013; Shinohara R, 2010, J EPIDEMIOL, V20, pS441, DOI 10.2188/jea.JE20090168; Sutton Carole, 2008, Community Pract, V81, P19; Takeuchi H, 2015, CEREB CORTEX, V25, P1188, DOI 10.1093/cercor/bht315; Takeuchi H, 2015, J NEUROSCI, V35, P2233, DOI 10.1523/JNEUROSCI.0598-14.2015; Taki Y, 2012, NEUROIMAGE, V59, P1023, DOI 10.1016/j.neuroimage.2011.08.092; Taki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015213; Tamura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08799; Terasawa Y, 2014, COGNITION EMOTION, V28, P1435, DOI 10.1080/02699931.2014.888988; Tomoda A, 2011, NEUROIMAGE, V54, pS280, DOI 10.1016/j.neuroimage.2010.05.027; Villemure C, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00281; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Wechsler D, 1991, WISC III MANUAL; Wechsler D., 1997, WECHSLER ADULT INTEL; Wechsler D., 1997, WAIS III WMS III TEC; Whittle S, 2014, DEV COGN NEUROS-NETH, V8, P7, DOI 10.1016/j.dcn.2013.10.006	52	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154220	10.1371/journal.pone.0154220	http://dx.doi.org/10.1371/journal.pone.0154220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27101139	gold, Green Published			2022-12-27	WOS:000374898500166
J	Sabatelli, L				Sabatelli, Lorenzo			Relationship between the Uncompensated Price Elasticity and the Income Elasticity of Demand under Conditions of Additive Preferences (vol 11, e0151390, 2016)	PLOS ONE			English	Correction																		Sabatelli L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151390	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154487	10.1371/journal.pone.0154487	http://dx.doi.org/10.1371/journal.pone.0154487			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101104	Green Published, gold			2022-12-27	WOS:000374898500190
J	Stoet, G; Bailey, DH; Moore, AM; Geary, DC				Stoet, Gijsbert; Bailey, Drew H.; Moore, Alex M.; Geary, David C.			Countries with Higher Levels of Gender Equality Show Larger National Sex Differences in Mathematics Anxiety and Relatively Lower Parental Mathematics Valuation for Girls	PLOS ONE			English	Article							MATH ANXIETY; INDIVIDUAL-DIFFERENCES; ROLE-MODELS; ACHIEVEMENT; SCIENCE; STRATIFICATION; EXPECTATIONS; ABILITY; CHOICES; SKILLS	Despite international advancements in gender equality across a variety of societal domains, the underrepresentation of girls and women in Science, Technology, Engineering, and Mathematics (STEM) related fields persists. In this study, we explored the possibility that the sex difference in mathematics anxiety contributes to this disparity. More specifically, we tested a number of predictions from the prominent gender stratification model, which is the leading psychological theory of cross-national patterns of sex differences in mathematics anxiety and performance. To this end, we analyzed data from 761,655 15-year old students across 68 nations who participated in the Programme for International Student Assessment (PISA). Most importantly and contra predictions, we showed that economically developed and more gender equal countries have a lower overall level of mathematics anxiety, and yet a larger national sex difference in mathematics anxiety relative to less developed countries. Further, although relatively more mothers work in STEM fields in more developed countries, these parents valued, on average, mathematical competence more in their sons than their daughters. The proportion of mothers working in STEM was unrelated to sex differences in mathematics anxiety or performance. We propose that the gender stratification model fails to account for these national patterns and that an alternative model is needed. In the discussion, we suggest how an interaction between socio-cultural values and sex-specific psychological traits can better explain these patterns. We also discuss implications for policies aiming to increase girls' STEM participation.	[Stoet, Gijsbert] Univ Glasgow, Sch Educ, Glasgow, Lanark, Scotland; [Bailey, Drew H.] Univ Calif Irvine, Sch Educ, Irvine, CA USA; [Moore, Alex M.; Geary, David C.] Univ Missouri, Dept Psychol Sci, Columbia, MO USA	University of Glasgow; University of California System; University of California Irvine; University of Missouri System; University of Missouri Columbia	Stoet, G (corresponding author), Univ Glasgow, Sch Educ, Glasgow, Lanark, Scotland.	gijsbert.stoet@glasgow.ac.uk	Stoet, Gijsbert/D-6710-2016	Stoet, Gijsbert/0000-0002-7557-483X	University of Glasgow	University of Glasgow	The University of Glasgow supported Gijsbert Stoet, Drew H. Bailey, and David C. Geary with an "International Partnership Development Funding (IPDF)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2012, LEARN INDIVID DIFFER, V22, P385, DOI 10.1016/j.lindif.2011.12.004; [Anonymous], 2015, BEHAV BRAIN SCI, DOI DOI 10.1177/2372732215601438; Ashcraft MH, 2009, J PSYCHOEDUC ASSESS, V27, P197, DOI 10.1177/0734282908330580; Ashcraft MH, 2002, CURR DIR PSYCHOL SCI, V11, P181, DOI 10.1111/1467-8721.00196; BAKER DP, 1993, SOCIOL EDUC, V66, P91, DOI 10.2307/2112795; Bamberger YM, 2014, J SCI EDUC TECHNOL, V23, P549, DOI 10.1007/s10956-014-9487-7; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beilock SL, 2010, P NATL ACAD SCI USA, V107, P1860, DOI 10.1073/pnas.0910967107; BENBOW C P, 1980, Science (Washington D C), V210, P1262, DOI 10.1126/science.7434028; BENBOW CP, 1983, SCIENCE, V222, P1029, DOI 10.1126/science.6648516; Betz DE, 2012, SOC PSYCHOL PERS SCI, V3, P738, DOI 10.1177/1948550612440735; Bieg M, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fpsyg.2075.01404, 10.3389/fpsyg.2015.01404]; Billger SM, 2009, ECON EDUC REV, V28, P393, DOI 10.1016/j.econedurev.2007.08.005; Briley DA, 2014, DEV PSYCHOL, V50, P2614, DOI 10.1037/a0038094; BRINTON MC, 1988, AM J SOCIOL, V94, P300, DOI 10.1086/228993; Bynner JM, 1997, CAREER DEV Q, V45, P305, DOI 10.1002/j.2161-0045.1997.tb00536.x; Carrington B, 2008, BRIT EDUC RES J, V34, P315, DOI 10.1080/01411920701532202; Ceci SJ, 2014, PSYCHOL SCI PUBL INT, V15, P75, DOI 10.1177/1529100614541236; Cheryan S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00049; Cohen J.E., 1988, STAT POWER ANAL BEHA; Devine A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-33; Domina T, 2014, CHILD DEV, V85, P1948, DOI 10.1111/cdev.12255; Eccles J, 2011, INT J BEHAV DEV, V35, P195, DOI 10.1177/0165025411398185; Eccles J, 2009, EDUC PSYCHOL-US, V44, P78, DOI 10.1080/00461520902832368; Ellison G, 2009, GENDER GAP SECONDARY; Else-Quest NM, 2010, PSYCHOL BULL, V136, P103, DOI 10.1037/a0018053; Ertl H, 2006, OXFORD REV EDUC, V32, P619, DOI 10.1080/03054980600976320; Farkas G, 2003, ANNU REV SOCIOL, V29, P541, DOI 10.1146/annurev.soc.29.010202.100023; Gaspard H, 2015, J EDUC PSYCHOL, V107, P663, DOI 10.1037/edu0000003; Goetz T, 2013, PSYCHOL SCI, V24, P2079, DOI 10.1177/0956797613486989; Grek S, 2009, J ED POLICY, V24; Guiso L, 2008, SCIENCE, V320, P1164, DOI 10.1126/science.1154094; HEMBREE R, 1990, J RES MATH EDUC, V21, P33, DOI 10.2307/749455; Hyde JS, 2014, ANNU REV PSYCHOL, V65, P373, DOI 10.1146/annurev-psych-010213-115057; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; HYDE JS, 1990, PSYCHOL WOMEN QUART, V14, P299, DOI 10.1111/j.1471-6402.1990.tb00022.x; Institute for Women's Policy Research, 2012, INCR OPP LOW INC WOM; Kell HJ, 2013, PSYCHOL SCI, V24, P648, DOI 10.1177/0956797612457784; Kuznetsova A., PACKAGE LMERTEST; Lazarides R, 2015, CONTEMP EDUC PSYCHOL, V41, P51, DOI 10.1016/j.cedpsych.2014.11.005; Lee J, 2009, LEARN INDIVID DIFFER, V19, P355, DOI 10.1016/j.lindif.2008.10.009; Leslie SJ, 2015, SCIENCE, V347, P262, DOI 10.1126/science.1261375; Lindberg SM, 2010, PSYCHOL BULL, V136, P1123, DOI 10.1037/a0021276; Lippa R, 1998, J PERS SOC PSYCHOL, V74, P996, DOI 10.1037/0022-3514.74.4.996; Lippa RA, 2006, AM PSYCHOL, V61, P639, DOI 10.1037/0003-066X.61.6.639; Lippa RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095960; Lippa RA, 2010, ARCH SEX BEHAV, V39, P990, DOI 10.1007/s10508-008-9460-8; Lubinski D, 2000, ANNU REV PSYCHOL, V51, P405, DOI 10.1146/annurev.psych.51.1.405; Lyons IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048076; Lyons IM, 2012, CEREB CORTEX, V22, P2102, DOI 10.1093/cercor/bhr289; Ma X, 1999, J RES MATH EDUC, V30, P520, DOI 10.2307/749772; Makel MC, PSYCHOL SCI IN PRESS; Maloney EA, 2015, PSYCHOL SCI, V26, P1480, DOI 10.1177/0956797615592630; Moore AM, 2015, ROUTLEDGE INT HDB DY, P326; Nielsen MW, 2015, NATURE, V525, P427, DOI 10.1038/525427a; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; OECD, 2014, PISA 2012 TECHN REP; OECD, 2003, PISA 2003 DAT AN MAN; OECD, 2013, RES WHAT STUD KNOW C, V1; OECD, 2003, PISA 2003 ASS FRAM; OECD, 2012, PISA 2009 TECHN REP; OECD, 2014, OECD SURV SOC EM SKI; OECD, 2004, LEARN TOM WORLD 1 RE; Parker PD, 2012, DEV PSYCHOL, V48, P1629, DOI 10.1037/a0029167; Programme UND, 2013, HUM DEV REP 2013; R Core Team, 2021, R LANGUAGE ENV STAT; RICHARDSON FC, 1972, J COUNS PSYCHOL, V19, P551, DOI 10.1037/h0033456; RIVERABATIZ FL, 1992, J HUM RESOUR, V27, P313, DOI 10.2307/145737; Schmitt DP, 2015, EVOL PSYCHOL-SER, P221, DOI 10.1007/978-3-319-09384-0_11; Stoet G, 2015, INTELLIGENCE, V48, P137, DOI 10.1016/j.intell.2014.11.006; Stoet G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057988; Su R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00189; Su R, 2009, PSYCHOL BULL, V135, P859, DOI 10.1037/a0017364; SUINN RM, 1972, J CLIN PSYCHOL, V28, P373, DOI 10.1002/1097-4679(197207)28:3+<373::AID-JCLP2270280320>3.0.CO;2-C; Supekar K, 2015, J NEUROSCI, V35, P12574, DOI 10.1523/JNEUROSCI.0786-15.2015; Tolley Kimberley., 2003, SCI ED AM GIRLS HIST; Tougaw PW, 2006, ENHANCING ENG RECRUI; Wai J, 2010, INTELLIGENCE, V38, P412, DOI 10.1016/j.intell.2010.04.006; Wang MT, 2013, PSYCHOL SCI, V24, P770, DOI 10.1177/0956797612458937; Wang Z, 2014, J CHILD PSYCHOL PSYC, V55, P1056, DOI 10.1111/jcpp.12224; Wiest LR., STRATEGIES ED SUPPOR; World Economic Forum, 2014, GLOBAL GENDER GAP RE; Young CB, 2012, PSYCHOL SCI, V23, P492, DOI 10.1177/0956797611429134	83	74	74	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153857	10.1371/journal.pone.0153857	http://dx.doi.org/10.1371/journal.pone.0153857			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100631	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500078
J	Li, F; Ma, J				Li, Fan; Ma, Jun			Pattern Selection in Network of Coupled Multi-Scroll Attractors	PLOS ONE			English	Article							SPATIAL COHERENCE RESONANCES; SPIRAL WAVES; NEURONAL NETWORKS; CARDIAC FIBRILLATION; NOISE; DYNAMICS; BREAKUP; SYSTEMS; MECHANISMS; GENERATION	Multi-scroll chaotic attractor makes the oscillator become more complex in dynamic behaviors. The collective behaviors of coupled oscillators with multi-scroll attractors are investigated in the regular network in two-dimensional array, which the local kinetics is described by an improved Chua circuit. A feasible scheme of negative feedback with diversity is imposed on the network to stabilize the spatial patterns. Firstly, the Chua circuit is improved by replacing the nonlinear term with Sine function to generate infinite aquariums so that multi-scroll chaotic attractors could be generated under appropriate parameters, which could be detected by calculating the Lyapunov exponent in the parameter region. Furthermore, negative feedback with different gains (D-1, D-2) is imposed on the local square center area A(2) and outer area A(1) of the network, it is found that spiral wave, target wave could be developed in the network under appropriate feedback gain with diversity and size of controlled area. Particularly, homogeneous state could be reached after synchronization by selecting appropriate feedback gain and controlled size in the network. Finally, the distribution for statistical factors of synchronization is calculated in the two-parameter space to understand the transition of pattern region. It is found that developed spiral waves, target waves often are associated with smaller factor of synchronization. These results show that emergence of sustained spiral wave and continuous target wave could be effective for further suppression of spatiotemporal chaos in network by generating stable pacemaker completely.	[Li, Fan] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan 430071, Peoples R China; [Li, Fan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Ma, Jun] Lanzhou Univ Technol, Dept Phys, Lanzhou 730050, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Lanzhou University of Technology	Ma, J (corresponding author), Lanzhou Univ Technol, Dept Phys, Lanzhou 730050, Peoples R China.	hyperchaos@163.com	Li, Fan/AGX-5549-2022; Ma, Jun/G-2376-2010	Li, Fan/0000-0002-9205-203X; Ma, Jun/0000-0002-6127-000X	National Natural Science Foundation of China [11265008, 11365014, 61164006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is partially supported by the National Natural Science Foundation of China under Grant Nos. 11265008, 11365014, and 61164006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi H, 1999, J Cardiol, V33 Suppl 1, P53; BAR M, 1994, J CHEM PHYS, V100, P1202, DOI 10.1063/1.466650; Cai MC, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.016208; Chen JX, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/34002; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Demirkol AS, 2008, IEEE INT SYMP CIRC S, P2374; Erichsen R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061917; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Gollub JP, 1999, REV MOD PHYS, V71, pS396, DOI 10.1103/RevModPhys.71.S396; Goryachev A, 1996, PHYS REV LETT, V76, P1619, DOI 10.1103/PhysRevLett.76.1619; Gosak M, 2009, PHYSICA D, V238, P506, DOI 10.1016/j.physd.2008.11.007; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Gu HG, 2013, PHYSICA A, V392, P1361, DOI 10.1016/j.physa.2012.11.049; He DH, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055204; HEAGY JF, 1994, PHYS REV E, V50, P1874, DOI 10.1103/PhysRevE.50.1874; Holden AV, 1997, NATURE, V387, P655, DOI 10.1038/42597; Hou ZH, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.280601; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Jiang LL, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103001; Jiang MX, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056202; Li F, 2016, NONLINEAR DYNAM, V84, P2305, DOI 10.1007/s11071-016-2646-z; Li WB, 2009, PHYS REV E, V79; Lu JH, 2004, IEEE T CIRCUITS-I, V51, P2476, DOI 10.1109/TCSI.2004.838151; Luo JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016214; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; Ma J, 2014, NONLINEAR DYNAM, V76, P1951, DOI 10.1007/s11071-014-1260-1; Ma J, 2013, SCI CHINA PHYS MECH, V56, P1126, DOI 10.1007/s11433-013-5096-3; Ma J, 2013, SCI CHINA PHYS MECH, V56, P952, DOI 10.1007/s11433-013-5070-0; Ma J, 2013, COMMUN NONLINEAR SCI, V18, P1665, DOI 10.1016/j.cnsns.2012.11.016; Pecora LM, 1998, PHYS REV LETT, V80, P2109, DOI 10.1103/PhysRevLett.80.2109; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; Pisarchik AN, 2014, PHYS REP, V540, P167, DOI 10.1016/j.physrep.2014.02.007; Qin H, 2014, SCI CHINA PHYS MECH, V57, P1918, DOI 10.1007/s11433-014-5466-5; Roth BJ, 2001, PHYSICA D, V150, P127, DOI 10.1016/S0167-2789(01)00145-2; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Schiff SJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178102; Sevilla-Escoboza R, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2015.0005; Sevilla-Escoboza R, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032804; Shajahan TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004738; Stich M, 2006, PHYSICA D, V215, P38, DOI 10.1016/j.physd.2006.01.011; SUYKENS JAK, 1993, IEEE T CIRCUITS-I, V40, P861, DOI 10.1109/81.251829; Tang WKS, 2001, IEEE T CIRCUITS-I, V48, P1369, DOI 10.1109/81.964432; Tang Z, 2012, COMMUN THEOR PHYS, V57, P61, DOI 10.1088/0253-6102/57/1/10; Wang QY, 2008, PHYS LETT A, V372, P5681, DOI 10.1016/j.physleta.2008.07.005; Wang QY, 2013, CHAOS SOLITON FRACT, V56, P19, DOI 10.1016/j.chaos.2013.05.003; Wu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055403; Xiao JH, 2005, EUROPHYS LETT, V69, P29, DOI 10.1209/epl/i2004-10310-7; Xu Y, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979215501647; Yagisita H, 1998, PHYSICA D, V124, P126, DOI 10.1016/S0167-2789(98)00182-1; Yalcin ME, 2002, INT J BIFURCAT CHAOS, V12, P23, DOI 10.1142/S0218127402004164; Yalcin ME, 2007, CHAOS SOLITON FRACT, V34, P1659, DOI 10.1016/j.chaos.2006.04.058	54	11	11	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2016	11	4							e0154282	10.1371/journal.pone.0154282	http://dx.doi.org/10.1371/journal.pone.0154282			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QZ	27119986	gold, Green Published, Green Submitted			2022-12-27	WOS:000374976200055
J	Bartsch, SM; Lopman, BA; Ozawa, S; Hall, AJ; Lee, BY				Bartsch, Sarah M.; Lopman, Benjamin A.; Ozawa, Sachiko; Hall, Aron J.; Lee, Bruce Y.			Global Economic Burden of Norovirus Gastroenteritis	PLOS ONE			English	Article							ACUTE GASTROINTESTINAL ILLNESS; SEEKING BEHAVIOR; UNITED-STATES; DIARRHEAL DURATION; COST-EFFECTIVENESS; DISEASE BURDEN; CARE-SEEKING; US ADULTS; CHILDREN; COMMUNITY	Background Despite accounting for approximately one fifth of all acute gastroenteritis illnesses, norovirus has received comparatively less attention than other infectious pathogens. With several candidate vaccines under development, characterizing the global economic burden of norovirus could help funders, policy makers, public health officials, and product developers determine how much attention and resources to allocate to advancing these technologies to prevent and control norovirus. Methods We developed a computational simulation model to estimate the economic burden of norovirus in every country/area (233 total) stratified by WHO region and globally, from the health system and societal perspectives. We considered direct costs of illness (e.g., clinic visits and hospitalization) and productivity losses. Results Globally, norovirus resulted in a total of $4.2 billion (95% UI: $3.2-5.7 billion) in direct health system costs and $60.3 billion (95% UI: $44.4-83.4 billion) in societal costs per year. Disease amongst children < 5 years cost society $39.8 billion, compared to $20.4 billion for all other age groups combined. Costs per norovirus illness varied by both region and age and was highest among adults >= 55 years. Productivity losses represented 84-99% of total costs varying by region. While low and middle income countries and high income countries had similar disease incidence (10,148 vs. 9,935 illness per 100,000 persons), high income countries generated 62% of global health system costs. In sensitivity analysis, the probability of hospitalization had the largest impact on health system cost estimates ($2.8 billion globally, assuming no hospitalization costs), while the probability of missing productive days had the largest impact on societal cost estimates ($35.9 billion globally, with a 25% probability of missing productive days). Conclusions The total economic burden is greatest in young children but the highest cost per illness is among older age groups in some regions. These large costs overwhelmingly are from productivity losses resulting from acute illness. Low, middle, and high income countries all have a considerable economic burden, suggesting that norovirus gastroenteritis is a truly global economic problem. Our findings can help identify which age group(s) and/or geographic regions may benefit the most from interventions.	[Bartsch, Sarah M.; Lee, Bruce Y.] Johns Hopkins Bloomberg Sch Publ Hlth, Publ Hlth Computat & Operat Res, Baltimore, MD USA; [Lopman, Benjamin A.; Hall, Aron J.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Ozawa, Sachiko] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lee, BY (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Publ Hlth Computat & Operat Res, Baltimore, MD USA.	brucelee@jhu.edu	Ozawa, Sachiko/Z-4944-2019	Ozawa, Sachiko/0000-0001-7608-9038	Agency for Healthcare Research and Quality (AHRQ) [R01HS023317]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Office of Behavioral and Social Sciences Research (OBSSR); Global Obesity Prevention Center (GOPC) [U54HD070725]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS023317] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD086861, U54HD070725] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Office of Behavioral and Social Sciences Research (OBSSR); Global Obesity Prevention Center (GOPC); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Agency for Healthcare Research and Quality (AHRQ) via grant R01HS023317, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Office of Behavioral and Social Sciences Research (OBSSR) and the Global Obesity Prevention Center (GOPC) via grant U54HD070725. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Adlam SB, 2011, EPIDEMIOL INFECT, V139, P302, DOI 10.1017/S0950268810000932; Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Bartsch SM, 2012, VACCINE, V30, P7097, DOI 10.1016/j.vaccine.2012.09.040; Baumann-Popczyk A, 2012, EPIDEMIOL INFECT, V140, P1173, DOI 10.1017/S0950268811001853; BLACK RE, 1984, AM J CLIN NUTR, V39, P87, DOI 10.1093/ajcn/39.1.87; Burke RM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-642; Cates SC, 2015, J FOOD PROTECT, V78, P484, DOI 10.4315/0362-028X.JFP-14-313; Chen Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-456; Danial J, 2011, J HOSP INFECT, V79, P354, DOI 10.1016/j.jhin.2011.06.018; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Grimwood Keith, 2010, Paediatr Drugs, V12, P235, DOI 10.2165/11537200-000000000-00000; GUERRANT RL, 1992, AM J TROP MED HYG, V47, P28, DOI 10.4269/ajtmh.1992.47.28; Hall AJ, 2014, MMWR-MORBID MORTAL W, V63, P491; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Head MG, 2014, J ROY SOC MED, V107, P110, DOI 10.1177/0141076813511450; Howidi M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-74; Institute for Health Metrics and Evaluation ( IHME), 2010, GLOB BURD DIS GBD DA; Institute for Health Metrics and Evaluation ( IHME), GLOB BURD DIS GLOB H; Johnston CP, 2007, CLIN INFECT DIS, V45, P534, DOI 10.1086/520666; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lee BY, 2008, CLIN INFECT DIS, V46, P1139, DOI 10.1086/529441; Lee BY, 2011, INFECT CONT HOSP EP, V32, P191, DOI 10.1086/657910; Loganathan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125878; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Marshall JA, 2003, J MED VIROL, V69, P568, DOI 10.1002/jmv.10346; Motlagh ME, 2012, INT J PREVENTIVE MED, V3, P60; Patel AB, 2012, INDIAN J PEDIATR, V79, P472, DOI 10.1007/s12098-011-0561-3; Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021; Pires SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142927; Porter CK, 2012, CLIN INFECT DIS, V55, P915, DOI 10.1093/cid/cis576; Ramani S, 2014, CURR OPIN GASTROEN, V30, P25, DOI 10.1097/MOG.0000000000000022; Rheingans RD, 2009, J INFECT DIS, V200, pS16, DOI 10.1086/605026; Robinson AE, 2014, GLOBAL TRENDS CARE S; Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408; Saha D, 2013, AM J TROP MED HYG, V89, P13, DOI 10.4269/ajtmh.12-0751; Saito M, 2014, CLINICAL INFECTIOUS, V8, P483; Sang XL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-787; Scallan E, 2005, INT J EPIDEMIOL, V34, P454, DOI 10.1093/ije/dyh413; Scavia G, 2012, EPIDEMIOL INFECT, V140, P1193, DOI 10.1017/S0950268811002020; SCHORLING JB, 1990, INT J EPIDEMIOL, V19, P728, DOI 10.1093/ije/19.3.728; Simanjuntak CH, 2004, J HEALTH POPUL NUTR, V22, P119; Sur D, 2004, J HEALTH POPUL NUTR, V22, P130; Tate JE, 2009, J INFECT DIS, V200, pS76, DOI 10.1086/605058; Tee GH, 2011, SE ASIAN J TROP MED, V42, P424; The World Bank, 2015, GNI CAP ATL METH CUR; U. S. Census Bureau, NAT POP EST 2010; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; United Nations Statistics Division, 2015, UNDATA GNI CAP; United States Department of Health & Human Services, 2012, HCUP FACTS FIG STAT; Van Cauteren D, 2012, EPIDEMIOL INFECT, V140, P697, DOI 10.1017/S0950268811000999; Verhoef L, 2013, EPIDEMIOL INFECT, V141, P496, DOI 10.1017/S0950268812000799; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker CLF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000768; World Bank, 2014, UPD INC CLASS; World Health Organization, 2019, CHOOSING INT AR COST; World Health Organization, 2009, WHO GUID ID EC CONS; World Health Organization, 2013, GLOB HLTH OBS COUNTR; World Health Organization, GLOB BURD DIS REG US; Zingg W, 2005, INFECT CONT HOSP EP, V26, P263, DOI 10.1086/502537	59	273	300	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0151219	10.1371/journal.pone.0151219	http://dx.doi.org/10.1371/journal.pone.0151219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115736	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600010
J	Bowden, JA; Cantu, TM; Chapman, RW; Somerville, SE; Guillette, MP; Botha, H; Hoffman, A; Luus-Powell, WJ; Smit, WJ; Lebepe, J; Myburgh, J; Govender, D; Tucker, J; Boggs, ASP; Guillette, LJ				Bowden, John A.; Cantu, Theresa M.; Chapman, Robert W.; Somerville, Stephen E.; Guillette, Matthew P.; Botha, Hannes; Hoffman, Andre; Luus-Powell, Wilmien J.; Smit, Willem J.; Lebepe, Jeffrey; Myburgh, Jan; Govender, Danny; Tucker, Jonathan; Boggs, Ashley S. P.; Guillette, Louis J., Jr.			Predictive Blood Chemistry Parameters for Pansteatitis-Affected Mozambique Tilapia (Oreochromis mossambicus)	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; CROCODILE CROCODYLUS-NILOTICUS; CLARIAS-GARIEPINUS BURCHELL; NILE CROCODILE; OLIFANTS RIVER; SHARPTOOTH CATFISH; SOUTH-AFRICA; CLINICAL-CHEMISTRY; OXIDATIVE STRESS; HEAVY-METALS	One of the largest river systems in South Africa, the Olifants River, has experienced significant changes in water quality due to anthropogenic activities. Since 2005, there have been various "outbreaks" of the inflammatory disease pansteatitis in several vertebrate species. Large-scale pansteatitis-related mortality events have decimated the crocodile population at Lake Loskop and decreased the population at Kruger National Park. Most pansteatitis-related diagnoses within the region are conducted post-mortem by either gross pathology or histology. The application of a non-lethal approach to assess the prevalence and pervasiveness of pansteatitis in the Olifants River region would be of great importance for the development of a management plan for this disease. In this study, several plasma-based biomarkers accurately classified pansteatitis in Mozambique tilapia (Oreochromis mossambicus) collected from Lake Loskop using a commercially available benchtop blood chemistry analyzer combined with data interpretation via artificial neural network analysis. According to the model, four blood chemistry parameters (calcium, sodium, total protein and albumin), in combination with total length, diagnose pansteatitis to a predictive accuracy of 92 percent. In addition, several morphometric traits (total length, age, weight) were also associated with pansteatitis. On-going research will focus on further evaluating the use of blood chemistry to classify pansteatitis across different species, trophic levels, and within different sites along the Olifants River.	[Bowden, John A.; Boggs, Ashley S. P.] NIST, Mat Measurement Lab, Div Chem Sci, Environm Chem Sci Grp,Hollings Marine Lab, Charleston, SC USA; [Cantu, Theresa M.; Somerville, Stephen E.; Guillette, Matthew P.; Guillette, Louis J., Jr.] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA; [Chapman, Robert W.; Tucker, Jonathan] South Carolina Dept Nat Resources, Marine Resources Res Inst, Hollings Marine Lab, Charleston, SC USA; [Botha, Hannes; Hoffman, Andre] Mpumalanga Tourism & Pk Agcy, Sci Serv, Nelspruit, South Africa; [Botha, Hannes; Luus-Powell, Wilmien J.; Smit, Willem J.; Lebepe, Jeffrey] Univ Limpopo, Dept Biodivers, Sovenga, South Africa; [Myburgh, Jan; Govender, Danny; Guillette, Louis J., Jr.] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0110 Onderstepoort, South Africa; [Govender, Danny] South African Natl Pk, Sci Serv, Skukuza, South Africa	National Institute of Standards & Technology (NIST) - USA; Medical University of South Carolina; University of Limpopo; University of Pretoria	Bowden, JA (corresponding author), NIST, Mat Measurement Lab, Div Chem Sci, Environm Chem Sci Grp,Hollings Marine Lab, Charleston, SC USA.	john.bowden@nist.gov	Govender, Danny/AAH-1699-2022; Govender, Danny/AFL-9589-2022; Botha, Hannes/J-1288-2019	Botha, Hannes/0000-0001-6870-5494; Lebepe, Jeffrey/0000-0001-9802-2846	CoEE Center for Marine Genomics; MUSC Center for Global Health; Heinz Foundation: Environmental Health and Sentinel Species; Biodiversity Research Chair, University of Limpopo	CoEE Center for Marine Genomics; MUSC Center for Global Health; Heinz Foundation: Environmental Health and Sentinel Species; Biodiversity Research Chair, University of Limpopo	This work was partially funded in part by the CoEE Center for Marine Genomics (LJG), MUSC Center for Global Health, Heinz Foundation: Environmental Health and Sentinel Species (2011, LJG), and the Biodiversity Research Chair, University of Limpopo (WJLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shayea QK, 2011, INT J COMPUT SCI ISS, V8, P150; Alharbi KB, 2012, TROP ANIM HEALTH PRO, V44, P173, DOI 10.1007/s11250-011-9905-2; [Anonymous], 1950, SRM D SRM; Ashton PJ, 2010, AQUAT CONSERV, V20, P489, DOI 10.1002/aqc.1132; Atkins A, 2010, J ZOO WILDLIFE MED, V41, P585, DOI 10.1638/2009-0023.1; Baral RM, 2014, J FELINE MED SURG, P1; BARSOTTI DA, 1976, FOOD COSMET TOXICOL, V14, P99, DOI 10.1016/S0015-6264(76)80251-9; Bertin MJ, 2014, AQUAT TOXICOL, V146, P1, DOI 10.1016/j.aquatox.2013.09.026; Bevelhimer MS, 2014, ENVIRON TOXICOL CHEM, V33, P1903, DOI 10.1002/etc.2622; BOLTEN AB, 1992, J WILDLIFE DIS, V28, P407, DOI 10.7589/0090-3558-28.3.407; Botha H, 2011, WATER SA, V37, P103; Bouwman H, 2014, ECOTOX ENVIRON SAFE, V104, P393, DOI 10.1016/j.ecoenv.2013.12.005; Bury NR, 1996, J EXP BIOL, V199, P1319; Caliendo Valentina, 2010, Journal of Herpetological Medicine and Surgery, V20, P117, DOI 10.5818/1529-9651-20.4.117; Ceron JJ, 2005, VET CLIN PATH, V34, P85, DOI 10.1111/j.1939-165X.2005.tb00019.x; Chen CY, 2003, AQUACULTURE, V218, P89, DOI 10.1016/S0044-8486(02)00499-4; da Silva AOF, 2014, AQUAT TOXICOL, V156, P161, DOI 10.1016/j.aquatox.2014.08.009; Dabrowski J, 2014, FRESHWATER BIOL, V59, P1484, DOI 10.1111/fwb.12360; Dabrowski J, 2013, WATER SA, V39, P675, DOI 10.4314/wsa.v39i5.12; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Dove ADM, 2010, AQUAT BIOL, V9, P177, DOI 10.3354/ab00252; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Ferreira SM, 2011, AQUAT CONSERV, V21, P155, DOI 10.1002/aqc.1175; Ferri J, 2011, MAR ENVIRON RES, V71, P218, DOI 10.1016/j.marenvres.2011.01.006; Firat O, 2010, ARCH ENVIRON CON TOX, V58, P151, DOI 10.1007/s00244-009-9344-5; Friedman AN, 2010, J AM SOC NEPHROL, V21, P223, DOI 10.1681/ASN.2009020213; German AJ, 2003, J SMALL ANIM PRACT, V44, P449, DOI 10.1111/j.1748-5827.2003.tb00104.x; Goodwin AE, 2006, J FISH DIS, V29, P61, DOI 10.1111/j.1365-2761.2005.00686.x; Gopal V, 1997, ENVIRON MONIT ASSESS, V48, P117, DOI 10.1023/A:1005767517819; Greenacre CB, 2008, J AVIAN MED SURG, V22, P291, DOI 10.1647/2007-034.1; Huchzermeyer KDA, 2013, J FISH DIS, V36, P897, DOI 10.1111/jfd.12010; Huchzermeyer KDA, 2011, J FISH DIS, V34, P489, DOI 10.1111/j.1365-2761.2011.01267.x; Huchzermeyer K. David A., 2012, J. S. Afr. Vet. Assoc., V83, P41; Huchzermeyer KDA, 2012, THESIS U PRETORIA; Hussein SY, 1996, B ENVIRON CONTAM TOX, V57, P503, DOI 10.1007/s001289900218; Jooste A, 2015, ECOTOX ENVIRON SAFE, V112, P96, DOI 10.1016/j.ecoenv.2014.10.033; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kodama H, 2014, J FISH DIS, V37, P619, DOI 10.1111/jfd.12154; Kumar N, 2016, ENVIRON TOXICOL, V31, P106, DOI 10.1002/tox.22026; Lane EP, 2013, J ZOO WILDLIFE MED, V44, P899, DOI 10.1638/2012-0264R.1; LARSEN RE, 1983, J AM VET MED ASSOC, V183, P1202; Lattin CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102106; Mahlatji ML, 2014, IMPACT WATER SEDIMEN; Masango MG, 2010, J WILDLIFE DIS, V46, P95, DOI 10.7589/0090-3558-46.1.95; McCain SL, 2010, VET CLIN PATH, V39, P474, DOI 10.1111/j.1939-165X.2010.00258.x; McKinney P, 2007, NEWSLETTER MIDDLE E, P32; Misra S, 2012, TOXICOL IN VITRO, V26, P621, DOI 10.1016/j.tiv.2012.02.001; Mooney A., 2013, THESIS U JOHANNESBUR; Myburgh J., 2009, VET NEWS, P20; Nalabotu SK, 2011, INT J NANOMED, V6, P2327, DOI 10.2147/IJN.S25119; National Institute of Standards Technology, CERT AN STAND REF MA; Niza MMRE, 2003, J FELINE MED SURG, V5, P271, DOI 10.1016/S1098-612X(03)00051-2; Oberholster PJ, 2012, ECOTOX ENVIRON SAFE, V75, P134, DOI 10.1016/j.ecoenv.2011.08.018; Oberholster PJ, 2009, SIL NEWS, V55, P8; Obuchowski NA, 2004, CLIN CHEM, V50, P1118, DOI 10.1373/clinchem.2004.031823; OLIVEIRA RF, 1995, J FISH BIOL, V46, P1055, DOI 10.1006/jfbi.1995.0100; Osthoff G, 2010, COMP BIOCHEM PHYS A, V155, P64, DOI 10.1016/j.cbpa.2009.09.025; Palmeiro BS, 2007, JAVMA-J AM VET MED A, V230, P708, DOI 10.2460/javma.230.5.708; Pleadin J, 2012, B ENVIRON CONTAM TOX, V88, P1043, DOI 10.1007/s00128-012-0615-x; Rea LD, 1998, COMP BIOCHEM PHYS A, V120, P617, DOI 10.1016/S1095-6433(98)10074-0; Roberts RJ, 2008, J FISH DIS, V31, P83, DOI 10.1111/j.1365-2761.2007.00901.x; ROLETTO J, 1993, J ZOO WILDLIFE MED, V24, P145; Sepulveda MS, 2012, J AQUAT ANIM HEALTH, V24, P135, DOI 10.1080/08997659.2012.675927; Sharafeldin K, 2014, OREOCHROMIS NILOTICU, V4, P8; St Aubin DJ, 2001, ARCTIC, V54, P317, DOI 10.14430/arctic791; Stegeman N, 2010, J EXOT PET MED, V19, P298, DOI 10.1053/j.jepm.2010.10.009; Swanepoel D, 2000, ONDERSTEPOORT J VET, V67, P141; Tape TG, 2015, AREA ROC CURVE; Truter JC, 2016, J FISH DIS, V39, P69, DOI 10.1111/jfd.12324; Use of Fish in Research Committee (joint committee of the American Fisheries Society the American Institute of Fishery Research Biologists and the American Society of Ichthyologists and Herpetologists), 2014, GUID US FISH RES; Vonck APMA, 1998, COMP BIOCHEM PHYS A, V119, P441, DOI 10.1016/S1095-6433(97)00450-9; Whiting Scott D., 2007, Comparative Clinical Pathology, V16, P109, DOI 10.1007/s00580-006-0646-y; Wolf KN, 2008, JAVMA-J AM VET MED A, V233, P470, DOI 10.2460/javma.233.3.470; Woodborne S, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00170.1; ZWEIG MH, 1993, CLIN CHEM, V39, P561	75	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153874	10.1371/journal.pone.0153874	http://dx.doi.org/10.1371/journal.pone.0153874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115488	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600032
J	Han, YW; Niu, J; Wang, D; Li, YY				Han, Yuewen; Niu, Jun; Wang, Dong; Li, Yuanyuan			Hepatitis C Virus Protein Interaction Network Analysis Based on Hepatocellular Carcinoma	PLOS ONE			English	Article							REPLICATION; NS5A; P53; APOPTOSIS; EXPRESSION; LANDSCAPE; PATHWAYS; COMPLEX; NS3	Epidemiological studies have validated the association between hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC). An increasing number of studies show that protein-protein interactions (PPIs) between HCV proteins and host proteins play a vital role in infection and mediate HCC progression. In this work, we collected all published interaction between HCV and human proteins, which include 455 unique human proteins participating in 524 HCV-human interactions. Then, we construct the HCV-human and HCV-HCC protein interaction networks, which display the biological knowledge regarding the mechanism of HCV pathogenesis, particularly with respect to pathogenesis of HCC. Through in-depth analysis of the HCV-HCC interaction network, we found that interactors are enriched in the JAK/STAT, p53, MAPK, TNF, Wnt, and cell cycle pathways. Using a random walk with restart algorithm, we predicted the importance of each protein in the HCV-HCC network and found that AKT1 may play a key role in the HCC progression. Moreover, we found that NS5A promotes HCC cells proliferation and metastasis by activating AKT/GSK3 beta/beta-catenin pathway. This work provides a basis for a detailed map tracking new cellular interactions of HCV and identifying potential targets for HCV-related hepatocellular carcinoma treatment.	[Han, Yuewen; Li, Yuanyuan] Xian Ctr Dis Control & Prevent, Xian, Peoples R China; [Niu, Jun] Gen Hosp Shenyang Mil, Shenyang, Peoples R China; [Wang, Dong; Li, Yuanyuan] Air Force Aviat Med Identificat & Training Ctr, Dalian, Peoples R China		Li, YY (corresponding author), Xian Ctr Dis Control & Prevent, Xian, Peoples R China.; Li, YY (corresponding author), Air Force Aviat Med Identificat & Training Ctr, Dalian, Peoples R China.	wudui220@163.com	li, yuanyuan/GZA-4435-2022					Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; [Anonymous], HEP C FACTSH; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Chen QL, 2010, CELL BIOCHEM BIOPHYS, V56, P49, DOI 10.1007/s12013-009-9069-0; Choudhari SR, 2007, MOL CANCER THER, V6, P112, DOI 10.1158/1535-7163.MCT-06-0561; De Beeck AO, 2001, J GEN VIROL, V82, P2589, DOI 10.1099/0022-1317-82-11-2589; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gurtsevitch VE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P504, DOI 10.1134/S0006297908050039; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Igaki T, 2011, ADV EXP MED BIOL, V691, P45, DOI 10.1007/978-1-4419-6612-4_5; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kao CF, 2004, ONCOGENE, V23, P2472, DOI 10.1038/sj.onc.1207368; Kasprzak A, 2008, HEPATOL RES, V38, P1, DOI 10.1111/j.1872-034X.2007.00261.x; Knoess M, 2006, WORLD J GASTROENTERO, V12, P5870, DOI 10.3748/wjg.v12.i36.5870; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kwofie SK, 2011, INFECT GENET EVOL, V11, P1971, DOI 10.1016/j.meegid.2011.09.001; Kwun HJ, 2001, J GEN VIROL, V82, P2235, DOI 10.1099/0022-1317-82-9-2235; Li SS, 2012, CELL MICROBIOL, V14, P994, DOI 10.1111/j.1462-5822.2012.01773.x; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Lorenz IC, 2010, VIRUSES-BASEL, V2, P1635, DOI 10.3390/v2081635; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Park KJ, 2001, VIRUS RES, V74, P89, DOI 10.1016/S0168-1702(00)00251-3; Prikhod'ko EA, 2004, VIROLOGY, V329, P53, DOI 10.1016/j.virol.2004.08.012; Qadri I, 2002, BBA-MOL CELL RES, V1592, P193, DOI 10.1016/S0167-4889(02)00315-4; Roohvand F, 2009, J BIOL CHEM, V284, P13778, DOI 10.1074/jbc.M807873200; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tripathi LP, 2010, MOL BIOSYST, V6, P2539, DOI 10.1039/c0mb00103a; Tsao TT-H, 2011, PREDICTION ANAL INTE, P322; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839	41	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153882	10.1371/journal.pone.0153882	http://dx.doi.org/10.1371/journal.pone.0153882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115606	Green Submitted, gold, Green Published			2022-12-27	WOS:000374973600033
J	Peng, JM; Du, B; Wang, Q; Weng, L; Hu, XY; Wu, CY; Shi, Y				Peng, Jin-Min; Du, Bin; Wang, Qian; Weng, Li; Hu, Xiao-Yun; Wu, Chan-Yuan; Shi, Yan			Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients	PLOS ONE			English	Article							SYSTEMIC RHEUMATIC-DISEASES; CRITICALLY-ILL PATIENTS; INTERSTITIAL LUNG-DISEASE; LONG-TERM OUTCOMES; LUPUS-ERYTHEMATOSUS; PROGNOSTIC-FACTORS; AMYOPATHIC DERMATOMYOSITIS; AUTOIMMUNE-DISEASES; PERIPHERAL-BLOOD; INFECTIONS	Introduction Patients with idiopathic inflammatory myopathies (IIMs) are sometimes complicated with life-threatening conditions requiring intensive care unit (ICU) admission. In the past, owing to the low incidence of IIM, little was known about such patients. Our aim was to investigate the clinical features and outcomes of these patients and identify their risk factors for mortality. Methods A retrospective study was performed of IIM patients admitted over an 8-year period to the medical ICU of a tertiary referral center in China. We collected data regarding demographic features, IIM-related clinical characteristics, reasons for admission, organ dysfunction, and outcomes. Independent predictors of ICU mortality were identified through multivariate logistic regression analysis. Results Of the 102 patients in our cohort, polymyositis (PM), dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM) accounted for 23.5%, 64.7%, and 11.7% respectively. The median duration from the onset of IIM to ICU admission was 4.3 months (interquartile range [IQR], 2.6-9.4 months). Reasons for ICU admission were infection alone (39.2%), acute exacerbation of IIM alone (27.5%), the coexistence of both (27.5%), or other reasons (5.8%). Pneumonia accounted for 97% of the infections; 63.2% of infections with documented pathogens were caused by opportunistic agents. Rapid progressive interstitial lung disease (RP-ILD) was responsible for 87.5% of acute exacerbation of IIM. The median Acute Physiology and Chronic Health Evaluation II (APACHE II) score on ICU day 1 was 17 (IQR 14-20). On ICU admission, acute respiratory failure (ARF) was the most common type (80.4%) of organ failure. The mortality rate in the ICU was 79.4%. Factors associated with increased ICU mortality included a diagnosis of DM (including CADM), a high APACHE II score, the presence of ARF, a decreased PaO2/FiO(2) ratio, and a low lymphocyte count at the time of ICU admission. Conclusions The outcome of IIM patients admitted to the ICU was extremely poor. A diagnosis of DM/CADM, the presence and severity of ARF, and the lymphocyte counts at ICU admission were shown to be valuable for predicting outcome. Opportunistic infections and rapidly progressive interstitial lung disease warrant concern in treating these patients.	[Peng, Jin-Min; Du, Bin; Weng, Li; Hu, Xiao-Yun] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Med, Intens Care Unit, Beijing 100021, Peoples R China; [Peng, Jin-Min; Du, Bin; Wang, Qian; Weng, Li; Hu, Xiao-Yun; Wu, Chan-Yuan; Shi, Yan] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wang, Qian; Wu, Chan-Yuan] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China; [Shi, Yan] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen, Intens Care Unit, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Wang, Q (corresponding author), Chinese Acad Med Sci, Beijing 100730, Peoples R China.; Wang, Q (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China.	wangqian@pumch.cn		Wang, Qian/0000-0002-4541-9898; Weng, Li/0000-0003-0403-0752	National Natural Science Foundation of China [81471615]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Grant number: 81471615, URL: http://www.nsfc.gov.cn/, to W. Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton JM, 2012, CLIN EXP RHEUMATOL, V30, P338; Befort P, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-27; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Camargo JF, 2005, LUPUS, V14, P315, DOI 10.1191/0961203305lu2082oa; Cavallasca JA, 2010, JCR-J CLIN RHEUMATOL, V16, P400, DOI 10.1097/RHU.0b013e3181ffe517; Chen IJ, 2010, RHEUMATOLOGY, V49, P2429, DOI 10.1093/rheumatology/keq279; Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dumas G, 2015, CHEST, V148, P927, DOI 10.1378/chest.14-3098; Faguer S, 2013, EUR J INTERN MED, V24, pE40, DOI 10.1016/j.ejim.2012.11.018; Falagas ME, 2007, CLIN RHEUMATOL, V26, P663, DOI 10.1007/s10067-006-0441-9; Fujisawa T, 2005, J RHEUMATOL, V32, P58; Fujisawa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098824; Ghazi E, 2013, CLIN EXP RHEUMATOL, V31, P128; Godeau B, 1997, J RHEUMATOL, V24, P1317; Harigai M, 2007, NEW ENGL J MED, V357, P1874, DOI 10.1056/NEJMc070728; HELLMANN DB, 1987, MEDICINE, V66, P341, DOI 10.1097/00005792-198709000-00002; Hsu CL, 2005, CRIT CARE, V9, pR177, DOI 10.1186/cc3481; Huh JW, 2007, RESP MED, V101, P1761, DOI 10.1016/j.rmed.2007.02.017; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Khan SA, 2007, CHEST, V131, P972, DOI 10.1378/chest.06-2464; Lee J, 2012, RHEUMATOL INT, V32, P3353, DOI 10.1007/s00296-011-2158-6; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Marie I, 2011, ARTHRITIS RHEUM-US, V63, P3439, DOI 10.1002/art.30513; Marie I, 2011, SEMIN ARTHRITIS RHEU, V41, P48, DOI 10.1016/j.semarthrit.2010.08.003; Migita K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078699; Moreels M, 2005, INTENS CARE MED, V31, P591, DOI 10.1007/s00134-005-2563-y; Murray SG, 2015, ARTHRIT CARE RES, V67, P673, DOI 10.1002/acr.22501; Namendys-Silva SA, 2009, LUPUS, V18, P1252, DOI 10.1177/0961203309345720; OGORMAN MRG, 1995, CLIN DIAGN LAB IMMUN, V2, P205, DOI 10.1128/CDLI.2.2.205-208.1995; Quintero OL, 2013, AUTOIMMUN REV, V12, P380, DOI 10.1016/j.autrev.2012.06.002; Radhakrishna SM, 2012, PEDIATR CRIT CARE ME, V13, pE181, DOI 10.1097/PCC.0b013e318238955c; Shalev T, 2006, CLIN EXP RHEUMATOL, V24, P380; Sherer Y, 2007, CLIN RHEUMATOL, V26, P1851, DOI 10.1007/s10067-007-0588-z; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Thong BYH, 2001, ANN ACAD MED SINGAP, V30, P254; Viguier M, 2003, MEDICINE, V82, P82, DOI 10.1097/00005792-200303000-00002; Whitelaw DA, 2005, CLIN RHEUMATOL, V24, P223, DOI 10.1007/s10067-004-1007-3; Yu KH, 2011, CLIN RHEUMATOL, V30, P1595, DOI 10.1007/s10067-011-1840-0	39	26	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154441	10.1371/journal.pone.0154441	http://dx.doi.org/10.1371/journal.pone.0154441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115138	Green Published, gold, Green Submitted			2022-12-27	WOS:000374973600066
J	Rossi, D; Barbosa, NM; Galvao, FC; Boldrin, PEG; Hershey, JWB; Zanelli, CF; Fraser, CS; Valentini, SR				Rossi, Danuza; Barbosa, Natalia M.; Galvao, Fabio C.; Boldrin, Paulo E. G.; Hershey, John W. B.; Zanelli, Cleslei F.; Fraser, Christopher S.; Valentini, Sandro R.			Evidence for a Negative Cooperativity between eIF5A and eEF2 on Binding to the Ribosome	PLOS ONE			English	Article							ELONGATION-FACTOR P; YEAST SACCHAROMYCES-CEREVISIAE; SYNTHESIS INITIATION-FACTORS; TRANSLATION INITIATION; PROTEIN-SYNTHESIS; EF-P; HYPUSINE MODIFICATION; TRANSFER-RNA; EUKARYOTIC RIBOSOME; CELL VIABILITY	eIF5A is the only protein known to contain the essential and unique amino acid residue hypusine. eIF5A functions in both translation initiation due to its stimulation of methionyl-puromycin synthesis and translation elongation, being highly required for peptide-bound formation of specific ribosome stalling sequences such as poly-proline. The functional interaction between eIF5A, tRNA, and eEF2 on the surface of the ribosome is further clarified herein. Fluorescence anisotropy assays were performed to determine the affinity of eIF5A to different ribosomal complexes and reveal its interaction exclusively and directly with the 60S ribosomal subunit in a hypusine-dependent manner (K-i(60S-eIF5A-Hyp) = 16 nM, K-i(60S-eIF5A-Lys) = 385 nM). A 3-fold increase in eIF5A affinity to the 80S is observed upon charged-tRNA(i)(Met) binding, indicating positive cooperativity between P-site tRNA binding and eIF5A binding to the ribosome. Previously identified conditional mutants of yeast eIF5A, eIF5A(Q22H/L93F) and eIF5A(K56A), display a significant decrease in ribosome binding affinity. Binding affinity between ribosome and eIF5A-wild type ormutants eIF5A(K56A), but not eIF5A(Q22H/L93F), is impaired in the presence of eEF2 by 4-fold, consistent with negative cooperativity between eEF2 and eIF5A binding to the ribosome. Interestingly, high-copy eEF2 is toxic only to eIF5A(Q22H/L93F) and causes translation elongation defects in this mutant. These results suggest that binding of eEF2 to the ribosome alters its conformation, resulting in a weakened affinity of eIF5A and impairment of this interplay compromises cell growth due to translation elongation defects.	[Rossi, Danuza; Barbosa, Natalia M.; Galvao, Fabio C.; Boldrin, Paulo E. G.; Zanelli, Cleslei F.; Valentini, Sandro R.] UNESP Univ Estadual Paulista, Sch Pharmaceut Sci, Dept Biol Sci, BR-14801 Araraquara, SP, Brazil; [Rossi, Danuza; Hershey, John W. B.; Fraser, Christopher S.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Universidade Estadual Paulista; University of California System; University of California Davis	Valentini, SR (corresponding author), UNESP Univ Estadual Paulista, Sch Pharmaceut Sci, Dept Biol Sci, BR-14801 Araraquara, SP, Brazil.	valentsr@fcfar.unesp.br	Valentini, Sandro R/C-4353-2012; Zanelli, Cleslei Fernando/AAE-1003-2019; Zanelli, Cleslei Fernando/C-1916-2013	Zanelli, Cleslei Fernando/0000-0001-7831-1149; Barbosa, Natalia/0000-0002-3952-558X; Valentini, Sandro Roberto/0000-0003-4453-5413	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/50044-6]; Faculdade de Ciencias Farmaceuticas - UNESP; National Institute of General Medical Sciences [R01GM092927]; FAPESP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092927] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Faculdade de Ciencias Farmaceuticas - UNESP; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to SRV from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant number 10/50044-6), PADC from Faculdade de Ciencias Farmaceuticas - UNESP and CSF was supported by grant number R01GM092927 from National Institute of General Medical Sciences. We also thank FAPESP for fellowships awarded to the authors (DR; NMB; PEGB; FCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; BENNE R, 1978, J BIOL CHEM, V253, P3078; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Dever TE, 2014, CRIT REV BIOCHEM MOL, V49, P413, DOI 10.3109/10409238.2014.939608; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Dias CAO, 2008, FEBS J, V275, P1874, DOI 10.1111/j.1742-4658.2008.06345.x; Dias CAO, 2012, AMINO ACIDS, V42, P697, DOI 10.1007/s00726-011-0985-0; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Firczuk H, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.73; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Galvao FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060140; Graifer D, 2015, INT J MOL SCI, V16, P7173, DOI 10.3390/ijms16047173; Graifer D, 2013, MOLECULES, V18, P14455, DOI 10.3390/molecules181214455; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Henderson A, 2011, P NATL ACAD SCI USA, V108, P6415, DOI 10.1073/pnas.1008150108; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; HERSHEY JWB, 1990, BIOCHIM BIOPHYS ACTA, V1050, P160, DOI 10.1016/0167-4781(90)90159-Y; Jorgensen R, 2002, ACTA CRYSTALLOGR D, V58, P712, DOI 10.1107/S0907444902003001; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; Lassak J, 2015, NAT CHEM BIOL, V11, P266, DOI [10.1038/nchembio.1751, 10.1038/NCHEMBIO.1751]; Moreno JMP, 1998, BIOCHEM BIOPH RES CO, V252, P465, DOI 10.1006/bbrc.1998.9664; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Park JH, 2011, PROTEIN ENG DES SEL, V24, P301, DOI 10.1093/protein/gzq110; PARK MH, 1984, J BIOL CHEM, V259, P2123; Park MH, 1998, J BIOL CHEM, V273, P1677, DOI 10.1074/jbc.273.3.1677; PARK MH, 1993, BIOFACTORS, V4, P95; PELTZ SW, 1992, MOL CELL BIOL, V12, P5778, DOI 10.1128/MCB.12.12.5778; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Puljung Michael C, 2012, Curr Protoc Protein Sci, VChapter 14, DOI 10.1002/0471140864.ps1414s70; Rossi D, 2014, WIRES RNA, V5, P209, DOI 10.1002/wrna.1211; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; Sokabe M, 2014, J BIOL CHEM, V289, P31827, DOI 10.1074/jbc.M114.602870; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Sulima SO, 2014, NUCLEIC ACIDS RES, V42, P2049, DOI 10.1093/nar/gkt1107; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Thompson GM, 2003, FEBS LETT, V555, P464, DOI 10.1016/S0014-5793(03)01305-X; Toseland Christopher P, 2013, J Chem Biol, V6, P85, DOI 10.1007/s12154-013-0094-5; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Woolstenhulme CJ, 2015, CELL REP, V11, P13, DOI 10.1016/j.celrep.2015.03.014; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195	48	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154205	10.1371/journal.pone.0154205	http://dx.doi.org/10.1371/journal.pone.0154205			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115996	Green Published, gold, Green Submitted			2022-12-27	WOS:000374973600048
J	Wang, YJ; Zhang, BW; Zhang, XP; Wang, XM; Cheng, J; Chen, BA				Wang, Yujie; Zhang, Bowen; Zhang, Xiaoping; Wang, Xuemei; Cheng, Jian; Chen, Baoan			Detection and Identification of Hematologic Malignancies and Solid Tumors by an Electrochemical Technique	PLOS ONE			English	Article							GLASSY-CARBON ELECTRODE; DIFFERENTIAL-PULSE VOLTAMMETRY; MINIMAL RESIDUAL DISEASE; CANCER-CELLS; SENSITIVE DETECTION; CYCLIC VOLTAMMETRY; LEUKEMIA; INTERFACE; RESPONSES; ACID	Purpose Develop and evaluate an electrochemical method to identify healthy individuals, malignant hematopathic patients and solid tumor patients by detecting the leukocytes in whole-blood. Methods A total of 114 individual blood samples obtained from our affiliated hospital in China (June 2015-August 2015) were divided into three groups: healthy individuals (n = 35), hematologic malignancies (n = 41) and solid tumors (n = 38). An electrochemical workstation system was used to measure differential pulse voltammetry due to the different electrochemical behaviors of leukocytes in blood samples. Then, one-way analysis of variance (ANOVA) was applied to analyze the scanning curves and to compare the peak potential and peak current. Results The scanning curve demonstrated the specific electrochemical behaviors of the blank potassium ferricyanide solution and that mixed with blood samples in different groups. Significant differences in mean peak potentials of mixture and shifts (Delta Ep (mV)) were observed of the three groups (P< = 0.001). 106.00+/-9.00 and 3.14+/-7.48 for Group healthy individuals, 120.90+/-11.18 and 18.10+/-8.81 for Group hematologic malignancies, 136.84+/-11.53 and 32.89+/-10.50 for Group solid tumors, respectively. In contrast, there were no significant differences in the peak currents and shifts. Conclusions The newly developed method to apply the electrochemical workstation system to identify hematologic malignancies and solid tumors with good sensitivity and specificity might be effective, suggesting a potential utility in clinical application.	[Wang, Yujie; Zhang, Xiaoping; Cheng, Jian; Chen, Baoan] Southeast Univ, Zhongda Hosp, Dept Hematol & Oncol, Key Discipline Jiangshu Prov,Sch Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Bowen; Wang, Xuemei] Southeast Univ, Chien Shiung Wu Lab, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Chen, BA (corresponding author), Southeast Univ, Zhongda Hosp, Dept Hematol & Oncol, Key Discipline Jiangshu Prov,Sch Med, Nanjing, Jiangsu, Peoples R China.	cba8888@hotmail.com	Wang, Xuemei/GXF-3702-2022	Zhang, Xiao-Ping/0000-0003-0995-4989	Health Research Projects of Jiangsu Province; National High Technology Research and Development Program 863 of People's Republic of China [2012AA022703]; Key Medical Projects of Jiangsu Province [BL2014078]; Key Discipline of Jiangsu Province	Health Research Projects of Jiangsu Province; National High Technology Research and Development Program 863 of People's Republic of China(National High Technology Research and Development Program of China); Key Medical Projects of Jiangsu Province; Key Discipline of Jiangsu Province	XPZ was supported by the Health Research Projects of Jiangsu Province (2013-2016). BAC was supported by the National High Technology Research and Development Program 863 of People's Republic of China (Grant no 2012AA022703), as well as the Key Medical Projects of Jiangsu Province (Grant no BL2014078), and the Key Discipline of Jiangsu Province (2011-2015). All the funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jaroudi SS, 2014, BIOMETALS, V27, P1115, DOI 10.1007/s10534-014-9771-2; Alves A, 2015, J PHYS CHEM B, V119, P7968, DOI 10.1021/acs.jpcb.5b03419; Baronian KHR, 2002, APPL MICROBIOL BIOT, V60, P108, DOI 10.1007/s00253-002-1108-3; Brett AMO, 1999, ANAL CHIM ACTA, V385, P401; Chamjangali MA, 2015, MEASUREMENT, V71, P23, DOI 10.1016/j.measurement.2015.04.012; Chen J, 2005, CHEM-EUR J, V11, P1467, DOI 10.1002/chem.200400956; Chen JH, 2008, ANAL CHEM, V80, P8028, DOI 10.1021/ac801040e; Ci YX, 1998, ELECTROANAL, V10, P921; Dachs GU, 1997, NAT MED, V3, P515, DOI 10.1038/nm0597-515; Du D, 2005, BIOCHEMISTRY-US, V44, P11539, DOI 10.1021/bi0507332; Feng LY, 2011, BIOMATERIALS, V32, P2930, DOI 10.1016/j.biomaterials.2011.01.002; Foletti A, 2015, ELECTROMAGN BIOL MED, V34, P147, DOI 10.3109/15368378.2015.1036073; Goda T, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00029; Halper B, 2015, EXERC IMMUNOL REV, V21, P154; Hayakawa T, 2014, J MOL CELL CARDIOL, V77, P178, DOI 10.1016/j.yjmcc.2014.09.010; He F, 2009, TALANTA, V77, P1009, DOI 10.1016/j.talanta.2008.07.063; Hebart H, 2002, BLOOD, V100, P4521, DOI 10.1182/blood-2002-01-0265; Hourigan CS, 2013, NAT REV CLIN ONCOL, V10, P460, DOI 10.1038/nrclinonc.2013.100; Hu JQ, 2010, ACTA PHYS-CHIM SIN, V26, P2205, DOI 10.3866/PKU.WHXB20100632; Huan SY, 2004, ELECTROANAL, V16, P1019, DOI 10.1002/elan.200302879; JULIUSSON G, 1993, J CLIN ONCOL, V11, P679, DOI 10.1200/JCO.1993.11.4.679; Keynes R D, 1975, Ciba Found Symp, P191; Kim K, 2014, BIOL SPORT, V31, P39, DOI 10.5604/20831862.1086731; Kim Y, 2009, CURR MOL MED, V9, P425, DOI 10.2174/156652409788167113; Laputkova G, 2002, BIOELECTROCHEMISTRY, V56, P185, DOI 10.1016/S1567-5394(02)00044-0; Lee AC, 2014, ANALYST, V139, P4223, DOI 10.1039/c3an01156a; Legeai S, 2005, ELECTROCHIM ACTA, V50, P4089, DOI 10.1016/j.electacta.2005.01.024; Levar CE, 2014, MBIO, V5, DOI 10.1128/mBio.02034-14; Li XL, 2006, SENSOR ACTUAT B-CHEM, V117, P35, DOI 10.1016/j.snb.2005.10.044; Liu JF, 2015, BIOSENS BIOELECTRON, V71, P82, DOI 10.1016/j.bios.2015.04.012; Lu S, 2014, CHEM RES CHINESE U, V30, P437, DOI 10.1007/s40242-014-4153-4; MATSUNAGA T, 1984, ANAL CHEM, V56, P798, DOI 10.1021/ac00268a047; Musolino A, 2010, TUMORI, V96, P24, DOI 10.1177/030089161009600104; Oberacher H, 2015, MASS SPECTROM REV, V34, P64, DOI 10.1002/mas.21409; Pandey CM, 2011, BIOMACROMOLECULES, V12, P2925, DOI 10.1021/bm200490b; Promsuwicha Orathai, 2014, Journal of the Medical Association of Thailand, V97, P1296; Scherer A, 2002, RADIOLOGE, V42, P222, DOI 10.1007/s00117-002-0721-6; Sharma A, 2012, BIOSENS BIOELECTRON, V38, P107, DOI 10.1016/j.bios.2012.05.010; Skapare E, 2011, CELL BIOCHEM FUNCT, V29, P171, DOI 10.1002/cbf.1723; Smith A, 2015, BRIT J CANCER, V112, P1575, DOI 10.1038/bjc.2015.94; Sun DP, 2015, ANAL CHIM ACTA, V885, P166, DOI 10.1016/j.aca.2015.05.027; Sun YM, 2015, BIOSENS BIOELECTRON, V68, P358, DOI 10.1016/j.bios.2015.01.017; van der Velden VHJ, 2003, LEUKEMIA, V17, P1013, DOI 10.1038/sj.leu.2402922; Venuta F, 1997, EUR J CARDIO-THORAC, V11, P218, DOI 10.1016/S1010-7940(96)01055-X; Wang J, 1999, ANAL CHEM, V71, p328R; Wei W, 2012, FOOD CHEM, V135, P888, DOI 10.1016/j.foodchem.2012.06.037; Winters N, 2015, SCI TOTAL ENVIRON, V526, P153, DOI 10.1016/j.scitotenv.2015.03.149; Wu WA, 2008, CHINESE J ANAL CHEM, V36, P1721; Wu YZ, 2014, CANCER LETT, V345, P164, DOI 10.1016/j.canlet.2013.08.014; Zhang SL, 2014, ANALYST, V139, P3629, DOI 10.1039/c4an00420e; Zhao XC, 2010, CAN J CHEM, V88, P569, DOI 10.1139/V10-051; Zheng TT, 2013, NANOSCALE, V5, P10360, DOI 10.1039/c3nr02903d; Zhu XL, 2013, ANAL CHIM ACTA, V764, P59, DOI 10.1016/j.aca.2012.12.024	53	3	3	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0153821	10.1371/journal.pone.0153821	http://dx.doi.org/10.1371/journal.pone.0153821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27115355	Green Published, Green Submitted, gold			2022-12-27	WOS:000374973600031
J	Zuk, A; Fitzpatrick, T; Rosella, LC				Zuk, Aleksandra; Fitzpatrick, Tiffany; Rosella, Laura C.			Effect of Vitamin D-3 Supplementation on Inflammatory Markers and Glycemic Measures among Overweight or Obese Adults: A Systematic Review of Randomized Controlled Trials	PLOS ONE			English	Review							NECROSIS-FACTOR-ALPHA; SERUM 25-HYDROXYVITAMIN D; PLACEBO-CONTROLLED TRIAL; HUMAN ADIPOSE-TISSUE; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; D DEFICIENCY; 1,25-DIHYDROXYVITAMIN D-3; FACTOR (TNF)-ALPHA	Background Obesity induced low-grade chronic inflammation disrupts proper immune and metabolic function. Vitamin D deficiency increases inflammation, which is associated with cardiometabolic risk. This systematic review examines the association between oral vitamin D (VD) supplementation and circulating inflammatory biomarkers and glycemic outcomes from randomized controlled trials (RCTs) of overweight and/or obese adults. Methods MEDLINE OVID, EMBASE and the Cochrane Central Register of Controlled Trials were searched according to a predefined protocol. Eligible RCTs included adults randomized to receive either oral VD or placebo. Two reviewers independently assessed RCTs for inclusion. Bias was assessed using the Cochrane Collaboration risk of bias tool. Mean differences were calculated comparing end-of-study sample means between the independent VD and placebo groups. Results Eleven unique RCTs met inclusion criteria from a total of 3,383 identified citations, including 79 screened articles and 14 full text data extractions. Inflammatory and glycemic measures were reported in 7 and 10 RCTs, respectively. Most trial findings were non-significant with considerable heterogeneity in design, participants and outcomes. All but one trial was rated as either high or unclear risk of bias. Two RCTs reported significant changes in inflammatory biomarkers; however, the mean difference between groups was not statistically significant: C-reactive protein 0.19 mg/L (p = 0.88); Tumor Necrosis Factor -0.54 pg/ml (p = 0.20). Two other trials found significant mean differences in fasting plasma glucose -0.32 mmol/L (p = 0.03), Hemoglobin A1c -0.13% (p = 0.04), and Homeostatic Model Assessment -0.86 (p = 0.02) following VD supplementation. Conclusions Overall, there is no clear established benefit of VD supplementation on inflammatory bio-markers among overweight/obese adults. Baseline serum VD possibly influences the effect of VD repletion on inflammatory markers. Risk of bias was present in most studies, thus supporting the need for higher quality studies in this area to more conclusively understand the role VD supplementation has on inflammatory pathways.	[Zuk, Aleksandra; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Fitzpatrick, Tiffany; Rosella, Laura C.] Publ Hlth Ontario, Toronto, ON, Canada; [Rosella, Laura C.] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto	Zuk, A (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.	Aleksandra.zuk@mail.utoronto.ca						Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809; Al-Badr W, 2008, CLIN J AM SOC NEPHRO, V3, P1555, DOI 10.2215/CJN.01150308; Alkharfy KM, 2013, BASIC CLIN PHARMACOL, V112, P42, DOI 10.1111/j.1742-7843.2012.00936.x; Almerighi C, 2009, CYTOKINE, V45, P190, DOI 10.1016/j.cyto.2008.12.009; Amer M, 2012, AM J CARDIOL, V109, P226, DOI 10.1016/j.amjcard.2011.08.032; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barker T, 2013, EUR J APPL PHYSIOL, V113, P1523, DOI 10.1007/s00421-012-2582-7; Beilfuss J, 2012, CYTOKINE, V60, P870, DOI 10.1016/j.cyto.2012.07.032; Bellia A, 2013, INTERN EMERG MED, V8, P33, DOI 10.1007/s11739-011-0559-x; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bigby M, 2003, ARCH DERMATOL, V139, P795, DOI 10.1001/archderm.139.6.795; Carrillo AE, 2013, CLIN NUTR, V32, P375, DOI 10.1016/j.clnu.2012.08.014; Carrillo AE, 2012, EUR J APPL PHYSIOL, V112, P3045, DOI 10.1007/s00421-011-2279-3; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cheng G, 2012, CRITICAL REV IMMUNOL, V32; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Cipriani C, 2013, J CLIN ENDOCR METAB, V98, P2709, DOI 10.1210/jc.2013-1586; Dalgard C, 2011, DIABETES CARE, V34, P1284, DOI 10.2337/dc10-2084; Dandona P, 2006, DRUG DEVELOP RES, V67, P619, DOI 10.1002/ddr.20137; Davidson MB, 2013, DIABETES CARE, V36, P260, DOI 10.2337/dc12-1204; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Diaz L, 2009, J REPROD IMMUNOL, V81, P17, DOI 10.1016/j.jri.2009.02.005; Ding C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061707; Ding C, 2012, BRIT J NUTR, V108, P1915, DOI 10.1017/S0007114512003285; Dumville JC, 2006, BMJ-BRIT MED J, V332, P969, DOI 10.1136/bmj.332.7547.969; Evans KN, 2006, BIOL REPROD, V75, P816, DOI 10.1095/biolreprod.106.054056; Field AE, 2013, JAMA-J AM MED ASSOC, V310, P2147, DOI 10.1001/jama.2013.281501; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Harris SS, 2012, DIABETES OBES METAB, V14, P789, DOI 10.1111/j.1463-1326.2012.01605.x; Heaney RP, 2012, NEW ENGL J MED, V367, P77, DOI 10.1056/NEJMe1206858; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Jorde R, 2010, J INTERN MED, V267, P462, DOI 10.1111/j.1365-2796.2009.02181.x; Jorde R, 2010, CYTOKINE, V50, P175, DOI 10.1016/j.cyto.2009.12.006; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765; Kong J, 2013, J ENDOCRINOL, V216, P265, DOI 10.1530/JOE-12-0344; Kositsawat J, 2010, DIABETES CARE, V33, P1236, DOI 10.2337/dc09-2150; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; Leal VD, 2013, CLIN CHIM ACTA, V419, P87, DOI 10.1016/j.cca.2013.02.003; Levine AB, 2006, METABOLIC SYNDROME C, P192; Littell J.H., 2008, SYSTEMATIC REV META; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lundh A, 2012, IND SPONSORSHIP RES; Maki KC, 2011, INT J FOOD SCI NUTR, V62, P318, DOI 10.3109/09637486.2010.536146; Manigrasso MR, 2005, J CLIN ENDOCR METAB, V90, P5876, DOI 10.1210/jc.2005-0281; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Mitri J, 2014, ENDOCRIN METAB CLIN, V43, P205, DOI 10.1016/j.ecl.2013.09.010; Mitri J, 2011, AM J CLIN NUTR, V94, P486, DOI 10.3945/ajcn.111.011684; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nagpal J, 2009, DIABETIC MED, V26, P19, DOI 10.1111/j.1464-5491.2008.02636.x; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Olszanecka-Glinianowicz M, 2004, METABOLISM, V53, P1268, DOI 10.1016/j.metabol.2004.07.001; Olszanecka-Glinianowicz M, 2011, METABOLISM, V60, P531, DOI 10.1016/j.metabol.2010.04.023; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007; Penckofer S, 2008, DIABETES EDUCATOR, V34, P939, DOI 10.1177/0145721708326764; de Heredia FP, 2012, P NUTR SOC, V71, P332, DOI 10.1017/S0029665112000092; Peterson CA, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-10; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Rytka JM, 2011, DIABETES, V60, P56, DOI 10.2337/db10-0697; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Schwalfenberg G, 2007, CAN FAM PHYSICIAN, V53, P841; Sun XM, 2014, NUTRIENTS, V6, P221, DOI 10.3390/nu6010221; Tarcin O, 2009, J CLIN ENDOCR METAB, V94, P4023, DOI 10.1210/jc.2008-1212; Teegarden D, 2009, NUTR RES REV, V22, P82, DOI 10.1017/S0954422409389301; Theodoratou E, 2014, BMJ-BRIT MED J, V348; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Tricco AC, 2008, J CLIN EPIDEMIOL, V61, P422, DOI 10.1016/j.jclinepi.2007.10.017; Verhagen AP, 2001, J CLIN EPIDEMIOL, V54, P651, DOI 10.1016/S0895-4356(00)00360-7; Viera AJ, 2005, FAM MED, V37, P360; Wamberg L, 2013, EUR J INTERN MED, V24, P644, DOI 10.1016/j.ejim.2013.03.005; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; WHYTE MP, 1979, J CLIN ENDOCR METAB, V48, P906, DOI 10.1210/jcem-48-6-906; Winkler G, 2003, EUR J ENDOCRINOL, V149, P129, DOI 10.1530/eje.0.1490129; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002; Zhu W, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-8; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	100	26	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154215	10.1371/journal.pone.0154215	http://dx.doi.org/10.1371/journal.pone.0154215			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27116227	gold, Green Submitted, Green Published			2022-12-27	WOS:000374973600050
J	Kawachi, Y				Kawachi, Yousuke			Visual Mislocalization of Moving Objects in an Audiovisual Event	PLOS ONE			English	Article							PERCEPTION; CUES	The present study investigated the influence of an auditory tone on the localization of visual objects in the stream/bounce display (SBD). In this display, two identical visual objects move toward each other, overlap, and then return to their original positions. These objects can be perceived as either streaming through or bouncing off each other. In this study, the closest distance between object centers on opposing trajectories and tone presentation timing (none, 0 ms, +/- 90 ms, and +/- 390 ms relative to the instant for the closest distance) were manipulated. Observers were asked to judge whether the two objects overlapped with each other and whether the objects appeared to stream through, bounce off each other, or reverse their direction of motion. A tone presented at or around the instant of the objects' closest distance biased judgments toward "non-overlapping," and observers overestimated the physical distance between objects. A similar bias toward direction change judgments (bounce and reverse, not stream judgments) was also observed, which was always stronger than the non-overlapping bias. Thus, these two types of judgments were not always identical. Moreover, another experiment showed that it was unlikely that this observed mislocalization could be explained by other previously known mislocalization phenomena (i.e., representational momentum, the Frohlich effect, and a turn-point shift). These findings indicate a new example of crossmodal mislocalization, which can be obtained without temporal offsets between audiovisual stimuli. The mislocalization effect is also specific to a more complex stimulus configuration of objects on opposing trajectories, with a tone that is presented simultaneously. The present study promotes an understanding of relatively complex audiovisual interactions beyond simple one-to-one audiovisual stimuli used in previous studies.	[Kawachi, Yousuke] Tohoku Fukushi Univ, Kansei Fukushi Res Inst, Sendai, Miyagi, Japan		Kawachi, Y (corresponding author), Tohoku Fukushi Univ, Kansei Fukushi Res Inst, Sendai, Miyagi, Japan.	kawachi@tfu-mail.tfu.ac.jp	Kawachi, Yousuke/P-9683-2019; Kawachi, Yousuke/O-1041-2019	Kawachi, Yousuke/0000-0003-3976-8386	Japan Society for the Promotion of Science (JSPS) [25530173, 26350995]; MEXT; Grants-in-Aid for Scientific Research [16K00212] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid of the Japan Society for the Promotion of Science (JSPS) for Scientific Research (no. 25530173 and 26350995) and MEXT-Supported program for the Strategic Research Foundation at Private Universities, 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertelson P., 1999, COGNITIVE CONTRIBUTI, P347, DOI DOI 10.1016/S0166-4115(99)80034-X; BERTENTHAL BI, 1993, PERCEPTION, V22, P193, DOI 10.1068/p220193; Chien S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00070; Choi H, 2006, PERCEPTION, V35, P385, DOI 10.1068/p5462; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Frohlich FW., 1923, Z SINNESPHYSIOL, V54, P58; GOLDBERG DM, 1982, J EXP PSYCHOL HUMAN, V8, P547, DOI 10.1037/0096-1523.8.4.547; Grassi M, 2012, SEEING PERCEIVING, V25, P223, DOI 10.1163/187847612X626372; Grove PM, 2012, J VISION, V12, DOI 10.1167/12.8.5; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Heron J, 2004, VISION RES, V44, P2875, DOI 10.1016/j.visres.2004.07.001; Kanai R, 2007, VISION RES, V47, P937, DOI 10.1016/j.visres.2006.12.009; Kawachi Y, 2006, PERCEPTION, V35, P1289, DOI 10.1068/p5594; Kawachi Y, 2014, J VISION, V14, DOI 10.1167/14.8.16; Kawachi Y, 2011, I-PERCEPTION, V2, P428, DOI 10.1068/i0399; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Makovski T, 2009, VIS COGN, V17, P180, DOI 10.1080/13506280802211334; Michotte A. E, 1963, PERCEPTION CAUSALITY; Nieman D, 2010, J VISION, V10, DOI 10.1167/10.6.9; QIAN N, 1994, J NEUROSCI, V14, P7357; Rolfs M, 2013, CURR BIOL, V23, P250, DOI 10.1016/j.cub.2012.12.017; Sekuler AB, 1999, PERCEPTION, V28, P415, DOI 10.1068/p2909; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Teramoto W, 2010, ATTEN PERCEPT PSYCHO, V72, P2215, DOI [10.3738/APP.72.8.2215, 10.3758/APP.72.8.2215]; Thornton IM, 2002, SPATIAL VISION, V15, P219, DOI 10.1163/15685680252875183; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; Watanabe K., 2001, CROSSMODAL INTERACTI; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Witt JK, 2015, PERCEPTION, V44, P289, DOI 10.1068/p7908; Yamada Y, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00166; Zhou F, 2007, EXP BRAIN RES, V180, P641, DOI 10.1007/s00221-007-0897-0	35	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154147	10.1371/journal.pone.0154147	http://dx.doi.org/10.1371/journal.pone.0154147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5OX	27111759	Green Published, Green Submitted, gold			2022-12-27	WOS:000374970600036
J	Masia, M; Padilla, S; Fernandez, M; Rodriguez, C; Moreno, A; Oteo, JA; Antela, A; Moreno, S; del Amo, J; Gutierrez, F				Masia, Mar; Padilla, Sergio; Fernandez, Marta; Rodriguez, Carmen; Moreno, Ana; Oteo, Jose A.; Antela, Antonio; Moreno, Santiago; del Amo, Julia; Gutierrez, Felix		CoRIS Biobanco	Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARDIOVASCULAR RISK; OXIDANT STRESS; MALONDIALDEHYDE; INFLAMMATION; INCREASE; BIOBANK; PLASMA; MARKER; COHORT	Objective We aimed to assess whether oxidative stress is a predictor of mortality in HIV-infected patients. Methods We conducted a nested case-control study in CoRIS, a contemporary, multicentre cohort of HIV-infected patients, antiretroviral-naive at entry, launched in 2004. Cases were patients who died with available stored plasma samples collected. Two age and sex-matched controls for each case were selected. We measured F2-isoprostanes (F-2-IsoPs) and malondialdehyde (MDA) plasma levels in the first blood sample obtained after cohort engagement. Results 54 cases and 93 controls were included. Median F-2-IsoPs and MDA levels were significantly higher in cases than in controls. When adjustment was performed for age, HIV-transmission category, CD4 cell count and HIV viral load at cohort entry, and subclinical inflammation measured with highly-sensitive C-reactive protein (hsCRP), the association of F-2-IsoPs with mortality remained significant (adjusted OR per 1 log10 increase, 2.34 [1.23-4.47], P = 0.009). The association of MDA with mortality was attenuated after adjustment: adjusted OR (95% CI) per 1 log10 increase, 2.05 [0.91-4.59], P = 0.080. Median hsCRP was also higher in cases, and it also proved to be an independent predictor of mortality in the adjusted analysis: OR (95% CI) per 1 log10 increase, 1.39 (1.01-1.91), P = 0.043; and OR (95% CI) per 1 log10 increase, 1.46 (1.07-1.99), P = 0.014, respectively, when adjustment included F-2-IsoPs and MDA. Conclusion Oxidative stress is a predictor of all-cause mortality in HIV-infected patients. For plasma F-2-IsoPs, this association is independent of HIV-related factors and subclinical inflammation.	[Masia, Mar; Padilla, Sergio; Gutierrez, Felix] Univ Miguel Hernandez, Hosp Gen Elche, Infect Dis Unit, Alicante, Spain; [Fernandez, Marta] Hosp Gen Elche, Infect Dis Res Lab, Alicante, Spain; [Rodriguez, Carmen] Ctr Sanitario Sandoval, HIV AIDS & Sexually Transmitted Dis Clin, Madrid, Spain; [Moreno, Ana; Moreno, Santiago] Hosp Ramon & Cajal, Inst Ramon & Cajal Invest Sanitaria, Infect Dis Serv, E-28034 Madrid, Spain; [Oteo, Jose A.] Hosp San Pedro La Rioja, Infect Dis Serv, Logrono, Spain; [Antela, Antonio] Hosp Clin Santiago, Infect Dis Unit, La Coruna, Spain; [del Amo, Julia] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain	Universidad Miguel Hernandez de Elche; Hospital Universitario Ramon y Cajal; Complexo Hospitalario Universitario de Santiago de Compostela; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE)	Gutierrez, F (corresponding author), Univ Miguel Hernandez, Hosp Gen Elche, Infect Dis Unit, Alicante, Spain.	gutierrez_fel@gva.es	Oteo, Jose A./AAB-3134-2020; Padilla, Sergio/U-7682-2017; Garcia, Elena/GWR-0291-2022; Rodero, Félix Gutiérrez/Q-7880-2018; Fernández-González, Marta/U-7492-2017; DEL AMO VALERO, JULIA/M-7020-2015; Masia, Mar/U-7510-2017	Oteo, Jose A./0000-0001-7080-6542; Rodero, Félix Gutiérrez/0000-0002-9485-6867; Fernández-González, Marta/0000-0001-9949-8504; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Masia, Mar/0000-0001-9878-2458; Padilla, Sergio/0000-0002-8420-7310	Plan Nacional R + D + I [RD12/0017/0023]; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) [FIS (PI08/893), FIS (PI13/02256), FISABIO UGP-14-197]; Contrato de Intensificacion de la Actividad Investigadora [INT 14/00207]; ISCIII [RD06/0006/0035]; FIPSE	Plan Nacional R + D + I; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); Contrato de Intensificacion de la Actividad Investigadora; ISCIII(Instituto de Salud Carlos III); FIPSE	This work has been (partially) funded by the RD12/0017/0023 project as part of the Plan Nacional R + D + I and cofinanced by ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER), FIS (PI08/893), FIS (PI13/02256), FISABIO UGP-14-197, and Contrato de Intensificacion de la Actividad Investigadora INT 14/00207. The HIV Biobank, integrated in the RIS, is also supported by the ISCIII (RD06/0006/0035) and FIPSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR Recomm Rep, V41, P1; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Aukrust P, 2005, BLOOD, V105, P4730, DOI 10.1182/blood-2004-11-4272; Balfour L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085607; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; Bestilny LJ, 2000, AIDS, V14, P771, DOI 10.1097/00002030-200005050-00002; Blanco JR, 2015, JAIDS-J ACQ IMM DEF, V68, P21, DOI 10.1097/QAI.0000000000000398; Chehne F, 2001, PROSTAG LEUKOTR ESS, V64, P307, DOI 10.1054/plef.2001.0277; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Gendron K, 2011, NUCLEIC ACIDS RES, V39, P902, DOI 10.1093/nar/gkq885; Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030; Herbein G, 2008, CURR HIV RES, V6, P117, DOI 10.2174/157016208783884985; Hernando V, 2012, AIDS, V26, P1829, DOI 10.1097/QAD.0b013e328352ada4; Hulgan T, 2003, CLIN INFECT DIS, V37, P1711, DOI 10.1086/379776; Hulgan T, 2006, JAIDS-J ACQ IMM DEF, V42, P450, DOI 10.1097/01.qai.0000226792.16216.1c; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Ingle SM, 2014, CLIN INFECT DIS, V59, P287, DOI 10.1093/cid/ciu261; Irlam JH, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003650.pub3; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Lorente L, 2013, CRIT CARE, V17, DOI 10.1186/cc13155; Manda KR, 2011, FREE RADICAL BIO MED, V50, P801, DOI 10.1016/j.freeradbiomed.2010.12.029; Masia M, 2007, CLIN THER, V29, P1448, DOI 10.1016/j.clinthera.2007.07.025; Masia M, 2007, ATHEROSCLEROSIS, V195, P167, DOI 10.1016/j.atherosclerosis.2006.09.013; Masia M, 2013, AIDS, V27, P181, DOI 10.1097/QAD.0b013e32835a1156; McComsey GA, 2003, JAIDS-J ACQ IMM DEF, V34, P45, DOI 10.1097/00126334-200309010-00006; Montuschi P, 2007, CURR MED CHEM, V14, P703, DOI 10.2174/092986707780059607; Nielsen F, 1997, CLIN CHEM, V43, P1209; Okoye AA, 2013, IMMUNOL REV, V254, P54, DOI 10.1111/imr.12066; Pyo CW, 2008, BIOCHEM BIOPH RES CO, V376, P180, DOI 10.1016/j.bbrc.2008.08.114; Robinson JM, 2009, HISTOCHEM CELL BIOL, V131, P465, DOI 10.1007/s00418-009-0565-5; Roest M, 2008, J CLIN LIPIDOL, V2, P298, DOI 10.1016/j.jacl.2008.06.004; Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0; Schottker B, 2015, J GERONTOL A-BIOL, V70, P518, DOI 10.1093/gerona/glu111; Sharma B, 2014, CURR HIV RES, V12, P13, DOI 10.2174/1570162X12666140402100959; Sinha JK, 2014, NEUROSCIENCE, V269, P256, DOI 10.1016/j.neuroscience.2014.03.040; Sobrino-Vegas P, 2011, ENFERM INFEC MICR CL, V29, P645, DOI 10.1016/j.eimc.2011.06.002; Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steiner J, 2006, ANTIOXID REDOX SIGN, V8, P2089, DOI 10.1089/ars.2006.8.2089; Suresh DR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-61; Tang AM, 2000, J ACQ IMMUN DEF SYND, V25, pS12, DOI 10.1097/00126334-200010001-00003; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Vassimon HS, 2010, CURR HIV RES, V8, P364, DOI 10.2174/157016210791330347	44	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153456	10.1371/journal.pone.0153456	http://dx.doi.org/10.1371/journal.pone.0153456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111769	Green Published, Green Submitted, gold			2022-12-27	WOS:000374970600015
J	Segura-Noguera, M; Blasco, D; Fortuno, JM				Segura-Noguera, Mariona; Blasco, Dolors; Fortuno, Jose-Manuel			Taxonomic and Environmental Variability in the Elemental Composition and Stoichiometry of Individual Dinoflagellate and Diatom Cells from the NW Mediterranean Sea	PLOS ONE			English	Article							MARINE-PHYTOPLANKTON; CHEMICAL-COMPOSITION; NUTRIENT RATIOS; EVOLUTIONARY INHERITANCE; GLYCINE BETAINE; CARBON CONTENT; SINGLE CELLS; TIME-SERIES; GROWTH-RATE; PHOSPHORUS	Here we present, for the first time, the elemental concentration, including C, N and O, of single phytoplankton cells collected from the sea. Plankton elemental concentration and stoichiometry are key variables in phytoplankton ecophysiology and ocean biogeochemistry, and are used to link cells and ecosystems. However, most field studies rely on bulk techniques that overestimate carbon and nitrogen because the samples include organic matter other than plankton organisms. Here we used X-ray microanalysis (XRMA), a technique that, unlike bulk analyses, gives simultaneous quotas of C, N, O, Mg, Si, P, and S, in single-cell organisms that can be collected directly from the sea. We analysed the elemental composition of dinoflagellates and diatoms (largely Chaetoceros spp.) collected from different sites of the Catalan coast (NW Mediterranean Sea). As expected, a lower C content is found in our cells compared to historical values of cultured cells. Our results indicate that, except for Si and O in diatoms, the mass of all elements is not a constant fraction of cell volume but rather decreases with increasing cell volume. Also, diatoms are significantly less dense in all the measured elements, except Si, compared to dinoflagellates. The N: P ratio of both groups is higher than the Redfield ratio, as it is the N: P nutrient ratio in deep NW Mediterranean Sea waters (N: P = 20-23). The results suggest that the P requirement is highest for bacterioplankton, followed by dinoflagellates, and lowest for diatoms, giving them a clear ecological advantage in P-limited environments like the Mediterranean Sea. Finally, the P concentration of cells of the same genera but growing under different nutrient conditions was the same, suggesting that the P quota of these cells is at a critical level. Our results indicate that XRMA is an accurate technique to determine single cell elemental quotas and derived conversion factors used to understand and model ocean biogeochemical cycles.	[Segura-Noguera, Mariona; Blasco, Dolors; Fortuno, Jose-Manuel] CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Spain; [Segura-Noguera, Mariona] Univ Sheffield, Dept Chem & Biol Engn, Adv Biomfg Ctr, ChELSI Inst, Sheffield, S Yorkshire, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Sheffield	Segura-Noguera, M (corresponding author), CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Spain.	mariona@marionasegura.cat	Segura-Noguera, Mariona/C-4524-2012	Segura-Noguera, Mariona/0000-0003-4832-7590; Fortuno, Jose-Manuel/0000-0003-3486-0685	Spanish Ministry of Economy and Competitiveness [REN2003-06637-C02]; I3P fellowship (CSIC, Spanish Ministry of Education and Culture)	Spanish Ministry of Economy and Competitiveness(Spanish Government); I3P fellowship (CSIC, Spanish Ministry of Education and Culture)	`This work was supported by project PUDEM (REN2003-06637-C02, Spanish Ministry of Science and Technology, now Spanish Ministry of Economy and Competitiveness); and by an I3P fellowship (CSIC, Spanish Ministry of Education and Culture) to M. Segura-Noguera. Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaras M., 1985, P435; Alonso-Saez L, 2008, ECOSYSTEMS, V11, P397, DOI 10.1007/s10021-008-9129-0; ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; Angles S, 2010, DEEP-SEA RES PT II, V57, P210, DOI 10.1016/j.dsr2.2009.09.002; Arin L, 2013, ESTUAR COAST SHELF S, V133, P116, DOI 10.1016/lecss2013.08.018; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Baines SB, 2012, NAT GEOSCI, V5, P886, DOI [10.1038/ngeo1641, 10.1038/NGEO1641]; BANSE K, 1974, LIMNOL OCEANOGR, V19, P695, DOI 10.4319/lo.1974.19.4.0695; Beardall J, 2009, NEW PHYTOL, V181, P295, DOI 10.1111/j.1469-8137.2008.02660.x; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bethoux JP, 1998, MAR CHEM, V63, P155, DOI 10.1016/S0304-4203(98)00059-0; Bethoux JP, 2002, DEEP-SEA RES PT II, V49, P2007, DOI 10.1016/S0967-0645(02)00024-3; BIENFANG PK, 1984, MAR ECOL PROG SER, V14, P297, DOI 10.3354/meps014297; BLASCO D, 1982, J PHYCOL, V18, P58, DOI 10.1111/j.0022-3646.1982.00058.x; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; COPINMONTEGUT C, 1983, DEEP-SEA RES, V30, P31, DOI 10.1016/0198-0149(83)90031-6; d'Alcala MR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001650; Deutsch C, 2012, ANNU REV MAR SCI, V4, P113, DOI 10.1146/annurev-marine-120709-142821; Diaz J, 2008, SCIENCE, V320, P652, DOI 10.1126/science.1151751; DORTCH Q, 1983, MAR ECOL PROG SER, V13, P61, DOI 10.3354/meps013061; Estrada M., 1991, OECOLOGIA AQUATICA, V10, P157; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Falster DS, 2006, SMATR STANDARISED MA; FANNING KA, 1992, J GEOPHYS RES-OCEANS, V97, P5693, DOI 10.1029/92JC00007; Flynn KJ, 2010, PROG OCEANOGR, V84, P52, DOI 10.1016/j.pocean.2009.09.006; Fraga F, 2001, SCI MAR, V65, P153, DOI 10.3989/scimar.2001.65s2153; Fraga F, 1998, SCI MAR, V62, P161, DOI 10.3989/scimar.1998.62n1-2161; FRAGA F, 1990, Scientia Marina, V54, P69; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Gisselson LA, 2001, LIMNOL OCEANOGR, V46, P1237, DOI 10.4319/lo.2001.46.5.1237; Guadayol O, 2009, MAR ECOL PROG SER, V381, P139, DOI 10.3354/meps07939; Gundersen K, 2002, LIMNOL OCEANOGR, V47, P1525, DOI 10.4319/lo.2002.47.5.1525; Hall EK, 2011, ECOSYSTEMS, V14, P261, DOI 10.1007/s10021-010-9408-4; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARRISON PJ, 1977, MAR BIOL, V43, P19, DOI 10.1007/BF00392568; Hedges JI, 2002, MAR CHEM, V78, P47, DOI 10.1016/S0304-4203(02)00009-9; Heldal M, 2003, LIMNOL OCEANOGR, V48, P1732, DOI 10.4319/lo.2003.48.5.1732; Hinder SL, 2012, NAT CLIM CHANGE, V2, P271, DOI [10.1038/nclimate1388, 10.1038/NCLIMATE1388]; Ho TY, 2003, J PHYCOL, V39, P1145, DOI 10.1111/j.0022-3646.2003.03-090.x; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Ivancic I, 2012, LIMNOL OCEANOGR, V57, P1721, DOI 10.4319/lo.2012.57.6.1721; Keller MD, 1999, MAR BIOL, V135, P237, DOI 10.1007/s002270050621; Keller MD, 1999, MAR BIOL, V135, P249, DOI 10.1007/s002270050622; Krom MD, 2010, PROG OCEANOGR, V85, P236, DOI 10.1016/j.pocean.2010.03.003; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Lomas MW, 2000, J PHYCOL, V36, P903, DOI 10.1046/j.1529-8817.2000.99029.x; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Margalef R., 1998, ACTA BOT BARCINO, V45, P633; Margalef R, 1945, FITOPLANCTON NERITIC; Markaki Z, 2010, MAR CHEM, V120, P187, DOI 10.1016/j.marchem.2008.10.005; Martiny AC, 2013, NAT GEOSCI, V6, P279, DOI [10.1038/NGEO1757, 10.1038/ngeo1757]; MATRAI PA, 1994, MAR BIOL, V119, P61, DOI 10.1007/BF00350107; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; MOAL J, 1987, OCEANOL ACTA, V10, P339; MONTAGNES DJS, 1994, LIMNOL OCEANOGR, V39, P1044, DOI 10.4319/lo.1994.39.5.1044; Mostajir B, 1998, OCEANOL ACTA, V21, P589, DOI 10.1016/S0399-1784(98)80041-8; MULLIN MM, 1966, LIMNOL OCEANOGR, V11, P307, DOI 10.4319/lo.1966.11.2.0307; NORLAND S, 1995, APPL ENVIRON MICROB, V61, P1357, DOI 10.1128/AEM.61.4.1357-1362.1995; Nunez-Milland DR, 2010, J SYNCHROTRON RADIAT, V17, P560, DOI 10.1107/S0909049510014020; PAASCHE E, 1973, MAR BIOL, V19, P117, DOI 10.1007/BF00353582; PARSONS TR, 1961, J FISH RES BOARD CAN, V18, P1001, DOI 10.1139/f61-063; Paulmier A, 2009, BIOGEOSCIENCES, V6, P923, DOI 10.5194/bg-6-923-2009; Pujo-Pay M, 2011, BIOGEOSCIENCES, V8, P883, DOI 10.5194/bg-8-883-2011; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Quigg A, 2011, P ROY SOC B-BIOL SCI, V278, P526, DOI 10.1098/rspb.2010.1356; Redfield A.C., 1963, SEA; REDFIELD AC, 1958, AM SCI, V46, P205; Reynolds C.S., 1997, VEGETATION PROCESSES, V9, DOI 10.1017/S0025315400036432; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; Rios AF, 1998, SCI MAR, V62, P257; Romero E, 2012, MAR ECOL PROG SER, V464, P69, DOI 10.3354/meps09846; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Scheffer M, 2003, HYDROBIOLOGIA, V491, P9, DOI 10.1023/A:1024404804748; Segura-Noguera M, 2016, BIOGEOCHEMI IN PRESS, p80S1; Segura-Noguera M, 2012, LIMNOL OCEANOGR-METH, V10, P666, DOI 10.4319/lom.2012.10.666; Segura-Noguera M, 2011, SCI MAR, V75, P321, DOI 10.3989/scimar.2011.75n2321; SICKOGOAD LM, 1984, LIMNOL OCEANOGR, V29, P1170, DOI 10.4319/lo.1984.29.6.1170; Sigee DC, 1999, AQUAT MICROB ECOL, V19, P177, DOI 10.3354/ame019177; Simo R, 2002, LIMNOL OCEANOGR, V47, P53, DOI 10.4319/lo.2002.47.1.0053; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Spector D.L., 1984, P107; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sterner RW, 2008, LIMNOL OCEANOGR, V53, P1169, DOI 10.4319/lo.2008.53.3.1169; STRATHMANN RR, 1967, LIMNOL OCEANOGR, V12, P411, DOI 10.4319/lo.1967.12.3.0411; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Thingstad TF, 2005, ECOL LETT, V8, P675, DOI 10.1111/j.1461-0248.2005.00768.x; Thingstad TF, 1998, LIMNOL OCEANOGR, V43, P88, DOI 10.4319/lo.1998.43.1.0088; Twining BS, 2010, LIMNOL OCEANOGR, V55, P492, DOI 10.4319/lo.2009.55.2.0492; Twining BS, 2003, ANAL CHEM, V75, P3806, DOI 10.1021/ac034227z; Twining BS, 2004, LIMNOL OCEANOGR, V49, P2115, DOI 10.4319/lo.2004.49.6.2115; Van Lenning K, 2007, J PHYCOL, V43, P892, DOI 10.1111/j.1529-8817.2007.00396.x; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Velasquez Z, 1997, THESIS TU CATALONIA; VERITY PG, 1992, LIMNOL OCEANOGR, V37, P1434, DOI 10.4319/lo.1992.37.7.1434; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403	97	9	9	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154050	10.1371/journal.pone.0154050	http://dx.doi.org/10.1371/journal.pone.0154050			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111067	Green Published, Green Accepted, gold			2022-12-27	WOS:000374970600030
J	Shumayla; Sharma, S; Pandey, AK; Singh, K; Upadhyay, SK				Shumayla; Sharma, Shailesh; Pandey, Ajay K.; Singh, Kashmir; Upadhyay, Santosh Kumar			Molecular Characterization and Global Expression Analysis of Lectin Receptor Kinases in Bread Wheat (Triticum aestivum)	PLOS ONE			English	Article							S-LOCUS; DIFFERENTIAL EXPRESSION; HIGH-TEMPERATURE; GENE; ARABIDOPSIS; DOMAIN; EVOLUTION; DUPLICATION; STRESS; FAMILY	Lectin receptor kinases (LRKs) play a critical role in plants during development and stress conditions, but a comprehensive analysis at genome level is still not carried out in Triticum aestivum. Herein, we performed the genome wide identification, characterization and expression analysis of these genes in T. aestivum (TaLRK). In-total 263 TaLRK genes were identified, which were further classified into three groups based on the nature of lectin domain. We identified, two TaLRKs consisted of calcium-dependent lectin (C-LRK), while 84 legume-lectin (L-LRK) and 177 bulb-lectin (B-LRK) domains. The L-LRK and B-LRK genes were distributed throughout the genome of T. aestivum. Most of the TaLRKs were clustered as homologs, which were distributed either in proximity on same chromosome or on homoeologous chromosomes of A, B and D sub-genomes. A total of 9 and 58 duplication events were also predicted in L-LRK and B-LRK, respectively. Phylogenetic analysis indicated conserved evolutionary relationship of homologous and orthologous genes from multiple plant species. Gene ontology analysis indicated TaLRKs role in binding, signaling and receptor activities. Most of the TaLRKs consisted of a trans-membrane domain and predicted to be localized in the plasma-membrane. A diverse expression pattern of TaLRK genes was found in various developmental stages and stress conditions. Some TaLRKs were found to be highly affected during a particular stress, which indicated a specialized role of each LRK gene in a specific stress condition. These results described various characteristic feature and expression pattern of TaLRK genes, which will pave the way for functional characterization in wheat.	[Shumayla; Upadhyay, Santosh Kumar] Panjab Univ, Deparment Bot, Chandigarh 160014, India; [Sharma, Shailesh; Pandey, Ajay K.] Govt India, Natl Agrifood Biotechnol Inst, Dept Biotechnol, C 127 Ind Area, Mohali 1600711, Punjab, India; [Shumayla; Singh, Kashmir] Panjab Univ, Deparment Biotechnol, Chandigarh 160014, India	Panjab University; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Panjab University	Upadhyay, SK (corresponding author), Panjab Univ, Deparment Bot, Chandigarh 160014, India.	santoshnbri@hotmail.com	Singh, Kashmir/ABA-3329-2020; Upadhyay, Santosh/ABD-2302-2020	Singh, Kashmir/0000-0002-9646-9043; Upadhyay, Santosh/0000-0001-6991-0502; Pandey, Ajay Kumar/0000-0003-1064-139X; ., Shumayla/0000-0001-6445-0703	Panjab University, Chandigarh, India; National Agri-Food Biotechnology Institute, Mohali, Punjab, India	Panjab University, Chandigarh, India; National Agri-Food Biotechnology Institute, Mohali, Punjab, India	Authors are thankful to Panjab University, Chandigarh, India and National Agri-Food Biotechnology Institute, Mohali, Punjab, India for providing support and research facilities. Authors are also thankful to URGI and NCBI for the availability of RNA sequences data and various other tools. S is grateful to UGC for JRF. Authors are grateful to Dr. Praveen C Verma for critical evaluation and language editing of manuscript.	Agarwal G., 2016, PLANT BIOTECHNOL J, P1; Akpinar BA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1641-y; Babbitt CC, 2007, CELL, V131, P225, DOI 10.1016/j.cell.2007.10.001; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bhati KK, 2014, PLANT SCI, V224, P74, DOI 10.1016/j.plantsci.2014.04.009; Bonaventure G, 2011, PLANT SIGNAL BEHAV, V6, P2060, DOI 10.4161/psb.6.12.18324; Bouwmeester K, 2009, J EXP BOT, V60, P4383, DOI 10.1093/jxb/erp277; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Deng KQ, 2009, J PLANT BIOL, V52, P493, DOI 10.1007/s12374-009-9063-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Garcia-Hernandez Margarita, 2002, Funct Integr Genomics, V2, P239, DOI 10.1007/s10142-002-0077-z; Gilardoni PA, 2011, PLANT CELL, V23, P3512, DOI 10.1105/tpc.111.088229; Glover NM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0754-6; Herve C, 1999, PLANT MOL BIOL, V39, P671, DOI 10.1023/A:1006136701595; Herve C, 1996, J MOL BIOL, V258, P778, DOI 10.1006/jmbi.1996.0286; Hirsch AM, 1999, CURR OPIN PLANT BIOL, V2, P320, DOI 10.1016/S1369-5266(99)80056-9; Hofberger JA, 2015, GENOME BIOL EVOL, V7, P720, DOI 10.1093/gbe/evv020; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jiang SY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-79; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joshi A, 2010, GLYCOCONJUGATE J, V27, P133, DOI 10.1007/s10719-009-9265-6; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; Magadum S, 2013, J GENET, V92, P155, DOI 10.1007/s12041-013-0212-8; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McClung CR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-55; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naithani S, 2007, P NATL ACAD SCI USA, V104, P12211, DOI 10.1073/pnas.0705186104; Navarro-Gochicoa MT, 2003, PLANT PHYSIOL, V133, P1893, DOI 10.1104/pp.103.027680; Nishiguchi M, 2002, MOL GENET GENOMICS, V267, P506, DOI 10.1007/s00438-002-0683-4; Ohno S., 1970, P1; Pfeifer M, 2014, SCIENCE, V345, DOI 10.1126/science.1250091; Pingault L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0601-9; Pradhan GP, 2012, FUNCT PLANT BIOL, V39, P190, DOI 10.1071/FP11245; Prasad PVV, 2011, J AGRON CROP SCI, V197, P430, DOI 10.1111/j.1439-037X.2011.00477.x; Ramachandraiah G, 2000, PROTEINS, V39, P358, DOI 10.1002/(SICI)1097-0134(20000601)39:4<358::AID-PROT80>3.0.CO;2-M; Riou C, 2002, PLANT PHYSIOL BIOCH, V40, P431, DOI 10.1016/S0981-9428(02)01390-6; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roy SW, 2007, MOL BIOL EVOL, V24, P171, DOI 10.1093/molbev/msl159; Sherman-Broyles S, 2007, PLANT CELL, V19, P94, DOI 10.1105/tpc.106.048199; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Singh P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00124; Singh P, 2012, PLANT CELL, V24, P1256, DOI 10.1105/tpc.112.095778; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vaid N, 2012, PLANT MOL BIOL, V80, P365, DOI 10.1007/s11103-012-9952-8; Van Damme EJM, 2007, BIOCHEM J, V404, P51, DOI 10.1042/BJ20061819; Wan JR, 2008, PLANT MOL BIOL, V67, P469, DOI 10.1007/s11103-008-9332-6; Wang Y, 2015, J EXP BOT, V66, P6731, DOI 10.1093/jxb/erv379; Wang Y, 2014, MOL PLANT MICROBE IN, V27, P1390, DOI 10.1094/MPMI-06-14-0191-R; Wendel JF, 2002, MOL BIOL EVOL, V19, P2346, DOI 10.1093/oxfordjournals.molbev.a004062; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x; Xing SL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-69; Yamamoto E, 2001, MOL BIOL EVOL, V18, P1522, DOI 10.1093/oxfordjournals.molbev.a003938; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-898; Zuo KJ, 2004, DNA SEQUENCE, V15, P58, DOI 10.1080/1042517042000191454	68	36	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0153925	10.1371/journal.pone.0153925	http://dx.doi.org/10.1371/journal.pone.0153925			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111449	Green Published, gold			2022-12-27	WOS:000374970600023
J	Sudo, T; Yokota, T; Okuzaki, D; Ueda, T; Ichii, M; Ishibashi, T; Isono, T; Habuchi, Y; Oritani, K; Kanakura, Y				Sudo, Takao; Yokota, Takafumi; Okuzaki, Daisuke; Ueda, Tomoaki; Ichii, Michiko; Ishibashi, Tomohiko; Isono, Tomomi; Habuchi, Yoko; Oritani, Kenji; Kanakura, Yuzuru			Endothelial Cell-Selective Adhesion Molecule Expression in Hematopoietic Stem/Progenitor Cells Is Essential for Erythropoiesis Recovery after Bone Marrow Injury	PLOS ONE			English	Article							BMP4-DEPENDENT STRESS ERYTHROPOIESIS; STEM-CELL; ERYTHROID-DIFFERENTIATION; IN-VIVO; GATA-1; GENE; PROGENITORS; ANEMIA; MACROPHAGES; HOMEOSTASIS	Numerous red blood cells are generated every second from proliferative progenitor cells under a homeostatic state. Increased erythropoietic activity is required after myelo-suppression as a result of chemo-radio therapies. Our previous study revealed that the endothelial cell-selective adhesion molecule (ESAM), an authentic hematopoietic stem cell marker, plays essential roles in stress-induced hematopoiesis. To determine the physiological importance of ESAM in erythroid recovery, ESAM-knockout (KO) mice were treated with the anticancer drug, 5-fluorouracil (5-FU). ESAM-KO mice experienced severe and prolonged anemia after 5-FU treatment compared to wild-type (WT) mice. Eight days after the 5-FU injection, compared to WT mice, ESAM-KO mice showed reduced numbers of erythroid progenitors in bone marrow (BM) and spleen, and reticulocytes in peripheral blood. Megakaryocyte-erythrocyte progenitors (MEPs) from the BM of 5-FU-treated ESAM-KO mice showed reduced burst forming unit-erythrocyte (BFU-E) capacities than those from WT mice. BM transplantation revealed that hematopoietic stem/progenitor cells from ESAM-KO donors were more sensitive to 5-FU treatment than that from WT donors in the WT host mice. However, hematopoietic cells from WT donors transplanted into ESAM-KO host mice could normally reconstitute the erythroid lineage after a BM injury. These results suggested that ESAM expression in hematopoietic cells, but not environmental cells, is critical for hematopoietic recovery. We also found that 5-FU treatment induces the up-regulation of ESAM in primitive erythroid progenitors and macrophages that do not express ESAM under homeostatic conditions. The phenotypic change seen in macrophages might be functionally involved in the interaction between erythroid progenitors and their niche components during stress-induced acute erythropoiesis. Microarray analyses of primitive erythroid progenitors from 5-FU-treated WT and ESAM-KO mice revealed that various signaling pathways, including the GATA1 system, were impaired in ESAM-KO mice. Thus, our data demonstrate that ESAM expression in hematopoietic progenitors is essential for erythroid recovery after a BM injury.	[Sudo, Takao; Yokota, Takafumi; Ueda, Tomoaki; Ichii, Michiko; Ishibashi, Tomohiko; Isono, Tomomi; Habuchi, Yoko; Oritani, Kenji; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr, Suita, Osaka 565, Japan	Osaka University; Osaka University	Yokota, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka, Japan.	yokotat@bldon.med.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020	Okuzaki, Daisuke/0000-0002-4552-783X; ISONO, TOMOMI/0000-0002-0652-2331; Ishibashi, Tomohiko/0000-0003-1953-5016	JSPS [25461416]; Grants-in-Aid for Scientific Research [15H06373] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (JSPS KAKENHI) Grant Number 25461416. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Dev A, 2010, BLOOD, V116, P5334, DOI 10.1182/blood-2009-12-258947; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Dzierzak E, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011601; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; FEINSTEIN E, 1992, ONCOGENE, V7, P1853; Haniff M, 2009, J EXP MED, V206, P371, DOI 10.1084/jem.20081633; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Hirata K, 2001, J BIOL CHEM, V276, P16223, DOI 10.1074/jbc.M100630200; Inoue M, 2010, MICROVASC RES, V80, P179, DOI 10.1016/j.mvr.2010.04.005; Ishida T, 2003, J BIOL CHEM, V278, P34598, DOI 10.1074/jbc.M304890200; Jacobs-Helber SM, 2002, J BIOL CHEM, V277, P4859, DOI 10.1074/jbc.M107243200; Kimura R, 2010, GENES CELLS, V15, P385, DOI 10.1111/j.1365-2443.2010.01387.x; Lee G, 2006, BLOOD, V108, P2064, DOI 10.1182/blood-2006-03-006759; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Malinge S, 2013, BLOOD, V121, P2440, DOI 10.1182/blood-2012-08-450627; Marques-Garcia F, 2009, J BIOL CHEM, V284, P21139, DOI 10.1074/jbc.M109.026849; Millot S, 2010, BLOOD, V116, P6072, DOI 10.1182/blood-2010-04-281840; Minami R, 2003, EXP HEMATOL, V31, P355, DOI 10.1016/S0301-472X(03)00040-7; Ooi AGL, 2009, STEM CELLS, V27, P653, DOI 10.1634/stemcells.2008-0824; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Perry JM, 2009, BLOOD, V113, P911, DOI 10.1182/blood-2008-03-147892; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; Soni S, 2006, J BIOL CHEM, V281, P20181, DOI 10.1074/jbc.M603226200; Sudo T, 2012, J IMMUNOL, V189, P200, DOI 10.4049/jimmunol.1200056; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Xie HF, 2014, CELL STEM CELL, V14, P68, DOI 10.1016/j.stem.2013.10.001; Yokota T, 2009, BLOOD, V113, P2914, DOI 10.1182/blood-2008-07-167106; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154189	10.1371/journal.pone.0154189	http://dx.doi.org/10.1371/journal.pone.0154189			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27111450	Green Submitted, Green Published, gold			2022-12-27	WOS:000374970600044
J	Azimi, P; Benzel, EC; Montazeri, A				Azimi, Parisa; Benzel, Edward C.; Montazeri, Ali			Predictive Score Card in Lumbar Disc Herniation: Is It Reflective of Patient Surgical Success after Discectomy?	PLOS ONE			English	Article							SPINE; OUTCOMES; SATISFACTION; SURGERY; ISSUES; PAIN	Does the Finneson-Cooper score reflect the true value of predicting surgical success before discectomy? The aim of this study was to identify reliable predictors for surgical success two year after surgery for patients with LDH. Prospective analysis of 154 patients with LDH who underwent single-level lumbar discectomy was performed. Pre- and post-surgical success was assessed by the Oswestry Disability Index (ODI) over a 2-year period. The Finneson-Cooper score also was used for evaluation of the clinical results. Using the ODI, surgical success was defined as a 30% (or more) improvement on the ODI score from the baseline. The ODI was considered the gold standard in this study. Finally, the sensitivity, specificity, and positive and negative predictive power of the Finneson-Cooper score in predicting surgical success were calculated. The mean age of the patients was 49.6 (SD = 9.3) years and 47.4% were male. Significant improvement from the pre- to post-operative ODI scores was observed (P < 0.001). Post-surgical success was 76.0% (n = 117). The patients' rating on surgical success assessments by the ODI discriminated well between sub-groups of patients who differed with respect to the Finneson-Cooper score. Regarding patients' surgical success, the sensitivity, specificity, and accuracy of the Finneson-Cooper ratings correlated with success rate. The findings indicated that the Finneson-Cooper score was reflective of surgical success before discectomy.	[Azimi, Parisa] Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Tehran, Iran; [Benzel, Edward C.] Cleveland Clin Fdn, Dept Neurosurg, Cleveland, OH 44195 USA; [Montazeri, Ali] ACECR, Iranian Inst Hlth Sci Res, Hlth Metr Res Ctr, Mental Hlth Res Grp, Tehran, Iran	Shahid Beheshti University Medical Sciences; Cleveland Clinic Foundation; Academic Center for Education, Culture & Research (ACECR)	Azimi, P (corresponding author), Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Tehran, Iran.	parisa.azimi@gmail.com	Sciences, Functional Neurosurgery Research Center Shahid Beheshti University of Medical/AAN-2817-2020; Montazeri, Ali/C-9276-2009	Montazeri, Ali/0000-0002-5198-9539				Alodaibi FA, 2013, CHIROPR MAN THER, V21, DOI 10.1186/2045-709X-21-40; Fardon D F, 2001, Spine (Phila Pa 1976), V26, pE93, DOI 10.1097/00007632-200103010-00006; Finneson B E, 1979, Spine (Phila Pa 1976), V4, P141, DOI 10.1097/00007632-197903000-00008; Freedman MK, 2011, SPINE, V36, P290, DOI 10.1097/BRS.0b013e3181ef9d8c; Kirkwood BR, 2004, ESSENTIAL MED STAT, P430; Mauffrey C, 2008, BRIT J HOSP MED, V69, P344, DOI 10.12968/hmed.2008.69.6.29625; Motiei-Langroudi R, 2014, ASIAN SPINE J, V8, P446, DOI 10.4184/asj.2014.8.4.446; Mousavi SJ, 2006, SPINE, V31, pE454, DOI 10.1097/01.brs.0000222141.61424.f7; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; SIMPSON JM, 1993, J BONE JOINT SURG AM, V75A, P1823, DOI 10.2106/00004623-199312000-00013; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; SPENGLER DM, 1990, J BONE JOINT SURG AM, V72A, P230, DOI 10.2106/00004623-199072020-00010; Stromqvist B, 2013, EUR SPINE J, V22, P953, DOI 10.1007/s00586-013-2758-9; Verbeek J H A M, 2005, Ned Tijdschr Geneeskd, V149, P1493; Voorhies RM, 2007, SPINE J, V7, P516, DOI 10.1016/j.spinee.2006.10.013; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; White Andrew P, 2012, Evid Based Spine Care J, V3, P45, DOI 10.1055/s-0031-1298600; Yuan S, 2014, ACTA ORTHOP BELG, V80, P575	19	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154114	10.1371/journal.pone.0154114	http://dx.doi.org/10.1371/journal.pone.0154114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100287	gold, Green Published			2022-12-27	WOS:000374898500148
J	Boos, CJ; O'Hara, JP; Mellor, A; Hodkinson, PD; Tsakirides, C; Reeve, N; Gallagher, L; Green, NDC; Woods, DR				Boos, Christopher John; O'Hara, John Paul; Mellor, Adrian; Hodkinson, Peter David; Tsakirides, Costas; Reeve, Nicola; Gallagher, Liam; Green, Nicholas Donald Charles; Woods, David Richard			A Four-Way Comparison of Cardiac Function with Normobaric Normoxia, Normobaric Hypoxia, Hypobaric Hypoxia and Genuine High Altitude	PLOS ONE			English	Article							PULMONARY-ARTERY PRESSURE; EXERCISE; BIOMARKERS; RESPONSES	Background There has been considerable debate as to whether different modalities of simulated hypoxia induce similar cardiac responses. Materials and Methods This was a prospective observational study of 14 healthy subjects aged 22-35 years. Echocardiography was performed at rest and at 15 and 120 minutes following two hours exercise under normobaric normoxia (NN) and under similar PiO(2) following genuine high altitude (GHA) at 3,375m, normobaric hypoxia (NH) and hypobaric hypoxia (HH) to simulate the equivalent hypoxic stimulus to GHA. Results All 14 subjects completed the experiment at GHA, 11 at NN, 12 under NH, and 6 under HH. The four groups were similar in age, sex and baseline demographics. At baseline rest right ventricular (RV) systolic pressure (RVSP, p = 0.0002), pulmonary vascular resistance (p = 0.0002) and acute mountain sickness (AMS) scores were higher and the SpO(2) lower (p<0.0001) among all three hypoxic groups (GHA, NH and HH) compared with NN. At both 15 minutes and 120 minutes post exercise, AMS scores, Cardiac output, septal S', lateral S', tricuspid S' and A' velocities and RVSP were higher and SpO(2) lower with all forms of hypoxia compared with NN. On post-test analysis, among the three hypoxia groups, SpO(2) was lower at baseline and 15 minutes post exercise with GHA (89.3 +/- 3.4% and 89.3 +/- 2.2%) and HH (89.0 +/- 3.1 and (89.8 +/- 5.0) compared with NH (92.9 +/- 1.7 and 93.6 +/- 2.5%). The RV Myocardial Performance (Tei) Index and RVSP were significantly higher with HH than NH at 15 and 120 minutes post exercise respectively and tricuspid A' was higher with GHA compared with NH at 15 minutes post exercise. Conclusions GHA, NH and HH produce similar cardiac adaptations over short duration rest despite lower SpO(2) levels with GHA and HH compared with NH. Notable differences emerge following exercise in SpO(2), RVSP and RV cardiac function.	[Boos, Christopher John] Poole Hosp NHS Fdn trust, Dept Cardiol, Poole, Dorset, England; [Boos, Christopher John] Bournemouth Univ, Dept Postgrad Med Educ, Bournemouth, Dorset, England; [Boos, Christopher John; O'Hara, John Paul; Mellor, Adrian; Tsakirides, Costas; Reeve, Nicola; Gallagher, Liam; Woods, David Richard] Leeds Beckett Univ, Res Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England; [Mellor, Adrian] James Cook Univ Hosp, Middlesbrough TS4 3BW, Cleveland, England; [Mellor, Adrian; Hodkinson, Peter David; Green, Nicholas Donald Charles; Woods, David Richard] Def Med Serv, Lichfield, England; [Hodkinson, Peter David; Green, Nicholas Donald Charles] RAF Henlow, RAF Ctr Aviat Med, Luton SG16 6DN, Beds, England; [Hodkinson, Peter David] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 93,Hills Rd, Cambridge CB2 2QQ, England; [Woods, David Richard] Wansbeck Gen & Royal Victoria Infirm, Northumbria & Newcastle NHS Trusts, Newcastle Upon Tyne, Tyne & Wear, England; [Woods, David Richard] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Bournemouth University; Leeds Beckett University; James Cook University Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Newcastle University - UK	Boos, CJ (corresponding author), Poole Hosp NHS Fdn trust, Dept Cardiol, Poole, Dorset, England.; Boos, CJ (corresponding author), Bournemouth Univ, Dept Postgrad Med Educ, Bournemouth, Dorset, England.; Boos, CJ (corresponding author), Leeds Beckett Univ, Res Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England.	christopherboos@hotmail.com	Hodkinson, Peter/GWZ-4309-2022		Drummond Foundation; Leeds Beckett University; Centre of Aviation Medicine, RAF Henlow; Defence Medical Services; Surgeon General's Department	Drummond Foundation; Leeds Beckett University; Centre of Aviation Medicine, RAF Henlow; Defence Medical Services; Surgeon General's Department	The authors would like to thank the Drummond Foundation, Leeds Beckett University, the Centre of Aviation Medicine, RAF Henlow, the Defence Medical Services and the Surgeon General's Department for their support. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the Defence Medical Services.	Bartsch P, 2013, NEW ENGL J MED, V368, P2294, DOI 10.1056/NEJMcp1214870; Baulig W, 2005, ANAESTHESIA, V60, P968, DOI 10.1111/j.1365-2044.2005.04296.x; Beidleman BA, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-8; Boos CJ, 2012, HIGH ALT MED BIOL, V13, P105, DOI 10.1089/ham.2012.1009; Boos CJ, 2013, INT J CARDIOL, V167, pE65, DOI 10.1016/j.ijcard.2013.03.119; Boos CJ, 2014, CLIN RES CARDIOL, V103, P291, DOI 10.1007/s00392-013-0654-2; Compton F, 2009, SEMIN CARDIOTHORAC V, V13, P44, DOI 10.1177/1089253208330711; Conkin J, 2011, AVIAT SPACE ENVIR MD, V82, P1157, DOI 10.3357/ASEM.3145.2011; Coppel J, 2015, EXTREME PHYSIOL MED, V4, DOI 10.1186/s13728-014-0021-6; Dempsey JA, 1999, J APPL PHYSIOL, V87, P1997, DOI 10.1152/jappl.1999.87.6.1997; DILL DB, 1970, J APPL PHYSIOL, V29, P914, DOI 10.1152/jappl.1970.29.6.914; Eldridge MW, 2006, J APPL PHYSIOL, V100, P972, DOI 10.1152/japplphysiol.01048.2005; Faiss R, 2013, MED SCI SPORT EXER, V45, P253, DOI 10.1249/MSS.0b013e31826d5aa2; Feriche B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114072; Girard O, 2012, J APPL PHYSIOL, V112, P1788, DOI 10.1152/japplphysiol.00356.2012; Holloway C, 2011, FASEB J, V25, P3130, DOI 10.1096/fj.11-183426; Huez S, 2009, ECHOCARDIOGRAPHIC TI; KAUL S, 1984, AM HEART J, V107, P526, DOI 10.1016/0002-8703(84)90095-4; KUIPERS H, 1987, PFLUG ARCH EUR J PHY, V410, P652, DOI 10.1007/BF00581327; Mellor A, 2014, HIGH ALT MED BIOL, V15, P452, DOI 10.1089/ham.2014.1035; Millet GP, 2012, J APPL PHYSIOL, V112, P1783, DOI 10.1152/japplphysiol.00067.2012; Miyagawa K, 2011, J APPL PHYSIOL, V110, P157, DOI 10.1152/japplphysiol.00950.2010; Mounier R, 2012, J APPL PHYSIOL, V112, P1784, DOI 10.1152/japplphysiol.00067.2012a; Naeije R, 2010, EUR RESPIR J, V36, P1049, DOI 10.1183/09031936.00024410; Naeije R, 2010, PROG CARDIOVASC DIS, V52, P456, DOI 10.1016/j.pcad.2010.03.004; Ogihara Y, 2014, J CARDIOL, V63, P149, DOI 10.1016/j.jjcc.2013.07.002; Page M, 2013, AM J CARDIOL, V103, P1605; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Rao MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116936; Saugy JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114418; Savourey G, 2003, EUR J APPL PHYSIOL, V89, P122, DOI 10.1007/s00421-002-0789-8; Schramm WM, 1997, INT J CLIN MONIT COM, V14, P17, DOI 10.1023/A:1016960810767; SESSLER DI, 1992, ANESTHESIOLOGY, V76, P670, DOI 10.1097/00000542-199205000-00002; Stembridge M, 2014, J APPL PHYSIOL, V117, P334, DOI 10.1152/japplphysiol.00233.2014; Sutton J., 1992, HYPOXIA MOUNTAIN MED, P327; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Woods DR, 2012, ACTA PHYSIOL, V205, P349, DOI 10.1111/j.1748-1716.2012.02407.x; Zhou QQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031097	38	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152868	10.1371/journal.pone.0152868	http://dx.doi.org/10.1371/journal.pone.0152868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100313	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000374898500016
J	Jersakova, R; Moulin, CJA; O'Connor, AR				Jersakova, Radka; Moulin, Chris J. A.; O'Connor, Akira R.			Investigating the Role of Assessment Method on Reports of Deja Vu and Tip-of-the-Tongue States during Standard Recognition Tests	PLOS ONE			English	Article							DEMAND CHARACTERISTICS; MEMORY; IDENTIFICATION; CONSCIOUSNESS; FAMILIARITY; EXPERIENCE	Deja vu and tip-of-the-tongue (TOT) are retrieval-related subjective experiences whose study relies on participant self-report. In four experiments (ns = 224, 273, 123 and 154), we explored the effect of questioning method on reported occurrence of deja vu and TOT in experimental settings. All participants carried out a continuous recognition task, which was not expected to induce deja vu or TOT, but were asked about their experiences of these subjective states. When presented with contemporary definitions, between 32% and 58% of participants nonetheless reported experiencing deja vu or TOT. Changing the definition of deja vu or asking participants to bring to mind a real-life instance of deja vu or TOT before completing the recognition task had no impact on reporting rates. However, there was an indication that changing the method of requesting subjective reports impacted reporting of both experiences. More specifically, moving from the commonly used retrospective questioning (e.g. "Have you experienced deja vu?") to free report instructions (e.g. "Indicate whenever you experience deja vu.") reduced the total number of reported deja vu and TOT occurrences. We suggest that research on subjective experiences should move toward free report assessments. Such a shift would potentially reduce the presence of false alarms in experimental work, thereby reducing the overestimation of subjective experiences prevalent in this area of research.	[Jersakova, Radka] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England; [Moulin, Chris J. A.] Univ Grenoble Alpes, LPNC CNRS UMR 5105, Grenoble, France; [O'Connor, Akira R.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of Leeds; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of St Andrews	O'Connor, AR (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	aro2@st-andrews.ac.uk		O'Connor, Akira/0000-0002-7943-5183; Jersakova, Radka/0000-0001-6846-7158				Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Brown A. S., 2012, TIP TONGUE STATE; Brown AS, 2009, PSYCHOL SCI, V20, P534, DOI 10.1111/j.1467-9280.2009.02337.x; Brown AS., 2004, DEJA VU EXPERIENCE; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Cleary AM, 2014, TIP-OF-THE-TONGUE STATES AND RELATED PHENOMENA, P75; Cleary AM, 2012, CONSCIOUS COGN, V21, P969, DOI 10.1016/j.concog.2011.12.010; Cleary AM, 2009, PSYCHON B REV, V16, P1082, DOI 10.3758/PBR.16.6.1082; Cleary AM, 2009, ACTA PSYCHOL, V131, P53, DOI 10.1016/j.actpsy.2009.02.006; Finn B, 2008, MEM COGNITION, V36, P813, DOI 10.3758/MC.36.4.813; Fortier J, 2015, CONSCIOUS COGN, V36, P12, DOI 10.1016/j.concog.2015.05.013; FOWLER FJ, 1992, PUBLIC OPIN QUART, V56, P218; Heine MK, 1999, PSYCHOL AGING, V14, P445, DOI 10.1037/0882-7974.14.3.445; JACOBY LL, 1989, J EXP PSYCHOL GEN, V118, P126, DOI 10.1037/0096-3445.118.2.126; Koriat A, 2000, CONSCIOUS COGN, V9, P149, DOI 10.1006/ccog.2000.0433; LOFTUS EF, 1974, J VERB LEARN VERB BE, V13, P585, DOI 10.1016/S0022-5371(74)80011-3; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Mill RD, 2014, CONSCIOUS COGN, V30, P91, DOI 10.1016/j.concog.2014.09.006; Norenzayan A, 1999, EUR J SOC PSYCHOL, V29, P1011, DOI 10.1002/(SICI)1099-0992(199912)29:8<1011::AID-EJSP974>3.0.CO;2-A; O'Connor AR, 2010, CURR PSYCHIAT REP, V12, P165, DOI 10.1007/s11920-010-0119-5; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; Overgaard M, 2016, TRENDS COGN SCI, V20, P241, DOI 10.1016/j.tics.2016.01.004; RYAN MP, 1982, ACTA PSYCHOL, V51, P137, DOI 10.1016/0001-6918(82)90058-0; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Urquhart JA, 2014, PEERJ, V2, DOI 10.7717/peerj.666; Widner RL, 1996, AM J PSYCHOL, V109, P525, DOI 10.2307/1423392; WINKLER JD, 1982, J APPL PSYCHOL, V67, P555, DOI 10.1037/0021-9010.67.5.555	27	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154334	10.1371/journal.pone.0154334	http://dx.doi.org/10.1371/journal.pone.0154334			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100292	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500184
J	Ni, GY; Chen, S; Yang, YD; Cummins, SF; Zhan, J; Li, ZX; Zhu, B; Mounsey, K; Walton, S; Wei, MQ; Wang, YJ; Zhou, YQ; Wang, TF; Liu, XS				Ni, Guoying; Chen, Shu; Yang, Yuedong; Cummins, Scott F.; Zhan, Jian; Li, Zhixiu; Zhu, Bin; Mounsey, Kate; Walton, Shelley; Wei, Ming Q.; Wang, Yuejian; Zhou, Yaoqi; Wang, Tianfang; Liu, Xiaosong			Investigation the Possibility of Using Peptides with a Helical Repeating Pattern of HydroPhobic and Hydrophilic Residues to Inhibit IL-10	PLOS ONE			English	Article							STRUCTURE-BASED DESIGN; HUMAN-PAPILLOMAVIRUS TYPE-16; ANTIGEN-EXPERIENCED HOST; T-CELL RESPONSES; IFN-GAMMA; VIROSOMAL FORMULATION; SIGNALING BLOCKADE; RECEPTOR ANTIBODY; VIRAL-INFECTION; DENDRITIC CELLS	Blockade of IL-10 signalling clears chronic viral and bacterial infections. Immunization together with blockade of IL-10 signalling or relatively low level of IL-10 further enhances viral and bacterial clearance. IL-10 functions through binding to interleukin 10 receptor (IL-10R). Here we showed that peptides P1 and P2 with the hydrophobic and hydrophilic pattern of the IL10R-binding helix in IL-10 could bind with either IL-10R1 or IL-10, and inhibit inflammatory signals with long duration and negligible cytotoxicity in vitro. Furthermore, P2 can enhance antigen specific CD8+ T cell responses in mice induced by the vaccine based on a long peptide of protein E7 in a human papillomavirus type 16.	[Ni, Guoying; Cummins, Scott F.; Wang, Tianfang; Liu, Xiaosong] Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Australia; [Mounsey, Kate; Walton, Shelley] Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Australia; [Ni, Guoying; Wei, Ming Q.] Griffith Univ, Griffith Hlth Inst, Sch Med Sci, Gold Coast, Australia; [Yang, Yuedong; Zhan, Jian; Zhou, Yaoqi] Griffith Univ, Inst Glyc, Gold Coast, Australia; [Yang, Yuedong; Zhan, Jian; Zhou, Yaoqi] Griffith Univ, Sch Informat & Commun Technol, Gold Coast, Australia; [Li, Zhixiu] Univ Queensland, Diamantina Inst, Woolloongabba, Qld, Australia; [Chen, Shu; Zhu, Bin; Wang, Yuejian; Liu, Xiaosong] Foshan First Peoples Hosp, Canc Res Inst, Foshan, Guangdong, Peoples R China	University of the Sunshine Coast; University of the Sunshine Coast; Griffith University; Menzies Health Institute Queensland; Griffith University; Griffith University; University of Queensland	Wang, TF; Liu, XS (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Australia.; Zhou, YQ (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Australia.; Zhou, YQ (corresponding author), Griffith Univ, Sch Informat & Commun Technol, Gold Coast, Australia.; Liu, XS (corresponding author), Foshan First Peoples Hosp, Canc Res Inst, Foshan, Guangdong, Peoples R China.	yaoqi.zhou@griffith.edu.au; twang@usc.edu.au; xliu@usc.edu.au	Walton, Shelley/A-9767-2012; Wang, Tianfang/L-5192-2016; Wang, Tianfang/AAG-4290-2020; Wang, Tianfang/GRO-0844-2022; Zhou, Yaoqi/B-3284-2009; Jian, Zhan/AAM-2759-2021; Yang, Yuedong/C-9394-2009; Li, Zhixiu/AAK-4021-2021; Cummins, Scott/I-6420-2016	Walton, Shelley/0000-0002-5857-6913; Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Zhou, Yaoqi/0000-0002-9958-5699; Jian, Zhan/0000-0003-0856-2385; Yang, Yuedong/0000-0002-6782-2813; Li, Zhixiu/0000-0002-2924-9120; Mounsey, Kate/0000-0003-0579-9424; Cummins, Scott/0000-0002-1454-2076	National Natural Science Foundation of China [81472451]; National Health and Medical Research Council of Australia [1059775]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by the National Natural Science Foundation of China (www.nsfc.gov.cn/publish/portal1/), 81472451 to XL and TW; and the National Health and Medical Research Council of Australia (www.nhmrc.gov.au), 1059775 to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaji K, 2011, J MED CHEM, V54, P7962, DOI 10.1021/jm200870n; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Barrera D, 2012, CYTOKINE, V57, P316, DOI 10.1016/j.cyto.2011.11.020; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Berezhnoy A, 2012, MOL THER, V20, P1242, DOI 10.1038/mt.2012.18; Bich C, 2009, CURR OPIN STRUC BIOL, V19, P632, DOI 10.1016/j.sbi.2009.08.004; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Brooks DG, 2008, J EXP MED; Carriero MV, 2009, MOL CANCER THER, V8, P2708, DOI 10.1158/1535-7163.MCT-09-0174; Caspar-Bauguil S, 2000, J INFECT DIS, V182, P1394, DOI 10.1086/315856; Chen S, 2014, CELL IMMUNOL, V290, P145, DOI 10.1016/j.cellimm.2014.06.002; Chen SM, 2013, J IMMUNOL, V191, P5097, DOI 10.4049/jimmunol.1300467; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Clutton G, 2015, HUM VACC IMMUNOTHER, V11, P1030, DOI 10.1080/21645515.2015.1009809; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Cua DJ, 1999, J EXP MED, V189, P1005, DOI 10.1084/jem.189.6.1005; De Bruijn MLH, 1998, CANCER RES, V58, P724; Diaz-Valdes N, 2011, HEPATOLOGY, V53, P23, DOI 10.1002/hep.23980; Dings RPM, 2007, ACCOUNTS CHEM RES, V40, P1057, DOI 10.1021/ar700086k; Driessler F, 2004, CLIN EXP IMMUNOL, V135, P64, DOI 10.1111/j.1365-2249.2004.02342.x; Ejrnaes M, 2007, AUTOIMMUN REV, V6, P267, DOI 10.1016/j.autrev.2006.09.002; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gautam S, 2011, J INFECT DIS, V204, P1134, DOI 10.1093/infdis/jir461; Griffioen AW, 2001, BIOCHEM J, V354, P233, DOI 10.1042/0264-6021:3540233; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Heal WP, 2011, CHEM SOC REV, V40, P246, DOI 10.1039/c0cs00004c; HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X; Hu DM, 2013, BIOSENSORS-BASEL, V3, P297, DOI 10.3390/bios3030297; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Josephson K, 2001, ACTA CRYSTALLOGR D, V57, P1908, DOI 10.1107/S0907444901016249; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Khammanivong V, 2003, IMMUNOL CELL BIOL, V81, P1, DOI 10.1046/j.1440-1711.2003.01130.x; Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011; Liu XS, 2006, J IMMUNOL, V177, P2873, DOI 10.4049/jimmunol.177.5.2873; Liu XS, 2009, J IMMUNOL, V183, P51, DOI 10.4049/jimmunol.0802047; Liu XS, 2003, J IMMUNOL, V171, P4765, DOI 10.4049/jimmunol.171.9.4765; Lofgren JA, 2007, J IMMUNOL, V178, P7467, DOI 10.4049/jimmunol.178.11.7467; Lyons A, 1997, ANN SURG, V226, P450, DOI 10.1097/00000658-199710000-00006; Madler S, 2013, TOP CURR CHEM, V331, P1, DOI 10.1007/128_2011_311; MATHESON RR, 1978, MACROMOLECULES, V11, P819, DOI 10.1021/ma60064a038; Matilainen JM, 2010, BBA-MOL CELL RES, V1803, P1276, DOI 10.1016/j.bbamcr.2010.07.009; Mueller MS, 2003, INFECT IMMUN, V71, P4749, DOI 10.1128/IAI.71.8.4749-4758.2003; Naiyer MM, 2013, HUM IMMUNOL, V74, P28, DOI 10.1016/j.humimm.2012.09.002; Ni GY, 2015, CELL IMMUNOL, V293, P126, DOI 10.1016/j.cellimm.2014.12.012; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Okitsu SL, 2007, CHEM BIOL, V14, P577, DOI 10.1016/j.chembiol.2007.04.008; PAULING L, 1953, NATURE, V171, P59, DOI 10.1038/171059a0; Pitt JM, 2012, J IMMUNOL, V189, P4079, DOI 10.4049/jimmunol.1201061; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Siegel M, 2007, BIOORGAN MED CHEM, V15, P6253, DOI 10.1016/j.bmc.2007.06.020; Stevenson CL, 2009, CURR PHARM BIOTECHNO, V10, P122, DOI 10.2174/138920109787048634; TAN JC, 1995, J BIOL CHEM, V270, P12906, DOI 10.1074/jbc.270.21.12906; Terai M, 2009, CANCER IMMUNOL IMMUN, V58, P1307, DOI 10.1007/s00262-008-0644-9; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; Torrens I, 2005, VACCINE, V23, P5768, DOI 10.1016/j.vaccine.2005.07.049; van der Burg SH, 2011, TRENDS IMMUNOL, V32, P97, DOI 10.1016/j.it.2010.12.006; van der Sluis TC, 2015, CURR OPIN IMMUNOL, V35, P9, DOI 10.1016/j.coi.2015.05.002; Vashist SK, 2012, PROCEDIA CHEM, V6, P184, DOI 10.1016/j.proche.2012.10.145; Vicari Alain P, 2004, Novartis Found Symp, V256, P241; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/281912; Whitehead M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-367; Wilson EB, 2011, CURR TOP MICROBIOL, V350, P39, DOI 10.1007/82_2010_96; Wortmann A, 2007, ANALYST, V132, P199, DOI 10.1039/b615411e; Zompra AA, 2009, FUTURE MED CHEM, V1, P361, DOI 10.4155/FMC.09.23	70	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153939	10.1371/journal.pone.0153939	http://dx.doi.org/10.1371/journal.pone.0153939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100390	gold, Green Published			2022-12-27	WOS:000374898500101
J	Rainard, P; Cunha, P; Gilbert, FB				Rainard, Pascal; Cunha, Patricia; Gilbert, Florence B.			Innate and Adaptive Immunity Synergize to Trigger Inflammation in the Mammary Gland	PLOS ONE			English	Article							AUREUS LIPOTEICHOIC ACID; ESCHERICHIA-COLI; DAIRY-COWS; BOVINE MASTITIS; LIPOPOLYSACCHARIDE; VACCINATION; RESPONSES; EXPRESSION; ANTIBODY; CELLS	The mammary gland is able to detect and react to bacterial intrusion through innate immunity mechanisms, but mammary inflammation can also result from antigen-specific adaptive immunity. We postulated that innate and adaptive immune responses could synergize to trigger inflammation in the mammary gland. To test this hypothesis, we immunized cows with the model antigen ovalbumin and challenged the sensitized animals with either Escherichia coli lipopolysaccharide (LPS) as innate immunity agonist, ovalbumin as adaptive immunity agonist, or both agonists in three different udder quarters of lactating cows. There was a significant amplification of the initial milk leukocytosis in the quarters challenged with the two agonists compared to leukocytosis in quarters challenged with LPS or ovalbumin alone. This synergistic response occurred only with the cows that developed the ovalbumin-specific inflammatory response, and there were significant correlations between milk leukocytosis and production of IL-17A and IFN-gamma in a whole-blood ovalbumin stimulation assay. The antigen-specific response induced substantial concentrations of IL-17A and IFN-gamma in milk contrary to the response to LPS. Such a synergy at the onset of the reaction of the mammary gland suggests that induction of antigen-specific immune response with bacterial antigens could improve the initial immune response to infection, hence reducing the bacterial load and contributing to protection.	[Rainard, Pascal; Cunha, Patricia; Gilbert, Florence B.] Univ Tours, INRA, ISP, Nouzilly, France	INRAE; Universite de Tours	Rainard, P (corresponding author), Univ Tours, INRA, ISP, Nouzilly, France.	pascal.rainard@tours.inra.fr		Rainard, Pascal/0000-0002-5477-2626	Region Centre (Mamimmunotypage project) [00073634]	Region Centre (Mamimmunotypage project)(Region Centre-Val de Loire)	This work was funded partly by the Region Centre (Mamimmunotypage project, Convention 2012 00073634, www.regioncentre.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; Bougarn S, 2010, CLIN VACCINE IMMUNOL, V17, P1797, DOI 10.1128/CVI.00268-10; Bruno DR, 2010, VET IMMUNOL IMMUNOP, V138, P15, DOI 10.1016/j.vetimm.2010.06.009; DECUENINCK BJ, 1979, INT ARCH ALLER A IMM, V59, P394, DOI 10.1159/000232286; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Erskine RJ, 2012, VET CLIN N AM-FOOD A, V28, P257, DOI 10.1016/j.cvfa.2012.03.002; Green BB, 2014, VET IMMUNOL IMMUNOP, V157, P49, DOI 10.1016/j.vetimm.2013.10.015; Herbelin C, 1997, J DAIRY SCI, V80, P2025, DOI 10.3168/jds.S0022-0302(97)76147-2; Heriazon A, 2013, VET IMMUNOL IMMUNOP, V154, P83, DOI 10.1016/j.vetimm.2013.03.014; Ibeagha-Awemu EM, 2008, VET RES, V39, DOI 10.1051/vetres:2007047; Kandasamy S, 2011, J DAIRY SCI, V94, P5963, DOI 10.3168/jds.2011-4288; Kim KW, 2011, COMP IMMUNOL MICROB, V34, P347, DOI 10.1016/j.cimid.2011.04.004; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kossaibati MA, 1997, VET J, V154, P41, DOI 10.1016/S1090-0233(05)80007-3; Leigh JA, 2000, ADV EXP MED BIOL, V480, P307; Middleton JR, 2008, EXPERT REV VACCINES, V7, P805, DOI 10.1586/14760584.7.6.805; NONNECKE BJ, 1984, J REPROD IMMUNOL, V6, P365, DOI 10.1016/0165-0378(84)90046-9; Porcherie A, 2016, J IMMUNOL, V196, P803, DOI 10.4049/jimmunol.1500705; Porcherie A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-14; Prenafeta A, 2010, VET IMMUNOL IMMUNOP, V134, P208, DOI 10.1016/j.vetimm.2009.09.020; Rainard P, 1997, VET RES, V28, P231; Rainard P, 2010, CLIN VACCINE IMMUNOL, V17, P848, DOI 10.1128/CVI.00447-09; Rainard P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137755; Rainard P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063471; Rainard P, 2008, VET RES, V39, DOI 10.1051/vetres:2008034; Riollet C, 2000, CLIN DIAGN LAB IMMUN, V7, P161, DOI 10.1128/CDLI.7.2.161-167.2000; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; SHUSTER DE, 1991, RES VET SCI, V51, P272, DOI 10.1016/0034-5288(91)90077-2; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Strandberg Y, 2005, CYTOKINE, V31, P72, DOI 10.1016/j.cyto.2005.02.010; Tao WJ, 2007, VET IMMUNOL IMMUNOP, V120, P201, DOI 10.1016/j.vetimm.2007.06.019; TARGOWSKI SP, 1975, AM J VET RES, V36, P1561; TARGOWSKI SP, 1982, AM J REPROD IMMUNOL, V2, P29, DOI 10.1111/j.1600-0897.1982.tb00081.x; Thompson-Crispi K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00493; Wedlock DN, 2014, VET IMMUNOL IMMUNOP, V160, P51, DOI 10.1016/j.vetimm.2014.03.012; Wellnitz O, 2004, VET IMMUNOL IMMUNOP, V101, P191, DOI 10.1016/j.vetimm.2004.04.019; Whelehan CJ, 2011, VET IMMUNOL IMMUNOP, V140, P181, DOI 10.1016/j.vetimm.2010.11.013; Wilson DJ, 2007, CLIN VACCINE IMMUNOL, V14, P693, DOI 10.1128/CVI.00104-07; Zhao YY, 2016, PHARM BIOL, V54, P130, DOI 10.3109/13880209.2015.1021816	39	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154172	10.1371/journal.pone.0154172	http://dx.doi.org/10.1371/journal.pone.0154172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100324	gold, Green Submitted, Green Published			2022-12-27	WOS:000374898500160
J	Tsang, JLY; Jia, SH; Parodo, J; Plant, P; Lodyga, M; Charbonney, E; Szaszi, K; Kapus, A; Marshall, JC				Tsang, Jennifer L. Y.; Jia, Song Hui; Parodo, Jean; Plant, Pamela; Lodyga, Monika; Charbonney, Emmanuel; Szaszi, Katalin; Kapus, Andras; Marshall, John C.			Tyrosine Phosphorylation of Caspase-8 Abrogates Its Apoptotic Activity and Promotes Activation of c-Src	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; T-CELL PROLIFERATION; HEPATOCELLULAR-CARCINOMA; SIGNAL-TRANSDUCTION; SH3 DOMAIN; KINASE; DEATH; PROTEIN; CANCER; CD95	Src family tyrosine kinases (SFKs) phosphorylate caspase-8A at tyrosine (Y) 397 resulting in suppression of apoptosis. In addition, the phosphorylation of caspase-8A at other sites including Y465 has been implicated in the regulation of caspase-8 activity. However, the functional consequences of these modifications on caspase-8 processing/activity have not been elucidated. Moreover, various Src substrates are known to act as potent Src regulators, but no such role has been explored for caspase-8. We asked whether the newly identified caspase-8 phosphorylation sites might regulate caspase-8 activation and conversely, whether caspase-8 phosphorylation might affect Src activity. Here we show that Src phosphorylates caspase-8A at multiple tyrosine sites; of these, we have focused on Y397 within the linker region and Y465 within the p12 subunit of caspase-8A. We show that phosphomimetic mutation of caspase-8A at Y465 prevents its cleavage and the subsequent activation of caspase-3 and suppresses apoptosis. Furthermore, simultaneous phosphomimetic mutation of caspase-8A at Y397 and Y465 promotes the phosphorylation of c-Src at Y416 and increases c-Src activity. Finally, we demonstrate that caspase-8 activity prevents its own tyrosine phosphorylation by Src. Together these data reveal that dual phosphorylation converts caspase-8 from a pro-apoptotic to a pro-survival mediator. Specifically, tyrosine phosphorylation by Src renders caspase-8 uncleavable and thereby inactive, and at the same time converts it to a Src activator. This novel dynamic interplay between Src and caspase-8 likely acts as a potent signal-integrating switch directing the cell towards apoptosis or survival.	[Tsang, Jennifer L. Y.] McMaster Univ, Dept Med, Div Crit Care, Hamilton, ON, Canada; [Tsang, Jennifer L. Y.] Niagara Hlth Syst, Dept Med, Div Crit Care, Niagara, ON, Canada; [Jia, Song Hui; Parodo, Jean; Plant, Pamela; Szaszi, Katalin; Kapus, Andras; Marshall, John C.] Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Lodyga, Monika] Univ Toronto, Fac Dent, Matrix Dynam Grp, Lab Tissue Repair & Regenerat, Toronto, ON, Canada; [Charbonney, Emmanuel] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Charbonney, Emmanuel] Hop Sacre Coeur, Ctr Rech, Montreal, PQ H4J 1C5, Canada; [Szaszi, Katalin; Kapus, Andras] St Michaels Hosp, Dept Surg, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Marshall, John C.] St Michaels Hosp, Dept Crit Care Med, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Marshall, John C.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada	McMaster University; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; Universite de Montreal; Universite de Montreal; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Tsang, JLY (corresponding author), McMaster Univ, Dept Med, Div Crit Care, Hamilton, ON, Canada.; Tsang, JLY (corresponding author), Niagara Hlth Syst, Dept Med, Div Crit Care, Niagara, ON, Canada.	tsangj10@mcmaster.ca		Kapus, Andras/0000-0002-6610-9530	Canadian Institutes of Health Research [MOP129493]; McMaster Medicine Internal Career Research Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McMaster Medicine Internal Career Research Award	This work was supported by Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html, grant number: MOP129493 to JM), and McMaster Medicine Internal Career Research Award (http://fhs.mcmaster.ca/medicine/research_awards.htm, E.J. Moran Campbell Internal Career Research Award to JT).; Dr. D. Flynn from West Virginia provided the constitutively active avian Src (Y527 Src) in pCMV1 vector. Jennifer LY Tsang is the recipient of the McMaster Medicine Internal Career Research Award.	Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Barbero S, 2008, J BIOL CHEM, V283, P13031, DOI 10.1074/jbc.M800549200; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Cam WR, 2001, CANCER, V92, P61, DOI 10.1002/1097-0142(20010701)92:1<61::AID-CNCR1292>3.0.CO;2-D; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Erpel T, 1996, J BIOL CHEM, V271, P16807, DOI 10.1074/jbc.271.28.16807; Falk M, 2004, J IMMUNOL, V173, P5077, DOI 10.4049/jimmunol.173.8.5077; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; Finlay D, 2009, CELL CYCLE, V8, P3441, DOI 10.4161/cc.8.21.9649; Finlay D, 2009, CANCER RES, V69, P5023, DOI 10.1158/0008-5472.CAN-08-3731; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Golks A, 2006, CELL DEATH DIFFER, V13, P489, DOI 10.1038/sj.cdd.4401766; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Hynes NE, 2000, BREAST CANCER RES, V2, P154, DOI 10.1186/bcr48; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Jia SH, 2008, J BIOL CHEM, V283, P5402, DOI 10.1074/jbc.M706462200; Jones RJ, 2002, BRIT J CANCER, V87, P1128, DOI 10.1038/sj.bjc.6600594; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Keller N, 2009, STRUCTURE, V17, P438, DOI 10.1016/j.str.2008.12.019; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kim HS, 2003, GASTROENTEROLOGY, V125, P708, DOI 10.1016/S0016-5085(03)01059-X; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Lavrik I, 2003, CELL DEATH DIFFER, V10, P144, DOI 10.1038/sj.cdd.4401156; Lodyga M, 2002, AM J PHYSIOL-LUNG C, V283, pL265, DOI 10.1152/ajplung.00492.2001; Luciano F, 2001, ONCOGENE, V20, P4935, DOI 10.1038/sj.onc.1204661; Luschen S, 2005, EXP CELL RES, V310, P33, DOI 10.1016/j.yexcr.2005.07.022; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Martin GS, 2004, ONCOGENE, V23, P7910, DOI 10.1038/sj.onc.1208077; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Masaki T, 1999, HEPATOLOGY, V29, P379, DOI 10.1002/hep.510290239; Masaki T, 1998, HEPATOLOGY, V27, P1257, DOI 10.1002/hep.510270511; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; PARK J, 1995, MOL CELL BIOL, V15, P2374; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Shen J, 2006, CANCER RES, V66, P11194, DOI 10.1158/0008-5472.CAN-04-1444; Shivapurkar N, 2002, CANCER BIOL THER, V1, P65, DOI 10.4161/cbt.1.1.45; Smart JE, 1981, CHARACTERIZATION SIT; Son JW, 2006, CANCER GENET CYTOGEN, V169, P121, DOI 10.1016/j.cancergencyto.2006.04.001; Soung YH, 2005, CANCER RES, V65, P815; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Sugimura M, 2000, JPN J CANCER RES, V91, P395, DOI 10.1111/j.1349-7006.2000.tb00958.x; Torres VA, 2010, MOL BIOL CELL, V21, P369, DOI 10.1091/mbc.E09-09-0769; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200	64	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153946	10.1371/journal.pone.0153946	http://dx.doi.org/10.1371/journal.pone.0153946			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27101103	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500106
J	Tseng, CL; Chen, ZY; Renn, TY; Hsiao, SH; Burnouf, T				Tseng, Ching-Li; Chen, Zhi-Yu; Renn, Ting-Yi; Hsiao, Shun-Hung; Burnouf, Thierry			Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BENZALKONIUM CHLORIDE; THERAPEUTIC-EFFICACY; SURFACE DISEASE; EPIGALLOCATECHIN GALLATE; GROWTH-FACTORS; ANIMAL-MODELS; WORKSHOP 2007; BLOOD-DONORS; PLASMA	Application of autologous serum eye drops (SEDs) is a recognized means to treat severe dry-eye syndrome (DES). Due to the inconvenience and difficulty of preparing SEDs from some patients, producing SEDs from allogeneic blood donations is gaining popularity. A major safety concern associated with allogeneic blood is virus transmission. We therefore herein evaluated the possibility of applying a solvent/detergent (S/D) treatment to inactivate viruses and studied the impacts of such treatment of SEDs to resolve DES in a rabbit model. Sera prepared from the blood of five rabbits were pooled and divided into two sub-pools. One was untreated (SEDs), while the other was virally-inactivated with 1% Tri-n-butyl phosphate/1% Triton X-45 at 31 degrees C for 1 h (S/D-SEDs). DES was induced in rabbits using 0.1% benzalkonium chloride (BAC). Rabbits were divided into five groups of two rabbits each. One group was untreated (control), three were treated twice daily for 3 weeks using PBS, SEDs, or S/D-SEDs, and the last received an additional 0.1% BAC (as the negative control). The DES condition was determined by measuring aqueous tear secretion (Schirmer's test), corneal fluorescein staining, a corneal histologic examination, TUNEL stain apoptosis, and corneal inflammatory marker (tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL8, and IL-6) expressions. We first confirmed that SEDs and S/D-SEDs had similar protein profiles and transforming growth factor (TGF)-beta contents. Animal experiments showed that tear secretion did not significantly differ between the SED and S/D-SED groups but was significantly higher than in the PBS group. Eye fluorescein staining revealed dramatic improvements in epithelial defects in groups treated with SEDs or S/D-SEDs, and hematoxylin/eosin staining revealed microscopic epithelial layers similar to those of the untreated controls. Inflammatory markers and TUNEL studies showed that healthy epithelium had been restored in groups treated with SEDs or S/D-SEDs. In conclusion, this preclinical study supports the possibility of using S/D virally inactivated SEDs to treat DES and restore a normal epithelium.	[Tseng, Ching-Li; Chen, Zhi-Yu; Renn, Ting-Yi; Hsiao, Shun-Hung; Burnouf, Thierry] Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan	Taipei Medical University	Burnouf, T (corresponding author), Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan.	thburnouf@gmail.com	Burnouf, Thierry/H-4784-2019	Burnouf, Thierry/0000-0002-0507-9243; Tseng, Ching-Li/0000-0001-9446-4030	National Health Research Institute, Taiwan [NHRI-EX103-10334EI]	National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by a project grant from the National Health Research Institute, Taiwan (NHRI-EX103-10334EI), awarded to CLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acera A, 2008, OPHTHALMIC RES, V40, P315, DOI 10.1159/000150445; Al-Abdulla I, 2014, J IMMUNOL METHODS, V402, P15, DOI 10.1016/j.jim.2013.11.001; Alio JL, 2015, CURR OPIN OPHTHALMOL, V26, P325, DOI 10.1097/ICU.0000000000000169; Azari AA, 2015, EYE CONTACT LENS, V41, P133, DOI 10.1097/ICL.0000000000000104; Barabino S, 2004, INVEST OPHTH VIS SCI, V45, P1641, DOI 10.1167/iovs.03-1055; Bitko V, 2007, J VIROL, V81, P783, DOI 10.1128/JVI.01437-06; Blajchman MA, 2009, TRANSFUS CLIN BIOL, V16, P70, DOI 10.1016/j.tracli.2009.04.004; Bradley JC, 2009, CORNEA, V28, P200, DOI 10.1097/ICO.0b013e318186321e; Burnouf T, 2013, VOX SANG, V104, P1, DOI 10.1111/j.1423-0410.2012.01621.x; Burnouf T, 2000, BLOOD REV, V14, P94, DOI 10.1054/blre.2000.0129; Burnouf T, 2008, TRANSFUSION, V48, P1090, DOI 10.1111/j.1537-2995.2008.01691.x; Burnouf T, 2009, ANAL BIOCHEM, V389, P69, DOI 10.1016/j.ab.2009.03.016; BURSTEIN NL, 1980, INVEST OPHTH VIS SCI, V19, P308; Cavet ME, 2011, MOL VIS, V17, P533; Celebi ARC, 2014, GRAEF ARCH CLIN EXP, V252, P619, DOI 10.1007/s00417-014-2599-1; Chiang CC, 2009, EYE, V23, P290, DOI 10.1038/sj.eye.6703079; Chiang CC, 2007, CORNEA, V26, P861, DOI 10.1097/ICO.0b013e3180645cd7; Chou ML, 2012, VOX SANG, V102, P277, DOI 10.1111/j.1423-0410.2011.01560.x; Chou ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117800; Dichtelmuller HO, 2009, TRANSFUSION, V49, P1931, DOI 10.1111/j.1537-2995.2009.02222.x; Dodd RY, 2012, BRIT J HAEMATOL, V159, P135, DOI 10.1111/bjh.12031; El-Ekiaby M, 2010, TRANSFUSION MED, V20, P48, DOI 10.1111/j.1365-3148.2009.00963.x; Espinosa A, 2015, TRANSFUS APHER SCI, V53, P88, DOI 10.1016/j.transci.2015.05.014; Geerling G, 2004, BRIT J OPHTHALMOL, V88, P1467, DOI 10.1136/bjo.2004.044347; Harritshoj LH, 2014, ACTA OPHTHALMOL, V92, P783, DOI 10.1111/aos.12386; Higuchi A, 2007, CURR EYE RES, V32, P83, DOI 10.1080/02713680601147690; Kojima T, 2008, CORNEA, V27, pS25, DOI 10.1097/ICO.0b013e31817f3a0e; Lee HS, 2011, CORNEA, V30, P1465, DOI 10.1097/ICO.0b013e31821c9b5a; Lemp MA, 2007, OCUL SURF, V5, P75; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Lin ZR, 2011, MOL VIS, V17, P257; Marks DC, 2015, TRANSFUS APHER SCI, V53, P92, DOI 10.1016/j.transci.2015.05.015; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Mondy P, 2015, TRANSFUS APHER SCI; Na KS, 2012, J OCUL PHARMACOL TH, V28, P479, DOI 10.1089/jop.2012.0002; Noble BA, 2004, BRIT J OPHTHALMOL, V88, P647, DOI 10.1136/bjo.2003.026211; Nubling CM, 2009, TRANSFUSION, V49, P1850, DOI 10.1111/j.1537-2995.2009.02212.x; Ogawa Y, 2003, BONE MARROW TRANSPL, V31, P579, DOI 10.1038/sj.bmt.1703862; Pisella PJ, 2002, BRIT J OPHTHALMOL, V86, P418, DOI 10.1136/bjo.86.4.418; Prowse CV, 2013, VOX SANG, V104, P183, DOI 10.1111/j.1423-0410.2012.01662.x; Renn TY, 2015, VOX SANG, V109, P138, DOI 10.1111/vox.12264; Schaumberg DA, 2002, ADV EXP MED BIOL, V506, P989; Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5; Segatchian J, TRANSFUS AP IN PRESS; Seghatchian J, 2015, TRANSFUS APHER SCI, V53, P85, DOI 10.1016/j.transci.2015.05.013; Shih DTB, 2011, TRANSFUSION, V51, P770, DOI 10.1111/j.1537-2995.2010.02915.x; Smith JA, 2007, OCUL SURF, V5, P93; Stramer SL, 2014, ISBT SCI SER, V9, P30, DOI 10.1111/voxs.12070; Su CY, 2009, VOX SANG, V97, P119, DOI 10.1111/j.1423-0410.2009.01180.x; Su CY, 2008, TRANSFUSION, V48, P2414, DOI 10.1111/j.1537-2995.2008.01862.x; Tseng CL, 2015, TRANSFUS APHER SCI, V53, P95, DOI 10.1016/j.transci.2015.05.016; Tsubota K, 1999, BRIT J OPHTHALMOL, V83, P390, DOI 10.1136/bjo.83.4.390; van der Meer PF, 2015, TRANSFUS APHER SCI, V53, P99, DOI 10.1016/j.transci.2015.05.017; VANSETTEN GB, 1992, ACTA OPHTHALMOL, V70, P54; Weusten J, 2011, TRANSFUSION, V51, P203, DOI 10.1111/j.1537-2995.2010.02804.x; Xiong C, 2008, INVEST OPHTH VIS SCI, V49, P1850, DOI 10.1167/iovs.07-0720; Yamada C, 2008, TRANSFUSION, V48, P1245, DOI 10.1111/j.1537-2995.2008.01665.x; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581	58	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153573	10.1371/journal.pone.0153573	http://dx.doi.org/10.1371/journal.pone.0153573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100624	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500042
J	Neves, JV; Caldas, C; Ramos, MF; Rodrigues, PNS				Neves, Joao V.; Caldas, Carolina; Ramos, Miguel F.; Rodrigues, Pedro N. S.			Hepcidin-Dependent Regulation of Erythropoiesis during Anemia in a Teleost Fish, Dicentrarchus labrax	PLOS ONE			English	Article							IRON-METABOLISM; TRANSCRIPTION FACTORS; MITOCHONDRIAL HEME; PEPTIDE HEPCIDIN; EXPRESSION; GENE; OVERLOAD; LIVER; BMP6; INFLAMMATION	Anemia is a common disorder, characterized by abnormally low levels of red blood cells or hemoglobin. The mechanisms of anemia development and response have been thoroughly studied in mammals, but little is known in other vertebrates, particularly teleost fish. In this study, different degrees of anemia were induced in healthy European sea bass specimens (Dicentrarchus labrax) and at pre-determined time points hematological parameters, liver iron content and the expression of genes involved in iron homeostasis and hematopoiesis, with particular attention on hepcidins, were evaluated. The experimental anemia prompted a decrease in hamp1 expression in all tested organs, in accordance to an increased need for iron absorption and mobilization, with slight increases in hamp2 in the kidney and intestine. The liver was clearly the major organ involved in iron homeostasis, decreasing its iron content and showing a gene expression profile consistent with an increased iron release and mobilization. Although both the spleen and head kidney are involved in erythropoiesis, the spleen was found to assume a more preponderant role in the recovery of erythrocyte levels. The intestine was also involved in the response to anemia, through the increase of iron transporting genes. Administration of Hamp1 or Hamp2 mature peptides showed that only Hamp1 affects hematological parameters and liver iron content. In conclusion, the molecular mechanisms of response to anemia present in sea bass are similar to the ones described for mammals, with these results indicating that the two hepcidin types from teleosts assume different roles during anemia.	[Neves, Joao V.; Caldas, Carolina; Ramos, Miguel F.; Rodrigues, Pedro N. S.] Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Neves, Joao V.; Caldas, Carolina; Ramos, Miguel F.; Rodrigues, Pedro N. S.] Univ Porto, IBMC, Iron & Innate Immun, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Rodrigues, Pedro N. S.] Univ Porto, ICBAS, Rua Campo Alegre 823, P-4100 Porto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto	Neves, JV (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Porto, Portugal.; Neves, JV (corresponding author), Univ Porto, IBMC, Iron & Innate Immun, Rua Campo Alegre 823, P-4100 Porto, Portugal.	jneves@ibmc.up.pt	Neves, Jessika M. M./F-9215-2017; Mott, Tamí/I-5317-2012; Caldas, Carlos/U-7250-2019; Rodrigues, Pedro/B-3228-2008; Pereira, Ricardo J/K-7451-2017	Neves, Jessika M. M./0000-0003-3983-5171; Mott, Tamí/0000-0002-5896-4780; Caldas, Carlos/0000-0003-3547-1489; Rodrigues, Pedro/0000-0002-3799-1544; Pereira, Ricardo J/0000-0002-8076-4822; Caldas, Carolina/0000-0003-3967-6211; Lima, Sergio Maia Queiroz/0000-0001-9365-4879; Neves, Joao/0000-0003-1993-0999	FEDER-Fundo Europeu de Desenvolvimento Regional funds through COMPETE - Operational Programme for Competitiveness and Internationalization (POCI), Portugal; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao [POCI-01-0145-FEDER-007274, FCOMP-01-0124-FEDER-029339 (PTDC/MAR-BIO/3204/2012)]; FCT [SFRH/BPD/86380/2012]	FEDER-Fundo Europeu de Desenvolvimento Regional funds through COMPETE - Operational Programme for Competitiveness and Internationalization (POCI), Portugal; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the projects "Institute for Research and Innovation in Health Sciences" (POCI-01-0145-FEDER-007274) and FCOMP-01-0124-FEDER-029339 (PTDC/MAR-BIO/3204/2012). JVN is supported by FCT under the grant SFRH/BPD/86380/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen P, 1999, CURR OPIN CHEM BIOL, V3, P200, DOI 10.1016/S1367-5931(99)80033-7; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arndt S, 2010, GASTROENTEROLOGY, V138, P372, DOI 10.1053/j.gastro.2009.09.048; Barnes AC, 2011, FISH SHELLFISH IMMUN, V31, P350, DOI 10.1016/j.fsi.2011.05.027; Boldt DH, 1999, AM J MED SCI, V318, P207, DOI 10.1097/00000441-199910000-00001; Bury N, 2003, COMP BIOCHEM PHYS C, V135, P97, DOI 10.1016/S1532-0456(03)00021-8; Bury NR, 2001, J EXP BIOL, V204, P3779; CATTON WT, 1951, BLOOD, V6, P39, DOI 10.1182/blood.V6.1.39.39; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Cho YS, 2009, DEV COMP IMMUNOL, V33, P46, DOI 10.1016/j.dci.2008.07.009; Clark SF, 2008, NUTR CLIN PRACT, V23, P128, DOI 10.1177/0884533608314536; Conrad ME, 1999, AM J MED SCI, V318, P213, DOI 10.1097/00000441-199910000-00002; Darshan D, 2009, BIOMETALS, V22, P77, DOI 10.1007/s10534-008-9187-y; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; ESTEBAN MA, 1989, ARCH HISTOL CYTOL, V52, P407, DOI 10.1679/aohc.52.407; Fleming MD, 2012, J CLIN INVEST, V122, P4328, DOI 10.1172/JCI66607; Ganz T, 2005, BEST PRACT RES CL HA, V18, P171, DOI 10.1016/j.beha.2004.08.020; Ganz T, 2004, CURR OPIN HEMATOL, V11, P251, DOI 10.1097/00062752-200407000-00004; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hilton KB, 2008, GENE, V415, P40, DOI 10.1016/j.gene.2008.02.016; Hu XY, 2007, COMP IMMUNOL MICROB, V30, P55, DOI 10.1016/j.cimid.2006.10.004; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Imagawa S, 1997, BLOOD, V89, P1430, DOI 10.1182/blood.V89.4.1430; Ingley E, 2004, IUBMB LIFE, V56, P177, DOI 10.1080/15216540410001703956; Kautz L, 2011, HAEMATOL-HEMATOL J, V96, P199, DOI 10.3324/haematol.2010.031963; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nam YK, 2011, FISH SHELLFISH IMMUN, V31, P1251, DOI 10.1016/j.fsi.2011.09.007; Neves JV, 2011, FISH SHELLFISH IMMUN, V31, P1154, DOI 10.1016/j.fsi.2011.10.006; Neves JV, 2015, J IMMUNOL, V195, P2696, DOI 10.4049/jimmunol.1501153; Neves JV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-106; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pereiro R, 2012, FISH SHELLFISH IMMUN, V32, P879, DOI 10.1016/j.fsi.2012.02.016; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Rodrigues PNS, 2006, DEV COMP IMMUNOL, V30, P1156, DOI 10.1016/j.dci.2006.02.005; Saboor Muhammad, 2011, J Ayub Med Coll Abbottabad, V23, P115; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Torrance J.D., 1980, METHODS HEMATOLOGY, P104; Viatte L, 2009, BIOCHIMIE, V91, P1223, DOI 10.1016/j.biochi.2009.06.012; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Wessling-Resnick M, 1999, CRIT REV BIOCHEM MOL, V34, P285, DOI 10.1080/10409239991209318; Worthen CA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00034; Zhou JG, 2011, FISH SHELLFISH IMMUN, V30, P559, DOI 10.1016/j.fsi.2010.11.021	50	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153940	10.1371/journal.pone.0153940	http://dx.doi.org/10.1371/journal.pone.0153940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27309356	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500102
J	Wang, W; Zhang, WS; Alayi, A; Yan, C; Zhang, WW; Cao, MQ				Wang Wei; Zhang Wei-Sheng; Alayi Ahan; Yan Ci; Zhang Wei-Wen; Cao Ming-Qin			The Characteristics of TB Epidemic and TB/HIV Co-Infection Epidemic: A 2007-2013 Retrospective Study in Urumqi, Xinjiang Province, China	PLOS ONE			English	Article							SPATIAL-ANALYSIS; DRUG-USERS; TUBERCULOSIS; MIGRANTS; SHANGHAI	Objective This study was aimed to find out epidemiologic characteristic of tuberculosis (TB) cases, and Human Immunodeficiency Virus (HIV) positive cases among TB patients (TB/HIV co-infection) through demographic, temporal, and spatial study in Urumqi. Methods Descriptive statistics and multivariate logistic regression were applied to identify the epidemiologic characteristics and risk factors of TB epidemic and TB/HIV co-infection epidemic. All addresses of each TB case, TB/HIV co-infection case, and administrative street were transformed into geographical coordinate. Subsequently, the geocoded address for 82 streets was transformed into a dot map used as the basis of spatial datasets. In addition, the paper also used quantile map and the spatial scan statistic in order to identify the spatial distribution and spatial clusters of TB epidemic and TB/HIV co-infection epidemic. Result There was a declining trend of the notification rates of TB epidemic from 2007 to 2009, as well as a rising trend from 2010 to 2013. However, the notification rates of TB/HIV co-infection epidemic showed a rising trend from 2007 to 2010, and a declining trend from 2011 to 2013. Moreover, a significant share of TB epidemic and TB/HIV co-infection epidemic happened between the age of 15 to 45 years old, indicating an increase in risk of TB and TB/HIV infection. It is worth noting that the risk of HIV infection for male TB patients was 2.947 times (95% CI [2.178, 3.988]) than that of female patients. Han ethnicity and Uygur ethnicity in urban region accounted for a large proportion of total TB and TB/HIV co-infection cases. Most of the TB cases of minorities in Urumqi showed a statistically significant increase in risk of HIV infection than Han ethnicity in Urumqi. In addition, the spatial distribution of TB epidemic and TB/HIV co-infection epidemic was highly skewed. Most of the local clusters were located in urban area and rural-urban continuum where showed an increase in risk of TB and TB/HIV infection. Conclusion The epidemiologic and spatial-temporal analysis of TB epidemic and TB/HIV co-infection epidemic demonstrates a potential connection between TB and HIV in Urumqi. Demographic, temporal, geographic factors are the reasons of causing TB and TB/HIV co-infection epidemic.	[Wang Wei; Alayi Ahan; Yan Ci; Zhang Wei-Wen; Cao Ming-Qin] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Urumqi, Xinjiang, Peoples R China; [Zhang Wei-Sheng] Urumqi Ctr Dis Control & Prevent CDC, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University	Cao, MQ (corresponding author), Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Urumqi, Xinjiang, Peoples R China.	573596229@qq.com	Yin, Xue-ren/B-3893-2008; Ge, Hang/GZB-0729-2022	Yin, Xue-ren/0000-0002-1282-4432; 	Natural Science Fund of Xinjiang Uyghur Autonomous Region [2016D01C167]	Natural Science Fund of Xinjiang Uyghur Autonomous Region	This study was funded by the Natural Science Fund of Xinjiang Uyghur Autonomous Region (grant number: 2016D01C167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article was funded by the Natural Science Fund of Xinjiang Uyghur Autonomous Region (grant number: 2016D01C167). We would like to express our gratitude to anonymous peer reviewers for carefully revising our manuscript and for his or her useful comments.	Ahmed AB, 2007, THORAX, V62, P672, DOI 10.1136/thx.2006.072611; Chen YangGui, 2012, Modern Preventive Medicine, V39, P5410; Chimoyi LA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-555; Chinese Center for Disease Control Prevention, DAT REP NOT INF DIS; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Feng W, 2002, INT MIGR REV, V36, P520, DOI 10.1111/j.1747-7379.2002.tb00091.x; Vendramini SHF, 2010, REV SOC BRAS MED TRO, V43, P536, DOI 10.1590/S0037-86822010000500013; Gelaw Sifrash Meseret, 2016, Tuberc Res Treat, V2016, P6207457, DOI 10.1155/2016/6207457; Goujon-Bellec S, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-53; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; Kulldorff M, 2006, AM J PREV MED, V30, pS37, DOI 10.1016/j.amepre.2005.09.009; Li WG, 2015, TRANSPL P, V47, P2456, DOI 10.1016/j.transproceed.2015.09.017; Pereira AGL, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005470; Martinez AN, 2014, INT J ENV RES PUB HE, V11, P3937, DOI 10.3390/ijerph110403937; MIJITI Peierdun, 2016, CHIN J ANTITUBERE, V38, P93; Uthman OA, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-65; Wang LY, 2010, JAIDS-J ACQ IMM DEF, V53, pS61, DOI 10.1097/QAI.0b013e3181c7db2e; Wang YP, 2000, INT J URBAN REGIONAL, V24, P397, DOI 10.1111/1468-2427.00254; Wei XL, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-9; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Wubuli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144010; Zhang Y, 2007, J INFECTION, V54, P285, DOI 10.1016/j.jinf.2006.06.001; Zhao RL, 2009, CHIN J ANTITUBERCUL, V31, P308	24	66	72	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2016	11	10							e0164947	10.1371/journal.pone.0164947	http://dx.doi.org/10.1371/journal.pone.0164947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9OE	27768740	Green Published, gold, Green Submitted			2022-12-27	WOS:000386205400039
J	Wang, F; Chen, W; Bruening, KS; Raj, S; Larsen, DA				Wang, Fang; Chen, Wei; Bruening, Kay Stearns; Raj, Sudha; Larsen, David A.			Nutrition Screening Tools and the Prediction of Clinical Outcomes among Chinese Hospitalized Gastrointestinal Disease Patients	PLOS ONE			English	Article							MALNUTRITION; RISK; PREVALENCE; UNDERNUTRITION; SUPPORT; IDENTIFICATION; POPULATION; ADMISSION	Nutrition risk Screening 2002 (NRS-2002) and Subjective Global Assessment (SGA) are widely used screening tools but have not been compared in a Chinese population. We conducted secondary data analysis of a cross-sectional study which included 332 hospitalized gastrointestinal disease patients, collected by the Gastrointestinal department of Peking Union Medical College Hospital (PUMCH) in 2008. Results of NRS-2002 and SGA screening tools, complications, length of stay (LOS), cost, and death were measured. The agreement between the tools was assessed via Kappa (kappa) statistics. The performance of NRS-2002 and SGA in predicting LOS and cost was assessed via linear regression. The complications and death prediction of tools was assessed using receiver operating characteristic (ROC) curves. NRS-2002 and SGA identified nutrition risk at 59.0% and 45.2% respectively. Moderate agreement (kappa > 0.50) between the two tools was found among all age groups except individuals aged <= 20, which only slight agreement was found (kappa = 0.087). NRS-2002 (R square 0.130) and SGA (R square 0.140) did not perform differently in LOS prediction. The cost prediction of NRS-2002 (R square 0.198) and SGA (R square 0.190) were not significantly different. There was no difference between NRS-2002 (infectious complications: area under ROC (AUROC) = 0.615, death: AUROC = 0.810) and SGA (infectious complications: AUROC = 0.600, death: AUROC = 0.846) in predicting infectious complication and death, but NRS-2002 (0.738) seemed to perform better than SGA (0.552) in predicting non-infectious complications. The risk of malnutrition among patients was high. NRS-2002 and SGA have similar capacity to predict LOS, cost, infectious complications and death, but NRS-2002 performed better in predicting non-infectious complications.	[Wang, Fang] Peking Union Med Coll Hosp, Dept Nutr, Beijing, Peoples R China; [Chen, Wei] Peking Union Med Coll Hosp, Parenteral & Enteral Dept, Beijing, Peoples R China; [Bruening, Kay Stearns; Raj, Sudha; Larsen, David A.] Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY 13244 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Syracuse University	Larsen, DA (corresponding author), Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY 13244 USA.	dalarsen@syr.edu	Larsen, David/D-4027-2016	Larsen, David/0000-0002-1876-6536; Raj, Sudha/0000-0002-3409-5920				Baldwin C, 2004, CLIN NUTR, V23, P1267, DOI 10.1016/j.clnu.2004.07.018; Bruun LI, 1999, CLIN NUTR, V18, P141, DOI 10.1016/S0261-5614(99)80003-X; Christensson L, 2002, EUR J CLIN NUTR, V56, P810, DOI 10.1038/sj.ejcn.1601394; Edington J, 2000, CLIN NUTR, V19, P191, DOI 10.1054/clnu.1999.0121; Gout BS, 2009, NUTR DIET, V66, P206, DOI 10.1111/j.1747-0080.2009.01372.x; Jensen GL, 2010, CLIN NUTR, V29, P151, DOI 10.1016/j.clnu.2009.11.010; Jensen GL, 2009, JPEN-PARENTER ENTER, V33, P710, DOI 10.1177/0148607109344724; Kubrak C, 2007, INT J NURS STUD, V44, P1036, DOI 10.1016/j.ijnurstu.2006.07.015; Kyle UG, 2005, CURR OPIN CLIN NUTR, V8, P397, DOI 10.1097/01.mco.0000172579.94513.db; Kyle UG, 2003, CLIN NUTR, V22, P473, DOI 10.1016/S0261-5614(03)00049-9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liang XK, 2008, NUTRITION, V24, P969, DOI 10.1016/j.nut.2008.05.001; Liang XK, 2009, ASIA PAC J CLIN NUTR, V18, P54; Marshall JA, 1999, J AM DIET ASSOC, V99, P315, DOI 10.1016/S0002-8223(99)00081-4; Mason P., 2006, HOSP PHARM, V13, P353, DOI [10.7748/ns2003, DOI 10.7748/NS2003.]; Natl Alliance Infusion Therapy, 2010, NUTR CLIN PRACT, V25, P548, DOI 10.1177/0884533610378524; Pirlich M, 2006, CLIN NUTR, V25, P563, DOI 10.1016/j.clnu.2006.03.005; Putwatana P, 2005, NUTRITION, V21, P691, DOI 10.1016/j.nut.2004.10.015; Raslan M, 2010, NUTRITION, V26, P721, DOI 10.1016/j.nut.2009.07.010; Rasmussen HH, 2004, CLIN NUTR, V23, P1009, DOI 10.1016/j.clnu.2004.01.001; Sherein A.I., 2003, EGYPT J NUTR, V18, P95; Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013; Valero M.ª A., 2005, Nutr. Hosp., V20, P259; van Bokhorst-de van der Schueren MAE, 2005, EUR J CLIN NUTR, V59, P1129, DOI 10.1038/sj.ejcn.1602222; Velasco C, 2011, EUR J CLIN NUTR, V65, P269, DOI 10.1038/ejcn.2010.243; Waitzberg DL, 2001, NUTRITION, V17, P573, DOI 10.1016/S0899-9007(01)00573-1; Wei C, 2005, CHINESE J CLIN NUTR, V3; White JV, 2012, JPEN-PARENTER ENTER, V36, P275, DOI 10.1177/0148607112440285; Winter TA, 2000, EUR J GASTROEN HEPAT, V12, P191, DOI 10.1097/00042737-200012020-00010; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929; ZWEIG MH, 1993, CLIN CHEM, V39, P561	31	228	272	15	212	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159436	10.1371/journal.pone.0159436	http://dx.doi.org/10.1371/journal.pone.0159436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490480	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900010
J	Wang, WQ; Zhang, J; Ge, H; Li, SJ; Li, X; Yin, XR; Grierson, D; Chen, KS				Wang, Wen-qiu; Zhang, Jing; Ge, Hang; Li, Shao-jia; Li, Xian; Yin, Xue-ren; Grierson, Donald; Chen, Kun-song			EjMYB8 Transcriptionally Regulates Flesh Lignification in Loquat Fruit	PLOS ONE			English	Article							SECONDARY WALL BIOSYNTHESIS; CHILLING INJURY; LIGNIN BIOSYNTHESIS; DIRECT TARGET; ARABIDOPSIS; GENES; PATHWAY; EXPRESSION; MYB46; REPRESSOR	Transcriptional regulatory mechanisms underlying lignin metabolism have been widely studied in model plants and woody trees, but seldom in fruits such as loquat, which undergo lignification. Here, twelve EjMYB genes, designed as EjMYB3-14, were isolated based on RNA-seq. Gene expression indicated that EjMYB8 and EjMYB9 were significantly induced in fruit with higher lignin content resulting from storage at low temperature (0 degrees C), while two treatments (low temperature conditioning, LTC; heat treatment, HT) both alleviated fruit lignification and inhibited EjMYB8 and EjMYB9 expression. Dual-luciferase assays indicated that EjMYB8, but not EjMYB9, could trans-activate promoters of lignin-related genes EjPAL1, Ej4CL1 and Ej4CL5. Yeast one-hybrid assay indicated that EjMYB8 physically bind to Ej4CL1 promoter. Furthermore, the putative functions of EjMYB8 were verified using transient over-expression in both N. tabacum and loquat leaves, which increased lignin content. Moreover, combination of EjMYB8 and previously isolated EjMYB1 generated strong transactivation effects on the Ej4CL1 promoter, indicating that EjMYB8 is a novel regulator of loquat fruit lignification.	[Wang, Wen-qiu; Zhang, Jing; Ge, Hang; Li, Shao-jia; Li, Xian; Yin, Xue-ren; Grierson, Donald; Chen, Kun-song] Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Wen-qiu; Zhang, Jing; Li, Xian; Yin, Xue-ren; Chen, Kun-song] Zhejiang Univ, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China; [Grierson, Donald] Univ Nottingham, Plant & Crop Sci Div, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England	Zhejiang University; Zhejiang University; University of Nottingham	Yin, XR (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.; Yin, XR (corresponding author), Zhejiang Univ, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	xuerenyin@zju.edu.cn	Yin, Xue-ren/B-3893-2008; Ge, Hang/GZB-0729-2022	Yin, Xue-ren/0000-0002-1282-4432; 	Program of the International Science and Technology Cooperation [2011DFB31580]; National Basic Research Program of China [2013CB127104]; National Natural Science Foundation of China [31372041, 31471922]; Natural Science Foundation of Zhejiang Province, China [LR16C150001]	Program of the International Science and Technology Cooperation; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This research was supported by the Program of the International Science and Technology Cooperation [2011DFB31580], National Basic Research Program of China [2013CB127104], the National Natural Science Foundation of China [31372041, 31471922], and the Natural Science Foundation of Zhejiang Province, China [LR16C150001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhargava A, 2013, PLANTA, V237, P1199, DOI 10.1007/s00425-012-1821-9; Cai C, 2006, POSTHARVEST BIOL TEC, V41, P252, DOI 10.1016/j.postharvbio.2006.04.015; Cai C, 2006, POSTHARVEST BIOL TEC, V40, P155, DOI 10.1016/j.postharvbio.2005.12.014; Craven-Bartle B, 2013, PLANT J, V74, P755, DOI 10.1111/tpj.12158; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin P, 2014, FOOD BIOPROCESS TECH, V7, P2259, DOI 10.1007/s11947-013-1232-3; Kamdee C, 2014, POSTHARVEST BIOL TEC, V97, P68, DOI 10.1016/j.postharvbio.2014.06.004; Kosma DK, 2014, PLANT J, V80, P216, DOI 10.1111/tpj.12624; Legay S, 2007, PLANT SCI, V173, P542, DOI 10.1016/j.plantsci.2007.08.007; Liu XF, 2013, PLANT CELL TISS ORG, V115, P285, DOI 10.1007/s11240-013-0361-8; McCarthy RL, 2010, PLANT CELL PHYSIOL, V51, P1084, DOI 10.1093/pcp/pcq064; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Min T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097043; Ohman D, 2013, PLANT J, V73, P63, DOI 10.1111/tpj.12018; Tang XF, 2015, SCI REP-UK, V5, DOI 10.1038/srep12240; Tian J, 2015, PLANT BIOTECHNOL J, V13, P948, DOI 10.1111/pbi.12331; Velez-Bermudez IC, 2015, PLANT CELL, V27, P3245, DOI 10.1105/tpc.15.00545; Vermerris W, 2015, CURR OPIN BIOTECH, V32, P104, DOI 10.1016/j.copbio.2014.11.024; Xu Q, 2015, POSTHARVEST BIOL TEC, V102, P25, DOI 10.1016/j.postharvbio.2015.02.002; Xu Q, 2014, J EXP BOT, V65, P4349, DOI 10.1093/jxb/eru208; Yang CY, 2007, PLANT CELL, V19, P534, DOI 10.1105/tpc.106.046391; Yauk YK, 2014, PLANT J, V80, P317, DOI 10.1111/tpj.12634; Yin XR, 2012, PLANTA, V235, P895, DOI 10.1007/s00425-011-1553-2; Yin XR, 2012, POSTHARVEST BIOL TEC, V66, P1, DOI 10.1016/j.postharvbio.2011.11.009; Ying Z, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0388-y; Zeng JK, 2015, PLANT BIOTECHNOL J, V13, P1325, DOI 10.1111/pbi.12351; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	34	66	72	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2016	11	4							e0154399	10.1371/journal.pone.0154399	http://dx.doi.org/10.1371/journal.pone.0154399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5OX	27768740	Green Published, gold, Green Submitted			2022-12-27	WOS:000374970600065
J	Wang, FJ; Wang, CL; Liu, PQ; Lei, CL; Hao, W; Gao, Y; Liu, YG; Zhao, KJ				Wang, Fujun; Wang, Chunlian; Liu, Piqing; Lei, Cailin; Hao, Wei; Gao, Ying; Liu, Yao-Guang; Zhao, Kaijun			Enhanced Rice Blast Resistance by CRISPR/Cas9-Targeted Mutagenesis of the ERF Transcription Factor Gene OsERF922	PLOS ONE			English	Article							CRISPR-CAS SYSTEM; NEGATIVELY REGULATES RESISTANCE; EFFICIENT TARGETED MUTAGENESIS; TAL EFFECTOR NUCLEASES; DISEASE RESISTANCE; SALT TOLERANCE; TRANSGENIC RICE; GUIDE RNA; GENOME MODIFICATION; MAGNAPORTHE-GRISEA	Rice blast is one of the most destructive diseases affecting rice worldwide. The adoption of host resistance has proven to be the most economical and effective approach to control rice blast. In recent years, sequence-specific nucleases (SSNs) have been demonstrated to be powerful tools for the improvement of crops via gene-specific genome editing, and CRISPR/Cas9 is thought to be the most effective SSN. Here, we report the improvement of rice blast resistance by engineering a CRISPR/Cas9 SSN (C-ERF922) targeting the OsERF922 gene in rice. Twenty-one C-ERF922-induced mutant plants (42.0%) were identified from 50 T-0 transgenic plants. Sanger sequencing revealed that these plants harbored various insertion or deletion (InDel) mutations at the target site. We showed that all of the C-ERF922-induced allele mutations were transmitted to subsequent generations. Mutant plants harboring the desired gene modification but not containing the transferred DNA were obtained by segregation in the T-1 and T-2 generations. Six T-2 homozygous mutant lines were further examined for a blast resistance phenotype and agronomic traits, such as plant height, flag leaf length and width, number of productive panicles, panicle length, number of grains per panicle, seed setting percentage and thousand seed weight. The results revealed that the number of blast lesions formed following pathogen infection was significantly decreased in all 6 mutant lines compared with wild-type plants at both the seedling and tillering stages. Furthermore, there were no significant differences between any of the 6 T2 mutant lines and the wild-type plants with regard to the agronomic traits tested. We also simultaneously targeted multiple sites within OsERF922 by using Cas9/Multi-target-sgRNAs (C-ERF922S1S2 and C-ERF922S1S2S3) to obtain plants harboring mutations at two or three sites. Our results indicate that gene modification via CRISPR/Cas9 is a useful approach for enhancing blast resistance in rice.	[Wang, Fujun; Liu, Piqing] Guangxi Univ, Coll Agr, Nanning 530004, Peoples R China; [Wang, Fujun; Wang, Chunlian; Lei, Cailin; Hao, Wei; Gao, Ying; Zhao, Kaijun] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China; [Liu, Yao-Guang] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Guangxi University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; South China Agricultural University	Zhao, KJ (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China.	zhaokaijun@caas.cn	Larsen, David/D-4027-2016	Larsen, David/0000-0002-1876-6536; Raj, Sudha/0000-0002-3409-5920	Major Science and Technology Project [2014ZX0801001B]	Major Science and Technology Project	This research was supported by a grant from the Major Science and Technology Project to Create New Crop Cultivars using Gene Transfer Technology (grant number 2014ZX0801001B.	Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Bundo M, 2016, PLANT BIOTECHNOL J, V14, P1357, DOI 10.1111/pbi.12500; Cao YF, 2006, J PLANT PHYSIOL, V163, P1167, DOI 10.1016/j.jplph.2005.11.004; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen XJ, 2008, INT J MOL SCI, V9, P2601, DOI 10.3390/ijms9122601; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Du HY, 2016, J BIOTECHNOL, V217, P90, DOI 10.1016/j.jbiotec.2015.11.005; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Feng C, 2016, J GENET GENOMICS, V43, P37, DOI 10.1016/j.jgg.2015.10.002; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Ikeda T, 2015, GENES GENET SYST, V90, P231, DOI 10.1266/ggs.15-00030; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jia Y. L., 2003, Pesticide Outlook, V14, P150, DOI 10.1039/b308503c; Jiang CJ, 2009, MOL PLANT MICROBE IN, V22, P820, DOI 10.1094/MPMI-22-7-0820; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kobayashi N., 2007, WORK REP, V53, P17; Lai Y, 2013, PLANT PHYSIOL BIOCH, V62, P70, DOI 10.1016/j.plaphy.2012.10.010; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li W, 2008, MOL BREEDING, V22, P141, DOI 10.1007/s11032-008-9163-9; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Liu DF, 2012, J EXP BOT, V63, P3899, DOI 10.1093/jxb/ers079; Liu WZ, 2015, MOL PLANT, V8, P1431, DOI 10.1016/j.molp.2015.05.009; Liu WD, 2014, ANNU REV PHYTOPATHOL, V52, P213, DOI 10.1146/annurev-phyto-102313-045926; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Ma J, 2015, MOL PLANT MICROBE IN, V28, P558, DOI 10.1094/MPMI-11-14-0367-R; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Ma XL, 2015, MOL PLANT, V8, P1285, DOI 10.1016/j.molp.2015.02.012; McGinnis KM, 2010, BRIEF FUNCT GENOMICS, V9, P111, DOI 10.1093/bfgp/elp052; Miah G, 2013, MOL BIOL REP, V40, P2369, DOI 10.1007/s11033-012-2318-0; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Muller M, 2015, PLANT PHYSIOL, V169, P32, DOI 10.1104/pp.15.00677; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Postel S, 2009, SEMIN CELL DEV BIOL, V20, P1025, DOI 10.1016/j.semcdb.2009.06.002; Rojo E, 2003, J PLANT GROWTH REGUL, V22, P82, DOI 10.1007/s00344-003-0027-6; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Sherif S, 2013, PLANT CELL REP, V32, P1111, DOI 10.1007/s00299-013-1405-6; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tian ZD, 2015, PLANT CELL PHYSIOL, V56, P992, DOI 10.1093/pcp/pcv025; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Vogel MO, 2014, PLANT CELL, V26, P1151, DOI 10.1105/tpc.113.121061; Wang C, 2015, J GENET GENOMICS, V42, P703, DOI 10.1016/j.jgg.2015.09.011; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wang MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122755; Wang SH, 2015, PLANT CELL REP, V34, P1473, DOI 10.1007/s00299-015-1816-7; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Yara A, 2008, BIOCHEM BIOPH RES CO, V376, P460, DOI 10.1016/j.bbrc.2008.08.157; Yara A, 2007, PLANT CELL PHYSIOL, V48, P1263, DOI 10.1093/pcp/pcm107; Zhang H, 2016, PLANT BIOTECHNOL J, V14, P186, DOI 10.1111/pbi.12372; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhu JJ, 2016, J GENET GENOMICS, V43, P25, DOI 10.1016/j.jgg.2015.10.006	83	228	272	15	212	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154027	10.1371/journal.pone.0154027	http://dx.doi.org/10.1371/journal.pone.0154027			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27490480	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600037
J	Neves, JMM; Lima, SMQ; Mendes, LF; Torres, RA; Pereira, RJ; Mott, T				Neves, Jessika M. M.; Lima, Sergio M. Q.; Mendes, Liana F.; Torres, Rodrigo A.; Pereira, Ricardo J.; Mott, Tami			Population Structure of the Rockpool Blenny Entomacrodus vomerinus Shows Source-Sink Dynamics among Ecoregions in the Tropical Southwestern Atlantic	PLOS ONE			English	Article							REEF FISH; LARVAL DISPERSAL; PHYLOGEOGRAPHY; BIOGEOGRAPHY; NEUTRALITY; TELEOSTEI; MIGRATION; PATTERNS; GENETICS; COASTAL	The Tropical Southwestern Atlantic is characterized by prominent ecosystems with large-scale oceanographic complexity. Yet, the evolutionary processes underlying genetic differentiation and connectivity in this region remain largely unknown. Entomacrodus vomerinus (Valenciennes, 1836) is a demersal fish with planktonic larvae endemic to this marine province, inhabiting shallow tidal pools in continental and oceanic reef environments. We evaluated the population structure, genetic diversity and gene flow of E. vomerinus using mitochondrial data (CYTB and COI) and nuclear (rhodopsin, RHO) DNA sequences. We sampled a total of 85 individuals, comprising 46 from three oceanic archipelagos with varying distance from the coast (Sao Pedro and Sao Paulo-SS, Fernando de Noronha-FE and Rocas Atoll-RA) and 39 from two localities in northeastern Brazilian coast (Rio Grande do Norte-RN and Bahia-BA). Multilocus analysis revealed the presence of three Evolutionarily Significant Units-ESUs (SS, FE+RA, and RN+BA), which are in accordance with distinct marine ecoregions. Coalescent analyses showed that the central ESU has a larger effective population size than the other two, suggesting strong asymmetries in the genetic diversity across the species range. Moreover, they showed that gene flow is highly asymmetric, suggesting a source-sink dynamics from the central ESU into the remaining ones, in agreement with oceanic currents. Together, these results provide insights in the evolutionary mechanisms facilitating diversification in this marine province.	[Neves, Jessika M. M.; Mott, Tami] Univ Fed Alagoas, Setor Biodiversidade, Lab Diversidade Mol, Maceio, Alagoas, Brazil; [Lima, Sergio M. Q.] Univ Fed Rio Grande do Norte, Dept Bot & Zool, Lab Ictiol Sistemat & Evolut, BR-59072970 Natal, RN, Brazil; [Mendes, Liana F.] Univ Fed Rio Grande do Norte, Dept Ecol, Lab Oceano, BR-59072970 Natal, RN, Brazil; [Torres, Rodrigo A.] Univ Fed Pernambuco, Dept Zool, Lab Genom Evolutiva & Ambiental, Recife, PE, Brazil; [Pereira, Ricardo J.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	Universidade Federal de Alagoas; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal de Pernambuco; University of Copenhagen	Neves, JMM (corresponding author), Univ Fed Alagoas, Setor Biodiversidade, Lab Diversidade Mol, Maceio, Alagoas, Brazil.	neves.jmm@gmail.com	Neves, Jessika M. M./F-9215-2017; Mott, Tamí/I-5317-2012; Caldas, Carlos/U-7250-2019; Rodrigues, Pedro/B-3228-2008; Pereira, Ricardo J/K-7451-2017	Neves, Jessika M. M./0000-0003-3983-5171; Mott, Tamí/0000-0002-5896-4780; Caldas, Carlos/0000-0003-3547-1489; Rodrigues, Pedro/0000-0002-3799-1544; Pereira, Ricardo J/0000-0002-8076-4822; Caldas, Carolina/0000-0003-3967-6211; Lima, Sergio Maia Queiroz/0000-0001-9365-4879; Neves, Joao/0000-0003-1993-0999	Fundacao Universitaria de Desenvolvimento de Extensao e Pesquisa (Fundepes); Financiadora de Estudos e Projetos (FINEP) [1312/10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301208/2012-3]; European Union's Horizon research and innovation program under the Marie Sklodowska-Curie (MSCA) [658706]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Universitaria de Desenvolvimento de Extensao e Pesquisa (Fundepes); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Union's Horizon research and innovation program under the Marie Sklodowska-Curie (MSCA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by Fundacao Universitaria de Desenvolvimento de Extensao e Pesquisa (Fundepes - http://www.fundepes.br/) and Financiadora de Estudos e Projetos (FINEP - http://www.finep.gov.br/) grant #1312/10 (TM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - http://www.cnpq.br/) grant #301208/2012-3 (RAT); and the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie (MSCA - http://ec.europa.eu/research/mariecurieactions/index_en.htm) grant #658706 (RJP). Scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - http://www.capes.gov.br/) (JMMN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Baldwin CC, 2009, ZOOTAXA, P1; Barroso R, 2010, MAR BIOL, V157, P69, DOI 10.1007/s00227-009-1296-9; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cruzan MB, 2000, TRENDS ECOL EVOL, V15, P491, DOI 10.1016/S0169-5347(00)01998-4; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EDWARDS A, 1983, J BIOGEOGR, V10, P65, DOI 10.2307/2844583; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feitoza Bertran M., 2003, Aqua (Miradolo Terme), V7, P61; Fitzpatrick BM, 2009, MOL ECOL, V18, P3961, DOI 10.1111/j.1365-294X.2009.04314.x; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Francisco SM, 2011, J EXP MAR BIOL ECOL, V403, P14, DOI 10.1016/j.jembe.2011.03.020; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2015, MOL ECOL, V24, P1543, DOI 10.1111/mec.13129; Gama-Maia DJ, 2016, J MAR BIOL ASSOC UK, V96, P1677, DOI 10.1017/S0025315415002052; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Jacobina UP, 2014, HELGOLAND MAR RES, V68, P17, DOI 10.1007/s10152-013-0365-0; Joyeux JC, 2001, J BIOGEOGR, V28, P831, DOI 10.1046/j.1365-2699.2001.00602.x; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Leao Zelinda M. A. N., 2000, Marine Pollution Bulletin, V41, P112, DOI 10.1016/S0025-326X(00)00105-3; Leao ZMAN, 2005, MAR POLLUT BULL, V51, P599, DOI 10.1016/j.marpolbul.2005.04.024; Leigh JW, POPART POPULATION AN; Macedo-Soares LCP, 2012, MAR ECOL PROG SER, V444, P207, DOI 10.3354/meps09436; Macieira RM, 2015, ENVIRON BIOL FISH, V98, P385, DOI 10.1007/s10641-014-0269-0; Mai ACG, 2014, ESTUAR COAST SHELF S, V149, P80, DOI 10.1016/j.ecss.2014.07.013; Medeiros Paulo R., 2007, Pan-American Journal of Aquatic Sciences, V2, P288; Mendes LF, 2000, THESIS; Mendes LD, 2006, REV BRAS ZOOL, V23, P817, DOI 10.1590/S0101-81752006000300029; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Motoki A, 2009, REM-REV ESC MINAS, V62, P331, DOI 10.1590/S0370-44672009000300011; Muss A, 2001, EVOLUTION, V55, P561, DOI 10.1554/0014-3820(2001)055[0561:POOTRO]2.0.CO;2; Nanninga GB, 2014, MOL ECOL, V23, P591, DOI 10.1111/mec.12623; Nielsen R, 2001, GENETICS, V158, P885; Paiva Maria Isabel G., 2015, Pan-American Journal of Aquatic Sciences, V10, P19; Pinheiro HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118180; Pringle JM, 2001, P NATL ACAD SCI USA, V108, P15288; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rangel Carlos A., 2010, Revista Brasileira de Zoociencias, V12, P17; Rangel CA, 2009, ZOOTAXA, P51, DOI 10.11646/zootaxa.2006.1.4; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Rodriguez-Rey GT, 2016, J EXP MAR BIOL ECOL, V474, P204, DOI 10.1016/j.jembe.2015.10.016; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Sacramento LA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/264270; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; SMITH MF, 1993, BIOL J LINN SOC, V50, P149, DOI 10.1111/j.1095-8312.1993.tb00924.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stephens M, 2004, DOCUMENTATION PHASE, P35; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Ward Robert D, 2012, Methods Mol Biol, V858, P423, DOI 10.1007/978-1-61779-591-6_21; Wares JP, 2001, EVOLUTION, V55, P295; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Williams JT, 2014, ENTOMACRODUS VOMERIN, DOI [10.2305/IUCN.UK.2014-3.RLTS.T185176A1776911.en, DOI 10.2305/IUCN.UK.2014-3.RLTS.T185176A1776911.EN]	65	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157472	10.1371/journal.pone.0157472	http://dx.doi.org/10.1371/journal.pone.0157472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309356	Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800079
